Citrus Sinensis ID: 005224
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 707 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGD7 | 953 | Probable LRR receptor-lik | yes | no | 0.991 | 0.735 | 0.691 | 0.0 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.973 | 0.717 | 0.515 | 0.0 | |
| Q9LFG1 | 937 | Putative leucine-rich rep | no | no | 0.966 | 0.728 | 0.502 | 0.0 | |
| Q9LT96 | 946 | Probable leucine-rich rep | no | no | 0.888 | 0.663 | 0.356 | 5e-87 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.437 | 0.363 | 0.461 | 8e-71 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.396 | 0.327 | 0.474 | 1e-68 | |
| Q9FLW0 | 824 | Probable receptor-like pr | no | no | 0.411 | 0.353 | 0.447 | 3e-68 | |
| Q9T020 | 878 | Probable receptor-like pr | no | no | 0.393 | 0.316 | 0.493 | 5e-68 | |
| Q9FID8 | 873 | Putative receptor-like pr | no | no | 0.574 | 0.465 | 0.369 | 2e-67 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.893 | 0.542 | 0.292 | 2e-67 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 1013 bits (2619), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/709 (69%), Positives = 587/709 (82%), Gaps = 8/709 (1%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
MSKLLK+SLRNCSLQGP+PDLS IPNLGYLDLS NQLNGSIP G+LS +ITTI LSNN L
Sbjct: 251 MSKLLKMSLRNCSLQGPVPDLSSIPNLGYLDLSQNQLNGSIPAGKLSDSITTIDLSNNSL 310
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
TGTIP+NFSGLPRLQ+L +ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG
Sbjct: 311 TGTIPTNFSGLPRLQKLSLANNALSGSIPSRIWQERELNSTESIIVDLRNNGFSNISGRS 370
Query: 121 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDD-NEIDRSTNSTLDCRAQSCPTDYEYSPT 179
++ PNVTV L+GNP C + N + CG +++D N+ ++N+T+ CP YE+SP
Sbjct: 371 DLRPNVTVWLQGNPLCSDGNLLRLCGPITEEDINQGSTNSNTTI---CSDCPPPYEFSPE 427
Query: 180 SPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRL 239
RCFCAAPLLVGYRLKSPG S F Y++ FE+Y+TSGL LNLYQL +DSF+W+KGPRL
Sbjct: 428 PLRRCFCAAPLLVGYRLKSPGFSDFVPYRSEFEQYITSGLSLNLYQLRLDSFQWQKGPRL 487
Query: 240 KMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDV 299
+MYLK FPV+ +++ NS++FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRDV
Sbjct: 488 RMYLKFFPVFGSNANNSFIFNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDV 547
Query: 300 FPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKI 359
FP + SG+S A+AGI+LG++A AVT++AI++L+I+R M+ Y A++RR+ SSK S+KI
Sbjct: 548 FPSASPSGLSNGAVAGIVLGSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLKI 607
Query: 360 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL 419
+GV+SFTY E+ALAT+NFNSSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEFL
Sbjct: 608 EGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFL 667
Query: 420 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 479
TEI+ LSRLHHRNLVSL+G+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL IA
Sbjct: 668 TEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIA 727
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
LGS++GILYLHTEA+PP+FHRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P HV
Sbjct: 728 LGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHV 787
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599
STVVKGTPGYLDPEYFLTH+LTDKSDVYSLGVV LEL TGMQPI+HGKNIVRE+NIAY+S
Sbjct: 788 STVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIAYES 847
Query: 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT- 658
+ S +D M S P EC+EKF LAL+CC++ETDARPSM+EV+RELE IW +MPES
Sbjct: 848 GSILSTVDKRMSSVPDECLEKFATLALRCCREETDARPSMAEVVRELEIIWELMPESHVA 907
Query: 659 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 707
KT + T + S+SS++KH Y S DVSGS+LVSGV P++ PR
Sbjct: 908 KTADL---SETMTHPSSSSNSSIMKHHYTSMDVSGSDLVSGVAPSVAPR 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 696 bits (1796), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/728 (51%), Positives = 497/728 (68%), Gaps = 40/728 (5%)
Query: 4 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGT 63
L+KLSLRNC+L+GP+PDLS+ L YLD+SSN+L G IP + S NITTI L NN L+G+
Sbjct: 248 LVKLSLRNCNLEGPIPDLSKSLVLYYLDISSNKLTGEIPKNKFSANITTINLYNNLLSGS 307
Query: 64 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NI 122
IPSNFSGLPRLQRL + NN+LSG IP IW++R L A E ILD +NN +N+S N
Sbjct: 308 IPSNFSGLPRLQRLQVQNNNLSGEIPV-IWENRILKAEEKLILDLRNNMFSNVSSVLLNP 366
Query: 123 PPNVTVRLRGNPFCLNTNAEQF---CG--SHSDDDNEIDRSTNSTLDCRAQSCPT--DYE 175
P NVTV+L GNP C N NA + CG + + T ST DC+ QSCP +Y+
Sbjct: 367 PSNVTVKLYGNPVCANVNAGKLADLCGISTLEVESPATSSETISTGDCKRQSCPVSENYD 426
Query: 176 YSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYK--NLFEEYMTSGLKLNLYQLDIDSFRW 233
Y SP+ CFCAAPL + RL+SP S F YK + + L +N YQ+ ID+F W
Sbjct: 427 YVIGSPVACFCAAPLGIDLRLRSPSFSDFRPYKVSYMLDVASPKNLGINPYQISIDTFAW 486
Query: 234 EKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQ 293
+ GPRL M +K+FP Y S NS FN++EV RI F + + D GPYE+I+
Sbjct: 487 QSGPRLFMNMKIFPEY--SELNSK-FNSTEVQRIVDFFATFTLNTDDSLGPYEIISIN-T 542
Query: 294 GPYRDV---FPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIV----------RAHM 340
G Y+DV FP + SG+S GII+GAIA + +S++ + + M
Sbjct: 543 GAYKDVTIIFP--KKSGMSIGVSVGIIIGAIAFFLVLSSLALVFFIKRSKRKRKTREVDM 600
Query: 341 KNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGT 400
+ H + K + ++ V+ + + E+ AT++F+ +QIG+GGYGKVYKG LP G
Sbjct: 601 EQEHPLP------KPPMNMESVKGYNFTELDSATSSFSDLSQIGRGGYGKVYKGHLPGGL 654
Query: 401 VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD 460
VVAVKRA++GSLQG+KEF TEI+ LSRLHHRNLVSL+GYCD++GEQMLVYE+M NG+L+D
Sbjct: 655 VVAVKRAEQGSLQGQKEFFTEIELLSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGSLQD 714
Query: 461 QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 520
LSA+ ++PL A+RL IALGS+RGILYLHTEADPP+ HRDIK SNILLD K KVADF
Sbjct: 715 ALSARFRQPLSLALRLRIALGSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKVADF 774
Query: 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM 580
G+S+L + D G+ HV+T+VKGTPGY+DPEY+L+H+LT+KSDVYSLG+VFLE+LTGM
Sbjct: 775 GISKLIAL-DGGGVQRDHVTTIVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILTGM 833
Query: 581 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 640
+PISHG+NIVREVN A + MM SVID +MG Y ECV++F++LA++CCQD +ARP M
Sbjct: 834 RPISHGRNIVREVNEACDAGMMMSVIDRSMGQYSEECVKRFMELAIRCCQDNPEARPWML 893
Query: 641 EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS-SDVSGSNLVSG 699
E++RELE+I+ ++P+ + P S +S + + + Y + S+ + + LVSG
Sbjct: 894 EIVRELENIYGLIPKEE--KPYSSPSVQSSASGMSGFAVASPRSSYTTFSEFTANQLVSG 951
Query: 700 VIPTITPR 707
VIP+I PR
Sbjct: 952 VIPSIAPR 959
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFG1|Y3359_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At3g53590 OS=Arabidopsis thaliana GN=At3g53590 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 649 bits (1673), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/715 (50%), Positives = 452/715 (63%), Gaps = 32/715 (4%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
S+L+KLSLRNC LQG +PDLSRI NL YLDLS N L G+IP +LS N+TTI+LS N L
Sbjct: 247 FSRLVKLSLRNCGLQGSIPDLSRIENLSYLDLSWNHLTGTIPESKLSDNMTTIELSYNHL 306
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
TG+IP +FS L LQ L + NNSLSGS+P+ IWQ ++ + + D NNN ++ +G+
Sbjct: 307 TGSIPQSFSDLNSLQLLSLENNSLSGSVPTEIWQDKSFENNKLQVYDL-NNNFSDATGNL 365
Query: 121 NIPPNVTVRLRGNPFCLNTNA-------EQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTD 173
P NVT+ LRGNP C +T+ E CG STNS C SCP
Sbjct: 366 RTPDNVTLYLRGNPICKSTSIPMVTQFFEYICGEKKQT------STNSNTPCSNVSCP-- 417
Query: 174 YEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAY-KNLFEEYMTSGLKLNLYQLDIDSFR 232
+E SP C C APL + YRLKSP +F Y + F EY+TS L+L +QL ID
Sbjct: 418 FENVKVSPGICLCTAPLSIDYRLKSPSFFFFTPYIERQFREYITSSLQLETHQLAIDRLV 477
Query: 233 WEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTL 292
E R +MYLKL P FN SEV RIR F W+ +D FGPYEL++F L
Sbjct: 478 DENRLRPRMYLKLVP------KGRITFNKSEVIRIRDRFMSWSFNKTDFFGPYELLDFPL 531
Query: 293 QGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHS 352
QGPY D+ ++ SGI I+ G++ A +S +LL VR +N H ++++R
Sbjct: 532 QGPYADLL--AQTSGIRTIVWMMIVAGSVVAATVLSVTATLLYVRKRRENSHTLTKKRVF 589
Query: 353 SKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL 412
S +I GV+ F++ E++ ATN F+SST IG+G YGKVYKGIL + T VA+KR +E SL
Sbjct: 590 RTISREIKGVKKFSFVELSDATNGFDSSTLIGRGSYGKVYKGILSNKTEVAIKRGEETSL 649
Query: 413 QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF 472
Q EKEFL EI LSRLHHRNLVSL+GY + GEQMLVYE+M NG +RD LSA + + L F
Sbjct: 650 QSEKEFLNEIDLLSRLHHRNLVSLIGYSSDIGEQMLVYEYMPNGNVRDWLSANAADTLSF 709
Query: 473 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532
+MR +ALGS++GILYLHTEA+PPV HRDIK SNILLD + AKVADFGLSRLAP
Sbjct: 710 SMRSHVALGSAKGILYLHTEANPPVIHRDIKTSNILLDCQLHAKVADFGLSRLAPAFGEG 769
Query: 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 592
PAHVSTVV+GTPGYLDPEYF+T +LT +SDVYS GVV LELLTGM P G +I+RE
Sbjct: 770 DGEPAHVSTVVRGTPGYLDPEYFMTQQLTVRSDVYSFGVVLLELLTGMHPFFEGTHIIRE 829
Query: 593 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652
V A + + SV D MG + V+K +LAL CC+D + RP MS+V++ELE I
Sbjct: 830 VRTANECGTVLSVADSRMGQCSPDKVKKLAELALWCCEDRPETRPPMSKVVKELEGICQS 889
Query: 653 MPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 707
+ E PE + T+K +S S P S + GSNL SG + PR
Sbjct: 890 VRE-----PEMFS--ETTKLLCSKTSPSSSSVPSPLSLLPGSNLDSGFFHAVKPR 937
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LT96|Y5977_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g49770 OS=Arabidopsis thaliana GN=At5g49770 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (826), Expect = 5e-87, Method: Compositional matrix adjust.
Identities = 246/690 (35%), Positives = 376/690 (54%), Gaps = 62/690 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNN 58
++ L +L L + G +P+L+ + +L LD+S+N L S P + +++T++L +
Sbjct: 268 LTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPSWIPFLNSLSTLRLEDI 327
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
+L G +P++ +LQ + + +N ++ ++ S+ L+ +D ++N +T
Sbjct: 328 QLDGPVPTSLFSPLQLQTVSLKHNLINTTLDLGTNYSKQLD-----FVDLRDNFITGYKS 382
Query: 119 SFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEID-RSTNSTLDCRAQSCPTDYEYS 177
N P V V L N C + A Q G N + ST STL C E +
Sbjct: 383 PANNP--VNVMLADNQVCQDP-ANQLSGYC----NAVQPNSTFSTLTKCGNHCGKGKEPN 435
Query: 178 PTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNL--FEEYMTSGLKLNLYQLDIDSFR-WE 234
C C PL + L+SP S F N F E + + K Y +D + R
Sbjct: 436 QG----CHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNGKYPVDSVAMRNIS 491
Query: 235 KGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFT 291
+ P L + L +FP SG FN +E+ I S FT + FGPY +
Sbjct: 492 ENPTDYHLLINLLIFP-----SGRDR-FNQTEMDSINSAFTIQDYKPPPRFGPYIFV--- 542
Query: 292 LQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRH 351
Y+ F +S + ++ + + + A+ + +R + A +
Sbjct: 543 -ADQYK-TFSDLEDSKTVSMKVIIGVVVGVVVLLLLLALAGIYALRQKKRAQRATDQMNP 600
Query: 352 SSK--------TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVA 403
+K + ++ G ++FT+ E++ TNNF+ + +G GGYG+VYKG LP+G V+A
Sbjct: 601 FAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIA 660
Query: 404 VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 463
+KRAQ+GS+QG EF TEI+ LSR+HH+N+V L+G+C ++ EQMLVYE++ NG+LRD LS
Sbjct: 661 IKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLS 720
Query: 464 AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523
K+ L + RL IALGS +G+ YLH ADPP+ HRD+K++NILLD TAKVADFGLS
Sbjct: 721 GKNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLS 780
Query: 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 583
+L P+ AHV+T VKGT GYLDPEY++T++LT+KSDVY GVV LELLTG PI
Sbjct: 781 KLVGDPE-----KAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPI 835
Query: 584 SHGKNIVREV--------NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDA 635
G +V+EV N+ ++ + I N G+ + EK++ +AL+C + E
Sbjct: 836 DRGSYVVKEVKKKMDKSRNLYDLQELLDTTIIQNSGNL--KGFEKYVDVALQCVEPEGVN 893
Query: 636 RPSMSEVMRELESIWNMM---PESDTKTPE 662
RP+MSEV++ELESI ++ P +D+ T E
Sbjct: 894 RPTMSEVVQELESILRLVGLNPNADSATYE 923
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (686), Expect = 8e-71, Method: Compositional matrix adjust.
Identities = 149/323 (46%), Positives = 200/323 (61%), Gaps = 14/323 (4%)
Query: 363 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 422
R FT E+ AT NF+ IG GG+GKVY+G L DGT++A+KRA S QG EF TEI
Sbjct: 506 RKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETEI 565
Query: 423 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 482
LSRL HR+LVSL+G+CDE E +LVYE+M+NGTLR L + PL + RL +GS
Sbjct: 566 VMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGS 625
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 542
+RG+ YLHT ++ + HRD+K +NILLD F AK++DFGLS+ P D HVST
Sbjct: 626 ARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMD-----HTHVSTA 680
Query: 543 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS----HGKNIVREVNIAYQ 598
VKG+ GYLDPEYF +LT+KSDVYS GVV E + I+ + + E +++Q
Sbjct: 681 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQ 740
Query: 599 SSM-MFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 656
+ S+ID N+ G+Y E +EK+ ++A KC DE RP M EV+ LE + + E+
Sbjct: 741 KQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIH-EA 799
Query: 657 DTKTPEFINSEHTSK--EETPPS 677
+ NS +S+ EE P S
Sbjct: 800 WLRKQNGENSFSSSQAVEEAPES 822
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 138/291 (47%), Positives = 184/291 (63%), Gaps = 11/291 (3%)
Query: 363 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 422
R F + E+ ATN F+ S+ +G GG+G+VYKG L DGT VAVKR S QG EF TEI
Sbjct: 496 RCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEI 555
Query: 423 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 482
+ LS+L HR+LVSL+GYCDE E +LVYE+M+NG LR L PL + RL I +G+
Sbjct: 556 EMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGA 615
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 542
+RG+ YLHT A + HRD+K +NILLD AKVADFGLS+ P D HVST
Sbjct: 616 ARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLD-----QTHVSTA 670
Query: 543 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT---GMQPISHGKNI-VREVNIAYQ 598
VKG+ GYLDPEYF +LT+KSDVYS GVV +E+L + P+ + + + E +A+Q
Sbjct: 671 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQ 730
Query: 599 SS-MMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
++ ++D N+ G ++KF + A KC + RPSM +V+ LE
Sbjct: 731 KKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLE 781
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (663), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 136/304 (44%), Positives = 186/304 (61%), Gaps = 13/304 (4%)
Query: 366 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFL 425
++ E+ TNNF+ S IG GG+G V++G L D T VAVKR GS QG EFL+EI L
Sbjct: 478 SFAELQSGTNNFDRSLVIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITIL 537
Query: 426 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 485
S++ HR+LVSLVGYC+E+ E +LVYE+M G L+ L + PL + RL + +G++RG
Sbjct: 538 SKIRHRHLVSLVGYCEEQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARG 597
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
+ YLHT + + HRDIK++NILLD+ + AKVADFGLSR P D HVST VKG
Sbjct: 598 LHYLHTGSSQGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCID-----ETHVSTGVKG 652
Query: 546 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA------YQS 599
+ GYLDPEYF +LTDKSDVYS GVV E+L +P + +VN+A +
Sbjct: 653 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA-RPAVDPLLVREQVNLAEWAIEWQRK 711
Query: 600 SMMFSVIDGNMGSYPSEC-VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 658
M+ ++D N+ C ++KF + A KCC D RP++ +V+ LE + +
Sbjct: 712 GMLDQIVDPNIADEIKPCSLKKFAETAEKCCADYGVDRPTIGDVLWNLEHVLQLQESGPL 771
Query: 659 KTPE 662
PE
Sbjct: 772 NIPE 775
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 5e-68, Method: Compositional matrix adjust.
Identities = 144/292 (49%), Positives = 184/292 (63%), Gaps = 14/292 (4%)
Query: 363 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 422
R F+ E+ AT NF +S IG GG+G VY G L DGT VAVKR S QG EF TEI
Sbjct: 512 RYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEI 571
Query: 423 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 482
Q LS+L HR+LVSL+GYCDE E +LVYEFMSNG RD L K+ PL + RL I +GS
Sbjct: 572 QMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGS 631
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 542
+RG+ YLHT + HRD+K++NILLD AKVADFGLS+ D+ HVST
Sbjct: 632 ARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK-----DV-AFGQNHVSTA 685
Query: 543 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA------ 596
VKG+ GYLDPEYF +LTDKSDVYS GVV LE L +P + + +VN+A
Sbjct: 686 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCA-RPAINPQLPREQVNLAEWAMQW 744
Query: 597 YQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
+ ++ +ID ++ G+ E ++KF + A KC +D RP+M +V+ LE
Sbjct: 745 KRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLE 796
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 172/466 (36%), Positives = 245/466 (52%), Gaps = 60/466 (12%)
Query: 226 LDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSY-------------------VFNASEVGR 266
L++D FR G + MYL + + SG + + N E+ +
Sbjct: 345 LEMDVFRMSGGSWIPMYLDYTVIAGSGSGRRHDLRLDLHPLVSINPKYYDAILNGVEILK 404
Query: 267 IRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGI--SKAALAGIILGAIAGA 324
+ N PD ++ GP L P D+ P I +K+ + I L +
Sbjct: 405 M-------NDPDGNLAGPNPD---PLVSP--DLIPNRATPRIRKNKSHILPITLAVVGSL 452
Query: 325 VTISA-IVSLLIVRAHMKNY------------HAISRRRHSSKTSIKIDGVRSFTYGEMA 371
V ++ +V +L++ K H S+ D R F+ E+
Sbjct: 453 VVLAMFVVGVLVIMKKKKKSKPSTNSSWCPLPHGTDSTNTKPAKSLPADLCRRFSIFEIK 512
Query: 372 LATNNFNSSTQIGQGGYGKVYKGILPDG-TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH 430
ATN+F IG GG+G VYKG + G T+VAVKR + S QG KEF TE++ LS+L H
Sbjct: 513 SATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFETELEMLSKLRH 572
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE---PLGFAMRLSIALGSSRGIL 487
+LVSL+GYCDE+ E +LVYE+M +GTL+D L + K PL + RL I +G++RG+
Sbjct: 573 VHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLEICIGAARGLQ 632
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
YLHT A + HRDIK +NILLD F KV+DFGLSR+ P + HVSTVVKGT
Sbjct: 633 YLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSASQ----THVSTVVKGTF 688
Query: 548 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG----MQPI-SHGKNIVREVNIAYQSSMM 602
GYLDPEY+ LT+KSDVYS GVV LE+L MQ + +++R V Y+ +
Sbjct: 689 GYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVKSNYRRGTV 748
Query: 603 FSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
+ID ++ + S +EKF ++A++C QD RP M++V+ LE
Sbjct: 749 DQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPMNDVVWALE 794
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 257 bits (657), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 225/769 (29%), Positives = 347/769 (45%), Gaps = 137/769 (17%)
Query: 14 LQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-------------------------- 46
L GP+P ++ +PNL L + +N L G+IP G
Sbjct: 438 LTGPIPKEIWMLPNLSDLVMWANNLTGTIPEGVCVKGGNLETLILNNNLLTGSIPESISR 497
Query: 47 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 106
N+ I LS+N+LTG IPS L +L L + NNSLSG++P + ++L L
Sbjct: 498 CTNMIWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSL-----IWL 552
Query: 107 DFQNNNLT-NISGSFNIPPNV----TVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNS 161
D +NNLT ++ G + +V + F N G+ + E R+
Sbjct: 553 DLNSNNLTGDLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERL 612
Query: 162 TLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYF--PAYKNLFEEYMTSGL 219
SCP YS + + F A ++ + + +S F P Y N+ Y+
Sbjct: 613 ERLPMVHSCPATRIYSGMT-MYTFSANGSMIYFDISYNAVSGFIPPGYGNM--GYLQV-- 667
Query: 220 KLNLYQLDI-----DSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGW 274
LNL I DSF LK V D S N + +G + S +
Sbjct: 668 -LNLGHNRITGTIPDSFGG---------LKAIGVLDLSHNNLQGYLPGSLGSL-SFLSDL 716
Query: 275 NIPDSDIFGPYELINFTLQGPYRDVFPPSR---NSGI----------------------S 309
++ ++++ GP G FP SR NSG+
Sbjct: 717 DVSNNNLTGPIPF------GGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIHAK 770
Query: 310 KAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRH------SSKTSIKIDGV- 362
K +A ++ IA + ++ + + R R ++ S S K+ V
Sbjct: 771 KQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVP 830
Query: 363 --------------RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQ 408
R T+ + ATN F++ T +G GG+G+VYK L DG+VVA+K+
Sbjct: 831 EPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLI 890
Query: 409 EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE 468
+ QG++EF+ E++ + ++ HRNLV L+GYC E++LVYE+M G+L L KS +
Sbjct: 891 RITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSK 950
Query: 469 P----LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524
L +A R IA+G++RG+ +LH P + HRD+K+SN+LLD F A+V+DFG++R
Sbjct: 951 KGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMAR 1010
Query: 525 LAPVPDIEGIVPAHVS-TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 583
L D H+S + + GTPGY+ PEY+ + + T K DVYS GV+ LELL+G +PI
Sbjct: 1011 LVSALD------THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPI 1064
Query: 584 SHGK-----NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF--IKLALKCCQDETDAR 636
G+ N+V Y+ ++D + + S VE F +K+A +C D R
Sbjct: 1065 DPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKR 1124
Query: 637 PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 685
P+M ++M M E T E + + S +ETP S K P
Sbjct: 1125 PTMIQLMA-------MFKEMKADTEEDESLDEFSLKETPLVEESRDKEP 1166
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 707 | ||||||
| 225434309 | 959 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.733 | 0.752 | 0.0 | |
| 297745743 | 960 | unnamed protein product [Vitis vinifera] | 0.992 | 0.731 | 0.748 | 0.0 | |
| 297848960 | 941 | predicted protein [Arabidopsis lyrata su | 0.992 | 0.746 | 0.701 | 0.0 | |
| 334182352 | 953 | putative leucine-rich repeat transmembra | 0.991 | 0.735 | 0.691 | 0.0 | |
| 224146594 | 865 | predicted protein [Populus trichocarpa] | 0.991 | 0.810 | 0.710 | 0.0 | |
| 224124832 | 926 | predicted protein [Populus trichocarpa] | 0.995 | 0.760 | 0.696 | 0.0 | |
| 356569432 | 953 | PREDICTED: probable LRR receptor-like se | 0.988 | 0.733 | 0.685 | 0.0 | |
| 357460549 | 955 | hypothetical protein MTR_3g062590 [Medic | 0.987 | 0.730 | 0.683 | 0.0 | |
| 356537716 | 954 | PREDICTED: probable LRR receptor-like se | 0.990 | 0.733 | 0.680 | 0.0 | |
| 147789396 | 782 | hypothetical protein VITISV_043541 [Viti | 0.994 | 0.898 | 0.674 | 0.0 |
| >gi|225434309|ref|XP_002276020.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1079 bits (2790), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/708 (75%), Positives = 600/708 (84%), Gaps = 5/708 (0%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
MSKLLKLSLRNCSLQG +P+LS+IP LGYLDLSSNQLNG+IPPGR S NITTI LSNN L
Sbjct: 256 MSKLLKLSLRNCSLQGEIPNLSKIPYLGYLDLSSNQLNGTIPPGRFSENITTIDLSNNNL 315
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
TGTIP+NFSGLP LQ+L + NNSLSG++ SSIWQ+RT N ET+++DFQNN+L+NISG+
Sbjct: 316 TGTIPANFSGLPHLQKLSLENNSLSGTVSSSIWQNRTSNGNETYVVDFQNNDLSNISGTL 375
Query: 121 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTS 180
++P NVTVRL GNP C N + QFCGS S+++N+ NST+DC A CP YE SP S
Sbjct: 376 DLPLNVTVRLYGNPLCTNESLVQFCGSQSEEENDTLNPVNSTVDCTAVRCPLYYEISPAS 435
Query: 181 PIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLK 240
C CAAPLLVGYRLKSPG S F AY+N+FE Y+TSGL LNL QL IDS WEKGPRLK
Sbjct: 436 LEICLCAAPLLVGYRLKSPGFSNFLAYQNMFEYYLTSGLSLNLDQLKIDSVEWEKGPRLK 495
Query: 241 MYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVF 300
MY KLFP + NS FN+SEV RIR MFTGWNIPDSD+FGPYELINFTL Y+DV
Sbjct: 496 MYFKLFP---DDVNNSSEFNSSEVLRIRGMFTGWNIPDSDVFGPYELINFTLTDIYKDVI 552
Query: 301 PPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKID 360
S +SGIS AL GIILG IA AVT+SAIV LLI++ +K YH ISRRR S++ SIKID
Sbjct: 553 GSSSSSGISTGALVGIILGTIAVAVTLSAIVFLLILKNRLKKYHTISRRRKSTRISIKID 612
Query: 361 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLT 420
GV+ FTYGEMALATNNFN S ++GQGGYGKVYKGIL DGTVVA+KRAQEGSLQG+KEF T
Sbjct: 613 GVKDFTYGEMALATNNFNDSAEVGQGGYGKVYKGILADGTVVAIKRAQEGSLQGQKEFFT 672
Query: 421 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIA 479
EI+ LSR+HHRNLVSL+GYCDEEGEQMLVYEFM NGTLRD LSA KSKEPL FAMRLSIA
Sbjct: 673 EIELLSRVHHRNLVSLIGYCDEEGEQMLVYEFMPNGTLRDHLSAAKSKEPLSFAMRLSIA 732
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
LGSS+GILYLHTEA+PP+FHRD+KASNILLD KF AKVADFGLSRLAPVPDIEG PAHV
Sbjct: 733 LGSSKGILYLHTEANPPIFHRDVKASNILLDSKFIAKVADFGLSRLAPVPDIEGSTPAHV 792
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599
STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN++YQS
Sbjct: 793 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVNVSYQS 852
Query: 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 659
M+FSVID MGSYPSECVEKF+KLALKCCQ++TDARPSM++V+RELE+IW MMPESDTK
Sbjct: 853 GMIFSVIDNRMGSYPSECVEKFVKLALKCCQEDTDARPSMAQVVRELENIWLMMPESDTK 912
Query: 660 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 707
T E + +E K +PPSSS+ K+PYVSSD+SGS LVSGV+PTI PR
Sbjct: 913 TTESLITE-PGKLISPPSSSTPTKNPYVSSDISGSELVSGVVPTIAPR 959
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745743|emb|CBI15799.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1071 bits (2770), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/707 (74%), Positives = 597/707 (84%), Gaps = 5/707 (0%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 61
S L+ LSLRNCSLQG +P+LS+IP LGYLDLSSNQLNG+IPPGR S NITTI LSNN LT
Sbjct: 258 SMLMNLSLRNCSLQGEIPNLSKIPYLGYLDLSSNQLNGTIPPGRFSENITTIDLSNNNLT 317
Query: 62 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 121
GTIP+NFSGLP LQ+L + NNSLSG++ SSIWQ+RT N ET+++DFQNN+L+NISG+ +
Sbjct: 318 GTIPANFSGLPHLQKLSLENNSLSGTVSSSIWQNRTSNGNETYVVDFQNNDLSNISGTLD 377
Query: 122 IPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSP 181
+P NVTVRL GNP C N + QFCGS S+++N+ NST+DC A CP YE SP S
Sbjct: 378 LPLNVTVRLYGNPLCTNESLVQFCGSQSEEENDTLNPVNSTVDCTAVRCPLYYEISPASL 437
Query: 182 IRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKM 241
C CAAPLLVGYRLKSPG S F AY+N+FE Y+TSGL LNL QL IDS WEKGPRLKM
Sbjct: 438 EICLCAAPLLVGYRLKSPGFSNFLAYQNMFEYYLTSGLSLNLDQLKIDSVEWEKGPRLKM 497
Query: 242 YLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFP 301
Y KLFP + NS FN+SEV RIR MFTGWNIPDSD+FGPYELINFTL Y+DV
Sbjct: 498 YFKLFP---DDVNNSSEFNSSEVLRIRGMFTGWNIPDSDVFGPYELINFTLTDIYKDVIG 554
Query: 302 PSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDG 361
S +SGIS AL GIILG IA AVT+SAIV LLI++ +K YH ISRRR S++ SIKIDG
Sbjct: 555 SSSSSGISTGALVGIILGTIAVAVTLSAIVFLLILKNRLKKYHTISRRRKSTRISIKIDG 614
Query: 362 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE 421
V+ FTYGEMALATNNFN S ++GQGGYGKVYKGIL DGTVVA+KRAQEGSLQG+KEF TE
Sbjct: 615 VKDFTYGEMALATNNFNDSAEVGQGGYGKVYKGILADGTVVAIKRAQEGSLQGQKEFFTE 674
Query: 422 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIAL 480
I+ LSR+HHRNLVSL+GYCDEEGEQMLVYEFM NGTLRD LSA KSKEPL FAMRLSIAL
Sbjct: 675 IELLSRVHHRNLVSLIGYCDEEGEQMLVYEFMPNGTLRDHLSAAKSKEPLSFAMRLSIAL 734
Query: 481 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 540
GSS+GILYLHTEA+PP+FHRD+KASNILLD KF AKVADFGLSRLAPVPDIEG PAHVS
Sbjct: 735 GSSKGILYLHTEANPPIFHRDVKASNILLDSKFIAKVADFGLSRLAPVPDIEGSTPAHVS 794
Query: 541 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 600
TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN++YQS
Sbjct: 795 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVNVSYQSG 854
Query: 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKT 660
M+FSVID MGSYPSECVEKF+KLALKCCQ++TDARPSM++V+RELE+IW MMPESDTKT
Sbjct: 855 MIFSVIDNRMGSYPSECVEKFVKLALKCCQEDTDARPSMAQVVRELENIWLMMPESDTKT 914
Query: 661 PEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 707
E + +E K +PPSSS+ K+PYVSSD+SGS LVSGV+PTI PR
Sbjct: 915 TESLITE-PGKLISPPSSSTPTKNPYVSSDISGSELVSGVVPTIAPR 960
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297848960|ref|XP_002892361.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297338203|gb|EFH68620.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1024 bits (2647), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/710 (70%), Positives = 592/710 (83%), Gaps = 8/710 (1%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
MSKLLK+SLRNCSLQGP+PDLS IPNLGYLDLS NQLNGSIP G+LS NITTI LS+N L
Sbjct: 237 MSKLLKMSLRNCSLQGPVPDLSSIPNLGYLDLSQNQLNGSIPTGKLSDNITTIDLSSNSL 296
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
TGTIP+NFSGLPRLQ+L +ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG
Sbjct: 297 TGTIPTNFSGLPRLQKLSLANNALSGSIPSRIWQERELNSTESIIVDLRNNRFSNISGRS 356
Query: 121 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDD-NEIDRSTNS-TLDCRAQSCPTDYEYSP 178
++ PNVTV L+GNP C + N + CG +++D N+ STNS T C CP YE+SP
Sbjct: 357 DLRPNVTVWLQGNPLCSDGNLLRLCGPITEEDINQGQGSTNSYTTTC--SDCPPPYEFSP 414
Query: 179 TSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPR 238
RCFCAAPLLVGYRLKSPG S F Y++ FEEY+TSGL LNLYQL +DSF+W+KGPR
Sbjct: 415 EPLRRCFCAAPLLVGYRLKSPGFSDFVPYRSEFEEYITSGLSLNLYQLRLDSFQWQKGPR 474
Query: 239 LKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRD 298
L+MYLK FPV+ +++ NS++FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRD
Sbjct: 475 LRMYLKFFPVFGSNANNSFIFNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRD 534
Query: 299 VFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIK 358
VFP + SG+SK A+AGI+LG++A AVT++AI++L+I+R M+ Y+A++RR+ SSK S+K
Sbjct: 535 VFPSASPSGLSKGAVAGIVLGSVAAAVTLTAIIALIIMRKRMRGYNAVARRKRSSKASLK 594
Query: 359 IDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEF 418
I+GV+SFTY E+ALAT+NFNSSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEF
Sbjct: 595 IEGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEF 654
Query: 419 LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI 478
LTEI+ LSRLHHRNLVSL+G+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL I
Sbjct: 655 LTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRI 714
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538
ALGS++GILYLHTEA+PP+FHRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P H
Sbjct: 715 ALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPHH 774
Query: 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598
VSTVVKGTPGYLDPEYFLTH+LTDKSDVYSLGVVFLELLTGMQPI+HGKNIVRE+NIAY+
Sbjct: 775 VSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVFLELLTGMQPITHGKNIVREINIAYE 834
Query: 599 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 658
S + S +D M S P EC+EKF LAL+CC++ETDARPSM+EV+RELE IW +MPES
Sbjct: 835 SGSILSAVDKRMSSVPDECLEKFATLALRCCREETDARPSMAEVVRELEIIWELMPESHV 894
Query: 659 -KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 707
KT + T + S+SS++KHPY S DVSGS+LVSG+ P++ PR
Sbjct: 895 AKTADL---SETMTHPSSSSNSSIMKHPYTSMDVSGSDLVSGIAPSVAPR 941
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334182352|ref|NP_172169.2| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|264664524|sp|C0LGD7.2|Y1684_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At1g06840; Flags: Precursor gi|332189923|gb|AEE28044.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1013 bits (2619), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/709 (69%), Positives = 587/709 (82%), Gaps = 8/709 (1%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
MSKLLK+SLRNCSLQGP+PDLS IPNLGYLDLS NQLNGSIP G+LS +ITTI LSNN L
Sbjct: 251 MSKLLKMSLRNCSLQGPVPDLSSIPNLGYLDLSQNQLNGSIPAGKLSDSITTIDLSNNSL 310
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
TGTIP+NFSGLPRLQ+L +ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG
Sbjct: 311 TGTIPTNFSGLPRLQKLSLANNALSGSIPSRIWQERELNSTESIIVDLRNNGFSNISGRS 370
Query: 121 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDD-NEIDRSTNSTLDCRAQSCPTDYEYSPT 179
++ PNVTV L+GNP C + N + CG +++D N+ ++N+T+ CP YE+SP
Sbjct: 371 DLRPNVTVWLQGNPLCSDGNLLRLCGPITEEDINQGSTNSNTTI---CSDCPPPYEFSPE 427
Query: 180 SPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRL 239
RCFCAAPLLVGYRLKSPG S F Y++ FE+Y+TSGL LNLYQL +DSF+W+KGPRL
Sbjct: 428 PLRRCFCAAPLLVGYRLKSPGFSDFVPYRSEFEQYITSGLSLNLYQLRLDSFQWQKGPRL 487
Query: 240 KMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDV 299
+MYLK FPV+ +++ NS++FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRDV
Sbjct: 488 RMYLKFFPVFGSNANNSFIFNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDV 547
Query: 300 FPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKI 359
FP + SG+S A+AGI+LG++A AVT++AI++L+I+R M+ Y A++RR+ SSK S+KI
Sbjct: 548 FPSASPSGLSNGAVAGIVLGSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLKI 607
Query: 360 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL 419
+GV+SFTY E+ALAT+NFNSSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEFL
Sbjct: 608 EGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFL 667
Query: 420 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 479
TEI+ LSRLHHRNLVSL+G+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL IA
Sbjct: 668 TEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIA 727
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
LGS++GILYLHTEA+PP+FHRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P HV
Sbjct: 728 LGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHV 787
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599
STVVKGTPGYLDPEYFLTH+LTDKSDVYSLGVV LEL TGMQPI+HGKNIVRE+NIAY+S
Sbjct: 788 STVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIAYES 847
Query: 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT- 658
+ S +D M S P EC+EKF LAL+CC++ETDARPSM+EV+RELE IW +MPES
Sbjct: 848 GSILSTVDKRMSSVPDECLEKFATLALRCCREETDARPSMAEVVRELEIIWELMPESHVA 907
Query: 659 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 707
KT + T + S+SS++KH Y S DVSGS+LVSGV P++ PR
Sbjct: 908 KTADL---SETMTHPSSSSNSSIMKHHYTSMDVSGSDLVSGVAPSVAPR 953
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224146594|ref|XP_002326064.1| predicted protein [Populus trichocarpa] gi|222862939|gb|EEF00446.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1011 bits (2615), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/708 (71%), Positives = 583/708 (82%), Gaps = 7/708 (0%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
M+KLLKLSLRNCSLQGPMPDLS IPNLGYLDLS NQL G IP +LS NITTI LS N L
Sbjct: 164 MTKLLKLSLRNCSLQGPMPDLSGIPNLGYLDLSFNQLAGPIPTNKLSKNITTIDLSYNNL 223
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
GTIP+NFS LP LQ+L IANNSLSGS+P + WQ+R N TE LDF+NN L+NISGS
Sbjct: 224 NGTIPANFSELPLLQQLSIANNSLSGSVPFTTWQTRA-NGTEGLDLDFENNTLSNISGSI 282
Query: 121 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTS 180
++P NVT+RL+GNP C N++ QFC S ++D N ST S C QSCP+ YEYSPTS
Sbjct: 283 SLPQNVTLRLKGNPVCSNSSIFQFCESQNNDMNN-QSSTESNATCFTQSCPSPYEYSPTS 341
Query: 181 PIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLK 240
P CFCAAPL+ GYRLKSPG S F Y+ FE Y+TSGLKL+L+QLD+ S WE GPRLK
Sbjct: 342 PTSCFCAAPLIFGYRLKSPGFSKFVPYRIRFENYLTSGLKLSLFQLDLASVVWESGPRLK 401
Query: 241 MYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVF 300
M+LKLFPVY N + FN SE RI SMFTGW IPDS+IFGPYEL+ TL PYRDV
Sbjct: 402 MHLKLFPVYVNGTN---TFNTSEARRIISMFTGWKIPDSEIFGPYELLYITLLDPYRDVI 458
Query: 301 PPSRNSG-ISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKI 359
S+ S IS AL GI+LGAIAGAVT+SA+VSLLI+R +++Y AIS+RR SK S+KI
Sbjct: 459 VTSQKSNKISTGALVGIVLGAIAGAVTLSAVVSLLILRRRLRDYTAISKRRRQSKASLKI 518
Query: 360 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL 419
+GV+ F+Y EMA+ATNNFNSS+Q+GQGGYGKVYKGIL DG VA+KR +EGSLQGEKEFL
Sbjct: 519 EGVKDFSYAEMAMATNNFNSSSQVGQGGYGKVYKGILADGRTVAIKRTEEGSLQGEKEFL 578
Query: 420 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 479
TEI+ LSRLHHRNLVSL+GYCDE+GEQMLVYEFM NGTLRD LS K KEPL FA RL IA
Sbjct: 579 TEIELLSRLHHRNLVSLLGYCDEQGEQMLVYEFMPNGTLRDHLSVKGKEPLSFATRLKIA 638
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
+ S++GILYLHTEA+PP+FHRDIKASNIL+D ++ AKVADFGLSRLAPVPDIEG VP H+
Sbjct: 639 MTSAKGILYLHTEANPPIFHRDIKASNILVDSRYDAKVADFGLSRLAPVPDIEGSVPDHI 698
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599
STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG QPISHGKNIVREV IAYQS
Sbjct: 699 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGKQPISHGKNIVREVKIAYQS 758
Query: 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 659
M+FS+ID MGSYPS+C++KF+ LA+KCC +ETDARPSM++V+RELE IW+MM ESDT
Sbjct: 759 GMIFSIIDERMGSYPSDCIDKFLTLAMKCCNEETDARPSMADVVRELEGIWHMMSESDTA 818
Query: 660 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 707
T + I++++ KE TPPSSSSM+ +P VSS+VSGS+LVSG +PTITPR
Sbjct: 819 TTDTISTDN-RKEMTPPSSSSMMMNPCVSSEVSGSDLVSGAVPTITPR 865
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124832|ref|XP_002319433.1| predicted protein [Populus trichocarpa] gi|222857809|gb|EEE95356.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2596), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/708 (69%), Positives = 581/708 (82%), Gaps = 4/708 (0%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
M++LLKLSLRNCSL+G MPDLS IPNLGYLDLS NQL G IPP +L NITTI LSNN L
Sbjct: 222 MTQLLKLSLRNCSLRGLMPDLSGIPNLGYLDLSFNQLAGPIPPNKLFENITTINLSNNTL 281
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
GTIP+ FS LPRLQ L IANNSLSGS+PS+IWQ+RT N E L F+NN L+NISGS
Sbjct: 282 NGTIPAYFSDLPRLQLLSIANNSLSGSVPSTIWQTRT-NGNEGLDLHFENNRLSNISGST 340
Query: 121 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTS 180
++P NVT+ L+GNP C N+N +FCGS + D N+ + ++ C QSCP YEY T
Sbjct: 341 SLPQNVTLWLQGNPACSNSNIVKFCGSQNGDMNDQSTTESNVTTCSVQSCPPPYEYFQTP 400
Query: 181 PIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLK 240
I C CAAPL+ YRLKSPG S F Y+ F++Y+TSGL+L+LYQLD+ S WEKGPRLK
Sbjct: 401 TISCVCAAPLIFEYRLKSPGFSKFIPYRVAFQDYLTSGLELHLYQLDLSSAIWEKGPRLK 460
Query: 241 MYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVF 300
M LKLFPVY N + +S+ FN SEV RI SMFTGWNIPDS +FGPYEL+ L GPY +V
Sbjct: 461 MQLKLFPVYVNEN-SSHKFNDSEVRRIISMFTGWNIPDSQLFGPYELLYINLLGPYINVL 519
Query: 301 PPS-RNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKI 359
+ + S +S AL GI+LGAIAGAV +SA+VSLLI+R +N+ AIS+RR SK S+KI
Sbjct: 520 SVTPQKSKLSTGALVGIVLGAIAGAVALSAVVSLLILRKRSRNHGAISKRRRVSKASLKI 579
Query: 360 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL 419
+GV+ F+Y EMALATNNFNSS+Q+GQGGYGKVYKG L DG VA+KRA+E S QGE+EFL
Sbjct: 580 EGVKYFSYAEMALATNNFNSSSQVGQGGYGKVYKGYLADGRTVAIKRAEEASFQGEREFL 639
Query: 420 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 479
TEI+ LSR+HHRNLVSL+G+CDE GEQMLVYEFMSNGTLRD LSAK+KEPL FA RL IA
Sbjct: 640 TEIELLSRVHHRNLVSLIGFCDEGGEQMLVYEFMSNGTLRDHLSAKAKEPLSFATRLGIA 699
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
L S++GILYLHTEADPP+FHRD+KASNILLD ++ AKVADFGLS+LAPVPDIEG VP H+
Sbjct: 700 LASAKGILYLHTEADPPIFHRDVKASNILLDSRYNAKVADFGLSKLAPVPDIEGDVPGHI 759
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599
STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ+
Sbjct: 760 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQT 819
Query: 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 659
M+FS++DG MGSYPS+CV+KF+ LA+KCC DETD RPSM +V+RELE++W+MMPESDTK
Sbjct: 820 GMIFSIVDGRMGSYPSDCVDKFLTLAMKCCNDETDERPSMIDVVRELENMWHMMPESDTK 879
Query: 660 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 707
T + +N++ T E T PSS S+LK+PYVSS+VS S+LVSGV PTITPR
Sbjct: 880 TTDTMNTD-TGMEMTSPSSCSLLKNPYVSSEVSSSDLVSGVAPTITPR 926
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569432|ref|XP_003552905.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 996 bits (2574), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/713 (68%), Positives = 586/713 (82%), Gaps = 14/713 (1%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
MSKLLK+SLRNCSLQGP+PDLSRIP+L YLDLS NQLN SIPP +LS +ITTI LS+N+L
Sbjct: 249 MSKLLKMSLRNCSLQGPIPDLSRIPHLLYLDLSLNQLNESIPPNKLSEHITTIDLSSNRL 308
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
TG IPS F+ LPRLQ+L +ANNSL G++ SSIWQ++T N T+TF+L+ +NNNLT ISGS
Sbjct: 309 TGNIPSYFADLPRLQKLSLANNSLDGTVSSSIWQNKTSNGTKTFLLELENNNLTTISGSI 368
Query: 121 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTS 180
++PPNVTV L GNP C N QFCGS + + +TNS+ C Q+CP YEYS
Sbjct: 369 DLPPNVTVGLNGNPLCSNVTLTQFCGSEGANVTDGSFTTNSS-SCPPQACPPPYEYS--- 424
Query: 181 PIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLK 240
+ CFC PL+V YRLKSPG S F Y N FE YM SG+K++ QL D F W+ GPRL+
Sbjct: 425 -VNCFCGLPLIVDYRLKSPGFSNFLPYLNDFEVYMASGVKISTNQLQYD-FYWQVGPRLR 482
Query: 241 MYLKLFPVY-DNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDV 299
M LK FP Y DNSS S+ FN SE+ R+ SMFTGW IPDSD+FGPYEL+ F L GPY+D
Sbjct: 483 MNLKFFPAYVDNSS--SHTFNRSELLRLTSMFTGWLIPDSDLFGPYELMGFNLLGPYQDE 540
Query: 300 FPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKI 359
S SGIS AL GI++GAIA AVT+SAIV++LI+R +++YHA+SRRRH+SK SIKI
Sbjct: 541 IGRSSKSGISTGALVGIVIGAIAFAVTLSAIVTILILRIRLRDYHAVSRRRHASKISIKI 600
Query: 360 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL 419
DGVR+F+YGE++ ATNNF++S Q+GQGGYGKVYKG+L DGT+VA+KRAQEGSLQGEKEFL
Sbjct: 601 DGVRAFSYGELSSATNNFSTSAQVGQGGYGKVYKGVLSDGTIVAIKRAQEGSLQGEKEFL 660
Query: 420 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 479
TEI LSRLHHRNLVSL+GYCDEEGEQMLVYEFMSNGTLRD LS +K+PL FAMRL +A
Sbjct: 661 TEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEFMSNGTLRDHLSVTAKDPLTFAMRLKMA 720
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
LG+++G+LYLH+EADPP+FHRD+KASNILLD KF+AKVADFGLSRLAPVPD+EG+VP HV
Sbjct: 721 LGAAKGLLYLHSEADPPIFHRDVKASNILLDSKFSAKVADFGLSRLAPVPDMEGVVPGHV 780
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599
STVVKGTPGYLDPEYFLT KLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN+AYQS
Sbjct: 781 STVVKGTPGYLDPEYFLTRKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVNVAYQS 840
Query: 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 659
++FS+IDG MGSYPSE VEKF+ LA+KCC+DE +ARP M+EV+RELE+IW+ MPESDTK
Sbjct: 841 GVIFSIIDGRMGSYPSEHVEKFLTLAMKCCEDEPEARPRMAEVVRELENIWSTMPESDTK 900
Query: 660 TPEFINSEHTSKE-----ETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 707
EF++S+ + + +S+S++K P+VS DVSGS+LVSGVIP+I PR
Sbjct: 901 RAEFMSSDSGKADSHSTPSSSSASASIMKTPFVSGDVSGSDLVSGVIPSIKPR 953
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357460549|ref|XP_003600556.1| hypothetical protein MTR_3g062590 [Medicago truncatula] gi|355489604|gb|AES70807.1| hypothetical protein MTR_3g062590 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 990 bits (2559), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/711 (68%), Positives = 579/711 (81%), Gaps = 13/711 (1%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
MSKLLKLSL+NC+LQGP+PDLSRIP+L YLDLSSNQLN S+P +L+ NITTI LSNN+L
Sbjct: 254 MSKLLKLSLKNCNLQGPIPDLSRIPHLLYLDLSSNQLNESLP-SKLAENITTIDLSNNQL 312
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
TG IPS+FS L +LQRL +ANNSL+GS+PS+IWQ + LN +E FIL+ +NN T +SGS
Sbjct: 313 TGNIPSSFSSLSKLQRLSLANNSLNGSVPSTIWQDKKLNGSERFILELENNQFTTVSGST 372
Query: 121 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTS 180
++P VTV LRGNP C N Q C S ++ ++ TN+ C QSCP YE+S
Sbjct: 373 DLPSKVTVLLRGNPLCSNNTLSQLCSSEGVNNTDVLVPTNNNGSCLVQSCPPPYEFS--- 429
Query: 181 PIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLK 240
+ CFCAAPLLVGYRLKSPG S F +KN FEEY+T+GL +N+ QL+ +FRW GPRL+
Sbjct: 430 -LDCFCAAPLLVGYRLKSPGFSDFLPFKNEFEEYLTTGLSINISQLNF-TFRWVAGPRLR 487
Query: 241 MYLKLFPVY-DNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDV 299
M LK FP+Y D++S S+ FN +EV RIRSMFTGWNIPDSD+FGPYELINF + G Y++
Sbjct: 488 MDLKFFPLYVDHNS--SHTFNETEVQRIRSMFTGWNIPDSDLFGPYELINFNM-GLYQNA 544
Query: 300 FPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKI 359
S SGIS A+ GI+LGAIA AVT+SAIV+LLI+R +K+YHA+S+RRH SK IK+
Sbjct: 545 TSTSSKSGISTGAIVGIVLGAIACAVTLSAIVTLLILRTKLKDYHAVSKRRHVSKIKIKM 604
Query: 360 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL 419
DGVRSFTY E++ ATNNF+SS Q+GQGGYGKVYKG++ GT VA+KRAQEGSLQGEKEFL
Sbjct: 605 DGVRSFTYEELSSATNNFSSSAQVGQGGYGKVYKGVISGGTAVAIKRAQEGSLQGEKEFL 664
Query: 420 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 479
TEI LSRLHHRNLVSL+GYCDEEGEQMLVYE+M NGTLRD LS +KEPL F MRL IA
Sbjct: 665 TEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEYMPNGTLRDHLSVSAKEPLTFIMRLKIA 724
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
LGS++G++YLH EADPP+FHRD+KASNILLD K +AKVADFGLSRLAPVPD+EGIVP HV
Sbjct: 725 LGSAKGLMYLHNEADPPIFHRDVKASNILLDSKLSAKVADFGLSRLAPVPDMEGIVPGHV 784
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599
STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE+LTGM PISHGKNIVREVN++YQS
Sbjct: 785 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEILTGMHPISHGKNIVREVNLSYQS 844
Query: 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 659
++FS+ID MGSYPSE VEKF+ LALKC DE D RP+M+EV+RELE+IWN+MPESDT+
Sbjct: 845 GVIFSIIDERMGSYPSEHVEKFLTLALKCVNDEPDNRPTMAEVVRELENIWNVMPESDTR 904
Query: 660 TPEFINS---EHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 707
E I S +SK + PSSSS ++ +VS DVSGS+LVSGVIP+I PR
Sbjct: 905 RAESITSGSVSDSSKAMSTPSSSSAIRTAFVSGDVSGSDLVSGVIPSIKPR 955
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537716|ref|XP_003537371.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 986 bits (2550), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/713 (68%), Positives = 581/713 (81%), Gaps = 13/713 (1%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
MSKLLK+SLRNC+L+GP+PDL RIP+L YLDLS NQLNGSIPP +LS NITTI LSNN L
Sbjct: 249 MSKLLKMSLRNCNLRGPLPDLRRIPHLLYLDLSFNQLNGSIPPNKLSENITTIDLSNNLL 308
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
TG IPS F+ LPRLQ+L +ANNSL G++ SSIWQ++TLN TE F L+ +NNNLT ISGS
Sbjct: 309 TGNIPSYFADLPRLQKLSLANNSLDGTVSSSIWQNKTLNGTEKFFLELENNNLTTISGSI 368
Query: 121 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTS 180
++PPNVTV L GNP C N QFCGS + +TN + C Q CP +EY+
Sbjct: 369 DLPPNVTVGLNGNPLCSNITLIQFCGSEAATVTNGSLTTNFS-SCPPQGCPPPFEYT--- 424
Query: 181 PIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLK 240
+ CFCA PL+V YRLKSPG + F Y N F++YMT GL+++ QL+ D F W+ GPRLK
Sbjct: 425 -VDCFCALPLIVFYRLKSPGFTNFLPYLNGFKDYMTHGLEISFDQLEYD-FYWQVGPRLK 482
Query: 241 MYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVF 300
M LK FP Y N++ N + FN SE+ RI+S FTGW IPD+D FGPYELI F L G Y+DV
Sbjct: 483 MDLKFFPPYLNNTSN-HTFNESELLRIKSKFTGWLIPDNDTFGPYELIGFNLLGSYQDVI 541
Query: 301 PP-SRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKI 359
P S + I L GI++GAIA AVT+SAIV++LI+R +++YHA+S++RH+SK SIKI
Sbjct: 542 PTRSESQNIRTGVLVGIVIGAIACAVTLSAIVTILILRIKLRDYHAVSKQRHASKISIKI 601
Query: 360 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL 419
DGVR+FTYGE++ ATNNF+ S Q+GQGGYGKVYKG+L DGTVVA+KRAQEGSLQGEKEFL
Sbjct: 602 DGVRAFTYGELSFATNNFSISAQVGQGGYGKVYKGVLSDGTVVAIKRAQEGSLQGEKEFL 661
Query: 420 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 479
TEI LSRLHHRNLVSL+GYCDEEGEQMLVYEFMSNGTLRD LS +K+PL FAMRL IA
Sbjct: 662 TEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEFMSNGTLRDHLSVTAKDPLTFAMRLKIA 721
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
LG+++G++YLHTEADPP+FHRD+KASNILLD KF+AKVADFGLSRLAPVPD+EG+VP HV
Sbjct: 722 LGAAKGLMYLHTEADPPIFHRDVKASNILLDSKFSAKVADFGLSRLAPVPDMEGVVPGHV 781
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599
STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN+AYQS
Sbjct: 782 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVNVAYQS 841
Query: 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 659
++FS+IDG MGSYPSE VEKF+ LA+KCC+DE +ARPSM+EV+RELE+IW+ MPESDTK
Sbjct: 842 GVIFSIIDGRMGSYPSEHVEKFLTLAMKCCEDEPEARPSMTEVVRELENIWSTMPESDTK 901
Query: 660 TPEFINSEHTSKE-----ETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 707
EFI+S+ + + +S+S++K P+VS DVSGS+LVSGVIP+I PR
Sbjct: 902 RAEFISSDSGKADSHSTPSSSSASASVMKTPFVSGDVSGSDLVSGVIPSIKPR 954
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147789396|emb|CAN75549.1| hypothetical protein VITISV_043541 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2541), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/734 (67%), Positives = 575/734 (78%), Gaps = 31/734 (4%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNIT-------- 51
++ L L L L G +P+ L +PNL + + NQ++GSIP +LN T
Sbjct: 53 ITTLELLLLNGNKLTGSLPEELGNLPNLDRIQIDQNQISGSIPRSFANLNKTKHFLLDNN 112
Query: 52 -----------------TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 94
++L NN G+IP+++S + +L +L + NNSLSG++ SSIWQ
Sbjct: 113 NLSGYLPPEFSEMPKLLIVQLDNNHFNGSIPASYSNMSKLLKLSLENNSLSGTVSSSIWQ 172
Query: 95 SRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNE 154
+RT N ET+++DFQNN+L+NISG+ ++P NVTVRL GNP C N + QFCGS S+++N+
Sbjct: 173 NRTSNGNETYVVDFQNNDLSNISGTLDLPLNVTVRLYGNPLCTNESLVQFCGSQSEEEND 232
Query: 155 IDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEY 214
NST+DC A CP YE SP S C CAAPLLVGYRLKSPG S F AY+N+FE Y
Sbjct: 233 TLNPVNSTVDCTAVRCPLYYEISPASLEICLCAAPLLVGYRLKSPGFSNFLAYQNMFEYY 292
Query: 215 MTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGW 274
+TSGL LNL QL IDS WEKGPRLKMY KLFP + NS FN+SEV RIR MFTGW
Sbjct: 293 LTSGLSLNLDQLKIDSVEWEKGPRLKMYFKLFP---DDVNNSSEFNSSEVLRIRGMFTGW 349
Query: 275 NIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLL 334
NIPDSD+FGPYELINFTL Y+DV S +SGIS AL GIILG IA AVT+SAI LL
Sbjct: 350 NIPDSDVFGPYELINFTLTDIYKDVIGSSSSSGISTGALVGIILGTIAVAVTLSAIXFLL 409
Query: 335 IVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKG 394
I++ +K YH ISRRR S++ SIKIDGV+ FTYGEMALATNNFN S ++GQGGYGKVYKG
Sbjct: 410 ILKNRLKKYHTISRRRKSTRISIKIDGVKDFTYGEMALATNNFNDSAEVGQGGYGKVYKG 469
Query: 395 ILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454
IL DGTVVA+KRAQEGSLQG+KEF TEI+ LSR+HHRNLVSL+GYCDEE EQMLVYEFM
Sbjct: 470 ILADGTVVAIKRAQEGSLQGQKEFFTEIELLSRVHHRNLVSLIGYCDEEVEQMLVYEFMP 529
Query: 455 NGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 513
NGTLRD LSA KSKEPL FAMRLSIALGSS+GILYLHTEA+PP+FHRD+KASNILLD KF
Sbjct: 530 NGTLRDHLSAAKSKEPLSFAMRLSIALGSSKGILYLHTEANPPIFHRDVKASNILLDSKF 589
Query: 514 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVF 573
AKVADFGLSRLAPVPDIEG PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVF
Sbjct: 590 IAKVADFGLSRLAPVPDIEGSTPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVF 649
Query: 574 LELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDET 633
LELLTGM PISHGKNIVREVN++YQS M+FSVID MGSYPSECVEKF+KLALKCCQ++T
Sbjct: 650 LELLTGMHPISHGKNIVREVNVSYQSGMIFSVIDNRMGSYPSECVEKFVKLALKCCQEDT 709
Query: 634 DARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 693
DARPSM++V+RELE+IW MMPESDTKT E + +E K +PPSSS+ K+PYVSSD+SG
Sbjct: 710 DARPSMAQVVRELENIWLMMPESDTKTTESLITE-PGKLISPPSSSTPTKNPYVSSDISG 768
Query: 694 SNLVSGVIPTITPR 707
S LVSGV+PTI PR
Sbjct: 769 SELVSGVVPTIAPR 782
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 707 | ||||||
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.988 | 0.735 | 0.577 | 7e-212 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.968 | 0.731 | 0.496 | 5.4e-166 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.869 | 0.633 | 0.388 | 1.1e-101 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.886 | 0.657 | 0.378 | 1.9e-99 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.886 | 0.662 | 0.367 | 1.3e-93 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.874 | 0.721 | 0.340 | 5.4e-86 | |
| TAIR|locus:2148151 | 866 | AT5G16900 [Arabidopsis thalian | 0.438 | 0.357 | 0.446 | 2.2e-76 | |
| TAIR|locus:2128625 | 898 | AT4G20450 [Arabidopsis thalian | 0.455 | 0.358 | 0.424 | 8.5e-75 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.441 | 0.492 | 0.385 | 3.2e-73 | |
| TAIR|locus:2195825 | 865 | AT1G51850 [Arabidopsis thalian | 0.410 | 0.335 | 0.459 | 1.4e-72 |
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2048 (726.0 bits), Expect = 7.0e-212, P = 7.0e-212
Identities = 411/712 (57%), Positives = 501/712 (70%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 61
S +LKLSLRNCSL+G +PD S+I +L YLDLS N+L G IP S ++TTI LSNN L
Sbjct: 247 SNILKLSLRNCSLKGALPDFSKIRHLKYLDLSWNELTGPIPSSNFSKDVTTINLSNNILN 306
Query: 62 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 121
G+IP +FS LP LQ L + NN LSGS+P S+W++ + +LD +NN+L+ + G
Sbjct: 307 GSIPQSFSDLPLLQMLLLKNNMLSGSVPDSLWKNISFPKKARLLLDLRNNSLSRVQGDLT 366
Query: 122 IPPNVTVRLRGNPFCLN---TNAEQFCGSHSDDDNEI-DRSTNSTLDCRAQSCPTD--YE 175
P NVT+RL GN C N +NA FC S + + + STNS LDC +CPT YE
Sbjct: 367 PPQNVTLRLDGNLICTNGSISNANLFCESKGKEWISLPNNSTNSALDCPPLACPTPDFYE 426
Query: 176 YSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEK 235
YSP SP+RCFCAAPL +GYRLKSP SYFP Y + F EY+T L++ YQL IDS++WEK
Sbjct: 427 YSPASPLRCFCAAPLRIGYRLKSPSFSYFPPYIDQFGEYVTDFLQMEPYQLWIDSYQWEK 486
Query: 236 GPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGP 295
GPRL+MYLKLFP + + + FN SEV RIR +F W P SD+FGPYEL+NFTLQGP
Sbjct: 487 GPRLRMYLKLFPKVNETYTRT--FNESEVLRIRGIFASWRFPGSDLFGPYELLNFTLQGP 544
Query: 296 YRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNYHAISRRRHSSKT 355
Y V S G+S V ISA+V+ L++R + K+ ISRRR SSK
Sbjct: 545 YSYVNFNSERKGVSWRRLAAITAGAVVTAVAISAVVAALLLRRYSKHEREISRRRSSSKA 604
Query: 356 SIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE 415
S+ G+R F++ E+A AT++F+SST +G+GGYGKVY+G+L D TV A+KRA EGSLQGE
Sbjct: 605 SLLNSGIRGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRADEGSLQGE 664
Query: 416 KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR 475
KEFL EI+ LSRLHHRNLVSL+GYCDEE EQMLVYEFMSNGTLRD LSAK KE L F MR
Sbjct: 665 KEFLNEIELLSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTLRDWLSAKGKESLSFGMR 724
Query: 476 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535
+ +ALG+++GILYLHTEA+PPVFHRDIKASNILLD F AKVADFGLSRLAPV + E V
Sbjct: 725 IRVALGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAPVLEDEEDV 784
Query: 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 595
P HVSTVV+GTPGYLDPEYFLTHKLTDKSDVYS+GVVFLELLTGM ISHGKNIVREV
Sbjct: 785 PKHVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGMHAISHGKNIVREVKT 844
Query: 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655
A Q MM S+ID M + E VEKF LAL+C D + RP M+EV++ELES+ P+
Sbjct: 845 AEQRDMMVSLIDKRMEPWSMESVEKFAALALRCSHDSPEMRPGMAEVVKELESLLQASPD 904
Query: 656 SDTKTPEFINXXXXXXXXXXXXXXXMLKHPYVSSDVSGSNLVSGVIPTITPR 707
+T+ E + + Y SS + GS+L SG +P+I PR
Sbjct: 905 RETRV-ELASSSSVLSTSSSNVTRDL----YESSSLLGSDLSSGFVPSIAPR 951
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1615 (573.6 bits), Expect = 5.4e-166, P = 5.4e-166
Identities = 353/711 (49%), Positives = 446/711 (62%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 61
S+L+KLSLRNC LQG +PDLSRI NL YLDLS N L G+IP +LS N+TTI+LS N LT
Sbjct: 248 SRLVKLSLRNCGLQGSIPDLSRIENLSYLDLSWNHLTGTIPESKLSDNMTTIELSYNHLT 307
Query: 62 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 121
G+IP +FS L LQ L + NNSLSGS+P+ IWQ ++ + + D NNN ++ +G+
Sbjct: 308 GSIPQSFSDLNSLQLLSLENNSLSGSVPTEIWQDKSFENNKLQVYDL-NNNFSDATGNLR 366
Query: 122 IPPNVTVRLRGNPFCLNTN---AEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSP 178
P NVT+ LRGNP C +T+ QF + + STNS C SCP +E
Sbjct: 367 TPDNVTLYLRGNPICKSTSIPMVTQFFEYICGEKKQT--STNSNTPCSNVSCP--FENVK 422
Query: 179 TSPIRCFCAAPLLVGYRLKSPGLSYFPAY-KNLFEEYMTSGLKLNLYQLDIDSFRWEKGP 237
SP C C APL + YRLKSP +F Y + F EY+TS L+L +QL ID E
Sbjct: 423 VSPGICLCTAPLSIDYRLKSPSFFFFTPYIERQFREYITSSLQLETHQLAIDRLVDENRL 482
Query: 238 RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYR 297
R +MYLKL P G FN SEV RIR F W+ +D FGPYEL++F LQGPY
Sbjct: 483 RPRMYLKLVP-----KGR-ITFNKSEVIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYA 536
Query: 298 DVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSI 357
D+ ++ SGI +S +LL VR +N H ++++R S
Sbjct: 537 DLL--AQTSGIRTIVWMMIVAGSVVAATVLSVTATLLYVRKRRENSHTLTKKRVFRTISR 594
Query: 358 KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE 417
+I GV+ F++ E++ ATN F+SST IG+G YGKVYKGIL + T VA+KR +E SLQ EKE
Sbjct: 595 EIKGVKKFSFVELSDATNGFDSSTLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKE 654
Query: 418 FLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 477
FL EI LSRLHHRNLVSL+GY + GEQMLVYE+M NG +RD LSA + + L F+MR
Sbjct: 655 FLNEIDLLSRLHHRNLVSLIGYSSDIGEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSH 714
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV-PDIEGIVP 536
+ALGS++GILYLHTEA+PPV HRDIK SNILLD + AKVADFGLSRLAP + +G P
Sbjct: 715 VALGSAKGILYLHTEANPPVIHRDIKTSNILLDCQLHAKVADFGLSRLAPAFGEGDG-EP 773
Query: 537 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 596
AHVSTVV+GTPGYLDPEYF+T +LT +SDVYS GVV LELLTGM P G +I+REV A
Sbjct: 774 AHVSTVVRGTPGYLDPEYFMTQQLTVRSDVYSFGVVLLELLTGMHPFFEGTHIIREVRTA 833
Query: 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 656
+ + SV D MG + V+K +LAL CC+D + RP MS+V++ELE I + E
Sbjct: 834 NECGTVLSVADSRMGQCSPDKVKKLAELALWCCEDRPETRPPMSKVVKELEGICQSVRE- 892
Query: 657 DTKTPEFINXXXXXXXXXXXXXXXMLKHPYVSSDVSGSNLVSGVIPTITPR 707
PE + + P S + GSNL SG + PR
Sbjct: 893 ----PEMFSETTKLLCSKTSPSSSSVPSPL--SLLPGSNLDSGFFHAVKPR 937
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1008 (359.9 bits), Expect = 1.1e-101, P = 1.1e-101
Identities = 262/674 (38%), Positives = 378/674 (56%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNN 58
++ +++L+L + L G +PDLS + ++ Y+DLS+N + S P S ++TT+ +
Sbjct: 272 LTNIIELNLAHNKLVGSLPDLSDMKSMNYVDLSNNSFDPSESPLWFSTLPSLTTLVMEYG 331
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
L G +P+ G P+LQ++ + N+ +G++ S+ T+ E ++D Q+N++++++
Sbjct: 332 SLQGPLPNKLFGFPQLQQVRLKKNAFNGTL--SLGD--TVGP-ELQLVDLQDNDISSVTL 386
Query: 119 SFNIPPNVTVRLRGNPFCLNTNAE-QFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYS 177
S N T+ L GNP C + +C I ST S +C +SCP D + S
Sbjct: 387 SSGYT-N-TLILEGNPVCTTALSNTNYCQIQQQQVKRI-YST-SLANCGGKSCPLDQKVS 442
Query: 178 PTSPIRCFCAAPLLVGYRLKSP---GLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWE 234
P S C CA P + P LS Y +L E + L L + + + +
Sbjct: 443 PQS---CECAYPYEGTLYFRGPMFRDLSNVNTYHSL-EMSLWVKLGLTPGSVSLQNPFFN 498
Query: 235 KGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQG 294
L++ L LFP Y FN +EV RI + +FGPY + +
Sbjct: 499 NDDYLQIQLALFPPM-----GKY-FNRTEVQRIGFDLSNQTYKPPPLFGPY----YFIAS 548
Query: 295 PYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNY--HAISRRR-- 350
PY FP N G S + + +V+L I K AI R
Sbjct: 549 PY--TFPADGN-GHSLSSRMVTGIITGCSALVL-CLVALGIYAMWQKRRAEQAIGLSRPF 604
Query: 351 ----HSSKTS---IKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVA 403
S K S ++ G R F+Y E+ TNNF+ S+++G GGYGKVYKG+L DG +VA
Sbjct: 605 VSWASSGKDSGGAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVA 664
Query: 404 VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 463
+KRAQ+GS QG EF TEI+ LSR+HH+NLV LVG+C E+GEQ+LVYE+MSNG+L+D L+
Sbjct: 665 IKRAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLT 724
Query: 464 AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523
+S L + RL +ALGS+RG+ YLH ADPP+ HRD+K++NILLD TAKVADFGLS
Sbjct: 725 GRSGITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLS 784
Query: 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 583
+L V D HVST VKGT GYLDPEY+ T KLT+KSDVYS GVV +EL+T QPI
Sbjct: 785 KL--VSDC---TKGHVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPI 839
Query: 584 SHGKNIVREVNIAYQSSM--MFSVIDG------NMGSYPSECVEKFIKLALKCCQDETDA 635
GK IVRE+ + S + + D ++G+ P + ++++LALKC + D
Sbjct: 840 EKGKYIVREIKLVMNKSDDDFYGLRDKMDRSLRDVGTLPE--LGRYMELALKCVDETADE 897
Query: 636 RPSMSEVMRELESI 649
RP+MSEV++E+E I
Sbjct: 898 RPTMSEVVKEIEII 911
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 987 (352.5 bits), Expect = 1.9e-99, P = 1.9e-99
Identities = 260/687 (37%), Positives = 378/687 (55%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS-IPPGRLSL-NITTIKLSNN 58
++ L +L L N G +P+L+ + +L LD+S+N L+ S IP SL +++T+++
Sbjct: 265 LTNLNELYLANNRFTGTLPNLTSLTSLYTLDVSNNTLDFSPIPSWISSLPSLSTLRMEGI 324
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
+L G IP +F P+LQ + + NS+ S+ S L F+ D Q N +T+
Sbjct: 325 QLNGPIPISFFSPPQLQTVILKRNSIVESLDFGTDVSSQLE----FV-DLQYNEITDYKP 379
Query: 119 SFNIPPNVTVRLRGNPFCLNT-NAEQFCGSHSDDDNEIDRSTN-STLDCRAQSCPTDYEY 176
S N + V L NP CL N +C + I +T+ STL C E
Sbjct: 380 SAN--KVLQVILANNPVCLEAGNGPSYCSA-------IQHNTSFSTLPTNCSPCEPGMEA 430
Query: 177 SPTSPIRCFCAAPLLVGYRLKSPGLS-YFPAYK-NLFEEYMTSGLKLNLYQLDIDSFR-W 233
SPT C CA P + +SP S F + ++ ++ + K Y +D R
Sbjct: 431 SPT----CRCAYPFMGTLYFRSPSFSGLFNSTNFSILQKAIADFFKKFNYPVDSVGVRNI 486
Query: 234 EKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINF 290
+ P +L + L +FP+ S FN + + + F+ IFGPY +
Sbjct: 487 RENPTDHQLLIDLLVFPLGRES------FNQTGMSLVGFAFSNQTYKPPPIFGPY-IFKA 539
Query: 291 TLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNYHAISRRR 350
L + DV S++S S +TI+ I +L R + A +
Sbjct: 540 DLYKQFSDVEVSSKSSNKSILIGAVVGVVVLLLLLTIAGIYAL---RQKKRAERATGQNN 596
Query: 351 -----HSSKTSI---KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVV 402
+SK+SI ++ G ++FT+ E+ T+NF+ + +G GGYGKVY+GILP+G ++
Sbjct: 597 PFAKWDTSKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLI 656
Query: 403 AVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL 462
A+KRAQ+GSLQG EF TEI+ LSR+HH+N+V L+G+C + EQMLVYE++SNG+L+D L
Sbjct: 657 AIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSL 716
Query: 463 SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522
S KS L + RL IALGS +G+ YLH ADPP+ HRDIK++NILLD TAKVADFGL
Sbjct: 717 SGKSGIRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGL 776
Query: 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
S+L P+ HV+T VKGT GYLDPEY++T++LT+KSDVY GVV LELLTG P
Sbjct: 777 SKLVGDPE-----KTHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSP 831
Query: 583 ISHGKNIVREVNIAYQSSMMF----SVIDGNM--GSYPSECVEKFIKLALKCCQDETDAR 636
I GK +VREV S ++D + S + EK++ LAL+C ++E R
Sbjct: 832 IERGKYVVREVKTKMNKSRSLYDLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNR 891
Query: 637 PSMSEVMRELESIWNMM---PESDTKT 660
PSM EV++E+E+I + P SD+ T
Sbjct: 892 PSMGEVVKEIENIMQLAGLNPNSDSAT 918
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 932 (333.1 bits), Expect = 1.3e-93, P = 1.3e-93
Identities = 254/691 (36%), Positives = 376/691 (54%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LN-ITTIKLSNN 58
++ L +L L + G +P+L+ + +L LD+S+N L S P + LN ++T++L +
Sbjct: 268 LTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPSWIPFLNSLSTLRLEDI 327
Query: 59 KLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
+L G +P++ FS L +LQ + + +N ++ ++ S+ L+ F+ D ++N +T
Sbjct: 328 QLDGPVPTSLFSPL-QLQTVSLKHNLINTTLDLGTNYSKQLD----FV-DLRDNFITGYK 381
Query: 118 GSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEID-RSTNSTLDCRAQSCPTDYEY 176
N P NV L N C + A Q G N + ST STL C E
Sbjct: 382 SPANNPVNVM--LADNQVCQDP-ANQLSGYC----NAVQPNSTFSTLTKCGNHCGKGKE- 433
Query: 177 SPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNL--FEEYMTSGLKLNLYQLDIDSFR-W 233
P C C PL + L+SP S F N F E + + K Y +D + R
Sbjct: 434 -PNQG--CHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNGKYPVDSVAMRNI 490
Query: 234 EKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINF 290
+ P L + L +FP SG FN +E+ I S FT + FGPY +
Sbjct: 491 SENPTDYHLLINLLIFP-----SGRDR-FNQTEMDSINSAFTIQDYKPPPRFGPYIFV-- 542
Query: 291 TLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNYHAISRRR 350
Y+ F +S + + A+ + +R + A +
Sbjct: 543 --ADQYK-TFSDLEDSKTVSMKVIIGVVVGVVVLLLLLALAGIYALRQKKRAQRATDQMN 599
Query: 351 HSSKTSI---KID-----GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVV 402
+K ++D G ++FT+ E++ TNNF+ + +G GGYG+VYKG LP+G V+
Sbjct: 600 PFAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVI 659
Query: 403 AVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL 462
A+KRAQ+GS+QG EF TEI+ LSR+HH+N+V L+G+C ++ EQMLVYE++ NG+LRD L
Sbjct: 660 AIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGL 719
Query: 463 SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522
S K+ L + RL IALGS +G+ YLH ADPP+ HRD+K++NILLD TAKVADFGL
Sbjct: 720 SGKNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGL 779
Query: 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
S+L P+ AHV+T VKGT GYLDPEY++T++LT+KSDVY GVV LELLTG P
Sbjct: 780 SKLVGDPE-----KAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSP 834
Query: 583 ISHGKNIVREV--------NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETD 634
I G +V+EV N+ ++ + I N G+ EK++ +AL+C + E
Sbjct: 835 IDRGSYVVKEVKKKMDKSRNLYDLQELLDTTIIQNSGNLKG--FEKYVDVALQCVEPEGV 892
Query: 635 ARPSMSEVMRELESIWNMM---PESDTKTPE 662
RP+MSEV++ELESI ++ P +D+ T E
Sbjct: 893 NRPTMSEVVQELESILRLVGLNPNADSATYE 923
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 860 (307.8 bits), Expect = 5.4e-86, P = 5.4e-86
Identities = 237/696 (34%), Positives = 370/696 (53%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL---NITTIKLSN 57
++ L +L L + G +P L+ + +L L +S+N+L S +SL ++ T++++
Sbjct: 144 LTNLQELYLSDNKFTGSLPSLTSLTSLSTLAVSNNRLTSSQISSWISLLPTSLATLRMAG 203
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN-I 116
+L G IP++ LP LQ + + N L+ ++ +S+ L+ F+ D Q N++T I
Sbjct: 204 LQLQGPIPTSLFSLPELQTVILKRNWLNETLDFGTNKSQNLD----FV-DLQYNDITEYI 258
Query: 117 SGSFNIPPNVTVRLRGNPFC--LNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDY 174
N + V L NP C + ++C + ++ N+ C + D
Sbjct: 259 KQPANKGSSRIVILANNPVCPEVGNPPNEYC-IEVEHNSSYSSPKNTCGRCSGE----DR 313
Query: 175 EYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEY---MTSGLKLNLYQLD---I 228
E PT+ C C P+ +SP S + + + FE +T + Y +D I
Sbjct: 314 EPIPTT---CRCVYPITGTLTFRSPSFSGY-SNNDTFENLRLNLTGFFENRNYTVDSVAI 369
Query: 229 DSFRWEKGPR-LKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYEL 287
+ R ++ L + L LFP Y FN + + + S F+ + FGPY +
Sbjct: 370 RNIREDEDDHYLLIDLSLFP-YKQDR-----FNETGMDSVISRFSTQTYKPPNTFGPY-I 422
Query: 288 INFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVR-AHMKN---- 342
+ P+ S S + I+ I +L R A N
Sbjct: 423 FKANKYNKF-----PAGGSNSSHIIGAVVGSTVFLLILMIAGIYALKQKRRAEKANDQIN 477
Query: 343 -------------------YHAISRRRHSSKTSI---KIDGVRSFTYGEMALATNNFNSS 380
+ ++ + +++ S+ ++ G ++FT+ EM NNF+ +
Sbjct: 478 PFGKDVLLSGKTDKILIAFFLYVTAKWDANQNSVDAPQLMGTKAFTFEEMRKCANNFSVA 537
Query: 381 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+G GGYG+VYKGILP G ++A+KRAQ GSLQG EF TEI+ LSR+HH+N+V L+G+C
Sbjct: 538 NDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGALEFKTEIELLSRVHHKNVVKLLGFC 597
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
+ GEQMLVYE++ NG+LRD LS KS L + RL IALGS +G+ YLH ADPP+ HR
Sbjct: 598 FDRGEQMLVYEYIPNGSLRDSLSGKSGIRLDWTRRLRIALGSGKGLAYLHELADPPIIHR 657
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
D+K+SN+LLD TAKVADFGLS+L V D E A+V+ VKGT GYLDPEY++T++L
Sbjct: 658 DVKSSNVLLDESLTAKVADFGLSQL--VEDAE---KANVTAQVKGTMGYLDPEYYMTNQL 712
Query: 561 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM-MFSV---IDGNMGSYPSE 616
T+KSDVY GV+ LELLTG PI +GK +V+E+ + S ++ + +D + + +
Sbjct: 713 TEKSDVYGFGVMMLELLTGKIPIENGKYVVKEMKMKMNKSKNLYDLQDFLDTTISATSNR 772
Query: 617 CV---EKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ EK++ +AL+C E RPSM+EV++E+E+I
Sbjct: 773 NLKGFEKYVDVALRCVDPEGVKRPSMNEVVKEIENI 808
|
|
| TAIR|locus:2148151 AT5G16900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 2.2e-76, Sum P(2) = 2.2e-76
Identities = 145/325 (44%), Positives = 200/325 (61%)
Query: 330 IVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGV-RSFTYGEMALATNNFNSSTQIGQGGY 388
I L+++ +K + R H S+ ++ ++ R TY E+ L TNNF IG+GG+
Sbjct: 527 IAVLVLIIVFIKKRPSSIRALHPSRANLSLENKKRRITYSEILLMTNNFERV--IGEGGF 584
Query: 389 GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448
G VY G L D VAVK S QG KEF E++ L R+HH NLVSLVGYCDE+ L
Sbjct: 585 GVVYHGYLNDSEQVAVKVLSPSSSQGYKEFKAEVELLLRVHHINLVSLVGYCDEQAHLAL 644
Query: 449 VYEFMSNGTLRDQLSAKSKE-PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 507
+YE+M+NG L+ LS K + L + RLSIA+ ++ G+ YLH+ P + HRD+K+ NI
Sbjct: 645 IYEYMANGDLKSHLSGKHGDCVLKWENRLSIAVETALGLEYLHSGCKPLMVHRDVKSMNI 704
Query: 508 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVY 567
LLD F AK+ADFGLSR V + +HVST V GTPGYLDPEY+ T++LT+KSDVY
Sbjct: 705 LLDEHFQAKLADFGLSRSFSVGE-----ESHVSTGVVGTPGYLDPEYYRTYRLTEKSDVY 759
Query: 568 SLGVVFLELLTGMQPI----SHGKNIVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFI 622
S G+V LE++T QP+ + ++I V S + +++D N+ G Y S V K +
Sbjct: 760 SFGIVLLEIITN-QPVLEQANENRHIAERVRTMLTRSDISTIVDPNLIGEYDSGSVRKAL 818
Query: 623 KLALKCCQDETDARPSMSEVMRELE 647
KLA+ C ARP MS V++EL+
Sbjct: 819 KLAMSCVDPSPVARPDMSHVVQELK 843
|
|
| TAIR|locus:2128625 AT4G20450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 8.5e-75, Sum P(2) = 8.5e-75
Identities = 144/339 (42%), Positives = 208/339 (61%)
Query: 328 SAIVSLLIVRAHMKNYHAISRRRHSSKT-SIKIDGVRSFTYGEMALATNNFNSSTQIGQG 386
+A V ++I + N + +++ S + S + RS+TY E+A+ TNNF +G+G
Sbjct: 543 AASVGIIIAVLLLVNILLLRKKKPSKASRSSMVANKRSYTYEEVAVITNNFERP--LGEG 600
Query: 387 GYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446
G+G VY G + D VAVK E S QG K+F E+ L R+HH NLV+LVGYCDE
Sbjct: 601 GFGVVYHGNVNDNEQVAVKVLSESSAQGYKQFKAEVDLLLRVHHINLVTLVGYCDEGQHL 660
Query: 447 MLVYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 505
+L+YE+MSNG L+ LS + S+ PL + RL IA +++G+ YLH PP+ HRDIK+
Sbjct: 661 VLIYEYMSNGNLKQHLSGENSRSPLSWENRLRIAAETAQGLEYLHIGCKPPMIHRDIKSM 720
Query: 506 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSD 565
NILLD+ F AK+ DFGLSR PV HVST V G+PGYLDPEY+ T+ LT+KSD
Sbjct: 721 NILLDNNFQAKLGDFGLSRSFPVGS-----ETHVSTNVAGSPGYLDPEYYRTNWLTEKSD 775
Query: 566 VYSLGVVFLELLTGMQPI---SHGKNIVRE-VNIAYQSSMMFSVIDGNM-GSYPSECVEK 620
V+S GVV LE++T QP+ + K+ + E V + + +++D +M G Y S + K
Sbjct: 776 VFSFGVVLLEIITS-QPVIDQTREKSHIGEWVGFKLTNGDIKNIVDPSMNGDYDSSSLWK 834
Query: 621 FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 659
++LA+ C + RP+MS+V EL+ ++ E+ K
Sbjct: 835 ALELAMSCVSPSSSGRPNMSQVANELQEC--LLTENSRK 871
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 3.2e-73, Sum P(2) = 3.2e-73
Identities = 128/332 (38%), Positives = 204/332 (61%)
Query: 327 ISAIVSLLIVRAHMKNYHAISRRRHSSKTS---IKIDGVRSFTYGEMALATNNFNSSTQI 383
+S I+SL + + K ++ R S K + + +RSFT+ E+ +AT+ F+S + +
Sbjct: 247 VSVILSLGFIW-YRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSIL 305
Query: 384 GQGGYGKVYKGILPDGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442
G GG+G VY+G DGTVVAVKR ++ G +F TE++ +S HRNL+ L+GYC
Sbjct: 306 GAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCAS 365
Query: 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 502
E++LVY +MSNG++ +L K+K L + R IA+G++RG+ YLH + DP + HRD+
Sbjct: 366 SSERLLVYPYMSNGSVASRL--KAKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDV 423
Query: 503 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 562
KA+NILLD F A V DFGL++L D +HV+T V+GT G++ PEY T + ++
Sbjct: 424 KAANILLDEYFEAVVGDFGLAKLLNHED------SHVTTAVRGTVGHIAPEYLSTGQSSE 477
Query: 563 KSDVYSLGVVFLELLTGMQPISHGKNIVRE------VNIAYQSSMMFSVIDGNMGS-YPS 615
K+DV+ G++ LEL+TGM+ + GK++ ++ V ++ + ++D +G+ Y
Sbjct: 478 KTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYDR 537
Query: 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
V + +++AL C Q RP MSEV++ LE
Sbjct: 538 IEVGEMLQVALLCTQFLPAHRPKMSEVVQMLE 569
|
|
| TAIR|locus:2195825 AT1G51850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 629 (226.5 bits), Expect = 1.4e-72, Sum P(2) = 1.4e-72
Identities = 140/305 (45%), Positives = 192/305 (62%)
Query: 348 RRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRA 407
R SS+ +I + R FTY ++A+ TNNF +G+GG+G VY G + VAVK
Sbjct: 532 RSPRSSEPAI-VTKNRRFTYSQVAIMTNNFQRI--LGKGGFGMVYHGFVNGTEQVAVKIL 588
Query: 408 QEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSA-K 465
S QG KEF E++ L R+HH+NLV LVGYCDE GE M L+YE+M+NG L++ +S +
Sbjct: 589 SHSSSQGYKEFKAEVELLLRVHHKNLVGLVGYCDE-GENMALIYEYMANGDLKEHMSGTR 647
Query: 466 SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525
++ L + RL I + S++G+ YLH PP+ HRD+K +NILL+ F AK+ADFGLSR
Sbjct: 648 NRFTLNWGTRLKIVVESAQGLEYLHNGCKPPMVHRDVKTTNILLNEHFQAKLADFGLSRS 707
Query: 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585
P IEG HVSTVV GTPGYLDPEY+ T+ LT+KSDVYS G+V LEL+T I
Sbjct: 708 FP---IEG--ETHVSTVVAGTPGYLDPEYYKTNWLTEKSDVYSFGIVLLELITNRPVIDK 762
Query: 586 GK---NIVREVNIAYQSSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSE 641
+ +I V + + S++D N+ Y S V K ++LA+ C + RP+MS+
Sbjct: 763 SREKPHIAEWVGVMLTKGDINSIMDPNLNEDYDSGSVWKAVELAMSCLNPSSARRPTMSQ 822
Query: 642 VMREL 646
V+ EL
Sbjct: 823 VVIEL 827
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGD7 | Y1684_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6911 | 0.9915 | 0.7355 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00023921001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (903 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 707 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-30 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-30 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.002 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 2e-55
Identities = 90/275 (32%), Positives = 133/275 (48%), Gaps = 33/275 (12%)
Query: 382 QIGQGGYGKVYKGIL--PDGTV---VAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 435
++G+G +G+VYKG L G VAVK +E S Q +EFL E + + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
L+G C EE +V E+M G L L K++ L + LS AL +RG+ YL ++
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG---YLDP 552
HRD+ A N L+ K++DFGLSR + +G ++ P
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRD---------LYDDDYYRKRGGKLPIRWMAP 172
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
E K T KSDV+S GV+ E+ T G QP N EV + Y + +G
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--EV-LEY-------LKNGYRL 222
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
P C + L L+C ++ + RP+ SE++ L
Sbjct: 223 PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 1e-54
Identities = 91/276 (32%), Positives = 135/276 (48%), Gaps = 34/276 (12%)
Query: 382 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 435
++G+G +G+VYKG L VAVK +E S Q +EFL E + + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
L+G C EE M+V E+M G L D L + L + LS AL +RG+ YL ++
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----EGIVPAHVSTVVKGTPGYLD 551
HRD+ A N L+ K++DFGLSR D G +P ++ ++
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP------IR----WMA 172
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
PE K T KSDV+S GV+ E+ T G +P + EV + Y + G
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEV-LEY-------LKKGYR 222
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
P C + KL L+C ++ + RP+ SE++ L
Sbjct: 223 LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 9e-53
Identities = 91/287 (31%), Positives = 130/287 (45%), Gaps = 47/287 (16%)
Query: 382 QIGQGGYGKVYKGILPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSL 436
++G+G +G+VYKG L T VAVK +E S + K+FL E + + +L H N+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYL 489
+G C EE LV E+M G L D L K L LS A+ ++G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVSTVVK 544
HRD+ A N L+ K++DFGLSR D G +P ++
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP------IR 172
Query: 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREVNIAYQSS 600
PE T KSDV+S GV+ E+ T G P +S EV + Y
Sbjct: 173 WMA----PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEV-LEY--- 219
Query: 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
+ G P C ++ +L L C Q + + RP+ SE++ LE
Sbjct: 220 ----LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 6e-48
Identities = 74/268 (27%), Positives = 116/268 (43%), Gaps = 28/268 (10%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 439
++G+G +GKVY G +VA+K ++ ++ ++E L EI+ L +L H N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
++E + LV E+ G L D L + + A + YLH + H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLH---SKGIVH 120
Query: 500 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 559
RD+K NILLD K+ADFGL+R + ++T V GTP Y+ PE L
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGE-------KLTTFV-GTPEYMAPEVLLGKG 172
Query: 560 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI---DGNMGSYPSE 616
D++SLGV+ ELLTG P + +F I +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQL----------LELFKKIGKPKPPFPPPEWD 222
Query: 617 CVEKFIKLALKCCQDETDARPSMSEVMR 644
+ L K + + R + E ++
Sbjct: 223 ISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 88/277 (31%), Positives = 130/277 (46%), Gaps = 36/277 (12%)
Query: 382 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVS 435
++G+G +G+VYKG L T VAVK +EG+ + E+ EFL E + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
L+G C + +V E+M G L D L E L L +AL ++G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVSTVVKGTPGYL 550
HRD+ A N L+ K++DFGLSR D G +P +K
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP------IKWMA--- 172
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609
PE K T KSDV+S GV+ E+ T G QP N ++ + DG
Sbjct: 173 -PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN----------EEVLELLEDGY 221
Query: 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
P C ++ +L L+C + + RP+ SE++ +L
Sbjct: 222 RLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 2e-46
Identities = 78/268 (29%), Positives = 111/268 (41%), Gaps = 57/268 (21%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 440
+G+GG+G VY G VA+K ++ E L EI+ L +L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
++E LV E+ G+L+D L L L I L G+ YLH+ + HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 501 DIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-TH 558
D+K NILLD K+ADFGLS+L + GTP Y+ PE L
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSL-------LKTIVGTPAYMAPEVLLGKG 169
Query: 559 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618
++KSD++SLGV+ EL
Sbjct: 170 YYSEKSDIWSLGVILYEL------------------------------------------ 187
Query: 619 EKFIKLALKCCQDETDARPSMSEVMREL 646
+ L K Q + + RPS E++ L
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 6e-43
Identities = 86/269 (31%), Positives = 126/269 (46%), Gaps = 26/269 (9%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
++G G +G VYK G +VAVK + + + ++ EI+ L RL H N+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+++ LV E+ G L D LS PL IAL RG+ YLH+ +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNG---II 120
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRD+K NILLD K+ADFGL++ + + T GTP Y+ PE L
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 559 KL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG-NMGSYPSE 616
K DV+SLGV+ ELLTG +P G+NI+ Q ++ ++ P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTG-KPPFSGENILD------QLQLIRRILGPPLEFDEPKW 226
Query: 617 C--VEKFIKLALKCCQDETDARPSMSEVM 643
E+ L KC + RP+ E++
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 76/270 (28%), Positives = 121/270 (44%), Gaps = 33/270 (12%)
Query: 382 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 438
+G+G +G VY + D G ++AVK + E + EI+ LS L H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 439 -YCDEEGEQMLVY-EFMSNGTLRDQLSAKSK--EPLGFAMRL---SIALGSSRGILYLHT 491
DEE + ++ E++S G+L L K EP+ +R I G+ YLH+
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL----EGLAYLHS 119
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ HRDIK +NIL+D K+ADFG ++ + I + V+GTP ++
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKR-----LGDIETGEGTGSVRGTPYWMA 171
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
PE + +D++SLG +E+ TG P S N + +++ G
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--------AALYKIGSSGEPP 223
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSE 641
P E+ KC + + RP+ E
Sbjct: 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 31/269 (11%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IG+GG+G+VYK G VA+K + S + +++ + EIQ L + H N+V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
++ E +V EF S G+L+D L + + L + + +G+ YLH+ + HR
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHR 122
Query: 501 DIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 559
DIKA+NILL K+ DFGLS +L+ +V GTP ++ PE
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---------GTPYWMAPEVINGKP 173
Query: 560 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG----SYPS 615
K+D++SLG+ +EL G P S + ++ +G G S
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYS---------ELPPMKALFKIATNGPPGLRNPEKWS 224
Query: 616 ECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ + F+K KC Q + RP+ ++++
Sbjct: 225 DEFKDFLK---KCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 81/282 (28%), Positives = 128/282 (45%), Gaps = 30/282 (10%)
Query: 371 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH 430
A+ + IG+G +G V G G VAVK ++ S + FL E ++ L H
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
NLV L+G + +V E+M+ G+L D L ++ + + A +L AL G+ YL
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ HRD+ A N+L+ AKV+DFGL++ A G +P VK T
Sbjct: 120 EKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP------VKWTA--- 167
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG--KNIVREVNIAYQSSMMFSVID 607
PE K + KSDV+S G++ E+ + G P K++V V Y+
Sbjct: 168 -PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR--------- 217
Query: 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
M + P C + K+ C + + RP+ ++ +L I
Sbjct: 218 --MEA-PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 23/283 (8%)
Query: 382 QIGQGGYGKVYKG---ILPDGT--VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVS 435
Q+G+G +GKV L D T VAVK G Q +F EI+ L L H N+V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 436 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
G C++ G + L+ E++ +G+LRD L + ++ + L + +G+ YL ++
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-YLDP 552
HRD+ A NIL++ + K++DFGL+++ P + +P + P
Sbjct: 130 ---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDK-----DYYYVKEPGESPIFWYAP 181
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG-KNIVREVNIAYQSSMMFSVI----D 607
E T K + SDV+S GV EL T P +R + IA ++ ++ +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650
G P C ++ L C + E RPS ++++ ++ +
Sbjct: 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 85/281 (30%), Positives = 124/281 (44%), Gaps = 47/281 (16%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442
+G G +G+V+ G T VAVK + G++ E FL E Q + +L H LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS----IALGSSRGILYLHTEADPPVF 498
E +V E+MS G+L D L K G +RL +A + G+ YL +
Sbjct: 73 EEPIYIVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YI 125
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTV--VKGTPGYLDPEYF 555
HRD+ A NIL+ K+ADFGL+RL IE A +K T PE
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARL-----IEDDEYTAREGAKFPIKWTA----PEAA 176
Query: 556 LTHKLTDKSDVYSLGVVFLELLT-------GMQPISHGKNIVREVNIAYQSSMMFSVIDG 608
+ T KSDV+S G++ E++T GM + ++ +V Y+
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM----TNREVLEQVERGYRMPR------- 225
Query: 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
P C E+ L L+C + + RP+ + LE
Sbjct: 226 -----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 31/272 (11%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G+V++G+ + T VAVK + G++ K+FL E Q + +L H L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
E +V E M G+L + L + L + +A + G+ YL + HRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDPEYFLTHK 559
+ A N+L+ KVADFGL+R+ E I A +K T PE L ++
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKFPIKWTA----PEAALYNR 180
Query: 560 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PS 615
+ KSDV+S G++ E++T +G+ + Y V+ Y P
Sbjct: 181 FSIKSDVWSFGILLTEIVT------YGR-------MPYPGMTNAEVLQQVDQGYRMPCPP 227
Query: 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
C ++ + L C +++ D RP+ + +LE
Sbjct: 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 87/281 (30%), Positives = 135/281 (48%), Gaps = 34/281 (12%)
Query: 383 IGQGGYGKVYKGILPDG----TVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV 437
IG+G +G VY G L D AVK L+ ++FL E + H N++SL+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 438 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEP-----LGFAMRLSIALGSSRGILYLHT 491
G C EG ++V +M +G LR+ + +++ P +GF ++++ +G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA------KGMEYL-- 114
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
A HRD+ A N +LD FT KVADFGL+R + D E H T K ++
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSV-HNHTGAKLPVKWMA 170
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
E T K T KSDV+S GV+ EL+T G P V +I ++ G
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD----VDSFDITVY------LLQGRR 220
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651
P C + ++ L C + + RP+ SE++ +E I++
Sbjct: 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 86/310 (27%), Positives = 138/310 (44%), Gaps = 60/310 (19%)
Query: 376 NFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL 428
N +G+G +GKV K T VAVK +E + E ++ L+E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 429 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--------------------- 467
+H +++ L G C ++G +L+ E+ G+LR L K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 468 -EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-- 524
L +S A SRG+ YL A+ + HRD+ A N+L+ K++DFGLSR
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 525 ---LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 580
+ V +G +P VK ++ E H T +SDV+S GV+ E++T G
Sbjct: 178 YEEDSYVKRSKGRIP------VK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227
Query: 581 QPISHGKNIVREVNIAYQSSMMFSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSM 639
P IA + +F+++ G P C E+ L L C + E D RP+
Sbjct: 228 NPYP---------GIAPER--LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF 276
Query: 640 SEVMRELESI 649
+++ +ELE +
Sbjct: 277 ADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 83/271 (30%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 382 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
++G G YG+VY+G+ VAVK +E +++ E EFL E + + H NLV L+G C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E ++ EFM+ G L D L +++ + + L +A S + YL + HR
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 128
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
D+ A N L+ KVADFGLSRL + A +K T PE +K
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKF 182
Query: 561 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID-GNMGSYPSECV 618
+ KSDV++ GV+ E+ T GM P S ++ +++ G P C
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYP-----------GIDLSQVYELLEKGYRMERPEGCP 231
Query: 619 EKFIKLALKCCQDETDARPSMSEVMRELESI 649
K +L C Q RPS +E+ + E++
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 71/213 (33%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRN 432
N+ IG+G +G VYKG+ L G VA+K+ ++ E K + EI L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 490
+V +G + ++ E+ NG+LR + E L A+ + L +G+ YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-VAVYVYQVL---QGLAYLH 116
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGY 549
+ V HRDIKA+NIL K+ADFG++ +L V + V GTP +
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV--------SKDDASVVGTPYW 165
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
+ PE + SD++SLG +ELLTG P
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G V+ G VA+K +EG++ E +F+ E + + +L H NLV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
++ +V E+M+NG L + L + K LG L + + YL + HRD
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 561
+ A N L+ KV+DFGL+R V D + VK P PE F + +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAP----PEVFDYSRFS 179
Query: 562 DKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGSYPSECV 618
KSDV+S GV+ E+ + G P N +V V+ Y+ P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR------------PKLAP 227
Query: 619 EKFIKLALKCCQDETDARPSMSEVMREL 646
+ + C ++ + RP+ +++ +L
Sbjct: 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G+V++G+ + VA+K + L +++F E+Q L RL H++L+SL C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
++ E M G+L L + + L A + +A + G+ YL + HRD
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRD 129
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYFLTHKL 560
+ A NIL+ KVADFGL+RL E + + + K T PE
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIK----EDVYLSSDKKIPYKWTA----PEAASHGTF 181
Query: 561 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSE 616
+ KSDV+S G++ E+ T +G+ + Y V D Y P++
Sbjct: 182 STKSDVWSFGILLYEMFT------YGQ-------VPYPGMNNHEVYDQITAGYRMPCPAK 228
Query: 617 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
C ++ K+ L+C E + RPS + EL++I
Sbjct: 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 83/272 (30%), Positives = 123/272 (45%), Gaps = 35/272 (12%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 439
IG G +GKVY + L G ++AVK R Q+ + KE E++ L L H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66
Query: 440 CDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ E++ ++ E+ S GTL + L ++ L G+ YLH+ +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSHG---IV 121
Query: 499 HRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 557
HRDIK +NI LDH K+ DFG + +L G ++ GTP Y+ PE
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA----GTPAYMAPEVITG 177
Query: 558 HKLTDK---SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
K +D++SLG V LE+ TG +P S N + +MF V G+ P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---------EFQIMFHVGAGHKPPIP 228
Query: 615 -----SECVEKFIKLALKCCQDETDARPSMSE 641
S + F+ C + + RP+ SE
Sbjct: 229 DSLQLSPEGKDFLDR---CLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 77/267 (28%), Positives = 122/267 (45%), Gaps = 21/267 (7%)
Query: 381 TQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+GQG G VYK P G + A+K+ + K+ L E++ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+EGE +V E+M G+L D L K P ++ + +G+ YLHT+ +
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI--LKGLDYLHTKRH--II 122
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRDIK SN+L++ K K+ADFG+S+ +E + + V GT Y+ PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISK-----VLENTLDQCNTFV--GTVTYMSPERIQGE 175
Query: 559 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618
+ +D++SLG+ LE G P +M ++ DG S P+E
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPS-------FFELMQAICDGPPPSLPAEEF 228
Query: 619 -EKFIKLALKCCQDETDARPSMSEVMR 644
+F C Q + RPS +E+++
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 84/274 (30%), Positives = 129/274 (47%), Gaps = 34/274 (12%)
Query: 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 439
+IG G +G V+ G + VA+K +EG++ E++F+ E Q + +L H LV L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADP 495
C E LV+EFM +G L D L A+ S+E L L + L G+ YL +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN-- 120
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
V HRD+ A N L+ KV+DFG++R V D + ST K + PE F
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRF--VLDDQ----YTSSTGTKFPVKWSSPEVF 173
Query: 556 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGS 612
K + KSDV+S GV+ E+ + G P + N +V +N ++
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK----------- 222
Query: 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
P + +L C ++ + RPS S ++ +L
Sbjct: 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 25/271 (9%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 440
+IG+G +G VYKG+L T VAVK + K FL E + L + H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
++ +V E + G+L L K K L L ++L ++ G+ YL ++ HR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLTHK 559
D+ A N L+ K++DFG+SR + EG + VS +K P + PE +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----EEEGGIYT-VSDGLKQIPIKWTAPEALNYGR 171
Query: 560 LTDKSDVYSLGVVFLELLT-GMQPISHGKNI-VREVNIAYQSSMMFSVIDGNMGSYPSEC 617
T +SDV+S G++ E + G P N RE + G P C
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-----------RIESGYRMPAPQLC 220
Query: 618 VEKFIKLALKCCQDETDARPSMSEVMRELES 648
E+ +L L+C + + RPS SE+ EL+
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 95/336 (28%), Positives = 146/336 (43%), Gaps = 21/336 (6%)
Query: 376 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRL-HHR 431
++ ++G+G +G+VY D +VA+K E + + FL EIQ L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLH 490
N+V L + +EG LV E++ G+L D L K PL + L I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 491 TEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
++ + HRDIK NILLD K+ DFGL++L P P +PA ST V GTPGY
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGY 174
Query: 550 LDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQP---ISHGKNIVREVNIAYQSSMMF 603
+ PE L + SD++SLG+ ELLTG+ P + + + I +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM-RELESIWNMMPESDTKTPE 662
+ S P + L K + R S S + +L + + ESD
Sbjct: 235 LASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK-LKESDLSDLL 292
Query: 663 FINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVS 698
+ + PPS +++ + +
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLD 328
|
Length = 384 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 88/310 (28%), Positives = 135/310 (43%), Gaps = 64/310 (20%)
Query: 375 NNFNSSTQIGQGGYGKVYK----GILP--DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSR 427
NN IGQG +G+V++ G+LP T+VAVK +E S + +F E ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 428 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------------K 467
H N+V L+G C L++E+M+ G L + L +S
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 468 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527
PL +L IA + G+ YL ++ HRD+ N L+ K+ADFGLSR
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR--- 178
Query: 528 VPDIEGIVPAHVSTVVKGTPG------YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 580
+I + + K + ++ PE ++ T +SDV++ GVV E+ + GM
Sbjct: 179 --NI------YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230
Query: 581 QP---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP 637
QP ++H E I Y V DGN+ S P C + L C RP
Sbjct: 231 QPYYGMAH------EEVIYY-------VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP 277
Query: 638 SMSEVMRELE 647
S + + R L+
Sbjct: 278 SFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 78/273 (28%), Positives = 124/273 (45%), Gaps = 35/273 (12%)
Query: 382 QIGQGGYGKVYKG-ILPDGTVVAVKRAQ-EGSLQGEKEF-LTEIQFLSRLHHRNLVSLVG 438
QIG+G +GKVY DG + +K + E+E L E++ L +L+H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK--- 63
Query: 439 YCD---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHT 491
Y + E+G+ +V E+ G L ++ + KE F + + L + YLH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL--ALKYLHS 121
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ HRDIK NI L K+ DFG+S++ + V TVV GTP YL
Sbjct: 122 RK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV-----LSSTVD-LAKTVV-GTPYYLS 171
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
PE KSD++SLG V EL T P G+N + ++ G
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGEN---------LLELALKILKGQYP 221
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
PS+ + L Q + + RPS++++++
Sbjct: 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 382 QIGQGGYGKVYKG----ILPDG--TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLV 434
++G+G +GKV+ G + P+ +VAVK +E + K+F E + L+ H N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGS 482
G C E ++V+E+M +G L L + L + L IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHV 539
+ G++YL A HRD+ N L+ + K+ DFG+SR D + G H
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG----HT 184
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP-ISHGKNIVREVNIAY 597
++ P PE + K T +SDV+S GVV E+ T G QP V E
Sbjct: 185 MLPIRWMP----PESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC---- 236
Query: 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
+ G + P C + + L C + + R ++ ++ L+
Sbjct: 237 -------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 87/267 (32%), Positives = 125/267 (46%), Gaps = 22/267 (8%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
EE +V E+MS G+L D L + + L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 127
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 561
++A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 562 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 620
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPES 231
Query: 621 FIKLALKCCQDETDARPSMSEVMRELE 647
L +C + E + RP+ + LE
Sbjct: 232 LHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 62/298 (20%)
Query: 381 TQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNL 433
++GQG +G VY+G+ T VA+K E + E+ EFL E + + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRG 485
V L+G ++V E M+ G L+ L ++ E P + +A + G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----------EGIV 535
+ YL A HRD+ A N ++ T K+ DFG++R DI +G++
Sbjct: 132 MAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYYRKGGKGLL 183
Query: 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 594
P ++ PE T KSDV+S GVV E+ T QP
Sbjct: 184 PVR----------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP------------ 221
Query: 595 IAYQ----SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648
YQ ++ VIDG P C +K ++L C Q RP+ E++ L+
Sbjct: 222 --YQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 81/272 (29%), Positives = 125/272 (45%), Gaps = 32/272 (11%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G V G VA+K +EGS+ E EF+ E + + +L H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
++ +V E+MSNG L + L K + L + G+ YL ++ HRD
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRF-QPSQLLEMCKDVCEGMAYLESKQ---FIHRD 125
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGYLDPEYFL 556
+ A N L+D + KV+DFGLSR V D E + S+V V+ +P PE L
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRY--VLDDE-----YTSSVGSKFPVRWSP----PEVLL 174
Query: 557 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615
K + KSDV++ GV+ E+ + G P N S + V G P
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----------SETVEKVSQGLRLYRPH 224
Query: 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
EK + C ++ + RP+ +++ +E
Sbjct: 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-----EIQFLSRLHHRNLVSL 436
+G+G YG VYK G +VA+K+ + L E+E + EI L L H N+V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIR---LDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEAD 494
+ E + LV+E+ L+ L K P + L SI RG+ Y H+
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLD---KRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
+ HRD+K NIL++ K+ADFGL+R +P + + VV T Y PE
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLARAFGIP-----LRTYTHEVV--TLWYRAPEI 169
Query: 555 FLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
L K + D++S+G +F E++TG +P+ G +
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITG-KPLFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 26/270 (9%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCD 441
+G+G +G+V+KG L D T VAVK +E Q K +FL+E + L + H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
+ +V E + G L K K+ L + AL ++ G+ YL ++ HRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRD 118
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLTHKL 560
+ A N L+ K++DFG+SR + +GI + S+ +K P + PE +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----QEDDGI---YSSSGLKQIPIKWTAPEALNYGRY 171
Query: 561 TDKSDVYSLGVVFLELLT-GMQPISHGKN-IVREVNIAYQSSMMFSVIDGNMGSYPSECV 618
+ +SDV+S G++ E + G+ P N RE V G S P +C
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-----------QVEKGYRMSCPQKCP 220
Query: 619 EKFIKLALKCCQDETDARPSMSEVMRELES 648
+ K+ +C + + RP SE+ +EL +
Sbjct: 221 DDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 432
+ + +IG+G G+VYK G VA+K+ + Q ++ + EI + H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRD---QLSAKSKEP-LGFAMRLSIALGSSRGILY 488
+V E +V E+M G+L D Q + EP + + R + +G+ Y
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-----QGLEY 131
Query: 489 LHTEADPPVFHRDIKASNILLDHKFTAKVADFG----LSRLAPVPDIEGIVPAHVSTVVK 544
LH++ V HRDIK+ NILL + K+ADFG L++ ++VV
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS----------KRNSVV- 177
Query: 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
GTP ++ PE K D++SLG++ +E+ G P
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 46/227 (20%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 435
QIG+G YG+VYK G +VA+K+ ++ EKE + EI+ L +L H N+V
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 436 LVGYCDEE--GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS---------- 483
L + G +V+E+M + D L+ G + S
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH----D-LT-------GLLDSPEVKFTESQIKCYMKQLL 110
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTV 542
G+ YLH+ + HRDIK SNIL+++ K+ADFGL+R + + V
Sbjct: 111 EGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-----ADYTNRV 162
Query: 543 VKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
+ T Y PE L + + D++S+G + EL G +PI G
Sbjct: 163 I--TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 90/294 (30%), Positives = 128/294 (43%), Gaps = 57/294 (19%)
Query: 383 IGQGGYGKVYKG----ILPDGT---VVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 434
+G G +G+VY+G IL G+ VAVK ++G+ EK EFL E +S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 435 SLVGYCDEEGEQMLVYEFMSNGT----LRDQLSAKSKEP-LGFAMRLSIALGSSRGILYL 489
L+G C Q ++ E M G LRD + P L L I L ++G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 490 HTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDI----------EGI 534
HRD+ A N L+ K K+ DFGL+R DI EG+
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDYYRKEGEGL 174
Query: 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 593
+P ++ PE L K T +SDV+S GV+ E+LT G QP N EV
Sbjct: 175 LPVR----------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EV 222
Query: 594 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
+ + V G P C +K +L C + RP+ + L+
Sbjct: 223 -LQH-------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 82/274 (29%), Positives = 119/274 (43%), Gaps = 29/274 (10%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGY 439
IG G VY I LP+ VA+KR Q E E+Q +S+ +H N+V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHTEADPP 496
E LV ++S G+L D + KS P G IA +G+ YLH+
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
HRDIKA NILL + K+ADFG+S A + D G V GTP ++ PE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVS--ASLAD-GGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 557 THK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615
K+D++S G+ +EL TG P S + + M+ + + S +
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLML--TLQNDPPSLET 229
Query: 616 ECVEK-----FIKLALKCCQDETDARPSMSEVMR 644
K F K+ C Q + RP+ E+++
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 83/282 (29%), Positives = 120/282 (42%), Gaps = 55/282 (19%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKR---AQEGSLQGE--KEFLTEIQFLSRLHHRNLVSL 436
+G G +G VY+G+ L DG AVK A +G E K+ EI LS+L H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
+G EE + E + G+L L EP+ I LG + YLH D
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH---D 120
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGY 549
HRDIK +NIL+D K+ADFG+++ V KG+P +
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK-------------QVVEFSFAKSFKGSPYW 167
Query: 550 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608
+ PE +D++SLG LE+ TG P S + +F + G
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ----------LEGVAAVFKI--G 215
Query: 609 NMGSYP------SECVEKFIKLALKCCQDETDARPSMSEVMR 644
P S+ + FI LKC Q + RP+ +E++
Sbjct: 216 RSKELPPIPDHLSDEAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 80/275 (29%), Positives = 126/275 (45%), Gaps = 42/275 (15%)
Query: 382 QIGQGGYGKVYKGI--LPDGTV--VAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
++G G +G V KG+ + G VAVK QE G+KEFL E +++L H +V L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C E MLV E G L L + + P+ + +A + G+ YL E+
Sbjct: 62 IGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV--SDLKELAHQVAMGMAYL--ESKHF 116
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG------YL 550
V HRD+ A N+LL ++ AK++DFG+SR A S + T +
Sbjct: 117 V-HRDLAARNVLLVNRHQAKISDFGMSR-ALGAG---------SDYYRATTAGRWPLKWY 165
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609
PE K + KSDV+S GV E + G +P K + + ++++
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----------AEVIAMLESG 214
Query: 610 --MGSYPSECVEKFIKLALKCCQDETDARPSMSEV 642
+ P EC ++ + L C + + RP+ SE+
Sbjct: 215 ERLPR-PEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 76/261 (29%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+G+G YG VYK I G VVA+K E LQ E + EI L + +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGSY 67
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
+ + +V E+ G++ D + +K L +I + +G+ YLH HR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLH---SNKKIHR 123
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
DIKA NILL+ + AK+ADFG+S A +TV+ GTP ++ PE
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVS------GQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 176
Query: 561 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 620
+K+D++SLG+ +E+ G P S + I + S P + +
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD--------PEKWSPE 228
Query: 621 FIKLALKCCQDETDARPSMSE 641
F KC + + RPS +
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 85/267 (31%), Positives = 123/267 (46%), Gaps = 22/267 (8%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
EE +V EFM G+L D L + L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 561
++A+NIL+ K+ADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 562 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 620
KSDV+S G++ EL+T G P N REV + V G P C E
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVN--REV--------LEQVERGYRMPCPQGCPES 231
Query: 621 FIKLALKCCQDETDARPSMSEVMRELE 647
+L C + + D RP+ + LE
Sbjct: 232 LHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 77/276 (27%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 383 IGQGGYGKVYKGIL--PDGTV--VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 437
IG G +G+V +G L P VA+K + GS ++ +FLTE + + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
G + M++ E+M NG+L D+ ++ + + G + G+ YL ++
Sbjct: 72 GVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNY 127
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLDP 552
HRD+ A NIL++ KV+DFGLSR + G +P + P
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR----------WTAP 177
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
E K T SDV+S G+V E+++ G +P N ++V + +V DG
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDV--------IKAVEDGYRL 227
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
P +C +L L C Q + + RP+ S+++ L+
Sbjct: 228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 83/267 (31%), Positives = 124/267 (46%), Gaps = 22/267 (8%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G+V+ G T VAVK + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
EE +V E+MS G+L D L L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 561
++++NIL+ K+ADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 562 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 620
KSDV+S G++ EL+T G P N REV + V G P +C
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNN--REV--------LEQVERGYRMPCPQDCPIS 231
Query: 621 FIKLALKCCQDETDARPSMSEVMRELE 647
+L L+C + + + RP+ + LE
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 79/266 (29%), Positives = 123/266 (46%), Gaps = 22/266 (8%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G V+ G VA+K EG++ E++F+ E + + +L H LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
++ +V EFM NG L + L + + L M LS+ G+ YL + HRD
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 561
+ A N L+ KV+DFG++R V D E + VK +P PE F K +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSP----PEVFNFSKYS 179
Query: 562 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 620
KSDV+S GV+ E+ T G P N Y+ M S G P
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMIS--RGFRLYRPKLASMT 229
Query: 621 FIKLALKCCQDETDARPSMSEVMREL 646
++ C ++ + RP+ +E++R +
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 39/294 (13%)
Query: 382 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
++G+G +GKV+ + P D +VAVK ++ +L K+F E + L+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSA--------------KSKEPLGFAMRLSIALG 481
G C + ++V+E+M +G L L A ++K LG + L IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 541
+ G++YL A HRD+ N L+ K+ DFG+SR D V H
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-VGGHTML 187
Query: 542 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 600
++ P PE + K T +SDV+S GV+ E+ T G QP N +
Sbjct: 188 PIRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----------TE 233
Query: 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654
++ + G + P C ++ + L C Q E R ++ E+ + L ++ P
Sbjct: 234 VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 82/285 (28%), Positives = 122/285 (42%), Gaps = 29/285 (10%)
Query: 383 IGQGGYGKVYKGIL------PDGT--VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNL 433
+G+G +GKV L DGT +VAVK + Q + EI L L+H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 434 VSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
V G C E+G + L+ E++ G+LRD L K L A L A G+ YLH+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ HRD+ A N+LLD+ K+ DFGL++ P EG V +
Sbjct: 126 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWYA 178
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP-ISHGKNIVREVNIAYQSSMMFSVID--- 607
E +K + SDV+S GV ELLT S K + + +I+
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
Query: 608 -GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651
G P C ++ L C + E RP+ ++ L+ + +
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 46/292 (15%)
Query: 382 QIGQGGYGKVYKGIL--PDG----TVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLV 434
++G+G +GKVYKG L P+ T VA+K +E + ++EF E + +S L H N+V
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----------------SAKSKEPLGFAMRLS 477
L+G C +E +++E++++G L + L S + F L
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF---LH 128
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 537
IA+ + G+ YL + HRD+ A N L+ T K++DFGLSR D +
Sbjct: 129 IAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 538 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 596
+ V ++ PE L K T +SD++S GVV E+ + G+QP N +EV
Sbjct: 186 SLLPV-----RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEV--- 235
Query: 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648
+ + + P +C + L ++C + RP ++ L S
Sbjct: 236 -----IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 79/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 383 IGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 437
IG G +G+V++GIL VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
G + M++ E+M NG L L E + + + + G + G+ YL +D
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL---SDMNY 128
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 557
HRD+ A NIL++ KV+DFGLSR+ D EG + ++ K + PE
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEG---TYTTSGGKIPIRWTAPEAIAY 184
Query: 558 HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 616
K T SDV+S G+V E+++ G +P N EV M ++ DG P +
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEV--------MKAINDGFRLPAPMD 234
Query: 617 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
C +L L+C Q + RP +++ L+ +
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 82/291 (28%), Positives = 129/291 (44%), Gaps = 36/291 (12%)
Query: 382 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
++G+G +GKV+ + P D +VAVK ++ S K+F E + L+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA-----------MRLSIALGSSR 484
G C E ++V+E+M +G L L A + + A L IA +
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 485 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544
G++YL A HRD+ N L+ K+ DFG+SR D V H ++
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR-VGGHTMLPIR 187
Query: 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 603
P PE + K T +SDV+SLGVV E+ T G QP N + ++
Sbjct: 188 WMP----PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----------NEVIE 233
Query: 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654
+ G + P C ++ L L C Q E R ++ E+ L+++ P
Sbjct: 234 CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 82/268 (30%), Positives = 124/268 (46%), Gaps = 30/268 (11%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
IG+G +G V +G G VAVK + + + Q FL E +++LHH+NLV L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
G +V E MS G L + L + + + L +L + G+ YL ++ + HR
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
D+ A NIL+ AKV+DFGL+R+ + +P VK T PE K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP------VKWTA----PEALKHKKF 174
Query: 561 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 619
+ KSDV+S GV+ E+ + G P + K ++EV + G P C
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP--YPKMSLKEVKECVEK--------GYRMEPPEGCPA 224
Query: 620 KFIKLALKCCQDETDARPSMSEVMRELE 647
L C + E RPS ++ +LE
Sbjct: 225 DVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 68/225 (30%), Positives = 96/225 (42%), Gaps = 37/225 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL-QGEKEFLT-EIQFLSRLHHRNLVSLVGY 439
IG+G +G V K DG ++ K G++ + EK+ L E+ L L H N+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 440 CDEE--GEQMLVY---EFMSNGTLRDQLSAKSKEP---------LGFAMRLSIALGSSRG 485
D +Y E+ G L QL K K+ +L +AL
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALY---- 119
Query: 486 ILYLHTEADPP--VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
H +DP V HRD+K +NI LD K+ DFGL+++ A T V
Sbjct: 120 --ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG----HDSSFAK--TYV 171
Query: 544 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
GTP Y+ PE +KSD++SLG + EL P +N
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 76/287 (26%), Positives = 122/287 (42%), Gaps = 38/287 (13%)
Query: 382 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
++G+G +GKV+ +LP D +VAVK +E S ++F E + L+ L H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE-------------PLGFAMRLSIALGS 482
G C E ++V+E+M +G L L + + L L+IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 542
+ G++YL A HRD+ N L+ K+ DFG+SR DI V
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGGR 183
Query: 543 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM 601
++ PE L K T +SD++S GVV E+ T G QP N +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----------TEA 233
Query: 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648
+ + G P C + + C Q E R + ++ L++
Sbjct: 234 IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 84/296 (28%), Positives = 132/296 (44%), Gaps = 49/296 (16%)
Query: 382 QIGQGGYGKVYK---GILPDGT--VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
Q+G+G +G V L D T VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 437 VGYCDEEG--EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
G C G LV E++ G+LRD L K +E L L A +G+ YL ++
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSKR- 128
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-----Y 549
HRD+ NIL++ + K+ DFGL+++ P D E V+ PG +
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKE-------YYKVR-EPGESPIFW 177
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTG-----------MQPISHGKNIVREVNIAYQ 598
PE K + SDV+S GVV EL T M+ + + K
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQ-------- 229
Query: 599 SSMMFSVIDGNMGSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650
+++ +I+ + P C + + +C ++ RPS SE+ ++E+I
Sbjct: 230 -MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 79/283 (27%), Positives = 124/283 (43%), Gaps = 38/283 (13%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE-----KEFLTEIQFLSRL 428
N+ +GQG +G+VY D G +AVK+ E EIQ L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 429 HHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--- 484
H +V G C + E + ++ E+M G+++DQL A A+ ++ +R
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQIL 114
Query: 485 -GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPV-PDIEGIVPAHVST 541
G+ YLH+ + HRDIK +NIL D K+ DFG S RL + G+
Sbjct: 115 EGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS----- 166
Query: 542 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601
V GTP ++ PE K+DV+S+G +E+LT P + + + IA Q +
Sbjct: 167 -VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT- 224
Query: 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ + S+ S F++ + RPS E++R
Sbjct: 225 -----NPQLPSHVSPDARNFLRRTFV---ENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 382 QIGQGGYGKVYKG-ILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 439
++G G G V K P G ++AVK + E + +K+ L E+ L + + +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSK----EPLGFAMRLSIALGSSRGILYLHTEADP 495
G+ + E+M G+L L LG IA+ +G+ YLH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-----IAVAVLKGLTYLHE--KH 120
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK---GTPGYLDP 552
+ HRD+K SNIL++ + K+ DFG+S V+++ K GT Y+ P
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------------VNSLAKTFVGTSSYMAP 168
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584
E + + KSD++SLG+ +EL TG P
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 67/256 (26%), Positives = 110/256 (42%), Gaps = 36/256 (14%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL-V 437
IG+G +GKV D + A+K + + + L E + L L+H LV+L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA---MRLSIA-LGSSRGILYLHTEA 493
+ DEE ++V + + G LR LS K K F+ ++ I + + YLH++
Sbjct: 68 SFQDEENMYLVV-DLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVL--ALEYLHSKG 120
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ HRDIK NILLD + + DF ++ P ++T GTPGY+ PE
Sbjct: 121 ---IIHRDIKPDNILLDEQGHVHITDFNIATKVT--------PDTLTTSTSGTPGYMAPE 169
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE--VNIAYQSSMMFSVIDGNMG 611
+ D +SLGV E L G +P +R+ + +++
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW---- 225
Query: 612 SYPSECVEKFIKLALK 627
+E ++ I L+
Sbjct: 226 --STEAID-AINKLLE 238
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 54/291 (18%)
Query: 383 IGQGGYGKVYKGI---LPDGTV---VAVK-RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
+G G +G+VY+G+ V VAVK + S Q E +FL E +S+ +H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLS---AKSKEPLGFAMR--LSIALGSSRGILYLH 490
L+G E + ++ E M+ G L+ L + + P M+ L A ++G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 491 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEG----------IVPA 537
HRDI A N LL K AK+ADFG++R DI ++P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLP- 184
Query: 538 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 596
+K P PE FL T K+DV+S GV+ E+ + G P N +EV
Sbjct: 185 -----IKWMP----PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEV--- 230
Query: 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
M F G + P C ++ C Q + RP+ + ++ ++
Sbjct: 231 ----MEFVTGGGRLD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 7e-23
Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 29/269 (10%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G+V+ G T VA+K ++GS+ E FL E + +L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVVT 71
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
+E ++ E+M NG+L D L L + +A + G+ ++ + HRD
Sbjct: 72 QE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRD 127
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 561
++A+NIL+ K+ADFGL+RL + D E +K T PE T
Sbjct: 128 LRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTA----PEAINYGTFT 181
Query: 562 DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSEC 617
KSDV+S G++ E++T +G+ I Y VI Y P C
Sbjct: 182 IKSDVWSFGILLTEIVT------YGR-------IPYPGMTNPEVIQNLERGYRMPRPDNC 228
Query: 618 VEKFIKLALKCCQDETDARPSMSEVMREL 646
E+ +L C +++ + RP+ E +R +
Sbjct: 229 PEELYELMRLCWKEKPEERPTF-EYLRSV 256
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 25/265 (9%)
Query: 383 IGQGGYGK--VYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+G +G+ +Y+ D ++V K L + ++ L EI LS L H N+++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ ++ ++ E+ + GTL D++ + + M L + Y+H +
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---IL 123
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRDIK NI L K+ DFG+S+ I G + TVV GTP Y+ PE
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISK------ILGSEYSMAETVV-GTPYYMSPELCQGV 176
Query: 559 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618
K KSD+++LG V ELLT + R + +++ ++ GN S
Sbjct: 177 KYNFKSDIWALGCVLYELLT----------LKRTFDATNPLNLVVKIVQGNYTPVVSVYS 226
Query: 619 EKFIKLALKCCQDETDARPSMSEVM 643
+ I L Q + + RP+ EV+
Sbjct: 227 SELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 78/277 (28%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 383 IGQGGYGKVYKGI-LPDG----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 436
+G G +G VYKG+ +P+G VA+K +E + + KE L E ++ + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 437 VGYCDEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
+G C Q L+ + M G L D + K+ +G L+ + ++G+ YL +
Sbjct: 75 LGIC--LSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLE---EK 128
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYL 550
+ HRD+ A N+L+ K+ DFGL++L V + E G VP +K ++
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP------IK----WM 178
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609
E L T KSDV+S GV EL+T G +P G E+ + + G
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIP-AVEI-----PDL---LEKGE 228
Query: 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
P C + +KC + ++RP+ E++ E
Sbjct: 229 RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 32/271 (11%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-CD 441
IG+G +G V G G VAVK + + + FL E +++L H NLV L+G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
E+G +V E+M+ G+L D L ++ + LG L +L + YL EA+ V HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EANNFV-HRD 127
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 561
+ A N+L+ AKV+DFGL++ A G +P VK T PE K +
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKFS 177
Query: 562 DKSDVYSLGVVFLELLT-GMQPISH--GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618
KSDV+S G++ E+ + G P K++V V Y+ M + P C
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------MDA-PDGCP 225
Query: 619 EKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ +C + RPS ++ +LE I
Sbjct: 226 PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 68/272 (25%), Positives = 122/272 (44%), Gaps = 23/272 (8%)
Query: 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRN 432
+F +IG+G +G V+K + D V A+K+ + + + +E + E + L++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
++ ++G+ +V E+ NG L L + PL + G+ +LH++
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ HRDIK+ N+ LD K+ D G+++L +T+V GTP YL P
Sbjct: 121 K---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIV-GTPYYLSP 170
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612
E +KSDV++LGVV E TG P + Q +++ +I G
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPF----------DANNQGALILKIIRGVFPP 220
Query: 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
++ +L +C + RP +++R
Sbjct: 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 70/274 (25%), Positives = 110/274 (40%), Gaps = 29/274 (10%)
Query: 382 QIGQGGYGKVYKG--ILPDGTV--VAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSL 436
++G G +G V +G G V VAVK + L +FL E + L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
G M+V E G+L D+L + + A+ + G+ YL ++
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYF 555
HRD+ A NILL K+ DFGL R P + +V P + PE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNE-----DHYVMEEHLKVPFAWCAPESL 172
Query: 556 LTHKLTDKSDVYSLGVVFLELLT-GMQPISH--GKNIVREVNIAYQSSMMFSVIDGNMGS 612
T + SDV+ GV E+ T G +P + G I+++++ +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL-----------E 221
Query: 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
P C + + L+C RP+ + + L
Sbjct: 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVG 438
+IG+G YG VYK G +VA+K+ + K L EI+ L L+H N++ L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+G+ LV+EFM +L + L ++ S +G+ + H+ +
Sbjct: 66 VFRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---IL 120
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRD+K N+L++ + K+ADFGL+R P V + VV T Y PE L
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSP-----VRPYTHYVV--TRWYRAPELLLGD 173
Query: 559 KLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVN 594
K D++S+G +F ELL+ +P+ GK+ + ++
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLF 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 75/237 (31%), Positives = 112/237 (47%), Gaps = 34/237 (14%)
Query: 373 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-F----LTEIQFLS 426
++ ++G+G +G+VYK + G VVA+K+ + EK+ F L EI+ L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILK 62
Query: 427 RLHHRNLVSL----VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMR 475
+L H N+V L V D+ + +V +M +G L + S K E
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP-SVKLTESQIKCYM 121
Query: 476 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL----APVPDI 531
L + GI YLH + + HRDIKA+NIL+D++ K+ADFGL+R P P
Sbjct: 122 LQLL----EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGK 587
G T + T Y PE L + T D++ +G VF E+ T +PI GK
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPILQGK 230
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 8e-21
Identities = 86/275 (31%), Positives = 124/275 (45%), Gaps = 32/275 (11%)
Query: 377 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 432
F +IG G +G VY + VVA+K+ + G EK + + E++FL +L H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+ G E LV E+ G+ D L K+PL +I G+ +G+ YLH+
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
HRDIKA NILL T K+ADFG + L PA+ S V GTP ++ P
Sbjct: 135 E---RIHRDIKAGNILLTEPGTVKLADFGSASLVS--------PAN-SFV--GTPYWMAP 180
Query: 553 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609
E L + K DV+SLG+ +EL P+ + + +IA S S D
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW- 239
Query: 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
S+ F+ C Q RPS E+++
Sbjct: 240 -----SDYFRNFVD---SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 9e-21
Identities = 86/281 (30%), Positives = 125/281 (44%), Gaps = 35/281 (12%)
Query: 376 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKE---FLTEIQFLSRLH 429
N+ +GQG +G+VY D G +A K+ Q S + KE EIQ L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 430 HRNLVSLVGYCDEEGEQMLV--YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 487
H +V G + E+ L E+M G+++DQL A A+ S+ +R IL
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQIL 116
Query: 488 ----YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
YLH+ + HRDIK +NIL D K+ DFG S+ + G V+
Sbjct: 117 EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT--- 170
Query: 544 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603
GTP ++ PE K+DV+SLG +E+LT P + + + IA Q +
Sbjct: 171 -GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--- 226
Query: 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ + S+ SE F L C E RPS E++R
Sbjct: 227 ---NPQLPSHISEHARDF----LGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 435
+IG+G YG VYK G +VA+K+ + L+ E E + EI L L+H N+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
L+ E + LV+EF+ + L+ + + L + S +GI Y H+
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
V HRD+K N+L+D + K+ADFGL+R VP V + VV T Y PE
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLARAFGVP-----VRTYTHEVV--TLWYRAPEIL 171
Query: 556 L-THKLTDKSDVYSLGVVFLELLTGMQPISHG 586
L + + + D++S+G +F E++ +P+ G
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNR-RPLFPG 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 435
+IG+G YG VYKG G +VA+K+ + L+ E+E + EI L L H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
L +E L++EF+S + S + + + S +GIL+ H+
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
V HRD+K N+L+D+K K+ADFGL+R +P V + VV T Y PE
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-----VRVYTHEVV--TLWYRAPEVL 173
Query: 556 L-THKLTDKSDVYSLGVVFLELLTGMQPISHG 586
L + + + D++S+G +F E+ T +P+ HG
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 66/258 (25%), Positives = 117/258 (45%), Gaps = 21/258 (8%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G+V+ G + T VAVK + G++ + FL E + L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
+E ++ E+M+ G+L D L + + + + + G+ Y+ + HRD
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRD 128
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 561
++A+N+L+ K+ADFGL+R+ + D E +K T PE T
Sbjct: 129 LRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFT 182
Query: 562 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 620
KSDV+S G++ E++T G P N S +M ++ G C ++
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSN----------SDVMSALQRGYRMPRMENCPDE 232
Query: 621 FIKLALKCCQDETDARPS 638
+ C +++ + RP+
Sbjct: 233 LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVKRAQ---EGSLQGEKEFLT---EIQFLSRLHHRNLVSL 436
+G+G YG VY G+ G ++AVK+ + L EKE+ E+ L L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C ++ + EF+ G++ L+ P + + + G+ YLH +
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH---NNC 122
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
V HRDIK +N++L K+ DFG +R + G +++ + GTP ++ PE
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG-THSNMLKSMHGTPYWMAPEVIN 181
Query: 557 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN--MGSYP 614
KSD++S+G E+ TG P++ + + MF + M P
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----------AAMFYIGAHRGLMPRLP 231
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMR 644
I C + RPS +++R
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 440
IG+G +G+VYK I VVA+K + E E + EIQFLS+ + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-S 67
Query: 441 DEEGEQM-LVYEFMSNGTLRDQL-SAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPPV 497
+G ++ ++ E+ G+ D L K E + F +R + G+ YLH E
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LGLEYLHEEG---K 119
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVK-----GTPGYLD 551
HRDIKA+NILL + K+ADFG V ++ T+ K GTP ++
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFG-------------VSGQLTSTMSKRNTFVGTPFWMA 166
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585
PE +K+D++SLG+ +EL G P+S
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVSL 436
+G+G Y VYK G +VA+K+ + G + K+ L EI+ L L H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+ + LV+EFM L + KS L A S L + RG+ YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSI-VLTPADIKSYMLMTLRGLEYLH---SNW 122
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
+ HRD+K +N+L+ K+ADFGL+R P+ + VV T Y PE
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-----MTHQVV--TRWYRAPELLF 175
Query: 557 THKL-TDKSDVYSLGVVFLELL 577
+ D++S+G +F ELL
Sbjct: 176 GARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 37/279 (13%)
Query: 383 IGQGGYGKVYKGI-LPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSL 436
+G G +G VYKGI +PDG VA+K +E S + KE L E ++ + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C Q LV + M G L D + ++K+ +G L+ + ++G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 551
+ HRD+ A N+L+ K+ DFGL+RL + + E G VP ++
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----------WMA 179
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
E L + T +SDV+S GV EL+T G +P RE+ + G
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLEK--------GER 229
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
P C + +KC +++ RP E++ E +
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 53/270 (19%)
Query: 400 TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458
+VAVK + + + +FL E++ LSRL N+ L+G C + ++ E+M NG L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 459 ---------RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 509
A + + L F+ L +A + G+ YL HRD+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLV 163
Query: 510 DHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 566
+T K+ADFG+SR D ++G P + ++ E L K T KSDV
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR--------WMAWESVLLGKFTTKSDV 215
Query: 567 YSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG------------S 612
++ GV E+LT QP H + VI+ N G
Sbjct: 216 WAFGVTLWEILTLCREQPYEHLTD--------------QQVIE-NAGHFFRDDGRQIYLP 260
Query: 613 YPSECVEKFIKLALKCCQDETDARPSMSEV 642
P C + +L L+C + + + RP+ E+
Sbjct: 261 RPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-20
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 26/274 (9%)
Query: 383 IGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 437
IG G +G+V G L VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
G + M+V E+M NG+L D K + + G + G+ YL +D
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGY 127
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
HRD+ A NIL++ KV+DFGLSR L P+ A+ + K + PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAIA 182
Query: 557 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615
K T SDV+S G+V E+++ G +P N ++ ++ +G P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----------QDVIKAIEEGYRLPAPM 232
Query: 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+C +L L C Q + + RP +++ L+ +
Sbjct: 233 DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 77/287 (26%), Positives = 122/287 (42%), Gaps = 41/287 (14%)
Query: 383 IGQGGYGKVYKGIL--PDGTV--VAVKRAQ-EGSLQGE-KEFLTEIQFLSRLHHRNLVSL 436
+G+G +G V +G L DG+ VAVK + + E +EFL+E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 437 VGYCDEEGEQ------MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRGI 486
+G C E M++ FM +G L L E L L + + G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI--EGIVPAHVSTV-V 543
YL HRD+ A N +L T VADFGLS+ D +G ++ + V
Sbjct: 127 EYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG----RIAKMPV 179
Query: 544 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 602
K ++ E T KSDV++ GV E+ T G P +N +
Sbjct: 180 K----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----------HEIY 225
Query: 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ GN P +C+++ L C + + RP+ +++ LE+I
Sbjct: 226 DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 87/313 (27%), Positives = 135/313 (43%), Gaps = 54/313 (17%)
Query: 371 ALATNNFNSSTQIGQGGYGKVYKG-ILPDGTVV--AVKRAQE-GSLQGEKEFLTEIQFLS 426
L N+ IG+G +G+V K I DG + A+KR +E S ++F E++ L
Sbjct: 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 62
Query: 427 RL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLG 471
+L HH N+++L+G C+ G L E+ +G L D L + + L
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 472 FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531
L A +RG+ YL + HRD+ A NIL+ + AK+ADFGLSR V
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--- 176
Query: 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISH 585
VK T G L + L T SDV+S GV+ E+++ G P
Sbjct: 177 ----------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC- 225
Query: 586 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 645
G + + + G P C ++ L +C +++ RPS +++
Sbjct: 226 GMTC---------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI--- 273
Query: 646 LESIWNMMPESDT 658
L S+ M+ E T
Sbjct: 274 LVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 76/278 (27%), Positives = 127/278 (45%), Gaps = 32/278 (11%)
Query: 383 IGQGGYGKVYKGIL-PDG---TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 437
IG G +G+V +G L G VA+K + G + + ++FL+E + + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
G + M++ EFM NG L D ++ + + G + G+ YL ++
Sbjct: 72 GVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNY 127
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFL 556
HRD+ A NIL++ KV+DFGLSR + + P + S++ P + PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 557 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY-- 613
K T SDV+S G+V E+++ G +P Y VI+ Y
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP--------------YWDMSNQDVINAIEQDYRL 230
Query: 614 --PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
P +C +L L C Q + +ARP +++ L+ +
Sbjct: 231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 44/297 (14%)
Query: 372 LATNNFNSSTQIGQGGYGKVY----KGILPDG--TVVAVKRAQEGSLQGEK-EFLTEIQF 424
+A S ++GQG +G VY KG++ D T VA+K E + E+ EFL E
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 425 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------SAKSKEPLGFAMRL 476
+ + ++V L+G + +++ E M+ G L+ L + + P +
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 477 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----- 531
+A + G+ YL+ HRD+ A N ++ FT K+ DFG++R D
Sbjct: 123 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 590
+G++P ++ PE T SDV+S GVV E+ T QP N
Sbjct: 180 KGLLPVR----------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-- 227
Query: 591 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
++ V++G + P C + +L C Q RPS E++ ++
Sbjct: 228 --------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-- 438
IG+G YGKVYK G +VA+K + E+E E L + +H N+ + G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 439 ----YCDEEGEQMLVYEFMSNGT-------LRDQLSAKSKEPLGFAMRLSIALGSSRGIL 487
+ + LV E G+ LR + +E + + +R ++ RG+
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL-----RGLA 127
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV-STVVK-- 544
YLH + V HRDIK NILL K+ DFG+S A + ST+ +
Sbjct: 128 YLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS-------------AQLDSTLGRRN 171
Query: 545 ---GTPGYLDPE-----YFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584
GTP ++ PE +SDV+SLG+ +EL G P+
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 435
+IG+G YG V+K +VA+KR + L + E L EI L L H+N+V
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 436 LVGYCDEEGEQMLVYEFMS----------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 485
L + + LV+E+ NG + D KS F +L +G
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKS-----FMFQLL------KG 111
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
+ + H+ V HRD+K N+L++ K+ADFGL+R +P V + + VV
Sbjct: 112 LAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP-----VRCYSAEVV-- 161
Query: 546 TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNI 589
T Y P+ KL S D++S G +F EL +P+ G ++
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 74/272 (27%), Positives = 130/272 (47%), Gaps = 26/272 (9%)
Query: 382 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 438
+IG+G +G+V+ G L D T VAVK +E +L + +FL E + L + H N+V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
C ++ +V E + G L + L + + ++ G+ YL ++
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLT 557
HRD+ A N L+ K K++DFG+SR + +G+ + + +K P + PE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYAS--TGGMKQIPVKWTAPEALNY 170
Query: 558 HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 616
+ + +SDV+S G++ E + G P + N++ Q + + G P
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYA---------NLSNQQTREA-IEQGVRLPCPEL 220
Query: 617 CVEKFIKLALKCCQDETDARPSMSEVMRELES 648
C + +L +C + + RPS S V +EL+S
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-19
Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 37/266 (13%)
Query: 399 GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLV--GYCDEEGEQMLVYEFM 453
G VA+K + + + E + F E +RL+H N+V+L+ G G V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 454 SNGTLRDQLSAKSKEPLGFAMRL------SIALGSSRGILYLHTEADPPVFHRDIKASNI 507
TLR+ L+A P G RL ++A ++GI+ HRD+K NI
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIV-----------HRDLKPQNI 110
Query: 508 LL---DHKFTAKVADFGLSRLAPVPDIEGIVPAHVS--TVVKGTPGYLDPEYFLTHKLTD 562
++ + AKV DFG+ L +P + A ++ T V GTP Y PE +T
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTL--LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 563 KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 622
SD+Y+ G++FLE LTG Q + G + V E+ S + S + + +P + + +
Sbjct: 169 NSDLYAWGLIFLECLTG-QRVVQGAS-VAEILYQQLSPVDVS-LPPWIAGHP---LGQVL 222
Query: 623 KLAL-KCCQDETDARPSMSEVMRELE 647
+ AL K + + P+++E R LE
Sbjct: 223 RKALNKDPRQRAASAPALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 73/289 (25%), Positives = 127/289 (43%), Gaps = 40/289 (13%)
Query: 382 QIGQGGYGKVYKG--ILP---DGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVS 435
++G+ +GK+YKG LP +VA+K ++ + Q EF E ++ LHH N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---------------KEPLGFAMRLSIAL 480
L+G +E +++E+++ G L + L +S K L L IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 481 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 540
+ G+ YL + H+D+ A NIL+ + K++D GLSR D + P +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 541 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 599
+ ++ PE + K + SD++S GVV E+ + G+QP N
Sbjct: 189 PI-----RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----------Q 233
Query: 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648
++ V + +C + L +C Q+ RP ++ L S
Sbjct: 234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 78/296 (26%), Positives = 136/296 (45%), Gaps = 53/296 (17%)
Query: 383 IGQGGYGKVYKGIL-----PDGTV-VAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 434
+G+G +G+V K P+ T VAVK ++ + + + + ++E++ + + H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIAL 480
+L+G C +EG +V E+ ++G LRD L A+ +E L +S A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 481 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 540
+RG+ +L A HRD+ A N+L+ K+ADFGL+R DI H+
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIH-----HID 186
Query: 541 TVVKGTPGYLD-----PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 594
K T G L PE T +SDV+S GV+ E+ T G P
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP---------G 237
Query: 595 IAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
I + +F ++ +G P C ++ L C + RP+ +++ +L+ +
Sbjct: 238 IPVEE--LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 35/281 (12%)
Query: 376 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKE---FLTEIQFLSRLH 429
N+ +GQG +G+VY D G +AVK+ Q S + KE EIQ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 430 HRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--- 484
H +V G + E+ L E M G+++DQL + A+ ++ +R
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQIL 116
Query: 485 -GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
G+ YLH+ + HRDIK +NIL D K+ DFG S+ + G V+
Sbjct: 117 EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT--- 170
Query: 544 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603
GTP ++ PE K+D++S+G +E+LT P + + + IA Q +
Sbjct: 171 -GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--- 226
Query: 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ + + S+ F+K E RPS E++R
Sbjct: 227 ---NPVLPPHVSDHCRDFLKRIFV----EAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 75/267 (28%), Positives = 117/267 (43%), Gaps = 49/267 (18%)
Query: 377 FNSSTQIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSLQGEKEFLT--------EIQFL 425
+ IG+G YG+VYK DG A+K+ +G+KE T EI L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-----FKGDKEQYTGISQSACREIALL 56
Query: 426 SRLHHRNLVSLVGYC--DEEGEQMLVYEFMSN---GTLRDQLSAKSKEPLGFAMRLSIAL 480
L H N+VSLV + L++++ + ++ AK + +M S+
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRV-SIPPSMVKSLLW 115
Query: 481 GSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL---APVPDIEG 533
G+ YLH+ V HRD+K +NIL+ + K+ D GL+RL P
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP---- 168
Query: 534 IVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 592
A + VV T Y PE L T D++++G +F ELLT ++PI G+ +
Sbjct: 169 --LADLDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAKIK 224
Query: 593 VNIAYQSSMM---FSVIDGNMGSYPSE 616
+ +Q + F V +G P+E
Sbjct: 225 KSNPFQRDQLERIFEV----LG-TPTE 246
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 4e-19
Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 383 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 438
+G+G +GKV G + A+K ++ + KE LTE LSR++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGILYLHTEAD 494
E + LV E+ G L LS + + +A + +AL YLH+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE------YLHSLG- 113
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
+ +RD+K NILLD K+ DFGL++ + +T GTP YL PE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------SRTNTFC-GTPEYLAPEV 164
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQP 582
L D +SLGV+ E+LTG P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 429
NF +IG+G YG VYK G VVA+K+ + L E E + EI L L+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELN 57
Query: 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 489
H N+V L+ E + LV+EF+ + L+ + A + + S +G+ +
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
H+ V HRD+K N+L++ + K+ADFGL+R VP V + VV T Y
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-----VRTYTHEVV--TLWY 166
Query: 550 LDPEYFLTHKL-TDKSDVYSLGVVFLELLT 578
PE L K + D++SLG +F E++T
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 6e-19
Identities = 83/314 (26%), Positives = 145/314 (46%), Gaps = 61/314 (19%)
Query: 383 IGQGGYGKVYK----GI---LPDGTV-VAVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRN 432
+G+G +G+V + GI PD TV VAVK ++ + + + ++E++ + + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 478
+++L+G C +EG ++ E+ + G LR+ L A+ +E L F +S
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------ 532
A +RG+ YL + HRD+ A N+L+ K+ADFGL+R V DI+
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTS 194
Query: 533 -GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 590
G +P VK ++ PE T +SDV+S G++ E+ T G P
Sbjct: 195 NGRLP------VK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP------ 238
Query: 591 REVNIAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
I + +F ++ +G+ PS C + L +C RP+ +++ L+ +
Sbjct: 239 ---GIPVEE--LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
Query: 650 WNMMPES--DTKTP 661
+ E D P
Sbjct: 294 LAAVSEEYLDLSMP 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 75/284 (26%), Positives = 132/284 (46%), Gaps = 46/284 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRA--------QEGSLQGE--KEFLTEIQFLSRLHHR 431
IG+G YG+VY + + G ++AVK+ + S Q + K +EI+ L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGILYL 489
N+V +G+ E + E++ G++ L + +E L +R G+ YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---VR-FFTEQVLEGLAYL 124
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
H++ + HRD+KA N+L+D K++DFG+S+ + + I + ++G+ +
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKS-----DDIYDNDQNMSMQGSVFW 176
Query: 550 LDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607
+ PE ++ + K D++SLG V LE+ G +P S + I + MF +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----------AAMFKL-- 224
Query: 608 GNMGS---YPSECVEKFIKLALK----CCQDETDARPSMSEVMR 644
GN S P + +AL C D RP+ E+++
Sbjct: 225 GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 69/225 (30%), Positives = 113/225 (50%), Gaps = 33/225 (14%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---F----LTEIQFLSRLHHRNLV 434
I +G YG VY+ G +VA+K+ L+ EKE F L EI L +L H N+V
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKK-----LKMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 435 SL----VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
++ VG + +V E++ + L+ + K+P + + L G+ +LH
Sbjct: 68 TVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
D + HRD+K SN+LL+++ K+ DFGL+R P + + VV T Y
Sbjct: 124 ---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-----LKPYTQLVV--TLWYR 173
Query: 551 DPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 594
PE L + + D++S+G +F ELLT +P+ GK+ + ++N
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLN 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 77/287 (26%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 382 QIGQGGYGKVYKGILPD------GTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLV 434
++GQG +G VY+G D T VAVK E SL+ EFL E + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSA---KSKEPLG-----FAMRLSIALGSSRGI 486
L+G + ++V E M++G L+ L + +++ G + +A + G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVST 541
YL+ + HRD+ A N ++ H FT K+ DFG++R D +G++P
Sbjct: 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 542 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 600
++ PE T SD++S GVV E+ + QP N +
Sbjct: 187 -------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------EQV 230
Query: 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
+ F V+DG P C E+ L C Q RP+ E++ L+
Sbjct: 231 LKF-VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 33/273 (12%)
Query: 382 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
++G G +GKVYK + G A K Q S + ++F+ EI LS H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 441 DEEGEQMLVYEFMSNGTLR---DQLSAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPP 496
E + ++ EF G L +L EP + + R + + +LH+
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSHK--- 123
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
V HRD+KA NILL K+ADFG+S T + GTP ++ PE
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL------QKRDTFI-GTPYWMAPEVVA 176
Query: 557 THKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
D K+D++SLG+ +E L M+P H N +R V + S +
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIE-LAQMEPPHHELNPMR-VLLKILKS------EPPTL 228
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
PS+ F C + D RP+ +E+++
Sbjct: 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 71/296 (23%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 383 IGQGGYGKVYK----GILPD----GTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRN 432
+G+G +G+V GI D VAVK ++ + + + + ++E++ + + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 478
+++L+G C ++G ++ E+ S G LR+ L A+ E + F +S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D+ I
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DVNNIDYYK 194
Query: 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 597
+T + ++ PE T +SDV+S GV+ E+ T G P
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-----------GI 243
Query: 598 QSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652
+F ++ +G+ P+ C + + C RP+ +++ +L+ I +
Sbjct: 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGY 439
+G G G V K +P GTV+A K G+ K+ L E+Q + +VS G
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
E + EFM G+L D++ K P+ + IA+ G+ YL+ + H
Sbjct: 72 FLNENNICMCMEFMDCGSL-DRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHR--IMH 127
Query: 500 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 559
RDIK SNIL++ + K+ DFG+S G + ++ GT Y+ PE K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---------GELINSIADTFVGTSTYMSPERIQGGK 178
Query: 560 LTDKSDVYSLGVVFLELLTGMQPIS 584
T KSDV+SLG+ +EL G P +
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 439
+G+G YG V K G +VA+K + E +K L E++ L +L H N+V+L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF---AMRLSIALGSSRGILYLHTEADPP 496
+G LV+E++ TL + L A P G A+R I + I Y H+
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEAS---PGGLPPDAVRSYI-WQLLQAIAYCHSHN--- 120
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
+ HRDIK NIL+ K+ DFG +R PA T T Y PE +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRAR------PASPLTDYVATRWYRAPELLV 174
Query: 557 THKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
K DV+++G + ELL G +P+ G +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 59/234 (25%), Positives = 90/234 (38%), Gaps = 28/234 (11%)
Query: 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRL-H 429
++F IG+G + V A+K + L EK E + L+RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 489
H ++ L +E V E+ NG L + L A + YL
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYL 118
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP------------- 536
H++ + HRD+K NILLD K+ DFG +++
Sbjct: 119 HSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 537 -AHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKN 588
++ V GT Y+ PE L K K SD+++LG + ++LTG P G N
Sbjct: 176 RRRFASFV-GTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPF-RGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 76/242 (31%), Positives = 118/242 (48%), Gaps = 40/242 (16%)
Query: 367 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKE-----FLT 420
+G+ + + F+ QIG+G YG+VYK D G +VA+K+ + L EKE +
Sbjct: 1 WGKRCV--DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIR 55
Query: 421 EIQFLSRLHHRNLVSL----------VGYCDEEGEQMLVYEFMSN---GTLRDQLSAKSK 467
EI+ L +L+HRN+V+L + + ++G LV+E+M + G L L S+
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 468 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527
+ + M+ + G+ Y H HRDIK SNILL++K K+ADFGL+RL
Sbjct: 116 DHIKSFMKQLL-----EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHG 586
+ + + V+ T Y PE L + DV+S G + EL T +PI
Sbjct: 168 SEESR----PYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQA 220
Query: 587 KN 588
Sbjct: 221 NQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKE-------FLTEIQFLSRLHHRN 432
IG G +G VY G+ G ++AVK+ + S + EI L L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNG---TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 489
+V +G + + E++ G L + A +E L I +G+ YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQIL----KGLNYL 122
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
H + HRDIK +NIL+D+K K++DFG+S+ + + ++G+ +
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609
+ PE T K+D++SLG + +E+LTG P Q +F + +
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD----------CTQLQAIFKIGENA 228
Query: 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
PS + I K + + + RP+ +E+++
Sbjct: 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 27/274 (9%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRA-----QEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
+G G +G VYKGI +P+G V + A + + EF+ E ++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C Q LV + M +G L D + + K+ +G + L+ + ++G++YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEERR--- 129
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
+ HRD+ A N+L+ K+ DFGL+RL +EG + + K ++ E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARL-----LEGDEKEYNADGGKMPIKWMALECIH 184
Query: 557 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615
K T +SDV+S GV EL+T G +P + RE+ + G P
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP--YDGIPTREIPDLLEK--------GERLPQPP 234
Query: 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
C + +KC + D+RP E+ E +
Sbjct: 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 383 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGY 439
IG+G +G V+K G VA+K+ L+G + L EI+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
+LV E+M L + L + PL A S +G+ Y+H + H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMHANG---IMH 122
Query: 500 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-TH 558
RD+K +N+L+ K+ADFGL+RL E + V T Y PE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFS----EEEPRLYSHQV--ATRWYRAPELLYGAR 176
Query: 559 KLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
K D++++G +F ELL G P+ G+N
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG-SPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 76/306 (24%), Positives = 120/306 (39%), Gaps = 61/306 (19%)
Query: 371 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQG-EKEFLTEIQ 423
A +N T +G+G +G+V+ T+V VK Q+ + + EF E+
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 424 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKE------PLGFAMRL 476
+L H+N+V L+G C E ++ E+ G L+ L A KSK+ PL ++
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 477 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR------------ 524
++ + G+ +L HRD+ A N L+ + KV+ LS+
Sbjct: 121 ALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 525 -LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 582
L P+ +L PE + KSDV+S GV+ E+ T G P
Sbjct: 178 ALIPLR-------------------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
Query: 583 ISHGKNIVREVNIAYQS-SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 641
EV Q+ + V P C + KL +C RPS SE
Sbjct: 219 --FYGLSDEEVLNRLQAGKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSE 268
Query: 642 VMRELE 647
++ L
Sbjct: 269 LVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 83/280 (29%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRNLVSLV 437
+IG G +G VY VVAVK+ + G EK + + E++FL +L H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
G +E LV E+ G+ D L K+PL +I G+ +G+ YLH+ +
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 557
HRDIKA NILL K+ADFG + + PA+ S V GTP ++ PE L
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSS--------PAN-SFV--GTPYWMAPEVILA 191
Query: 558 H---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
+ K DV+SLG+ +EL P+ + + +IA S
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ---------S 242
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654
+E + F C Q RP+ +E++R + + P
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH-DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 53/243 (21%)
Query: 376 NFNSSTQIGQGGYGKVYKG-ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 429
F +IG+G YG VY+ G +VA+K+ + + E++ L EI L L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR---MDNERDGIPISSLREITLLLNLR 64
Query: 430 HRNLVSL---------------VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 474
H N+V L + YC EQ L +L D + P +
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYC----EQDL-------ASLLDNMPT----PFSESQ 109
Query: 475 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534
+ L RG+ YLH + HRD+K SN+LL K K+ADFGL+R G+
Sbjct: 110 VKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY------GL 160
Query: 535 VPAHVS-TVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVRE 592
++ VV T Y PE L + D++++G + ELL +P+ GK+ + +
Sbjct: 161 PAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEIEQ 217
Query: 593 VNI 595
+++
Sbjct: 218 LDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 37/281 (13%)
Query: 383 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLV 437
IG+G +G VY+G+ + VAVK + + +E FL E + + H ++V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
G E +V E G LR L +K L A + + S + YL ++
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESKR---F 128
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-----YLDP 552
HRDI A N+L+ K+ DFGLSR + K + G ++ P
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRY-----------LEDESYYKASKGKLPIKWMAP 177
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
E + T SDV+ GV E+L G++P KN + ++ + +G
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----------NDVIGRIENGERL 227
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652
P C L KC + RP +E+ +L I
Sbjct: 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 69/276 (25%), Positives = 125/276 (45%), Gaps = 33/276 (11%)
Query: 376 NFNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSL-QGEKE-FLTEIQFLSRLHHRN 432
+F ++G+G YG VYK L D A+K GS+ Q E+E + EI+ L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 433 LVSLVGYCDE--EGEQM-LVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGIL 487
++S Y + +G ++ +V E+ G L +S K ++ + I + RG+
Sbjct: 61 IIS---YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
LH + + HRD+K++NILL K+ D G+S++ +++ GTP
Sbjct: 118 ALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---------KNMAKTQIGTP 165
Query: 548 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607
Y+ PE + + KSD++SLG + E+ T P +++ + + V
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSM---------QDLRYKVQR 215
Query: 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 643
G P + Q + RP+ +++
Sbjct: 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 30/271 (11%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G+V+ T VAVK + GS+ E FL E + L H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVT 71
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
+E ++ EFM+ G+L D L + SK+PL + S + + G+ ++ H
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQRN---YIH 125
Query: 500 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 559
RD++A+NIL+ K+ADFGL+R+ + D E +K T PE
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGS 179
Query: 560 LTDKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGSYPSE 616
T KSDV+S G++ +E++T G P N ++R + Y+ +
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN------------ 227
Query: 617 CVEKFIKLALKCCQDETDARPSMSEVMRELE 647
C E+ + ++C ++ + RP+ + L+
Sbjct: 228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-18
Identities = 80/328 (24%), Positives = 150/328 (45%), Gaps = 53/328 (16%)
Query: 383 IGQGGYGKVYK----GILPD----GTVVAVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRN 432
+G+G +G+V GI D VAVK ++ + + + ++E++ + + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSI 478
+++L+G C ++G ++ E+ S G LR+ L A+ +E L F +S
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R D+ I
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DVHNIDYYK 191
Query: 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598
+T + ++ PE T +SDV+S GV+ E+ T + + V E
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-LGGSPYPGIPVEE------ 244
Query: 599 SSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 657
+F ++ +G+ P+ C + + +C RP+ +++ +L+ + +
Sbjct: 245 ---LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV----- 296
Query: 658 TKTPEFINSEHTSKEETP-----PSSSS 680
T T E+++ ++ +P PSS S
Sbjct: 297 TSTDEYLDLSVPFEQYSPGCPDSPSSCS 324
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 76/301 (25%), Positives = 135/301 (44%), Gaps = 55/301 (18%)
Query: 383 IGQGGYGKVYK----GILPDG----TVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRN 432
+G+G +G+V G+ + T VAVK + + + + + ++E++ + + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSI 478
+++L+G C ++G ++ E+ S G LR+ L A+ +E L F +S
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R DI H
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIH-----H 192
Query: 539 VSTVVKGTPG-----YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 592
+ K T G ++ PE T +SDV+S GV+ E+ T G P
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-------- 244
Query: 593 VNIAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651
+F ++ +G+ PS C + + C RP+ +++ +L+ I
Sbjct: 245 ---GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
Query: 652 M 652
+
Sbjct: 302 L 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 27/222 (12%)
Query: 375 NNFNSSTQIGQGGYGKVYK----GILPDGTV--VAVKRAQEGSLQGEKEFL-TEIQFLSR 427
NN + +G G +GKV + G+ V VAVK + + E+E L +E++ +S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 428 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 486
L +H N+V+L+G C G +++ E+ G L + L K + L LS + ++G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST-VVKG 545
+L A HRD+ A N+LL H K+ DFGL+R DI + S VVKG
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DI-----MNDSNYVVKG 201
Query: 546 TP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 582
++ PE T +SDV+S G++ E+ + G P
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 37/271 (13%)
Query: 383 IGQGGYGKVY--KGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 439
+G+G +G V+ + V+ + E + E+ E Q L L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAK------SKEPLGFAMRLSIALGSSRGILYLHTEA 493
E+ M+V E+ GTL + + + L F +++ +AL ++HT+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH------HVHTKL 121
Query: 494 DPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ HRD+K NILLD HK K+ DFG+S++ + TVV GTP Y+ P
Sbjct: 122 ---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYTVV-GTPCYISP 170
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612
E KSD+++LG V EL + + R A +++ ++ G
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELAS----------LKRAFEAANLPALVLKIMSGTFAP 220
Query: 613 YPSECVEKFIKLALKCCQDETDARPSMSEVM 643
+L L + RP +S++M
Sbjct: 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 79/295 (26%), Positives = 124/295 (42%), Gaps = 59/295 (20%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGILPDGTV-VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 432
+ +G+G YG VY V +A+K E + + EI S L HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK-----SKEP-LGFAMRLSIALGSSRGI 486
+V +G E G + E + G+L L +K E + F + + G+
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGL 121
Query: 487 LYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK 544
YLH D + HRDIK N+L++ + K++DFG S RLA GI P +
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA------GINP--CTETFT 170
Query: 545 GTPGYLDPEYFLTHKLTDK--------SDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 596
GT Y+ PE + DK +D++SLG +E+ TG P + +
Sbjct: 171 GTLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPF---------IELG 215
Query: 597 YQSSMMFSVIDGNMGSYP------SECVEKFIKLALKCCQDETDARPSMSEVMRE 645
+ MF V G +P S + FI L+C + + D R S +++++
Sbjct: 216 EPQAAMFKV--GMFKIHPEIPESLSAEAKNFI---LRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 70/268 (26%), Positives = 118/268 (44%), Gaps = 28/268 (10%)
Query: 382 QIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
++G G +G V KG+ D + +K E S++ E + E + + +L + +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR--DEMMREAEIMHQLDNPYIVR 59
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
++G C+ E MLV E S G L LS K K+ + + + + S G+ YL +
Sbjct: 60 MIGVCEAEA-LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN-- 115
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
HRD+ A N+LL ++ AK++DFGLS+ D + K + PE
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----YKARSAGKWPLKWYAPECI 170
Query: 556 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
K + +SDV+S G+ E + G +P K +M + G P
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----------PEVMSFIEQGKRLDCP 220
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEV 642
+EC + L C + + RP+ ++V
Sbjct: 221 AECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 35/285 (12%)
Query: 383 IGQGGYGKVYKGILP--DGTV--VAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
+G+G +G V + L DG+ VAVK +A S +EFL E + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 437 VGYCDEEGEQ------MLVYEFMSNGTLRDQL--SAKSKEPLGFAMR--LSIALGSSRGI 486
+G + M++ FM +G L L S +EP ++ + + + G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
YL ++ HRD+ A N +L+ T VADFGLS+ D K
Sbjct: 127 EYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY-----YRQGCASKLP 178
Query: 547 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 605
+L E + T SDV++ GV E++T G P + +N S + +
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----------SEIYNYL 228
Query: 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650
I GN P +C+E +L +C E RPS + +LE IW
Sbjct: 229 IKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGY- 439
IG+G YG VY+G +P G VVA+K + + + E+ LS+L ++ Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 440 -CDEEGEQM-LVYEFMSNGTLRDQLSA-KSKEP-LGFAMR-LSIALGSSRGILYLHTEAD 494
+G ++ ++ E+ G++R + A E + +R + +AL Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK------YIHKV-- 120
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
V HRDIKA+NIL+ + K+ DFG++ L + ST V GTP ++ PE
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALL------NQNSSKRSTFV-GTPYWMAPEV 172
Query: 555 FLTHKLTD-KSDVYSLGVVFLELLTGMQPIS 584
K D K+D++SLG+ E+ TG P S
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYS 203
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 51/289 (17%)
Query: 383 IGQGGYGKVYKGILP-DGTVV--AVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRNLVSLV 437
IG+G +G+V + ++ DG + A+K +E S ++F E++ L +L HH N+++L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLS---------AKSKE-----PLGFAMRLSIALGSS 483
G C+ G + E+ G L D L A +KE L L A +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
G+ YL ++ HRD+ A N+L+ +K+ADFGLSR V V
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV-------------YV 173
Query: 544 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 597
K T G L + L T KSDV+S GV+ E+++ G P G
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC-GMTCAELYEKLP 232
Query: 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
Q M P C ++ +L +C +D RP +++ +L
Sbjct: 233 QGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 74/266 (27%), Positives = 118/266 (44%), Gaps = 39/266 (14%)
Query: 401 VVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 459
+VAVK +E + + + +FL EI+ +SRL N++ L+ C ++ E+M NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 460 DQLSA-KSKEPLGFAMRLSIALGS--------SRGILYLHTEADPPVFHRDIKASNILLD 510
LS + +E A ++I+ + + G+ YL + HRD+ N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVG 164
Query: 511 HKFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSD 565
+T K+ADFG+SR D I+G ++P ++ E L K T SD
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----------WMSWESILLGKFTTASD 214
Query: 566 VYSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY---PSECVEK 620
V++ GV E+LT QP S + + + + F D Y P+ C +
Sbjct: 215 VWAFGVTLWEILTLCKEQPYSQ----LSDEQVIENTGEFFR--DQGRQVYLPKPALCPDS 268
Query: 621 FIKLALKCCQDETDARPSMSEVMREL 646
KL L C + RPS E+ L
Sbjct: 269 LYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLH 429
NF +IG+G + VYK I L DG VVA+K+ Q + K + L EI L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPL------GFAMRLSIALG 481
H N++ + E E +V E G L + K K + + ++L AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 541
++H++ + HRDIK +N+ + K+ D GL R AH S
Sbjct: 121 ------HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA----AH-SL 166
Query: 542 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 576
V GTP Y+ PE + KSD++SLG + E+
Sbjct: 167 V--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF--------LTEIQFLSRL-HHR 431
Q+G G +G VY G +VA+K+ + K+F L E++ L +L H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHP 58
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
N+V L E E V+E+M G L + + +P ++ SI +G+ ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP--AHVSTVVKGTPGY 549
FHRD+K N+L+ K+ADFGL+R +I P +VS T Y
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVS-----TRWY 164
Query: 550 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
PE L D+++LG + EL T ++P+ G +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSS 203
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 439
+G+G YG V K + G +VA+K+ E K + EI+ L +L H NLV+L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
+ LV+EF+ + T+ D L K L + RGI + H+ + H
Sbjct: 69 FRRKKRLYLVFEFVDH-TVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHN---IIH 123
Query: 500 RDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
RDIK NIL+ K+ DFG +R LA P V T T Y PE +
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLA--------APGEVYTDYVATRWYRAPELLVGD 175
Query: 559 -KLTDKSDVYSLGVVFLELLTG 579
K D++++G + E+LTG
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 80/277 (28%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 377 FNSSTQIGQGGYGKVY-KGILPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 432
F +IG G +G VY + VVA+K+ + G EK + + E++FL R+ H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+ G E LV E+ G+ D L K+PL +I G+ +G+ YLH+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ HRDIKA NILL K+ADFG + +A PA+ GTP ++ P
Sbjct: 145 N---MIHRDIKAGNILLTEPGQVKLADFGSASIAS--------PANSFV---GTPYWMAP 190
Query: 553 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609
E L + K DV+SLG+ +EL P+ + + +IA S
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ----- 245
Query: 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
+E + F C Q RP+ E+++ +
Sbjct: 246 ----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 43/227 (18%)
Query: 383 IGQGGYGKVY---KGILPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSL 436
I +G YG+V+ K G + A+K ++ + + + LTE LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 437 VGYCDEEGEQML--VYEFMSNGTLR---------DQLSAK--SKEPLGFAMRLSIALGSS 483
Y +G++ L V E++ G L D+ A+ E I L
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE---------IVLA-- 105
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI--EGIVPAHVST 541
+ YLH+ + HRD+K NIL+D K+ DFGLS++ V
Sbjct: 106 --LEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 542 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
+V GTP Y+ PE L + D +SLG + E L G+ P HG+
Sbjct: 161 IV-GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF-HGET 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 78/292 (26%), Positives = 129/292 (44%), Gaps = 45/292 (15%)
Query: 383 IGQGGYGKV----YKGILPDG----TVVAVKRAQEGSLQGEKEFL-TEIQFLSRLHHRNL 433
+G+G +GKV Y P+G VAVK + S L EI+ L L+H N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 434 VSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
V G C E+G L+ EF+ +G+L++ L ++K + +L A+ +G+ YL +
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
HRD+ A N+L++ + K+ DFGL++ V + + V +
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYA 180
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT----GMQPIS---------HGK-NIVREVNIAY 597
PE + K SDV+S GV ELLT P++ HG+ + R V +
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-- 238
Query: 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ +G P C E+ +L KC + + R + ++ E+I
Sbjct: 239 -------LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 83/334 (24%), Positives = 144/334 (43%), Gaps = 90/334 (26%)
Query: 382 QIGQGGYGKVYK------GILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
++G G +GKVYK G L V+ K +E ++++ EI+ L+ +H +V
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYMVEIEILATCNHPYIVK 73
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRD---QLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
L+G +G+ ++ EF G + +L EP +++ I + YLH+
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHSM 129
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK-----GTP 547
+ HRD+KA N+LL K+ADFG+S +V T+ + GTP
Sbjct: 130 K---IIHRDLKAGNVLLTLDGDIKLADFGVS------------AKNVKTLQRRDSFIGTP 174
Query: 548 GYLDPEYFLTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602
++ PE + + D K+D++SLG+ +E + ++P H N +R
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIE-MAQIEPPHHELNPMR----------- 222
Query: 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 662
+ LK + E P++S+ S W+M + +
Sbjct: 223 ---------------------VLLKIAKSEP---PTLSQ-----PSKWSM------EFRD 247
Query: 663 FINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNL 696
F+ + ET PS++ +L+HP+VSS S L
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 19/234 (8%)
Query: 376 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRA--QEGSLQGEKE---FLTEIQFLSRLH 429
N+ +G+G +G+VY D G +AVK+ S + KE EIQ L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 430 HRNLVSLVGYC--DEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 486
H +V G C D E +++ ++ E+M G+++DQL A R + + +G+
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGV 119
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
YLH+ + HRDIK +NIL D K+ DFG S+ + G V+ GT
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GT 172
Query: 547 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 600
P ++ PE K+DV+S+ +E+LT P + + + IA Q +
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR----AQEGSLQGEKEFLTEIQFLSRLHH 430
NF ++G+G Y VYKG G +VA+K A+EG+ + EI + L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT---PSTAIREISLMKELKH 57
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
N+V L E + MLV+E+M + + + L S +GI + H
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ V HRD+K N+L++ + K+ADFGL+R +P V + VV T Y
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-----VNTFSNEVV--TLWYR 167
Query: 551 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
P+ L + S D++S+G + E++TG +P+ G N
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 2e-16
Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHRNLVSLV- 437
IG G YG V + G VA+K+ L K L EI+ L L H N++ L+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD 66
Query: 438 ----GYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHT 491
++ + +V E M D L KS +PL RG+ YLH+
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST-VVKGTPGYL 550
A+ V HRD+K SNIL++ K+ DFGL+R D + ++ VV T Y
Sbjct: 122 -AN--VIHRDLKPSNILVNSNCDLKICDFGLARGV---DPDEDEKGFLTEYVV--TRWYR 173
Query: 551 DPEYFLT-HKLTDKSDVYSLGVVFLELLTG 579
PE L+ + T D++S+G +F ELLT
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 430
+F TQ+GQGGYG+V+ D G +VA+KR ++ L E LTE L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 431 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGI 486
LV L+ Y ++ E + L E++ G R L+ S++ F M +
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
LH HRD+K N L+D K+ DFGLS+ + A+ S V G+
Sbjct: 117 --LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYAN-SVV--GS 161
Query: 547 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584
P Y+ PE D +SLG + E L G P S
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 29/272 (10%)
Query: 377 FNSSTQIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRN 432
F +IG+G +G+V+KGI D VVA+K + E E + EI LS+
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+ G + + ++ E++ G+ D L A + A L L +G+ YLH+E
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE 120
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
HRDIKA+N+LL + K+ADFG++ I+ +T V GTP ++ P
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR------NTFV-GTPFWMAP 170
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612
E K+D++SLG+ +EL G P S + ++F + N +
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSD----------MHPMRVLFLIPKNNPPT 220
Query: 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
E + F + C + RP+ E+++
Sbjct: 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 439
+G G G VYK L ++AVK + +++ +K+ ++E++ L + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
E + EFM G+L D + LG IA+ +G+ YL + + H
Sbjct: 68 FFVENRISICTEFMDGGSL-DVYRKIPEHVLG-----RIAVAVVKGLTYLWSLK---ILH 118
Query: 500 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 559
RD+K SN+L++ + K+ DFG+S +V + T V GT Y+ PE +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST--------QLVNSIAKTYV-GTNAYMAPERISGEQ 169
Query: 560 LTDKSDVYSLGVVFLELLTGMQPISH-GKNIVREVNIAYQSSMM-----FSVIDGNMGSY 613
SDV+SLG+ F+EL G P KN Q S+M ++D +
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKN---------QGSLMPLQLLQCIVDEDPPVL 220
Query: 614 P-SECVEKFIKLALKCCQDETDARPSMSEVM 643
P + EKF+ +C + + RP+ +M
Sbjct: 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 73/283 (25%), Positives = 117/283 (41%), Gaps = 61/283 (21%)
Query: 401 VVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458
+VAVK R + + +FL E++ LSRL N++ L+G C +E ++ E+M NG L
Sbjct: 48 LVAVKILRP-DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 459 RDQLSAKSKE-----------------PLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
LS+ + + ++ L +AL + G+ YL + HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRD 163
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFL 556
+ N L+ T K+ADFG+SR D I+G ++P ++ E L
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR----------WMAWECIL 213
Query: 557 THKLTDKSDVYSLGVVFLEL-----------LTGMQPISHGKNIVREVNIAYQSSMMFSV 605
K T SDV++ GV E+ LT Q I + R+ Q ++
Sbjct: 214 MGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRD-----QGRQVYL- 267
Query: 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648
P C + +L L+C + RPS S++ L
Sbjct: 268 ------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 35/274 (12%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 440
++G G +GKVYK + V+A + + + E E ++ EI L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E ++ EF + G + D + + + PL + + + YLH + + HR
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK-----GTPGYLDPEYF 555
D+KA NIL K+ADFG+S + T+ + GTP ++ PE
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS------------AKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 556 LTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
+ D K+DV+SLG+ +E + ++P H N +R + + + +
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIE-MAQIEPPHHELNPMRVL-------LKIAKSEPPT 227
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ PS +F KC + DAR + +++++
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 63/215 (29%), Positives = 90/215 (41%), Gaps = 34/215 (15%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+G G V K L + G + A+K LQ K+ L E++ +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKYYG 66
Query: 439 YCDEEGEQML--VYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRGILY 488
+E + E+ G+L D + K K+ LG IA +G+ Y
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSY 120
Query: 489 LHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 548
LH+ + HRDIK SNILL K K+ DFG+S V + T GT
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL--------VNSLAGTFT-GTSF 168
Query: 549 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 583
Y+ PE + SDV+SLG+ LE+ P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 32/271 (11%)
Query: 383 IGQGGYGKV----YKGILPDGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
+G+G YG+V ++ DG +K+ + S + K E Q LS+L H N+V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 437 V-GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
+ E+G +V F G L +L + + L + + + + YLH +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
+ HRD+K N+ L KV D G++R L D+ ST++ GTP Y+ PE
Sbjct: 123 -ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM-------ASTLI-GTPYYMSPEL 173
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
F KSDV++LG E+ T + H N +++N S+++ +I+G + P
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMAT----LKHAFN-AKDMN-----SLVYRIIEGKLPPMP 223
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRE 645
+ + +L + RPS+ ++R+
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 35/275 (12%)
Query: 383 IGQGGYGKVYKGI-LPDGTV----VAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 436
+G G +G V+KGI +P+G VA+K Q+ S Q +E + + L H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C Q LV + G+L D + + ++ L L+ + ++G+ YL
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
+ HR++ A NILL ++ADFG++ L PD + + T +K ++ E L
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLY-PDDKKYFYSEHKTPIK----WMALESIL 184
Query: 557 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID----GNMG 611
+ T +SDV+S GV E+++ G +P Y V D G
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEP--------------YAGMRPHEVPDLLEKGERL 230
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
+ P C + +KC + + RP+ E+ E
Sbjct: 231 AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 39/288 (13%)
Query: 372 LATNNFNSSTQIGQGGYGKVYKGI-LPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFL 425
L F +G G +G VYKG+ +P+G VA+K +E S + KE L E +
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 426 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 485
+ + + ++ L+G C Q L+ + M G L D + + K+ +G L+ + ++G
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKG 121
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVS 540
+ YL + + HRD+ A N+L+ K+ DFGL++L + E G VP
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK-- 176
Query: 541 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 599
++ E L T +SDV+S GV EL+T G +P +
Sbjct: 177 --------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-----------GIPA 217
Query: 600 SMMFSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
S + S+++ G P C + +KC + D+RP E++ E
Sbjct: 218 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 80/289 (27%), Positives = 126/289 (43%), Gaps = 51/289 (17%)
Query: 383 IGQGGYGKVYKGILP-DGTVV--AVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRNLVSLV 437
IG+G +G+V K + DG + A+KR +E S ++F E++ L +L HH N+++L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSS 483
G C+ G L E+ +G L D L + L L A +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
RG+ YL + HRD+ A NIL+ + AK+ADFGLSR V V
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------------YV 166
Query: 544 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 597
K T G L + L T SDV+S GV+ E+++ G P G
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTC-------- 217
Query: 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
+ + + G P C ++ L +C +++ RPS ++++ L
Sbjct: 218 -AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-16
Identities = 69/240 (28%), Positives = 110/240 (45%), Gaps = 30/240 (12%)
Query: 419 LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI 478
+EI + +L H N+V L+G C E L++E++ L + L S E R I
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWE-----RRRKI 785
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538
A+G ++ + +LH P V ++ I++D K + RL+ P
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSL--------PGL 831
Query: 539 VSTVVKG--TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP--ISHGKN--IVRE 592
+ T K + Y+ PE T +T+KSD+Y G++ +ELLTG P G + IV
Sbjct: 832 LCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
Query: 593 VNIAYQSSMMFSVID----GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648
Y + ID G++ +E VE + LAL C + ARP ++V++ LES
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 54/284 (19%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTEIQFLSR-LHHRNLVSLV 437
++G+G YG V K +P GT++AVKR A S Q +K L ++ R + V+
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEP--------LGFAMRLSIALGSSRGILYL 489
G EG+ + E M T D+ K + LG IA+ + + YL
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYL 119
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTVVKGTPG 548
H++ V HRD+K SN+L++ K+ DFG+S G +V + T+ G
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS---------GYLVDSVAKTIDAGCKP 168
Query: 549 YLDPEYF---LTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604
Y+ PE L K D KSDV+SLG+ +EL TG P K +++
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK---------Q 219
Query: 605 VIDGN-----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 643
V++ + E + F+ KC + RP+ E++
Sbjct: 220 VVEEPSPQLPAEKFSPEFQD-FVN---KCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 74/277 (26%), Positives = 116/277 (41%), Gaps = 28/277 (10%)
Query: 375 NNFNSSTQIGQGGYGKVYKG-ILPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHH-R 431
N+ + +IG G G+VYK G V+AVK+ + G+ + K L ++ + + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
+V GY + + + E MS T D+L + + P+ + + + + + YL
Sbjct: 75 YIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ V HRD+K SNILLD K+ DFG+S RL V + T G Y+
Sbjct: 133 KHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL---------VDSKAKTRSAGCAAYM 181
Query: 551 DPEYFLTHKLTDK----SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606
PE K +DV+SLG+ +EL TG P + K + Q +
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP--PSL 239
Query: 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 643
N G P F C + RP E++
Sbjct: 240 PPNEGFSP-----DFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 40/267 (14%)
Query: 401 VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 459
+VAVK + + + +FL EI+ +SRL + N++ L+G C + ++ E+M NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 460 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------ADPPVFHRDIKASNILLDH 511
LS + E F +I S +LY+ + A HRD+ N L+ +
Sbjct: 106 QFLSQREIES-TFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 512 KFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 566
+T K+ADFG+SR D I+G ++P ++ E L K T SDV
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----------WMAWESILLGKFTTASDV 214
Query: 567 YSLGVVFLEL--LTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG-----SYPSECVE 619
++ GV E+ L QP S ++ + + + F N G S C
Sbjct: 215 WAFGVTLWEMFTLCKEQPYS----LLSDEQVIENTGEFFR----NQGRQIYLSQTPLCPS 266
Query: 620 KFIKLALKCCQDETDARPSMSEVMREL 646
KL ++C + RP+ +++ L
Sbjct: 267 PVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 14/211 (6%)
Query: 376 NFNSSTQIGQGGYGKVY--KGILPDGTVVAVKRAQEGSLQGEKEF-LTEIQFLSRLHHRN 432
+ +IG+G +GK+Y K V + EKE E+ L+++ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+V+ E G +V E+ G L +++ + LS + S G+ ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH-- 118
Query: 493 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
D + HRDIK+ NI L + AK+ DFG++R + D ++ GTP YL
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LND-----SMELAYTCVGTPYYLS 170
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
PE +K+D++SLG V EL T P
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 65/279 (23%), Positives = 125/279 (44%), Gaps = 26/279 (9%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRA---QEGSLQGEK---EFLTEIQFLSRL 428
+ Q+G G + Y+ + GT++AVK+ + S + E+ EI+ ++RL
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 429 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 488
+H +++ ++G E+ L E+M+ G++ LS A+ ++ RG+ Y
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSY 118
Query: 489 LHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGT 546
LH + + HRD+K +N+L+D ++ADFG + RLA G + GT
Sbjct: 119 LH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA--AKGTG--AGEFQGQLLGT 171
Query: 547 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606
++ PE + DV+S+G V +E+ T P + + +++F +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-------AEKHSNHLALIFKIA 224
Query: 607 DGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
S P + L+C + + + RP E+++
Sbjct: 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 377 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 432
F+ +IG G +G VY + + VVA+K+ + G EK + + E++FL +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+ G E LV E+ G+ D L K+PL ++ G+ +G+ YLH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ HRD+KA NILL K+ DFG + + + PA+ GTP ++ P
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASI--------MAPANXFV---GTPYWMAP 180
Query: 553 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPI 583
E L + K DV+SLG+ +EL P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 83/320 (25%), Positives = 132/320 (41%), Gaps = 41/320 (12%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 430
TN + +G G +G V G VA+K+ + + K E++ L L H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 431 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 489
N++SL E + V E + L L+++ E L L RG+ Y+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQIL---RGLKYV 124
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
H+ V HRD+K SNIL++ K+ DFGL+R+ P + G V T Y
Sbjct: 125 HSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD-PQMTGYV---------STRYY 171
Query: 550 LDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608
PE LT K + D++S G +F E+L G +P+ GK+ V + FS+I
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQ----------FSIITD 220
Query: 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 668
+G+ P + + C + T R S RE +D + +
Sbjct: 221 LLGTPPDDVINTI-------CSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML 272
Query: 669 TSKEETPPSSSSMLKHPYVS 688
+ S++ L HPY++
Sbjct: 273 VFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 382 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNL 433
+IG+G YG VYK D +A+K+ + L+ E E + EI L + H N+
Sbjct: 9 KIGEGTYGVVYKA--RDRVTNETIALKKIR---LEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLH 490
V L E LV+E++ + L+ + + +K P L L RGI Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH 119
Query: 491 TEADPPVFHRDIKASNILLDHKFTA-KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
+ V HRD+K N+L+D + A K+ADFGL+R +P V VV T Y
Sbjct: 120 SHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-----VRTFTHEVV--TLWY 169
Query: 550 LDPEYFL-THKLTDKSDVYSLGVVFLELLT 578
PE L + + D++S+G +F E++
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 83/274 (30%), Positives = 121/274 (44%), Gaps = 38/274 (13%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 437
+IG G G VYK I P G + A+K E +++ ++ EI+ L ++H N+V
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEILRDVNHPNVVKCH 138
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR-LSIALGSSRGILYLHTEADPP 496
D GE ++ EFM G+L A + A + LS GI YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-------GIAYLHRRH--- 188
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
+ HRDIK SN+L++ K+ADFG+SR LA D P + S GT Y+ PE
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-----PCNSSV---GTIAYMSPERI 240
Query: 556 ---LTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
L H D D++SLGV LE G P G+ +S+M ++
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-------GDWASLMCAICMSQP 293
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
P+ +F C Q E R S ++++
Sbjct: 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 46/241 (19%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEF------------LTEIQFLSR 427
+G+G YGKV K G +VA+K+ + E S K+ L E++ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 428 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALG 481
+ H N++ LV E LV + M+ L+ + K +RL+ I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--------IRLTESQVKCILLQ 127
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH--- 538
G+ LH HRD+ +NI ++ K K+ADFGL+R P +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 539 ------VSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 591
S VV T Y PE + K D++S+G +F ELLTG +P+ G+N +
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEID 241
Query: 592 E 592
+
Sbjct: 242 Q 242
|
Length = 335 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLHHR 431
NF +IG+G + +VY+ L DG VA+K+ Q L K + + EI L +L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----PLGFAMRLSIALGSSRGIL 487
N++ E+ E +V E G L + K+ P + + L S+ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
++H+ V HRDIK +N+ + K+ D GL R AH + GTP
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHS---LVGTP 170
Query: 548 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
Y+ PE + KSD++SLG + E+ P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 377 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLV 434
F +IG+G +G+V+KGI VVA+K + E E + EI LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
G ++ + ++ E++ G+ D L + A L L +G+ YLH+E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKK 122
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
HRDIKA+N+LL K+ADFG++ I+ GTP ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEV 172
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN----M 610
K+D++SLG+ +EL G P S + ++F + N
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSE----------LHPMKVLFLIPKNNPPTLE 222
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
G+Y S+ +++F++ C E RP+ E+++
Sbjct: 223 GNY-SKPLKEFVE---ACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 377 FNSSTQIGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLV 434
F +IG+G +G+VYKGI VVA+K + E E + EI LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
G + + ++ E++ G+ D L E A L L +G+ YLH+E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSERK 122
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
HRDIKA+N+LL + K+ADFG++ I+ GTP ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEV 172
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584
K+D++SLG+ +EL G P S
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 45/222 (20%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEG----SLQGEKEFLTEIQFLSRLHHRNLV 434
+IG G YG VYK + G +VA+K + + G +Q E I L H N+V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE------ISMLKECRHPNIV 63
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHT 491
+ G + +V E+ G+L+D ++ PL L IA + +G+ YLH
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLS---ELQIAYVCRETLKGLAYLHE 119
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVK-----G 545
HRDIK +NILL K+ADFG+S A ++ T+ K G
Sbjct: 120 TG---KIHRDIKGANILLTEDGDVKLADFGVS-------------AQLTATIAKRKSFIG 163
Query: 546 TPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPIS 584
TP ++ PE + K D+++LG+ +EL P+
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+GG+G+V + G + A K+ + L +GE+ L E + L ++ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ + + LV M+ G L+ + + A + A G+ +LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
+RD+K N+LLD +++D GL+ +++G GTPGY+ PE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA-----VELKGGKKIKGRA---GTPGYMAPEVLQGE 169
Query: 559 KLTDKSDVYSLGVVFLELLTGMQPI-SHGKNIVRE 592
D ++LG E++ G P + + +E
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHRNLVSL--- 436
IG+G YG V P G VA+K+ E ++ L EI+ L R H N++ +
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENIIGILDI 71
Query: 437 --VGYCDEEGEQMLVYEFMSNG---TLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLH 490
+ + +V E M ++ Q LS + + + RG+ Y+H
Sbjct: 72 IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL--------RGLKYIH 123
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA-PVPDIEGIVPAHVSTVVKGTPGY 549
+ A+ V HRD+K SN+LL+ K+ DFGL+R+A P D G + +V+ T Y
Sbjct: 124 S-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-----TRWY 175
Query: 550 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGK 587
PE L K K+ D++S+G + E+L+ +P+ GK
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 45/220 (20%)
Query: 383 IGQGGYGKVYKGIL-PDGTVVAVKR---------AQEGSLQGEKEFLTEI--QFLSRLHH 430
+G GG+G+V + A+K Q+ + EKE L E F+ +L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGF---AMRLSIALGSSR 484
+ D++ ML+ E+ G L L + + F + L+ +R
Sbjct: 61 T-------FKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112
Query: 485 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544
GI+Y RD+K N+LLD K+ DFG ++ ++ T
Sbjct: 113 GIIY-----------RDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTW--TFC- 153
Query: 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584
GTP Y+ PE L D +SLG++ ELLTG P
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 385 QGGYGKVYKGILPDGTV-----VAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVG 438
+G +G+++ GIL D V VK ++ + + + L E L L H+N++ ++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 439 YCDEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSSRGILYLHT 491
C E+GE ++Y +M+ G L+ L LS +A+ + G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAP-----VPDIEGIVPAHVSTVVKG 545
V H+DI A N ++D + K+ D LSR L P + D E + VK
Sbjct: 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE-------NRPVK- 184
Query: 546 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 582
++ E + + + SDV+S GV+ EL+T G P
Sbjct: 185 ---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 440
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 441 DEEG-----EQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
++ +Q+ LV EF G++ D + L I RG+ +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 131
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
V HRDIK N+LL K+ DFG+S ++ V + + GTP ++ PE
Sbjct: 132 --VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFI--GTPYWMAPEV 182
Query: 555 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPI 583
+ D KSD++SLG+ +E+ G P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 34/283 (12%)
Query: 383 IGQGGYGKVYKGIL-PDGTV--VAVKRAQEG-SLQGEKE-FLTEIQFLSRLHHRNLVSLV 437
+G+G +G V +G L D ++ VAVK + + E E FL+E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 438 GYCDEEGEQ------MLVYEFMSNGTLRDQL--SAKSKEPLGFAMRLSIALGS--SRGIL 487
G C + E +++ FM +G L L S P ++ + + + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
YL +++ HRD+ A N +L+ VADFGLS+ D + K
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY-----YRQGRIAKMPV 178
Query: 548 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606
++ E T KSDV+S GV E+ T G P +N S + +
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----------SEIYDYLR 228
Query: 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
GN P +C++ L C RPS + ELE
Sbjct: 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 381 TQIGQGGYGKVYKGILPD-GTVVAVKR--AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 437
++IG+G YG V+K + G +VA+K+ E +K L EI+ L +L H NLV+L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---- 493
+ + LV+E+ + T+ ++L K P G + + I++ +A
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELE---KNPRG------VPEHLIKKIIWQTLQAVNFC 116
Query: 494 -DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
HRD+K NIL+ + K+ DFG +R+ P + T T Y P
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-------YTDYVATRWYRAP 169
Query: 553 EYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 587
E + + DV+++G VF ELLTG QP+ GK
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 29/278 (10%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHR 431
NF +IG+G + +VY+ L D VA+K+ Q + + ++ + EI L +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----PLGFAMRLSIALGSSRGIL 487
N++ + E+ E +V E G L + K+ P + + L S+ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VE 120
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
++H+ V HRDIK +N+ + K+ D GL R AH S V GTP
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAH-SLV--GTP 170
Query: 548 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607
Y+ PE + KSD++SLG + E+ P K +N+ S+ +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLF---SLCQKIEQ 222
Query: 608 GNMGSYPSE-CVEKFIKLALKCCQDETDARPSMSEVMR 644
+ P+E EK +L C + D RP + V +
Sbjct: 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 421 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 480
E L+++ H N+V+ + +G +V E+ G L ++ + + L +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 481 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 540
G+ ++H + V HRDIK+ NI L K+ DFG +RL P A+
Sbjct: 108 QMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP------GAYAC 158
Query: 541 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG--KNIVREV 593
T V GTP Y+ PE + +KSD++SLG + EL T P KN++ +V
Sbjct: 159 TYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY- 439
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 440 -----CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
+ + LV EF G++ D + L I RG+ +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK- 141
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
V HRDIK N+LL K+ DFG+S ++ V + + GTP ++ PE
Sbjct: 142 --VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFI--GTPYWMAPEV 192
Query: 555 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPI 583
+ D +SD++SLG+ +E+ G P+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 19/230 (8%)
Query: 382 QIGQGGYGKVYKGILPDGTVVA---VKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 437
+IG G +GKV G G A VK + + E+ FL E+Q L+H N++ +
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA---MRLSIALGSSRGILYLHTEAD 494
G C E +LV EF G L++ L + A + +A + G+L+LH +AD
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD 120
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP-- 552
H D+ N L + K+ D+GL+ D H + P ++
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN------IVREVNI 595
+ L T KS+++SLGV EL T QP + +VRE +I
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 71/271 (26%), Positives = 113/271 (41%), Gaps = 36/271 (13%)
Query: 383 IGQGGYGKVYKGILP----DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 437
+G G +G++ +G L VA+ + G S + + FL E L + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
G M+V E+MSNG L D K + L + + G + G+ YL ++
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGY 128
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL--DPEYF 555
H+ + A +L++ K++ F RL E I T + G L PE
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RL-QEDKSEAIY-----TTMSGKSPVLWAAPEAI 180
Query: 556 LTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
H + SDV+S G+V E+++ G +P +S ++ +V DG
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------------QDVIKAVEDGFRL 227
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEV 642
P C +L L C Q E RP S++
Sbjct: 228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 71/224 (31%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 382 QIGQGGYGKVYKGILPDG---TVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLV 437
+IG G +GKV G + G V VK + S+Q + +FL E Q L H NL+ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------EPLGFA-MRLSIALGSSRGILYLH 490
G C E +LV EF G L+ L + K +P M IAL G+L+LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL----GLLHLH 117
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GY 549
H D+ N LL T K+ D+GLS D +V+ P +
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY------YVTPDQLWVPLRW 168
Query: 550 LDPEY-------FLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 585
+ PE L T +S+V+SLGV EL G QP H
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 74/281 (26%), Positives = 115/281 (40%), Gaps = 39/281 (13%)
Query: 380 STQIGQGGYGKV-YKGILPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLH- 429
S +G G G V + DG AVK A + Q E L F S +
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 430 HRNLVSLVGYCDEEGEQM-----LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR 484
H + D + LV ++ + G LR ++ +++K F L +
Sbjct: 97 HEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH-EAGLLFIQ 151
Query: 485 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL--APVPDIEGIVPAHVSTV 542
+L +H + HRDIK++NILL K+ DFG S++ A V D V
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD-------DVGRT 204
Query: 543 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602
GTP Y+ PE + + K+D++SLGV+ ELLT +P G+N+ EV M
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-GENM-EEV--------M 254
Query: 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 643
+ G P + ++ + RPS S+++
Sbjct: 255 HKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 438
+G+G +GKV L G + AVK ++ + + + +TE + LS + ++ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 439 YCDEEGEQML-VYEFMSNGTL--RDQLSAKSKEPLG--FAMRLSIALGSSRGILYLHTEA 493
C + +++ V EF++ G L Q S + E +A ++ AL ++LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSAL------MFLH--- 113
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
D + +RD+K N+LLDH+ K+ADFG+ + EGI ++ GTP Y+ PE
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGIFNGKTTSTFCGTPDYIAPE 166
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
D +++GV+ E+L G P
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 46/304 (15%)
Query: 369 EMALATNNFNSSTQIGQGGYGKVYKGIL-------PDGTVV--AVKRAQEGSLQGEKEFL 419
E+ L+T F ++G+ +GKVYKG L V +K EG L+ +EF
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFK 56
Query: 420 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS------------- 466
E SRL H N+V L+G +E +++ + S+ L + L +S
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 467 -KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525
K L A + I + G+ +L + V H+D+ N+L+ K K++D GL R
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 584
D ++ + + ++ PE + K + SD++S GVV E+ + G+QP
Sbjct: 174 VYAADYYKLMGNSLLPI-----RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
Query: 585 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
N ++V ++ + P +C L L+C + RP ++
Sbjct: 229 GYSN--QDVIEMIRNRQVLPC--------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278
Query: 645 ELES 648
L +
Sbjct: 279 RLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 68/238 (28%), Positives = 104/238 (43%), Gaps = 45/238 (18%)
Query: 375 NNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-F----LTEIQFLSR 427
+ + +IGQG +G+V+K +VA+K+ ++ EKE F L EI+ L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKT-KQIVALKKVL---MENEKEGFPITALREIKILQL 67
Query: 428 LHHRNLVSLVGYCDEEGEQ--------MLVYEF--------MSNGTLRDQLSAKSKEPLG 471
L H N+V+L+ C + LV+EF +SN ++ LS K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV--- 124
Query: 472 FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531
M L+ G+ Y+H + HRD+KA+NIL+ K+ADFGL+R A
Sbjct: 125 MKMLLN-------GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR-AFSLSK 173
Query: 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKN 588
+ + VV T Y PE L + D++ G + E+ T PI G
Sbjct: 174 NSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNT 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 383 IGQGGYGKVY---KGILPD-GTVVAVKRAQEGSLQGEKEFLT--EIQFLSRLHHRNLVSL 436
+GQG +GKV+ K PD G + A+K ++ +L+ T E L+ ++H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAM-RLSIALGS--SRGILYLH 490
EG+ L+ +F+ G L +LS + ++E + F + L++AL S GI+Y
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY-- 121
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
RD+K NILLD + K+ DFGLS+ E I + GT Y+
Sbjct: 122 ---------RDLKPENILLDEEGHIKLTDFGLSK-------ESIDHEKKAYSFCGTVEYM 165
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
PE T +D +S GV+ E+LTG P GK+
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF-QGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 376 NFNSSTQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 432
++ +IG+G G V I D G VAVK+ Q + E+ + H N
Sbjct: 20 YLDNFVKIGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSSRGI 486
+V + E +V EF+ G L D ++ R++ + L + +
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIATVCLAVLKAL 128
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
+LH + V HRDIK+ +ILL K++DFG + VP S V GT
Sbjct: 129 SFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGF-----CAQVSKEVPRRKSLV--GT 178
Query: 547 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
P ++ PE + D++SLG++ +E++ G P
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 64/208 (30%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 382 QIGQGGYGKVYKGILPD-GTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLH---HRNLVS 435
+IG G YG VYK P G VA+K R Q + E+ L RL H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 436 LVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
L+ C D E + LV+E + LR L L + RG+ +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGY 549
+ HRD+K NIL+ K+ADFGL+R I ++ T V T Y
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLAR---------IYSCQMALTPVVVTLWY 173
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELL 577
PE L D++S+G +F E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 68/215 (31%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 380 STQIGQGGYGKVYKGI-LPDGTVVAVKR-----AQEGSLQGEKEFLTEIQFLSRL---HH 430
+IG+G YG VYK L G VA+K+ ++EG L EI L +L H
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFEH 60
Query: 431 RNLVSLVGYC-----DEEGEQMLVYEFMSN--GTLRDQLSAK--SKEPLGFAMRLSIALG 481
N+V L+ C D E + LV+E + T + E + MR +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL--- 117
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 541
RG+ +LH+ + HRD+K NIL+ K+ADFGL+R I A S
Sbjct: 118 --RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMALTSV 166
Query: 542 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 576
VV T Y PE L D++S+G +F EL
Sbjct: 167 VV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 382 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IG+G G V G VAVK+ Q + E+ + HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E +V EF+ G L D ++ A ++ L R + YLH + V HR
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---TVCLSVLRALSYLHNQG---VIHR 142
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
DIK+ +ILL K++DFG + VP S V GTP ++ PE
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGF-----CAQVSKEVPKRKSLV--GTPYWMAPEVISRLPY 195
Query: 561 TDKSDVYSLGVVFLELLTGMQP 582
+ D++SLG++ +E++ G P
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 32/219 (14%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRN--- 432
+IG+G YGKVYK G +VA+K+ + L+ ++E L EI L L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTR---LEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 433 -LVSLVGYCDEEGEQM--LVYEFMSNGTLR--DQLSAKSKEPLGFAMRLSIALGSSRGIL 487
L+ + ++ G+ LV+E++ + + D PL S +G+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 488 YLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
+ H V HRD+K N+L+D K K+AD GL R +P V ++ +V T
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP-----VKSYTHEIV--T 174
Query: 547 PGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPI 583
Y PE L TH T D++S+G +F E+ QP+
Sbjct: 175 LWYRAPEVLLGSTHYST-PVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 33/223 (14%)
Query: 382 QIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEK--EFLTEIQFLSRLHHRNLVS 435
+IG+G +GK IL DG +K + ++ E E+ LS + H N+V
Sbjct: 7 KIGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAK------SKEPLGFAMRLSIALGSSRGILYL 489
+E G +V ++ G L +++A+ + L + +++ +AL ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------HV 117
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
H D + HRDIK+ NI L T K+ DFG++R+ + V ++ GTP Y
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV-----LNSTV--ELARTCIGTPYY 167
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG--KNIV 590
L PE +KSD+++LG V E+ T G KN+V
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFL-TEIQFLSRLHHRNLVSLVGY 439
+IGQG G VY I + G VA+K+ Q +KE + EI + H N+V+ +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 440 CDEEGEQMLVYEFMSNGTLRD----------QLSAKSKEPLGFAMRLSIALGSSRGILYL 489
E +V E+++ G+L D Q++A +E L + + +L
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------------QALEFL 131
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPG 548
H+ V HRDIK+ NILL + K+ DFG +++ P + ST+V GTP
Sbjct: 132 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPY 180
Query: 549 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
++ PE K D++SLG++ +E++ G P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 372 LATNNFNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH 429
L ++F +++G G G V K P G ++A K E + + E+Q L +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 489
+V G +GE + E M G+L L + P ++SIA+ RG+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYL 119
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
+ + HRD+K SNIL++ + K+ DFG+S G + ++ GT Y
Sbjct: 120 REKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDSMANSFVGTRSY 168
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 583
+ PE + +SD++S+G+ +EL G PI
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-13
Identities = 47/127 (37%), Positives = 63/127 (49%), Gaps = 11/127 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLN-ITTIKLSNNK 59
M L LSL G +PD L LDLS NQ +G++P SL+ + +KLS NK
Sbjct: 451 MPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 119
L+G IP S +L L +++N LSG IP+S + L+ LD N L S
Sbjct: 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ-----LDLSQNQL-----S 560
Query: 120 FNIPPNV 126
IP N+
Sbjct: 561 GEIPKNL 567
|
Length = 968 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-13
Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 28/283 (9%)
Query: 420 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 479
+E+ L+ H +V + + +L+ E+ S G L Q+ + KE L F +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF-QEYEVG 172
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
L + +L L + HRD+K++NI L K+ DFG S+ V V
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-----QYSDSVSLDV 227
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599
++ GTP YL PE + + + K+D++SLGV+ ELLT +P Q
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----------QR 277
Query: 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIWNMMPE-- 655
+M V+ G +P L RP+ +++ L+ + N+ +
Sbjct: 278 EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIV 337
Query: 656 --SDTKTP----EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692
S+T +P E + S E PP SS +++ V+SDV+
Sbjct: 338 RHSETISPHDREEILRQLQESGERAPPPSS--IRYGVVTSDVT 378
|
Length = 478 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 71/277 (25%), Positives = 115/277 (41%), Gaps = 71/277 (25%)
Query: 376 NFNSSTQIGQGGYGKVY----KG--------------ILPDGTVVAV---KRAQEGSLQG 414
+FN +G+G +GKV KG I+ D V KR +L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVL--ALPG 58
Query: 415 EKEFLTEI----QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL--RDQLSAKSKE 468
+ FLT++ Q + RL+ V E+++ G L Q K KE
Sbjct: 59 KPPFLTQLHSCFQTMDRLY------------------FVMEYVNGGDLMYHIQQVGKFKE 100
Query: 469 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528
P IA+G + +LH++ + +RD+K N++LD + K+ADFG+ +
Sbjct: 101 PHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK---- 149
Query: 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK- 587
E I + GTP Y+ PE D ++ GV+ E+L G QP G+
Sbjct: 150 ---ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG-QPPFDGED 205
Query: 588 -----NIVREVNIAYQSSM---MFSVIDGNMGSYPSE 616
+ E N++Y S+ S+ G + +P++
Sbjct: 206 EDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAK 242
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 382 QIGQGGYGKV-YKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IG+G G V + G +VAVK+ Q + E+ + H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E +V EF+ G L D ++ A ++ L + + LH + V HR
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---AVCLAVLKALSVLHAQG---VIHR 140
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
DIK+ +ILL H K++DFG + VP S V GTP ++ PE
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGF-----CAQVSKEVPRRKSLV--GTPYWMAPELISRLPY 193
Query: 561 TDKSDVYSLGVVFLELLTGMQP 582
+ D++SLG++ +E++ G P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 372 LATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH 429
L ++F +++G G G V+K P G ++A K E + + E+Q L +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 489
+V G +GE + E M G+L L + P ++SIA+ +G+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYL 119
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
+ + HRD+K SNIL++ + K+ DFG+S G + ++ GT Y
Sbjct: 120 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDSMANSFVGTRSY 168
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 583
+ PE + +SD++S+G+ +E+ G PI
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 437
IG+G +GKV DG AVK Q+ ++ +KE + E L + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 438 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSSRGILYLHTE 492
Y + +++ V ++++ G L L + EP +A ++ ALG YLH+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG------YLHSL 115
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ +RD+K NILLD + + DFGL + EGI + ++ GTP YL P
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGIEHSKTTSTFCGTPEYLAP 165
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
E D + LG V E+L G+ P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 74/280 (26%), Positives = 111/280 (39%), Gaps = 34/280 (12%)
Query: 381 TQIGQGGYGKVYKGIL---PDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
++G G +G V KG+ VAVK + + E L E + +L + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLS----AKSKEPLGFAMRLSIALGSSRGILYLHT 491
++G C+ E MLV E G L L K ++S+ G+ YL
Sbjct: 61 MIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLE- 112
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ HRD+ A N+LL + AK++DFGLS+ + H VK +
Sbjct: 113 --ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYA 166
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
PE +K + KSDV+S GV+ E + G +P K EV +S G
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIES--------GER 216
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650
P C + L C D RP + V L + +
Sbjct: 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 59/265 (22%), Positives = 114/265 (43%), Gaps = 31/265 (11%)
Query: 391 VYKGILPDGTVV--AVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY----CDEEG 444
+YKGI + V+ K+ +G EI+ L R+ N++ + G+ D+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 504
L+ E+ + G LR+ L K K+ L F +L +A+ +G+ L+ + P ++++ +
Sbjct: 96 RLSLILEYCTRGYLREVLD-KEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 505 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTD 562
+ L+ + K+ GL ++ P + +V+ +V Y + + T
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFK-----NVNFMV-----YFSYKMLNDIFSEYTI 201
Query: 563 KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 622
K D+YSLGVV E+ TG P N+ + + N P +C +
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFE---------NLTTKEIYDLIINKNNSLKLPLDCPLEIK 252
Query: 623 KLALKCCQDETDARPSMSEVMRELE 647
+ C ++ RP++ E++ L
Sbjct: 253 CIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 377 FNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRN 432
F +G+GG+G+V + G + A K+ ++ ++ GE L E Q L +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+VSL + + LV M+ G L+ + + + A G+ LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGY 549
+ +RD+K NILLD +++D GL+ VP+ I+G V GT GY
Sbjct: 122 R---IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV---------GTVGY 167
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH-GKNIVRE 592
+ PE + T D ++LG + E++ G P K I RE
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 64/246 (26%), Positives = 100/246 (40%), Gaps = 56/246 (22%)
Query: 383 IGQGGYGKV----YKGILPDGTVVAVKRAQEG---------SLQGEKEFLTEIQFLSRLH 429
+G+G +GKV KG + AVK ++ EK L L+
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLA----LAG-K 54
Query: 430 HRNLVSLVGYCDEEGEQML--VYEFMSNGTL--RDQLSAKSKEPLG--FAMRLSIALG-- 481
H L L + + + L V E+++ G L Q S + EP +A + + L
Sbjct: 55 HPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 541
RGI+Y RD+K N+LLD + K+ADFG+ + EGI+ ++
Sbjct: 113 HERGIIY-----------RDLKLDNVLLDSEGHIKIADFGMCK-------EGILGGVTTS 154
Query: 542 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVNI 595
GTP Y+ PE D ++LGV+ E+L G P G + + E +
Sbjct: 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEV 213
Query: 596 AYQSSM 601
Y +
Sbjct: 214 RYPRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 54/224 (24%)
Query: 382 QIGQGGYGKVYKGILPD---GTVVAVKR---AQEGSLQGEKEFLTEIQFLSRL-HHRNLV 434
++G+G YG V+K I D VVA+K+ A + ++ F EI FL L H N+V
Sbjct: 14 KLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 435 SLVGYCDEEGEQ--MLVYEFMSN--------GTLRD--------QLSAKSKEPLGFAMRL 476
L+ E ++ LV+E+M L D QL
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLL------------- 117
Query: 477 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 536
+ + Y+H+ V HRD+K SNILL+ K+ADFGL+R + ++E
Sbjct: 118 -------KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS--LSELEENPE 165
Query: 537 AHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTG 579
V T T Y PE L + + T D++S+G + E+L G
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 37/98 (37%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 485 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544
G+ LH + HRDIK N+L+D K+ DFGLSR G+
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN-------GLENKKFV---- 154
Query: 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
GTP YL PE L SD +SLG V E L G P
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 84/338 (24%), Positives = 128/338 (37%), Gaps = 96/338 (28%)
Query: 383 IGQGGYGKVYK----GI--LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 434
+G+G +GKV + GI VAVK +EG+ E K +TE++ L + HH N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 435 SLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAK----------------SKEPLGFAMRL- 476
+L+G C + G M++ E+ G L + L +K K+ G RL
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 477 ------------------------------------------SIALGSSRGILYLHTEAD 494
S + +RG+ +L A
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTP----GY 549
HRD+ A NILL K+ DFGL+R + PD V KG +
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----------VRKGDARLPLKW 241
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 608
+ PE T +SDV+S GV+ E+ + G P G I E + +G
Sbjct: 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-GVQIDEEFCRRLK--------EG 292
Query: 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
P + + L C + + RP+ SE++ L
Sbjct: 293 TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 437
IG+G +GKV DG+ AVK Q+ ++ +KE + E L L H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 438 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKS--KEPLG--FAMRLSIALGSSRGILYLHTE 492
Y + E++ V ++++ G L L + EP +A ++ A+G YLH+
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG------YLHSL 115
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ +RD+K NILLD + + DFGL + EG+ P ++ GTP YL P
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGVEPEETTSTFCGTPEYLAP 165
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
E D + LG V E+L G+ P
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 70/289 (24%), Positives = 113/289 (39%), Gaps = 63/289 (21%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHH-RNLVSLVGY 439
IG+G +G V K + GT++AVKR + + E K L ++ + R +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 440 CDEEGEQMLVYEFMS--------------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 485
EG+ + E M + +++ K IA+ + +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK------------IAVATVKA 119
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTVVK 544
+ YL E + HRD+K SNILLD K+ DFG+S G +V + T
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---------GQLVDSIAKTRDA 168
Query: 545 GTPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601
G Y+ PE +SDV+SLG+ E+ TG P ++ ++
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT------- 221
Query: 602 MFSVIDGN---MGSYP----SECVEKFIKLALKCCQDETDARPSMSEVM 643
V+ G+ + + S FI L C + RP E++
Sbjct: 222 --QVVKGDPPILSNSEEREFSPSFVNFINL---CLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 33/229 (14%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVS---- 435
IG+G YG V I G VA+K+ + + L EI+ L L H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 436 -LVGYCDEEGEQMLVYEFMSNG-----TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 489
L E + +V+E M + D L+ + + + + R + Y+
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--------RALKYI 119
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
HT VFHRD+K NIL + K+ DFGL+R+A A T T Y
Sbjct: 120 HTAN---VFHRDLKPKNILANADCKLKICDFGLARVA----FNDTPTAIFWTDYVATRWY 172
Query: 550 LDPEY---FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 595
PE F + K T D++S+G +F E+LTG +P+ GKN+V ++++
Sbjct: 173 RAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDL 219
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IGQG G V+ I + G VA+K+ ++ + EI + L + N+V+ +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E +V E+++ G+L D ++ + A ++ + + +LH V HR
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA---AVCRECLQALEFLHANQ---VIHR 139
Query: 501 DIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 559
DIK+ N+LL + K+ DFG +++ P + ST+V GTP ++ PE
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 560 LTDKSDVYSLGVVFLELLTGMQP 582
K D++SLG++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 6e-12
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 375 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSR 427
++F +G G +G+V +K G A+K A+ L+ + L E + L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 428 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS--IALGSSRG 485
+ H LV+L G ++ LV E++ G L L + P A + + L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA---- 113
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
+ YLH+ + +RD+K N+LLD K+ DFG ++ V T+ G
Sbjct: 114 LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK---------RVKGRTYTLC-G 160
Query: 546 TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
TP YL PE L K K+ D ++LG++ E+L G P
Sbjct: 161 TPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 383 IGQGGYGKVYKGILPDGT--VVAVKRAQEGSLQGEKEF---LTEIQFLS-RLHHRNLVSL 436
+G+G +GKV L GT V A+K ++ + + + +TE + L+ H L +L
Sbjct: 3 LGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQL--SAKSKEPLG--FAMRLSIALGSSRGILYLHTE 492
+ V E+++ G L Q+ S K EP +A +++AL ++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MFLHRH 115
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
V +RD+K NILLD + K+ADFG+ + EGI+ +T GTP Y+ P
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTTTFCGTPDYIAP 165
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
E + D ++LGV+ E++ G P
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 41/288 (14%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLTEIQFLSR 427
T+ + IG+G YGKVYK DG++ AVK + ++ E L Q L
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNIL---QSLP- 76
Query: 428 LHHRNLVSLVG--YCDEE---GEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIAL 480
+H N+V G Y ++ G+ LV E + G++ + + + L AM I
Sbjct: 77 -NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 481 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 540
G+ G+ +LH + HRD+K +NILL + K+ DFG+S + +
Sbjct: 136 GALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR------N 186
Query: 541 TVVKGTPGYLDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQPISHGKNIVREVNI 595
T V GTP ++ PE + D S DV+SLG+ +EL G P+ + I
Sbjct: 187 TSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
Query: 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 643
+P + F +C + +ARPS++ ++
Sbjct: 246 PRNPPPTL--------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 63/246 (25%), Positives = 94/246 (38%), Gaps = 51/246 (20%)
Query: 375 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRA---------QEGSLQGEKEFLTE 421
++F IG+G +G+V+ L G V A+K Q ++ E++ L +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 422 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 481
+V L +E LV E+M G L + L K P A R IA
Sbjct: 58 A------DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIA-- 108
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS--------------RLAP 527
+L L + HRDIK NIL+D K+ADFGL
Sbjct: 109 --ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 528 VPDIEGIVPA---------HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 578
+ + ++ ++ V GTP Y+ PE + D +SLGV+ E+L
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 579 GMQPIS 584
G P
Sbjct: 226 GFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 81/322 (25%), Positives = 124/322 (38%), Gaps = 57/322 (17%)
Query: 382 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH---HR 431
+IG+G YGKV+K + G VA+KR + +Q +E + E+ L L H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 432 NLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 486
N+V L C D E + LV+E + L L + + + RG+
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
+LH+ V HRD+K NIL+ K+ADFGL+R+ T V T
Sbjct: 124 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--------QMALTSVVVT 172
Query: 547 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606
Y PE L D++S+G +F E+ +P+ G + V Q + VI
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVD------QLGKILDVI 225
Query: 607 DGNMGSYPSECVEKFIKLALKCCQD--ETDARPSMSEVMRELESIWNMMPESDTKTPEFI 664
P E +D A P + + + I + + D + +
Sbjct: 226 -----GLPGE-------------EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 267
Query: 665 NSEHTSKEETPPSSSSMLKHPY 686
T S+ S L HPY
Sbjct: 268 LKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 437
IG+G +GKV DG AVK Q+ + KE + E L + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 438 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
Y + E++ V +F++ G L L + P A + + S+ G YLH+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHSIN--- 116
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
+ +RD+K NILLD + + DFGL + EGI + +T GTP YL PE
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK-------EGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 557 THKLTDKSDVYSLGVVFLELLTGMQP 582
+ D + LG V E+L G+ P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-12
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IGQG G VY I + G VA+K+ ++ + EI + + N+V+ +
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E +V E+++ G+L D ++ + A ++ + + +LH+ V HR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALDFLHSNQ---VIHR 139
Query: 501 DIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 559
DIK+ NILL + K+ DFG +++ P + ST+V GTP ++ PE
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 560 LTDKSDVYSLGVVFLELLTGMQP 582
K D++SLG++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-12
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVG 438
IG+GG G+VY P VA+K+ +E + K FL E + + L H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 439 YCDEEGEQMLVY---EFMSNGTLR---------DQLSAKSKEPLGFAMRLSIALGSSRGI 486
C + G+ VY ++ TL+ + LS + E LSI I
Sbjct: 70 ICSD-GD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL------------APVPDI--- 531
Y+H++ V HRD+K NILL + D+G + +I
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 578
+P + GTP Y+ PE L ++ +D+Y+LGV+ ++LT
Sbjct: 184 SMTIPGKIV----GTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 437
IG+G Y KV L + + + L + E + +Q F +H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
E V E+++ G L + + K P A S + S + YLH +
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNYLHERG---I 117
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 557
+RD+K N+LLD + K+ D+G+ + EG+ P ++ GTP Y+ PE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 558 HKLTDKSDVYSLGVVFLELLTGMQP 582
D ++LGV+ E++ G P
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 57/285 (20%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEG-SLQGEKEFLT-------------EIQFLSR 427
++G+G +G VY +V K+A L+ KE E Q LS+
Sbjct: 7 RLGKGSFGTVY--------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK 58
Query: 428 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------EPLGFAMRLSIALG 481
L H +V E ++ E+ L +L E + + LG
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 541
+ Y+H + HRD+KA NI L + K+ DFG+SRL + ++T
Sbjct: 119 ----VHYMHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-------MGSCDLAT 163
Query: 542 VVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 600
GTP Y+ PE L H+ D KSD++SLG + E+ + G+N + S
Sbjct: 164 TFTGTPYYMSPEA-LKHQGYDSKSDIWSLGCILYEMCC-LAHAFEGQNFL---------S 212
Query: 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDA-RPSMSEVMR 644
++ +++G S P E + + ++ ++ + RPS +E++R
Sbjct: 213 VVLRIVEGPTPSLP-ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 383 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 438
+G+GG+G+V + G + A K+ + L+ K + + E + L+++H R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS--RGILYLHTEADPP 496
+ + LV M+ G LR + +E GF + + G+ +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
+ +RD+K N+LLD+ +++D GL+ +E + GTPG++ PE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA-------VELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 557 THKLTDKSDVYSLGVVFLELLTGMQP 582
+ D ++LGV E++ P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 17/220 (7%)
Query: 377 FNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRN 432
F +G+GG+G+V + G + A KR ++ ++ GE L E Q L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+V+L + + LV M+ G L+ + L A G+ LH E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD-IEGIVPAHVSTVVKGTPGYLD 551
+RD+K NILLD +++D GL+ P + I G V GT GY+
Sbjct: 122 N---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---------GTVGYMA 169
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 591
PE + T D + LG + E++ G P K V+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 68/222 (30%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 382 QIGQGGYGKVYKGILP-DGTVVAVK----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
++G+G Y VYKGI +G +VA+K + +EG + E L L H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV---PFTAIREASLLKGLKHANIVLL 68
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG---FAMRLSIALGSSRGILYLHTEA 493
+ V+E+M D + P G + +RL RG+ Y+H +
Sbjct: 69 HDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQH 123
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ HRD+K N+L+ + K+ADFGL+R +P + S VV T Y P+
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-----QTYSSEVV--TLWYRPPD 173
Query: 554 YFLTHKLTDKS---DVYSLGVVFLELLTGMQPISHGKNIVRE 592
L TD S D++ G +F+E+L G QP G + V E
Sbjct: 174 VLLGA--TDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFE 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 39/277 (14%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRN---LVSL 436
++G+G YG VYK + P G +A+K E L+ E +F I L LH +V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMK---EIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF--AMRLSIALGSSRGILYLHTEAD 494
G EG + E+M G+L D+L A G + I +G+ +L E +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
+ HRD+K +N+L++ K+ DFG+S G + A ++ G Y+ PE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS---------GNLVASLAKTNIGCQSYMAPER 172
Query: 555 FLTHKLTD------KSDVYSLGVVFLELLTGMQPISHGKNIVREV--NIAYQSSMMFSVI 606
+ +SDV+SLG+ LE+ G P E NI Q S +++
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP------PETYANIFAQLS---AIV 223
Query: 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 643
DG+ + PS + KC + RP+ ++++
Sbjct: 224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 422 IQFLSRLHHRNLVSLVGYCD---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI 478
I+ L LH N +VG+ +GE + E M G+L L + P ++SI
Sbjct: 47 IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI 106
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538
A+ RG+ YL + + HRD+K SNIL++ + K+ DFG+S G +
Sbjct: 107 AV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDS 153
Query: 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 583
++ GT Y+ PE T +SD++SLG+ +E+ G PI
Sbjct: 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 66/225 (29%), Positives = 94/225 (41%), Gaps = 44/225 (19%)
Query: 377 FNSSTQIGQGGYGKV----YKGILPDGTVVAVKRAQEG---------SLQGEKE-FLTEI 422
F +G+G +GKV YK G + A+K ++G SL EK F T
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFET-- 55
Query: 423 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL-----RDQLSAKSKEPLGFAMRLS 477
+ H LV+L E V E+ + G L D S EP
Sbjct: 56 --ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAAC 109
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 537
+ LG + YLH + + +RD+K N+LLD + K+ADFGL + EG+
Sbjct: 110 VVLG----LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-------EGMGFG 155
Query: 538 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
++ GTP +L PE T D + LGV+ E+L G P
Sbjct: 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 71/277 (25%)
Query: 376 NFNSSTQIGQGGYGKVY----KG--------ILPDGTVV---------AVKRAQEGSLQG 414
+FN +G+G +GKV KG IL V+ KR +L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVL--ALSG 58
Query: 415 EKEFLTEI----QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKE 468
+ FLT++ Q + RL+ V E+++ G L Q+ + KE
Sbjct: 59 KPPFLTQLHSCFQTMDRLY------------------FVMEYVNGGDLMYQIQQVGRFKE 100
Query: 469 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528
P IA+G + +LH++ + +RD+K N++LD + K+ADFG+ +
Sbjct: 101 PHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---- 149
Query: 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
E + + GTP Y+ PE D ++ GV+ E+L G P G++
Sbjct: 150 ---ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE-GED 205
Query: 589 ------IVREVNIAYQSSM---MFSVIDGNMGSYPSE 616
+ E N+AY SM ++ G M +P +
Sbjct: 206 EDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 242
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 383 IGQGGYGKV----YKGILPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVS 435
+GQG YG V + VA+K+ K L E++ L H+N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 436 LVG----YCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYL 489
L + E L E M L +S +PL A S G+ Y+
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEA-----DLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPG 548
H+ A+ V HRD+K N+L++ K+ DFGL+R + P G ++ V T
Sbjct: 122 HS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENP---GENAGFMTEYV-ATRW 174
Query: 549 YLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVN 594
Y PE L+ + K+ DV+S+G + ELL G +P+ GK+ V ++N
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-11
Identities = 43/116 (37%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNN 58
+ L L L L GP+P + + L LDLS N L+G IP + L N+ + L +N
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
TG IP + LPRLQ L + +N SG IP ++ + L +LD NNLT
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT-----VLDLSTNNLT 369
|
Length = 968 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 18/221 (8%)
Query: 382 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVG 438
++G+G Y VYKG L D +VA+K + +G + E+ L L H N+V+L
Sbjct: 13 KLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
E LV+E++ + L+ L ++L + RG+ Y H V
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHRRK---VL 126
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-T 557
HRD+K N+L++ + K+ADFGL+R +P + + VV T Y P+ L +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIP-----TKTYSNEVV--TLWYRPPDILLGS 179
Query: 558 HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598
+ + D++ +G +F E+ TG +P+ G + +++ ++
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQLHFIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL- 436
+IG+G + +V K G A+K SL+ + L EIQ L RL H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLI 64
Query: 437 -VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
V + + G LV+E M + L + L K PL S + + ++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYE-LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
+FHRDIK NIL+ K+ADFG R GI T T Y PE
Sbjct: 121 -IFHRDIKPENILIK-DDILKLADFGSCR--------GIYSKPPYTEYISTRWYRAPECL 170
Query: 556 LTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 594
LT K D++++G VF E+L+ + P+ G N + ++
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIA 209
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IGQG G VY + + G VA+++ ++ + EI + + N+V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E +V E+++ G+L D ++ + A ++ + + +LH+ V HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSNQ---VIHR 140
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGYLDPEYFLTHK 559
DIK+ NILL + K+ DFG I P + + GTP ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFC--------AQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 560 LTDKSDVYSLGVVFLELLTGMQP 582
K D++SLG++ +E++ G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 383 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+GG+G+V + G + A K+ ++ ++ GE L E + L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 439 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--GILYLHTEADP 495
Y E + + LV M+ G L+ + GF + +I + G+ L E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFDEQRAIFYAAELCCGLEDLQRER-- 122
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD-IEGIVPAHVSTVVKGTPGYLDPEY 554
+ +RD+K NILLD + +++D GL+ P + + G V GT GY+ PE
Sbjct: 123 -IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---------GTVGYMAPEV 172
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 591
K T D + LG + E++ G P K V+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 383 IGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 438
IG+G +GKV + D + A+K ++ + E L E L++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ LV F++ G L L + + L A + L + L V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL-----LCALENLHKFNVI 115
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
+RD+K NILLD++ + DFGL +L + + GTP YL PE L H
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKL-------NMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 559 KLTDKSDVYSLGVVFLELLTGMQP 582
T D ++LGV+ E+LTG+ P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK----EFLTEIQFLSRLHHRNLVSLV 437
+G+G Y VYKG G +VA+K E L+ E+ + E L L H N+V+L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK---EIRLEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR-----LSIALGSSRGILYLHTE 492
+ LV+E++ D G +M L L RG+ Y H
Sbjct: 70 DIIHTKKTLTLVFEYLD----TDLKQYMDDCGGGLSMHNVRLFLFQLL---RGLAYCH-- 120
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
V HRD+K N+L+ + K+ADFGL+R VP + + VV T Y P
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-----SKTYSNEVV--TLWYRPP 172
Query: 553 EYFLTHKLTDKS---DVYSLGVVFLELLTGM 580
+ L T+ S D++ +G +F E+ TG
Sbjct: 173 DVLLGS--TEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 36/205 (17%)
Query: 424 FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTL--RDQLSAKSKEPLGFAMRLSIAL 480
FL++LH C + +++ V E+++ G L Q K KEP I++
Sbjct: 62 FLTQLHS---------CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV 112
Query: 481 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 540
G + +LH + +RD+K N++LD + K+ADFG+ + E +V +
Sbjct: 113 G----LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGVTT 158
Query: 541 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVN 594
GTP Y+ PE D ++ GV+ E+L G QP G++ + E N
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG-QPPFDGEDEDELFQSIMEHN 217
Query: 595 IAYQSSM---MFSVIDGNMGSYPSE 616
++Y S+ S+ G M +PS+
Sbjct: 218 VSYPKSLSKEAVSICKGLMTKHPSK 242
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 40/99 (40%), Positives = 57/99 (57%), Gaps = 4/99 (4%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNK 59
S L L+L N + G +P S IPNL LDLS+N L+G IP G S ++ + L N
Sbjct: 118 SSLRYLNLSNNNFTGSIPRGS-IPNLETLDLSNNMLSGEIPNDIGSFS-SLKVLDLGGNV 175
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 98
L G IP++ + L L+ L +A+N L G IP + Q ++L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSL 214
|
Length = 968 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 437
IG+G Y KV L + + + L + E + +Q F + +H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALG--SSRGILYLHT 491
E V EF+S G L + + K P ++ +S+AL RGI+Y
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY--- 119
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
RD+K N+LLD + K+ D+G+ + EGI P ++ GTP Y+
Sbjct: 120 --------RDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTTSTFCGTPNYIA 164
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
PE D ++LGV+ E++ G P
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 67/258 (25%), Positives = 115/258 (44%), Gaps = 25/258 (9%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT---EIQFLSRLHHR 431
+F +IG G YG VYK + G + A+K + L+ ++F EI + H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
N+V+ G + + EF G+L+D PL + ++ + +G+ YLH+
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS 124
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ HRDIK +NILL K+ADFG+S I + S + GTP ++
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRKSFI--GTPYWMA 174
Query: 552 PEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608
PE + D++++G+ +E L +QP + +R + + +S+ +
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIE-LAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233
Query: 609 NMGSYPSECVEKFIKLAL 626
M S F+K+AL
Sbjct: 234 KMKW--SNSFHHFVKMAL 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 67/250 (26%), Positives = 108/250 (43%), Gaps = 44/250 (17%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGY 439
IG G YG V I G VA+K+ K L E++ L H N++++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 440 CDEEGEQM----LVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSSRGILYL 489
G +V + M + S +PL F +L RG+ Y+
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHH---IIHSDQPLTEEHIRYFLYQLL------RGLKYI 123
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--GIVPAHVSTVVKGTP 547
H+ A+ V HRD+K SN+L++ ++ DFG++R E + +V+T
Sbjct: 124 HS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR----- 175
Query: 548 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606
Y PE L+ + T D++S+G +F E+L G + + GKN V +Q ++ SV
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYV------HQLKLILSV- 227
Query: 607 DGNMGSYPSE 616
+GS E
Sbjct: 228 ---LGSPSEE 234
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 382 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVG 438
++G+G Y V+KG L + +VA+K + +G + E+ L L H N+V+L
Sbjct: 13 KLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS----IALGSSRGILYLHTEAD 494
+ LV+E++ D+ + + G M + RG+ Y H
Sbjct: 72 IVHTDKSLTLVFEYL------DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
V HRD+K N+L++ + K+ADFGL+R VP + + VV T Y P+
Sbjct: 125 --VLHRDLKPQNLLINERGELKLADFGLARAKSVP-----TKTYSNEVV--TLWYRPPDV 175
Query: 555 FL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598
L + + + + D++ +G +F E+ +G +P+ G + E+++ ++
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDELHLIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEF---LTEIQFLS-RLHHRNLVSLV 437
+G+G +GKV+ L A+K ++ + + + + E + LS H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 438 GYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
YC + ++ L V E+++ G L + + K L A + + G+ +LH++
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC--GLQFLHSKG-- 116
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
+ +RD+K NILLD K+ADFG+ + E ++ + GTP Y+ PE
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCK-------ENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 556 LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
L K D +S GV+ E+L G P HG +
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPF-HGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 437
IG+G Y KV L + + + L + E + +Q F + LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGILYLHTEA 493
LV E+++ G L + + K P +A + IAL +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------FLHERG 116
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ +RD+K N+LLD K+ D+G+ + EG+ P ++ GTP Y+ PE
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCK-------EGLGPGDTTSTFCGTPNYIAPE 166
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
+ D ++LGV+ E++ G P
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 383 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+GG+G+V + G + A K+ ++ ++ GE L E Q L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 439 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI--ALGSSRGILYLHTEADP 495
Y E + + LV M+ G L+ + + GF ++ A + G+ LH E
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGLEDLHRER-- 122
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGYLDP 552
+ +RD+K NILLD +++D GL+ +P+ I G V GT GY+ P
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV---------GTVGYMAP 170
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 591
E + T D + LG + E++ G P K V+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 38/221 (17%)
Query: 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---------QGEKEFLT---EIQFLSRLH 429
+G+G +GKV L G AVK ++ + EK L E FL+ L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 430 HRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 487
YC + ++ L V EF++ G L + K + L A + + G+
Sbjct: 62 ---------YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQ 110
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
+LH++ + +RD+K N++LD K+ADFG+ + E + + ++ GTP
Sbjct: 111 FLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRASTFCGTP 160
Query: 548 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
Y+ PE K T D +S GV+ E+L G P HG +
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF-HGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-10
Identities = 42/117 (35%), Positives = 66/117 (56%), Gaps = 9/117 (7%)
Query: 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSN 57
++ L L+L + L G +P +L ++ +L ++ L N L+G IP G L+ ++ + L
Sbjct: 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT-SLNHLDLVY 245
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
N LTG IPS+ L LQ LF+ N LSG IP SI+ + L + LD +N+L+
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS-----LDLSDNSLS 297
|
Length = 968 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 383 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+GG+G+V + G + A K+ + L+ GEK L E + L +++ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ + LV M+ G L+ + + L + + + GIL+LH+ +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IV 117
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
+RD+K N+LLD + +++D GL+ + D + I T GT GY+ PE
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI------TQRAGTNGYMAPEILKEE 169
Query: 559 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 590
+ D +++G E++ G P K V
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 382 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL-- 436
++G+G YG VYK DG A+K+ + + EI L L H N++SL
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 65
Query: 437 VGYCDEEGEQMLVYEFMSNGTLR----DQLSAKSKEPLGF--AMRLSIALGSSRGILYLH 490
V + + L++++ + + S +K+P+ M S+ GI YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 491 TEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL--APVPDIEGIVPAHVSTVVK 544
V HRD+K +NIL+ + K+AD G +RL +P+ + + P V
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----- 177
Query: 545 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISH 585
T Y PE L + K+ D++++G +F ELLT +PI H
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 36/225 (16%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLT-----EIQFLSRLHHRNLVS 435
++G+G YG VYK DG K +E +L Q E ++ EI L L H N+++
Sbjct: 8 KVGRGTYGHVYKAKRKDG-----KDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA 62
Query: 436 L--VGYCDEEGEQMLVYEFMSNGTLR----DQLSAKSKEPLGF--AMRLSIALGSSRGIL 487
L V + + L++++ + + S +K+P+ +M S+ GI
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 488 YLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL--APVPDIEGIVPAHVST 541
YLH V HRD+K +NIL+ + K+AD G +RL +P+ + + P V
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 177
Query: 542 VVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISH 585
T Y PE L + K+ D++++G +F ELLT +PI H
Sbjct: 178 ----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 30/211 (14%)
Query: 383 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 435
+G+G +GKV IL G A+K ++ + + E LTE + L H L +
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGF-AMRLSIALGSSRGILYLHT 491
L V E+ + G L LS + S++ F + ALG YLH+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHS 113
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
V +RD+K N++LD K+ DFGL + EGI GTP YL
Sbjct: 114 CD---VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPEYLA 163
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
PE + D + LGVV E++ G P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 376 NFNSSTQIGQGGYGKVYKGILPDGTV--VAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 430
+FN +G G +G+V + VA+KR ++ + +K+ +E + L+ ++H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
V+L G +E LV EF+ G L + P +++ +L
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-----CFYAAQIVLIFE 145
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ +RD+K N+LLD K+ DFG ++ +V T+ GTP Y+
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK---------VVDTRTYTLC-GTPEYI 195
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
PE L +D ++LG+ E+L G P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 430
+++ ++G G YG VYK L G + AVK + L+ +F EI + H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKH 65
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
N+V+ G + + E+ G+L+D PL + + +G+ YLH
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLH 123
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
++ HRDIK +NILL K+ADFG++ I + S + GTP ++
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVA-----AKITATIAKRKSFI--GTPYWM 173
Query: 551 DPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 582
PE K D++++G+ +E L +QP
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 13/184 (7%)
Query: 399 GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458
G VAVK Q + E+ + H+N+V + E ++ EF+ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 518
D +S A L + + YLH++ V HRDIK+ +ILL K++
Sbjct: 106 TDIVSQTRLNEEQIATVCESVL---QALCYLHSQG---VIHRDIKSDSILLTLDGRVKLS 159
Query: 519 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 578
DFG I VP S V GTP ++ PE + D++SLG++ +E++
Sbjct: 160 DFGF-----CAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD 212
Query: 579 GMQP 582
G P
Sbjct: 213 GEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 21/221 (9%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRN 432
+++ ++G+G Y VYKG +G +VA+K + +G + E L L H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF---AMRLSIALGSSRGILYL 489
+V L + LV+E++ D K P G ++L + RG+ Y+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYI 119
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
H + HRD+K N+L+ K+ADFGL+R VP+H + T Y
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS-------VPSHTYSNEVVTLWY 169
Query: 550 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 589
P+ L + + + D++ +G +F+E++ G+ K+I
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 382 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGY 439
++G+G Y V+KG +VA+K + +G + E+ L L H N+V+L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 440 CDEEGEQMLVYEFMSN---------GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
E LV+E++ + G L + K F +L RG+ Y H
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-----FMFQL------LRGLSYCH 120
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ HRD+K N+L++ K K+ADFGL+R VP + + VV T Y
Sbjct: 121 KRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP-----TKTYSNEVV--TLWYR 170
Query: 551 DPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598
P+ L + + + D++ +G + E+ TG +P+ G + E+++ ++
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 37/229 (16%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
IG+G YG V + VA+K+ A + + K L EI+ L L H N++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA-KRTLREIKLLRHLDHENVIAIKD 71
Query: 439 YCDEEGEQM-----LVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSSRGIL 487
+ +VYE M T Q+ +S + L F +L RG+
Sbjct: 72 IMPPPHREAFNDVYIVYELMD--TDLHQI-IRSSQTLSDDHCQYFLYQLL------RGLK 122
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
Y+H+ A+ V HRD+K SN+LL+ K+ DFGL+R + + +V T
Sbjct: 123 YIHS-AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVV-----TR 172
Query: 548 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 595
Y PE L + T DV+S+G +F ELL G +P+ GK+ V ++ +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKL 220
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (150), Expect = 7e-10
Identities = 73/254 (28%), Positives = 104/254 (40%), Gaps = 58/254 (22%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG------SLQGEKE-----FLTEIQ 423
N + +IG G +G+V+ +V KR QE S +G KE + E+
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 424 FLSRLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 481
+ L H+N+V + + Q L + EF G L + K + G +I +
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ-KCYKMFGKIEEHAI-VD 122
Query: 482 SSRGIL----YLHTEADPP----VFHRDIKASNILLDH------KFTA-----------K 516
+R +L Y H D P V HRD+K NI L K TA K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 517 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFL 574
+ DFGLS+ + + AH GTP Y PE L T DKSD+++LG +
Sbjct: 183 IGDFGLSKNIGIESM-----AHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 575 ELLTGMQPISHGKN 588
EL +G P N
Sbjct: 235 ELCSGKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 377 FNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNL 433
+ + + +G G YG+V G VA+K+ S K E++ L + H N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 434 VSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 483
+ L V E LV M N ++ Q LS + L + +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL-------- 128
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
RG+ Y+H+ A + HRD+K SNI ++ K+ DFGL+R ++ G V
Sbjct: 129 RGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDD-EMTGYV-------- 176
Query: 544 KGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTG 579
T Y PE L H D++S+G + ELLTG
Sbjct: 177 -ATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 37/93 (39%), Positives = 56/93 (60%), Gaps = 2/93 (2%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNI-TTIKLSNN 58
+S+L++L L L G +PD LS L LDLS NQL+G IP + + + + LS N
Sbjct: 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN 557
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 91
+L+G IP N + L ++ I++N L GS+PS+
Sbjct: 558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 41/110 (37%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 7 LSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI 64
++L N L GP+PD + +L YL+LS+N GSIP G + N+ T+ LSNN L+G I
Sbjct: 98 INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIP-NLETLDLSNNMLSGEI 156
Query: 65 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
P++ L+ L + N L G IP+S+ N T L +N L
Sbjct: 157 PNDIGSFSSLKVLDLGGNVLVGKIPNSL-----TNLTSLEFLTLASNQLV 201
|
Length = 968 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 383 IGQGGYGKVYKGILPDGT----VVAVKRAQEGSL-QGEKEFL---TEIQFLSRLHHRNLV 434
+G+GGYGKV++ G + A+K ++ ++ + +K+ E L + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR---------LSIALGSSRG 485
L+ G+ L+ E++S G L L E G M +S+AL
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALE---- 114
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
+LH + + +RD+K NILLD + K+ DFGL + E I V+ G
Sbjct: 115 --HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-------ESIHEGTVTHTFCG 162
Query: 546 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584
T Y+ PE + D +SLG + ++LTG P +
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 39/116 (33%), Positives = 65/116 (56%), Gaps = 9/116 (7%)
Query: 7 LSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGT 63
L L N L+G +P D+S++ +L ++LS N + G+IPP G ++ ++ + LS N G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT-SLEVLDLSYNSFNGS 481
Query: 64 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN-NLTNISG 118
IP + L L+ L + NSLSG +P+++ R L+ +F +N L I G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL-GGRLLHRA---SFNFTDNAGLCGIPG 533
|
Length = 623 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 77/339 (22%), Positives = 127/339 (37%), Gaps = 80/339 (23%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
+G G G V+ + D VAVK+ Q K L EI+ + RL H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKS----------KEPLGFAMRLSIALGSS-------- 483
VYE + S +E + + + G
Sbjct: 67 -------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119
Query: 484 -----RGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPA 537
RG+ Y+H+ V HRD+K +N+ ++ K+ DFGL+R IV
Sbjct: 120 MYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR---------IVDP 167
Query: 538 HVSTVVKG-------TPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 589
H S KG T Y P L+ + T D+++ G +F E+LTG +P+ G +
Sbjct: 168 HYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHE 224
Query: 590 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ ++ + +S + D N E + + R E R L
Sbjct: 225 LEQMQLILESVPVVREEDRN------ELL----------NVIPSFVRNDGGEPRRPLR-- 266
Query: 650 WNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688
+++P + + +F+ T ++ L HPY+S
Sbjct: 267 -DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLV 437
IG+G +GKV + AVK Q+ ++ + EK ++E L + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--KEPLG--FAMRLSIALGSSRGILYLHTEA 493
+ V ++++ G L L + EP +A ++ ALG YLH+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG------YLHSLN 116
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ +RD+K NILLD + + DFGL + E I ++ GTP YL PE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCK-------ENIEHNGTTSTFCGTPEYLAPE 166
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
D + LG V E+L G+ P
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 485 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544
G+ +LH + + +RD+K N+LLD K+ADFG+ + E + ++
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK-------ENMNGEGKASTFC 157
Query: 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
GTP Y+ PE K + D +S GV+ E+L G P HG++
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF-HGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 73/300 (24%), Positives = 112/300 (37%), Gaps = 57/300 (19%)
Query: 384 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGYCD 441
+ K P T+VAVK+ S E K EI +L H N++ V
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHTEADPPVF 498
+ E +V M+ G+ D L K+ P G L+IA + Y+H++
Sbjct: 70 VDSELYVVSPLMAYGSCEDLL--KTHFPEGLP-ELAIAFILKDVLNALDYIHSKG---FI 123
Query: 499 HRDIKASNILLDHKFTAKVADFGLS--------RLAPVPDIEGIVPAHVSTVVKGTPGYL 550
HR +KAS+ILL ++ S R V D P + +L
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF----PKSSVKNLP----WL 175
Query: 551 DPEYFLTHKL---TDKSDVYSLGVVFLELLTGMQPISH---GKNIVREVN---------- 594
PE L L +KSD+YS+G+ EL G P + ++ +V
Sbjct: 176 SPE-VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234
Query: 595 --IAYQSSMMFSVIDGNMGSYPSECV---------EKFIKLALKCCQDETDARPSMSEVM 643
Y+ SM S N + V E F + C Q + ++RPS S+++
Sbjct: 235 TYPLYEDSMSQSR-SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVG-Y 439
IG+G YGKV+K + +G+ AVK + ++E E L L H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 440 CDEE---GEQM-LVYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYL 489
++ G+Q+ LV E + G++ D + + +EP+ A L AL G+ +L
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-IAYILHEAL---MGLQHL 140
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
H HRD+K +NILL + K+ DFG+S A + GTP +
Sbjct: 141 HVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTR-----LRRNTSVGTPFW 190
Query: 550 LDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQPIS 584
+ PE + D + DV+SLG+ +EL G P++
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 383 IGQGGYGKV----YKGILPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 435
+G G +G+V +KG G A+K + +E ++ + E L L H +V+
Sbjct: 26 LGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 436 LV-GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL---YLHT 491
++ + DE + EF+ G L L + P A L +L YLH+
Sbjct: 83 MMCSFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL-----VLAFEYLHS 136
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ + +RD+K N+LLD+K KV DFG ++ VP T+ GTP YL
Sbjct: 137 KD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK---------VPDRTFTLC-GTPEYLA 183
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
PE + D +++GV+ E + G P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 31/245 (12%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL 428
+F+ + +G+G +G+V ++ + G + A+K ++ L ++ F E LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 429 HHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAM-RLSIALGSSRGI 486
+ + L Y ++ + + LV E+ G L L+ + ++ M + +A +
Sbjct: 59 NSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLN-RYEDQFDEDMAQFYLA----ELV 112
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKG 545
L +H+ HRDIK N+L+D K+ADFG + RL +V S + G
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL----TANKMV---NSKLPVG 165
Query: 546 TPGYLDPEYFLTHKLTDKS------DVYSLGVVFLELLTGMQPISHGKNIVREVNI-AYQ 598
TP Y+ PE T K D +SLGV+ E++ G P G + NI +Q
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225
Query: 599 SSMMF 603
+ F
Sbjct: 226 RFLKF 230
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 54/282 (19%)
Query: 376 NFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGS-LQGEK---EFLTEIQFLSR 427
NF +G G YGKV+ G G + A+K ++ + +Q K TE Q L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 428 LHHRN-LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK----EPLGFAMRLSIALGS 482
+ LV+L + + L+ ++++ G L L + E + + +AL
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 483 --SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR--LAPVPD-------- 530
GI+Y RDIK NILLD + + DFGLS+ LA +
Sbjct: 121 LHQLGIIY-----------RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP--ISHGKN 588
IE + P + G+ G+ D +SLGV+ ELLTG P + +N
Sbjct: 170 IEYMAPEVIRG---GSGGH-----------DKAVDWWSLGVLTFELLTGASPFTVDGEQN 215
Query: 589 IVREVN--IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKC 628
E++ I + + + +EK K L
Sbjct: 216 SQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGA 257
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 383 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 435
+G+G +GKV IL G A+K ++ + + E LTE + L H L S
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS--RGILYLHTEA 493
L + V E+++ G L LS + F+ + G+ + YLH+
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSGK 115
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ +RD+K N++LD K+ DFGL + EGI A GTP YL PE
Sbjct: 116 ---IVYRDLKLENLMLDKDGHIKITDFGLCK-------EGITDAATMKTFCGTPEYLAPE 165
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
+ D + LGVV E++ G P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-09
Identities = 35/116 (30%), Positives = 56/116 (48%), Gaps = 7/116 (6%)
Query: 7 LSLRNCSLQGPMPDLS-RIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIP 65
L + N +LQG + +P+L L L+ N+ G +P S + + LS N+ +G +P
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVP 492
Query: 66 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NISGSF 120
L L +L ++ N LSG IP + + L + LD +N L+ I SF
Sbjct: 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS-----LDLSHNQLSGQIPASF 543
|
Length = 968 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 383 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 435
+G+G +GKV IL G A+K ++ + + E LTE + L H L +
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 436 LVGYCDEEGEQMLVYEFMSNGTL-----RDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
L V E+ + G L R+++ ++ + + + AL YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALD------YLH 112
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+E + V +RD+K N++LD K+ DFGL + EGI GTP YL
Sbjct: 113 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYL 163
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
PE + D + LGVV E++ G P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 382 QIGQGGYGKVYKGILP-DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV- 437
IG G +G V+ P DG VA+K+ +L K E++ L H N++S +
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 438 ----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
+ D E +V E M + + +S + + L L RG+ YLH+
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLHSAG 123
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ HRDIK N+L++ K+ DFGL+R+ PD + V T Y PE
Sbjct: 124 ---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE-PDESKHMTQEVVTQY-----YRAPE 174
Query: 554 YFL-THKLTDKSDVYSLGVVFLELLTG 579
+ + T D++S+G +F ELL
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 38/107 (35%), Positives = 57/107 (53%), Gaps = 14/107 (13%)
Query: 23 RIPNLGYLDLSSNQLNGSIPPG--RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80
R+P + ++LS+NQL+G IP S ++ + LSNN TG+IP +P L+ L ++
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGS--IPNLETLDLS 148
Query: 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVT 127
NN LSG IP+ I +L +LD N L IP ++T
Sbjct: 149 NNMLSGEIPNDIGSFSSLK-----VLDLGGNVLVG-----KIPNSLT 185
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 43/140 (30%), Positives = 60/140 (42%), Gaps = 31/140 (22%)
Query: 1 MSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPGRLSL----------- 48
+ KL+ L L + SL G +P+L ++ NL L L SN G IP SL
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 49 --------------NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 94
N+T + LS N LTG IP L +L + +NSL G IP S+
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 95 SRTLNATETFILDFQNNNLT 114
R+L Q+N+ +
Sbjct: 403 CRSLRRVR-----LQDNSFS 417
|
Length = 968 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 68/257 (26%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQF 424
++F S IG+G +G+V D G + A+K + Q ++ E++ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-- 58
Query: 425 LSRLHHRNLVSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSI- 478
+ +V L Y + E L+ E++ G + L K ++E F + +I
Sbjct: 59 ----DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL 112
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS---RLAPVPDIEGIV 535
A+ S + Y+H RDIK N+LLD K K++DFGL + + + I+
Sbjct: 113 AIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 536 PAHV------------------------------STVVKGTPGYLDPEYFLTHKLTDKSD 565
+ STV GTP Y+ PE FL + D
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV--GTPDYIAPEVFLQTGYNKECD 221
Query: 566 VYSLGVVFLELLTGMQP 582
+SLGV+ E+L G P
Sbjct: 222 WWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRN--LVSL 436
IG+GG+G+VY D G + A+K + + QGE L E LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 437 VGYCDEEGEQM-LVYEFMSNGTLRDQLSA----KSKEPLGFAMRLSIALGSSRGILYLHT 491
+ Y +++ + + M+ G L LS KE +A + + G+ ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMHN 115
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
V +RD+K +NILLD +++D GL+ D P H S GT GY+
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKP-HASV---GTHGYMA 163
Query: 552 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGK 587
PE D S D +SLG + +LL G P K
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 34/231 (14%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQE----GSLQGEKEFLTEIQFLSRLHHRNLVSLV 437
+IG G +GKV + T VA +E S + + EFL + L H N++ +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLGFAMRLS-IALGSSRGILYLHTEADP 495
G C E +LV+E+ G L+ LS + + L +A + G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGL--SRLAP---VPDIEGIVPAHVSTVVKGTPGYL 550
H D+ N L T KV D+G+ SR + + VP +L
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----------WL 168
Query: 551 DPEY-------FLTHKLTDKSDVYSLGVVFLELL-TGMQPISHGKNIVREV 593
PE +T + T S+V++LGV EL QP SH + REV
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REV 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 38/222 (17%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLV 437
Q+G G YG V + G VA+K+ Q E K E++ L + H N++ L+
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 438 GY------CDEEGEQMLVYEFMSN--GTL--RDQLSAKSKEPLGFAMRLSIALGSSRGIL 487
D + LV FM G L ++LS + L + M +G+
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML--------KGLK 132
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
Y+H + HRD+K N+ ++ K+ DFGL+R ++ G V T
Sbjct: 133 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVV---------TR 179
Query: 548 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
Y PE L T D++S+G + E+LTG +P+ G +
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 34/95 (35%), Positives = 44/95 (46%), Gaps = 10/95 (10%)
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
YLH+ V +RDIK N++LD K+ DFGL + EGI GTP
Sbjct: 110 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTP 159
Query: 548 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
YL PE + D + LGVV E++ G P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 64/250 (25%), Positives = 109/250 (43%), Gaps = 25/250 (10%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHR 431
N F +G+G YG V K + +VA+K+ + E + + ++ L E++ L L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
N+V L G+ LV+E++ ++ L + P G + + I +H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVE----KNMLELLEEMPNG-VPPEKVRSYIYQLIKAIHW 115
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ HRDIK N+L+ H K+ DFG +R EG + V T Y
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS----EGSNANYTEYV--ATRWYRS 169
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
PE L D++S+G + EL G QP+ G++ + + +F+ I +G
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG-QPLFPGESEIDQ---------LFT-IQKVLG 218
Query: 612 SYPSECVEKF 621
P+E ++ F
Sbjct: 219 PLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 64/250 (25%), Positives = 100/250 (40%), Gaps = 59/250 (23%)
Query: 376 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQFL 425
+F S IG+G +G+V D G V A+K + Q G ++ E++ L E L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 426 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGS 482
+V + ++ L+ EF+ G + L K ++E F +
Sbjct: 62 W------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYI-------- 107
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-------RLAPVPDIEGIV 535
+ +L + + HRDIK N+LLD K K++DFGL R ++ +
Sbjct: 108 AETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 536 PAH-----------------------VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 572
P+ STV GTP Y+ PE F+ D +SLGV+
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTV--GTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 573 FLELLTGMQP 582
E+L G P
Sbjct: 226 MYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 38/202 (18%)
Query: 386 GGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 444
G G+V+ P V +K Q+G+ L E L ++H +++ +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRM-------- 122
Query: 445 EQMLVYEFMS-------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
+ LV ++ + L L+ +S+ PL L I G+ YLH + +
Sbjct: 123 KDTLVSGAITCMVLPHYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQR---I 178
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPV--PDIEGIVPAHVSTVVKGTPGYLDPEYF 555
HRD+K NI ++ + D G ++ PV P G + GT PE
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG---------LAGTVETNAPEVL 228
Query: 556 LTHKLTDKSDVYSLGVVFLELL 577
K K+D++S G+V E+L
Sbjct: 229 ARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 59/281 (20%), Positives = 114/281 (40%), Gaps = 44/281 (15%)
Query: 382 QIGQGGYGKVYKGILPDG--TVVAVKRA-----QEGSLQGEKE-----FLTEIQFL-SRL 428
+G G +G VYK + ++A+K G + E++ ++E+ + +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 429 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSK-----EPLGFAMRLSIALGS 482
H N+V E +V + + L + ++ K K E + + + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 542
+ YLH E + HRD+ +NI+L + DFGL++ P T
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ--------PESKLTS 172
Query: 543 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602
V GT Y PE +K+DV++ G + ++ T +QP + N++ S+
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNML---------SLA 222
Query: 603 FSVIDGNMGSYPSECVEKFIKLALK-CCQDETDARPSMSEV 642
+++ P + + + C + +ARP + +V
Sbjct: 223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 32/89 (35%), Positives = 44/89 (49%), Gaps = 12/89 (13%)
Query: 499 HRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 557
HRD+K N+LLD K+ADFG ++ D G+V T V GTP Y+ PE +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKM----DANGMV--RCDTAV-GTPDYISPEVLKS 217
Query: 558 HKLTD----KSDVYSLGVVFLELLTGMQP 582
+ D +S+GV E+L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 45/224 (20%)
Query: 376 NFNSSTQIGQGGYGKVYKG------------ILPDGTVVAVKRAQEGSLQGEKEFLTEIQ 423
+ +G G +G+V+ ++ V+ +K QE + EK L E+
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK--QEQHVHNEKRVLKEVS 59
Query: 424 FLSRLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 481
H ++ L + E ++ L + E++ G L L + F+ +
Sbjct: 60 ------HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYA 107
Query: 482 SS--RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
S + YLH++ + +RD+K NILLD + K+ DFG ++ + D
Sbjct: 108 SEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRD--------R 154
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
+ + GTP YL PE + K +K+ D ++LG++ E+L G P
Sbjct: 155 TWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 58/187 (31%), Positives = 83/187 (44%), Gaps = 27/187 (14%)
Query: 404 VKRAQEGSLQGEKEFLT--EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 461
+KRA+ + E+ L + Q+++ LH+ +E LV ++ G L
Sbjct: 40 LKRAETACFREERNVLVNGDCQWITTLHYA--------FQDENYLYLVMDYYVGGDLLTL 91
Query: 462 LSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 520
LS + + P A R IA +L +H+ HRDIK N+LLD ++ADF
Sbjct: 92 LSKFEDRLPEDMA-RFYIA----EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADF 146
Query: 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLE 575
G S L D G V S+V GTP Y+ PE K + D +SLGV E
Sbjct: 147 G-SCLKMNQD--GTVQ---SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200
Query: 576 LLTGMQP 582
+L G P
Sbjct: 201 MLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 509
Y+ ++ +++ LS E L LS +RG+ +L A HRD+ A N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 510 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV-KGTP----GYLDPEYFLTHKLTDKS 564
K+ DFGL+R DI H S V KG+ ++ PE + T S
Sbjct: 271 AQGKIVKICDFGLAR-----DI-----MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS 320
Query: 565 DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKL 624
DV+S G++ E+ + + + IV S+ + G + P ++ +
Sbjct: 321 DVWSYGILLWEIFS-LGGTPYPGMIV-------DSTFYNKIKSGYRMAKPDHATQEVYDI 372
Query: 625 ALKCCQDETDARPSMSEVMRELESI 649
+KC E + RPS + +ES+
Sbjct: 373 MVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 438
IG+G +G+VY+ D + A+K + + +KE + E L R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 439 Y---CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
+ + LV ++MS G L L + + A + IA +L L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA-KFYIA----ELVLALEHLHKY 115
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
+ +RD+K NILLD + DFGLS+ ++ + GT YL PE
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK----ANLTD---NKTTNTFCGTTEYLAPEVL 168
Query: 556 LTHK-LTDKSDVYSLGVVFLELLTGMQP 582
L K T D +SLGV+ E+ G P
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 39/122 (31%), Positives = 57/122 (46%), Gaps = 11/122 (9%)
Query: 7 LSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLN-ITTIKLSNNKLTGTI 64
L L +L G +P+ L NL L L SN L G IP + + ++L +N +G +
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 65 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN----LTNISGSF 120
PS F+ LP + L I+NN+L G I S W +L +L N L + GS
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ-----MLSLARNKFFGGLPDSFGSK 475
Query: 121 NI 122
+
Sbjct: 476 RL 477
|
Length = 968 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 383 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRN--LVSL 436
IG+GG+G+VY D G + A+K + + QGE L E LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 437 VGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
+ Y +++ + + M+ G L LS G + ++ IL L +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
V +RD+K +NILLD +++D GL+ D P H S GT GY+ PE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKP-HASV---GTHGYMAPEVL 167
Query: 556 LTHKLTDKS-DVYSLGVVFLELLTGMQP 582
D S D +SLG + +LL G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 377 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRN 432
+ S Q+G G YG V I G VA+K+ Q E K E+ L + H N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 433 LVSLVGY------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 486
++ L+ DE + LV +M + S++ + + + + G+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML-----CGL 130
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
Y+H+ + HRD+K N+ ++ K+ DFGL+R A ++ G V T
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVV---------T 177
Query: 547 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 579
Y PE L +++ D++S+G + E+LTG
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 35/89 (39%), Positives = 44/89 (49%), Gaps = 11/89 (12%)
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-- 556
HRDIK N+LLD ++ADFG S L + D G V S V GTP Y+ PE
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFG-SCLRLLAD--GTV---QSNVAVGTPDYISPEILQAM 178
Query: 557 ---THKLTDKSDVYSLGVVFLELLTGMQP 582
+ + D +SLGV E+L G P
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 67/266 (25%), Positives = 96/266 (36%), Gaps = 89/266 (33%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQ- 423
++F S IG+G +G+V D G + A+K + Q ++ E++ L E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 424 ------FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAM 474
F S RNL L+ EF+ G + L K S+E F +
Sbjct: 61 AWVVKMFYSFQDKRNL-------------YLIMEFLPGGDMMTLLMKKDTLSEEATQFYI 107
Query: 475 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534
+ +L + HRDIK N+LLD K K++DFGL G+
Sbjct: 108 --------AETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC--------TGL 151
Query: 535 VPAH--------------------------------------VSTVVKGTPGYLDPEYFL 556
AH STV GTP Y+ PE F+
Sbjct: 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV--GTPDYIAPEVFM 209
Query: 557 THKLTDKSDVYSLGVVFLELLTGMQP 582
D +SLGV+ E+L G P
Sbjct: 210 QTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 28/186 (15%)
Query: 467 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-L 525
K PL + + +RG+ +L A HRD+ A NILL K+ DFGL+R +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 526 APVPDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 580
PD V KG+ ++ PE T +SDV+S GV+ E+ + G
Sbjct: 225 YKDPDY----------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 274
Query: 581 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 640
P G I E + DG P + ++ L C Q + RP+ S
Sbjct: 275 SPYP-GVQINEEFCQRLK--------DGTRMRAPENATPEIYRIMLACWQGDPKERPTFS 325
Query: 641 EVMREL 646
++ L
Sbjct: 326 ALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 485 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544
GI +LH+ + HRD+K SNI++ T K+ DFGL+R A G VV
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV- 179
Query: 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 579
T Y PE L + D++S+G + E++ G
Sbjct: 180 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 11/103 (10%)
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK--- 544
YLH + HRD+K N+L+ K+ DFGLS++ + + H+ +
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 545 -----GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
GTP Y+ PE L D +++G++ E L G P
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 383 IGQGGYGKV---YKGILPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
IG G G V + +L G VAVK R + ++ + E+ L ++H+N++SL
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 437 VGY------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
+ +E + LV E M + E + + + + GI +LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ + HRD+K SNI++ T K+ DFGL+R A + + P V T Y
Sbjct: 141 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVV------TRYYR 189
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTG 579
PE L + D++S+G + EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 383 IGQGGYGKVYKGILPDGTVV----------AVKRAQEGSLQGEKEFLT--EIQFLSRLHH 430
IG+G +G+V L + V +KRA+ + E++ L + Q+++ LH+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNG---TLRDQLSAKSKEPLG--FAMRLSIALGSSRG 485
+E LV ++ G TL + + E + + + IA+ S
Sbjct: 69 A--------FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
+ Y+H RDIK NIL+D ++ADFG S L + D G V S+V G
Sbjct: 121 LHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMED--GTVQ---SSVAVG 165
Query: 546 TPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQP 582
TP Y+ PE K + D +SLGV E+L G P
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 49/186 (26%), Positives = 74/186 (39%), Gaps = 28/186 (15%)
Query: 467 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-L 525
K+ L + + ++G+ +L A HRD+ A NILL K+ DFGL+R +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 526 APVPDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 580
PD V KG ++ PE T +SDV+S GV+ E+ + G
Sbjct: 230 YKDPDY----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 279
Query: 581 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 640
P G I E + +G P + + L C E RP+ S
Sbjct: 280 SPYP-GVKIDEE--------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 330
Query: 641 EVMREL 646
E++ L
Sbjct: 331 ELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-06
Identities = 28/63 (44%), Positives = 37/63 (58%), Gaps = 7/63 (11%)
Query: 26 NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 81
NL LDLS+N+L IP G L N+ + LS N LT +I FSGLP L+ L ++
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLP-NLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSG 57
Query: 82 NSL 84
N+L
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 55/202 (27%), Positives = 80/202 (39%), Gaps = 54/202 (26%)
Query: 469 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528
PL L + ++G+ +L A HRD+ A N+LL AK+ DFGL+R
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---- 260
Query: 529 PDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584
DI + VVKG ++ PE T +SDV+S G++ E+ S
Sbjct: 261 -DIMN----DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------S 309
Query: 585 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE-KFIKLALKCCQ-DETD-ARPSMSE 641
GK+ YP V KF K+ + Q D A P +
Sbjct: 310 LGKS-----------------------PYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYS 346
Query: 642 VMRELESIWNMMPESDTKTPEF 663
+M+ WN+ P T+ P F
Sbjct: 347 IMK---MCWNLEP---TERPTF 362
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 376 NFNSSTQIGQGGYGKVY---------------KGILPDGTVVAVKRAQEGSLQGEKEFLT 420
NF +G G YGKV+ +L T+V + E + + E++ L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLE 59
Query: 421 EIQ---FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 477
I+ FL LH+ + + L+ ++++ G L LS + + F +
Sbjct: 60 HIRQSPFLVTLHYA--------FQTDTKLHLILDYINGGELFTHLSQRER----FKEQ-E 106
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 537
+ + S +L L + +RDIK NILLD + DFGLS+ ++E
Sbjct: 107 VQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER---- 162
Query: 538 HVSTVVKGTPGYLDPEYFLTHKLT-DKS-DVYSLGVVFLELLTGMQPIS 584
+ GT Y+ P+ DK+ D +S+GV+ ELLTG P +
Sbjct: 163 --AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 5e-06
Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 5/65 (7%)
Query: 49 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 108
N+ ++ LSNN+LT F GLP L+ L ++ N+L+ P + +L LD
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSL-----RSLDL 55
Query: 109 QNNNL 113
NNL
Sbjct: 56 SGNNL 60
|
Length = 60 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 41/220 (18%)
Query: 377 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNL 433
+ + + +G G YG V G VAVK+ S+ K E++ L + H N+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 434 VSLVGY------CDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 483
+ L+ +E + LV M N ++ Q L+ + L + +
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL-------- 130
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
RG+ Y+H+ AD + HRD+K SN+ ++ K+ DFGL+R H +
Sbjct: 131 RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEM 174
Query: 544 KG---TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 579
G T Y PE L +++ D++S+G + ELLTG
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 33/225 (14%)
Query: 376 NFNSSTQIGQGGYGKVY---KGILPD-GTVVAVKRAQEGSL-QGEK---EFLTEIQFLSR 427
NF +G G YGKV+ K D G + A+K Q+ +L Q K TE L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 428 LHHRN-LVSLVGYCDEEGEQMLVYEFMSNGTL------RDQLSAKSKEPLGFAMRLSIAL 480
+ LV+L E + L+ +++S G + RD S + L++
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 481 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 540
GI+Y RDIK NILLD + + DFGLS+ + E +
Sbjct: 121 LHKLGIVY-----------RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER------T 163
Query: 541 TVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPIS 584
GT Y+ PE K+ D +SLG++ ELLTG P +
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 26/143 (18%)
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
+Q + E + D+L+ +++ L F+ +++ +G+ +L A H
Sbjct: 191 SGSYIDQDVTSEILEE----DELALDTEDLLSFSYQVA------KGMSFL---ASKNCIH 237
Query: 500 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP----GYLDPEYF 555
RD+ A NILL H K+ DFGL+R DI + VVKG ++ PE
Sbjct: 238 RDLAARNILLTHGRITKICDFGLAR-----DIRN----DSNYVVKGNARLPVKWMAPESI 288
Query: 556 LTHKLTDKSDVYSLGVVFLELLT 578
T +SDV+S G++ E+ +
Sbjct: 289 FNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 32/124 (25%), Positives = 46/124 (37%), Gaps = 40/124 (32%)
Query: 499 HRDIKASNILLDHKFTAKVADFGLS-------------RL-------APVPDIEGIVPAH 538
HRDIK NIL+D K++DFGLS +L + + +
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 539 VSTVVK--------------------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 578
++ + GTP Y+ PE FL + D +SLG + E L
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
Query: 579 GMQP 582
G P
Sbjct: 244 GWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 38/119 (31%), Positives = 55/119 (46%), Gaps = 13/119 (10%)
Query: 30 LDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 88
L L + L G IP L ++ +I LS N + G IP + + L+ L ++ NS +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 89 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR-LRGNPFCLNTNAEQFCG 146
P S+ Q +L IL+ N+L S +P + R L F NA CG
Sbjct: 483 PESLGQLTSLR-----ILNLNGNSL-----SGRVPAALGGRLLHRASFNFTDNA-GLCG 530
|
Length = 623 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 37/126 (29%), Positives = 62/126 (49%), Gaps = 8/126 (6%)
Query: 375 NNFNSSTQIGQGGYGKVYK----GILPDGTV--VAVKRAQEGSLQGEKEFL-TEIQFLSR 427
+N +G G +GKV + G+ + V VAVK + + E+E L +E++ LS
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 428 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 486
L H+N+V+L+G C G +++ E+ G L + L K++ L F M L +S
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157
Query: 487 LYLHTE 492
+ E
Sbjct: 158 KNITLE 163
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 72/284 (25%), Positives = 112/284 (39%), Gaps = 48/284 (16%)
Query: 383 IGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ----GEK-----EFLTEIQFLSRLHHRN 432
+GQG + +YKG+L + V QE S+ G F +S+L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
LV L G C + M V E++ G L D + K + +L +A + + YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGT 546
D + H ++ NIL VA +GL VP I+ I V+
Sbjct: 119 -DKKLVHGNVCGKNIL--------VARYGL-NEGYVPFIKLSDPGIPITVLSREERVERI 168
Query: 547 PGYLDPEYF--LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS-MM 602
P ++ PE LT +D +S G LE+ + G +P+S SS
Sbjct: 169 P-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS-----------TLSSSEKE 216
Query: 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
D + P +C E L +C + RPS ++R+L
Sbjct: 217 RFYQDQHRLPMP-DCAELA-NLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 32/79 (40%), Positives = 44/79 (55%), Gaps = 9/79 (11%)
Query: 1 MSKLLKL---SLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPP--GRL-SLNITTI 53
+SKL L +L S++G +P L I +L LDLS N NGSIP G+L SL I +
Sbjct: 438 ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRI--L 495
Query: 54 KLSNNKLTGTIPSNFSGLP 72
L+ N L+G +P+ G
Sbjct: 496 NLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 381 TQIGQGGYGKVYKGILPDGTV---VAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVS 435
T +G G YG V D + VAVK+ SL + E++ L + H N++
Sbjct: 21 TPVGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 436 LVGY------CDEEGEQMLVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 486
L+ + E LV M N ++ Q S E + F + + RG+
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLL-----RGL 131
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
Y+H+ + HRD+K SN+ ++ ++ DFGL+R A ++ G V T
Sbjct: 132 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYV---------AT 178
Query: 547 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 579
Y PE L +++ D++S+G + ELL G
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 24/153 (15%)
Query: 439 YCDEEGEQML--VYEFMSNGTLRDQLS---AKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
+C + ++ L V E+M G L + +S K + + +AL + +H+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMG 162
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ HRD+K N+LLD K+ADFG D G+V T V GTP Y+ PE
Sbjct: 163 ---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM---DETGMV--RCDTAV-GTPDYISPE 213
Query: 554 YFLTHK----LTDKSDVYSLGVVFLELLTGMQP 582
+ + D +S+GV E+L G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 383 IGQGGYGKVYKGI---LPDG-----TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 434
+GQG + K++KGI + D T V +K + + F +S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
G C E ++V E++ G+L D K+K + + +L +A + + +L D
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFLE---D 118
Query: 495 PPVFHRDIKASNILL 509
+ H ++ A N+LL
Sbjct: 119 KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 27/205 (13%)
Query: 383 IGQGGYGKV---YKGILPDGTVVA-VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
IG G G V Y +L + + R + ++ + E+ + ++H+N++SL+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLN 83
Query: 439 Y------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+E + LV E M + E + + + + GI +LH+
Sbjct: 84 VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSA 138
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ HRD+K SNI++ T K+ DFGL+R A + + T T Y P
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--------SFMMTPYVVTRYYRAP 187
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELL 577
E L + D++S+G + E++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 33/120 (27%), Positives = 46/120 (38%), Gaps = 36/120 (30%)
Query: 499 HRDIKASNILLDHKFTAKVADFGL---------SR------------LAPVPDIEGIVPA 537
HRDIK NIL+D K+ DFGL S+ + P + I
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 538 HVSTVVK---------------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
+ + + GTP Y+ PE L T D +S+GV+ E+L G P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 74/312 (23%), Positives = 124/312 (39%), Gaps = 46/312 (14%)
Query: 397 PDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454
P GT+V V+ + E K E+ H N+++ ++ FM+
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 514
G+ L E + A+ +I G+ RG+ YLH HR+IKAS+IL
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL------ 133
Query: 515 AKVADFGLSRLAPVPDIEGIVP-AHVSTVVKGTPGY-------LDPEYFLT--HKLTDKS 564
++ GL L+ + + +V + VV P + L PE + KS
Sbjct: 134 --ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191
Query: 565 DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG------NMGSYP-SEC 617
D+YS+G+ EL TG P ++ M+ + G ++ ++P E
Sbjct: 192 DIYSVGITACELATGRVPFQD----------MLRTQMLLQKLKGPPYSPLDITTFPCEES 241
Query: 618 VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP-- 675
K + + E+ M++ M E + P S T +P F N ++ P
Sbjct: 242 RMKNSQSGVDSGIGESVVAAGMTQTMTS-ERLRT--PSSKTFSPAFQNLVELCLQQDPEK 298
Query: 676 -PSSSSMLKHPY 686
PS+SS+L H +
Sbjct: 299 RPSASSLLSHAF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 383 IGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-- 439
IG G +G VY+ I D + VA+K+ LQ + E+ + L+H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 440 --CDEEGEQML----VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS---SRGILYLH 490
C ++ E+ + V EF+ T+ + ++ + L + L S R + Y+H
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFL-VKLYSYQLCRALAYIH 187
Query: 491 TEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
++ + HRD+K N+L+D + T K+ DFG ++ ++ S + Y
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--------NLLAGQRSVSYICSRFY 236
Query: 550 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 593
PE L T D++SLG + E++ G PI G++ V ++
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGY-PIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 485 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544
GI +LH+ + HRD+K SNI++ T K+ DFGL+R A G VV
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV- 187
Query: 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 579
T Y PE L + D++S+G + E++ G
Sbjct: 188 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 41/154 (26%), Positives = 60/154 (38%), Gaps = 25/154 (16%)
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGIL 487
N+V L Y E LV + G L +S P +A + +AL +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFG-LSRLAPVPDIEGIVPAHVSTVVKGT 546
LH E + RD+ +NILLD + ++ F S + D E +
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-----------E 145
Query: 547 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM 580
Y PE + T+ D +SLG + ELLTG
Sbjct: 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 383 IGQGGYGKVYK----GILPDGT--VVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 434
+G+G +G+V + GI T VAVK +EG+ E + ++E++ L + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 435 SLVGYCDEE-GEQMLVYEFMSNGTLRDQLSAKSKE 468
+L+G C + G M++ EF G L + L +K E
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGE 109
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 58/248 (23%), Positives = 93/248 (37%), Gaps = 48/248 (19%)
Query: 377 FNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLH 429
F +G+G G+V+ KG G + A+K + + + LTE + L+ L
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSS 483
H L +L E LV ++ G L L + + L +A + +AL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE-- 117
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD--IEGIVPAHVS- 540
YLH + +RD+K NILL ++DF LS+ + V + +
Sbjct: 118 ----YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 541 ---------TVVK----------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ 581
T + GT Y+ PE D ++LG++ E+L G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 582 PISHGKNI 589
P G N
Sbjct: 231 PFK-GSNR 237
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 30/88 (34%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRD+K N+LLD K+ADFG + EG+V + GTP Y+ PE +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDTAV---GTPDYISPEVLKSQ 218
Query: 559 K----LTDKSDVYSLGVVFLELLTGMQP 582
+ D +S+GV E+L G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 30/133 (22%), Positives = 50/133 (37%), Gaps = 15/133 (11%)
Query: 2 SKLLKLSLRNCSLQ----GPMPDLSRIPNLGYLDLSSNQLNGSIPP------GRLSLNIT 51
L +L L + +L G + L R +L L L++N L L +
Sbjct: 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140
Query: 52 TIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 107
+ L N+L G + L+ L +ANN + + ++ + N +LD
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKAN-CNLEVLD 199
Query: 108 FQNNNLTNISGSF 120
NN LT+ S
Sbjct: 200 LNNNGLTDEGASA 212
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-04
Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 47 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 106
S + +I LS ++G I S LP +Q + ++NN LSG IP I+ + ++ L
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTT----SSSLRYL 123
Query: 107 DFQNNNLTNISGSFNIPPNVTVRLRGNPF 135
+ NNN T +IP T+ L N
Sbjct: 124 NLSNNNFTGSIPRGSIPNLETLDLSNNML 152
|
Length = 968 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 49/178 (27%), Positives = 69/178 (38%), Gaps = 18/178 (10%)
Query: 402 VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 461
V +K Q G TE L ++H +++ L G L+ L
Sbjct: 120 VVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCY 172
Query: 462 LSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 521
L+AK + L+I R I YLH + HRDIKA NI ++H + DFG
Sbjct: 173 LAAKRNIAI--CDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG 227
Query: 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 579
+ PV DI A+ GT PE D++S G+V E+ T
Sbjct: 228 -AACFPV-DIN----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.001
Identities = 26/85 (30%), Positives = 35/85 (41%), Gaps = 12/85 (14%)
Query: 499 HRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 557
H DIK N+L D K + D+GL + + GT Y PE
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCK-----------IIGTPSCYDGTLDYFSPEKIKG 180
Query: 558 HKLTDKSDVYSLGVVFLELLTGMQP 582
H D +++GV+ ELLTG P
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 54/201 (26%), Positives = 79/201 (39%), Gaps = 29/201 (14%)
Query: 397 PDGTVVAVKRAQEGSLQGEK-EFL-TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454
P G V V+R + E FL E+ +H N+V + E +V FM+
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 514
G+ +D + + + I G + + Y+H HR +KAS+IL+
Sbjct: 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILI--SVD 137
Query: 515 AKVADFGL----------SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT--- 561
KV GL RL V D P + V+ +L PE L L
Sbjct: 138 GKVYLSGLRSNLSMINHGQRLRVVHDF----PKYSVKVLP----WLSPE-VLQQNLQGYD 188
Query: 562 DKSDVYSLGVVFLELLTGMQP 582
KSD+YS+G+ EL G P
Sbjct: 189 AKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 421 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIA 479
E + L RL H +++L+ G LV ++ S+ L L A+ + PLG A ++A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGARLR-PLGLAQVTAVA 266
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL------SRLAPVP-DIE 532
I Y+H E + HRDIK N+L++ + DFG S P I
Sbjct: 267 RQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 575
G V + V+ G P T D++S G+V E
Sbjct: 324 GTVDTNAPEVLAGDP------------YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 32/112 (28%), Positives = 49/112 (43%), Gaps = 8/112 (7%)
Query: 25 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 84
NL LDLS N++ P R N+ + LS N L+ +P S L L L ++ N +
Sbjct: 140 SNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198
Query: 85 SGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVT-VRLRGNPF 135
S +P I L LD NN++ + S + N++ + L N
Sbjct: 199 S-DLPPEIELLSALE-----ELDLSNNSIIELLSSLSNLKNLSGLELSNNKL 244
|
Length = 394 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 707 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.51 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.44 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.42 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.38 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.38 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.35 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.3 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.25 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.17 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.14 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.13 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.11 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.07 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.06 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.05 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.01 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.0 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.94 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.92 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.73 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.69 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.68 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.67 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.64 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.6 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.6 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.58 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.55 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.55 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.53 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.53 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.49 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.37 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.27 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.24 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.16 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.16 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.14 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.12 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-55 Score=528.40 Aligned_cols=513 Identities=24% Similarity=0.394 Sum_probs=343.1
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
|++|+.|+|++|++++.++ .+..+++|+.|+|++|++.|.+|......+|+.|+|++|++++.+|..|.++++|+.|+|
T Consensus 427 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~L 506 (968)
T PLN00113 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKL 506 (968)
T ss_pred CCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEEC
Confidence 4689999999999999888 688899999999999999988887665558999999999999999999999999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCC-CC-CCCCCceeeccCCCccccCCcccccCCCCCCCccccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG-SF-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDR 157 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~-~~-~~~~l~~l~l~~N~~~~~~~~~~~~~~~~~~~~~~~~ 157 (707)
++|+++|.+|..+.++++|+ +|+|++|.+++..+ .+ .+++|+.|+|++|++...-+ ..+.+-.. -..++.
T Consensus 507 s~N~l~~~~p~~~~~l~~L~-----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~--L~~l~l 578 (968)
T PLN00113 507 SENKLSGEIPDELSSCKKLV-----SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP-KNLGNVES--LVQVNI 578 (968)
T ss_pred cCCcceeeCChHHcCccCCC-----EEECCCCcccccCChhHhCcccCCEEECCCCcccccCC-hhHhcCcc--cCEEec
Confidence 99999999999988877665 99999999998644 44 78999999999999864322 11111000 001111
Q ss_pred CCCCCCcccccCCCCCCccCCCCCCccccccceeeEEEecCCCCCCCchhHHHHHHHHhhcccccccceeccceeeecCC
Q 005224 158 STNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGP 237 (707)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (707)
+.+. +.+ ..|....+ ..+
T Consensus 579 s~N~-l~~---~~p~~~~~-------------------------~~~--------------------------------- 596 (968)
T PLN00113 579 SHNH-LHG---SLPSTGAF-------------------------LAI--------------------------------- 596 (968)
T ss_pred cCCc-cee---eCCCcchh-------------------------ccc---------------------------------
Confidence 1110 000 00100000 000
Q ss_pred ccceeeeecccccCCCCCcccccccccceeeeeecccccCCCCCcCCcccccccccCCCCCCCCCCCCCCCcccceeeee
Q 005224 238 RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGII 317 (707)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii 317 (707)
....+.+... .+..++....++......+... ..++
T Consensus 597 ---------------------------------------~~~~~~~n~~----lc~~~~~~~~~~c~~~~~~~~~-~~~~ 632 (968)
T PLN00113 597 ---------------------------------------NASAVAGNID----LCGGDTTSGLPPCKRVRKTPSW-WFYI 632 (968)
T ss_pred ---------------------------------------ChhhhcCCcc----ccCCccccCCCCCcccccccee-eeeh
Confidence 0000000000 0000000000100000011111 1222
Q ss_pred hhHHHHHHHHHHHH-HhhhhhhccccccccccccCCCCccccc-----cCcccccHHHHHHHhcCCCccceEeeeCceEE
Q 005224 318 LGAIAGAVTISAIV-SLLIVRAHMKNYHAISRRRHSSKTSIKI-----DGVRSFTYGEMALATNNFNSSTQIGQGGYGKV 391 (707)
Q Consensus 318 ~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~V 391 (707)
++++++++++++++ ++++++++++ ....+... ....... .....++++++. ..|...+.||+|+||.|
T Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~V 706 (968)
T PLN00113 633 TCTLGAFLVLALVAFGFVFIRGRNN--LELKRVEN-EDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGAS 706 (968)
T ss_pred hHHHHHHHHHHHHHHHHHHHHhhhc--cccccccc-ccccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeE
Confidence 22222222222222 2222222211 11111000 0000110 011223444443 45778899999999999
Q ss_pred EEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCc
Q 005224 392 YKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPL 470 (707)
Q Consensus 392 y~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l 470 (707)
|+|.. .+++.||||++...... ..+|++.+++++|||||+++++|.+.+..++||||+++|+|.++++. +
T Consensus 707 y~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l 777 (968)
T PLN00113 707 YKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----L 777 (968)
T ss_pred EEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----C
Confidence 99996 47899999998753322 23468899999999999999999999999999999999999999952 8
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCcc
Q 005224 471 GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550 (707)
Q Consensus 471 ~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ 550 (707)
+|..+..++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+..... .....++..|+
T Consensus 778 ~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----------~~~~~~t~~y~ 845 (968)
T PLN00113 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----------DTKCFISSAYV 845 (968)
T ss_pred CHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----------CCCcccccccc
Confidence 899999999999999999997766669999999999999999988876 665543211 11235789999
Q ss_pred chhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC----chhHHHHHHHhhcccchhhccCCCC---CCChHHHHHHHH
Q 005224 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG----KNIVREVNIAYQSSMMFSVIDGNMG---SYPSECVEKFIK 623 (707)
Q Consensus 551 aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 623 (707)
|||++.+..++.++|||||||++|||+||+.||+.. ....+|.............+++... ..+.++..++.+
T Consensus 846 aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (968)
T PLN00113 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMN 925 (968)
T ss_pred CcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHH
Confidence 999999999999999999999999999999998542 2344444443333223333343332 244567778899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 624 LALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 624 l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
++.+||+.+|++||+|.++++.|+.+....+
T Consensus 926 l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 926 LALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred HHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 9999999999999999999999998766443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=444.63 Aligned_cols=285 Identities=52% Similarity=0.882 Sum_probs=249.5
Q ss_pred CcccccHHHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEE
Q 005224 361 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440 (707)
Q Consensus 361 ~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 440 (707)
....|+|+++..||++|...+.||+|+||.||+|.+++|+.||||++........++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765443155699999999999999999999999
Q ss_pred EeCC-eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 005224 441 DEEG-EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 519 (707)
Q Consensus 441 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 519 (707)
.+.+ +.+||||||++|+|.++|+.....+++|.+|++||.++|+||+|||+.+.++||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999875443799999999999999999999999999999999999999999999999999
Q ss_pred ecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC-----chhHHHHH
Q 005224 520 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG-----KNIVREVN 594 (707)
Q Consensus 520 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~-----~~~~~~~~ 594 (707)
||+|+...... ........||.+|+|||++..+..+.|+|||||||+|+|++||+.+.+.. ..+.+|..
T Consensus 221 FGLa~~~~~~~------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 221 FGLAKLGPEGD------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred ccCcccCCccc------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99997654210 11111117999999999999999999999999999999999999888743 23678887
Q ss_pred HHhhcccchhhccCCCC--CCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 595 IAYQSSMMFSVIDGNMG--SYPS-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 595 ~~~~~~~~~~~~~~~~~--~~~~-~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
..+....+.+++|+.+. .++. +....+.+++.+|++.+|..||+|.+|+++|+.+..
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 77777789999999874 4554 688889999999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=403.09 Aligned_cols=261 Identities=38% Similarity=0.582 Sum_probs=222.0
Q ss_pred CCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhh--HHHHHHHHHHHHccCCCcceeEEEEEEeCC-eEEEEEecC
Q 005224 377 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLVYEFM 453 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~E~~ 453 (707)
+...+.||+|+||+||+|.++....||||++....... .++|.+|+.+|++++|||||+++|+|.... ..++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 33456699999999999999655559999998644332 568999999999999999999999998887 799999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeeecccccCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 532 (707)
++|+|.++++......+++..++.++.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 99999999987656679999999999999999999999874 99999999999999997 99999999998764321
Q ss_pred CccccceecccccCCCccchhhhc--cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ..... .-+..+.+
T Consensus 199 -----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~--------~v~~~~~R 264 (362)
T KOG0192|consen 199 -----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVAS--------AVVVGGLR 264 (362)
T ss_pred -----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHH--------HHHhcCCC
Confidence 2233467999999999999 66999999999999999999999999986655 22111 11234556
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
+..|..++..+..++.+||+.+|..||++.+++..|+.+......
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 667888999999999999999999999999999999998776554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=395.51 Aligned_cols=261 Identities=25% Similarity=0.419 Sum_probs=207.7
Q ss_pred HhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChh-------hHHHHHHHHHHHHccCCCcceeEEEEEEeCC
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ-------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 444 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 444 (707)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++..... ....+.+|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345677899999999999999995 58999999999753221 2234679999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEeeec
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFG 521 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFG 521 (707)
..|||||||+||+|.+.+-.+. .+.+..-+.+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999996654 4777778999999999999999999 9999999999999765 789999999
Q ss_pred ccccCCCCCCCCccccceecccccCCCccchhhhccCCC---CCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhh
Q 005224 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL---TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598 (707)
Q Consensus 522 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~ 598 (707)
+|+.... .......+||+.|.|||++.+..+ ..++|+||+||+||-+++|..||..........+
T Consensus 325 lAK~~g~--------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e---- 392 (475)
T KOG0615|consen 325 LAKVSGE--------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE---- 392 (475)
T ss_pred hhhcccc--------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH----
Confidence 9998753 345667899999999999987543 3478999999999999999999975332110000
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCC
Q 005224 599 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS 678 (707)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa 678 (707)
.+..+.....|. . ....+.++.|||++||++||++|+|+
T Consensus 393 -----QI~~G~y~f~p~-~-----------------------------------w~~Iseea~dlI~~mL~VdP~~R~s~ 431 (475)
T KOG0615|consen 393 -----QILKGRYAFGPL-Q-----------------------------------WDRISEEALDLINWMLVVDPENRPSA 431 (475)
T ss_pred -----HHhcCcccccCh-h-----------------------------------hhhhhHHHHHHHHHhhEeCcccCcCH
Confidence 011111111111 0 01123345589999999999999999
Q ss_pred CcCCCCCCCCCCC
Q 005224 679 SSMLKHPYVSSDV 691 (707)
Q Consensus 679 ~e~L~Hp~f~~~~ 691 (707)
+|||+||||....
T Consensus 432 ~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 432 DEALNHPWFKDAP 444 (475)
T ss_pred HHHhcChhhhccc
Confidence 9999999998554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=386.36 Aligned_cols=259 Identities=27% Similarity=0.395 Sum_probs=205.5
Q ss_pred CccceEeeeCceEEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC-eEEEEEecCC
Q 005224 378 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLVYEFMS 454 (707)
Q Consensus 378 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~E~~~ 454 (707)
+....||+|..|+|||+.++ +++.+|+|.+... .....+++.+|+++++..+||+||.+||.|..++ ...++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34678999999999999976 7899999999543 3344688999999999999999999999999999 5999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
+|+|++++... ..+++...-.|+.+|++||.|||+ .+ ||||||||+|||++..|++||+|||.+..+...
T Consensus 162 gGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred CCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 99999999765 459999999999999999999996 66 999999999999999999999999999876432
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
......||..|||||.+.+..|+.++||||||++++|+.+|+.||.....
T Consensus 233 -----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~------------------------- 282 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP------------------------- 282 (364)
T ss_pred -----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-------------------------
Confidence 33567899999999999999999999999999999999999999975311
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCCC
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 693 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~ 693 (707)
-...+.+++..-+...|-+=|. ...++++.+|+..||+.||.+|+|++|+|+|||+......
T Consensus 283 ---~~~~~~~Ll~~Iv~~ppP~lP~---------------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 283 ---PYLDIFELLCAIVDEPPPRLPE---------------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred ---CCCCHHHHHHHHhcCCCCCCCc---------------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 0011122222222222211111 0234455566666677777777777777777777655543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=370.19 Aligned_cols=283 Identities=26% Similarity=0.449 Sum_probs=223.4
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhh--HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.+|...++||+|.||.||+|+. .+|+.||||+++.....+ .....+|++.|+.++|+||+.++++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688899999999999999995 589999999998654332 4578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
||+. +|...++.+ ...++...++.++.++++||+|||++. |+||||||.|+|++++|.+||+|||+|+.+...+
T Consensus 82 fm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred eccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 9965 999999764 456999999999999999999999999 9999999999999999999999999999887544
Q ss_pred CCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
......+-|..|+|||.+.| ..|+..+||||.||++.||+.| .||..+.+..+++..++.. +
T Consensus 156 ------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL~~If~~----------L 218 (318)
T KOG0659|consen 156 ------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFRA----------L 218 (318)
T ss_pred ------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHHH----------c
Confidence 22333467899999999988 6799999999999999999998 6666777767766654432 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH-HhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE-SIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~-~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
+...++.+.++.++ |+..++...-. .....++....+..||+.+|+++||.+|+||+|+|+||||++
T Consensus 219 GTP~~~~WP~~~~l------------pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSL------------PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred CCCCcccCcccccc------------ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 11111111111111 11111110000 011145666777799999999999999999999999999997
Q ss_pred CCC
Q 005224 690 DVS 692 (707)
Q Consensus 690 ~~~ 692 (707)
...
T Consensus 287 ~P~ 289 (318)
T KOG0659|consen 287 LPL 289 (318)
T ss_pred CCC
Confidence 444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=404.43 Aligned_cols=262 Identities=30% Similarity=0.507 Sum_probs=224.2
Q ss_pred HHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 370 MALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 370 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
++.....+...+.||+|.||.||.|.++....||+|.++.... ..+.|.+|+++|++++|+|||+++++|..++.++||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 3333344445788999999999999998777999999987543 446899999999999999999999999998899999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
||||+.|+|.++|+...+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+....+
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999999998867778999999999999999999999999 999999999999999999999999999954433
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.+. ......-+..|.|||.+..+.++.|||||||||+||||+| |+.||....+. +.+..+-.+
T Consensus 357 ~Y~------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------ev~~~le~G 420 (468)
T KOG0197|consen 357 EYT------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------EVLELLERG 420 (468)
T ss_pred cee------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------HHHHHHhcc
Confidence 221 1222234678999999999999999999999999999999 99998765441 122334456
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.+.+.|+.|+..++++|..||+.+|++|||+..+...++++..
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 6777899999999999999999999999999999888887654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=402.26 Aligned_cols=254 Identities=25% Similarity=0.448 Sum_probs=216.2
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.+|...+.||+|+|+.||.++. .+|+.||+|++..... ...+.+.+|+++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999996 7899999999986432 33467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
|+|++++|..+++ .+.++++.+++.+..||+.||.|||+.+ |+|||||-.|+++++++++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 9999999999996 4557999999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......+||+.|+|||++....++..+||||+||+||-|+.|++||....-
T Consensus 172 ------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v---------------------- 223 (592)
T KOG0575|consen 172 ------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV---------------------- 223 (592)
T ss_pred ------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH----------------------
Confidence 2456678999999999999999999999999999999999999999964211
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
.+.+ .|+..+--.+|+ ..+..+.|||.+||+.||.+|||++++|.|+||.+.
T Consensus 224 --------kety----~~Ik~~~Y~~P~----------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 224 --------KETY----NKIKLNEYSMPS----------------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred --------HHHH----HHHHhcCccccc----------------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 1111 111111112222 234566789999999999999999999999999433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=380.82 Aligned_cols=272 Identities=23% Similarity=0.364 Sum_probs=223.4
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
..++|++.++||+|+||.||.++.+ +++.+|+|++++.... ..+...+|..+|.+++||.||+++..|++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4568999999999999999999964 6899999999875433 24567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|+||+.||.|..+|++++ .+++..++.++..|+.||.|||+.+ ||||||||+|||+|.+|+++|+|||+++....
T Consensus 103 Vld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999997654 4999999999999999999999999 99999999999999999999999999985432
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
. .......+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+. ..
T Consensus 178 ~-------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-~~----------------- 232 (357)
T KOG0598|consen 178 D-------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-KK----------------- 232 (357)
T ss_pred C-------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-HH-----------------
Confidence 2 2334557999999999999999999999999999999999999999964332 11
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC-CCCCCCccccCCCCCCCCCCC----CCCcCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPP----SSSSMLK 683 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~-~~~~~~dll~~~L~~dP~~R~----sa~e~L~ 683 (707)
+.+-+..+- ....+. .+....|+++++|+.||++|+ .+.++-+
T Consensus 233 ------------~~~~I~~~k--------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 233 ------------MYDKILKGK--------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ------------HHHHHhcCc--------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 111111110 011122 455567899999999999996 5778889
Q ss_pred CCCCCCCCCCCCcccccCcccCC
Q 005224 684 HPYVSSDVSGSNLVSGVIPTITP 706 (707)
Q Consensus 684 Hp~f~~~~~~~~~~~~~~~~~~~ 706 (707)
||||.+..+..-.-..+.|++.|
T Consensus 281 HpfF~~inW~~l~~k~l~PpF~P 303 (357)
T KOG0598|consen 281 HPFFKGINWEKLLAKKLSPPFKP 303 (357)
T ss_pred CcccccCCHHHHHhcCCCCCeec
Confidence 99999988855444556666655
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=393.40 Aligned_cols=287 Identities=22% Similarity=0.358 Sum_probs=228.2
Q ss_pred hcCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCChhh-HHHHHHHHHHHHccC-CCcceeEEEEEEeCC-eEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEG-EQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~lV 449 (707)
.++|...++||.|+||.||+|+ ..+|..||||+++..-... +-.=.+|++.|+++. ||||+++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4688899999999999999999 4579999999998643322 334478999999998 999999999998887 99999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
||||+ .+|+++++++ +..+++..++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||....
T Consensus 89 fE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS- 162 (538)
T ss_pred HHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc-
Confidence 99995 6999999887 778999999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
....+.++.|..|+|||++.. +.|+.+.||||+|||++|+.+-++.|. +.+..++...+.. ++
T Consensus 163 -------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP-G~sE~Dqi~KIc~------VL-- 226 (538)
T KOG0661|consen 163 -------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP-GASEIDQIYKICE------VL-- 226 (538)
T ss_pred -------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC-CCcHHHHHHHHHH------Hh--
Confidence 334566788999999999865 789999999999999999999876665 4444444433221 11
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
+....+...+-.+++..+=-.-|..-|+- +...++....++.++|.+|+.|||++||||+|+|+||||.
T Consensus 227 --GtP~~~~~~eg~~La~~mnf~~P~~~~~~---------l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq 295 (538)
T KOG0661|consen 227 --GTPDKDSWPEGYNLASAMNFRFPQVKPSP---------LKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ 295 (538)
T ss_pred --CCCccccchhHHHHHHHhccCCCcCCCCC---------hHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence 12222222333455555444444444432 2233455677788899999999999999999999999997
Q ss_pred CCCCC
Q 005224 689 SDVSG 693 (707)
Q Consensus 689 ~~~~~ 693 (707)
...+.
T Consensus 296 ~~~~~ 300 (538)
T KOG0661|consen 296 VGRAS 300 (538)
T ss_pred ccccc
Confidence 66553
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=377.00 Aligned_cols=268 Identities=25% Similarity=0.406 Sum_probs=212.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
..+|...+.||+|+||+||+|+++ ++..||||.+... .....+.+..|+++|+.++|||||.+++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888889999999999999975 6899999998776 4445567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC------CcEEEeeecccc
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK------FTAKVADFGLSR 524 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~------~~~kl~DFGla~ 524 (707)
|||.||+|.++++.++ .+++..++.++.|+|.||++||+++ ||||||||.|||++.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999997765 5999999999999999999999999 9999999999999764 568999999999
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
.+.. .......+|++-|||||+++.++|+.|+|+||+|+++|+|++|+.||...... +......+.
T Consensus 164 ~L~~--------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~-eL~~~~~k~----- 229 (429)
T KOG0595|consen 164 FLQP--------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK-ELLLYIKKG----- 229 (429)
T ss_pred hCCc--------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH-HHHHHHhcc-----
Confidence 8864 33456789999999999999999999999999999999999999999754321 111111000
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
.......+........++...-++.++.+|-++.+ .|...++..+|.+|..+.++=
T Consensus 230 --~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~--------------------~~~~~~l~~~p~~~~~~~~~~ 285 (429)
T KOG0595|consen 230 --NEIVPVLPAELSNPLRELLISLLQRNPKDRISFED--------------------FFDHPFLAANPQDRADAFELE 285 (429)
T ss_pred --ccccCchhhhccCchhhhhhHHHhcCccccCchHH--------------------hhhhhhcccCcccccCccccc
Confidence 01112233444445556666666666666655432 355666777777776665543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=389.84 Aligned_cols=287 Identities=26% Similarity=0.397 Sum_probs=221.4
Q ss_pred hcCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 448 (707)
.+.|+.+++||+|+||.||+|+ ..+|+.||+|++.... .....-..+||.+|++++||||++|.+...+. +.+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3457778899999999999999 4689999999987654 33345678999999999999999999998776 68999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|+|||++ +|.-++... .-.|++.+++.++.|++.||+|+|.++ |+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 196 VFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999976 888888543 346999999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.. ....+..+-|..|+|||++.| ..|+.++|+||.||||.||++|++.|. +...+++++.++..
T Consensus 271 ~~------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~-G~tEveQl~kIfkl-------- 335 (560)
T KOG0600|consen 271 SG------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ-GRTEVEQLHKIFKL-------- 335 (560)
T ss_pred CC------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC-CccHHHHHHHHHHH--------
Confidence 43 233566678999999999998 579999999999999999999976664 45555555544332
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
.+...++++. ..++- .+....|. +|.- +.+.+ .+...+...++|+..||.+||++|.||.+||+|+||
T Consensus 336 --cGSP~e~~W~-~~kLP-~~~~~kp~-~~y~----r~l~E---~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 336 --CGSPTEDYWP-VSKLP-HATIFKPQ-QPYK----RRLRE---TFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred --hCCCChhccc-cccCC-cccccCCC-Cccc----chHHH---HhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 1222233322 11111 11111111 1111 11222 234455677899999999999999999999999999
Q ss_pred CCCCC
Q 005224 688 SSDVS 692 (707)
Q Consensus 688 ~~~~~ 692 (707)
.....
T Consensus 404 ~t~p~ 408 (560)
T KOG0600|consen 404 TTEPL 408 (560)
T ss_pred ccCCC
Confidence 55444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=370.50 Aligned_cols=282 Identities=24% Similarity=0.374 Sum_probs=219.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
+.|+...++|+|+||+|||++.+ +|+.||||++..... .-.+-.++|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999976 699999999976433 234667899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
||+. ++.+-|.+. ...++...+.++++|+++|+.|+|+++ +|||||||+|||++.++.+||+|||+|+.+..+
T Consensus 82 ~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred ecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 9976 555555443 345899999999999999999999999 999999999999999999999999999987632
Q ss_pred CCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
....+.++.|..|+|||.+.+ .+|...+||||+||++.||++|.+.|. +....+++..+... +
T Consensus 155 -----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P-G~SDiDQLy~I~kt----------L 218 (396)
T KOG0593|consen 155 -----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP-GRSDIDQLYLIRKT----------L 218 (396)
T ss_pred -----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC-CcchHHHHHHHHHH----------H
Confidence 344566778999999999998 789999999999999999999976664 44444444332111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCCC----CCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETD----ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 686 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~----~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 686 (707)
+...+. ..++ +..+|- .=|.. +.++.+...+|.......||+++||.+||++|++.+|+|.|||
T Consensus 219 G~L~pr----hq~i----F~~N~~F~Gv~lP~~----~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y 286 (396)
T KOG0593|consen 219 GNLIPR----HQSI----FSSNPFFHGVRLPEP----EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY 286 (396)
T ss_pred cccCHH----HHHH----hccCCceeeeecCCC----CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence 111111 1111 111110 00100 1223344566777778889999999999999999999999999
Q ss_pred CCCCC
Q 005224 687 VSSDV 691 (707)
Q Consensus 687 f~~~~ 691 (707)
|++-+
T Consensus 287 Fd~~~ 291 (396)
T KOG0593|consen 287 FDGFI 291 (396)
T ss_pred HHHHH
Confidence 96543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=405.63 Aligned_cols=264 Identities=30% Similarity=0.507 Sum_probs=226.0
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
...+....+.||+|+||.||+|... +...||||.+++.... ..++|++|++++..++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3445555789999999999999852 3568999999987665 57899999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcC------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 005224 446 QMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 513 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 513 (707)
.++|+|||..|||.++|.... +.+++..+.+.||.|||.||+||-++. +|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999997521 234899999999999999999999999 99999999999999999
Q ss_pred cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHH
Q 005224 514 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 592 (707)
Q Consensus 514 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~ 592 (707)
.|||+|||+++.....|+.... ....-+++|||||.++.++||.+||||||||+|||+++ |+.||..-.+.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~-----~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--- 712 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVR-----GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--- 712 (774)
T ss_pred EEEecccccchhhhhhhhhccc-----CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---
Confidence 9999999999987666544321 12223679999999999999999999999999999999 99999765441
Q ss_pred HHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 593 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
+.+..+-.+...+.|+.|+.+++++|..||+..|.+||++.|+-..|+......+
T Consensus 713 -------EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 713 -------EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -------HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 2233344566677899999999999999999999999999999999998766544
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=360.83 Aligned_cols=286 Identities=24% Similarity=0.322 Sum_probs=216.7
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEE--eCCeEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~~lV 449 (707)
+.|+..+.|++|+||.||+|+.+ +++.||+|+++-.... -.-...+|+.+|.+++|||||.+..+.. +-+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45777899999999999999965 7899999999754321 1235689999999999999999998874 44679999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
||||++ +|..+++... +++...+++.++.|+++|++|||... |+|||||++|+|++..|.+||+|||+|+.+..+
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999976 9999998754 67999999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
....+..+-|..|+|||.+.+ ..|+.+.||||+|||+.||+++++.|. +....+++..++..-.
T Consensus 231 -------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~-G~sE~dQl~~If~llG------- 295 (419)
T KOG0663|consen 231 -------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP-GKSEIDQLDKIFKLLG------- 295 (419)
T ss_pred -------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC-CCchHHHHHHHHHHhC-------
Confidence 233556678999999999988 579999999999999999999977665 4555555555443211
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC--CCCCCCccccCCCCCCCCCCCCCCcCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE--SDTKTPEFINSEHTSKEETPPSSSSMLKHPY 686 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~--~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 686 (707)
...+..+..+.++-. ++ -..+|.. -...|+ ..++. .+....||++.+|++||++|+||+|+|+|+|
T Consensus 296 ---tPte~iwpg~~~lp~--~k--~~~f~~~--pyn~lr---~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 296 ---TPSEAIWPGYSELPA--VK--KMTFSEH--PYNNLR---KKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred ---CCccccCCCccccch--hh--ccccCCC--Cchhhh---hhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 111111111111100 00 0001100 011222 22332 3366789999999999999999999999999
Q ss_pred CCCCCC
Q 005224 687 VSSDVS 692 (707)
Q Consensus 687 f~~~~~ 692 (707)
|.....
T Consensus 364 F~e~P~ 369 (419)
T KOG0663|consen 364 FRETPL 369 (419)
T ss_pred cccCCC
Confidence 987443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=353.81 Aligned_cols=266 Identities=21% Similarity=0.316 Sum_probs=218.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhH---HHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|+..+.||.|+||.|.+++.+ +|..+|+|++........ +...+|..+|+.+.||.++++++.|.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56788999999999999999965 789999999987655443 34678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||++||.|.+++++.+ .+++..++.+|.+|+.||+|||+.+ |++|||||+|||+|.+|.+||+|||.|+...
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 9999999999997644 5999999999999999999999999 9999999999999999999999999998763
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
....+.+||+.|+|||++....+..++|.|||||++|||+.|.+||...... .
T Consensus 196 -------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-~------------------- 248 (355)
T KOG0616|consen 196 -------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-Q------------------- 248 (355)
T ss_pred -------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-H-------------------
Confidence 3366789999999999999999999999999999999999999999754431 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCC-----CCCCcCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP-----PSSSSMLKHP 685 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R-----~sa~e~L~Hp 685 (707)
+++-+..| -.....-.+.++.||+.++|+.|-.+| ...+++.+||
T Consensus 249 ----------iY~KI~~~--------------------~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~ 298 (355)
T KOG0616|consen 249 ----------IYEKILEG--------------------KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHP 298 (355)
T ss_pred ----------HHHHHHhC--------------------cccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCc
Confidence 11111111 111112234445577777888888888 3567899999
Q ss_pred CCCCCCCCCCcccccCcccC
Q 005224 686 YVSSDVSGSNLVSGVIPTIT 705 (707)
Q Consensus 686 ~f~~~~~~~~~~~~~~~~~~ 705 (707)
||.+-.+..-....+.||+-
T Consensus 299 wF~~v~W~~i~~r~ie~P~~ 318 (355)
T KOG0616|consen 299 WFKGVDWEAILQRKIEPPFE 318 (355)
T ss_pred ccccccHHHHhhccccCCCC
Confidence 99988885444444555543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=358.79 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=214.1
Q ss_pred cCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEE-EEEeCCe-EEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVG-YCDEEGE-QMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~-~~~~~~~-~~lV 449 (707)
.+|.+.++||+|.||+||++. ..+|..||.|.++..... ..+....|+.+|++++|||||++++ .+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357788999999999999999 569999999998854433 3457889999999999999999999 4555555 8999
Q ss_pred EecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhCC-CCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 450 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEA-DPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
||||..|+|..+++. +.+..+++..+|++..|++.||.++|+.- ...|+||||||.||+++.+|.+|++|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999975 45567999999999999999999999832 123999999999999999999999999999987
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
... .......+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||... +....- ..+.
T Consensus 179 ~s~-------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~---------~KI~ 241 (375)
T KOG0591|consen 179 SSK-------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLC---------KKIE 241 (375)
T ss_pred cch-------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHH---------HHHH
Confidence 642 23345678999999999999999999999999999999999999999755 332221 2233
Q ss_pred cCCCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 607 DGNMGSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 607 ~~~~~~~~-~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
.+..++.| +.++..+.+++..|+..|++.||+...+++.++.
T Consensus 242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 44555566 7789999999999999999999987666555543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=366.26 Aligned_cols=290 Identities=24% Similarity=0.366 Sum_probs=226.5
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEec--cCChhhHHHHHHHHHHHHccCCCcceeEEEEEEe-----C
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----E 443 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~ 443 (707)
.....|...+.||+|+||.|++|..+ +|+.||||++. .......++..+|+++|+.++|+||+.+.+.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34456666889999999999999964 79999999987 3455567889999999999999999999999854 3
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
+..|+|+|+| .-+|...++. .+.++...+..+.+|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 99 ~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 5789999999 5699999954 345999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
+...... .....+..+.|..|+|||++.. ..|+.+.||||.||++.||++|+..|. +.+...++..+..
T Consensus 173 R~~~~~~-----~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp-G~d~v~Ql~lI~~---- 242 (359)
T KOG0660|consen 173 RYLDKFF-----EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP-GKDYVHQLQLILE---- 242 (359)
T ss_pred eeccccC-----cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC-CCchHHHHHHHHH----
Confidence 9875431 1233456778999999999865 789999999999999999999987775 4444444443221
Q ss_pred hhhccCCCCCCChHHHHHHH-HHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC
Q 005224 603 FSVIDGNMGSYPSECVEKFI-KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 681 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~-~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 681 (707)
..+..+++....+. +-+..-++..|...+. .+...++..++.+.||+.+||++||.+|+||+||
T Consensus 243 ------~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~---------~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA 307 (359)
T KOG0660|consen 243 ------LLGTPSEEDLQKIRSEKARPYIKSLPQIPKQ---------PFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA 307 (359)
T ss_pred ------hcCCCCHHHHHHhccHHHHHHHHhCCCCCCC---------CHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH
Confidence 12333333333332 1222233333332221 1234567888999999999999999999999999
Q ss_pred CCCCCCCCCCC
Q 005224 682 LKHPYVSSDVS 692 (707)
Q Consensus 682 L~Hp~f~~~~~ 692 (707)
|+||||+.--.
T Consensus 308 L~hPYl~~~hd 318 (359)
T KOG0660|consen 308 LAHPYLAPYHD 318 (359)
T ss_pred hcChhhhhhcC
Confidence 99999976544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=377.81 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=217.4
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhh---HHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|...+.||+|+|++|++|+. ..++.||||++.+..... .+.+..|-.+|.+| .||.|++|+-.|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 45777889999999999999995 479999999997644333 34577899999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|+||+++|+|.++|++.+ .+++...+.++.+|+.||+|||++| ||||||||+|||+|+||++||+|||.|+.+..
T Consensus 152 vLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999997764 4999999999999999999999999 99999999999999999999999999998865
Q ss_pred CCCCCc------cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 529 PDIEGI------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 529 ~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
...... .........+||..|.+||++.....+..+|+|+|||++|+|+.|.+||....+..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------------ 294 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------------ 294 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------------
Confidence 432210 01111255789999999999999999999999999999999999999997654311
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
-+.+++..-.. -| +...+.+.||++++|..||.+|+|++|+.
T Consensus 295 -----------------iFqkI~~l~y~-fp--------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 295 -----------------IFQKIQALDYE-FP--------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred -----------------HHHHHHHhccc-CC--------------------CCCCHHHHHHHHHHHccCccccccHHHHh
Confidence 11111111111 11 12223445788999999999999999999
Q ss_pred CCCCCCCCCCC
Q 005224 683 KHPYVSSDVSG 693 (707)
Q Consensus 683 ~Hp~f~~~~~~ 693 (707)
+||||.+-.+.
T Consensus 337 ~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 337 AHPFFEGVDWE 347 (604)
T ss_pred hCcccccCChh
Confidence 99999998884
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=365.02 Aligned_cols=275 Identities=26% Similarity=0.330 Sum_probs=218.1
Q ss_pred HhcCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCChhh-HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
..+.|+..+.||.|..++||+|+ .+.++.||||++..+.-.. .+.+.+|+..|+.++||||++++..|..+...|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34678899999999999999999 4578999999998644333 478999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
.||.+|++.++++..-...+++..+..|.+++++||.|||++| .||||||+.||||+++|.|||+|||.+..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999999877777999999999999999999999999 9999999999999999999999999987655432
Q ss_pred CCCccccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
...........||++|||||+++. ..|+.|+||||||++..||.+|..||..-...
T Consensus 181 ---~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------------------- 238 (516)
T KOG0582|consen 181 ---DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------------------- 238 (516)
T ss_pred ---ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-------------------
Confidence 111222266789999999999654 68999999999999999999999999753321
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
++...-++.+|- +|-+.-. -.+........+..|+..||+.||++||||+++|+|+||.
T Consensus 239 --------------kvLl~tLqn~pp-~~~t~~~------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk 297 (516)
T KOG0582|consen 239 --------------KVLLLTLQNDPP-TLLTSGL------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK 297 (516)
T ss_pred --------------HHHHHHhcCCCC-CcccccC------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence 111111222221 0000000 0001111222555788889999999999999999999998
Q ss_pred CCCCC
Q 005224 689 SDVSG 693 (707)
Q Consensus 689 ~~~~~ 693 (707)
.....
T Consensus 298 ~~k~~ 302 (516)
T KOG0582|consen 298 KAKSK 302 (516)
T ss_pred hccch
Confidence 76653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=372.55 Aligned_cols=282 Identities=21% Similarity=0.299 Sum_probs=224.3
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
....++|+.+..||+|+||.||+|+-+ +|..+|+|++++..... .+.++.|-.+|....+|.||+++..|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345678999999999999999999954 79999999998865544 35578899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
||||||++||++..+|... ..|++..++.++.+++.|+.-||+.| +|||||||+|+|||..|++||+||||+.-+
T Consensus 217 YLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999999654 46999999999999999999999999 999999999999999999999999998533
Q ss_pred CCCCC------------------CCccc-----c-----------------ceecccccCCCccchhhhccCCCCCchhh
Q 005224 527 PVPDI------------------EGIVP-----A-----------------HVSTVVKGTPGYLDPEYFLTHKLTDKSDV 566 (707)
Q Consensus 527 ~~~~~------------------~~~~~-----~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV 566 (707)
..... ....+ . ......+|||.|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 21100 00000 0 00123579999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 567 YSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 567 wS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
||+|||||||+.|.+||........+-... . -..||+.-.+.+.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~--------------------------n-wr~~l~fP~~~~~--------- 415 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIV--------------------------N-WRETLKFPEEVDL--------- 415 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------------------H-HhhhccCCCcCcc---------
Confidence 999999999999999997654322221110 0 0123433322222
Q ss_pred HHhhhcCCCCCCCCCccccCCCCCCCCCCCC---CCcCCCCCCCCCCCCCCCcccccCcccCC
Q 005224 647 ESIWNMMPESDTKTPEFINSEHTSKEETPPS---SSSMLKHPYVSSDVSGSNLVSGVIPTITP 706 (707)
Q Consensus 647 ~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s---a~e~L~Hp~f~~~~~~~~~~~~~~~~~~~ 706 (707)
++++.|||.++|+ ||++|+- ++|+.+||||.+-.+ +.+....|++-|
T Consensus 416 ----------s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W--~~l~~~~apfvP 465 (550)
T KOG0605|consen 416 ----------SDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW--DHLREMPAPFVP 465 (550)
T ss_pred ----------cHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc--chhhcCCCCCCC
Confidence 2456689999999 9999986 789999999999999 666666566655
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=388.53 Aligned_cols=271 Identities=28% Similarity=0.475 Sum_probs=231.2
Q ss_pred cccHHHHHHHhcCC---------CccceEeeeCceEEEEEEeC----CCcEEEEEEeccCChhh-HHHHHHHHHHHHccC
Q 005224 364 SFTYGEMALATNNF---------NSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLH 429 (707)
Q Consensus 364 ~~~~~~l~~~~~~~---------~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~ 429 (707)
.++|+|.-.+...| .+.++||.|.||.||+|.++ ....||||.++....+. ..+|+.|+.||.++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 46777665554443 46789999999999999975 24579999999866554 568999999999999
Q ss_pred CCcceeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005224 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 509 (707)
Q Consensus 430 H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 509 (707)
||||++|.|+.......+||+|||++|+|+.+|+.+..+ +.+.+...+.++||.|+.||-+.+ +|||||.++||||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILV 764 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILV 764 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheee
Confidence 999999999999999999999999999999999887654 999999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCch
Q 005224 510 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 588 (707)
Q Consensus 510 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~ 588 (707)
+.+..+||+|||+++.++++. +. ......-.-+.+|.|||.+...+++.+|||||||++|||.++ |.+||.+..+
T Consensus 765 NsnLvCKVsDFGLSRvledd~-~~---~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDP-EA---AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred ccceEEEeccccceeecccCC-Cc---cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 999999999999999775432 11 112222233679999999999999999999999999999998 9999976655
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
. +.+..+.++.+.+.|.+|+..++++|..||+++-.+||++.+++..|.++...
T Consensus 841 Q----------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 841 Q----------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred H----------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 1 23445566777788999999999999999999999999999999999987653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=375.66 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=216.0
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
..|+...+||+|+.|.||.|.. .+++.||||++........+-+.+|+.+|+..+|+|||++++.|...++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4677789999999999999994 578999999998877666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++|+|.+.+... .+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++.......
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--- 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--- 423 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc---
Confidence 999999998543 3999999999999999999999999 9999999999999999999999999998765432
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
......+||+.|||||++....|+.+.||||||++++||+-|.+||.....+.....
T Consensus 424 ----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL------------------- 480 (550)
T KOG0578|consen 424 ----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------------------- 480 (550)
T ss_pred ----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------------------
Confidence 245677899999999999999999999999999999999999999975443221111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
++. + -+|.. +.....++.+.|||.+||+.|+++|++|+|+|+||||..-..
T Consensus 481 ----------Ia~---n----g~P~l-----------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 481 ----------IAT---N----GTPKL-----------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred ----------Hhh---c----CCCCc-----------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 000 0 01110 111233455668999999999999999999999999955443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=382.85 Aligned_cols=291 Identities=22% Similarity=0.335 Sum_probs=219.8
Q ss_pred CCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccC-C-----CcceeEEEEEEeCCeEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-H-----RNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~~l 448 (707)
+|++.+.||+|+||.|-+|.. ++++.||||+++.. .....+...|+.+|..++ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 899999999999999999995 47999999999874 344457788999999996 4 389999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEeeecccccC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLA 526 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~~ 526 (707)
|+|.+ ..+|+++++.+....++...++.|+.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||.|+..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 569999999988888999999999999999999999999 999999999999964 347999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.. .......+..|+|||++.|.+|+.+.||||||||+.||++| .|+..+.+..+++..+.+...
T Consensus 342 ~q----------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG----- 405 (586)
T KOG0667|consen 342 SQ----------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLG----- 405 (586)
T ss_pred CC----------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhC-----
Confidence 42 22366788999999999999999999999999999999999 555567776776665433211
Q ss_pred cCCCCCCChHHHHHH---HH-------HHHHhcccCCCCCCCHHHHHHHHHHhh-------------hcCC-CCCCCCCc
Q 005224 607 DGNMGSYPSECVEKF---IK-------LALKCCQDETDARPSMSEVMRELESIW-------------NMMP-ESDTKTPE 662 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l---~~-------l~~~c~~~~p~~RPt~~~v~~~L~~~~-------------~~~~-~~~~~~~d 662 (707)
..|....+.. .+ ....|...+-.+-+...++...+.... ...+ ..+..+.|
T Consensus 406 -----~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d 480 (586)
T KOG0667|consen 406 -----LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID 480 (586)
T ss_pred -----CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence 1111111100 00 011122222110011111112111111 1111 22344578
Q ss_pred cccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 663 FINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 663 ll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
||.+||.|||++|+|+.|||+||||++...
T Consensus 481 flk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 481 FLKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHHhccCchhcCCHHHHhcCcccccccc
Confidence 999999999999999999999999996554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=367.35 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=217.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.... ..+.+.+|+++++.++|||||.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999965 7899999998764322 34678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+.| +|..+|...+ .++++.+..++.++..||.|||+.+ |+|||+||.|||++..|.+|++|||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-- 153 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC--
Confidence 9976 9999997654 4999999999999999999999999 999999999999999999999999999977542
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
....+...||+-|||||+..+++|+..+|.||+||++||+++|++||..
T Consensus 154 -----t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------------------------- 202 (808)
T KOG0597|consen 154 -----TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------------------------- 202 (808)
T ss_pred -----ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH--------------------------
Confidence 4567788999999999999999999999999999999999999999952
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
..+.+++..-+. +|-.-|+ ..+..+..|++.+|..||..|+|=.+++.|||..+.+
T Consensus 203 -------~si~~Lv~~I~~-d~v~~p~----------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 203 -------RSITQLVKSILK-DPVKPPS----------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred -------HHHHHHHHHHhc-CCCCCcc----------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 223334333333 3333232 2233445788899999999999999999999998877
Q ss_pred CC
Q 005224 692 SG 693 (707)
Q Consensus 692 ~~ 693 (707)
+.
T Consensus 259 ~~ 260 (808)
T KOG0597|consen 259 NI 260 (808)
T ss_pred hh
Confidence 64
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=369.00 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=209.9
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC----Ch-hhHHHHHHHHHHHHccC-CCcceeEEEEEEeCC
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG----SL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEG 444 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 444 (707)
...++|...+.||+|+||+|+.|... +++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44568999999999999999999854 7899999977653 11 23456778999999998 999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeeeccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 523 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla 523 (707)
..++||||+.+|+|.+++.. ..++.+...+.++.|++.|++|||+.+ |+||||||+|||+|.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999977 345888999999999999999999999 9999999999999999 99999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCC-CC-CchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhccc
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 601 (707)
..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.... .
T Consensus 169 ~~~~~-------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-~---------- 230 (370)
T KOG0583|consen 169 AISPG-------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-N---------- 230 (370)
T ss_pred cccCC-------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-H----------
Confidence 87631 123456778999999999999977 86 6799999999999999999999763221 0
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCC--CCCCCccccCCCCCCCCCCCCCC
Q 005224 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES--DTKTPEFINSEHTSKEETPPSSS 679 (707)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~--~~~~~dll~~~L~~dP~~R~sa~ 679 (707)
+..-+... .-.+|.. +.++.+|+.+||..||.+|+|+.
T Consensus 231 -------------------l~~ki~~~---------------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~ 270 (370)
T KOG0583|consen 231 -------------------LYRKIRKG---------------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLL 270 (370)
T ss_pred -------------------HHHHHhcC---------------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHH
Confidence 00001110 0111222 44556788899999999999999
Q ss_pred cCCCCCCCCC
Q 005224 680 SMLKHPYVSS 689 (707)
Q Consensus 680 e~L~Hp~f~~ 689 (707)
|++.||||..
T Consensus 271 ~i~~h~w~~~ 280 (370)
T KOG0583|consen 271 EILEHPWFQK 280 (370)
T ss_pred HHhhChhhcc
Confidence 9999999987
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=348.57 Aligned_cols=294 Identities=24% Similarity=0.355 Sum_probs=222.9
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCc-ceeEEEEEEeCC-----
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEG----- 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~----- 444 (707)
...|+..++||+|+||+||+|+. .+|+.||+|++...... ......+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566778899999999999995 48999999998765432 3456789999999999999 999999998776
Q ss_pred -eEEEEEecCCCCCHHHHHhhcCC--CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeec
Q 005224 445 -EQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 521 (707)
Q Consensus 445 -~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 521 (707)
..++||||++ -+|..++..... ..++...++.++.||++||+|||+++ |+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7889999995 599999987553 35777899999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcc
Q 005224 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 600 (707)
Q Consensus 522 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~ 600 (707)
+|+....+ ....+..++|..|+|||++.+. .|+...||||+||++.||++++..|....+ .++...++..-
T Consensus 166 lAra~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~l 237 (323)
T KOG0594|consen 166 LARAFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLL 237 (323)
T ss_pred hHHHhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHc
Confidence 99965432 3445677889999999999985 799999999999999999998777765444 44443332221
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
. ...++.+..+..+... +.....++....+. ...+..++...|++.+||+++|++|+||+.
T Consensus 238 ------G----tP~e~~Wp~v~~~~~~--k~~f~~~~~~~~l~-------~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 238 ------G----TPNEKDWPGVSSLPDY--KAPFPKWPGPKDLS-------SILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred ------C----CCCccCCCCccccccc--cccCcCCCCccchH-------HhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 1 1111111111111110 00111122222222 233455577889999999999999999999
Q ss_pred CCCCCCCCCCCCCCCccc
Q 005224 681 MLKHPYVSSDVSGSNLVS 698 (707)
Q Consensus 681 ~L~Hp~f~~~~~~~~~~~ 698 (707)
||.||||.......-.+.
T Consensus 299 al~h~yf~~~~~~~~~~~ 316 (323)
T KOG0594|consen 299 ALTHPYFSELPEKSSQLL 316 (323)
T ss_pred HhcChhhcccccchhhhh
Confidence 999999998766544443
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=354.02 Aligned_cols=276 Identities=22% Similarity=0.326 Sum_probs=206.4
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC-----eEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQMLV 449 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV 449 (707)
.|...+.+|.|+||.||+|... +++.||||+...+... -.+|+++|+.++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4666899999999999999964 6799999988654332 236999999999999999999885432 34689
Q ss_pred EecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeeecccccC
Q 005224 450 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLA 526 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~~~ 526 (707)
||||+. +|.+.++. ..+..++...++-+.+||.+||+|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 99999975 23456888889999999999999999988 9999999999999976 99999999999987
Q ss_pred CCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
...+ .......|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.. ++..+++..+...
T Consensus 177 ~~~e--------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~------ 241 (364)
T KOG0658|consen 177 VKGE--------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKV------ 241 (364)
T ss_pred ccCC--------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHH------
Confidence 6432 2345677899999999998 6799999999999999999999777754 4444444433221
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCC
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDE--TDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 683 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~--p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 683 (707)
++....+... |++.+ -.+-|.....- +.+ -.....+++..||+.++|+++|.+|.+|.|+|.
T Consensus 242 ----lG~Pt~e~I~--------~mn~~y~~~~~p~ik~~~--~~~--~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 242 ----LGTPTREDIK--------SMNPNYTEFKFPQIKAHP--WHK--VFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ----hCCCCHHHHh--------hcCcccccccCccccccc--cee--ecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111221111 11211 01111111000 000 123455677789999999999999999999999
Q ss_pred CCCCCCC
Q 005224 684 HPYVSSD 690 (707)
Q Consensus 684 Hp~f~~~ 690 (707)
||||+.-
T Consensus 306 h~fFdel 312 (364)
T KOG0658|consen 306 HPFFDEL 312 (364)
T ss_pred chhhHHh
Confidence 9999643
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=359.95 Aligned_cols=281 Identities=23% Similarity=0.347 Sum_probs=208.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|...++||+|+||+||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56889999999999999999965 789999999875332 2345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
++ ++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 97 59999886543 35789999999999999999999998 9999999999999999999999999997543221
Q ss_pred CccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+........ .+
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~----------~~ 221 (288)
T cd07871 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-KEELHLIFRL----------LG 221 (288)
T ss_pred -----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH----------hC
Confidence 11233467899999999876 5689999999999999999999999965432 1211111100 01
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
..+.+....+.......-...|..|+.. .....+..+....|||.+||++||.+|+|++|+|+||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 222 TPTEETWPGITSNEEFRSYLFPQYRAQP---------LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CCChHHhhccccchhhhccccCccCCCc---------hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1111111110000000000011111110 111224445667899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.51 Aligned_cols=269 Identities=25% Similarity=0.460 Sum_probs=221.4
Q ss_pred ccHHHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEe
Q 005224 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 442 (707)
.+.+++++..+.+.+.+.||+|.||+||+|.|.. .||||+++..... ..+.|++|+.++++-+|.||+-|.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3346777777778889999999999999999853 5999999865443 45789999999999999999999999998
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
+.. .||+.+|+|.+|+.+++... ..++..+.+.||.|||+|+.|||.++ |||||||..||++.+++.|||+|||+
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 877 99999999999999998754 56999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhcc---CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~ 599 (707)
+..-..- ..........|...|||||+++. .+|+..+||||||+|+|||++|..||. ..+. +
T Consensus 535 atvk~~w-----~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~---------d 599 (678)
T KOG0193|consen 535 ATVKTRW-----SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNR---------D 599 (678)
T ss_pred eeeeeee-----ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCCh---------h
Confidence 9653211 11223334457889999999975 579999999999999999999999997 3321 1
Q ss_pred ccchhhccCCC----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 600 SMMFSVIDGNM----GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 600 ~~~~~~~~~~~----~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
..++.+-.+.+ .....+|+.++.+++..||..++++||.+.+++..|+.+....|.
T Consensus 600 qIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 600 QIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred heEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 22333333322 224568899999999999999999999999999988887664443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=359.14 Aligned_cols=200 Identities=27% Similarity=0.418 Sum_probs=175.4
Q ss_pred CCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.|+..+.||+|+||+||+|.. .+|+.||+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377789999999999999996 4799999999865332 223467899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999998887655556899999999999999999999998 9999999999999999999999999997653211
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 157 -------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred -------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 123346899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=371.02 Aligned_cols=282 Identities=20% Similarity=0.246 Sum_probs=215.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..+|++.+.||+|+||.||+|... +++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 457999999999999999999964 789999997532 3567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+. ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 165 ~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-- 236 (391)
T PHA03212 165 YK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-- 236 (391)
T ss_pred CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc--
Confidence 94 7898888654 35889999999999999999999998 9999999999999999999999999997532211
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch------hHHHHHHHhhcccchhhc
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~------~~~~~~~~~~~~~~~~~~ 606 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... ..
T Consensus 237 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~------~~ 306 (391)
T PHA03212 237 ----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR------RS 306 (391)
T ss_pred ----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH------Hh
Confidence 1122345799999999999999999999999999999999999988754321 1111111110 01
Q ss_pred cCCCCCCCh---HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCC
Q 005224 607 DGNMGSYPS---ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 683 (707)
Q Consensus 607 ~~~~~~~~~---~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 683 (707)
......++. .....+..-...+....|..||....+.. ......++|.+||++||++||||+|+|+
T Consensus 307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYE-----------LPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhh-----------hhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 100111121 11222222233445556777777654432 1223457999999999999999999999
Q ss_pred CCCCCCC
Q 005224 684 HPYVSSD 690 (707)
Q Consensus 684 Hp~f~~~ 690 (707)
||||..-
T Consensus 376 hp~f~~~ 382 (391)
T PHA03212 376 FAAFQDI 382 (391)
T ss_pred ChhhccC
Confidence 9999763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=351.28 Aligned_cols=203 Identities=31% Similarity=0.498 Sum_probs=173.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC--eEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~E 451 (707)
.++...+.||+|+||+||++... +|+..|||.+........+.+.+|+.+|++++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35666889999999999999965 59999999987654333567899999999999999999999854444 6899999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeeecccccCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 530 (707)
|+++|+|.+++.+.+. .+++..++.++.||++||+|||+++ ||||||||+|||++. ++.+||+|||+++......
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999988766 7999999999999999999999999 999999999999999 7999999999998765311
Q ss_pred CCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
..........||+.|||||++..+ ....++||||+||++.||+||+.||..
T Consensus 173 ----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 173 ----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 012233457899999999999963 344599999999999999999999864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=366.86 Aligned_cols=205 Identities=25% Similarity=0.434 Sum_probs=179.4
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHHHcc-CCCcceeEEEEEEeCCe
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 445 (707)
....++|....+||+|.||+|+++..+ +++.+|||++++...-. .+..+.|.+++... +||.+++++.+|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 455678999999999999999999976 68899999998765432 35667888888877 59999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+.||++..+. ....+++..++.+|..|+.||.|||+++ ||+||||-+|||+|.+|++||+|||+++.
T Consensus 444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999943333 3456999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
-- .......+.+||+.|||||++.+..|+.++|+|||||+||||+.|..||..+++
T Consensus 518 ~m-------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 518 GM-------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred cC-------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 32 124466788999999999999999999999999999999999999999975443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=364.98 Aligned_cols=256 Identities=27% Similarity=0.383 Sum_probs=214.0
Q ss_pred CCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
-|...+.||.|+.|.|-.|++ .+|+.+|||++...... ....+.+|+-+|+.+.||||+++|+++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 356678899999999999995 58999999999765221 23568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++|.|.+++-+++ ++.+.+..+++.||+.|+.|+|..+ |+|||+||+|+|+|..+++||+|||+|.+..+
T Consensus 93 yv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--- 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP--- 164 (786)
T ss_pred ecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC---
Confidence 999999999997655 5899999999999999999999999 99999999999999999999999999987543
Q ss_pred CCccccceecccccCCCccchhhhccCCCC-CchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......+|++.|.|||+++|.+|. .++||||.|||||.|+||+.||+++ +....+.. .+
T Consensus 165 -----gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-Nir~LLlK-V~------------ 225 (786)
T KOG0588|consen 165 -----GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-NIRVLLLK-VQ------------ 225 (786)
T ss_pred -----CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-cHHHHHHH-HH------------
Confidence 3345567899999999999999886 5799999999999999999999743 22111110 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
+..+.+......++.|||.+||++||++|+|.+|+++|||+.+.
T Consensus 226 ------------------------------------~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 226 ------------------------------------RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ------------------------------------cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 01122223345566689999999999999999999999999887
Q ss_pred CCCC
Q 005224 691 VSGS 694 (707)
Q Consensus 691 ~~~~ 694 (707)
....
T Consensus 270 ~~~~ 273 (786)
T KOG0588|consen 270 TSLP 273 (786)
T ss_pred CCCC
Confidence 7643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=386.98 Aligned_cols=262 Identities=32% Similarity=0.526 Sum_probs=220.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeC--CCc----EEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP--DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
..+.+..+.||+|+||.||.|... +|. .||||.+.... .+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 344556789999999999999964 343 49999998754 44567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC-----CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeec
Q 005224 447 MLVYEFMSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 521 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 521 (707)
++++|||++|+|..+|++.. ...++....+.++.|||+|+.||++++ +|||||.++|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998741 345889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcc
Q 005224 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 600 (707)
Q Consensus 522 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~ 600 (707)
+|+.....++..... ...-...|||||.++.+.++.|+|||||||++||++| |..||....+..
T Consensus 848 lArDiy~~~yyr~~~-----~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---------- 912 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHG-----EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---------- 912 (1025)
T ss_pred hhHhhhhchheeccC-----ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH----------
Confidence 999655444322111 1123468999999999999999999999999999999 999997655521
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
.+..+..+.+.+.|..|++.++++|..||+.+|++||++..+++.+..+.+..
T Consensus 913 v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 913 VLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 12223344467789999999999999999999999999999999888776643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=359.65 Aligned_cols=263 Identities=27% Similarity=0.463 Sum_probs=209.4
Q ss_pred HHhcCCCccceEeeeCceEEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 443 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 443 (707)
...++|++.++||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+.+++.+ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3457899999999999999999974 2357899999875432 2346789999999999 899999999998764
Q ss_pred -CeEEEEEecCCCCCHHHHHhhcC--------------------------------------------------------
Q 005224 444 -GEQMLVYEFMSNGTLRDQLSAKS-------------------------------------------------------- 466 (707)
Q Consensus 444 -~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------------------- 466 (707)
+..++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 45889999999999999997532
Q ss_pred ----CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecc
Q 005224 467 ----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 542 (707)
Q Consensus 467 ----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~ 542 (707)
..++++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ......
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~ 235 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKGS 235 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc-----hhcccC
Confidence 134788899999999999999999998 99999999999999999999999999986532210 011123
Q ss_pred cccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHH
Q 005224 543 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 621 (707)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 621 (707)
..++..|+|||++.+..++.++|||||||++|||++ |..||........... . +..+.....+..++..+
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~~l 306 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ-R--------LKDGTRMRAPENATPEI 306 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH-H--------HhcCCCCCCCCCCCHHH
Confidence 345688999999999999999999999999999997 9999965332111111 1 11222223455667789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 622 IKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 622 ~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=352.83 Aligned_cols=278 Identities=24% Similarity=0.353 Sum_probs=206.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC--CCcEEEEEEeccCChh--hHHHHHHHHHHHHcc---CCCcceeEEEEEEe-----
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCDE----- 442 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~----- 442 (707)
++|++.+.||+|+||+||+|... +++.||+|++...... ....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47889999999999999999863 4788999988653222 234566777777766 69999999999852
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
....++||||++ ++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 356899999996 69999997765566899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
++..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||....+... .....
T Consensus 157 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~----- 222 (290)
T cd07862 157 ARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKIL----- 222 (290)
T ss_pred eEeccCC--------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHH-----
Confidence 9765322 122345689999999999999999999999999999999999999976543211 11111
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
+......+.+++..+ .+...++...+. .... ...+..+....+++.+||+.||++|||+.|+|
T Consensus 223 ----~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 223 ----DVIGLPGEEDWPRDV-ALPRQAFHSKSA--QPIE----------KFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred ----HHhCCCChhhchhhh-cccchhccCCCC--CCHH----------HHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 000001111111111 111222222111 1111 12234455667899999999999999999999
Q ss_pred CCCCC
Q 005224 683 KHPYV 687 (707)
Q Consensus 683 ~Hp~f 687 (707)
+||||
T Consensus 286 ~hp~f 290 (290)
T cd07862 286 SHPYF 290 (290)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=332.68 Aligned_cols=258 Identities=23% Similarity=0.380 Sum_probs=210.6
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
+++|++.+.||+|.|+.||++.. ++|+.+|+|++.... ..+.+++.+|+++-+.++||||+++.+.+.+.+..++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 56788899999999999999985 489999999876432 234578899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeeecccccCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAP 527 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~~~ 527 (707)
|+|+|++|..-+-.+ ..+++..+-..+.||+++|.|+|.++ |||||+||.|+++- ...-+|++|||+|....
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997766443 45788889999999999999999999 99999999999995 34469999999998775
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
. ........||++|||||++...+|+..+|||+-||+||-|+.|+.||...... +.
T Consensus 165 ~--------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rl--------------- 220 (355)
T KOG0033|consen 165 D--------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RL--------------- 220 (355)
T ss_pred C--------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HH---------------
Confidence 2 23445678999999999999999999999999999999999999999753321 11
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
+.+++..-...++.+ .+..++++.+++++||+.||.+|+||.|||+|||+
T Consensus 221 -------------ye~I~~g~yd~~~~~-----------------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 221 -------------YEQIKAGAYDYPSPE-----------------WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred -------------HHHHhccccCCCCcc-----------------cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 111222222222222 23344556689999999999999999999999999
Q ss_pred CCC
Q 005224 688 SSD 690 (707)
Q Consensus 688 ~~~ 690 (707)
+..
T Consensus 271 ~~r 273 (355)
T KOG0033|consen 271 CNR 273 (355)
T ss_pred cch
Confidence 754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=354.97 Aligned_cols=287 Identities=22% Similarity=0.324 Sum_probs=209.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||+||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 789999999875432 223467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 6888888653 345888999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+............ .
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------~--- 222 (303)
T cd07869 158 ------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL------G--- 222 (303)
T ss_pred ------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh------C---
Confidence 12233467899999999876 4688899999999999999999999976554333322211100 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCC--CCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETD--ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~--~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
....+....... +-...|+ ...+...+.+. +.. ....+.+.||+.+||+.||++|+|++|+|+||||.
T Consensus 223 -~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 223 -TPNEDTWPGVHS----LPHFKPERFTLYSPKNLRQA----WNK-LSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292 (303)
T ss_pred -CCChhhccchhh----ccccccccccccCCccHHHH----hhc-cCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence 000000000000 0000000 00011111111 111 11234566899999999999999999999999997
Q ss_pred CCC
Q 005224 689 SDV 691 (707)
Q Consensus 689 ~~~ 691 (707)
...
T Consensus 293 ~~~ 295 (303)
T cd07869 293 DLP 295 (303)
T ss_pred cCC
Confidence 643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.93 Aligned_cols=197 Identities=25% Similarity=0.424 Sum_probs=174.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 689999999875322 22356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 999999999999754 35888999999999999999999998 999999999999999999999999999865321
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 172 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 172 ---------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred ---------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 12346899999999999999999999999999999999999999653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.09 Aligned_cols=253 Identities=20% Similarity=0.273 Sum_probs=204.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999975 789999999865322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999999654 35889999999999999999999998 999999999999999999999999999765321
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~----------------- 207 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-GIY----------------- 207 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH-----------------
Confidence 12346899999999999999999999999999999999999999643321 100
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCC-----CCcCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSSMLKHP 685 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s-----a~e~L~Hp 685 (707)
+.+..+-..-| ...+....+++.+||..||++|++ ++|+++||
T Consensus 208 ------------~~i~~~~~~~~--------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 208 ------------EKILAGKLEFP--------------------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred ------------HHHHhCCcCCC--------------------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 00000000000 011223457888899999999995 99999999
Q ss_pred CCCCCCC
Q 005224 686 YVSSDVS 692 (707)
Q Consensus 686 ~f~~~~~ 692 (707)
||....+
T Consensus 256 ~~~~~~~ 262 (291)
T cd05612 256 WFKSVDW 262 (291)
T ss_pred cccCCCH
Confidence 9976443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=342.93 Aligned_cols=280 Identities=23% Similarity=0.315 Sum_probs=226.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|+..+.||+|.-|+||++.++ ++..+|+|++.+..... ..++..|-+||+.++||.+..||+.|+.++..|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 345666889999999999999986 46899999998765543 35677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
||||+||+|..+.+++....++++.++.++..|+.||+|||..| ||.|||||+||||-++|++.|+||.++......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999999998889999999999999999999999999 999999999999999999999999987543210
Q ss_pred -------C-------------------------CCC-----------------ccccceecccccCCCccchhhhccCCC
Q 005224 530 -------D-------------------------IEG-----------------IVPAHVSTVVKGTPGYLDPEYFLTHKL 560 (707)
Q Consensus 530 -------~-------------------------~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~~ 560 (707)
. ... ..........+||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 000 000122345679999999999999999
Q ss_pred CCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 005224 561 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 640 (707)
Q Consensus 561 s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~ 640 (707)
+.++|+|+|||++|||+.|..||....+... +..++...+ .+|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------l~NIv~~~l-~Fp-------------------------- 355 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------LRNIVGQPL-KFP-------------------------- 355 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------HHHHhcCCC-cCC--------------------------
Confidence 9999999999999999999999976554221 111111110 011
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCC----CCcCCCCCCCCCCCCCCCcccccCcccCC
Q 005224 641 EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS----SSSMLKHPYVSSDVSGSNLVSGVIPTITP 706 (707)
Q Consensus 641 ~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~~~~~~~~~~~~~~~~~ 706 (707)
..+.....+.|||+++|..||.+|+- |.|+-+||||.+--+. ++...+||.=|
T Consensus 356 -----------~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa--Lir~~~PP~iP 412 (459)
T KOG0610|consen 356 -----------EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA--LIRCARPPEIP 412 (459)
T ss_pred -----------CCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh--heeccCCCcCC
Confidence 01122244568999999999999999 9999999999999995 77777777644
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=352.13 Aligned_cols=284 Identities=22% Similarity=0.290 Sum_probs=209.2
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|++.+.||+|+||+||+|+.+ +++.||+|++..... ...+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999975 688999999875322 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|++++.+..+... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 154 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS- 154 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence 9998776655432 345899999999999999999999998 9999999999999999999999999998653221
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
........|+..|+|||++.+..++.++|||||||++|||++|+.||............. ...+
T Consensus 155 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~-----------~~~~ 218 (287)
T cd07848 155 -----NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ-----------KVLG 218 (287)
T ss_pred -----cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------HhhC
Confidence 111223468999999999999899999999999999999999999997544322111110 0111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
..+.+....+.. .-.......|....... .+ .......+..+.||+.+||+.||++|+|++|+|+||||
T Consensus 219 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~-~~--~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 219 PLPAEQMKLFYS----NPRFHGLRFPAVNHPQS-LE--RRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CCCHHHHHhhhc----cchhcccccCcccCccc-HH--HhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 122222221110 00000000111000000 00 01112234567799999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=359.53 Aligned_cols=194 Identities=26% Similarity=0.343 Sum_probs=169.2
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 456 (707)
+.||+|+||.||+|..+ +|+.||+|++..... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 789999999875321 22356788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccc
Q 005224 457 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 536 (707)
Q Consensus 457 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 536 (707)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------- 148 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-------
Confidence 999998654 35899999999999999999999999 999999999999999999999999998753211
Q ss_pred cceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 537 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 537 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=357.75 Aligned_cols=300 Identities=23% Similarity=0.367 Sum_probs=217.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||.||++... ++..||+|.+..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999975 688999999876432 334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999996543 4889999999999999999999853 2999999999999999999999999998755321
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... + ......... .+....
T Consensus 158 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~-~~~~~~~~~----~~~~~~ 224 (331)
T cd06649 158 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-E-LEAIFGRPV----VDGEEG 224 (331)
T ss_pred -------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-H-HHHHhcccc----cccccC
Confidence 122346899999999999999999999999999999999999999654321 1 111111000 000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC------CCCCCCCccccCCCCCCCCCCCCCCcCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP------ESDTKTPEFINSEHTSKEETPPSSSSMLKHP 685 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~------~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 685 (707)
. +.............+.......+|++. +.+.+..+..... ...+.+.+|+.+||..||++|||++|+|+||
T Consensus 225 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 225 E-PHSISPRPRPPGRPVSGHGMDSRPAMA-IFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred C-ccccCcccccccccccccccccccchh-HHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 000000000000001112223333332 1122222222111 1223456899999999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 686 YVSSDVSGS 694 (707)
Q Consensus 686 ~f~~~~~~~ 694 (707)
||.......
T Consensus 303 ~~~~~~~~~ 311 (331)
T cd06649 303 FIKRSEVEE 311 (331)
T ss_pred HHhhccccc
Confidence 998766543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=359.33 Aligned_cols=199 Identities=26% Similarity=0.397 Sum_probs=174.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeCC--CcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|++.+.||+|+||.||+|..++ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568899999999999999998543 4689999886432 2234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999996543 5899999999999999999999999 99999999999999999999999999976532
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 184 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 184 R----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred C----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 1 123568999999999999999999999999999999999999997543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=358.10 Aligned_cols=297 Identities=22% Similarity=0.364 Sum_probs=224.2
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
..++|++.++||+|+||.||+|... ++..||+|.+..... ...+.+.+|+++++.++|+||++++++|.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3478999999999999999999976 688999998875422 33467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999654 3488999999999999999999974 5 999999999999999999999999998754321
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......... ..+.
T Consensus 158 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-----~~~~ 221 (333)
T cd06650 158 ---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK--ELELMFGCP-----VEGD 221 (333)
T ss_pred ---------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh--HHHHHhcCc-----ccCC
Confidence 112346889999999999989999999999999999999999999754321 111111000 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC------CCCCCCccccCCCCCCCCCCCCCCcCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE------SDTKTPEFINSEHTSKEETPPSSSSMLK 683 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~------~~~~~~dll~~~L~~dP~~R~sa~e~L~ 683 (707)
... .............|....|..||++.. .+....+....+. .+.+..+|+.+||+.||++|||++|+++
T Consensus 222 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 222 PAE--SETSPRPRPPGRPLSSYGPDSRPPMAI-FELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccc--cccCcccCCccchhhhhcccccccccH-HHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000 000001111223344567888887642 2222322222111 1234568999999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 684 HPYVSSDVSG 693 (707)
Q Consensus 684 Hp~f~~~~~~ 693 (707)
||||......
T Consensus 299 h~~~~~~~~~ 308 (333)
T cd06650 299 HAFIKRSEAE 308 (333)
T ss_pred CHHHhcCccc
Confidence 9999876553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=345.32 Aligned_cols=265 Identities=28% Similarity=0.386 Sum_probs=207.7
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--------------hHHHHHHHHHHHHccCCCcceeE
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------------GEKEFLTEIQFLSRLHHRNLVSL 436 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--------------~~~~~~~E~~~l~~l~H~nIv~l 436 (707)
...++|++.+.||+|.||.|-+|... +++.||||++.+.... ..+.+.+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999954 7999999998753221 12478899999999999999999
Q ss_pred EEEEEeC--CeEEEEEecCCCCCHHHHHhhcCCCC-cCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 005224 437 VGYCDEE--GEQMLVYEFMSNGTLRDQLSAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 513 (707)
Q Consensus 437 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 513 (707)
+.+..+. +..|||+|||..|.+...= ...+ +++.++++++.++..||+|||.++ ||||||||+|+|++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 9998664 5799999999988764332 2233 999999999999999999999999 99999999999999999
Q ss_pred cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCC----CCCchhhHHHHHHHHHHHcCCCCCCCCchh
Q 005224 514 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGKNI 589 (707)
Q Consensus 514 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwS~Gvll~elltG~~pf~~~~~~ 589 (707)
++||+|||.+.........+. ........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||......
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~--d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGS--DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred cEEeeccceeeecccCCcccc--HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999987754422221 22334478999999999998732 345789999999999999999999754331
Q ss_pred HHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCC
Q 005224 590 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHT 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~ 669 (707)
.- . .++ ..+|-.-|...+ ..+...|+|.+||.
T Consensus 326 ~l-~----------------------------~KI-----vn~pL~fP~~pe--------------~~e~~kDli~~lL~ 357 (576)
T KOG0585|consen 326 EL-F----------------------------DKI-----VNDPLEFPENPE--------------INEDLKDLIKRLLE 357 (576)
T ss_pred HH-H----------------------------HHH-----hcCcccCCCccc--------------ccHHHHHHHHHHhh
Confidence 11 0 011 112222233322 23334489999999
Q ss_pred CCCCCCCCCCcCCCCCCCCCCCC
Q 005224 670 SKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 670 ~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
.||++|++..++..|||.+.+..
T Consensus 358 KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 358 KDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred cChhheeehhhheecceeccCCC
Confidence 99999999999999999988755
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=348.21 Aligned_cols=261 Identities=30% Similarity=0.423 Sum_probs=217.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhh-HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.+...+.++||+|-||.|..+....+..||||+++...... ..+|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 44566789999999999999999888999999998765554 48999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
|++|+|.+++.++..+.........|+.|||.||+||.+.. +|||||.++|+|+|.++++||+|||+++-+...++.
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999998875555566677889999999999999998 999999999999999999999999999976555433
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc--CCCCCCCCchhHHHHHHHhhcccchhhccC--
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVIDG-- 608 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 608 (707)
. .....+-+.+|||+|.+.-++++.+||||+||+++||+++ ...||....+.. +.. ....+++.
T Consensus 694 ~-----vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vve-----n~~~~~~~~~ 761 (807)
T KOG1094|consen 694 R-----VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVE-----NAGEFFRDQG 761 (807)
T ss_pred e-----eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHH-----hhhhhcCCCC
Confidence 2 2233345689999999999999999999999999999887 678887543311 110 01111111
Q ss_pred --CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 609 --NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 609 --~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.....|.-|+..+++++.+||..+..+||+++++...|++.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12335778999999999999999999999999999888753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.68 Aligned_cols=242 Identities=29% Similarity=0.516 Sum_probs=207.6
Q ss_pred CCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCC
Q 005224 377 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 456 (707)
...++-||.|+-|.||+|+++ ++.||||+++.-. ..+|+-|++++|+||+.|.|+|...-.+|||||||..|
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 345678999999999999995 6889999875421 24788999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccc
Q 005224 457 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 536 (707)
Q Consensus 457 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 536 (707)
-|...|+. ..++.......+..+||.|+.|||.+. |||||||+-||||+.+..+||+|||-++....
T Consensus 198 qL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~-------- 264 (904)
T KOG4721|consen 198 QLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD-------- 264 (904)
T ss_pred cHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh--------
Confidence 99999965 445888888999999999999999998 99999999999999999999999999986542
Q ss_pred cceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC-CCCCh
Q 005224 537 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM-GSYPS 615 (707)
Q Consensus 537 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 615 (707)
.......+||..|||||++...+.++|+||||||||||||+||..||.+.+. ...++.+-...+ ...|.
T Consensus 265 ~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----------sAIIwGVGsNsL~LpvPs 334 (904)
T KOG4721|consen 265 KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----------SAIIWGVGSNSLHLPVPS 334 (904)
T ss_pred hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----------heeEEeccCCcccccCcc
Confidence 2234567899999999999999999999999999999999999999965332 223333333333 34788
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 616 ~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.|++.+.-++..||+..|..||++++++..|.-.
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 9999999999999999999999999999888644
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=371.54 Aligned_cols=297 Identities=22% Similarity=0.293 Sum_probs=209.4
Q ss_pred HHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCC------CcceeEEEEE
Q 005224 368 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH------RNLVSLVGYC 440 (707)
Q Consensus 368 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~~~~ 440 (707)
+++...+++|++.++||+|+||+||+|... +++.||||+++... .....+..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556789999999999999999999964 68899999986532 223455667777777654 4588999998
Q ss_pred EeC-CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCC-----
Q 005224 441 DEE-GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKF----- 513 (707)
Q Consensus 441 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~----- 513 (707)
... ++.++|||++ +++|.+++... ..+++..+..++.||+.||+|||+ .+ ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 654 5789999998 77999988654 358999999999999999999997 47 99999999999998765
Q ss_pred -----------cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCC
Q 005224 514 -----------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582 (707)
Q Consensus 514 -----------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~p 582 (707)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 49999999876432 122345789999999999999999999999999999999999999
Q ss_pred CCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHH-----HHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCC
Q 005224 583 ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK-----FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 657 (707)
Q Consensus 583 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~ 657 (707)
|....+. +.+... ...++.+|.+.... ..++....-...|...|. .+.+............+
T Consensus 345 f~~~~~~-~~~~~i----------~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 411 (467)
T PTZ00284 345 YDTHDNL-EHLHLM----------EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPK--HLARIARARPVREVIRD 411 (467)
T ss_pred CCCCChH-HHHHHH----------HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHH--HHHhhhcccchhhhhch
Confidence 9765432 211111 11112223222111 111111111111111111 11111100000001123
Q ss_pred CCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCCCC
Q 005224 658 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGS 694 (707)
Q Consensus 658 ~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~~ 694 (707)
+.+.|||.+||++||++|+||+|+|+||||.......
T Consensus 412 ~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~ 448 (467)
T PTZ00284 412 DLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPEC 448 (467)
T ss_pred HHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCcc
Confidence 4567999999999999999999999999998765543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=359.46 Aligned_cols=285 Identities=24% Similarity=0.373 Sum_probs=215.3
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC-----eEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQM 447 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 447 (707)
+|+..+.||+|+||+||+|... +++.||||++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999964 7899999998653 2234467889999999999999999999998776 789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+. ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 688888754 345899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
... ........++..|+|||++.+. .++.++|||||||++|||++|+.||...... +.......
T Consensus 155 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~-------- 219 (372)
T cd07853 155 PDE------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITD-------- 219 (372)
T ss_pred cCc------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHH--------
Confidence 321 1112234578899999999874 5789999999999999999999999754432 22221111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCC
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 686 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 686 (707)
..+..+.+......+-....+...+...|....+. ......++...+||.+||..||++|+|++|+|+|||
T Consensus 220 --~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 220 --LLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLY-------TLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred --HcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhc-------ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 11111222222222222333334444445433221 122334556678999999999999999999999999
Q ss_pred CCCC
Q 005224 687 VSSD 690 (707)
Q Consensus 687 f~~~ 690 (707)
|.+.
T Consensus 291 ~~~~ 294 (372)
T cd07853 291 LDEG 294 (372)
T ss_pred hCCC
Confidence 9874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.39 Aligned_cols=192 Identities=29% Similarity=0.405 Sum_probs=168.1
Q ss_pred EeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCH
Q 005224 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 383 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
||+|+||+||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 68899999986432 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccc
Q 005224 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538 (707)
Q Consensus 459 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 538 (707)
.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-------~ 148 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-------D 148 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-------C
Confidence 9999654 35899999999999999999999998 9999999999999999999999999997542211 1
Q ss_pred eecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 223456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=321.25 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=214.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|.||.||.|+.+ ++..||+|++...... .+.++.+|+++-+.++||||+++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357889999999999999999954 7889999998765433 256889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
+||.++|++...|.......+++.....++.|+|.||.|+|..+ |+||||||+|+|++.++..||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999998777777999999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||.....
T Consensus 176 -------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------------------- 227 (281)
T KOG0580|consen 176 -------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------------------- 227 (281)
T ss_pred -------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------------------
Confidence 2345678999999999999999999999999999999999999999963221
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
.+.++-+.++--..| ...+..+.|+|.++|..+|.+|.+-.|++.|||+-.
T Consensus 228 ---------~etYkrI~k~~~~~p--------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 228 ---------SETYKRIRKVDLKFP--------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ---------HHHHHHHHHccccCC--------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 112222222211222 223445568899999999999999999999999754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.00 Aligned_cols=267 Identities=31% Similarity=0.495 Sum_probs=219.9
Q ss_pred HHHHHHhcCCCccceEeeeCceEEEEEEeC--CC--cE-EEEEEeccC---ChhhHHHHHHHHHHHHccCCCcceeEEEE
Q 005224 368 GEMALATNNFNSSTQIGQGGYGKVYKGILP--DG--TV-VAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGY 439 (707)
Q Consensus 368 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~-vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~ 439 (707)
+.++..-++....++||+|+||.||+|.++ ++ .. ||||..+.. .....++|.+|+++|++++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 344555555566799999999999999964 33 23 899998852 34456789999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 005224 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 519 (707)
Q Consensus 440 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 519 (707)
+.....+++|||+|.||+|.++|+.... .++..++..++.+.|.||+|||+++ +|||||.++|+|++.++.+||+|
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999987544 6999999999999999999999999 99999999999999999999999
Q ss_pred ecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhh
Q 005224 520 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQ 598 (707)
Q Consensus 520 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~ 598 (707)
||+++....-. .......-+..|+|||.+....|+.++|||||||++||+++ |..||....... +.
T Consensus 306 FGLs~~~~~~~-------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~---- 372 (474)
T KOG0194|consen 306 FGLSRAGSQYV-------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VK---- 372 (474)
T ss_pred cccccCCccee-------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HH----
Confidence 99987543110 11111234679999999999999999999999999999999 888997655421 11
Q ss_pred cccchhh-ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 599 SSMMFSV-IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 599 ~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
..+ ..+.+...|...+..+..++..||..+|++||+|.++.+.++.+......
T Consensus 373 ----~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 373 ----AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 112 23444556778888999999999999999999999999999998776543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=353.07 Aligned_cols=284 Identities=25% Similarity=0.378 Sum_probs=209.4
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC-----CeEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQM 447 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~ 447 (707)
+|++.++||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999965 7899999998743 223345788999999999999999999988543 2579
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+. ++|.+++... ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6999988654 35899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCCCccccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
..... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ........ ..
T Consensus 155 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-~~~~~~~~------~~ 223 (338)
T cd07859 155 NDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLIT------DL 223 (338)
T ss_pred cccCc----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHH------HH
Confidence 22110 111234568999999999876 6789999999999999999999999965433 11111110 00
Q ss_pred ccCCCCCCChHHHHHHH-----HHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 606 IDGNMGSYPSECVEKFI-----KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~-----~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
.+..+.+....+. +....+.. ..|.. ....++..++...+++.+||..||++|||++|
T Consensus 224 ----~~~~~~~~~~~i~~~~~~~~~~~~~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e 286 (338)
T cd07859 224 ----LGTPSPETISRVRNEKARRYLSSMRK----KQPVP---------FSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286 (338)
T ss_pred ----hCCCCHHHHHHhhhhhHHHHHHhhcc----cCCCc---------hHHhcCCCChHHHHHHHHHcCcCcccCCCHHH
Confidence 1111222211111 11111111 11110 01123444556678999999999999999999
Q ss_pred CCCCCCCCCCCCC
Q 005224 681 MLKHPYVSSDVSG 693 (707)
Q Consensus 681 ~L~Hp~f~~~~~~ 693 (707)
+|+||||.+....
T Consensus 287 ~l~hp~f~~~~~~ 299 (338)
T cd07859 287 ALADPYFKGLAKV 299 (338)
T ss_pred HhcCchhhhcCcc
Confidence 9999999775553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.59 Aligned_cols=261 Identities=20% Similarity=0.334 Sum_probs=209.9
Q ss_pred CcccccHHHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhh---HHHHHHHHHHHHccCCCcceeEE
Q 005224 361 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLV 437 (707)
Q Consensus 361 ~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~ 437 (707)
+...++.+++. ......||+|++|.||+|.+ +|+.||||++....... .+.+.+|+.+|++++||||++++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 34445555552 22346899999999999998 68999999987643322 35678999999999999999999
Q ss_pred EEEEe----CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCC
Q 005224 438 GYCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHK 512 (707)
Q Consensus 438 ~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~ 512 (707)
+++.+ ....++||||+++|+|.+++... ..+++.....++.+++.||.|||+. + ++||||||+||+++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTEN 159 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCC
Confidence 99876 34689999999999999999654 3588999999999999999999984 6 7899999999999999
Q ss_pred CcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhH
Q 005224 513 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 590 (707)
Q Consensus 513 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~ 590 (707)
+.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... .
T Consensus 160 ~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-~ 228 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-K 228 (283)
T ss_pred CcEEEcccchHhhhcccc----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-H
Confidence 999999999998653211 12457889999999976 6899999999999999999999999975432 1
Q ss_pred HHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 591 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
+....... .......+..++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 229 ~~~~~i~~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 229 EIYDLIIN--------KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHh--------cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11111110 111223445677889999999999999999999999999987754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.06 Aligned_cols=194 Identities=27% Similarity=0.352 Sum_probs=169.0
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 456 (707)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 78999999987532 223356788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccc
Q 005224 457 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 536 (707)
Q Consensus 457 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 536 (707)
+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-------
Confidence 999988654 35899999999999999999999998 999999999999999999999999998753211
Q ss_pred cceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 537 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 537 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 11123456899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=352.20 Aligned_cols=195 Identities=26% Similarity=0.345 Sum_probs=169.0
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 456 (707)
+.||+|+||.||++... +|+.||+|++..... .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 789999999875322 22346778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccc
Q 005224 457 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 536 (707)
Q Consensus 457 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 536 (707)
+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~------ 149 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC------
Confidence 999988654 35899999999999999999999998 9999999999999999999999999987532211
Q ss_pred cceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 537 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 537 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 11233568999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=350.52 Aligned_cols=194 Identities=27% Similarity=0.422 Sum_probs=167.1
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||+||+|..+ +++.||||++.... ....+.+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68999999987532 12235667888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~------ 149 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN------ 149 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC------
Confidence 9999998654 35899999999999999999999998 999999999999999999999999998753221
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 150 -GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred -CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.76 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=207.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh----hh----HHHHHHHHHHHHcc-CCCcceeEEEEEEeC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL----QG----EKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 443 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 443 (707)
-+.|...+.||+|..++|-++..+ +|..+|+|++..... +. .+.-.+|+.+|+++ .||+|+.+.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356778899999999999999865 788999998764221 11 23456799999998 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
...++|+|.|+.|.|.|+|.. .-.++++..++|+.|+..|++|||... ||||||||+|||+|++.++||+|||.|
T Consensus 96 sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 999999999999999999954 446999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhcc------CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHh
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~ 597 (707)
+.+.. .......+||++|.|||.+.. ..|+...|+||.||+||.|+.|.+||.+....
T Consensus 171 ~~l~~--------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-------- 234 (411)
T KOG0599|consen 171 CQLEP--------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-------- 234 (411)
T ss_pred eccCC--------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH--------
Confidence 98764 345567899999999999864 46788999999999999999999999643321
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCC
Q 005224 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 677 (707)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s 677 (707)
..+.-++..-.+.. -| ...+.+....|+|.++|++||.+|+|
T Consensus 235 ---------------------lMLR~ImeGkyqF~---sp--------------eWadis~~~KdLIsrlLqVdp~~Rit 276 (411)
T KOG0599|consen 235 ---------------------LMLRMIMEGKYQFR---SP--------------EWADISATVKDLISRLLQVDPTKRIT 276 (411)
T ss_pred ---------------------HHHHHHHhcccccC---Cc--------------chhhccccHHHHHHHHHeeCchhccc
Confidence 01111111111100 01 11223445678999999999999999
Q ss_pred CCcCCCCCCCCCC
Q 005224 678 SSSMLKHPYVSSD 690 (707)
Q Consensus 678 a~e~L~Hp~f~~~ 690 (707)
++|+|+||||...
T Consensus 277 ake~LaHpff~q~ 289 (411)
T KOG0599|consen 277 AKEALAHPFFIQI 289 (411)
T ss_pred HHHHhcChHHHHH
Confidence 9999999999443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=354.10 Aligned_cols=197 Identities=30% Similarity=0.441 Sum_probs=175.1
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999976 689999999875322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999654 35889999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 123456899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=328.02 Aligned_cols=296 Identities=24% Similarity=0.350 Sum_probs=216.9
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC---C--CcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEe-CC
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP---D--GTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EG 444 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~ 444 (707)
....|+....||+|+||.||+|+-. + .+.+|+|.++..... -.....+|+.+++.++||||+.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3457888999999999999999743 2 237999999764322 23568899999999999999999999866 78
Q ss_pred eEEEEEecCCCCCHHHHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEE
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKV 517 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl 517 (707)
..++++||.+. +|.+.++-+. ...++...++.|..||+.|+.|||++- |+||||||.||||..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999976 9999997532 246889999999999999999999999 9999999999999877 99999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 596 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~ 596 (707)
+|||+++.+..+- .+-.....++.|..|+|||.+.+ ..|+.+.||||.||++.||+|-.+.|.......+
T Consensus 178 aDlGlaR~~~~pl----kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~----- 248 (438)
T KOG0666|consen 178 ADLGLARLFNNPL----KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIK----- 248 (438)
T ss_pred ecccHHHHhhccc----cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcc-----
Confidence 9999999876432 12233445677999999999998 5699999999999999999998777753221100
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccC---CCCCCCHHHHHHHHH----------HhhhcCCCCCCCCCcc
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDE---TDARPSMSEVMRELE----------SIWNMMPESDTKTPEF 663 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~---p~~RPt~~~v~~~L~----------~~~~~~~~~~~~~~dl 663 (707)
+. .++..+...++.+++..=.+.+ -.+-|.....+..++ .........++...++
T Consensus 249 ----------~~--~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~L 316 (438)
T KOG0666|consen 249 ----------TK--NPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDL 316 (438)
T ss_pred ----------cC--CCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHH
Confidence 00 0122222233333221111100 001122212222211 1222233456668899
Q ss_pred ccCCCCCCCCCCCCCCcCCCCCCCCCCCCC
Q 005224 664 INSEHTSKEETPPSSSSMLKHPYVSSDVSG 693 (707)
Q Consensus 664 l~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~ 693 (707)
+.+||++||.+|+||++||+|+||+.+.-.
T Consensus 317 L~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 317 LQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred HHHHhccCchhhccHHHHhcccccccCCCC
Confidence 999999999999999999999999998553
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=361.45 Aligned_cols=283 Identities=21% Similarity=0.268 Sum_probs=206.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
...|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999975 578999996432 2456899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+ .++|.+++.... ..+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~- 315 (461)
T PHA03211 242 Y-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS- 315 (461)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc-
Confidence 9 479998886532 36999999999999999999999998 99999999999999999999999999986543211
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch------hHHHHHHHhhcccchhhc
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~------~~~~~~~~~~~~~~~~~~ 606 (707)
........||..|+|||++.+..++.++|||||||++|||++|..++..... ....+.........
T Consensus 316 ----~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~---- 387 (461)
T PHA03211 316 ----TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV---- 387 (461)
T ss_pred ----cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc----
Confidence 1112345699999999999999999999999999999999998876643221 01111111110000
Q ss_pred cCCCCCCChHHHHHHHHHHHH---hcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCC
Q 005224 607 DGNMGSYPSECVEKFIKLALK---CCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 683 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~---c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 683 (707)
....++......+...... .....+..++.. ..+...+....+||.+||++||++|||++|+|+
T Consensus 388 --~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 388 --HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAW-----------TRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred --ccccCCCCcchHHHHHHHhhhhcccCCccCCcch-----------hhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0001111111111111110 001111111111 111233445678999999999999999999999
Q ss_pred CCCCCC
Q 005224 684 HPYVSS 689 (707)
Q Consensus 684 Hp~f~~ 689 (707)
||||.+
T Consensus 455 hp~f~~ 460 (461)
T PHA03211 455 LPLFQS 460 (461)
T ss_pred CcccCC
Confidence 999976
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=343.30 Aligned_cols=200 Identities=27% Similarity=0.417 Sum_probs=175.1
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
+|++.++||+|+||+||++... +++.||+|++...... ....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999964 7899999998753322 23457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 999999999987655567999999999999999999999998 9999999999999999999999999997653211
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 112346899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=351.89 Aligned_cols=199 Identities=27% Similarity=0.346 Sum_probs=170.4
Q ss_pred CCCccceEeeeCceEEEEEEe----CCCcEEEEEEeccCC----hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeE
Q 005224 376 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 446 (707)
+|++.+.||+|+||+||++.. .+++.||+|++.... ....+.+.+|+++++.+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999885 368899999986422 12235678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999999654 35899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
.... ........||..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 156 LSEE------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cccC------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 3221 1122345689999999999875 478899999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=349.72 Aligned_cols=282 Identities=26% Similarity=0.348 Sum_probs=196.9
Q ss_pred cceEeeeCceEEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEe--CCeEEEEEecCC
Q 005224 380 STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVYEFMS 454 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~E~~~ 454 (707)
.++||+|+||+||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999964 46789999987543 23457889999999999999999999854 456899999995
Q ss_pred CCCHHHHHhhc-------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEeeeccc
Q 005224 455 NGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLS 523 (707)
Q Consensus 455 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla 523 (707)
++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5898887532 1235889999999999999999999999 9999999999999 46679999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhH--------HHHH
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV--------REVN 594 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~--------~~~~ 594 (707)
+....... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... +...
T Consensus 160 ~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07868 160 RLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235 (317)
T ss_pred eccCCCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence 86543211 1112234568999999999987 458999999999999999999999996432210 0010
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHH-----HHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCC
Q 005224 595 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLA-----LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHT 669 (707)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~-----~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~ 669 (707)
.. .. ..+.........+.+.. ...+........ .+...++ ......+..+.|||.+||+
T Consensus 236 ~~------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~dli~~mL~ 299 (317)
T cd07868 236 RI------FN----VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC---SLIKYME---KHKVKPDSKAFHLLQKLLT 299 (317)
T ss_pred HH------HH----hcCCCChHHhHHHhhccchhhhhhhhhccccCcc---cccchHH---hcCCCCChHHHHHHHHHhc
Confidence 00 00 00111111111111000 000000000000 0111111 1112234456789999999
Q ss_pred CCCCCCCCCCcCCCCCCC
Q 005224 670 SKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 670 ~dP~~R~sa~e~L~Hp~f 687 (707)
+||++|+|++|+|+||||
T Consensus 300 ~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 300 MDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCcccCCCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.82 Aligned_cols=208 Identities=26% Similarity=0.381 Sum_probs=175.8
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999975 68999999987532 122356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999999654 35899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCccc-------------------------------cceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcC
Q 005224 531 IEGIVP-------------------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 579 (707)
Q Consensus 531 ~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG 579 (707)
...... ........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000000 0011134699999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 005224 580 MQPISHGK 587 (707)
Q Consensus 580 ~~pf~~~~ 587 (707)
..||....
T Consensus 236 ~~Pf~~~~ 243 (364)
T cd05599 236 YPPFCSDN 243 (364)
T ss_pred CCCCCCCC
Confidence 99996543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=357.60 Aligned_cols=263 Identities=21% Similarity=0.276 Sum_probs=203.8
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
...++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44568999999999999999999965 68999999986422 122345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999998653 4788889999999999999999998 9999999999999999999999999997653
Q ss_pred CCCCCCccccceecccccCCCccchhhhccC----CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...
T Consensus 194 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~--------- 257 (370)
T cd05596 194 ANG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYS--------- 257 (370)
T ss_pred CCC------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHH---------
Confidence 221 1112345689999999998753 47889999999999999999999996533211 000
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCC--CCCCCcC
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET--PPSSSSM 681 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~--R~sa~e~ 681 (707)
+++. ..+ .... ......+..+.+||.+||+.+|++ |+|++|+
T Consensus 258 -------------------~i~~----~~~--~~~~-----------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 258 -------------------KIMD----HKN--SLTF-----------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred -------------------HHHc----CCC--cCCC-----------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 0000 000 0000 000112334457788888888877 8899999
Q ss_pred CCCCCCCCCCC
Q 005224 682 LKHPYVSSDVS 692 (707)
Q Consensus 682 L~Hp~f~~~~~ 692 (707)
++||||....+
T Consensus 302 l~h~~~~~~~~ 312 (370)
T cd05596 302 KSHPFFKNDQW 312 (370)
T ss_pred hcCcccCCCCh
Confidence 99999887654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=355.92 Aligned_cols=205 Identities=22% Similarity=0.319 Sum_probs=175.5
Q ss_pred HHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 370 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 370 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
+....++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3444578999999999999999999975 68899999986422 1223467889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999999643 4788999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccC----CCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 192 ~~~~~------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 192 MDETG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred cccCC------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 53221 1122345799999999999764 3788999999999999999999999654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=350.38 Aligned_cols=192 Identities=26% Similarity=0.389 Sum_probs=166.8
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999987532 22335677899988877 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|..++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~----- 150 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----- 150 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-----
Confidence 9999988654 35899999999999999999999998 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~ 584 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 12234568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=353.22 Aligned_cols=207 Identities=26% Similarity=0.370 Sum_probs=175.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|+..+.||+|+||+||+|... +++.||+|++..... .....+.+|+.++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 689999999875322 22356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999654 35899999999999999999999998 9999999999999999999999999997543211
Q ss_pred CCCc----------------------------cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCC
Q 005224 531 IEGI----------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582 (707)
Q Consensus 531 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~p 582 (707)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0000 000011245799999999999999999999999999999999999999
Q ss_pred CCCC
Q 005224 583 ISHG 586 (707)
Q Consensus 583 f~~~ 586 (707)
|...
T Consensus 236 f~~~ 239 (363)
T cd05628 236 FCSE 239 (363)
T ss_pred CCCC
Confidence 9653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=345.77 Aligned_cols=287 Identities=22% Similarity=0.353 Sum_probs=211.2
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|...+.||+|+||+||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999965 688999999875432 2234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++ +|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 974 8888886543 35889999999999999999999998 9999999999999999999999999997543221
Q ss_pred CccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... +....... .. +
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~------~~----~ 222 (309)
T cd07872 159 -----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFR------LL----G 222 (309)
T ss_pred -----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH------Hh----C
Confidence 11223457889999999875 56889999999999999999999999654331 11111110 00 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
..+.+....+.......-...|..+|. ......+..+....||+.+||..||++|+|++|+|+||||..-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNFPKYKPQ---------PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhcCccCCC---------chhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 111111111110000000011111111 01122234455667999999999999999999999999998755
Q ss_pred CC
Q 005224 692 SG 693 (707)
Q Consensus 692 ~~ 693 (707)
..
T Consensus 294 ~~ 295 (309)
T cd07872 294 TR 295 (309)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=349.07 Aligned_cols=195 Identities=27% Similarity=0.414 Sum_probs=168.1
Q ss_pred ceEeeeCceEEEEEEe----CCCcEEEEEEeccCCh----hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 381 TQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+.||+|+||.||++.. .+++.||||++..... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 3578999999875321 2234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.... .+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 99999999996543 4788889999999999999999998 9999999999999999999999999987532211
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 155 -----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred -----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 11233568999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=341.19 Aligned_cols=194 Identities=25% Similarity=0.404 Sum_probs=167.9
Q ss_pred EeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCH
Q 005224 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 383 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
||+|+||+||++... +++.||+|.+...... ..+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 7899999998653322 224677899999999999999999999999999999999999999
Q ss_pred HHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccc
Q 005224 459 RDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 536 (707)
Q Consensus 459 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 536 (707)
.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~------ 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ------ 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC------
Confidence 9888542 3346899999999999999999999998 9999999999999999999999999997654321
Q ss_pred cceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 537 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 537 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 152 -SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred -ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1122346899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=357.46 Aligned_cols=207 Identities=26% Similarity=0.339 Sum_probs=173.7
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999864 78999999986532 122356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999653 45889999999999999999999999 9999999999999999999999999996432110
Q ss_pred CCC----------ccc------------------------------cceecccccCCCccchhhhccCCCCCchhhHHHH
Q 005224 531 IEG----------IVP------------------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLG 570 (707)
Q Consensus 531 ~~~----------~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~G 570 (707)
... ... ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 000 0000124699999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 005224 571 VVFLELLTGMQPISHG 586 (707)
Q Consensus 571 vll~elltG~~pf~~~ 586 (707)
|++|||++|+.||...
T Consensus 236 vil~elltG~~Pf~~~ 251 (377)
T cd05629 236 AIMFECLIGWPPFCSE 251 (377)
T ss_pred hhhhhhhcCCCCCCCC
Confidence 9999999999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=351.19 Aligned_cols=194 Identities=26% Similarity=0.338 Sum_probs=167.8
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 456 (707)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 78999999987532 222356778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 457 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 457 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~----- 150 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----- 150 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-----
Confidence 999988654 358999999999999999999997 67 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 1123356899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=355.10 Aligned_cols=207 Identities=23% Similarity=0.323 Sum_probs=174.1
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.|+..+.||+|+||+||+|... +++.||||++..... ...+.+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999964 789999999875322 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999654 35889999999999999999999998 99999999999999999999999999864321100
Q ss_pred CCc----------------------------------------cccceecccccCCCccchhhhccCCCCCchhhHHHHH
Q 005224 532 EGI----------------------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 571 (707)
Q Consensus 532 ~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gv 571 (707)
... ..........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000112356999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCc
Q 005224 572 VFLELLTGMQPISHGK 587 (707)
Q Consensus 572 ll~elltG~~pf~~~~ 587 (707)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (381)
T cd05626 237 ILFEMLVGQPPFLAPT 252 (381)
T ss_pred HHHHHHhCCCCCcCCC
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=333.09 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=208.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|++.+.||+|+||.||+|.++ .+..||+|.++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457888999999999999999853 357899999886433 334578999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997643 46899999999999999999999998 99999999999999999999999998765321
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.. ........++..|+|||++.+..++.++|||||||++||+++ |+.||...... +.... +.+
T Consensus 160 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~~~~~---------~~~ 223 (266)
T cd05064 160 EA------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DVIKA---------VED 223 (266)
T ss_pred cc------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHH---------HHC
Confidence 11 011112234678999999999999999999999999999875 99999654331 11111 112
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
+.....+..++..+.+++.+||+.+|.+||++.++.+.|..+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 222334566778899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.25 Aligned_cols=290 Identities=22% Similarity=0.312 Sum_probs=212.5
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC-----
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 444 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 444 (707)
..++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999964 6899999998643 2233467889999999999999999999986443
Q ss_pred -eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 445 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 445 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999964 67776632 3788899999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........+....
T Consensus 171 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~------- 235 (359)
T cd07876 171 RTACTN--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI------- 235 (359)
T ss_pred cccccC--------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------
Confidence 754321 11233568999999999999999999999999999999999999997654332221110
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHH--HhhhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELE--SIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-t~~~v~~~L~--~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
...+..+.+....+...........|.... +..++..... .........+....+||.+||+.||++|+|++|
T Consensus 236 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 311 (359)
T cd07876 236 ----EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311 (359)
T ss_pred ----HhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHH
Confidence 011222333333333333333333332221 2222111100 000001112345578999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 681 MLKHPYVSS 689 (707)
Q Consensus 681 ~L~Hp~f~~ 689 (707)
+|+||||..
T Consensus 312 ~l~hp~~~~ 320 (359)
T cd07876 312 ALRHPYITV 320 (359)
T ss_pred HhcCchhhh
Confidence 999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.11 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=216.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 448 (707)
...|+..+.||+|.||.||+++.+ +|+.+|+|.+....... ...+.+|+++|+++. |||||.++++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456888899999999999999976 59999999998755433 358999999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEeeecccc
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKVADFGLSR 524 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFGla~ 524 (707)
|||++.||.|.+.+... .+++..+..++.|++.|+.|||+.+ |+||||||+|+|+... +.+|++|||+|.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999776 3999999999999999999999999 9999999999999633 579999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|..||....+.....
T Consensus 188 ~~~~--------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----------- 248 (382)
T KOG0032|consen 188 FIKP--------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----------- 248 (382)
T ss_pred EccC--------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----------
Confidence 7653 235667899999999999999999999999999999999999999997654321111
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 684 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 684 (707)
++...=+... + ..++.....+.||+++||..||.+|+||.++|+|
T Consensus 249 ------------------~i~~~~~~f~---~--------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 ------------------AILRGDFDFT---S--------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------------------HHHcCCCCCC---C--------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111001001 1 1223334556689999999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 685 PYVSSDVSG 693 (707)
Q Consensus 685 p~f~~~~~~ 693 (707)
||+.+....
T Consensus 294 pWi~~~~~~ 302 (382)
T KOG0032|consen 294 PWIKSIGEA 302 (382)
T ss_pred ccccCCccc
Confidence 999987443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=345.85 Aligned_cols=265 Identities=29% Similarity=0.470 Sum_probs=227.9
Q ss_pred HHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 367 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 367 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
+++++....+....++||-|.||.||.|+|+ -.-.||||.++.+.++ .++|+.|+.+|+.++|||+|+++|+|..+-.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4677777778888999999999999999986 4678999999886554 4689999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.|||+|||..|+|.+||++..+..++....+.+|.||+.|++||..++ +|||||.++|+||.++..+||+|||++++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999999988888888899999999999999999988 99999999999999999999999999999
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
+..+.++.- ....-.+.|.|||-+....++.|+|||+|||+|||+.| |..||...+- .+ .+.
T Consensus 415 MtgDTYTAH------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-Sq----------VY~ 477 (1157)
T KOG4278|consen 415 MTGDTYTAH------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQ----------VYG 477 (1157)
T ss_pred hcCCceecc------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-HH----------HHH
Confidence 865433211 11123578999999999999999999999999999999 8899864321 11 112
Q ss_pred h-ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 605 V-IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 605 ~-~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
+ ..+.+...|+.|+..++++|+.||+..|.+||+++|+-+.++.++..
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 2 22344557899999999999999999999999999999999877653
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.57 Aligned_cols=192 Identities=26% Similarity=0.394 Sum_probs=167.4
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 689999999975322 2234578899999998 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~------ 149 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP------ 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC------
Confidence 9999988654 35899999999999999999999998 999999999999999999999999998742211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~ 584 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 112234578999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.64 Aligned_cols=268 Identities=27% Similarity=0.390 Sum_probs=204.7
Q ss_pred CCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHcc--CCCcceeEEEEEEeCC----eEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL--HHRNLVSLVGYCDEEG----EQMLV 449 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~~----~~~lV 449 (707)
..+..+.||+|+||.||||.+. ++.||||++.. +..+.|.+|-++++.. +|+||++|+++-.... +++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3445788999999999999994 59999999965 3445788888887764 8999999999875544 89999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA------DPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
+||.+.|+|.++|..+ .++|....+|+..+++||+|||+.. +|+|+|||||++||||.+|+++.|+|||+|
T Consensus 287 t~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999999765 4899999999999999999999853 688999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCC-CC-----CchhhHHHHHHHHHHHcCCCCCCCCc--h----hHH
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LT-----DKSDVYSLGVVFLELLTGMQPISHGK--N----IVR 591 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~sDVwS~Gvll~elltG~~pf~~~~--~----~~~ 591 (707)
..+..... .......+||.+|||||++.+.. +. .+.||||+|.|||||+++...+..+. + ...
T Consensus 364 l~~~p~~~-----~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 364 LRLEPGKP-----QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred EEecCCCC-----CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 98865432 22334578999999999998743 22 26899999999999999865543110 0 000
Q ss_pred HHHHHhhcccc--hhhccCCCCCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 592 EVNIAYQSSMM--FSVIDGNMGSYPS-----ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 592 ~~~~~~~~~~~--~~~~~~~~~~~~~-----~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
.+-..-..+.+ .-+-++.++.+|+ ..+..+.+.+..||..|++.|-|+.=+.+++.++....+.
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 00000000011 1122333444444 3467889999999999999999999998888877654443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.63 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=197.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
+|+..++||+|+||+||+|... +++.||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456788999999999999965 789999999865432 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++|+|.+. ....+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 155 ~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 222 (353)
T PLN00034 155 DGGSLEGT------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--- 222 (353)
T ss_pred CCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc---
Confidence 99998643 23567788899999999999999998 9999999999999999999999999998653221
Q ss_pred ccccceecccccCCCccchhhhcc-----CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||...... ++
T Consensus 223 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~---------------- 281 (353)
T PLN00034 223 ----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DW---------------- 281 (353)
T ss_pred ----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cH----------------
Confidence 11223468999999998743 23456899999999999999999999632210 00
Q ss_pred CCCCCChHHHHHHHHHHHH-hcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALK-CCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~-c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
..++.. +....+. .+ ......+.+||.+||..||++|+|++|+|+||||
T Consensus 282 -------------~~~~~~~~~~~~~~-~~----------------~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~ 331 (353)
T PLN00034 282 -------------ASLMCAICMSQPPE-AP----------------ATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331 (353)
T ss_pred -------------HHHHHHHhccCCCC-CC----------------CccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 000000 1111111 00 1122334578888999999999999999999999
Q ss_pred CCCCCCCC
Q 005224 688 SSDVSGSN 695 (707)
Q Consensus 688 ~~~~~~~~ 695 (707)
.......+
T Consensus 332 ~~~~~~~~ 339 (353)
T PLN00034 332 LRAQPGQG 339 (353)
T ss_pred ccCCcccc
Confidence 88765544
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.10 Aligned_cols=250 Identities=37% Similarity=0.593 Sum_probs=200.6
Q ss_pred ccceEeeeCceEEEEEEeC-----CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 379 SSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 379 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..+.||.|.||.||+|.+. .+..|+||.++.... ...+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999976 357899999966433 3467899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++|+|.++|.......+++..+..|+.||++||+|||+.+ ++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 99999999998876677999999999999999999999998 99999999999999999999999999987632211
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
............|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.... +.++...
T Consensus 159 ----~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~~---------~~~~~~~ 224 (259)
T PF07714_consen 159 ----YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIEK---------LKQGQRL 224 (259)
T ss_dssp ----EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHHH---------HHTTEET
T ss_pred ----ccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccc---------ccccccc
Confidence 122233446778999999999999999999999999999999 7788865432 221111 1222233
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
..+..++..+.+++..||+.+|++||++.++++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 45566788899999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=344.02 Aligned_cols=200 Identities=23% Similarity=0.365 Sum_probs=171.2
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCC-CcceeEEEEEEeCCeEEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~ 450 (707)
+|++.+.||+|+||.||+|..+ +++.||||++.... ....+.+..|.+++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999965 67899999987532 2234567889999999976 46888999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 999999999998654 34889999999999999999999998 999999999999999999999999998743211
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 ------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred ------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 112234568999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=336.56 Aligned_cols=261 Identities=27% Similarity=0.430 Sum_probs=203.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeCC-----------------CcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCccee
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPD-----------------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVS 435 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~ 435 (707)
.++|.+.++||+|+||.||+|.+++ +..||+|.+..... ....++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999998532 34799999876432 33567999999999999999999
Q ss_pred EEEEEEeCCeEEEEEecCCCCCHHHHHhhcC-----------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 005224 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498 (707)
Q Consensus 436 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 498 (707)
+++++...+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986531 124688899999999999999999998 99
Q ss_pred ecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc
Q 005224 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 578 (707)
Q Consensus 499 H~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt 578 (707)
||||||+|||+++++.+||+|||+++.....+. ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 999999999999999999999999976533221 111223345788999999999999999999999999999997
Q ss_pred --CCCCCCCCchh--HHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 579 --GMQPISHGKNI--VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 579 --G~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
+..||...... .......... .........+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRD-----QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhh-----ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 55677543321 1111111100 0001111223456678999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=353.47 Aligned_cols=208 Identities=26% Similarity=0.342 Sum_probs=178.1
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+|... +++.||||++..... .....+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999975 789999999875321 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 46899999999999999999999988 9999999999999999999999999997654322
Q ss_pred CC----------------------CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 531 IE----------------------GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 531 ~~----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.. ............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 00 0000112234568999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.36 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=213.5
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhh-HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
...|+..+.||+|.||.||+|.. +.++.||+|++....... .+++.+|+.++..++++||.++|+.+..+...+++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 44677889999999999999996 478999999998655444 4678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
||.+|++.+.++.. ..+.+..+..+.++++.||.|||.++ .+|||||+.|||+..+|.+|++|||.+-......
T Consensus 92 y~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred HhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 99999999999543 34588888899999999999999999 9999999999999999999999999997765432
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
......+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+..... +..++.+.....+
T Consensus 166 ------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------mrvlflIpk~~PP 229 (467)
T KOG0201|consen 166 ------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------MRVLFLIPKSAPP 229 (467)
T ss_pred ------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------ceEEEeccCCCCC
Confidence 223567899999999999999999999999999999999999999975432 2233333333344
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
.....+...+.+++..|++++|+.||++.++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 455678888999999999999999999999875
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=342.00 Aligned_cols=283 Identities=22% Similarity=0.326 Sum_probs=208.3
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||+||+|... +++.||||++..... ...+.+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 678999999875321 2234566788888764 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 150 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----- 150 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-----
Confidence 9999999653 35889999999999999999999998 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (707)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... ...... ......++.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~i----------~~~~~~~~~ 217 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-ELFQSI----------RMDNPCYPR 217 (316)
T ss_pred --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-HHHHHH----------HhCCCCCCc
Confidence 1223456899999999999999999999999999999999999999754321 111111 001112333
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCCCC
Q 005224 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGS 694 (707)
Q Consensus 616 ~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~~ 694 (707)
.....+.+++.+|++.+|.+||++.+.+.... -+...+ ...+ .-..++|.-++...+...+.||.......
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~----~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQHP----FFREID---WSAL-EEREIEPPFKPKVKSANDCSNFDKEFLNE 288 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHcCc----ccCCCC---HHHH-HhCCCCCCcCCCCCCccchhhcChhhhcC
Confidence 44566777888888888888887752221100 000000 0001 01234566677777777777776655543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=348.62 Aligned_cols=203 Identities=26% Similarity=0.349 Sum_probs=175.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999965 789999999875322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999764 246899999999999999999999998 9999999999999999999999999998654322
Q ss_pred CCCccccceecccccCCCccchhhhc------cCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 157 ------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred ------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 11223346899999999987 4567889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=347.46 Aligned_cols=288 Identities=19% Similarity=0.283 Sum_probs=201.9
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999975 5789999975432 23568999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+ .++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 138 HY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred cc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 99 46898888654 346899999999999999999999998 999999999999999999999999999753221
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhH-HHHHHHhhcccchhhcc---
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-REVNIAYQSSMMFSVID--- 607 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~--- 607 (707)
.......||..|+|||++.+..++.++|||||||++|||+++..++....... ..... .....+..++.
T Consensus 211 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~-~~~~~l~~~~~~~~ 283 (357)
T PHA03209 211 ------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK-SCHSHLLKIISTLK 283 (357)
T ss_pred ------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHH-HHHHHHHHHHHHhc
Confidence 11234568999999999999999999999999999999999666553322110 00000 00000000000
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
.....++.+....+ ....+......|..... ...++ .........+||.+||+.||++||||+|+|+||||
T Consensus 284 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 284 VHPEEFPRDPGSRL---VRGFIEYASLERQPYTR-YPCFQ-----RVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred cChhhcCCCCccHH---HHHHHhhcccCCCcccc-cHHHh-----ccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 00000110000000 00000101111110000 00011 11233455679999999999999999999999999
Q ss_pred CC
Q 005224 688 SS 689 (707)
Q Consensus 688 ~~ 689 (707)
..
T Consensus 355 ~~ 356 (357)
T PHA03209 355 AQ 356 (357)
T ss_pred cc
Confidence 75
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.58 Aligned_cols=238 Identities=24% Similarity=0.382 Sum_probs=185.7
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHH---HccCCCcceeEEEEEEeCCeEEEE
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFL---SRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667899999999999999965 78999999987532 12234566676655 566899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|..++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988854 35899999999999999999999998 999999999999999999999999998743221
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
........|++.|+|||++.+..++.++|||||||++|||++|+.||...... +..... .. .
T Consensus 155 -------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~~~~i---------~~-~ 216 (324)
T cd05589 155 -------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFDSI---------VN-D 216 (324)
T ss_pred -------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHH---------Hh-C
Confidence 11223456899999999999999999999999999999999999999754321 111110 00 0
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPS 638 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt 638 (707)
...++...+..+.+++.+|++.+|.+||+
T Consensus 217 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 245 (324)
T cd05589 217 EVRYPRFLSREAISIMRRLLRRNPERRLG 245 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHhHcCC
Confidence 11233334455566666666666666664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=354.53 Aligned_cols=207 Identities=22% Similarity=0.307 Sum_probs=173.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
+|+..++||+|+||+||+|+.. +++.||+|++..... .....+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 788999999875322 223568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++|+|.+++.+. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999654 35888999999999999999999998 99999999999999999999999999854321000
Q ss_pred CC----------------------------------------ccccceecccccCCCccchhhhccCCCCCchhhHHHHH
Q 005224 532 EG----------------------------------------IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 571 (707)
Q Consensus 532 ~~----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gv 571 (707)
.. ...........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00 00000112346899999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCc
Q 005224 572 VFLELLTGMQPISHGK 587 (707)
Q Consensus 572 ll~elltG~~pf~~~~ 587 (707)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=348.20 Aligned_cols=290 Identities=20% Similarity=0.291 Sum_probs=212.3
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC------
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 443 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 443 (707)
..++|...+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999964 68899999987532 23346788999999999999999999987543
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
...++||||++ ++|.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999996 578777743 3788999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........+... .
T Consensus 174 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~-~------ 238 (364)
T cd07875 174 RTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV-I------ 238 (364)
T ss_pred cccCCC--------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH-H------
Confidence 765321 1123346899999999999999999999999999999999999999765443222111 1
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHH-Hh-hhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELE-SI-WNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Pt~~~v~~~L~-~~-~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
. ..+....+....+...+.......|... ..+.++..... .. .......+..+.|||.+||+.||++|+|++|
T Consensus 239 ---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e 314 (364)
T cd07875 239 ---E-QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314 (364)
T ss_pred ---H-hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence 0 1111223333333333333333222211 12221111100 00 0001112334578999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 681 MLKHPYVSS 689 (707)
Q Consensus 681 ~L~Hp~f~~ 689 (707)
+|+||||..
T Consensus 315 ~L~hp~~~~ 323 (364)
T cd07875 315 ALQHPYINV 323 (364)
T ss_pred HhcCccccc
Confidence 999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=330.55 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=210.9
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 346788999999999999999998888899999987533 2356889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.++++......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 157 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-- 157 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc--
Confidence 99999999998765667899999999999999999999988 9999999999999999999999999998654321
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..... . .....
T Consensus 158 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~-~--------~~~~~ 223 (261)
T cd05072 158 ----YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-VMSAL-Q--------RGYRM 223 (261)
T ss_pred ----eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-HHHHH-H--------cCCCC
Confidence 011122345678999999999899999999999999999998 999986543211 11111 1 11111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
+....++..+.+++.+|++.+|++||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2233456778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=342.36 Aligned_cols=194 Identities=26% Similarity=0.409 Sum_probs=166.3
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||.||+|..+ +|+.||+|+++.... ...+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 689999999875321 2234567788888764 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 149 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG------ 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC------
Confidence 9999998654 35889999999999999999999998 999999999999999999999999998743211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=355.92 Aligned_cols=277 Identities=22% Similarity=0.345 Sum_probs=200.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC--------C
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--------G 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~ 444 (707)
..+|++.+.||+|+||+||+|... +++.||||++.... ....+|+.+++.++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999964 68999999885432 2345799999999999999999987432 2
Q ss_pred eEEEEEecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeeec
Q 005224 445 EQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFG 521 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFG 521 (707)
..++||||++ ++|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4678999996 578777754 23456899999999999999999999999 99999999999999664 79999999
Q ss_pred ccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcc
Q 005224 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 600 (707)
Q Consensus 522 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~ 600 (707)
+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+......
T Consensus 217 la~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~- 286 (440)
T PTZ00036 217 SAKNLLAGQ--------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQV- 286 (440)
T ss_pred cchhccCCC--------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH-
Confidence 998654221 1223567999999999876 468999999999999999999999997544321 11111100
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHHHHHhhhcCC-CCCCCCCccccCCCCCCCCCCCC
Q 005224 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQ--DETDARPSMSEVMRELESIWNMMP-ESDTKTPEFINSEHTSKEETPPS 677 (707)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~--~~p~~RPt~~~v~~~L~~~~~~~~-~~~~~~~dll~~~L~~dP~~R~s 677 (707)
.+..+.+....+ ...+. .-|...+ .+ +. ..++ ..++++.+||.+||++||++|+|
T Consensus 287 ---------~~~p~~~~~~~~----~~~~~~~~~~~~~~--~~----l~---~~~p~~~~~~~~~li~~~L~~dP~~R~t 344 (440)
T PTZ00036 287 ---------LGTPTEDQLKEM----NPNYADIKFPDVKP--KD----LK---KVFPKGTPDDAINFISQFLKYEPLKRLN 344 (440)
T ss_pred ---------hCCCCHHHHHHh----chhhhcccCCccCc--hh----HH---HHhccCCCHHHHHHHHHHCCCChhHCcC
Confidence 001111111000 00000 0010000 01 11 1122 23456679999999999999999
Q ss_pred CCcCCCCCCCCCC
Q 005224 678 SSSMLKHPYVSSD 690 (707)
Q Consensus 678 a~e~L~Hp~f~~~ 690 (707)
+.|+|+||||..-
T Consensus 345 a~e~l~hp~f~~~ 357 (440)
T PTZ00036 345 PIEALADPFFDDL 357 (440)
T ss_pred HHHHhCChhHHhh
Confidence 9999999999754
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=357.00 Aligned_cols=267 Identities=23% Similarity=0.356 Sum_probs=218.1
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCC-cEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEE-Ee------C
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDG-TVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYC-DE------E 443 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~-~~------~ 443 (707)
...++++.+.|.+|||+.||.|....+ ..||+|++-..+....+.+.+|+++|+.|+ |+|||.+++.. .. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345677889999999999999997655 999999998877777889999999999996 99999999932 11 1
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
-+.+|.||||.+|.|-+++..+-...|++.++++|+.|+++|+++||.. .+||||||||-+||||+.++..||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 3678999999999999999876666699999999999999999999987 488999999999999999999999999998
Q ss_pred ccCCCCC--CCCccccceecccccCCCccchhhh---ccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhh
Q 005224 524 RLAPVPD--IEGIVPAHVSTVVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598 (707)
Q Consensus 524 ~~~~~~~--~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~ 598 (707)
.-....- ..............-|+.|+|||.+ .+..+++|+|||||||+||-|+....||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 6432111 0000000111123468999999987 467899999999999999999999999986533
Q ss_pred cccchhhccCCCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 599 SSMMFSVIDGNMGSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 599 ~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
..++.+...-.+ ..+...+..||..|++.+|.+||++-+|+..+..+...-.
T Consensus 264 ----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 264 ----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 344454443322 5899999999999999999999999999999988876443
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=342.78 Aligned_cols=194 Identities=28% Similarity=0.422 Sum_probs=165.1
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHH-HHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||+||+|... +|+.||+|++..... ...+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 789999999865321 12234555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~------ 149 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH------ 149 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC------
Confidence 9999998653 35889999999999999999999998 999999999999999999999999998753221
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.49 Aligned_cols=277 Identities=25% Similarity=0.379 Sum_probs=201.6
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHcc---CCCcceeEEEEEEe-----CC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCDE-----EG 444 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~~ 444 (707)
+|++.+.||+|+||+||+|... +++.||+|.+...... ....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999965 7899999988753221 223566777777665 69999999998854 34
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..++||||++ ++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999997 59999987765566899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
...... ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... .......
T Consensus 157 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~------ 221 (288)
T cd07863 157 IYSCQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFD------ 221 (288)
T ss_pred cccCcc--------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHH------
Confidence 654221 1223467899999999999999999999999999999999999986543321 1111100
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 684 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 684 (707)
..... .....+.. ..+..... .+..... .....+..+....|++.+||..||++|+|++|+|.|
T Consensus 222 ~~~~~---~~~~~~~~-~~~~~~~~--~~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 222 LIGLP---PEDDWPRD-VTLPRGAF--SPRGPRP----------VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred HhCCC---ChhhCccc-cccccccc--CCCCCCc----------hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00000000 00000000 0000001 111223344455689999999999999999999999
Q ss_pred CCC
Q 005224 685 PYV 687 (707)
Q Consensus 685 p~f 687 (707)
|||
T Consensus 286 p~f 288 (288)
T cd07863 286 PFF 288 (288)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=347.91 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=206.2
Q ss_pred HhcCCCccceEeeeCceEEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCC
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 444 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 444 (707)
..++|+..+.||+|+||.||+|.+ +++..||||+++... ....+.+.+|+++++.+ +||||++++++|...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345788899999999999999973 246689999987533 23346788999999999 8999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcC----------------------------------------------------------
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKS---------------------------------------------------------- 466 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 466 (707)
..++||||+++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999986432
Q ss_pred ---------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 467 ---------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 467 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 124788999999999999999999998 99999999999999999999999999986543211
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
........++..|+|||++.+..++.++|||||||++|||++ |..||............ .. .+..
T Consensus 270 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~-~~--------~~~~ 335 (375)
T cd05104 270 -----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM-IK--------EGYR 335 (375)
T ss_pred -----ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH-HH--------hCcc
Confidence 011122335678999999999999999999999999999998 88888654322111111 11 1111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
...+...+.++.+++..||+.+|++||++.++++.|++
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 12233345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.45 Aligned_cols=251 Identities=29% Similarity=0.476 Sum_probs=205.7
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
++|+..+.||+|+||.||+|.++++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4678889999999999999999888899999886533 334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce---
Confidence 999999997543 35899999999999999999999998 99999999999999999999999999876532211
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... +..... ..+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~~~~i---------~~~~~~~~ 222 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI---------SRGFRLYR 222 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH---------HCCCCCCC
Confidence 11122235668999999998899999999999999999999 88998654432 111111 11112222
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 334456789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.19 Aligned_cols=208 Identities=23% Similarity=0.315 Sum_probs=174.2
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.+|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999964 689999999865322 22356789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999999654 35888999999999999999999998 9999999999999999999999999985332100
Q ss_pred CCC------------------------------------ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHH
Q 005224 531 IEG------------------------------------IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFL 574 (707)
Q Consensus 531 ~~~------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ 574 (707)
... ...........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000 00000112347999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCc
Q 005224 575 ELLTGMQPISHGK 587 (707)
Q Consensus 575 elltG~~pf~~~~ 587 (707)
||++|+.||....
T Consensus 236 ell~G~~Pf~~~~ 248 (376)
T cd05598 236 EMLVGQPPFLADT 248 (376)
T ss_pred ehhhCCCCCCCCC
Confidence 9999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.48 Aligned_cols=195 Identities=26% Similarity=0.413 Sum_probs=167.6
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
++||+|+||.||+|... +++.||+|++..... ...+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 688999999875321 2234577889998876 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 150 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----- 150 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-----
Confidence 9999998654 35889999999999999999999998 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 12234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=339.83 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=218.7
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe-EEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE-QMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lV~ 450 (707)
++|...+.+|+|+||.++..+.+ +++.|++|.+..... .......+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999865 678999998875433 234478899999999999999999999998888 99999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
+|++||++.+.+.++....+++..+..++.|++.|+.|||++. |+|||||+.||+++.+..|||+|||+|+.+...+
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999999877778999999999999999999999888 9999999999999999999999999999886543
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.....+.||+.||.||++.+.+|..|+|||||||++|||++-+++|...+- ... ...+.....
T Consensus 161 -------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-~~L---------i~ki~~~~~ 223 (426)
T KOG0589|consen 161 -------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-SEL---------ILKINRGLY 223 (426)
T ss_pred -------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-HHH---------HHHHhhccC
Confidence 234567899999999999999999999999999999999999999965432 221 222333344
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 645 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~ 645 (707)
.+.|..+..++..++..|++.+|..||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 56788899999999999999999999999999876
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=332.91 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=199.4
Q ss_pred EeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCH
Q 005224 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 383 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
||+|+||+||++..+ +|+.||+|.+..... ...+.+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 689999999864322 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccc
Q 005224 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538 (707)
Q Consensus 459 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 538 (707)
.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--------
Confidence 99987766667999999999999999999999998 9999999999999999999999999987653211
Q ss_pred eecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 005224 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618 (707)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (707)
......|+..|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-------------------------- 203 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-------------------------- 203 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--------------------------
Confidence 122346889999999999988999999999999999999999999643221100
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCC----CcCCCCCCCCCCCC
Q 005224 619 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS----SSMLKHPYVSSDVS 692 (707)
Q Consensus 619 ~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa----~e~L~Hp~f~~~~~ 692 (707)
. ++....+...... .....+....|++.+||..||++|+++ ++++.||||.+-.+
T Consensus 204 ~---~~~~~~~~~~~~~----------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 204 E---ELKRRTLEDEVKF----------------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred H---HHHHHhhcccccc----------------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 0 0011111111100 001122334578889999999999999 56779999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=351.49 Aligned_cols=286 Identities=21% Similarity=0.251 Sum_probs=208.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
..+|.+.+.||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999853 4678999988643 24568999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
|++. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 689898843 346899999999999999999999998 9999999999999999999999999997654322
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch--hHHHHHHHhhcccchhhccC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 608 (707)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+...... +..
T Consensus 240 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~------~~~ 308 (392)
T PHA03207 240 D-----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC------MQV 308 (392)
T ss_pred c-----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH------hcc
Confidence 1 1122345689999999999999999999999999999999999999965332 11111111100 000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHH--HHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMS--EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 686 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~--~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 686 (707)
....++......+.+-.. +.....||... +.+. -...+..+.+||.+||++||++|+|+.|+|+|||
T Consensus 309 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFK---QYAIVLRPPYTIPPVIR--------KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred CccccCCccchhHHHHHH---hhcccccCCccccchhh--------ccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 001111111111111111 11112222110 0000 0112334567899999999999999999999999
Q ss_pred CCCCCC
Q 005224 687 VSSDVS 692 (707)
Q Consensus 687 f~~~~~ 692 (707)
|....+
T Consensus 378 f~~~~~ 383 (392)
T PHA03207 378 FTKEPI 383 (392)
T ss_pred hhccch
Confidence 976443
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=330.26 Aligned_cols=256 Identities=29% Similarity=0.499 Sum_probs=215.5
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
...+|+..++||.|+||.||+|...+++.||+|.+..........+.+|+.+++.++|+||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678889999999999999999888999999999876665567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.......+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 99999999998766667899999999999999999999998 9999999999999999999999999997653211
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... +.... +......
T Consensus 159 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~~---------~~~~~~~ 223 (261)
T cd05148 159 -----YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYDQ---------ITAGYRM 223 (261)
T ss_pred -----ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHHH---------HHhCCcC
Confidence 11113345678999999999899999999999999999998 88998654321 11111 1112222
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
..+..++..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 3455667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=342.63 Aligned_cols=193 Identities=24% Similarity=0.377 Sum_probs=167.6
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 688999999976432 2234678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------ 149 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP------ 149 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC------
Confidence 9999988654 35899999999999999999999998 999999999999999999999999998753211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 150 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred -CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 1122345689999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=348.67 Aligned_cols=209 Identities=22% Similarity=0.301 Sum_probs=178.2
Q ss_pred HHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEe
Q 005224 367 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442 (707)
Q Consensus 367 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 442 (707)
..++....++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455666789999999999999999999975 68899999986422 1223457889999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
.+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998643 3788889999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccC----CCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
++...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 189 a~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 189 CMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred eeEcCcCC------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 98654221 1122345799999999999754 37889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=349.50 Aligned_cols=292 Identities=21% Similarity=0.268 Sum_probs=210.5
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC-----
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE----- 443 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----- 443 (707)
...++|+..+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 68999999987532 23346788999999999999999999988543
Q ss_pred -CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 444 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 444 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
...++||||++ +++.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 35799999996 477777643 3788999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........+......
T Consensus 166 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---- 233 (355)
T cd07874 166 ARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ---- 233 (355)
T ss_pred cccCCCc--------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH----
Confidence 9764321 1223356899999999999999999999999999999999999999755433222111100
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHH-HHHHHhhh-cCCCCCCCCCccccCCCCCCCCCCCCCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVM-RELESIWN-MMPESDTKTPEFINSEHTSKEETPPSSS 679 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Pt~~~v~-~~L~~~~~-~~~~~~~~~~dll~~~L~~dP~~R~sa~ 679 (707)
......+....+......+....|... ..+.... +.+..... .....+....+||.+||..||++|||++
T Consensus 234 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ 306 (355)
T cd07874 234 -------LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306 (355)
T ss_pred -------hCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHH
Confidence 111122333333333333332222110 0110000 00000000 0011123446899999999999999999
Q ss_pred cCCCCCCCCCC
Q 005224 680 SMLKHPYVSSD 690 (707)
Q Consensus 680 e~L~Hp~f~~~ 690 (707)
|+|+||||..-
T Consensus 307 ell~hp~~~~~ 317 (355)
T cd07874 307 EALQHPYINVW 317 (355)
T ss_pred HHhcCcchhcc
Confidence 99999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=340.92 Aligned_cols=194 Identities=25% Similarity=0.390 Sum_probs=167.2
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||+||+|... +++.||||++.... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999987532 12234567889999888 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 150 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----- 150 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-----
Confidence 9999988654 35899999999999999999999998 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 1123346899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=329.60 Aligned_cols=199 Identities=29% Similarity=0.469 Sum_probs=180.3
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHH---HHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~---~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
..+|++.+.||+|+||.|-+|.. ..|+.||||.+......++. .+.+|+++|+.++||||+.+|.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788889999999999999995 68999999999876555543 578999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||..+|.|++++.+.+ .+++.+.+.++.||..|+.|+|.++ ++|||||.+|||+|+++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 99999999999997654 4999999999999999999999999 99999999999999999999999999987754
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCC-CchhhHHHHHHHHHHHcCCCCCCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
.......+|++-|.+||++.+.+|. +.+|-||+||+||-|+.|..||+.
T Consensus 206 -------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 206 -------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred -------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 3345678999999999999998885 579999999999999999999974
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.91 Aligned_cols=256 Identities=30% Similarity=0.531 Sum_probs=209.9
Q ss_pred cCCCccceEeeeCceEEEEEEeCC------CcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
++|+..+.||+|+||.||+|.... ...||+|.+..... .....+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998642 25799999875432 33457899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCC--------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 513 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 513 (707)
++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999976421 45888999999999999999999998 99999999999999999
Q ss_pred cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHH
Q 005224 514 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 592 (707)
Q Consensus 514 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~ 592 (707)
.+||+|||+++.....+. ........++..|+|||++.+..++.++|||||||++|||++ |..||...... +.
T Consensus 162 ~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-~~ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-EV 235 (283)
T ss_pred cEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-HH
Confidence 999999999976533221 111223346788999999999999999999999999999998 99998654321 11
Q ss_pred HHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 593 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
.. .+..+.....+..++.++.+++.+||+.+|.+||++.++++.|++
T Consensus 236 ~~---------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IE---------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH---------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 111223334566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=340.95 Aligned_cols=241 Identities=20% Similarity=0.320 Sum_probs=190.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
+|++.+.||+|+||.||+|... +++.||+|++..... ...+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999965 678999999875322 2234567788888877 5899999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999998654 34889999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... . ...
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i---------~-~~~ 217 (323)
T cd05616 156 -------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSI---------M-EHN 217 (323)
T ss_pred -------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHHH---------H-hCC
Confidence 1223456899999999999999999999999999999999999999754331 111111 0 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSM 639 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~ 639 (707)
..+|.....++.+++.+|++.+|.+|++.
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 12344445566677777777777777653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=346.45 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=207.7
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEEe
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 442 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 442 (707)
....++|++.+.||+|+||.||+|+.. ++..||||++..... .....+.+|+++++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 344567889999999999999999842 345799999975432 3345688999999999 89999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcC--------------------------------------------------------
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKS-------------------------------------------------------- 466 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------------------- 466 (707)
.+..++||||+++|+|.+++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999986421
Q ss_pred ------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 467 ------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 467 ------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
..++++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~--- 267 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--- 267 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc---
Confidence 124788899999999999999999998 99999999999999999999999999976532210
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
........++..|+|||++.+..++.++|||||||++|||++ |+.||............. . .+.....
T Consensus 268 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~-~--------~~~~~~~ 336 (374)
T cd05106 268 --YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV-K--------RGYQMSR 336 (374)
T ss_pred --eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH-H--------cccCccC
Confidence 111122335678999999999999999999999999999997 999996543211111111 0 0111122
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
+...+.++.+++.+||+.+|.+||++.++++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 3334578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.36 Aligned_cols=255 Identities=31% Similarity=0.486 Sum_probs=210.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.+|+..+.||+|+||.||+|..+ +++.||+|.+.... ...+++.+|+++++.++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999965 68899999987543 33567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-- 159 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-- 159 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee--
Confidence 9999999997766667899999999999999999999998 99999999999999999999999999986543211
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
.......++..|+|||++.+..++.++|||||||++|||++ |..||..... .+..... . ......
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~-~--------~~~~~~ 225 (263)
T cd05052 160 ----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELL-E--------KGYRME 225 (263)
T ss_pred ----eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH-H--------CCCCCC
Confidence 01112234568999999999999999999999999999998 8889865332 2211111 1 111223
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.+..++..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 4455678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=334.23 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=205.3
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.|+..+.||+|+||+||++... +++.||||.+..... ...+.+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677899999999999999965 789999998865322 223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999999997665567999999999999999999999988 9999999999999999999999999987543211
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~------------------- 210 (285)
T cd05630 157 -------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR------------------- 210 (285)
T ss_pred -------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-------------------
Confidence 112346899999999999999999999999999999999999999643221000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCC-----CCcCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSSMLKHPY 686 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s-----a~e~L~Hp~ 686 (707)
+... .+. ...+. .......+...+|+.+||+.||++|+| ++|+++|||
T Consensus 211 ----~~~~---~~~----~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 211 ----EEVE---RLV----KEVQE----------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred ----HHHH---hhh----hhhhh----------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 0000 000 00000 000112233457889999999999999 889999999
Q ss_pred CCCC
Q 005224 687 VSSD 690 (707)
Q Consensus 687 f~~~ 690 (707)
|..-
T Consensus 264 ~~~~ 267 (285)
T cd05630 264 FKQI 267 (285)
T ss_pred hhcc
Confidence 9764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.15 Aligned_cols=256 Identities=28% Similarity=0.489 Sum_probs=211.0
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..++|++.+.||+|++|.||+|...+++.||+|.+.... ...+++.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456788999999999999999998778899999987643 3356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999997655556899999999999999999999998 99999999999999999999999999987642211
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
........+..|+|||++.+..++.++||||||+++|||++ |+.||....... ..... . .....
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~-~--------~~~~~ 223 (261)
T cd05068 159 -----EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQV-D--------QGYRM 223 (261)
T ss_pred -----cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH-H--------cCCCC
Confidence 01111223457999999999999999999999999999999 998986543211 11111 0 11112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
..+..++..+.+++.+|++.+|.+||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 2344566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=338.69 Aligned_cols=261 Identities=29% Similarity=0.477 Sum_probs=224.2
Q ss_pred HHHHhcCCCccceEeeeCceEEEEEEeCC---C--cEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC
Q 005224 370 MALATNNFNSSTQIGQGGYGKVYKGILPD---G--TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 443 (707)
Q Consensus 370 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 443 (707)
.++..+..+..++||.|-||.||+|++.+ | -.||||..+.+. ....+.|++|+.+|++++||||++++|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 34444555567899999999999999532 3 359999998744 4456789999999999999999999999975
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
...|+|||.++-|.|..+|+.+ ...++......++.||+.||+|||+.. +|||||..+||||.+.-.+|++|||++
T Consensus 463 ~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred cceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 4789999999999999999765 456899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccc
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
+......+.. .+...-++.|||||.+.-.+++.+||||.|||.|||++. |..||..-.+ .+.+
T Consensus 539 R~~ed~~yYk------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------sDVI 602 (974)
T KOG4257|consen 539 RYLEDDAYYK------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------SDVI 602 (974)
T ss_pred hhccccchhh------ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------cceE
Confidence 9887655332 122334678999999999999999999999999999998 9999976544 3456
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
..+..+.+.+.|+.|+..++.++.+||..+|.+||.+.++...|..+..
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 6777888999999999999999999999999999999999998887765
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=343.56 Aligned_cols=194 Identities=29% Similarity=0.415 Sum_probs=165.3
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHH-HHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||+||+|... +|+.||+|++.... ....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 78999999986532 122345556655 56779999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~------ 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ------ 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC------
Confidence 9999988653 35899999999999999999999998 999999999999999999999999998753211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 150 -SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred -CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=341.13 Aligned_cols=202 Identities=28% Similarity=0.344 Sum_probs=172.9
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999965 68999999986422 122356888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999653 345889999999999999999999999 9999999999999999999999999987653321
Q ss_pred CCCccccceecccccCCCccchhhhcc-----CCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 157 ------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 111223468999999999973 45788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=348.58 Aligned_cols=207 Identities=26% Similarity=0.375 Sum_probs=175.1
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|+..+.||+|+||+||++..+ +++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 68999999986432 222356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999999654 35899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCc----------------------------cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCC
Q 005224 531 IEGI----------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582 (707)
Q Consensus 531 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~p 582 (707)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0000 000011235799999999999999999999999999999999999999
Q ss_pred CCCC
Q 005224 583 ISHG 586 (707)
Q Consensus 583 f~~~ 586 (707)
|...
T Consensus 236 f~~~ 239 (360)
T cd05627 236 FCSE 239 (360)
T ss_pred CCCC
Confidence 9643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=294.79 Aligned_cols=282 Identities=24% Similarity=0.372 Sum_probs=217.4
Q ss_pred CCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|...++||+|.||+||+|+ +++++.||+|++.... ........+|+-+++.++|.|||++++....++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 56678899999999999999 4578999999886533 23356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
| ..+|..+...-. ..++.+.++.++.|+++||.|+|+++ +.|||+||.|.|++.+|+.|++|||+++-+..+
T Consensus 83 c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip--- 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--- 154 (292)
T ss_pred h-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc---
Confidence 9 568888886543 45899999999999999999999999 999999999999999999999999999976532
Q ss_pred CccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......+.|..|++|.++.+ .-|+...|+||-||++.|+.....|..++.+..+++..++..-.
T Consensus 155 ----vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg---------- 220 (292)
T KOG0662|consen 155 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG---------- 220 (292)
T ss_pred ----eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC----------
Confidence 344555667899999999988 45889999999999999999966777777777777665543211
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCC--CCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDAR--PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~R--Pt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
...++.+..+.++-.. ..-|.-- -+..+++ |.......|+++++|.-+|..|++|++||+||||+.
T Consensus 221 ~p~ed~wps~t~lpdy--k~yp~ypattswsqiv----------p~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 221 TPTEDQWPSMTKLPDY--KPYPIYPATTSWSQIV----------PKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCccccCCccccCCCC--cccCCccccchHHHHh----------hhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 1111111111111000 0011111 1223333 333445568999999999999999999999999976
Q ss_pred CC
Q 005224 690 DV 691 (707)
Q Consensus 690 ~~ 691 (707)
..
T Consensus 289 ~s 290 (292)
T KOG0662|consen 289 FS 290 (292)
T ss_pred cC
Confidence 43
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=306.72 Aligned_cols=268 Identities=25% Similarity=0.364 Sum_probs=213.9
Q ss_pred HHhcCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEe-----CCe
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EGE 445 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~~~ 445 (707)
...++|++.+.||+|||+-||.++ ..+++.+|+|++.....++.+..++|++..++++|||+++++++... ..+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 445789999999999999999999 66899999999998887888899999999999999999999988733 346
Q ss_pred EEEEEecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
.|++++|...|+|.+.+... .+..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999999763 3446999999999999999999999975 68999999999999999999999999999
Q ss_pred ccCCCCCCCCc--cccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhh
Q 005224 524 RLAPVPDIEGI--VPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598 (707)
Q Consensus 524 ~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~ 598 (707)
+.....-.... ..-........|..|+|||.+. +...++++|||||||++|+|+.|..||+..-. +
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------Q 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------c
Confidence 76542111000 0011122345789999999996 45678999999999999999999999963211 1
Q ss_pred ccc-chhhccCCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 599 SSM-MFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 599 ~~~-~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.+. ...+..+.... -...+++.+.+++..|++.||.+||+..+++..+..+
T Consensus 248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111 12222222111 1122788999999999999999999999999887653
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=333.12 Aligned_cols=284 Identities=22% Similarity=0.348 Sum_probs=209.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|++.+.||+|+||.||++... ++..||+|.+..... ....++.+|++++++++||||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999965 688999998875422 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+ ++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999754 458899999999999999999997 46 999999999999999999999999998754321
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .. ....+... .........
T Consensus 154 -------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~-~~~~~~~~-~~~~~~~~~- 222 (308)
T cd06615 154 -------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KE-LEAMFGRP-VSEGEAKES- 222 (308)
T ss_pred -------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hh-HHHhhcCc-cccccccCC-
Confidence 12234688999999999888899999999999999999999999964432 11 11111100 000000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC------CCCCCCCccccCCCCCCCCCCCCCCcCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP------ESDTKTPEFINSEHTSKEETPPSSSSMLKHP 685 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~------~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 685 (707)
. .+....+...+....+.+.++.+....+ ..+....+|+.+||..+|++|||++|+++||
T Consensus 223 --~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 223 --H------------RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred --c------------ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0 0000011111111111111221111111 1123356899999999999999999999999
Q ss_pred CCCCC
Q 005224 686 YVSSD 690 (707)
Q Consensus 686 ~f~~~ 690 (707)
||...
T Consensus 289 ~~~~~ 293 (308)
T cd06615 289 FIKRA 293 (308)
T ss_pred hhhhc
Confidence 99764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=321.25 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=203.2
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHcc--CCCcceeEEEEEEeC----CeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL--HHRNLVSLVGYCDEE----GEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~----~~~~l 448 (707)
.+....+.||+|.||.||+|.|+ |+.||||++.. .+++.+.+|.++++.+ +|+||+.|++.-..+ .+.||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 45667899999999999999994 88999999964 4567888999998875 999999999986443 26899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-----EADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
|++|.++|||+|+|.+ ..++....+++++.+|.||++||. +++|.|.|||||+.||||..++.+.|+|+|+|
T Consensus 287 vTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 9999999999999965 458999999999999999999996 57899999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCC----CC--CchhhHHHHHHHHHHHcC----------CCCCCCC-
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LT--DKSDVYSLGVVFLELLTG----------MQPISHG- 586 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s--~~sDVwS~Gvll~elltG----------~~pf~~~- 586 (707)
.........- .......+||.+|||||++...- +. ..+||||||.|+||+..+ +.||.+.
T Consensus 364 v~h~~~t~~i---di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 364 VRHDSDTDTI---DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred EEecccCCcc---cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 7654432110 12234568999999999996532 21 259999999999999864 3566432
Q ss_pred --chhHHHHHHHhhcccchhhccCCCCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 587 --KNIVREVNIAYQSSMMFSVIDGNMGS-----YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 587 --~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
+...++.....-. ++.++. ...++...+.++|..||..+|..|-|+-.+-+.+.++.+
T Consensus 441 p~DPs~eeMrkVVCv-------~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCV-------QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCHHHHhcceee-------cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2222222221111 122222 235788899999999999999999999888888877654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=344.92 Aligned_cols=253 Identities=30% Similarity=0.454 Sum_probs=213.2
Q ss_pred ccceEeeeCceEEEEEEe-CCC----cEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 379 SSTQIGQGGYGKVYKGIL-PDG----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 379 ~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..++||+|+||+||+|.| ++| -+||+|++.... ....+++.+|+-+|.+++|||+++++|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 467999999999999996 444 368999887643 344678999999999999999999999998765 8899999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
|+.|+|.++++.+ +..+..+..+.+..|||+||.|||.+. +|||||.++||||..-..+||.|||+|+.+...+.+
T Consensus 779 mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 779 MPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred cccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999874 556899999999999999999999988 999999999999999999999999999988765432
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
. ......-.+.|||-|.+....|+.++|||||||++||++| |..|++...- +. .-..+..+.+.
T Consensus 855 y-----~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--~e--------I~dlle~geRL 919 (1177)
T KOG1025|consen 855 Y-----SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--EE--------IPDLLEKGERL 919 (1177)
T ss_pred c-----cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--HH--------hhHHHhccccC
Confidence 1 2222334678999999999999999999999999999999 9999975321 11 11122345566
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
..|+.|..+++.++.+||..|+..||+++++...+.++.+
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 7889999999999999999999999999999988877654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.25 Aligned_cols=200 Identities=24% Similarity=0.374 Sum_probs=170.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 450 (707)
+|+..+.||+|+||+||+|... +|+.||+|++..... ...+.+..|..+++.+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999965 789999999875321 22356778899988885 577888999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999998654 35899999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 156 -------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred -------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 11234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=351.96 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=207.4
Q ss_pred CCCccceEeeeCceEEEEEEeC-C-CcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-D-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.|...+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999854 4 6788999876655555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 454 SNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 454 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
++|+|.++++.. ...++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988652 3446899999999999999999999998 99999999999999999999999999986543210
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+... .+..+...
T Consensus 225 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-~~~~~---------~~~~~~~~ 289 (478)
T PTZ00267 225 -----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-REIMQ---------QVLYGKYD 289 (478)
T ss_pred -----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH---------HHHhCCCC
Confidence 1123345689999999999999999999999999999999999999965432 11111 11222233
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
..+..++..+.+++..|++.+|+.||++.+++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 345556678999999999999999999998864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=328.81 Aligned_cols=256 Identities=28% Similarity=0.505 Sum_probs=209.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeCC------CcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
.++|.+.+.||+|+||.||+|...+ ++.||||.+...... ..+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568889999999999999998633 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 005224 447 MLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 514 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 514 (707)
++||||+++++|.+++...+ ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997542 235789999999999999999999998 999999999999999999
Q ss_pred EEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHH
Q 005224 515 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 593 (707)
Q Consensus 515 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~ 593 (707)
+||+|||+++.....+. ........+++.|+|||++.+..++.++|||||||++|||++ |..||...... +..
T Consensus 161 ~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~~~ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EVI 234 (280)
T ss_pred EEECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Confidence 99999999975432211 011123345788999999999999999999999999999998 99998654332 111
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 594 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
.. +..+.....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 235 ~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 EC---------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH---------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11 1122233345566788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=342.65 Aligned_cols=238 Identities=24% Similarity=0.301 Sum_probs=188.0
Q ss_pred ceEeeeCceEEEEEEe----CCCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 381 TQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3689999999875322 223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+|+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---- 152 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---- 152 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC----
Confidence 99999999653 35899999999999999999999998 9999999999999999999999999987643221
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (707)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ......+
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~i~----------~~~~~~p 218 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-ETMTMIL----------KAKLGMP 218 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-HHHHHHH----------cCCCCCC
Confidence 1223456899999999999989999999999999999999999999754321 1111110 0111223
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005224 615 SECVEKFIKLALKCCQDETDARPSMSE 641 (707)
Q Consensus 615 ~~~~~~l~~l~~~c~~~~p~~RPt~~~ 641 (707)
...+..+.+++.+|++.+|++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 334455566666666666666666655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=328.57 Aligned_cols=261 Identities=29% Similarity=0.508 Sum_probs=213.7
Q ss_pred cCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.+|...+.||+|+||.||+|... ++..|++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777899999999999999842 356799999887666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 005224 449 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 514 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 514 (707)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997532 234889999999999999999999999 999999999999999999
Q ss_pred EEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHH
Q 005224 515 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 593 (707)
Q Consensus 515 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~ 593 (707)
+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VI 235 (291)
T ss_pred EEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 99999999976533211 111223446788999999999999999999999999999999 999986544321 11
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 594 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
.. ...+.....+..++..+.+++.+||+.+|.+||++.++++.|+++....
T Consensus 236 ~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 236 EC---------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred HH---------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 11 1112222234445678999999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=328.32 Aligned_cols=262 Identities=30% Similarity=0.480 Sum_probs=212.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
.++|.+.+.||+|+||+||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357888999999999999999842 35679999987765555678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC-----------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 005224 448 LVYEFMSNGTLRDQLSAKS-----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 516 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 516 (707)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999997532 235899999999999999999999998 99999999999999999999
Q ss_pred EeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHH
Q 005224 517 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 595 (707)
Q Consensus 517 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~ 595 (707)
|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||...... +....
T Consensus 161 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-~~~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIEC 234 (288)
T ss_pred eccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH
Confidence 999999976532211 011122335778999999999999999999999999999998 88888654321 11111
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
. ..+.....+..++..+.+++.+||+.+|.+||++.++.+.|+.+....
T Consensus 235 i---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 235 I---------TQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred H---------HcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 1 111122223345567999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=335.98 Aligned_cols=197 Identities=28% Similarity=0.387 Sum_probs=161.0
Q ss_pred cceEeeeCceEEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEe--CCeEEEEEecCC
Q 005224 380 STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVYEFMS 454 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~E~~~ 454 (707)
..+||+|+||+||+|..+ +++.||+|.+.... ....+.+|+++++.++||||+++++++.. ....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999964 45789999987543 23467889999999999999999999853 457899999996
Q ss_pred CCCHHHHHhhc-------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEeeeccc
Q 005224 455 NGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLS 523 (707)
Q Consensus 455 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla 523 (707)
++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5888877532 2235889999999999999999999998 9999999999999 56779999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
+........ ........||..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 865432211 112234568999999999977 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.62 Aligned_cols=251 Identities=30% Similarity=0.466 Sum_probs=205.6
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
++|+..+.||+|+||+||+|.+.++..||+|.+.... ...+++.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999998777789999887543 334678999999999999999999999998889999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+|+|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.++......
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~---- 154 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---- 154 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc----
Confidence 9999999976433 6899999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
........++..|+|||++.+..++.++|||||||++|||++ |+.||....... .... +..+.....
T Consensus 155 --~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~~~~---------~~~~~~~~~ 222 (256)
T cd05113 155 --YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-TVEK---------VSQGLRLYR 222 (256)
T ss_pred --eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHH---------HhcCCCCCC
Confidence 111122335678999999998889999999999999999999 999986544311 1111 111222223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
+...+..+.+++.+||+.+|.+||++.++++.+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 344567889999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.66 Aligned_cols=206 Identities=21% Similarity=0.236 Sum_probs=168.8
Q ss_pred ccceEeee--CceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 379 SSTQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 379 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
..++||+| +|++||++..+ +|+.||+|++..... ...+.+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 36789999 78999999964 799999999875432 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999997655556899999999999999999999998 9999999999999999999999998754432111000
Q ss_pred ccccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
...........++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 000011122346778999999976 468999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=323.09 Aligned_cols=256 Identities=31% Similarity=0.470 Sum_probs=208.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.++|++.++||+|+||+||+|.+++...||+|++.... ...+.+.+|++++++++|+||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 45789999999999999999998776789999987533 23467899999999999999999999875 45679999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++|+|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-- 157 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 157 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc--
Confidence 9999999997655556899999999999999999999998 99999999999999999999999999976543221
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
.......++..|+|||+..+..++.++|||||||++|||++ |+.||....... .... ........
T Consensus 158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~~---------~~~~~~~~ 223 (262)
T cd05071 158 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQ---------VERGYRMP 223 (262)
T ss_pred ----ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHHH---------HhcCCCCC
Confidence 11122346678999999999999999999999999999999 888886543211 1111 11111122
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
.+.+++..+.+++.+|++.+|++||++.++.+.|+...
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 34566788999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=343.16 Aligned_cols=282 Identities=24% Similarity=0.373 Sum_probs=206.4
Q ss_pred HHhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeC-----
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE----- 443 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----- 443 (707)
...++|++.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|++++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3467899999999999999999996 4788999999875322 2345678899999999999999999987533
Q ss_pred -CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 444 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 444 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
...++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 4578999998 7899888753 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 601 (707)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+.....
T Consensus 165 ~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~--- 230 (343)
T cd07878 165 ARQADDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIME--- 230 (343)
T ss_pred ceecCCC----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH---
Confidence 9865321 123468999999999987 57899999999999999999999999654322 11111100
Q ss_pred chhhccCCCCCCChHHHHHHH-HHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 602 MFSVIDGNMGSYPSECVEKFI-KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~l~-~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
.. ...+.+....+. .........-|.. |. .+ +. ..+...++...+|+.+||..||++|+|++|
T Consensus 231 ---~~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~----~~---~~~~~~~~~~~~li~~mL~~dp~~R~s~~e 294 (343)
T cd07878 231 ---VV----GTPSPEVLKKISSEHARKYIQSLPHM-PQ-QD----LK---KIFRGANPLAIDLLEKMLVLDSDKRISASE 294 (343)
T ss_pred ---Hh----CCCCHHHHHhcchhhHHHHhhccccc-cc-hh----HH---HhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 00 001111111110 0011111111110 10 00 11 111223445678999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 681 MLKHPYVSSD 690 (707)
Q Consensus 681 ~L~Hp~f~~~ 690 (707)
+|+||||...
T Consensus 295 ll~hp~~~~~ 304 (343)
T cd07878 295 ALAHPYFSQY 304 (343)
T ss_pred HhcCcchhcc
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.75 Aligned_cols=284 Identities=23% Similarity=0.366 Sum_probs=207.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|...+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57889999999999999999975 688999999864332 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
++ ++|.+++... ...+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 96 6999988654 335889999999999999999999998 9999999999999999999999999997543221
Q ss_pred CccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+...... ... .
T Consensus 159 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~------~~~----~ 222 (301)
T cd07873 159 -----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIF------RIL----G 222 (301)
T ss_pred -----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH------HHc----C
Confidence 11223356889999999876 4578899999999999999999999975432 12111110 000 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
.........+......+....|..++. .+ ....+..++...++|.+||+.||++|+|++|+|+||||..-
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 223 TPTEETWPGILSNEEFKSYNYPKYRAD------CL---HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred CCChhhchhhhccccccccccCccccc------cH---HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 001111111100000000001111110 00 01123334456789999999999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=330.22 Aligned_cols=201 Identities=27% Similarity=0.410 Sum_probs=175.1
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.|+..+.||+|+||+||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999964 7899999998654322 23457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999999987665557999999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 -------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 157 -------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred -------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1123468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=323.17 Aligned_cols=254 Identities=30% Similarity=0.480 Sum_probs=208.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.++|++.+.||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457888999999999999999988888899999876433 3467999999999999999999999885 45689999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc--
Confidence 9999999997755556899999999999999999999998 99999999999999999999999999976543221
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
.......++..|+|||++.+..++.++||||||+++|||++ |..||..... .+.... +......+
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~---------~~~~~~~~ 223 (260)
T cd05070 158 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQ---------VERGYRMP 223 (260)
T ss_pred ----ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHHH---------HHcCCCCC
Confidence 11112235678999999998999999999999999999999 8888865332 111111 11111223
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
.+.+.+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 455667789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=341.32 Aligned_cols=262 Identities=25% Similarity=0.379 Sum_probs=208.9
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHHccC-CCcceeEEEEEEeC
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE 443 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~ 443 (707)
...++|.+.+.||+|+||.||+|... .+..||||++...... ..+.+.+|+++++++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34567888999999999999999852 2347999999754332 3467899999999996 99999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcC---------------------------------------------------------
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKS--------------------------------------------------------- 466 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 466 (707)
+..++||||+++|+|.++++...
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999999886421
Q ss_pred -------------------------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005224 467 -------------------------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 509 (707)
Q Consensus 467 -------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 509 (707)
...+++..+..++.|+++||+|||+.+ |+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 124788889999999999999999998 9999999999999
Q ss_pred cCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCch
Q 005224 510 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 588 (707)
Q Consensus 510 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~ 588 (707)
++++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred eCCCEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999999999999986532211 111223346788999999999999999999999999999997 8899865322
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
....... +..+.....+..++..+.+++.+||+.+|++||++.++.+.|+.+.
T Consensus 346 ~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 346 DSTFYNK---------IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred hHHHHHH---------HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1111111 1111122344566788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=326.72 Aligned_cols=258 Identities=28% Similarity=0.480 Sum_probs=207.2
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 444 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 444 (707)
..+++|+..+.||+|+||.||+|.++ ++..||||.+.... .....++.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999853 35679999986533 233457889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcC--------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 516 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 516 (707)
..++||||+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 9999999999999999996532 124678899999999999999999988 99999999999999999999
Q ss_pred EeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHH
Q 005224 517 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 595 (707)
Q Consensus 517 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~ 595 (707)
|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... ......
T Consensus 160 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~~ 233 (277)
T cd05062 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRF 233 (277)
T ss_pred ECCCCCccccCCcce-----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH
Confidence 999999875533221 011112345678999999999999999999999999999999 6888864432 111111
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
+........+..++..+.+++.+|++.+|++||++.++++.++
T Consensus 234 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 ---------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---------HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1122223345556778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=333.27 Aligned_cols=284 Identities=20% Similarity=0.297 Sum_probs=210.9
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||.||+|... +++.||+|+++.... ...+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 688999999875321 2234456677777654 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----- 150 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----- 150 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----
Confidence 99999986543 5899999999999999999999998 9999999999999999999999999997543211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... +......++.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~----------i~~~~~~~~~ 217 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDS----------ILNDRPHFPR 217 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHH----------HHcCCCCCCC
Confidence 122345689999999999999999999999999999999999999975443 111111 1112233455
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCCCCC
Q 005224 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSN 695 (707)
Q Consensus 616 ~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~~~ 695 (707)
....++.+++.+|++.+|.+||++.+.+.... .+...+ .+.+.+ -...|.-++.......+++|......++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~----~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQHP----FFRGID---WERLEK-REIPPPFKPKVKSPSDASNFDREFTNEK 289 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHcCc----ccCCCC---HHHHHh-CCCCCCcCCCCCCcchhhhcCccccccc
Confidence 56677889999999999999998753222100 000000 001111 1234555666677777777765555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.48 Aligned_cols=257 Identities=29% Similarity=0.481 Sum_probs=209.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|++.+.||+|+||+||+|.+. +...||||.+...... ....+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 457889999999999999999974 2457999998754333 34678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999997643 36899999999999999999999988 99999999999999999999999999987642
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.+. ........++..|+|||.+.+..++.++||||||+++|||++ |..||........ .. .+..
T Consensus 159 ~~~-----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-~~---------~~~~ 223 (266)
T cd05033 159 SEA-----TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-IK---------AVED 223 (266)
T ss_pred ccc-----ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-HH---------HHHc
Confidence 111 111122335678999999999999999999999999999998 9999865443211 11 1111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
....+.+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 224 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112233455677899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.08 Aligned_cols=202 Identities=28% Similarity=0.332 Sum_probs=172.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.++||+|+||+||++..+ +++.||+|++..... .....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999975 578999999864221 12345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999753 235899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCCccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 157 ------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred ------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 11223456899999999986 346888999999999999999999999644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.79 Aligned_cols=239 Identities=23% Similarity=0.307 Sum_probs=185.3
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHH-HHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||+||+|... +++.||+|++..... .....+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 678999999875321 12234444544 56788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++... ..+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~----- 150 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN----- 150 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-----
Confidence 9999999654 34788888999999999999999999 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... . ....+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~---------~-~~~~~~ 217 (325)
T cd05602 151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILN---------K-PLQLKP 217 (325)
T ss_pred --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-HHHHHHHh---------C-CcCCCC
Confidence 1223456899999999999999999999999999999999999999754332 11111110 0 111223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005224 616 ECVEKFIKLALKCCQDETDARPSMSEV 642 (707)
Q Consensus 616 ~~~~~l~~l~~~c~~~~p~~RPt~~~v 642 (707)
.....+.+++.+|++.+|.+|++..+.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 344556677777777777777766543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=335.59 Aligned_cols=237 Identities=25% Similarity=0.344 Sum_probs=185.6
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHH-HHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
++||+|+||.||+|... +++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 689999999865322 22334555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+.+... ..+.+..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~------ 149 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP------ 149 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC------
Confidence 9999888653 35888899999999999999999998 999999999999999999999999998753221
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... . ......+.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i---------~-~~~~~~~~ 217 (321)
T cd05603 150 -EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-SQMYDNI---------L-HKPLQLPG 217 (321)
T ss_pred -CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-HHHHHHH---------h-cCCCCCCC
Confidence 1122345689999999999999999999999999999999999999975432 1111111 1 11122333
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 005224 616 ECVEKFIKLALKCCQDETDARPSMS 640 (707)
Q Consensus 616 ~~~~~l~~l~~~c~~~~p~~RPt~~ 640 (707)
.....+.+++.+|++.+|.+|++..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 4455667777777777777777653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=320.50 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=204.6
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
.+|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35778899999999999999988778899999865332 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--- 155 (256)
T cd05059 83 NGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--- 155 (256)
T ss_pred CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc---
Confidence 999999997643 36899999999999999999999998 99999999999999999999999999876532110
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ .... ........
T Consensus 156 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~---------~~~~~~~~ 222 (256)
T cd05059 156 ---TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-VESV---------SAGYRLYR 222 (256)
T ss_pred ---cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-HHHH---------HcCCcCCC
Confidence 11111223467999999999999999999999999999999 8888865433211 1111 11111223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
+..++..+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 445677899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=321.12 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=209.4
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..++|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3467888999999999999999988899999999876443 3467899999999999999999999874 4578999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 99999999997766667899999999999999999999988 99999999999999999999999999976542211
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......++..|+|||++.+..++.++||||||+++||+++ |+.||...... +..... ......
T Consensus 158 -----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~---------~~~~~~ 222 (260)
T cd05067 158 -----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-EVIQNL---------ERGYRM 222 (260)
T ss_pred -----ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-HHHHHH---------HcCCCC
Confidence 11122345678999999999899999999999999999999 99999654321 111111 111112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
..+...+.++.+++.+|++.+|++||++.++...|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 2344456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=329.62 Aligned_cols=282 Identities=25% Similarity=0.384 Sum_probs=209.6
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5788999999999999999964 789999999876442 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+ +++|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999987543 56999999999999999999999998 99999999999999999999999999986643221
Q ss_pred CccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......|+..|+|||.+.+. .++.++||||+||++|||++|..+|....+. ........ . ..
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~------~----~~ 218 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFR------T----LG 218 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHH------H----cC
Confidence 112334688999999998754 4688999999999999999997777544332 11111110 0 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
.........+.++....-...+..++.. + ....++.+....+++.+||..+|++|||++++|+||||.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKITFPESKPIP------L---EEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCChHHHhhccCcchhhcccCCCCCcch------H---HHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0011111111111000000011111111 1 112344456667899999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=326.89 Aligned_cols=282 Identities=23% Similarity=0.353 Sum_probs=206.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|+..+.||+|++|+||+|..+ +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999975 7899999998653322 234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
++ ++|.+++.... ..+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 97 59999887643 36899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......++..|+|||++.+ ..++.++||||+||++|||++|+.||.......+.+...+.. ..
T Consensus 158 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~----------~~ 222 (291)
T cd07844 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRV----------LG 222 (291)
T ss_pred -----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHh----------cC
Confidence 11122346788999999876 568899999999999999999999996554333322221111 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCC--CCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD--TKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~--~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
....+...........+....+...+ ..+ ....+... ....+++.+||..+|++|||++|+|+||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 223 TPTEETWPGVSSNPEFKPYSFPFYPP--RPL-------INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CCChhhhhhhhhccccccccccccCC--hhH-------HHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11111111111100000000000000 111 11112222 455689999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.51 Aligned_cols=256 Identities=28% Similarity=0.488 Sum_probs=206.2
Q ss_pred cCCCccceEeeeCceEEEEEEe-----CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
++|+..+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999984 256789999987533 3334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC---------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 005224 449 VYEFMSNGTLRDQLSAKS---------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 513 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 513 (707)
||||+++++|.+++.... ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999986432 234788999999999999999999998 99999999999999999
Q ss_pred cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHH
Q 005224 514 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 592 (707)
Q Consensus 514 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~ 592 (707)
.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADY-----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEV 235 (283)
T ss_pred cEEeccccccccccCCcc-----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHH
Confidence 999999999976543221 111223345678999999998889999999999999999999 9889865332 111
Q ss_pred HHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 593 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
.... ........+..++..+.+++.+|++.+|.+||++.++.+.+..
T Consensus 236 ~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMV---------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH---------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 1111223445567789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=326.82 Aligned_cols=280 Identities=27% Similarity=0.389 Sum_probs=204.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|++|.||+|..+ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999975 789999999865322 2246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 453 MSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 453 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
++ ++|.+++.... ...+++..++.++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68988886533 356899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||............ ... .
T Consensus 156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~-~~~------~---- 218 (285)
T cd07861 156 ------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI-FRI------L---- 218 (285)
T ss_pred ------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HHH------h----
Confidence 11223356889999999876 45788999999999999999999999754432221111 000 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
.............+... -...+... . . .+.......++...++|.+||..||++|||+++++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~-~~~~~~~~--~----~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 219 GTPTEDVWPGVTSLPDY-KNTFPKWK--K----G---SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CCCChhhhhcchhhHHH-HhhccccC--c----c---hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00001100000000000 00000000 0 0 0011122344555689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.07 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=206.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
..+|+..+.||+|+||+||+|.+. +++ .||+|.+.... ....+++.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356889999999999999999864 344 48999987543 33456789999999999999999999999764 567
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999997643 35889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... + ......
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~-~~~~~~-------- 225 (316)
T cd05108 161 ADEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E-ISSILE-------- 225 (316)
T ss_pred CCCc-----ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-H-HHHHHh--------
Confidence 3221 111122234678999999999999999999999999999998 99998653321 1 111111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.+.....+..+...+.+++..||+.+|.+||++.+++..+..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 111222344556778999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.83 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=207.9
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCC
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 444 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 444 (707)
...++|++.+.||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.+++.++|+||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 245899998865432 23456889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcC--------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 516 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 516 (707)
..++||||+++|+|.+++.... .....+..+..++.|++.||.|||+.+ |+||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999997532 234577888999999999999999998 99999999999999999999
Q ss_pred EeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHH
Q 005224 517 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 595 (707)
Q Consensus 517 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~ 595 (707)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 160 L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-~~~~~- 232 (288)
T cd05061 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLK- 232 (288)
T ss_pred ECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH-
Confidence 999999986533221 011112235678999999999999999999999999999999 7888864332 11111
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.+.++.....+..++..+.+++.+|++.+|++||++.++++.+++.
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 --------FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1122223334455667899999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.25 Aligned_cols=249 Identities=26% Similarity=0.440 Sum_probs=201.2
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|++|.||+|... +++.|++|.+... .....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999975 7899999988643 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 99999999998765567999999999999999999999988 9999999999999999999999999988654321
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
.......|++.|+|||+..+..++.++|||||||++|||++|+.||...... .... .+..+....
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~---------~~~~~~~~~ 220 (256)
T cd08529 156 -----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-ALIL---------KIIRGVFPP 220 (256)
T ss_pred -----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHH---------HHHcCCCCC
Confidence 1122345788999999999999999999999999999999999999754421 1111 111222233
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
.+..+...+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 33345566777777777777777777766654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.73 Aligned_cols=280 Identities=24% Similarity=0.391 Sum_probs=207.0
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5788899999999999999975 789999999865322 2235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
++ ++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 96 5888887653 245899999999999999999999998 9999999999999999999999999997653221
Q ss_pred CccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......++..|+|||++.+. .++.++|||||||++|||++|..|+....+........... . .
T Consensus 154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------~----~ 218 (284)
T cd07839 154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL------L----G 218 (284)
T ss_pred -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHH------h----C
Confidence 112234568899999998774 47899999999999999999999976555433332221110 0 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
..+......+.++... ...+...... ......+.......+|+.+||..||++|||++|+|+||||
T Consensus 219 ~~~~~~~~~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 219 TPTEESWPGVSKLPDY------KPYPMYPATT----SLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCChHHhHHhhhcccc------cccCCCCCcc----hhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1111111111111000 0001110000 0111223445566789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=317.24 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=209.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999964 78999999875422 233457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 451 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 451 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988642 2345889999999999999999999998 99999999999999999999999999886542
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.............. ...
T Consensus 159 ~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~--------~~~ 223 (267)
T cd08228 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI--------EQC 223 (267)
T ss_pred hh-------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH--------hcC
Confidence 21 111234578899999999998899999999999999999999999865432111111111 111
Q ss_pred CCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 609 NMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 609 ~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.... .+...+..+.+++.+||+.+|++||++.++++.++.+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1122 2345667899999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.61 Aligned_cols=257 Identities=30% Similarity=0.491 Sum_probs=211.8
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
...++|++.+.||+|+||+||+|..++++.||||.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3457899999999999999999998888899999987643 345679999999999999999999999998899999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.+++.......+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+|++|||+++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999998765567999999999999999999999998 99999999999999999999999999876543110
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ...... .....
T Consensus 159 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~---------~~~~~ 222 (261)
T cd05034 159 ------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQV---------ERGYR 222 (261)
T ss_pred ------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH---------HcCCC
Confidence 01112234568999999999999999999999999999999 99998654321 111111 11111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
...+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 22334456789999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.92 Aligned_cols=253 Identities=30% Similarity=0.460 Sum_probs=206.7
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
++|.+.+.||+|+||.||+|..+++..||+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688899999999999999998777789999886533 23467889999999999999999999885 456889999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+++|.++++......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc---
Confidence 999999997755556899999999999999999999998 99999999999999999999999999976543221
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
.......++..|+|||+..+..++.++|||||||++|||++ |+.||........ .... ........
T Consensus 158 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~---------~~~~~~~~ 224 (260)
T cd05069 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-LEQV---------ERGYRMPC 224 (260)
T ss_pred ---cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHH---------HcCCCCCC
Confidence 11112335678999999999999999999999999999999 8889865443211 1111 11111233
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
+...+..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 45567889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=333.54 Aligned_cols=262 Identities=27% Similarity=0.459 Sum_probs=206.9
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC-
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE- 443 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~- 443 (707)
..++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457899999999999999999742 357899999875432 2345688899999999 899999999988654
Q ss_pred CeEEEEEecCCCCCHHHHHhhcC---------------------------------------------------------
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKS--------------------------------------------------------- 466 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 466 (707)
...++||||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 56889999999999999986422
Q ss_pred --CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccc
Q 005224 467 --KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544 (707)
Q Consensus 467 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 544 (707)
..++++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ........
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-----~~~~~~~~ 236 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKGDAR 236 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc-----hhhccCCC
Confidence 126899999999999999999999998 99999999999999999999999999986532210 01122334
Q ss_pred cCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHH
Q 005224 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIK 623 (707)
Q Consensus 545 gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 623 (707)
++..|+|||++.+..++.++|||||||++|||++ |..||........ ...... .+.....+.....++.+
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRLK--------EGTRMRAPEYATPEIYS 307 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHHh--------ccCCCCCCccCCHHHHH
Confidence 5678999999999999999999999999999998 9999864322111 111111 11112234455678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 624 LALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 624 l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
++.+||+.+|++||++.++++.|+.+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=327.90 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=214.2
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
...+.|+.-++||+|+||.||-++.+ +|+.+|.|.+.+.. ...+...+.|-.+|+++..+.||.+--.|...+..|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34567888999999999999999965 79999999886543 334567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+|+..|.||+|.-+|...+...++++.++.++.+|+.||++||+.. ||.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999999888888999999999999999999999999 9999999999999999999999999999776
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
..+ .....+||.+|||||++.+..|+...|.||+||++|||+.|+.||.....-+.+-+.
T Consensus 339 ~g~--------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv------------ 398 (591)
T KOG0986|consen 339 EGK--------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV------------ 398 (591)
T ss_pred CCC--------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH------------
Confidence 432 233458999999999999999999999999999999999999999654332221100
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC-----CCCcCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSML 682 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L 682 (707)
.+.+..++. +.....++++.++.+.+|+-||++|+ .++++-
T Consensus 399 ------------------drr~~~~~~----------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk 444 (591)
T KOG0986|consen 399 ------------------DRRTLEDPE----------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVK 444 (591)
T ss_pred ------------------HHHHhcchh----------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhh
Confidence 000011111 01112233444566677777887775 567899
Q ss_pred CCCCCCCCCCC
Q 005224 683 KHPYVSSDVSG 693 (707)
Q Consensus 683 ~Hp~f~~~~~~ 693 (707)
+||||.+-.+.
T Consensus 445 ~HpfFk~lnw~ 455 (591)
T KOG0986|consen 445 EHPFFKDLNWR 455 (591)
T ss_pred hCcccccCCHh
Confidence 99999986663
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.24 Aligned_cols=257 Identities=22% Similarity=0.326 Sum_probs=208.8
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC---
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--- 444 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--- 444 (707)
....++|.+.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+.++..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457999999999999999999985 479999999986543 233456889999999999999999988775432
Q ss_pred -----eEEEEEecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 005224 445 -----EQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 517 (707)
Q Consensus 445 -----~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 517 (707)
..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999999753 2346899999999999999999999998 999999999999999999999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHh
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~ 597 (707)
+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+.
T Consensus 185 ~DFGls~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-~~~~~--- 255 (496)
T PTZ00283 185 GDFGFSKMYAATVS-----DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-EEVMH--- 255 (496)
T ss_pred EecccCeecccccc-----ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHH---
Confidence 99999986543211 1122345789999999999999999999999999999999999999975432 22111
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005224 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 645 (707)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~ 645 (707)
....+.....+..++..+.+++..||+.+|.+||++.++++.
T Consensus 256 ------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 ------KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ------HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 112223333556677889999999999999999999998753
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=335.77 Aligned_cols=203 Identities=27% Similarity=0.318 Sum_probs=174.0
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+++.. +++.||+|++.... ......+.+|..++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 68899999986522 122345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997632 35889999999999999999999998 9999999999999999999999999997654321
Q ss_pred CCCccccceecccccCCCccchhhhcc-----CCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 157 ------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 111223568999999999876 567889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.75 Aligned_cols=281 Identities=24% Similarity=0.440 Sum_probs=220.3
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHcc-CCCcceeEEEEEE
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 441 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 441 (707)
...++|.+.+.||+|+||.||+|... ....||+|.+.... ......+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 33467888999999999999999742 24579999987543 23346788999999999 6999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 005224 442 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 507 (707)
Q Consensus 442 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 507 (707)
..+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 9999999999999999999997532 235889999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCC
Q 005224 508 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 586 (707)
Q Consensus 508 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~ 586 (707)
|+++++.+||+|||+++.....+.. .......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred EEcCCCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999865432210 01111234567999999999999999999999999999999 88888543
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccC
Q 005224 587 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINS 666 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~ 666 (707)
.. .+..... ..+.....+..++..+.+++.+|++.+|++||++.++++.|+.+.....+ ...++..+
T Consensus 241 ~~-~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~---~~~~~~~~ 307 (314)
T cd05099 241 PV-EELFKLL---------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE---EYLDLSMP 307 (314)
T ss_pred CH-HHHHHHH---------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC---CceeeEEe
Confidence 22 1111111 11122234456667888999999999999999999999999988765432 33466667
Q ss_pred CCCCCCC
Q 005224 667 EHTSKEE 673 (707)
Q Consensus 667 ~L~~dP~ 673 (707)
+.+++|+
T Consensus 308 ~~~~~~~ 314 (314)
T cd05099 308 FEQYSPS 314 (314)
T ss_pred hhhcCCC
Confidence 7777763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.34 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=206.9
Q ss_pred CCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
+|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667889999999999999853 2578999999754332 24568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhc--------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 005224 449 VYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 514 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 514 (707)
++||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998532 1235788999999999999999999998 999999999999999999
Q ss_pred EEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHH
Q 005224 515 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 593 (707)
Q Consensus 515 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~ 593 (707)
+||+|||+++.....+. ........+++.|+|||++.+..++.++|||||||++|||++ |..||..... .+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVI 236 (283)
T ss_pred eEecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHH
Confidence 99999999886543221 111223345778999999998899999999999999999998 8888864332 1221
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 594 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
. .+..+.....+.+++..+.+++..||+.+|++||++.++++.|+.
T Consensus 237 ~---------~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 E---------MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H---------HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 122233334566788889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.27 Aligned_cols=279 Identities=27% Similarity=0.396 Sum_probs=207.3
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|++|.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999965 789999998865332 2235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+. ++|.+++.......+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 95 68999987766667999999999999999999999998 9999999999999999999999999987553221
Q ss_pred CccccceecccccCCCccchhhhccCC-CCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......++..|+|||++.+.. ++.++|||||||++|||+||+.||......... ...... . .
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~-~~~~~~------~----~ 218 (284)
T cd07860 155 -----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL-FRIFRT------L----G 218 (284)
T ss_pred -----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHH------h----C
Confidence 1122334678999999887644 688999999999999999999999754432211 111100 0 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCC-CCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~-~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
..+......+..+...+. ..+. .+....+ ..+..+....++|.+|+..||++|||++|+|+||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 219 TPDEVVWPGVTSLPDYKP-SFPKWARQDFSK----------VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CCChhhhhhhhHHHHHHh-hcccccccCHHH----------HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 001111111111111111 1111 1111111 112233445689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.16 Aligned_cols=264 Identities=27% Similarity=0.495 Sum_probs=212.1
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHcc-CCCcceeEEEEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 440 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 440 (707)
++....++|+..+.||+|+||.||+|... +...||+|.+.... .....++.+|+++++++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34555678899999999999999999863 23689999987532 23345688999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhc--------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 005224 441 DEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 506 (707)
Q Consensus 441 ~~~~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 506 (707)
...+..++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 9999999999999999999999652 2346899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCC
Q 005224 507 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 585 (707)
Q Consensus 507 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~ 585 (707)
|++++++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred EEEcCCCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 99999999999999999865432210 11112234678999999999999999999999999999998 9899864
Q ss_pred CchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 586 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
.... +.... ...+.....+..+...+.+++.+|++.+|++||++.++++.|+.+.
T Consensus 238 ~~~~-~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 238 IPVE-ELFKL---------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCHH-HHHHH---------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 4321 11111 1112222344556778999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=319.64 Aligned_cols=265 Identities=28% Similarity=0.423 Sum_probs=205.1
Q ss_pred CC-CccceEeeeCceEEEEEEe-----CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeE
Q 005224 376 NF-NSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 446 (707)
Q Consensus 376 ~~-~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 446 (707)
+| +..+.||+|+||+||++.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 7889999999999988653 3678999999876432 3456788999999999999999999998654 468
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++++|.+++... .+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 8999999999999999653 4899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHH-HHh---hcccc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN-IAY---QSSMM 602 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~-~~~---~~~~~ 602 (707)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.|+........... ... .....
T Consensus 158 ~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 158 PEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred CCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 432110 0111122356679999999988999999999999999999999999864332111000 000 00001
Q ss_pred hhhcc-CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 603 FSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 603 ~~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
....+ ......+..++..+.+++..||+.+|.+||++.++++.|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111 1122245566788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=319.35 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=204.8
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCc----EEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
++|++.+.||+|+||+||+|.+. +++ .|++|.+..... ....++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999964 444 478888764332 223577888999999999999999998854 45788
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997543 35899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.+. ........++..|+|||++.+..++.++|||||||++||+++ |+.||...... ....... .
T Consensus 162 ~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~--------~ 226 (279)
T cd05111 162 DDK-----KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLE--------K 226 (279)
T ss_pred CCc-----ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH--------C
Confidence 221 111223456788999999999999999999999999999998 99998654321 1111111 1
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
+.....+..+...+.+++.+||..+|.+||++.++++.+..+.+..
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 1122233345567888999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.46 Aligned_cols=283 Identities=23% Similarity=0.365 Sum_probs=205.7
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh-HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.+++.++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999864 78999999986543222 346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+. +++.+++.... ..+.+..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 68877775432 35788889999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......+.....+... .
T Consensus 158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~------~-- 222 (291)
T cd07870 158 -------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVL------G-- 222 (291)
T ss_pred -------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHc------C--
Confidence 11123346889999999876 4578899999999999999999999976544333222211110 0
Q ss_pred CCCCChHHHHHHHHHH---HHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCC
Q 005224 610 MGSYPSECVEKFIKLA---LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 686 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~---~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 686 (707)
....+....+..+- ...+...+ ++. +..+..... ......+++.+|+..||++|+|++|++.|||
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~-~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 223 --VPTEDTWPGVSKLPNYKPEWFLPCK--PQQ-------LRVVWKRLS-RPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred --CCChhhhhhhhhcccccchhccccC--Ccc-------hhhhccccC-CChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 00000000000000 00000000 111 111111111 2345568999999999999999999999999
Q ss_pred C
Q 005224 687 V 687 (707)
Q Consensus 687 f 687 (707)
|
T Consensus 291 ~ 291 (291)
T cd07870 291 F 291 (291)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.12 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=207.8
Q ss_pred cCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.+|...++||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677899999999999999742 466899999887666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCC-------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 005224 449 VYEFMSNGTLRDQLSAKSK-------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 515 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 515 (707)
||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999976432 34889999999999999999999998 9999999999999999999
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHH
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 594 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~ 594 (707)
||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 162 kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-AIE 235 (280)
T ss_pred EECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-HHH
Confidence 9999999975532210 011122335678999999999999999999999999999998 899986543321 111
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 595 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
....+.....+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 236 ---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 ---------CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---------HHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11122222334456678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=314.94 Aligned_cols=250 Identities=29% Similarity=0.475 Sum_probs=209.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888999999999999999974 78999999987544 4678999999999999999999999999899999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999998766557999999999999999999999998 9999999999999999999999999998653211
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
.....+..|+|||++.+..++.++||||||+++||+++ |..||...... + ...... ......
T Consensus 157 -------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~-~~~~~~--------~~~~~~ 219 (256)
T cd05039 157 -------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-D-VVPHVE--------KGYRME 219 (256)
T ss_pred -------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-H-HHHHHh--------cCCCCC
Confidence 12234568999999998899999999999999999997 99998654321 1 111111 111122
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
.+..++..+.+++.+|++.+|++||++.+++++|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 344566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.95 Aligned_cols=260 Identities=24% Similarity=0.409 Sum_probs=203.4
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3677889999999999999996 478999999986542 33346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999996542 3678889999999999999999998 999999999999999999999999999755321
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-------------------~ 203 (279)
T cd06619 149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-------------------L 203 (279)
T ss_pred ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-------------------c
Confidence 122346889999999999999999999999999999999999999642110000 0
Q ss_pred CChHHHHHHHHHHHHhc-ccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 613 YPSECVEKFIKLALKCC-QDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~-~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
.+ ... ..|+ ..++...| ....+....+|+.+|+..+|++||+++|+++||||....
T Consensus 204 ~~----~~~----~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 204 MP----LQL----LQCIVDEDPPVLP---------------VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred ch----HHH----HHHHhccCCCCCC---------------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 00 000 0111 11111100 011122345788899999999999999999999998765
Q ss_pred CCC
Q 005224 692 SGS 694 (707)
Q Consensus 692 ~~~ 694 (707)
.++
T Consensus 261 ~~~ 263 (279)
T cd06619 261 DGN 263 (279)
T ss_pred Ccc
Confidence 543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=314.68 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=207.6
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
+|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999965 7899999988643 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++.......+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--- 154 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--- 154 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc---
Confidence 9999999987655566899999999999999999999998 9999999999999999999999999997654321
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||...... .... .+..+.....
T Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~---------~~~~~~~~~~ 220 (255)
T cd08219 155 ----AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-NLIL---------KVCQGSYKPL 220 (255)
T ss_pred ----cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-HHHH---------HHhcCCCCCC
Confidence 1122346888999999999999999999999999999999999999754321 1111 1112222334
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRE 645 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~ 645 (707)
+...+..+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 55566778999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=314.86 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=200.3
Q ss_pred eEeeeCceEEEEEEeC---CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCC
Q 005224 382 QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 457 (707)
Q Consensus 382 ~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 457 (707)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 456799999876533 23467899999999999999999999885 457899999999999
Q ss_pred HHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcccc
Q 005224 458 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 537 (707)
Q Consensus 458 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 537 (707)
|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......... .
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~----~ 152 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----Y 152 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc----e
Confidence 99998653 346899999999999999999999998 999999999999999999999999999765432210 0
Q ss_pred ceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChH
Q 005224 538 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 616 (707)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (707)
.......++..|+|||.+.+..++.++|||||||++||+++ |..||...... +... .+..+.....+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~---------~~~~~~~~~~~~~ 222 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMS---------FIEQGKRLDCPAE 222 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-HHHH---------HHHCCCCCCCCCC
Confidence 11112234578999999998889999999999999999996 99999754331 1111 1112223345566
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 617 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 617 ~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
++.++.+++.+||+.+|++||++.++.+.|+.+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 778999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=317.68 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=204.7
Q ss_pred CCccceEeeeCceEEEEEEeC-C---CcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe-----
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 445 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 445 (707)
|++.+.||+|+||.||+|.+. + +..||+|+++.... .....+.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999864 2 36799999875432 234678999999999999999999998865544
Q ss_pred -EEEEEecCCCCCHHHHHhhc----CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeee
Q 005224 446 -QMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 520 (707)
Q Consensus 446 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 520 (707)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999998553 2346899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhc
Q 005224 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 599 (707)
Q Consensus 521 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 599 (707)
|+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||....+. +...
T Consensus 158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-~~~~----- 226 (273)
T cd05035 158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-EIYD----- 226 (273)
T ss_pred cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHH-----
Confidence 999865432211 01112234678999999998999999999999999999999 88888654331 1111
Q ss_pred ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.+..+.....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 ----YLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----HHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1122223334566778899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.17 Aligned_cols=279 Identities=24% Similarity=0.361 Sum_probs=207.7
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 68999999886532 2234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|..++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998888876443 35899999999999999999999988 99999999999999999999999999986643221
Q ss_pred CCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||................ ..+..
T Consensus 156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~--- 222 (286)
T cd07847 156 -------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL---GDLIP--- 222 (286)
T ss_pred -------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh---CCCCh---
Confidence 1123357789999999876 567899999999999999999999997544322111110000 00000
Q ss_pred CCCChHHHHHHHH---HHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 611 GSYPSECVEKFIK---LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 611 ~~~~~~~~~~l~~---l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
. ...+.. .........+..+++... ..+..+....+|+.+|+..+|++|||+.|++.||||
T Consensus 223 -----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 223 -----R-HQQIFSTNQFFKGLSIPEPETREPLES----------KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred -----H-HhhhcccccccccccCCCcccccCHHH----------HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 000000 000001112222222211 123335566789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=316.18 Aligned_cols=258 Identities=28% Similarity=0.482 Sum_probs=207.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CC---cEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999964 33 379999987543 3335678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997643 45899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.... .........+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+..... ..
T Consensus 160 ~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i---------~~ 225 (268)
T cd05063 160 DPEG----TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAI---------ND 225 (268)
T ss_pred cccc----ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHH---------hc
Confidence 2110 111111223467999999998899999999999999999998 9999965432 1111111 11
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
....+.+.+++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112223445677889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=319.44 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=210.6
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCC-----CcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEe-CCe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGE 445 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 445 (707)
..++|+..+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45688899999999999999999765 6889999987543 2335678899999999999999999998865 467
Q ss_pred EEEEEecCCCCCHHHHHhhcCC------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSK------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 519 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 519 (707)
.++++||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999976322 45899999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhh
Q 005224 520 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQ 598 (707)
Q Consensus 520 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~ 598 (707)
||+++.+...+.. .......++..|+|||++.+..++.++|||||||++||+++ |+.||..... .+..... .
T Consensus 161 ~g~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~-~ 233 (280)
T cd05043 161 NALSRDLFPMDYH-----CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAYL-K 233 (280)
T ss_pred CCCcccccCCceE-----EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHHHH-H
Confidence 9999865432210 11122345678999999999999999999999999999999 9999975432 1211111 1
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 599 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.+.....+..++..+.+++.+||..+|++||++.++++.|+.+.+
T Consensus 234 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 --------DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --------cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111112234456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.09 Aligned_cols=258 Identities=25% Similarity=0.407 Sum_probs=211.8
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|+..+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 89999999886422 223567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 451 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 451 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||+++++|.+++... ....+++..++.++.++++||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998652 3455899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||.........+.. ....+
T Consensus 159 ~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~ 223 (267)
T cd08224 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--------KIEKC 223 (267)
T ss_pred CC-------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh--------hhhcC
Confidence 21 1112345788999999999999999999999999999999999999644321111111 11112
Q ss_pred CCCCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 609 NMGSYPS-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 609 ~~~~~~~-~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
.....+. ..+..+.+++.+||..+|++||++.++++.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 2233333 56678999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.08 Aligned_cols=192 Identities=27% Similarity=0.357 Sum_probs=161.6
Q ss_pred EeeeCceEEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHHHcc---CCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL---HHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 383 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
||+|+||+||+|... +++.||||++....... ...+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 68999999986532221 23445677777665 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----- 150 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN----- 150 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-----
Confidence 9999998654 35899999999999999999999998 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......||..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 112345689999999999764 5889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.67 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=205.7
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
..++|.+.+.||+|+||.||+|.+. .+..||+|...... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567889999999999999999974 35789999887543 3334678999999999999999999999999899
Q ss_pred EEEEEecCCCCCHHHHHhhcCC-----CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEE
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKV 517 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl 517 (707)
.++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 35899999999999999999999998 99999999999998754 5999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 596 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~ 596 (707)
+|||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |+.||...... +.....
T Consensus 161 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~~~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVMEFV 234 (277)
T ss_pred ccCccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH
Confidence 999999865322110 00112223568999999999999999999999999999997 99998754331 111111
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
........+..++..+.+++.+|++.+|++||++.++++.|+
T Consensus 235 ---------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 ---------TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111122334556678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=334.13 Aligned_cols=250 Identities=27% Similarity=0.442 Sum_probs=211.6
Q ss_pred ccceEeeeCceEEEEEEeC--CCc--EEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 379 SSTQIGQGGYGKVYKGILP--DGT--VVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 379 ~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
..+.||+|.||.|++|.|+ +|+ .||||.+...... ...+|++|+.+|.+|+|+|+++|||+..+ ....||||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4678999999999999985 454 5899999876554 45789999999999999999999999987 7788999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
+.|+|.+.|++.....|-......++.|||.||.||.+++ +|||||..+|+|+-....+||+|||+.+-+...+...
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 9999999999866778999999999999999999999999 9999999999999999999999999999876543211
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
. ......-.+.|+|||.+....++.++|||+|||++||||| |..||..-.. .+ .+..+-++++..
T Consensus 270 v----m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-~q---------IL~~iD~~erLp 335 (1039)
T KOG0199|consen 270 V----MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-IQ---------ILKNIDAGERLP 335 (1039)
T ss_pred E----ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-HH---------HHHhccccccCC
Confidence 1 1122334678999999999999999999999999999999 8888864332 11 122233556677
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
-|..|++.+++++..||..+|.+||++..+.+.+
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 8899999999999999999999999999997543
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.13 Aligned_cols=258 Identities=27% Similarity=0.455 Sum_probs=206.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCc--EEEEEEeccC-ChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGT--VVAVKRAQEG-SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 449 (707)
++|++.+.||+|+||.||+|..+ ++. .+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999975 343 4788888743 233456789999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 005224 450 YEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 515 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 515 (707)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 134889999999999999999999988 9999999999999999999
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHH
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 594 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~ 594 (707)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||...... +...
T Consensus 159 kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV--------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-ELYE 229 (297)
T ss_pred EECCcCCCcccccee--------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Confidence 999999986432110 0111123557999999999999999999999999999998 99999654321 1111
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 595 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
. +..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 230 ~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 K---------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred H---------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 1111122234456678899999999999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=314.19 Aligned_cols=248 Identities=28% Similarity=0.465 Sum_probs=200.0
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCH
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
+.||+|+||.||+|... +++.||+|...... ......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999974 78999999876533 23356789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccc
Q 005224 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538 (707)
Q Consensus 459 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 538 (707)
.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~ 151 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-----AS 151 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc-----cc
Confidence 99996543 35899999999999999999999998 99999999999999999999999999875432110 00
Q ss_pred eecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHH
Q 005224 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSEC 617 (707)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (707)
.......+..|+|||.+.+..++.++|||||||++|||++ |..||........ ... +........+..+
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--~~~--------~~~~~~~~~~~~~ 221 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--REA--------IEQGVRLPCPELC 221 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--HHH--------HHcCCCCCCcccC
Confidence 0111123457999999999999999999999999999998 8888864332111 110 1111122345566
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 618 VEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 618 ~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
+..+.+++.+|++.+|++||++.++.++|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=314.27 Aligned_cols=249 Identities=29% Similarity=0.470 Sum_probs=204.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEE-eCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~E~ 452 (707)
..+|++.+.||+|+||.||+|..+ |..||+|...... ..+.+.+|+.++++++|+|++++++++. ..+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 347888999999999999999874 7889999986533 3457899999999999999999999764 45678999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999998766666899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+..... . .+...
T Consensus 157 --------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~-~--------~~~~~ 218 (256)
T cd05082 157 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRV-E--------KGYKM 218 (256)
T ss_pred --------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH-h--------cCCCC
Confidence 12234568999999999999999999999999999998 9999864322 1111111 1 11112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
..+..++..+.+++.+|++.+|++||++.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 2345567789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=324.19 Aligned_cols=289 Identities=20% Similarity=0.293 Sum_probs=219.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccC-C-C----cceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-H-R----NLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-~----nIv~l~~~~~~~~~~ 446 (707)
+++|.+...+|+|+||.|-.+.++ .+..||||+++.-. ...+..+-|+++++++. + | -+|.+.+||...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 789999999999999999999864 57899999987633 23456778999999993 2 2 378889999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---------------
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--------------- 511 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--------------- 511 (707)
|+|+|.+ |.|+.++|..++-.+++...++.|+.|++++++|||+.+ ++|.||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999 669999999888889999999999999999999999999 999999999999932
Q ss_pred -----CCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 512 -----KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 512 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
+..+||+|||.|+.....+ ...+.|.-|+|||++.+-.++.++||||+||||+|++||...|...
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3468999999998754322 4567899999999999999999999999999999999999998755
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHH-----HHHHHHhcc--cCCCCCCCHHHHHH---HHHHhhhcCCCC
Q 005224 587 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF-----IKLALKCCQ--DETDARPSMSEVMR---ELESIWNMMPES 656 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-----~~l~~~c~~--~~p~~RPt~~~v~~---~L~~~~~~~~~~ 656 (707)
.+... +. +++ ..++++|....... ..-. +++ .....| .+..+.+ -|..+......+
T Consensus 313 en~EH-La-------MMe---rIlGp~P~~mi~r~~~~Kyf~~~--rldw~e~~~~~-~~k~v~~~ckpl~~~~~~~d~e 378 (415)
T KOG0671|consen 313 ENLEH-LA-------MME---RILGPIPSRMIKKTRKEKYFRRG--RLDWPEVSSKG-KSKYVFEPCKPLKKYMLQDDLE 378 (415)
T ss_pred CcHHH-HH-------HHH---HhhCCCcHHHhhhhhhHhhhhcc--cccCccccccc-cchhhhcCCccHHHHhccCcHH
Confidence 54221 11 111 12233444333222 1111 222 111111 1122221 222222333344
Q ss_pred CCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 657 DTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 657 ~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
..++.|||++||.+||.+|+|+.|||.||||..-.
T Consensus 379 ~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 379 HVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 45678999999999999999999999999998754
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=322.45 Aligned_cols=263 Identities=25% Similarity=0.488 Sum_probs=211.1
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHcc-CCCcceeEEEEEE
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 441 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 441 (707)
...++|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567888999999999999999741 34579999987533 23346789999999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 005224 442 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 507 (707)
Q Consensus 442 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 507 (707)
..+..++||||+++|+|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999997632 235788899999999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCC
Q 005224 508 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 586 (707)
Q Consensus 508 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~ 586 (707)
++++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EEcCCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999866432211 11122345678999999999999999999999999999998 77887543
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 587 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
. ..+...... .+.....+..++..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 244 ~-~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 244 P-VEELFKLLK---------EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred C-HHHHHHHHH---------cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2 222222111 1112223456678899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=319.19 Aligned_cols=265 Identities=28% Similarity=0.438 Sum_probs=205.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-----CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQM 447 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 447 (707)
.+|++.+.||+|+||+||+|..+ +++.||+|.+........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888999999999999999742 5789999999876656667899999999999999999999987543 4689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999999654 235899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcc-------
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS------- 600 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~------- 600 (707)
..... ........++..|+|||++.+..++.++|||||||++|||++|..++...... +........
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 160 QDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FMRMMGNDKQGQMIVY 233 (284)
T ss_pred CCCcc----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hhhhcccccccccchH
Confidence 32210 00111122345699999999989999999999999999999987765432211 000000000
Q ss_pred cchhhc-cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 601 MMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 601 ~~~~~~-~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.+.+.+ .......+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000111 1112223445667899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=320.30 Aligned_cols=257 Identities=28% Similarity=0.468 Sum_probs=208.9
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCC------CcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
..++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45688899999999999999998642 3689999987543 2334678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcC--------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 005224 446 QMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 517 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 517 (707)
.++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999997532 224788999999999999999999988 999999999999999999999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 596 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~ 596 (707)
+|||+++.....+.. .......++..|+|||.+.+..++.++|||||||++||+++ |..||...... ....
T Consensus 161 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~-- 232 (277)
T cd05032 161 GDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-EVLK-- 232 (277)
T ss_pred CCcccchhhccCccc-----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-HHHH--
Confidence 999999765432210 11223346788999999998899999999999999999998 88888643321 1111
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
....+.....+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 -------FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11122233445566788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.99 Aligned_cols=283 Identities=27% Similarity=0.401 Sum_probs=208.6
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh-----hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-----GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
+|+..+.||+|+||.||+|... +++.||||.+...... ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999965 6899999998764332 235677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+ +++|.+++.... ..+++..++.++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999997643 36999999999999999999999998 999999999999999999999999999866432
Q ss_pred CCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
. .......++..|+|||.+.+ ..++.++|||||||++|||++|..+|....+. +....... ..
T Consensus 156 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~------~~-- 219 (298)
T cd07841 156 N-------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFE------AL-- 219 (298)
T ss_pred C-------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHH------Hc--
Confidence 1 11122345778999999865 56789999999999999999997777543332 11111110 00
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
.............+...+... ..+... .............+|+.+||..||++|+|++|+|+||||.
T Consensus 220 --~~~~~~~~~~~~~~~~~~~~~---~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~ 286 (298)
T cd07841 220 --GTPTEENWPGVTSLPDYVEFK---PFPPTP--------LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286 (298)
T ss_pred --CCCchhhhhhccccccccccc---ccCCcc--------hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence 000011111111111111000 001100 0111223344566899999999999999999999999998
Q ss_pred CCCC
Q 005224 689 SDVS 692 (707)
Q Consensus 689 ~~~~ 692 (707)
....
T Consensus 287 ~~~~ 290 (298)
T cd07841 287 NDPA 290 (298)
T ss_pred CCCC
Confidence 8654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=351.00 Aligned_cols=293 Identities=19% Similarity=0.242 Sum_probs=201.7
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC--CCcEEEEEEec-----------------cCChhhHHHHHHHHHHHHccCCCcc
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQ-----------------EGSLQGEKEFLTEIQFLSRLHHRNL 433 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~-----------------~~~~~~~~~~~~E~~~l~~l~H~nI 433 (707)
..++|++.+.||+|+||+||++.++ ++..+++|.+. .........+.+|++++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3568999999999999999998754 22222222110 0111223567899999999999999
Q ss_pred eeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005224 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD 510 (707)
Q Consensus 434 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 510 (707)
+++++++...+..++|+|++ .++|.+++.... ........++.++.||+.||+|||+.+ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 99999999999999999999 468888775432 122345667889999999999999998 99999999999999
Q ss_pred CCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCC-CCCCc-h
Q 005224 511 HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP-ISHGK-N 588 (707)
Q Consensus 511 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~p-f~~~~-~ 588 (707)
.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||++|||++|..+ +.... .
T Consensus 302 ~~~~vkL~DFGla~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKER------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred CCCCEEEEeCCCceecCccc------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 99999999999998664322 1122335689999999999999999999999999999999998754 43221 2
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhhcCCCCCCCCCccccCC
Q 005224 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPESDTKTPEFINSE 667 (707)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-t~~~v~~~L~~~~~~~~~~~~~~~dll~~~ 667 (707)
............ ..... .++.. ...+.+.+.. ......+ +...+++.+ .....+.++|.+|
T Consensus 376 ~~~~~~~~~~~~---~~~~~---~~p~~-~~~~~~~i~~---~~~~~~~~~~~~~~~~~--------~~~~~~~~li~km 437 (501)
T PHA03210 376 PGKQLLKIIDSL---SVCDE---EFPDP-PCKLFDYIDS---AEIDHAGHSVPPLIRNL--------GLPADFEYPLVKM 437 (501)
T ss_pred HHHHHHHHHHhc---ccChh---hcCCc-HHHHHHHhhh---hhcccCccchhhHHHhc--------CCChHHHHHHHHH
Confidence 222221111100 00111 11111 1112222211 1111111 222222211 1234566889999
Q ss_pred CCCCCCCCCCCCcCCCCCCCCCCCCC
Q 005224 668 HTSKEETPPSSSSMLKHPYVSSDVSG 693 (707)
Q Consensus 668 L~~dP~~R~sa~e~L~Hp~f~~~~~~ 693 (707)
|++||++||||+|+|+||||......
T Consensus 438 L~~DP~~Rpsa~elL~hp~f~~~~~~ 463 (501)
T PHA03210 438 LTFDWHLRPGAAELLALPLFSAEEEE 463 (501)
T ss_pred hccCcccCcCHHHHhhChhhhcCCch
Confidence 99999999999999999999876553
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=333.70 Aligned_cols=265 Identities=22% Similarity=0.383 Sum_probs=210.4
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChhh-HHHHHHHHHHHHccC-CCcceeEEEEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLH-HRNLVSLVGYC 440 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~-H~nIv~l~~~~ 440 (707)
++....++|.+.++||+|+||.||+|.++ .++.||||++....... .+.+.+|++++.++. ||||++++++|
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 34555667888999999999999999863 34689999997643332 347889999999997 99999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCC-----------------------------------------------------
Q 005224 441 DEEGEQMLVYEFMSNGTLRDQLSAKSK----------------------------------------------------- 467 (707)
Q Consensus 441 ~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------- 467 (707)
...+..++||||+++|+|.+++++...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999965321
Q ss_pred -------------------------------------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005224 468 -------------------------------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 504 (707)
Q Consensus 468 -------------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 504 (707)
..+++..++.++.|++.||+|||+.+ |+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 23677888999999999999999988 99999999
Q ss_pred CCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCC
Q 005224 505 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPI 583 (707)
Q Consensus 505 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf 583 (707)
+|||+++++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSN-----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccc-----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999976432210 011122346788999999999899999999999999999998 88898
Q ss_pred CCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 584 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
............. ..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 343 ~~~~~~~~~~~~~---------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 343 PELPMNEQFYNAI---------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCchHHHHHHH---------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 6433211111111 111122344556788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=313.95 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=199.7
Q ss_pred eEeeeCceEEEEEEe---CCCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCC
Q 005224 382 QIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 382 ~lG~G~~g~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 456 (707)
.||+|+||.||+|.+ +++..||+|++..... ...+++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 3578999999865432 23567899999999999999999999885 45678999999999
Q ss_pred CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccc
Q 005224 457 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 536 (707)
Q Consensus 457 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 536 (707)
+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---- 151 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---- 151 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe----
Confidence 999999653 35899999999999999999999998 999999999999999999999999999865432210
Q ss_pred cceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 005224 537 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615 (707)
Q Consensus 537 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (707)
........++..|+|||.+....++.++|||||||++|||++ |+.||..... ....... ..+.....+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~i---------~~~~~~~~~~ 221 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMI---------ESGERMECPQ 221 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH---------HCCCCCCCCC
Confidence 011122234678999999988889999999999999999998 9999965432 1111111 1122233455
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 616 ~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.++.++.+++.+||+.+|++||++.+|.+.|++.
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 6778899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=326.90 Aligned_cols=284 Identities=24% Similarity=0.341 Sum_probs=205.9
Q ss_pred CCCccceEeeeCceEEEEEEeC---CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP---DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQM 447 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 447 (707)
+|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999987633 23345678899999999999999999999888 7899
Q ss_pred EEEecCCCCCHHHHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEeee
Q 005224 448 LVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH----KFTAKVADF 520 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~DF 520 (707)
+||||+++ +|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 7777775422 236899999999999999999999998 999999999999999 999999999
Q ss_pred cccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhc
Q 005224 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599 (707)
Q Consensus 521 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~ 599 (707)
|+++........ ........++..|+|||++.+ ..++.++|||||||+++||++|+.||.........
T Consensus 157 g~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~------- 225 (316)
T cd07842 157 GLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK------- 225 (316)
T ss_pred ccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc-------
Confidence 999865432210 111233467889999998876 45889999999999999999999999643321100
Q ss_pred ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH----------------HHHHhhhcCCCCCCCCCcc
Q 005224 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR----------------ELESIWNMMPESDTKTPEF 663 (707)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~----------------~L~~~~~~~~~~~~~~~dl 663 (707)
. .+ .....+.+++..+-...+..++.+.+..+ .+..........+....++
T Consensus 226 ----------~--~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (316)
T cd07842 226 ----------S--NP-FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292 (316)
T ss_pred ----------c--ch-hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHH
Confidence 0 00 00011112222221112111111111100 0111111112445566789
Q ss_pred ccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 664 INSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 664 l~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
+.+||+.||++|||++|+++||||
T Consensus 293 i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 293 LRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhcCCcccCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.99 Aligned_cols=258 Identities=30% Similarity=0.489 Sum_probs=206.7
Q ss_pred CCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
+|++.+.||+|+||.||+|... ....||+|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999852 235799998875433 334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC----------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 005224 449 VYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 506 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 506 (707)
||||+.+++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 235789999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCC
Q 005224 507 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 585 (707)
Q Consensus 507 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~ 585 (707)
|++++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999765322110 01122345678999999999999999999999999999998 9988864
Q ss_pred CchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 586 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
... .+..... . .......+..++..+.+++..|++.+|++||++.++++.|+++..
T Consensus 233 ~~~-~~~~~~~-~--------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 233 IAP-ERLFNLL-K--------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCH-HHHHHHH-h--------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 332 1111111 1 111122345566789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.12 Aligned_cols=247 Identities=29% Similarity=0.485 Sum_probs=201.1
Q ss_pred ceEeeeCceEEEEEEeCCCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCHH
Q 005224 381 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 459 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~ 459 (707)
++||+|+||.||+|..++++.||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999876433 23456889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccce
Q 005224 460 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539 (707)
Q Consensus 460 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 539 (707)
+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++........ ..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~------~~ 150 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY------SS 150 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc------cc
Confidence 9986543 35889999999999999999999998 99999999999999999999999999875432110 01
Q ss_pred ecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 005224 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618 (707)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (707)
.....++..|+|||++.+..++.++||||||+++||+++ |..||...... ..... +..+.....+..++
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-~~~~~---------~~~~~~~~~~~~~~ 220 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAREQ---------VEKGYRMSCPQKCP 220 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHH---------HHcCCCCCCCCCCC
Confidence 112234578999999999999999999999999999998 99999654322 11111 11111223344567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 619 EKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 619 ~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
..+.+++.+|++.+|++||++.++.+.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 78999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.21 Aligned_cols=281 Identities=25% Similarity=0.361 Sum_probs=206.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 449 (707)
++|+..+.||+|+||.||+|..+ +++.||+|.++..... ....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999976 6899999998754322 234577899999999999999999998777 899999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 59999887643 36899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
. .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ....... .
T Consensus 160 ~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~------~---- 221 (293)
T cd07843 160 L-------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIF------K---- 221 (293)
T ss_pred c-------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH------H----
Confidence 1 111234568899999998764 4688999999999999999999999754332 1111110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCC--CCCCCccccCCCCCCCCCCCCCCcCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES--DTKTPEFINSEHTSKEETPPSSSSMLKHPY 686 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~--~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 686 (707)
............+.++...- .....++.... +...++.. .+...+++++||..+|++|||++|+|+|||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 222 LLGTPTEKIWPGFSELPGAK--KKTFTKYPYNQ-------LRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred HhCCCchHHHHHhhccchhc--ccccccccchh-------hhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 00011111111111110000 00001111111 11223332 555678999999999999999999999999
Q ss_pred C
Q 005224 687 V 687 (707)
Q Consensus 687 f 687 (707)
|
T Consensus 293 f 293 (293)
T cd07843 293 F 293 (293)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.69 Aligned_cols=290 Identities=21% Similarity=0.309 Sum_probs=212.7
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC------
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 443 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 443 (707)
..++|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 7899999998642 223345678899999999999999999998543
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 5888888532 888999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
+...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........+.. ..
T Consensus 166 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~------ 230 (353)
T cd07850 166 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK-II------ 230 (353)
T ss_pred eeCCCCC--------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH-HH------
Confidence 8653211 12234578899999999999999999999999999999999999975544222211 11
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhhc---CCCCCCCCCccccCCCCCCCCCCCCCC
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNM---MPESDTKTPEFINSEHTSKEETPPSSS 679 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-t~~~v~~~L~~~~~~---~~~~~~~~~dll~~~L~~dP~~R~sa~ 679 (707)
...+..+.+....+...........+..++ ...++.......... .....+...+||.+||+.||++|||++
T Consensus 231 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 306 (353)
T cd07850 231 ----EQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306 (353)
T ss_pred ----HhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence 112223344444433333333333332221 222221110000000 001223456899999999999999999
Q ss_pred cCCCCCCCCC
Q 005224 680 SMLKHPYVSS 689 (707)
Q Consensus 680 e~L~Hp~f~~ 689 (707)
|+|+||||..
T Consensus 307 eiL~~~~~~~ 316 (353)
T cd07850 307 DALQHPYINV 316 (353)
T ss_pred HHhcChhHhh
Confidence 9999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=322.02 Aligned_cols=198 Identities=36% Similarity=0.588 Sum_probs=173.1
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHH--HHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK--EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
|+..+.||+|+||+||++... +++.||+|++......... ...+|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999976 6779999999876554432 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---- 151 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---- 151 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST----
T ss_pred ccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc----
Confidence 99999999973 335899999999999999999999998 999999999999999999999999999754111
Q ss_pred ccccceecccccCCCccchhhhc-cCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
........++..|+|||++. +..++.++||||+|+++|+|++|..||...
T Consensus 152 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 152 ---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp ---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ---ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22334556889999999998 889999999999999999999999999754
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.15 Aligned_cols=264 Identities=23% Similarity=0.375 Sum_probs=208.2
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999995 478999999987655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 999999998543 4899999999999999999999998 9999999999999999999999999987654321
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||.......... ...... ......
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-~~~~~~-------~~~~~~ 237 (296)
T cd06655 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNG-------TPELQN 237 (296)
T ss_pred ----ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcC-------CcccCC
Confidence 11223457889999999999899999999999999999999999997544321110 000000 000000
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCCC
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 693 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~ 693 (707)
+. ...+...+++.+||..||++|+|+++++.||||..-...
T Consensus 238 ~~---------------------------------------~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~ 278 (296)
T cd06655 238 PE---------------------------------------KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278 (296)
T ss_pred cc---------------------------------------cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccc
Confidence 00 111223357778888888888888899999999876654
Q ss_pred CCccc
Q 005224 694 SNLVS 698 (707)
Q Consensus 694 ~~~~~ 698 (707)
+....
T Consensus 279 ~~~~~ 283 (296)
T cd06655 279 SSLTP 283 (296)
T ss_pred ccCCc
Confidence 44433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=322.41 Aligned_cols=261 Identities=26% Similarity=0.485 Sum_probs=209.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeC--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 443 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 443 (707)
.++|.+.+.||+|+||.||+|... +...||+|.+.... .....++.+|+++++.+ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 457889999999999999999852 23579999987543 23345788899999999 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCC--------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 509 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 509 (707)
+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999976421 35889999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCch
Q 005224 510 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 588 (707)
Q Consensus 510 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~ 588 (707)
++++.+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~- 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 247 (307)
T ss_pred cCCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-
Confidence 99999999999998765322110 01111224568999999999999999999999999999998 888885432
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
..+..... . .......+..++..+.+++.+|++.+|++||++.++++.|+.+...
T Consensus 248 ~~~~~~~~-~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 VEELFKLL-K--------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHH-H--------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 22111111 1 1112234556678899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=314.50 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=208.1
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..++|+..+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 456788999999999999999998778889999887533 234678899999999999999999999877 778999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 99999999997765567899999999999999999999988 99999999999999999999999999976543211
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......++..|+|||++....++.++|||||||++||+++ |+.||....... ..... ......
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~---------~~~~~~ 222 (260)
T cd05073 158 -----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRAL---------ERGYRM 222 (260)
T ss_pred -----ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH---------hCCCCC
Confidence 11122345678999999998899999999999999999999 898986543311 11110 111111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
..+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2334556779999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.87 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=173.6
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++|+||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788999999999999999996 47899999998765444456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.++++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 9999999998654 35899999999999999999999998 9999999999999999999999999997653211
Q ss_pred CccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 161 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 161 -----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1112345788999999985 355788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.15 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=200.5
Q ss_pred CCccceEeeeCceEEEEEEeCC-Cc--EEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC------Ce
Q 005224 377 FNSSTQIGQGGYGKVYKGILPD-GT--VVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GE 445 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~ 445 (707)
|.+.+.||+|+||.||+|.+.+ +. .||+|.++.. .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999753 33 6899988653 233356788999999999999999999987432 25
Q ss_pred EEEEEecCCCCCHHHHHhhc----CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeec
Q 005224 446 QMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 521 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 521 (707)
.++||||+++|+|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 2345899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcc
Q 005224 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 600 (707)
Q Consensus 522 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~ 600 (707)
+++....... ........+++.|+|||+..+..++.++|||||||++|||++ |+.||..... .+.....
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~---- 227 (272)
T cd05075 158 LSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYL---- 227 (272)
T ss_pred cccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH----
Confidence 9987543221 011122345678999999999999999999999999999999 7888864332 1111111
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
..+.....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 228 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 -----RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -----HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11222223445667789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.94 Aligned_cols=287 Identities=26% Similarity=0.414 Sum_probs=225.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCc----EEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
.++|+..+.||+|+||.||+|.+. +++ .||+|.+..... ....++.+|+.+++.++|+||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456788899999999999999863 444 578998875433 2234788999999999999999999998654 467
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999998754 335889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... ........
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~-------- 225 (303)
T cd05110 161 GDEK-----EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLE-------- 225 (303)
T ss_pred Cccc-----ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH--------
Confidence 2211 111122345678999999999999999999999999999998 8899864322 11111111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCC
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 686 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 686 (707)
.+.....+..++..+.+++..||..+|++||++.++++.++.+.... .+.+.+.++.|+.+...-.|||
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 294 (303)
T cd05110 226 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP-----------QRYLVIQGDDRMKLPSPNDSKF 294 (303)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch-----------hhheeeccCCcCCCCCCchhhH
Confidence 11112223345567899999999999999999999999998764422 3357788999999999999999
Q ss_pred CCCCC
Q 005224 687 VSSDV 691 (707)
Q Consensus 687 f~~~~ 691 (707)
|..-.
T Consensus 295 ~~~~~ 299 (303)
T cd05110 295 FQNLL 299 (303)
T ss_pred Hhccc
Confidence 87633
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=316.96 Aligned_cols=204 Identities=30% Similarity=0.456 Sum_probs=174.2
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC------
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE------ 443 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------ 443 (707)
.+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678889999999999999999965 68899999987543 3456788999999998 799999999998653
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
...++||||+++++|.+++.......+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 46899999999999999998755567899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 159 AQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred eeccccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 7653211 1223456889999999986 346888999999999999999999999643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=325.35 Aligned_cols=268 Identities=23% Similarity=0.310 Sum_probs=209.1
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|+..+.||+|+||+||+|... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999975 5899999998764332 3457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+.+++|.+++.......+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999997665567999999999999999999999998 9999999999999999999999999987553221
Q ss_pred CCCc----------------------cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 531 IEGI----------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 531 ~~~~----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
.... ..........|+..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0000 000111234678999999999999999999999999999999999999964332
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCC
Q 005224 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 668 (707)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L 668 (707)
.... .++. ...+ ..|.. ...+....+++.+|+
T Consensus 238 ~~~~-----------------------------~~~~----~~~~-~~~~~--------------~~~~~~~~~li~~~l 269 (316)
T cd05574 238 DETF-----------------------------SNIL----KKEV-TFPGS--------------PPVSSSARDLIRKLL 269 (316)
T ss_pred HHHH-----------------------------HHHh----cCCc-cCCCc--------------cccCHHHHHHHHHHc
Confidence 1110 0000 0000 00000 001233446788888
Q ss_pred CCCCCCCCC----CCcCCCCCCCCCCCCC
Q 005224 669 TSKEETPPS----SSSMLKHPYVSSDVSG 693 (707)
Q Consensus 669 ~~dP~~R~s----a~e~L~Hp~f~~~~~~ 693 (707)
..||++|+| ++|+|+||||.+..+.
T Consensus 270 ~~~p~~R~s~~~~~~~ll~~~~~~~~~~~ 298 (316)
T cd05574 270 VKDPSKRLGSKRGAAEIKQHPFFRGVNWA 298 (316)
T ss_pred cCCHhHCCCchhhHHHHHcCchhhcCChh
Confidence 888999999 9999999999886553
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.97 Aligned_cols=260 Identities=24% Similarity=0.403 Sum_probs=208.3
Q ss_pred HhcCCCccceEeeeCceEEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCC
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 444 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 444 (707)
..++|...+.||+|+||.||+|.. .++..||||++..... ...+.+.+|+++++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 345788899999999999999974 1355899999875432 3345789999999999 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..++||||+++|+|.++++......+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+|++|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999997655455899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccch
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||............ ..
T Consensus 190 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~-~~----- 258 (302)
T cd05055 190 DIMNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL-IK----- 258 (302)
T ss_pred cccCCCc-----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH-HH-----
Confidence 6533210 011122345778999999999999999999999999999998 99998654322111111 11
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.+.....+...+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 259 ---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 ---EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111122334456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.99 Aligned_cols=287 Identities=25% Similarity=0.339 Sum_probs=207.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 448 (707)
.++|++.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999975 6899999998653322 123567899999999999999999998655 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+. ++|.+++... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 5898888654 256899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.. .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... +.+......
T Consensus 161 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~-------- 224 (309)
T cd07845 161 PA-------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQL-------- 224 (309)
T ss_pred cc-------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh--------
Confidence 21 11122345778999999876 56789999999999999999999999754432 211111100
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
.+.........+..+........+.... ..+...+...++...|||.+||.+||++|||++|+|+||||
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 225 --LGTPNESIWPGFSDLPLVGKFTLPKQPY---------NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred --cCCCChhhchhhhcccccccccccCCCC---------CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 0000011111111100000000000000 00111122235556789999999999999999999999999
Q ss_pred CCCCC
Q 005224 688 SSDVS 692 (707)
Q Consensus 688 ~~~~~ 692 (707)
.....
T Consensus 294 ~~~~~ 298 (309)
T cd07845 294 KEKPL 298 (309)
T ss_pred ccCCC
Confidence 86555
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=327.08 Aligned_cols=280 Identities=26% Similarity=0.362 Sum_probs=207.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|+..+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999976 589999998765322 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.++.... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999888877543 34899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 155 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--------- 219 (286)
T cd07846 155 ------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN--------- 219 (286)
T ss_pred ------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCC---------
Confidence 11223457889999999876 45788999999999999999999888654432211111100000
Q ss_pred CCCChHHHHHH--HHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 611 GSYPSECVEKF--IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 611 ~~~~~~~~~~l--~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
........+ ..+..... .|. ..+ ........+..+....+|+.+|+..+|++||+++++++||||
T Consensus 220 --~~~~~~~~~~~~~~~~~~~--~~~----~~~----~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 220 --LIPRHQEIFQKNPLFAGMR--LPE----VKE----IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred --CchhhHHHhccchHhhccc--ccc----ccC----cchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000000000 00000011 111 000 001112234455667789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.83 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=206.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-C---CcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|++.+.||+|+||.||+|... + +..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999863 2 3479999987543 2334678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999997643 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.... ........++..|+|||++.+..++.++|||||||++||+++ |..||...... +..... .+
T Consensus 159 ~~~~----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~~~---------~~ 224 (267)
T cd05066 159 DPEA----AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAI---------EE 224 (267)
T ss_pred ccce----eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHHHH---------hC
Confidence 2210 011112223568999999999899999999999999999887 99999654321 111111 11
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
....+.+..++..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111223344567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=321.89 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=204.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCc--EEEEEEeccCC-hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.+.... ....+.+.+|++++.++ +|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888999999999999999964 454 46888776532 23346788999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 005224 449 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 514 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 514 (707)
||||+++++|.++++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997532 235789999999999999999999998 999999999999999999
Q ss_pred EEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHH
Q 005224 515 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 593 (707)
Q Consensus 515 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~ 593 (707)
+||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||+| |..||...... +..
T Consensus 163 ~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~ 233 (303)
T cd05088 163 AKIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELY 233 (303)
T ss_pred EEeCccccCcccchh--------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-HHH
Confidence 999999998642210 01111224567999999988889999999999999999998 99998643321 111
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 594 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
... ..+.....+...+..+.+++.+||+.+|++||++.++++.++.+...
T Consensus 234 ~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 234 EKL---------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHH---------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111 11111123334556789999999999999999999999999877553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.09 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=209.4
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|+..+.||+|+||.||+|.. .+++.||||.+.... ....+++.+|+++++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 489999999876432 223457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 451 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 451 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998642 2346899999999999999999999998 99999999999999999999999999876542
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.. .......|+..|+|||++.+..++.++||||||+++|||++|..||............ .+...
T Consensus 159 ~~-------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~ 223 (267)
T cd08229 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--------KIEQC 223 (267)
T ss_pred CC-------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh--------hhhcC
Confidence 21 1112345788999999999989999999999999999999999999643321111111 11111
Q ss_pred CCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 609 NMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 609 ~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.... .+...+..+.+++.+||+.+|.+|||+.++++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1122 2345677899999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=347.42 Aligned_cols=270 Identities=25% Similarity=0.353 Sum_probs=209.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.++||+|+||.||+|... +++.||+|++..... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 689999999875322 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcC---------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeec
Q 005224 451 EFMSNGTLRDQLSAKS---------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 521 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 521 (707)
||+++|+|.+++.... ....++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 234567788999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCCC-----------ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhH
Q 005224 522 LSRLAPVPDIEG-----------IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 590 (707)
Q Consensus 522 la~~~~~~~~~~-----------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~ 590 (707)
+++......... ...........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998652211000 000011123569999999999999999999999999999999999999996532211
Q ss_pred HHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhhcCCC
Q 005224 591 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPE 655 (707)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-t~~~v~~~L~~~~~~~~~ 655 (707)
.... . ....+.......+.+..+.+++.+|++.+|++|+ ++.++.+.|+......+.
T Consensus 239 i~~~-----~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 239 ISYR-----D---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred hhhh-----h---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 0000 0 0001000011134556788999999999999996 667788888877665444
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.98 Aligned_cols=200 Identities=25% Similarity=0.426 Sum_probs=176.1
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788899999999999999996 478999999988755555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--- 170 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc---
Confidence 999999998542 4789999999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 171 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred ----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457889999999999889999999999999999999999996544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=318.73 Aligned_cols=257 Identities=32% Similarity=0.504 Sum_probs=207.1
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
..++|+..+.||+|+||.||+|... ++..||+|.+..... ...+++.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467889999999999999999863 467899999876432 334678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcC--------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 005224 446 QMLVYEFMSNGTLRDQLSAKS--------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 505 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 505 (707)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999996421 134788899999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCC
Q 005224 506 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 584 (707)
Q Consensus 506 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~ 584 (707)
||++++++.+||+|||+++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYY-----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred heEecCCCceEECccccceecccCccc-----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999998754322110 11112234567999999999999999999999999999998 888886
Q ss_pred CCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 585 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
.... .+... .+.++.....+..++.++.+++.+|++.+|.+||++.|+++.|+
T Consensus 235 ~~~~-~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 235 GMAH-EEVIY---------YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCH-HHHHH---------HHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 4332 11111 11122222334556788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=322.96 Aligned_cols=259 Identities=23% Similarity=0.361 Sum_probs=203.9
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
|.....||+|+||.||++... +++.||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 334567999999999999964 6899999998765555567789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 104 ~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----- 172 (292)
T cd06658 104 GALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----- 172 (292)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----
Confidence 999998854 24889999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (707)
.......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ .
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~---------------------- 227 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-M---------------------- 227 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H----------------------
Confidence 111234578999999999988999999999999999999999999864332100 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCCCCC
Q 005224 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSN 695 (707)
Q Consensus 616 ~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~~~ 695 (707)
..+........... ...+....+|+.+|+..||++|||++|+++||||......+-
T Consensus 228 -------~~~~~~~~~~~~~~-----------------~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 228 -------RRIRDNLPPRVKDS-----------------HKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred -------HHHHhcCCCccccc-----------------cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 00111111100000 011122335778889999999999999999999987766553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=315.78 Aligned_cols=263 Identities=26% Similarity=0.362 Sum_probs=205.7
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999964 68899999987533 23456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 453 MSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976433 56899999999999999999999998 99999999999999999999999999976654321
Q ss_pred CCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.. ........|+..|+|||++... .++.++|||||||++|||++|+.||........ .
T Consensus 158 ~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~----------------- 216 (267)
T cd06610 158 RT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-L----------------- 216 (267)
T ss_pred cc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-H-----------------
Confidence 10 1122344688999999999876 789999999999999999999999964332110 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
.+.. +..+..-+.... .........+++.+|+..||++|||++|+++||||
T Consensus 217 -----------~~~~----~~~~~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 217 -----------MLTL----QNDPPSLETGAD-----------YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----------HHHh----cCCCCCcCCccc-----------cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000 001100000000 01112233478888999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=319.63 Aligned_cols=198 Identities=26% Similarity=0.438 Sum_probs=174.8
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 689999999865322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999664 45899999999999999999999988 999999999999999999999999998765322
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 223457899999999998889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.61 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=205.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
.++|+..++||+|+||+||+|.+. +++ .||+|.+.... ....+.+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 457888999999999999999853 454 48999987543 33456788999999999999999999999754 577
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
++|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999999754 235899999999999999999999998 9999999999999999999999999998664
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.... ........++..|+|||...+..++.++|||||||++|||++ |..||....... ......
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~-------- 225 (279)
T cd05109 161 IDET-----EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLE-------- 225 (279)
T ss_pred cccc-----eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH--------
Confidence 3211 011112234678999999999999999999999999999998 888986433211 111111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.+.....+..++..+.+++..||+.+|+.||++.++++.++.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111222344566788999999999999999999999998887644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.09 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=207.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeCC----CcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|+..+.||+|+||.||+|.+.+ ...||||...... ....+.+.+|+.++++++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568889999999999999998643 3479999887654 3445689999999999999999999999875 45789
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999997543 35899999999999999999999988 99999999999999999999999999976543
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
... .......++..|+|||.+....++.++|||||||++||+++ |..||......... .. +..
T Consensus 160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~---------~~~ 223 (270)
T cd05056 160 ESY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GR---------IEN 223 (270)
T ss_pred ccc------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HH---------HHc
Confidence 211 11112234568999999988899999999999999999996 99999765432111 11 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
+.....+..++..+.+++.+|+..+|++||++.++++.|+.+.+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 224 GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 12223445667789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=311.00 Aligned_cols=203 Identities=30% Similarity=0.438 Sum_probs=173.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-----hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
++|...+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999964 689999998764321 123568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999999654 35889999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.... ........++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 157 ICSS----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred cccc----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 2100 11112345788999999999989999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.96 Aligned_cols=249 Identities=29% Similarity=0.486 Sum_probs=200.4
Q ss_pred ceEeeeCceEEEEEEeC--C--CcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP--D--GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~--~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
++||+|+||.||+|.+. + +..||+|.+..... ...+++.+|+++++.+.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999853 2 26899999886544 34567899999999999999999999876 4568999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++.... .+++..+..++.|++.||+|||..+ ++|+||||+||++++++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc---
Confidence 99999997644 6899999999999999999999998 999999999999999999999999999865432210
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (707)
........++..|+|||.+.+..++.++|||||||++|||++ |..||...... +..... . .......+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~-~--------~~~~~~~~ 220 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAML-E--------SGERLPRP 220 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHH-H--------cCCcCCCC
Confidence 001111224568999999999999999999999999999998 99999654431 111111 1 11122345
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 615 ~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
..++..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 55677899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.10 Aligned_cols=250 Identities=27% Similarity=0.424 Sum_probs=203.4
Q ss_pred ceEeeeCceEEEEEEeCC--C--cEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILPD--G--TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|++++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3699999987665 456789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
++|.+++.......+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 153 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--- 153 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---
Confidence 99999997754356899999999999999999999998 999999999999999999999999999876432211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (707)
........++..|+|||++.+..++.++|||||||++|||++ |+.||...... +....... .......+
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~--------~~~~~~~~ 223 (257)
T cd05040 154 -YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-QILKKIDK--------EGERLERP 223 (257)
T ss_pred -eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh--------cCCcCCCC
Confidence 011123456789999999999999999999999999999998 99999644332 11111111 11112234
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 615 ~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 455678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=308.80 Aligned_cols=246 Identities=26% Similarity=0.434 Sum_probs=210.3
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
-|++.++||+|+||+||+|.++ .|.+||||.+.... +.+++..|+.+|++.+.+++|++||.|......|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3667899999999999999975 79999999987533 45789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
.|+..+.++.+ +.+++++++..+..+.++||+|||... -||||||+.|||++-+|.+|++|||.|-.+...
T Consensus 112 AGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT----- 182 (502)
T KOG0574|consen 112 AGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT----- 182 (502)
T ss_pred CCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh-----
Confidence 99999999764 457999999999999999999999988 799999999999999999999999999765421
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC--
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS-- 612 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 612 (707)
-.....+.||+-|||||++..-.|+.++||||+|++..||..|++||.+-.. ...++-+.....+.
T Consensus 183 --MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP----------MRAIFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 183 --MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP----------MRAIFMIPTKPPPTFK 250 (502)
T ss_pred --HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc----------cceeEeccCCCCCCCC
Confidence 2234567899999999999999999999999999999999999999975443 22222222222222
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
-|+.++.++.+++..|+-+.|++|-|+.++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 46788899999999999999999999877654
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.45 Aligned_cols=254 Identities=31% Similarity=0.503 Sum_probs=197.5
Q ss_pred ceEeeeCceEEEEEEeC----CCcEEEEEEeccC-ChhhHHHHHHHHHHHHccCCCcceeEEEEEE-eCCeEEEEEecCC
Q 005224 381 TQIGQGGYGKVYKGILP----DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQMLVYEFMS 454 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~E~~~ 454 (707)
+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998643 2334567889999999999999999999875 4556899999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+|+|.+++.... ....+..+..++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~- 155 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS- 155 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee-
Confidence 999999997543 34677888999999999999999988 9999999999999999999999999997553221100
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcC-CCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG-MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
........++..|+|||++.+..++.++|||||||++|||++| ..||... +....... +..+.....
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~---------~~~~~~~~~ 223 (262)
T cd05058 156 --VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVY---------LLQGRRLLQ 223 (262)
T ss_pred --ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHH---------HhcCCCCCC
Confidence 0111233456789999999999999999999999999999995 4555433 22222111 112222223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
+...+..+.+++..||+.+|++||++.++++.++++..
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 44456789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.92 Aligned_cols=201 Identities=26% Similarity=0.419 Sum_probs=175.6
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|+||.||++... +|+.||+|.+.... ....+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999964 78999999986432 23346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 99999999997655556899999999999999999999998 9999999999999999999999999997654321
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......|+..|+|||+..+..++.++|||||||+++||++|+.||...
T Consensus 156 -----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 156 -----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred -----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 1112345788999999999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=321.11 Aligned_cols=266 Identities=25% Similarity=0.469 Sum_probs=211.0
Q ss_pred HHHHhcCCCccceEeeeCceEEEEEEeC--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHcc-CCCcceeEEEE
Q 005224 370 MALATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGY 439 (707)
Q Consensus 370 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~ 439 (707)
++....+|++.+.||+|+||.||+|... .+..||+|.+.... ....+++.+|+++++++ +|+||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3444567899999999999999999742 12368999887533 23346789999999999 79999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 005224 440 CDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 505 (707)
Q Consensus 440 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 505 (707)
|...+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 999999999999999999999997532 235788999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCC
Q 005224 506 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 584 (707)
Q Consensus 506 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~ 584 (707)
||++++++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred eEEEcCCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999765432110 01112234567999999999999999999999999999998 888886
Q ss_pred CCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 585 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
.... .+..... ..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 239 ~~~~-~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 239 GIPV-EELFKLL---------KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CCCH-HHHHHHH---------HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 4332 2221111 111222334456678999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.74 Aligned_cols=259 Identities=28% Similarity=0.472 Sum_probs=205.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CC---cEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
..|++.+.||+|+||.||+|.+. ++ ..||||.+.... ....++|..|+.+++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34778899999999999999964 33 369999987642 33356899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999997643 35899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
...... ........+..|+|||++.+..++.++|||||||++||+++ |..||...... +..... . ..
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~i-~--------~~ 227 (269)
T cd05065 160 TSDPTY--TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAI-E--------QD 227 (269)
T ss_pred cccccc--ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHHH-H--------cC
Confidence 211000 00011112457999999999999999999999999999987 99999654332 111111 0 11
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.....+.+++..+.+++..||+.+|++||++.+++..|+.+
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11223455677889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.53 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=202.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeCC---------------CcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPD---------------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLV 437 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~ 437 (707)
.++|++.+.||+|+||.||++...+ ...||+|.+.... ......+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578899999999999999987532 2358999987643 23345789999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcC----------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 005224 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 507 (707)
Q Consensus 438 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 507 (707)
+++...+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999996532 124788999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc--CCCCCCC
Q 005224 508 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPISH 585 (707)
Q Consensus 508 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt--G~~pf~~ 585 (707)
++++++.+||+|||++........ ........++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999976532211 111223345678999999999999999999999999999998 5667754
Q ss_pred Cchh--HHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 586 GKNI--VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 586 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
.... .......+.. .........+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 236 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRN-----QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhh-----ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 3221 1111110100 0001111123345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=310.75 Aligned_cols=205 Identities=27% Similarity=0.400 Sum_probs=175.1
Q ss_pred HHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 370 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 370 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
++.+++++.....||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4556777777889999999999999964 678999999887666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCc--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeeeccccc
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRL 525 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~ 525 (707)
|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999997642 234 78889999999999999999998 999999999999986 67999999999875
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccC--CCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
....+ .......|+..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 159 LAGIN-------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred cccCC-------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 53221 111223578899999998764 378899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=311.07 Aligned_cols=271 Identities=23% Similarity=0.324 Sum_probs=219.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHH---HHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~---~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|+.+++||+|.||.|.+++-+ +++.+|+|++++.......+ -..|-++|+..+||.+..+.-.|+..+..|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 457888999999999999999955 79999999998765444333 35688999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||..||.|.-+|.+ ...+++...+.+-..|..||.|||+.+ ||.||||.+|.|+|.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--- 318 (516)
T ss_pred EEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc---
Confidence 999999999988855 345899999999999999999999998 999999999999999999999999999742
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
+.........+||+.|.|||++....|..++|.|.+||+||||++|+.||...+.
T Consensus 319 ----I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------------------- 373 (516)
T KOG0690|consen 319 ----IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------------------- 373 (516)
T ss_pred ----ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---------------------
Confidence 2234566788999999999999999999999999999999999999999964332
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCC-----CCcCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSSMLKH 684 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s-----a~e~L~H 684 (707)
+.+.+++..|--.-| ...++++..++..+|..||.+|+. |.|+.+|
T Consensus 374 ---------~kLFeLIl~ed~kFP--------------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 374 ---------EKLFELILMEDLKFP--------------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ---------hHHHHHHHhhhccCC--------------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 334445444322222 122344456777888888888864 5788899
Q ss_pred CCCCCCCCCCCcccccCcccCC
Q 005224 685 PYVSSDVSGSNLVSGVIPTITP 706 (707)
Q Consensus 685 p~f~~~~~~~~~~~~~~~~~~~ 706 (707)
+||.+..+..-.--.+.||++|
T Consensus 425 ~FF~~v~W~~~~~Kki~PPfKP 446 (516)
T KOG0690|consen 425 RFFASVDWEATYRKKIEPPFKP 446 (516)
T ss_pred hhhccCCHHHHHHhccCCCCCC
Confidence 9998887754443445566655
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.34 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=204.2
Q ss_pred hcCCCccceEeeeCceEEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC-C
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE-G 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 444 (707)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... .....+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46789999999999999999973 3578999999975432 2345788999999999 689999999988654 4
Q ss_pred eEEEEEecCCCCCHHHHHhhcC----------------------------------------------------------
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKS---------------------------------------------------------- 466 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 466 (707)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986431
Q ss_pred -------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccce
Q 005224 467 -------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539 (707)
Q Consensus 467 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 539 (707)
...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++........ ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~ 237 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVR 237 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc-----hhh
Confidence 123678888999999999999999998 99999999999999999999999999976532110 011
Q ss_pred ecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 005224 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618 (707)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (707)
.....++..|+|||++.+..++.++|||||||++|||++ |..||......... .... ..+.....+....
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~--------~~~~~~~~~~~~~ 308 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CRRL--------KEGTRMRAPDYTT 308 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-HHHH--------hccCCCCCCCCCC
Confidence 122345678999999999999999999999999999997 88998653321111 1111 1111122233344
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 619 EKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 619 ~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
..+.+++..||+.+|++||++.++++.|+.+.+
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.78 Aligned_cols=251 Identities=31% Similarity=0.510 Sum_probs=204.0
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
.+|+..+.||+|+||.||+|.+.+++.+|+|.+.... .....+.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4678889999999999999998778899999887533 234578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+++|.+++.... ..+++..++.++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---- 154 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---- 154 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc----
Confidence 999999987543 35889999999999999999999998 9999999999999999999999999987553221
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
........++.+|+|||++.+..++.++||||||+++|||++ |+.||..... ....... ..+.....
T Consensus 155 --~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~---------~~~~~~~~ 222 (256)
T cd05112 155 --YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETI---------NAGFRLYK 222 (256)
T ss_pred --ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHH---------hCCCCCCC
Confidence 011122234678999999999999999999999999999998 9999865432 1111111 01111112
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 333457899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.68 Aligned_cols=281 Identities=24% Similarity=0.355 Sum_probs=204.7
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHccC-CCcceeEEEEEEeCCe-----
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGE----- 445 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~----- 445 (707)
++|++.+.||+|+||.||+|... +++.||+|........ ....+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999965 7899999987653222 2357888999999995 6999999999977665
Q ss_pred EEEEEecCCCCCHHHHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeeec
Q 005224 446 QMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFG 521 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFG 521 (707)
.++||||+++ +|.+++.... ...+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8988886532 246899999999999999999999998 999999999999998 8999999999
Q ss_pred ccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcc
Q 005224 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 600 (707)
Q Consensus 522 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~ 600 (707)
+++...... .......+++.|+|||++.+ ..++.++|||||||++|||++|..||............ ...
T Consensus 157 ~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~- 227 (295)
T cd07837 157 LGRAFSIPV-------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI-FKL- 227 (295)
T ss_pred cceecCCCc-------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HHH-
Confidence 987553221 11122346788999999875 56789999999999999999999999754443222111 100
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
+. ..+........++.... ..|..+|. .+....+..+....+||.+||..||++||+++|
T Consensus 228 -----~~----~~~~~~~~~~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 228 -----LG----TPTEQVWPGVSKLRDWH--EFPQWKPQ---------DLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred -----hC----CCChhhCcchhhccchh--hcCcccch---------hHHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 00 00000000000000000 00111111 111223445566678999999999999999999
Q ss_pred CCCCCCCC
Q 005224 681 MLKHPYVS 688 (707)
Q Consensus 681 ~L~Hp~f~ 688 (707)
+|.||||.
T Consensus 288 il~~~~~~ 295 (295)
T cd07837 288 ALTHPYFD 295 (295)
T ss_pred HhcCCCcC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=326.92 Aligned_cols=243 Identities=30% Similarity=0.487 Sum_probs=205.3
Q ss_pred CCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhh---HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.|..++.||.|+||.||-|.. ++.++||||++....... -.++..|++.|++++|||++.+.|+|-.+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355578899999999999995 578999999998654433 3578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|| -|+-.|++.-. +.++.+..+..|+.+.++||+|||+.+ .||||||+.|||+++.|.||++|||.|....+
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 99 56989988654 456999999999999999999999999 99999999999999999999999999987543
Q ss_pred CCccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
....+||+.|||||++. .+.|+-++||||+|++..||.-.++|++...-.. .++.+...
T Consensus 179 --------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS----------ALYHIAQN 240 (948)
T KOG0577|consen 179 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------ALYHIAQN 240 (948)
T ss_pred --------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH----------HHHHHHhc
Confidence 24568999999999986 3789999999999999999999999987544322 22333333
Q ss_pred CCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 609 NMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 609 ~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
.-+. ...++++.+..++..|+++-|.+|||..++++
T Consensus 241 esPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3333 24578889999999999999999999887654
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=308.40 Aligned_cols=200 Identities=27% Similarity=0.408 Sum_probs=172.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEe-CCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~E 451 (707)
+|++.+.||+|++|.||++..+ +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999965 67899999986532 2334578899999999999999999998764 446799999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.+++.......+++..++.++.+++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999998755566899999999999999999999998 9999999999999999999999999997653321
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
.......+++.|+|||++.+..++.++|||||||+++||++|+.||..
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 204 (257)
T cd08223 157 ------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204 (257)
T ss_pred ------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 112234578899999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.96 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=198.3
Q ss_pred CCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|+||.||.+.. ++++.|++|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999985 468999999876532 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.......+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999997765566899999999999999999999998 99999999999999999999999999976543221
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
......++..|+|||++.+..++.++||||||+++|||++|..||..... .+.... +..+....
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-~~~~~~---------~~~~~~~~ 220 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-LNLVVK---------IVQGNYTP 220 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-HHHHHH---------HHcCCCCC
Confidence 12234578999999999988899999999999999999999999865332 111111 11122222
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
.+...+..+.+++.+|++.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 23344455666666666666666666666554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=332.68 Aligned_cols=250 Identities=26% Similarity=0.462 Sum_probs=197.1
Q ss_pred cceEeeeCceEEEEEEeC-CCcEEEEEEec---c-CChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe--EEEEEec
Q 005224 380 STQIGQGGYGKVYKGILP-DGTVVAVKRAQ---E-GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE--QMLVYEF 452 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~---~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lV~E~ 452 (707)
.++||+|+|-+||+|.+. +|-.||---++ . ......++|..|+.+|+.|+|+||+++|+++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 567999999999999975 57677632222 1 123344789999999999999999999999976654 7889999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeeecccccCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~ 531 (707)
|..|+|..|+++.++ .+...++.+++||++||.|||++ .|||||||||-+||+|+. .|.|||+|+|+|.......
T Consensus 125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 999999999987654 78889999999999999999997 589999999999999974 5899999999998875322
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
...+.|||.|||||... ..|++.+||||||+.|+||+|+..||..-.+..+-++.. ..+..+
T Consensus 201 --------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV---------~SGiKP 262 (632)
T KOG0584|consen 201 --------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV---------TSGIKP 262 (632)
T ss_pred --------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH---------HcCCCH
Confidence 33478999999999987 889999999999999999999999997655543322221 111110
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
. . | ..-.+++..+||.+||.. .++|+||.|+|.||||..+
T Consensus 263 ~----s----------------------------l------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 263 A----A----------------------------L------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred H----H----------------------------h------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 0 0 0 011244455677778887 8888999999999999886
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=315.42 Aligned_cols=263 Identities=28% Similarity=0.430 Sum_probs=206.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeCC-----------------CcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCccee
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPD-----------------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVS 435 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 435 (707)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999998542 2468999987643 234567899999999999999999
Q ss_pred EEEEEEeCCeEEEEEecCCCCCHHHHHhhcC---------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 005224 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 506 (707)
Q Consensus 436 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 506 (707)
+++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999997643 226899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc--CCCCCC
Q 005224 507 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPIS 584 (707)
Q Consensus 507 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt--G~~pf~ 584 (707)
|++++++.++|+|||+++.....+. ........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY-----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999999999999976543221 111223446788999999998899999999999999999998 667776
Q ss_pred CCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 585 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
....... ...... .....-.......+..++.++.+++.+|++.+|.+||++.++++.|+
T Consensus 236 ~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 236 HLTDQQV-IENAGH--FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CcChHHH-HHHHHh--ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 4332111 111100 00000000111223345578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.78 Aligned_cols=249 Identities=30% Similarity=0.485 Sum_probs=198.3
Q ss_pred ceEeeeCceEEEEEEeC-CCc--EEEEEEeccCC-hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||.||+|.+. ++. .+|+|.+.... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999975 443 47888887533 33456788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeec
Q 005224 456 GTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 521 (707)
Q Consensus 456 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 521 (707)
|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 124789999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcc
Q 005224 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 600 (707)
Q Consensus 522 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~ 600 (707)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||..... .+.....
T Consensus 158 l~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~---- 224 (270)
T cd05047 158 LSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKL---- 224 (270)
T ss_pred Cccccchh--------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHHHHHH----
Confidence 98632210 01111223567999999998999999999999999999997 9999864332 1111111
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
..+.....+..+...+.+++.+||+.+|.+||++.+++..|+.+.
T Consensus 225 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 -----PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111112233445677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.75 Aligned_cols=267 Identities=26% Similarity=0.364 Sum_probs=205.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356788899999999999999964 68999999876543 2345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
|+++++|.+++... ..+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999998653 358999999999999999999997 46 999999999999999999999999998654221
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
......|+..|+|||++.+..++.++|||||||++||+++|+.||.......+
T Consensus 158 --------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~------------------- 210 (284)
T cd06620 158 --------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD------------------- 210 (284)
T ss_pred --------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh-------------------
Confidence 11234688999999999888999999999999999999999999974332110
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
.......+.+.....+...+..-++. + ......+|+.+|+..||++|||++|+++||||-..
T Consensus 211 ---~~~~~~~~~~~~~~~~~~~~~~~~~~-~--------------~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 211 ---GQDDPMGILDLLQQIVQEPPPRLPSS-D--------------FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ---hhhhhhHHHHHHHHHhhccCCCCCch-h--------------cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00111112222222222221111111 0 11123467788888888888888888888888554
Q ss_pred C
Q 005224 691 V 691 (707)
Q Consensus 691 ~ 691 (707)
.
T Consensus 273 ~ 273 (284)
T cd06620 273 L 273 (284)
T ss_pred c
Confidence 4
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.33 Aligned_cols=267 Identities=25% Similarity=0.414 Sum_probs=205.4
Q ss_pred cCCCccceEeeeCceEEEEEEe-----CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 446 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 446 (707)
..|++.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+++++.++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999984 257889999987543 33346789999999999999999999998775 568
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999996543 35899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHH----HHhh-ccc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN----IAYQ-SSM 601 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~----~~~~-~~~ 601 (707)
...... ........++..|+|||++.+..++.++|||||||++|||++++.|............ .... ...
T Consensus 160 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 160 ETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 432210 1112234567789999999988999999999999999999998766532111000000 0000 000
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
......+...+.+..++..+.+++.+|++.+|++||++.++++.++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 001111222223445678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=321.34 Aligned_cols=276 Identities=26% Similarity=0.338 Sum_probs=208.7
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCC----
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG---- 444 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 444 (707)
...++|++.+.||+|+||.||+|..+ +|+.||+|++..... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 689999999875332 22356788999999999999999999986654
Q ss_pred ------eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 005224 445 ------EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 518 (707)
Q Consensus 445 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 518 (707)
..++|+||+++ ++.+.+... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 777777554 346899999999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHh
Q 005224 519 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597 (707)
Q Consensus 519 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~ 597 (707)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 159 dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-------- 224 (302)
T cd07864 159 DFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-------- 224 (302)
T ss_pred cccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--------
Confidence 9999986543221 11122345778999998865 45788999999999999999999998643321
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH---------HHHhhhcCCCCCCCCCccccCCC
Q 005224 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE---------LESIWNMMPESDTKTPEFINSEH 668 (707)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~---------L~~~~~~~~~~~~~~~dll~~~L 668 (707)
..+..+...|....+..+|.+.+.... ................+++.+||
T Consensus 225 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 283 (302)
T cd07864 225 ---------------------AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHML 283 (302)
T ss_pred ---------------------HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHc
Confidence 112222233333333333333221100 00111122223455678999999
Q ss_pred CCCCCCCCCCCcCCCCCCC
Q 005224 669 TSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 669 ~~dP~~R~sa~e~L~Hp~f 687 (707)
..||++|||+++++.||||
T Consensus 284 ~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 284 TLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cCChhhCCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=314.85 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=203.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-----------------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCccee
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-----------------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVS 435 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 435 (707)
.++|++.++||+|+||.||++... ++..||+|++.... ......+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999998532 24579999987543 233567899999999999999999
Q ss_pred EEEEEEeCCeEEEEEecCCCCCHHHHHhhcCC---------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 005224 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK---------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 506 (707)
Q Consensus 436 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 506 (707)
+++++...+..++||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999976321 24778899999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc--CCCCCC
Q 005224 507 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPIS 584 (707)
Q Consensus 507 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt--G~~pf~ 584 (707)
|++++++.++|+|||+++....... ........++..|+|||+..++.++.++|||||||++|||++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999976533211 011122334678999999988899999999999999999998 677886
Q ss_pred CCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 585 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
..... +...... ..............+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 236 ~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 236 QLSDE-QVIENTG--EFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccChH-HHHHHHH--HHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 43321 1111000 000000001111223446678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=308.64 Aligned_cols=248 Identities=35% Similarity=0.545 Sum_probs=206.2
Q ss_pred ceEeeeCceEEEEEEeCC----CcEEEEEEeccCChhh-HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||.||+|.... +..||+|.+....... .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 7899999998654433 57889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC-------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 456 GTLRDQLSAKS-------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 456 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642 356999999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
... ........++..|+|||.+....++.++||||+||++|||++ |..||...... +... .+..
T Consensus 158 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~---------~~~~ 222 (262)
T cd00192 158 DDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-EVLE---------YLRK 222 (262)
T ss_pred ccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-HHHH---------HHHc
Confidence 321 112233456889999999998899999999999999999999 69998765321 1111 1112
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
+.....+..++..+.+++.+|++.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 233345566678899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.48 Aligned_cols=257 Identities=21% Similarity=0.337 Sum_probs=212.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh--HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.-|+..+.||+|.|..|-+|++- +|+.||||++.+..... ...+.+|++.|+.++|||||++|.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777889999999999999854 89999999998754433 4578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-cCCCcEEEeeecccccCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-DHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kl~DFGla~~~~~~~ 530 (707)
.=++|+|+++|-++. ..+.+....+++.||+.|+.|+|+.+ +|||||||+||.+ ..-|-+|++|||++..+.+
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-- 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-- 171 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence 999999999997653 45999999999999999999999999 9999999999876 5678999999999976653
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCC-chhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.......+|+..|-|||++.+..|+. ++||||+|||||.|++|+.||....+..
T Consensus 172 ------G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE------------------- 226 (864)
T KOG4717|consen 172 ------GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE------------------- 226 (864)
T ss_pred ------cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------------
Confidence 44566789999999999999988875 6899999999999999999997654421
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
-...++.|--.-| ...+++..|||.+||+-||.+|.|.+|+..|+|+..
T Consensus 227 -----------TLTmImDCKYtvP--------------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 227 -----------TLTMIMDCKYTVP--------------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred -----------hhhhhhcccccCc--------------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 1122333432222 112234457888999999999999999999999977
Q ss_pred CCCC
Q 005224 690 DVSG 693 (707)
Q Consensus 690 ~~~~ 693 (707)
...+
T Consensus 276 ~D~~ 279 (864)
T KOG4717|consen 276 GDRG 279 (864)
T ss_pred CCCC
Confidence 6653
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.14 Aligned_cols=239 Identities=21% Similarity=0.370 Sum_probs=189.6
Q ss_pred ceEeeeCceEEEEEEeCC-------------CcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 381 TQIGQGGYGKVYKGILPD-------------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
+.||+|+||.||+|.+.+ ...||+|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887655444567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-------EEEeee
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-------AKVADF 520 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-------~kl~DF 520 (707)
+||||+++|+|..++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999886543 45899999999999999999999998 999999999999987664 899999
Q ss_pred cccccCCCCCCCCccccceecccccCCCccchhhhc-cCCCCCchhhHHHHHHHHHHH-cCCCCCCCCchhHHHHHHHhh
Q 005224 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELL-TGMQPISHGKNIVREVNIAYQ 598 (707)
Q Consensus 521 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvll~ell-tG~~pf~~~~~~~~~~~~~~~ 598 (707)
|++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||...... +. .....
T Consensus 157 g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~-~~~~~ 223 (262)
T cd05077 157 GIPITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-EK-ERFYE 223 (262)
T ss_pred CCCccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-HH-HHHHh
Confidence 998654221 1235778899999987 467899999999999999998 588877543221 11 11000
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 599 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
... .........+.+++.+||+.+|.+||++.++++.+
T Consensus 224 ---------~~~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 ---------GQC-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---------cCc-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 11122346788999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.90 Aligned_cols=254 Identities=21% Similarity=0.316 Sum_probs=195.3
Q ss_pred HHHHHhcCCCccceE--eeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCC
Q 005224 369 EMALATNNFNSSTQI--GQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 444 (707)
Q Consensus 369 ~l~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 444 (707)
+.....++|++.+.+ |+|+||.||++..+ +++.+|+|.......... |+.....+ +|+||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344445677777776 99999999999964 788999999865322211 22222222 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeeeccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLS 523 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla 523 (707)
..++||||+++++|.+++.... .+++..++.++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999996643 6999999999999999999999998 99999999999999998 9999999998
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
+..... ....++..|+|||++.+..++.++|||||||++|||++|+.||.......-
T Consensus 158 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~------------ 214 (267)
T PHA03390 158 KIIGTP-----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL------------ 214 (267)
T ss_pred eecCCC-----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh------------
Confidence 755321 123578899999999999999999999999999999999999963322100
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCC-CcCC
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS-SSML 682 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa-~e~L 682 (707)
....+. .+....+ ...+..+..+.+||.+||+.+|++|+++ +|+|
T Consensus 215 -------------~~~~~~----~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 215 -------------DLESLL----KRQQKKL-----------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred -------------hHHHHH----HhhcccC-----------------CcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 000000 0000000 0011234455689999999999999975 9999
Q ss_pred CCCCCCC
Q 005224 683 KHPYVSS 689 (707)
Q Consensus 683 ~Hp~f~~ 689 (707)
+||||..
T Consensus 261 ~h~~~~~ 267 (267)
T PHA03390 261 KHPFLKI 267 (267)
T ss_pred cCCcccC
Confidence 9999963
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=307.37 Aligned_cols=205 Identities=28% Similarity=0.505 Sum_probs=174.2
Q ss_pred CCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCCh------hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
+|+..+.||+|+||+||+|...+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998864321 1234688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999654 35789999999999999999999998 999999999999999999999999998765321
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
..... .........|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 156 GLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred ccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 11100 011123345889999999999989999999999999999999999999643
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=311.05 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=171.9
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567888999999999999975 5788999998765555567789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
++|..++... ..++++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~----- 157 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----- 157 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-----
Confidence 9999988653 346899999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 1122345889999999984 456788999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=308.61 Aligned_cols=205 Identities=27% Similarity=0.481 Sum_probs=173.0
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---------hHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
+|.+...||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999964 6889999988643221 12467889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999654 35889999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
......... .........|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 156 LEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 642211100 011122345788999999999989999999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.03 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=200.8
Q ss_pred cceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCH
Q 005224 380 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999964 7899999998765545566788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccc
Q 005224 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538 (707)
Q Consensus 459 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 538 (707)
.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-------~ 172 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-------P 172 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-------c
Confidence 998754 34899999999999999999999998 9999999999999999999999999987543221 1
Q ss_pred eecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 005224 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618 (707)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (707)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~----------------------- 228 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKR----------------------- 228 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-----------------------
Confidence 12335688999999999998999999999999999999999999964332111 000
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCCCCC
Q 005224 619 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSN 695 (707)
Q Consensus 619 ~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~~~ 695 (707)
+......... ..........+|+.+|++.+|++||+++|+++||||......+.
T Consensus 229 ------~~~~~~~~~~-----------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 229 ------LRDSPPPKLK-----------------NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred ------HhccCCCCcc-----------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence 0000000000 00111222346788888888888888888888888876554444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=303.18 Aligned_cols=286 Identities=20% Similarity=0.330 Sum_probs=216.2
Q ss_pred cHHHHHHHhcCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC
Q 005224 366 TYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 443 (707)
Q Consensus 366 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 443 (707)
+++|+...+ .+.||+|+|+.|-.++ +.+|..+|||++.+.......++.+|++++.+. .|+||+.++++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 467777776 5789999999999998 679999999999887667788999999999998 599999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEeee
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADF 520 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DF 520 (707)
...|||||-|.||+|...|+++ ..+++.++.++..+|+.||.|||.++ |.|||+||+|||-.+.. -+||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999999654 45999999999999999999999999 99999999999996544 4899999
Q ss_pred cccccCCCCCCCCccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005224 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 595 (707)
Q Consensus 521 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~ 595 (707)
.+..-..................+|+..|||||+.. ...|+.+.|.||+|||+|-|++|..||...-...-
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---- 299 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---- 299 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----
Confidence 887644322211122233445678999999999874 35688999999999999999999999964221000
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCC
Q 005224 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 675 (707)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R 675 (707)
.| .+++.-..|-..+++-+..=--.-|++- ....+....|++..+|..|+..|
T Consensus 300 GW-----------drGe~Cr~CQ~~LFesIQEGkYeFPdkd----------------WahIS~eakdlisnLlvrda~~r 352 (463)
T KOG0607|consen 300 GW-----------DRGEVCRVCQNKLFESIQEGKYEFPDKD----------------WAHISSEAKDLISNLLVRDAKQR 352 (463)
T ss_pred Cc-----------cCCCccHHHHHHHHHHHhccCCcCChhh----------------hHHhhHHHHHHHHHHHhccHHhh
Confidence 00 0111222333333332221111111110 01112344588999999999999
Q ss_pred CCCCcCCCCCCCCCCCC
Q 005224 676 PSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 676 ~sa~e~L~Hp~f~~~~~ 692 (707)
.+|.+.++|||+.+-..
T Consensus 353 lsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 353 LSAAQVLNHPWVQRCAP 369 (463)
T ss_pred hhhhhccCCccccccch
Confidence 99999999999987544
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.63 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=198.5
Q ss_pred EeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCH
Q 005224 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 383 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
||+|+||+||+|... +|+.||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 789999999865322 2244567899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccc
Q 005224 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538 (707)
Q Consensus 459 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 538 (707)
.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+...... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--------~ 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--------K 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--------C
Confidence 99997766567999999999999999999999998 999999999999999999999999998765321 1
Q ss_pred eecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 005224 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618 (707)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (707)
......++..|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------------------- 203 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------------------------- 203 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--------------------------
Confidence 112345778999999999888999999999999999999999999643221000
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC-----CCCcCCCCCCCCCCCC
Q 005224 619 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKHPYVSSDVS 692 (707)
Q Consensus 619 ~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~Hp~f~~~~~ 692 (707)
..+. ..... .+.. .....++...++|.+||+.||++|+ ++.++++||||..-.+
T Consensus 204 ~~~~---~~~~~-~~~~----------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 204 EELK---RRTLE-MAVE----------------YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred HHHH---hcccc-cccc----------------CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 0000 00000 0000 0111233445788888889999999 6777999999976555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.60 Aligned_cols=278 Identities=26% Similarity=0.404 Sum_probs=205.6
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
|++.+.||.|++|.||+|... +|+.||+|++..... ...+.+.+|+++++.++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 667899999999999999965 799999999875432 22356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
+ ++|.+++.......+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--- 153 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--- 153 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc---
Confidence 5 69999997665456899999999999999999999988 9999999999999999999999999997553221
Q ss_pred ccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||........... .... ...
T Consensus 154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~----------~~~ 218 (283)
T cd07835 154 ----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR-IFRT----------LGT 218 (283)
T ss_pred ----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHH----------hCC
Confidence 111223467899999988764 578899999999999999999999976544222111 1100 000
Q ss_pred CChHHHHHHHHHHHHhcccCCC-CCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 613 YPSECVEKFIKLALKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~-~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
...........+.... ..-+. ..+... ...+..+....+++.+|+..||++|||++|+++||||
T Consensus 219 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 219 PDEDVWPGVTSLPDYK-PTFPKWARQDLS----------KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred CChHHhhhhhhchhhh-hhcccccccchh----------hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0011100111100000 00000 011111 1123334456689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.87 Aligned_cols=280 Identities=25% Similarity=0.365 Sum_probs=204.8
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeEEEEEe
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVYE 451 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~E 451 (707)
|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667899999999999999975 58999999998653 23345788999999999999999999999888 89999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 48988886542 46899999999999999999999998 99999999999999999999999999986643321
Q ss_pred CCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .......... .
T Consensus 156 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~----------~ 218 (287)
T cd07840 156 ------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFEL----------C 218 (287)
T ss_pred ------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHH----------h
Confidence 11223356788999998765 4678999999999999999999999975443 1111111100 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC-CCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~-~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
..........+.++ +.......++..... +... ... ......+++.+|+..+|++||+++++++||||
T Consensus 219 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 219 GSPTDENWPGVSKL---PWFENLKPKKPYKRR---LREF---FKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred CCCchhhccccccc---hhhhhccccccchhH---HHHH---hcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000000000 001111111111111 1111 111 24556789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=318.58 Aligned_cols=279 Identities=25% Similarity=0.380 Sum_probs=206.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999975 68899999886532 2234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|++++.+..+... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9988666665533 344899999999999999999999998 99999999999999999999999999987643321
Q ss_pred CCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||...... +....... . .
T Consensus 156 ------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~------~----~ 218 (288)
T cd07833 156 ------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQK------C----L 218 (288)
T ss_pred ------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH------H----h
Confidence 122334578899999999887 8899999999999999999999998654332 11111000 0 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCC----CCCCHHHHHHHHHHhhhcCCC-CCCCCCccccCCCCCCCCCCCCCCcCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETD----ARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHP 685 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~----~RPt~~~v~~~L~~~~~~~~~-~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 685 (707)
...+...... +..++. +.+...+. ..+...++. ......+|+.+||..+|++|||++++++||
T Consensus 219 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 286 (288)
T cd07833 219 GPLPPSHQEL--------FSSNPRFAGVAFPEPSQP----ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286 (288)
T ss_pred CCCCHHHhhh--------cccCccccccccCCCCCc----HHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCC
Confidence 0000000000 000000 00111000 011112222 256677899999999999999999999999
Q ss_pred CC
Q 005224 686 YV 687 (707)
Q Consensus 686 ~f 687 (707)
||
T Consensus 287 ~f 288 (288)
T cd07833 287 YF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=349.10 Aligned_cols=276 Identities=24% Similarity=0.296 Sum_probs=221.8
Q ss_pred HHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEe
Q 005224 367 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442 (707)
Q Consensus 367 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 442 (707)
..++....++|.+.++||+|+||.|..++.+ ++++||.|++.+..+- ...-|..|-.+|..-+.+-|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4566777889999999999999999999975 6899999999874332 23568889999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
+.+.|+|||||+||+|-.++.... .++++.++.++..|.-||.-||+.| +|||||||+|||+|..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999997655 6999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhcc-----CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHh
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~ 597 (707)
+-.+..++ .......+|||.|++||++.. +.|+..+|+||+||++|||+.|..||.... ++
T Consensus 222 Clkm~~dG------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-lv------- 287 (1317)
T KOG0612|consen 222 CLKMDADG------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-LV------- 287 (1317)
T ss_pred HHhcCCCC------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-HH-------
Confidence 87765433 344566789999999999963 578999999999999999999999996322 11
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHH--hcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCC
Q 005224 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALK--CCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 675 (707)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R 675 (707)
+...+++.. ++.. | ...+.+.++.|||+++++ +|+.|
T Consensus 288 ---------------------eTY~KIm~hk~~l~F-----P--------------~~~~VSeeakdLI~~ll~-~~e~R 326 (1317)
T KOG0612|consen 288 ---------------------ETYGKIMNHKESLSF-----P--------------DETDVSEEAKDLIEALLC-DREVR 326 (1317)
T ss_pred ---------------------HHHHHHhchhhhcCC-----C--------------cccccCHHHHHHHHHHhc-Chhhh
Confidence 112222221 1111 1 011234455577777666 48899
Q ss_pred CC---CCcCCCCCCCCCCCCCCCcccccCccc
Q 005224 676 PS---SSSMLKHPYVSSDVSGSNLVSGVIPTI 704 (707)
Q Consensus 676 ~s---a~e~L~Hp~f~~~~~~~~~~~~~~~~~ 704 (707)
+. ++++-.||||.++.+ +.+...-||+
T Consensus 327 Lgrngiedik~HpFF~g~~W--~~iR~~~pP~ 356 (1317)
T KOG0612|consen 327 LGRNGIEDIKNHPFFEGIDW--DNIRESVPPV 356 (1317)
T ss_pred cccccHHHHHhCccccCCCh--hhhhhcCCCC
Confidence 88 999999999999999 4444433444
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=314.81 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=203.4
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
+|++.+.||.|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788999999999999999975 689999999875332 335688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+.+++|.+++... .++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999654 46899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------------- 206 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--------------------- 206 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---------------------
Confidence 1233457889999999999889999999999999999999999997543210
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCC--CcCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS--SSMLKHPYV 687 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa--~e~L~Hp~f 687 (707)
...+.+.........|. .......++|.+|+..||.+|+++ +|+++||||
T Consensus 207 ------~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 207 ------RDQIRAKQETADVLYPA--------------------TWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ------HHHHHHHhccccccCcc--------------------cCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 00111111100001111 112334468888999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=309.65 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=207.0
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCc----EEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.+|+..+.||+|+||.||+|.++ +|+ .||+|....... ....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788899999999999999964 333 689998876543 345678899999999999999999999987 78899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999997643 34899999999999999999999988 99999999999999999999999999986643
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
... ........++..|+|||.+....++.++|||||||++||+++ |+.||..... .+. ... +..
T Consensus 162 ~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~-~~~--------~~~ 226 (279)
T cd05057 162 DEK-----EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEI-PDL--------LEK 226 (279)
T ss_pred ccc-----ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-HHH-HHH--------HhC
Confidence 211 011112224568999999998899999999999999999999 9999865432 111 111 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
+.....+..+...+.+++.+||..+|..||++.++++.+.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 227 GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22223344456778999999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=313.86 Aligned_cols=259 Identities=23% Similarity=0.377 Sum_probs=206.0
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788999999999999999996 479999999997655555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 99999999854 34789999999999999999999998 9999999999999999999999999987653321
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC--
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG-- 611 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 611 (707)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||......... .........
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~----------~~~~~~~~~~~ 235 (297)
T cd06656 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----------YLIATNGTPEL 235 (297)
T ss_pred ----cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe----------eeeccCCCCCC
Confidence 1122345788999999999999999999999999999999999999643321100 000000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
..+.. ......+|+.+|+..+|++||+++++++||||..-.
T Consensus 236 ~~~~~---------------------------------------~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 236 QNPER---------------------------------------LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred CCccc---------------------------------------cCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 00111 111223577788888888888899999999987665
Q ss_pred CCCC
Q 005224 692 SGSN 695 (707)
Q Consensus 692 ~~~~ 695 (707)
.-..
T Consensus 277 ~~~~ 280 (297)
T cd06656 277 PLSS 280 (297)
T ss_pred cccc
Confidence 5433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.11 Aligned_cols=286 Identities=23% Similarity=0.331 Sum_probs=201.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCC------
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 444 (707)
-++|+..+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999965 789999998864322 22345678999999999999999999986554
Q ss_pred --eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 445 --EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 445 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
..++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999996 58888886543 35899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 601 (707)
+.......... ........++..|+|||++.+. .++.++||||||+++|||++|+.||...... .......
T Consensus 166 ~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~---- 237 (310)
T cd07865 166 ARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLIS---- 237 (310)
T ss_pred cccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH----
Confidence 98664322111 1112234578899999998764 4788999999999999999999998654332 1111100
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCC
Q 005224 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQD--ETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 679 (707)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~--~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~ 679 (707)
.+ .+..+.+.......+ .++.. .|.. ....+...+. ....+....|||.+||..||++|||++
T Consensus 238 --~~----~~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~l~-----~~~~~~~~~dli~~~l~~~P~~R~t~~ 302 (310)
T cd07865 238 --QL----CGSITPEVWPGVDKL--ELFKKMELPQG--QKRKVKERLK-----PYVKDPHALDLIDKLLVLDPAKRIDAD 302 (310)
T ss_pred --HH----hCCCChhhcccccch--hhhhhccCCCc--cchhhHHhcc-----cccCCHHHHHHHHHHhcCChhhccCHH
Confidence 00 001111100000000 00000 0100 0000001110 011234456899999999999999999
Q ss_pred cCCCCCCC
Q 005224 680 SMLKHPYV 687 (707)
Q Consensus 680 e~L~Hp~f 687 (707)
|+|+||||
T Consensus 303 e~l~h~~f 310 (310)
T cd07865 303 TALNHDFF 310 (310)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=308.54 Aligned_cols=253 Identities=27% Similarity=0.347 Sum_probs=192.5
Q ss_pred ceEeeeCceEEEEEEeCC---CcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCC
Q 005224 381 TQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 456 (707)
+.||+|+||.||+|.+.+ +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 46799998875432 33457889999999999999999999999989999999999999
Q ss_pred CHHHHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 457 TLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 457 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
+|.+++.... ....++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 9999997532 224677888899999999999999998 99999999999999999999999999875432211
Q ss_pred ccccceecccccCCCccchhhhccC-------CCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTH-------KLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
........++..|+|||++.+. .++.++|||||||++|||++ |+.||......... ...... .....
T Consensus 156 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~-~~~~~ 230 (269)
T cd05087 156 ---YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL-TYTVRE-QQLKL 230 (269)
T ss_pred ---eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH-HHHhhc-ccCCC
Confidence 0112234567889999998642 35789999999999999996 99999654432211 111111 00111
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
.. +.........+.+++..|| .+|++||++.++++.|.
T Consensus 231 ~~---~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PK---PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CC---CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 1112234456788999999 57999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.93 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=197.0
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHH-HHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|++.+.||+|+||.||+|... +|+.||+|++..... ....++..|+.. ++..+|+||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 799999999875432 234556667665 666789999999999999999999999
Q ss_pred cCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 452 FMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 452 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|++ |+|.+++... ....+++..++.++.|++.||+|||++ + ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6898888652 235689999999999999999999986 6 99999999999999999999999999876532
Q ss_pred CCCCCccccceecccccCCCccchhhhcc----CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
. .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......+.....
T Consensus 157 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------- 220 (283)
T cd06617 157 S--------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-------- 220 (283)
T ss_pred c--------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH--------
Confidence 1 11223457889999999865 456889999999999999999999996432211111100
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 684 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 684 (707)
........+ .. .......+|+.+||..+|++||+++++++|
T Consensus 221 -~~~~~~~~~-------------------~~-------------------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 221 -VEEPSPQLP-------------------AE-------------------KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -HhcCCCCCC-------------------cc-------------------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00 011223467788888889999999999999
Q ss_pred CCCCCCCC
Q 005224 685 PYVSSDVS 692 (707)
Q Consensus 685 p~f~~~~~ 692 (707)
|||.....
T Consensus 262 ~~~~~~~~ 269 (283)
T cd06617 262 PFFELHLS 269 (283)
T ss_pred chhhhccc
Confidence 99987654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=312.79 Aligned_cols=280 Identities=24% Similarity=0.389 Sum_probs=207.3
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
+|+..+.||+|++|.||+|+.. +|+.||||.+...... ..+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999975 6899999998764332 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 454 SNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 454 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
++ +|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+|++|||++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 74 8988886543 346899999999999999999999998 9999999999999999999999999997543211
Q ss_pred CccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......++..|++||++.+ ..++.++|||||||++|||++|+.||...... +........ ..
T Consensus 155 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~----------~~ 218 (284)
T cd07836 155 -----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRI----------MG 218 (284)
T ss_pred -----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHH----------hC
Confidence 11223456889999999876 45788999999999999999999999754432 111111100 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
.........+.. ....-...|. ...... ....+..+....+++.+|+..||++|++++|+++||||
T Consensus 219 ~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~-------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 219 TPTESTWPGISQ-LPEYKPTFPR--YPPQDL-------QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChhhHHHHhc-CchhcccccC--CChHHH-------HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 001111111110 0000011111 111111 11123345667789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.56 Aligned_cols=289 Identities=24% Similarity=0.372 Sum_probs=208.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC-----CeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 446 (707)
.++|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999964 78999999986422 22345688899999999999999999987544 357
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++|+||++ ++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 588887743 35899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
...... ........|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..... ...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~------~~~ 225 (336)
T cd07849 157 DPEHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLI------LGV 225 (336)
T ss_pred cccccc----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH------HHH
Confidence 432111 111223467899999998765 568999999999999999999999996543211 11110 000
Q ss_pred ccCCCCCCChHHHHHHHHHH-HHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCC
Q 005224 606 IDGNMGSYPSECVEKFIKLA-LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 684 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~-~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 684 (707)
+...+.+....+.... ...+...|.. +... .....+..+....+|+.+||..||++|||++|+++|
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 226 ----LGTPSQEDLNCIISLRARNYIKSLPFK-PKVP--------WNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred ----cCCCCHHHHHHhhchhhhhHHhhcCcC-Cccc--------HHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111111111110 1111111111 1110 001123345667799999999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 685 PYVSSDVSG 693 (707)
Q Consensus 685 p~f~~~~~~ 693 (707)
|||..-...
T Consensus 293 p~~~~~~~~ 301 (336)
T cd07849 293 PYLEQYHDP 301 (336)
T ss_pred ccccccCCC
Confidence 999866554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=302.79 Aligned_cols=291 Identities=22% Similarity=0.316 Sum_probs=211.9
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEe--------C
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------E 443 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~ 443 (707)
..|....+||+|.||.||+|+.+ +|+.||+|+.--+ .........+|+++|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34566788999999999999965 6888998865321 11223567899999999999999999988733 2
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
...++||++|+. +|.-+|... ...++..++.+++.++..||.|+|... |+|||+|+.|||++.++.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 358999999976 898888543 356999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
+.+...+... ....+..+.|..|++||.+.+ ..|+.+.|||+.||+|.||+||.+-+....+ ..++..+.
T Consensus 172 r~fs~~~n~~---kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte-qqql~~Is----- 242 (376)
T KOG0669|consen 172 RAFSTSKNVV---KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE-QQQLHLIS----- 242 (376)
T ss_pred cceecccccC---CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH-HHHHHHHH-----
Confidence 8776544221 233455667999999999987 6799999999999999999999666654333 22222211
Q ss_pred hhhccCCCCCCChHHHH-----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCC
Q 005224 603 FSVIDGNMGSYPSECVE-----KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 677 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~-----~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s 677 (707)
...+.+..+.+. .+++-+ ...|--.-+.+.+ +...+.+ ..++.+.|++.+||.+||.+|+.
T Consensus 243 -----~LcGs~tkevWP~~d~lpL~~si----e~ePl~~~~~rkv----~n~~kp~-~kd~~a~dLle~ll~~DP~kR~~ 308 (376)
T KOG0669|consen 243 -----QLCGSITKEVWPNVDNLPLYQSI----ELEPLPKGQKRKV----KNRLKPY-VKDDEALDLLEKLLKLDPTKRID 308 (376)
T ss_pred -----HHhccCCcccCCCcccchHHHhc----cCCCCCcchhhhh----hhhcccc-cCChhHHHHHHHHhccCcccCcc
Confidence 111111111111 111111 1121111122222 2222222 23667889999999999999999
Q ss_pred CCcCCCCCCCCCCCCC
Q 005224 678 SSSMLKHPYVSSDVSG 693 (707)
Q Consensus 678 a~e~L~Hp~f~~~~~~ 693 (707)
|+++|+|.||..+...
T Consensus 309 ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 309 ADQALNHDFFWKDPMP 324 (376)
T ss_pred hHhhhchhhhhcCCcc
Confidence 9999999999988776
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.84 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=201.2
Q ss_pred CCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCCh------hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
+|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999995 5789999998864321 124678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeeecccccCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAP 527 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~ 527 (707)
||||+++++|.+++.+. .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999654 35889999999999999999999998 99999999999998776 59999999987664
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
...... ........++..|+|||.+.+..++.++||||+||+++||++|..||........ .
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~-------------- 217 (268)
T cd06630 156 AKGTGA---GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-L-------------- 217 (268)
T ss_pred cccccC---CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-H--------------
Confidence 321100 1112234578999999999988999999999999999999999999853221000 0
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
..+.+.. .... .+... ...++...+++.+|++.+|++||++.|+++||||
T Consensus 218 -----------~~~~~~~---~~~~---~~~~~-------------~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 218 -----------ALIFKIA---SATT---APSIP-------------EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred -----------HHHHHHh---ccCC---CCCCc-------------hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence 0000000 0000 01000 0112334468888999999999999999999998
Q ss_pred C
Q 005224 688 S 688 (707)
Q Consensus 688 ~ 688 (707)
.
T Consensus 268 ~ 268 (268)
T cd06630 268 R 268 (268)
T ss_pred C
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.73 Aligned_cols=284 Identities=22% Similarity=0.335 Sum_probs=206.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|+..+.||+|++|+||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47889999999999999999975 789999998865332 223578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeeecccccCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 530 (707)
|++ ++|.+++.......+++..++.++.||+.||+|||+.+ ++|+||+|+||++++ ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 58888886655555788899999999999999999998 999999999999985 5679999999997543211
Q ss_pred CCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||........... ... ....
T Consensus 158 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~-~~~------~~~~- 222 (294)
T PLN00009 158 -------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK-IFR------ILGT- 222 (294)
T ss_pred -------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHH------HhCC-
Confidence 11123456889999999876 4578999999999999999999999975443211111 000 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
...........+-.. ....|..++. ......+..+..+.+|+.+||..+|++||+++++++||||..
T Consensus 223 ---~~~~~~~~~~~~~~~-~~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 223 ---PNEETWPGVTSLPDY-KSAFPKWPPK---------DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred ---CChhhccccccchhh-hhhcccCCCC---------CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 000000000000000 0000111110 001112444556678999999999999999999999999975
Q ss_pred C
Q 005224 690 D 690 (707)
Q Consensus 690 ~ 690 (707)
.
T Consensus 290 ~ 290 (294)
T PLN00009 290 L 290 (294)
T ss_pred H
Confidence 4
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=304.50 Aligned_cols=248 Identities=30% Similarity=0.485 Sum_probs=201.6
Q ss_pred ceEeeeCceEEEEEEeCCCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCHH
Q 005224 381 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 459 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~ 459 (707)
++||+|+||.||+|...+++.||+|........ ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 4567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccce
Q 005224 460 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539 (707)
Q Consensus 460 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 539 (707)
+++.... ..+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-----~~~ 151 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-----TVS 151 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-----eec
Confidence 9996543 35889999999999999999999998 99999999999999999999999999976432110 001
Q ss_pred ecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 005224 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618 (707)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (707)
......+..|+|||.+.+..++.++|||||||++|||++ |..||....... ..... . .......+...+
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-~~~~~-~--------~~~~~~~~~~~~ 221 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-TRERI-E--------SGYRMPAPQLCP 221 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-HHHHH-h--------cCCCCCCCccCC
Confidence 111223567999999998899999999999999999999 888886543211 11110 0 111122455667
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 619 EKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 619 ~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
..+.+++.+|++.+|++||++.++++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 78999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=329.57 Aligned_cols=258 Identities=23% Similarity=0.402 Sum_probs=208.5
Q ss_pred CCCccceEeeeCceEEEEEEeCC-CcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
.|.++..||.|+||.||+|+.++ +-..|.|++...+.+..++|+-|++||...+||+||++++.|..++.+|++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45567789999999999999764 45567788877777777899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
||-.+.++-.-+ ..+.+.++.-+++|++.||.|||++. |||||||+.|||++-+|.++++|||.+.....
T Consensus 113 GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~------ 182 (1187)
T KOG0579|consen 113 GGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS------ 182 (1187)
T ss_pred CchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh------
Confidence 999988876543 46999999999999999999999998 99999999999999999999999999854321
Q ss_pred cccceecccccCCCccchhhhcc-----CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.........||+.|||||+.+. .+|++++||||||++|.||..+.+|...-...
T Consensus 183 -t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-------------------- 241 (1187)
T KOG0579|consen 183 -TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------------------- 241 (1187)
T ss_pred -HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--------------------
Confidence 1233456789999999999864 68999999999999999999998886532211
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
.-+.++ -..+| ||.. ....|+..+.|||.+||..+|+.||++.++|+||||.+
T Consensus 242 ---------RVllKi----aKSeP---PTLl-----------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 242 ---------RVLLKI----AKSEP---PTLL-----------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred ---------HHHHHH----hhcCC---Cccc-----------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 111111 12222 3221 12334556678999999999999999999999999985
Q ss_pred CC
Q 005224 690 DV 691 (707)
Q Consensus 690 ~~ 691 (707)
..
T Consensus 295 ~~ 296 (1187)
T KOG0579|consen 295 AP 296 (1187)
T ss_pred CC
Confidence 43
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=307.32 Aligned_cols=246 Identities=30% Similarity=0.485 Sum_probs=201.6
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
++|++.+.||+|+||.||++.. +++.||+|...... ..+.+.+|+.++++++|+|++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999985 67889999986532 345788999999999999999999998654 4799999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 999999998766667899999999999999999999988 999999999999999999999999998754221
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
......+..|+|||.+.+..++.++|||||||++|||++ |+.||...... +.... .. .+.....
T Consensus 154 -----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~-~~--------~~~~~~~ 218 (254)
T cd05083 154 -----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVKEC-VE--------KGYRMEP 218 (254)
T ss_pred -----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-HHHHH-Hh--------CCCCCCC
Confidence 111233567999999998899999999999999999998 99998654321 11111 11 1111223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
+..++..+.+++.+||+.+|+.||++.+++..++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 4456678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=309.98 Aligned_cols=199 Identities=31% Similarity=0.429 Sum_probs=175.2
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999965 68999999987543 33346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++... ++++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 9999999999653 6899999999999999999999998 9999999999999999999999999998764321
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 1122345788999999999988999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.83 Aligned_cols=203 Identities=28% Similarity=0.419 Sum_probs=177.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|+..+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357889999999999999999964 6789999999876555567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.+.......
T Consensus 82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 9999999998654 245899999999999999999999998 9999999999999999999999999987653211
Q ss_pred CccccceecccccCCCccchhhhccC---CCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 156 -----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 156 -----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred -----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 112234678899999999876 88999999999999999999999997544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=311.08 Aligned_cols=256 Identities=21% Similarity=0.376 Sum_probs=203.3
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
.|...+.||+|++|.||+|... +++.|++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3455689999999999999964 789999999876555556678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||.+.......
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---- 169 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---- 169 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC----
Confidence 9999999865 35899999999999999999999998 9999999999999999999999999886543211
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (707)
.......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ....
T Consensus 170 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~-------------------- 225 (285)
T cd06648 170 ---PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMK-------------------- 225 (285)
T ss_pred ---cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHH--------------------
Confidence 1122345789999999999988999999999999999999999998643221 1100
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 615 ~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
.+.... .|... .....+....+|+++||+.+|++||+++++++||||..-.
T Consensus 226 ---------~~~~~~------~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 226 ---------RIRDNL------PPKLK-----------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ---------HHHhcC------CCCCc-----------ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 000000 00000 0011122345788889999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.36 Aligned_cols=200 Identities=31% Similarity=0.470 Sum_probs=176.2
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|+..+.||+|+||.||+|... +++.||+|.+..... .+++.+|+++++.++|+||+++++++......++|+||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 367889999999999999999976 488999999875432 56899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (256)
T cd06612 80 CGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-- 153 (256)
T ss_pred CCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence 9999999998653 346899999999999999999999998 9999999999999999999999999998654321
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 154 -----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred -----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1122344788999999999999999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=315.02 Aligned_cols=207 Identities=24% Similarity=0.387 Sum_probs=173.2
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999965 678999999876432 22356789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999654 35899999999999999999999998 9999999999999999999999999987422111
Q ss_pred CCCc--------cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 531 IEGI--------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 531 ~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.... ..........++..|+|||.+.+..++.++|||||||++|||++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 0000 0001112245788999999999889999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=308.91 Aligned_cols=200 Identities=27% Similarity=0.411 Sum_probs=173.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46778899999999999999964 68999999987655444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--- 160 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--- 160 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc---
Confidence 9999999986543 5899999999999999999999998 9999999999999999999999999987553211
Q ss_pred ccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......|+..|+|||++. ...++.++|||||||++|||++|..||...
T Consensus 161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 1123346889999999985 456888999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.28 Aligned_cols=239 Identities=23% Similarity=0.405 Sum_probs=191.8
Q ss_pred ceEeeeCceEEEEEEeCC--------CcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 381 TQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+.||+|+||+||+|..+. ...||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888888665545556789999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--------EEEeeecccc
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--------AKVADFGLSR 524 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl~DFGla~ 524 (707)
+++|+|.++++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999997643 35899999999999999999999998 999999999999987765 6999999886
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCC-CCCCCCchhHHHHHHHhhcccc
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGM-QPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~-~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
..... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+..... .......
T Consensus 157 ~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~~~------ 218 (258)
T cd05078 157 TVLPK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQFY------ 218 (258)
T ss_pred ccCCc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHHHH------
Confidence 54321 22457889999999987 45899999999999999999985 45443222 1111110
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
......+.....++.+++.+||+.+|++||++.++++.|
T Consensus 219 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 219 -----EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 011223444456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=311.04 Aligned_cols=238 Identities=24% Similarity=0.370 Sum_probs=188.4
Q ss_pred eEeeeCceEEEEEEeCC-------------------------CcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeE
Q 005224 382 QIGQGGYGKVYKGILPD-------------------------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436 (707)
Q Consensus 382 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 436 (707)
.||+|+||.||+|.+.. ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13589999876554445678899999999999999999
Q ss_pred EEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---
Q 005224 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF--- 513 (707)
Q Consensus 437 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~--- 513 (707)
+++|......++||||+++|+|..++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998653 345889999999999999999999988 99999999999997644
Q ss_pred ----cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHH-cCCCCCCCCc
Q 005224 514 ----TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELL-TGMQPISHGK 587 (707)
Q Consensus 514 ----~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~ell-tG~~pf~~~~ 587 (707)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred CccceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4899999988643211 12346788999999876 56899999999999999995 6899986543
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 588 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
.... ..... . ....+......+.+++.+||+.+|++||++.++++.|
T Consensus 227 ~~~~--~~~~~---------~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 227 PSEK--ERFYE---------K-KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hHHH--HHHHH---------h-ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2111 11110 0 0112222335688999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=312.02 Aligned_cols=199 Identities=26% Similarity=0.428 Sum_probs=170.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788999999999999999975 78999999886532 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 453 MSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 453 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
+++++|.+++.... ...+++..+..++.|+++||.|||+. + |+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999986532 23689999999999999999999974 6 999999999999999999999999998755321
Q ss_pred CCCccccceecccccCCCccchhhhccC------CCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
......++..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 157 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 157 --------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred --------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 11234578899999998654 357899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=310.34 Aligned_cols=202 Identities=29% Similarity=0.392 Sum_probs=175.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|++.+.||+|+||.||+|... ++..||+|..........+.+.+|++++++++|+||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999975 6899999999876655667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-- 157 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence 99999999986543 35899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......++..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 158 -----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred -----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 1123346889999999985 345778999999999999999999999643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.35 Aligned_cols=201 Identities=26% Similarity=0.413 Sum_probs=174.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.+.|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++|+||+++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 357889999999999999999975 5899999999876666667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|..++.+.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 99999988876543 45899999999999999999999988 9999999999999999999999999986532211
Q ss_pred CccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
.......++..|+|||++. ...++.++|||||||++|||++|..||..
T Consensus 165 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 165 -----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred -----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 1122345788999999985 34578899999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.95 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=195.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999975 68899999987543 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.. .++++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 999999999854 35888999999999999999999988 9999999999999999999999999997654322
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
.......++..|+|||++.+..++.++|||||||++|||++|..||....... ... .........
T Consensus 156 -----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~---------~~~~~~~~~ 220 (277)
T cd06640 156 -----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-VLF---------LIPKNNPPT 220 (277)
T ss_pred -----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-Hhh---------hhhcCCCCC
Confidence 11223457889999999999899999999999999999999999986443211 000 001111222
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
.+..++..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 34455566666666666666666666666543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.78 Aligned_cols=200 Identities=27% Similarity=0.413 Sum_probs=174.0
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788999999999999999964 78899999986543 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeeecccccCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~~~~~~~~ 531 (707)
+++++|.+++.......+++..+..++.++++||+|||+++ ++|+||||+||+++++ +.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999998765667899999999999999999999998 9999999999999855 468999999998654321
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 112345788999999999988999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=300.66 Aligned_cols=261 Identities=20% Similarity=0.294 Sum_probs=206.0
Q ss_pred hcCCCc-cceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEe----CCeE
Q 005224 374 TNNFNS-STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGEQ 446 (707)
Q Consensus 374 ~~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~ 446 (707)
+++|++ .++||-|-.|.|-.+..+ +++.+|+|++.+. ....+|++.--.. .|||||.++++|.. ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 445554 368999999999999965 7999999998653 3456788764444 79999999999843 3567
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeeeccc
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLS 523 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla 523 (707)
++|||.|+||.|.+.+++++...+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|.. .+..+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccc
Confidence 89999999999999999999999999999999999999999999999 99999999999996 4567999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
+.... .......+-|+.|.|||++...+|+...|+||+||+||-|++|.+||...... ... ..+.
T Consensus 212 K~t~~--------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~------ais-pgMk 276 (400)
T KOG0604|consen 212 KETQE--------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------AIS-PGMK 276 (400)
T ss_pred cccCC--------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc------cCC-hhHH
Confidence 86543 12344567899999999999999999999999999999999999999643321 000 0111
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCC
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 683 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 683 (707)
.-+......||.+++..+. ..+.|+|+.+|..+|++|+|.+|.+.
T Consensus 277 ~rI~~gqy~FP~pEWs~VS-----------------------------------e~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVS-----------------------------------EAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhhccCccCCChhHhHHH-----------------------------------HHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1111122334544443332 22347899999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 684 HPYVSSDVS 692 (707)
Q Consensus 684 Hp~f~~~~~ 692 (707)
|||+++..+
T Consensus 322 hpwi~~~~~ 330 (400)
T KOG0604|consen 322 HPWINQYEA 330 (400)
T ss_pred Cchhccccc
Confidence 999988765
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=309.31 Aligned_cols=249 Identities=32% Similarity=0.505 Sum_probs=200.0
Q ss_pred ceEeeeCceEEEEEEeCC-------CcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 381 TQIGQGGYGKVYKGILPD-------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+.||+|+||.||+|...+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999876543 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-----CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-----cEEEeeecc
Q 005224 453 MSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-----TAKVADFGL 522 (707)
Q Consensus 453 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-----~~kl~DFGl 522 (707)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++ .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 234789999999999999999999988 99999999999999887 899999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM 601 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 601 (707)
++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ....
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-~~~~------ 225 (269)
T cd05044 158 ARDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQH------ 225 (269)
T ss_pred cccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-HHHH------
Confidence 9765332211 11122345678999999999999999999999999999998 999986544321 1111
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
+..+.....+...+..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 ---VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111222344556788999999999999999999999998876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=345.56 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=203.2
Q ss_pred HHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEe--
Q 005224 368 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-- 442 (707)
Q Consensus 368 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-- 442 (707)
.+.....++|.+.+.||+|+||+||+|... ++..||+|.+.... ......+..|+.+++.++||||++++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 334455678999999999999999999965 67889999887532 2334678999999999999999999998854
Q ss_pred CCeEEEEEecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCEEEcC-----
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEAD----PPVFHRDIKASNILLDH----- 511 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dlkp~NILl~~----- 511 (707)
....+|||||+++|+|.++|... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 35689999999999999999753 23469999999999999999999998542 34999999999999964
Q ss_pred ------------CCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHH
Q 005224 512 ------------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELL 577 (707)
Q Consensus 512 ------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~ell 577 (707)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||+
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 3458999999997653221 1234568999999999864 45889999999999999999
Q ss_pred cCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 578 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 578 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
+|+.||................ ........+..+.+++..||+.+|.+||++.+++.
T Consensus 238 TGk~PF~~~~~~~qli~~lk~~----------p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 238 SGKTPFHKANNFSQLISELKRG----------PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HCCCCCCcCCcHHHHHHHHhcC----------CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999997655433322211110 00111234567889999999999999999999884
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=311.32 Aligned_cols=246 Identities=27% Similarity=0.414 Sum_probs=198.0
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566788999999999999864 68899999987543 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++++|||++.......
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc---
Confidence 99999998853 35899999999999999999999988 9999999999999999999999999987654321
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
.......++..|+|||++.+..++.++|||||||++|||++|+.|+....... .. ..+........
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~---------~~~~~~~~~~~ 221 (277)
T cd06642 156 ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VL---------FLIPKNSPPTL 221 (277)
T ss_pred ----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-HH---------hhhhcCCCCCC
Confidence 11123457889999999999999999999999999999999999986432211 00 01111112223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
+..++..+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 3445566778888888888888888888776
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.21 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=191.1
Q ss_pred eEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHc---cCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 382 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSR---LHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 382 ~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~---l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
.||+|+||.||++... +++.||+|.+..... .....+.+|..+++. .+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 689999998865322 122334455544443 479999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99999998654 35899999999999999999999998 9999999999999999999999999987543211
Q ss_pred cccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|..||........
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---------------------- 204 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---------------------- 204 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----------------------
Confidence 123458999999999874 5689999999999999999999999964221000
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC-----CCCcCCCCCCCC
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKHPYVS 688 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~Hp~f~ 688 (707)
..+.+... ...+ . ..+..+....++|.+||..||++|+ |++|+++||||.
T Consensus 205 -----~~~~~~~~---~~~~----~-------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~ 259 (279)
T cd05633 205 -----HEIDRMTL---TVNV----E-------------LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259 (279)
T ss_pred -----HHHHHHhh---cCCc----C-------------CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence 00000000 0000 0 0011122344677888888888888 699999999998
Q ss_pred CCCCCCCc
Q 005224 689 SDVSGSNL 696 (707)
Q Consensus 689 ~~~~~~~~ 696 (707)
+-.+....
T Consensus 260 ~~~~~~~~ 267 (279)
T cd05633 260 GIDWQQVY 267 (279)
T ss_pred CCCHhHHh
Confidence 86665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=311.05 Aligned_cols=267 Identities=27% Similarity=0.446 Sum_probs=207.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-----CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEe--CCeE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQ 446 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 446 (707)
..|+..+.||+|+||.||+|.+. +++.||||.+...... ..+.+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999853 3689999999865443 45789999999999999999999999877 5578
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999997643 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHH-HHHH---hhcccc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE-VNIA---YQSSMM 602 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~-~~~~---~~~~~~ 602 (707)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.|+......... .... .....+
T Consensus 160 ~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 160 PEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 422110 01111233456799999999889999999999999999999999998543221100 0000 000000
Q ss_pred hhhcc-CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 603 FSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 603 ~~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
...+. ......+..++..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 01111 111223445668899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.95 Aligned_cols=251 Identities=34% Similarity=0.553 Sum_probs=204.5
Q ss_pred CCccceEeeeCceEEEEEEeCC-----CcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 377 FNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
|++.+.||+|+||.||++...+ +..||+|.+...... ..+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999753 388999999765443 4678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999997654433899999999999999999999998 9999999999999999999999999998665432
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.. ......++..|+|||.+.+..++.++||||+||+++||++ |+.||..... ...... +....
T Consensus 158 ~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~~~~~~---------~~~~~ 221 (258)
T smart00219 158 YY------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-EEVLEY---------LKKGY 221 (258)
T ss_pred cc------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH---------HhcCC
Confidence 11 1112236789999999988899999999999999999999 7788764322 111111 11122
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
....+...+..+.+++.+|++.+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 2233445677899999999999999999999988653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=323.32 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=205.9
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCHH
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 459 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~ 459 (707)
-+||+|+||+||.|++. +...+|||-+.....+..+-+..|+.+-++++|.|||+++|.|.++++.-+.||.++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999965 55679999998766666677889999999999999999999999999999999999999999
Q ss_pred HHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEeeecccccCCCCCCCCcccc
Q 005224 460 DQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPA 537 (707)
Q Consensus 460 ~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~ 537 (707)
++|+.+ +.-.=.+.+.-.+.+||++||.|||+.. |||||||-+||||+ -.|.+||+|||-++.+..- .
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-------n 730 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-------N 730 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-------C
Confidence 999763 3222378888999999999999999998 99999999999996 6799999999999876422 1
Q ss_pred ceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh-ccCCCCCCC
Q 005224 538 HVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV-IDGNMGSYP 614 (707)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 614 (707)
......-||..|||||++.. ..|..++|||||||++.||.||++||..-.+.... ++.+ .-+..++.|
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---------MFkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---------MFKVGMYKVHPPIP 801 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---------hhhhcceecCCCCc
Confidence 23445679999999999976 46888999999999999999999999754442221 1111 123346688
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 615 SECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 615 ~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
++...+...++.+|+..+|.+||++.++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 999999999999999999999999999875
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.40 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=191.1
Q ss_pred eEeeeCceEEEEEEeCC---CcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCC
Q 005224 382 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 457 (707)
Q Consensus 382 ~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 457 (707)
.||+|+||.||+|...+ ...+|+|.+..... .....+.+|+++++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 45789998765432 234578899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCC---CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 458 LRDQLSAKSK---EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 458 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
|.+++..... ...++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....+..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 9999976432 23567888999999999999999998 999999999999999999999999998754322100
Q ss_pred cccceecccccCCCccchhhhcc-------CCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||....+... ........ ..
T Consensus 157 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~-~~--- 228 (269)
T cd05042 157 ---ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVREQ-DI--- 228 (269)
T ss_pred ---eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhhcc-Cc---
Confidence 01122345678999999753 456789999999999999999 7788865443211 11111110 00
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
.......+..++..+.+++..|| .+|++||++.++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11111233456677788899998 5999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=311.87 Aligned_cols=264 Identities=25% Similarity=0.356 Sum_probs=202.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 450 (707)
++|+..+.||.|++|.||+|... +++.||+|.+..... ....++.+|++++++++|+||++++++|... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999975 689999999875432 3456789999999999999999999998654 4689999
Q ss_pred ecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 451 EFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 451 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||+++++|.+++.. .....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998764 23455889999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 158 ~~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------------------ 210 (287)
T cd06621 158 SL---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP------------------ 210 (287)
T ss_pred cc---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC------------------
Confidence 11 113346789999999999999999999999999999999999996432100
Q ss_pred CCCCCChHHHHHHHHHHHHh----cccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKC----CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 684 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c----~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 684 (707)
..+. ++.+.+..+ +...+..+-. .++...+|+.+|+..+|++|||+.|+++|
T Consensus 211 ---~~~~----~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 211 ---LGPI----ELLSYIVNMPNPELKDEPGNGIK-----------------WSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ---CChH----HHHHHHhcCCchhhccCCCCCCc-----------------hHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0000 011111110 0000000000 11223478899999999999999999999
Q ss_pred CCCCCCCC
Q 005224 685 PYVSSDVS 692 (707)
Q Consensus 685 p~f~~~~~ 692 (707)
|||.....
T Consensus 267 ~~~~~~~~ 274 (287)
T cd06621 267 PWIKAQMK 274 (287)
T ss_pred cccccccc
Confidence 99955443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.39 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=204.9
Q ss_pred cCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
++|+..+.||+|+||+||+|..+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999964 3467999988764433 3467999999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHHhhcCC-------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeee
Q 005224 448 LVYEFMSNGTLRDQLSAKSK-------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 520 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 520 (707)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976441 25899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhc
Q 005224 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 599 (707)
Q Consensus 521 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 599 (707)
|++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..+... .
T Consensus 162 ~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~~~~~~-~- 232 (275)
T cd05046 162 SLSKDVYNSE------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRL-Q- 232 (275)
T ss_pred ccccccCccc------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-HHHHHH-H-
Confidence 9987543221 111122345678999999998889999999999999999999 78888643321 111111 0
Q ss_pred ccchhhccCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 600 SMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 600 ~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
.+.. ...+..++..+.+++.+|++.+|.+||++.++++.|.
T Consensus 233 -------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 -------AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0111 1123445678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.11 Aligned_cols=203 Identities=30% Similarity=0.445 Sum_probs=170.9
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 446 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 446 (707)
.+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999964 68999999876432 12235688899999999999999999998653 577
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++++|.+++.... .+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999996543 4889999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 157 QTICMS----GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccc----CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 321111 11112345788999999999999999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.34 Aligned_cols=212 Identities=27% Similarity=0.401 Sum_probs=176.8
Q ss_pred ccHHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEE-
Q 005224 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD- 441 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~- 441 (707)
+.++.+..+.++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666778899999999999999999999964 68899999876532 2245688899999999 6999999999884
Q ss_pred ----eCCeEEEEEecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 005224 442 ----EEGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 515 (707)
Q Consensus 442 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 515 (707)
..+..++||||+++++|.+++... ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999999988642 3346889999999999999999999998 9999999999999999999
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhcc-----CCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 164 KLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EEccCCceeecccCC-------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999987653221 11223458899999999853 457889999999999999999999996543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.02 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=204.3
Q ss_pred cHHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEe-
Q 005224 366 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE- 442 (707)
Q Consensus 366 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~- 442 (707)
++.++....+.|++.+.||+|+||.||+|... +++.||+|+..... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45566667789999999999999999999964 68999999986543 2345688899999998 69999999999843
Q ss_pred -----CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 005224 443 -----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 517 (707)
Q Consensus 443 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 517 (707)
....++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 457899999999999999997765566889999999999999999999998 999999999999999999999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 592 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~ 592 (707)
+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||.........
T Consensus 163 ~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 163 VDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred eeCcchhhhhccc-------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 9999987543211 1122346889999999986 356888999999999999999999999643321110
Q ss_pred HHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCC
Q 005224 593 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE 672 (707)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP 672 (707)
..+ .. .+. +... ....+..+.+|+.+||..||
T Consensus 236 -----------------------------~~~-~~----~~~--~~~~------------~~~~~~~~~~li~~cl~~~p 267 (282)
T cd06636 236 -----------------------------FLI-PR----NPP--PKLK------------SKKWSKKFIDFIEGCLVKNY 267 (282)
T ss_pred -----------------------------hhH-hh----CCC--CCCc------------ccccCHHHHHHHHHHhCCCh
Confidence 000 00 000 0000 00112234567888888889
Q ss_pred CCCCCCCcCCCCCCC
Q 005224 673 ETPPSSSSMLKHPYV 687 (707)
Q Consensus 673 ~~R~sa~e~L~Hp~f 687 (707)
++||++.|+|+||||
T Consensus 268 ~~Rp~~~ell~~~~~ 282 (282)
T cd06636 268 LSRPSTEQLLKHPFI 282 (282)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=322.42 Aligned_cols=281 Identities=23% Similarity=0.367 Sum_probs=203.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeC------C
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 444 (707)
.++|...+.||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999964 789999999865321 2235688999999999999999999998654 3
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..++|+||+. .+|.++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 5699999996 4777665 235889999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+......
T Consensus 166 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~---- 230 (342)
T cd07879 166 HADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKV---- 230 (342)
T ss_pred CCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh----
Confidence 54221 123456888999999876 56889999999999999999999999754332 111111110
Q ss_pred hhccCCCCCCChHHHHHHHHHH-HHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 604 SVIDGNMGSYPSECVEKFIKLA-LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~-~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
. +.........+.... .......|. .|. ..+....+..+....+|+.+||+.||++|++++|+|
T Consensus 231 --~----~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 231 --T----GVPGPEFVQKLEDKAAKSYIKSLPK-YPR--------KDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred --c----CCCCHHHHHHhcccchHHHHhhcCC-ccc--------chHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0 001111111110000 000000000 000 001112234455667999999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 683 KHPYVSSDVS 692 (707)
Q Consensus 683 ~Hp~f~~~~~ 692 (707)
.||||.+-..
T Consensus 296 ~h~~f~~~~~ 305 (342)
T cd07879 296 EHPYFDSFRD 305 (342)
T ss_pred cCcchhhccc
Confidence 9999977544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=301.72 Aligned_cols=199 Identities=30% Similarity=0.478 Sum_probs=173.2
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
+|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999976 78999999876533 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999999654 35889999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCCccccceecccccCCCccchhhhccCC-CCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
. ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||....
T Consensus 156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 1 123345788999999998766 8999999999999999999999996543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=321.71 Aligned_cols=285 Identities=23% Similarity=0.340 Sum_probs=207.2
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC----------
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE---------- 443 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~---------- 443 (707)
.+|...+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 68999999999999999999964 6899999998766555567789999999999999999999876543
Q ss_pred ----CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEe
Q 005224 444 ----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVA 518 (707)
Q Consensus 444 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~ 518 (707)
...++||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++ +++.+|++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 589888853 34889999999999999999999998 99999999999997 45678999
Q ss_pred eecccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHh
Q 005224 519 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597 (707)
Q Consensus 519 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~ 597 (707)
|||+++........ ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 158 dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~- 232 (342)
T cd07854 158 DFGLARIVDPHYSH----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL- 232 (342)
T ss_pred CcccceecCCcccc----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-
Confidence 99999765322110 111122357889999998754 568889999999999999999999997654432211110
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCC
Q 005224 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 677 (707)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s 677 (707)
+......+.+.......+...+.......+.+..++ .+..+....+|+.+||+.||++|+|
T Consensus 233 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 233 ---------ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDL----------LPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred ---------HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHH----------ccCCCHHHHHHHHHHhCCCchhccC
Confidence 000000111111111122222221111112222211 2334455678999999999999999
Q ss_pred CCcCCCCCCCCCC
Q 005224 678 SSSMLKHPYVSSD 690 (707)
Q Consensus 678 a~e~L~Hp~f~~~ 690 (707)
++|+|+||||...
T Consensus 294 ~~ell~h~~~~~~ 306 (342)
T cd07854 294 AEEALMHPYMSCY 306 (342)
T ss_pred HHHHhCCCccccc
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=317.35 Aligned_cols=288 Identities=26% Similarity=0.349 Sum_probs=203.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEeC-------
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------- 443 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------- 443 (707)
.++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999965 6899999988653322 234678899999999999999999987443
Q ss_pred -CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 444 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 444 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
...++||||+. +++...+... ...+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 34699999996 4777777543 346999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCcc----ccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHh
Q 005224 523 SRLAPVPDIEGIV----PAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597 (707)
Q Consensus 523 a~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~ 597 (707)
++........... .........++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 9865432211100 0111233467888999998875 45889999999999999999999998654332 2211111
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHh-cccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC
Q 005224 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKC-CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 676 (707)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c-~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 676 (707)
.. .. ..+.........+.... +...+...+...+ .+........+|+.+||..||++||
T Consensus 241 ~~------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~ 300 (311)
T cd07866 241 KL------CG----TPTEETWPGWRSLPGCEGVHSFTNYPRTLEE----------RFGKLGPEGLDLLSKLLSLDPYKRL 300 (311)
T ss_pred HH------hC----CCChhhchhhhhcccccccccCCCCCccHHH----------HcccCChhHHHHHHHHcccCcccCc
Confidence 10 00 00000000000000000 0001111111111 1223345567899999999999999
Q ss_pred CCCcCCCCCCC
Q 005224 677 SSSSMLKHPYV 687 (707)
Q Consensus 677 sa~e~L~Hp~f 687 (707)
|+.|++.||||
T Consensus 301 t~~ell~~~~f 311 (311)
T cd07866 301 TASDALEHPYF 311 (311)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.84 Aligned_cols=286 Identities=20% Similarity=0.328 Sum_probs=210.4
Q ss_pred HHHHHHHhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC
Q 005224 367 YGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 443 (707)
Q Consensus 367 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 443 (707)
.+++...+++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345666789999999999999999999985 478999999987532 22345688899999999999999999988543
Q ss_pred ------CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 005224 444 ------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 517 (707)
Q Consensus 444 ------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 517 (707)
...+++++++ +++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3468888887 78998888542 4899999999999999999999998 999999999999999999999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 596 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~ 596 (707)
+|||+++.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ......
T Consensus 162 ~dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~ 230 (345)
T cd07877 162 LDFGLARHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLI 230 (345)
T ss_pred ecccccccccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence 99999875422 1123457889999999876 56888999999999999999999999654332 111111
Q ss_pred hhcccchhhccCCCCCCChHHHH----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCC
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVE----KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE 672 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~----~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP 672 (707)
.... ...+..... ...+....++...|..+.. ......++...+||.+||..||
T Consensus 231 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~L~~dp 288 (345)
T cd07877 231 LRLV----------GTPGAELLKKISSESARNYIQSLTQMPKMNFA------------NVFIGANPLAVDLLEKMLVLDS 288 (345)
T ss_pred HHHh----------CCCCHHHHhhcccHhHHHHHHHhcccCCcchh------------hhcCCCCHHHHHHHHHHcCCCh
Confidence 0000 000111100 0111111222222211110 0112334556789999999999
Q ss_pred CCCCCCCcCCCCCCCCCCCC
Q 005224 673 ETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 673 ~~R~sa~e~L~Hp~f~~~~~ 692 (707)
++|+++.++|+||||.....
T Consensus 289 ~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 289 DKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred hhcCCHHHHhcChhhhhcCC
Confidence 99999999999999985443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=307.78 Aligned_cols=211 Identities=30% Similarity=0.444 Sum_probs=176.2
Q ss_pred ccHHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEe
Q 005224 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 442 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 442 (707)
++.+++..++++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 444566667889999999999999999999964 78999999986532 2345778899999999 89999999999865
Q ss_pred C-----CeEEEEEecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 005224 443 E-----GEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 515 (707)
Q Consensus 443 ~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 515 (707)
. +..++||||+++++|.++++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3 3589999999999999998642 3346899999999999999999999998 9999999999999999999
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhccC-----CCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
||+|||++....... .......|+..|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 168 kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 168 KLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEeecccchhccccc-------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 999999987654321 112234578899999998643 3688999999999999999999999654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=307.45 Aligned_cols=192 Identities=24% Similarity=0.382 Sum_probs=168.1
Q ss_pred EeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCH
Q 005224 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 383 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
||.|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++|+||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 589999999865332 3346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccc
Q 005224 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538 (707)
Q Consensus 459 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 538 (707)
.+++.+. ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------- 147 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------- 147 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--------
Confidence 9999654 34889999999999999999999988 9999999999999999999999999998654321
Q ss_pred eecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
......++..|+|||.+.+..++.++|+||||+++|||++|..||....
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 1223457889999999998889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=310.57 Aligned_cols=276 Identities=24% Similarity=0.358 Sum_probs=199.0
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccC-CCcceeEEEEEEeC--CeEEEEEe
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQMLVYE 451 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~E 451 (707)
|++.+.||+|+||.||+|... +++.||+|++..... .......+|+.+++++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999964 789999999875322 22334567899999885 99999999999887 88999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|++ ++|.+.+.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 996 58888886533 46899999999999999999999998 999999999999999 999999999997653221
Q ss_pred CCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
......++..|+|||++.. ..++.++|||||||++|||++|+.||...... +.+..... ..
T Consensus 154 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~~----------~~ 215 (282)
T cd07831 154 -------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIHD----------VL 215 (282)
T ss_pred -------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHHH----------Hc
Confidence 1122357889999998754 56788999999999999999999999654331 11111100 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
+..+......+.. ....-...|..-+. .+....+.......+++.+||..+|++|||++++|+||||
T Consensus 216 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 216 GTPDAEVLKKFRK-SRHMNYNFPSKKGT---------GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred CCCCHHHHHhhcc-cccccccCcccccc---------cHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111111000000 00000000000000 0111122335566789999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=301.30 Aligned_cols=202 Identities=29% Similarity=0.443 Sum_probs=170.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 446 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 446 (707)
.+|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999964 68999999875321 12235788899999999999999999998663 467
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999986543 4788889999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
...... ........|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 157 QTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 322110 1112234578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.78 Aligned_cols=237 Identities=24% Similarity=0.413 Sum_probs=190.0
Q ss_pred ceEeeeCceEEEEEEeCC-C----------cEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 381 TQIGQGGYGKVYKGILPD-G----------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~-~----------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
+.||+|+||.||+|.+.+ + ..|++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999754 3 25788877654433 6788999999999999999999999988 778999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-------cEEEeeecc
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-------TAKVADFGL 522 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-------~~kl~DFGl 522 (707)
|||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976432 6899999999999999999999988 99999999999999888 799999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccC--CCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 599 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 599 (707)
+..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||...... .... .+.
T Consensus 155 a~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~-~~~- 220 (259)
T cd05037 155 PITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKER-FYQ- 220 (259)
T ss_pred cccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHH-HHh-
Confidence 976432 1123466789999999876 78999999999999999999 57777544321 1111 111
Q ss_pred ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
.... .+......+.+++.+||..+|.+||++.++++.|
T Consensus 221 -------~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -------DQHR--LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -------cCCC--CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1111 1111127888999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=320.77 Aligned_cols=292 Identities=22% Similarity=0.349 Sum_probs=212.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEe----CCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~ 446 (707)
.++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999964 699999999875322 234677889999999999999999998753 3468
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+. ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6999988543 34899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
...... .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 158 ~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~------- 226 (334)
T cd07855 158 SSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILS------- 226 (334)
T ss_pred cccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHH-------
Confidence 432211 1111223468889999999866 56889999999999999999999999654332 11111000
Q ss_pred ccCCCCCCChHHHHH-HHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCC
Q 005224 606 IDGNMGSYPSECVEK-FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 684 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~-l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 684 (707)
..+..+.+.... ..+.+..+++..+...+... ....+..+..+.+||.+||..+|++|||+++++.|
T Consensus 227 ---~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 227 ---VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPW---------SKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred ---HhCCChhHhhhhhchhhHHHHHhhcccCCCCCH---------HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011111111111 11122223333232222111 01123345567789999999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 685 PYVSSDVSGS 694 (707)
Q Consensus 685 p~f~~~~~~~ 694 (707)
|||..-...+
T Consensus 295 ~~~~~~~~~~ 304 (334)
T cd07855 295 PFLAQYHDPD 304 (334)
T ss_pred hhhhhccCCc
Confidence 9997665543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=304.19 Aligned_cols=255 Identities=29% Similarity=0.433 Sum_probs=200.1
Q ss_pred CCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC------
Q 005224 377 FNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 444 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 444 (707)
|.+.+.||+|+||+||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 36889999987542 233567889999999999999999999885532
Q ss_pred eEEEEEecCCCCCHHHHHhhc----CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeee
Q 005224 445 EQMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 520 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 520 (707)
..++++||+.+|+|.+++... ....+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887532 1235789999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhc
Q 005224 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 599 (707)
Q Consensus 521 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 599 (707)
|+++........ .......++..|++||.+....++.++|||||||++|||++ |+.||..... .......
T Consensus 158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~~--- 228 (273)
T cd05074 158 GLSKKIYSGDYY-----RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYL--- 228 (273)
T ss_pred cccccccCCcce-----ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHHH---
Confidence 999865432110 01112234678999999999999999999999999999999 8888864433 1111111
Q ss_pred ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
........+..++..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 229 ------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 ------IKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ------HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111122344567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=301.59 Aligned_cols=203 Identities=32% Similarity=0.468 Sum_probs=174.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999964 7899999998765443 457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++... ..+++..+..++.++++||+|||+.+ |+|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999999654 34788999999999999999999998 999999999999999999999999999876433211
Q ss_pred CccccceecccccCCCccchhhhccCC---CCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
. ........++..|+|||++.+.. ++.++||||||+++||+++|+.||...
T Consensus 156 ~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 156 M---GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred c---cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 0 11012345788999999998766 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=303.09 Aligned_cols=251 Identities=20% Similarity=0.361 Sum_probs=201.7
Q ss_pred CCCccceEeeeCceEEEEEEeCC--CcEEEEEEeccCC----------hhhHHHHHHHHHHHHc-cCCCcceeEEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGS----------LQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDE 442 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~ 442 (707)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999764 7889999875321 1223457788888875 799999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEee
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVAD 519 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~D 519 (707)
.+..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998854 234568999999999999999999996 56 99999999999999999999999
Q ss_pred ecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhc
Q 005224 520 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599 (707)
Q Consensus 520 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~ 599 (707)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .....
T Consensus 158 fg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~~~~---- 224 (269)
T cd08528 158 FGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SLATK---- 224 (269)
T ss_pred ccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HHHHH----
Confidence 99997654321 223456788999999999988999999999999999999999999654332 11111
Q ss_pred ccchhhccCCCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 600 SMMFSVIDGNMGSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 600 ~~~~~~~~~~~~~~~-~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
+........+ ..+...+.+++.+||+.+|++||++.++..+++
T Consensus 225 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 -----IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111111 234577899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=306.31 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=198.5
Q ss_pred EeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCH
Q 005224 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 383 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
||+|+||.||++... +|+.||+|.+..... ...+.+.+|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 599999999876443 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC-cccc
Q 005224 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPA 537 (707)
Q Consensus 459 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 537 (707)
.+++.+.. .+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997644 5899999999999999999999998 9999999999999999999999999987643321100 0001
Q ss_pred ceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHH
Q 005224 538 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSEC 617 (707)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (707)
.......++..|+|||......++.++||||||+++||+++|+.||...... ....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~----------------------- 211 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-EIFQ----------------------- 211 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHH-----------------------
Confidence 1223345788999999999888999999999999999999999999643321 0000
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCC---CcCCCCCCCCC
Q 005224 618 VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS---SSMLKHPYVSS 689 (707)
Q Consensus 618 ~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa---~e~L~Hp~f~~ 689 (707)
.+ .. ....+|... .......+|+.+|+..+|++|||+ .++|+||||+.
T Consensus 212 -----~~----~~-~~~~~~~~~--------------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 212 -----NI----LN-GKIEWPEDV--------------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred -----HH----hc-CCcCCCccc--------------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 00 00 000011000 012333578888999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.68 Aligned_cols=199 Identities=28% Similarity=0.443 Sum_probs=174.8
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|+..+.||+|+||.||++..+ +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778899999999999999976 68999999987643 23456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 99999999997643 568999999999999999999999 77 9999999999999999999999999987543211
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 --------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred --------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11156788999999999999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=300.27 Aligned_cols=202 Identities=25% Similarity=0.423 Sum_probs=172.0
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEe--CCeEEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVY 450 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ 450 (707)
+|++.+.||.|+||.||++... +++.||+|.+.... ....+.+.+|+++++.++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999964 78899999987533 2334678899999999999999999998754 45679999
Q ss_pred ecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 451 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLH-----TEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 451 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
||+++++|.+++... ...++++..++.++.|++.||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999753 2456899999999999999999999 666 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
....... .......++..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~-------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 158 KILGHDS-------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccCCc-------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 8764322 11223457899999999999889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=301.51 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=189.3
Q ss_pred eEeeeCceEEEEEEeCCC---cEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCC
Q 005224 382 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 457 (707)
Q Consensus 382 ~lG~G~~g~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 457 (707)
.||+|+||+||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985433 356677766433 3345689999999999999999999999999999999999999999
Q ss_pred HHHHHhhcC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 458 LRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 458 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|.+++++.. ....++..++.++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++......+.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999997642 234677788899999999999999988 99999999999999999999999999864321110
Q ss_pred ccceecccccCCCccchhhhcc-------CCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
........++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+........ ......+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~-~~~~~~~ 231 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKD-QQVKLFK 231 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhh-cccccCC
Confidence 011223457889999999853 345789999999999999997 5667754433 2222221111 1111111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
+ ..+......+.+++..|| .+|++||++.++++.|
T Consensus 232 ~---~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 232 P---QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred C---ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1 122335567888999999 5799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=317.31 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=210.2
Q ss_pred cceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCC
Q 005224 380 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 456 (707)
.++||+|.||+||-|+++ +|+.||||++.+... ..+.++.+|+.+|++++||.||.+.-.|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 588999999999999965 899999999876432 34578899999999999999999999999999999999999 56
Q ss_pred CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEeeecccccCCCCCCCC
Q 005224 457 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 457 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFGla~~~~~~~~~~ 533 (707)
+..+++-......+++.....++.||+.||.|||.++ |+|+||||+|||+.+. .++||+|||.|++..+.
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---- 720 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---- 720 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh----
Confidence 7777776656667999999999999999999999999 9999999999999643 57999999999988653
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
.....++||+.|.|||++..+.|...-|+||.||++|--++|..||..+.+..++...+ .
T Consensus 721 ----sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA----a------------ 780 (888)
T KOG4236|consen 721 ----SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA----A------------ 780 (888)
T ss_pred ----hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc----c------------
Confidence 34556789999999999999999999999999999999999999998766654432211 0
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
-+.-.+| ..+.+..+.|||+.+|++.=++|.|.+..|.|||+....
T Consensus 781 -------------FMyPp~P-------------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 781 -------------FMYPPNP-------------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred -------------cccCCCc-------------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 0011111 123345667899999999999999999999999997654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=301.98 Aligned_cols=200 Identities=28% Similarity=0.466 Sum_probs=173.6
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|+||.||+|..+ +|..||+|.+.... ....+.+.+|+++++.++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999975 68899999986532 12345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeeecccccCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 531 (707)
+++++|.+++.......+++..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999997765556899999999999999999999998 99999999999999885 46999999987654221
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
.......|++.|+|||+..+..++.++|||||||++|||++|..||..
T Consensus 157 ------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 157 ------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred ------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 112234588899999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=302.96 Aligned_cols=276 Identities=26% Similarity=0.377 Sum_probs=200.5
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHcc---CCCcceeEEEEEEeCCe-----
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCDEEGE----- 445 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~----- 445 (707)
|++.+.||+|+||.||+|..+ +++.||+|++...... ....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999976 5899999998743222 234566788777666 59999999999987776
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.+++|||+. ++|.+++.......+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 58999987655556999999999999999999999998 99999999999999999999999999977
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||..... .+............
T Consensus 157 ~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~-- 225 (287)
T cd07838 157 YSFEM--------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLP-- 225 (287)
T ss_pred ccCCc--------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCC--
Confidence 54321 11223468899999999999999999999999999999999888865333 22222111100000
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCC
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 685 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 685 (707)
.....+.. ......++...+. +.+.++. +.......+++.+||..||++||+++|+++||
T Consensus 226 ---~~~~~~~~-----~~~~~~~~~~~~~--~~~~~~~----------~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 226 ---SEEEWPRN-----VSLPRSSFPSYTP--RSFKSFV----------PEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred ---ChHhcCCC-----cccchhhcccccc--cchhhhh----------hhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 00000000 0000001110000 1111111 12234455899999999999999999999999
Q ss_pred CC
Q 005224 686 YV 687 (707)
Q Consensus 686 ~f 687 (707)
||
T Consensus 286 ~~ 287 (287)
T cd07838 286 YF 287 (287)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=317.99 Aligned_cols=295 Identities=25% Similarity=0.362 Sum_probs=214.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC-----eEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQM 447 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 447 (707)
+|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999975 58999999987643 334567899999999999999999999987765 789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||++ ++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58999886543 6999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
..... ........++..|+|||++.+. .++.++||||||+++|+|++|+.||...... ........ .
T Consensus 155 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~------~- 222 (330)
T cd07834 155 PDEDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-DQLNLIVE------V- 222 (330)
T ss_pred ccccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHH------h-
Confidence 32210 0112334578899999999887 8999999999999999999999999654431 11111100 0
Q ss_pred cCCCCCCChHHHHH-HHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCC
Q 005224 607 DGNMGSYPSECVEK-FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 685 (707)
Q Consensus 607 ~~~~~~~~~~~~~~-l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 685 (707)
.+..+.+.... ....+...+...+..++ . ......+.......+|+.+||..+|++|||++++|+||
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 223 ---LGTPSEEDLKFITSEKARNYLKSLPKKPK-K--------PLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred ---cCCCChhHhhhccccchhhHHhhcccCCc-c--------hhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 00011110000 00000000000000000 0 01112233455667899999999999999999999999
Q ss_pred CCCCCCCCCCccccc
Q 005224 686 YVSSDVSGSNLVSGV 700 (707)
Q Consensus 686 ~f~~~~~~~~~~~~~ 700 (707)
||.+-...+.-.+.+
T Consensus 291 ~~~~~~~~~~~~~~~ 305 (330)
T cd07834 291 YLAQLHDPEDEPVAK 305 (330)
T ss_pred cHHhhcccccCCCCC
Confidence 998766655544443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.15 Aligned_cols=291 Identities=25% Similarity=0.343 Sum_probs=207.7
Q ss_pred cCCCc-cceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh--------------HHHHHHHHHHHHccCCCcceeEEE
Q 005224 375 NNFNS-STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--------------EKEFLTEIQFLSRLHHRNLVSLVG 438 (707)
Q Consensus 375 ~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~~ 438 (707)
++|.. .+.||+|+||+||+|... +++.||||.+....... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999965 78999999886532221 125778999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 005224 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 518 (707)
Q Consensus 439 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 518 (707)
++...+..++||||+. |+|.+++... ..+++.....++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 6999998653 34889999999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCCCCCc-------cccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhH
Q 005224 519 DFGLSRLAPVPDIEGI-------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 590 (707)
Q Consensus 519 DFGla~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~ 590 (707)
|||+++.......... ..........++..|+|||++.+. .++.++|||||||++|||++|+.||....+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999976542111000 001112233467889999999764 47899999999999999999999997554321
Q ss_pred HHHHHHhhcccchhhccCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCC
Q 005224 591 REVNIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHT 669 (707)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~ 669 (707)
. ...... ...... ..++.. ..+...+ ...+...+.. ....+..+....+|+.+||.
T Consensus 242 ~-~~~i~~------~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~ 298 (335)
T PTZ00024 242 Q-LGRIFE------LLGTPNEDNWPQA-----KKLPLYT-EFTPRKPKDL----------KTIFPNASDDAIDLLQSLLK 298 (335)
T ss_pred H-HHHHHH------HhCCCchhhCcch-----hhccccc-ccCcCCcccH----------HHhCcCCChHHHHHHHHHcC
Confidence 1 111100 000000 000000 0000000 0000011111 11123345566789999999
Q ss_pred CCCCCCCCCCcCCCCCCCCCCCCCC
Q 005224 670 SKEETPPSSSSMLKHPYVSSDVSGS 694 (707)
Q Consensus 670 ~dP~~R~sa~e~L~Hp~f~~~~~~~ 694 (707)
.+|++|+|++|+|.||||.+....-
T Consensus 299 ~~P~~R~s~~~~l~~~~~~~~~~~~ 323 (335)
T PTZ00024 299 LNPLERISAKEALKHEYFKSDPLPC 323 (335)
T ss_pred CCchhccCHHHHhcCcccCCCCCCC
Confidence 9999999999999999999887653
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=301.30 Aligned_cols=203 Identities=32% Similarity=0.452 Sum_probs=172.9
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCC------
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG------ 444 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~------ 444 (707)
.+++|++.+.||+|+||+||+|..+ +++.|++|++..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4688999999999999999999975 678999999876443 346789999999999 7999999999996644
Q ss_pred eEEEEEecCCCCCHHHHHhhcC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987533 456899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhcc-----CCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
+....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 160 SAQLDSTL-------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ceecccch-------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 87643211 11223458889999999854 35678999999999999999999999643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.98 Aligned_cols=278 Identities=26% Similarity=0.405 Sum_probs=208.4
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
|+..+.||+|++|.||+|... +++.+++|.+...... ....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999965 7899999998754332 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 65 8888886643 46899999999999999999999998 9999999999999999999999999997664321
Q ss_pred ccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ........ ...
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~----------~~~ 217 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRT----------LGT 217 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH----------cCC
Confidence 111234577889999999876 78999999999999999999999996554422 21111100 000
Q ss_pred CChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 613 YPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~R-Pt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
...+....+.+.+..+....+... ....++. +..+....+|+.+|+..||.+||++++++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF----------PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred CchHhcccchhhhhhhhhhhccccccCHHHhh----------hhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 111111112221111111112111 1221111 2234556689999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.57 Aligned_cols=246 Identities=26% Similarity=0.420 Sum_probs=194.1
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
-|+..+.||+|+||.||+|... +++.||+|....... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667889999999999999864 789999998865332 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch---
Confidence 99999999854 35889999999999999999999998 9999999999999999999999999987654321
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
.......++..|+|||.+.+..++.++|||||||++|||++|..||..... ...... +........
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~---------~~~~~~~~~ 221 (277)
T cd06641 156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-MKVLFL---------IPKNNPPTL 221 (277)
T ss_pred ----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-HHHHHH---------HhcCCCCCC
Confidence 112234578899999999988899999999999999999999999864332 111111 011111223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
+..++..+.+++.+|++.+|.+||++.++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 3344455666666777666666666666655
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.86 Aligned_cols=201 Identities=30% Similarity=0.436 Sum_probs=177.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|++.+.||+|++|.||+|... +++.||||++..... ...+.+.+|++.+++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999976 599999999876544 3457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~- 154 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL- 154 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC-
Confidence 9999999999754 468999999999999999999999 88 9999999999999999999999999988654322
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 155 ------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 ------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 11123457889999999999999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=307.90 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=199.2
Q ss_pred cceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCH
Q 005224 380 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
..+||+|+||.||+|... +++.||||.+........+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 467999999999999974 7899999998665545566789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccc
Q 005224 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538 (707)
Q Consensus 459 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 538 (707)
.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 105 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------~ 171 (292)
T cd06657 105 TDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------P 171 (292)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-------c
Confidence 998743 24889999999999999999999998 9999999999999999999999999887543211 1
Q ss_pred eecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 005224 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618 (707)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (707)
......|+..|+|||++.+..++.++||||||+++|||++|..||...... ...
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~------------------------- 225 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAM------------------------- 225 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH-------------------------
Confidence 122345788999999998888999999999999999999999998643221 100
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 619 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 619 ~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
..+..++.... ......+....+++.+||+.+|.+|+++.++|+||||.....
T Consensus 226 ----~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 226 ----KMIRDNLPPKL-----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred ----HHHHhhCCccc-----------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 00111110000 000111222336778888889999999999999999876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.52 Aligned_cols=201 Identities=27% Similarity=0.450 Sum_probs=170.1
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh----------hHHHHHHHHHHHHccCCCcceeEEEEEEeCC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ----------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 444 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~----------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 444 (707)
+|...+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999854 7899999987532111 1245788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999765 35899999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCC--CCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
....... ........|+..|+|||.+.... ++.++||||||+++||+++|..||...
T Consensus 157 ~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 157 KSDDIYD-----NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred ccccccc-----ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 6432110 11123345788999999988754 889999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.05 Aligned_cols=198 Identities=29% Similarity=0.470 Sum_probs=171.1
Q ss_pred CCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHccC---CCcceeEEEEEEeCCeEEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|+.+++.++ |+|++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999996 478999999986542 233467889999999996 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998543 5899999999999999999999998 9999999999999999999999999998664322
Q ss_pred CCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus 156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 156 -------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred -------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11223458889999999875 45788999999999999999999999643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.50 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=190.3
Q ss_pred eEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHH---HHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 382 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQ---FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 382 ~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~---~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
.||+|+||.||+|... +++.||+|.+...... ....+..|.. .++...|++|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999964 6899999988653321 1223444443 4445579999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc-----
Confidence 99999988653 35899999999999999999999988 999999999999999999999999998754321
Q ss_pred cccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
......|+..|+|||++.++ .++.++||||+||++|||++|+.||........
T Consensus 151 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~---------------------- 204 (278)
T cd05606 151 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---------------------- 204 (278)
T ss_pred ----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----------------------
Confidence 11234689999999999754 689999999999999999999999964321000
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC-----CCCcCCCCCCCC
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKHPYVS 688 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~Hp~f~ 688 (707)
....+... . .++.. ....+....+++.+||..+|++|+ +++++++||||.
T Consensus 205 -----~~~~~~~~---~----~~~~~-------------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~ 259 (278)
T cd05606 205 -----HEIDRMTL---T----MAVEL-------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259 (278)
T ss_pred -----HHHHHHhh---c----cCCCC-------------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence 00000000 0 00000 011233445778888888888888 899999999998
Q ss_pred CCCCC
Q 005224 689 SDVSG 693 (707)
Q Consensus 689 ~~~~~ 693 (707)
...+.
T Consensus 260 ~~~~~ 264 (278)
T cd05606 260 SLDWQ 264 (278)
T ss_pred CCCch
Confidence 76653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.77 Aligned_cols=283 Identities=25% Similarity=0.373 Sum_probs=207.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC-----Ce
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 445 (707)
.++|.+.+.||+|+||+||+|... +++.||||.+... .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999964 7899999988653 223345678899999999999999999988544 35
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7899988653 45899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
..... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||..... ........ .
T Consensus 158 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~------~ 223 (337)
T cd07858 158 TSEKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLIT------E 223 (337)
T ss_pred cCCCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHH------H
Confidence 54321 11223457889999999875 5689999999999999999999999964432 11111110 0
Q ss_pred hccCCCCCCChHHH-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCC
Q 005224 605 VIDGNMGSYPSECV-----EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 679 (707)
Q Consensus 605 ~~~~~~~~~~~~~~-----~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~ 679 (707)
... ..+.+.. ....+.+. +.....++... ...+...+...+++.+||+.+|++|||++
T Consensus 224 ~~~----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rps~~ 286 (337)
T cd07858 224 LLG----SPSEEDLGFIRNEKARRYIR---SLPYTPRQSFA----------RLFPHANPLAIDLLEKMLVFDPSKRITVE 286 (337)
T ss_pred HhC----CCChHHhhhcCchhhhHHHH---hcCcccccCHH----------HHcccCCHHHHHHHHHHhcCChhhccCHH
Confidence 000 0000000 00000000 00011111111 12234455667999999999999999999
Q ss_pred cCCCCCCCCCCCCC
Q 005224 680 SMLKHPYVSSDVSG 693 (707)
Q Consensus 680 e~L~Hp~f~~~~~~ 693 (707)
|+|+||||......
T Consensus 287 ell~h~~~~~~~~~ 300 (337)
T cd07858 287 EALAHPYLASLHDP 300 (337)
T ss_pred HHHcCcchhhhcCc
Confidence 99999999875443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.89 Aligned_cols=200 Identities=26% Similarity=0.432 Sum_probs=175.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 68889999999999999999854 78899999987554445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--- 169 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc---
Confidence 999999998643 4789999999999999999999998 9999999999999999999999999987554321
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.......+++.|+|||.+....++.++|||||||++||+++|+.||....
T Consensus 170 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred ----cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457889999999998889999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.92 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=204.2
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 449 (707)
++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999975 79999999986532 223467889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997643 5999999999999999999999998 999999999999999999999999999866433
Q ss_pred CCCCcc-------------ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005224 530 DIEGIV-------------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 596 (707)
Q Consensus 530 ~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~ 596 (707)
...... .........++..|+|||...+..++.++||||||++++++++|+.||........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----- 230 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT----- 230 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-----
Confidence 211000 01122334578899999999988899999999999999999999999964332100
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 676 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 676 (707)
+..+....+. .....++...+|+.+||+.+|++||
T Consensus 231 ------------------------~~~~~~~~~~---------------------~~~~~~~~~~~li~~~l~~~p~~R~ 265 (280)
T cd05581 231 ------------------------FQKILKLEYS---------------------FPPNFPPDAKDLIEKLLVLDPQDRL 265 (280)
T ss_pred ------------------------HHHHHhcCCC---------------------CCCccCHHHHHHHHHHhcCCHhhCC
Confidence 0000000000 0011123345788889999999999
Q ss_pred CC----CcCCCCCCC
Q 005224 677 SS----SSMLKHPYV 687 (707)
Q Consensus 677 sa----~e~L~Hp~f 687 (707)
|+ +++|+||||
T Consensus 266 ~~~~~~~~ll~~~~~ 280 (280)
T cd05581 266 GVNEGYDELKAHPFF 280 (280)
T ss_pred CcccCHHHHhcCCCC
Confidence 99 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=313.54 Aligned_cols=281 Identities=22% Similarity=0.354 Sum_probs=206.7
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC-----
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 444 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 444 (707)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999954 78999999986432 223456889999999999999999999986543
Q ss_pred -eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 445 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 445 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 468999999 7799888853 35899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
...... .....++..|+|||.+.+ ..++.++|||||||++|++++|+.||........ .......
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~--- 231 (343)
T cd07880 166 RQTDSE----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKV--- 231 (343)
T ss_pred cccccC----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh---
Confidence 754321 123356889999999876 4688999999999999999999999975443211 1111000
Q ss_pred hhhccCCCCCCChHHHHHHHHH-HHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKL-ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 681 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l-~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 681 (707)
....+.+....+..- ...-...-|..++. + +....+...+...++|.+||..||++|+|+.++
T Consensus 232 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~ 295 (343)
T cd07880 232 -------TGTPSKEFVQKLQSEDAKNYVKKLPRFRKK--D-------FRSLLPNANPLAVNVLEKMLVLDAESRITAAEA 295 (343)
T ss_pred -------cCCCCHHHHHhhcchhHHHHHHhccccCcc--h-------HHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence 001122221111100 00000001111111 0 111123445566789999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 682 LKHPYVSSD 690 (707)
Q Consensus 682 L~Hp~f~~~ 690 (707)
++||||.+.
T Consensus 296 l~~~~~~~~ 304 (343)
T cd07880 296 LAHPYFEEF 304 (343)
T ss_pred hcCccHhhh
Confidence 999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.36 Aligned_cols=204 Identities=26% Similarity=0.363 Sum_probs=173.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
...|++.++||+||.+.||++...+.+.||+|++... +.....-|..|+..|.++ .|.+||++++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3468889999999999999999888899999987643 333356799999999999 5999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||= ..+|..+|.........| .++.+..|++.++.++|+++ |||.||||.|+|+-+ |.+||+|||+|.....+.
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 986 569999998877666666 78899999999999999999 999999999999965 689999999998765432
Q ss_pred CCCccccceecccccCCCccchhhhccC-----------CCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-----------KLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
..-.....+||+.||+||.+... +.+.++||||+||+||+|+.|+.||..-.+
T Consensus 514 -----TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 514 -----TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred -----cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 12334567899999999999643 256789999999999999999999975444
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.39 Aligned_cols=277 Identities=28% Similarity=0.433 Sum_probs=205.6
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|+++++.++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 58999999987643 223467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
+ ++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||.++......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 152 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--- 152 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc---
Confidence 7 59999997653 45999999999999999999999998 9999999999999999999999999997654321
Q ss_pred ccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ......... ...
T Consensus 153 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~----------~~~ 217 (282)
T cd07829 153 ----RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQI----------LGT 217 (282)
T ss_pred ----cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHH----------hCC
Confidence 112223456789999999876 8899999999999999999999888654432 111111000 000
Q ss_pred CChHHHHHHHHHH-HHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 613 YPSECVEKFIKLA-LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 613 ~~~~~~~~l~~l~-~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
........+.++. ..+.. +..... .....++..+....+++.+||..||++||++++++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~--~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 218 PTEESWPGVTKLPDYKPTF--PKFPPK---------DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CcHHHHHhhcccccccccc--cccCcc---------chHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111111111110 00000 000000 0011223335567789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=302.05 Aligned_cols=244 Identities=30% Similarity=0.468 Sum_probs=187.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
+.|+..+.||+|+||+||+|... +++.||+|.+..... ...+++.+|+++++.++||||++++++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 46888999999999999999965 689999998864322 23457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9996 68878775433 35899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCCccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
....++..|+|||++. ...++.++||||||+++|||++|+.||............ ..
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~----------~~ 228 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----------AQ 228 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH----------hc
Confidence 1235778999999884 356888999999999999999999998654432211110 00
Q ss_pred CCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 608 GNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 608 ~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
..... .+..++..+.+++.+||+.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 229 NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11111 12233445555555555555555555555543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.93 Aligned_cols=290 Identities=25% Similarity=0.394 Sum_probs=208.8
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC--CeE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE--GEQ 446 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~--~~~ 446 (707)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999975 6889999988542 223345677899999999 999999999998654 368
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||++ ++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 5999988653 5889999999999999999999988 999999999999999999999999999866
Q ss_pred CCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
....... .........|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... ........
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~------ 228 (337)
T cd07852 158 SELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEV------ 228 (337)
T ss_pred ccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH------
Confidence 4322110 0112233568899999998865 567889999999999999999999996543321 11111000
Q ss_pred ccCCCCCCChHHHHHHH-HHHHHhcccCC-CCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCC
Q 005224 606 IDGNMGSYPSECVEKFI-KLALKCCQDET-DARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 683 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~-~l~~~c~~~~p-~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 683 (707)
.+..+.+....+. .....++...+ ..++.+. ...+..+....+|+.+|++.||++|||+.++++
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 229 ----IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD----------ELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred ----hCCCCHHHHHHHHhhhHHHhhhhcccccccchh----------hhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0111111111111 11111111111 1111111 112333455678999999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 684 HPYVSSDVS 692 (707)
Q Consensus 684 Hp~f~~~~~ 692 (707)
||||..-..
T Consensus 295 ~~~~~~~~~ 303 (337)
T cd07852 295 HPYVAQFHN 303 (337)
T ss_pred Chhhhhhcc
Confidence 999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=305.20 Aligned_cols=198 Identities=27% Similarity=0.370 Sum_probs=169.0
Q ss_pred CCCccceEeeeCceEEEEEEe----CCCcEEEEEEeccCCh----hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeE
Q 005224 376 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 446 (707)
+|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 3689999999875322 2235678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999999654 35889999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCccccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCCC
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPIS 584 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf~ 584 (707)
...+. .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.
T Consensus 156 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 156 HEDEV------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred ccccc------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 33221 11223458889999999875 346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.66 Aligned_cols=203 Identities=28% Similarity=0.437 Sum_probs=177.8
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++.|+..+.||+|+||.||+|..+ +++.||+|++..... ..+.+.+|+++++.++|+|++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 689999999976544 45678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999997654 46999999999999999999999988 9999999999999999999999999986543211
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 171 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 171 ------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred ------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457889999999998889999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.85 Aligned_cols=279 Identities=26% Similarity=0.384 Sum_probs=204.2
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEEecC
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
|++.+.||+|+||+||+|... +++.||||++..... .......+|+..+++++ |+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 588999999865432 22334567999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
+|+|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 889999997765557899999999999999999999998 9999999999999999999999999997653221
Q ss_pred ccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
......++..|+|||++.+ ..++.++||||||++++||++|+.||....... ...... ... ..
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~------~~~----~~ 217 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKIC------SVL----GT 217 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHH------Hhc----CC
Confidence 1123457889999998854 567899999999999999999999986543211 111100 000 01
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
...+....-..+. ..+...-..++.. + + ....+.......+|+.+|++.+|++|||++|++.||||
T Consensus 218 ~~~~~~~~~~~~~-~~~~~~~~~~~~~-~----~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 218 PTKQDWPEGYKLA-SKLGFRFPQFAPT-S----L---HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred CChhhhhhHhhhh-ccccccccccccc-c----H---HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 1111111101110 0111000000000 0 0 11122334556789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=299.20 Aligned_cols=248 Identities=23% Similarity=0.293 Sum_probs=190.8
Q ss_pred ceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHH-HccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFL-SRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||.||+|... +++.||+|.+....... ...+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999964 68999999987543221 23344555544 445899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9999999654 35889999999999999999999998 99999999999999999999999999875422
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (707)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...... ....
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~--------------------- 203 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFD--------------------- 203 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHH---------------------
Confidence 12335788999999999888999999999999999999999999643221 0000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCC---CcCCCCCCCCCC
Q 005224 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS---SSMLKHPYVSSD 690 (707)
Q Consensus 616 ~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa---~e~L~Hp~f~~~ 690 (707)
.+....... .+. .....++...+++.+||+.+|++|+++ +|+|.||||..-
T Consensus 204 -------~~~~~~~~~----~~~-------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 204 -------NILSRRINW----PEE-------------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred -------HHHhcccCC----CCc-------------ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 000000000 000 001123345578899999999999977 599999999654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.70 Aligned_cols=292 Identities=21% Similarity=0.218 Sum_probs=200.3
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCC
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 457 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 457 (707)
.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555544 7899999998754 23345689999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcccc
Q 005224 458 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 537 (707)
Q Consensus 458 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 537 (707)
|.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+..............
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999998765566899999999999999999999998 99999999999999999999999999875533221111111
Q ss_pred ceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 005224 538 HVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615 (707)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (707)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||............. . ......++... .+.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~-~-~~~~~~~~~~~--~~~ 238 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-R-GTVPCLLDKST--YPL 238 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-h-ccCccccccCc--hhh
Confidence 11233456788999999976 458899999999999999999999997654322211111 0 00000111000 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 616 ECVEKFIKLALKCCQDETDARPSMS-EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 616 ~~~~~l~~l~~~c~~~~p~~RPt~~-~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
.. ..+.+ .+ .+..-+... ..-.... ...+....+|+.+||.+||++|||++|+|+||||...-.
T Consensus 239 ~~-~~~~~---~~---~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~ 303 (314)
T cd08216 239 YE-DSMSQ---SR---SSNEHPNNRDSVDHPYT------RTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR 303 (314)
T ss_pred hc-CCcCc---cc---ccccccchhhhhhcchh------hHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence 00 00000 00 000000000 0000000 011223457899999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=283.42 Aligned_cols=247 Identities=24% Similarity=0.392 Sum_probs=190.5
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEEecC
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.+....||.|+.|.||++..+ +|..+|||.+.... .+..++++..++++..-+ +|+||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344677999999999999976 68999999987643 444578888888877764 999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
. -.+..++++ -..++++...-++...+.+||.||.+++ .|+|||+||+|||+|+.|++|++|||++-.+...
T Consensus 174 s-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---- 245 (391)
T KOG0983|consen 174 S-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---- 245 (391)
T ss_pred H-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc----
Confidence 3 356666654 3456999999999999999999998865 4999999999999999999999999999766432
Q ss_pred ccccceecccccCCCccchhhhcc---CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
...+...|.+.|||||.+.- ..|+.++||||||++++||.||+.||...+...+.+..+ .+.+.
T Consensus 246 ----kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv---------ln~eP 312 (391)
T KOG0983|consen 246 ----KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV---------LNEEP 312 (391)
T ss_pred ----cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH---------HhcCC
Confidence 33445678999999999964 578889999999999999999999997644332222221 12111
Q ss_pred CC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 611 GS--YPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 611 ~~--~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
+. ....++..+.+++..|+++|+.+||...++++
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11 11225566666666777766666666666554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=307.03 Aligned_cols=299 Identities=20% Similarity=0.266 Sum_probs=206.4
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccC-----C---CcceeEEEEEEeC-
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----H---RNLVSLVGYCDEE- 443 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~~~~~~~- 443 (707)
..+|.+.++||-|.|++||+|.+ .+.+.||+|+.+... ...+..+.||++|++++ | .+||+|++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36899999999999999999985 478899999998633 34567889999999984 3 3699999999654
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--------
Q 005224 444 ---GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-------- 512 (707)
Q Consensus 444 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-------- 512 (707)
.+.|||+|++ |-+|..+|....-+.++...+++|++||+.||.|||.++ +|||.||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence 5899999999 779999998877778999999999999999999999987 49999999999999100
Q ss_pred --------------------------------------------------------------------------------
Q 005224 513 -------------------------------------------------------------------------------- 512 (707)
Q Consensus 513 -------------------------------------------------------------------------------- 512 (707)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------Cc
Q 005224 513 ------------------------------------------------------------------------------FT 514 (707)
Q Consensus 513 ------------------------------------------------------------------------------~~ 514 (707)
.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 01
Q ss_pred EEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch---hHH
Q 005224 515 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVR 591 (707)
Q Consensus 515 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~---~~~ 591 (707)
+||+|||-|+.... ..+.-..|..|+|||++.+..|+..+||||++|++|||+||...|++... ..+
T Consensus 393 vKIaDlGNACW~~k----------hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD 462 (590)
T KOG1290|consen 393 VKIADLGNACWVHK----------HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD 462 (590)
T ss_pred EEEeeccchhhhhh----------hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence 34444444443221 11223468899999999999999999999999999999999999964211 111
Q ss_pred HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCC
Q 005224 592 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSK 671 (707)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~d 671 (707)
+...+...+.+..+-. .+ ......+.+++.--...-+..--+-....+| |.+...-..+...++.|||..||+++
T Consensus 463 EDHiA~i~ELLG~iPr-~i-a~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~V---L~eKY~~s~e~A~~fsdFL~PmLef~ 537 (590)
T KOG1290|consen 463 EDHIALIMELLGKIPR-KI-ALGGKYSRDFFNRRGELRHIRRLKPWPLYEV---LIEKYEWSEEDAQQFSDFLSPMLEFD 537 (590)
T ss_pred HHHHHHHHHHHhhccH-HH-HhcCcchHhhhccccceecccccCCCcHHHH---HHHHhCCCHHHHHHHHHHHHHHHhcC
Confidence 1111111111100000 00 0000111111111100001110111233333 33333333344567789999999999
Q ss_pred CCCCCCCCcCCCCCCCCCCC
Q 005224 672 EETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 672 P~~R~sa~e~L~Hp~f~~~~ 691 (707)
|++|+||.++|+|||++...
T Consensus 538 PeKR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 538 PEKRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred ccccccHHHHhcCccccCCC
Confidence 99999999999999998543
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=290.62 Aligned_cols=199 Identities=34% Similarity=0.515 Sum_probs=177.0
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
+|+..+.||+|++|.||++... +++.|++|++........+.+.+|+++++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 789999999987655456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+++|.+++.... ..+++..+..++.|+++||+|||..+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999986643 46899999999999999999999988 99999999999999999999999999876543210
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.....++..|+|||++.+..++.++||||||+++++|++|+.||...
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23456788999999999888999999999999999999999999654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=303.83 Aligned_cols=198 Identities=28% Similarity=0.356 Sum_probs=168.5
Q ss_pred CCCccceEeeeCceEEEEEEe----CCCcEEEEEEeccCCh----hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeE
Q 005224 376 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 446 (707)
+|++.+.||+|+||.||++.. .+++.||||.+..... ...+.+.+|+++++++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999984 3578899999875322 2235688999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++|+|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998653 35889999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCC--CCCchhhHHHHHHHHHHHcCCCCCC
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPIS 584 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvll~elltG~~pf~ 584 (707)
.... ........|+..|+|||.+.+.. .+.++||||||+++|||++|..||.
T Consensus 156 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 156 LAEE------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred cccc------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 4322 11122345788999999987755 7889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=293.17 Aligned_cols=201 Identities=30% Similarity=0.514 Sum_probs=176.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|+||.||++... +++.||+|++..... ...+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999975 689999999876433 4456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 453 MSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 453 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
+++++|.+++.... ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 467999999999999999999999998 9999999999999999999999999997654321
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||...
T Consensus 158 -------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 -------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred -------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1223346788999999999989999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=330.30 Aligned_cols=265 Identities=28% Similarity=0.476 Sum_probs=218.6
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC----C----CcEEEEEEeccCChh-hHHHHHHHHHHHHcc-CCCcceeEEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP----D----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSLVG 438 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~nIv~l~~ 438 (707)
.++...++..+.+.||+|.||.||+|... . ...||||.++..... ..+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45555666667779999999999999843 1 457999999865433 457899999999999 6999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcC------------C--CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005224 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKS------------K--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 504 (707)
Q Consensus 439 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 504 (707)
+|...+..++|+||+..|+|.++++... . ..+.....+.++.|||.|++||++.. +|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998754 0 23889999999999999999999988 99999999
Q ss_pred CCEEEcCCCcEEEeeecccccCCCCCCCCccccceeccccc--CCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCC
Q 005224 505 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG--TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 581 (707)
Q Consensus 505 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~ 581 (707)
+|||+.++..+||+|||+|+.....+.. ......| +..|||||.+....|+.++|||||||+|||++| |..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y------~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYY------RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCce------EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 9999999999999999999975543321 1111122 346999999999999999999999999999999 889
Q ss_pred CCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 582 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 582 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
||.......+. ...+.++.+...|..|..+++++|..||+.+|++||++.++.+.++....
T Consensus 521 PYp~~~~~~~l---------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 521 PYPGIPPTEEL---------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCcHHHH---------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 99652211111 11344566777899999999999999999999999999999999988543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=303.84 Aligned_cols=205 Identities=24% Similarity=0.297 Sum_probs=165.9
Q ss_pred ceEeee--CceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
..||+| +||+||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||++++++|...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999964 79999999987533 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|++||+.+............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999998765566899999999999999999999998 999999999999999999999999865433211100000
Q ss_pred ccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 215 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR 215 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh
Confidence 0000111234667999999976 4578999999999999999999999975543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=342.74 Aligned_cols=254 Identities=27% Similarity=0.381 Sum_probs=208.9
Q ss_pred hcCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
+-++....+||.|.||.||.|. .++|...|+|-+.... ....+.+.+|+.++..++|||+|+++|+=.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4567778899999999999999 5689999999775432 223467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
|||++|+|.+++... ...++.....+..|++.|++|||+++ ||||||||.||+++.+|.+|++|||.|......-
T Consensus 1314 EyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999999543 34777788889999999999999999 9999999999999999999999999998765431
Q ss_pred CCCccccceecccccCCCccchhhhccC---CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
... ........||+.|||||++.+. ....+.||||+|||+.||+||++||..-++. ...++.+..
T Consensus 1389 --~~~-~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1389 --QTM-PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------WAIMYHVAA 1456 (1509)
T ss_pred --hcC-CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------hHHHhHHhc
Confidence 111 1223467899999999999863 4556899999999999999999999754431 234567777
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
+..+++|+....+=.+++..|++.||+.|.++.|+++
T Consensus 1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 7778888887777788888888888888877665543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=298.59 Aligned_cols=264 Identities=14% Similarity=0.160 Sum_probs=189.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeCC----CcEEEEEEeccCChhh--H---------HHHHHHHHHHHccCCCcceeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQG--E---------KEFLTEIQFLSRLHHRNLVSLVG 438 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~--~---------~~~~~E~~~l~~l~H~nIv~l~~ 438 (707)
.++|.+.+.||+|+||+||+|...+ +..+|+|+........ + .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4679999999999999999999653 4567777543222111 1 11223445566778999999999
Q ss_pred EEEeCC----eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 005224 439 YCDEEG----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 514 (707)
Q Consensus 439 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 514 (707)
++.... ..++++|++. .++.+.+... ...++..+..++.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 775543 4578888874 4777776543 23578889999999999999999998 999999999999999999
Q ss_pred EEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005224 515 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 594 (707)
Q Consensus 515 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~ 594 (707)
+||+|||+|+....................||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999986643221111111122334699999999999999999999999999999999999999975432111111
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 595 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
... .+....+..+.. ....++..+.+++..|++.+|++||++.++.+.+
T Consensus 245 ~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAK-CDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhH-HHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 100 000111111111 1223467799999999999999999999998765
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.54 Aligned_cols=199 Identities=29% Similarity=0.410 Sum_probs=165.6
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++.++. |+||+++++++..++..++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999965 689999999875332 34567889999999996 99999999999999999999999
Q ss_pred CCCCCHHHHH---hhcCCCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 453 MSNGTLRDQL---SAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 453 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
+. +++.++. .......+++..+..++.++++||+|||+. + |+||||||+||++++++.+||+|||+++....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 4665543 233345699999999999999999999975 6 99999999999999999999999999975432
Q ss_pred CCCCCccccceecccccCCCccchhhhccC---CCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 161 SI--------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred CC--------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 21 11233578899999999876 6899999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=291.48 Aligned_cols=268 Identities=23% Similarity=0.335 Sum_probs=224.4
Q ss_pred HHHHHHHhcCCCccceEeeeCceEEEEEEeCC------CcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEE
Q 005224 367 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGY 439 (707)
Q Consensus 367 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~ 439 (707)
..++....++++....+-+|.||.||.|.|++ .+.|.||.++.... .....+..|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 35677778889999999999999999998653 34577887765432 234578899999999999999999999
Q ss_pred EEeC-CeEEEEEecCCCCCHHHHHhh------cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 005224 440 CDEE-GEQMLVYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 512 (707)
Q Consensus 440 ~~~~-~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~ 512 (707)
+.++ ...+++|.++.-|+|..+|.. ...+.+...+...++.|++.|++|||+++ |||.||.++|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8554 577899999999999999972 34456788889999999999999999999 9999999999999999
Q ss_pred CcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHH
Q 005224 513 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 591 (707)
Q Consensus 513 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~ 591 (707)
.++||+|=.+++.+-+.|++... .....+..||+||.+....|+.++|||||||+||||+| |+.|+..-+..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLG-----DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-- 505 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLG-----DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-- 505 (563)
T ss_pred eeEEeccchhccccCcccccccC-----CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--
Confidence 99999999999988777654322 12235678999999999999999999999999999999 99999754432
Q ss_pred HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 592 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
+....+.|+.+...|-+|+++++.+|..||...|++||++++++.-|.++...
T Consensus 506 --------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 506 --------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred --------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 22234567777788999999999999999999999999999999998876543
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=289.99 Aligned_cols=202 Identities=29% Similarity=0.449 Sum_probs=176.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeEEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVY 450 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 450 (707)
+|+..+.||+|++|.||+|..+ +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 789999999876443 3457889999999999999999999999888 8999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++++|.+++.... .+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997654 6999999999999999999999988 9999999999999999999999999998765432
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.. .......++..|+|||.+.+..++.++||||||+++++|++|..||....
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 10 01234567889999999998889999999999999999999999997544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=314.05 Aligned_cols=282 Identities=22% Similarity=0.353 Sum_probs=207.6
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe----
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE---- 445 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---- 445 (707)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3568999999999999999999975 68899999986532 2234567889999999999999999998765554
Q ss_pred --EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 446 --QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 446 --~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 6799999864 35899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+......
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~--- 231 (343)
T cd07851 166 RHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNL--- 231 (343)
T ss_pred cccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHh---
Confidence 765321 123357888999999875 46788999999999999999999999754432 222211110
Q ss_pred hhhccCCCCCCChHHHHHHHHH-H-HHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 603 FSVIDGNMGSYPSECVEKFIKL-A-LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l-~-~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
....++.....+..- . ..+.......++...++ .+..+....||+.+||..||++|||++|
T Consensus 232 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 232 -------VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV----------FSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred -------cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHH----------hccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 011111111111000 0 00000011111222111 1233556779999999999999999999
Q ss_pred CCCCCCCCCCCC
Q 005224 681 MLKHPYVSSDVS 692 (707)
Q Consensus 681 ~L~Hp~f~~~~~ 692 (707)
+++||||..-..
T Consensus 295 ll~h~~~~~~~~ 306 (343)
T cd07851 295 ALAHPYLAEYHD 306 (343)
T ss_pred HhcCCCccccCC
Confidence 999999976444
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.75 Aligned_cols=287 Identities=24% Similarity=0.364 Sum_probs=208.2
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEe-CC
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EG 444 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~ 444 (707)
++...+++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44567889999999999999999999965 78999999875422 2234678899999999999999999999865 55
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..++|+||+ +++|.+++.. ..+++.....++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||.+.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999999 5699888853 34788888999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||......... ....
T Consensus 157 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~-~~~~------ 219 (328)
T cd07856 157 IQDPQ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF-SIIT------ 219 (328)
T ss_pred ccCCC----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH------
Confidence 54221 122356788999999866 57899999999999999999999999654321111 0000
Q ss_pred hhccCCCCCCChHHHHHHHH-HHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 604 SVIDGNMGSYPSECVEKFIK-LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~-l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
...+..+.+....+.. -....+..-+...+.. .....+..+....+++.+||+.+|++|+|+++++
T Consensus 220 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 220 ----DLLGTPPDDVINTICSENTLRFVQSLPKREPVP---------FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred ----HHhCCCCHHHHHhccchhhHHHHhhccccCCCc---------HHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0011112111111000 0000011111111100 0012233445567899999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 683 KHPYVSSDVS 692 (707)
Q Consensus 683 ~Hp~f~~~~~ 692 (707)
.||||.....
T Consensus 287 ~~~~~~~~~~ 296 (328)
T cd07856 287 AHPYLAPYHD 296 (328)
T ss_pred cCCccccccC
Confidence 9999965444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=292.81 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=193.0
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|++.+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788999999999999999864 78899999987533 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 453 MSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 453 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998662 2356899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... . ... .+.....
T Consensus 157 --------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~-~~~--------~~~~~~~ 218 (256)
T cd08530 157 --------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-D-LRY--------KVQRGKY 218 (256)
T ss_pred --------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H-HHH--------HHhcCCC
Confidence 112245788999999999999999999999999999999999999654321 1 000 0111222
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVM 643 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~ 643 (707)
...+..+...+.+++.+|++.+|++||++.+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 251 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 223334445555555555555555555555544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=290.27 Aligned_cols=200 Identities=32% Similarity=0.521 Sum_probs=175.8
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 688999999876544 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 9999999999654 46899999999999999999999998 99999999999999999999999999987643221
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
......++..|+|||...+..++.++||||+|+++|+|++|+.||....
T Consensus 155 ------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 155 ------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred ------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1233457889999999988888999999999999999999999986443
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.77 Aligned_cols=282 Identities=24% Similarity=0.327 Sum_probs=201.5
Q ss_pred CCCccceEeeeCceEEEEEEeC-C--CcEEEEEEeccCC--hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC----Ce
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-D--GTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE----GE 445 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~ 445 (707)
+|++.+.||+|+||.||++... + +..||+|++.... ....+.+.+|+++++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999965 4 7899999886432 22346788999999999 599999999975432 45
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++++||+. ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788999985 699998854 345899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
....... .........|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...... .........
T Consensus 155 ~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~----- 225 (332)
T cd07857 155 FSENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQV----- 225 (332)
T ss_pred ccccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHH-----
Confidence 5432211 0111233568899999998866 56899999999999999999999998654321 111111000
Q ss_pred hccCCCCCCChHHHHHHHH----HHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 605 VIDGNMGSYPSECVEKFIK----LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~----l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
.+..+.+....+.. ....-....+ ++.+ ....+..+....+|+.+||..||++|+|++|
T Consensus 226 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----------~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 288 (332)
T cd07857 226 -----LGTPDEETLSRIGSPKAQNYIRSLPNIP--KKPF----------ESIFPNANPLALDLLEKLLAFDPTKRISVEE 288 (332)
T ss_pred -----hCCCCHHHHHhhhhhhHHHHHHhccccC--Ccch----------HhhCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 00111111111100 0000000000 0000 0112333455678999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 681 MLKHPYVSS 689 (707)
Q Consensus 681 ~L~Hp~f~~ 689 (707)
++.||||..
T Consensus 289 ll~~~~~~~ 297 (332)
T cd07857 289 ALEHPYLAI 297 (332)
T ss_pred HhcChhhhh
Confidence 999999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.83 Aligned_cols=202 Identities=29% Similarity=0.439 Sum_probs=170.7
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC-----ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 446 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 446 (707)
.+|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999964 6899999987532 122345788999999999999999999998654 468
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++|+||+++++|.+++.... .+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999986543 4789999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 157 QTICMS----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred cccccc----CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 321110 1112234588999999999998899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=292.50 Aligned_cols=284 Identities=24% Similarity=0.346 Sum_probs=215.5
Q ss_pred CccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC-----CeEEEE
Q 005224 378 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQMLV 449 (707)
Q Consensus 378 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lV 449 (707)
+..+.||.|+||.||...++ +|+.||.|++... +....+.+.+|+++|..++|.|++..++..... .++|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34678999999999999964 8999999998752 334457899999999999999999998887544 367888
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
+|.|. .+|..++ -+.+.++.+.++-+.+||++||+|||+.+ |.||||||.|.|++++...||+|||+|+..+.+
T Consensus 136 TELmQ-SDLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELMQ-SDLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHH-hhhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 99984 5888877 45677999999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
+ ....+..+-|..|+|||++++ ..|+.+.||||.||++.|++.++..|..... .+++..+ ..
T Consensus 210 ~------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-iqQL~lI----------td 272 (449)
T KOG0664|consen 210 D------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-IEQLQMI----------ID 272 (449)
T ss_pred h------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-HHHHHHH----------HH
Confidence 3 223344556889999999998 5799999999999999999988877754333 3333221 12
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
.++....+.+.-..+-++.-+-..+.+-|+..-+.. |. .......+..+++.+||..||++|++.++++.|+|..
T Consensus 273 LLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYt-ls----S~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 273 LLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYK-IA----SPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred HhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceee-ec----CCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 233334444444444444444444555555543221 11 1112333456789999999999999999999999974
Q ss_pred C
Q 005224 689 S 689 (707)
Q Consensus 689 ~ 689 (707)
.
T Consensus 348 e 348 (449)
T KOG0664|consen 348 E 348 (449)
T ss_pred c
Confidence 3
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.58 Aligned_cols=244 Identities=30% Similarity=0.477 Sum_probs=193.4
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
|+..+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+++++.++|+|++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667889999999999999964 789999999864322 2335788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
++ |+|.+++... ..++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 96 5888877543 345899999999999999999999998 999999999999999999999999998654321
Q ss_pred CccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||........... +....
T Consensus 179 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----------~~~~~ 240 (317)
T cd06635 179 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----------IAQNE 240 (317)
T ss_pred --------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----------HHhcc
Confidence 1235788999999984 45788999999999999999999999865432211111 11111
Q ss_pred CC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 610 MG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 610 ~~-~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
.. .....++..+.+++.+|++.+|.+||++.++++..
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 11 12234556677888888888888888888777643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=296.81 Aligned_cols=206 Identities=23% Similarity=0.403 Sum_probs=175.7
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHH---HHHHHHHHHcc-CCCcceeEEEEEEeCCe
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL-HHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~---~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 445 (707)
+....+|..+.+||+|+||.|-+|..+ +.+.+|||+++..-.....+ -+.|-++|... +-|.++++..+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 344457888999999999999999966 56889999998654332222 24566777666 57899999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.|+||||+.||+|-..+++-+ .+.+..+..+|..||-||-|||+++ ||.||||.+|||+|.+|++||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 999999999999999887654 3778889999999999999999999 99999999999999999999999999974
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
- ..........+||+.|+|||++..++|+.++|+|||||+||||+.|+.||+..++
T Consensus 500 n-------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 500 N-------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred c-------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 2 2334556778999999999999999999999999999999999999999976543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=287.65 Aligned_cols=247 Identities=25% Similarity=0.388 Sum_probs=197.6
Q ss_pred cceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHc-cCCCcceeEEEEEEeCCeEEEEEecCCCC
Q 005224 380 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSR-LHHRNLVSLVGYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 456 (707)
...||.|+||+|+|-.++ .|+..|||++..... ...++++.|.+...+ -++||||++||.+..++..|+.||.| .-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 567999999999999975 799999999987655 445788889886554 47999999999999999999999999 45
Q ss_pred CHHHHHh---hcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 457 TLRDQLS---AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 457 sL~~~l~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
+|+.+-+ ......+++...-.|+.....||.||-+.. .|||||+||+|||+|..|.+|++|||++-.+..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~----- 220 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD----- 220 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH-----
Confidence 7765543 234456889999999999999999998754 499999999999999999999999999865532
Q ss_pred ccccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
+...+.-.|...|||||.+.. ..|+.+|||||+|++|||+.||+.|+..+.+..+++...... ++...
T Consensus 221 ---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g-------dpp~l 290 (361)
T KOG1006|consen 221 ---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG-------DPPIL 290 (361)
T ss_pred ---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC-------CCCee
Confidence 233445578899999999974 458999999999999999999999998887766665544322 12222
Q ss_pred CCChH---HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 612 SYPSE---CVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 612 ~~~~~---~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
.++.+ +...+...+..|+.++-..||.+.++.+
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 23333 5677888888888888888888877754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=292.45 Aligned_cols=243 Identities=27% Similarity=0.365 Sum_probs=195.2
Q ss_pred EeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCH
Q 005224 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 383 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
||+|+||.||++... +++.||+|.+...... ....+..|+++++.++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 5899999998764332 345788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccc
Q 005224 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538 (707)
Q Consensus 459 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 538 (707)
.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------~ 148 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-------S 148 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-------C
Confidence 99996543 5899999999999999999999988 9999999999999999999999999997654321 1
Q ss_pred eecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 005224 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618 (707)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (707)
......++..|+|||...+..++.++|+||||+++||+++|+.||..... ......
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~----------------------- 204 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEK----------------------- 204 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHH-----------------------
Confidence 22345578899999999988899999999999999999999999964332 100000
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCC---CcCCCCCCC
Q 005224 619 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS---SSMLKHPYV 687 (707)
Q Consensus 619 ~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa---~e~L~Hp~f 687 (707)
+. +. ++.+ .........+++.+|+..||++||++ +++++||||
T Consensus 205 ------~~---~~----~~~~-------------~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 205 ------IL---KD----PLRF-------------PEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ------Hh---cC----CCCC-------------CCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 00 00 0000 00012233468888899999999999 899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.86 Aligned_cols=199 Identities=29% Similarity=0.459 Sum_probs=166.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 450 (707)
-++|++.+.||+|+||.||+|..+ +++.||||.+..... .....+..|+.++.+.. |+||+++++++......++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 456888999999999999999986 489999999875432 23456777887777764 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
||++ +++.+++.... ..+++..+..++.|+++||+|||+ .+ |+||||+|+||++++++.+||+|||++......
T Consensus 94 e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 57877775533 368999999999999999999997 46 999999999999999999999999998765321
Q ss_pred CCCCccccceecccccCCCccchhhhccCC----CCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
. ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 169 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 169 K--------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred C--------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 1 112234678999999997654 78899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=328.88 Aligned_cols=146 Identities=25% Similarity=0.378 Sum_probs=131.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|.+.++||+|+||+||+|... +++.||||++..... .....+.+|+.+++.++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999975 789999999875332 22357889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
||+.+++|.+++... ..+++..++.++.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 999999999999654 34888999999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.41 Aligned_cols=271 Identities=20% Similarity=0.312 Sum_probs=187.0
Q ss_pred HhcCCCccceEeeeCceEEEEEEe-----------------CCCcEEEEEEeccCChhhHHH--------------HHHH
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGIL-----------------PDGTVVAVKRAQEGSLQGEKE--------------FLTE 421 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E 421 (707)
..++|++.++||+|+||+||+|.+ .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 245789999987543322223 3346
Q ss_pred HHHHHccCCCcc-----eeEEEEEEe--------CCeEEEEEecCCCCCHHHHHhhcC----------------------
Q 005224 422 IQFLSRLHHRNL-----VSLVGYCDE--------EGEQMLVYEFMSNGTLRDQLSAKS---------------------- 466 (707)
Q Consensus 422 ~~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------- 466 (707)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677887743 356899999999999999987421
Q ss_pred CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccC
Q 005224 467 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546 (707)
Q Consensus 467 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt 546 (707)
...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ........++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~------~~~~~~g~~t 373 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI------NFNPLYGMLD 373 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC------ccCccccCCC
Confidence 123467888999999999999999998 9999999999999999999999999997543211 0111122347
Q ss_pred CCccchhhhccCC--------------------C--CCchhhHHHHHHHHHHHcCCC-CCCCCchhHHHHHHHhhcccch
Q 005224 547 PGYLDPEYFLTHK--------------------L--TDKSDVYSLGVVFLELLTGMQ-PISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 547 ~~y~aPE~~~~~~--------------------~--s~~sDVwS~Gvll~elltG~~-pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
+.|+|||.+.... + ..+.||||+||+++||++|.. ||............
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-------- 445 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-------- 445 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh--------
Confidence 8999999986422 1 124799999999999999875 66422111110000
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCC---CCCCCCCc
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE---ETPPSSSS 680 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP---~~R~sa~e 680 (707)
+. ..... |......+..+. .....+....||+.+||+.+| .+|+|++|
T Consensus 446 ---------~~-~~~~~--------~r~~~~~~~~~~-----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 446 ---------YD-NDLNR--------WRMYKGQKYDFS-----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred ---------cc-chHHH--------HHhhcccCCCcc-----------cccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 00 00000 111111111111 122334556789999999766 78999999
Q ss_pred CCCCCCCCC
Q 005224 681 MLKHPYVSS 689 (707)
Q Consensus 681 ~L~Hp~f~~ 689 (707)
+|+||||..
T Consensus 497 aL~Hp~f~~ 505 (507)
T PLN03224 497 ALSHRFFLP 505 (507)
T ss_pred HhCCCCcCC
Confidence 999999964
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.84 Aligned_cols=276 Identities=24% Similarity=0.371 Sum_probs=211.6
Q ss_pred HHHhcCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCCh-hh------HHHHHHHHHHHHccCCCcceeEEEEEEe
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL-QG------EKEFLTEIQFLSRLHHRNLVSLVGYCDE 442 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 442 (707)
....++|-.++.||+|+|+.||+|. +...+.||||+-..... .+ .+...+|.++-+.+.||.||++|+||.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3445678888999999999999999 45789999998654322 22 2457789999999999999999999954
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEe
Q 005224 443 -EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVA 518 (707)
Q Consensus 443 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~ 518 (707)
.+..|-|+|||+|.+|+-+|+.+. .+++.+++.|+.||+.||.||.+. ++||||-||||.|||+. ..|.+||+
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 567889999999999999997643 489999999999999999999986 58899999999999994 45889999
Q ss_pred eecccccCCCCCCCCccccceecccccCCCccchhhhcc----CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005224 519 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 594 (707)
Q Consensus 519 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~ 594 (707)
|||+++.+....+.....-....-..||+.|.+||.+.- .+.+.|+||||+||++|.++.|+.||.......+.+.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 999999987665443333444556789999999999863 3578899999999999999999999976543222111
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCC
Q 005224 595 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 674 (707)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~ 674 (707)
. ..+. ...-..| ..-|..+..+.+||++||.+.-++
T Consensus 696 e----NTIl---kAtEVqF-------------------------------------P~KPvVsseAkaFIRRCLaYRKeD 731 (775)
T KOG1151|consen 696 E----NTIL---KATEVQF-------------------------------------PPKPVVSSEAKAFIRRCLAYRKED 731 (775)
T ss_pred h----hchh---cceeccC-------------------------------------CCCCccCHHHHHHHHHHHHhhhhh
Confidence 0 0000 0000000 111233445568999999999999
Q ss_pred CCCCCcCCCCCCCCCCCCC
Q 005224 675 PPSSSSMLKHPYVSSDVSG 693 (707)
Q Consensus 675 R~sa~e~L~Hp~f~~~~~~ 693 (707)
|+...++-.||||.-.+..
T Consensus 732 R~DV~qLA~dpyllPh~rr 750 (775)
T KOG1151|consen 732 RIDVQQLACDPYLLPHIRR 750 (775)
T ss_pred hhhHHHHccCccccchhhh
Confidence 9999999999998654443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.75 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=209.2
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh--HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
...|.+...||+|.|+.|..|++. ++..||||.+.+..... ...+.+|+++|..+.|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457888999999999999999965 79999999998754332 345889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+.+|.+.+++..+++ ..+..+..+..|+.+|++|||+++ |||||||++|||++.++++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--
Confidence 99999999999987765 455888899999999999999999 99999999999999999999999999988753
Q ss_pred CCCccccceecccccCCCccchhhhccCCCC-CchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.......+|++.|.|||++.+..|. +.+|+||+|+++|-|+.|..||+...-. .
T Consensus 208 ------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------------~----- 262 (596)
T KOG0586|consen 208 ------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------------E----- 262 (596)
T ss_pred ------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------------c-----
Confidence 3445677899999999999997764 6899999999999999999999743210 0
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
+-.+|+... ..-.--...+..++|+++|..+|.+|++.++++.|.|...
T Consensus 263 --------------Lr~rvl~gk-----------------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 263 --------------LRPRVLRGK-----------------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred --------------ccchheeee-----------------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 000011000 0000111233457888899999999999999999999876
Q ss_pred CCCC
Q 005224 690 DVSG 693 (707)
Q Consensus 690 ~~~~ 693 (707)
.-..
T Consensus 312 ~~~~ 315 (596)
T KOG0586|consen 312 LLEA 315 (596)
T ss_pred hhhh
Confidence 5554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=274.85 Aligned_cols=278 Identities=16% Similarity=0.347 Sum_probs=210.4
Q ss_pred hcCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEEEeC--CeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV 449 (707)
.++|++.+++|+|.++.||.|. ..+.+.++||+++. ...+.+.+|+++|+.++ ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678899999999999999999 56788999999975 34568899999999996 99999999998655 467899
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeeecccccCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPV 528 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~~~~~ 528 (707)
+||+.+-+...+- +.++...++.++.++++||.|+|+.| |.|||+||.||++|.. -.++|+|+|+|.++.+
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999987776654 23777888999999999999999999 9999999999999954 5799999999998764
Q ss_pred CCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhc---ccchh
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS---SMMFS 604 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~---~~~~~ 604 (707)
.. .....+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||..+.+-.+++-.+... ..+..
T Consensus 186 ~~--------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 186 GK--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred Cc--------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 32 2333455778999999976 678999999999999999999999999887655554332211 11111
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH-HHhhhcCC------CCCCCCCccccCCCCCCCCCCCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL-ESIWNMMP------ESDTKTPEFINSEHTSKEETPPS 677 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L-~~~~~~~~------~~~~~~~dll~~~L~~dP~~R~s 677 (707)
.+.+- -+..+ |.+.+++..- +.-+..+. -..+++.||+.++|.+|-.+|+|
T Consensus 258 Yl~KY------------------~i~Ld----p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 258 YLNKY------------------QIDLD----PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT 315 (338)
T ss_pred HHHHH------------------ccCCC----hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc
Confidence 11111 11111 2222222111 11111111 12467789999999999999999
Q ss_pred CCcCCCCCCCCCCCC
Q 005224 678 SSSMLKHPYVSSDVS 692 (707)
Q Consensus 678 a~e~L~Hp~f~~~~~ 692 (707)
|+||+.||||..-..
T Consensus 316 akEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 316 AKEAMAHPYFAPVRE 330 (338)
T ss_pred hHHHhcCchHHHHHH
Confidence 999999999976544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.98 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=204.5
Q ss_pred ccHHHHHHHhcCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEe
Q 005224 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 442 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 442 (707)
..++.+...++.|++.+.||.|.+|.||+++ .++++.+|+|++..... .++++..|.++++.. .|||++.++|+|..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3455566677889999999999999999999 45899999999876443 345788899999988 69999999999843
Q ss_pred -----CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 005224 443 -----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 517 (707)
Q Consensus 443 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 517 (707)
++.+|||||||.+||..|+++.-....+.|..+..|+..++.||.+||... ++|||||-.|||++.++.||+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 468999999999999999998766778999999999999999999999988 999999999999999999999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhcc-----CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 592 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~ 592 (707)
.|||.+..+... ........||+.|||||++.. ..|+.++|+||+|++..||--|.+|+.+.....
T Consensus 165 vDFGvSaQldsT-------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-- 235 (953)
T KOG0587|consen 165 VDFGVSAQLDST-------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-- 235 (953)
T ss_pred eeeeeeeeeecc-------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--
Confidence 999999876432 234456789999999999974 357789999999999999999999997654311
Q ss_pred HHHHhhcccchhhccCCCCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 593 VNIAYQSSMMFSVIDGNMGS--YPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
.++.+.....+. -|..+..++.+++..|+.++...||++.++++
T Consensus 236 --------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 --------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111111111111 24455566666666666666666666555543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=324.30 Aligned_cols=277 Identities=23% Similarity=0.317 Sum_probs=178.0
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-C----CcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEE------EE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-D----GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY------CD 441 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~ 441 (707)
..++|...+.||+|+||.||+|.+. + +..||||++...... +....| .++...+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999975 4 789999987643211 111111 1122222222222211 24
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCC------------------CcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 005224 442 EEGEQMLVYEFMSNGTLRDQLSAKSKE------------------PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 503 (707)
Q Consensus 442 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 503 (707)
.....++||||+++++|.+++...... ......+..++.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566899999999999999998653211 1123446689999999999999998 9999999
Q ss_pred CCCEEEcC-CCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccC----------------------CC
Q 005224 504 ASNILLDH-KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----------------------KL 560 (707)
Q Consensus 504 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 560 (707)
|+|||+++ ++.+||+|||+|+...... ........+++.|+|||.+... .+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999985 5899999999998653221 1222345688999999976422 23
Q ss_pred CCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 005224 561 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 640 (707)
Q Consensus 561 s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~ 640 (707)
+.++|||||||++|||+++..++.. +... ........ .... ..+.+. ..+..++...
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~--~~~~-~~~~l~~~-----------~~~~---~~~~~~------~~~~~~~~~~ 413 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDS--NLIQ-FNRQLKRN-----------DYDL---VAWRKL------VEPRASPDLR 413 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCch--HHHH-HHHHHHhc-----------CCcH---HHHHHh------hccccchhhh
Confidence 4567999999999999987655431 1111 11110000 0000 001000 0111112211
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 641 EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 641 ~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
+.. ...........|||.+||+.||++|||++|+|+||||.+...
T Consensus 414 ~~~-------~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 414 RGF-------EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hhh-------hhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 111 111112223458999999999999999999999999987554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.82 Aligned_cols=248 Identities=22% Similarity=0.269 Sum_probs=198.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++.|.....+|.|+|+.|-.+... +++..+||++.... .+-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 566777888999999999999854 78899999997652 2334577666665 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-cCCCcEEEeeecccccCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-DHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kl~DFGla~~~~~~~ 530 (707)
.+.++-+.+.+.... .....+..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 999998888775433 222777889999999999999999 9999999999999 69999999999999876532
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
....+-|..|.|||+.....|+.++|+||||++||+|++|+.||.......
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-------------------- 520 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-------------------- 520 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--------------------
Confidence 122345789999999999999999999999999999999999996433310
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC-CC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV-SS 689 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f-~~ 689 (707)
-+..|++ +|++. ...+..+.|||++||+.||++|+++++++.|||| +.
T Consensus 521 -------------ei~~~i~-----~~~~s-------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~ 569 (612)
T KOG0603|consen 521 -------------EIHTRIQ-----MPKFS-------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSH 569 (612)
T ss_pred -------------HHHHhhc-----CCccc-------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcC
Confidence 1112222 22222 2234566799999999999999999999999999 44
Q ss_pred CCC
Q 005224 690 DVS 692 (707)
Q Consensus 690 ~~~ 692 (707)
+..
T Consensus 570 ~t~ 572 (612)
T KOG0603|consen 570 PTF 572 (612)
T ss_pred CCC
Confidence 443
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=294.46 Aligned_cols=195 Identities=32% Similarity=0.516 Sum_probs=166.1
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.|+..+.||+|+||.||+|... +++.||+|.+... .....+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4667788999999999999965 6889999988642 22234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+. |++.+++... ..++++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 996 6888877543 345899999999999999999999998 999999999999999999999999998764321
Q ss_pred CCccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
....++..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 169 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 ---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 1235788999999985 356788999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=289.14 Aligned_cols=199 Identities=26% Similarity=0.366 Sum_probs=165.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
+|.+.+.||+|+||.||++... .+..+++|.++... .....++..|+.++++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788999999999999999864 34556666554321 12234577899999999999999999999988999999
Q ss_pred EecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 450 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
|||+++++|.+++.. .....+++..++.++.|+++||.|||+.+ ++|+||||+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999865 23456899999999999999999999998 999999999999975 569999999987653
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
... .......|+..|+|||...+..++.++||||||+++|+|++|..||..
T Consensus 157 ~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSC-------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCc-------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 321 112234578899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=321.51 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=189.0
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEe-------
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------- 442 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------- 442 (707)
.-..+|+..+.||+||||.||+++.+ ||+.||||++.... ...-..+.+|+.++++++|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888999999999999999976 99999999987653 2223578899999999999999998732100
Q ss_pred --------------------------------------------------------------------------------
Q 005224 443 -------------------------------------------------------------------------------- 442 (707)
Q Consensus 443 -------------------------------------------------------------------------------- 442 (707)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHH
Q 005224 443 ------------------------E--------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490 (707)
Q Consensus 443 ------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH 490 (707)
+ ...||-||||+..++.++++++... -.....++++.+|++||+|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHH
Confidence 0 1247889999998888888665421 157788999999999999999
Q ss_pred hCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC----CC-------CCCCccccceecccccCCCccchhhhccC-
Q 005224 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP----VP-------DIEGIVPAHVSTVVKGTPGYLDPEYFLTH- 558 (707)
Q Consensus 491 ~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~----~~-------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 558 (707)
+++ ||||||||.||++|++..|||+|||+|+... .. +..........+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998722 00 00111112245677899999999999874
Q ss_pred --CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC---CChHHHHHHHHHHHHhcccCC
Q 005224 559 --KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS---YPSECVEKFIKLALKCCQDET 633 (707)
Q Consensus 559 --~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~c~~~~p 633 (707)
.|+.|+||||+|||++||+ .||....+-.. .+..+.++.++. +..+....-.+++.++++.||
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~---------iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEML---YPFGTSMERAS---------ILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred cccccchhhhHHHHHHHHHHh---ccCCchHHHHH---------HHHhcccCCCCCCcccccccchHHHHHHHHHhcCCC
Confidence 4999999999999999999 46754433221 112222333222 233334444566677777777
Q ss_pred CCCCCHHHHHH
Q 005224 634 DARPSMSEVMR 644 (707)
Q Consensus 634 ~~RPt~~~v~~ 644 (707)
.+|||+.|++.
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 77777776653
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=292.37 Aligned_cols=195 Identities=33% Similarity=0.522 Sum_probs=166.2
Q ss_pred CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
|...+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+++++.++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556788999999999999964 689999999864322 2235688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+. |++.+++... ..++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 6888887653 345899999999999999999999998 99999999999999999999999998864321
Q ss_pred CccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.....|+..|+|||++. ...++.++|||||||++|||++|..||....
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12345788999999984 4568889999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=286.30 Aligned_cols=179 Identities=23% Similarity=0.214 Sum_probs=153.2
Q ss_pred eCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCHHHHHhh
Q 005224 386 GGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA 464 (707)
Q Consensus 386 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 464 (707)
|.||.||++... +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 78999999987643 233455555566799999999999999999999999999999999865
Q ss_pred cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccc
Q 005224 465 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544 (707)
Q Consensus 465 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 544 (707)
.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------~~~~~ 143 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------CDGEA 143 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----------cccCC
Confidence 43 4899999999999999999999998 999999999999999999999999987654321 11233
Q ss_pred cCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCC
Q 005224 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584 (707)
Q Consensus 545 gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~ 584 (707)
++..|+|||.+.+..++.++||||+||++|||++|+.|+.
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 5678999999988889999999999999999999987764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=282.85 Aligned_cols=287 Identities=22% Similarity=0.313 Sum_probs=215.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC------C
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 444 (707)
..+|.....+|.|.- .|..|.+. .++.||+|++... .....++..+|..++..+.|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777788899888 66666643 6899999987643 233457888999999999999999999998543 3
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
+.|+||||| .++|...+. ..++-.+...|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 95 e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 679999999 569999886 34778889999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
.... ....+..+.|..|+|||++.+..+.+.+||||.||++.||++|+..|.......+|....
T Consensus 167 ~e~~--------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~-------- 230 (369)
T KOG0665|consen 167 TEDT--------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKII-------- 230 (369)
T ss_pred ccCc--------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHH--------
Confidence 6432 234566778999999999999889999999999999999999999887544444443332
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHH--HHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMREL--ESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 681 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Pt~~~v~~~L--~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 681 (707)
..++...+.+..++...+..-+...|+.- -++.+.+... ....+..+.....+.|++.+||..||++|+++++|
T Consensus 231 ---~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da 307 (369)
T KOG0665|consen 231 ---EQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA 307 (369)
T ss_pred ---HHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence 22344556677777776666555222111 0111111000 00000111222345679999999999999999999
Q ss_pred CCCCCCC
Q 005224 682 LKHPYVS 688 (707)
Q Consensus 682 L~Hp~f~ 688 (707)
|+|||+.
T Consensus 308 L~HPY~~ 314 (369)
T KOG0665|consen 308 LRHPYIK 314 (369)
T ss_pred hcCCeee
Confidence 9999997
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.86 Aligned_cols=200 Identities=31% Similarity=0.464 Sum_probs=172.0
Q ss_pred CCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC------CeEEE
Q 005224 377 FNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GEQML 448 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 448 (707)
+...+.||+|+||.||+|+. .+|+.||||.+.... ....+...+|+++|++++|+|||+++++=++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44568899999999999995 589999999987643 34457788999999999999999999876443 46789
Q ss_pred EEecCCCCCHHHHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCC--cEEEeeeccc
Q 005224 449 VYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKF--TAKVADFGLS 523 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~--~~kl~DFGla 523 (707)
|||||.+|||+..|.+. +...+++...+.+..+++.||.|||+++ |+||||||.||++- .+| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999763 3456999999999999999999999999 99999999999983 333 5799999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
+..+.. ......+||..|.+||+... +.|+..+|.|||||++||++||..||.+..
T Consensus 172 rel~d~--------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDN--------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCC--------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 977542 24567889999999999995 889999999999999999999999996543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=287.91 Aligned_cols=295 Identities=22% Similarity=0.337 Sum_probs=217.8
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 443 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 443 (707)
.+....+.|...++||+|.|++||+|.+. ..+.||+|.+...+ ....+.+|+++|..+ .+.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34445677889999999999999999953 46789999987533 345789999999999 599999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeeecc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGL 522 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGl 522 (707)
+..++|+||+++....++... ++...+..+.+.++.||+++|+.| ||||||||+|+|.+. .+.-.|.|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 999999999999999888843 668889999999999999999999 999999999999984 56789999999
Q ss_pred cccCCCCC------C------C-------------C------------ccccceecccccCCCccchhhhcc-CCCCCch
Q 005224 523 SRLAPVPD------I------E-------------G------------IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKS 564 (707)
Q Consensus 523 a~~~~~~~------~------~-------------~------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~s 564 (707)
|...+... . . . ...........||+||+|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97211000 0 0 0 001112234579999999999976 6678899
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHH--hcccCCCCCCCHHHH
Q 005224 565 DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALK--CCQDETDARPSMSEV 642 (707)
Q Consensus 565 DVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c~~~~p~~RPt~~~v 642 (707)
||||.||+++.+++++.||....+..+........ +-...+.....+-.+ .|++ ..+|+..++
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~ti-------------fG~~~mrk~A~l~g~~~l~~k--sn~~~~~e~ 324 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATI-------------FGSAEMRKCAALPGRILLWQK--SNIPTIPEL 324 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHH-------------hChHHHHHHhhcCCceeeecc--ccccccHHH
Confidence 99999999999999999998665533322211000 111122222222122 2332 446777776
Q ss_pred HHHHHHhh-hcCCC--------------CCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 643 MRELESIW-NMMPE--------------SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 643 ~~~L~~~~-~~~~~--------------~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
....+.+. ....+ ....+.||+.++|+.||.+|+||+|||+||||.
T Consensus 325 ~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 325 RVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred HhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 66555552 21111 112456899999999999999999999999998
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.81 Aligned_cols=201 Identities=22% Similarity=0.341 Sum_probs=178.0
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCc-EEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.++.....||-|+||.|-++..+..+ .+|+|++++.... .++.+..|-.+|...+.|.||++|-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566778999999999999876433 4899988764433 3456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
|-|-||.|+..|++++ .++..+.+.++..+++|++|||+++ ||.|||||+|.++|.+|.+||.|||+|+....
T Consensus 500 EaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~-- 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS-- 572 (732)
T ss_pred HhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc--
Confidence 9999999999997654 5999999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
.......+||+.|.|||++.....+.++|.||+|+++|||++|.+||...+.
T Consensus 573 ------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 573 ------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred ------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 3456678999999999999999999999999999999999999999976544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=309.94 Aligned_cols=256 Identities=27% Similarity=0.381 Sum_probs=197.1
Q ss_pred CCCccceEeeeCceE-EEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecC
Q 005224 376 NFNSSTQIGQGGYGK-VYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
-|...+++|.|+.|+ ||+|.. +|+.||||++-. +...-+.+|+..|+.- .|||||++++.-.+.++.|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355567899999987 799999 689999999854 3345678999999988 6999999999999999999999999
Q ss_pred CCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---C--CcEEEeeecccccC
Q 005224 454 SNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---K--FTAKVADFGLSRLA 526 (707)
Q Consensus 454 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~--~~~kl~DFGla~~~ 526 (707)
..+|.++++.. ..........+.+..|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 56999999774 1111222445788999999999999988 999999999999975 2 57999999999987
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcC-CCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG-MQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
...... -.......||.+|+|||++....-+.++||||+||++|+.++| ..||.+. ..++.........
T Consensus 662 ~~~~sS----~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~---- 731 (903)
T KOG1027|consen 662 AGGKSS----FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYT---- 731 (903)
T ss_pred CCCcch----hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccc----
Confidence 654311 1224567799999999999998888999999999999999995 8999642 2222221100000
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCC
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 685 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 685 (707)
..+++.++ +..+.|||.+|+..||..||+|.++|.||
T Consensus 732 --------------------L~~L~~~~-----------------------d~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 732 --------------------LVHLEPLP-----------------------DCEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred --------------------eeeeccCc-----------------------hHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 00111111 11456899999999999999999999999
Q ss_pred CCCCCCC
Q 005224 686 YVSSDVS 692 (707)
Q Consensus 686 ~f~~~~~ 692 (707)
+|.....
T Consensus 769 lFW~~ek 775 (903)
T KOG1027|consen 769 LFWDSEK 775 (903)
T ss_pred ccCChHH
Confidence 9976543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=270.08 Aligned_cols=202 Identities=24% Similarity=0.392 Sum_probs=177.7
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCe
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 445 (707)
....++|+..++||+|+|+.|-.++++ +.+.+|+|++++.-. ++...++.|-.+..+. +||.+|.+..+|..+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 345678999999999999999999965 688999999876432 3334567788888776 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++|.||++||+|--.++++ ..++++.++.+...|.-||.|||+.+ ||.||||.+|||+|.+|++|++|+|+++.
T Consensus 326 lffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999997777543 45999999999999999999999999 99999999999999999999999999874
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCC
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~ 584 (707)
- ..+.......+||+.|+|||++.+..|....|+|++||+|+||+.|+.||+
T Consensus 401 ~-------l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 401 G-------LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred C-------CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 2 233556678899999999999999999999999999999999999999996
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-34 Score=292.90 Aligned_cols=215 Identities=24% Similarity=0.273 Sum_probs=181.4
Q ss_pred cCcccccHHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccC------CCc
Q 005224 360 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH------HRN 432 (707)
Q Consensus 360 ~~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~n 432 (707)
+....|.+.-.++...+|.+....|+|-|++|..|... -|..||||++..+... .+.=+.|+++|++|. --|
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhH
Confidence 34456677777778889999999999999999999964 5789999999874432 345578999999995 348
Q ss_pred ceeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 005224 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH 511 (707)
Q Consensus 433 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~ 511 (707)
+++++..|...+++|||+|-+ .-+|.++|+.-+. ..+....+..++.|+.-||..|-..+ |+|.||||+||||++
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEecc
Confidence 999999999999999999988 5699999987443 35888999999999999999999998 999999999999986
Q ss_pred C-CcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 512 K-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 512 ~-~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
. ..+||||||.|......+ .+.+..+.-|+|||++.|.+|+...|+||.||+||||.||+..|....+
T Consensus 572 ~k~iLKLCDfGSA~~~~ene---------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENE---------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred CcceeeeccCcccccccccc---------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 5 578999999998765433 2334456789999999999999999999999999999999999976444
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=251.38 Aligned_cols=218 Identities=26% Similarity=0.378 Sum_probs=177.9
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHc-cCCCcceeEEEEEEeCCe
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~ 445 (707)
.++...+.......||+|++|.|-+-++ .+|...|+|++...- .+..++..+|+.+..+ ..+|.+|.+||....++.
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3455555666678899999999998885 489999999987532 3345677888887555 479999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 446 QMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
.++.||.|. -||..+-++ ......++...-+||..+.+||.|||++- .+||||+||+|||++.+|++|++|||.+
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 999999995 478766544 34556899999999999999999999965 4999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhcc----CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHh
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~ 597 (707)
-.+.. +-..+...|...|||||.+.. ..|+-++||||+|+++.||.+++.||+.+...-+++....
T Consensus 197 G~L~d--------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 197 GYLVD--------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred eeehh--------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 76542 222334568889999999864 4789999999999999999999999988777666555443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=282.50 Aligned_cols=209 Identities=22% Similarity=0.324 Sum_probs=174.4
Q ss_pred cCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCChhhH---HHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.-|..++.||-|+||.|.++. .++...+|.|.+.+.+.-.. ..++.|-.||.....+-||+||-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 456678899999999999998 44577899999876543322 34678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||++||++-.+|-+.+ .|.+..++.++..+..|+++.|..| +|||||||+|||||.+|++||+|||++.-+....
T Consensus 709 dYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999997654 4889999999999999999999999 9999999999999999999999999985432211
Q ss_pred ---CCC---------ccc-----------------------cceecccccCCCccchhhhccCCCCCchhhHHHHHHHHH
Q 005224 531 ---IEG---------IVP-----------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 575 (707)
Q Consensus 531 ---~~~---------~~~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~e 575 (707)
+.. ..+ .......+||+.|+|||++....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 000 000 001124579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCch
Q 005224 576 LLTGMQPISHGKN 588 (707)
Q Consensus 576 lltG~~pf~~~~~ 588 (707)
|+.|+.||.....
T Consensus 864 m~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 864 MLVGQPPFLADTP 876 (1034)
T ss_pred HhhCCCCccCCCC
Confidence 9999999976544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=261.01 Aligned_cols=187 Identities=35% Similarity=0.548 Sum_probs=165.8
Q ss_pred CceEEEEEEeC-CCcEEEEEEeccCChhh-HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCHHHHHhh
Q 005224 387 GYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA 464 (707)
Q Consensus 387 ~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 464 (707)
+||.||+|... +++.||+|++....... .+.+.+|++.+++++|+|++++++++......++||||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999998755444 67899999999999999999999999999999999999999999999965
Q ss_pred cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccc
Q 005224 465 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544 (707)
Q Consensus 465 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 544 (707)
... +++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--------cccccc
Confidence 433 889999999999999999999998 9999999999999999999999999998764321 223455
Q ss_pred cCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 545 gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
++..|++||.+.+..++.++||||||++++++++|..||...
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 189 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD 189 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 788999999999888999999999999999999999999653
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=273.75 Aligned_cols=301 Identities=21% Similarity=0.285 Sum_probs=224.0
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|+....+|.|+||.||||+. +.++..|||+++.......+-+.+|+-+++..+|+||+.++|.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 45788899999999999999995 47999999999876666667788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
|.+|+|.+.-+. ..++++.++..+++..++||+|||+.+ =+|||||-.|||+++.|.+|++|||.+-.+...
T Consensus 94 cgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--- 165 (829)
T ss_pred cCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh---
Confidence 999999987743 456999999999999999999999999 799999999999999999999999998654321
Q ss_pred CccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
-.......||+.|||||+.. .+.|...+|||+.|++..|+---+.|..+-...... +. .....+++.
T Consensus 166 ----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l----~L--mTkS~~qpp 235 (829)
T KOG0576|consen 166 ----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL----FL--MTKSGFQPP 235 (829)
T ss_pred ----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH----HH--hhccCCCCC
Confidence 22345678999999999974 477999999999999999998877776543321110 00 111222222
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCC-CCcCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-SSSMLKHPYVS 688 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s-a~e~L~Hp~f~ 688 (707)
...-+..+...+.++++.|+.++|++||++..+++. -....+.......++|+++=..+|.-|-- ..|.=.++|+.
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h---~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH---PFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhheec---eeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 222344566677777777777777777777665541 11112233334456666666665444322 22333466666
Q ss_pred CCCCCCC
Q 005224 689 SDVSGSN 695 (707)
Q Consensus 689 ~~~~~~~ 695 (707)
+.+.+.+
T Consensus 313 ~~i~s~~ 319 (829)
T KOG0576|consen 313 MRICSTG 319 (829)
T ss_pred hhhhcCC
Confidence 6666544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-29 Score=259.94 Aligned_cols=196 Identities=25% Similarity=0.374 Sum_probs=168.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhH--------HHHHHHHHHHHccC---CCcceeEEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGE--------KEFLTEIQFLSRLH---HRNLVSLVGYCDE 442 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~--------~~~~~E~~~l~~l~---H~nIv~l~~~~~~ 442 (707)
.+|+..+.+|.|+||.|+.|+++ +...|+||.+.++..-.. -.+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46889999999999999999976 567899998876432111 23567999999997 9999999999999
Q ss_pred CCeEEEEEecC-CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeec
Q 005224 443 EGEQMLVYEFM-SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 521 (707)
Q Consensus 443 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 521 (707)
++.+||+||-. ++.+|.+++..+. .+++.....|++||+.|+++||+++ |||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 99999999975 4668999996654 4899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCCCccccceecccccCCCccchhhhccCCCCC-chhhHHHHHHHHHHHcCCCCCC
Q 005224 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPIS 584 (707)
Q Consensus 522 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-~sDVwS~Gvll~elltG~~pf~ 584 (707)
.|..... ......+||.+|.|||++.+.+|-- .-|||++|++||.++....||.
T Consensus 716 saa~~ks---------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKS---------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcC---------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9876542 2344568999999999999987754 5899999999999999988885
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=231.76 Aligned_cols=210 Identities=37% Similarity=0.605 Sum_probs=182.5
Q ss_pred EeeeCceEEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCHHH
Q 005224 383 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD 460 (707)
Q Consensus 383 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 460 (707)
||+|.+|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++||||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999975 4899999999865433 34678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeeecccccCCCCCCCCccccce
Q 005224 461 QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDIEGIVPAHV 539 (707)
Q Consensus 461 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~ 539 (707)
++.... ..+++..++.++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------h
Confidence 997542 45899999999999999999999998 999999999999999 89999999999986543210 1
Q ss_pred ecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 005224 540 STVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618 (707)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (707)
.....+...|++||..... .++.++|+|++|++++++
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2234567899999999887 888999999999999998
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005224 619 EKFIKLALKCCQDETDARPSMSEVMRE 645 (707)
Q Consensus 619 ~~l~~l~~~c~~~~p~~RPt~~~v~~~ 645 (707)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 456788999999999999999988753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=234.84 Aligned_cols=199 Identities=36% Similarity=0.527 Sum_probs=173.4
Q ss_pred CCccceEeeeCceEEEEEEeCC-CcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 377 FNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
|+..+.||+|++|+||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999764 899999999875554 56789999999999999999999999999899999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+++|.+++...... +++..+..++.+++.++.|||+.+ ++|+|++|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~---- 152 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL---- 152 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc----
Confidence 99999999764322 789999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccceecccccCCCccchhhh-ccCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 153 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 --AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0122334577889999999 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=222.78 Aligned_cols=255 Identities=21% Similarity=0.334 Sum_probs=188.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEE-EEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY-CDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~-~~~~~~~~lV~ 450 (707)
.+.|++.+.+|+|.||.+-++.++ ..+.+++|.+.... ...++|.+|..-=-.+ .|.||+.-|+. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467999999999999999999976 67889999887633 3456888888765455 58999987765 67778899999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-c-CCCcEEEeeecccccCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-D-HKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-~-~~~~~kl~DFGla~~~~~ 528 (707)
||++.|+|.+-+.. ..+.+.....++.|+++|+.|+|++. +||||||.+|||| + +..++|++|||+++..+.
T Consensus 102 E~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999988854 34888899999999999999999999 9999999999999 3 345899999999876431
Q ss_pred CCCCCccccceecccccCCCccchhhhccC-----CCCCchhhHHHHHHHHHHHcCCCCCCCCc--hhHHHHHHHhhccc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGK--NIVREVNIAYQSSM 601 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDVwS~Gvll~elltG~~pf~~~~--~~~~~~~~~~~~~~ 601 (707)
......-+..|.+||..... ...+.+|||.||+++|.++||+.||.... +..-|-...|....
T Consensus 176 ----------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 176 ----------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred ----------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 12223345679999988642 35678999999999999999999996422 12222223333332
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
... .+..-.-..+...++..+-+..++++|-...++.++....+
T Consensus 246 ~~~-----~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 246 NPA-----LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred Ccc-----CchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 221 11111223455666777778888888866666655544433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-26 Score=267.61 Aligned_cols=201 Identities=19% Similarity=0.188 Sum_probs=132.9
Q ss_pred ccCC-CcceeEEEEE-------EeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 005224 427 RLHH-RNLVSLVGYC-------DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498 (707)
Q Consensus 427 ~l~H-~nIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 498 (707)
.++| +||++++++| ......++++||+ +++|.++|... ...+++..++.++.||++||+|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3455 5888888887 2234567788988 66999999653 345999999999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCcE-------------------EEeeecccccCCCCC---CCC------ccccceecccccCCCcc
Q 005224 499 HRDIKASNILLDHKFTA-------------------KVADFGLSRLAPVPD---IEG------IVPAHVSTVVKGTPGYL 550 (707)
Q Consensus 499 H~Dlkp~NILl~~~~~~-------------------kl~DFGla~~~~~~~---~~~------~~~~~~~~~~~gt~~y~ 550 (707)
||||||+||||+..+.+ |++|||+++...... ... ...........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999655544 555555554321100 000 00000112245888999
Q ss_pred chhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcc
Q 005224 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQ 630 (707)
Q Consensus 551 aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~ 630 (707)
|||++.+..++.++|||||||+||||++|..|+............ .. .+............++.+|++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~--------~~----~~~~~~~~~~~~~~~~~~~L~ 250 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH--------RV----LPPQILLNWPKEASFCLWLLH 250 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH--------hh----cChhhhhcCHHHHHHHHHhCC
Confidence 999999999999999999999999999998876432211111100 00 000001112234456666777
Q ss_pred cCCCCCCCHHHHHH
Q 005224 631 DETDARPSMSEVMR 644 (707)
Q Consensus 631 ~~p~~RPt~~~v~~ 644 (707)
.+|.+||++.++++
T Consensus 251 ~~P~~Rps~~eil~ 264 (793)
T PLN00181 251 PEPSCRPSMSELLQ 264 (793)
T ss_pred CChhhCcChHHHhh
Confidence 77777777776654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=204.38 Aligned_cols=168 Identities=21% Similarity=0.291 Sum_probs=125.8
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.++++.. ...+++..++.++.|+++||+|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence 6899999754 346999999999999999999999865 999999999999999 9998765321
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (707)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.................. . ........+.
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~ 133 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP--A-DDPRDRSNLE 133 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc--c-CCccccccHH
Confidence 125789999999999999999999999999999999999999654332222221111000 0 0000011223
Q ss_pred HHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 616 ECVE--KFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 616 ~~~~--~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
.... .+.+++.+|++.+|.+||++.++++.+....
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 3333 5888899999999999999998888776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=212.55 Aligned_cols=245 Identities=19% Similarity=0.353 Sum_probs=197.5
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCC
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 457 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 457 (707)
..+|.+...|..|+|+|+ |..+++|++.-.. ....++|..|.-.|+-+.||||+.++|.|...-...++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 457889999999999995 4556677765432 2234679999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe--eecccccCCCCCCCCcc
Q 005224 458 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA--DFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 458 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~--DFGla~~~~~~~~~~~~ 535 (707)
|+..+++...-..+..++.+++.++|+|++|||+.. +-|.---|.+..|++|++.+++|+ |--++.
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf----------- 341 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF----------- 341 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee-----------
Confidence 999999887777888899999999999999999975 445555789999999999988875 222221
Q ss_pred ccceecccccCCCccchhhhccCCCC---CchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLT---DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s---~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
......-.+.||+||.++..+-+ .++|+|||++++||+.|...||.+.....- .+.-.+.+.+..
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec---------gmkialeglrv~ 409 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------GMKIALEGLRVH 409 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------hhhhhhcccccc
Confidence 11222346889999999876544 469999999999999999999986554322 222334556667
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.|......+.+++.-|+++||.+||.+..++-.|+++
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 7888889999999999999999999999999888765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=221.56 Aligned_cols=171 Identities=19% Similarity=0.203 Sum_probs=131.8
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeC--CCcEEEEEEeccC-----ChhhHHHHHHHHHHHHccCCCccee-EEEEEEe
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVS-LVGYCDE 442 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~ 442 (707)
....++|...+.||+|+||+||+|.++ +++.||||++... .....+.+.+|+++|++++|+|+++ +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 445678999999999999999999864 5788899987533 1223456899999999999999985 443
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCcEEEeeec
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI-KASNILLDHKFTAKVADFG 521 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DFG 521 (707)
.+..++||||+++++|.. +.. .. ...++.++++||.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 246799999999999963 211 11 1467889999999999998 999999 9999999999999999999
Q ss_pred ccccCCCCCCCCcccc-ceecccccCCCccchhhhcc
Q 005224 522 LSRLAPVPDIEGIVPA-HVSTVVKGTPGYLDPEYFLT 557 (707)
Q Consensus 522 la~~~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 557 (707)
+|+............. .......+++.|+|||++..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9997754321111111 11245678899999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=214.24 Aligned_cols=266 Identities=21% Similarity=0.267 Sum_probs=200.9
Q ss_pred CCCccceEeeeCceEEEEEEeCCC--cEEEEEEeccCChhhHHHHHHHHHHHHccCC----CcceeEEEEE-EeCCeEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILPDG--TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH----RNLVSLVGYC-DEEGEQML 448 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~l 448 (707)
+|.+.+.||+|+||.||.+...+. ..+|+|............+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 5789988766433332367788999888863 6899999999 57788999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-----CcEEEeeeccc
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLS 523 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kl~DFGla 523 (707)
||+.+ |.+|.++........++..+...|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 889999887666677999999999999999999999999 9999999999999755 46999999999
Q ss_pred ccCC--CCCCCCccccce-ecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchh--HHHHHHHhh
Q 005224 524 RLAP--VPDIEGIVPAHV-STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI--VREVNIAYQ 598 (707)
Q Consensus 524 ~~~~--~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~--~~~~~~~~~ 598 (707)
+... ..+.....+... .....||..|.++....+...+.+.|+||++.++.|++.|..||...... ...+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8433 222111011111 23456999999999999999999999999999999999999998543321 111111111
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 599 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
... ... .....+.++.++...+-..+...+|....+...++......
T Consensus 255 ~~~----~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 KLL----TDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhc----ccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 100 000 22233455666666666689999999999998887766543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-21 Score=191.47 Aligned_cols=271 Identities=19% Similarity=0.282 Sum_probs=206.0
Q ss_pred CCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecC
Q 005224 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.|.+.++||+|.||..+.|+ +-+++.||||.-...+ ...++..|.+.++.+ ..+.|...|-+..+..+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68899999999999999999 5689999999865433 235778899999988 5789999888888888899999998
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCcEEEeeecccccCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLAPV 528 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFGla~~~~~ 528 (707)
|.+|.|+..-.+ ..++.+++.-+|.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|+.+..
T Consensus 107 -GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 889999886544 46999999999999999999999999 999999999999964 34689999999998877
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc--hhHHHHHHHhhcccchhhc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK--NIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~--~~~~~~~~~~~~~~~~~~~ 606 (707)
++...-.+-.......||.+||+---..+...+.+-|+-|+|-++++.+.|..||..-. ..-+..+. +-
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK---------IG 252 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK---------IG 252 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH---------hc
Confidence 66544444445566789999999999999999999999999999999999999996422 11111111 11
Q ss_pred cCCCCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCc
Q 005224 607 DGNMGS----YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 662 (707)
Q Consensus 607 ~~~~~~----~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~d 662 (707)
+..... .-+..+.++..-+...-..+-++-|...-+...+.++.......++...|
T Consensus 253 e~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yD 312 (449)
T KOG1165|consen 253 ETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYD 312 (449)
T ss_pred cccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccc
Confidence 111111 11223444555444444556677788877777666666655555544444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-24 Score=240.40 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=189.4
Q ss_pred CccceEeeeCceEEEEEEeC-CCcEEEEEEec----c-CCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 378 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQ----E-GSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 378 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~----~-~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
...+.+|.|++|.|+..... ..+.++.|... . ... .....+..|+-+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988887743 34444444332 1 111 11223667888888899999987777666655555569
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
|||++ +|..++... ..+....+..+..|++.|++|+|..| |.|||+|++|++++.+|.+||+|||.+.....+.
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999999654 34788889999999999999999999 9999999999999999999999999997765433
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCc-hhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.. ........+|+..|+|||++.+..|... .||||.|+++..|.+|+.||...........
T Consensus 475 e~---~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--------------- 536 (601)
T KOG0590|consen 475 EK---NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--------------- 536 (601)
T ss_pred ch---hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---------------
Confidence 11 1244567789999999999999999875 8999999999999999999854332111000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
+-. . ..-..+..-.+.++..++. .....|.+||++||++|+|++++++++||..
T Consensus 537 ------------------~~~-~----~~~~~~~~~~~~~~~~lp~---~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 537 ------------------TNN-Y----SDQRNIFEGPNRLLSLLPR---ETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred ------------------hhc-c----ccccccccChHHHHHhchh---hHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 000 0 0000000111112222222 2235789999999999999999999999976
Q ss_pred CC
Q 005224 690 DV 691 (707)
Q Consensus 690 ~~ 691 (707)
-.
T Consensus 591 i~ 592 (601)
T KOG0590|consen 591 IE 592 (601)
T ss_pred cc
Confidence 43
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-20 Score=198.65 Aligned_cols=262 Identities=32% Similarity=0.489 Sum_probs=198.1
Q ss_pred CCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCC-cceeEEEEEEeCCeEEEEEec
Q 005224 377 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHR-NLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~E~ 452 (707)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999986 78999988764333 356899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeeecccccCCCCC
Q 005224 453 MSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPD 530 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 530 (707)
+.++++.+++..... ..+.......+..|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977754332 26889999999999999999999999 99999999999999988 79999999998554322
Q ss_pred CCCccccceecccccCCCccchhhhcc---CCCCCchhhHHHHHHHHHHHcCCCCCCCCch---hHHHHHHHhhcccchh
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREVNIAYQSSMMFS 604 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvll~elltG~~pf~~~~~---~~~~~~~~~~~~~~~~ 604 (707)
..... ........|+..|+|||.+.+ ..++...|+||+|++++++++|..||..... ............. ..
T Consensus 157 ~~~~~-~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 234 (384)
T COG0515 157 STSSI-PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT-PS 234 (384)
T ss_pred ccccc-cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC-cc
Confidence 11000 013456779999999999998 5788899999999999999999999765443 1111111111110 00
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 645 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~ 645 (707)
................+.+++..|+..+|..|.+..+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000012223577888999999999999988876654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=186.02 Aligned_cols=271 Identities=20% Similarity=0.274 Sum_probs=201.4
Q ss_pred HhcCCCccceEeeeCceEEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCC-CcceeEEEEEEeCCeEEEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~ 450 (707)
..++|...++||.|+||.+|.|. ..+|+.||||.-..... ..++..|.++.+.+++ ..|..+.-+..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35689999999999999999999 57899999998765332 2467789999999975 67777788888888999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeeecccccCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLAP 527 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~~~~ 527 (707)
|.+ |.+|.++..-.. ..++..+++-+|-|++.-++|+|.++ +|||||||+|.|..- ...+.++|||+|+.+.
T Consensus 91 dLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 998 889999886543 35899999999999999999999999 999999999999963 3468999999998775
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHH-HHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR-EVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 606 (707)
......-.+-.......||.+|.+--...+...+.+-|+-|+|.+|..+-.|..||..-..... +..+...+..+...+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 4433333333444567799999998888888888899999999999999999999975332111 111111111111111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
.. .-...+.++.-.+..|-...-++.|...-+.+.+..+...+-
T Consensus 246 e~----LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 246 EV----LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred HH----HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 11 112234556666778888777888887766666665555443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5e-21 Score=188.35 Aligned_cols=171 Identities=15% Similarity=0.104 Sum_probs=134.7
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHH---------HHHHHHHHHccCCCcceeEEEEEEeC
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE---------FLTEIQFLSRLHHRNLVSLVGYCDEE 443 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~H~nIv~l~~~~~~~ 443 (707)
..++|...+.+|.|+||.||.+.. ++..+|||.+.......++. +.+|++.+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 368999999999999999999766 57789999997644333322 67899999999999999999886533
Q ss_pred --------CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 005224 444 --------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 515 (707)
Q Consensus 444 --------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 515 (707)
+..++||||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||++++++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 35789999999999988741 222 24568999999999999 99999999999999988 9
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHH
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELL 577 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ell 577 (707)
+|+|||.......... ...+.....+..++|+|+||+++.-+.
T Consensus 174 ~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 9999998865432110 011444556778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=183.64 Aligned_cols=139 Identities=19% Similarity=0.155 Sum_probs=108.8
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChh--h------------------------HHHHHHHHHHHHccCCCcc
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--G------------------------EKEFLTEIQFLSRLHHRNL 433 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~H~nI 433 (707)
...||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999889999999998753211 0 1123459999999988776
Q ss_pred eeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCEEEcCC
Q 005224 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL-HTEADPPVFHRDIKASNILLDHK 512 (707)
Q Consensus 434 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~NILl~~~ 512 (707)
.....+.. ...++||||++++++...... ...+++.....++.|++.+|.|+ |+.+ |+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 44333322 223899999998777654322 23588999999999999999999 6888 99999999999998 4
Q ss_pred CcEEEeeecccccC
Q 005224 513 FTAKVADFGLSRLA 526 (707)
Q Consensus 513 ~~~kl~DFGla~~~ 526 (707)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-21 Score=210.06 Aligned_cols=186 Identities=29% Similarity=0.341 Sum_probs=155.7
Q ss_pred eEeeeCceEEEEEE----eCCCcEEEEEEeccCChhh--HHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEEecCC
Q 005224 382 QIGQGGYGKVYKGI----LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 382 ~lG~G~~g~Vy~~~----~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
.+|+|+||.|+.+. .+.|..+|.|.+....... ......|..++..++ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999765 2357788998877543221 124456788888886 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+|.|...+.. ...+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-..+
T Consensus 81 gg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 9999888744 344777777788888999999999999 9999999999999999999999999998754322
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
..+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 152 -------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 -------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 128999999999998 667899999999999999999999964
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=176.35 Aligned_cols=139 Identities=20% Similarity=0.155 Sum_probs=111.1
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChh---------------------h-----HHHHHHHHHHHHccCCCcc
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ---------------------G-----EKEFLTEIQFLSRLHHRNL 433 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~nI 433 (707)
...||+|+||.||+|...+|+.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999999878999999998754211 0 1224578999999999987
Q ss_pred eeEEEEEEeCCeEEEEEecCCCCCHHHH-HhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcC
Q 005224 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDH 511 (707)
Q Consensus 434 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~ 511 (707)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444333 24899999988865443 322 347788899999999999999999 88 99999999999999
Q ss_pred CCcEEEeeecccccCC
Q 005224 512 KFTAKVADFGLSRLAP 527 (707)
Q Consensus 512 ~~~~kl~DFGla~~~~ 527 (707)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=174.10 Aligned_cols=191 Identities=13% Similarity=0.047 Sum_probs=141.6
Q ss_pred CccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhh----HHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEEec
Q 005224 378 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 378 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.+...|++|+||+||.+.. .+..++.+.+....... ...+.+|+++|+++. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997766 67888888777644322 125789999999995 5889999886 346999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI-KASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
+.|.+|.+.+.. ....++.|++++|.++|+.+ |+|||| ||+|||++.++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998754321 11346788999999999999 999999 79999999999999999999985443210
Q ss_pred C------CccccceecccccCCCccchhhhccC-CCC-CchhhHHHHHHHHHHHcCCCCCCC
Q 005224 532 E------GIVPAHVSTVVKGTPGYLDPEYFLTH-KLT-DKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 532 ~------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s-~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
. .....-.......++.|++|+...-. ..+ ...+.++-|+-+|.++|+..+...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 00000001223467888888866432 334 467899999999999999887643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.1e-20 Score=196.91 Aligned_cols=217 Identities=26% Similarity=0.411 Sum_probs=162.0
Q ss_pred HHccCCCcceeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005224 425 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 504 (707)
Q Consensus 425 l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 504 (707)
|+.+.|.|+.+++|.+.+....+.|.+||..|+|.+.+.. ....+++.....++++|+.||+|||... -..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 4578999999999999999999999999999999999976 3456999999999999999999999854 239999999
Q ss_pred CCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccC-------CCCCchhhHHHHHHHHHHH
Q 005224 505 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-------KLTDKSDVYSLGVVFLELL 577 (707)
Q Consensus 505 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDVwS~Gvll~ell 577 (707)
+|+++|....+|++|||+......... ........-..-|.|||.+... ..+.+.||||||++++|++
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred ccceeeeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 999999999999999999877642100 0011111234569999999763 1467799999999999999
Q ss_pred cCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC-h-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 578 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP-S-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 578 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
+.+.||.......+..+....... .-....++... . +..+.+..++..||..+|..||++.++...++.+..
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred hccCccccccccCChHHHHHHHHh--cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999999764332221111111000 00001111111 1 445579999999999999999999999887776554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-20 Score=209.34 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=180.3
Q ss_pred CCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCC-hhhHHHHH---HHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS-LQGEKEFL---TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
+|...+.||++.|=.|.+|++++|. |+||++-... ....+.|. .|++ ...++|||.+++.-+-......|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667889999999999999998888 8888876543 22233443 4444 555689999999888777778889999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+.+ +|+|.+. .+.-+...+.++|+.|++.||.-+|..+ |+|||||.+|||++.-.-+.|+||..-+...-++.
T Consensus 102 yvkh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHhh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 9965 9999884 3455888899999999999999999999 99999999999999999999999987654322221
Q ss_pred CCccccceecccccCCCccchhhhccC----------C-CCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHH-Hhh
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTH----------K-LTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI-AYQ 598 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~-~~~ 598 (707)
+.............-.+|+|||.+... . .+++.||||+||++.||++ |+++|.-. .+..+-.. ...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-QL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-QLLAYRSGNADD 254 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-HHHhHhccCccC
Confidence 111112222233344689999998542 1 5678999999999999999 77777421 11000000 000
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005224 599 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646 (707)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L 646 (707)
.+...+.+ . ...+..++..|++.+|..|-++.+.++.-
T Consensus 255 ~e~~Le~I-------e---d~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 255 PEQLLEKI-------E---DVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HHHHHHhC-------c---CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 00011100 1 12577889999999999999999998763
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=169.02 Aligned_cols=137 Identities=17% Similarity=0.223 Sum_probs=107.2
Q ss_pred CCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHcc-----CCCcceeEEEEEEeCC---e-EE
Q 005224 377 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-----HHRNLVSLVGYCDEEG---E-QM 447 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~-~~ 447 (707)
++..+.||+|+||.||. +++....+||+.........+.+.+|+++++.+ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34578899999999996 443333469988765444567899999999999 5799999999998763 3 34
Q ss_pred EEEec--CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEeee
Q 005224 448 LVYEF--MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI-LYLHTEADPPVFHRDIKASNILLDH----KFTAKVADF 520 (707)
Q Consensus 448 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~DF 520 (707)
+|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5579999999653 25555 35577888777 9999999 999999999999974 348999995
Q ss_pred ccc
Q 005224 521 GLS 523 (707)
Q Consensus 521 Gla 523 (707)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=199.01 Aligned_cols=253 Identities=23% Similarity=0.273 Sum_probs=182.6
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccC---CCcceeEEEEEEeCCe
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGE 445 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~ 445 (707)
+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-+..+... |.-=.+++.+|+ -+.|+.+...+...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 5566677899999999999999999998889999999987655432 111123334443 2344555555566778
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-------CCCcEEEe
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-------HKFTAKVA 518 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-------~~~~~kl~ 518 (707)
.+||+||.+.|+|.+++. ....++|..+..++.|+++-++.||..+ |||+||||+|.||. +..-++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 899999999999999996 5567999999999999999999999999 99999999999993 34569999
Q ss_pred eecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhh
Q 005224 519 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598 (707)
Q Consensus 519 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~ 598 (707)
|||.+-.+..-. ........++|-.+-.+|...|.+|++.+|-|.++.+++-|+.|+..= ..
T Consensus 844 DfG~siDm~lfp-----~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------~~ 905 (974)
T KOG1166|consen 844 DFGRSIDMKLFP-----DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------VK 905 (974)
T ss_pred ecccceeeeEcC-----CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------hc
Confidence 999986543211 123455677899999999999999999999999999999999995421 01
Q ss_pred cccchhhccCCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 599 SSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 599 ~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.+..+.+-.+ +.. ...+.+..++.++ ++.+-..-|...++...+++++.
T Consensus 906 ~g~~~~~~~~-~~Ry~~~~~W~~~F~~l---LN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 NGSSWMVKTN-FPRYWKRDMWNKFFDLL---LNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred CCcceecccc-chhhhhHHHHHHHHHHH---hCcCcccchhHHHHHHHHHHHHH
Confidence 1111111111 111 2234444444444 44555555677777777766554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=174.42 Aligned_cols=230 Identities=21% Similarity=0.243 Sum_probs=148.1
Q ss_pred CccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCC----------CcceeEEEEEE--
Q 005224 378 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHH----------RNLVSLVGYCD-- 441 (707)
Q Consensus 378 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H----------~nIv~l~~~~~-- 441 (707)
...+.||.|+++.||.+++. +++.+|||+...... ...+++.+|.-....+.+ -.++-.++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34688999999999999976 689999998754332 223566666655555322 12222222221
Q ss_pred -------eC---C-----eEEEEEecCCCCCHHHHHhh---cCC--CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 005224 442 -------EE---G-----EQMLVYEFMSNGTLRDQLSA---KSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501 (707)
Q Consensus 442 -------~~---~-----~~~lV~E~~~~gsL~~~l~~---~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 501 (707)
.. . ..+++|+-+ -++|.+++.. ... ..+....+..+..|+++.+++||+.+ ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 11 1 236788888 5699888643 221 23556667788899999999999999 99999
Q ss_pred CCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccC--------CCCCchhhHHHHHHH
Q 005224 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--------KLTDKSDVYSLGVVF 573 (707)
Q Consensus 502 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~~sDVwS~Gvll 573 (707)
|+|+|++++.+|.++|+||+....... .......+..|.+||..... .++.+.|.|++|+++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~----------~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT----------RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE----------EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc----------eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999999999999987765421 11113456789999987542 478899999999999
Q ss_pred HHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCC
Q 005224 574 LELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR 636 (707)
Q Consensus 574 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R 636 (707)
|.|.+|..||........ .+..+..+. +.++.+..++...++.+|.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~--------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEAD--------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGST--------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCcccc--------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999975433110 000233445 777888888888888888776
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-19 Score=198.63 Aligned_cols=172 Identities=28% Similarity=0.432 Sum_probs=124.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..+|+.++.|..|+||.||..+++ ..+.+|.|+-+. ... .+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~li-----lRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NLI-----LRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-chh-----hhc--cccccCCccee------------------
Confidence 457888999999999999999976 466788854332 111 110 22222333333
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC----
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV---- 528 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~---- 528 (707)
|+-...++..+. ++.+. +.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+++.-..
T Consensus 136 ---gDc~tllk~~g~--lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP--LPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCC--Ccchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 555566644333 33322 67899999999 99999999999999999999999999864211
Q ss_pred ----CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 529 ----PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 529 ----~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
..++.....-....++||+.|+|||++..+.|...+|+|++|+++||.+-|+.||+.+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt 262 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 262 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence 11111111112334689999999999999999999999999999999999999998653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=163.16 Aligned_cols=134 Identities=20% Similarity=0.330 Sum_probs=114.0
Q ss_pred ceEeeeCceEEEEEEeCCCcEEEEEEeccCChh--------hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 381 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
+.||+|++|.||+|.. +|..|++|+....... ....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999998 6778999976543211 124578899999999999998888887777888999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
++|++|.+++.... . .+..++.+++.+|.++|+.+ ++|+|++|+|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985432 2 78899999999999999998 99999999999999 78999999998864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-17 Score=165.87 Aligned_cols=202 Identities=20% Similarity=0.234 Sum_probs=145.0
Q ss_pred CCCcceeEEEEEEe---------------------------CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHH
Q 005224 429 HHRNLVSLVGYCDE---------------------------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 481 (707)
Q Consensus 429 ~H~nIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 481 (707)
+|||||++.++|.+ ....|+||...+ .+|.+++-.+. .+.....-|..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999887633 235789998874 59999995543 556667788999
Q ss_pred HHHHHHHHHhCCCCCeEecCCCCCCEEE--cCCC--cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhcc
Q 005224 482 SSRGILYLHTEADPPVFHRDIKASNILL--DHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 557 (707)
Q Consensus 482 ia~gL~yLH~~~~~~ivH~Dlkp~NILl--~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 557 (707)
+++|+.|||+++ |.|||+|++|||+ |+|+ ...|+|||.+--.+.....- ..........|.-.-||||+...
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlql-py~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQL-PYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeecccccccc-ccccccccCCCcceecchhhhhc
Confidence 999999999999 9999999999999 4444 57889999874332211000 00111223446778999999875
Q ss_pred CC------CCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhccc
Q 005224 558 HK------LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQD 631 (707)
Q Consensus 558 ~~------~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~ 631 (707)
.+ --.|+|.|+.|.+.||++....||....+..-.. ...-...++..|+.++..+.+++...++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~---------r~Yqe~qLPalp~~vpp~~rqlV~~lL~r 496 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT---------RTYQESQLPALPSRVPPVARQLVFDLLKR 496 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech---------hhhhhhhCCCCcccCChHHHHHHHHHhcC
Confidence 32 1248999999999999999999997633211000 01112345567888889999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 005224 632 ETDARPSMSEVMRELE 647 (707)
Q Consensus 632 ~p~~RPt~~~v~~~L~ 647 (707)
+|.+|++..-....++
T Consensus 497 ~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 497 DPSKRVSPNIAANVLN 512 (598)
T ss_pred CccccCCccHHHhHHH
Confidence 9999998765555443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.2e-17 Score=159.83 Aligned_cols=144 Identities=19% Similarity=0.180 Sum_probs=112.3
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChh----------------------hHHHHHHHHHHHH
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----------------------GEKEFLTEIQFLS 426 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~ 426 (707)
++......|...+.||+|+||.||+|..++|+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333333447788999999999999999888999999986542210 1123677899999
Q ss_pred ccCCC--cceeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005224 427 RLHHR--NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 504 (707)
Q Consensus 427 ~l~H~--nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 504 (707)
.+.|+ .+...++. ...++||||+++++|.++... .....++.++++++.++|+.+ |+||||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 99877 44445442 345899999999998775421 234678899999999999988 99999999
Q ss_pred CCEEEcCCCcEEEeeecccccCC
Q 005224 505 SNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 505 ~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.6e-17 Score=159.72 Aligned_cols=131 Identities=22% Similarity=0.329 Sum_probs=107.7
Q ss_pred eEeeeCceEEEEEEeCCCcEEEEEEeccCCh--------hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 382 ~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.||+|+||.||+|.+ +|..|++|....... ....++.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999996 578899998653221 11256778999999999887766666666677789999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
+|++|.+++..... .++.+++++|.+||+.+ ++|+|++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998754211 78999999999999998 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.2e-17 Score=163.53 Aligned_cols=142 Identities=20% Similarity=0.155 Sum_probs=110.1
Q ss_pred CCCccceEeeeCceEEEEEE--eCCCcEEEEEEeccCChh------------------------hHHHHHHHHHHHHccC
Q 005224 376 NFNSSTQIGQGGYGKVYKGI--LPDGTVVAVKRAQEGSLQ------------------------GEKEFLTEIQFLSRLH 429 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 429 (707)
-|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36778999999999999998 568999999988743210 0123568999999997
Q ss_pred CCc--ceeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 005224 430 HRN--LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 507 (707)
Q Consensus 430 H~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 507 (707)
+.. +.+++++ ...++||||+++.+|....... ..+.......++.|++.++++||+.+ .|+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence 533 3444443 2358999999998887654222 23556667899999999999999876 399999999999
Q ss_pred EEcCCCcEEEeeecccccC
Q 005224 508 LLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 508 Ll~~~~~~kl~DFGla~~~ 526 (707)
+++ ++.++|+|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 889999999998754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-17 Score=182.35 Aligned_cols=140 Identities=20% Similarity=0.282 Sum_probs=113.5
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEE-eccC-Ch------hhHHHHHHHHHHHHccCCCcceeEEEEEEe
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKR-AQEG-SL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~-l~~~-~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 442 (707)
......|...+.||+|+||+||+|.+.+.. +++|+ .... .. ...+.+.+|+++++.++|++++..+.++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 333455667899999999999999975443 33333 2211 10 123568899999999999999988888877
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
....++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 778899999999999999884 35678999999999999998 9999999999999 678999999999
Q ss_pred ccc
Q 005224 523 SRL 525 (707)
Q Consensus 523 a~~ 525 (707)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.7e-17 Score=172.51 Aligned_cols=127 Identities=28% Similarity=0.413 Sum_probs=108.3
Q ss_pred eEEEEEecCCCCCHHHHHhh-cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
..++.|++|.-.+|.+||.+ ......++.....++.|++.|++| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 57899999999999999974 445567889999999999999999 66 899999999999999999999999998
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 578 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt 578 (707)
....... .........+...||..||+||.+.+..|+.++||||||++|+|++.
T Consensus 404 ts~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCC-cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7665432 11112233456679999999999999999999999999999999997
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.1e-15 Score=145.69 Aligned_cols=136 Identities=23% Similarity=0.212 Sum_probs=98.5
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChhh--HHH----------------------HHHHHHHHHccCCCc--c
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKE----------------------FLTEIQFLSRLHHRN--L 433 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~----------------------~~~E~~~l~~l~H~n--I 433 (707)
.+.||+|+||+||+|...+++.||||++....... ... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999876532211 111 135666666664432 4
Q ss_pred eeEEEEEEeCCeEEEEEecCCCCCHHH-HHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcC
Q 005224 434 VSLVGYCDEEGEQMLVYEFMSNGTLRD-QLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDH 511 (707)
Q Consensus 434 v~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~ 511 (707)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 24589999999854321 111111 11 5578899999999999999 77 99999999999999
Q ss_pred CCcEEEeeecccccCC
Q 005224 512 KFTAKVADFGLSRLAP 527 (707)
Q Consensus 512 ~~~~kl~DFGla~~~~ 527 (707)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5e-15 Score=138.15 Aligned_cols=135 Identities=19% Similarity=0.163 Sum_probs=114.6
Q ss_pred ccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCC--CcceeEEEEEEeCCeEEEEEecCCCC
Q 005224 379 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 379 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~E~~~~g 456 (707)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++.++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999854 7899999866433 4578899999999976 58999999888888899999999887
Q ss_pred CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 457 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 457 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.+..+ +......++.+++++|+++|.....+++|+|++|+||++++++.+++.|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 5566778899999999999986545599999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-14 Score=145.23 Aligned_cols=135 Identities=21% Similarity=0.254 Sum_probs=105.7
Q ss_pred cceEe-eeCceEEEEEEeCCCcEEEEEEeccCC-------------hhhHHHHHHHHHHHHccCCCcc--eeEEEEEEeC
Q 005224 380 STQIG-QGGYGKVYKGILPDGTVVAVKRAQEGS-------------LQGEKEFLTEIQFLSRLHHRNL--VSLVGYCDEE 443 (707)
Q Consensus 380 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~ 443 (707)
...|| .|+.|+||.+... +..++||++.... ......+.+|++++..++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999884 6778898875321 1223567889999999998875 6777765433
Q ss_pred C----eEEEEEecCCC-CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 005224 444 G----EQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 518 (707)
Q Consensus 444 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 518 (707)
. ..++||||+++ .+|.+++... +++.. .+.+++++|.+||+.+ |+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6999988542 34443 3568899999999999 9999999999999999999999
Q ss_pred eeccccc
Q 005224 519 DFGLSRL 525 (707)
Q Consensus 519 DFGla~~ 525 (707)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-16 Score=177.70 Aligned_cols=262 Identities=21% Similarity=0.244 Sum_probs=194.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC--CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 449 (707)
..|...+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+=+.+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45666778999999999888753 34567777665433 222344555777777775 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCEEEcCCC-cEEEeeecccccCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH-TEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAP 527 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~ 527 (707)
++|..++++.+-+........+....-.+..|+..++.|+| ..+ +.|+|+||+|.+++..+ ..|++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999988883222223555666778999999999999 877 99999999999999999 99999999998776
Q ss_pred C-CCCCCccccceeccccc-CCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 528 V-PDIEGIVPAHVSTVVKG-TPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 528 ~-~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
. .+. .......+| ++.|+|||...+. ......|+||.|+++.-+++|..|+........ .
T Consensus 177 ~~~g~-----~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---------~--- 239 (601)
T KOG0590|consen 177 NKNGA-----ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---------R--- 239 (601)
T ss_pred ccCCc-----ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---------c---
Confidence 5 221 233445667 9999999999884 456679999999999999999999864322100 0
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 684 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 684 (707)
....+..| .|.+ ...+........+++.+++..+|+.|.+.+++-.+
T Consensus 240 ----------------~~~~~~~~------~~~~-----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 240 ----------------YSSWKSNK------GRFT-----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ----------------ceeecccc------cccc-----------cCccccCChhhhhcccccccCCchhcccccccccc
Confidence 00000011 0000 01122334456688999999999999999999999
Q ss_pred CCCCC
Q 005224 685 PYVSS 689 (707)
Q Consensus 685 p~f~~ 689 (707)
||+..
T Consensus 287 ~~~~~ 291 (601)
T KOG0590|consen 287 NWLSS 291 (601)
T ss_pred ccccc
Confidence 99988
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.8e-16 Score=138.66 Aligned_cols=128 Identities=26% Similarity=0.454 Sum_probs=115.3
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++++.|.||+|+|+-.+|.+..|.+|+.|++++|+|+ .+|..+.++ +|+.|+++-|++. .+|..|+.++.|+.|||+
T Consensus 33 s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 33 SNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence 4678899999999999999999999999999999999 999998887 8999999999999 999999999999999999
Q ss_pred Cccccc-CCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCcc
Q 005224 81 NNSLSG-SIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g-~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~ 136 (707)
.|+++. .+|..|+.++.|+ -|+|++|.+.-+|+.+ .+.+|+.|.+++|.+-
T Consensus 111 ynnl~e~~lpgnff~m~tlr-----alyl~dndfe~lp~dvg~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 111 YNNLNENSLPGNFFYMTTLR-----ALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL 163 (264)
T ss_pred ccccccccCCcchhHHHHHH-----HHHhcCCCcccCChhhhhhcceeEEeeccCchh
Confidence 999873 6788888877776 7899999999998888 8889999999888763
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-15 Score=137.18 Aligned_cols=132 Identities=23% Similarity=0.460 Sum_probs=122.0
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCC-CCCcccCCCcccceEe
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTG-TIPSNFSGLPRLQRLF 78 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ 78 (707)
|.+|+.|++++|+|+.++++++++++|+.|+++-|+|. .+|.++++. .|+.|||.+|++.. .+|..|..++.|+.|+
T Consensus 55 l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 46899999999999999999999999999999999999 999999987 89999999999964 6899999999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCccccC
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNT 139 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~~~ 139 (707)
|++|.+. .+|..++++++|+ .|.+.+|.|-.+|.++ .+..|+.|.+.+|++..-+
T Consensus 134 l~dndfe-~lp~dvg~lt~lq-----il~lrdndll~lpkeig~lt~lrelhiqgnrl~vlp 189 (264)
T KOG0617|consen 134 LGDNDFE-ILPPDVGKLTNLQ-----ILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTVLP 189 (264)
T ss_pred hcCCCcc-cCChhhhhhccee-----EEeeccCchhhCcHHHHHHHHHHHHhcccceeeecC
Confidence 9999999 9999999987776 9999999999999988 7899999999999986544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3e-13 Score=148.26 Aligned_cols=141 Identities=23% Similarity=0.247 Sum_probs=101.3
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChhh----------------------------------------HHHHH
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----------------------------------------EKEFL 419 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~~ 419 (707)
.+.||.|++|.||+|++++|+.||||+........ +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46899999999999999999999999986532110 01245
Q ss_pred HHHHHHHccC----CCcceeEEEEE-EeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHH-HHHHHHhCC
Q 005224 420 TEIQFLSRLH----HRNLVSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR-GILYLHTEA 493 (707)
Q Consensus 420 ~E~~~l~~l~----H~nIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~ 493 (707)
+|++.+.+++ |.+-+.+-.++ ...+..+|||||++|++|.++...... .. .+..++..++. .+..+|..+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 5666655552 33333333333 334567999999999999887653211 12 23456666665 478899888
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 494 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
++|+|+||.||+++++++++++|||++....
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.2e-13 Score=154.87 Aligned_cols=106 Identities=28% Similarity=0.447 Sum_probs=73.5
Q ss_pred cccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCCCCccc
Q 005224 26 NLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 104 (707)
Q Consensus 26 ~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~ 104 (707)
.++.|+|++|.|+|.+|..+..+ +|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..+.++++|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~----- 493 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR----- 493 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCC-----
Confidence 36677777777777777766665 677777777777777777777777777777777777777777777665554
Q ss_pred eEEccCccCCCC-CCCC-C-CCCCceeeccCCCcc
Q 005224 105 ILDFQNNNLTNI-SGSF-N-IPPNVTVRLRGNPFC 136 (707)
Q Consensus 105 ~l~l~~N~l~~~-~~~~-~-~~~l~~l~l~~N~~~ 136 (707)
.|+|++|+|++. |..+ . ..++..+++.+|+..
T Consensus 494 ~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred EEECcCCcccccCChHHhhccccCceEEecCCccc
Confidence 777777777753 3333 1 234456677777643
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1e-14 Score=154.86 Aligned_cols=130 Identities=28% Similarity=0.467 Sum_probs=115.8
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcc-cCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNG-SIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
|.+|++|.+++|+|..+..++..|+.|+.+++..|+|.. -||..++.+ .|+.||||+|+|+ ..|..+..-+++-+|+
T Consensus 54 lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLN 132 (1255)
T KOG0444|consen 54 LQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLN 132 (1255)
T ss_pred HhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEE
Confidence 457899999999999888899999999999999999973 389999988 8999999999999 8999999999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCcc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~ 136 (707)
||+|+|. .||.+++ .+++.|-+||||+|+|..+|+.+ .+..|++|.|++||+.
T Consensus 133 LS~N~Ie-tIPn~lf----inLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 133 LSYNNIE-TIPNSLF----INLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred cccCccc-cCCchHH----HhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhh
Confidence 9999999 9998764 13345559999999999999988 8899999999999974
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.5e-13 Score=164.53 Aligned_cols=108 Identities=37% Similarity=0.585 Sum_probs=55.1
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
++|++|+|++|.+++..| .++++++|++|+|++|.+++.+|..+..+ +|++|+|++|++++.+|..|+++++|+.|+|
T Consensus 140 ~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 219 (968)
T PLN00113 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL 219 (968)
T ss_pred CCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEEC
Confidence 344555555555554444 35555555555555555555555544443 4555555555555555555555555555555
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCC
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~ 114 (707)
++|++++.+|..+.++++|+ +|+|++|+++
T Consensus 220 ~~n~l~~~~p~~l~~l~~L~-----~L~L~~n~l~ 249 (968)
T PLN00113 220 GYNNLSGEIPYEIGGLTSLN-----HLDLVYNNLT 249 (968)
T ss_pred cCCccCCcCChhHhcCCCCC-----EEECcCceec
Confidence 55555555555554443332 4444444444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.9e-13 Score=132.97 Aligned_cols=155 Identities=24% Similarity=0.362 Sum_probs=115.4
Q ss_pred HHHHccCCCcceeEEEEEEeCC-----eEEEEEecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCC
Q 005224 423 QFLSRLHHRNLVSLVGYCDEEG-----EQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADP 495 (707)
Q Consensus 423 ~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 495 (707)
.-+-.+.|.|||+++.|+.+.+ ...+++|||..|++..+|++. ....+....-.+++-||+.||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 3344557999999999985543 578899999999999999863 334567777788999999999999996 68
Q ss_pred CeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHH
Q 005224 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 575 (707)
Q Consensus 496 ~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~e 575 (707)
+|+|+++.-+-|++..++-+|++---- ..... ... ...........+-++|.|||+-.....+.++|||+||+..+|
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap-~s~h~-s~~-~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHP-SVN-STREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCc-cccch-hhh-hhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 999999999999999999888752111 10000 000 000111223346789999998888888889999999999999
Q ss_pred HHcCCC
Q 005224 576 LLTGMQ 581 (707)
Q Consensus 576 lltG~~ 581 (707)
|.-+..
T Consensus 275 mailEi 280 (458)
T KOG1266|consen 275 MAILEI 280 (458)
T ss_pred HHHhee
Confidence 987754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.4e-13 Score=143.23 Aligned_cols=166 Identities=19% Similarity=0.195 Sum_probs=128.5
Q ss_pred eCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHH
Q 005224 396 LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR 475 (707)
Q Consensus 396 ~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~ 475 (707)
..++.+|.|...+...........+-++.|+.+|||||+++++.+..++..|+|+|-+ ..|..++.+.+ ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHH
Confidence 3478888888887655444456778899999999999999999999999999999998 36777886543 5667
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhh
Q 005224 476 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555 (707)
Q Consensus 476 ~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 555 (707)
...+.||+.||.|||..++ ++|++|.-+.|+|+..|+.||++|-++........ ......--..|..|+.+
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-------~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-------PAKSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------ccccchhhhcccChhhc
Confidence 7789999999999997664 99999999999999999999999998865432110 00111112346667655
Q ss_pred ccCCCCCchhhHHHHHHHHHHHcC
Q 005224 556 LTHKLTDKSDVYSLGVVFLELLTG 579 (707)
Q Consensus 556 ~~~~~s~~sDVwS~Gvll~elltG 579 (707)
.... -..|.|.|||+++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 4332 357999999999999999
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.9e-14 Score=149.86 Aligned_cols=132 Identities=23% Similarity=0.285 Sum_probs=96.2
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
|+.|+.|+||+|.|..+.+ .+...++|++|+||+|+|+ .++++-+.. .|++|+|++|+|+..--..|..+++|+.|
T Consensus 292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~L 370 (873)
T KOG4194|consen 292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKL 370 (873)
T ss_pred cchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhh
Confidence 5677888888888887776 5777788888888888888 887765543 68888888888886666677888888888
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCc
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPF 135 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~ 135 (707)
||++|.|++.|-+.-.-... +++|+.|+|.+|+|..++.-. +++.|+.|+|.+|++
T Consensus 371 dLr~N~ls~~IEDaa~~f~g--l~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 371 DLRSNELSWCIEDAAVAFNG--LPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred cCcCCeEEEEEecchhhhcc--chhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 88888888777654332222 234457788888887776643 677777777777765
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-13 Score=146.58 Aligned_cols=128 Identities=27% Similarity=0.365 Sum_probs=76.8
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
..|+.||||+|+|+..|..+..-+++-.|+||+|+|. +||..++-. .|-.||||+|+|. .+|..+..|..|++|+|
T Consensus 103 ~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL 180 (1255)
T ss_pred ccceeeecchhhhhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence 3455555555555555445555555555555555555 555554432 4555566666665 55555555556666666
Q ss_pred cCcccc-------------------------cCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCC
Q 005224 80 ANNSLS-------------------------GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGN 133 (707)
Q Consensus 80 s~N~l~-------------------------g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N 133 (707)
|+|.|. ..+|.++..+.+ |..+|||.|+|..+|+.+ .+++|+.|+|++|
T Consensus 181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~N-----L~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N 255 (1255)
T KOG0444|consen 181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHN-----LRDVDLSENNLPIVPECLYKLRNLRRLNLSGN 255 (1255)
T ss_pred CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhh-----hhhccccccCCCcchHHHhhhhhhheeccCcC
Confidence 665332 123444444333 347888888888888776 7888888888888
Q ss_pred Ccc
Q 005224 134 PFC 136 (707)
Q Consensus 134 ~~~ 136 (707)
.+.
T Consensus 256 ~it 258 (1255)
T KOG0444|consen 256 KIT 258 (1255)
T ss_pred cee
Confidence 874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.2e-13 Score=140.46 Aligned_cols=125 Identities=25% Similarity=0.395 Sum_probs=111.0
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccC-CCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFS-GLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l 79 (707)
+.|++||...|-++.+||+++.+.+|.-|||..|+|. .+| ++... .|.+|+++.|+|. .+|.+.. ++.+|.+|||
T Consensus 183 ~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 183 KRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 4688999999999988889999999999999999999 999 44444 7899999999999 8888876 8999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCcc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~ 136 (707)
.+|+++ ..|+.+.-+.+|+ .||||+|.|+++|.++ ++ .|..|.+.|||+.
T Consensus 260 RdNklk-e~Pde~clLrsL~-----rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 260 RDNKLK-EVPDEICLLRSLE-----RLDLSNNDISSLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred cccccc-cCchHHHHhhhhh-----hhcccCCccccCCcccccc-eeeehhhcCCchH
Confidence 999999 9999998877776 8999999999999988 56 8899999999984
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.7e-13 Score=145.09 Aligned_cols=141 Identities=23% Similarity=0.357 Sum_probs=124.0
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCc---ccCCCcccc
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPS---NFSGLPRLQ 75 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~---~~~~l~~L~ 75 (707)
.+|++|+|++|+|+.+.+ .|..|..|++|+|++|+++ .|-++.+.. +|+.|||++|.|+..+.+ .|.+|++|+
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lr 395 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLR 395 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhh
Confidence 579999999999999988 6999999999999999999 999887764 899999999999988765 588999999
Q ss_pred eEeccCcccccCCC-CCccccccCCCCccceEEccCccCCCCCC-CC-CCCCCceeeccCCCccccCCcccccCCCCC
Q 005224 76 RLFIANNSLSGSIP-SSIWQSRTLNATETFILDFQNNNLTNISG-SF-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 150 (707)
Q Consensus 76 ~L~ls~N~l~g~~p-~~~~~l~~L~~~~L~~l~l~~N~l~~~~~-~~-~~~~l~~l~l~~N~~~~~~~~~~~~~~~~~ 150 (707)
.|+|.+|+|. .|| .+|..+..|+ +|||.+|.|.++-+ .+ .+ .|..|.+..-.|-|||++..+-.|.-.
T Consensus 396 kL~l~gNqlk-~I~krAfsgl~~LE-----~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qWl~~ 466 (873)
T KOG4194|consen 396 KLRLTGNQLK-SIPKRAFSGLEALE-----HLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQWLYR 466 (873)
T ss_pred heeecCceee-ecchhhhccCcccc-----eecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHHHHh
Confidence 9999999999 666 4677777666 99999999999854 44 45 888999999999999999998888743
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.2e-11 Score=137.26 Aligned_cols=143 Identities=20% Similarity=0.201 Sum_probs=96.7
Q ss_pred cCCCccceEeeeCceEEEEEEeCC-CcEEEEEEeccCChh----------------------------------hHH---
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ----------------------------------GEK--- 416 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~----------------------------------~~~--- 416 (707)
..|+. +.||+|++|.||+|++++ |+.||||+....-.. ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45766 789999999999999987 999999998753110 011
Q ss_pred ---HHHHHHHHHHccC----CCcceeEEEEEE-eCCeEEEEEecCCCCCHHHHH--hhcCC--CCcCHHHHHHHHHHHHH
Q 005224 417 ---EFLTEIQFLSRLH----HRNLVSLVGYCD-EEGEQMLVYEFMSNGTLRDQL--SAKSK--EPLGFAMRLSIALGSSR 484 (707)
Q Consensus 417 ---~~~~E~~~l~~l~----H~nIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l--~~~~~--~~l~~~~~~~i~~~ia~ 484 (707)
++.+|+..+.+++ +.+.+.+-.++. .....+|||||++|+.+.++- ...+. ..+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2444555554442 444444444443 245788999999999998753 22211 12333333333333
Q ss_pred HHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeeecccccCCC
Q 005224 485 GILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGLSRLAPV 528 (707)
Q Consensus 485 gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFGla~~~~~ 528 (707)
+...+ ++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34567 99999999999999888 999999999977643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.8e-13 Score=139.01 Aligned_cols=85 Identities=21% Similarity=0.279 Sum_probs=69.5
Q ss_pred ccCCCcccceEeccCcccccCCCCCccccccC-------------------CCCccceEEccCccCCCCCCC-C-CCCCC
Q 005224 67 NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL-------------------NATETFILDFQNNNLTNISGS-F-NIPPN 125 (707)
Q Consensus 67 ~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L-------------------~~~~L~~l~l~~N~l~~~~~~-~-~~~~l 125 (707)
.|..|++|+.|+|++|+|++.-+.+|..+..+ .+.+|+.|+|.+|+|+.+.+. + .+..|
T Consensus 269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL 348 (498)
T ss_pred HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence 34568899999999999997777777665554 345678999999999998554 4 78889
Q ss_pred ceeeccCCCccccCCcccccCCCCCC
Q 005224 126 VTVRLRGNPFCLNTNAEQFCGSHSDD 151 (707)
Q Consensus 126 ~~l~l~~N~~~~~~~~~~~~~~~~~~ 151 (707)
.+|+|-.|||+|+|.+..+-+|....
T Consensus 349 ~~l~l~~Np~~CnC~l~wl~~Wlr~~ 374 (498)
T KOG4237|consen 349 STLNLLSNPFNCNCRLAWLGEWLRKK 374 (498)
T ss_pred eeeehccCcccCccchHHHHHHHhhC
Confidence 99999999999999999999998653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-11 Score=118.29 Aligned_cols=130 Identities=16% Similarity=0.109 Sum_probs=96.7
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcce-eEEEEEEeCCeEEEEEecCCCCCH
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV-SLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
.+.|+.|.++.||++... ++.|++|....... ....+.+|+++++.+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999875 77899998765432 223567899999988655544 455443 2345799999999887
Q ss_pred HHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 459 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
.+.. . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5430 1 11345678999999999876 22359999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.4e-12 Score=135.84 Aligned_cols=248 Identities=21% Similarity=0.229 Sum_probs=178.3
Q ss_pred CCCccceEee--eCceEEEEEEe---CCCcEEEEEEecc--CChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEE
Q 005224 376 NFNSSTQIGQ--GGYGKVYKGIL---PDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 376 ~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 447 (707)
.|.+...+|. |.+|.||.+.. .++..+|+|+-+. ........=.+|+...+.+ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788999 99999999986 3688999997432 2222233345677776777 4999999888899999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeeecc
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----GILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGL 522 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGl 522 (707)
+-+|++ +.+|.++.+.... .++....+.+..+..+ ||.++|... ++|-|+||.||+...+ ...+++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 999998 5788888765432 2666777777888888 999999988 9999999999999999 8999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
.......+..... .......|...|++||...+ -++...|+|++|.+..|..++..+...+.+.. |
T Consensus 270 v~~i~~~~~~~~~--~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W---------- 335 (524)
T KOG0601|consen 270 VSKISDGNFSSVF--KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS-W---------- 335 (524)
T ss_pred eEEccCCccccce--eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-c----------
Confidence 9887665433221 11233367788999998764 56789999999999999999877765442210 0
Q ss_pred hhhccCCC--CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005224 603 FSVIDGNM--GSYPSECVEKFIKLALKCCQDETDARPSMSEVM 643 (707)
Q Consensus 603 ~~~~~~~~--~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~ 643 (707)
.-+++.. .++-+.-...+......+++.++..|++.+.+.
T Consensus 336 -~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 336 -SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred -cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 0011100 001111223445577888888988888877654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.3e-12 Score=145.70 Aligned_cols=269 Identities=19% Similarity=0.235 Sum_probs=181.4
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
..+.+.+.+.+-+|.++.++.+.-. .|...++|....... ..-+....+-.++-..+||-+++..-.+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456777778889999999887733 344444443322111 111222333333333456666665555555667899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|++|..+++|...|+..+ ..+....+.....+.++++|||... +.|+|++|.|.+...++..+++|||.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999997644 4555566667777889999999987 89999999999999999999999984332111
Q ss_pred C----CC-----------------C---CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCC
Q 005224 529 P----DI-----------------E---GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584 (707)
Q Consensus 529 ~----~~-----------------~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~ 584 (707)
. +. . ............||+.|.+||...+......+|+|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00 0 0001123445678999999999999999999999999999999999999996
Q ss_pred CCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccc
Q 005224 585 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFI 664 (707)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll 664 (707)
...... .+..+..+.. ..-......++...+++
T Consensus 1037 a~tpq~----------~f~ni~~~~~-------------------------------------~~p~g~~~~s~~aq~~~ 1069 (1205)
T KOG0606|consen 1037 AETPQQ----------IFENILNRDI-------------------------------------PWPEGPEEGSYEAQDLI 1069 (1205)
T ss_pred Ccchhh----------hhhccccCCC-------------------------------------CCCCCccccChhhhhhh
Confidence 433210 0000000000 00011122345566788
Q ss_pred cCCCCCCCCCCCCCC---cCCCCCCCCCCCCC
Q 005224 665 NSEHTSKEETPPSSS---SMLKHPYVSSDVSG 693 (707)
Q Consensus 665 ~~~L~~dP~~R~sa~---e~L~Hp~f~~~~~~ 693 (707)
..+++.+|.+|..+. +.-.||||....++
T Consensus 1070 ~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1070 NRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred hhhhccCchhccCcccccccccCCccCCCCcc
Confidence 899999999999988 88899999988874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.4e-12 Score=132.69 Aligned_cols=123 Identities=35% Similarity=0.508 Sum_probs=103.0
Q ss_pred EEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCccc
Q 005224 6 KLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 84 (707)
Q Consensus 6 ~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 84 (707)
.+.+++|.++-.+..++.+++|+.|+|++|-+. .+|.+.+.. .|+.||||+|+|. .+|..+-.+..|+.+-.++|++
T Consensus 416 ~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi 493 (565)
T KOG0472|consen 416 DLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQI 493 (565)
T ss_pred HHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccc
Confidence 345566666544446788899999999999999 999988887 7999999999999 8998888888888888888999
Q ss_pred ccCCCCC-ccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCcc
Q 005224 85 SGSIPSS-IWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 85 ~g~~p~~-~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~ 136 (707)
. .++.+ +.+|.+|. .|||.+|.|..+|+.+ ++.++.+|.+.||||.
T Consensus 494 ~-~vd~~~l~nm~nL~-----tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 494 G-SVDPSGLKNMRNLT-----TLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred c-ccChHHhhhhhhcc-----eeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 8 66555 77766555 9999999999999998 8999999999999996
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-11 Score=132.21 Aligned_cols=246 Identities=20% Similarity=0.241 Sum_probs=171.4
Q ss_pred HHHHhcCCCccceEeeeCceEEEEEEeC--CCcEEEEEEeccCChhhHHH--HHHHHHHHHcc-CCCcceeEEEEEEeCC
Q 005224 370 MALATNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRL-HHRNLVSLVGYCDEEG 444 (707)
Q Consensus 370 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 444 (707)
......+|.....||.|.|+.|++...+ ++..|++|.+.........+ -..|+-+...+ .|.++++.+..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3444668888999999999999998743 67899999877643333222 24566666555 5888888887777777
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeeeccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 523 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla 523 (707)
..++=-||++++++...+ .....+++..++.+..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||.+
T Consensus 340 ~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 778999999999987665 33445788889999999999999999988 9999999999999886 88899999988
Q ss_pred ccCCCCCCCCccccceecccccCCCc-cchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGY-LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
..+... .......+..| .+++......+..+.|++|||..+.|.+++...-..... .
T Consensus 415 t~~~~~---------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------------~ 472 (524)
T KOG0601|consen 415 TRLAFS---------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------------S 472 (524)
T ss_pred ccccee---------cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------------c
Confidence 642211 11111122333 355555668888999999999999999998543222111 1
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 643 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~ 643 (707)
..+..+.....+... ..+..+.......++..||.+.++.
T Consensus 473 ~~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~ 512 (524)
T KOG0601|consen 473 LTIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELS 512 (524)
T ss_pred eeeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhc
Confidence 122222233333333 5555666666666776666665543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.2e-11 Score=115.31 Aligned_cols=122 Identities=29% Similarity=0.456 Sum_probs=42.0
Q ss_pred eeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcccccC
Q 005224 9 LRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 87 (707)
Q Consensus 9 L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 87 (707)
|..+.|. ..+.+.+..++++|+|++|+|+ .|..-...+ +|+.|+|++|+|+ .++ .+..+++|+.|+|++|+|+ .
T Consensus 4 lt~~~i~-~~~~~~n~~~~~~L~L~~n~I~-~Ie~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~ 78 (175)
T PF14580_consen 4 LTANMIE-QIAQYNNPVKLRELNLRGNQIS-TIENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-S 78 (175)
T ss_dssp ----------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S
T ss_pred ccccccc-cccccccccccccccccccccc-cccchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-c
Confidence 4444444 3345667778999999999999 886422233 7999999999999 565 5888999999999999999 6
Q ss_pred CCCCcc-ccccCCCCccceEEccCccCCCCCCCC---CCCCCceeeccCCCccccCC
Q 005224 88 IPSSIW-QSRTLNATETFILDFQNNNLTNISGSF---NIPPNVTVRLRGNPFCLNTN 140 (707)
Q Consensus 88 ~p~~~~-~l~~L~~~~L~~l~l~~N~l~~~~~~~---~~~~l~~l~l~~N~~~~~~~ 140 (707)
++..+. .+++| +.|+|++|+|..+.... .+++|..|+|.+||++....
T Consensus 79 i~~~l~~~lp~L-----~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~ 130 (175)
T PF14580_consen 79 ISEGLDKNLPNL-----QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKN 130 (175)
T ss_dssp -CHHHHHH-TT-------EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTT
T ss_pred cccchHHhCCcC-----CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhh
Confidence 665443 45555 49999999999876532 78999999999999875543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.7e-12 Score=136.13 Aligned_cols=131 Identities=30% Similarity=0.449 Sum_probs=101.9
Q ss_pred ceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccCcc
Q 005224 4 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 83 (707)
Q Consensus 4 L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 83 (707)
|+.|.|++|.+..+++.+.+|..|++|||+.|+++ .+|..++.+-|+.|.+++|+++ .+|..++.+..|..||.+.|+
T Consensus 100 Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ne 177 (722)
T KOG0532|consen 100 LESLILYHNCIRTIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNE 177 (722)
T ss_pred HHHHHHHhccceecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEecCccc-cCCcccccchhHHHhhhhhhh
Confidence 45566777777766667777788888888888888 8888777777888888888888 777777777777777877777
Q ss_pred cccCCCCCccccccCCC-----------------CccceEEccCccCCCCCCCC-CCCCCceeeccCCCccc
Q 005224 84 LSGSIPSSIWQSRTLNA-----------------TETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 84 l~g~~p~~~~~l~~L~~-----------------~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~ 137 (707)
+. .+|..++.+.+|+- ..|..||+|+|+++.+|-.+ .|..|+.|.|.+||+..
T Consensus 178 i~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 178 IQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCceeecchhhhhhhhheeeeeccCCCCC
Confidence 77 67766666655421 33568999999999999998 89999999999999853
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.5e-10 Score=107.41 Aligned_cols=137 Identities=17% Similarity=0.084 Sum_probs=98.4
Q ss_pred cceEeeeCceEEEEEEeCC-------CcEEEEEEeccCCh----------------------hhHHH----HHHHHHHHH
Q 005224 380 STQIGQGGYGKVYKGILPD-------GTVVAVKRAQEGSL----------------------QGEKE----FLTEIQFLS 426 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~----------------------~~~~~----~~~E~~~l~ 426 (707)
...||.|.-+.||.|...+ +..+|||+.+.... ...+. ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3468999999999998543 47999997642100 00122 348999999
Q ss_pred ccCC--CcceeEEEEEEeCCeEEEEEecCCCCCHH-HHHhhcCCCCcCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCC
Q 005224 427 RLHH--RNLVSLVGYCDEEGEQMLVYEFMSNGTLR-DQLSAKSKEPLGFAMRLSIALGSSRGILYL-HTEADPPVFHRDI 502 (707)
Q Consensus 427 ~l~H--~nIv~l~~~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dl 502 (707)
++.. -++.+++++ ...++||||+.+..+. ..+++ ..++......+..+++.+|..| |..+ +||+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9853 455666654 4678999999764332 22322 1244556677889999999999 7888 999999
Q ss_pred CCCCEEEcCCCcEEEeeecccccCC
Q 005224 503 KASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 503 kp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
++.||+++ ++.+.|+|||.|....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.1e-10 Score=103.74 Aligned_cols=132 Identities=22% Similarity=0.305 Sum_probs=100.0
Q ss_pred ceEeeeCceEEEEEEeCCCcEEEEEEeccCChh--------hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 381 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..+++|+-+.+|.+.+. |..+++|.-....-. ...+-.+|++++.+++--.|...+=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999874 444667754322111 123457799999998766665555567778888999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++|-.|.+.+... ...++..+-.-+.-||..+ |+|+||.++||.+..+. +.++|||++...
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9998999888554 2445666666778899999 99999999999998765 999999999753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.9e-10 Score=113.69 Aligned_cols=143 Identities=22% Similarity=0.344 Sum_probs=110.9
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCC--cceeEEEEEEeC---CeEEEEEecC
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHR--NLVSLVGYCDEE---GEQMLVYEFM 453 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~~---~~~~lV~E~~ 453 (707)
.+.|+.|.++.||++...+|+.+++|....... .....+.+|+++++.+++. .+.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999987778999998765332 1345788999999999763 457777777654 2568999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---------------------------------------- 493 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 493 (707)
++.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99888775521 34677778888888888888888521
Q ss_pred -------------CCCeEecCCCCCCEEEcC--CCcEEEeeeccccc
Q 005224 494 -------------DPPVFHRDIKASNILLDH--KFTAKVADFGLSRL 525 (707)
Q Consensus 494 -------------~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~ 525 (707)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 244899999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.1e-09 Score=101.40 Aligned_cols=143 Identities=22% Similarity=0.233 Sum_probs=108.1
Q ss_pred ccceEeeeCceEEEEEEeCCCcEEEEEEeccCCh--------hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 379 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 379 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
....|-+|+-+.|+++.+ .|+.+.||.-..... -..++-.+|++.+.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 578899999999999998 578777775432111 12356778999999986555555555666777778999
Q ss_pred ecCCC-CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEeeeccccc
Q 005224 451 EFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRL 525 (707)
Q Consensus 451 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFGla~~ 525 (707)
||+++ .++.+++...............++..|-+.+.-||..+ |+|+||..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99966 47888887654443444444788888999999999999 99999999999997655 358999999864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4e-12 Score=141.80 Aligned_cols=125 Identities=35% Similarity=0.492 Sum_probs=109.8
Q ss_pred CCceEEEeeCCcCCCC-CCCcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGP-MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
+.|+.|+|.+|.|+.. .|-|-+..+|+.|+|++|+|. ++|...... .|+.|+||+|+|+ .+|.++.++.+|++|.
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR 436 (1081)
T ss_pred HHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence 3578899999999974 478999999999999999999 999977664 7999999999999 8999999999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCC--CCCCCCCCCceeeccCCCc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI--SGSFNIPPNVTVRLRGNPF 135 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~--~~~~~~~~l~~l~l~~N~~ 135 (707)
..+|+|. .+| .+.+++.|+ .+|||.|+|+.+ +.....|+|+.|+|+||++
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~-----~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLK-----VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hcCCcee-ech-hhhhcCcce-----EEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999 999 677665554 999999999975 4444568999999999996
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.2e-11 Score=134.70 Aligned_cols=15 Identities=27% Similarity=0.286 Sum_probs=7.9
Q ss_pred CceEEEeeCCcCCCC
Q 005224 3 KLLKLSLRNCSLQGP 17 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~ 17 (707)
+|+.|+|++|+|+++
T Consensus 303 ~L~~LdLS~N~L~~L 317 (788)
T PRK15387 303 GLQELSVSDNQLASL 317 (788)
T ss_pred ccceeECCCCccccC
Confidence 455555555555543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.5e-12 Score=126.68 Aligned_cols=138 Identities=24% Similarity=0.402 Sum_probs=116.6
Q ss_pred CceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc--Cc-cEEEccCccCCCCCCcccCCCcccceEe
Q 005224 3 KLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NI-TTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
.-+.|+|..|+|+.+++ .|+.+++|+.||||+|+|+ .|-+..|.. +| +-+++++|+|+...-..|++|..|+.|.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 35789999999999998 7999999999999999999 888776654 54 4556666999955557899999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCccccCCcccccC
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQFCG 146 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~~~~~~~~~ 146 (707)
++-|++.-...+.+..+++|+ .|.|-+|.+..++.. + .+..++++.+..||+.|+|++..+..
T Consensus 147 lNan~i~Cir~~al~dL~~l~-----lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~ 211 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLS-----LLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLAD 211 (498)
T ss_pred cChhhhcchhHHHHHHhhhcc-----hhcccchhhhhhccccccchhccchHhhhcCccccccccchhhh
Confidence 999999955556677777766 799999999999874 4 88899999999999999999877654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-11 Score=120.74 Aligned_cols=127 Identities=24% Similarity=0.290 Sum_probs=101.1
Q ss_pred CceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccCc
Q 005224 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 82 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 82 (707)
.|+.||||+|.|+.+-.+..-++.++.|+||+|.|. .+..-....+|+.||||+|.++ .+-.+-..|-+.+.|.|+.|
T Consensus 285 ~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N 362 (490)
T KOG1259|consen 285 ELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQN 362 (490)
T ss_pred hhhhccccccchhhhhhhhhhccceeEEecccccee-eehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhh
Confidence 478899999999977777777899999999999999 7776222238999999999999 67777677888999999999
Q ss_pred ccccCCCCCccccccCCCCccceEEccCccCCCCCCC--C-CCCCCceeeccCCCcccc
Q 005224 83 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS--F-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 83 ~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~--~-~~~~l~~l~l~~N~~~~~ 138 (707)
.|. . +..+.+|- +|..||+++|+|..+... + .+|.|+++.|.+||+...
T Consensus 363 ~iE-~----LSGL~KLY--SLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 363 KIE-T----LSGLRKLY--SLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hHh-h----hhhhHhhh--hheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 987 3 33344332 455899999999988553 3 789999999999998644
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-10 Score=110.65 Aligned_cols=119 Identities=26% Similarity=0.441 Sum_probs=49.9
Q ss_pred CceEEEeeCCcCCCCCCCcC-CCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCccc-CCCcccceEec
Q 005224 3 KLLKLSLRNCSLQGPMPDLS-RIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNF-SGLPRLQRLFI 79 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~-~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l 79 (707)
+++.|+|++|+|+.+ ..++ .+.+|+.|+|++|.|+ .|+. +..+ .|+.|+|++|+|+ .+...+ ..+++|+.|+|
T Consensus 20 ~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~-~l~~-l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQIT-KLEG-LPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYL 95 (175)
T ss_dssp -----------------S--TT-TT--EEE-TTS--S---TT-----TT--EEE--SS----S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccccc-cchhhhhcCCCEEECCCCCCc-cccC-ccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEEC
Confidence 578999999999965 4566 6899999999999999 8874 3333 8999999999999 566555 46899999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC----C-CCCCCceee
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS----F-NIPPNVTVR 129 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~----~-~~~~l~~l~ 129 (707)
++|+|. .+-+ +..+.. +++|+.|+|.+|.++..+.. + .+|+|+.|+
T Consensus 96 ~~N~I~-~l~~-l~~L~~--l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 96 SNNKIS-DLNE-LEPLSS--LPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp TTS----SCCC-CGGGGG---TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred cCCcCC-ChHH-hHHHHc--CCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 999998 4432 444443 34667999999999976542 1 678888765
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.5e-10 Score=129.77 Aligned_cols=117 Identities=26% Similarity=0.369 Sum_probs=55.8
Q ss_pred CceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccCc
Q 005224 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 82 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 82 (707)
+|+.|+|++|+|+.++..+. .+|++|+|++|+|+ .||..+.. +|+.|+|++|+|+ .+|..+. .+|+.|+|++|
T Consensus 200 ~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~-~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N 272 (754)
T PRK15370 200 QITTLILDNNELKSLPENLQ--GNIKTLYANSNQLT-SIPATLPD-TIQEMELSINRIT-ELPERLP--SALQSLDLFHN 272 (754)
T ss_pred CCcEEEecCCCCCcCChhhc--cCCCEEECCCCccc-cCChhhhc-cccEEECcCCccC-cCChhHh--CCCCEEECcCC
Confidence 34555555555554443322 35555555555555 55543332 4555555555555 4444442 34555555555
Q ss_pred ccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCc
Q 005224 83 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 135 (707)
Q Consensus 83 ~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~ 135 (707)
+|+ .+|..+. .+|+.|+|++|+|+.+|..+. +++..|++++|.+
T Consensus 273 ~L~-~LP~~l~-------~sL~~L~Ls~N~Lt~LP~~lp-~sL~~L~Ls~N~L 316 (754)
T PRK15370 273 KIS-CLPENLP-------EELRYLSVYDNSIRTLPAHLP-SGITHLNVQSNSL 316 (754)
T ss_pred ccC-ccccccC-------CCCcEEECCCCccccCcccch-hhHHHHHhcCCcc
Confidence 555 4454332 123355555555555543321 2344444444444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.3e-09 Score=125.44 Aligned_cols=17 Identities=18% Similarity=0.231 Sum_probs=10.6
Q ss_pred ccceEEccCccCCCCCC
Q 005224 102 ETFILDFQNNNLTNISG 118 (707)
Q Consensus 102 ~L~~l~l~~N~l~~~~~ 118 (707)
+|+.|+|++|+|+.+|.
T Consensus 343 ~Lq~LdLS~N~Ls~LP~ 359 (788)
T PRK15387 343 GLQELSVSDNQLASLPT 359 (788)
T ss_pred ccceEecCCCccCCCCC
Confidence 45566666666666553
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.5e-10 Score=129.11 Aligned_cols=119 Identities=19% Similarity=0.331 Sum_probs=83.2
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
.+|+.|+|++|+|+.++..+. ++|+.|+|++|+|+ .+|..+.. +|+.|+|++|+|+ .+|..+. ++|+.|+|++
T Consensus 241 ~~L~~L~Ls~N~L~~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~~-sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~ 313 (754)
T PRK15370 241 DTIQEMELSINRITELPERLP--SALQSLDLFHNKIS-CLPENLPE-ELRYLSVYDNSIR-TLPAHLP--SGITHLNVQS 313 (754)
T ss_pred ccccEEECcCCccCcCChhHh--CCCCEEECcCCccC-ccccccCC-CCcEEECCCCccc-cCcccch--hhHHHHHhcC
Confidence 368889999999986655554 57889999999998 78876654 7889999999888 5666553 4677788888
Q ss_pred cccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
|+|+ .+|..+. ++|+.|++++|.|+.+|..+. ++|+.|++++|.+.
T Consensus 314 N~Lt-~LP~~l~-------~sL~~L~Ls~N~Lt~LP~~l~-~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 314 NSLT-ALPETLP-------PGLKTLEAGENALTSLPASLP-PELQVLDVSKNQIT 359 (754)
T ss_pred Cccc-cCCcccc-------ccceeccccCCccccCChhhc-CcccEEECCCCCCC
Confidence 8877 5665432 234466666666666655432 45666666666654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.4e-08 Score=105.95 Aligned_cols=168 Identities=19% Similarity=0.250 Sum_probs=128.5
Q ss_pred ceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEE----eCCeEEEEEecCCC-CCHHHH
Q 005224 388 YGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----EEGEQMLVYEFMSN-GTLRDQ 461 (707)
Q Consensus 388 ~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~ 461 (707)
-.+.||+.. .||..|++|+++............-+++++++.|+|+|++.++|. .+..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899985 489999999995544333333445688999999999999999885 33478999999875 467665
Q ss_pred Hhhc-------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 462 LSAK-------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 462 l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
-... .....++...|.++.|+..||.++|+.| +.-+-|.+++|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4321 1234678899999999999999999999 99999999999999999999999988776543
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~p 582 (707)
++. |-+.+ -.+-|.=.||.+++.|.||..-
T Consensus 446 d~~---------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11111 2356888999999999999543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.8e-08 Score=102.94 Aligned_cols=141 Identities=14% Similarity=0.142 Sum_probs=102.5
Q ss_pred ceEeeeCceEEEEEEeCCCcEEEEEEeccCChhh-H----------HHHHHHHHHHHccCCCcc--eeEEEEEEe-----
Q 005224 381 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-E----------KEFLTEIQFLSRLHHRNL--VSLVGYCDE----- 442 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~----------~~~~~E~~~l~~l~H~nI--v~l~~~~~~----- 442 (707)
+.+-.-....|.+..+ +|+.|.||+........ . ..+.+|...+.++...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444445667766 67889999775433211 1 147889999888853333 344555533
Q ss_pred CCeEEEEEecCCCC-CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-------CCc
Q 005224 443 EGEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------KFT 514 (707)
Q Consensus 443 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-------~~~ 514 (707)
....++|||++++. +|.+++......+.+...+..++.+++..+.-||..+ |+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23578999999876 7999986433344566778899999999999999999 999999999999975 468
Q ss_pred EEEeeeccccc
Q 005224 515 AKVADFGLSRL 525 (707)
Q Consensus 515 ~kl~DFGla~~ 525 (707)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.2e-09 Score=125.60 Aligned_cols=89 Identities=36% Similarity=0.645 Sum_probs=42.4
Q ss_pred ceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 4 LLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 4 L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
++.|+|++|+|+|.+| +++.|++|+.|+|++|+|+|.+|..+..+ +|+.|+|++|+|+|.+|..+++|++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 3444444444444444 34444444444444444444444444333 444444444444444444444444444444444
Q ss_pred cccccCCCCCc
Q 005224 82 NSLSGSIPSSI 92 (707)
Q Consensus 82 N~l~g~~p~~~ 92 (707)
|+|+|.+|..+
T Consensus 500 N~l~g~iP~~l 510 (623)
T PLN03150 500 NSLSGRVPAAL 510 (623)
T ss_pred CcccccCChHH
Confidence 44444444444
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.1e-08 Score=96.64 Aligned_cols=126 Identities=25% Similarity=0.311 Sum_probs=82.0
Q ss_pred EEEEEEeCCCcEEEEEEeccCCh-------------h-------------hHHHHHHHHHHHHccCCC--cceeEEEEEE
Q 005224 390 KVYKGILPDGTVVAVKRAQEGSL-------------Q-------------GEKEFLTEIQFLSRLHHR--NLVSLVGYCD 441 (707)
Q Consensus 390 ~Vy~~~~~~~~~vavK~l~~~~~-------------~-------------~~~~~~~E~~~l~~l~H~--nIv~l~~~~~ 441 (707)
.||.|...+|..+|||+...... . ......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999997653110 0 123467899999999765 456666443
Q ss_pred eCCeEEEEEecCC--CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 005224 442 EEGEQMLVYEFMS--NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY-LHTEADPPVFHRDIKASNILLDHKFTAKVA 518 (707)
Q Consensus 442 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 518 (707)
..++||||++ |..+..+.... ++......++.+++..+.. +|..+ |+|+|+.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 3479999998 54454433221 1123345667777775555 57888 9999999999999988 99999
Q ss_pred eecccccCC
Q 005224 519 DFGLSRLAP 527 (707)
Q Consensus 519 DFGla~~~~ 527 (707)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.7e-10 Score=101.07 Aligned_cols=129 Identities=26% Similarity=0.327 Sum_probs=107.6
Q ss_pred ceEEEeeCCcCCCCCC---CcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 4 LLKLSLRNCSLQGPMP---DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 4 L~~L~L~~N~l~~~~~---~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
+..++|++++|--+.. .+.....|+..+|++|.|. .+|+.+... .++.|+|++|+|+ .+|.++..++.|+.|+
T Consensus 29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 5678999998876554 3677788999999999999 999877665 7999999999999 8999999999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCc-eeeccCCCccccCC
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNV-TVRLRGNPFCLNTN 140 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~-~l~l~~N~~~~~~~ 140 (707)
++.|.|. ..|..+..+.+|. .||..+|.+..++..+-.+.+. ...+.+|||...|.
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~-----~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLD-----MLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cccCccc-cchHHHHHHHhHH-----HhcCCCCccccCcHHHhccccHHHHHhcCCcccccCc
Confidence 9999999 8999998877666 8999999999988765333333 45678899976654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.8e-09 Score=80.81 Aligned_cols=58 Identities=52% Similarity=0.751 Sum_probs=30.6
Q ss_pred cccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceEeccCccc
Q 005224 26 NLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 84 (707)
Q Consensus 26 ~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 84 (707)
+|++|+|++|+|+ .||.+.+.. +|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4555555555555 555444432 455555555555544445555555555555555543
|
... |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=5.5e-10 Score=125.05 Aligned_cols=134 Identities=28% Similarity=0.321 Sum_probs=91.0
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccc--------------------------c-CccEEE
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--------------------------L-NITTIK 54 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~--------------------------~-~L~~L~ 54 (707)
++|+.|++.+|.++-++|.+..++.|+.|+|..|+|. .+|+.++. . .|+.|.
T Consensus 287 ~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Ly 365 (1081)
T KOG0618|consen 287 TSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELY 365 (1081)
T ss_pred hhHHHHHhhhhhhhhCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHH
Confidence 3566666677777766666666777777777777776 66552110 0 466677
Q ss_pred ccCccCCCCCCcccCCCcccceEeccCcccccCCCCCc-cccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccC
Q 005224 55 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI-WQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRG 132 (707)
Q Consensus 55 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~ 132 (707)
|.+|.|+...-..|.+.+.|+.|+|++|+|. .+|++. .++. .|+.|+||+|+|+.+|..+ .++.|++|...+
T Consensus 366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle-----~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahs 439 (1081)
T KOG0618|consen 366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLE-----ELEELNLSGNKLTTLPDTVANLGRLHTLRAHS 439 (1081)
T ss_pred HhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchH-----HhHHHhcccchhhhhhHHHHhhhhhHHHhhcC
Confidence 7777777666666777788888888888887 777653 3333 3447888888888887665 777778888888
Q ss_pred CCccccCCcc
Q 005224 133 NPFCLNTNAE 142 (707)
Q Consensus 133 N~~~~~~~~~ 142 (707)
|.+.|.+.+.
T Consensus 440 N~l~~fPe~~ 449 (1081)
T KOG0618|consen 440 NQLLSFPELA 449 (1081)
T ss_pred Cceeechhhh
Confidence 8877776543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.7e-10 Score=124.00 Aligned_cols=128 Identities=27% Similarity=0.359 Sum_probs=96.0
Q ss_pred CceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCc-ccCCCcccceEecc
Q 005224 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPS-NFSGLPRLQRLFIA 80 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls 80 (707)
.|...+.++|.|.-.-.++.-++.|+.|+|++|+++ ... .+..+ .|++|||+.|+|+ .+|. ....+. |+.|.|+
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 466778888998866667888899999999999999 665 33333 8999999999999 5553 334444 9999999
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC---CCCCCceeeccCCCccccCCc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF---NIPPNVTVRLRGNPFCLNTNA 141 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~---~~~~l~~l~l~~N~~~~~~~~ 141 (707)
||.++ .+- .+.++. +|..|||++|-|++..... .+..|..|+|.|||++|.+--
T Consensus 241 nN~l~-tL~-gie~Lk-----sL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~h 297 (1096)
T KOG1859|consen 241 NNALT-TLR-GIENLK-----SLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPWH 297 (1096)
T ss_pred ccHHH-hhh-hHHhhh-----hhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHHH
Confidence 99988 322 244444 4458999999998865432 566788899999999998654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=9.3e-07 Score=91.80 Aligned_cols=260 Identities=15% Similarity=0.153 Sum_probs=160.2
Q ss_pred ccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEE------EeC-CeEEEEE
Q 005224 379 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC------DEE-GEQMLVY 450 (707)
Q Consensus 379 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~------~~~-~~~~lV~ 450 (707)
..+.||+|+-+.+|..-- -+..+.|+.......... +.+..|... .||-+-.-+.+= .+. ...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 357799999999986431 122345666543322221 122333333 566443312221 112 2356778
Q ss_pred ecCCCCC-HHHHHh----hcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 451 EFMSNGT-LRDQLS----AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 451 E~~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
..+.+.. ...+.. +++-....|+..++.+..+|.+.+-||..| .+-+|+.++|+||++++.+.+.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 8776643 222222 123345789999999999999999999999 88999999999999999999987543332
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcC-CCCCCCCch---hHHHHHHH
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTG-MQPISHGKN---IVREVNIA 596 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG-~~pf~~~~~---~~~~~~~~ 596 (707)
.. ........+|...|.+||... +..-+...|-|.+|+++++++.| +.||....- .....+..
T Consensus 167 ~~--------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 167 NA--------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cc--------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 21 123344567889999999875 34456679999999999999996 999964211 00000100
Q ss_pred hhcccchhhccCCCC------CCC-hHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhhhcCC
Q 005224 597 YQSSMMFSVIDGNMG------SYP-SECVEKFIKLALKCCQDE--TDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~------~~~-~~~~~~l~~l~~~c~~~~--p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
+....+...-+...+ ..| .-.+..+..+..+|+... +.-||+....+..|..+...+.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 111111111111111 111 233466778888888764 5689999999998887766544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-08 Score=79.03 Aligned_cols=58 Identities=47% Similarity=0.647 Sum_probs=52.8
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccC
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKL 60 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l 60 (707)
++|++|+|++|+|+.+++ .|.++++|++|+|++|.|+ .+|++.+.. +|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCCcC
Confidence 589999999999999987 6999999999999999999 888876653 899999999986
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.8e-07 Score=92.68 Aligned_cols=136 Identities=22% Similarity=0.202 Sum_probs=96.9
Q ss_pred CCccceEeeeCceEEEEEEeCCCcEEEEEEeccCCh----------------------hhHHHHHHHHHHHHccCCC--c
Q 005224 377 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----------------------QGEKEFLTEIQFLSRLHHR--N 432 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~H~--n 432 (707)
..+.++||-|.-+.||.|..++|..+|||.=..... .......+|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345688999999999999999999999995321110 0123467899999998654 5
Q ss_pred ceeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 005224 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 512 (707)
Q Consensus 433 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~ 512 (707)
+.+.+++ +..++||||++|-.|...- ++......++..|++-+.-+-..| |||+|+.+-||++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 6666543 4567999999885554321 122233344455555555555677 9999999999999999
Q ss_pred CcEEEeeecccccC
Q 005224 513 FTAKVADFGLSRLA 526 (707)
Q Consensus 513 ~~~kl~DFGla~~~ 526 (707)
|.+.++||--+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999766543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1e-08 Score=112.61 Aligned_cols=182 Identities=19% Similarity=0.302 Sum_probs=117.9
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc--cccceecccccCCCccchhhhcc
Q 005224 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI--VPAHVSTVVKGTPGYLDPEYFLT 557 (707)
Q Consensus 480 ~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~ 557 (707)
.+++.||.|+|... .+||++|.|++|.++..+..||+.|+.+........... ..........-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999854 599999999999999999999999998765443111000 00111112233568999999999
Q ss_pred CCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCC
Q 005224 558 HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR 636 (707)
Q Consensus 558 ~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R 636 (707)
...+.++|+||+||++|.+.. |+.-+.........-... ...+-....+..+.+.++.+-+.+.+..++.-|
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------NLLNAGAFGYSNNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------cccccccccccccCcHHHHHHHHHHhcCCcccC
Confidence 888999999999999999995 444443322211111100 001111112345666778888888889999999
Q ss_pred CCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCC
Q 005224 637 PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 675 (707)
Q Consensus 637 Pt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R 675 (707)
|++..+... ..+.+....++.|+..+.+.||.+-
T Consensus 257 p~~~~l~~~-----~ff~D~~~~aLrfLD~l~~kdn~qK 290 (700)
T KOG2137|consen 257 PTLDLLLSI-----PFFSDPGLKALRFLDDLPQKDNSQK 290 (700)
T ss_pred cchhhhhcc-----cccCCchhhhhhhcccccccCcHHH
Confidence 977655432 1233334455677888888777654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.6e-07 Score=116.01 Aligned_cols=124 Identities=27% Similarity=0.299 Sum_probs=87.5
Q ss_pred CceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
+|+.|++.+|.++.++..| .+.+|+.|+|++|+|. .+|.+...+ +|+.|+|++|+..+.+|. ++.+++|+.|+|++
T Consensus 590 ~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 590 KLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD 666 (1153)
T ss_pred ccEEEEecCCCCCCCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence 4677777777776555555 4677888888888877 777766555 788888877654446664 77778888888887
Q ss_pred cccccCCCCCccccccCCCCccceEEccC-ccCCCCCCCCCCCCCceeeccCCC
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQN-NNLTNISGSFNIPPNVTVRLRGNP 134 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~-N~l~~~~~~~~~~~l~~l~l~~N~ 134 (707)
|.....+|.++.++++|+ .|++++ ++++.+|....+++|+.|++++|.
T Consensus 667 c~~L~~lp~si~~L~~L~-----~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~ 715 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLE-----DLDMSRCENLEILPTGINLKSLYRLNLSGCS 715 (1153)
T ss_pred CCCccccchhhhccCCCC-----EEeCCCCCCcCccCCcCCCCCCCEEeCCCCC
Confidence 765557787777666555 788877 467777766677777777777764
|
syringae 6; Provisional |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.1e-08 Score=109.76 Aligned_cols=131 Identities=30% Similarity=0.430 Sum_probs=83.4
Q ss_pred CceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
+|+.|++++|++..++..+..+++|+.|++++|+++ .+|...... +|+.|++++|+++ .+|.....+..|++|.+++
T Consensus 141 nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~ 218 (394)
T COG4886 141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSN 218 (394)
T ss_pred hcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcC
Confidence 678888888888866656777888888888888888 777765333 7788888888888 6776655555677777777
Q ss_pred cccccCCCCCccccccCC------------------CCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 82 NSLSGSIPSSIWQSRTLN------------------ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~------------------~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
|++. .++..+..+..+. +++|+.|++++|.++.++....+.+++.|++++|.+.
T Consensus 219 N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 219 NSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLS 290 (394)
T ss_pred Ccce-ecchhhhhcccccccccCCceeeeccchhccccccceeccccccccccccccccCccCEEeccCcccc
Confidence 7543 3444444433332 1123355555555555555334555555555555543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.58 E-value=7.4e-09 Score=102.13 Aligned_cols=106 Identities=24% Similarity=0.285 Sum_probs=87.4
Q ss_pred CCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCCC
Q 005224 22 SRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 100 (707)
Q Consensus 22 ~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 100 (707)
..+..|++||||+|.|+ .|.++.-.. .++.|++|+|.|. .+-. +..|++|+.||||+|.++ .+-.+-.. +
T Consensus 281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~K-----L 351 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLK-----L 351 (490)
T ss_pred chHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhh-----h
Confidence 34567999999999999 998876554 8999999999999 5554 889999999999999998 55544322 3
Q ss_pred CccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 101 TETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 101 ~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
-+.+.|.|+.|.|..+++.-.+-+|..|++++|++-
T Consensus 352 GNIKtL~La~N~iE~LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 352 GNIKTLKLAQNKIETLSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred cCEeeeehhhhhHhhhhhhHhhhhheeccccccchh
Confidence 355689999999999877667888999999999974
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.8e-07 Score=87.87 Aligned_cols=124 Identities=24% Similarity=0.237 Sum_probs=91.6
Q ss_pred CCcEEEEEEeccCCh-------hhHHHHHHHHHHHHccCCC--cceeEEEEEEeC----CeEEEEEecCCCC-CHHHHHh
Q 005224 398 DGTVVAVKRAQEGSL-------QGEKEFLTEIQFLSRLHHR--NLVSLVGYCDEE----GEQMLVYEFMSNG-TLRDQLS 463 (707)
Q Consensus 398 ~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~ 463 (707)
.++.+.+|.....-. .....+.+|...+..+... .+.+.+++.... ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 355666665432111 1234678888888887533 345566665543 2458999999874 7999986
Q ss_pred hcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEeeecccccC
Q 005224 464 AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLA 526 (707)
Q Consensus 464 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFGla~~~ 526 (707)
.... .+......++.++++.++-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 111 ~~~~--~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ--LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc--cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 5333 566678899999999999999999 99999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.4e-08 Score=108.32 Aligned_cols=108 Identities=26% Similarity=0.416 Sum_probs=80.3
Q ss_pred ceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCc
Q 005224 4 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 82 (707)
Q Consensus 4 L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 82 (707)
|+.|-+++|+++.++++++.+..|..||.+.|++. ++|..+..+ +|+.|++..|++. .+|.++.. -.|..||+|.|
T Consensus 145 Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScN 221 (722)
T KOG0532|consen 145 LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCN 221 (722)
T ss_pred ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccC
Confidence 55666666666655556666666666666666666 666666655 6777777777777 66777763 36889999999
Q ss_pred ccccCCCCCccccccCCCCccceEEccCccCCCCCCCC
Q 005224 83 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120 (707)
Q Consensus 83 ~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~ 120 (707)
+++ .||..|..|+.|+ +|-|.+|.|+.-|..+
T Consensus 222 kis-~iPv~fr~m~~Lq-----~l~LenNPLqSPPAqI 253 (722)
T KOG0532|consen 222 KIS-YLPVDFRKMRHLQ-----VLQLENNPLQSPPAQI 253 (722)
T ss_pred cee-ecchhhhhhhhhe-----eeeeccCCCCCChHHH
Confidence 999 9999999888776 9999999999977654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=1e-06 Score=85.42 Aligned_cols=138 Identities=19% Similarity=0.174 Sum_probs=105.0
Q ss_pred EeeeCceEEEEEEeCCCcEEEEEEeccC---C---hhhHHHHHHHHHHHHccCCC--cceeEEEEEE-e----CCeEEEE
Q 005224 383 IGQGGYGKVYKGILPDGTVVAVKRAQEG---S---LQGEKEFLTEIQFLSRLHHR--NLVSLVGYCD-E----EGEQMLV 449 (707)
Q Consensus 383 lG~G~~g~Vy~~~~~~~~~vavK~l~~~---~---~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~-~----~~~~~lV 449 (707)
-|+||.+.|+.-.+. |+.+-+|+-... . ...+..|.+|+..++++... .+.+.+ ++. . ...-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477899999998774 457888876521 1 23567899999999998532 244444 332 1 1246899
Q ss_pred EecCCC-CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEeeeccccc
Q 005224 450 YEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSRL 525 (707)
Q Consensus 450 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFGla~~ 525 (707)
+|-+++ .+|.+++......+.+...+..+..++++.++-||..+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 58999987655556788888999999999999999999 999999999999986666 99999986653
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.1e-07 Score=114.81 Aligned_cols=120 Identities=20% Similarity=0.273 Sum_probs=50.3
Q ss_pred CceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 3 KLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
+|+.|+|++|...+.+| .++++++|+.|+|++|..-+.+|......+|+.|+|++|..-..+|.. .++|+.|+|++
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~ 855 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDI---STNISDLNLSR 855 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccccc---ccccCEeECCC
Confidence 34444444444333333 344444455555544322214444332114444444443322233322 13444445555
Q ss_pred cccccCCCCCccccccCCCCccceEEccC-ccCCCCCCCC-CCCCCceeecc
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQN-NNLTNISGSF-NIPPNVTVRLR 131 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~-N~l~~~~~~~-~~~~l~~l~l~ 131 (707)
|.++ .+|.++..+++|+ .|+|++ |+|+.++... .++.|..+++.
T Consensus 856 n~i~-~iP~si~~l~~L~-----~L~L~~C~~L~~l~~~~~~L~~L~~L~l~ 901 (1153)
T PLN03210 856 TGIE-EVPWWIEKFSNLS-----FLDMNGCNNLQRVSLNISKLKHLETVDFS 901 (1153)
T ss_pred CCCc-cChHHHhcCCCCC-----EEECCCCCCcCccCcccccccCCCeeecC
Confidence 5444 4444444333332 444444 4444444433 34444444443
|
syringae 6; Provisional |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.4e-08 Score=108.11 Aligned_cols=121 Identities=30% Similarity=0.477 Sum_probs=76.4
Q ss_pred EEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceEeccCcc
Q 005224 6 KLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 83 (707)
Q Consensus 6 ~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 83 (707)
.|+++.|.+...+..+..++.++.|++.+|.++ .||...... +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 356666666555555555566777777777777 666655554 5777777777777 566666677777777777777
Q ss_pred cccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCC-CceeeccCCC
Q 005224 84 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPP-NVTVRLRGNP 134 (707)
Q Consensus 84 l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~-l~~l~l~~N~ 134 (707)
++ .+|.....++.|+ .|++++|+++.+|.....+. +..+.+.+|+
T Consensus 175 l~-~l~~~~~~~~~L~-----~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 175 LS-DLPKLLSNLSNLN-----NLDLSGNKISDLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred hh-hhhhhhhhhhhhh-----heeccCCccccCchhhhhhhhhhhhhhcCCc
Confidence 76 6665444333333 67777777777766553333 6666666664
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.7e-08 Score=106.97 Aligned_cols=129 Identities=22% Similarity=0.279 Sum_probs=76.2
Q ss_pred CceEEEeeCCcCCCCC----C-CcCCC-CcccEEeccCCcCcccCCCc----cccc-CccEEEccCccCCCC----CCcc
Q 005224 3 KLLKLSLRNCSLQGPM----P-DLSRI-PNLGYLDLSSNQLNGSIPPG----RLSL-NITTIKLSNNKLTGT----IPSN 67 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~----~-~~~~l-~~L~~L~Ls~N~l~g~ip~~----~~~~-~L~~L~Ls~N~l~~~----~p~~ 67 (707)
+|+.|+|++|++++.. . .+..+ ++|+.|+|++|.+++..... +... +|+.|+|++|.+++. ++..
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 188 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188 (319)
T ss_pred cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence 4778888888777421 1 24555 77788888888877432221 1122 677888888877742 3334
Q ss_pred cCCCcccceEeccCcccccCCC----CCccccccCCCCccceEEccCccCCCCCC-----CC--CCCCCceeeccCCCcc
Q 005224 68 FSGLPRLQRLFIANNSLSGSIP----SSIWQSRTLNATETFILDFQNNNLTNISG-----SF--NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 68 ~~~l~~L~~L~ls~N~l~g~~p----~~~~~l~~L~~~~L~~l~l~~N~l~~~~~-----~~--~~~~l~~l~l~~N~~~ 136 (707)
+..+++|+.|+|++|.+++.-. ..+..+ ++|++|++++|.++.... .+ ..+.|+.|++.+|.+.
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~-----~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASL-----KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhccc-----CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 5555678888888887763322 222233 344477887777774211 11 1356777777777764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=2e-08 Score=106.42 Aligned_cols=83 Identities=29% Similarity=0.287 Sum_probs=37.7
Q ss_pred CceEEEeeCCcCCCCC------C-CcCCCCcccEEeccCCcCcccCCCccccc-C---ccEEEccCccCCC----CCCcc
Q 005224 3 KLLKLSLRNCSLQGPM------P-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-N---ITTIKLSNNKLTG----TIPSN 67 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~------~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~---L~~L~Ls~N~l~~----~~p~~ 67 (707)
+|+.|++++|.+.+.. + .+..+++|++|+|++|.+.+..+..+... + |+.|++++|++++ .+...
T Consensus 52 ~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~ 131 (319)
T cd00116 52 SLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKG 131 (319)
T ss_pred CceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHH
Confidence 3555555555554211 1 23445555555555555553222222211 2 5555555555542 12223
Q ss_pred cCCC-cccceEeccCcccc
Q 005224 68 FSGL-PRLQRLFIANNSLS 85 (707)
Q Consensus 68 ~~~l-~~L~~L~ls~N~l~ 85 (707)
+..+ ++|+.|+|++|.++
T Consensus 132 l~~~~~~L~~L~L~~n~l~ 150 (319)
T cd00116 132 LKDLPPALEKLVLGRNRLE 150 (319)
T ss_pred HHhCCCCceEEEcCCCcCC
Confidence 3344 45555555555555
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=8.1e-07 Score=98.33 Aligned_cols=140 Identities=21% Similarity=0.254 Sum_probs=94.5
Q ss_pred ceEeeeCceEEEEEEeCCCcEEEEEEeccCChh----------------------------------------hHHHHHH
Q 005224 381 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----------------------------------------GEKEFLT 420 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------------------------------------~~~~~~~ 420 (707)
+.|+.++-|.||+|++++|+.||||+....-.. .+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 789999999999999999999999986542110 0112455
Q ss_pred HHHHHHccC-----CCcceeEEEEE-EeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHH-HHHHHhCC
Q 005224 421 EIQFLSRLH-----HRNLVSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG-ILYLHTEA 493 (707)
Q Consensus 421 E~~~l~~l~-----H~nIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~ 493 (707)
|+.-+.+++ .+++ .+=.+| +..+...|+|||++|-.+.+...-+. ...+.+. ++..++++ +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 666655552 3333 232333 44567899999999998888743222 2344332 33333322 33333456
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 494 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
++|.|..|.||+++.+|++.+.|||+......
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.7e-06 Score=82.33 Aligned_cols=138 Identities=16% Similarity=0.213 Sum_probs=85.3
Q ss_pred ceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCc--ceeEEEEEEeCCeEEEEEecCCCCC-
Q 005224 381 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLVGYCDEEGEQMLVYEFMSNGT- 457 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~E~~~~gs- 457 (707)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 67899999999984 24457788876533 3345788999999986433 4667778777777889999998863
Q ss_pred HHHHH---------------------hhcCCCCcCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEecCCC
Q 005224 458 LRDQL---------------------SAKSKEPLGFAMRL-SIAL----------GSSR-GILYLHTE-ADPPVFHRDIK 503 (707)
Q Consensus 458 L~~~l---------------------~~~~~~~l~~~~~~-~i~~----------~ia~-gL~yLH~~-~~~~ivH~Dlk 503 (707)
+...+ |.-........... .+.. .+.+ ...+|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 11000111111100 0000 0001 12222211 23457899999
Q ss_pred CCCEEEcCCCcEEEeeecccc
Q 005224 504 ASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 504 p~NILl~~~~~~kl~DFGla~ 524 (707)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.5e-05 Score=78.54 Aligned_cols=152 Identities=18% Similarity=0.158 Sum_probs=101.1
Q ss_pred ccHHHHHHHhcCCCccceEe---eeCceEEEEEEeCCCcEEEEEEeccCChhhH------------------------HH
Q 005224 365 FTYGEMALATNNFNSSTQIG---QGGYGKVYKGILPDGTVVAVKRAQEGSLQGE------------------------KE 417 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG---~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~------------------------~~ 417 (707)
.+++.+.....+..+.+..| +|.-+.||+|...++..||||+......... ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45566666666776666655 5666789999988899999998764321110 12
Q ss_pred HHHHHHHHHccC--CCcceeEEEEEEeCCeEEEEEecCCCCC-HHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CC
Q 005224 418 FLTEIQFLSRLH--HRNLVSLVGYCDEEGEQMLVYEFMSNGT-LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EA 493 (707)
Q Consensus 418 ~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~ 493 (707)
..+|+.-|+++. +-.+.+.+++. .-.|||||+.... -.-.|.+- ++.......+..++++.+.-|-. .+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 356777777763 33444555444 3479999995431 11111111 12222556677778888888777 55
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 494 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||+||..-|||+. ++.+.|+|||-|....
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999887654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.6e-05 Score=77.56 Aligned_cols=136 Identities=18% Similarity=0.189 Sum_probs=91.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHH---------HHHHHHHHccC---CCcceeEEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEF---------LTEIQFLSRLH---HRNLVSLVGYCD 441 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~---H~nIv~l~~~~~ 441 (707)
..+|...+++-......|.+-.. +|+.+++|.........++.| .+++..+..++ ......++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 56788888888777777766666 678899998776544333322 33444444443 333333333322
Q ss_pred -----eCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 005224 442 -----EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 516 (707)
Q Consensus 442 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 516 (707)
.....++||||++|..|.++.. ++. .++..+.+++.-+|+.| ++|+|..|.|+++++++ ++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EE
Confidence 2245678999999988766541 222 24456777899999999 99999999999998654 99
Q ss_pred Eeeecccc
Q 005224 517 VADFGLSR 524 (707)
Q Consensus 517 l~DFGla~ 524 (707)
+.||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.4e-07 Score=96.29 Aligned_cols=129 Identities=22% Similarity=0.295 Sum_probs=68.9
Q ss_pred CCCceEEEeeCCcCCCCCC--C-cCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCC--------------
Q 005224 1 MSKLLKLSLRNCSLQGPMP--D-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLT-------------- 61 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~--~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~-------------- 61 (707)
|++++.||||.|-|...-+ . ...|++|+.|+||.|+|.-......... .|+.|.|+.+.|+
T Consensus 145 ~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl 224 (505)
T KOG3207|consen 145 LPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSL 224 (505)
T ss_pred CCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcH
Confidence 4566777777776665444 2 3456777777777777662222211111 3444444444443
Q ss_pred -----------CCCCcccCCCcccceEeccCcccccCCC--CCccccccCCCCccceEEccCccCCCC--CCC------C
Q 005224 62 -----------GTIPSNFSGLPRLQRLFIANNSLSGSIP--SSIWQSRTLNATETFILDFQNNNLTNI--SGS------F 120 (707)
Q Consensus 62 -----------~~~p~~~~~l~~L~~L~ls~N~l~g~~p--~~~~~l~~L~~~~L~~l~l~~N~l~~~--~~~------~ 120 (707)
+.--.....+..|+.|||++|++- ..+ ...+.++.|+ .|+++.+.++.+ |+. .
T Consensus 225 ~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~-----~Lnls~tgi~si~~~d~~s~~kt~ 298 (505)
T KOG3207|consen 225 EVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLN-----QLNLSSTGIASIAEPDVESLDKTH 298 (505)
T ss_pred HHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchh-----hhhccccCcchhcCCCccchhhhc
Confidence 222223334556666666666665 444 2233333333 666666666665 222 1
Q ss_pred CCCCCceeeccCCCc
Q 005224 121 NIPPNVTVRLRGNPF 135 (707)
Q Consensus 121 ~~~~l~~l~l~~N~~ 135 (707)
.+++|+.|++..|++
T Consensus 299 ~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 299 TFPKLEYLNISENNI 313 (505)
T ss_pred ccccceeeecccCcc
Confidence 566777777777775
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.2e-07 Score=100.90 Aligned_cols=127 Identities=27% Similarity=0.312 Sum_probs=93.8
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
..++.++|..|.+......+..+++|..|+|.+|+|. .|...+..+ +|++|+|++|+|+..-+ +..++.|+.|+++
T Consensus 72 ~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLS 148 (414)
T ss_pred HhHHhhccchhhhhhhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhhheec
Confidence 4566777888888875556888888999999999988 776633334 88999999999884433 5667778889999
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCC--CCCCCCceeeccCCCcccc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS--FNIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~--~~~~~l~~l~l~~N~~~~~ 138 (707)
+|.|+ .+.. +.. +..|+.+++++|+++.+... -.+.++..+++.+|.+...
T Consensus 149 ~N~i~-~~~~-~~~-----l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i 201 (414)
T KOG0531|consen 149 GNLIS-DISG-LES-----LKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREI 201 (414)
T ss_pred cCcch-hccC-Ccc-----chhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcc
Confidence 99888 4443 222 33555888899998888772 4777888888888887544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=2e-05 Score=79.13 Aligned_cols=142 Identities=18% Similarity=0.194 Sum_probs=85.4
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCC--cceeEEEEEE---eCCeEEEEEecCC
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR--NLVSLVGYCD---EEGEQMLVYEFMS 454 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~---~~~~~~lV~E~~~ 454 (707)
.+.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+.. .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999877 68999987654 4456788899998888533 3556666543 3345789999999
Q ss_pred CCCHHH----------------HH---hhc--CCCCcCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005224 455 NGTLRD----------------QL---SAK--SKEPLGFAM---------RLSI------------ALGSSR-GILYLHT 491 (707)
Q Consensus 455 ~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~ 491 (707)
+..+.. .+ +.. ...+..... .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111 111111110 0000 111222 2333332
Q ss_pred ----CCCCCeEecCCCCCCEEEc-CCCcEEEeeecccc
Q 005224 492 ----EADPPVFHRDIKASNILLD-HKFTAKVADFGLSR 524 (707)
Q Consensus 492 ----~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~ 524 (707)
.....++|+|+.+.||+++ +++.+-|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234599999999999999 66666899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.7e-07 Score=100.43 Aligned_cols=182 Identities=20% Similarity=0.187 Sum_probs=131.2
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCc-ceeEEEEEEeCCeEEEEEecCCCC-C
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEGEQMLVYEFMSNG-T 457 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~E~~~~g-s 457 (707)
.+-.++|+++.+||.+-.-.+....+.+... ....-++++|.+++||| .+..++-++.+...+++++|+.++ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 4567899999999988533344446655442 34556899999999999 777777777788899999999776 2
Q ss_pred HHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcccc
Q 005224 458 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 537 (707)
Q Consensus 458 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 537 (707)
-..... .....+...+...+.+.-+++++|+|+.. =+|+| ||+..+ +..|..||+....+....
T Consensus 322 ~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~------- 385 (829)
T KOG0576|consen 322 SALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM------- 385 (829)
T ss_pred ccccCC-hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-------
Confidence 211110 11112333444555666678899999864 48998 777765 688999999887664321
Q ss_pred ceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCC
Q 005224 538 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 583 (707)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf 583 (707)
......+++.|+|||+.....+....|+|+.|+-..++--|..|-
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 334567899999999999999999999999998777777776664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.1e-07 Score=83.79 Aligned_cols=105 Identities=20% Similarity=0.341 Sum_probs=86.2
Q ss_pred CceEEEeeCCcCCCCCCCcC-CCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 3 KLLKLSLRNCSLQGPMPDLS-RIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~-~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
.|+.++|++|.+...++.|. .++.++.|+|++|.|+ .+|.++..+ .|+.|+++.|.|. ..|.-|..|.+|..|+..
T Consensus 54 el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 54 ELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP 131 (177)
T ss_pred eEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence 57889999999999888654 5679999999999999 999997766 8999999999999 889999889999999999
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCC
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~ 115 (707)
+|.+. .||..+.....+- ..++.+|.+.+
T Consensus 132 ~na~~-eid~dl~~s~~~a-----l~~lgnepl~~ 160 (177)
T KOG4579|consen 132 ENARA-EIDVDLFYSSLPA-----LIKLGNEPLGD 160 (177)
T ss_pred CCccc-cCcHHHhccccHH-----HHHhcCCcccc
Confidence 99998 8887654322222 34556666554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.3e-07 Score=99.15 Aligned_cols=127 Identities=24% Similarity=0.254 Sum_probs=93.7
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
+++|+.|+|.+|+|.++...+..+++|++|+|++|.|+ .+..--....|+.|++++|.|+ .+. .+..+++|+.++++
T Consensus 94 ~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~-~i~~l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~l~ 170 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKIT-KLEGLSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLDLS 170 (414)
T ss_pred ccceeeeeccccchhhcccchhhhhcchheeccccccc-cccchhhccchhhheeccCcch-hcc-CCccchhhhcccCC
Confidence 46899999999999987776889999999999999999 7765333337999999999999 444 46668999999999
Q ss_pred CcccccCCCCC-ccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPSS-IWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~~-~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
+|+++ .+... +..+.++ ..+++.+|.+..+...-.+..+..+++..|.+.
T Consensus 171 ~n~i~-~ie~~~~~~~~~l-----~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 171 YNRIV-DIENDELSELISL-----EELDLGGNSIREIEGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred cchhh-hhhhhhhhhccch-----HHHhccCCchhcccchHHHHHHHHhhcccccce
Confidence 99999 54442 2333333 478888888777654333333334455666654
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.2e-06 Score=62.83 Aligned_cols=40 Identities=38% Similarity=0.582 Sum_probs=30.9
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCC
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 42 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip 42 (707)
++|++|+|++|+|+.+++.+++|++|++|+|++|+|+ .++
T Consensus 1 ~~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 4788888888888876666888888888888888888 655
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 707 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-59 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-52 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-51 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-29 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-26 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-25 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-25 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-25 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-25 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-25 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-25 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-25 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-25 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-25 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-24 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-24 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-24 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-24 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 455 bits (1173), Expect = e-157
Identities = 122/314 (38%), Positives = 174/314 (55%), Gaps = 17/314 (5%)
Query: 347 SRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKR 406
SS + + ++ ATNNF+ IG G +GKVYKG+L DG VA+KR
Sbjct: 12 INDALSSSYLVPFES-YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 407 AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--SA 464
S QG +EF TEI+ LS H +LVSL+G+CDE E +L+Y++M NG L+ L S
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 465 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524
+ + RL I +G++RG+ YLHT + HRD+K+ NILLD F K+ DFG+S+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584
D H+STVVKGT GY+DPEYF+ +LT+KSDVYS GVV E+L I
Sbjct: 188 KGTELD-----QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 585 HGK-----NIVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPS 638
N+ ++ + + ++D N+ E + KF A+KC ++ RPS
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 639 MSEVMRELESIWNM 652
M +V+ +LE +
Sbjct: 303 MGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-129
Identities = 123/298 (41%), Positives = 184/298 (61%), Gaps = 17/298 (5%)
Query: 362 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-EKEFLT 420
++ F+ E+ +A++NF++ +G+GG+GKVYKG L DGT+VAVKR +E QG E +F T
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 421 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--SAKSKEPLGFAMRLSI 478
E++ +S HRNL+ L G+C E++LVY +M+NG++ L +S+ PL + R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538
ALGS+RG+ YLH DP + HRD+KA+NILLD +F A V DFGL++L D H
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD------TH 190
Query: 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI-------SHGKNIVR 591
V+T V+GT G++ PEY T K ++K+DV+ GV+ LEL+TG + ++
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 592 EVNIAYQSSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648
V + + +++D ++ Y E VE+ I++AL C Q RP MSEV+R LE
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 378 bits (974), Expect = e-127
Identities = 100/304 (32%), Positives = 164/304 (53%), Gaps = 25/304 (8%)
Query: 361 GVRSFTYGEMALATNNFNSSTQ------IGQGGYGKVYKGILPDGTVVAVKR----AQEG 410
SF++ E+ TNNF+ +G+GG+G VYKG + + T VAVK+
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 411 SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL-SAKSKEP 469
+ + +++F EI+ +++ H NLV L+G+ + + LVY +M NG+L D+L P
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 470 LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529
L + MR IA G++ GI +LH + HRDIK++NILLD FTAK++DFGL+R +
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 589
+++ + GT Y+ PE L ++T KSD+YS GVV LE++TG+ + +
Sbjct: 187 AQT-----VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 590 VREVNIAY----QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 645
++I + + ID M S VE +A +C ++ + RP + +V +
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 646 LESI 649
L+ +
Sbjct: 301 LQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 3e-78
Identities = 64/316 (20%), Positives = 109/316 (34%), Gaps = 44/316 (13%)
Query: 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF 424
+ + +G +G V+K VAVK Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 425 LSRLHHRNLVSLVGYCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 480
L + H N++ +G + + L+ F G+L D L + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIAE 128
Query: 481 GSSRGILYLHTEAD-------PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533
+RG+ YLH + P + HRDIK+ N+LL + TA +ADFGL+ G
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 534 IVPAHVSTVVKGTPGYLDPEYF-----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
+ GT Y+ PE + D+Y++G+V EL +
Sbjct: 189 -----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG--- 240
Query: 589 IVREVNIAYQS---------SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDET 633
V E + ++ M V+ + + +C +
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 634 DARPSMSEVMRELESI 649
+AR S V + +
Sbjct: 301 EARLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-72
Identities = 78/334 (23%), Positives = 129/334 (38%), Gaps = 45/334 (13%)
Query: 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE--I 422
E +L +N IG+G YG VYKG L D VAVK S + F+ E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNI 58
Query: 423 QFLSRLHHRNLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 477
+ + H N+ + D E +LV E+ NG+L LS +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 478 IALGSSRGILYLHTEAD------PPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPD 530
+A +RG+ YLHTE P + HRD+ + N+L+ + T ++DFGLS L
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 531 IEGIVPAHVSTVVKGTPGYLDPEYF-------LTHKLTDKSDVYSLGVVFLELLTGMQPI 583
+ + + GT Y+ PE + D+Y+LG+++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 584 SHGKNIVREVNIAYQS---------SMMFSVIDGNM-------GSYPSECVEKFIKLALK 627
G++ V E +A+Q+ M V S V +
Sbjct: 236 FPGES-VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 628 CCQDETDARPSMSEVMRELESIWNMMPESDTKTP 661
C + +AR + + + + + + +P
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-71
Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 25/303 (8%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
+G+G +G V K VA+K+ + S K F+ E++ LSR++H N+V L G C
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 442 EEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
LV E+ G+L + L A+ A +S L S+G+ YLH+ + HR
Sbjct: 72 NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 501 DIKASNILLDHKFT-AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 559
D+K N+LL T K+ DFG + T KG+ ++ PE F
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDI----------QTHMTNNKGSAAWMAPEVFEGSN 179
Query: 560 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 619
++K DV+S G++ E++T +P + M++V +G +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI--------MWAVHNGTRPPLIKNLPK 231
Query: 620 KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 679
L +C + RPSM E+++ + + P +D E+
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPY 291
Query: 680 SML 682
Sbjct: 292 VDF 294
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 4e-70
Identities = 84/272 (30%), Positives = 130/272 (47%), Gaps = 23/272 (8%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 439
+IG G +G V++ G+ VAVK Q+ + EFL E+ + RL H N+V +G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 440 CDEEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ +V E++S G+L L + ++E L RLS+A ++G+ YLH +PP+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HR++K+ N+L+D K+T KV DFGLSRL + S GTP ++ PE
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-------SKSAAGTPEWMAPEVLRDE 214
Query: 559 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG-SYPSEC 617
+KSDVYS GV+ EL T QP + ++ +V P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPA----------QVVAAVGFKCKRLEIPRNL 264
Query: 618 VEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ + C +E RPS + +M L +
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 4e-68
Identities = 77/284 (27%), Positives = 132/284 (46%), Gaps = 38/284 (13%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-------KEFLTEIQFLSRLHHRNL 433
QIG+GG+G V+KG + D +VVA+K G +GE +EF E+ +S L+H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
V L G +V EF+ G L +L P+ ++++L + L + GI Y+ +
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 494 DPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 548
+PP+ HRD+++ NI L AKVADFGLS+ + H + + G
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----------VHSVSGLLGNFQ 191
Query: 549 YLDPEYFLTHKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606
++ PE + T+K+D YS ++ +LTG P + + +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--------KIKFINMIR 243
Query: 607 DGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ + + P +C + + C + RP S +++EL +
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-66
Identities = 83/281 (29%), Positives = 125/281 (44%), Gaps = 36/281 (12%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----GEKEFLTEIQFLSRLHHRNLVSLV 437
IG GG+GKVY+ G VAVK A+ + + E + + L H N+++L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
G C +E LV EF G L L S + + + ++ A+ +RG+ YLH EA P+
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 498 FHRDIKASNILLDHKF--------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
HRD+K+SNIL+ K K+ DFGL+R G +
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---------EWHRTTKMSAAGAYAW 180
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609
+ PE + SDV+S GV+ ELLTG P + ++ + V
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----------AVAYGVAMNK 230
Query: 610 M-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ PS C E F KL C + +RPS + ++ +L +I
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-65
Identities = 65/310 (20%), Positives = 117/310 (37%), Gaps = 28/310 (9%)
Query: 382 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+G+G +G+ K G V+ +K + ++ FL E++ + L H N++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
++ + E++ GTLR + ++ R+S A + G+ YLH+ + HR
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHR 132
Query: 501 DIKASNILLDHKFTAKVADFGLSRL-------APVPDIEGIVPAHVSTVVKGTPGYLDPE 553
D+ + N L+ VADFGL+RL V G P ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613
+K DV+S G+V E++ + G
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADP------------DYLPRTMDFGLNVRGFL 240
Query: 614 ----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHT 669
P C F + ++CC + + RPS ++ LE++ + P+ +
Sbjct: 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRG 300
Query: 670 SKEETPPSSS 679
E S
Sbjct: 301 FWETYRRGES 310
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 4e-64
Identities = 54/278 (19%), Positives = 111/278 (39%), Gaps = 34/278 (12%)
Query: 381 TQIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
T++ + G+++KG G + VK + ++ S + ++F E L H N++ ++G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 439 YCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
C L+ +M G+L + L + + + + AL +RG+ +LHT +P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
+ + + ++++D TA+++ + S P ++ PE L
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS------------FQSPGRMYAPAWVAPE-AL 180
Query: 557 THK----LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG- 611
K +D++S V+ EL+T P + N+ + V +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM----------EIGMKVALEGLRP 230
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ P KL C ++ RP ++ LE +
Sbjct: 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-61
Identities = 73/277 (26%), Positives = 126/277 (45%), Gaps = 30/277 (10%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 439
+IG G +G VYKG G V AVK + + + F E+ L + H N++ +GY
Sbjct: 31 RIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
+ +V ++ +L L S+ + IA ++RG+ YLH + H
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 500 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---YFL 556
RD+K++NI L T K+ DFGL+ +H + G+ ++ PE
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATE-----KSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 557 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM----GS 612
++ + +SDVY+ G+V EL+TG P S+ N ++ V G++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---------DQIIEMVGRGSLSPDLSK 249
Query: 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
S C ++ +L +C + + D RPS ++ E+E +
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-60
Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 31/280 (11%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 439
IG+G +G+VY G G V A++ + K F E+ + H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
C ++ TL + +K L IA +G+ YLH + H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 500 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 559
+D+K+ N+ D+ + DFGL ++ V + G +L PE
Sbjct: 154 KDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGR--REDKLRIQNGWLCHLAPEIIRQLS 210
Query: 560 L---------TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
+ SDV++LG ++ EL P ++++ + G
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----------EAIIWQMGTGMK 260
Query: 611 GSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ ++ + L C E + RP+ +++M LE +
Sbjct: 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-58
Identities = 66/300 (22%), Positives = 108/300 (36%), Gaps = 46/300 (15%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGY 439
+G+G YG+V++G G VAVK S + EK + TE+ L H N++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 440 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 494
+ L+ + G+L D L L L I L + G+ +LH E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 495 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
P + HRD+K+ NIL+ +AD GL+ + + V + GT Y+
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG---NNPRVGTKRYM 184
Query: 551 DPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ------ 598
PE + D+++ G+V E+ M IV + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG----IVEDYKPPFYDVVPND 240
Query: 599 ---SSMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
M V + + KL +C AR + + + L I
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-56
Identities = 74/304 (24%), Positives = 113/304 (37%), Gaps = 46/304 (15%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGY 439
QIG+G YG+V+ G G VAVK E + TEI + H N++ +
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 440 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 494
+ L+ ++ NG+L D L L L +A S G+ +LHTE
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 495 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
P + HRD+K+ NIL+ T +AD GL+ E +P GT Y+
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP---PNTRVGTKRYM 213
Query: 551 DPE-----YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS----- 599
PE H + +D+YS G++ E+ IV E + Y
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG----IVEEYQLPYHDLVPSD 269
Query: 600 ----SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
M V + EC+ + KL +C +R + V + L +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 650 WNMM 653
Sbjct: 330 SESQ 333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 6e-54
Identities = 65/300 (21%), Positives = 117/300 (39%), Gaps = 46/300 (15%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE--IQFLSRLHHRNLVSLVGY 439
IG+G +G+V++G G VAVK S + E+ + E I L H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 440 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 494
+ LV ++ +G+L D L+ + + + +AL ++ G+ +LH E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 495 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
P + HRD+K+ NIL+ T +AD GL+ D GT Y+
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYM 218
Query: 551 DPE-----YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS----- 599
PE + H + ++D+Y++G+VF E+ + + Y
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI----HEDYQLPYYDLVPSD 274
Query: 600 ----SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
M V + + E + K+ +C AR + + + L +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-47
Identities = 81/314 (25%), Positives = 138/314 (43%), Gaps = 30/314 (9%)
Query: 342 NYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGT 400
++ +++ + K+ + + R+ + L + QIG+G +G+V+ G L D T
Sbjct: 83 DHLLSTQQPLTKKSGVVL--HRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNT 140
Query: 401 VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 459
+VAVK +E + +FL E + L + H N+V L+G C ++ +V E + G
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 460 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 519
L L L + ++ G+ YL ++ HRD+ A N L+ K K++D
Sbjct: 201 TFLR-TEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISD 256
Query: 520 FGLSRLAPVPDIEGIVPAHVSTV---VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 576
FG+SR +G+ A VK T PE + + +SDV+S G++ E
Sbjct: 257 FGMSREEA----DGVYAASGGLRQVPVKWTA----PEALNYGRYSSESDVWSFGILLWET 308
Query: 577 LT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDA 635
+ G P + N ++ V G P C + +L +C E
Sbjct: 309 FSLGASPYPNLSN--QQT--------REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQ 358
Query: 636 RPSMSEVMRELESI 649
RPS S + +EL+SI
Sbjct: 359 RPSFSTIYQELQSI 372
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 26/311 (8%)
Query: 382 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
Q+G+G +G V G +VAVK+ Q +++F EIQ L LH +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 437 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
G G Q LV E++ +G LRD L + + L + L + +G+ YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSRR- 147
Query: 495 PPVF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
HRD+ A NIL++ + K+ADFGL++L P+ +V + + PE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA----PE 200
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612
+ + +SDV+S GVV EL T + S +R + + +++
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260
Query: 613 Y----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 668
P C + +L C RPS S + +L+ +W+ +T F + H
Sbjct: 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG--SRGCETHAF--TAH 316
Query: 669 TSKEETPPSSS 679
+ S S
Sbjct: 317 PEGKHHSLSFS 327
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 79/307 (25%), Positives = 132/307 (42%), Gaps = 65/307 (21%)
Query: 382 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
++G+G +GKV+ + +VAVK ++ +L K+F E + L+ L H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALG 481
G C + ++V+E+M +G L L A K LG + L IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--------- 532
+ G++YL A HRD+ N L+ K+ DFG+SR D+
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGG 193
Query: 533 -GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGK 587
++P ++ P PE + K T +SDV+S GV+ E+ T G QP +S+
Sbjct: 194 HTMLP------IRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-- 241
Query: 588 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
EV + + G + P C ++ + L C Q E R ++ E+ + L
Sbjct: 242 ---TEV--------IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
Query: 648 SIWNMMP 654
++ P
Sbjct: 291 ALGKATP 297
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-43
Identities = 80/274 (29%), Positives = 122/274 (44%), Gaps = 36/274 (13%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC- 440
IG+G +G V G G VAVK + + + FL E +++L H NLV L+G
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
+E+G +V E+M+ G+L D L ++ + LG L +L + YL HR
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 141
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
D+ A N+L+ AKV+DFGL++ A G +P VK T PE K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKF 191
Query: 561 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PS 615
+ KSDV+S G++ E+ + G P ++V + V G Y P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPL--KDV--------VPRVEKG----YKMDAPD 237
Query: 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
C ++ C + RPS ++ +LE I
Sbjct: 238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 79/320 (24%), Positives = 128/320 (40%), Gaps = 58/320 (18%)
Query: 382 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 434
++GQG +G VY+G+ T VA+K E + E+ EFL E + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRGI 486
L+G + +++ E M+ G L+ L + P + + +A + G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----------EGIVP 536
YL HRD+ A N ++ FT K+ DFG++R DI +G++P
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLP 203
Query: 537 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 595
V+ PE T SDV+S GVV E+ T QP N +V
Sbjct: 204 ------VRWMS----PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQV-- 249
Query: 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655
+ V++G + P C + +L C Q RPS E++ ++ E
Sbjct: 250 ------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE----EME 299
Query: 656 SDTKTPEFINSEHTSKEETP 675
+ F SE E
Sbjct: 300 PGFREVSFYYSEENKLPEPE 319
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-42
Identities = 83/321 (25%), Positives = 128/321 (39%), Gaps = 37/321 (11%)
Query: 336 VRAHMKNYHAISRR-RHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKG 394
V + + + R + F AL IG+G +G V G
Sbjct: 153 VEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLG 212
Query: 395 ILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEFM 453
G VAVK + + + FL E +++L H NLV L+G +E+G +V E+M
Sbjct: 213 DY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 513
+ G+L D L ++ + LG L +L + YL HRD+ A N+L+
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDN 326
Query: 514 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVF 573
AKV+DFGL++ A G +P VK T PE K + KSDV+S G++
Sbjct: 327 VAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKFSTKSDVWSFGILL 376
Query: 574 LELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSECVEKFIKLALKC 628
E+ + G P Y + V+ Y P C + C
Sbjct: 377 WEIYSFGRVP--------------YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNC 422
Query: 629 CQDETDARPSMSEVMRELESI 649
+ RP+ ++ +LE I
Sbjct: 423 WHLDAATRPTFLQLREQLEHI 443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 25/283 (8%)
Query: 382 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVS 435
+G+G +GKV G VAVK + S + EI+ L L+H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 436 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
G C E+G L+ EF+ +G+L++ L K+K + +L A+ +G+ YL +
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLD 551
HRD+ A N+L++ + K+ DFGL++ + + V
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKA--IETDKEYYTVKDDRDSPVFWYA---- 197
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID--- 607
PE + K SDV+S GV ELLT S ++ + + + +++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 608 -GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
G P C ++ +L KC + + R S ++ E++
Sbjct: 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-42
Identities = 87/282 (30%), Positives = 126/282 (44%), Gaps = 22/282 (7%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442
+GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 502
E +V E+MS G+L D L ++ + L + +A + G+ Y+ HRD+
Sbjct: 251 EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 306
Query: 503 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 562
+A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 307 RAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 360
Query: 563 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 621
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPESL 410
Query: 622 IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 663
L +C + E + RP+ + LE +
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 79/302 (26%), Positives = 127/302 (42%), Gaps = 54/302 (17%)
Query: 382 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
++G+G +GKV+ + +VAVK +E S ++F E + L+ L H+++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQL-------------SAKSKEPLGFAMRLSIALGS 482
G C E ++V+E+M +G L L + PLG L++A
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPA 537
+ G++YL A HRD+ N L+ K+ DFG+SR D ++P
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 223
Query: 538 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREV 593
++ P PE L K T +SDV+S GVV E+ T G QP +S+ E
Sbjct: 224 -----IRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEA 269
Query: 594 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653
+ + G P C + + C Q E R S+ +V L+++
Sbjct: 270 --------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321
Query: 654 PE 655
P
Sbjct: 322 PV 323
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-42
Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 38/289 (13%)
Query: 383 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 437
IG+G +G VY G D A+K + + FL E + L+H N+++L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 438 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
G EG ++ +M +G L + + +S L +RG+ YL A+
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL---AEQK 144
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRL-------APVPDIEGIVPAHVSTVVKGTPGY 549
HRD+ A N +LD FT KVADFGL+R + +P VK T
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP------VKWTA-- 196
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 608
E T++ T KSDV+S GV+ ELLT G P H ++ + G
Sbjct: 197 --LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDL--------THFLAQG 244
Query: 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 657
P C + ++ +C + + RP+ ++ E+E I + +
Sbjct: 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-42
Identities = 84/284 (29%), Positives = 128/284 (45%), Gaps = 22/284 (7%)
Query: 382 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
++G G YG+VY+G+ VAVK +E +++ +EFL E + + H NLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E ++ EFM+ G L D L +++ + + L +A S + YL + HR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 342
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
++ A N L+ KVADFGLSRL + A +K T PE +K
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKF 396
Query: 561 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 619
+ KSDV++ GV+ E+ T GM P +V + P C E
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV--------YELLEKDYRMERPEGCPE 446
Query: 620 KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 663
K +L C Q RPS +E+ + E+++ SD E
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 86/294 (29%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 383 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 437
IG+G +G VY G L D AVK + GE +FLTE + H N++SL+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 438 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
G C EG ++V +M +G LR+ + + L ++G+ YL A
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 148
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------------GIVPAHVSTVVK 544
HRD+ A N +LD KFT KVADFGL+R D+ +P VK
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKLP------VK 197
Query: 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 603
E T K T KSDV+S GV+ EL+T G P ++
Sbjct: 198 WMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDI--------TV 243
Query: 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 657
++ G P C + ++ LKC + + RPS SE++ + +I++
Sbjct: 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-42
Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
+IG G +G V+ G + VA+K +EG++ E++F+ E + + +L H LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
E+ LV EFM +G L D L + L + L G+ YL + V HRD
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 555
+ A N L+ KV+DFG++R V D + P VK PE F
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFP------VKWAS----PEVF 177
Query: 556 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
+ + KSDV+S GV+ E+ + G P + N EV + + G P
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEV--------VEDISTGFRLYKP 227
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
++ C ++ + RP+ S ++R+L I
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-42
Identities = 80/314 (25%), Positives = 125/314 (39%), Gaps = 56/314 (17%)
Query: 382 QIGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 435
+G+G +G V + L VAVK + + +EFL E + H ++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 436 LVGYCDEEGEQ------MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRG 485
LVG + M++ FM +G L L ++ L + + + G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE----------GIV 535
+ YL + HRD+ A N +L T VADFGLSR I +
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASKL 201
Query: 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 594
P VK E + T SDV++ GV E++T G P + +N E+
Sbjct: 202 P------VKWLA----LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEI- 248
Query: 595 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW-NMM 653
+I GN P EC+E+ L +C + RPS + + ELE+I ++
Sbjct: 249 -------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
Query: 654 PESDTKTPEFINSE 667
S ++ P +IN E
Sbjct: 302 VLSTSQDPLYINIE 315
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 25/285 (8%)
Query: 382 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
Q+G+G +G V G VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 437 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
G C G + L+ E++ G+LRD L K KE + L +G+ YL T+
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR- 134
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDP 552
HRD+ NIL++++ K+ DFGL+++ +P + + P
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEFFKVKEPGESPIFWYA----P 186
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFS-VIDGNM 610
E K + SDV+S GVV EL T + S +R + Q M+ +I+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 611 GSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651
+ P C ++ + +C + + RPS ++ ++ I +
Sbjct: 247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 74/288 (25%), Positives = 117/288 (40%), Gaps = 35/288 (12%)
Query: 382 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVS 435
+G+G +GKV G +VAVK + + + EI L L+H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 436 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
G C++ G LV E++ G+LRD L + +G A L A G+ YLH +
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 494 DPPVF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL-- 550
+ HRD+ A N+LLD+ K+ DFGL++ VP G
Sbjct: 155 ----YIHRDLAARNVLLDNDRLVKIGDFGLAKA---------VPEGHEYYRVREDGDSPV 201
Query: 551 ---DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606
PE +K SDV+S GV ELLT S + + IA + +
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 607 DGNMGSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650
+ P +C + L C + E RP+ ++ L+++
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 30/288 (10%)
Query: 382 QIGQGGYGKVYKGILPDGTV-VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
++G G YG+VY+G+ ++ VAVK +E +++ +EFL E + + H NLV L+G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E ++ EFM+ G L D L +++ + + L +A S + YL HR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 135
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAP----VPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
D+ A N L+ KVADFGLSRL P +K T PE
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTA----PESLA 185
Query: 557 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615
+K + KSDV++ GV+ E+ T GM P +V + P
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV--------YELLEKDYRMERPE 235
Query: 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 663
C EK +L C Q RPS +E+ + E+++ SD E
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 54/300 (18%)
Query: 382 QIGQGGYGKVYKGILPDG----TVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
+G+G +G V +G L VAVK + S + +EFL+E + H N++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 436 LVGYCDEEGEQ-----MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRGI 486
L+G C E Q M++ FM G L L + + L + + G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE----------GIVP 536
YL ++ HRD+ A N +L T VADFGLS+ I +P
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKMP 212
Query: 537 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 595
VK E T KSDV++ GV E+ T GM P +N E+
Sbjct: 213 ------VKWIA----IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEM-- 258
Query: 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655
++ G+ P +C+++ ++ C + + RP+ S + +LE + +P+
Sbjct: 259 ------YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 34/275 (12%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G+V+ G T VAVK ++GS+ FL E + +L H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
+E ++ E+M NG+L D L S L L +A + G+ ++ + HRD
Sbjct: 79 QEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRD 134
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 555
++A+NIL+ + K+ADFGL+RL + D E P +K T PE
Sbjct: 135 LRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFP------IKWTA----PEAI 182
Query: 556 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
T KSDV+S G++ E++T G P N EV + ++ G P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEV--------IQNLERGYRMVRP 232
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
C E+ +L C ++ + RP+ + LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-41
Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 25/287 (8%)
Query: 382 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
Q+G+G +G V G VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 437 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
G C G + L+ E++ G+LRD L K KE + L +G+ YL T+
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR- 165
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDP 552
HRD+ NIL++++ K+ DFGL+++ +P + + P
Sbjct: 166 --YIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEYYKVKEPGESPIFWYA----P 217
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM-----MFSVI 606
E K + SDV+S GVV EL T + S +R + Q M + +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653
+ P C ++ + +C + + RPS ++ ++ I + M
Sbjct: 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-41
Identities = 87/282 (30%), Positives = 126/282 (44%), Gaps = 22/282 (7%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442
+GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 502
E +V E+MS G+L D L ++ + L + +A + G+ Y+ HRD+
Sbjct: 334 EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 389
Query: 503 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 562
+A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 390 RAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 443
Query: 563 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 621
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPESL 493
Query: 622 IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 663
L +C + E + RP+ + LE +
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 535
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-41
Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 34/275 (12%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G V G VAVK +EGS+ E EF E Q + +L H LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
+E +V E++SNG L + L + K L + L + G+ +L HRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL---ESHQFIHRD 129
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 555
+ A N L+D KV+DFG++R V D + P VK + PE F
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFP------VKWSA----PEVF 177
Query: 556 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
K + KSDV++ G++ E+ + G P N EV + V G+ P
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEV--------VLKVSQGHRLYRP 227
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ ++ C + + RP+ +++ +E +
Sbjct: 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-41
Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 30/272 (11%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442
+G G +G+V+ T VAVK + GS+ + FL E + L H LV L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 502
E ++ EFM+ G+L D L + + + + G+ ++ HRD+
Sbjct: 255 EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDL 310
Query: 503 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 562
+A+NIL+ K+ADFGL+R+ + D E +K T PE T
Sbjct: 311 RAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFTI 364
Query: 563 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSEC 617
KSDV+S G++ +E++T G P N EV + ++ G Y P C
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSN--PEV--------IRALERG----YRMPRPENC 410
Query: 618 VEKFIKLALKCCQDETDARPSMSEVMRELESI 649
E+ + ++C ++ + RP+ + L+
Sbjct: 411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 34/278 (12%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
++G G +G V G VA+K +EGS+ E EF+ E + + L H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
++ ++ E+M+NG L + L + + L + + YL HRD
Sbjct: 90 KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 145
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 555
+ A N L++ + KV+DFGLSR V D E P V+ +P PE
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFP------VRWSP----PEVL 193
Query: 556 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
+ K + KSD+++ GV+ E+ + G P N E + G P
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SET--------AEHIAQGLRLYRP 243
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652
EK + C ++ D RP+ ++ + + +
Sbjct: 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 76/313 (24%), Positives = 126/313 (40%), Gaps = 44/313 (14%)
Query: 382 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 434
+G G +G+VY+G + P VAVK E + ++ +FL E +S+ +H+N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----SAKSKEPLGFAMRLSIALGSSRGILYL 489
+G + + ++ E M+ G L+ L L L +A + G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 490 HTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDI-----EGIVPAHVST 541
+ HRDI A N LL AK+ DFG++R ++P
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP----- 208
Query: 542 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 600
VK P PE F+ T K+D +S GV+ E+ + G P N +EV
Sbjct: 209 -VKWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEV------- 254
Query: 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKT 660
+ V G P C ++ +C Q + + RP+ + ++ +E +T
Sbjct: 255 -LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
Query: 661 PEFINSEHTSKEE 673
P +E+
Sbjct: 314 PIEYGPLVEEEEK 326
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 81/283 (28%), Positives = 126/283 (44%), Gaps = 26/283 (9%)
Query: 383 IGQGGYGKVYKGILPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 437
IG+G +G VY G L D AVK + +FLTE + H N++SL+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 438 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
G C EG ++V +M +G LR+ + + L ++G+ +L A
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 212
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYF 555
HRD+ A N +LD KFT KVADFGL+R + + + + + VK E
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA----LESL 268
Query: 556 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
T K T KSDV+S GV+ EL+T G P ++ ++ G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDI--------TVYLLQGRRLLQP 318
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 657
C + ++ LKC + + RPS SE++ + +I++
Sbjct: 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 66/305 (21%), Positives = 124/305 (40%), Gaps = 66/305 (21%)
Query: 382 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 434
++G+ +GKVYKG L VA+K ++ +EF E +RL H N+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIAL 480
L+G ++ +++ + S+G L + L +S K L + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 481 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-------- 532
+ G+ YL + V H+D+ N+L+ K K++D GL R ++
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKLL 187
Query: 533 --GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHG 586
++P ++ PE + K + SD++S GVV E+ + G+QP S+
Sbjct: 188 GNSLLP------IRWMA----PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN- 236
Query: 587 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
++V + + + + P +C L ++C + RP ++ L
Sbjct: 237 ----QDV--------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 647 ESIWN 651
+ N
Sbjct: 285 RAWGN 289
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 74/331 (22%), Positives = 136/331 (41%), Gaps = 62/331 (18%)
Query: 382 QIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 431
+G+G +G+V T VAVK + + + + + ++E++ + + H+
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 477
N+++L+G C ++G ++ E+ S G LR+ L S +E L +S
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 532
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 588
G +P VK PE T +SDV+S GV+ E+ T G P +
Sbjct: 253 GRLP------VKWMA----PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299
Query: 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648
E+ + +G+ PS C + + C RP+ +++ +L+
Sbjct: 300 --EEL--------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD- 348
Query: 649 IWNMMPESDTKTPEFINSEHTSKEETPPSSS 679
++ + + + + H + P + +
Sbjct: 349 --RIVALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-40
Identities = 67/294 (22%), Positives = 112/294 (38%), Gaps = 33/294 (11%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
++G+GG+ V L DG A+KR Q +E E +H N++ LV YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 441 DEEGEQM----LVYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEAD 494
E L+ F GTL +++ + L + LG RG+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLA--PVPDIEGIVPAHVSTVVKGTPGYLDP 552
HRD+K +NILL + + D G A V + + T Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 553 EYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609
E F + +++DV+SLG V ++ G P ++ +Q ++ N
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY----------DMVFQKGDSVALAVQN 262
Query: 610 MGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 658
S P S + + + + RP + ++ +LE++ P T
Sbjct: 263 QLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 80/318 (25%), Positives = 127/318 (39%), Gaps = 54/318 (16%)
Query: 382 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 434
+G G +G+VY+G + VAVK E S Q E +FL E +S+ +H+N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----SAKSKEPLGFAMRLSIALGSSRGILYL 489
+G + + ++ E M+ G L+ L L L +A + G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 490 HTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDI----------EGIVP 536
+ HRDI A N LL AK+ DFG++R DI ++P
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLP 249
Query: 537 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 595
VK P PE F+ T K+D +S GV+ E+ + G P N +EV
Sbjct: 250 ------VKWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEV-- 295
Query: 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655
+ V G P C ++ +C Q + + RP+ + ++ +E
Sbjct: 296 ------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349
Query: 656 SDTKTPEFINSEHTSKEE 673
+T P +E+
Sbjct: 350 INTALPIEYGPLVEEEEK 367
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 383 IGQGGYGKVYKGIL-PDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 436
+G G +G VYKG+ P+G VA+K +E + E L E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C L+ + M G L D + + K+ +G L+ + ++G+ YL D
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 551
+ HRD+ A N+L+ K+ DFGL++L + E G VP +K
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA---- 187
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
E L T +SDV+S GV EL+T G +P E+ + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEI--------SSILEKGER 237
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
P C + KC + D+RP E++ E +
Sbjct: 238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 59/301 (19%)
Query: 382 QIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 431
+G+G +G+V + VAVK ++ + + + + ++E++ + + H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 477
N+++L+G C ++G ++ E+ S G LR+ L + +E + F +S
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 532
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 588
G +P VK PE T +SDV+S GV+ E+ T G P I
Sbjct: 265 GRLP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 311
Query: 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648
E+ + +G+ P+ C + + C RP+ +++ +L+
Sbjct: 312 --EEL--------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 649 I 649
I
Sbjct: 362 I 362
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 383 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 437
+G+G +G+VY+G+ + VAVK ++ K +F++E + L H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
G +EE ++ E G L L ++K L + +L + + YL E+ V
Sbjct: 80 GIIEEE-PTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL--ESINCV 135
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE---------GIVPAHVSTVVKGTPG 548
HRDI NIL+ K+ DFGLSR IE +P +K
Sbjct: 136 -HRDIAVRNILVASPECVKLGDFGLSR-----YIEDEDYYKASVTRLP------IKWMS- 182
Query: 549 YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607
PE + T SDV+ V E+L+ G QP +N ++V + +
Sbjct: 183 ---PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDV--------IGVLEK 229
Query: 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652
G+ P C L +C + RP +E++ L ++ M
Sbjct: 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 41/274 (14%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 438
+IG+G + VYKG+ VA Q+ L + F E + L L H N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 439 YC-DEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTE 492
+ + E M++GTL+ L K +++ S +G+ +LHT
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 493 ADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
PP+ HRD+K NI + + K+ D GL+ + A + V GTP ++
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---------LKRASFAKAVIGTPEFMA 198
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
PE + K + DVY+ G+ LE+ T P S +N + + V G
Sbjct: 199 PEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRVTSGVKP 248
Query: 612 SYP----SECVEKFIKLALKCCQDETDARPSMSE 641
+ V++ I+ C + D R S+ +
Sbjct: 249 ASFDKVAIPEVKEIIE---GCIRQNKDERYSIKD 279
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 32/306 (10%)
Query: 382 QIGQGGYGKVYKGILPDGTV-----VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVS 435
IG G +G+VYKG+L + VA+K + G + ++ +FL E + + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
L G + M++ E+M NG L L + + + G + G+ YL A+
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEY 554
HRD+ A NIL++ KV+DFGLSR+ D E + ++ T PE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEATYTTSGGKIPIRWTA----PEA 221
Query: 555 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613
K T SDV+S G+V E++T G +P N EV M ++ DG
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEV--------MKAINDGFRLPT 271
Query: 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 673
P +C +L ++C Q E RP ++++ L+ + P+S +F
Sbjct: 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-APDSLKTLADFDPRVSIR--- 327
Query: 674 TPPSSS 679
PS+S
Sbjct: 328 -LPSTS 332
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 72/320 (22%), Positives = 132/320 (41%), Gaps = 64/320 (20%)
Query: 382 QIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 431
+G+G +G+V VAVK ++ + + + + ++E++ + + H+
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 477
N+++L+G C ++G ++ E+ S G LR+ L + +E + F +S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 532
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 588
G +P VK PE T +SDV+S GV+ E+ T G P I
Sbjct: 219 GRLP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265
Query: 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648
E+ + +G+ P+ C + + C RP+ +++ +L+
Sbjct: 266 --EEL--------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
Query: 649 IWNMMPESDTKTPEFINSEH 668
I + T E+++
Sbjct: 316 IL-----TLTTNEEYLDLSQ 330
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-39
Identities = 74/297 (24%), Positives = 118/297 (39%), Gaps = 51/297 (17%)
Query: 382 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 433
+G+G +G+V + VAVK +EG+ E ++E++ L + HH N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 434 VSLVGYC-DEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLSI 478
V+L+G C G M++ EF G L L K+ L +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EG 533
+ ++G+ +L A HRD+ A NILL K K+ DFGL+R +
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 592
+P +K PE T +SDV+S GV+ E+ + G P G I E
Sbjct: 211 RLP------LKWMA----PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEE 259
Query: 593 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ +G P + + L C E RP+ SE++ L ++
Sbjct: 260 F--------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 81/311 (26%), Positives = 131/311 (42%), Gaps = 74/311 (23%)
Query: 382 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 434
+G+G +GKV K T VAVK +E + E + L+E L +++H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQL----------------------SAKSKEPLGF 472
L G C ++G +L+ E+ G+LR L + L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 473 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 531
+S A S+G+ YL A+ + HRD+ A NIL+ K++DFGLSR D+
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVY 201
Query: 532 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 581
+G +P VK E H T +SDV+S GV+ E++T G
Sbjct: 202 EEDSYVKRSQGRIP------VKWMA----IESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 582 P---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS 638
P I + + G+ P C E+ +L L+C + E D RP
Sbjct: 252 PYPGIPP-----ERL--------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 639 MSEVMRELESI 649
+++ ++LE +
Sbjct: 299 FADISKDLEKM 309
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 24/280 (8%)
Query: 381 TQIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 436
++G G +G V +G+ + VA+K ++G+ + + E + E Q + +L + +V L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C E MLV E G L L +E + + + S G+ YL +
Sbjct: 76 IGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
HRD+ A N+LL ++ AK++DFGLS+ D + +K PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 186
Query: 557 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615
K + +SDV+S GV E L+ G +P K EV M + G P
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEV--------MAFIEQGKRMECPP 236
Query: 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655
EC + L C + + RP V + + + + +
Sbjct: 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 61/298 (20%)
Query: 382 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNLVSL 436
IG+G +G+V K + A+KR +E + + + +F E++ L +L HH N+++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLSIALGS 482
+G C+ G L E+ +G L D L + + L L A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-------GIV 535
+RG+ YL + HRD+ A NIL+ + AK+ADFGLSR E G +
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 203
Query: 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVR 591
P V+ E T SDV+S GV+ E+++ G P ++
Sbjct: 204 P------VRWMA----IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A 248
Query: 592 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
E+ + G P C ++ L +C +++ RPS ++++ L +
Sbjct: 249 EL--------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 65/336 (19%), Positives = 123/336 (36%), Gaps = 30/336 (8%)
Query: 351 HSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE 409
H +S G + + M + +IG+G +GK DG +K
Sbjct: 4 HHHHSSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI 59
Query: 410 GSL-QGEKEF-LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 467
+ E+E E+ L+ + H N+V +E G +V ++ G L +++A+
Sbjct: 60 SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 468 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527
L + + ++H D + HRDIK+ NI L T ++ DFG++R+
Sbjct: 120 VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587
+ GTP YL PE +KSD+++LG V EL T
Sbjct: 177 STV------ELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF-EAG 228
Query: 588 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE-- 645
++ +++ +I G+ L + + RPS++ ++ +
Sbjct: 229 SM---------KNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279
Query: 646 -LESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680
+ I + + + + P+
Sbjct: 280 IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRP 315
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 70/304 (23%), Positives = 116/304 (38%), Gaps = 68/304 (22%)
Query: 382 QIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 433
+G G +GKV + VAVK + + EK ++E++ +S L H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL------------SAKSKEPLGFAMRLSIALG 481
V+L+G C G +++ E+ G L + L A + L +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI---------- 531
++G+ +L A HRD+ A N+LL + AK+ DFGL+R DI
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKG 224
Query: 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 590
+P VK PE T +SDV+S G++ E+ + G+ P
Sbjct: 225 NARLP------VKWMA----PESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-------- 266
Query: 591 REVNIAYQSSM-----MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 645
Y + V DG + P+ + + C E RP+ ++
Sbjct: 267 ------YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
Query: 646 LESI 649
L+
Sbjct: 321 LQEQ 324
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 382 QIGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 436
IG G G+V G L VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
G M+V E+M NG+L L + + G G+ YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG--- 171
Query: 497 VF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEY 554
+ HRD+ A N+L+D KV+DFGLSR+ D + + ++ T PE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTA----PEA 225
Query: 555 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613
+ SDV+S GVV E+L G +P + N R+V + SV +G
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDV--------ISSVEEGYRLPA 275
Query: 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
P C +L L C + RP S+++ L+++
Sbjct: 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 74/276 (26%), Positives = 112/276 (40%), Gaps = 30/276 (10%)
Query: 382 QIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSL 436
++G G +G V KG VAVK + + + E L E + +L + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C+ E MLV E G L L + + + + S G+ YL E
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL--EESNF 138
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDPEY 554
V HRD+ A N+LL + AK++DFGLS+ + E A VK PE
Sbjct: 139 V-HRDLAARNVLLVTQHYAKISDFGLSKA--LRADENYYKAQTHGKWPVKWYA----PEC 191
Query: 555 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613
+K + KSDV+S GV+ E + G +P K EV + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEV--------TAMLEKGERMGC 241
Query: 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
P+ C + L C + + RP + V L +
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-38
Identities = 83/311 (26%), Positives = 131/311 (42%), Gaps = 74/311 (23%)
Query: 382 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 434
IG+G +G+V++ P T+VAVK +E S + +F E ++ + N+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----------------------PLGF 472
L+G C L++E+M+ G L + L + S PL
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 473 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 531
A +L IA + G+ YL ++ HRD+ N L+ K+ADFGLSR +I
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIY 225
Query: 532 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 581
+P ++ P PE ++ T +SDV++ GVV E+ + G+Q
Sbjct: 226 SADYYKADGNDAIP------IRWMP----PESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 582 P---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS 638
P ++H EV I Y V DGN+ + P C + L C RPS
Sbjct: 276 PYYGMAH-----EEV-IYY-------VRDGNILACPENCPLELYNLMRLCWSKLPADRPS 322
Query: 639 MSEVMRELESI 649
+ R L+ +
Sbjct: 323 FCSIHRILQRM 333
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 76/279 (27%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 383 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 437
IG+G +G V++GI VA+K + + + +FL E + + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
G E ++ E + G LR L K L A + A S + YL E+ V
Sbjct: 83 GVITEN-PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL--ESKRFV 138
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLD 551
HRDI A N+L+ K+ DFGLSR + D G +P +K
Sbjct: 139 -HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP------IKWMA---- 185
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
PE + T SDV+ GV E+L G++P KN +V + + +G
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDV--------IGRIENGER 235
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
P C L KC + RP +E+ +L +I
Sbjct: 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 70/304 (23%), Positives = 115/304 (37%), Gaps = 48/304 (15%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 433
+F IG GG+G+V+K DG +KR + ++ E++ L++L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNI 66
Query: 434 VSLVGYCDEEGEQM----------------LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 477
V G D + EF GTL + + E L + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 537
+ ++G+ Y+H + +RD+K SNI L K+ DFGL +
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--------LKND 175
Query: 538 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597
T KGT Y+ PE + + D+Y+LG++ ELL ++
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL---- 231
Query: 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 657
G +K L K + + RP+ SE++R L +W PE +
Sbjct: 232 -----------RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT-VWKKSPEKN 279
Query: 658 TKTP 661
+
Sbjct: 280 ERHT 283
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 66/310 (21%), Positives = 116/310 (37%), Gaps = 54/310 (17%)
Query: 382 QIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 433
+GQG + K++KG+ T V +K + + F +S+L H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
V G C E +LV EF+ G+L L K+K + +L +A + + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL---E 130
Query: 494 DPPVFHRDIKASNILLDHKFT--------AKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
+ + H ++ A NILL + K++D G+S +P +
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQER------IPW 183
Query: 546 TPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 603
P PE K +D +S G E+ + G +P+S + + +
Sbjct: 184 VP----PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRK--------LQ 229
Query: 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 663
D + P + L C E D RPS ++R+L S++ TP+
Sbjct: 230 FYEDRHQLPAPKAA--ELANLINNCMDYEPDHRPSFRAIIRDLNSLF---------TPDL 278
Query: 664 INSEHTSKEE 673
+
Sbjct: 279 VPRGSHHHHH 288
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 72/311 (23%), Positives = 124/311 (39%), Gaps = 42/311 (13%)
Query: 383 IGQGGYGKVYKGILPDG-----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 436
+G G +G V+KG+ V +K ++ S Q + + + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C LV +++ G+L D + + + LG + L+ + ++G+ YL +
Sbjct: 81 LGLCPGS-SLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYL---EEHG 135
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 551
+ HR++ A N+LL +VADFG++ L P D + P +K
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP------IKWMA---- 185
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
E K T +SDV+S GV EL+T G +P + + EV + G
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEV--------PDLLEKGER 235
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 670
+ P C + +KC + + RP+ E+ E + P I E
Sbjct: 236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLV-----IKRESGP 290
Query: 671 KEETPPSSSSM 681
P +
Sbjct: 291 GIAPGPEPHGL 301
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 74/310 (23%), Positives = 124/310 (40%), Gaps = 45/310 (14%)
Query: 383 IGQGGYGKVYKGILPDG-----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 436
+G G +G VYKG+ VA+K +E + E L E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C L+ + M G L D + + K+ +G L+ + ++G+ YL D
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 551
+ HRD+ A N+L+ K+ DFGL++L + E G VP +K
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA---- 187
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
E L T +SDV+S GV EL+T G +P E+ + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEI--------SSILEKGER 237
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 670
P C + +KC + D+RP E++ E + + P+
Sbjct: 238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM--------ARDPQRYLVIQGD 289
Query: 671 KEETPPSSSS 680
+ PS +
Sbjct: 290 ERMHLPSPTD 299
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 68/298 (22%), Positives = 114/298 (38%), Gaps = 52/298 (17%)
Query: 382 QIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 433
+G G +GKV + VAVK + + E+ ++E++ LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL----------------SAKSKEPLGFAMRLS 477
V+L+G C G +++ E+ G L + L + L LS
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 532
+ ++G+ +L A HRD+ A NILL H K+ DFGL+R
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 591
+P VK PE T +SDV+S G+ EL + G P G +
Sbjct: 207 ARLP------VKWMA----PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-GMPVDS 255
Query: 592 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ + +G P + + C + RP+ ++++ +E
Sbjct: 256 KF--------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-37
Identities = 76/311 (24%), Positives = 132/311 (42%), Gaps = 34/311 (10%)
Query: 382 QIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 436
+G G +G+V G L VA+K + G + ++ +FL E + + H N++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
G + M+V E+M NG+L L K + + G + G+ YL +D
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGYLD 551
HRD+ A NIL++ KV+DFGL R +E A +T ++ T
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGR-----VLEDDPEAAYTTRGGKIPIRWTS---- 218
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
PE K T SDV+S G+V E+++ G +P N ++V + +V +G
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDV--------IKAVDEGYR 268
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 670
P +C +L L C Q + + RP +++ L+ + T +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLL 328
Query: 671 KEETPPSSSSM 681
+++ ++
Sbjct: 329 LDQSNVDITTF 339
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 26/284 (9%)
Query: 382 QIGQGGYGKVYKGIL--PDGTV--VAVKRAQEGSLQGEK---EFLTEIQFLSRLHHRNLV 434
++G G +G V +G P G VAVK + L + +F+ E+ + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
L G +V E G+L D+L K + A+ + G+ YL E+
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYL--ESK 140
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
+ HRD+ A N+LL + K+ DFGL R P D ++ H PE
Sbjct: 141 RFI-HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PES 195
Query: 555 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613
T + SD + GV E+ T G +P ++ + +G
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQI-------LHKIDKEGERLPR 246
Query: 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 657
P +C + + ++C + + RP+ + L ++
Sbjct: 247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRAE 290
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 70/308 (22%), Positives = 114/308 (37%), Gaps = 67/308 (21%)
Query: 382 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 433
+G G +GKV VAVK +E + E+ ++E++ +++L H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL---------------------SAKSKEPLGF 472
V+L+G C G L++E+ G L + L + L F
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 473 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 531
L A ++G+ +L HRD+ A N+L+ H K+ DFGL+R DI
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIM 223
Query: 532 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 581
+P VK PE T KSDV+S G++ E+ + G+
Sbjct: 224 SDSNYVVRGNARLP------VKWMA----PESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 582 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 641
P G + + +G P E+ + C ++ RPS
Sbjct: 274 P-YPGIPVDANF--------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324
Query: 642 VMRELESI 649
+ L
Sbjct: 325 LTSFLGCQ 332
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 66/289 (22%), Positives = 112/289 (38%), Gaps = 30/289 (10%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLV 437
+IG+G + +VY+ L DG VA+K+ Q L K + EI L +L+H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF--AMRLSIALGSSRGILYLHTEADP 495
E+ E +V E G L + K+ + + ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
V HRDIK +N+ + K+ D GL R ++V GTP Y+ PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT------TAAHSLV-GTPYYMSPERI 208
Query: 556 LTHKLTDKSDVYSLGVVFLELLTGMQP-ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
+ KSD++SLG + E+ P N+ S+ + + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---------SLCKKIEQCDYPPLP 259
Query: 615 SECV-EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 662
S+ E+ +L C + + RP ++ V + M + +
Sbjct: 260 SDHYSEELRQLVNMCINPDPEKRPDVTYV---YDVAKRMHACTASSLEH 305
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 26/284 (9%)
Query: 370 MALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL-QGEKEFL-TEIQFLS 426
M ++ IG G YG+ K DG ++ K GS+ + EK+ L +E+ L
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 427 RLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGS 482
L H N+V + L V E+ G L ++ +KE L +
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 483 SRGILYLHTEADPP--VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 540
+ + H +D V HRD+K +N+ LD K K+ DFGL+R+ +
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT------SFAK 174
Query: 541 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 600
T V GTP Y+ PE +KSD++SLG + EL M P +
Sbjct: 175 TFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQ---------KE 223
Query: 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ + +G P ++ ++ + + RPS+ E++
Sbjct: 224 LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 4e-36
Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 24/281 (8%)
Query: 381 TQIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 436
++G G +G V +G+ + VA+K ++G+ + + E + E Q + +L + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C E MLV E G L L +E + + + S G+ YL E
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL--EEKNF 457
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
V HR++ A N+LL ++ AK++DFGLS+ D + +K PE
Sbjct: 458 V-HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 512
Query: 557 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615
K + +SDV+S GV E L+ G +P K EV M + G P
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEV--------MAFIEQGKRMECPP 562
Query: 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 656
EC + L C + + RP V + + + + +
Sbjct: 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 8e-36
Identities = 76/279 (27%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 383 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 437
IG+G +G V++GI VA+K + + + +FL E + + H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
G E ++ E + G LR L K L A + A S + YL E+ V
Sbjct: 458 GVITEN-PVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYL--ESKRFV 513
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLD 551
HRDI A N+L+ K+ DFGLSR + D G +P +K
Sbjct: 514 -HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP------IKWMA---- 560
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
PE + T SDV+ GV E+L G++P KN +V + + +G
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDV--------IGRIENGER 610
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
P C L KC + RP +E+ +L +I
Sbjct: 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 57/282 (20%), Positives = 104/282 (36%), Gaps = 43/282 (15%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNL--VSLV 437
QIG GG KV++ + + A+K + + EI +L++L + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
Y + +V E N L L K + + +H +
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 148
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 553
H D+K +N L+ K+ DFG++ ++ + V GT Y+ PE
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 554 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 253
Query: 607 DGN----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
D N P + ++ +K C + + R S+ E++
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLA 292
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 63/295 (21%), Positives = 114/295 (38%), Gaps = 40/295 (13%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 432
++F +GQG +G+V K D A+K+ + + L+E+ L+ L+H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 433 LVSLVG-YCDEEGEQM------------LVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSI 478
+V + + + E+ NGTL D + S + RL
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-------LAPVPDI 531
+ + Y+H++ + HRD+K NI +D K+ DFGL++ + +
Sbjct: 124 QILE--ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNI 589
+ T GT Y+ E L K D+YSLG++F E++ P S G
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234
Query: 590 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
V + S+ F + + +K I+ + + RP ++
Sbjct: 235 VNILKKLRSVSIEF---PPDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 57/279 (20%), Positives = 103/279 (36%), Gaps = 37/279 (13%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRL--HHRNLVSLV 437
QIG GG KV++ + + A+K + + EI +L++L H ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
Y + +V E N L L K + + +H +
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 129
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 553
H D+K +N L+ K+ DFG++ ++ + V GT Y+ PE
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 554 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 234
Query: 607 DGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
D N +P + + C + + R S+ E++
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 69/278 (24%), Positives = 110/278 (39%), Gaps = 45/278 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
+G+G YG VY G L + +A+K E + + EI L H+N+V +G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SF 88
Query: 442 EEGEQMLVY-EFMSNGTLRDQLSAK-----SKEPLGFAMRLSIALGSSRGILYLHTEADP 495
E + ++ E + G+L L +K E + G+ YLH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IG-FYTKQILEGLKYLHDNQ-- 142
Query: 496 PVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
+ HRDIK N+L++ K++DFG S+ + GI P + GT Y+ PE
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINPCTET--FTGTLQYMAPEI 194
Query: 555 FLTHKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612
+D++SLG +E+ TG P MF V G
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---------AMFKV--GMFKV 243
Query: 613 YP------SECVEKFIKLALKCCQDETDARPSMSEVMR 644
+P S + FI KC + + D R ++++
Sbjct: 244 HPEIPESMSAEAKAFIL---KCFEPDPDKRACANDLLV 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 61/292 (20%), Positives = 106/292 (36%), Gaps = 39/292 (13%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRN 432
+F +G+GG+G V++ D A+KR + + + +E + E++ L++L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 433 LVSLVGYCDEEGEQM------------LVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIA 479
+V E+ + + L+D ++ + E ++ L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-------LAPVPDIE 532
L + + +LH + HRD+K SNI KV DFGL V
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 592
H V GT Y+ PE + + K D++SLG++ ELL P S VR
Sbjct: 182 PAYARHTGQV--GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236
Query: 593 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ V + ++ + RP ++
Sbjct: 237 LTD---------VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 62/307 (20%), Positives = 111/307 (36%), Gaps = 58/307 (18%)
Query: 368 GEMALATN---NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTE 421
G M + + F+ +IG G +G V+K + DG + A+KR E+ L E
Sbjct: 1 GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 422 IQFLSRL-HHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGF--AMRLS 477
+ + L H ++V E + ML+ E+ + G+L D +S + F A
Sbjct: 61 VYAHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------------KFTAKVA 518
+ L RG+ Y+H+ + + H DIK SNI + K K+
Sbjct: 120 LLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 519 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELL 577
D G P V +G +L E + K+D+++L + +
Sbjct: 177 DLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225
Query: 578 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP 637
+G + G + P ++F +L + + RP
Sbjct: 226 GAEPLPRNG-------------DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRP 272
Query: 638 SMSEVMR 644
S +++
Sbjct: 273 SAMALVK 279
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 64/340 (18%), Positives = 119/340 (35%), Gaps = 47/340 (13%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNL--VSLV 437
QIG GG KV++ + + A+K + + EI +L++L + + L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
Y + +V E N L L K + + +H +
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 176
Query: 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 553
H D+K +N L+ K+ DFG++ ++ + V G Y+ PE
Sbjct: 177 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 554 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 281
Query: 607 DGN----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIWNMMPESDTKT 660
D N P + ++ +K C + + R S+ E++ ++ + + + T
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 338
Query: 661 PEFINS--EHTSKEETPPSSSSMLKHPYVSSDVSGSNLVS 698
E + +P S K Y S+ S
Sbjct: 339 TEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSS 378
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 58/270 (21%), Positives = 103/270 (38%), Gaps = 36/270 (13%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL-HHRNLVSL 436
++G G YG+V+K DG + AVKR+ +G K+ L E+ ++ H V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 437 VGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
EEG + L E +L+ L A + + +LH++
Sbjct: 123 EQ-AWEEGGILYLQTEL-CGPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLHSQG-- 177
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
+ H D+K +NI L + K+ DFGL + A V +G P Y+ PE
Sbjct: 178 -LVHLDVKPANIFLGPRGRCKLGDFGLLVE--------LGTAGAGEVQEGDPRYMAPE-L 227
Query: 556 LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM-GSYP 614
L +DV+SLG+ LE+ M+ + + G + +
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMEL-------------PHGGEGWQQLRQGYLPPEFT 274
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ + + + + + R + ++
Sbjct: 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 65/321 (20%), Positives = 120/321 (37%), Gaps = 41/321 (12%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY 439
+ +GG+ VY+ + G A+KR + + + E+ F+ +L H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 440 C-------DEEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHT 491
D + L+ + G L + L +S+ PL L I + R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGT 546
PP+ HRD+K N+LL ++ T K+ DFG + + V T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 547 PGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603
P Y PE + + +K D+++LG + L P ++
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--------------FEDGAKL 259
Query: 604 SVIDGN--MGSYP--SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 659
+++G + + I+ Q + R S++EV+ +L+ I + K
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEI-AAARNVNPK 315
Query: 660 TPEFINSEHTSKEETPPSSSS 680
+P E + S
Sbjct: 316 SPITELLEQNGGYGSATLSRG 336
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-33
Identities = 66/313 (21%), Positives = 123/313 (39%), Gaps = 33/313 (10%)
Query: 383 IGQGGYGKVYKGIL-PDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+G G G V+K P G V+A K E + + E+Q L + +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
+GE + E M G+L L K + + +++ +G+ YL + + HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHR 156
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
D+K SNIL++ + K+ DFG+S ++ + ++ V GT Y+ PE
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSG--------QLIDSMANSFV-GTRSYMSPERLQGTHY 207
Query: 561 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 620
+ +SD++S+G+ +E+ G PI + + + + +E +
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIP-----------PPDAKELELMFGCQVEGDAAETPPR 256
Query: 621 FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTP------EFINSEHTSKEET 674
+ D+RP M+ + L+ I N P +F+N
Sbjct: 257 PRTPGRPLNKFGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315
Query: 675 PPSSSSMLKHPYV 687
++ H ++
Sbjct: 316 RADLKQLMVHAFI 328
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 70/282 (24%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 382 QIGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRN 432
++G GG VY IL VA+K + ++E L E+ S+L H+N
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIP---PREKEETLKRFEREVHNSSQLSHQN 72
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+VS++ +E+ LV E++ TL + + +S PL ++ GI + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ HRDIK NIL+D T K+ DFG+++ + + V+ GT Y P
Sbjct: 131 R---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-----TQTNHVL-GTVQYFSP 181
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612
E + +D+YS+G+V E+L G P + G+ V+IA + I ++ +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFN-GET---AVSIAIKH------IQDSVPN 231
Query: 613 YPSECV----EKFIKLALKCCQDETDARP-SMSEVMRELESI 649
++ + + L+ + + R ++ E+ +L S+
Sbjct: 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 55/265 (20%), Positives = 96/265 (36%), Gaps = 30/265 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
+G+G +G+V++ G AVK+ + + E E+ + L +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 120
Query: 442 EEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
E + E + G+L + E L AL G+ YLHT + H
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-ALYYLGQAL---EGLEYLHTRR---ILH 173
Query: 500 RDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
D+KA N+LL A + DFG + + + + GT ++ PE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVVMGK 231
Query: 559 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN--MGSYPSE 616
K D++S + L +L G P + ++ + + + P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQ----------YFRGPLCLKIASEPPPIREIPPS 281
Query: 617 CVEKFIKLALKCCQDETDARPSMSE 641
C + + + E R S E
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAME 306
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 76/315 (24%), Positives = 131/315 (41%), Gaps = 41/315 (13%)
Query: 383 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRNL 433
+G GG +V+ VAVK RA L + F E Q + L+H +
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRAD---LARDPSFYLRFRREAQNAAALNHPAI 74
Query: 434 VSL--VGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 489
V++ G + + +V E++ TLRD + ++ P+ + + + + + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFS 132
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
H + + HRD+K +NI++ KV DFG++R + + V GT Y
Sbjct: 133 H-QNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA----DSGNSVTQTAAVIGTAQY 185
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ--SSMMFSVID 607
L PE + +SDVYSLG V E+LTG P + G + V++AYQ
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDS---PVSVAYQHVREDPIPPSA 241
Query: 608 GNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPESDTKTPEFINS 666
+ G ++ + LK + R + +E+ +L + N P K ++
Sbjct: 242 RHEGLSAD--LDAVV---LKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLT--DA 294
Query: 667 EHTSKEETPPSSSSM 681
E TS + + S
Sbjct: 295 ERTSLLSSAAGNLSG 309
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 383 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRNL 433
+G+GG G VY+ + +VA+K L + F T E + RL ++
Sbjct: 42 VGRGGMGDVYEAEDTVR--ERIVALKLMSET---LSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
V + + + +G+ + ++ L L + + PL ++I + H A
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH-AA 153
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
HRD+K NIL+ A + DFG++ + + V GT Y+ PE
Sbjct: 154 G--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-----TQLGNTV-GTLYYMAPE 205
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
F T ++D+Y+L V E LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 71/314 (22%), Positives = 118/314 (37%), Gaps = 53/314 (16%)
Query: 352 SSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ-E 409
S +KI + + + +IG+G YG V K + P G ++AVKR +
Sbjct: 4 ESSGKLKISPEQHWD-----FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 410 GSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE 468
+ +K+ L ++ + R +V G EG+ + E MS + S
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 469 PLGFAMRL--SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RL 525
+ I L + + + +L + HRDIK SNILLD K+ DFG+S +L
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 526 APVPDIEGIVPAHVSTVVK----GTPGYLDPEYFLTHKLTD----KSDVYSLGVVFLELL 577
V ++ K G Y+ PE +SDV+SLG+ EL
Sbjct: 177 -------------VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 578 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK-------FIKLALKCCQ 630
TG P ++ + V+ G+ + + F+ C
Sbjct: 224 TGRFPYPKWNSVFD---------QLTQVVKGDPPQLSNSEEREFSPSFINFVN---LCLT 271
Query: 631 DETDARPSMSEVMR 644
+ RP E+++
Sbjct: 272 KDESKRPKYKELLK 285
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 37/232 (15%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVK-----------------RAQEGSLQGEKEFLTEIQFL 425
+ QG + K+ D A+K + +F E+Q +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 426 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS-- 483
+ + + ++ G E ++YE+M N ++ + + I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 484 ----RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
Y+H E + + HRD+K SNIL+D K++DFG S +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--------DKKI 207
Query: 540 STVVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNI 589
GT ++ PE+F + K D++SLG+ + + P S ++
Sbjct: 208 KGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 440
+GQG V++G G + A+K S + E + L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 441 DEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEAD 494
+E + L+ EF G+L L S G + + + G+ +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVG--GMNHLRENG- 132
Query: 495 PPVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ HR+IK NI+ D + K+ DFG +R + + GT YL
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEYL 182
Query: 551 DPEYFLTHKLTD--------KSDVYSLGVVFLELLTGMQP 582
P+ + L D++S+GV F TG P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+GG+ K ++ V A K ++ ++ EI L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ ++ +V E +L + + A + G YLH V
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL--GCQYLHRNR---VI 137
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRD+K N+ L+ K+ DFGL+ V+ GTP Y+ PE L+
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPNYIAPE-VLSK 189
Query: 559 KLTD-KSDVYSLGVVFLELLTGMQP 582
K + DV+S+G + LL G P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-30
Identities = 60/239 (25%), Positives = 93/239 (38%), Gaps = 29/239 (12%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLV--- 437
+G GG+G V + I G VA+K+ ++ +E EIQ + +L+H N+VS
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 438 ---GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLH 490
+L E+ G LR L+ G L + S + YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISS--ALRYLH 138
Query: 491 TEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
+ HRD+K NI+L + K+ D G ++ + + T GT
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--------LDQGELCTEFVGTL 187
Query: 548 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606
YL PE K T D +S G + E +TG +P V+ + S V+
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+GG+ K ++ V A K ++ ++ EI L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ ++ +V E +L + + A + G YLH V
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL--GCQYLHRNR---VI 163
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRD+K N+ L+ K+ DFGL+ V+ GTP Y+ PE L+
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPNYIAPE-VLSK 215
Query: 559 KLTD-KSDVYSLGVVFLELLTGMQP 582
K + DV+S+G + LL G P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 48/281 (17%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQF-LSRLHHRNLVSLVGY 439
+G+G YG V K +P G ++AVKR + Q +K L ++ + + V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPV 497
EG+ + E M + +L + + IA+ + + +LH++ V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 498 FHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK----GTPGYLDP 552
HRD+K SN+L++ K+ DFG+S L V V K G Y+ P
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL-------------VDDVAKDIDAGCKPYMAP 178
Query: 553 EYFLTHKLTD----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608
E KSD++SLG+ +EL P + + V++
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---------QLKQVVEE 229
Query: 609 NM-----GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ +E V+ F +C + + RP+ E+M+
Sbjct: 230 PSPQLPADKFSAEFVD-FTS---QCLKKNSKERPTYPELMQ 266
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 43/210 (20%), Positives = 79/210 (37%), Gaps = 32/210 (15%)
Query: 383 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL- 436
I GG G +Y + +G V +K G + + + E QFL+ + H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 437 -VGYCDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+ + Y E++ +L+ + L A ++ L + YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ + D+K NI+L + K+ D G + GTPG+ P
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----------NSFGYLY-GTPGFQAP 246
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
E + T +D+Y++G L +
Sbjct: 247 EI-VRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 41/277 (14%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGY 439
+G G G+V+K G V+AVK+ + G+ + K L ++ + + H +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
+ + E M GT ++L + + P+ + + + + + YL + V H
Sbjct: 93 FITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIH 148
Query: 500 RDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK----GTPGYLDPEY 554
RD+K SNILLD + K+ DFG+S RL V K G Y+ PE
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL-------------VDDKAKDRSAGCAAYMAPER 195
Query: 555 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609
T ++DV+SLG+ +EL TG P + K ++ V+
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---------VLTKVLQEE 246
Query: 610 MGSYPSECV--EKFIKLALKCCQDETDARPSMSEVMR 644
P F C + RP ++++
Sbjct: 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 9e-29
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 440
+GQG V++G G + A+K S + E + L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 441 DEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEAD 494
+E + L+ EF G+L L S G + + + G+ +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVG--GMNHLRENG- 132
Query: 495 PPVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ HR+IK NI+ D + K+ DFG +R + + GT YL
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEYL 182
Query: 551 DPEYF--------LTHKLTDKSDVYSLGVVFLELLTGMQP 582
P+ + K D++S+GV F TG P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
IG G V P VA+KR E E L EIQ +S+ HH N+VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS---IAL---GSSRGILYLHTEAD 494
+ E LV + +S G++ D + + + L IA G+ YLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG- 141
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
HRD+KA NILL + ++ADFG+S LA DI T V GTP ++ PE
Sbjct: 142 --QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK--TFV-GTPCWMAPE 196
Query: 554 YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISH 585
+ D K+D++S G+ +EL TG P
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 64/284 (22%), Positives = 112/284 (39%), Gaps = 40/284 (14%)
Query: 376 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLT----EIQFLSRL-HH 430
+F +G G G + + D VAVKR E + E+Q L H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADREVQLLRESDEH 77
Query: 431 RNLVSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 488
N++ +C E+ Q + E + TL++ + K LG ++ ++ G+ +
Sbjct: 78 PNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133
Query: 489 LHTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
LH+ + HRD+K NIL+ A ++DFGL + G + V
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA----VGRHSFSRRSGV 186
Query: 544 KGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 600
GT G++ PE T D++S G VF +++ GK++ R+ NI +
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-FGKSLQRQANILLGAC 245
Query: 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ + + + I+ K + RPS V++
Sbjct: 246 SLDCLHPEK---HEDVIARELIE---KMIAMDPQKRPSAKHVLK 283
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+G +G VY ++A+K +AQ E + E++ S L H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 496
Y + L+ E+ GT+ +L SK E +A + Y H++
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYCHSKR--- 129
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
V HRDIK N+LL K+ADFG S A P+ T + GT YL PE
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRTDLCGTLDYLPPEMIE 180
Query: 557 THKLTDKSDVYSLGVVFLELLTGMQP 582
+K D++SLGV+ E L G P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 60/320 (18%), Positives = 111/320 (34%), Gaps = 30/320 (9%)
Query: 383 IGQG--GYGKVYKGI-LPDGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 437
IG+G V P G V V+R + S + E+ +H N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
+ E +V FM+ G+ +D + + + I G + + Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---Y 149
Query: 498 FHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
HR +KAS+IL+ ++ + + + +V V +L PE
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV-KVLPWLSPEVLQ 208
Query: 557 THKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS-MMFSVIDGNM--- 610
+ KSD+YS+G+ EL G P ++ M+ ++G +
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKD-----------MPATQMLLEKLNGTVPCL 257
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 670
+ E+ + + + + R P T +P F +
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 671 KEETP---PSSSSMLKHPYV 687
+ P PS+S++L H +
Sbjct: 318 LQRNPDARPSASTLLNHSFF 337
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+G + VY+ + G VA+K + + E++ +L H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK---EPLGFAMRLSIALGSSRGILYLHTEADP 495
Y ++ LV E NG + L + K E I G+LYLH+
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSHG-- 132
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
+ HRD+ SN+LL K+ADFGL+ +P + GTP Y+ PE
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-------EKHYTLCGTPNYISPE-I 183
Query: 556 LTHKLTD-KSDVYSLGVVFLELLTGMQP 582
T +SDV+SLG +F LL G P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 440
IG+G +G+V+KGI VVA+K + E E + EI LS+ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
++ + ++ E++ G+ D L PL +I +G+ YLH+E HR
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHR 143
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
DIKA+N+LL K+ADFG++ + D + +T V GTP ++ PE
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQ----IKRNTFV-GTPFWMAPEVIKQSAY 196
Query: 561 TDKSDVYSLGVVFLELLTGMQPISH 585
K+D++SLG+ +EL G P S
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSE 221
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+G +G VY + ++A+K ++Q E + EI+ S L H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
Y + L+ EF G L +L + + L + Y H V
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD--ALHYCHERK---VI 136
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK---GTPGYLDPEYF 555
HRDIK N+L+ +K K+ADFG S AP S + GT YL PE
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAP------------SLRRRTMCGTLDYLPPEMI 184
Query: 556 LTHKLTDKSDVYSLGVVFLELLTGMQP 582
+K D++ GV+ E L GM P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
+G G +GKVYK G + A K + S + ++++ EI+ L+ H +V L+G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
+G+ ++ EF G + + + L + + +LH++ + HRD
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKR---IIHRD 142
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-------TVVKGTPGYLDPEY 554
+KA N+L+ + ++ADFG+S A + + GTP ++ PE
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS-------------AKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 555 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPISH 585
+ + D K+D++SLG+ +E+ P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 377 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
+ +IGQG G VY + + G VA+++ ++ + EI + + N+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
+ E +V E+++ G+L D ++ + A ++ + + +LH+
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSNQ-- 136
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS---TVVKGTPGYLDP 552
V HRDIK+ NILL + K+ DFG + S T+V GTP ++ P
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFC---------AQITPEQSKRSTMV-GTPYWMAP 185
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
E K D++SLG++ +E++ G P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVS----- 435
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ +
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 436 LVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
+ +Q+ LV EF G++ D + L I RG+ +LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 149
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-------TVVKGTP 547
V HRDIK N+LL K+ DFG+S A + T + GTP
Sbjct: 150 --VIHRDIKGQNVLLTENAEVKLVDFGVS-------------AQLDRTVGRRNTFI-GTP 193
Query: 548 GYLDPEYFLTHKLTD-----KSDVYSLGVVFLELLTGMQPISH 585
++ PE + D KSD++SLG+ +E+ G P+
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 29/300 (9%), Positives = 59/300 (19%), Gaps = 55/300 (18%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+ G V+ + A+K E S + +RL +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 439 YC--------------------------DEEGEQMLVYEFMSNGTLRDQLSA-----KSK 467
+L+ S L S +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 468 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527
G + R L ++ + H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL--TDKSDVYSLGVVFLELLTGMQPISH 585
Y E+ T + + LG+ + P
Sbjct: 243 -------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 586 GKNIVRE-VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
++ + + + V+ I + + R E M
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAME 352
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 34/217 (15%)
Query: 377 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
+S +IG+G G V G VAVK Q + E+ + H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRD----------QLSAKSKEPLGFAMRLSIALGSSRG 485
+ E ++ EF+ G L D Q++ + L +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL-------------QA 153
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
+ YLH + V HRDIK+ +ILL K++DFG A + ++V G
Sbjct: 154 LAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDV----PKRKSLV-G 203
Query: 546 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
TP ++ PE + D++SLG++ +E++ G P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 64/248 (25%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 350 RHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ 408
H +S G + + M + + +G+G YG V K G +VA+K+
Sbjct: 4 HHHHHSSGVDLGTENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59
Query: 409 EGSLQGEKEF-----LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 463
E + + + EI+ L +L H NLV+L+ C ++ LV+EF+ + T+ D L
Sbjct: 60 ESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE 115
Query: 464 AKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 521
P G ++ GI + H+ + HRDIK NIL+ K+ DFG
Sbjct: 116 LF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFG 169
Query: 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGM 580
+R P + V T Y PE + K+ DV+++G + E+ G
Sbjct: 170 FARTLAAP-----GEVYDDEVA--TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG- 221
Query: 581 QPISHGKN 588
+P+ G +
Sbjct: 222 EPLFPGDS 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRL 428
+ +IG+G YG V+K +VA+KR + L + E L EI L L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKEL 58
Query: 429 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGI 486
H+N+V L + + LV+EF D + L + S +G+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
+ H+ V HRD+K N+L++ K+A+FGL+R +P V + + VV T
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----VRCYSAEVV--T 164
Query: 547 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
Y P+ KL S D++S G +F EL +P+ G +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+G G + +V+ G + A+K ++ + EI L ++ H N+V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ LV + +S G L D++ + E + + + YLH +
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----SAVKYLHENG---IV 128
Query: 499 HRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
HRD+K N+L + DFGLS++ +ST GTPGY+ PE
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM--------EQNGIMSTAC-GTPGYVAPEVL 179
Query: 556 LTHKLTDKSDVYSLGVVFLELLTGMQP 582
+ D +S+GV+ LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHR 431
F+ ++G+G YG VYK I G +VA+K+ ++ + +E + EI + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSP 84
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
++V G + + +V E+ G++ D + ++K L +I + +G+ YLH
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHF 143
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
HRDIKA NILL+ + AK+ADFG++ + D A +TV+ GTP ++
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTM----AKRNTVI-GTPFWMA 193
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585
PE +D++SLG+ +E+ G P +
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 77/352 (21%), Positives = 130/352 (36%), Gaps = 55/352 (15%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNL 433
N S +G G G V G VAVKR + L EI+ L+ H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 434 VSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMR-----LSIALGSSRGI 486
+ YC E ++ + E N L+D + +K+ ++ +S+ + G+
Sbjct: 72 IRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 487 LYLHTEADPPVFHRDIKASNILLDHK-------------FTAKVADFGLSRLAPVPDIEG 533
+LH+ + HRD+K NIL+ ++DFGL + + +
Sbjct: 129 AHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK--LDSGQS 183
Query: 534 IVPAHVSTVVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVFLELLTGMQPISHG 586
+++ GT G+ PE +LT D++S+G VF +L+ +
Sbjct: 184 SFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 587 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR-E 645
K RE NI + + I + + RP+ +V+R
Sbjct: 243 KYS-RESNI-IRGIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKVLRHP 297
Query: 646 LESIWNMMPESDTKTPEFIN--SEHTSKEETPPSSSSMLKHPYVSSDVSGSN 695
L W +K EF+ S+ E P S+ ++K S V S
Sbjct: 298 L--FWP-----KSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSG 342
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF----LTEIQFLSRLHHRNLVSL 436
++G G Y VYKG+ G VA+K + L E+ + EI + L H N+V L
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 437 VGYCDEEGEQMLVYEFMSN---GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
E + LV+EFM N + + + L + +G+ + H
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ HRD+K N+L++ + K+ DFGL+R +P V S VV T Y P+
Sbjct: 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-----VNTFSSEVV--TLWYRAPD 178
Query: 554 YFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
+ + S D++S G + E++TG +P+ G N
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTN 213
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 63/250 (25%), Positives = 103/250 (41%), Gaps = 21/250 (8%)
Query: 339 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LP 397
H ++H+ R + ++ F + + + ++G G YG+V
Sbjct: 2 HHHHHHSSGRENLYFQGDLQA-TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 398 DGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455
A+K ++ S+ L E+ L L H N++ L + +++ LV E
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--- 512
G L D++ + K A + + S G+ YLH + HRD+K N+LL+ K
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLS--GVTYLHKHN---IVHRDLKPENLLLESKEKD 175
Query: 513 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 572
K+ DFGLS + GT Y+ PE L K +K DV+S+GV+
Sbjct: 176 ALIKIVDFGLSAV--------FENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 573 FLELLTGMQP 582
LL G P
Sbjct: 227 LFILLAGYPP 236
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 36/128 (28%), Positives = 61/128 (47%), Gaps = 14/128 (10%)
Query: 1 MSKLLKLSLRN-CSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLS 56
+ L L + +L GP+P ++++ L YL ++ ++G+IP ++ + T+ S
Sbjct: 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK-TLVTLDFS 133
Query: 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N L+GT+P + S LP L + N +SG+IP S L + N L
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT----SMTISRNRL--- 186
Query: 117 SGSFNIPP 124
+G IPP
Sbjct: 187 TGK--IPP 192
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 35/130 (26%), Positives = 59/130 (45%), Gaps = 17/130 (13%)
Query: 1 MSKLLKLSLRNCSLQGPM---PDLSRIPNLGYLDLSS-NQLNGSIPP--GRLSLNITTIK 54
++ L L +L P L+ +P L +L + N L G IPP +L+ + +
Sbjct: 49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT-QLHYLY 107
Query: 55 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
+++ ++G IP S + L L + N+LSG++P SI L + F N +
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV-----GITFDGNRI- 161
Query: 115 NISGSFNIPP 124
SG+ IP
Sbjct: 162 --SGA--IPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 34/126 (26%), Positives = 57/126 (45%), Gaps = 13/126 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLG-YLDLSSNQLNGSIPPGRLSLNITTIKLSNN 58
+ L+ ++ + G +PD L + +S N+L G IPP +LN+ + LS N
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRN 207
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
L G F Q++ +A NSL+ + + S+ LN LD +NN + G
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLN-----GLDLRNNRI---YG 258
Query: 119 SFNIPP 124
+ +P
Sbjct: 259 T--LPQ 262
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 36/125 (28%), Positives = 56/125 (44%), Gaps = 17/125 (13%)
Query: 7 LSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS--IPP--GRLSLNITTIKLSN-NKL 60
N + G + D ++ + LDLS L IP L + + + N L
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNL 89
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
G IP + L +L L+I + ++SG+IP + Q +TL LDF N L SG+
Sbjct: 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV-----TLDFSYNAL---SGT- 140
Query: 121 NIPPN 125
+PP+
Sbjct: 141 -LPPS 144
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 27/111 (24%), Positives = 44/111 (39%), Gaps = 7/111 (6%)
Query: 3 KLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 61
L + L L+G N + L+ N L + LS N+ + L NN++
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257
Query: 62 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 112
GT+P + L L L ++ N+L G IP + + + NN
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDV-----SAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 20/89 (22%), Positives = 26/89 (29%), Gaps = 24/89 (26%)
Query: 1 MSKLLKLSLRNCSLQGPMP-----------DLSR------IP-------NLGYLDLSSNQ 36
K+ L SL + DL +P L L++S N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 37 LNGSIPPGRLSLNITTIKLSNNKLTGTIP 65
L G IP G +NNK P
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 22/84 (26%), Positives = 31/84 (36%), Gaps = 11/84 (13%)
Query: 43 PGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS--IPSSIWQSRTLNA 100
P LS + T N G + + R+ L ++ +L IPSS+ LN
Sbjct: 21 PTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN- 79
Query: 101 TETFILDFQNNNLTNISGSFNIPP 124
L N N+ G IPP
Sbjct: 80 ----FLYIGGIN--NLVGP--IPP 95
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 429
+ ++G+G YG VYK G +VA+KR + L E E + EI L LH
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKELH 77
Query: 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 487
H N+VSL+ E LV+EFM D ++ ++K L + RG+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
+ H + HRD+K N+L++ K+ADFGL+R +P V ++ VV T
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-----VRSYTHEVV--TL 183
Query: 548 GYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
Y P+ + K S D++S+G +F E++TG +P+ G
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVT 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-26
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 437
+G+G +G+V G AVK + Q ++ L E+Q L +L H N++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 497
+ +++G LV E + G L D++ ++ + A R+ + S GI Y+H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS--GITYMHKNK---I 147
Query: 498 FHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
HRD+K N+LL+ K ++ DFGLS + GT Y+ PE
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTH--------FEASKKMKDKIGTAYYIAPE- 198
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQP 582
L +K DV+S GV+ LL+G P
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 57/249 (22%), Positives = 89/249 (35%), Gaps = 54/249 (21%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 435
IGQG YG V I + A+K + ++ + + + TE++ + +LHH N+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----------- 484
L ++E LV E G L D+L+ + G +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 485 ---------------------------GILYLHTEADPPVFHRDIKASNILLDHKFTA-- 515
+ YLH + + HRDIK N L +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEI 209
Query: 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE--YFLTHKLTDKSDVYSLGVVF 573
K+ DFGLS+ + ++T GTP ++ PE K D +S GV+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYG--MTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 574 LELLTGMQP 582
LL G P
Sbjct: 267 HLLLMGAVP 275
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
+G G +G V++ + G V K + EI +++LHH L++L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----GILYLHTEADPPV 497
++ E +L+ EF+S G L D+++A+ + M + + R G+ ++H + +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 498 FHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
H DIK NI+ + K + K+ DFGL+ + P + V T + PE
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATK--------LNPDEIVKVTTATAEFAAPEIV 222
Query: 556 LTHKLTDKSDVYSLGVVFLELLTGMQP 582
+ +D++++GV+ LL+G+ P
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 429
++ +IG+G YG VYK G A+K+ + L+ E E + EI L L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELK 58
Query: 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 487
H N+V L + +LV+E + D +L + L S L GI
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
Y H V HRD+K N+L++ + K+ADFGL+R +P V + +V T
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-----VRKYTHEIV--TL 164
Query: 548 GYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
Y P+ + K + D++S+G +F E++ G P+ G +
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVS 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
IG G +G VY + + VVA+K+ + + S + ++ + E++FL +L H N + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
E LV E+ G+ D L K PL ++ G+ +G+ YLH+ +
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHN---MI 176
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS---TVVKGTPGYLDPEYF 555
HRD+KA NILL K+ DFG + + ++ + V GTP ++ PE
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSA-------------SIMAPANSFV-GTPYWMAPEVI 222
Query: 556 LTHKLTD---KSDVYSLGVVFLELLTGMQPISH 585
L K DV+SLG+ +EL P+ +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 65/259 (25%), Positives = 108/259 (41%), Gaps = 42/259 (16%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-F----LTEIQFLSRL 428
+ + +IGQG +G+V+K G VA+K+ ++ EKE F L EI+ L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLL 73
Query: 429 HHRNLVSLVGYCDEEGEQM--------LVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSI 478
H N+V+L+ C + LV++F + D L + + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIKRV 129
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538
G+ Y+H + HRD+KA+N+L+ K+ADFGL+R + +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLA-KNSQPNRY 185
Query: 539 VSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597
+ VV T Y PE L D++ G + E+ T PI G E +
Sbjct: 186 TNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNT---EQH--- 236
Query: 598 QSSMMFSVIDGNMGSYPSE 616
Q +++ + GS +
Sbjct: 237 QLALISQL----CGS-ITP 250
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF-----LTEIQFLSRL 428
+ +IG+G YG V+K G +VA+K+ E + L EI+ L +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQL 59
Query: 429 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGI 486
H NLV+L+ + LV+E+ + T+ +L G L SI + + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRY---QRGVPEHLVKSITWQTLQAV 115
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
+ H HRD+K NIL+ K+ DFG +RL P + V T
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP-----SDYYDDEVA--T 165
Query: 547 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
Y PE + DV+++G VF ELL+G P+ GK+
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKS 207
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 44/305 (14%), Positives = 93/305 (30%), Gaps = 46/305 (15%)
Query: 369 EMALATNNFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGEKEFLTEI 422
E L + +G+G + +VY+ + +K + + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 423 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE-----PLGFAMRLS 477
+ L + + +LV E S GTL + ++ P G + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA-----------KVADFGLSRLA 526
+ + I +H + H DIK N +L + F + D G S
Sbjct: 179 MRM--LYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI-- 231
Query: 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586
D++ + T T G+ E + D + + +L G
Sbjct: 232 ---DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM---- 284
Query: 587 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 646
V+ + +F + +F + L + PS+ + ++L
Sbjct: 285 --KVKNEGGECKPEGLFR------RLPHLDMWNEFFHVMLN--IPDCHHLPSLDLLRQKL 334
Query: 647 ESIWN 651
+ ++
Sbjct: 335 KKVFQ 339
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 440
+G+G YG+V + VAVK E + EI L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E Q L E+ S G L D++ P A R L + G++YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHR 129
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
DIK N+LLD + K++DFGL+ + ++ + GT Y+ PE L +
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR----YNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 561 TD--KSDVYSLGVVFLELLTGMQPISHGKNIVRE 592
DV+S G+V +L G P + +E
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT----EIQFLSRLHHRNLVSLV 437
+G+G YGKV + + AVK ++ L+ EIQ L RL H+N++ LV
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 438 GYCDEEGEQM--LVYEFMSNGT--LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
E +Q +V E+ G + D + K + P+ A L G+ YLH++
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLID--GLEYLHSQG 129
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ H+DIK N+LL T K++ G++ + S G+P + PE
Sbjct: 130 ---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RTSQ---GSPAFQPPE 181
Query: 554 YFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNIVR 591
K D++S GV + TG+ P G NI +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYK 220
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-25
Identities = 46/140 (32%), Positives = 63/140 (45%), Gaps = 11/140 (7%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSN 57
+ L +L L+N G +P LS L L LS N L+G+IP G LS + +KL
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWL 451
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NI 116
N L G IP + L+ L + N L+G IPS + LN + NN LT I
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLN-----WISLSNNRLTGEI 506
Query: 117 SGSFNIPPNVTV-RLRGNPF 135
N+ + +L N F
Sbjct: 507 PKWIGRLENLAILKLSNNSF 526
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-24
Identities = 43/142 (30%), Positives = 57/142 (40%), Gaps = 12/142 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRI-PNLGYLDLSSNQLNGSIPP--GRLSL-NITTIKL 55
M L L L G +P+ L+ + +L LDLSSN +G I P + + + L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401
Query: 56 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT- 114
NN TG IP S L L ++ N LSG+IPSS+ L L N L
Sbjct: 402 QNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR-----DLKLWLNMLEG 456
Query: 115 NISGSFNIPPN-VTVRLRGNPF 135
I T+ L N
Sbjct: 457 EIPQELMYVKTLETLILDFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-24
Identities = 36/132 (27%), Positives = 55/132 (41%), Gaps = 15/132 (11%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-GRLSLNITTIKLSNNK 59
+L L++ + G + +SR NL +LD+SSN + IP G S + + +S NK
Sbjct: 177 CGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSNNFSTGIPFLGDCS-ALQHLDISGNK 234
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 119
L+G S L+ L I++N G IP +S L N T G
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQ-------YLSLAENKFT---GE 284
Query: 120 FNIPPNVTVRLR 131
IP ++
Sbjct: 285 --IPDFLSGACD 294
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-24
Identities = 28/118 (23%), Positives = 47/118 (39%), Gaps = 11/118 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPD----LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLS 56
++ L L L S+ G L +L +S N+++G + R N+ + +S
Sbjct: 150 LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV-NLEFLDVS 208
Query: 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
+N + IP LQ L I+ N LSG +I L +L+ +N
Sbjct: 209 SNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELK-----LLNISSNQFV 260
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-23
Identities = 32/133 (24%), Positives = 57/133 (42%), Gaps = 11/133 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP---GRLSLNITTIKLSN 57
++L L++ + GP+P + +L YL L+ N+ G IP G +T + LS
Sbjct: 246 CTELKLLNISSNQFVGPIPP-LPLKSLQYLSLAENKFTGEIPDFLSGACD-TLTGLDLSG 303
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NI 116
N G +P F L+ L +++N+ SG +P +LD N + +
Sbjct: 304 NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL----KMRGLKVLDLSFNEFSGEL 359
Query: 117 SGSF-NIPPNVTV 128
S N+ ++
Sbjct: 360 PESLTNLSASLLT 372
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-23
Identities = 39/150 (26%), Positives = 60/150 (40%), Gaps = 18/150 (12%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSN 57
+ L L L L G +P LS NL ++ LS+N+L G IP GRL N+ +KLSN
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE-NLAILKLSN 523
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
N +G IP+ L L + N +G+IP+++++ N +
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS---------GKIAANFIAG-- 572
Query: 118 GSFNIPPNVTVRLRGNPFCLNTNAEQFCGS 147
+ N +F G
Sbjct: 573 ---KRYVYIKNDGMKKECHGAGNLLEFQGI 599
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-20
Identities = 29/119 (24%), Positives = 48/119 (40%), Gaps = 8/119 (6%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP----GRLSLNITTIKLS 56
++ L L L N + G + +L LDLS N L+G + G S + + +S
Sbjct: 76 LTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS-GLKFLNVS 134
Query: 57 NNKLTGTIP-SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
+N L S L L+ L ++ NS+SG+ S + L N ++
Sbjct: 135 SNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH--LAISGNKIS 191
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-20
Identities = 30/117 (25%), Positives = 53/117 (45%), Gaps = 9/117 (7%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSN 57
+S ++ + G ++ +LD+S N L+G IP G + + + L +
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP-YLFILNLGH 665
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
N ++G+IP L L L +++N L G IP ++ L +D NNNL+
Sbjct: 666 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT-----EIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-19
Identities = 35/127 (27%), Positives = 52/127 (40%), Gaps = 14/127 (11%)
Query: 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSN 57
M K + QG L+R+ +++S G P ++ + +S
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG-SMMFLDMSY 641
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
N L+G IP +P L L + +N +SGSIP + R LN ILD +N L
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN-----ILDLSSNKL---D 693
Query: 118 GSFNIPP 124
G IP
Sbjct: 694 GR--IPQ 698
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-18
Identities = 27/133 (20%), Positives = 55/133 (41%), Gaps = 11/133 (8%)
Query: 2 SKLLKLSLRNCSLQGPM----PDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSN 57
K+ + L + L L + L L LS++ +NGS+ + S ++T++ LS
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109
Query: 58 NKLTGTIPS--NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT- 114
N L+G + + + L+ L +++N+L S L +LD N+++
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG----LKLNSLEVLDLSANSISG 165
Query: 115 NISGSFNIPPNVT 127
+ +
Sbjct: 166 ANVVGWVLSDGCG 178
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 63/218 (28%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK-------------RAQEGSLQGEKEFLTEIQFLSR 427
++G G YG+V + A+K + + +E EI L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 428 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 487
L H N++ L +++ LV EF G L +Q+ + K A + + S GI
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS--GIC 160
Query: 488 YLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544
YLH + HRDIK NILL++K K+ DFGLS +
Sbjct: 161 YLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF--------FSKDYKLRDRL 209
Query: 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
GT Y+ PE L K +K DV+S GV+ LL G P
Sbjct: 210 GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-24
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 435
+G+G + VYK +VA+K+ + G K+ L EI+ L L H N++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
L+ + LV++FM D + + L + + L + +G+ YLH
Sbjct: 77 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ HRD+K +N+LLD K+ADFGL++ P A+ VV T Y PE
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-----NRAYTHQVV--TRWYRAPE 182
Query: 554 YFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
++ D++++G + ELL P G +
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDS 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 434
+ + +G G +G+V+K G +A K + ++ ++E EI +++L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMR--LSIALGSSRGIL 487
L + + + +LV E++ G L D++ +S + + F M+ GI
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-MKQICE-------GIR 201
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
++H + H D+K NIL ++ K+ DFGL+R P V G
Sbjct: 202 HMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--------YKPREKLKVNFG 250
Query: 546 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
TP +L PE ++ +D++S+GV+ LL+G+ P
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 41/211 (19%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 437
+G+G +G V++ + K + + + EI L+ HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-----QVLVKKEISILNIARHRNILHLH 67
Query: 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL----YLHTEA 493
+ E ++++EF+S + ++++ F + + + +LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 494 DPPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ H DI+ NI+ + ++ K+ +FG +R + P ++ P Y
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--------LKPGDNFRLLFTAPEYYA 171
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
PE ++ +D++SLG + LL+G+ P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 23/210 (10%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 439
++G G +G V+ G +K + Q E EI+ L L H N++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEADP 495
++ +V E G L +++ + L + + + Y H++
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN--ALAYFHSQH-- 144
Query: 496 PVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
V H+D+K NIL K+ DFGL+ L ST GT Y+ P
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--------FKSDEHSTNAAGTALYMAP 195
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
E +T K D++S GVV LLTG P
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 438
+G+G +G+V K AVK + S + + L E++ L +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
++ +V E + G L D++ + + A R+ + S GI Y+H +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMHKHN---IV 143
Query: 499 HRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
HRD+K NILL+ K K+ DFGLS GT Y+ PE
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC--------FQQNTKMKDRIGTAYYIAPE-V 194
Query: 556 LTHKLTDKSDVYSLGVVFLELLTGMQP 582
L +K DV+S GV+ LL+G P
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 18/205 (8%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
IG+G +G+V + A K+ + ++ F EI+ + L H N++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
++ + LV E + G L +++ K A R+ + S + Y H V HR
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS--AVAYCHKLN---VAHR 130
Query: 501 DIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 557
D+K N L K+ DFGL+ P + GTP Y+ P+ L
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAAR--------FKPGKMMRTKVGTPYYVSPQ-VLE 181
Query: 558 HKLTDKSDVYSLGVVFLELLTGMQP 582
+ D +S GV+ LL G P
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 440
+G+G YG+V + VAVK E + EI L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E Q L E+ S G L D++ P A R L + G++YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHR 129
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
DIK N+LLD + K++DFGL+ + ++ + GT Y+ PE L +
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR----YNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 561 TD--KSDVYSLGVVFLELLTGMQPISHGKNIVRE 592
DV+S G+V +L G P + +E
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
+G G +G V++ G A K ++ EIQ +S L H LV+L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMR--LSIALGSSRGILYLHTEAD 494
++ E +++YEFMS G L ++++ + E + + MR G+ ++H
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MRQVCK-------GLCHMHENN- 275
Query: 495 PPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
H D+K NI+ K + K+ DFGL+ + P V GT + P
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--------LDPKQSVKVTTGTAEFAAP 325
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
E + +D++S+GV+ LL+G+ P
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 58/220 (26%), Positives = 84/220 (38%), Gaps = 34/220 (15%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK---------RAQEGSLQGEKEFLTEIQFLSRL-HH 430
+G+G V + I P AVK + E + + L E+ L ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILY 488
N++ L + LV++ M G L D L+ K E + ++ I
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL----EVICA 139
Query: 489 LHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 548
LH + HRD+K NILLD K+ DFG S + P V GTP
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--------LDPGEKLREVCGTPS 188
Query: 549 YLDPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
YL PE + D++S GV+ LL G P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRLHHRNLVSLVG 438
+G+G +G+V K AVK + S + + L E++ L +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 496
++ +V E + G L D++ + + E + + GI Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----SGITYMHKHN--- 141
Query: 497 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ HRD+K NILL+ K K+ DFGLS GT Y+ PE
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------FQQNTKMKDRIGTAYYIAPE 193
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
L +K DV+S GV+ LL+G P
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLV 434
++G G + V K G A K R S +G +E E+ L + H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILY 488
+L + + + +L+ E +S G L D L+ K E F ++ L G+ Y
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD-------GVHY 123
Query: 489 LHTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVK 544
LH++ + H D+K NI+L K K+ DFG++ I + +
Sbjct: 124 LHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--------IEAGNEFKNIF 172
Query: 545 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
GTP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 435
+G G + V K G A K R S +G +E E+ L ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 489
L + + +L+ E +S G L D L+ K +E F ++ L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 490 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
HT+ + H D+K NI+L K K+ DFGL+ I + G
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------IEDGVEFKNIFG 180
Query: 546 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF----LTEIQFLSRLH 429
+ ++G+G Y VYKG +VA+K + L+ E+ + E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLK 58
Query: 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 487
H N+V+L E LV+E++ +D Q + RG+
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
Y H V HRD+K N+L++ + K+ADFGL+R +P + + VV T
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-----TKTYDNEVV--TL 164
Query: 548 GYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
Y P+ L + + + D++ +G +F E+ TG +P+ G
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGST 205
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 51/213 (23%), Positives = 80/213 (37%), Gaps = 25/213 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSL 436
IG+G + V + I G AVK S E E L H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL----YLHTE 492
+ +G +V+EFM L ++ ++ ++ ++ R IL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY--MRQILEALRYCHDN 149
Query: 493 ADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
+ HRD+K +LL K K+ FG++ + V GTP +
Sbjct: 150 N---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV------AGGRV-GTPHF 199
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
+ PE DV+ GV+ LL+G P
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 32/240 (13%), Positives = 63/240 (26%), Gaps = 49/240 (20%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRL---------- 428
+GQ + G V + K+ E+ L L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 429 ------------HHRNLVSLVGYCDEEGEQMLVYEF-------MSNGTLRDQLSAKSK-- 467
++ +E + ++ F + T + L + S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 468 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527
+ L RL + L R + LH + H ++ +I+LD + + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259
Query: 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-----LTDKSDVYSLGVVFLELLTGMQP 582
+G P + +T D ++LG+ + P
Sbjct: 260 ---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 438
++G+G + V + + G A K L ++ E + +L H N+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 496
EE LV++ ++ G L + + A+ E I I Y H+
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG--- 125
Query: 497 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ HR++K N+LL K K+ADFGL+ + + GTPGYL PE
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--------VNDSEAWHGFAGTPGYLSPE 177
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
+ D+++ GV+ LL G P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 57/250 (22%), Positives = 98/250 (39%), Gaps = 36/250 (14%)
Query: 348 RRRHSSKTSIKIDGVRSFTYGEMALATNNFN-SSTQIGQGGYGKVYKGI-LPDGTVVAVK 405
HSS + + + + N + +S ++G+G + V + I G A K
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENF---NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 406 --RAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL 462
+ + E L EI L +++L + E +L+ E+ + G +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 463 SAKSKEPLG-----FAMR--LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 515
+ E + ++ L G+ YLH + H D+K NILL +
Sbjct: 121 LPELAEMVSENDVIRLIKQILE-------GVYYLHQNN---IVHLDLKPQNILLSSIYPL 170
Query: 516 ---KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 572
K+ DFG+SR I A + GTP YL PE +T +D++++G++
Sbjct: 171 GDIKIVDFGMSRK--------IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 573 FLELLTGMQP 582
LLT P
Sbjct: 223 AYMLLTHTSP 232
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 38/282 (13%), Positives = 72/282 (25%), Gaps = 74/282 (26%)
Query: 349 RRHSSKTSIKIDGVRSFTY--GEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK 405
G R T G + +GQ + G V
Sbjct: 57 NTGQPFRVESELGERPRTLVRGTV------------LGQEDPYAYLEATDQETGESFEVH 104
Query: 406 ------RAQEGSLQGEKE----------------------FLTEIQFLSRLHHRNLVSLV 437
R +++ KE F+ + + ++ +
Sbjct: 105 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164
Query: 438 GYCDEEGEQMLVYEFM----SNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHT 491
+ + + + T + L + S + L RL + L R + LH
Sbjct: 165 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ H ++ +I+LD + + F V V + G+
Sbjct: 225 YG---LVHTYLRPVDIVLDQRGGVFLTGFEHL-----------VRDGARVVSSVSRGFEP 270
Query: 552 PEYFLTHKL-----------TDKSDVYSLGVVFLELLTGMQP 582
PE T D ++LG+V + P
Sbjct: 271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/233 (27%), Positives = 94/233 (40%), Gaps = 33/233 (14%)
Query: 373 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT--------EIQ 423
AT+ + +IG G YG VYK G VA+K + + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVA 63
Query: 424 FLSRLH---HRNLVSLV-----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR 475
L RL H N+V L+ D E + LV+E + LR L L
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 476 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535
+ RG+ +LH + HRD+K NIL+ T K+ADFGL+R+
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ------ 173
Query: 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
A VV T Y PE L D++S+G +F E+ +P+ G +
Sbjct: 174 MALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPLFCGNS 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 54/224 (24%), Positives = 86/224 (38%), Gaps = 33/224 (14%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLHHRN 432
+G G G+V VA++ TEI+ L +L+H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 490
++ + + D E + +V E M G L D++ + E + L + YLH
Sbjct: 202 IIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLH 256
Query: 491 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
+ HRD+K N+LL + K+ DFG S++ + + + GTP
Sbjct: 257 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--------LGETSLMRTLCGTP 305
Query: 548 GYLDPE---YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
YL PE T D +SLGV+ L+G P S +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 65/233 (27%), Positives = 92/233 (39%), Gaps = 47/233 (20%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK----------------------RAQEGSLQGEKEFL 419
IG+G YG V D T A+K R G + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 420 T----EIQFLSRLHHRNLVSL--VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLGF 472
EI L +L H N+V L V E +V+E ++ G + + + K E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ-- 138
Query: 473 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532
A L GI YLH + + HRDIK SN+L+ K+ADFG+S D
Sbjct: 139 ARFYFQDLIK--GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-- 191
Query: 533 GIVPAHVSTVVKGTPGYLDPEYFL-THKLTD--KSDVYSLGVVFLELLTGMQP 582
A +S V GTP ++ PE T K+ DV+++GV + G P
Sbjct: 192 ----ALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 435
+G G + V K G A K R + S +G ++ E+ L + H N+++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 489
L + + + +L+ E ++ G L D L+ K +E F ++ L+ G+ YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILN-------GVYYL 130
Query: 490 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
H+ + H D+K NI+L + K+ DFGL+ I + + G
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--------IDFGNEFKNIFG 179
Query: 546 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 5e-23
Identities = 69/254 (27%), Positives = 109/254 (42%), Gaps = 34/254 (13%)
Query: 382 QIGQGGYGKVYKGI---LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
++G+G YG VYK D A+K+ + + EI L L H N++SL
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 439 YCDEEGEQ--MLVYEFMSN------GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
++ L++++ + R + K L M S+ GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 491 TEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
V HRD+K +NIL+ + K+AD G +RL P + VV T
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL--KPLADLDPVVV--T 198
Query: 547 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAY---QSSMM 602
Y PE L + K+ D++++G +F ELLT +PI H + + + Y Q +
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHHDQLDRI 257
Query: 603 FSVIDGNMGSYPSE 616
F+V MG P++
Sbjct: 258 FNV----MGF-PAD 266
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 435
+G G + V K G A K R S +G +E E+ L ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 489
L + + +L+ E +S G L D L+ K +E F ++ L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 490 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
HT+ + H D+K NI+L K K+ DFGL+ I + G
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------IEDGVEFKNIFG 180
Query: 546 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-23
Identities = 26/141 (18%), Positives = 55/141 (39%), Gaps = 11/141 (7%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSN 57
+ L+ L + + + + + +L L ++ N + P + N+T + LS
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
+L P+ F+ L LQ L +++N+ +L +LD+ N++
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ-----VLDYSLNHIMTSK 534
Query: 118 GS--FNIPPN-VTVRLRGNPF 135
+ P + + L N F
Sbjct: 535 KQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-19
Identities = 28/138 (20%), Positives = 48/138 (34%), Gaps = 10/138 (7%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNN 58
+ L L L + + + L +LD + L N+ + +S+
Sbjct: 372 TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFILDFQNNNLTNIS 117
F+GL L+ L +A NS + I+ R L LD L +S
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT-----FLDLSQCQLEQLS 486
Query: 118 -GSFNIPPNVTV-RLRGN 133
+FN ++ V + N
Sbjct: 487 PTAFNSLSSLQVLNMSHN 504
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-19
Identities = 31/141 (21%), Positives = 50/141 (35%), Gaps = 12/141 (8%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSN 57
L L L+ P L LDLS ++ LS +++T+ L+
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS-HLSTLILTG 85
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT--N 115
N + FSGL LQ+L +L+ I +TL L+ +N +
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK-----ELNVAHNLIQSFK 140
Query: 116 ISGSFNIPPN-VTVRLRGNPF 135
+ F+ N + L N
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKI 161
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-17
Identities = 31/154 (20%), Positives = 54/154 (35%), Gaps = 7/154 (4%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSN 57
+S L L L +Q + S + +L L L G L + + +++
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK-TLKELNVAH 133
Query: 58 NKLTGT-IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N + +P FS L L+ L +++N + + + + LD N + I
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS-LDLSLNPMNFI 192
Query: 117 S-GSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHS 149
G+F + LR N LN G
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAG 226
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 17/113 (15%), Positives = 38/113 (33%), Gaps = 4/113 (3%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNN 58
+ L L L C L+ P + + +L L++S N L ++ + S N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
Query: 59 KLTGTIPSNFSGLPR-LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 110
+ + P L L + N + + + + +++ +
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCE-HQSFLQWIKDQRQLLVEVER 580
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 20/117 (17%), Positives = 39/117 (33%), Gaps = 10/117 (8%)
Query: 19 PDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78
P + +PN+ IP L + + LS N L +F P LQ L
Sbjct: 2 PCVEVVPNI-TYQCMELNFY-KIPDN-LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLD 58
Query: 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 133
++ + + L+ L N + +++ G+F+ ++
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLS-----TLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 22/132 (16%), Positives = 42/132 (31%), Gaps = 8/132 (6%)
Query: 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGY----LDLSSNQLNGSIPPGRLSLNITTIKL 55
++ L L L + +Q DL + + LDLS N +N P + + + L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207
Query: 56 SNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
NN + + GL L+ + + L L + L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN--LTIEEFRLA 265
Query: 115 NISGSFNIPPNV 126
+ + ++
Sbjct: 266 YLDYYLDDIIDL 277
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 26/139 (18%), Positives = 52/139 (37%), Gaps = 29/139 (20%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL------------ 48
++ + SL + +++ + D S +L+L + + SL
Sbjct: 281 LTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
Query: 49 --------NITTIKLSNNKLT--GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 98
++ + LS N L+ G + G L+ L ++ N + + S+ L
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQL 398
Query: 99 NATETFILDFQNNNLTNIS 117
LDFQ++NL +S
Sbjct: 399 E-----HLDFQHSNLKQMS 412
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 25/167 (14%), Positives = 52/167 (31%), Gaps = 28/167 (16%)
Query: 5 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT--- 61
+L+ + L + + + N+ L S + + + ++L N K
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFP 320
Query: 62 ----------------GTIPSNFSGLPRLQRLFIANNSLS--GSIPSSIWQSRTLNATET 103
G + LP L+ L ++ N LS G S + + +L
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK---- 376
Query: 104 FILDFQNNNLTNISGSFNIPPN-VTVRLRGNPFCLNTNAEQFCGSHS 149
LD N + +S +F + + + + F +
Sbjct: 377 -YLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 15/130 (11%), Positives = 33/130 (25%), Gaps = 19/130 (14%)
Query: 3 KLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLSL----NITTIKLS 56
+L KL+LRN + + + L L + + + + +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 57 NNKLT------GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 110
+L I F+ L + + + ++ S L+ N
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS-------YNFGWQHLELVN 313
Query: 111 NNLTNISGSF 120
Sbjct: 314 CKFGQFPTLK 323
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 13/77 (16%), Positives = 27/77 (35%), Gaps = 5/77 (6%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIP-NLGYLDLSSNQLNGSIPPGRLSLNI---TTIKL 55
++ L L + L P +L +L+L+ N + I + +
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLV 576
Query: 56 SNNKLTGTIPSNFSGLP 72
++ PS+ G+P
Sbjct: 577 EVERMECATPSDKQGMP 593
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 29/226 (12%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRL 428
+ + T++G+G YG+VYK I VA+KR + L+ E+E + E+ L L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKEL 90
Query: 429 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 488
HRN++ L L++E+ N L+ + + + S G+ +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLINGVNF 147
Query: 489 LHTEADPPVFHRDIKASNILLDHKFTA-----KVADFGLSRLAPVPDIEGIVPAHVSTVV 543
H HRD+K N+LL + K+ DFGL+R +P + ++
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-----IRQFTHEII 199
Query: 544 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
T Y PE L + S D++S+ ++ E+L P+ G +
Sbjct: 200 --TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDS 242
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 31/254 (12%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 440
+G+G + +V I L AVK ++ E++ L + HRN++ L+ +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+EE LV+E M G++ + + E A + + S + +LH +
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELE----ASVVVQDVAS--ALDFLH---NKG 131
Query: 497 VFHRDIKASNILLDHK---FTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ HRD+K NIL +H K+ DF L + D I + T G+ Y+ P
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAP 190
Query: 553 EYFLTHKLTDKS-----DVYSLGVVFLELLTGMQP-----ISHGKNIVREVNIAYQSSMM 602
E D++SLGV+ LL+G P S E A Q+ +
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 603 FSVIDGNMGSYPSE 616
S+ +G +P +
Sbjct: 251 ESIQEGKY-EFPDK 263
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 60/266 (22%), Positives = 107/266 (40%), Gaps = 44/266 (16%)
Query: 348 RRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQ---------IGQGGYGKVYKGILPD 398
++ +K++ + LA++ + IG G +G V++ L +
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 399 GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL------VGYCDEEGEQMLVYEF 452
VA+K+ LQ ++ E+Q + + H N+V L G +E LV E+
Sbjct: 64 SDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIKASN 506
+ T+ +K + + L R + Y+H+ + HRDIK N
Sbjct: 120 VPE-TVYRASRHYAKLK----QTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQN 171
Query: 507 ILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKS 564
+LLD K+ DFG ++ + +VS + + Y PE T
Sbjct: 172 LLLDPPSGVLKLIDFGSAK-ILIAG-----EPNVSYIC--SRYYRAPELIFGATNYTTNI 223
Query: 565 DVYSLGVVFLELLTGMQPISHGKNIV 590
D++S G V EL+ G QP+ G++ +
Sbjct: 224 DIWSTGCVMAELMQG-QPLFPGESGI 248
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-23
Identities = 65/229 (28%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 375 NNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSR 427
+ +IG+G YGKV+K + G VA+KR + +Q +E + E+ L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 428 LH---HRNLVSL-----VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 479
L H N+V L V D E + LV+E + L L + + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
RG+ +LH+ V HRD+K NIL+ K+ADFGL+R+ A
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ------MALT 177
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
S VV T Y PE L D++S+G +F E+ +P+ G +
Sbjct: 178 SVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSS 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-23
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 35/220 (15%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLH-HR 431
IG+G V + + G AVK + E + + E L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYL 489
++++L+ + LV++ M G L D L+ K E ++ S+ + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL----EAVSFL 216
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV-STVVKGTPG 548
H + HRD+K NILLD +++DFG S + P + GTPG
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--------LEPGEKLRELC-GTPG 264
Query: 549 YLDPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
YL PE + D+++ GV+ LL G P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 67/269 (24%), Positives = 109/269 (40%), Gaps = 46/269 (17%)
Query: 347 SRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQ----------IGQGGYGKVYKGIL 396
++ S+ S+K+ + + +AT IG G +G VY+ L
Sbjct: 16 PVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKL 75
Query: 397 -PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM------LV 449
G +VA+K+ LQ ++ E+Q + +L H N+V L + GE+ LV
Sbjct: 76 CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIK 503
+++ + + ++ L + R + Y+H+ + HRDIK
Sbjct: 132 LDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIK 183
Query: 504 ASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-T 561
N+LLD K+ DFG ++ V +VS + + Y PE T
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAK-QLVRG-----EPNVSYIC--SRYYRAPELIFGATDYT 235
Query: 562 DKSDVYSLGVVFLELLTGMQPISHGKNIV 590
DV+S G V ELL G QPI G + V
Sbjct: 236 SSIDVWSAGCVLAELLLG-QPIFPGDSGV 263
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 47/214 (21%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL--VG 438
+G+G Y +V++ I + + V VK + +K+ EI+ L L N+++L +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADPP 496
LV+E ++N + + + F M L + + Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------KALDYCHSMG--- 150
Query: 497 VFHRDIKASNILLDHKFTA-KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
+ HRD+K N+++DH+ ++ D+GL+ P V + + PE
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAE--------FYHPGQEYNVRVASRYFKGPELL 202
Query: 556 LTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 588
+ +++ D S D++SLG + ++ +P HG +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G G +GKV G G VAVK R + SL + EIQ L H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ +V E++S G L D + + A RL + S + Y H V
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS--AVDYCHRHM---VV 133
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRD+K N+LLD AK+ADFGLS + + T G+P Y PE ++
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDG------EFLRTSC-GSPNYAAPE-VISG 184
Query: 559 KLTD--KSDVYSLGVVFLELLTGMQP 582
+L + D++S GV+ LL G P
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 38/228 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLH----HR 431
+G+GG+G V+ G L D VA+K L E+ L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGT-LRDQLSAKSK--EPLG---FAMRLSIALGSSRG 485
++ L+ + + + MLV E L D ++ K E F ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-------A 151
Query: 486 ILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544
I + H+ V HRDIK NIL+D + AK+ DFG L +
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--------DEPYTDFD- 199
Query: 545 GTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVR 591
GT Y PE+ H+ + V+SLG++ +++ G P + I+
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE 247
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 73/270 (27%), Positives = 113/270 (41%), Gaps = 36/270 (13%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
IG+G + KV + G VA+K + Q +K F E++ + L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ E L+ E+ S G + D L A + A + S + Y H + +
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--AVQYCHQKR---IV 136
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRD+KA N+LLD K+ADFG S + G P Y PE F
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNE-FTVG------GKLDAFC-GAPPYAAPELFQ-G 187
Query: 559 KLTD--KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN--MGSYP 614
K D + DV+SLGV+ L++G P G+N+ + V+ G + Y
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNL---------KELRERVLRGKYRIPFYM 237
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMR 644
S E +K L R ++ ++M+
Sbjct: 238 STDCENLLKRFL---VLNPIKRGTLEQIMK 264
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 26/221 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLHHR--NL 433
+G GG+G VY GI + D VA+K + G L E+ L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 434 VSLVGYCDEEGEQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+ L+ + + +L+ E L D ++ + A + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE--AVRHCHNC 168
Query: 493 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
V HRDIK NIL+D ++ K+ DFG L + GT Y
Sbjct: 169 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--------DTVYTDFD-GTRVYSP 216
Query: 552 PEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVR 591
PE+ H+ + V+SLG++ +++ G P H + I+R
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 257
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 438
++G+G + V + + G A K L ++ E + +L H N+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 496
EE LV++ ++ G L + + A+ E I I Y H+
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG--- 148
Query: 497 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ HR++K N+LL K K+ADFGL+ + + GTPGYL PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--------VNDSEAWHGFAGTPGYLSPE 200
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
+ D+++ GV+ LL G P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 45/242 (18%), Positives = 83/242 (34%), Gaps = 25/242 (10%)
Query: 411 SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEP 469
S +I+ + +N V + + + + L+D ++ S E
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 470 LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR----- 524
+ L I + + + +LH++ + HRD+K SNI KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 525 --LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
V H V GT Y+ PE + + K D++SLG++ ELL
Sbjct: 218 EEEQTVLTPMPAYATHTGQV--GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
Query: 583 ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEV 642
I+ +V + ++ + + RP +++
Sbjct: 276 QMERVRIITDVR------------NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
Query: 643 MR 644
+
Sbjct: 324 IE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 17/83 (20%), Positives = 33/83 (39%), Gaps = 2/83 (2%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRN 432
+F +G+GG+G V++ D A+KR ++ + E++ L++L H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 433 LVSLVGYCDEEGEQMLVYEFMSN 455
+V E + E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEI 88
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 36/217 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLT---EIQFLSRLHHRNL 433
+G G +G V+ + V VK + E + + EI LSR+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGT-LRDQLSAKSK--EPLG---FAMRLSIALGSSRGIL 487
+ ++ + +G LV E +G L + + EPL F +S +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS-------AVG 144
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
YL + + HRDIK NI++ FT K+ DFG + T GT
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERG------KLFYTFC-GTI 193
Query: 548 GYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQP 582
Y PE L + +++SLGV L+ P
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 33/218 (15%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLHHRN 432
+G G G+V VA+K TEI+ L +L+H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 490
++ + + D E + +V E M G L D++ + E + L + YLH
Sbjct: 77 IIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLH 131
Query: 491 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
+ HRD+K N+LL + K+ DFG S++ + + + GTP
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--------LGETSLMRTLCGTP 180
Query: 548 GYLDPE---YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
YL PE T D +SLGV+ L+G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-22
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 22/209 (10%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVG 438
++G+G + V + + + G A L ++ E + L H N+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 496
EEG L+++ ++ G L + + A+ E I +L+ H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----EAVLHCHQMG--- 130
Query: 497 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
V HR++K N+LL K K+ADFGL+ GTPGYL PE
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ------QAWFGFA-GTPGYLSPE 183
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
D+++ GV+ LL G P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 49/214 (22%), Positives = 79/214 (36%), Gaps = 36/214 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 439
+G G GKV + G A+K L + E+ + ++V ++ Y
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALK-----LLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 440 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPL-----GFAMRLSIALGSSRGILYLHT 491
+ + + E M G L ++ + + MR I I +LH+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR-DIG----TAIQFLHS 146
Query: 492 EADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 548
+ HRD+K N+L K K+ DFG ++ + T TP
Sbjct: 147 HN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--------TTQNALQTPC-YTPY 194
Query: 549 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
Y+ PE K D++SLGV+ LL G P
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-21
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G G +GKV G G VAVK R + SL + EIQ L H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ +V E++S G L D + + + RL + S G+ Y H V
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYCHRHM---VV 138
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRD+K N+LLD AK+ADFGLS + + T G+P Y PE ++
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDG------EFLRTSC-GSPNYAAPE-VISG 189
Query: 559 KLTD--KSDVYSLGVVFLELLTGMQP 582
+L + D++S GV+ LL G P
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 34/213 (15%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL 436
+G+G + K + AVK + E + Q EI L H N+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVKL 71
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTE 492
++ LV E ++ G L +++ K E A + L S + ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE----ASYIMRKLVS--AVSHMHDV 125
Query: 493 ADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
V HRD+K N+L + K+ DFG +RL P + + T T Y
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN------QPLKTPC-FTLHY 175
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
PE + + D++SLGV+ +L+G P
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 63/237 (26%), Positives = 98/237 (41%), Gaps = 40/237 (16%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEF----LTEIQFLSRL 428
+ F GQG +G V G G VA+K+ +Q + F L +Q L+ L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQ-DPRFRNRELQIMQDLAVL 76
Query: 429 HHRNLVSLVGYCDEEGEQ-------MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 481
HH N+V L Y GE+ +V E++ D L + + L
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILI 131
Query: 482 SS------RGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGI 534
R I LH + V HRDIK N+L++ T K+ DFG ++ P
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPS---- 185
Query: 535 VPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIV 590
+V+ + + Y PE ++ T D++S+G +F E++ G +PI G N
Sbjct: 186 -EPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSA 238
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAV----KRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
++G+G VY+ A+ K + ++ TEI L RL H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR------TEIGVLLRLSHPNIIKL 113
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEAD 494
+ E LV E ++ G L D++ K E I + YLH
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL----EAVAYLHENG- 168
Query: 495 PPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ HRD+K N+L K+ADFGLS++ + + V GTPGY
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--------VEHQVLMKTVCGTPGYCA 218
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
PE + D++S+G++ LL G +P
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY 439
IG G Y + I AVK + +E I+ L R H N+++L
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKDV 84
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEADP 495
D+ +V E M G L D++ + F A + + + YLH +
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKF----FSEREASAVLFTITK--TVEYLHAQG-- 136
Query: 496 PVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
V HRD+K SNIL + + ++ DFG ++ + + T T ++
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN------GLLMTPC-YTANFVA 188
Query: 552 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
PE L + D + D++SLGV+ +LTG P
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 29/140 (20%), Positives = 51/140 (36%), Gaps = 10/140 (7%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSN 57
+ KLL L + + + + +L L ++ N + + N+T + LS
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI- 116
+L F L RLQ L +++N+L S Q +L+ LD N +
Sbjct: 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS-----TLDCSFNRIETSK 537
Query: 117 SGSFNIPPN-VTVRLRGNPF 135
+ P + L N
Sbjct: 538 GILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-18
Identities = 27/137 (19%), Positives = 44/137 (32%), Gaps = 8/137 (5%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNN 58
+ L L L + + L +LD + L + + +S
Sbjct: 375 TNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS- 117
F GL L L +A NS + S+++ N T LD L IS
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA----NTTNLTFLDLSKCQLEQISW 490
Query: 118 GSFNIPPNVTV-RLRGN 133
G F+ + + + N
Sbjct: 491 GVFDTLHRLQLLNMSHN 507
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 38/167 (22%), Positives = 62/167 (37%), Gaps = 13/167 (7%)
Query: 2 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNN 58
S + L L+ S L +LDLS ++ +I +++ + L+ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TIEDKAWHGLHHLSNLILTGN 90
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS- 117
+ P +FSGL L+ L L+ I Q TL L+ +N + +
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK-----KLNVAHNFIHSCKL 145
Query: 118 -GSFNIPPN-VTVRLRGNPF-CLNTNAEQFCGSHSDDDNEIDRSTNS 161
F+ N V V L N + N QF + + +D S N
Sbjct: 146 PAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-15
Identities = 31/170 (18%), Positives = 56/170 (32%), Gaps = 14/170 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ + +SL S++ + D+ + L + QL P L + ++ L+ NK
Sbjct: 284 LANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLK-QFPTLDLP-FLKSLTLTMNKG 340
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
+ I LP L L ++ N+LS S S T + LD N +S +F
Sbjct: 341 S--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH---LDLSFNGAIIMSANF 395
Query: 121 NIPPN-VTVRLRGNPFCLNTNAEQFCGSHS----D-DDNEIDRSTNSTLD 164
+ + + T F D +
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-14
Identities = 19/113 (16%), Positives = 43/113 (38%), Gaps = 5/113 (4%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 57
+ L L L C L+ + L L++S N L + + +++T+ S
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL-FLDSSHYNQLYSLSTLDCSF 530
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 110
N++ + L + NNS++ I + + + F+++ +
Sbjct: 531 NRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQ 582
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 22/119 (18%), Positives = 41/119 (34%), Gaps = 10/119 (8%)
Query: 17 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 76
P + +PN+ +L+ +P + + I LS N L +FS LQ
Sbjct: 4 LNPCIEVVPNI-TYQCMDQKLS-KVPDD-IPSSTKNIDLSFNPLKILKSYSFSNFSELQW 60
Query: 77 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 133
L ++ + + L+ L N + + S GSF+ ++
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLS-----NLILTGNPIQSFSPGSFSGLTSLENLVAVET 114
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 24/139 (17%), Positives = 47/139 (33%), Gaps = 14/139 (10%)
Query: 1 MSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNGSIPPG------RLSLNITT 52
+ L KL++ + + S + NL ++DLS N + +I +
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQFLRENPQVNLS 185
Query: 53 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 112
+ +S N + F G+ +L L + N S +I + Q N +
Sbjct: 186 LDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQ----NLAGLHVHRLILGE 240
Query: 113 LTNISGSFNIPPNVTVRLR 131
+ P++ L
Sbjct: 241 FKDERNLEIFEPSIMEGLC 259
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 17/129 (13%), Positives = 32/129 (24%), Gaps = 18/129 (13%)
Query: 3 KLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNG-----SIPPGRL----SLNIT 51
KL +L+LR + L + L L + P + + I
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264
Query: 52 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 111
+L+ F L + + +A S+ + + L
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQ------SLSIIRC 317
Query: 112 NLTNISGSF 120
L
Sbjct: 318 QLKQFPTLD 326
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 13/142 (9%), Positives = 30/142 (21%), Gaps = 15/142 (10%)
Query: 4 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG--------RLSLNITTIKL 55
L L + + + L L L N + +I + I
Sbjct: 183 NLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242
Query: 56 SNNKLTGTIPSNFSGLPRLQRLFI--ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 113
L PS GL + + ++ + ++
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVS-----AMSLAGVSI 297
Query: 114 TNISGSFNIPPNVTVRLRGNPF 135
+ ++ +
Sbjct: 298 KYLEDVPKHFKWQSLSIIRCQL 319
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 67/344 (19%), Positives = 113/344 (32%), Gaps = 95/344 (27%)
Query: 382 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNL 433
+G+G +G+V + VAVK +EG+ E + ++E++ L + HH N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 434 VSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR----------------- 475
V+L+G C G M++ EF G L L +K E + + +
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 476 --------------LSIALGSSRGILYLHTEADPPVFHRDIKASNILL------------ 509
S + + + E P ++D L+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 510 ------------------DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
K K+ DFGL+R DI V+ L
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIY-----KDPDYVRKGDARLP 258
Query: 552 -----PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 605
PE T +SDV+S GV+ E+ + G P + +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---------GVKIDEEFCRRL 309
Query: 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+G P + + L C E RP+ SE++ L ++
Sbjct: 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 32/233 (13%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 430
+ + IG G G V VA+K+ + K E+ + ++H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 431 RNLVSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALG 481
+N++ L V + E+ +V E M ++ +L + L + M
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML------ 137
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 541
GI +LH+ A + HRD+K SNI++ T K+ DFGL+R + + T
Sbjct: 138 --CGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTSFMMT 184
Query: 542 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 594
T Y PE L + D++S+G + E++ G + G + + + N
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWN 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 6e-20
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 430
+ F +G+GG+G+V+ + G + A K+ + L+ K + + E + L+++H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 431 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSS 483
R +VSL Y E + LV M+ G +R + ++ GF + I G
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
+ +LH + +RD+K N+LLD +++D GL+ E +
Sbjct: 302 --LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV-------ELKAGQTKTKGY 349
Query: 544 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
GTPG++ PE L + D ++LGV E++ P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 60/271 (22%), Positives = 91/271 (33%), Gaps = 45/271 (16%)
Query: 383 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE-----------KEFLTEIQFLSRLHHR 431
I G YG V G+ +G VA+KR G K L EI+ L+ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 432 NLVSLV-----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 486
N++ L + LV E M T Q+ + + G+
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 487 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST--VVK 544
LH A V HRD+ NILL + DF L+R T V
Sbjct: 148 HVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAR--------EDTADANKTHYVT- 195
Query: 545 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603
Y PE + K K D++S G V E+ + + G Q + +
Sbjct: 196 -HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYN------QLNKIV 247
Query: 604 SVI----DGNMGSYPSECVEKFIKLALKCCQ 630
V+ ++ + S +++ +L
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 21/206 (10%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G+G +GKV VA+K R EI +L L H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ ++V E+ + G L D + K + R + I Y H +
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC--AIEYCHRHK---IV 130
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRD+K N+LLD K+ADFGLS + + T G+P Y PE +
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNI-MTDG------NFLKTSC-GSPNYAAPE-VING 181
Query: 559 KLTD--KSDVYSLGVVFLELLTGMQP 582
KL + DV+S G+V +L G P
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 20/205 (9%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
IG G +G +VAVK + G+ E EI L H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPNIVRFKEVIL 86
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
++ E+ S G L +++ + A L S G+ Y H+ + HRD
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS--GVSYCHSMQ---ICHRD 141
Query: 502 IKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 559
+K N LLD K+ DFG S+ V + + V GTP Y+ PE L +
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKS-SVLH------SQPKSTV-GTPAYIAPE-VLLRQ 192
Query: 560 LTD--KSDVYSLGVVFLELLTGMQP 582
D +DV+S GV +L G P
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 35/214 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 439
+G G GKV + A+K LQ + E++ R ++V +V Y
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 440 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPL-----GFAMRLSIALGSSRGILYLHT 491
+ + + E + G L ++ + + M+ SI I YLH+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-SIG----EAIQYLHS 179
Query: 492 EADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 548
+ HRD+K N+L K K+ DFG ++ + ++T TP
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-------LTTPC-YTPY 228
Query: 549 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
Y+ PE K D++SLGV+ LL G P
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 45/267 (16%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 430
+ S T +G G YG V I G VA+K+ S K E+ L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 431 RNLVSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALG 481
N++ L V LV FM + + S + + L + M
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML------ 136
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 541
+G+ Y+H+ A V HRD+K N+ ++ K+ DFGL+R A ++ G V
Sbjct: 137 --KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYV------ 184
Query: 542 VVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 600
T Y PE L+ +++ D++S+G + E+LTG + + GK+ + Q +
Sbjct: 185 ---VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLD------QLT 234
Query: 601 MMFSVI----DGNMGSYPSECVEKFIK 623
+ V + + + +I+
Sbjct: 235 QILKVTGVPGTEFVQKLNDKAAKSYIQ 261
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 9e-19
Identities = 57/264 (21%), Positives = 104/264 (39%), Gaps = 32/264 (12%)
Query: 339 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LP 397
+ I++ + SK+ + + + IG G G V
Sbjct: 26 KQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAV 85
Query: 398 DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--VGYCDEEGEQM----LV 449
VA+K+ + K E+ + ++H+N++SL V + E+ LV
Sbjct: 86 LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 450 YEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 506
E M ++ +L + L + M GI +LH+ A + HRD+K SN
Sbjct: 146 MELMDANLCQVIQMELDHERMSYLLYQML--------CGIKHLHS-AG--IIHRDLKPSN 194
Query: 507 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 566
I++ T K+ DFGL+R A + + T T Y PE L + D+
Sbjct: 195 IVVKSDCTLKILDFGLARTAG--------TSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 567 YSLGVVFLELLTGMQPISHGKNIV 590
+S+G + E++ + + G++ +
Sbjct: 247 WSVGCIMGEMVRH-KILFPGRDYI 269
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 64/268 (23%), Positives = 104/268 (38%), Gaps = 61/268 (22%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV--- 437
+G+G YG V P G +VA+K+ + L EI+ L H N++++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 438 --GYCDEEGEQMLVYEFM--------SNGTLRD--------QLSAKSKEPLGFAMRLSIA 479
+ E ++ E M S L D Q
Sbjct: 79 RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT----------------- 121
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
L R + LH ++ V HRD+K SN+L++ KV DFGL+R+ + P
Sbjct: 122 L---RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 540 STVVKG---TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNI 595
+ + T Y PE LT ++ DV+S G + EL +PI G++
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRH---- 230
Query: 596 AYQSSMMFSVIDGNMGSYPSECVEKFIK 623
Q ++F +I G+ S+ + I+
Sbjct: 231 --QLLLIFGII----GTPHSDNDLRCIE 252
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 26/139 (18%), Positives = 51/139 (36%), Gaps = 22/139 (15%)
Query: 1 MSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNG-------SIPPGRLSL-NI 50
++ LS + L+ + D + + +D S N++ + P N+
Sbjct: 376 TEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 51 TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG-------SIPSSIWQSRTLNATET 103
++I LSNN+++ FS L + + N L+ + + L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT---- 491
Query: 104 FILDFQNNNLTNISGSFNI 122
+D + N LT +S F
Sbjct: 492 -SIDLRFNKLTKLSDDFRA 509
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-17
Identities = 25/148 (16%), Positives = 48/148 (32%), Gaps = 19/148 (12%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQL--------NGSIPPGRLSL-NI 50
+ L + + NC +P L +P + ++++ N+ + I
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
Query: 51 TTIKLSNNKL-TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 109
I + N L T + ++ + +L L N L G +P + L L+
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLA-----SLNLA 361
Query: 110 NNNLTNI-SGSFNIPPNVTV-RLRGNPF 135
N +T I + V N
Sbjct: 362 YNQITEIPANFCGFTEQVENLSFAHNKL 389
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-16
Identities = 27/146 (18%), Positives = 55/146 (37%), Gaps = 20/146 (13%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNN 58
M KL L L+G +P L L+L+ NQ+ IP + + ++N
Sbjct: 329 MKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHN 387
Query: 59 KLTGTIPSNFS--GLPRLQRLFIANNSLSG-------SIPSSIWQSRTLNATETFILDFQ 109
KL IP+ F + + + + N + + + ++ ++ ++
Sbjct: 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS-----SINLS 441
Query: 110 NNNLT-NISGSFNIPPNVTV-RLRGN 133
NN ++ F+ ++ L GN
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGN 467
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 8e-16
Identities = 9/127 (7%), Positives = 33/127 (25%), Gaps = 9/127 (7%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
K ++ + ++ + R+ L + ++ +
Sbjct: 182 TLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENE----NSEYAQQ 237
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
T + L L + + N +P+ + + +++ N +
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ-----LINVACNRGISGEQLK 292
Query: 121 NIPPNVT 127
+ +
Sbjct: 293 DDWQALA 299
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 27/144 (18%), Positives = 48/144 (33%), Gaps = 20/144 (13%)
Query: 1 MSKLLKLSLRNCSLQGPMPDL--SRIPNLGYLDLSSNQLNGSIPP--GRLS----LNITT 52
L + LR L D + +P L +DLS N + P S I
Sbjct: 487 TYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545
Query: 53 IK-LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 111
+ N+ P + P L +L I +N + + I + ++ +LD ++N
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPN--IS-----VLDIKDN 597
Query: 112 NLT--NISGSFNIPPNVTVRLRGN 133
++S L +
Sbjct: 598 PNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 23/128 (17%), Positives = 44/128 (34%), Gaps = 13/128 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIP---PGRLSLNIT--TIK 54
++ LSL G +PD + ++ L L L S+ + P +S N++ +
Sbjct: 80 NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQ 139
Query: 55 LSNNKLTGTIPSNFSGL--PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 112
T L + I ++ SI S + + +NN
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT-----QIGQLSNN 194
Query: 113 LTNISGSF 120
+T +S +
Sbjct: 195 ITFVSKAV 202
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 14/92 (15%), Positives = 28/92 (30%), Gaps = 9/92 (9%)
Query: 1 MSKLLKLSLRNC------SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTI 53
S L +RN P+ ++ P+L L + SN + + NI+ +
Sbjct: 535 SSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP-NISVL 592
Query: 54 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 85
+ +N S + +
Sbjct: 593 DIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 13/115 (11%), Positives = 37/115 (32%), Gaps = 4/115 (3%)
Query: 49 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 108
+T + L +G +P L L+ L + ++ + + + N ++
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 109 QNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN--AEQFCGSHSDDDNEIDRSTNS 161
+ + P L + + + + + D +I + +N+
Sbjct: 142 RMHYQKTFVDY--DPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNN 194
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 36/223 (16%)
Query: 375 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 427
++F IG+G +GKV + A+K + E E+Q +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 428 LHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGS 482
L H LV+L Y ++ E M +V + + G LR L E F L +AL
Sbjct: 72 LEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD- 129
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 542
YL + + HRD+K NILLD + DF ++ + + T
Sbjct: 130 -----YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAM--------LPRETQITT 173
Query: 543 VKGTPGYLDPEYFLTHKLT--DKS-DVYSLGVVFLELLTGMQP 582
+ GT Y+ PE F + K + D +SLGV ELL G +P
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-18
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 430
N F +G+GG+G+V + G + A K+ ++ ++ K L E Q L +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 431 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSS 483
R +VSL Y E + + LV M+ G L+ + + GF + I G
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQA--GFPEARAVFYAAEICCG-- 298
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
+ LH E + +RD+K NILLD +++D GL+ + V
Sbjct: 299 --LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAV-------HVPEGQTIKGRV 346
Query: 544 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
GT GY+ PE + T D ++LG + E++ G P
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 6e-18
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 39/231 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV-- 437
IG G YG V + + VVA+K+ L K L EI L+RL+H ++V ++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 438 ---GYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTE 492
++ E +V E + D ++ L ++ G+ Y+H+
Sbjct: 121 VIPKDVEKFDELYVVLEIA--DS--D-FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS- 174
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
A + HRD+K +N L++ + KV DFGL+R P+
Sbjct: 175 AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 553 EYFLTHKLTD--------------------KS-DVYSLGVVFLELLTGMQP 582
L +LT ++ DV+S+G +F ELL ++
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 30/220 (13%)
Query: 375 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 427
+F +G+G + V A+K ++ + E + E +SR
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 428 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 483
L H V L ++ + + NG L + E + + AL
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE-- 144
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
YLH + + HRD+K NILL+ ++ DFG +++ + A+ + V
Sbjct: 145 ----YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV--LSPESKQARAN--SFV 193
Query: 544 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
GT Y+ PE LT K KS D+++LG + +L+ G+ P
Sbjct: 194 -GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 68/257 (26%), Positives = 103/257 (40%), Gaps = 33/257 (12%)
Query: 339 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVY----KG 394
R S S + S + + N F +G+G +GKV K
Sbjct: 112 KQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA 171
Query: 395 ILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVGYCDEEGEQM-LVY 450
G A+K ++ + + E LTE + L H L +L Y + +++ V
Sbjct: 172 ---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM 227
Query: 451 EFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 506
E+ + G L LS + E + + AL YLH+E + V +RD+K N
Sbjct: 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALD------YLHSEKN--VVYRDLKLEN 279
Query: 507 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-D 565
++LD K+ DFGL + EGI GTP YL PE L ++ D
Sbjct: 280 LMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 331
Query: 566 VYSLGVVFLELLTGMQP 582
+ LGVV E++ G P
Sbjct: 332 WWGLGVVMYEMMCGRLP 348
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 9e-18
Identities = 59/236 (25%), Positives = 94/236 (39%), Gaps = 42/236 (17%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQF 424
N+F+ IG+GG+G+VY D G + A+K + E E+ L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV-- 246
Query: 425 LSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------ 477
S +V + Y +++ + + M+ G L LS F+
Sbjct: 247 -STGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAE 300
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 537
I LG + ++H V +RD+K +NILLD +++D GL+ V
Sbjct: 301 IILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 538 HVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVRE 592
GT GY+ PE D S D +SLG + +LL G P K +
Sbjct: 352 -------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-17
Identities = 27/155 (17%), Positives = 57/155 (36%), Gaps = 13/155 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL-----SLNITTIK 54
+ L L++ + + G + + + NL YL LS++ + + +
Sbjct: 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILN 387
Query: 55 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
L+ NK++ FS L L+ L + N + + W+ F + N
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR----GLENIFEIYLSYNKYL 443
Query: 115 NI-SGSFNIPPNVTV-RLRGNPFC-LNTNAEQFCG 146
+ SF + P++ LR ++++ F
Sbjct: 444 QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-17
Identities = 34/148 (22%), Positives = 54/148 (36%), Gaps = 18/148 (12%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQL-------NGSIPPGRLS--LNI 50
+ L L L N ++ D L + L LDL N L N P L ++
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538
Query: 51 TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 110
+ L +N F L L+ + + N+L+ S +L L+ Q
Sbjct: 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK-----SLNLQK 593
Query: 111 NNLTNISGSF--NIPPNVTV-RLRGNPF 135
N +T++ N+T +R NPF
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-17
Identities = 28/137 (20%), Positives = 56/137 (40%), Gaps = 11/137 (8%)
Query: 2 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNN 58
+ + L+L + L+ P + +R L LD+ N ++ P +L + + L +N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLP-MLKVLNLQHN 83
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS- 117
+L+ F+ L L + +NS+ + + + L LD +N L++
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLI-----TLDLSHNGLSSTKL 138
Query: 118 GSFNIPPNVTV-RLRGN 133
G+ N+ L N
Sbjct: 139 GTQVQLENLQELLLSNN 155
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-17
Identities = 26/121 (21%), Positives = 47/121 (38%), Gaps = 6/121 (4%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLN---ITTIKLS 56
L+ L L + L + ++ NL L LS+N++ + ++LS
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
+N++ P F + RL LF+ N L S+ + + L N+ L+
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRN--LSLSNSQLSTT 237
Query: 117 S 117
S
Sbjct: 238 S 238
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-15
Identities = 26/134 (19%), Positives = 47/134 (35%), Gaps = 12/134 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLS 56
+ L L L + + + N+ + LS N+ + ++ + L
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVP-SLQRLMLR 462
Query: 57 NNKLTG--TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
L + PS F L L L ++NN+++ + L ILD Q+NNL
Sbjct: 463 RVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE-----ILDLQHNNLA 517
Query: 115 NISGSFNIPPNVTV 128
+ N +
Sbjct: 518 RLWKHANPGGPIYF 531
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 29/148 (19%), Positives = 53/148 (35%), Gaps = 13/148 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPD----LSRIPNLGYLDLSSNQLNGSIPP---GRLSLNITTI 53
+ +L L L N L + + ++ L LS++QL+ + G N+T +
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253
Query: 54 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN----ATETFILDFQ 109
LS N L +F+ LP+L+ F+ N++ S+ +
Sbjct: 254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS 313
Query: 110 NNNLTNI-SGSFNIPPNVTV-RLRGNPF 135
+L I SF + + N
Sbjct: 314 LASLPKIDDFSFQWLKCLEHLNMEDNDI 341
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 29/110 (26%), Positives = 50/110 (45%), Gaps = 9/110 (8%)
Query: 26 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 85
+ D S +L +P L NIT + L++N+L +NF+ +L L + N++S
Sbjct: 5 SHEVADCSHLKLT-QVPDD-LPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 86 GSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 133
P + L +L+ Q+N L+ +S +F N+T L N
Sbjct: 63 KLEPELCQKLPMLK-----VLNLQHNELSQLSDKTFAFCTNLTELHLMSN 107
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 32/185 (17%), Positives = 57/185 (30%), Gaps = 36/185 (19%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPG----------RLSLN 49
+ L L L +L D + +P L Y L N + L +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 50 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL-------NATE 102
T +S L +F L L+ L + +N + G + L + T
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 103 TF----------------ILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPFCLNTNAEQF 144
IL+ N ++ I S +F+ ++ V L N +++
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW 426
Query: 145 CGSHS 149
G +
Sbjct: 427 RGLEN 431
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 23/207 (11%), Positives = 51/207 (24%), Gaps = 49/207 (23%)
Query: 382 QIGQGGYGKVYKGILPD---GTVVAVK--RAQEGSLQGEKE-FLTEIQFLSRLHHRNLVS 435
G + ++ + D VA+ Q + L+ LSR+ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 436 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 495
++ ++V E++ G+L++ + + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 496 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 555
V S + + +A + +P+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPAT--MPDA----------------------NPQ-- 182
Query: 556 LTHKLTDKSDVYSLGVVFLELLTGMQP 582
D+ +G LL P
Sbjct: 183 --------DDIRGIGASLYALLVNRWP 201
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 51/256 (19%), Positives = 96/256 (37%), Gaps = 70/256 (27%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF-LTEIQFLSRLHHRNLVSLVGY- 439
+G G +G V + + G A+K+ + + + E+ + L H N++ LV Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLVDYF 69
Query: 440 -------------------------------------CDEEGEQMLVYEFMSNGTLRDQL 462
+ ++ E++ D L
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-----DTL 124
Query: 463 SAKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIKASNILLD-HKFTA 515
K + + + L S R + ++H+ + HRDIK N+L++ T
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTL 181
Query: 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFL 574
K+ DFG ++ +P V+ + + Y PE L + T D++S+G VF
Sbjct: 182 KLCDFGSAKKL-IPS-----EPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 575 ELLTGMQPISHGKNIV 590
EL+ G +P+ G+ +
Sbjct: 234 ELILG-KPLFSGETSI 248
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 25/142 (17%), Positives = 57/142 (40%), Gaps = 13/142 (9%)
Query: 1 MSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLS 56
+ +L L ++ +L+ + NL YLD+S G + ++ +K++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMA 453
Query: 57 NNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115
N + F+ L L L ++ L + + + + + +L+ +N L +
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN----SLSSLQVLNMASNQLKS 508
Query: 116 I-SGSFNIPPN-VTVRLRGNPF 135
+ G F+ + + L NP+
Sbjct: 509 VPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 38/153 (24%), Positives = 66/153 (43%), Gaps = 15/153 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL----NITTIKLS 56
+ L +L+ + +P+L +LDLS N L+ S ++ + LS
Sbjct: 324 LKSLKRLTFTSNKGGNA-FSEVDLPSLEFLDLSRNGLS-FKGCCSQSDFGTTSLKYLDLS 381
Query: 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFILDFQNNNLTN 115
N + T+ SNF GL +L+ L +++L S++ S R L LD + +
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI-----YLDISHTHTRV 435
Query: 116 I-SGSFNIPPNVTV-RLRGNPFCLNTNAEQFCG 146
+G FN ++ V ++ GN F N + F
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 34/167 (20%), Positives = 58/167 (34%), Gaps = 13/167 (7%)
Query: 2 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNN 58
L L L+ P L LDLS ++ +I G +++T+ L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS- 117
+ FSGL LQ+L +L+ I +TL L+ +N + +
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK-----ELNVAHNLIQSFKL 141
Query: 118 -GSFNIPPN-VTVRLRGNPF-CLNTNAEQFCGSHSDDDNEIDRSTNS 161
F+ N + L N + + + +D S N
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 5/111 (4%)
Query: 1 MSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLS 56
+S L L + S Q + + NL +LDLS QL + P + ++ + ++
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMA 502
Query: 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 107
+N+L F L LQ++++ N S P + SR LN
Sbjct: 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQG 553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 17/105 (16%), Positives = 33/105 (31%), Gaps = 9/105 (8%)
Query: 31 DLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 90
IP L + + LS N L +F P LQ L ++ +
Sbjct: 13 QCMELNFY-KIPDN-LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 91 SIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 133
+ L+ L N + +++ G+F+ ++
Sbjct: 71 AYQSLSHLS-----TLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 38/165 (23%), Positives = 66/165 (40%), Gaps = 20/165 (12%)
Query: 1 MSKLLKLSLRNCSLQ--GPMPDLSRIPNLGYLDLSSNQLNGSIPPG------RLSLNITT 52
+ L +L++ + +Q S + NL +LDLSSN++ SI ++ L +
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS 181
Query: 53 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ--- 109
+ LS N + P F + RL +L + NN S ++ + Q L E L
Sbjct: 182 LDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQG--LAGLEVHRLVLGEFR 238
Query: 110 -NNNLTNIS-GSFNIPPNVTV---RLRGNPFCLNTNAEQFCGSHS 149
NL + N+T+ RL + L+ + F +
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 20/149 (13%), Positives = 44/149 (29%), Gaps = 24/149 (16%)
Query: 5 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTG-- 62
+L+ + L + + + N+ L S + + + ++L N K
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFP 320
Query: 63 -----------------TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 105
+ LP L+ L ++ N LS + +
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS-FKGCCSQSDFGTTSLKY-- 377
Query: 106 LDFQNNNLTNISGSFNIPPNVTV-RLRGN 133
LD N + +S +F + + +
Sbjct: 378 LDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 21/127 (16%), Positives = 37/127 (29%), Gaps = 11/127 (8%)
Query: 4 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL----SLNITTIKL---- 55
L L L + P + L L L +N + ++ + L + + L
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 56 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115
+ L S GL L L + I L +F + +
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF--SLVSVTIER 296
Query: 116 I-SGSFN 121
+ S+N
Sbjct: 297 VKDFSYN 303
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 59/259 (22%), Positives = 102/259 (39%), Gaps = 46/259 (17%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--V 437
+G G YG V + G VA+K+ S K E++ L + H N++ L V
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 438 GYCDEEGEQM----LVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYL 489
DE + LV FM ++ + L + L + M +G+ Y+
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML--------KGLRYI 144
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
H A + HRD+K N+ ++ K+ DFGL+R VV T Y
Sbjct: 145 HA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVV--TRWY 191
Query: 550 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI-- 606
PE L ++ D++S+G + E++TG + + G + + Q + V
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLD------QLKEIMKVTGT 244
Query: 607 --DGNMGSYPSECVEKFIK 623
+ S+ + ++K
Sbjct: 245 PPAEFVQRLQSDEAKNYMK 263
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-17
Identities = 28/142 (19%), Positives = 54/142 (38%), Gaps = 13/142 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL----NITTIKL 55
+ L L+L + L +P L +L+L N SL + + L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 56 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115
S L+ F+ L + + +++N L+ S ++ + + L+ +N+++
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI------YLNLASNHISI 537
Query: 116 IS-GSFNIPPN-VTVRLRGNPF 135
I I T+ LR NP
Sbjct: 538 ILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 30/138 (21%), Positives = 47/138 (34%), Gaps = 7/138 (5%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSN 57
+S L L+L + P L LDL+ +L + + LS+
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
+ L + F GLP LQ L + N +TL E L +L++I
Sbjct: 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI--LVLSFCDLSSID 492
Query: 118 -GSFNIPPNVTV-RLRGN 133
+F + L N
Sbjct: 493 QHAFTSLKMMNHVDLSHN 510
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-16
Identities = 24/137 (17%), Positives = 47/137 (34%), Gaps = 8/137 (5%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 57
+L L L L LS L +L ++ SI L + ++ L +
Sbjct: 80 QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGS 138
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI- 116
N ++ +L+ L NN++ + +L L+ N++ I
Sbjct: 139 NHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM---SSLQQATNLSLNLNGNDIAGIE 195
Query: 117 SGSFNIPPNVTVRLRGN 133
G+F+ ++ G
Sbjct: 196 PGAFDSAVFQSLNFGGT 212
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 33/144 (22%), Positives = 59/144 (40%), Gaps = 15/144 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLSL----NITTIK 54
L LS++ + + + L + NL LDLS + + + L L ++ ++
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE-TSDCCNLQLRNLSHLQSLN 382
Query: 55 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFILDFQNNNL 113
LS N+ F P+L+ L +A L S +Q+ L +L+ ++ L
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK-----VLNLSHSLL 437
Query: 114 TNIS-GSFNIPPNVTV-RLRGNPF 135
S F+ P + L+GN F
Sbjct: 438 DISSEQLFDGLPALQHLNLQGNHF 461
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 28/138 (20%), Positives = 48/138 (34%), Gaps = 9/138 (6%)
Query: 2 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNK 59
+ L L SR+ NL +LDL+ Q+ S + T+ L+ N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-G 118
L + SG L+ LF +S + +TL L +N++++I
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE-----SLYLGSNHISSIKLP 147
Query: 119 SFNIPPNVTV-RLRGNPF 135
+ V + N
Sbjct: 148 KGFPTEKLKVLDFQNNAI 165
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-14
Identities = 25/143 (17%), Positives = 48/143 (33%), Gaps = 14/143 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLS 56
+L L L L+ + L L+LS + L+ + + L
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD-ISSEQLFDGLPALQHLNLQ 457
Query: 57 NNKLTGTI---PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 113
N ++ L RL+ L ++ LS + + +N +D +N L
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN-----HVDLSHNRL 512
Query: 114 TNIS-GSFNIPPNVTVRLRGNPF 135
T+ S + + + + L N
Sbjct: 513 TSSSIEALSHLKGIYLNLASNHI 535
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 26/157 (16%), Positives = 48/157 (30%), Gaps = 14/157 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMP---DLSRIPNLGYLDLSSNQLNG---SIPPGRLSLNITTIK 54
+ L+ + S I +L ++ G +++ +I
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260
Query: 55 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
L + + F LQ L + LS +PS + TL L N
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK-----KLVLSANKFE 314
Query: 115 NI-SGSFNIPPNVTV-RLRGNPFCLNTNAEQFCGSHS 149
N+ S + P++T ++GN L +
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 24/112 (21%), Positives = 48/112 (42%), Gaps = 4/112 (3%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNN 58
+ +L L L C L + + + ++DLS N+L S LS L + L++N
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHLKGIYLNLASN 533
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 110
++ +PS L + + + + N L + S+I+ + D ++
Sbjct: 534 HISIILPSLLPILSQQRTINLRQNPLDCT-CSNIYFLEWYKENMQKLEDTED 584
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 18/106 (16%), Positives = 33/106 (31%), Gaps = 9/106 (8%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89
+ + LN IP L + ++ S N L + FS L L L + +
Sbjct: 17 YNCENLGLN-EIPGT-LPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE 74
Query: 90 SSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 133
+ L+ L N L ++ + + P +
Sbjct: 75 DTFQSQHRLD-----TLVLTANPLIFMAETALSGPKALKHLFFIQT 115
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 18/123 (14%), Positives = 36/123 (29%), Gaps = 10/123 (8%)
Query: 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIK---LSNNK 59
L L+L + G P L+ Q I G + I ++ +
Sbjct: 180 TNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239
Query: 60 LTGTIPSNFSGLPR--LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
P+ F GL ++ + + + ++ L LD +L+ +
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQ-----ELDLTATHLSELP 294
Query: 118 GSF 120
Sbjct: 295 SGL 297
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 22/144 (15%), Positives = 46/144 (31%), Gaps = 14/144 (9%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS----LNITTIKL 55
L L L + + +P L LD +N ++ + +S ++ L
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNL 186
Query: 56 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115
+ N + I Q L I + + ++ F++ + +
Sbjct: 187 NGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGL---KNSTIQSLWLGTFEDMDDED 242
Query: 116 IS-GSFNIPPNVTVR---LRGNPF 135
IS F ++V L+ + F
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYF 266
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 57/250 (22%), Positives = 82/250 (32%), Gaps = 64/250 (25%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV-- 437
IG+G YG VY VA+K+ L K L EI L+RL ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 438 ---GYCDEEGEQMLVYEFM---------SNGTLRD--------QLSAKSKEPLGFAMRLS 477
+ E +V E + L + L
Sbjct: 94 IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL--------------- 138
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 537
L G ++H + + HRD+K +N LL+ + KV DFGL+R IV
Sbjct: 139 --L---LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 538 HVSTVVKGTPGYLD---------------PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQ 581
G PE L + KS D++S G +F ELL +Q
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 582 PISHGKNIVR 591
+
Sbjct: 251 SHINDPTNRF 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 66/302 (21%), Positives = 122/302 (40%), Gaps = 53/302 (17%)
Query: 340 MKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPD 398
M ++H + + +++ + + + + +G G YG V
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTI-WE------VPERYQNLSPVGSGAYGSVCAAFDTKT 53
Query: 399 GTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--VGYCDEEGEQM----LVY 450
G VAVK+ S+ K E++ L + H N++ L V E+ LV
Sbjct: 54 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 451 EFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 506
M N ++ Q L+ + L + + RG+ Y+H+ AD + HRD+K SN
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQFLIYQIL--------RGLKYIHS-AD--IIHRDLKPSN 162
Query: 507 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-D 565
+ ++ K+ DFGL+R ++ G V T Y PE L +++ D
Sbjct: 163 LAVNEDCELKILDFGLARHT-ADEMTGYV---------ATRWYRAPEIMLNWMHYNQTVD 212
Query: 566 VYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI----DGNMGSYPSECVEKF 621
++S+G + ELLTG + + G + + Q ++ ++ + SE +
Sbjct: 213 IWSVGCIMAELLTG-RTLFPGTDHID------QLKLILRLVGTPGAELLKKISSESARNY 265
Query: 622 IK 623
I+
Sbjct: 266 IQ 267
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL----- 436
+G GG G V+ + VA+K+ Q K L EI+ + RL H N+V +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 437 ---------VGYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 483
VG E +V E+M L L + + +
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL-------- 130
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSR-LAPVPDIEGIVPAHVST 541
RG+ Y+H+ A+ V HRD+K +N+ ++ + K+ DFGL+R + P +G + +
Sbjct: 131 RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV- 186
Query: 542 VVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 590
T Y P L+ + T D+++ G +F E+LTG + + G + +
Sbjct: 187 ----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHEL 231
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 35/143 (24%), Positives = 61/143 (42%), Gaps = 12/143 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 57
++ L L L + L + +PNL YLDLSSN L+ ++ S + + L N
Sbjct: 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYN 121
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N + + N F + +LQ+L+++ N +S P + + + +LD +N L +
Sbjct: 122 NHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGN-KLPKLMLLDLSSNKLKKL 178
Query: 117 S-GSFNIPPN---VTVRLRGNPF 135
P + L NP
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 25/109 (22%), Positives = 43/109 (39%), Gaps = 12/109 (11%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN--FSGLPRLQRLFIANNSLSGS 87
L S QL ++P L + LS+N L+ + + + L L L +++N L+
Sbjct: 23 LSCSKQQLP-NVPQS-LPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-F 78
Query: 88 IPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNP 134
I S + LD +N+L + F+ + V L N
Sbjct: 79 ISSEAFV----PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNH 123
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 33/136 (24%), Positives = 57/136 (41%), Gaps = 26/136 (19%)
Query: 11 NCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPG----RLSLNITTIKLSNNKLT 61
+CS Q L +P LDLS N L + RL+ N+ ++ LS+N L
Sbjct: 24 SCSKQQ----LPNVPQSLPSYTALLDLSHNNL-SRLRAEWTPTRLT-NLHSLLLSHNHLN 77
Query: 62 GTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRT-LNATETFILDFQNNNLTNI-SG 118
I S F +P L+ L +++N L ++ ++ L +L NN++ +
Sbjct: 78 -FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALE-----VLLLYNNHIVVVDRN 130
Query: 119 SFNIPPNVT-VRLRGN 133
+F + + L N
Sbjct: 131 AFEDMAQLQKLYLSQN 146
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 85/343 (24%), Positives = 138/343 (40%), Gaps = 61/343 (17%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVSL-- 436
+G+G YG V+K I G VVAVK+ + + + EI L+ L H N+V+L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 437 VGYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
V D + + LV+++M + +R L K+ + + + + + I YLH+
Sbjct: 77 VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL-----I---KVIKYLHS- 127
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD- 551
+ HRD+K SNILL+ + KVADFGLSR
Sbjct: 128 GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 552 -------------PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597
PE L K D++SLG + E+L G +PI G + +
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSSTMN------ 238
Query: 598 QSSMMFSVI----DGNMGSYPSECVEKFIK-LALKCCQDETDARPSMSEVMRELESIWNM 652
Q + VI + ++ S S + I+ L K +++ R ++ L I
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 653 MPESD------TKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689
++ K +F ++ S + LKHP+VS
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISAND-------ALKHPFVSI 334
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 66/258 (25%), Positives = 114/258 (44%), Gaps = 40/258 (15%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV--- 437
IG+G YG V + VA+K+ + L EI+ L R H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 438 --GYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
++ + +V + M L+ Q LS + + L RG+ Y+H+
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI-----L---RGLKYIHS 146
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA-PVPDIEGIVPAHVSTVVKGTPGYL 550
A+ V HRD+K SN+LL+ K+ DFGL+R+A P D G + +V+ T Y
Sbjct: 147 -AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-----TRWYR 198
Query: 551 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI--- 606
PE L K KS D++S+G + E+L+ +PI GK+ + Q + + ++
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLD------QLNHILGILGSP 251
Query: 607 -DGNMGSYPSECVEKFIK 623
++ + ++
Sbjct: 252 SQEDLNCIINLKARNYLL 269
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 25/142 (17%), Positives = 57/142 (40%), Gaps = 13/142 (9%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSN 57
+ L+ L + + + + + +L L ++ N + P + N+T + LS
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
+L + F+ L LQ L +++N+ S+ + ++ +LD+ N++
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK----CLNSLQVLDYSLNHIMTS 238
Query: 117 SGS--FNIPPN-VTVRLRGNPF 135
+ P + + L N F
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 13/150 (8%)
Query: 4 LLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLN-GSIPPGRLS--LNITTIKLSNNK 59
+L L + LQ P ++ L L LSSN L+ ++ + LS N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFILDFQNNNLTNI-S 117
+ T+ SNF GL +L+ L +++L S++ S R L LD + + +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI-----YLDISHTHTRVAFN 143
Query: 118 GSFNIPPNVTV-RLRGNPFCLNTNAEQFCG 146
G FN ++ V ++ GN F N + F
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 26/125 (20%), Positives = 46/125 (36%), Gaps = 11/125 (8%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL--SL-NITTIKLSNN 58
+ L L L + + + L +LD + L + + SL N+ + +S+
Sbjct: 78 TSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 59 KLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
+ F+GL L+ L +A NS + I+ LD L +S
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT----ELRNLTFLDLSQCQLEQLS 191
Query: 118 -GSFN 121
+FN
Sbjct: 192 PTAFN 196
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 20/116 (17%)
Query: 11 NCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLT-- 61
C+ +G L+ +P + L+L SN+L S+P G +T + LS+N L+
Sbjct: 13 RCNSKG----LTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 62 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
G + G L+ L ++ N + ++ S+ L LDFQ++NL +S
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE-----HLDFQHSNLKQMS 117
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 24/107 (22%), Positives = 43/107 (40%), Gaps = 8/107 (7%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS-GSI 88
+ +S L S+P G + + T ++L +NKL F L +L +L +++N LS
Sbjct: 12 IRCNSKGLT-SVPTG-IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC 69
Query: 89 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGNP 134
S T LD N + +S +F + + +
Sbjct: 70 CSQSDF----GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 112
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 34/140 (24%), Positives = 56/140 (40%), Gaps = 11/140 (7%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 57
+ +L L L C LQ + L YL L N L ++P N+T + L
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHG 162
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
N+++ F GL L RL + N ++ + ++ L T L NNL+ +
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD--LGRLMT--LYLFANNLSALP 217
Query: 118 -GSFNIPPNVT-VRLRGNPF 135
+ + +RL NP+
Sbjct: 218 TEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 30/134 (22%), Positives = 48/134 (35%), Gaps = 12/134 (8%)
Query: 6 KLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTG 62
++ L + P NL L L SN L I + + + LS+N
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 63 TIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSF 120
++ F GL RL L + L + +++ L Q+N L + +F
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR----GLAALQYLYLQDNALQALPDDTF 149
Query: 121 NIPPNVTV-RLRGN 133
N+T L GN
Sbjct: 150 RDLGNLTHLFLHGN 163
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 21/120 (17%)
Query: 11 NCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGT 63
+C QG L +P + L N+++ +P N+T + L +N L
Sbjct: 17 SCPQQG----LQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-R 70
Query: 64 IPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFILDFQNNNLTNI-SGSF 120
I + F+GL L++L +++N+ S+ + + L+ L L + G F
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH-----TLHLDRCGLQELGPGLF 125
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 19/106 (17%), Positives = 39/106 (36%), Gaps = 8/106 (7%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89
L ++P G + I L N+++ ++F L L++ +N L+ I
Sbjct: 16 TSCPQQGLQ-AVPVG-IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RID 72
Query: 90 SSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 133
++ + L E L N L ++ +F+ + L
Sbjct: 73 AAAFTG--LALLEQLDLS-DNAQLRSVDPATFHGLGRLHTLHLDRC 115
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 4e-16
Identities = 23/138 (16%), Positives = 52/138 (37%), Gaps = 22/138 (15%)
Query: 1 MSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-------LNIT 51
++ L + L+ + + + +G +D S N++ GS +N +
Sbjct: 618 TDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKI-GSEGRNISCSMDDYKGINAS 676
Query: 52 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS-------GSIPSSIWQSRTLNATETF 104
T+ LS N++ F+ + + ++NN ++ + + L
Sbjct: 677 TVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT----- 731
Query: 105 ILDFQNNNLTNISGSFNI 122
+D + N LT++S F
Sbjct: 732 TIDLRFNKLTSLSDDFRA 749
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 27/146 (18%), Positives = 54/146 (36%), Gaps = 18/146 (12%)
Query: 1 MSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNGSIPP-GRLSLNITTIKLSN 57
K+ + +L+ L ++ LG LD N++ + G +T +KL
Sbjct: 547 GPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNV-KLTDLKLDY 604
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N++ IP + + +++ L ++N L IP+ +DF N + +
Sbjct: 605 NQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS---VDFSYNKIGSE 659
Query: 117 SGSFNIPPN-------VTVRLRGNPF 135
+ + + TV L N
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEI 685
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 2e-14
Identities = 14/127 (11%), Positives = 37/127 (29%), Gaps = 16/127 (12%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIP-------NLGYLDLSSNQLNGSIPPGRLSLNITTIK 54
K ++SL++ + ++ I L + +++ ++
Sbjct: 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA----VDWEDAN 473
Query: 55 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
K ++S L L + + N +P ++ L L+ N
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ-----SLNIACNRGI 528
Query: 115 NISGSFN 121
+ +
Sbjct: 529 SAAQLKA 535
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 22/134 (16%), Positives = 40/134 (29%), Gaps = 19/134 (14%)
Query: 1 MSKLLKLSLRNCSLQGPM----------PDLSRIPNLGYLDLSSNQLNGSIPPGRLS--L 48
+ +L L++ D P + + N L L +
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573
Query: 49 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 108
+ + +NK+ + + F +L L + N + IP + L F
Sbjct: 574 KLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCA----FTDQVEGLGF 626
Query: 109 QNNNLTNISGSFNI 122
+N L I FN
Sbjct: 627 SHNKLKYIPNIFNA 640
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 7e-13
Identities = 29/145 (20%), Positives = 48/145 (33%), Gaps = 20/145 (13%)
Query: 1 MSKLLKLSLRNCSLQGPMPDL--SRIPNLGYLDLSSNQLNGSIPP--GRLS----LNIT- 51
L + LR L D + +P L +D+S N + S P S I
Sbjct: 727 TYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRH 785
Query: 52 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 111
N++ P+ + P L +L I +N + + + L ILD +N
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQ--LY-----ILDIADN 837
Query: 112 NLTNISGSFNIP--PNVTVRLRGNP 134
+I + P L +
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 4e-11
Identities = 22/125 (17%), Positives = 40/125 (32%), Gaps = 16/125 (12%)
Query: 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN-----GSIPPG-RLSLNITTIKLS 56
+ + + L L DL + +N I R+SL T I
Sbjct: 374 DMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL 433
Query: 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N++T I L +LQ ++ AN+ + + W+ + N
Sbjct: 434 TNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD---------YAKQYENE 483
Query: 117 SGSFN 121
S++
Sbjct: 484 ELSWS 488
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 18/123 (14%), Positives = 44/123 (35%), Gaps = 3/123 (2%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP-GRLSLNITTIKLSNN 58
++ LSL +G +PD + ++ L L ++ S G L + +
Sbjct: 322 NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKH 381
Query: 59 KLTGTIPSNF-SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
++ F RL + ++++ + + + + + + N +T IS
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFIS 441
Query: 118 GSF 120
+
Sbjct: 442 KAI 444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 23/156 (14%), Positives = 41/156 (26%), Gaps = 28/156 (17%)
Query: 13 SLQGPMPDLSRIPNLGYLDLSSNQLN------GSIPPGRLSLN--ITTIKLSNNKLTGTI 64
+L G + + N G P L N +T + L+ G +
Sbjct: 280 ALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339
Query: 65 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI------------------- 105
P L L+ L +S + S + T + +E
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399
Query: 106 -LDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN 140
D + + I + + L+ TN
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 31/141 (21%), Positives = 57/141 (40%), Gaps = 13/141 (9%)
Query: 1 MSKLLKLSL-RNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 57
+ +L L + L P+ NL L ++ L ++P + + + + LS
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSY 257
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N ++ TI + L RLQ + + L+ + ++ LN +L+ N LT +
Sbjct: 258 NPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRG--LNYLR--VLNVSGNQLTTL 311
Query: 117 S-GSFNIPPN-VTVRLRGNPF 135
F+ N T+ L NP
Sbjct: 312 EESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 34/160 (21%), Positives = 68/160 (42%), Gaps = 29/160 (18%)
Query: 2 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNN 58
++ L L ++ + + P+L L+L+ N + ++ PG + N+ T+ L +N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSN 90
Query: 59 KLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS----RTLN---------ATETF 104
+L IP F+GL L +L I+ N + + ++Q ++L + F
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAF 148
Query: 105 -------ILDFQNNNLTNI-SGSFNIPPN-VTVRLRGNPF 135
L + NLT+I + + + + +RLR
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 34/154 (22%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 57
+ L L LR+ L+ P+ + + NL LD+S N++ + N+ ++++ +
Sbjct: 79 LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGD 137
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N L I FSGL L++L + +L+ SIP+ L+ L ++ N+ I
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSH--LHGLIV--LRLRHLNINAI 191
Query: 117 -SGSFNIPPNV-TVRLRGNPFCLNTNAEQFCGSH 148
SF + + + P+ G +
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN 225
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 20/107 (18%), Positives = 40/107 (37%), Gaps = 11/107 (10%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89
+ + ++P G + + L N++ F+ P L+ L + N +S ++
Sbjct: 16 VLCHRKRFV-AVPEG-IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVE 72
Query: 90 SSIWQS-RTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 133
+ + L L ++N L I G F N+T + N
Sbjct: 73 PGAFNNLFNLR-----TLGLRSNRLKLIPLGVFTGLSNLTKLDISEN 114
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 13/140 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSN 57
+ L L L + LQ +P L LD+S N+L S+P G L + + L
Sbjct: 76 LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG-ELQELYLKG 133
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N+L T+P + P+L++L +ANN+L+ +P+ + L +T L Q N+L I
Sbjct: 134 NELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNG--LENLDT--LLLQENSLYTI 187
Query: 117 S-GSFNIPPNVTVRLRGNPF 135
G F L GNP+
Sbjct: 188 PKGFFGSHLLPFAFLHGNPW 207
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 28/126 (22%), Positives = 46/126 (36%), Gaps = 14/126 (11%)
Query: 6 KLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI 64
L L L + L L L+L +L + + T+ LS+N+L ++
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQ-SL 92
Query: 65 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPP 124
P LP L L ++ N L+ S+P + E L + N L +PP
Sbjct: 93 PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG-ELQE---LYLKGNELK------TLPP 141
Query: 125 NVTVRL 130
+
Sbjct: 142 GLLTPT 147
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 10/110 (9%)
Query: 25 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 84
+ ++ L ++PP L + T + LS N L + RL +L + L
Sbjct: 10 ASHLEVNCDKRNL-TALPPD-LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 85 SGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 133
+ + TL T LD +N L ++ P +TV + N
Sbjct: 68 -----TKLQVDGTLPVLGT--LDLSHNQLQSLPLLGQTLPALTVLDVSFN 110
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 28/137 (20%), Positives = 54/137 (39%), Gaps = 15/137 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ L L + + + +L+LSS + + + + +SNN L
Sbjct: 386 LKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ-TLEVLDVSNNNL 443
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GS 119
+ LPRLQ L+I+ N L ++P + L ++ N L ++ G
Sbjct: 444 D-SFSLF---LPRLQELYISRNKLK-TLPDA-SLFPVLL-----VMKISRNQLKSVPDGI 492
Query: 120 FNIPPNVT-VRLRGNPF 135
F+ ++ + L NP+
Sbjct: 493 FDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 27/113 (23%), Positives = 49/113 (43%), Gaps = 9/113 (7%)
Query: 25 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 84
G D S SIP G L+ + ++ LS NK+T + LQ L + ++ +
Sbjct: 5 DASGVCDGRSRSFT-SIPSG-LTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 85 SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGNPF 135
+ + + +L LD +N+L+++S F ++ L GNP+
Sbjct: 63 NTIEGDAFYSLGSLE-----HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 28/106 (26%), Positives = 43/106 (40%), Gaps = 4/106 (3%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 61
L L + N +L L P L L +S N+L ++P L + +K+S N+L
Sbjct: 431 QTLEVLDVSNNNLDSFSLFL---PRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLK 486
Query: 62 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 107
F L LQ++++ N S P + SR LN
Sbjct: 487 SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQG 532
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 28/235 (11%), Positives = 70/235 (29%), Gaps = 17/235 (7%)
Query: 1 MSKLLKLSLRNCSLQ--GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLS 56
+S L L+L Q G + NL L + + + I + ++ +++
Sbjct: 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
L + + + L + + + + ++ L+ ++ NL
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVR-----YLELRDTNLARF 211
Query: 117 SGSFNIPPNVTVRLRGNPFCLNT-NAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYE 175
S V+ ++ F + E F ++ S DC
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG----LG 267
Query: 176 YSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDS 230
S + ++ + F Y + S L+ + ++ +++
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQF--YLFYDLSTVYSLLE-KVKRITVEN 319
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 29/162 (17%), Positives = 48/162 (29%), Gaps = 32/162 (19%)
Query: 4 LLKLSLRNCSLQGPMPDLSRI--PNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNK 59
L L N S + +L ++ + L + L SL + I + N+K
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSK 321
Query: 60 LTGTIPSN-FSGLPRLQRLFIANNSLSG-----SIPSSIWQS-RTLN-----------AT 101
+ +P + L L+ L ++ N + S W S +TL
Sbjct: 322 VF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380
Query: 102 ETF-------ILDFQNNNLTNISGSFNIPPNVTV-RLRGNPF 135
E LD N + S P + L
Sbjct: 381 EILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 31/158 (19%), Positives = 56/158 (35%), Gaps = 27/158 (17%)
Query: 2 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNN 58
+ + L L + DL NL L L S+++N +I ++ + LS+N
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDN 84
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS----RTLN----------ATETF 104
L+ S F L L+ L + N +S++ + +TL F
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 105 -------ILDFQNNNLTNIS-GSF-NIPPNVTVRLRGN 133
L+ + +L N S +I + L +
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 23/119 (19%), Positives = 46/119 (38%), Gaps = 10/119 (8%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDL-SRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNN 58
S++ L L+ + +L + L +L+L N + + + + T+ LS+N
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSN 201
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
KL + F + + + NN L I ++ S+ L D + N +
Sbjct: 202 KLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE-----HFDLRGNGFHCGT 253
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 31/134 (23%), Positives = 53/134 (39%), Gaps = 12/134 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+S L L L N +Q +L P++ L ++N ++ + R I L+NNK+
Sbjct: 79 LSTLRTLDLNNNYVQ----ELLVGPSIETLHAANNNIS-RVSCSRGQ-GKKNIYLANNKI 132
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSG-SIPSSIWQSRTLNATETFILDFQNNNLTNISGS 119
T + R+Q L + N + + S TL L+ Q N + ++ G
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE-----HLNLQYNFIYDVKGQ 187
Query: 120 FNIPPNVTVRLRGN 133
T+ L N
Sbjct: 188 VVFAKLKTLDLSSN 201
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 26/140 (18%), Positives = 51/140 (36%), Gaps = 14/140 (10%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRL---SLNITTIKLS 56
+ L N + D + YLDL N+++ ++ L S + + L
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQ 177
Query: 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N + + +L+ L +++N L+ + + + + +NN L I
Sbjct: 178 YNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-----WISLRNNKLVLI 229
Query: 117 SGSFNIPPNVTV-RLRGNPF 135
+ N+ LRGN F
Sbjct: 230 EKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 26/122 (21%), Positives = 47/122 (38%), Gaps = 16/122 (13%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 57
++ + + SL+ + N+ LDLS N L+ I L+ + + LS+
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSS 67
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
N L L L+ L + NN + + ++ L NNN++ +S
Sbjct: 68 NVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIE-----TLHAANNNISRVS 115
Query: 118 GS 119
S
Sbjct: 116 CS 117
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 32/136 (23%), Positives = 52/136 (38%), Gaps = 17/136 (12%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 59
+ +L L L DL+ L L+LSSN L ++ LS + T+ L+NN
Sbjct: 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLS-TLRTLDLNNNY 91
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SG 118
+ P ++ L ANN++S + S Q + + NN +T +
Sbjct: 92 VQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKK-------NIYLANNKITMLRDL 138
Query: 119 SFNIPPNVTV-RLRGN 133
V L+ N
Sbjct: 139 DEGCRSRVQYLDLKLN 154
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 14/85 (16%), Positives = 31/85 (36%), Gaps = 5/85 (5%)
Query: 49 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 108
K++++ L + S ++ L ++ N LS + + L +L+
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE-----LLNL 65
Query: 109 QNNNLTNISGSFNIPPNVTVRLRGN 133
+N L ++ T+ L N
Sbjct: 66 SSNVLYETLDLESLSTLRTLDLNNN 90
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 25/134 (18%), Positives = 55/134 (41%), Gaps = 9/134 (6%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
M++L L + N + + L+ + L +L++ +NQ++ L+ + + + +N++
Sbjct: 220 MTRLNSLKIGNNKITD-LSPLANLSQLTWLEIGTNQISDINAVKDLT-KLKMLNVGSNQI 277
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
+ S + L +L LF+ NN L I L L N++T+I
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT-----TLFLSQNHITDIRPLA 330
Query: 121 NIPPNVTVRLRGNP 134
++ +
Sbjct: 331 SLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 24/118 (20%), Positives = 50/118 (42%), Gaps = 10/118 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++K+ L+L + LS + L YL ++ +++ P L+ ++ ++ L+ N++
Sbjct: 131 LTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIANLT-DLYSLSLNYNQI 189
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
S + L L N ++ P + LN L NN +T++S
Sbjct: 190 ED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLN-----SLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 24/114 (21%), Positives = 47/114 (41%), Gaps = 9/114 (7%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+S+L L + + + + L L++ SNQ++ LS + ++ L+NN+L
Sbjct: 242 LSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISDISVLNNLS-QLNSLFLNNNQL 299
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
GL L LF++ N ++ P + ++ DF N +
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMD-----SADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 25/136 (18%), Positives = 53/136 (38%), Gaps = 13/136 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ L + + + ++ + L L + +N++ P LS +T +++ N++
Sbjct: 198 LTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDLSPLANLS-QLTWLEIGTNQI 255
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
+ + L +L+ L + +N +S S + LN L NN L N
Sbjct: 256 SD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLN-----SLFLNNNQLGNEDMEV 306
Query: 121 --NIPPNVTVRLRGNP 134
+ T+ L N
Sbjct: 307 IGGLTNLTTLFLSQNH 322
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 24/134 (17%), Positives = 53/134 (39%), Gaps = 20/134 (14%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ + KL + + + + + NL YL+L+ NQ+ P L +T + + NK+
Sbjct: 43 LESITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQITDISPLSNLV-KLTNLYIGTNKI 100
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS-RTL----NATETFI---------- 105
T S L L+ L++ +++S P + +L N + +
Sbjct: 101 --TDISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLN 158
Query: 106 -LDFQNNNLTNISG 118
L + + +++
Sbjct: 159 YLTVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 9e-09
Identities = 17/115 (14%), Positives = 36/115 (31%), Gaps = 11/115 (9%)
Query: 4 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGT 63
L+ + + + + L + + L +IT + ++ K+
Sbjct: 2 AATLATLPAPINQ-IFPDADLAEGIRAVLQKASVTDVVTQEELE-SITKLVVAGEKVAS- 58
Query: 64 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
L L+ L + N ++ P + L L N +T+IS
Sbjct: 59 -IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLT-----NLYIGTNKITDISA 105
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 48/241 (19%)
Query: 364 SFTYGEMALATNNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVK----------RAQE 409
S G + F +G+GGYGKV+ K + G + A+K
Sbjct: 6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT 65
Query: 410 GSLQGEKEFLTEIQ--FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKS 466
+ E+ L E++ F+ L Y + G ++ L+ E++S G L QL +
Sbjct: 66 AHTKAERNILEEVKHPFIVDLI---------YAFQTGGKLYLILEYLSGGELFMQLEREG 116
Query: 467 K--EPLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522
E + +S+ALG +LH + + +RD+K NI+L+H+ K+ DFGL
Sbjct: 117 IFMEDTACFYLAEISMALG------HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167
Query: 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQ 581
+ E I V+ GT Y+ PE L +++ D +SLG + ++LTG
Sbjct: 168 CK-------ESIHDGTVTHTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAP 219
Query: 582 P 582
P
Sbjct: 220 P 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 50/229 (21%)
Query: 375 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 421
N+F+ +G+G +GKV K G A+K + + E L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 422 IQ--FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAM 474
+ FL+ L Y + +++ V E+ + G L LS + E +
Sbjct: 62 TRHPFLTALK---------YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA 112
Query: 475 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534
+ AL YLH+ V +RDIK N++LD K+ DFGL + EGI
Sbjct: 113 EIVSALE------YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGI 156
Query: 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
GTP YL PE L ++ D + LGVV E++ G P
Sbjct: 157 SDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 51/230 (22%)
Query: 375 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 421
+F+ IG+G Y KV K + A+K +Q EK +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 422 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 473
FL LH C + ++ V E+++ G L + + K E ++
Sbjct: 66 ASNHPFLVGLH---------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116
Query: 474 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533
+S+AL YLH + +RD+K N+LLD + K+ D+G+ + EG
Sbjct: 117 AEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EG 160
Query: 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
+ P ++ GTP Y+ PE L + S D ++LGV+ E++ G P
Sbjct: 161 LRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 358 KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVKRAQEGSLQ 413
+I G + F +GQG +GKV+ K D + A+K ++ +L+
Sbjct: 7 EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK 66
Query: 414 --GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--E 468
E L ++H +V L Y + ++ L+ +F+ G L +LS + E
Sbjct: 67 VRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE 125
Query: 469 PLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526
+ L++AL +LH+ + +RD+K NILLD + K+ DFGLS+
Sbjct: 126 EDVKFYLAELALALD------HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-- 174
Query: 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
E I + GT Y+ PE + + +S D +S GV+ E+LTG P
Sbjct: 175 -----ESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 51/230 (22%)
Query: 375 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 421
+NF +G+G +GKV K G + AVK EK L+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 422 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 473
+ FL++L C + +++ V EF++ G L + + E +A
Sbjct: 80 ARNHPFLTQLF---------CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 474 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533
+ AL +LH + + +RD+K N+LLDH+ K+ADFG+ + EG
Sbjct: 131 AEIISALM------FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-------EG 174
Query: 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
I + GTP Y+ PE L L + D +++GV+ E+L G P
Sbjct: 175 ICNGVTTATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 57/235 (24%), Positives = 86/235 (36%), Gaps = 41/235 (17%)
Query: 369 EMALATNNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKE---FLTE 421
E+ L ++F IG+G + +V K G V A+K + + E F E
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 422 IQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK---EPLG--FAMR 475
L R + L + ++ + LV E+ G L LS + + +
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 476 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535
+ +A+ +H HRDIK NILLD ++ADFG +
Sbjct: 171 IVMAID------SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL-------KLRA 214
Query: 536 PAHVST-VVKGTPGYLDPEYFLTHKLTDKSDVY-------SLGVVFLELLTGMQP 582
V + V GTP YL PE + Y +LGV E+ G P
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 51/230 (22%)
Query: 375 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 421
+FN +G+G +GKV KG + AVK EK L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 422 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 473
FL++LH C + +++ V E+++ G L + + EP +A
Sbjct: 77 PGKPPFLTQLH---------SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 127
Query: 474 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533
++I L +L ++ + +RD+K N++LD + K+ADFG+ + E
Sbjct: 128 AEIAIGLF------FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EN 171
Query: 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
I + GTP Y+ PE + ++ KS D ++ GV+ E+L G P
Sbjct: 172 IWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 375 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 421
+F+ IG+G Y KV K + A++ +Q EK +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 422 IQ---FLSRLHHRNLVSLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FA 473
FL LH C + E V E+++ G L + + K E ++
Sbjct: 109 ASNHPFLVGLH---------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 159
Query: 474 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533
+S+AL YLH + +RD+K N+LLD + K+ D+G+ + EG
Sbjct: 160 AEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EG 203
Query: 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
+ P ++ GTP Y+ PE L + S D ++LGV+ E++ G P
Sbjct: 204 LRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 51/230 (22%)
Query: 375 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 421
+FN +G+G +GKV KG + AVK EK L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 422 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLS--AKSKEPLG--FA 473
FL++LH C + +++ V E+++ G L + + KEP +A
Sbjct: 398 PGKPPFLTQLH---------SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 448
Query: 474 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533
++I L +L ++ + +RD+K N++LD + K+ADFG+ + E
Sbjct: 449 AEIAIGLF------FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EN 492
Query: 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
I + GTP Y+ PE + ++ KS D ++ GV+ E+L G P
Sbjct: 493 IWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 29/136 (21%), Positives = 53/136 (38%), Gaps = 12/136 (8%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNK 59
+L L L++ +L L P L +DLS N+L I + + +SNN+
Sbjct: 232 VELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNR 289
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 119
L + +P L+ L +++N L + + Q L L +N++ + S
Sbjct: 290 LV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE-----NLYLDHNSIVTLKLS 342
Query: 120 FNIPPNVTVRLRGNPF 135
+ L N +
Sbjct: 343 -THHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 12/137 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ +L + S+ ++ L L L N L + + LS N+L
Sbjct: 210 PIAVEELDASHNSINVVRGPVN--VELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNEL 266
Query: 61 TGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SG 118
I + F + RL+RL+I+NN L ++ TL +LD +N+L ++
Sbjct: 267 E-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK-----VLDLSHNHLLHVERN 319
Query: 119 SFNIPPNVTVRLRGNPF 135
+ L N
Sbjct: 320 QPQFDRLENLYLDHNSI 336
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 30/139 (21%), Positives = 57/139 (41%), Gaps = 13/139 (9%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 57
++ ++ +N +++ P L + L+L+ Q+ I + I + +
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 108
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N + +P + F +P L L + N LS S+P I+ N + L NNNL I
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH----NTPKLTTLSMSNNNLERI 162
Query: 117 -SGSFNIPPN-VTVRLRGN 133
+F + ++L N
Sbjct: 163 EDDTFQATTSLQNLQLSSN 181
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 31/125 (24%), Positives = 53/125 (42%), Gaps = 14/125 (11%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 57
+ KL + +++ P +P L L L N L+ S+P G +TT+ +SN
Sbjct: 98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSN 156
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N L I + F LQ L +++N L+ + S+ S L F + N L+ +
Sbjct: 157 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS--L-----FHANVSYNLLSTL 207
Query: 117 SGSFN 121
+
Sbjct: 208 AIPIA 212
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 21/134 (15%), Positives = 60/134 (44%), Gaps = 13/134 (9%)
Query: 5 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTG 62
+ + ++ + D++ + N + ++ + +P L + + L++ ++
Sbjct: 32 VHIDMQTQDVYFGFEDIT-LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE- 88
Query: 63 TIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSF 120
I + F+ +Q+L++ N++ +P ++Q N +L + N+L+++ G F
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ----NVPLLTVLVLERNDLSSLPRGIF 143
Query: 121 NIPPN-VTVRLRGN 133
+ P T+ + N
Sbjct: 144 HNTPKLTTLSMSNN 157
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 22/119 (18%), Positives = 48/119 (40%), Gaps = 12/119 (10%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNN 58
L+++ L L+ ++ L L +S+N+L ++ + + + LS+N
Sbjct: 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
L + N RL+ L++ +NS+ ++ S + L +N+ S
Sbjct: 312 HLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLK-------NLTLSHNDWDCNS 361
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 47/213 (22%), Positives = 75/213 (35%), Gaps = 54/213 (25%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 439
+G G GKV + A+K LQ + E++ R ++V +V Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 440 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTE 492
+ + + E + G L ++ + + F A + ++G I YLH+
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGE--AIQYLHSI 136
Query: 493 ADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
+ HRD+K N+L K K+ DFG A Y
Sbjct: 137 N---IAHRDVKPENLLYTSKRPNAILKLTDFG---FAKE-------------TTGE--KY 175
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582
D D++SLGV+ LL G P
Sbjct: 176 -DKS----------CDMWSLGVIMYILLCGYPP 197
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 23/119 (19%), Positives = 46/119 (38%), Gaps = 10/119 (8%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDL-SRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNN 58
S++ L L+ + +L + L +L+L N + + + + T+ LS+N
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSN 201
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
KL + F + + + NN L I ++ S+ L D + N +
Sbjct: 202 KLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE-----HFDLRGNGFHCGT 253
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 31/134 (23%), Positives = 53/134 (39%), Gaps = 12/134 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+S L L L N +Q +L P++ L ++N ++ + R I L+NNK+
Sbjct: 79 LSTLRTLDLNNNYVQ----ELLVGPSIETLHAANNNIS-RVSCSRGQ-GKKNIYLANNKI 132
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSG-SIPSSIWQSRTLNATETFILDFQNNNLTNISGS 119
T + R+Q L + N + + S TL L+ Q N + ++ G
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE-----HLNLQYNFIYDVKGQ 187
Query: 120 FNIPPNVTVRLRGN 133
T+ L N
Sbjct: 188 VVFAKLKTLDLSSN 201
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 26/122 (21%), Positives = 48/122 (39%), Gaps = 16/122 (13%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 57
++ + + SL+ + N+ LDLS N L+ I L+ + + LS+
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSS 67
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
N L + L L+ L + NN + + ++ L NNN++ +S
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIE-----TLHAANNNISRVS 115
Query: 118 GS 119
S
Sbjct: 116 CS 117
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 32/138 (23%), Positives = 52/138 (37%), Gaps = 17/138 (12%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 59
+ +L L L DL+ L L+LSSN L ++ LS + T+ L+NN
Sbjct: 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLS-TLRTLDLNNNY 91
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SG 118
+ P ++ L ANN++S + S Q + + NN +T +
Sbjct: 92 VQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKK-------NIYLANNKITMLRDL 138
Query: 119 SFNIPPNVTV-RLRGNPF 135
V L+ N
Sbjct: 139 DEGCRSRVQYLDLKLNEI 156
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 19/135 (14%), Positives = 32/135 (23%), Gaps = 1/135 (0%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ + +SLRN L L NL + DL N + S N ++ +
Sbjct: 213 AAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGS 119
N + L E +L Q + +
Sbjct: 273 KKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECER 332
Query: 120 FNIPPNVTVRLRGNP 134
N +
Sbjct: 333 ENQARQREIDALKEQ 347
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 14/85 (16%), Positives = 31/85 (36%), Gaps = 5/85 (5%)
Query: 49 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 108
K++++ L + S ++ L ++ N LS + + L +L+
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE-----LLNL 65
Query: 109 QNNNLTNISGSFNIPPNVTVRLRGN 133
+N L ++ T+ L N
Sbjct: 66 SSNVLYETLDLESLSTLRTLDLNNN 90
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 16/124 (12%), Positives = 30/124 (24%), Gaps = 8/124 (6%)
Query: 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS----IPPGRLSLN-ITTIKLSN 57
L C P P R+ L + + GS + R + I
Sbjct: 287 TLGHYG-AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
+ I L +L + + L+ T + L + +
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV--GQIELQHAT 403
Query: 118 GSFN 121
+
Sbjct: 404 EEQS 407
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 35/146 (23%), Positives = 59/146 (40%), Gaps = 24/146 (16%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIP--------NLGYLDLSSNQLNGSIPPGRLSLNITT 52
+ L +L L LS I NL YL+L+ L IP + +
Sbjct: 159 IPSLRRLDLGEL------KRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDE 211
Query: 53 IKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 111
+ LS N L+ I F GL LQ+L++ + + I + + + L + ++ +N
Sbjct: 212 LDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDN--LQSLVE--INLAHN 265
Query: 112 NLTNIS-GSFNIPPN-VTVRLRGNPF 135
NLT + F + + L NP+
Sbjct: 266 NLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 39/155 (25%), Positives = 64/155 (41%), Gaps = 30/155 (19%)
Query: 7 LSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGT 63
L+L +Q + + +L L LS N + +I G + N+ T++L +N+LT T
Sbjct: 69 LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-T 126
Query: 64 IPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS----RTLN----------ATETF---- 104
IP+ F L +L+ L++ NN + SIPS + R L+ + F
Sbjct: 127 IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLS 185
Query: 105 ---ILDFQNNNLTNISGSFNIPPNVTV-RLRGNPF 135
L+ NL I + + L GN
Sbjct: 186 NLRYLNLAMCNLREIP-NLTPLIKLDELDLSGNHL 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 11/114 (9%)
Query: 25 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 84
+ L +P G +S N + L N++ ++F L L+ L ++ N +
Sbjct: 43 NQFSKVICVRKNLR-EVPDG-ISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 85 SGSIPSSI-WQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGNPF 135
+I LN L+ +N LT I G+F + LR NP
Sbjct: 101 R-TIEIGAFNGLANLN-----TLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI 148
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 58/233 (24%), Positives = 89/233 (38%), Gaps = 39/233 (16%)
Query: 369 EMALATNNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKE---FLTE 421
+M L +F IG+G +G+V K V A+K + + E F E
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREE 124
Query: 422 IQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK---EPLG--FAMR 475
L + + +L Y ++ + LV ++ G L LS E + +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 476 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535
+ IA+ +H HRDIK NIL+D ++ADFG + +
Sbjct: 184 MVIAID------SVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL-------KLME 227
Query: 536 PAHVSTVVK-GTPGYLDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQP 582
V + V GTP Y+ PE + D +SLGV E+L G P
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 51/230 (22%)
Query: 375 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 421
+F +G+G +GKV +K A+K EK L+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 422 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 473
FL+ + + E + V E+++ G L + + K +A
Sbjct: 74 AWEHPFLTHMF---------CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124
Query: 474 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533
+ + L +LH++ + +RD+K NILLD K+ADFG+ + E
Sbjct: 125 AEIILGLQ------FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK-------EN 168
Query: 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
++ + GTP Y+ PE L + + S D +S GV+ E+L G P
Sbjct: 169 MLGDAKTNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 51/230 (22%)
Query: 375 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 421
++F+ IG+G +GKV K + AVK + +E + E+ L +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 422 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 473
FL LH + + +++ V ++++ G L L + EP +A
Sbjct: 95 NVKHPFLVGLH---------FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA 145
Query: 474 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533
++ ALG YLH+ + +RD+K NILLD + + DFGL + E
Sbjct: 146 AEIASALG------YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-------EN 189
Query: 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
I ++ GTP YL PE L + D++ D + LG V E+L G+ P
Sbjct: 190 IEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 375 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 427
+ F+ +G G +G+V K G A+K + + K+ L E + L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 428 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 483
++ LV L + +V E+++ G + L + EP +A ++ +
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE-- 155
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
YLH+ + +RD+K N+L+D + +V DFG ++ V T+
Sbjct: 156 ----YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLC 199
Query: 544 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
GTP L PE + K +K+ D ++LGV+ E+ G P
Sbjct: 200 -GTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 29/118 (24%), Positives = 53/118 (44%), Gaps = 11/118 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ L +L + + + L+++ NL L ++NQ++ P G L+ N+ + L+ N+L
Sbjct: 176 LTTLERLDISSNKVSDI-SVLAKLTNLESLIATNNQISDITPLGILT-NLDELSLNGNQL 233
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
+ L L L +ANN +S P + L L N ++NIS
Sbjct: 234 KD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLT-----ELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 34/135 (25%), Positives = 59/135 (43%), Gaps = 11/135 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ L L L N + + LS + L L L +NQ++ P L+ +T ++L+ N+L
Sbjct: 242 LTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISNISPLAGLT-ALTNLELNENQL 299
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
P S L L L + N++S P S + T+ L F NN ++++S
Sbjct: 300 EDISP--ISNLKNLTYLTLYFNNISDISPVS-------SLTKLQRLFFYNNKVSDVSSLA 350
Query: 121 NIPPNVTVRLRGNPF 135
N+ + N
Sbjct: 351 NLTNINWLSAGHNQI 365
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 24/118 (20%), Positives = 51/118 (43%), Gaps = 11/118 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ ++ L ++ + + NL ++ S+NQL P L+ + I ++NN++
Sbjct: 45 LDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITPLKNLT-KLVDILMNNNQI 102
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
+ + L L L + NN ++ P + LN L+ +N +++IS
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLN-----RLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 27/132 (20%), Positives = 56/132 (42%), Gaps = 18/132 (13%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ L +++ N L + L + L + +++NQ+ P L+ N+T + L NN++
Sbjct: 67 LNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITPLANLT-NLTGLTLFNNQI 124
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIP-------SSIWQSRTLNATETF-------IL 106
T P L L RL +++N++S + + + L
Sbjct: 125 TDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERL 182
Query: 107 DFQNNNLTNISG 118
D +N +++IS
Sbjct: 183 DISSNKVSDISV 194
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 30/137 (21%), Positives = 58/137 (42%), Gaps = 28/137 (20%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++KL+ + + N + L+ + NL L L +NQ+ P L+ N+ ++LS+N +
Sbjct: 89 LTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQITDIDPLKNLT-NLNRLELSSNTI 146
Query: 61 TG-------------------TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 101
+ T + L L+RL I++N +S S + + L
Sbjct: 147 SDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLE-- 202
Query: 102 ETFILDFQNNNLTNISG 118
L NN +++I+
Sbjct: 203 ---SLIATNNQISDITP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-10
Identities = 24/136 (17%), Positives = 50/136 (36%), Gaps = 10/136 (7%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++KL +L N + L+ + N+ +L NQ++ P L+ IT + L++
Sbjct: 330 LTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLTPLANLT-RITQLGLNDQAW 387
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GS 119
T + + + + +L P++I + D N + + S
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTE-----PDITWNLPSYTNEVS 440
Query: 120 FNIPPNVTVRLRGNPF 135
+ VT+ F
Sbjct: 441 YTFSQPVTIGKGTTTF 456
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 14/98 (14%), Positives = 32/98 (32%), Gaps = 10/98 (10%)
Query: 21 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80
+ + L + ++ L +TT++ + L L ++ +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVSQTDLD-QVTTLQADRLGI--KSIDGVEYLNNLTQINFS 76
Query: 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
NN L+ P + L + NN + +I+
Sbjct: 77 NNQLTDITP--LKNLTKLV-----DILMNNNQIADITP 107
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 25/143 (17%), Positives = 49/143 (34%), Gaps = 13/143 (9%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 57
++ +L L ++ + L L+L S +I N+ + L +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSI--PSSIWQSRTLNATETFILDFQNNNLTN 115
+K+ P F GL L L + LS ++ + L LD N + +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT-----RLDLSKNQIRS 137
Query: 116 I--SGSFNIPPNV-TVRLRGNPF 135
+ SF ++ ++ N
Sbjct: 138 LYLHPSFGKLNSLKSIDFSSNQI 160
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 31/152 (20%), Positives = 49/152 (32%), Gaps = 16/152 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNG----SIPPGRLSL--NITT 52
+ L L L D S P+L L L N L + ++
Sbjct: 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 53 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 112
+ L++N L P FS L L+ L + +N L+ + + + L ILD N
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPAN-LE-----ILDISRNQ 537
Query: 113 LTNISGSFNIPPNVTVRLRGNPFCLNTNAEQF 144
L + + + N F F
Sbjct: 538 LLAPNPDV-FVSLSVLDITHNKFICECELSTF 568
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 8e-12
Identities = 35/137 (25%), Positives = 59/137 (43%), Gaps = 12/137 (8%)
Query: 2 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNN 58
S + L L + + + +L L+L+ N++N I N+ + LS N
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYN 324
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
L SNF GLP++ + + N ++ I ++ L +T LD ++N LT I
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKF--LEKLQT--LDLRDNALTTIHF 379
Query: 119 SFNIPPNVTVRLRGNPF 135
+IP + L GN
Sbjct: 380 IPSIP---DIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 8e-11
Identities = 30/141 (21%), Positives = 55/141 (39%), Gaps = 14/141 (9%)
Query: 4 LLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNK 59
+ L L+ + L R+P+L L L+ N+ + S ++ + L N
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 60 LTGTIPSN-----FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
L + F GL LQ L++ +N L+ S+P ++ + T L +N LT
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFS----HLTALRGLSLNSNRLT 517
Query: 115 NISGSFNIPPNVTVRLRGNPF 135
+S + + + N
Sbjct: 518 VLSHNDLPANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 19/171 (11%), Positives = 51/171 (29%), Gaps = 12/171 (7%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQL-NGSIPPGRLS--LNITTIKLS 56
+ L L L + + + +L L L L + + G +T + LS
Sbjct: 72 LPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 57 NNKLTG-TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS------RTLNATETFILDFQ 109
N++ + +F L L+ + ++N + + + + +
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRV 190
Query: 110 NNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTN 160
+ + F + + GN + ++ + + +
Sbjct: 191 SVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 36/163 (22%), Positives = 57/163 (34%), Gaps = 35/163 (21%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ KL L LR+ +L + IP++ + LS N+L ++P L+ N I LS N+L
Sbjct: 361 LEKLQTLDLRDNALT----TIHFIPSIPDIFLSGNKLV-TLPKINLTAN--LIHLSENRL 413
Query: 61 TG-TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS----RTLN--------------AT 101
I +P LQ L + N S L
Sbjct: 414 ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW 473
Query: 102 ETF-------ILDFQNNNLTNIS-GSFNIPPNVTV-RLRGNPF 135
+ F +L +N L ++ G F+ + L N
Sbjct: 474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 22/141 (15%), Positives = 49/141 (34%), Gaps = 14/141 (9%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS----LNITTIKLSN 57
+ + + N + L ++ + + + ++ + LS+
Sbjct: 217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSH 275
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
+ ++ S F L L+ L +A N ++ I + L+ + L+ N L +
Sbjct: 276 GFVF-SLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYG--LDNLQV--LNLSYNLLGEL 329
Query: 117 -SGSFNIPPNVTV-RLRGNPF 135
S +F P V L+ N
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 19/106 (17%), Positives = 38/106 (35%), Gaps = 9/106 (8%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89
L +P L+ + LS N + S+F L +LQ L + + +I
Sbjct: 9 AFYRFCNLT-QVPQV-LN-TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 90 SSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 133
+++ L LD ++ + + +F ++ RL
Sbjct: 66 KEAFRN--LPNLRI--LDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 30/159 (18%), Positives = 54/159 (33%), Gaps = 29/159 (18%)
Query: 1 MSKLLKLSLRNCSLQ-------GPMPDLSRIPNLGYLDLSSNQLNGSIP----------- 42
L SL SL G + R L LD+S N I
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 43 --PGRLSLNITTIKLSNNKLTGTIPSNFSGLPR--LQRLFIANNSLSGSIPSSIWQSRTL 98
L+ +I + + + F+GL R ++ L +++ + S+ S +++
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFE---- 287
Query: 99 NATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 135
+ +L+ N + I +F N+ V L N
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 31/116 (26%), Positives = 56/116 (48%), Gaps = 11/116 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNN 58
+ L L+L C+++ MP+L+ + L L++S N I PG ++ + + N+
Sbjct: 195 LFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNS 252
Query: 59 KLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 113
+++ I N F GL L L +A+N+LS S+P ++ L L +N
Sbjct: 253 QVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTP--LRYLVE--LHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 34/156 (21%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 6 KLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTG 62
L+L ++Q + +L L L N + I G + ++ T++L +N LT
Sbjct: 79 YLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT- 136
Query: 63 TIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS----RTLN----------ATETF--- 104
IPS F L +L+ L++ NN + SIPS + L+ + F
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195
Query: 105 ----ILDFQNNNLTNISGSFNIPPNVTV-RLRGNPF 135
L+ N+ ++ + + + GN F
Sbjct: 196 FNLKYLNLGMCNIKDMP-NLTPLVGLEELEMSGNHF 230
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 28/115 (24%), Positives = 45/115 (39%), Gaps = 13/115 (11%)
Query: 25 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNS 83
+ + L+ +P G + N + L N + I ++ F L L+ L + NS
Sbjct: 54 NQFSKVVCTRRGLS-EVPQG-IPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110
Query: 84 LSGSIPSSI-WQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 135
+ I +LN L+ +N LT I SG+F + LR NP
Sbjct: 111 IR-QIEVGAFNGLASLN-----TLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI 159
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 34/159 (21%), Positives = 56/159 (35%), Gaps = 28/159 (17%)
Query: 4 LLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNG------SIPPGRLSLNITTIKLS 56
L LS+ + P L LDLS N G ++ P + + + L
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP-TLQVLALR 209
Query: 57 NNKLT---GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS----RTLNATETFI---- 105
N + G + + +LQ L +++NSL + + +LN + T +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 106 ---------LDFQNNNLTNISGSFNIPPNVTVRLRGNPF 135
LD N L +P + L+GNPF
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 25/89 (28%), Positives = 37/89 (41%), Gaps = 6/89 (6%)
Query: 1 MSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNN 58
+L L L + SL+ P L L+LS L +P G L ++ + LS N
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG-LPAKLSVLDLSYN 284
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGS 87
+L PS LP++ L + N S
Sbjct: 285 RLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 23/129 (17%), Positives = 42/129 (32%), Gaps = 9/129 (6%)
Query: 1 MSKLLKLSLRNCSLQGPMPD---LSRIPNLGYLDLSSNQLNGSIP-----PGRLSLNITT 52
+S L +L+L N + G P + P+L L+L + L +
Sbjct: 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153
Query: 53 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 112
+ ++ P L L +++N G I L +L +N
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG-LISALCPLKFPTLQVLALRNAG 212
Query: 113 LTNISGSFN 121
+ SG +
Sbjct: 213 METPSGVCS 221
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 29/138 (21%), Positives = 62/138 (44%), Gaps = 16/138 (11%)
Query: 6 KLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKL 60
+L L N ++P L ++ S+N++ I G S + I L++N+L
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS-GVNEILLTSNRL 93
Query: 61 TGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-G 118
+ F GL L+ L + +N ++ + + + + +L +N +T ++ G
Sbjct: 94 E-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFI----GLSSVRLLSLYDNQITTVAPG 147
Query: 119 SFNIPPNVT-VRLRGNPF 135
+F+ +++ + L NPF
Sbjct: 148 AFDTLHSLSTLNLLANPF 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 35/137 (25%), Positives = 65/137 (47%), Gaps = 15/137 (10%)
Query: 6 KLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLT 61
++ L +++ P S L +DLS+NQ++ + P L ++ ++ L NK+T
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR-SLNSLVLYGNKIT 93
Query: 62 GTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GS 119
+P + F GL LQ L + N ++ + +Q + +L +N L I+ G+
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQ----DLHNLNLLSLYDNKLQTIAKGT 147
Query: 120 FNIPPNV-TVRLRGNPF 135
F+ + T+ L NPF
Sbjct: 148 FSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 24/84 (28%), Positives = 36/84 (42%), Gaps = 11/84 (13%)
Query: 40 SIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSI-WQSRT 97
IP L IT I+L N + IP FS +L+R+ ++NN +S + R+
Sbjct: 25 EIPTN-LPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 98 LNATETFILDFQNNNLTNI-SGSF 120
LN L N +T + F
Sbjct: 82 LN-----SLVLYGNKITELPKSLF 100
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 29/142 (20%), Positives = 55/142 (38%), Gaps = 15/142 (10%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLS 56
S + L + S +L L L+ N++N I L+ ++ + LS
Sbjct: 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLT-HLLKLNLS 331
Query: 57 NNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115
N L +I S F L +L+ L ++ N + ++ + L N L +
Sbjct: 332 QNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFL----GLPNLKELALDTNQLKS 385
Query: 116 I-SGSFNIPPNVT-VRLRGNPF 135
+ G F+ ++ + L NP+
Sbjct: 386 VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 26/144 (18%), Positives = 52/144 (36%), Gaps = 15/144 (10%)
Query: 2 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGS-IPPG---RLSLNITTIKLS 56
S L+ L L + + NL L L+ L+G+ + L+ ++ + L
Sbjct: 79 SSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT-SLEMLVLR 137
Query: 57 NNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115
+N + P++ F + R L + N + SI + +L + L +
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLN--FQGKHFTLLRLSSITLQD 194
Query: 116 ISGSFNIPPNVTVRLRGNPFCLNT 139
++ + GNPF +
Sbjct: 195 MN-----EYWLGWEKCGNPFKNTS 213
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 23/106 (21%), Positives = 43/106 (40%), Gaps = 11/106 (10%)
Query: 31 DLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 90
+ L+ +P L ++ + LS N + ++FS L LQ L + + I +
Sbjct: 16 ICINRGLH-QVPE--LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN 72
Query: 91 SIWQS-RTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 133
+ ++ +L IL N + +G+FN N+ V L
Sbjct: 73 NTFRGLSSLI-----ILKLDYNQFLQLETGAFNGLANLEVLTLTQC 113
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 31/183 (16%), Positives = 59/183 (32%), Gaps = 51/183 (27%)
Query: 1 MSKLLKLSLRNCSLQ--GPMPDLSRIPNLGYLDLSSNQLNGSIPPG-----------RLS 47
++ L L LR+ +++ P + LDL+ N++ SI L
Sbjct: 128 LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLR 186
Query: 48 L-------------------------NITTIKLSNNKLTGTIPSNFSGLP---RLQRLFI 79
L +ITT+ LS N ++ F ++Q L +
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 80 ANNSLSGSIPSSI-------WQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RL 130
+N+ GS + + L A+ D + + + F+ ++ L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306
Query: 131 RGN 133
N
Sbjct: 307 AQN 309
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 29/130 (22%), Positives = 52/130 (40%), Gaps = 12/130 (9%)
Query: 2 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNN 58
L +L L + +Q + DL R L L L NQ+ I G LS + + L NN
Sbjct: 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNN 251
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI--LDFQNNNLTNI 116
KL+ +P+ L LQ +++ N+++ + + + + + NN +
Sbjct: 252 KLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309
Query: 117 SGSFNIPPNV 126
+ P
Sbjct: 310 E----VQPAT 315
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 26/139 (18%), Positives = 44/139 (31%), Gaps = 12/139 (8%)
Query: 1 MSKLLKLSLRNCSLQGPM--PDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNN 58
+ + + + L+ P L YL +S +L IP + + L +N
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPE-TLNELHLDHN 203
Query: 59 KLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
K+ I +L RL + +N + I + L L NN L+ +
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSF--LPTLRE--LHLDNNKLSRVP 257
Query: 118 GSFNIPPN-VTVRLRGNPF 135
V L N
Sbjct: 258 AGLPDLKLLQVVYLHTNNI 276
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 31/137 (22%), Positives = 52/137 (37%), Gaps = 14/137 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 59
+ L L L N + S + L L +S N L IPP S ++ +++ +N+
Sbjct: 77 LQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS-SLVELRIHDNR 134
Query: 60 LTGTIPSN-FSGLPRLQRLFIANNSL-SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
+ +P FSGL + + + N L + + LN L LT I
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLN-----YLRISEAKLTGIP 188
Query: 118 GSFNIPPNVTV-RLRGN 133
++P + L N
Sbjct: 189 K--DLPETLNELHLDHN 203
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 15/92 (16%), Positives = 26/92 (28%), Gaps = 11/92 (11%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG--------RLSLNITT 52
+ L +L L N L L + L + L +N + +
Sbjct: 240 LPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNG 298
Query: 53 IKLSNNKLT-GTIPSN-FSGLPRLQRLFIANN 82
I L NN + + F + + N
Sbjct: 299 ISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 14/111 (12%)
Query: 26 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 84
+L + S L ++P +S + T + L NN ++ + + F GL L L + NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKE-ISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 85 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 133
S I + R L L N+L I N+P ++ R+ N
Sbjct: 91 S-KIHEKAFSPLRKLQ-----KLYISKNHLVEIPP--NLPSSLVELRIHDN 133
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 27/134 (20%), Positives = 55/134 (41%), Gaps = 13/134 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNN 58
M KL + + + ++ L P+L L L N++ + L N+ + LS N
Sbjct: 170 MKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFN 226
Query: 59 KLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
++ + + + P L+ L + NN L +P + + + ++ NNN++ I
Sbjct: 227 SIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ-----VVYLHNNNISAIG 279
Query: 118 GSFNIPPNVTVRLR 131
+ PP +
Sbjct: 280 SNDFCPPGYNTKKA 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 33/138 (23%), Positives = 61/138 (44%), Gaps = 15/138 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 59
+ L L L N + P + + L L LS NQL +P + +++ N+
Sbjct: 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK-TLQELRVHENE 132
Query: 60 LTGTIPSN-FSGLPRLQRLFIANNSL-SGSIPSSIWQS-RTLNATETFILDFQNNNLTNI 116
+T + + F+GL ++ + + N L S I + +Q + L+ + + N+T I
Sbjct: 133 IT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS-----YIRIADTNITTI 186
Query: 117 SGSFNIPPNVTV-RLRGN 133
+PP++T L GN
Sbjct: 187 PQ--GLPPSLTELHLDGN 202
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 35/134 (26%), Positives = 58/134 (43%), Gaps = 24/134 (17%)
Query: 11 NCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGT 63
CS G L ++P + LDL +N++ I G N+ T+ L NNK++
Sbjct: 37 QCSDLG----LEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-K 90
Query: 64 IPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFN 121
I F+ L +L+RL+++ N L +P + ++ L N +T + FN
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQE-------LRVHENEITKVRKSVFN 142
Query: 122 IPPNVTV-RLRGNP 134
+ V L NP
Sbjct: 143 GLNQMIVVELGTNP 156
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 14/92 (15%), Positives = 31/92 (33%), Gaps = 11/92 (11%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--------NITT 52
L +L L N L L+ + + L +N ++ +I + +
Sbjct: 239 TPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSG 297
Query: 53 IKLSNNKLTGT-IPSN-FSGLPRLQRLFIANN 82
+ L +N + I + F + + + N
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 25/121 (20%), Positives = 46/121 (38%), Gaps = 16/121 (13%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNN 58
++ L KL L S+ L+ P+L L L++N+L +P G I + L NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 59 KLTGTIPSN-------FSGLPRLQRLFIANNSLS-GSIPSSIWQSRTLNATETFILDFQN 110
++ I SN + + + +N + I S ++ + + N
Sbjct: 274 NIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC--VYVRAA--VQLGN 328
Query: 111 N 111
Sbjct: 329 Y 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 26/111 (23%), Positives = 39/111 (35%), Gaps = 14/111 (12%)
Query: 26 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 84
+L + S L +P L + + L NNK+T I F L L L + NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKD-LPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKI 88
Query: 85 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 133
S I + L L N L + +P + R+ N
Sbjct: 89 S-KISPGAFAPLVKLE-----RLYLSKNQLKELPE--KMPKTLQELRVHEN 131
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 67/284 (23%), Positives = 107/284 (37%), Gaps = 66/284 (23%)
Query: 326 TISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQ 385
+ A+V L A KN + + T KI +R + ++ IG+
Sbjct: 28 GLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLR--------MKAEDYEVVKVIGR 79
Query: 386 GGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTEIQ--FLSRLHH 430
G +G+V K V A+K R+ E++ + ++ +L +
Sbjct: 80 GAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 431 -----RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLG--FAMRLSIALGS 482
R L Y +V E+M G L + +S E + + +AL
Sbjct: 137 AFQDDRYL-----Y--------MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD- 182
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 542
+H+ HRD+K N+LLD K+ADFG + EG+V T
Sbjct: 183 -----AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCD--TA 229
Query: 543 VKGTPGYLDPEYFLTHKLT---DKS-DVYSLGVVFLELLTGMQP 582
V GTP Y+ PE + + D +S+GV E+L G P
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 21/126 (16%), Positives = 48/126 (38%), Gaps = 9/126 (7%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNN 58
+ L LR+ L R+ +L ++ + + L +P + + + T+ L+ N
Sbjct: 80 QPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA-GLETLTLARN 137
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF----ILDFQNNNLT 114
L +P++ + L RL+ L I +P + + + L + +
Sbjct: 138 PLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196
Query: 115 NISGSF 120
++ S
Sbjct: 197 SLPASI 202
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 27/121 (22%), Positives = 43/121 (35%), Gaps = 15/121 (12%)
Query: 2 SKLLKLSLRNCSLQGPMPDL---SRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLS 56
S ++ R DL + P L+L S L P RLS ++ + +
Sbjct: 55 SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS-HLQHMTID 112
Query: 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ-NNNLTN 115
L +P L+ L +A N L ++P+SI L L + LT
Sbjct: 113 AAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR-----ELSIRACPELTE 165
Query: 116 I 116
+
Sbjct: 166 L 166
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 24/118 (20%), Positives = 46/118 (38%), Gaps = 8/118 (6%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNN 58
+ L L L ++ ++ + NL L + ++ L+ ++ P L + + L
Sbjct: 182 LVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP-KLEELDLRGC 239
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
P F G L+RL + + S ++P I + L E L NL+ +
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL---EKLDLR-GCVNLSRL 293
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 26/120 (21%), Positives = 46/120 (38%), Gaps = 12/120 (10%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSN 57
+ L L +RN L P + +P L LDL + PP G + + + L +
Sbjct: 205 LQNLKSLKIRNSPLSALG-PAIHHLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLILKD 262
Query: 58 -NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
+ L T+P + L +L++L + +PS I Q I+ + +
Sbjct: 263 CSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC-----IILVPPHLQAQL 316
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 375 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 427
+F +G G +G+V+ + +G A+K ++ + K+ E LS
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 428 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 483
+ H ++ + G + + ++ +++ G L L + P+ +A + +AL
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE-- 120
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
YLH++ + +RD+K NILLD K+ DFG ++ VP T+
Sbjct: 121 ----YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTYTLC 164
Query: 544 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 582
GTP Y+ PE ++ K +KS D +S G++ E+L G P
Sbjct: 165 -GTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 12/137 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ +L + S+ ++ L L L N L + + LS N+L
Sbjct: 204 PIAVEELDASHNSINVVRGPVN--VELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNEL 260
Query: 61 TGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SG 118
I + F + RL+RL+I+NN L ++ TL +LD +N+L ++
Sbjct: 261 E-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK-----VLDLSHNHLLHVERN 313
Query: 119 SFNIPPNVTVRLRGNPF 135
+ L N
Sbjct: 314 QPQFDRLENLYLDHNSI 330
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 27/138 (19%), Positives = 56/138 (40%), Gaps = 14/138 (10%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSN 57
++ L+L + ++ + + L + N + +PP +T + L
Sbjct: 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLER 126
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N L+ ++P F P+L L ++NN+L I +Q T L +N LT++
Sbjct: 127 NDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQ----ATTSLQNLQLSSNRLTHV 180
Query: 117 SGSFNIPPNVT-VRLRGN 133
++ P++ + N
Sbjct: 181 --DLSLIPSLFHANVSYN 196
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 32/152 (21%), Positives = 50/152 (32%), Gaps = 29/152 (19%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN------------------GSIP 42
+ L L L + L DLS IP+L + ++S N L+ +
Sbjct: 164 TTSLQNLQLSSNRLT--HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVR 221
Query: 43 PGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 102
+T +KL +N LT P L + ++ N L I +
Sbjct: 222 GPVNV-ELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFV----KMQR 273
Query: 103 TFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 133
L NN L ++ P + V L N
Sbjct: 274 LERLYISNNRLVALNLYGQPIPTLKVLDLSHN 305
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 25/146 (17%), Positives = 55/146 (37%), Gaps = 14/146 (9%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNN 58
L+++ L L+ ++ L L +S+N+L ++ + + + LS+N
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 305
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
L + N RL+ L++ +NS+ ++ S + L L +N+ S
Sbjct: 306 HLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHT--LKN-----LTLSHNDWDCNSL 356
Query: 119 SFNIPPNVT-VRLRGNPFCLNTNAEQ 143
+ NV + + +
Sbjct: 357 RA-LFRNVARPAVDDADQHCKIDYQL 381
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 17/120 (14%), Positives = 40/120 (33%), Gaps = 12/120 (10%)
Query: 20 DLSRIPNLGYLDLSSNQLNGSIPPGRLSL---NITTIKLSNNKLTGTIPSN-FSGLPRLQ 75
D + + + D+ + + G + N + N+ + +P+ +++
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72
Query: 76 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 133
L + + + I + + A L N + + F P +TV L N
Sbjct: 73 LLNLNDLQIE-EIDTYAFA----YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 63/233 (27%), Positives = 95/233 (40%), Gaps = 50/233 (21%)
Query: 375 NNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVK----------RAQEGSLQGEKEFLT 420
NF +G G YGKV+ K D G + A+K + E++ L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 421 EIQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--F 472
I+ FL LH Y + ++ L+ ++++ G L LS + + E +
Sbjct: 114 HIRQSPFLVTLH---------YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 473 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532
+ +AL +LH + +RDIK NILLD + DFGLS+ E
Sbjct: 165 VGEIVLALE------HLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-------E 208
Query: 533 GIVPAHVSTV-VKGTPGYLDPEYFLTHKL-TDKS-DVYSLGVVFLELLTGMQP 582
+ GT Y+ P+ DK+ D +SLGV+ ELLTG P
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 39/147 (26%), Positives = 59/147 (40%), Gaps = 24/147 (16%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 61
S+L KL N L +P L L L +S NQL S+P L + NN+LT
Sbjct: 161 SELCKLWAYNNQLTS-LPML--PSGLQELSVSDNQLA-SLPTLPSEL--YKLWAYNNRLT 214
Query: 62 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI------------LDFQ 109
++P+ L+ L ++ N L+ S+P + + L + + L
Sbjct: 215 -SLPAL---PSGLKELIVSGNRLT-SLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVY 269
Query: 110 NNNLTNISGSFNIPPNVTV-RLRGNPF 135
N LT + S + T L GNP
Sbjct: 270 RNQLTRLPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 29/162 (17%), Positives = 53/162 (32%), Gaps = 15/162 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
S L +L + L +P L L L +S N+L S+P L ++ + N+L
Sbjct: 220 PSGLKELIVSGNRLTS-LPVL--PSELKELMVSGNRLT-SLPMLPSGL--LSLSVYRNQL 273
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
T +P + L + + N LS + T + + +
Sbjct: 274 T-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITS-------APGYSGPIIRFDMAG 324
Query: 121 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNST 162
P T L A + + +D + + N+
Sbjct: 325 ASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNAD 366
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 22/124 (17%), Positives = 40/124 (32%), Gaps = 28/124 (22%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPGRLSLNITTIKLS 56
+ L++ L + +P ++ L + N L S+P + T+++S
Sbjct: 40 NGNAVLNVGESGL-------TTLPDCLPAHITTLVIPDNNLT-SLPA-LPP-ELRTLEVS 89
Query: 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
N+LT ++P GL L L L N LT++
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG--LCK----------LWIFGNQLTSL 136
Query: 117 SGSF 120
Sbjct: 137 PVLP 140
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 32/140 (22%), Positives = 56/140 (40%), Gaps = 12/140 (8%)
Query: 4 LLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKL 60
L L L+ P S +PN+ + +S + + +T I++ N +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 61 TGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN-LTNIS- 117
I + LP L+ L I N L P ++ + FIL+ +N +T+I
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDL---TKVYSTDIFFILEITDNPYMTSIPV 148
Query: 118 GSFNIPPN--VTVRLRGNPF 135
+F N +T++L N F
Sbjct: 149 NAFQGLCNETLTLKLYNNGF 168
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 27/125 (21%), Positives = 49/125 (39%), Gaps = 13/125 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRI---PNLGYLDLSSNQLNGSIPPG---RLSLNITTIK 54
+ L L + N L+ PDL+++ L+++ N SIP L T+K
Sbjct: 104 LPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162
Query: 55 LSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 113
L NN T ++ F+G +L +++ N I + + LD ++
Sbjct: 163 LYNNGFT-SVQGYAFNGT-KLDAVYLNKNKYLTVIDKDAFGGVYSGPSL---LDVSQTSV 217
Query: 114 TNISG 118
T +
Sbjct: 218 TALPS 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 25/109 (22%), Positives = 37/109 (33%), Gaps = 18/109 (16%)
Query: 20 DLSRIP----NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLS-NNKLTGTIPSN-FSG 70
D+ RIP + L L L +IP L NI+ I +S + L + S+ F
Sbjct: 22 DIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLP-NISRIYVSIDVTLQ-QLESHSFYN 78
Query: 71 LPRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFILDFQNNNLTNISG 118
L ++ + I N I + L L N L
Sbjct: 79 LSKVTHIEIRNTRNLTYIDPDALKELPLLK-----FLGIFNTGLKMFPD 122
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 22/97 (22%), Positives = 40/97 (41%), Gaps = 9/97 (9%)
Query: 26 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 84
++ + IP L + T+KL L TIPS+ FS LP + R++++ +
Sbjct: 12 QEEDFRVTCKDIQ-RIP--SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVT 67
Query: 85 SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSF 120
+ S + + L+ + NLT I +
Sbjct: 68 LQQLESHSFYN--LSKVTHIEI-RNTRNLTYIDPDAL 101
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 23/134 (17%), Positives = 43/134 (32%), Gaps = 23/134 (17%)
Query: 11 NCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTG 62
C +IP + LDLS N L + + + LS ++
Sbjct: 13 QCMELN----FYKIPDNLPFSTKNLDLSFNPL-RHLGSYSFFSFP-ELQVLDLSRCEIQ- 65
Query: 63 TIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSF 120
TI + L L L + N + S+ + L++ + L NL ++ +
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSG--LSSLQK--LVAVETNLASLENFPI 120
Query: 121 NIPPNVTV-RLRGN 133
+ + N
Sbjct: 121 GHLKTLKELNVAHN 134
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 24/101 (23%), Positives = 45/101 (44%), Gaps = 12/101 (11%)
Query: 20 DLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQ 75
P L LDLS ++ +I G LS +++T+ L+ N + ++ FSGL LQ
Sbjct: 47 SFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS-HLSTLILTGNPIQ-SLALGAFSGLSSLQ 103
Query: 76 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116
+L +L+ S+ + + L+ +N + +
Sbjct: 104 KLVAVETNLA-SLENFPIG----HLKTLKELNVAHNLIQSF 139
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 24/141 (17%), Positives = 47/141 (33%), Gaps = 34/141 (24%)
Query: 25 PNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN--FSGLPRLQRLFI 79
+L L L S+ L + + +++N + + FS L L+ L +
Sbjct: 100 SSLQKLVAVETNLA-SLENFPIGHLK-TLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDL 156
Query: 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSF----------------NI 122
++N + SI + + LD N + I G+F ++
Sbjct: 157 SSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSV 215
Query: 123 PPNV--------TVRLRGNPF 135
P + + L NP+
Sbjct: 216 PDGIFDRLTSLQKIWLHTNPW 236
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 8e-08
Identities = 24/89 (26%), Positives = 41/89 (46%), Gaps = 9/89 (10%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGY----LDLSSNQLNGSIPPGRL-SLNITTIK 54
++ L L L + +Q DL + + LDLS N +N I PG + + +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELA 206
Query: 55 LSNNKLTGTIPSN-FSGLPRLQRLFIANN 82
L N+L ++P F L LQ++++ N
Sbjct: 207 LDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 22/98 (22%), Positives = 38/98 (38%), Gaps = 10/98 (10%)
Query: 40 SIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 98
IP L + + LS N L + S F P LQ L ++ + +I +QS L
Sbjct: 21 KIPDN-LPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQS--L 75
Query: 99 NATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNP 134
+ T L N + ++ G+F+ ++
Sbjct: 76 SHLST--LILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 26/119 (21%), Positives = 51/119 (42%), Gaps = 8/119 (6%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
M+ L ++L N ++ + + N+ L +++ P LS N+ +++ +
Sbjct: 43 MNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHATNYNPISGLS-NLERLRIMGKDV 100
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN-LTNISG 118
T N SGL L L I++++ SI + I +N +D N +T+I
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN-----SIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 7e-11
Identities = 20/119 (16%), Positives = 46/119 (38%), Gaps = 8/119 (6%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNK 59
+ L++ N P +S + NL L + + P L ++T + +S++
Sbjct: 65 AHNIKDLTINNIHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
+I + + LP++ + ++ N I + L L+ Q + + + G
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELK-----SLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 20/117 (17%), Positives = 45/117 (38%), Gaps = 14/117 (11%)
Query: 3 KLLKLSLRNCSLQGPMPDLSR--IPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
L L S +++ + +L Y+ L++ + + + NI + ++N
Sbjct: 24 AYLNGLLGQSSTA----NITEAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHA 78
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
T + SGL L+RL I ++ ++ +L +LD ++ +
Sbjct: 79 TNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT-----LLDISHSAHDDSI 128
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 49/264 (18%), Positives = 94/264 (35%), Gaps = 49/264 (18%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLH---------- 429
+G G + V+ + + T VA+K R + + EI+ L R++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 430 -HRNLVSLVG---YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGS 482
+++ L+ + G + +V+E + L + K E G + I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALI--KKYEHRGIPLIYVKQISKQL 140
Query: 483 SRGILYLHTEADPPVFHRDIKASNILLDH------KFTAKVADFGLSRLAPVPDIEGIVP 536
G+ Y+H + H DIK N+L++ K+AD G +
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---------YD 189
Query: 537 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 596
H + ++ T Y PE L +D++S + EL+TG +
Sbjct: 190 EHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDD 247
Query: 597 YQSSMMFSVIDGNMGSYPSECVEK 620
+ + ++ G PS +
Sbjct: 248 DHIAQIIELL----GELPSYLLRN 267
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 29/132 (21%), Positives = 49/132 (37%), Gaps = 21/132 (15%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 61
L L + N L+ +P+L L +D+ +N L +P L ++ I NN+L
Sbjct: 131 PLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLK-KLPD--LPPSLEFIAAGNNQLE 186
Query: 62 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI--------------LD 107
+P LP L ++ NNSL +P ++ A + +
Sbjct: 187 -ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 243
Query: 108 FQNNNLTNISGS 119
NN L +
Sbjct: 244 ADNNLLKTLPDL 255
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 33/140 (23%), Positives = 53/140 (37%), Gaps = 22/140 (15%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
L ++ N L+ P+L +P L + +N L +P LSL +I NN L
Sbjct: 172 PPSLEFIAAGNNQLEEL-PELQNLPFLTAIYADNNSLK-KLPDLPLSL--ESIVAGNNIL 227
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI------------LDF 108
LP L ++ NN L ++P LN + ++ LD
Sbjct: 228 --EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDV 284
Query: 109 QNNNLTNISGSFNIPPNVTV 128
N + +S +PPN+
Sbjct: 285 SENIFSGLS---ELPPNLYY 301
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 31/120 (25%), Positives = 50/120 (41%), Gaps = 19/120 (15%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
L L + G + +L PNL YL+ SSN++ S+ L ++ + +SNNKL
Sbjct: 276 PQSLTFLDVSENIFSG-LSEL--PPNLYYLNASSNEIR-SLCD--LPPSLEELNVSNNKL 329
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
+P+ PRL+RL + N L+ +P + L + N L
Sbjct: 330 I-ELPAL---PPRLERLIASFNHLA-EVPELPQNLKQ--------LHVEYNPLREFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 31/120 (25%), Positives = 49/120 (40%), Gaps = 17/120 (14%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIP-NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 59
L L + N +L+ LS +P L YL +S+NQL +P + S + I + NN
Sbjct: 110 PQSLKSLLVDNNNLK----ALSDLPPLLEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNS 164
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 119
L +P P L+ + NN L +P + L + NN+L +
Sbjct: 165 LK-KLP---DLPPSLEFIAAGNNQLE-ELP-ELQNLPFLT-----AIYADNNSLKKLPDL 213
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 21/147 (14%), Positives = 51/147 (34%), Gaps = 31/147 (21%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL------------- 48
+ L + + +L + + + + ++ + PPG
Sbjct: 11 TFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD 70
Query: 49 -NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 107
++L+N L+ ++P P L+ L + NSL+ +P ++L + +
Sbjct: 71 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLL-----VDN 120
Query: 108 FQNNNLTNISGSFNIPPNVTV-RLRGN 133
L+ ++PP + + N
Sbjct: 121 NNLKALS------DLPPLLEYLGVSNN 141
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 9/85 (10%), Positives = 29/85 (34%), Gaps = 7/85 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ L + + + P NL L + +N L P + ++ +++++ ++
Sbjct: 376 PESVEDLRMNSHLAEVP----ELPQNLKQLHVETNPLR-EFPD--IPESVEDLRMNSERV 428
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLS 85
+L+ ++
Sbjct: 429 VDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 12/85 (14%), Positives = 28/85 (32%), Gaps = 10/85 (11%)
Query: 41 IPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 99
I P +S + ++ LT +P + + A + + P + R +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 100 ATETFI--------LDFQNNNLTNI 116
+ L+ N L+++
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSL 86
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 31/126 (24%), Positives = 47/126 (37%), Gaps = 15/126 (11%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG-----RLSLNITTIKL 55
+ L LS+RN L +P+L +L LD+S+N L S+P +
Sbjct: 159 PTSLEVLSVRNNQLTF-LPEL--PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214
Query: 56 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115
N++T IP N L + + +N LS I S+ Q T +
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ-----TAQPDYHGPRIYFSM 268
Query: 116 ISGSFN 121
G N
Sbjct: 269 SDGQQN 274
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 34/172 (19%), Positives = 61/172 (35%), Gaps = 47/172 (27%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP--PGRL-SLNI-------- 50
++ L + +L +P+L +L YLD N+L+ ++P P L L++
Sbjct: 80 PQITVLEITQNALI-SLPEL--PASLEYLDACDNRLS-TLPELPASLKHLDVDNNQLTML 135
Query: 51 -------TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 103
I NN+LT +P L+ L + NN L+ +P L+ +
Sbjct: 136 PELPALLEYINADNNQLT-MLPEL---PTSLEVLSVRNNQLT-FLPELPESLEALDVSTN 190
Query: 104 FI-------------------LDFQNNNLTNISGSFNIPPN-VTVRLRGNPF 135
+ + N +T+I + T+ L NP
Sbjct: 191 LLESLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPL 242
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 25/128 (19%), Positives = 47/128 (36%), Gaps = 20/128 (15%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
K + + I L L+ L+ S+P L IT ++++ N L
Sbjct: 36 WEKQALPGENRNEAVSLLKE-CLINQFSELQLNRLNLS-SLPDN-LPPQITVLEITQNAL 92
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE---TFI---------LDF 108
++P + L+ L +N LS ++P + L+ T + ++
Sbjct: 93 I-SLPELPAS---LEYLDACDNRLS-TLPELPASLKHLDVDNNQLTMLPELPALLEYINA 147
Query: 109 QNNNLTNI 116
NN LT +
Sbjct: 148 DNNQLTML 155
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 22/112 (19%), Positives = 31/112 (27%), Gaps = 6/112 (5%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNL----GYLDLSSNQLNGSIPPGRLSL-NITTIKL 55
L L + L+ R + + N++ IP LSL TI L
Sbjct: 179 PESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIIL 237
Query: 56 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 107
+N L+ I + S S S R L T
Sbjct: 238 EDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFP 289
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 5e-11
Identities = 38/217 (17%), Positives = 61/217 (28%), Gaps = 56/217 (25%)
Query: 360 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVK--------RAQEGS 411
G F++ L T +IG+G +G+V++ I D T VA+K
Sbjct: 8 KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 412 LQGEKEFLTEIQFLSRLH---------HRNLVSLVGYCDEEGE----------------- 445
+ +E L EI L + L +G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 446 -------------QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+V EF G L + A SI + +
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEAS 180
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529
HRD+ N+LL K+ + + +P
Sbjct: 181 --LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 26/168 (15%), Positives = 58/168 (34%), Gaps = 35/168 (20%)
Query: 1 MSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLS 56
++KL L + N + + + L L++ ++ L S P L N++ + L
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILH 206
Query: 57 NNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSI-----------WQSRTLNATETF 104
+ + ++ L + + L S + + R + T+
Sbjct: 207 MKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265
Query: 105 I---------------LDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 135
+ L+F N L ++ G F+ ++ + L NP+
Sbjct: 266 LFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 31/163 (19%), Positives = 52/163 (31%), Gaps = 33/163 (20%)
Query: 2 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSN 57
+ L L N + DL R NL L L+SN +N +I L ++ + LS
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG-SLEHLDLSY 109
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI----------- 105
N L+ + S+ F L L L + N ++ + S +
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
Query: 106 -----------LDFQNNNLTNIS-GSFNIPPN-VTVRLRGNPF 135
L+ ++L + S N + L
Sbjct: 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 11/114 (9%)
Query: 25 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 84
G SS LN SIP G L+ + ++ LSNN++T S+ LQ L + +N +
Sbjct: 31 DRNGICKGSSGSLN-SIPSG-LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88
Query: 85 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 135
+ +I + S +L LD N L+N+ S F ++T L GNP+
Sbjct: 89 N-TIEEDSFSSLGSLE-----HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY 136
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 28/121 (23%), Positives = 49/121 (40%), Gaps = 14/121 (11%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ L L N S+ M + ++ L L +SN + ++ + + N+T + +NKL
Sbjct: 41 LATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNIT-TLDLSQNT-NLTYLACDSNKL 97
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
T + + L +L L N L+ + S L+ N LT I S
Sbjct: 98 T-NLD--VTPLTKLTYLNCDTNKLT-KLDVS-------QNPLLTYLNCARNTLTEIDVSH 146
Query: 121 N 121
N
Sbjct: 147 N 147
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 19/139 (13%), Positives = 45/139 (32%), Gaps = 13/139 (9%)
Query: 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 61
++L+ C + D++ L LD + + + + + + L+N +LT
Sbjct: 275 TQLIYFQAEGCR-KIKELDVTHNTQLYLLDCQAAGIT-ELDLSQNP-KLVYLYLNNTELT 331
Query: 62 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 121
+ S +L+ L N + S + + LN +
Sbjct: 332 -ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALN-----NNFEAEGQTITMPKETL 381
Query: 122 IPPNVTVRLRGNPFCLNTN 140
++T+ + + N
Sbjct: 382 TNNSLTIAVSPDLLDQFGN 400
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 21/121 (17%), Positives = 42/121 (34%), Gaps = 14/121 (11%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++L +L D++ L LD S N++ + + + + N +
Sbjct: 147 NTQLTELDCHLNKKITK-LDVTPQTQLTTLDCSFNKIT-ELDVSQNK-LLNRLNCDTNNI 203
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
T + + +L L ++N L+ I + T+ D N LT + S
Sbjct: 204 T-KLD--LNQNIQLTFLDCSSNKLT-EIDVT-------PLTQLTYFDCSVNPLTELDVST 252
Query: 121 N 121
Sbjct: 253 L 253
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 24/121 (19%), Positives = 44/121 (36%), Gaps = 15/121 (12%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++L L + D+S+ L L+ +N + + + +T + S+NKL
Sbjct: 169 QTQLTTLDCSFNKITEL--DVSQNKLLNRLNCDTNNIT-KLDLNQNI-QLTFLDCSSNKL 224
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
T I + L +L + N L+ + S T L +L I +
Sbjct: 225 T-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLSKLT-------TLHCIQTDLLEIDLTH 273
Query: 121 N 121
N
Sbjct: 274 N 274
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 24/123 (19%), Positives = 46/123 (37%), Gaps = 8/123 (6%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++L L + + DLS+ P L YL L++ +L + + + ++ N +
Sbjct: 296 NTQLYLLDCQAAGIT--ELDLSQNPKLVYLYLNNTELT-ELDVSHNT-KLKSLSCVNAHI 351
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN-ATETFILDFQNNNLTNISGS 119
S +P L F A ++P + +L A +LD N + G
Sbjct: 352 Q-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGD 408
Query: 120 FNI 122
+
Sbjct: 409 GGV 411
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 20/121 (16%), Positives = 41/121 (33%), Gaps = 13/121 (10%)
Query: 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+Q ++ L LD ++ + + +T + ++N +
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNI 76
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
T T+ S L L +N L+ ++ + T+ L+ N LT + S
Sbjct: 77 T-TLD--LSQNTNLTYLACDSNKLT-NLDVT-------PLTKLTYLNCDTNKLTKLDVSQ 125
Query: 121 N 121
N
Sbjct: 126 N 126
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 25/121 (20%), Positives = 45/121 (37%), Gaps = 14/121 (11%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ L L+ + L D++ + L YL+ +N+L + + +T + + N L
Sbjct: 84 NTNLTYLACDSNKLTNL--DVTPLTKLTYLNCDTNKLT-KLDVSQNP-LLTYLNCARNTL 139
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
T I S +L L N + + T+ LD N +T + S
Sbjct: 140 T-EID--VSHNTQLTELDCHLNKKITKLDVT-------PQTQLTTLDCSFNKITELDVSQ 189
Query: 121 N 121
N
Sbjct: 190 N 190
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 23/133 (17%), Positives = 40/133 (30%), Gaps = 14/133 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+SKL L L DL+ L Y + + + + + +
Sbjct: 253 LSKLTTLHCIQTDLLEI--DLTHNTQLIYFQAEGCRKIKELDVTHNT-QLYLLDCQAAGI 309
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
T + S P+L L++ N L+ + S L L N ++ + S
Sbjct: 310 T-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNTK--LK-----SLSCVNAHIQDFSSVG 358
Query: 121 NIPPNVTVRLRGN 133
IP
Sbjct: 359 KIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 25/140 (17%), Positives = 42/140 (30%), Gaps = 31/140 (22%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+L L + L D++ + L Y D S N L + LS +TT+ L
Sbjct: 211 NIQLTFLDCSSNKLT--EIDVTPLTQLTYFDCSVNPLT-ELDVSTLS-KLTTLHCIQTDL 266
Query: 61 T-------------------GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 101
+ + +L L ++ + + Q+ L
Sbjct: 267 LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLV-- 321
Query: 102 ETFILDFQNNNLTNISGSFN 121
L N LT + S N
Sbjct: 322 ---YLYLNNTELTELDVSHN 338
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 31/114 (27%), Positives = 53/114 (46%), Gaps = 9/114 (7%)
Query: 6 KLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTI 64
L L + L + L ++ + +LDLS N+L ++PP +L + ++ S+N L +
Sbjct: 445 VLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501
Query: 65 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
+ LPRLQ L + NN L ++I + L+ Q N+L G
Sbjct: 502 D-GVANLPRLQELLLCNNRLQQ--SAAIQPLVSCPRLVL--LNLQGNSLCQEEG 550
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 7e-07
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-GRLSLNITTIKLSNNK 59
+ + L L + L+ P L+ + L L S N L ++ L + + L NN+
Sbjct: 462 LLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDGVANLP-RLQELLLCNNR 519
Query: 60 LTGTIPS--NFSGLPRLQRLFIANNSLS 85
L + PRL L + NSL
Sbjct: 520 LQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 27/159 (16%), Positives = 53/159 (33%), Gaps = 25/159 (15%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL----NITTIKL 55
+S L L N L + + L L L NQL + ++ + +
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDI 381
Query: 56 SNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL---------------- 98
S N ++ S L L +++N L+ +I + +
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVV 441
Query: 99 NATETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 135
L+ +N L ++ G F+ ++ + L NP+
Sbjct: 442 KLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 22/111 (19%), Positives = 41/111 (36%), Gaps = 7/111 (6%)
Query: 26 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 85
N+ +S ++ + P ++S + SNN LT T+ N L L+ L + N L
Sbjct: 303 NIKNFTVSGTRMVHMLCPSKIS-PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 86 GSIPSSIWQSRTLNATETFILDFQNNNLTNIS--GSFNIPPNVTV-RLRGN 133
+ T LD N+++ G + ++ + N
Sbjct: 362 -ELSKIA--EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN 409
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 28/107 (26%), Positives = 47/107 (43%), Gaps = 10/107 (9%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89
+D S N L +P LS T + +S N ++ S+ L +L+ L I++N + +
Sbjct: 5 VDRSKNGLI-HVPKD-LSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLD 61
Query: 90 SSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGNPF 135
S+++ E LD +N L I S + N+ L N F
Sbjct: 62 ISVFKF--NQELEY--LDLSHNKLVKI--SCHPTVNLKHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 29/248 (11%), Positives = 73/248 (29%), Gaps = 39/248 (15%)
Query: 17 PMPDLSRIPNLGYLDLSSNQLNGSIPPG---------RLSL--------------NITTI 53
D+ + L L +S N++ + L L N+ +
Sbjct: 37 WTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHL 95
Query: 54 KLSNNKLTGTIPSN--FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 111
LS N +P F + +L+ L ++ L S I LN ++ ++ +
Sbjct: 96 DLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH---LNISKVLLVLGETY 151
Query: 112 NLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCP 171
++ + P + + + E+ S + C +
Sbjct: 152 GEKEDPEGLQDFNTESLHIV-FPTNKEFHFILDVSVKTVANLEL-----SNIKCVLEDNK 205
Query: 172 TDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSF 231
Y S + ++ L +++ S+ + + + T+ ++ + +
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV---WHTTVWYFSISNVKLQGQ 262
Query: 232 RWEKGPRL 239
+
Sbjct: 263 LDFRDFDY 270
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 32/177 (18%), Positives = 57/177 (32%), Gaps = 16/177 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL--SL-NITTIKLSN 57
+L L L + L NL +LDLS N + ++P + ++ + + LS
Sbjct: 68 NQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLST 124
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANN---------SLSGSIPSSIWQSRTLNATETFILDF 108
L + + L + L + L S+ N FILD
Sbjct: 125 THLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDV 184
Query: 109 QNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDC 165
+ N+ S NI + + + + N I+ + NS +
Sbjct: 185 SVKTVANLELS-NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 32/141 (22%), Positives = 54/141 (38%), Gaps = 15/141 (10%)
Query: 4 LLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN-NK 59
++L L+ S +L +++S N + I S + I++ N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 60 LTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ-NNNLTNIS 117
L I F LP LQ L I+N + +P +++ + +LD Q N N+ I
Sbjct: 92 LL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHK----IHSLQKVLLDIQDNINIHTIE 145
Query: 118 -GSF-NIPPN-VTVRLRGNPF 135
SF + V + L N
Sbjct: 146 RNSFVGLSFESVILWLNKNGI 166
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 25/122 (20%), Positives = 50/122 (40%), Gaps = 13/122 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRI--PNLGYLDLSSNQLNGSIPPG---RLSLNITTIKL 55
+ L L + N ++ +PD+ +I LD+ N +I LS + L
Sbjct: 103 LPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 56 SNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114
+ N + I ++ F+G + NN+L +P+ ++ A+ ILD +
Sbjct: 162 NKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFH----GASGPVILDISRTRIH 215
Query: 115 NI 116
++
Sbjct: 216 SL 217
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 26/125 (20%), Positives = 46/125 (36%), Gaps = 17/125 (13%)
Query: 21 LSRIP-----NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLP 72
++ IP N L +L I G S ++ I++S N + I ++ FS LP
Sbjct: 21 VTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79
Query: 73 RLQRLFIAN-NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-R 129
+L + I N+L I +Q N L N + ++ +
Sbjct: 80 KLHEIRIEKANNLL-YINPEAFQ----NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134
Query: 130 LRGNP 134
++ N
Sbjct: 135 IQDNI 139
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 22/107 (20%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSI 88
+++ IP L N ++ KL I FSG L+++ I+ N + I
Sbjct: 14 FLCQESKVT-EIPSD-LPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 89 PSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 133
+ ++ + L ++ + NNL I +F PN+ +
Sbjct: 71 EADVFSN--LPKLHEIRIE-KANNLLYINPEAFQNLPNLQYLLISNT 114
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 17/94 (18%), Positives = 32/94 (34%), Gaps = 9/94 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS-NQLNGSIPPGRLS--LNITTIKLSN 57
+ + L L +Q L L+LS N L +P + +S
Sbjct: 153 SFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISR 211
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPS 90
++ ++PS L +L+ N +P+
Sbjct: 212 TRIH-SLPSYGLENLKKLRARSTYNLK---KLPT 241
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 26/99 (26%), Positives = 44/99 (44%), Gaps = 8/99 (8%)
Query: 2 SKLLKLSLRNCSLQ----GPMPDLSRIP-NLGYLDLSSNQLNGSIPPGRLSLNITTIKLS 56
+ L + SL ++ L+LSSN L GS+ L + + L
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLH 458
Query: 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 95
NN++ +IP + + L LQ L +A+N L S+P ++
Sbjct: 459 NNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 28/139 (20%), Positives = 48/139 (34%), Gaps = 10/139 (7%)
Query: 1 MSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNG--SIPPGRLSLNITTIKLSN 57
+ L+ ++N L S + LS + + P S + T + +
Sbjct: 304 LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS-SFTFLNFTQ 362
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI- 116
N T ++ S L RLQ L + N L + T N + LD N+L +
Sbjct: 363 NVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVA--LMTKNMSSLETLDVSLNSLNSHA 419
Query: 117 -SGSFNIPPNVTV-RLRGN 133
+ ++ V L N
Sbjct: 420 YDRTCAWAESILVLNLSSN 438
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 28/172 (16%), Positives = 55/172 (31%), Gaps = 32/172 (18%)
Query: 11 NCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTG 62
+ S + L+ +P L LS N ++ + LS + ++LS+N++
Sbjct: 37 DYSNRN----LTHVPKDLPPRTKALSLSQNSIS-ELRMPDISFLS-ELRVLRLSHNRIR- 89
Query: 63 TIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI--SGS 119
++ + F L+ L +++N L +I S LD N+ +
Sbjct: 90 SLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLR-------HLDLSFNDFDVLPVCKE 141
Query: 120 FNIPPNVTV------RLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDC 165
F +T + R + C I +L
Sbjct: 142 FGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI 193
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 7/89 (7%)
Query: 29 YLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 88
+D S+ L +P L + LS N ++ + S L L+ L +++N + S+
Sbjct: 35 MVDYSNRNLT-HVPKD-LPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SL 91
Query: 89 PSSIWQSRTLNATETFILDFQNNNLTNIS 117
++ E LD +N L NIS
Sbjct: 92 DFHVFLF--NQDLEY--LDVSHNRLQNIS 116
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++K+ +L L L+ + ++ + ++ LDL+S Q+ P LS N+ + L N++
Sbjct: 84 LTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTPLAGLS-NLQVLYLDLNQI 141
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
T S +GL LQ L I N +S + + + L L +N +++IS
Sbjct: 142 TNI--SPLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLT-----TLKADDNKISDISPLA 192
Query: 121 NIPPNVTVRLRGNP 134
++P + V L+ N
Sbjct: 193 SLPNLIEVHLKNNQ 206
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 25/118 (21%), Positives = 54/118 (45%), Gaps = 11/118 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ L+ L L++ + + L + + L+LS N L L +I T+ L++ ++
Sbjct: 62 LNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPLKNVSAIAGLQ-SIKTLDLTSTQI 119
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
T + +GL LQ L++ N ++ +I S + L L N +++++
Sbjct: 120 TDV--TPLAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQ-----YLSIGNAQVSDLTP 168
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 27/119 (22%), Positives = 51/119 (42%), Gaps = 13/119 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-GRLSLNITTIKLSNNK 59
+ + LS + + + + NL L+L NQ+ + P L+ IT ++LS N
Sbjct: 40 LDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQIT-DLAPLKNLT-KITELELSGNP 96
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
L + S +GL ++ L + + + + + L+ + L N +TNIS
Sbjct: 97 LK-NV-SAIAGLQSIKTLDLTSTQI-----TDVTPLAGLSNLQV--LYLDLNQITNISP 146
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 26/135 (19%), Positives = 54/135 (40%), Gaps = 13/135 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-GRLSLNITTIKLSNNK 59
+ + L L + + + L+ + NL L L NQ+ +I P L+ N+ + + N +
Sbjct: 106 LQSIKTLDLTSTQITD-VTPLAGLSNLQVLYLDLNQIT-NISPLAGLT-NLQYLSIGNAQ 162
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 119
++ + + L +L L +N +S I + + +NN ++++S
Sbjct: 163 VSDL--TPLANLSKLTTLKADDNKIS-DISP------LASLPNLIEVHLKNNQISDVSPL 213
Query: 120 FNIPPNVTVRLRGNP 134
N V L
Sbjct: 214 ANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 16/118 (13%), Positives = 53/118 (44%), Gaps = 11/118 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ +K++ ++ + + + + L + +I + N+ ++L +N++
Sbjct: 18 LANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQI 75
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
T + + L ++ L ++ N L ++ S+I +++ LD + +T+++
Sbjct: 76 T-DL-APLKNLTKITELELSGNPLK-NV-SAIAGLQSIK-----TLDLTSTQITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 20/98 (20%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 21 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80
+ N + + + ++ L ITT+ +T TI L L L +
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADLD-GITTLSAFGTGVT-TI-EGVQYLNNLIGLELK 71
Query: 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
+N ++ P N T+ L+ N L N+S
Sbjct: 72 DNQITDLAPLK-------NLTKITELELSGNPLKNVSA 102
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 26/127 (20%), Positives = 50/127 (39%), Gaps = 6/127 (4%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+SKL L + + + L+ +PNL + L +NQ++ P S N+ + L+N +
Sbjct: 172 LSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSPLANTS-NLFIVTLTNQTI 229
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
T + L + S + P++I S + + + N+S +F
Sbjct: 230 TNQPVFYNNNLVVP--NVVKGPSGAPIAPATI--SDNGTYASPNLTWNLTSFINNVSYTF 285
Query: 121 NIPPNVT 127
N
Sbjct: 286 NQSVTFK 292
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 13/105 (12%)
Query: 22 SRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRL 77
R+ L L L+ N+L ++P G L N+ T+ +++NKL +P F L L L
Sbjct: 58 HRLTKLRLLYLNDNKLQ-TLPAGIFKELK-NLETLWVTDNKLQ-ALPIGVFDQLVNLAEL 114
Query: 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFN 121
+ N L S+P ++ S T T L N L ++ G F+
Sbjct: 115 RLDRNQLK-SLPPRVFDSLT-KLTY---LSLGYNELQSLPKGVFD 154
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 40/161 (24%), Positives = 69/161 (42%), Gaps = 31/161 (19%)
Query: 2 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSN 57
+KL L L + LQ P + NL L ++ N+L ++P G +L N+ ++L
Sbjct: 61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLV-NLAELRLDR 118
Query: 58 NKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPS----------SIW----QSRTLNA-- 100
N+L ++P F L +L L + N L S+P + Q + +
Sbjct: 119 NQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGA 176
Query: 101 ----TETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 135
TE L NN L + G+F+ + ++L+ NP+
Sbjct: 177 FDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 31/112 (27%), Positives = 53/112 (47%), Gaps = 9/112 (8%)
Query: 26 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 85
N +D SS +L +IP + + + L +NKL+ F L +L+ L++ +N L
Sbjct: 17 NKNSVDCSSKKLT-AIPSN-IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74
Query: 86 GSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 135
++P+ I++ L ET L +N L + G F+ N+ RL N
Sbjct: 75 -TLPAGIFKE--LKNLET--LWVTDNKLQALPIGVFDQLVNLAELRLDRNQL 121
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 3e-10
Identities = 29/181 (16%), Positives = 52/181 (28%), Gaps = 26/181 (14%)
Query: 11 NCSLQGPMPDLSRIP---NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIP 65
C+ G + L +P NL L + + Q + L + + + + L +
Sbjct: 14 RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA 72
Query: 66 SN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT---------- 114
+ F PRL RL ++ N+L S+ Q +L L N L
Sbjct: 73 PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ-----ELVLSGNPLHCSCALRWLQR 126
Query: 115 ---NISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCP 171
G N + + +D + L C+ +
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRG 186
Query: 172 T 172
Sbjct: 187 L 187
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 5e-10
Identities = 57/350 (16%), Positives = 104/350 (29%), Gaps = 97/350 (27%)
Query: 384 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 443
G G GK T VA+ +Q + +F +I +L+ + C+
Sbjct: 157 GVLGSGK---------TWVALDVCLSYKVQCKMDF--KIFWLN----------LKNCNSP 195
Query: 444 GE-----QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
Q L+Y+ N T R S+ K +R+ R +L
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIK------LRIHSIQAELRRLL----------K 239
Query: 499 HRDIKASNILLDHKFTAKVAD-FGL-------SRLAPVPD-IEGIVPAHVSTVVKGTPGY 549
+ + ++L + AK + F L +R V D + H+S + +
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS-LDHHSMTL 298
Query: 550 LDPEYFLTHKLTDKSDVYSLGVV--FLELLTGMQPISHGKNIVREVN------IAYQSSM 601
E ++ +L+ P V N IA
Sbjct: 299 TPDE--------------VKSLLLKYLDCRPQDLPRE-----VLTTNPRRLSIIAESIRD 339
Query: 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE--VMRE--------LESIWN 651
+ D N + + I+ +L + + R V L IW
Sbjct: 340 GLATWD-NWKHVNCDKLTTIIESSLNV-LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWF 397
Query: 652 MMPESDTKTPEFINSEHTSK---EETPPSSSSMLKHPYVSSDVSGSNLVS 698
+ +SD + ++ E+ P S+ + Y+ V N +
Sbjct: 398 DVIKSD---VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA 444
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 2e-08
Identities = 48/250 (19%), Positives = 88/250 (35%), Gaps = 63/250 (25%)
Query: 7 LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPS 66
L+L+NC P L + L + N + S + L I +I+
Sbjct: 187 LNLKNC--NSPETVLEMLQKL-LYQIDPNWTSRSDHSSNIKLRIHSIQ------------ 231
Query: 67 NFSGLPRLQRLFIA---NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIP 123
L+RL + N L + ++ ++ NA F + L
Sbjct: 232 -----AELRRLLKSKPYENCLL--VLLNVQNAKAWNA---F--NLSCKIL---------- 269
Query: 124 PNVTVRLRGNPFCLNTNAE-QFCGSHSDDDNEIDRSTN---STLDCRAQSCPTDYEYSPT 179
+T R + L+ H D + LDCR Q P E T
Sbjct: 270 --LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR--EVLTT 325
Query: 180 SPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRL 239
+P R ++ ++ GL+ + +K++ + +T+ ++ +L L+ +R
Sbjct: 326 NPRRL-----SIIAESIR-DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR------- 372
Query: 240 KMYLKL--FP 247
KM+ +L FP
Sbjct: 373 KMFDRLSVFP 382
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 41/142 (28%), Positives = 65/142 (45%), Gaps = 15/142 (10%)
Query: 1 MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLS 56
++KL L+L LQ + LG L L++NQL S+P G L+ + + L
Sbjct: 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLT-QLDKLYLG 115
Query: 57 NNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115
N+L ++PS F L +L+ L + N L SIP+ + T L N L +
Sbjct: 116 GNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK----LTNLQTLSLSTNQLQS 169
Query: 116 IS-GSFNIPPNVT-VRLRGNPF 135
+ G+F+ + + L GN F
Sbjct: 170 VPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 23/96 (23%), Positives = 40/96 (41%), Gaps = 8/96 (8%)
Query: 40 SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 99
S+P G + + + L + L + F GL +L L + N L ++ + ++
Sbjct: 28 SVPSG-IPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDD---- 81
Query: 100 ATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 133
TE L NN L ++ G F+ + L GN
Sbjct: 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGN 117
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 31/134 (23%), Positives = 53/134 (39%), Gaps = 12/134 (8%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ L +L L + + + L + L L ++ N+L ++ ++ + L NN+L
Sbjct: 62 FTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRLK-NLNGIPS-ACLSRLFLDNNEL 118
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
T + L L+ L I NN L SI + L +LD N +TN G
Sbjct: 119 RDT--DSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLE-----VLDLHGNEITNTGGLT 169
Query: 121 NIPPNVTVRLRGNP 134
+ + L G
Sbjct: 170 RLKKVNWIDLTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 18/118 (15%), Positives = 47/118 (39%), Gaps = 12/118 (10%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ +K +L S+ + + + + ++ + S+ + N+ + LS+N++
Sbjct: 18 LANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHNQI 75
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
+ + S L +L+ L + N L ++ + + L NN L +
Sbjct: 76 S-DL-SPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSR---LFLDNNELRDTDS 123
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 16/98 (16%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 21 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80
+ N +L + + LS + N+ + ++ + L+ L ++
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQKELS-GVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLS 71
Query: 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
+N +S + S + L L N L N++G
Sbjct: 72 HNQIS-DL-SPLKDLTKLE-----ELSVNRNRLKNLNG 102
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 4e-09
Identities = 23/118 (19%), Positives = 55/118 (46%), Gaps = 11/118 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ +K +L+ S+ + + ++ + +++ + S+ + N+T + L+ NKL
Sbjct: 20 FAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKL 77
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
T + L L LF+ N + + SS+ + L L ++N +++I+G
Sbjct: 78 TDI--KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLK-----SLSLEHNGISDING 126
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 28/149 (18%), Positives = 60/149 (40%), Gaps = 21/149 (14%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ + ++ N ++ + + +PN+ L L+ N+L I P N+ + L NK+
Sbjct: 42 LNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKI 99
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIP--SSIWQSRTLNATETFI------------- 105
+ S+ L +L+ L + +N +S I + Q +L I
Sbjct: 100 K-DL-SSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKITDITVLSRLTKLD 156
Query: 106 -LDFQNNNLTNISGSFNIPPNVTVRLRGN 133
L ++N +++I + + L N
Sbjct: 157 TLSLEDNQISDIVPLAGLTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 28/163 (17%), Positives = 51/163 (31%), Gaps = 16/163 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ +L L L N + + LSR+ L L L NQ++ I P + + LS N +
Sbjct: 130 LPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHI 187
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 120
+ + +GL L L + + N + N GS
Sbjct: 188 S-DL-RALAGLKNLDVLELFSQEC------------LNKPINHQSNLVVPNTVKNTDGSL 233
Query: 121 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTL 163
P ++ + + +F S + +
Sbjct: 234 VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 16/98 (16%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 21 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80
+L + ++ L+ +I I +N+ + ++ LP + +LF+
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQNELN-SIDQIIANNSDIK-SV-QGIQYLPNVTKLFLN 73
Query: 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
N L+ P + N L N + ++S
Sbjct: 74 GNKLTDIKPLT-------NLKNLGWLFLDENKIKDLSS 104
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 24/118 (20%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ +K +L+ S+ + + ++ + +++ + S+ + N+T + L+ NKL
Sbjct: 23 FAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKL 80
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
T I + L L LF+ N + + SS+ + L L ++N +++I+G
Sbjct: 81 T-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLK-----SLSLEHNGISDING 129
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 27/144 (18%), Positives = 51/144 (35%), Gaps = 13/144 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-GRLSLNITTIKLSNNK 59
+ L L L ++ + L + L L L N ++ I L + ++ L NNK
Sbjct: 89 LKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DINGLVHLP-QLESLYLGNNK 145
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 119
+T + S L +L L + +N +S I L + L N+++++
Sbjct: 146 IT--DITVLSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQN--LYLSKNHISDLRAL 196
Query: 120 FNIPPNVTVRLRGNPFCLNTNAEQ 143
+ + L Q
Sbjct: 197 AGLKNLDVLELFSQECLNKPINHQ 220
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 26/118 (22%), Positives = 54/118 (45%), Gaps = 11/118 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++ + ++ N ++ + + +PN+ L L+ N+L I P N+ + L NK+
Sbjct: 45 LNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLFLDENKV 102
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
+ S+ L +L+ L + +N +S I + + L L NN +T+I+
Sbjct: 103 K-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLE-----SLYLGNNKITDITV 151
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 26/132 (19%), Positives = 52/132 (39%), Gaps = 15/132 (11%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ +L L L N + + LSR+ L L L NQ++ I P + + LS N +
Sbjct: 133 LPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHI 190
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSG---------SIPSSIWQSRTLNATETFILDFQNN 111
+ + +GL L L + + +P+++ + T I D +
Sbjct: 191 S-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISD--DG 246
Query: 112 NLTNISGSFNIP 123
+ + +++P
Sbjct: 247 DYEKPNVKWHLP 258
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 21 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80
+L + ++ L+ +I I +N+ + ++ LP + +LF+
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQNELN-SIDQIIANNSDIK-SV-QGIQYLPNVTKLFLN 76
Query: 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
N L+ I + + L L N + ++S
Sbjct: 77 GNKLT-DI-KPLANLKNLG-----WLFLDENKVKDLSS 107
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 23/131 (17%), Positives = 46/131 (35%), Gaps = 13/131 (9%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
++KL LSL + + + L+ + L L LS N ++ + N+ ++L + +
Sbjct: 155 LTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQEC 212
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLSG----------SIPSSIWQSRTLNATETFILDFQN 110
++ S L + + SL P+ W +FI Q
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFY-QP 271
Query: 111 NNLTNISGSFN 121
+ F+
Sbjct: 272 VTIGKAKARFH 282
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 24/88 (27%), Positives = 43/88 (48%), Gaps = 8/88 (9%)
Query: 6 KLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTG 62
+L L +LS +L +DLS+N+++ ++ ++ + T+ LS N+L
Sbjct: 35 ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMT-QLLTLILSYNRLR- 91
Query: 63 TIPSN-FSGLPRLQRLFIANNSLSGSIP 89
IP F GL L+ L + N +S +P
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 16/121 (13%)
Query: 22 SRIP-NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRL 77
IP ++ L L NQ ++ P LS ++T I LSNN+++ T+ + FS + +L L
Sbjct: 27 KGIPRDVTELYLDGNQF--TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTL 83
Query: 78 FIANNSLSGSIPSSIWQSRT-LNATETFILDFQNNNLTNI-SGSFNIPPNVT-VRLRGNP 134
++ N L IP + L +L N+++ + G+FN ++ + + NP
Sbjct: 84 ILSYNRLR-CIPPRTFDGLKSLR-----LLSLHGNDISVVPEGAFNDLSALSHLAIGANP 137
Query: 135 F 135
Sbjct: 138 L 138
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 49/233 (21%), Positives = 89/233 (38%), Gaps = 46/233 (19%)
Query: 382 QIGQGGYGKVYKGI---------LPDGTVVAVKR-AQEGSLQGEKEFLT------EIQFL 425
+ G +Y+ P ++K A++G L E+ F ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 426 SRLHHRNLV---SLVGYCDEEGE-QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 481
+L+ L+ + +G+ + + + LV + +L+ L K L L +A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLS-RLAP----VPDIEGI 534
+ +LH H ++ A NI +D + ++V A +G + R P V +EG
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 535 VPAHVSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 582
H G + +D HK + +SD+ SLG L+ L G P
Sbjct: 225 RSPHE-----GDLEFISMD-----LHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------N 432
IG+G +G+V K + VA+K + ++ Q E++ L ++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYY 117
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+V L + LV+E +S L D L + + + A +L+L T
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 493 ADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ + H D+K NILL + + K+ DFG S + + ++ + Y
Sbjct: 177 -ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---------QLGQRIYQYIQ-SRFYR 225
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588
PE L D++SLG + +E+ TG +P+ G N
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGAN 262
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 67/309 (21%), Positives = 112/309 (36%), Gaps = 54/309 (17%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSL-QGEKEFLTEIQFLSRLHHR------N 432
IG+G +G+V K VA+K R ++ Q EI+ L L + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLH 490
++ ++ + +E +S L + + K + GF++ L A + + LH
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELI--KKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 491 TEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 548
+ H D+K NILL + KV DFG S V T ++ +
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---------YEHQRVYTYIQ-SRF 264
Query: 549 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608
Y PE L + D++SLG + ELLTG P+ G++ E + Q + M ++
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGED---EGD---QLACMIELL-- 315
Query: 609 NMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVM---RELESIWNMMPESDTK 659
G + ++ F+ S V+ R PES
Sbjct: 316 --GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREW 373
Query: 660 TPEFINSEH 668
+
Sbjct: 374 GNALKGCDD 382
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 29/95 (30%), Positives = 42/95 (44%), Gaps = 12/95 (12%)
Query: 1 MSKLLKLSLRNCSLQG-P--MPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIK 54
+ L +L L + L P + D + L LDL +NQL +P RL ++ +
Sbjct: 63 LINLKELYLGSNQLGALPVGVFD--SLTQLTVLDLGTNQLT-VLPSAVFDRLV-HLKELF 118
Query: 55 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89
+ NKLT +P L L L + N L SIP
Sbjct: 119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP 151
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 16/61 (26%), Positives = 27/61 (44%), Gaps = 2/61 (3%)
Query: 23 RIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81
R+ +L L + N+L +P G L ++T + L N+L F L L ++
Sbjct: 110 RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168
Query: 82 N 82
N
Sbjct: 169 N 169
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 52/271 (19%), Positives = 91/271 (33%), Gaps = 50/271 (18%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVK--------RAQEGSLQGEKEFLTEIQ---FLSRLHH 430
IGQGG+G +Y + V + G L E +F + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 431 RNLVSLVG-----YCDEEGEQMLVYEFM-------SNGTLRDQLSAKSKEPLGFAMR--L 476
+ +G + Y FM + + + + F+ + L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR------FSRKTVL 155
Query: 477 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLSRLAPVPDIEGI 534
++L + Y+H H DIKASN+LL++K +V D+GL+ +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 535 VPAHVSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGM---QPISHG 586
A GT + +D H + + D+ LG ++ LTG +
Sbjct: 213 YAADPKRCHDGTIEFTSID-----AHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267
Query: 587 KNIVREVNIAYQ-SSMMFSVIDGNMGSYPSE 616
VR+ I Y+ + + P E
Sbjct: 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGE 298
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 26/213 (12%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IG G +G +Y G + G VA+K E + E + + + + +C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 441 DEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADP 495
EG+ ++V E + S L + S K F+++ L +A I Y+H++
Sbjct: 74 GAEGDYNVMVMELLGPSLEDLFNFCSRK------FSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 496 PVFHRDIKASNILLDHKFTAK---VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
HRD+K N L+ + DFGL++ +P + + GT Y
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 553 EYFLTHKLTDKS---DVYSLGVVFLELLTGMQP 582
TH ++S D+ SLG V + G P
Sbjct: 185 N---THLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 30/128 (23%), Positives = 60/128 (46%), Gaps = 17/128 (13%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-GRLSLNITTIKLSNNK 59
++ + ++ N ++ + + +PN+ YL L N+L+ I L+ N+T + L+ N+
Sbjct: 40 LNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLH-DISALKELT-NLTYLILTGNQ 96
Query: 60 LTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
L ++P+ F L L+ L + N L S+P ++ T L+ +N L
Sbjct: 97 LQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDK----LTNLTYLNLAHNQLQ---- 146
Query: 119 SFNIPPNV 126
++P V
Sbjct: 147 --SLPKGV 152
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 19/119 (15%), Positives = 37/119 (31%), Gaps = 21/119 (17%)
Query: 22 SRIPNLG-YLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80
+L + +I I +N+ + ++ LP ++ L +
Sbjct: 15 DDAFAETIKANLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALG 71
Query: 81 NNSLSGSIPSSIWQSRTLNA----TETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGN 133
N L ++A T L N L ++ G F+ N+ + L N
Sbjct: 72 GNKLH-----------DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN 119
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 58/335 (17%), Positives = 109/335 (32%), Gaps = 52/335 (15%)
Query: 383 IGQGGYGKVYKGI--LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------ 431
+G+G +GKV + + + VA+K R EI L ++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENKF 82
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYL 489
V + + + G + +E + + L K + + +A + +L
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGK-NTFEFL--KENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI----------VPAHV 539
H + + H D+K NIL + + + S I H
Sbjct: 140 H---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599
+T+V T Y PE L DV+S+G + E G +
Sbjct: 197 TTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG-FTLFQTHE---NRE---HL 248
Query: 600 SMMFSVIDGNMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVMRELESIWNMM 653
MM ++ G PS + + F K L ++ +D R + E + L+S
Sbjct: 249 VMMEKIL----GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR-YVKENCKPLKSYMLQD 303
Query: 654 PESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688
+ + + + + L HP+ +
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IG+G +G +++G L + VA+K E + E + L + V Y
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 441 DEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADP 495
+EG +LV + + S L D K F+++ A + +H ++
Sbjct: 75 GQEGLHNVLVIDLLGPSLEDLLDLCGRK------FSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 496 PVFHRDIKASNILLDHKFTAK-----VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ +RDIK N L+ + V DFG+ + P + +P + GT Y+
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 551 DPEYFLTHKLTDKS---DVYSLGVVFLELLTGMQP 582
TH ++S D+ +LG VF+ L G P
Sbjct: 186 SIN---THLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 18/209 (8%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IG G +G++Y G + VA+K E + L E + L + V +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 441 DEEGE-QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
EG+ +LV + + G + L L L +A + ++H+++ H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLH 126
Query: 500 RDIKASNILLDHKFTAK---VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
RDIK N L+ A + DFGL++ +P + + GT Y
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS---VN 183
Query: 557 THKLTDKS---DVYSLGVVFLELLTGMQP 582
TH ++S D+ SLG V + L G P
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 53/229 (23%), Positives = 80/229 (34%), Gaps = 41/229 (17%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVA-----VKRAQEGSLQGEKEFLTEIQ---FLSRLHHRN 432
+IG GG+G +Y A V+ + G L E +F + + + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 433 LVSLVG-----YCDEEGEQMLVYEFM-------SNGTLRDQLSAKSKEPLGFAMRLSIAL 480
+ +G + Y FM L+ ++L I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID---LQKISGQNGTFKKSTVLQLGIRM 160
Query: 481 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLSRLAPVPDIEGIVPAH 538
+ Y+H H DIKA+N+LL +K +V AD+GLS +
Sbjct: 161 LDV--LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 539 VSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 582
GT + LD HK L+ +SDV LG L L G P
Sbjct: 216 PRKGHNGTIEFTSLD-----AHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 33/136 (24%), Positives = 58/136 (42%), Gaps = 22/136 (16%)
Query: 11 NCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGT 63
+C+ +G L IP + L L+ N+L G ++ ++L N+LT
Sbjct: 14 DCTGRG----LKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-G 68
Query: 64 IPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRT-LNATETFILDFQNNNLTNIS-GSF 120
I N F G +Q L + N + I + ++ L L+ +N ++ + GSF
Sbjct: 69 IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLK-----TLNLYDNQISCVMPGSF 122
Query: 121 NIPPNVT-VRLRGNPF 135
++T + L NPF
Sbjct: 123 EHLNSLTSLNLASNPF 138
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 54/305 (17%), Positives = 96/305 (31%), Gaps = 91/305 (29%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRL-----HHRNLV 434
+G G + V+ + VA+K ++ E + + EI+ L + + N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101
Query: 435 SLVGYCDE------EGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 487
+V D+ G + +V+E + + L + + + L I +G+
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 488 YLHTEADPPVFHRDIKASNILL-------------------------------------- 509
YLHT+ + H DIK NILL
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 510 -----------DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
K K+AD G + E I Y E +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----------YRSLEVLIGS 268
Query: 559 KLTDKSDVYSLGVVFLELLTG---MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615
+D++S + EL TG +P S + E +IA ++ + +G P
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA----LIIEL----LGKVPR 320
Query: 616 ECVEK 620
+ +
Sbjct: 321 KLIVA 325
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 28/141 (19%), Positives = 52/141 (36%), Gaps = 22/141 (15%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNN 58
M + + L LRN + + L L + + N G + N+ + L N
Sbjct: 10 MKRRIHLELRNRTPA----------AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV 59
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
L ++ SN LP+L++L ++ N + G + + L L+ N L +IS
Sbjct: 60 GLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT-----HLNLSGNKLKDIST 112
Query: 119 SFNIPPN---VTVRLRGNPFC 136
+ ++ L
Sbjct: 113 LEPLKKLECLKSLDLFNCEVT 133
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 24/68 (35%), Positives = 37/68 (54%), Gaps = 8/68 (11%)
Query: 26 NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 81
L L LS NQ+ S+P G +L+ +T + L NKL ++P+ F L +L+ L +
Sbjct: 53 QLTKLSLSQNQIQ-SLPDGVFDKLT-KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDT 109
Query: 82 NSLSGSIP 89
N L S+P
Sbjct: 110 NQLK-SVP 116
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 17/63 (26%), Positives = 30/63 (47%), Gaps = 5/63 (7%)
Query: 23 RIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79
++ L L L N+L S+P G +L+ + + L N+L F L LQ++++
Sbjct: 74 KLTKLTILYLHENKLQ-SLPNGVFDKLT-QLKELALDTNQLKSVPDGIFDRLTSLQKIWL 131
Query: 80 ANN 82
N
Sbjct: 132 HTN 134
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 25/145 (17%), Positives = 54/145 (37%), Gaps = 22/145 (15%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNN 58
M + + L LRN + ++ L L +++ N G + + N
Sbjct: 3 MGRRIHLELRNRTPS----------DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV 52
Query: 59 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118
LT +I +N L +L++L +++N +SG + + L L+ N + ++S
Sbjct: 53 GLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT-----HLNLSGNKIKDLST 105
Query: 119 SFNIPPN---VTVRLRGNPFCLNTN 140
+ ++ L +
Sbjct: 106 IEPLKKLENLKSLDLFNCEVTNLND 130
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 63/333 (18%), Positives = 111/333 (33%), Gaps = 48/333 (14%)
Query: 383 IGQGGYGKVYKGI--LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------ 431
+G+G +GKV + I G VAVK + + +EIQ L L+
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNSTF 77
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
V ++ + + G +V+E + + D + P +A + + +LH
Sbjct: 78 RCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH- 135
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI----------VPAHVST 541
+ H D+K NIL + + + R I H ST
Sbjct: 136 --SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHST 193
Query: 542 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601
+V T Y PE L + DV+S+G + +E G + + +M
Sbjct: 194 LVS-TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG-FTVFPTHD---SKE---HLAM 245
Query: 602 MFSVIDGNMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655
M ++ G P ++K F L + + R +S + L+
Sbjct: 246 MERIL----GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR-YVSRACKPLKEFMLSQDV 300
Query: 656 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688
+ + I + LKHP+
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 15/137 (10%)
Query: 6 KLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLT 61
L L SL+ P + +L L L N+L S+P G +L+ ++T + LS N+L
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLT-SLTYLNLSTNQLQ 89
Query: 62 GTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGS 119
++P+ F L +L+ L + N L S+P ++ T + L N L ++ G
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLT-QLKD---LRLYQNQLKSVPDGV 143
Query: 120 FNIPPNVT-VRLRGNPF 135
F+ ++ + L NP+
Sbjct: 144 FDRLTSLQYIWLHDNPW 160
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 22/161 (13%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 433
NF +IG G +G++ G L VA+K E + E +F +L +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 434 VSLVGYCDEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILY 488
+ V Y G+ +V E + S L D F+++ L IA+ + Y
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT------FSLKTVLMIAIQLISRMEY 120
Query: 489 LHTEADPPVFHRDIKASNILLDHKFTAK-----VADFGLSR 524
+H++ + +RD+K N L+ + DF L++
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 29/145 (20%), Positives = 56/145 (38%), Gaps = 14/145 (9%)
Query: 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-GRLSLNITTIKLSNNKLT 61
+ ++L ++ LS + +L LS+N + I + N+ + L N +
Sbjct: 26 EKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKISSLSGME-NLRILSLGRNLIK 83
Query: 62 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 121
I + + L+ L+I+ N ++ S+ S I + L +L NN +TN
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLR-----VLYMSNNKITNWGEIDK 135
Query: 122 IPPN---VTVRLRGNPFCLNTNAEQ 143
+ + L GNP +
Sbjct: 136 LAALDKLEDLLLAGNPLYNDYKENN 160
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 18/85 (21%), Positives = 34/85 (40%), Gaps = 1/85 (1%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 60
+ +L LR + + + +D S N++ + L + T+ ++NN++
Sbjct: 18 AVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRI 76
Query: 61 TGTIPSNFSGLPRLQRLFIANNSLS 85
LP L L + NNSL
Sbjct: 77 CRIGEGLDQALPDLTELILTNNSLV 101
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 51/303 (16%), Positives = 97/303 (32%), Gaps = 48/303 (15%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRL-----HHRNL 433
+G G +G+V + + AVK R + + E L ++ ++ N+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNNI 98
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
V G L++E + +L + ++ + + + + YL
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--- 154
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA---------------- 537
+ H D+K NILLD + K +
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214
Query: 538 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597
+ +++ T Y PE L SD++S G V EL TG + +
Sbjct: 215 YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG-SLLFRTHE---HME--- 266
Query: 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI---WNMMP 654
+MM S+I P + + K ++ + + + E + SI +P
Sbjct: 267 HLAMMESII----QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322
Query: 655 ESD 657
Sbjct: 323 LYK 325
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 28/129 (21%), Positives = 50/129 (38%), Gaps = 19/129 (14%)
Query: 3 KLLKLSLRNCSLQ-------GPMPDLSRIPNLGYLDLSSNQLNGS----IPPGRLSLN-- 49
K+ KLSL+NC L L +P L L LS N L + + G L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSST--LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 50 ITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 105
+ ++L L+ + S P + L ++NN ++ + + Q + +
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 106 LDFQNNNLT 114
L ++ +T
Sbjct: 204 LKLESCGVT 212
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 7/61 (11%)
Query: 26 NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 81
L LDL +NQL +P G +L+ +T + L++N+L +IP F L L +++ N
Sbjct: 55 QLTRLDLDNNQLT-VLPAGVFDKLT-QLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLN 111
Query: 82 N 82
N
Sbjct: 112 N 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 7/61 (11%)
Query: 26 NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 81
NL L +SN+L +IP G +L+ +T + L++N L +IP F L L +++ N
Sbjct: 58 NLQQLYFNSNKLT-AIPTGVFDKLT-QLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYN 114
Query: 82 N 82
N
Sbjct: 115 N 115
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 707 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.76 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.74 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.71 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.71 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.69 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.68 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.68 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.68 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.68 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.67 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.66 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.65 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.65 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.64 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.62 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.61 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.61 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.6 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.6 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.6 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.6 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.59 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.59 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.58 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.58 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.58 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.58 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.57 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.57 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.57 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.56 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.56 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.55 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.55 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.55 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.55 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.54 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.54 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.54 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.54 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.53 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.53 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.53 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.53 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.53 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.53 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.52 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.52 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.51 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.51 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.5 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.5 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.5 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.5 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.49 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.49 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.49 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.49 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.48 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.48 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.48 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.47 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.47 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.47 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.47 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.47 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.47 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.47 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.47 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.46 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.46 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.46 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.45 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.45 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.45 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.45 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.45 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.44 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.44 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.43 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.43 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.43 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.43 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.42 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.42 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.42 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.41 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.41 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.41 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.41 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.4 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.4 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.4 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.38 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.38 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.35 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.35 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.34 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.33 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.31 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.31 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.31 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.3 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.28 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.27 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.27 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.25 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.23 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.22 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.12 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.1 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.03 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.02 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.01 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.99 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.88 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.81 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.71 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.62 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.58 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.56 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.24 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.18 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.13 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.11 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.04 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.97 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.94 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.91 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.91 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.8 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.79 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.78 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.62 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.54 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.32 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.19 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.92 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.85 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.83 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.67 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.61 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.41 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.34 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.33 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.33 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.31 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.28 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.1 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.98 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.97 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.79 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 95.78 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.46 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 95.42 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.27 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 95.25 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 94.9 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 94.29 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.18 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 93.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 93.94 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 93.54 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 93.5 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 93.42 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 92.88 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 92.65 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 92.54 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 92.42 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 92.17 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 91.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 91.79 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 91.62 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 91.6 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 91.53 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 90.61 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 90.32 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 90.32 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 90.3 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 90.18 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.1 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.95 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 89.76 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.44 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.06 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 86.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 82.1 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 80.15 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-55 Score=455.89 Aligned_cols=262 Identities=30% Similarity=0.488 Sum_probs=222.8
Q ss_pred cCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999863 478899999988776667889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-----------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 005224 449 VYEFMSNGTLRDQLSAKS-----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 517 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 517 (707)
|||||++|+|.++|+..+ ...++|..++.|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997632 356999999999999999999999998 999999999999999999999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 596 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~ 596 (707)
+|||+|+.....+. ........||+.|||||++.+..|+.++|||||||++|||+| |+.||...... +.
T Consensus 170 ~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-~~---- 239 (299)
T 4asz_A 170 GDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EV---- 239 (299)
T ss_dssp CCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HH----
T ss_pred CCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HH----
Confidence 99999986543221 122234568999999999999999999999999999999999 89999764431 11
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
...+..+.....|..++.++.+++.+||+.+|++|||+.++.+.|+++.+..|
T Consensus 240 -----~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 240 -----IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp -----HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -----HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 12233344556677888999999999999999999999999999999877654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=456.74 Aligned_cols=262 Identities=29% Similarity=0.492 Sum_probs=216.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
++|...++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667889999999999999864 478999999988776667889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 005224 449 VYEFMSNGTLRDQLSAKS-------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 515 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 515 (707)
|||||++|+|.++++... ..+++|..++.|+.|||+||+|||+.+ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997642 246999999999999999999999998 9999999999999999999
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHH
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 594 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~ 594 (707)
||+|||+|+.....+. ........||+.|||||++.+..++.++|||||||++|||+| |+.||...... +..
T Consensus 198 Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-~~~- 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-EAI- 270 (329)
T ss_dssp EECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-HHH-
T ss_pred EEcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-HHH-
Confidence 9999999987643321 122344679999999999999999999999999999999999 89999765432 111
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 595 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
..+..+.....|..++.++.+++.+||+.+|++|||+.++++.|+.+.+..|
T Consensus 271 --------~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 271 --------DCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp --------HHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred --------HHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 1222344455677888999999999999999999999999999999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=457.17 Aligned_cols=260 Identities=22% Similarity=0.379 Sum_probs=214.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
+.|+..++||+|+||+||+|+.+ +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999975 79999999997655445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++|+|.+++... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--- 224 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--- 224 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC---
Confidence 999999999753 4999999999999999999999999 9999999999999999999999999998764321
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... +.
T Consensus 225 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~--------------------- 278 (346)
T 4fih_A 225 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KA--------------------- 278 (346)
T ss_dssp ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HH---------------------
T ss_pred ----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HH---------------------
Confidence 2234568999999999999999999999999999999999999999653321 11
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCCC
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 693 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~ 693 (707)
.+.+..... | .-+. ....++.+.|||.+||+.||++|+|++|+|+||||......
T Consensus 279 --------~~~i~~~~~--~-~~~~--------------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 279 --------MKMIRDNLP--P-RLKN--------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp --------HHHHHHSSC--C-CCSC--------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred --------HHHHHcCCC--C-CCCc--------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 111111110 0 0000 01123344579999999999999999999999999876543
Q ss_pred C
Q 005224 694 S 694 (707)
Q Consensus 694 ~ 694 (707)
+
T Consensus 334 ~ 334 (346)
T 4fih_A 334 A 334 (346)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=451.73 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=216.3
Q ss_pred CCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
+++..++||+|+||+||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3456789999999999999963 468999999975432 335789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 005224 449 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 514 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 514 (707)
|||||++|+|.++|..+. ...++|..++.|+.|||+||+|||+++ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999997532 235899999999999999999999998 999999999999999999
Q ss_pred EEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHH
Q 005224 515 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 593 (707)
Q Consensus 515 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~ 593 (707)
+||+|||+|+.....+. ........||+.|||||++.++.|+.++|||||||++|||+| |+.||..... .+..
T Consensus 184 ~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-~~~~ 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVV 257 (308)
T ss_dssp EEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-HHHH
T ss_pred EEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-HHHH
Confidence 99999999986543221 122345679999999999999999999999999999999999 8999976543 1111
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 594 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
..+..+...+.|.+++..+.+++.+||+.+|++||+|.++++.|+.+.
T Consensus 258 ---------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 ---------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp ---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 122344455677888999999999999999999999999999998653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-54 Score=445.22 Aligned_cols=258 Identities=20% Similarity=0.313 Sum_probs=212.9
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999965 79999999997532 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
|||++|+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997654 4999999999999999999999999 9999999999999999999999999998765322
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+
T Consensus 187 ~-----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~------------------- 241 (311)
T 4aw0_A 187 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GL------------------- 241 (311)
T ss_dssp T-----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HH-------------------
T ss_pred C-----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HH-------------------
Confidence 1 1233456899999999999999999999999999999999999999965332 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC------CCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM------LKH 684 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~------L~H 684 (707)
+.+-+..+ .+. -| ...++++.|||.+||+.||++|+|++|+ ++|
T Consensus 242 ----------~~~~i~~~---~~~-~p----------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~H 291 (311)
T 4aw0_A 242 ----------IFAKIIKL---EYD-FP----------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 291 (311)
T ss_dssp ----------HHHHHHHT---CCC-CC----------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred ----------HHHHHHcC---CCC-CC----------------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCC
Confidence 11111111 110 01 1122334578999999999999999996 789
Q ss_pred CCCCCCCC
Q 005224 685 PYVSSDVS 692 (707)
Q Consensus 685 p~f~~~~~ 692 (707)
|||.+-.+
T Consensus 292 p~F~~idw 299 (311)
T 4aw0_A 292 PFFESVTW 299 (311)
T ss_dssp GGGTTCCC
T ss_pred CCcCCCCH
Confidence 99998766
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=441.15 Aligned_cols=268 Identities=25% Similarity=0.447 Sum_probs=214.8
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
++..++|...++||+|+||+||+|++++ .||||+++... ....+.|.+|+++|++++|||||+++|+|.+ +..+|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3445678889999999999999999753 59999987533 3345789999999999999999999998864 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|||||++|+|.++|+... ..+++..+..|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 109 VmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999997643 45999999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCccccceecccccCCCccchhhhcc---CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
... ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||....+........ .. ..
T Consensus 185 ~~~-----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~-~~----~~ 254 (307)
T 3omv_A 185 WSG-----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV-GR----GY 254 (307)
T ss_dssp --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-HT----TC
T ss_pred CCc-----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH-hc----CC
Confidence 221 223345679999999999964 468999999999999999999999997654432221111 11 11
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
..+.....+.+++..+.+++.+||+.+|++|||+.++++.|+.+...+|+
T Consensus 255 ~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 255 ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 22233345667888999999999999999999999999999988776654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=458.42 Aligned_cols=260 Identities=22% Similarity=0.375 Sum_probs=215.8
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
+.|+..++||+|+||+||+|..+ +|+.||||++........+.+.+|+++|+.++|||||+++++|.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 79999999997655555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--- 301 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--- 301 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC---
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC---
Confidence 999999999653 4899999999999999999999999 9999999999999999999999999998764321
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... +
T Consensus 302 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~---------------------- 354 (423)
T 4fie_A 302 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-K---------------------- 354 (423)
T ss_dssp ----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-H----------------------
T ss_pred ----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-H----------------------
Confidence 2234568999999999999999999999999999999999999999643321 1
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCCC
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 693 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~ 693 (707)
+.+.+........ ......++.+.|||.+||+.||++|+|++|+|+||||......
T Consensus 355 -------~~~~i~~~~~~~~-----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 355 -------AMKMIRDNLPPRL-----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp -------HHHHHHHSCCCCC-----------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred -------HHHHHHcCCCCCC-----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 1111111110000 0111223345689999999999999999999999999875543
Q ss_pred C
Q 005224 694 S 694 (707)
Q Consensus 694 ~ 694 (707)
+
T Consensus 411 ~ 411 (423)
T 4fie_A 411 A 411 (423)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=439.45 Aligned_cols=255 Identities=21% Similarity=0.283 Sum_probs=208.9
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
+.|+..++||+|+||+||+|+.+ +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 46778899999999999999975 799999999976432 246999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeeecccccCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 532 (707)
++|+|.++++..+ .+++..++.++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999997654 5999999999999999999999999 99999999999999987 6999999999876543211
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC--C
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN--M 610 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 610 (707)
.. .......+||+.|||||++.+..|+.++|||||||++|||+||+.||...... .....+.... .
T Consensus 208 ~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----------~~~~~i~~~~~~~ 275 (336)
T 4g3f_A 208 KS--LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG----------PLCLKIASEPPPI 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS----------CCHHHHHHSCCGG
T ss_pred cc--eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----------HHHHHHHcCCCCc
Confidence 10 11223457999999999999999999999999999999999999999753321 0111111111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
...+..++..+.+++.+||+.||.+|||+.|+++.+.....
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 23456677889999999999999999999999998876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-53 Score=443.94 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=208.9
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999965 79999999997543 2335679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
||++|+|.++|..+....+++..++.++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 999999999998776677899999999999999999999999 999999999999999999999999999865321
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+... .+..+...
T Consensus 179 -----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~~---------~i~~~~~~ 243 (350)
T 4b9d_A 179 -----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-KNLVL---------KIISGSFP 243 (350)
T ss_dssp -----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHH---------HHHHTCCC
T ss_pred -----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHH---------HHHcCCCC
Confidence 1223456799999999999999999999999999999999999999975443 22221 22233334
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
..+..++.++.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 455666778899999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-53 Score=433.02 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=196.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 799999999875432 23467999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+ +|+|.+++..++ .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 999 689999997653 5999999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCccccceecccccCCCccchhhhccCCC-CCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||..... ..
T Consensus 166 -------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-~~------------------ 219 (275)
T 3hyh_A 166 -------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-PV------------------ 219 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HH------------------
T ss_pred -------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-HH------------------
Confidence 22345689999999999998876 5799999999999999999999964322 11
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
+.+.+..+.-.-| ...++.+.+||.+||+.||++|+|++|+|+||||..
T Consensus 220 -----------~~~~i~~~~~~~p--------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 220 -----------LFKNISNGVYTLP--------------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----------HHHHHHHTCCCCC--------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----------HHHHHHcCCCCCC--------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1111111110001 011233457899999999999999999999999987
Q ss_pred CCC
Q 005224 690 DVS 692 (707)
Q Consensus 690 ~~~ 692 (707)
+..
T Consensus 269 ~~p 271 (275)
T 3hyh_A 269 DLP 271 (275)
T ss_dssp TCC
T ss_pred CCC
Confidence 653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=433.05 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=199.5
Q ss_pred CccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEe----CCeEEEEE
Q 005224 378 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQMLVY 450 (707)
Q Consensus 378 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 450 (707)
...++||+|+||+||+|.+. +++.||||++.... ....+.|.+|+++|++++|||||+++++|.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999975 68999999986532 3335679999999999999999999999865 34589999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeeecccccCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~ 529 (707)
|||++|+|.+++.+.. .+++..++.++.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 9999999999997643 5899999999999999999999875 46999999999999984 79999999999986432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||....+........
T Consensus 185 --------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i------------- 242 (290)
T 3fpq_A 185 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------------- 242 (290)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-------------
T ss_pred --------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH-------------
Confidence 12345689999999999865 69999999999999999999999997544322111110
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
... .+|.. ......+.+.+||.+||+.||++|||++|+|+||||..
T Consensus 243 ----------------~~~------~~~~~------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 243 ----------------TSG------VKPAS------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------TTT------CCCGG------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------HcC------CCCCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 000 00100 00011223447888899999999999999999999975
Q ss_pred C
Q 005224 690 D 690 (707)
Q Consensus 690 ~ 690 (707)
.
T Consensus 289 ~ 289 (290)
T 3fpq_A 289 E 289 (290)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=444.01 Aligned_cols=270 Identities=23% Similarity=0.308 Sum_probs=207.1
Q ss_pred cCCCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 478999999875322 223468889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|||||++|+|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997654 5999999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... .+..
T Consensus 179 ~~-------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~--------------- 235 (304)
T 3ubd_A 179 HE-------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETM--------------- 235 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH---------------
T ss_pred CC-------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-HHHH---------------
Confidence 21 223456899999999999999999999999999999999999999965332 1111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCC-----CcCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS-----SSMLK 683 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa-----~e~L~ 683 (707)
+.+..+ .+ ..| ...++.+.|||.+||+.||++|+|| +|+++
T Consensus 236 --------------~~i~~~---~~-~~p----------------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 236 --------------TMILKA---KL-GMP----------------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --------------HHHHHC---CC-CCC----------------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --------------HHHHcC---CC-CCC----------------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111111 00 001 0112334578888899999999987 58999
Q ss_pred CCCCCCCCCCCCcccccCcccCC
Q 005224 684 HPYVSSDVSGSNLVSGVIPTITP 706 (707)
Q Consensus 684 Hp~f~~~~~~~~~~~~~~~~~~~ 706 (707)
||||++-.+..-.-....||+.|
T Consensus 282 Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 282 HSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp SGGGTTCCHHHHHTTCSCCSSCC
T ss_pred CccccCCCHHHHHhCCCCcCcCC
Confidence 99998765422112234466554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=440.09 Aligned_cols=271 Identities=25% Similarity=0.409 Sum_probs=224.9
Q ss_pred cHHHHHHHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCC-CcceeEE
Q 005224 366 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHH-RNLVSLV 437 (707)
Q Consensus 366 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H-~nIv~l~ 437 (707)
..++++...++|++.+.||+|+||+||+|.+. .++.||||++...... ..+.|.+|+++|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34567777889999999999999999999863 2468999999865443 35679999999999965 8999999
Q ss_pred EEEEeC-CeEEEEEecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 005224 438 GYCDEE-GEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 502 (707)
Q Consensus 438 ~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl 502 (707)
|+|.+. +..++|||||++|+|.++|+... ...+++..++.++.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999765 56899999999999999997532 345899999999999999999999999 999999
Q ss_pred CCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCC
Q 005224 503 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 581 (707)
Q Consensus 503 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~ 581 (707)
||+|||+++++.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 99999999999999999999987643321 123345678999999999999999999999999999999998 999
Q ss_pred CCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 582 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 582 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
||........... .+..+.....|+.++.++.+++.+||+.+|++|||+.++++.|+.+.+..
T Consensus 287 Pf~~~~~~~~~~~---------~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 287 PYPGVKIDEEFCR---------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp SSTTCCCSHHHHH---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCHHHHHHH---------HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 9975433211111 12233445567778889999999999999999999999999999886643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=436.14 Aligned_cols=307 Identities=18% Similarity=0.267 Sum_probs=216.0
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 443 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 443 (707)
.+....++|++.++||+|+||+||+|+.+ +++.||||++.... ...++.+|+++|+.+ +||||+++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 33445688999999999999999999853 46899999986543 345788999999998 699999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeeecc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGL 522 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGl 522 (707)
++.++||||+++|+|.+++. .+++..++.++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 99999999999999999983 3899999999999999999999999 9999999999999877 7999999999
Q ss_pred cccCCCCCCCCc---------------------cccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCC
Q 005224 523 SRLAPVPDIEGI---------------------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGM 580 (707)
Q Consensus 523 a~~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~ 580 (707)
|+.......... .........+||+.|+|||++.+. .|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 986543221100 001122345799999999999875 5899999999999999999999
Q ss_pred CCCCCCchhHHHHHHHhhcccch------hhccC---CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 581 QPISHGKNIVREVNIAYQSSMMF------SVIDG---NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 581 ~pf~~~~~~~~~~~~~~~~~~~~------~~~~~---~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.||..+.+..+.+.......... ..... .....+......+.+.+...-...| ....-.........
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p----~~~~~~~~~~~~~~ 320 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTP----KLTSDIQGHATNLE 320 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------------------
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccc----cccccccccccccc
Confidence 99987776555444322110000 00000 0001111111112221111111111 11111111111112
Q ss_pred cCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 652 MMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 652 ~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
.....++++.|||.+||++||++|+||+|||+||||..
T Consensus 321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 23444566789999999999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-51 Score=439.19 Aligned_cols=287 Identities=22% Similarity=0.343 Sum_probs=215.1
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEe------CCe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGE 445 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~ 445 (707)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 79999999997533 2335678899999999999999999999754 367
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.|||||||+ |+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 6899999653 46999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
....... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||..... .+.+..+.....
T Consensus 208 ~~~~~~~---~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~-~~~l~~I~~~~g--- 280 (398)
T 4b99_A 208 LCTSPAE---HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY-VHQLQLIMMVLG--- 280 (398)
T ss_dssp C----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHC---
T ss_pred cccCccc---cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcC---
Confidence 6432111 12234457899999999999875 569999999999999999999999975443 222222211100
Q ss_pred hccCCCCCCChHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCC
Q 005224 605 VIDGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 683 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 683 (707)
..+......+ .......+...|...|.. +...++..++++.|||.+||+.||++|+||+|+|+
T Consensus 281 -------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 281 -------TPSPAVIQAVGAERVRAYIQSLPPRQPVP---------WETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -------CCCGGGTC-----CHHHHHHSSCCCCCCC---------HHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------CCChHHhhhhhhhhhhhhhhcCCCcCCCC---------HHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000 000111222233333321 11223455667789999999999999999999999
Q ss_pred CCCCCCC
Q 005224 684 HPYVSSD 690 (707)
Q Consensus 684 Hp~f~~~ 690 (707)
||||...
T Consensus 345 Hp~f~~~ 351 (398)
T 4b99_A 345 HPFLAKY 351 (398)
T ss_dssp SGGGTTT
T ss_pred CHhhCcC
Confidence 9999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=421.95 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=200.5
Q ss_pred CCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC----eEEEEEe
Q 005224 376 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQMLVYE 451 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV~E 451 (707)
+|...++||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++++|.+++ ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 467789999999999999998 689999999975322 1223345666667889999999999997654 5799999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-----ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
||++|+|.++++.. .++|..+.+++.|+++||+|||++ ..++||||||||+|||+|+++++||+|||+|+..
T Consensus 82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999764 489999999999999999999987 2345999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccC------CCCCchhhHHHHHHHHHHHcCCCCCCCCch------------
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTGMQPISHGKN------------ 588 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvll~elltG~~pf~~~~~------------ 588 (707)
...... .........||+.|||||++.+. .++.++|||||||++|||+||+.||.....
T Consensus 159 ~~~~~~---~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 159 DSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp ETTTTE---ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred cCCCCc---eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 432210 01122345799999999999764 367799999999999999999877642111
Q ss_pred -hHHHHHHHhhcccchhhccCCCCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 589 -IVREVNIAYQSSMMFSVIDGNMGS--YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 589 -~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
........... ....+..+. .+.+++..+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 236 ~~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 236 PSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11111111110 011111111 1236778899999999999999999999999999988653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=418.69 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=192.7
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCC--------
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-------- 444 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-------- 444 (707)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45889999999999999999975 799999999875443 33567999999999999999999999986544
Q ss_pred ----eEEEEEecCCCCCHHHHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 005224 445 ----EQMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 519 (707)
Q Consensus 445 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 519 (707)
..|+|||||++|+|.+++..... ....+..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976543 23567778999999999999999999 99999999999999999999999
Q ss_pred ecccccCCCCCCCCcc-----ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005224 520 FGLSRLAPVPDIEGIV-----PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 594 (707)
Q Consensus 520 FGla~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~ 594 (707)
||+|+........... ........+||+.|||||++.+..|+.++|||||||++|||++ ||....+......
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 9999876543211110 0112344679999999999999999999999999999999996 7753211111000
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCC
Q 005224 595 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 674 (707)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~ 674 (707)
. +.. ..+|. ...+. .+...+||.+||+.||++
T Consensus 239 ~---------~~~---~~~p~----------------------~~~~~--------------~~~~~~li~~~L~~dP~~ 270 (299)
T 4g31_A 239 D---------VRN---LKFPP----------------------LFTQK--------------YPCEYVMVQDMLSPSPME 270 (299)
T ss_dssp H---------HHT---TCCCH----------------------HHHHH--------------CHHHHHHHHHHTCSSGGG
T ss_pred H---------Hhc---CCCCC----------------------CCccc--------------CHHHHHHHHHHcCCChhH
Confidence 0 000 00111 11110 111236889999999999
Q ss_pred CCCCCcCCCCCCCCCCCC
Q 005224 675 PPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 675 R~sa~e~L~Hp~f~~~~~ 692 (707)
|||++|+|+||||..-.+
T Consensus 271 Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 271 RPEAINIIENAVFEDLDF 288 (299)
T ss_dssp SCCHHHHHTSGGGCCC--
T ss_pred CcCHHHHhcCHhhCCCCC
Confidence 999999999999987554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=436.35 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=204.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHH---HHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFL---TEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
.++|++.++||+|+||+||+|+.+ +|+.||||++..... .....+. .++.+++.++|||||+++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999975 799999999864321 1122333 346677788999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
|||||||+||+|.++|...+ .+++..++.++.||+.||+|||+++ ||||||||+|||++.+|++||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999997654 4999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
... .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||........
T Consensus 343 ~~~---------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-------------- 399 (689)
T 3v5w_A 343 SKK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------------- 399 (689)
T ss_dssp SSC---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--------------
T ss_pred CCC---------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--------------
Confidence 432 2334689999999999975 6799999999999999999999999964221000
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCC-----CCc
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSS 680 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s-----a~e 680 (707)
..+.+.+ +...+. -| ...++.+.|||.+||+.||++|++ |+|
T Consensus 400 -------------~~i~~~i---~~~~~~-~p----------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~e 446 (689)
T 3v5w_A 400 -------------HEIDRMT---LTMAVE-LP----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 446 (689)
T ss_dssp -------------HHHHHHH---HHCCCC-CC----------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHH
T ss_pred -------------HHHHHhh---cCCCCC-CC----------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHH
Confidence 0011111 111110 01 112334457888999999999998 589
Q ss_pred CCCCCCCCCCCC
Q 005224 681 MLKHPYVSSDVS 692 (707)
Q Consensus 681 ~L~Hp~f~~~~~ 692 (707)
+++||||.+-.+
T Consensus 447 i~~HpfF~~idW 458 (689)
T 3v5w_A 447 VKESPFFRSLDW 458 (689)
T ss_dssp HTTSGGGTTCCH
T ss_pred HhcCccccCCCH
Confidence 999999988665
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=435.72 Aligned_cols=260 Identities=22% Similarity=0.367 Sum_probs=216.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|++.+.||+|+||+||+|..+ +|+.||+|++........+.+.+|+++|+.++|||||+++++|.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 7999999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEeeecccccCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 530 (707)
|++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999643 345999999999999999999999999 9999999999999854 89999999999876532
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...... +..
T Consensus 311 -------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~~~----------------- 365 (573)
T 3uto_A 311 -------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETL----------------- 365 (573)
T ss_dssp -------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHH-----------------
T ss_pred -------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHH-----------------
Confidence 2334568999999999999999999999999999999999999999754331 111
Q ss_pred CCCChHHHHHHHHHHHHh-cccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKC-CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c-~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
+.+..+ +...+ ...+..++.+.|||.+||+.||++|+|++|+|+||||..
T Consensus 366 ------------~~i~~~~~~~~~-----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 366 ------------RNVKSCDWNMDD-----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp ------------HHHHTTCCCCCS-----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred ------------HHHHhCCCCCCc-----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 111111 11000 011222344568999999999999999999999999987
Q ss_pred CCC
Q 005224 690 DVS 692 (707)
Q Consensus 690 ~~~ 692 (707)
...
T Consensus 417 ~~~ 419 (573)
T 3uto_A 417 GNA 419 (573)
T ss_dssp CCC
T ss_pred CCC
Confidence 554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=383.64 Aligned_cols=257 Identities=24% Similarity=0.337 Sum_probs=210.3
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999997 58999999998653 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 9999999999997653 4899999999999999999999999 999999999999999999999999999765432
Q ss_pred CCCccccceecccccCCCccchhhhccCCCC-CchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.......||+.|+|||++.+..+. .++||||+||++|||++|+.||...... .
T Consensus 168 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~------------------ 221 (328)
T 3fe3_A 168 -------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-E------------------ 221 (328)
T ss_dssp -------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-H------------------
T ss_pred -------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-H------------------
Confidence 123456799999999999988875 7899999999999999999999653321 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
+.+.+.......|. ..++...+|+.+||..||++|||++|+|+||||..
T Consensus 222 -----------~~~~i~~~~~~~p~--------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 222 -----------LRERVLRGKYRIPF--------------------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp -----------HHHHHHHCCCCCCT--------------------TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred -----------HHHHHHhCCCCCCC--------------------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 11111111000110 11223347888999999999999999999999987
Q ss_pred CCCC
Q 005224 690 DVSG 693 (707)
Q Consensus 690 ~~~~ 693 (707)
....
T Consensus 271 ~~~~ 274 (328)
T 3fe3_A 271 GHEE 274 (328)
T ss_dssp TCTT
T ss_pred CCcc
Confidence 6543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=381.68 Aligned_cols=284 Identities=43% Similarity=0.754 Sum_probs=234.3
Q ss_pred ccCcccccHHHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEE
Q 005224 359 IDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLV 437 (707)
Q Consensus 359 ~~~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~ 437 (707)
......+++.++....++|+..+.||+|+||+||+|..++++.||||++...... ....+.+|+++++.++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 3445678999999999999999999999999999999888999999998764322 234689999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 005224 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 515 (707)
Q Consensus 438 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 515 (707)
+++...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+.++|+||||||+|||+++++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999997643 3459999999999999999999999922239999999999999999999
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCC-------Cch
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH-------GKN 588 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~-------~~~ 588 (707)
||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.. ...
T Consensus 174 kl~Dfg~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 174 VVGDFGLAKLMDYKD------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp EECCCSSCEECCSSS------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred EeccCccccccCccc------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 999999998764322 2233445699999999999999999999999999999999999999952 112
Q ss_pred hHHHHHHHhhcccchhhccCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 589 IVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
..+++.............+... ..++.+++..+.+++..||+.+|.+||++.++++.|+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 2333333223333333333333 34678889999999999999999999999999999985
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=374.65 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=212.1
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|+..+.||+|+||+||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999996 47999999998765555667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence 9999999999764 4899999999999999999999999 9999999999999999999999999998664322
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 171 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------------------ 227 (297)
T 3fxz_A 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------------------ 227 (297)
T ss_dssp -----CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------------------
T ss_pred -----cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------------
Confidence 123345789999999999999999999999999999999999999965443211111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
+.... .+... .. ...+....+|+.+||..||++|||++|+|+||||.....
T Consensus 228 -----------~~~~~---~~~~~-~~--------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 228 -----------IATNG---TPELQ-NP--------------EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp -----------HHHHC---SCCCS-CG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred -----------HHhCC---CCCCC-Cc--------------cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 00000 00000 00 011122346888899999999999999999999986654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=377.86 Aligned_cols=279 Identities=43% Similarity=0.719 Sum_probs=232.7
Q ss_pred cHHHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 366 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 366 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
.+.++...+++|+..+.||+|+||+||+|.+++++.||||++........+.+.+|+++++.++||||+++++++...+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34455567889999999999999999999988899999999887666666789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
.++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999996543 235899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc-----hhHHHHHHHhh
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK-----NIVREVNIAYQ 598 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~-----~~~~~~~~~~~ 598 (707)
+....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+......
T Consensus 187 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 187 KKGTELDQ-----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp EECSSSSC-----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred cccccccc-----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 86542221 122234568999999999999999999999999999999999999996432 22333322233
Q ss_pred cccchhhccCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 599 SSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 599 ~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
.......+++.. ...+.+++..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 333333444333 236788999999999999999999999999999999988754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=396.75 Aligned_cols=272 Identities=24% Similarity=0.277 Sum_probs=217.2
Q ss_pred ccHHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHHHccCCCcceeEEEEE
Q 005224 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYC 440 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~ 440 (707)
+.+.++....++|++.++||+|+||+||+|+.+ +++.||||++....... ...+.+|+.+++.++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345667777899999999999999999999976 58999999986532211 23488999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeee
Q 005224 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 520 (707)
Q Consensus 441 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 520 (707)
.+.+..++|||||++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999999763 345999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCCCccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005224 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 595 (707)
Q Consensus 521 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~ 595 (707)
|+|+...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||...... +...
T Consensus 220 Gla~~~~~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~- 291 (437)
T 4aw2_A 220 GSCLKLMEDG------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYG- 291 (437)
T ss_dssp TTCEECCTTS------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHH-
T ss_pred hhhhhcccCC------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHH-
Confidence 9997654322 22234467999999999997 467899999999999999999999999754321 1110
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcc-cCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCC
Q 005224 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQ-DETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 674 (707)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~-~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~ 674 (707)
+++..... .-|.. ....++.+.|||.+||..+|++
T Consensus 292 ---------------------------~i~~~~~~~~~p~~-----------------~~~~s~~~~dLi~~lL~~~~~r 327 (437)
T 4aw2_A 292 ---------------------------KIMNHKERFQFPTQ-----------------VTDVSENAKDLIRRLICSREHR 327 (437)
T ss_dssp ---------------------------HHHTHHHHCCCCSS-----------------CCCSCHHHHHHHHTTSSCGGGC
T ss_pred ---------------------------hhhhccccccCCcc-----------------cccCCHHHHHHHHHHhcccccc
Confidence 11100000 00100 1123344567899999998888
Q ss_pred --CCCCCcCCCCCCCCCCCC
Q 005224 675 --PPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 675 --R~sa~e~L~Hp~f~~~~~ 692 (707)
|++++|+++||||.+..+
T Consensus 328 ~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 328 LGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp TTTTTTHHHHTSGGGTTCCT
T ss_pred cCCCCHHHHhCCCccCCCCH
Confidence 999999999999988766
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=388.88 Aligned_cols=204 Identities=26% Similarity=0.409 Sum_probs=174.0
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeE
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 446 (707)
...++|++.+.||+|+||+||+|+.+ +++.||||++.... ....+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999975 68999999997532 22345678899999988 799999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999997653 4899999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 175 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 175 ICN-------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp CC----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccC-------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 321 123345679999999999999999999999999999999999999997543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=379.68 Aligned_cols=277 Identities=25% Similarity=0.350 Sum_probs=210.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||+||+|...+|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4689999999999999999999988999999998753322 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|++ |+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 100 FME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp CCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred CCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 997 5888888654 345899999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 174 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----------------- 230 (311)
T 3niz_A 174 ------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP----------------- 230 (311)
T ss_dssp ------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH-----------------
T ss_pred ------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH-----------------
Confidence 22334568999999999987 568999999999999999999999997543311110
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH---------HhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE---------SIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 681 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~---------~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 681 (707)
.+...+-...|...+...++....+ ......+...+...+||.+||..||++|||++|+
T Consensus 231 ------------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 298 (311)
T 3niz_A 231 ------------KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298 (311)
T ss_dssp ------------HHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred ------------HHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 0111111111111111110000000 0001122334455689999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 682 LKHPYVSSDV 691 (707)
Q Consensus 682 L~Hp~f~~~~ 691 (707)
|+||||..-.
T Consensus 299 l~hp~f~~~~ 308 (311)
T 3niz_A 299 MNHPYFKDLD 308 (311)
T ss_dssp HTSGGGTTSC
T ss_pred hcCcccccCC
Confidence 9999998653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=393.99 Aligned_cols=209 Identities=22% Similarity=0.310 Sum_probs=181.2
Q ss_pred HHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEe
Q 005224 367 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442 (707)
Q Consensus 367 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 442 (707)
..++....++|++.++||+|+||+||+|+.+ +++.||+|++..... ...+.+.+|+.+++.++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4456667789999999999999999999976 689999999865221 112357899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
.+..++||||+++|+|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999653 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCC----CCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
++...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 215 a~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 215 CMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp CEECCTTS------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eEeeccCC------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 98764322 12234567999999999998765 7899999999999999999999997543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=391.02 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=176.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|++.++||+|+||+||+|+.+ +++.||+|+++..... ..+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467899999999999999999975 6889999999754322 224578899999887 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999997643 5999999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 206 ~-------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 206 P-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp T-------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred C-------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 1 2234456799999999999999999999999999999999999999963
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=381.49 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=210.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh------hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
.++|++.+.||+|+||+||+|... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999975 6999999998764322 246789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeeecc
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 522 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFGl 522 (707)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+++++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999653 46999999999999999999999999 99999999999998877 799999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... +.....
T Consensus 166 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~~i------ 230 (361)
T 2yab_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANI------ 230 (361)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHH------
T ss_pred ceEcCCCC--------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH------
Confidence 98764321 223456999999999999999999999999999999999999999754321 111000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
... ...++... .+..+..+.+||.+||..||++|||++|+|
T Consensus 231 ---~~~-~~~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 231 ---TAV-SYDFDEEF-----------------------------------FSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp ---HTT-CCCCCHHH-----------------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ---Hhc-CCCCCchh-----------------------------------ccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 00111110 012233445799999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 683 KHPYVSSDV 691 (707)
Q Consensus 683 ~Hp~f~~~~ 691 (707)
+||||....
T Consensus 272 ~hp~~~~~~ 280 (361)
T 2yab_A 272 RHPWITPVD 280 (361)
T ss_dssp TSTTTSCSS
T ss_pred cCcCcCCCc
Confidence 999998543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=381.13 Aligned_cols=202 Identities=26% Similarity=0.343 Sum_probs=178.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|+..+.||+|+||+||+|..+ +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367889999999999999999975 79999999997532 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999997643 5899999999999999999999999 999999999999999999999999999854321
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 159 -------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp -------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 122345679999999999999999999999999999999999999997543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=373.99 Aligned_cols=270 Identities=21% Similarity=0.314 Sum_probs=216.3
Q ss_pred ccccHHHHHHHhcC----------CCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCC
Q 005224 363 RSFTYGEMALATNN----------FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR 431 (707)
Q Consensus 363 ~~~~~~~l~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ 431 (707)
..++++++..+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 35777777777654 677789999999999999976 7999999999876656667899999999999999
Q ss_pred cceeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 005224 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH 511 (707)
Q Consensus 432 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~ 511 (707)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 999999999999999999999999999999854 35899999999999999999999998 999999999999999
Q ss_pred CCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHH
Q 005224 512 KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 591 (707)
Q Consensus 512 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~ 591 (707)
++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV-------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSS-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCcEEEeeeeeeeecccCc-------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999998654321 122345789999999999999999999999999999999999999965432111
Q ss_pred HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCC
Q 005224 592 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSK 671 (707)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~d 671 (707)
... +.... .|... . ....++...+|+.+||..|
T Consensus 250 -~~~-----------------------------~~~~~--~~~~~-~--------------~~~~~~~l~~li~~~l~~d 282 (321)
T 2c30_A 250 -MKR-----------------------------LRDSP--PPKLK-N--------------SHKVSPVLRDFLERMLVRD 282 (321)
T ss_dssp -HHH-----------------------------HHHSS--CCCCT-T--------------GGGSCHHHHHHHHHHSCSS
T ss_pred -HHH-----------------------------HhcCC--CCCcC-c--------------cccCCHHHHHHHHHHccCC
Confidence 000 00000 00000 0 0001122346788899999
Q ss_pred CCCCCCCCcCCCCCCCCCCCC
Q 005224 672 EETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 672 P~~R~sa~e~L~Hp~f~~~~~ 692 (707)
|++|||++|+|+||||.....
T Consensus 283 p~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 283 PQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp TTTSCCHHHHHTSGGGGGCCC
T ss_pred hhhCcCHHHHhcChhhccCCC
Confidence 999999999999999976544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=375.09 Aligned_cols=276 Identities=24% Similarity=0.394 Sum_probs=211.1
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 689999999875432 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++ ++.+.+... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9975 666666543 345999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCccccceecccccCCCccchhhhccCC-CCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..||....+..+.......
T Consensus 156 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~------------ 217 (292)
T 3o0g_A 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR------------ 217 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH------------
T ss_pred ------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH------------
Confidence 2233456899999999998765 899999999999999999999997665554333322211
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--------HHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--------LESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~--------L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
.+-...+...+.+.+.... ........+..++...+||.+||+.||++|||++|+|
T Consensus 218 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 218 ----------------LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp ----------------HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ----------------HhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 1111111111111100000 0000111222334446899999999999999999999
Q ss_pred CCCCCCCC
Q 005224 683 KHPYVSSD 690 (707)
Q Consensus 683 ~Hp~f~~~ 690 (707)
+||||+..
T Consensus 282 ~hp~f~~~ 289 (292)
T 3o0g_A 282 QHPYFSDF 289 (292)
T ss_dssp TSGGGTTC
T ss_pred cCcccccC
Confidence 99999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=376.56 Aligned_cols=199 Identities=24% Similarity=0.419 Sum_probs=177.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357889999999999999999975 799999999875322 2345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 9999999999999764 35899999999999999999999998 99999999999999999999999999986532
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 159 ---------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp ---------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1234579999999999999999999999999999999999999997543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=380.24 Aligned_cols=200 Identities=25% Similarity=0.382 Sum_probs=176.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|+..+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357889999999999999999975 68999999997542 23345688999999988 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 v~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999997643 5899999999999999999999999 99999999999999999999999999985432
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 163 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 163 P-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp T-------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 1 1223456799999999999999999999999999999999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=382.42 Aligned_cols=301 Identities=19% Similarity=0.243 Sum_probs=225.7
Q ss_pred CcccccHHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccC-----CCcce
Q 005224 361 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----HRNLV 434 (707)
Q Consensus 361 ~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~nIv 434 (707)
....+++.+.....++|.+.++||+|+||+||+|... +++.||||++.. .....+.+..|+++++.++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 4456777777788899999999999999999999974 789999999975 2344567788999999996 99999
Q ss_pred eEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---
Q 005224 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--- 511 (707)
Q Consensus 435 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--- 511 (707)
++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 9999999999999999999 899999998876667999999999999999999999999 999999999999975
Q ss_pred ----------------------CCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHH
Q 005224 512 ----------------------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSL 569 (707)
Q Consensus 512 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~ 569 (707)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHcCCCCCCccchHHH
Confidence 789999999999864321 234568999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHH-------hcccCCCCCCCHHHH
Q 005224 570 GVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALK-------CCQDETDARPSMSEV 642 (707)
Q Consensus 570 Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~-------c~~~~p~~RPt~~~v 642 (707)
||++|||++|+.||....... ....... .....+............. .....|.........
T Consensus 246 G~il~ell~g~~pf~~~~~~~-~~~~~~~----------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 314 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHEHME-HLAMMES----------IIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314 (360)
T ss_dssp HHHHHHHHHSSCSCCCSSHHH-HHHHHHH----------HTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHH
T ss_pred HHHHHHHHHCCCCCCCCcHHH-HHHHHHH----------hcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhh
Confidence 999999999999997654322 1111100 0112222222111100000 001112222222221
Q ss_pred HHHHHHhhh-cCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 643 MRELESIWN-MMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 643 ~~~L~~~~~-~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
. .+..... .....++.+.+||.+||+.||++|||++|+|+||||.
T Consensus 315 ~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 315 K-HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp H-HHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred h-hhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 1 1111000 0011234455899999999999999999999999995
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=380.45 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=208.4
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCe
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 445 (707)
....++|.+.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+..|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999975 68999999997532 12345678899999887 99999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999997643 4899999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 168 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~------------- 226 (345)
T 1xjd_A 168 NMLGD-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-EL------------- 226 (345)
T ss_dssp CCCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH-------------
T ss_pred cccCC-------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-HH-------------
Confidence 43221 1234567999999999999999999999999999999999999999653321 10
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCC-cCCCC
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS-SMLKH 684 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~-e~L~H 684 (707)
.+.+... .+.- | ...++.+.+||.+||+.||++|+++. |+++|
T Consensus 227 ----------------~~~i~~~---~~~~-p----------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 227 ----------------FHSIRMD---NPFY-P----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp ----------------HHHHHHC---CCCC-C----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ----------------HHHHHhC---CCCC-C----------------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 0111100 0000 0 01122334788889999999999998 99999
Q ss_pred CCCCCCCC
Q 005224 685 PYVSSDVS 692 (707)
Q Consensus 685 p~f~~~~~ 692 (707)
|||.+-.+
T Consensus 271 p~f~~~~w 278 (345)
T 1xjd_A 271 PLFREINW 278 (345)
T ss_dssp GGGTTCCH
T ss_pred ccccCCCH
Confidence 99987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=388.57 Aligned_cols=213 Identities=28% Similarity=0.314 Sum_probs=183.9
Q ss_pred ccHHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEE
Q 005224 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYC 440 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~ 440 (707)
+.+++.....++|++.+.||+|+||+||+|+.+ +|+.||||++...... ..+.+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445566677889999999999999999999975 7999999999753221 123478899999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeee
Q 005224 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 520 (707)
Q Consensus 441 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 520 (707)
.+.+..++||||+++|+|.+++.+.+ ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999997643 35899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCCCccccceecccccCCCccchhhhc-------cCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 521 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
|+++...... ........||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 207 Gla~~~~~~~------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 207 GSCLKLRADG------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp TTCEECCTTS------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhheeccCCC------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 9998764322 11233467999999999997 3578999999999999999999999997543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=387.07 Aligned_cols=307 Identities=19% Similarity=0.219 Sum_probs=213.2
Q ss_pred hcCCCccceEeee--CceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|++.+.||+| +||+||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999976 79999999987543 2334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999998776667999999999999999999999999 99999999999999999999999999865432
Q ss_pred CCCCCccccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
................||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. ........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~ 258 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVPCLL 258 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh--cCCCCccc
Confidence 21111111112233478999999999987 679999999999999999999999997543321111100 00000000
Q ss_pred cCCCCCCChHHH-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC
Q 005224 607 DGNMGSYPSECV-----EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 681 (707)
Q Consensus 607 ~~~~~~~~~~~~-----~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 681 (707)
+... .+.+.. .................||...+.. ........++.+.+||.+||+.||++|||++|+
T Consensus 259 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 259 DTST--IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP-----SHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred cccc--cccccccccccccccccccccccccCccccccCCCC-----CCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 0000 000000 0000000000000001111111000 001112234456689999999999999999999
Q ss_pred CCCCCCCCCCC
Q 005224 682 LKHPYVSSDVS 692 (707)
Q Consensus 682 L~Hp~f~~~~~ 692 (707)
|+||||.....
T Consensus 332 l~hp~f~~~~~ 342 (389)
T 3gni_B 332 LNHSFFKQIKR 342 (389)
T ss_dssp TTSGGGGGC--
T ss_pred hcCHHHHHHhh
Confidence 99999986543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=371.74 Aligned_cols=274 Identities=23% Similarity=0.335 Sum_probs=206.1
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|++.+.||+|+||+||+|...+|+.||+|++...... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578899999999999999999988999999998754332 236788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++ +|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp CSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence 975 999998654 345899999999999999999999998 9999999999999999999999999998653211
Q ss_pred CccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~--------------- 213 (288)
T 1ob3_A 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRI--------------- 213 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH---------------
T ss_pred -----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH---------------
Confidence 12234568999999999976 4589999999999999999999999975443211 1111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH--------HhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE--------SIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 683 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~--------~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 683 (707)
....-.......|...+....-. .........++...+||.+||..||++|||++|+|+
T Consensus 214 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 214 -------------FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp -------------HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------------HHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000011111111000000000 000111223334458999999999999999999999
Q ss_pred CCCCCC
Q 005224 684 HPYVSS 689 (707)
Q Consensus 684 Hp~f~~ 689 (707)
||||..
T Consensus 281 hp~f~~ 286 (288)
T 1ob3_A 281 HAYFKE 286 (288)
T ss_dssp SGGGGC
T ss_pred Ccchhh
Confidence 999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=374.58 Aligned_cols=259 Identities=19% Similarity=0.337 Sum_probs=209.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|++.+.||+|+||+||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999975 68999999987543 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEeeecccccCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~~ 530 (707)
+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999653 345899999999999999999999999 999999999999987 789999999999876432
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...... ....... ...
T Consensus 158 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~---------~~~- 219 (321)
T 1tki_A 158 -------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIM---------NAE- 219 (321)
T ss_dssp -------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHH---------HTC-
T ss_pred -------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHH---------cCC-
Confidence 2234457899999999999988999999999999999999999999754331 1111000 000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
..++.. ..+..+..+.+|+.+||..||++|||++|+|+||||...
T Consensus 220 ~~~~~~-----------------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 220 YTFDEE-----------------------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CCCCHH-----------------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCChh-----------------------------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 000100 011223334578888999999999999999999998765
Q ss_pred C
Q 005224 691 V 691 (707)
Q Consensus 691 ~ 691 (707)
.
T Consensus 265 ~ 265 (321)
T 1tki_A 265 I 265 (321)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=376.84 Aligned_cols=262 Identities=25% Similarity=0.474 Sum_probs=217.7
Q ss_pred hcCCCccceEeeeCceEEEEEEe--------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 443 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 443 (707)
.++|++.+.||+|+||+||+|.+ .++..||||++..... ...+.+.+|+++++.+ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46788999999999999999985 2456899999976533 3346799999999999 899999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCC--------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 509 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 509 (707)
+..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 35899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCch
Q 005224 510 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 588 (707)
Q Consensus 510 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~ 588 (707)
+.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999866433211 11223456789999999999999999999999999999999 9999965432
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
. +. ...+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 312 ~-~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 312 E-EL---------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp G-GH---------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H-HH---------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 11 1112223334456677788999999999999999999999999999887643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=382.75 Aligned_cols=305 Identities=25% Similarity=0.347 Sum_probs=208.4
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccC-CCcceeEEEEEEeCC--eE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEG--EQ 446 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~ 446 (707)
..++|++.+.||+|+||+||+|... +|+.||||++... .....+.+.+|+.+++.+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 7899999998643 3344567889999999997 999999999997554 78
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++|||||+ ++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999996 6999999753 5899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCC--------------ccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHH
Q 005224 527 PVPDIEG--------------IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 591 (707)
Q Consensus 527 ~~~~~~~--------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~ 591 (707)
....... ...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~ 238 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-N 238 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 4311000 001122344679999999999987 67999999999999999999999999765442 2
Q ss_pred HHHHHhhcccc--hhhccCCCCCCChHHHHHHHHHHHHhccc-CCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCC
Q 005224 592 EVNIAYQSSMM--FSVIDGNMGSYPSECVEKFIKLALKCCQD-ETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 668 (707)
Q Consensus 592 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~c~~~-~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L 668 (707)
.+......... ...+......+. ..+.+-....... ....+..+......+... ......++.+.|||.+||
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFA----KTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI-NPKADCNEEALDLLDKLL 313 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSH----HHHHHHHHHHCC-----CCCCHHHHHHHHHHH-CTTCCCCHHHHHHHHHHC
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHH----HHHHHhCcccccccCCCHHHhCcchhhhcccc-cccccCCHHHHHHHHHhh
Confidence 22221110000 000000001111 1111111111111 112222333332222221 122344556789999999
Q ss_pred CCCCCCCCCCCcCCCCCCCCCC
Q 005224 669 TSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 669 ~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
++||++|+|++|+|+||||+.-
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTTTT
T ss_pred ccCcccCCCHHHHhCCHHHHHh
Confidence 9999999999999999999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=377.95 Aligned_cols=260 Identities=22% Similarity=0.399 Sum_probs=212.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|++.+.||+|+||+||+|... +|+.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357999999999999999999975 7899999999876655667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEeeecccccCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~~ 530 (707)
+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999999653 345999999999999999999999999 999999999999974 5789999999998764321
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 206 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~----------------- 259 (387)
T 1kob_A 206 --------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETL----------------- 259 (387)
T ss_dssp --------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHH-----------------
T ss_pred --------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHH-----------------
Confidence 223446899999999999999999999999999999999999999754321 111
Q ss_pred CCCChHHHHHHHHHHHHh-cccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKC-CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c-~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
.-+..+ +...+.. ....++.+.+||.+||..||++|||++|+|+||||.+
T Consensus 260 ------------~~i~~~~~~~~~~~-----------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 260 ------------QNVKRCDWEFDEDA-----------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp ------------HHHHHCCCCCCSST-----------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ------------HHHHhCCCCCCccc-----------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 011111 1111100 1112233457889999999999999999999999987
Q ss_pred CCC
Q 005224 690 DVS 692 (707)
Q Consensus 690 ~~~ 692 (707)
...
T Consensus 311 ~~~ 313 (387)
T 1kob_A 311 DHS 313 (387)
T ss_dssp CCT
T ss_pred Ccc
Confidence 644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=377.59 Aligned_cols=198 Identities=23% Similarity=0.355 Sum_probs=177.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|+..+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57889999999999999999975 799999999865322 23467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999997653 4899999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 195 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 234578999999999999999999999999999999999999997543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=375.64 Aligned_cols=293 Identities=22% Similarity=0.394 Sum_probs=200.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||+||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999965 6899999998754322 34678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcC----CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 452 FMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
|++ |+|.+++.... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999987532 245899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........ .
T Consensus 160 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~------~ 225 (317)
T 2pmi_A 160 IPV-------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDI------M 225 (317)
T ss_dssp SCC-------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH------H
T ss_pred CCc-------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH------h
Confidence 321 12234568999999999987 468999999999999999999999997554321 11111110 0
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCC
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARP--SMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 684 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP--t~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 684 (707)
........ ..+.++. -+..+...++ ...+. +.. ......+..+.+||.+||+.||++|||++|+|+|
T Consensus 226 ~~~~~~~~----~~~~~~~--~~~~~~~~~~~~~~~~~---~~~--~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 226 GTPNESLW----PSVTKLP--KYNPNIQQRPPRDLRQV---LQP--HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CSCCTTTC----GGGGGCT--TCCTTCCCCCCCCSHHH---HGG--GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhHh----hhhhhhh--hcccccccccchhHHHh---hcc--cccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000000 0000000 0000000111 11111 110 0112234456689999999999999999999999
Q ss_pred CCCCCCCCCCC
Q 005224 685 PYVSSDVSGSN 695 (707)
Q Consensus 685 p~f~~~~~~~~ 695 (707)
|||........
T Consensus 295 p~f~~~~~~~~ 305 (317)
T 2pmi_A 295 PWFAEYYHHAS 305 (317)
T ss_dssp GGGGGGCC---
T ss_pred hhhhcccchhh
Confidence 99987655433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=369.15 Aligned_cols=264 Identities=28% Similarity=0.435 Sum_probs=216.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|++.+.||+|+||+||+|.+. .+..||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457888999999999999999974 45579999998643 3345679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999654 345999999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||........ .. .+..
T Consensus 204 ~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~---------~~~~ 269 (325)
T 3kul_A 204 DPDA----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-IS---------SVEE 269 (325)
T ss_dssp ---C----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-HH---------HHHT
T ss_pred Cccc----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-HH---------HHHc
Confidence 2211 112233456778999999999999999999999999999999 9999975443211 11 1112
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
+.....+..++..+.+++..||+.+|.+||++.++++.|+.+......
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 223345566778899999999999999999999999999998775443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.43 Aligned_cols=269 Identities=23% Similarity=0.422 Sum_probs=216.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|...+.||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 457888999999999999999975 6899999998776666778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999764 345999999999999999999999999 999999999999999999999999999876433211
Q ss_pred Ccc-------ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 533 GIV-------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 533 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
... .........||+.|+|||++.+..++.++|||||||++|||++|..|+......... ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~-----~~~~~~~~ 239 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD-----FGLNVRGF 239 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-----SSBCHHHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-----Hhhhhhcc
Confidence 000 011112457999999999999999999999999999999999999988642210000 00000000
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
.. ...+..++..+.+++.+||+.+|++||++.++++.|+.+.....
T Consensus 240 ~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 240 LD---RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HH---HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cc---ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 01234455678999999999999999999999999998876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=370.94 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=209.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh------hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
.++|++.+.||+|+||+||+|... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356889999999999999999975 6899999998754321 356899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeeecc
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 522 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFGl 522 (707)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999653 46999999999999999999999999 99999999999999887 899999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 165 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~---- 231 (326)
T 2y0a_A 165 AHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSA---- 231 (326)
T ss_dssp CEECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHH----
T ss_pred CeECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHh----
Confidence 98764321 12345689999999999999999999999999999999999999965432111 000000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
. ...++.. ..+..+....+||.+||..||++|||++|+|
T Consensus 232 -----~-~~~~~~~-----------------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 270 (326)
T 2y0a_A 232 -----V-NYEFEDE-----------------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270 (326)
T ss_dssp -----T-CCCCCHH-----------------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred -----c-CCCcCcc-----------------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0 0000100 0011223345788999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 683 KHPYVSSDV 691 (707)
Q Consensus 683 ~Hp~f~~~~ 691 (707)
+||||....
T Consensus 271 ~hp~~~~~~ 279 (326)
T 2y0a_A 271 QHPWIKPKD 279 (326)
T ss_dssp HSTTTSCCS
T ss_pred cCCCccCCc
Confidence 999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.58 Aligned_cols=283 Identities=25% Similarity=0.357 Sum_probs=207.9
Q ss_pred HHhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCCh-----hhHHHHHHHHHHHHcc---CCCcceeEEEEEEe
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL-----QGEKEFLTEIQFLSRL---HHRNLVSLVGYCDE 442 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~ 442 (707)
...++|++.+.||+|+||+||+|.. .+++.||||++..... .....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999996 4789999999864221 1134667788777776 49999999999977
Q ss_pred CC-----eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 005224 443 EG-----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 517 (707)
Q Consensus 443 ~~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 517 (707)
.. ..++||||++ ++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 65 5899999996 69999998776667999999999999999999999999 999999999999999999999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHh
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~ 597 (707)
+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus 162 ~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~ 232 (308)
T 3g33_A 162 ADFGLARIYSYQ--------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIF 232 (308)
T ss_dssp CSCSCTTTSTTC--------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHHHH
T ss_pred eeCccccccCCC--------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 999999865432 123456789999999999999999999999999999999999999976543221 11111
Q ss_pred hcccchhhccCCCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCC
Q 005224 598 QSSMMFSVIDGNMG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 674 (707)
Q Consensus 598 ~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~ 674 (707)
...... ....+. ..+. . ...+....... ...+..++...+||.+||+.||++
T Consensus 233 ~~~~~~--~~~~~~~~~~~~~-----------~--~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~ 287 (308)
T 3g33_A 233 DLIGLP--PEDDWPRDVSLPR-----------G--AFPPRGPRPVQ----------SVVPEMEESGAQLLLEMLTFNPHK 287 (308)
T ss_dssp HHHCCC--CTTTSCSSCSSCG-----------G--GSCCCCCCCHH----------HHSCSCCHHHHHHHHHHTCSSTTT
T ss_pred HHhCCC--Chhhccchhhccc-----------c--ccCCCCCCcHH----------HhCccccHHHHHHHHHHhcCCCcc
Confidence 100000 000000 0000 0 00111111111 122444555668999999999999
Q ss_pred CCCCCcCCCCCCCCCCCC
Q 005224 675 PPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 675 R~sa~e~L~Hp~f~~~~~ 692 (707)
|||++|+|+||||.....
T Consensus 288 R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 288 RISAFRALQHSYLHKDEG 305 (308)
T ss_dssp SCCHHHHHTSTTC-----
T ss_pred CCCHHHHhcCccccCCCC
Confidence 999999999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=374.10 Aligned_cols=202 Identities=26% Similarity=0.407 Sum_probs=169.0
Q ss_pred hcCCCccceEeeeCceEEEEEEe----CCCcEEEEEEeccCCh----hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999996 4789999999976432 233567889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999997643 4889999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 171 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 171 SIHD-------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccC-------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 4321 112334578999999999999999999999999999999999999997543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.07 Aligned_cols=280 Identities=35% Similarity=0.617 Sum_probs=232.5
Q ss_pred CcccccHHHHHHHhcCCCcc------ceEeeeCceEEEEEEeCCCcEEEEEEeccCC----hhhHHHHHHHHHHHHccCC
Q 005224 361 GVRSFTYGEMALATNNFNSS------TQIGQGGYGKVYKGILPDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHH 430 (707)
Q Consensus 361 ~~~~~~~~~l~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H 430 (707)
....|++.++..++++|... +.||+|+||+||+|.. +++.||||++.... ....+.+.+|+++++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999887 8999999999999997 68899999986532 2335678999999999999
Q ss_pred CcceeEEEEEEeCCeEEEEEecCCCCCHHHHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005224 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 509 (707)
Q Consensus 431 ~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 509 (707)
|||+++++++.+.+..++||||+++++|.+++... ...++++..++.++.|+++||+|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999999753 3456999999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch-
Q 005224 510 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN- 588 (707)
Q Consensus 510 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~- 588 (707)
++++.+||+|||+++....... ........||+.|+|||++.+ .++.++|||||||++|||++|+.||.....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSS-----CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred cCCCcEEEeecccccccccccc-----cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 9999999999999986543221 112334568999999998875 578999999999999999999999975432
Q ss_pred --hHHHHHHHh-hcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 589 --IVREVNIAY-QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 589 --~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
......... ....+...+++.....+..++..+.+++..||+.+|.+||++.++++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111111111 12223445556666678889999999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=366.73 Aligned_cols=267 Identities=32% Similarity=0.502 Sum_probs=211.6
Q ss_pred HHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 368 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 368 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
+++....++|++.+.||+|+||+||+|.. +|+.||||++..... ...+.+.+|++++++++||||+++++++...+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34445567899999999999999999987 688999999876442 334678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
.++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999976432 24899999999999999999999875 459999999999999999999999999997
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 188 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~-------- 252 (309)
T 3p86_A 188 LKASTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-------- 252 (309)
T ss_dssp ---------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--------
T ss_pred cccccc-------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------
Confidence 543221 12234578999999999999999999999999999999999999997654322111110
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
........+..++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 253 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 253 -FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11223345666778899999999999999999999999999988654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=374.90 Aligned_cols=202 Identities=22% Similarity=0.356 Sum_probs=177.5
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 447 (707)
..++|+..+.||+|+||+||+|..+ +++.||||++..... ...+.+..|..+++.+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4568999999999999999999976 588999999875321 2345688999999988 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999997643 4899999999999999999999999 9999999999999999999999999998543
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 173 WD-------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CT-------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cC-------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 21 12234567999999999999999999999999999999999999999654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=395.78 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=211.1
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
..++|+..+.||+|+||.||+|..+ +|+.||||++..... .....+.+|+++|+.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999975 799999999865321 234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999998766667999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 339 ~~--------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~------------------ 392 (576)
T 2acx_A 339 GQ--------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI------------------ 392 (576)
T ss_dssp TC--------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC------------------
T ss_pred Cc--------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch------------------
Confidence 21 2234579999999999999999999999999999999999999996532200
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC-----CCCcCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLK 683 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~ 683 (707)
. ...+.+.+... +..-| ...++.+.+||.+||+.||++|+ +++|+++
T Consensus 393 -----~---~~~i~~~i~~~----~~~~p----------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 393 -----K---REEVERLVKEV----PEEYS----------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----C---HHHHHHHHHHC----CCCCC----------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----h---HHHHHHHhhcc----cccCC----------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0 00111111110 00000 11223345678888888888888 6788999
Q ss_pred CCCCCCCCC
Q 005224 684 HPYVSSDVS 692 (707)
Q Consensus 684 Hp~f~~~~~ 692 (707)
||||.+..+
T Consensus 445 HpfF~~i~w 453 (576)
T 2acx_A 445 HPLFKKLNF 453 (576)
T ss_dssp SGGGTTCCH
T ss_pred ChhhccCCH
Confidence 999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=379.73 Aligned_cols=199 Identities=27% Similarity=0.390 Sum_probs=176.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367889999999999999999975 68999999986532 12346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999653 45999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCccccceecccccCCCccchhhhcc---CCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 169 --------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 169 --------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp --------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 22345679999999999974 4589999999999999999999999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=376.02 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=207.2
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.++|++.+.||+|+||.||+|..+ +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999975 689999999975432 33467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEeeecccccCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAP 527 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFGla~~~~ 527 (707)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999653 45899999999999999999999999 9999999999999865 459999999998664
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 183 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~--------------- 238 (362)
T 2bdw_A 183 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RL--------------- 238 (362)
T ss_dssp TCC--------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH---------------
T ss_pred CCc--------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HH---------------
Confidence 321 223457999999999999999999999999999999999999999654321 10
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
.+.+.......|. +. ....++.+.+||.+||..||++|||++|+|+||||
T Consensus 239 --------------~~~i~~~~~~~~~--~~--------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 239 --------------YAQIKAGAYDYPS--PE--------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp --------------HHHHHHTCCCCCT--TG--------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred --------------HHHHHhCCCCCCc--cc--------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 0001110000000 00 01112234478899999999999999999999999
Q ss_pred CC
Q 005224 688 SS 689 (707)
Q Consensus 688 ~~ 689 (707)
..
T Consensus 289 ~~ 290 (362)
T 2bdw_A 289 CN 290 (362)
T ss_dssp HT
T ss_pred CC
Confidence 64
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=376.50 Aligned_cols=203 Identities=23% Similarity=0.338 Sum_probs=176.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
.++|++.+.||+|+||+||+|..+ +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457899999999999999999975 78999999986421 123567999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEeeecc
Q 005224 448 LVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGL 522 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGl 522 (707)
+||||+++++|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888653 3345899999999999999999999999 999999999999986654 99999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESG-------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTS-------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCC-------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 98764322 1223457999999999999999999999999999999999999999753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=357.47 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=217.2
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
...++|++.+.||+|+||+||+|..+++..||||++.... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3457889999999999999999999888899999997643 335679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 158 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ- 158 (268)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-
T ss_pred ccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh-
Confidence 999999999997643 35899999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.||........... +..+..
T Consensus 159 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----------~~~~~~ 223 (268)
T 3sxs_A 159 -----YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----------VSQGHR 223 (268)
T ss_dssp -----EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----------HHTTCC
T ss_pred -----hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH----------HHcCCC
Confidence 112233456778999999999999999999999999999999 9999975544222111 111222
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
...+..++..+.+++..||+.+|.+||++.++++.|+.+.+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 23344556789999999999999999999999999987754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=356.32 Aligned_cols=258 Identities=29% Similarity=0.484 Sum_probs=216.6
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..++|+..+.||+|+||+||+|...+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 346788999999999999999999889999999998643 3346799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 160 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 160 (269)
T ss_dssp CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc--
Confidence 9999999999654 345899999999999999999999999 9999999999999999999999999998654321
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +.... +......
T Consensus 161 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-~~~~~---------~~~~~~~ 226 (269)
T 4hcu_A 161 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVED---------ISTGFRL 226 (269)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHH---------HHTTCCC
T ss_pred ----cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-HHHHH---------HhcCccC
Confidence 112233456778999999999999999999999999999999 99999754432 11111 1112223
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
..+...+..+.+++..|++.+|.+||++.++++.|+++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 3445556789999999999999999999999999998765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=382.17 Aligned_cols=259 Identities=23% Similarity=0.347 Sum_probs=207.4
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
..++|++.+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3567999999999999999999964 799999999876443 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeeecccccC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLA 526 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~~ 526 (707)
|||+++|+|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999764 35999999999999999999999999 99999999999998 5688999999999866
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...
T Consensus 164 ~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~------------ 223 (444)
T 3soa_A 164 EGEQ-------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQ------------ 223 (444)
T ss_dssp CTTC-------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH------------
T ss_pred cCCC-------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHH------------
Confidence 4322 12234579999999999999999999999999999999999999996543211 000
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCC
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 686 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 686 (707)
.+........+.. .+..++.+.+||.+||+.||++|||++|+|+|||
T Consensus 224 ----------------~i~~~~~~~~~~~-----------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 224 ----------------QIKAGAYDFPSPE-----------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp ----------------HHHHTCCCCCTTT-----------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred ----------------HHHhCCCCCCccc-----------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 1111111100000 0112233457889999999999999999999999
Q ss_pred CCC
Q 005224 687 VSS 689 (707)
Q Consensus 687 f~~ 689 (707)
|..
T Consensus 271 ~~~ 273 (444)
T 3soa_A 271 ISH 273 (444)
T ss_dssp THH
T ss_pred ccC
Confidence 964
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=390.05 Aligned_cols=257 Identities=22% Similarity=0.280 Sum_probs=198.2
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999965 7899999998753 222335678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999997643 58999999999999999999998 88 99999999999999999999999999975432
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 302 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~--------------- 358 (446)
T 4ejn_A 302 D-------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLF--------------- 358 (446)
T ss_dssp ------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH---------------
T ss_pred C-------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-HHH---------------
Confidence 2 12234567999999999999999999999999999999999999999654321 111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC-----CCCcCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLK 683 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~ 683 (707)
+.+...-..-| ...++.+.+||.+||..||++|+ |++|+|+
T Consensus 359 --------------~~i~~~~~~~p--------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 359 --------------ELILMEEIRFP--------------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --------------HHHHHCCCCCC--------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------------HHHHhCCCCCC--------------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11100000000 01122334678888888888888 8999999
Q ss_pred CCCCCCCCC
Q 005224 684 HPYVSSDVS 692 (707)
Q Consensus 684 Hp~f~~~~~ 692 (707)
||||.+..+
T Consensus 405 hp~f~~~~~ 413 (446)
T 4ejn_A 405 HRFFAGIVW 413 (446)
T ss_dssp SGGGTTCCH
T ss_pred CccccCCCH
Confidence 999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=373.41 Aligned_cols=204 Identities=27% Similarity=0.409 Sum_probs=174.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999976 789999999865433 224578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999998543 45999999999999999999999999 99999999999999999999999999986532211
Q ss_pred CCccccceecccccCCCccchhhhccCCC-CCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 161 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp -----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred -----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 122334678999999999988765 778999999999999999999997543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=372.54 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=204.0
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|.+.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999996 5789999999864321 12357889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+ +|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 999 789999987643 4899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCccccceecccccCCCccchhhhccCCC-CCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .....+...
T Consensus 162 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----------~~~~~i~~~ 223 (336)
T 3h4j_B 162 -------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----------NLFKKVNSC 223 (336)
T ss_dssp -------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----------TCBCCCCSS
T ss_pred -------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----------HHHHHHHcC
Confidence 12234569999999999998776 67999999999999999999999643210 001001000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
....|.. .++...+||.+||..||++|||++|+++||||..
T Consensus 224 ~~~~p~~---------------------------------------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 224 VYVMPDF---------------------------------------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CCCCCTT---------------------------------------SCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred CCCCccc---------------------------------------CCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 0111111 1222346888899999999999999999999976
Q ss_pred CCC
Q 005224 690 DVS 692 (707)
Q Consensus 690 ~~~ 692 (707)
...
T Consensus 265 ~~~ 267 (336)
T 3h4j_B 265 NLP 267 (336)
T ss_dssp TCC
T ss_pred CCc
Confidence 543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=388.73 Aligned_cols=265 Identities=24% Similarity=0.439 Sum_probs=220.8
Q ss_pred HHHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 367 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 367 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
.++++...++|+..+.||+|+||+||+|.++++..||||+++... ...+.+.+|+++|++++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 344566678899999999999999999999888999999998644 34678999999999999999999999986 5678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++|+|.++++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999999999997654446889999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
.... ........++..|+|||++....++.++|||||||++|||++ |+.||...... +... .+
T Consensus 335 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-~~~~---------~i 398 (454)
T 1qcf_A 335 EDNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIR---------AL 398 (454)
T ss_dssp CCHH------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHH---------HH
T ss_pred CCCc------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-HHHH---------HH
Confidence 4211 111123346788999999999999999999999999999999 99999754432 1111 11
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
..+.....+..++..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 399 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 399 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 12223345667788899999999999999999999999999987553
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=371.08 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=196.6
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
..++|++.+.||+|+||+||+|... +++.||||++.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467999999999999999999976 68899999997643 34578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeeecccccCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLAPV 528 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~~~~~ 528 (707)
|+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999653 45899999999999999999999998 999999999999975 89999999999986542
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 204 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------------- 261 (349)
T 2w4o_A 204 Q--------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR-------------- 261 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH--------------
T ss_pred c--------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH--------------
Confidence 2 122345689999999999999999999999999999999999999965443211111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
.+..+....+. | ..+..+....+||.+||..||++|||++|+|+||||.
T Consensus 262 ---------------~i~~~~~~~~~--~--------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 262 ---------------RILNCEYYFIS--P--------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp ---------------HHHTTCCCCCT--T--------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred ---------------HHHhCCCccCC--c--------------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 11111100000 0 0011223345799999999999999999999999998
Q ss_pred CCCCC
Q 005224 689 SDVSG 693 (707)
Q Consensus 689 ~~~~~ 693 (707)
+....
T Consensus 311 ~~~~~ 315 (349)
T 2w4o_A 311 GKAAN 315 (349)
T ss_dssp STTCC
T ss_pred CCccc
Confidence 87653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=391.17 Aligned_cols=284 Identities=21% Similarity=0.322 Sum_probs=206.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC------C
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 444 (707)
.++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999965 7899999999753 333456788999999999999999999999654 4
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..++||||+++ +|.+.+.. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999965 57777732 3899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+......
T Consensus 213 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~----- 278 (464)
T 3ttj_A 213 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQ----- 278 (464)
T ss_dssp ----C--------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH-----
T ss_pred ecCCC--------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-----
Confidence 65432 22345678999999999999999999999999999999999999997654432 22221110
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhcCCCC-------CCCCCccccCCCCCCCCCCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPES-------DTKTPEFINSEHTSKEETPP 676 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Pt~~~v~~~L~~~~~~~~~~-------~~~~~dll~~~L~~dP~~R~ 676 (707)
.+....+....+...........|... ..+...... ..++.. ++.+.|||.+||++||++|+
T Consensus 279 -----lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 348 (464)
T 3ttj_A 279 -----LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD-----SLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348 (464)
T ss_dssp -----HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCG-----GGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred -----cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcc-----cccccccccccccCHHHHHHHHHHcCCChhhCC
Confidence 011112222222122222222222211 122111000 000000 22356899999999999999
Q ss_pred CCCcCCCCCCCCC
Q 005224 677 SSSSMLKHPYVSS 689 (707)
Q Consensus 677 sa~e~L~Hp~f~~ 689 (707)
|++|+|+||||..
T Consensus 349 ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 349 SVDDALQHPYINV 361 (464)
T ss_dssp CHHHHHTSTTTGG
T ss_pred CHHHHhcChhhhh
Confidence 9999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=379.38 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=216.5
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC-eEEEE
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLV 449 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV 449 (707)
....++|+..+.||+|+||.||+|.++ ++.||||+++... ..+.+.+|+++|++++||||+++++++.... ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 345678889999999999999999985 7899999998643 4468999999999999999999999987665 79999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999998876666899999999999999999999999 999999999999999999999999999854321
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... . ...+..+
T Consensus 343 ----------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~---------~~~i~~~ 402 (450)
T 1k9a_A 343 ----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-V---------VPRVEKG 402 (450)
T ss_dssp --------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-H---------HHHHHTT
T ss_pred ----------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-H---------HHHHHcC
Confidence 122356889999999999999999999999999999998 999997543211 1 1112223
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
.....|..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 33456677888999999999999999999999999999988653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=377.62 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=202.4
Q ss_pred ccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCCCC
Q 005224 379 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 457 (707)
Q Consensus 379 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 457 (707)
..+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3678999999999999964 799999999987666667789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE--cCCCcEEEeeecccccCCCCCCCCcc
Q 005224 458 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL--DHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 458 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+ ++++.+||+|||+++......
T Consensus 173 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----- 243 (373)
T 2x4f_A 173 LFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----- 243 (373)
T ss_dssp EHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-----
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-----
Confidence 99988653 235899999999999999999999999 9999999999999 567899999999998764322
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (707)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 244 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------------------------- 295 (373)
T 2x4f_A 244 ---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------------------------- 295 (373)
T ss_dssp ---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------------------------
T ss_pred ---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------------------------
Confidence 2233468999999999999999999999999999999999999997543311
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 616 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 616 ~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
.+.++....+...+. ..+..++.+.+||.+||..||++|||++|+|+||||...
T Consensus 296 ----~~~~i~~~~~~~~~~-----------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 296 ----TLNNILACRWDLEDE-----------------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ----HHHHHHHTCCCSCSG-----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ----HHHHHHhccCCCChh-----------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 111111111111111 011223344578999999999999999999999999754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=361.76 Aligned_cols=272 Identities=25% Similarity=0.405 Sum_probs=214.5
Q ss_pred hcCCCccceEeeeCceEEEEEEe-----CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 446 (707)
.++|++.+.||+|+||+||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788999999999999999984 36899999999877666667899999999999999999999998543 568
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999997643 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHH------Hhhcc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI------AYQSS 600 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~------~~~~~ 600 (707)
...... ........++..|+|||++.+..++.++|||||||++|||++|..|+............ .....
T Consensus 165 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 165 PQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 432210 11223345677899999999999999999999999999999999988643211100000 00000
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
....+........+..++..+.+++..||+.+|.+||++.++++.|+.+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11112223344456777889999999999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=375.92 Aligned_cols=264 Identities=28% Similarity=0.454 Sum_probs=217.7
Q ss_pred HHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 370 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 370 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
+....++|...+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3445678889999999999999999986 789999999876432 23456889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 189 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999997643 34899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.... ........++..|+|||++.+..++.++|||||||++|||++ |..||....... ... .+.
T Consensus 265 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~--------~~~ 329 (377)
T 3cbl_A 265 DGVY-----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TRE--------FVE 329 (377)
T ss_dssp TSEE-----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHH--------HHH
T ss_pred CCce-----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH--------HHH
Confidence 2110 011112235778999999999999999999999999999998 999997654321 111 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
.+.....+..++..+.+++.+||+.+|++||++.++++.|+.+.+.
T Consensus 330 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 2223345666778899999999999999999999999999988653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=369.88 Aligned_cols=285 Identities=22% Similarity=0.390 Sum_probs=206.2
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh-HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|.+.+.||+|+||+||+|... +++.||||++....... ...+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999975 78999999987543222 12456799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
++ |+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 154 (324)
T ss_dssp CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc--
Confidence 96 5999998764 346899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC-
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM- 610 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 610 (707)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +....... ......
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~------~~~~~~~ 222 (324)
T 3mtl_A 155 -----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFR------ILGTPTE 222 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH------HHCCCCT
T ss_pred -----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH------HhCCCCh
Confidence 22234568999999999987 67899999999999999999999999754432 11111110 000000
Q ss_pred CCCChHHH-HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 611 GSYPSECV-EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 611 ~~~~~~~~-~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
...+.... ..+.. . ..|..+.. ......+..++...+||.+||..||++|||++|+|+||||.+
T Consensus 223 ~~~~~~~~~~~~~~-----~-~~~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 223 ETWPGILSNEEFKT-----Y-NYPKYRAE---------ALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp TTSTTGGGCHHHHH-----T-CCCCCCCC---------CHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred Hhchhhhcchhhcc-----c-ccccccch---------hhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 00000000 00000 0 01111110 011122344455678999999999999999999999999987
Q ss_pred CCCC
Q 005224 690 DVSG 693 (707)
Q Consensus 690 ~~~~ 693 (707)
....
T Consensus 288 ~~~~ 291 (324)
T 3mtl_A 288 LGER 291 (324)
T ss_dssp GCST
T ss_pred cccc
Confidence 6554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=387.28 Aligned_cols=298 Identities=21% Similarity=0.298 Sum_probs=197.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC-----Ce
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 445 (707)
.++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+++|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999965 7899999998653 233457889999999999999999999999433 57
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+ +++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 57999999653 45999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCcc--------------------ccceecccccCCCccchhhh-ccCCCCCchhhHHHHHHHHHHHcC-----
Q 005224 526 APVPDIEGIV--------------------PAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTG----- 579 (707)
Q Consensus 526 ~~~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDVwS~Gvll~elltG----- 579 (707)
.......... .........||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6532211000 01123456789999999987 456799999999999999999994
Q ss_pred ------CCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH--------HH
Q 005224 580 ------MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM--------RE 645 (707)
Q Consensus 580 ------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~--------~~ 645 (707)
+.+|............ ................+..+.. .+. .|+..++. ..
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~i~~-~~g-----~p~~~~~~~~~~~~~~~~ 350 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQ---------KAGNDFKFHTRGNRDQLNVIFN-ILG-----TPSEEDIEALEKEDAKRY 350 (458)
T ss_dssp SSGGGCCCSCC-----------------------------CHHHHHHHHHHHH-HHC-----CCCHHHHHTSSCHHHHHH
T ss_pred cccccccccCCCCccccccccc---------cccccccccccCCHHHHHHHHH-HcC-----CCCHHHHhhcCCHHHHHH
Confidence 4444321110000000 0000000001111222222211 111 11211110 01
Q ss_pred HH--------HhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 646 LE--------SIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 646 L~--------~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
++ .+...++..++.+.|||.+||++||++|+|++|+|+||||.....
T Consensus 351 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 10 112233445666779999999999999999999999999987644
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=372.27 Aligned_cols=261 Identities=27% Similarity=0.457 Sum_probs=204.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|++.+.||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457899999999999999999864 57789999997643 3345679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.++++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999754 345999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||...... +.... +..
T Consensus 200 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-~~~~~---------i~~ 265 (373)
T 2qol_A 200 DPEA----AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-DVIKA---------VDE 265 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-HHHHH---------HHT
T ss_pred CCcc----ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH---------HHc
Confidence 2210 111122345778999999999999999999999999999998 99999755432 11111 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
+.....+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 112234556778899999999999999999999999999988653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=384.37 Aligned_cols=265 Identities=30% Similarity=0.462 Sum_probs=216.1
Q ss_pred HHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 368 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 368 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
+.++...++|+..+.||+|+||.||+|.++++..||||+++... ...+.+.+|+++|++++||||+++++++.. +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34455667899999999999999999999888889999998644 335689999999999999999999999876 6789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999999999997654456899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... +... .+.
T Consensus 332 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~---------~i~ 395 (452)
T 1fmk_A 332 DNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLD---------QVE 395 (452)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH---------HHH
T ss_pred CCc------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-HHHH---------HHH
Confidence 321 111223456788999999999999999999999999999999 99999754432 1111 112
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
.+.....+..++..+.+++.+||+.+|++||++.++++.|+.+....
T Consensus 396 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 22333456677889999999999999999999999999999876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=364.33 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=197.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--------------------------hHHHHHHHHHHHH
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------------------------GEKEFLTEIQFLS 426 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~ 426 (707)
.++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999964 7899999998654321 1246889999999
Q ss_pred ccCCCcceeEEEEEEe--CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005224 427 RLHHRNLVSLVGYCDE--EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 504 (707)
Q Consensus 427 ~l~H~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 504 (707)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.|+++||+|||+.+ |+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 9999999999999986 568999999999999987653 346999999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCC---CCCchhhHHHHHHHHHHHcCCC
Q 005224 505 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQ 581 (707)
Q Consensus 505 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvll~elltG~~ 581 (707)
+|||++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD-------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS-------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEECCCCCEEEecCCCcccccccc-------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999999999998754321 1233457899999999998765 3778999999999999999999
Q ss_pred CCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCC
Q 005224 582 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTP 661 (707)
Q Consensus 582 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~ 661 (707)
||...... .. ...+.......|. .+..++...
T Consensus 239 pf~~~~~~-~~-----------------------------~~~~~~~~~~~~~------------------~~~~~~~l~ 270 (298)
T 2zv2_A 239 PFMDERIM-CL-----------------------------HSKIKSQALEFPD------------------QPDIAEDLK 270 (298)
T ss_dssp SSCCSSHH-HH-----------------------------HHHHHHCCCCCCS------------------SSCCCHHHH
T ss_pred CCCCccHH-HH-----------------------------HHHHhcccCCCCC------------------ccccCHHHH
Confidence 99653321 00 0000000000010 011222334
Q ss_pred ccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 662 EFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 662 dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
++|.+||..||++|||++|+|+||||+
T Consensus 271 ~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 271 DLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 688889999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=364.63 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=185.4
Q ss_pred cceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEEecCCCCC
Q 005224 380 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGT 457 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~gs 457 (707)
.+.||+|+||+||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 6899999999642 3467789999999997 9999999999999999999999999999
Q ss_pred HHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEeeecccccCCCCCCCCc
Q 005224 458 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 458 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 534 (707)
|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---- 163 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---- 163 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC----
Confidence 99999764 45999999999999999999999999 99999999999998765 89999999998654321
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..
T Consensus 164 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~-------------~~ 220 (325)
T 3kn6_A 164 ---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-------C-------------TS 220 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------------C-------------CC
T ss_pred ---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-------c-------------cc
Confidence 223345689999999999999999999999999999999999999964322100 0 00
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 615 ~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
..+++...........+.. ....++...+||.+||..||++|||++|+++||||.....
T Consensus 221 ------~~~~~~~i~~~~~~~~~~~-------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 221 ------AVEIMKKIKKGDFSFEGEA-------------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp ------HHHHHHHHTTTCCCCCSHH-------------HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred ------HHHHHHHHHcCCCCCCccc-------------ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 0011111111111000000 0112334457999999999999999999999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=354.71 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=209.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999965 78999999985432 23346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++.... ++++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999997653 5899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||............. .. .....
T Consensus 165 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~-~~~~~---- 232 (294)
T 4eqm_A 165 S------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-QD-SVPNV---- 232 (294)
T ss_dssp ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH-SS-CCCCH----
T ss_pred c------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-hc-cCCCc----
Confidence 2 122334568999999999999999999999999999999999999997655432221111 11 00000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhh
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWN 651 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RP-t~~~v~~~L~~~~~ 651 (707)
....+.+.+..+.+++.+|++.+|.+|| ++.++.+.|+.+..
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0112344567899999999999999998 88999988887644
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=378.96 Aligned_cols=200 Identities=23% Similarity=0.306 Sum_probs=175.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc------CCCcceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL------HHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~~~ 446 (707)
..+|++.+.||+|+||+||+|... +++.||||++... ....+.+.+|+++++.+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999865 6899999999763 33346778888888887 577999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEeeecccc
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSR 524 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFGla~ 524 (707)
++||||+. ++|.+++.......+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 69999998876667999999999999999999999998 999999999999999987 9999999997
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 251 ~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEHQ----------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETTC----------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCC----------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 6432 12345789999999999999999999999999999999999999975543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=365.36 Aligned_cols=282 Identities=20% Similarity=0.310 Sum_probs=204.5
Q ss_pred cCCCcc-ceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|.+. +.||+|+||+||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 78999999999999954 7999999999776555567899999999985 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEeeecccccCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGLSRLAPV 528 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGla~~~~~ 528 (707)
|+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999997643 5899999999999999999999998 999999999999998776 99999999976543
Q ss_pred CCCCCccccceecccccCCCccchhhhcc-----CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
................||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----------~~~ 236 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD----------CGW 236 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC----------SCC
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc----------ccc
Confidence 22111111122234568999999999975 568899999999999999999999996533210 000
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCC
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 683 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 683 (707)
............+.+.+...... -|. . .....+....+||.+||..||++|||++|+|+
T Consensus 237 -----~~~~~~~~~~~~~~~~i~~~~~~----~~~-~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 237 -----DRGEACPACQNMLFESIQEGKYE----FPD-K-----------DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp ---------CCHHHHHHHHHHHHHCCCC----CCH-H-----------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----cccccchhHHHHHHHHHhccCcc----cCc-h-----------hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00001111222222222221110 010 0 00122334568999999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 684 HPYVSSDVS 692 (707)
Q Consensus 684 Hp~f~~~~~ 692 (707)
||||.+...
T Consensus 296 hp~~~~~~~ 304 (316)
T 2ac3_A 296 HPWVQGCAP 304 (316)
T ss_dssp STTCC----
T ss_pred ChhhcCCCC
Confidence 999987544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=374.02 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=196.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|++.+.||+|+||+||+|... +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999976 789999999976433 335788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEeeecccccCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSRLAPVPD 530 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFGla~~~~~~~ 530 (707)
+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999997643 4899999999999999999999999 999999999999987765 999999999743221
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCc-hhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........
T Consensus 172 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------------------ 226 (361)
T 3uc3_A 172 -------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD------------------ 226 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC------------------
T ss_pred -------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH------------------
Confidence 12234569999999999998887766 8999999999999999999964322100
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
....+..+ ...... .|. ....++.+.+||.+||..||++|||++|+|+||||..
T Consensus 227 -------~~~~~~~~----~~~~~~-~~~--------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 227 -------YRKTIQRI----LSVKYS-IPD--------------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp -------HHHHHHHH----HTTCCC-CCT--------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred -------HHHHHHHH----hcCCCC-CCC--------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 00000000 000000 000 0011223347888899999999999999999999865
Q ss_pred CC
Q 005224 690 DV 691 (707)
Q Consensus 690 ~~ 691 (707)
..
T Consensus 281 ~~ 282 (361)
T 3uc3_A 281 NL 282 (361)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=357.98 Aligned_cols=263 Identities=25% Similarity=0.429 Sum_probs=216.3
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.+....++|++.+.||+|+||+||+|.+++++.||||++..... ..+++.+|++++++++||||+++++++.+.+..++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 34455678999999999999999999998889999999986433 35679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 97 ITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999763 235999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.. ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ ... +..
T Consensus 173 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-~~~---------~~~ 236 (283)
T 3gen_A 173 DE------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEH---------IAQ 236 (283)
T ss_dssp HH------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHH---------HHT
T ss_pred cc------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-HHH---------Hhc
Confidence 21 111223446778999999999999999999999999999998 9999976543211 111 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
......+..++..+.+++..||+.+|.+||++.++++.|+++.+.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 237 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 222233445567899999999999999999999999999987653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=370.50 Aligned_cols=270 Identities=25% Similarity=0.428 Sum_probs=220.6
Q ss_pred ccHHHHHHHhcCCCccceEeeeCceEEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeE
Q 005224 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSL 436 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l 436 (707)
+...++....++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44566777789999999999999999999983 2468999999976433 3346799999999999 79999999
Q ss_pred EEEEEeCC-eEEEEEecCCCCCHHHHHhhcCC------------------------------------------------
Q 005224 437 VGYCDEEG-EQMLVYEFMSNGTLRDQLSAKSK------------------------------------------------ 467 (707)
Q Consensus 437 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 467 (707)
++++.+.+ ..++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 48999999999999999976432
Q ss_pred ----------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 468 ----------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 468 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12899999999999999999999999 99999999999999999999999999986543221
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||............ +..+..
T Consensus 249 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---------~~~~~~ 314 (359)
T 3vhe_A 249 -----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---------LKEGTR 314 (359)
T ss_dssp -----CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH---------HHHTCC
T ss_pred -----chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH---------HHcCCC
Confidence 123345568899999999999999999999999999999998 99999754432221111 111222
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
...+..++..+.+++..||+.+|.+||++.++++.|+.+..
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 33455566789999999999999999999999999998765
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=371.50 Aligned_cols=286 Identities=22% Similarity=0.350 Sum_probs=203.6
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh--HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
..++|++.+.||+|+||+||+|... +++.||||++....... .+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3467999999999999999999964 78999999997543322 35678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-----cCCCcEEEeeecccc
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-----DHKFTAKVADFGLSR 524 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-----~~~~~~kl~DFGla~ 524 (707)
|||++ |+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99997 59999997653 4899999999999999999999999 9999999999999 455569999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........... .......
T Consensus 186 ~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~- 256 (329)
T 3gbz_A 186 AFGIPI-------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK-IFEVLGL- 256 (329)
T ss_dssp HHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCC-
T ss_pred ccCCcc-------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH-HHHHhCC-
Confidence 654221 223345679999999999874 589999999999999999999999976544222111 1110000
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Pt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
......+. ... .....+..|..+ ......+. ...++.+.+||.+||..||++|||++|+|
T Consensus 257 ----~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 257 ----PDDTTWPG-----VTA-LPDWKQSFPKFRGKTLKRVLG---------ALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp ----CCTTTSTT-----GGG-STTCCTTCCCCCCCCHHHHHG---------GGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ----Cchhhhhh-----hhh-hhhhhhhhhhhccccHhhhcc---------cccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 00000000 000 000001111111 12221111 11233456899999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 683 KHPYVSSDVS 692 (707)
Q Consensus 683 ~Hp~f~~~~~ 692 (707)
+||||++..+
T Consensus 318 ~hp~f~~~~~ 327 (329)
T 3gbz_A 318 EHPYFSHNDF 327 (329)
T ss_dssp TSGGGSSSCS
T ss_pred CCcccCCCCC
Confidence 9999998654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=367.10 Aligned_cols=266 Identities=29% Similarity=0.486 Sum_probs=218.7
Q ss_pred HHHHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEe
Q 005224 370 MALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442 (707)
Q Consensus 370 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 442 (707)
+....++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999974 348999999986433 335679999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcC----------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 500 (707)
.+..++||||+++|+|.+++.... ...+++..++.++.||++||+|||+.+ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 999999999999999999997642 256999999999999999999999999 9999
Q ss_pred CCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-C
Q 005224 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-G 579 (707)
Q Consensus 501 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G 579 (707)
||||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 9999999999999999999999976532211 112234467889999999999999999999999999999999 9
Q ss_pred CCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 580 MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 580 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
..||...... +.. ..+..+.....+..++..+.+++..||+.+|.+||++.++++.|+++....
T Consensus 274 ~~p~~~~~~~-~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 274 LQPYYGMAHE-EVI---------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp CCTTTTSCHH-HHH---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCcCCCCChH-HHH---------HHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 9999754431 111 112223334456677788999999999999999999999999999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=374.97 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=185.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHH-HHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|+..+.||+|+||.||+|+.+ +++.||||++..... .....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357889999999999999999975 689999999976432 223456677776 577899999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999997643 4889999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...... ..
T Consensus 192 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~---------~~ 254 (373)
T 2r5t_A 192 H-------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNIL---------NK 254 (373)
T ss_dssp C-------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HHHHHHH---------HS
T ss_pred C-------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHH---------hc
Confidence 1 12234567999999999999999999999999999999999999999754431 1111111 11
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMS 640 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~ 640 (707)
...++...+..+.+++.+|++.+|.+||++.
T Consensus 255 -~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 255 -PLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp -CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred -ccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1112233344455555666666666665554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=368.24 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=198.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|+..++||+|+||+||+|... +|+.||||++.... ......+..|+..+..+ +|+||++++++|.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999976 79999999986533 23334556666666655 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 779999987653 46999999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...... .. +..+
T Consensus 211 ~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~~---------~~~~- 267 (311)
T 3p1a_A 211 G--------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----QQ---------LRQG- 267 (311)
T ss_dssp ------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----HH---------HTTT-
T ss_pred C--------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HH---------Hhcc-
Confidence 1 2234568999999999876 7899999999999999999997776532210 00 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
..+.+. ....++.+.+|+.+||..||++|||++|+|+||||+.
T Consensus 268 --~~~~~~-----------------------------------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 268 --YLPPEF-----------------------------------TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --CCCHHH-----------------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --CCCccc-----------------------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 001100 0112233457888999999999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=354.94 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=208.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|++.+.||+|+||+||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467899999999999999999975 5789999999775555667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeeecccccCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~~~ 529 (707)
+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999987643 4899999999999999999999999 9999999999999 88899999999999866432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
. ......||+.|+|||++.+. ++.++|||||||++|||++|+.||......... ... ..+.
T Consensus 163 ~--------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~---------~~~~ 223 (277)
T 3f3z_A 163 K--------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM-LKI---------REGT 223 (277)
T ss_dssp S--------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHH---------HHCC
T ss_pred c--------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH-HHH---------HhCC
Confidence 2 22345689999999998765 899999999999999999999999754331110 000 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
...+... ....++...+++.+||..||++|||+.|+|+||||..
T Consensus 224 -~~~~~~~-----------------------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 224 -FTFPEKD-----------------------------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp -CCCCHHH-----------------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred -CCCCchh-----------------------------------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 0011100 0112233446888999999999999999999999975
Q ss_pred CCC
Q 005224 690 DVS 692 (707)
Q Consensus 690 ~~~ 692 (707)
...
T Consensus 268 ~~~ 270 (277)
T 3f3z_A 268 QLS 270 (277)
T ss_dssp HHC
T ss_pred ccc
Confidence 443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=386.63 Aligned_cols=203 Identities=24% Similarity=0.420 Sum_probs=179.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|...+.||+|+||.||+|+.+ +|+.||+|++..... .....+.+|++++++++||||+++++++...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999975 699999999965322 2346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 450 YEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 446999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 341 ~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQ-------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTC-------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCC-------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 321 1123457999999999999999999999999999999999999999653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=360.35 Aligned_cols=285 Identities=23% Similarity=0.332 Sum_probs=209.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|++.+.||+|+||+||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999975 6899999998654332 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 99999999988643 45899999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......||..|+|||++.+ ..++.++|||||||++|||++|+.||............... .
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~---- 219 (311)
T 4agu_A 157 ------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT-------L---- 219 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-------H----
T ss_pred ------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-------h----
Confidence 12234568999999999986 67899999999999999999999999765442221111000 0
Q ss_pred CCCChHHHHHHHH--HHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 611 GSYPSECVEKFIK--LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 611 ~~~~~~~~~~l~~--l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
..........+.. ........++...... ....+..+....+|+.+||..||++|||++|+|+||||.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 289 (311)
T 4agu_A 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPL----------ELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289 (311)
T ss_dssp CSCCHHHHHHHHTCGGGTTCCCCCCSSCCCH----------HHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred cccccccccccccccccccCcCCCccccchh----------hhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence 0011111000000 0000000111111111 112234445566899999999999999999999999998
Q ss_pred CCCC
Q 005224 689 SDVS 692 (707)
Q Consensus 689 ~~~~ 692 (707)
.-..
T Consensus 290 ~~~~ 293 (311)
T 4agu_A 290 NIRE 293 (311)
T ss_dssp TCC-
T ss_pred hccC
Confidence 7544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=361.67 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=209.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh------hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
.++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457899999999999999999975 6899999998754321 356799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeeecc
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 522 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFGl 522 (707)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999653 45899999999999999999999998 99999999999999888 799999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 166 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~----- 231 (321)
T 2a2a_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANIT----- 231 (321)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHH-----
T ss_pred ceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHH-----
Confidence 98764321 1234568999999999999999999999999999999999999996543211 110000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
. .....+... ....+....+||.+||..||++|||++|+|
T Consensus 232 ----~-~~~~~~~~~-----------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 271 (321)
T 2a2a_A 232 ----S-VSYDFDEEF-----------------------------------FSHTSELAKDFIRKLLVKETRKRLTIQEAL 271 (321)
T ss_dssp ----T-TCCCCCHHH-----------------------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHH
T ss_pred ----h-cccccChhh-----------------------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0 000011000 011223345789999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 683 KHPYVSSDV 691 (707)
Q Consensus 683 ~Hp~f~~~~ 691 (707)
+||||....
T Consensus 272 ~hp~~~~~~ 280 (321)
T 2a2a_A 272 RHPWITPVD 280 (321)
T ss_dssp HSTTTSCSS
T ss_pred cCccccCCC
Confidence 999998654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=361.39 Aligned_cols=269 Identities=24% Similarity=0.289 Sum_probs=209.0
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC----eE
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQ 446 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~ 446 (707)
....++|++.++||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 344578999999999999999999985 7999999997543 23345667999999999999999999997744 47
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCCEEEcCCCcEE
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE----------ADPPVFHRDIKASNILLDHKFTAK 516 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivH~Dlkp~NILl~~~~~~k 516 (707)
++||||+++|+|.++++.. .+++..++.++.|+++||+|||+. + |+||||||+|||++.++.+|
T Consensus 98 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999999764 399999999999999999999998 7 99999999999999999999
Q ss_pred EeeecccccCCCCCCCCccccceecccccCCCccchhhhccC-----CCCCchhhHHHHHHHHHHHcCCCCCCCCchhH-
Q 005224 517 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV- 590 (707)
Q Consensus 517 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~- 590 (707)
|+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....+..
T Consensus 172 L~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 246 (322)
T 3soc_A 172 IADFGLALKFEAGKS-----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246 (322)
T ss_dssp ECCCTTCEEECTTSC-----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred EccCCcccccccccC-----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence 999999987643321 1122345789999999999873 45568899999999999999999996432100
Q ss_pred -HHHHHHhhc---ccch-hhccCC-CCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 591 -REVNIAYQS---SMMF-SVIDGN-MGS-----YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 591 -~~~~~~~~~---~~~~-~~~~~~-~~~-----~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
......... .... .+.... ... ....++..+.+++.+||+.+|.+|||+.++++.|+.+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 000000000 0000 001111 111 1235677899999999999999999999999999988753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=362.04 Aligned_cols=280 Identities=18% Similarity=0.320 Sum_probs=211.2
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEEEe--CCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE--EGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+|.. .+++.||||++... ..+.+.+|++++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6788999999999999999996 47899999999753 3467899999999997 9999999999987 66789999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeeecccccCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVP 529 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~ 529 (707)
||+++++|.+++.. +++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999843 889999999999999999999999 99999999999999776 8999999999865432
Q ss_pred CCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
. ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.......+..........
T Consensus 185 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~------- 249 (330)
T 3nsz_A 185 Q--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG------- 249 (330)
T ss_dssp C--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC-------
T ss_pred C--------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC-------
Confidence 2 2234468899999999987 67999999999999999999999999766554433322211100
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH--HhhhcC-----CCCCCCCCccccCCCCCCCCCCCCCCcC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE--SIWNMM-----PESDTKTPEFINSEHTSKEETPPSSSSM 681 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~--~~~~~~-----~~~~~~~~dll~~~L~~dP~~R~sa~e~ 681 (707)
...+.+.+.. ......|...+...... ...... ...++.+.+||.+||..||++|||++|+
T Consensus 250 ---------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~ 317 (330)
T 3nsz_A 250 ---------TEDLYDYIDK---YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317 (330)
T ss_dssp ---------HHHHHHHHHH---TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred ---------CchhhhHHHH---hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 0111111111 11111222221110000 000000 0123445689999999999999999999
Q ss_pred CCCCCCCCCCC
Q 005224 682 LKHPYVSSDVS 692 (707)
Q Consensus 682 L~Hp~f~~~~~ 692 (707)
|+||||.+...
T Consensus 318 l~hp~f~~~~~ 328 (330)
T 3nsz_A 318 MEHPYFYTVVK 328 (330)
T ss_dssp HTSGGGTTCC-
T ss_pred hcCccHhhhcc
Confidence 99999987543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=387.52 Aligned_cols=263 Identities=30% Similarity=0.463 Sum_probs=221.1
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
+++...++|+..+.||+|+||.||+|.++ ++..||||++.... ...++|.+|+++|++++||||++++++|...+..+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 34455677889999999999999999986 48899999997643 34578999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999998766677999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... .... .+.
T Consensus 370 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~---------~~~ 433 (495)
T 1opk_A 370 GDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYE---------LLE 433 (495)
T ss_dssp TCC------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHH---------HHH
T ss_pred CCc------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHH---------HHH
Confidence 322 111223446788999999999999999999999999999999 99999754321 1111 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 434 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 222334566778889999999999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=367.15 Aligned_cols=265 Identities=26% Similarity=0.464 Sum_probs=219.4
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC--------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEEe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 442 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 442 (707)
..++|.+.+.||+|+||+||+|... ++..||||++..... ...+.+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4568889999999999999999852 346899999976433 3346789999999999 99999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 508 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 508 (707)
.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 999999999999999999998654 245999999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCc
Q 005224 509 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 587 (707)
Q Consensus 509 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~ 587 (707)
+++++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCT-----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCcEEEcccCcccccccccc-----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999986643321 112233457889999999999999999999999999999999 999996543
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 588 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
. .+.... +..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+......
T Consensus 299 ~-~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 299 V-EELFKL---------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp H-HHHHHH---------HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred H-HHHHHH---------HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 2 111111 112223334556678899999999999999999999999999998876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=380.18 Aligned_cols=301 Identities=23% Similarity=0.298 Sum_probs=208.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC-----Ce
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 445 (707)
.++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999965 6899999999753 333457889999999999999999999999766 57
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||++ ++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999995 6999999653 45999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCcc---------------ccceecccccCCCccchhhh-ccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchh
Q 005224 526 APVPDIEGIV---------------PAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 589 (707)
Q Consensus 526 ~~~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~ 589 (707)
.......... .........||+.|+|||++ ....++.++|||||||++|||++|..||......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6533211000 00123566799999999986 4567999999999999999999865555321100
Q ss_pred HHHHHHHhhcccchhhccCC----------CCCCC-hHHHHHHHHHHHHhcccCCC--CCCCHHHHHHHHHHh-------
Q 005224 590 VREVNIAYQSSMMFSVIDGN----------MGSYP-SECVEKFIKLALKCCQDETD--ARPSMSEVMRELESI------- 649 (707)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~----------~~~~~-~~~~~~l~~l~~~c~~~~p~--~RPt~~~v~~~L~~~------- 649 (707)
-.-.+.+. ..... ......+..++..+-....+ .+....++.+.+...
T Consensus 259 ------------~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (432)
T 3n9x_A 259 ------------RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326 (432)
T ss_dssp ------------CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred ------------ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCC
Confidence 00000000 00000 01111111111111000000 000001111111111
Q ss_pred -hhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 650 -WNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 650 -~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
...++..++.+.+||.+||++||++|+|++|+|+||||.+...
T Consensus 327 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 1123445666778999999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=359.28 Aligned_cols=263 Identities=29% Similarity=0.465 Sum_probs=217.5
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 443 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 443 (707)
....++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34467899999999999999999985 245899999997643 33356789999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCC----------------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSK----------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 501 (707)
+..++||||+++++|.+++..... ..+++..++.++.|+++||+|||+++ |+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999976432 34899999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CC
Q 005224 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 580 (707)
Q Consensus 502 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~ 580 (707)
|||+||++++++.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cchheEEEcCCCCEEEcccccccccccccc-----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999986643221 111233456788999999999999999999999999999999 99
Q ss_pred CCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 581 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 581 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.||.......- . ..+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 251 ~p~~~~~~~~~-~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 251 NPYPGIPPERL-F---------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CSSTTCCGGGH-H---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHH-H---------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99975433111 1 1111222334556677889999999999999999999999999998765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=353.22 Aligned_cols=265 Identities=28% Similarity=0.451 Sum_probs=218.3
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
++....++|++.+.||+|+||+||+|..++++.||||++.... ...+.+.+|+++++.++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3444567899999999999999999999888899999997643 34568999999999999999999999986 456899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++++|.+++.......+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999997543346899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.. ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... +.... +..
T Consensus 162 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~---------~~~ 225 (279)
T 1qpc_A 162 NE------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQN---------LER 225 (279)
T ss_dssp SC------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHH---------HHT
T ss_pred cc------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-HHHHH---------Hhc
Confidence 22 112233456789999999999999999999999999999999 89999754432 11111 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
+.....+..++..+.+++..|++.+|.+||++.++++.|+.+.....
T Consensus 226 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 12223445667889999999999999999999999999999876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=365.99 Aligned_cols=295 Identities=23% Similarity=0.317 Sum_probs=214.2
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEe--------
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDE-------- 442 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-------- 442 (707)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... ....+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999997 47999999998654322 24578899999999999999999999976
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
.+..++||||+++ +|.+.+... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4568999999974 888877654 345999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 601 (707)
++........ .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. .
T Consensus 171 a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-~--- 243 (351)
T 3mi9_A 171 ARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS-Q--- 243 (351)
T ss_dssp CEECCCCSSS---SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-H---
T ss_pred cccccccccc---cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-H---
Confidence 9876532211 1222344578999999999986 568999999999999999999999997654322111110 0
Q ss_pred chhhccCCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 602 MFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 602 ~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
........ .+...... . ..-+......++...+.+.... .++.+.+||.+||..||++|+|++|
T Consensus 244 ---~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 244 ---LCGSITPEVWPNVDNYE---L-YEKLELVKGQKRKVKDRLKAYV--------RDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp ---HHCCCCTTTSTTGGGCG---G-GTSSCCCSSCCCCHHHHHHHHH--------CCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ---HhCCCChhhccccccch---h-hcccccccccccCHHHHhhhcc--------CChHHHHHHHHHhcCChhhCCCHHH
Confidence 00000000 00000000 0 0001111222233332222111 1334568999999999999999999
Q ss_pred CCCCCCCCCCCCCCC
Q 005224 681 MLKHPYVSSDVSGSN 695 (707)
Q Consensus 681 ~L~Hp~f~~~~~~~~ 695 (707)
+|+||||.++...+.
T Consensus 309 ~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 309 ALNHDFFWSDPMPSD 323 (351)
T ss_dssp HHTSGGGGSSSCCCC
T ss_pred HhCCCCcCCCCCccc
Confidence 999999988776543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=352.13 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=207.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999975 68999999986533 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEeeecccccCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGLSRLAP 527 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGla~~~~ 527 (707)
||+++++|.+.+... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999988764 35899999999999999999999999 999999999999986655 9999999997654
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..
T Consensus 160 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~------------- 217 (284)
T 3kk8_A 160 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YA------------- 217 (284)
T ss_dssp SSC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH-------------
T ss_pred cCc--------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-HH-------------
Confidence 321 22345689999999999999999999999999999999999999965433111 00
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
.+...... .|... .....+...+|+.+||..||++|||++|+|+||||
T Consensus 218 ---------------~~~~~~~~-~~~~~----------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 218 ---------------QIKAGAYD-YPSPE----------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp ---------------HHHHTCCC-CCTTT----------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred ---------------HHHhcccc-CCchh----------------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 00000010 01000 01112223468888999999999999999999999
Q ss_pred CCCCC
Q 005224 688 SSDVS 692 (707)
Q Consensus 688 ~~~~~ 692 (707)
.....
T Consensus 266 ~~~~~ 270 (284)
T 3kk8_A 266 CNRER 270 (284)
T ss_dssp HSCCC
T ss_pred cCChh
Confidence 76544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=355.79 Aligned_cols=265 Identities=30% Similarity=0.457 Sum_probs=223.0
Q ss_pred HHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 368 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 368 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
+++....++|++.+.||+|+||+||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 344556778999999999999999999976 58899999997643 3456889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999998877778999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
.... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||....... ... .+
T Consensus 162 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-~~~---------~~ 225 (288)
T 3kfa_A 162 TGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYE---------LL 225 (288)
T ss_dssp CSSS------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHH---------HH
T ss_pred cCCc------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HH
Confidence 5322 223344557889999999999999999999999999999999 999986543211 111 11
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
........+..++..+.+++..|++.+|.+||++.++++.|+.+...
T Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11122334556678899999999999999999999999999887653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.16 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=203.9
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
...++|++.+.||+|+||+||+|... .+..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34568999999999999999999964 25679999987643 333567899999999999999999999984 5678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999999764 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
.... ........+++.|+|||++.+..++.++|||||||++|||++ |..||........ ...+
T Consensus 167 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~----------~~~i 230 (281)
T 1mp8_A 167 EDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----------IGRI 230 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------HHHH
T ss_pred Cccc------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH----------HHHH
Confidence 4322 111223456788999999999999999999999999999997 9999975443211 1112
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
........+..++..+.+++.+|++.+|.+||++.++++.|+.+..
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2223334556677889999999999999999999999999998765
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=369.01 Aligned_cols=278 Identities=22% Similarity=0.364 Sum_probs=205.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC------C
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 444 (707)
.++|+..+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467899999999999999999974 7999999998653 223356789999999999999999999999765 3
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 8899999975 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... +.+......
T Consensus 177 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~---- 241 (367)
T 1cm8_A 177 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKV---- 241 (367)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH----
T ss_pred ccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh----
Confidence 65321 234568999999999987 78999999999999999999999999755432 222211110
Q ss_pred hhccCCCCCCChHHHHH-----HHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCC
Q 005224 604 SVIDGNMGSYPSECVEK-----FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS 678 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~-----l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa 678 (707)
.+..+.+.... ....+... ...+ +.. +...++..++.+.+||.+||+.||++|+|+
T Consensus 242 ------~g~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~----------~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~ 302 (367)
T 1cm8_A 242 ------TGTPPAEFVQRLQSDEAKNYMKGL-PELE--KKD----------FASILTNASPLAVNLLEKMLVLDAEQRVTA 302 (367)
T ss_dssp ------HCCCCHHHHHTCSCHHHHHHHHHS-CCCC--CCC----------GGGTCTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred ------cCCCCHHHHHHhhhHHHHHHHHhC-CCCC--CCC----------HHHHCCCCCHHHHHHHHHHccCChhHCCCH
Confidence 01112211111 01111110 0000 001 111233445566789999999999999999
Q ss_pred CcCCCCCCCCCCCC
Q 005224 679 SSMLKHPYVSSDVS 692 (707)
Q Consensus 679 ~e~L~Hp~f~~~~~ 692 (707)
+|+|+||||.....
T Consensus 303 ~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 303 GEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHSGGGTTTC-
T ss_pred HHHhcChHHHhhcC
Confidence 99999999986543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.46 Aligned_cols=258 Identities=29% Similarity=0.480 Sum_probs=216.1
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
..++|+..+.||+|+||.||+|...+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3467889999999999999999998889999999986443 346899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 158 (267)
T ss_dssp CTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc--
Confidence 9999999999764 345899999999999999999999999 9999999999999999999999999998653211
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
........++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..... +..+...
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~---------i~~~~~~ 224 (267)
T 3t9t_A 159 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVED---------ISTGFRL 224 (267)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHH---------HHTTCCC
T ss_pred ----ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-HHHHH---------HhcCCcC
Confidence 111223456788999999999999999999999999999999 89999754432 11111 1112222
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
..+..++..+.+++.+||+.+|.+||++.++++.|+++..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3344566789999999999999999999999999998865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.31 Aligned_cols=266 Identities=28% Similarity=0.417 Sum_probs=202.9
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeCC-Cc---EEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEe
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILPD-GT---VVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 442 (707)
++....++|++.+.||+|+||+||+|.... +. .||||++... .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 444556789999999999999999999653 32 7999998764 23345789999999999999999999999987
Q ss_pred CCeE------EEEEecCCCCCHHHHHhhcC----CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 005224 443 EGEQ------MLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 512 (707)
Q Consensus 443 ~~~~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~ 512 (707)
.... ++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7655 99999999999999996532 235899999999999999999999999 9999999999999999
Q ss_pred CcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHH
Q 005224 513 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 591 (707)
Q Consensus 513 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~ 591 (707)
+.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp SCEEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred CCEEEeecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence 9999999999986543221 112233456788999999999999999999999999999999 8999975443211
Q ss_pred HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 592 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
...+..+.....+..++..+.+++.+|++.+|.+||++.++++.|+++...
T Consensus 249 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 249 ----------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp ----------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----------HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111222333345566778899999999999999999999999999987653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=361.60 Aligned_cols=273 Identities=22% Similarity=0.315 Sum_probs=213.6
Q ss_pred cccHHHHHHHhcCCCcc-ceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHcc-CCCcceeEEE
Q 005224 364 SFTYGEMALATNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVG 438 (707)
Q Consensus 364 ~~~~~~l~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~ 438 (707)
.+.+.......++|.+. +.||+|+||+||+|... +++.||||++.... ......+.+|+.+++.+ +||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34455566667788887 89999999999999975 68999999987533 23357889999999999 4699999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcE
Q 005224 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTA 515 (707)
Q Consensus 439 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ 515 (707)
++...+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 9999999999999999999999997665667999999999999999999999999 999999999999998 7899
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 595 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~ 595 (707)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 174 kL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~- 244 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC--------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN- 244 (327)
T ss_dssp EECCGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred EEeeCccccccCCcc--------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-
Confidence 999999998764321 22345689999999999999999999999999999999999999965443211110
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCC
Q 005224 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 675 (707)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R 675 (707)
+........+.. .........+||.+||..||++|
T Consensus 245 ----------------------------i~~~~~~~~~~~-----------------~~~~~~~~~~li~~~L~~dP~~R 279 (327)
T 3lm5_A 245 ----------------------------ISQVNVDYSEET-----------------FSSVSQLATDFIQSLLVKNPEKR 279 (327)
T ss_dssp ----------------------------HHHTCCCCCTTT-----------------TTTSCHHHHHHHHHHSCSSGGGS
T ss_pred ----------------------------HHhcccccCchh-----------------hcccCHHHHHHHHHHcCCChhhC
Confidence 000000000000 01112223468888999999999
Q ss_pred CCCCcCCCCCCCCCCCCC
Q 005224 676 PSSSSMLKHPYVSSDVSG 693 (707)
Q Consensus 676 ~sa~e~L~Hp~f~~~~~~ 693 (707)
||++|+|+||||....+.
T Consensus 280 pt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 280 PTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp CCHHHHTTCGGGCCCCTT
T ss_pred cCHHHHhCCHhhcccccc
Confidence 999999999999876554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=368.81 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=214.2
Q ss_pred hcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
.++|++.+.||+|+||+||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457888999999999999999953 46789999997543 34456789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC-----CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEe
Q 005224 447 MLVYEFMSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVA 518 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~ 518 (707)
++||||+++|+|.+++.... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997643 245899999999999999999999999 99999999999999555 59999
Q ss_pred eecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHh
Q 005224 519 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 597 (707)
Q Consensus 519 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~ 597 (707)
|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |..||...... +...
T Consensus 227 DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-~~~~--- 297 (367)
T 3l9p_A 227 DFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLE--- 297 (367)
T ss_dssp CCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHH---
T ss_pred CCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH---
Confidence 9999975422110 112234457899999999999999999999999999999998 99999754432 1111
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
.+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 298 ------~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 298 ------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1122223344566778899999999999999999999999999887653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=356.07 Aligned_cols=272 Identities=17% Similarity=0.233 Sum_probs=216.0
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||+||+|.. .+++.||||++..... .+.+.+|+++++.+ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36789999999999999999996 4799999999875432 24688999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEeeecccccC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADFGLSRLA 526 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~DFGla~~~ 526 (707)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999764 346999999999999999999999998 999999999999998887 999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc--hhHHHHHHHhhcccchh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK--NIVREVNIAYQSSMMFS 604 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~--~~~~~~~~~~~~~~~~~ 604 (707)
.........+........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.......... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-AT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-HS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-cC
Confidence 4433221111222345679999999999999999999999999999999999999997532 22221111110000 00
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 658 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~ 658 (707)
........++ ++.+++..||+.+|.+||++.++.+.|+++.........
T Consensus 240 ----~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 288 (330)
T 2izr_A 240 ----PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD 288 (330)
T ss_dssp ----CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred ----CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence 0000011234 899999999999999999999999999988876654433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=364.53 Aligned_cols=282 Identities=18% Similarity=0.201 Sum_probs=214.5
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCC------CcEEEEEEeccCChhhH-----------HHHHHHHHHHHccCCCccee
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGE-----------KEFLTEIQFLSRLHHRNLVS 435 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~ 435 (707)
..++|++.+.||+|+||+||+|.+++ ++.||||++........ ..+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999999754 47899999876542211 12445666778889999999
Q ss_pred EEEEEEeC----CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-
Q 005224 436 LVGYCDEE----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD- 510 (707)
Q Consensus 436 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~- 510 (707)
+++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 99998664 4589999999 99999999764 346999999999999999999999998 99999999999999
Q ss_pred -CCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchh
Q 005224 511 -HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 589 (707)
Q Consensus 511 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~ 589 (707)
.++.+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876533221111112223456999999999999999999999999999999999999999743222
Q ss_pred HHHH---HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCc
Q 005224 590 VREV---NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 662 (707)
Q Consensus 590 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~d 662 (707)
.... ..... .....+++..+. ...++.++.+++..||+.+|.+||++.++++.|+.+............|
T Consensus 268 ~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d 340 (364)
T 3op5_A 268 PKYVRDSKIRYR-ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLD 340 (364)
T ss_dssp HHHHHHHHHHHH-HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCC
T ss_pred HHHHHHHHHHhh-hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccc
Confidence 1111 11111 112222221111 1234577899999999999999999999999999998866554444333
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=347.94 Aligned_cols=255 Identities=20% Similarity=0.351 Sum_probs=212.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 449 (707)
.++|+..+.||+|+||+||+|.++ ++.||||++.... ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357889999999999999999984 8899999997643 33456799999999999999999999999877 788999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++|+|.+++.......+++..++.++.|+++||+|||+.+ ++|+||||||+||++++++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 99999999999998766667999999999999999999999865 4599999999999999999999999998754321
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCC---chhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
....||+.|+|||++.+..++. ++|||||||++|||++|+.||............ ..
T Consensus 166 -----------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---------~~ 225 (271)
T 3kmu_A 166 -----------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV---------AL 225 (271)
T ss_dssp -----------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH---------HH
T ss_pred -----------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH---------Hh
Confidence 2345789999999998765554 799999999999999999999765442221111 11
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.......+..++..+.+++..||+.+|.+||++.++++.|+.+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 222334556677889999999999999999999999999988753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=350.01 Aligned_cols=273 Identities=18% Similarity=0.256 Sum_probs=217.8
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||+||+|.. .+++.||||++.... ..+.+.+|+++++.+ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 579999999986533 234678899999999 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEeeecccccC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADFGLSRLA 526 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~DFGla~~~ 526 (707)
|+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999997643 45999999999999999999999998 999999999999987776 999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch--hHHHHHHHhhcccchh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFS 604 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~ 604 (707)
.........+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 237 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---- 237 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH----
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc----
Confidence 54332221112234456799999999999999999999999999999999999999975322 111111110000
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 658 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~ 658 (707)
...........++..+.+++..||+.+|.+||++.++++.|+++.........
T Consensus 238 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~ 290 (298)
T 1csn_A 238 -QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 290 (298)
T ss_dssp -HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred -cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCC
Confidence 00000011223457899999999999999999999999999999876654443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=347.80 Aligned_cols=253 Identities=32% Similarity=0.513 Sum_probs=201.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChh----hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|+..+.||+|+||+||+|.+. ++.||||++...... ..+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467889999999999999999984 889999998753322 246789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------CCcEEEeeec
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--------KFTAKVADFG 521 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--------~~~~kl~DFG 521 (707)
|||+++++|.+++.. ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999853 35899999999999999999999988666899999999999986 7789999999
Q ss_pred ccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhccc
Q 005224 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601 (707)
Q Consensus 522 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 601 (707)
+++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 162 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----- 227 (271)
T 3dtc_A 162 LAREWHRT---------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA----- 227 (271)
T ss_dssp C----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-----
T ss_pred cccccccc---------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh-----
Confidence 99765422 1224468999999999999999999999999999999999999997654422211111
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
........+..++..+.+++.+||+.+|.+||++.++++.|++
T Consensus 228 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 ----MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1112233456667889999999999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=368.45 Aligned_cols=272 Identities=23% Similarity=0.312 Sum_probs=204.9
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC-----ChhhHHHHHHHHHHHHccCCCcceeEEEEEEe
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 442 (707)
++....++|++.+.||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45667789999999999999999999974 7889999998643 22345678999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhc--------------------------------------CCCCcCHHHHHHHHHHHHH
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAK--------------------------------------SKEPLGFAMRLSIALGSSR 484 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~ 484 (707)
.+..++||||+++|+|.+++... ....+++..++.++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 0112467788999999999
Q ss_pred HHHHHHhCCCCCeEecCCCCCCEEEcCCC--cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhcc--CCC
Q 005224 485 GILYLHTEADPPVFHRDIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKL 560 (707)
Q Consensus 485 gL~yLH~~~~~~ivH~Dlkp~NILl~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~ 560 (707)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++........ .........||+.|+|||++.+ ..+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG---EYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCcc---ccccccccCCCccccCchhhccCCCCC
Confidence 999999998 99999999999998776 8999999999865322111 0112344568999999999975 678
Q ss_pred CCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 005224 561 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 640 (707)
Q Consensus 561 s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~ 640 (707)
+.++|||||||++|||++|+.||........ ...... ... ....|..
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~---------~~~----------------------~~~~~~~- 300 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADT-ISQVLN---------KKL----------------------CFENPNY- 300 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH---------CCC----------------------CTTSGGG-
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHh---------ccc----------------------ccCCccc-
Confidence 9999999999999999999999975443211 111000 000 0000000
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 641 EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 641 ~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
...++...+||.+||..||++|||++|+|+||||+....
T Consensus 301 -------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 301 -------------NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp -------------GGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred -------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 011223346778888888888889999999999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=352.17 Aligned_cols=259 Identities=20% Similarity=0.319 Sum_probs=209.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457889999999999999999976 68899999986532 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999986643 5899999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 169 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------------- 226 (294)
T 2rku_A 169 G-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR--------------- 226 (294)
T ss_dssp T-------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---------------
T ss_pred c-------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------------
Confidence 1 122345689999999999999999999999999999999999999965432111000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
+.......|. ..+....+++.+||..||++|||++|+++||||.+
T Consensus 227 ---------------~~~~~~~~~~--------------------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 227 ---------------IKKNEYSIPK--------------------HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp ---------------HHTTCCCCCT--------------------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred ---------------HhhccCCCcc--------------------ccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 0000000000 11122336788899999999999999999999987
Q ss_pred CCCCC
Q 005224 690 DVSGS 694 (707)
Q Consensus 690 ~~~~~ 694 (707)
....+
T Consensus 272 ~~~~~ 276 (294)
T 2rku_A 272 GYIPA 276 (294)
T ss_dssp SCCCS
T ss_pred CCcCC
Confidence 65543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=360.77 Aligned_cols=269 Identities=25% Similarity=0.391 Sum_probs=215.9
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYC 440 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 440 (707)
+++...++|++.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3455678899999999999999999996 2467899999975432 2346789999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCC---------------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 005224 441 DEEGEQMLVYEFMSNGTLRDQLSAKSK---------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499 (707)
Q Consensus 441 ~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 499 (707)
...+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 999999999999999999999976432 24799999999999999999999999 999
Q ss_pred cCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-
Q 005224 500 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT- 578 (707)
Q Consensus 500 ~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt- 578 (707)
|||||+|||++.++.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCcc-----ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 99999999999999999999999986543221 122344567889999999999999999999999999999998
Q ss_pred CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 579 GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 579 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
|..||............. . .+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+....+
T Consensus 271 g~~p~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 271 GVNPYPGIPVDANFYKLI-Q--------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp SCCSSTTCCCSHHHHHHH-H--------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCCCcccCCcHHHHHHHH-h--------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 999997544322111111 1 112223455567889999999999999999999999999998765443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=366.30 Aligned_cols=258 Identities=21% Similarity=0.349 Sum_probs=201.1
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
..++|+..+.||+|+||+||+|..+ +++.||||++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999975 689999999976432 234688888888 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEeeecccccC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKVADFGLSRLA 526 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFGla~~~ 526 (707)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999999654 35999999999999999999999999 9999999999998543 35999999999865
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 171 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------------- 227 (342)
T 2qr7_A 171 RAEN-------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---------------- 227 (342)
T ss_dssp BCTT-------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC----------------
T ss_pred cCCC-------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC----------------
Confidence 4321 12234578999999999998889999999999999999999999996432100
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCC
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 686 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 686 (707)
..++.+.+...--..+.. ..+..++.+.+||.+||+.||++|+|++|+|+|||
T Consensus 228 -----------~~~~~~~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 228 -----------PEEILARIGSGKFSLSGG----------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp -----------HHHHHHHHHHCCCCCCST----------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred -----------HHHHHHHHccCCcccCcc----------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 001111111100000000 00112233457888999999999999999999999
Q ss_pred CCC
Q 005224 687 VSS 689 (707)
Q Consensus 687 f~~ 689 (707)
|..
T Consensus 281 ~~~ 283 (342)
T 2qr7_A 281 IVH 283 (342)
T ss_dssp HHT
T ss_pred ecC
Confidence 954
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=354.67 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=200.2
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57889999999999999999975 68999999987543 23457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeeecccccCC
Q 005224 453 MSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 453 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 527 (707)
+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998653 2356999999999999999999999999 9999999999999 556889999999997654
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.. .......||+.|+|||++. ..++.++|||||||++|||++|+.||............
T Consensus 179 ~~--------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~------------ 237 (285)
T 3is5_A 179 SD--------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------------ 237 (285)
T ss_dssp ----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------------
T ss_pred Cc--------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh------------
Confidence 32 1223456899999999986 56889999999999999999999999654321100000
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
...........++ .++...+|+.+||..||++|||++|+|+||||
T Consensus 238 -----------------~~~~~~~~~~~~~------------------~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f 282 (285)
T 3is5_A 238 -----------------TYKEPNYAVECRP------------------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282 (285)
T ss_dssp -----------------HHCCCCCCC--CC------------------CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred -----------------ccCCcccccccCc------------------CCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence 0000000000011 12233468888999999999999999999999
Q ss_pred CC
Q 005224 688 SS 689 (707)
Q Consensus 688 ~~ 689 (707)
..
T Consensus 283 ~~ 284 (285)
T 3is5_A 283 KQ 284 (285)
T ss_dssp GC
T ss_pred hc
Confidence 74
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=356.11 Aligned_cols=277 Identities=27% Similarity=0.438 Sum_probs=214.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeCC-----CcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
.++|+..+.||+|+||+||+|.... +..||||++..... .....+.+|+++++.++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999998642 34699999976433 33467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999999764 346999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
..... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +... .+.
T Consensus 199 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~---------~~~ 264 (333)
T 1mqb_A 199 DDPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMK---------AIN 264 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH---------HHH
T ss_pred ccccc----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-HHHH---------HHH
Confidence 32210 111223346788999999999999999999999999999999 99999754431 1111 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 676 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 676 (707)
.+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+.... +.+..+..++|..|+
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~--------~~~~~~~~~~p~~~~ 326 (333)
T 1mqb_A 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP--------DSLKTLADFDPRVSI 326 (333)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG--------GGGGSBCCC------
T ss_pred CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc--------hhhhhhcCCCccchh
Confidence 22233345567788999999999999999999999999999887633 345566777776665
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=388.45 Aligned_cols=265 Identities=30% Similarity=0.461 Sum_probs=220.0
Q ss_pred HHHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 367 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 367 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
.++++...++|++.+.||+|+||.||+|.++++..||||+++... ...++|.+|+++|++++|+||+++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 344556677889999999999999999999888889999998644 345689999999999999999999999876 678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999999999997654456899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... +... .+
T Consensus 414 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-~~~~---------~i 477 (535)
T 2h8h_A 414 EDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLD---------QV 477 (535)
T ss_dssp CCHH------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-HHHH---------HH
T ss_pred CCCc------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH---------HH
Confidence 4211 011123346788999999999999999999999999999999 99999754431 1111 11
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
..+.....+..++..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 478 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 478 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 12223345667778899999999999999999999999999977543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=357.84 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=205.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
.++|+..+.||+|+||+||+|.+. +++ .||+|.+.... ....+.+.+|+.++++++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357889999999999999999964 444 36888876432 234578999999999999999999999998754 78
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+|+||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999997643 45999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......- . ..+.
T Consensus 169 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~--------~~~~ 233 (327)
T 3poz_A 169 AEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S--------SILE 233 (327)
T ss_dssp TTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H--------HHHH
T ss_pred CCcc-----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--H--------HHHH
Confidence 3321 112233456889999999999999999999999999999999 9999975433111 0 0111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 122333456677889999999999999999999999999988764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=369.75 Aligned_cols=297 Identities=20% Similarity=0.318 Sum_probs=214.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457899999999999999999975 78999999987643 3335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
|+++++|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999999997653 489999999999999999999985 7 99999999999999999999999999865421
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... ...+..
T Consensus 185 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~-----~~~~~~ 250 (360)
T 3eqc_A 185 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE--LMFGC-----QVEGDA 250 (360)
T ss_dssp -------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH--HHHC------------
T ss_pred -------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHhcc-----cccccC
Confidence 1223457899999999999999999999999999999999999999765432111 11000 000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC-C--CCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM-P--ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~-~--~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
...+... ....... .-+..+........++++.+....... + ..+..+.+||.+||+.||++|||++|+|+||||
T Consensus 251 ~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 251 AETPPRP-RTPGRPL-NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp -------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCCCCCc-ccCCCcc-cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 0000000 0000000 001111112223334443333221110 1 112345689999999999999999999999999
Q ss_pred CCCCCC
Q 005224 688 SSDVSG 693 (707)
Q Consensus 688 ~~~~~~ 693 (707)
......
T Consensus 329 ~~~~~~ 334 (360)
T 3eqc_A 329 KRSDAE 334 (360)
T ss_dssp HHHHHS
T ss_pred hcchHh
Confidence 765543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=351.74 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=207.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.++|++.+.||+|+||+||+|.+. ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 357888999999999999999984 788999998753 34568899999999999999999999886 3479999999
Q ss_pred CCCCHHHHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-EEEeeecccccCCCCCC
Q 005224 454 SNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-AKVADFGLSRLAPVPDI 531 (707)
Q Consensus 454 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-~kl~DFGla~~~~~~~~ 531 (707)
++|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999976433 24789999999999999999999932223999999999999998886 799999999754321
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............ ....+...
T Consensus 160 --------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~~ 223 (307)
T 2eva_A 160 --------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--------AVHNGTRP 223 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH--------HHHTTCCC
T ss_pred --------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH--------HHhcCCCC
Confidence 12345899999999999999999999999999999999999999754322111111 11122233
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 658 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~ 658 (707)
..+..++..+.+++.+||+.+|.+||++.++++.|+.+...++..+.
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 34455667899999999999999999999999999999887765443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.37 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=202.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHc--cCCCcceeEEEEEEeC----CeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDEE----GEQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~~ 447 (707)
.++|++.+.||+|+||+||+|.. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999998 6899999998653 34566677777766 7999999999997543 4589
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH--------TEADPPVFHRDIKASNILLDHKFTAKVAD 519 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 519 (707)
+||||+++|+|.++++. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999953 35999999999999999999999 777 99999999999999999999999
Q ss_pred ecccccCCCCCCCCccccceecccccCCCccchhhhccC------CCCCchhhHHHHHHHHHHHcC----------CCCC
Q 005224 520 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTG----------MQPI 583 (707)
Q Consensus 520 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvll~elltG----------~~pf 583 (707)
||+++........ .........||+.|+|||++.+. .++.++|||||||++|||++| +.||
T Consensus 157 fg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 157 LGLAVMHSQSTNQ---LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp CTTCEEEETTTTE---EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCeeeccccccc---ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999765432211 01112334789999999999876 455789999999999999999 8888
Q ss_pred CCCch---hHHHHHHHhhcccchhhccCCCCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 584 SHGKN---IVREVNIAYQSSMMFSVIDGNMGS-----YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 584 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
..... .......... ....... .+..++..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVC-------VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHHHHHHT-------TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHHh-------ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54221 1111111111 1111222 2346788999999999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=379.22 Aligned_cols=200 Identities=29% Similarity=0.435 Sum_probs=176.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57889999999999999999975 799999999875322 22457899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999653 45999999999999999999999998 9999999999999999999999999998764321
Q ss_pred CCCccccceecccccCCCccchhhhccCCC-CCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 171 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 171 --------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp --------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 2234579999999999998765 679999999999999999999997543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=367.90 Aligned_cols=287 Identities=22% Similarity=0.352 Sum_probs=204.0
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh-----HHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-----EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
...++|++.+.||+|+||.||+|... +|+.||||++....... .+.+.+|+++++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 68999999987533221 2467899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+++ +|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999975 899888654 345888999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||...... +..........
T Consensus 162 ~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~--- 230 (346)
T 1ua2_A 162 FGSPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLG--- 230 (346)
T ss_dssp TTSCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC---
T ss_pred ccCCc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcC---
Confidence 64321 123345689999999999764 5889999999999999999999888654432 21111111000
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 684 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 684 (707)
.......+..+. +. . ......+|... + .......+....+||.+||..||++|||++|+|+|
T Consensus 231 --~~~~~~~~~~~~-----~~-~--~~~~~~~~~~~-----~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 231 --TPTEEQWPDMCS-----LP-D--YVTFKSFPGIP-----L---HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp --CCCTTTSSSTTS-----ST-T--CCCCCCCCCCC-----H---HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --CCChhhhhhhcc-----Cc-c--cccccccCCCC-----h---HHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000000 00 0 00000111100 0 01123334455679999999999999999999999
Q ss_pred CCCCCCCC
Q 005224 685 PYVSSDVS 692 (707)
Q Consensus 685 p~f~~~~~ 692 (707)
|||.....
T Consensus 293 ~~f~~~~~ 300 (346)
T 1ua2_A 293 KYFSNRPG 300 (346)
T ss_dssp GGGTSSSC
T ss_pred hhhhcCCC
Confidence 99976543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=374.12 Aligned_cols=198 Identities=22% Similarity=0.272 Sum_probs=172.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccC--------CCcceeEEEEEE---
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH--------HRNLVSLVGYCD--- 441 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~--- 441 (707)
.++|++.++||+|+||+||+|... +++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 468999999999999999999964 7899999999753 334567889999999985 788999999987
Q ss_pred -eCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCC------
Q 005224 442 -EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKF------ 513 (707)
Q Consensus 442 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~------ 513 (707)
.....++||||+ +++|.+.+.......+++..++.++.||++||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 455789999999 67777777666556799999999999999999999998 8 99999999999999775
Q ss_pred -------------------------------------------cEEEeeecccccCCCCCCCCccccceecccccCCCcc
Q 005224 514 -------------------------------------------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550 (707)
Q Consensus 514 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ 550 (707)
.+||+|||+++..... .....||+.|+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~gt~~y~ 260 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQTRQYR 260 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCSCGGGC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCCCCccc
Confidence 8999999999865321 23346899999
Q ss_pred chhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 551 aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
|||++.+..++.++|||||||++|||++|+.||...
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999999999999999643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=352.93 Aligned_cols=266 Identities=24% Similarity=0.396 Sum_probs=218.9
Q ss_pred HHhcCCCccceEeeeCceEEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 443 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 443 (707)
...++|+..+.||+|+||+||+|.+ .+++.||||++..... ...+.+.+|+++++++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3456888999999999999999985 3578999999976443 3356789999999999 999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCC----------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSK----------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 507 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 507 (707)
+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999976542 25899999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCC
Q 005224 508 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 586 (707)
Q Consensus 508 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~ 586 (707)
+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred EEcCCCCEEEcccccccccccccc-----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999987654321 112234457889999999999999999999999999999999 99999754
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 587 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
.......... . .......+..++..+.+++.+|++.+|.+||++.++++.|+++.....
T Consensus 252 ~~~~~~~~~~-~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 252 PVDSKFYKMI-K--------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp CSSHHHHHHH-H--------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred cchhHHHHHh-c--------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 4322211111 1 111122344566789999999999999999999999999998876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=358.43 Aligned_cols=258 Identities=21% Similarity=0.323 Sum_probs=207.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999975 68899999986532 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999998764 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 195 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------------- 252 (335)
T 2owb_A 195 G-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR--------------- 252 (335)
T ss_dssp T-------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---------------
T ss_pred c-------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---------------
Confidence 1 122345689999999999999999999999999999999999999965432111100
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
+ .......| ...+....++|.+||..||++|||++|+|+||||.+
T Consensus 253 --------------~-~~~~~~~~--------------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 253 --------------I-KKNEYSIP--------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp --------------H-HHTCCCCC--------------------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred --------------H-hcCCCCCC--------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0 00000000 001112235778888889999999999999999977
Q ss_pred CCCC
Q 005224 690 DVSG 693 (707)
Q Consensus 690 ~~~~ 693 (707)
....
T Consensus 298 ~~~~ 301 (335)
T 2owb_A 298 GYIP 301 (335)
T ss_dssp SCCC
T ss_pred CCcc
Confidence 6553
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=371.27 Aligned_cols=196 Identities=24% Similarity=0.363 Sum_probs=163.0
Q ss_pred cCCCcc-ceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHc-cCCCcceeEEEEEEe----CCeEE
Q 005224 375 NNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDE----EGEQM 447 (707)
Q Consensus 375 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~----~~~~~ 447 (707)
++|.+. +.||+|+||+||+|... +++.||||++... ..+.+|++++.+ .+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456565 78999999999999975 7899999998642 356788888744 589999999999865 56789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeeecccc
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 524 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~ 524 (707)
+||||+++|+|.+++.......+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998766667999999999999999999999998 999999999999997 7899999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 213 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 213 ETTSH--------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp ECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ccCCC--------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 65421 1233567899999999999999999999999999999999999999653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=394.41 Aligned_cols=204 Identities=22% Similarity=0.348 Sum_probs=178.1
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeE
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 446 (707)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+..|..++..+ +|++|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999975 68999999987532 12235678899999988 799999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999997653 4999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 493 ~~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 493 IWDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CCTT-------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCC-------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 3221 22345679999999999999999999999999999999999999997543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=368.05 Aligned_cols=280 Identities=20% Similarity=0.297 Sum_probs=202.5
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC------
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 443 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 443 (707)
....++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999996 4799999999865432 234799999999999999999998443
Q ss_pred --------------------------------CeEEEEEecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHH
Q 005224 444 --------------------------------GEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYL 489 (707)
Q Consensus 444 --------------------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yL 489 (707)
...++||||++ |+|.+.+.. .....+++..++.++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34889999997 588888764 3455799999999999999999999
Q ss_pred HhCCCCCeEecCCCCCCEEEc-CCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhH
Q 005224 490 HTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVY 567 (707)
Q Consensus 490 H~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVw 567 (707)
|+.+ |+||||||+|||++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++|||
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--------CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9998 99999999999998 68999999999998664322 22345689999999999875 589999999
Q ss_pred HHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCC-CCCCHHHHHHHH
Q 005224 568 SLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETD-ARPSMSEVMREL 646 (707)
Q Consensus 568 S~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~-~RPt~~~v~~~L 646 (707)
|+||++|||++|+.||................ +..+.+....+..-.. ... -|. ......
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------g~p~~~~~~~~~~~~~-~~~-~~~~~~~~~~------ 287 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIM-----------GTPTKEQMIRMNPHYT-EVR-FPTLKAKDWR------ 287 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-----------CCCCHHHHHHHCTTC---CC-CCCCCCCCHH------
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-----------CCCCHHHHHHhCcccc-ccc-CCccCcccHH------
Confidence 99999999999999997654422211111000 0001111000000000 000 000 000010
Q ss_pred HHhhhcCC-CCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 647 ESIWNMMP-ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 647 ~~~~~~~~-~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
..++ ..++.+.+||.+||++||++|+|++|+|+||||..
T Consensus 288 ----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 288 ----KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp ----HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred ----hhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 1111 23344568999999999999999999999999964
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=360.21 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=206.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcE----EEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTV----VAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+.... ....+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357888999999999999999964 4443 8888875432 222346778999999999999999999986 45689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999999754 345889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.... ........|+..|+|||++.+..++.++|||||||++|||++ |+.||........ ... +.
T Consensus 167 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~---------~~ 231 (325)
T 3kex_A 167 PDDK-----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-PDL---------LE 231 (325)
T ss_dssp CCTT-----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-HHH---------HH
T ss_pred cccc-----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-HHH---------HH
Confidence 4321 122344567889999999999999999999999999999999 9999975433111 111 11
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.......+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 122233445566678899999999999999999999999988754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=367.42 Aligned_cols=292 Identities=22% Similarity=0.268 Sum_probs=211.9
Q ss_pred cHHHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCCh-----------hhHHHHHHHHHHHHccCCCcce
Q 005224 366 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-----------QGEKEFLTEIQFLSRLHHRNLV 434 (707)
Q Consensus 366 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~nIv 434 (707)
...++....++|++.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35678888999999999999999999999988899999999864221 1236789999999999999999
Q ss_pred eEEEEEEeC-----CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005224 435 SLVGYCDEE-----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 509 (707)
Q Consensus 435 ~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 509 (707)
++++++... ...++||||++ |+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 999998543 36899999997 6898888753 346999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 510 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 510 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
+.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD--------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp CTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCCEEEEecCcccccccc--------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999754321 12334568899999999987 7799999999999999999999999976543
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHH-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCcc
Q 005224 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECV-----EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 663 (707)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dl 663 (707)
.. ........ . ...+.+.. ....+.........|... . ....+..++...+|
T Consensus 240 ~~-~~~~i~~~------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~----------~~~~~~~~~~~~~l 296 (362)
T 3pg1_A 240 YN-QLNKIVEV------V----GTPKIEDVVMFSSPSARDYLRNSLSNVPARA--W----------TAVVPTADPVALDL 296 (362)
T ss_dssp HH-HHHHHHHH------H----CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC--H----------HHHSTTSCHHHHHH
T ss_pred HH-HHHHHHHH------c----CCCChHHhhhccchhhhHHHHhhcccCChhh--H----------HhhCCCCCHHHHHH
Confidence 21 11111100 0 00000000 011111111111111110 0 11223344556789
Q ss_pred ccCCCCCCCCCCCCCCcCCCCCCCCCCCCC
Q 005224 664 INSEHTSKEETPPSSSSMLKHPYVSSDVSG 693 (707)
Q Consensus 664 l~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~ 693 (707)
|.+||..||++|||++|+|+||||.+....
T Consensus 297 i~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 297 IAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 999999999999999999999999886543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=374.22 Aligned_cols=285 Identities=25% Similarity=0.344 Sum_probs=194.9
Q ss_pred CCCc-cceEeeeCceEEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEe--CCeEEEE
Q 005224 376 NFNS-STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLV 449 (707)
Q Consensus 376 ~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV 449 (707)
.|++ .++||+|+||+||+|..+ +++.||||++..... ...+.+|+++++.++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4554 458999999999999965 578999999975432 3468899999999999999999999954 6789999
Q ss_pred EecCCCCCHHHHHhhc-------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEe
Q 005224 450 YEFMSNGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVA 518 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~ 518 (707)
|||++ |+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 5888888632 2235899999999999999999999999 9999999999999 778999999
Q ss_pred eecccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHh
Q 005224 519 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597 (707)
Q Consensus 519 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~ 597 (707)
|||+++....... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 175 Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~----- 245 (405)
T 3rgf_A 175 DMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT----- 245 (405)
T ss_dssp CTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC----------
T ss_pred ECCCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc-----
Confidence 9999987643211 1122345678999999999987 45899999999999999999999999654321100
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHH--------------------HHhcccCCCCCCCHHHHHHHHHHhhhcCCCCC
Q 005224 598 QSSMMFSVIDGNMGSYPSECVEKFIKLA--------------------LKCCQDETDARPSMSEVMRELESIWNMMPESD 657 (707)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~--------------------~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~ 657 (707)
...+..+....+.+.+ ...+...........+. + .......+
T Consensus 246 ------------~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~ 307 (405)
T 3rgf_A 246 ------------SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKY---M---EKHKVKPD 307 (405)
T ss_dssp -------------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHH---H---HTTTCCTT
T ss_pred ------------cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhh---H---hhcCCCCC
Confidence 0000111111111110 00011111111111111 1 11223335
Q ss_pred CCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCCC
Q 005224 658 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 693 (707)
Q Consensus 658 ~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~ 693 (707)
..+.+||.+||++||++|+|++|+|+||||......
T Consensus 308 ~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP 343 (405)
T ss_dssp SHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCC
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCC
Confidence 566789999999999999999999999999886554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=368.63 Aligned_cols=203 Identities=24% Similarity=0.300 Sum_probs=174.9
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccC-CC-----cceeEEEEEEeC
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HR-----NLVSLVGYCDEE 443 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~~~~~~~ 443 (707)
....++|++.+.||+|+||+||+|... +++.||||++... .....++..|+++++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 334678999999999999999999965 7899999999753 333567788999988885 44 499999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh--CCCCCeEecCCCCCCEEEc--CCCcEEEee
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT--EADPPVFHRDIKASNILLD--HKFTAKVAD 519 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~--~~~~~ivH~Dlkp~NILl~--~~~~~kl~D 519 (707)
+..++||||++ |+|.+++.......+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999995 599999987766679999999999999999999995 45 99999999999994 578899999
Q ss_pred ecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 520 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 520 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 205 FG~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 205 FGSSCQLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CTTCEETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCceecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999876321 2345689999999999999999999999999999999999999976544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.85 Aligned_cols=281 Identities=21% Similarity=0.348 Sum_probs=196.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC------C
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 444 (707)
.++|+..+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999964 7899999998653 233456788999999999999999999999654 5
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..++|+||+ +++|.+++.. ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 7899998854 45999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhc-ccc
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS-SMM 602 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~-~~~ 602 (707)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+...... ...
T Consensus 181 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p 249 (367)
T 2fst_X 181 HTAD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTP 249 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSC
T ss_pred cccc----------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence 6432 1234578999999999987 78999999999999999999999999765432 222221110 000
Q ss_pred -hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC
Q 005224 603 -FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 681 (707)
Q Consensus 603 -~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 681 (707)
.... ......... +.+. .+...| +....+ .++..++.+.|||.+||+.||++|+|++|+
T Consensus 250 ~~~~~----~~~~~~~~~---~~~~-~~~~~~--~~~~~~----------~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~ 309 (367)
T 2fst_X 250 GAELL----KKISSESAR---NYIQ-SLTQMP--KMNFAN----------VFIGANPLAVDLLEKMLVLDSDKRITAAQA 309 (367)
T ss_dssp CHHHH----TTCCCHHHH---HHHH-TSCCCC--CCCHHH----------HTTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CHHHH----HHhhhHHHH---HHHh-ccCCCC--CCCHHH----------HCCCCCHHHHHHHHHhCCCCcccCcCHHHH
Confidence 0000 001111111 1111 111111 112221 223445566789999999999999999999
Q ss_pred CCCCCCCCCCC
Q 005224 682 LKHPYVSSDVS 692 (707)
Q Consensus 682 L~Hp~f~~~~~ 692 (707)
|+||||.....
T Consensus 310 L~hp~~~~~~~ 320 (367)
T 2fst_X 310 LAHAYFAQYHD 320 (367)
T ss_dssp HTSGGGTTTCC
T ss_pred hcChhhhhccC
Confidence 99999986543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=349.29 Aligned_cols=265 Identities=22% Similarity=0.280 Sum_probs=211.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCC--eEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV 449 (707)
.++|.+.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357889999999999999999976 589999999975432 33567889999999999999999999997765 78999
Q ss_pred EecCCCCCHHHHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEeeecccc
Q 005224 450 YEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSR 524 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla~ 524 (707)
|||+++++|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999997643 234999999999999999999999999 9999999999999 788889999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhc--------cCCCCCchhhHHHHHHHHHHHcCCCCCCCCch---hHHHH
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--------THKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREV 593 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~---~~~~~ 593 (707)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..... .....
T Consensus 165 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 165 ELEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp ECCTTC--------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred ecCCCC--------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 764322 223456899999999986 57889999999999999999999999964222 11211
Q ss_pred HHHhhccc---chhh------------ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 594 NIAYQSSM---MFSV------------IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 594 ~~~~~~~~---~~~~------------~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
........ ...+ ..+.....+......+.+++.+|++.||++||++.|+++...+.
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11111100 0000 00111235578888999999999999999999999999887653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=359.91 Aligned_cols=285 Identities=24% Similarity=0.359 Sum_probs=209.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357889999999999999999975 589999999865432 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999998887543 35999999999999999999999999 9999999999999999999999999997654321
Q ss_pred CCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||.................
T Consensus 179 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 242 (331)
T 4aaa_A 179 -------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG--------- 242 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC---------
T ss_pred -------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC---------
Confidence 122345689999999999875 789999999999999999999999976554322211110000
Q ss_pred CCCCChHHHHHHHHHHHH--hcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALK--CCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~--c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
..+......+..-... ........+.... ...+..++...+|+.+||..||++|||++|+|+||||
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 243 --NLIPRHQELFNKNPVFAGVRLPEIKEREPLE----------RRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp --SCCHHHHHHHHHCGGGTTCCCCCCSSCCCHH----------HHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred --CCChhhhhHhhhccccccccCccccccchhh----------hcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0111110000000000 0000001111111 1223344556689999999999999999999999999
Q ss_pred CCCC
Q 005224 688 SSDV 691 (707)
Q Consensus 688 ~~~~ 691 (707)
..+.
T Consensus 311 ~~~~ 314 (331)
T 4aaa_A 311 QMDG 314 (331)
T ss_dssp HGGG
T ss_pred ccCC
Confidence 8754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.62 Aligned_cols=200 Identities=25% Similarity=0.431 Sum_probs=174.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|.+.+.||+|+||+||+|... +|+.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467889999999999999999975 7999999999865544556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeeecccccCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~~~ 529 (707)
+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999997643 4899999999999999999999998 9999999999999 78899999999998754321
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 163 ---------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp ---------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1234568999999999999999999999999999999999999996543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=346.67 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=184.7
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5788999999999999999997 4799999999865322 12367899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999754 346899999999999999999999998 9999999999999999999999999998654321
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 167 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~~----- 224 (278)
T 3cok_A 167 -------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------LNKV----- 224 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------C-----
T ss_pred -------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------HHHH-----
Confidence 112335689999999999999999999999999999999999999964332100 0000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
...+. ..|. ..+....+++.+||..||++|||++|+|+||||...
T Consensus 225 ------------------~~~~~-~~~~----------------~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 225 ------------------VLADY-EMPS----------------FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------------------CSSCC-CCCT----------------TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------------------hhccc-CCcc----------------ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00000 0010 011223368888999999999999999999999865
Q ss_pred CC
Q 005224 691 VS 692 (707)
Q Consensus 691 ~~ 692 (707)
..
T Consensus 270 ~~ 271 (278)
T 3cok_A 270 SS 271 (278)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=355.25 Aligned_cols=265 Identities=25% Similarity=0.482 Sum_probs=216.6
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC--------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEEe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 442 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 442 (707)
..++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999863 467899999976433 3356789999999999 89999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCC--------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 508 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 508 (707)
.+..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999976432 34899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCc
Q 005224 509 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 587 (707)
Q Consensus 509 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~ 587 (707)
++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999986643221 111233456788999999999999999999999999999999 999996543
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 588 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
.. +.... +..+.....+..++..+.+++..||+.+|.+||++.++++.|+.+......
T Consensus 265 ~~-~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 265 VE-ELFKL---------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HH-HHHHH---------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HH-HHHHH---------HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 21 11111 111222334556678899999999999999999999999999998775443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=362.67 Aligned_cols=285 Identities=21% Similarity=0.325 Sum_probs=204.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC------
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 444 (707)
.++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999965 7899999998753 2334567889999999999999999999997654
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..++||||++ ++|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999996 588888852 4889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........+ ....
T Consensus 176 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~------- 239 (371)
T 2xrw_A 176 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW-NKVI------- 239 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHH-------
T ss_pred ccccc--------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH-------
Confidence 65321 1223457899999999999999999999999999999999999999765543222 1111
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhcCCCC-------CCCCCccccCCCCCCCCCCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPES-------DTKTPEFINSEHTSKEETPP 676 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Pt~~~v~~~L~~~~~~~~~~-------~~~~~dll~~~L~~dP~~R~ 676 (707)
. ..+....+....+...........|... .++.+.... . .++.. +..+.+||.+||+.||++||
T Consensus 240 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 311 (371)
T 2xrw_A 240 --E-QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPD---V--LFPADSEHNKLKASQARDLLSKMLVIDASKRI 311 (371)
T ss_dssp --C--CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCG---G--GSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC
T ss_pred --H-HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhccc---c--cCcccccccccccHHHHHHHHHHCcCChhhCC
Confidence 1 1111222222222222222222222211 122211100 0 00100 12345899999999999999
Q ss_pred CCCcCCCCCCCCCC
Q 005224 677 SSSSMLKHPYVSSD 690 (707)
Q Consensus 677 sa~e~L~Hp~f~~~ 690 (707)
|++|+|+||||...
T Consensus 312 t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 312 SVDEALQHPYINVW 325 (371)
T ss_dssp CHHHHHHSHHHHTT
T ss_pred CHHHHhCCcchhhh
Confidence 99999999999753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=361.07 Aligned_cols=272 Identities=15% Similarity=0.171 Sum_probs=212.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeCC---------CcEEEEEEeccCChhhHHHHHHHHHHHHccCCCccee---------
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPD---------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS--------- 435 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~--------- 435 (707)
.++|++.+.||+|+||+||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678999999999999999999753 789999998754 36788999999999999987
Q ss_pred ------EEEEEEe-CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 005224 436 ------LVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 508 (707)
Q Consensus 436 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 508 (707)
+++++.. .+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6778876 67899999999 999999998764567999999999999999999999998 999999999999
Q ss_pred EcCCC--cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 509 LDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 509 l~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
++.++ .+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876532211111112223457999999999999999999999999999999999999999754
Q ss_pred chhHHHHHHHhh--cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005224 587 KNIVREVNIAYQ--SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 656 (707)
Q Consensus 587 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~ 656 (707)
............ ........... ......+..+.+++..||+.+|.+||++.++++.|+.+.......
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPC--GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTT--SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CcCHHHHHHHHHhccCChhhhhhhc--cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 321111111110 00000000000 001233578999999999999999999999999999988765433
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=358.21 Aligned_cols=288 Identities=20% Similarity=0.311 Sum_probs=210.8
Q ss_pred hcCCCccceEeeeCceEEEEEEe-C-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCC------cceeEEEEEEeCCe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-P-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR------NLVSLVGYCDEEGE 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~~~~~~~~~ 445 (707)
.++|++.+.||+|+||+||+|.. . +++.||||++... ....+.+.+|+++++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 3 6899999999753 33456788999999988665 49999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------------
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------- 511 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-------------- 511 (707)
.++||||+ +++|.+++......++++..++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999998876667999999999999999999999999 999999999999987
Q ss_pred -----CCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 512 -----KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 512 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 678999999999864321 23456899999999999999999999999999999999999999755
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC-------CCCCCC
Q 005224 587 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM-------PESDTK 659 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~-------~~~~~~ 659 (707)
..... ..... .. ....|......... ...+..+....+......+......... ....+.
T Consensus 238 ~~~~~-~~~~~------~~----~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (339)
T 1z57_A 238 DSKEH-LAMME------RI----LGPLPKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304 (339)
T ss_dssp CHHHH-HHHHH------HH----HCSCCHHHHHHCSC--GGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred ChHHH-HHHHH------HH----hCCCCHHHHhhccc--hhHHhhccccccccccccchhhhcCcchhhhcccchhhHHH
Confidence 43211 11100 00 01122221111000 0000000000011111111111111000 001123
Q ss_pred CCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 660 TPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 660 ~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
+.+||.+||..||++|||++|+|+||||..
T Consensus 305 l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 305 LFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred HHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 457999999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=360.87 Aligned_cols=261 Identities=24% Similarity=0.378 Sum_probs=207.7
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHHcc-CCCcceeEEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRL-HHRNLVSLVG 438 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l~~ 438 (707)
......++|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34445678999999999999999999985 799999999865331 1135678999999999 7999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 005224 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 518 (707)
Q Consensus 439 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 518 (707)
++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999999754 35899999999999999999999999 9999999999999999999999
Q ss_pred eecccccCCCCCCCCccccceecccccCCCccchhhhcc------CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005224 519 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 592 (707)
Q Consensus 519 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~ 592 (707)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 243 DfG~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~- 313 (365)
T 2y7j_A 243 DFGFSCHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM- 313 (365)
T ss_dssp CCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-
T ss_pred ecCcccccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH-
Confidence 999998764321 2234578999999999864 3588899999999999999999999965432111
Q ss_pred HHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCC
Q 005224 593 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE 672 (707)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP 672 (707)
.. .+..... ++.... ....+....+||.+||..||
T Consensus 314 ~~----------------------------~i~~~~~------~~~~~~-----------~~~~~~~~~~li~~~L~~dP 348 (365)
T 2y7j_A 314 LR----------------------------MIMEGQY------QFSSPE-----------WDDRSSTVKDLISRLLQVDP 348 (365)
T ss_dssp HH----------------------------HHHHTCC------CCCHHH-----------HSSSCHHHHHHHHHHSCSST
T ss_pred HH----------------------------HHHhCCC------CCCCcc-----------cccCCHHHHHHHHHHcCCCh
Confidence 00 0000000 000000 01122234578899999999
Q ss_pred CCCCCCCcCCCCCCCC
Q 005224 673 ETPPSSSSMLKHPYVS 688 (707)
Q Consensus 673 ~~R~sa~e~L~Hp~f~ 688 (707)
++|||++|+|+||||.
T Consensus 349 ~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 349 EARLTAEQALQHPFFE 364 (365)
T ss_dssp TTSCCHHHHHHSGGGC
T ss_pred hHCcCHHHHhcCcccC
Confidence 9999999999999996
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=366.16 Aligned_cols=201 Identities=27% Similarity=0.346 Sum_probs=172.4
Q ss_pred hcCCCccceEeeeCceEEEEEEe----CCCcEEEEEEeccCC----hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 444 (707)
.++|++.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+++++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788999999999999999997 378999999987532 12234677899999999 6999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..++||||+++|+|.+++.... .+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999997643 5899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 208 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 208 EFVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp ECCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred ecccCC------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 653221 122334579999999999986 4578999999999999999999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.79 Aligned_cols=269 Identities=27% Similarity=0.412 Sum_probs=214.1
Q ss_pred CCccceEeeeCceEEEEEEeC-----CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeC--CeEEE
Q 005224 377 FNSSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 448 (707)
Q Consensus 377 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 448 (707)
|++.+.||+|+||+||++.++ +++.||||++..... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 388999999999999998752 688999999986533 3356789999999999999999999999874 67899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999654 3899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHH----HHhhcccchh
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN----IAYQSSMMFS 604 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~----~~~~~~~~~~ 604 (707)
... .........+|..|+|||++.+..++.++|||||||++|||++|+.||........... ..........
T Consensus 187 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 187 GHE----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp TCS----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccc----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 221 01123344578889999999999999999999999999999999999864322110000 0000000111
Q ss_pred -hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 605 -VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 605 -~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
+........+..++..+.+++.+||+.+|.+||++.++++.|+.+.+.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 122233445667778999999999999999999999999999998776543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=381.66 Aligned_cols=262 Identities=26% Similarity=0.430 Sum_probs=211.2
Q ss_pred cCCCccc-eEeeeCceEEEEEEeC---CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 375 NNFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 375 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
+++.+.+ .||+|+||.||+|.++ ++..||||+++... ....+++.+|+++|++++||||++++++|.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999864 56789999998643 2346789999999999999999999999976 568999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 414 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999999654 446999999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .. ..+..+
T Consensus 490 ~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~---------~~i~~~ 555 (613)
T 2ozo_A 490 DSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VM---------AFIEQG 555 (613)
T ss_dssp ----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-HH---------HHHHTT
T ss_pred Cce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HH---------HHHHcC
Confidence 211 111122345789999999999999999999999999999998 999997654321 11 112223
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
.....+..++..+.+++..||+.+|++||++.++++.|+.++.....
T Consensus 556 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 556 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 34456677888999999999999999999999999999998765433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=355.50 Aligned_cols=274 Identities=27% Similarity=0.387 Sum_probs=216.9
Q ss_pred hcCCCccceEeeeCceEEEEEEe-----CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEE--eCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~ 446 (707)
.++|+..+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++|+||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46788999999999999999984 368899999998776666778999999999999999999999986 45678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999997643 25899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHH-HHh----hccc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN-IAY----QSSM 601 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~-~~~----~~~~ 601 (707)
...... ........||..|+|||++.+..++.++|||||||++|||++|+.||........... ... ....
T Consensus 178 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 178 PLDKDY----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CTTCSE----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ccCCcc----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 433211 1122334578889999999999999999999999999999999999864322110000 000 0001
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
...+..+.....+..++..+.+++.+|++.+|.+||++.++++.|+.++.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 111222333445667788899999999999999999999999999988765543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.55 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=199.5
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCC----e
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----E 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~ 445 (707)
.++|++.+.||+|+||+||+|.. .+++.||||++...... ....+.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 57899999999764332 2457889999999999999999999986654 3
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999997643 5899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||............ ........
T Consensus 166 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~- 239 (311)
T 3ork_A 166 IADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VREDPIPP- 239 (311)
T ss_dssp --------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHCCCCCH-
T ss_pred ccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hcCCCCCc-
Confidence 5432211 11223456899999999999999999999999999999999999999765442221111 11100000
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHHhhh
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM-RELESIWN 651 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~-~~L~~~~~ 651 (707)
......++..+.+++.+|++.+|.+||+..+++ ..+.....
T Consensus 240 -----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 240 -----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp -----HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred -----ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 001123557789999999999999999666544 45554433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=356.75 Aligned_cols=266 Identities=24% Similarity=0.398 Sum_probs=216.4
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC-CC-----cEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP-DG-----TVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYC 440 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 440 (707)
++....++|+..+.||+|+||+||+|... ++ +.||+|.+..... ...+.+.+|+++++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45556788999999999999999999964 22 4799999976433 3456789999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcC------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 005224 441 DEEGEQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 508 (707)
Q Consensus 441 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 508 (707)
...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999997532 345899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCc
Q 005224 509 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 587 (707)
Q Consensus 509 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~ 587 (707)
++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTT-----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ECCCCeEEECccccccccccccc-----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 99999999999999986533211 112234557889999999999999999999999999999999 999997543
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 588 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
......... . .......+..++..+.+++..||+.+|.+||++.++++.|+.+..
T Consensus 272 ~~~~~~~~~-~--------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 272 VNSKFYKLV-K--------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp SSHHHHHHH-H--------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHHH-h--------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 322111111 1 111122344456788999999999999999999999999988754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=348.77 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=208.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CC-------cEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DG-------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
.++|.+.+.||+|+||+||+|... ++ +.||+|++........+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457888999999999999999864 33 5799999987666667889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--------EEE
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--------AKV 517 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl 517 (707)
.++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997643 34899999999999999999999999 999999999999998887 999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 596 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~ 596 (707)
+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+....+........
T Consensus 163 ~Dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 163 SDPGISITVLP-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp CCCCSCTTTSC-----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred ccCcccccccC-----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 99999875421 123457899999999987 779999999999999999999665554443322222111
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.. ....+...+..+.+++.+||+.+|.+||++.++++.|+++..
T Consensus 232 ~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 ED-----------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HT-----------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hc-----------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 111223334568899999999999999999999999998765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=352.35 Aligned_cols=270 Identities=26% Similarity=0.440 Sum_probs=209.3
Q ss_pred HHHHHHhcCCCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEE
Q 005224 368 GEMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441 (707)
Q Consensus 368 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 441 (707)
+++....++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 445556778999999999999999999853 34589999987543 333467899999999999999999999997
Q ss_pred eCC-----eEEEEEecCCCCCHHHHHhh----cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 005224 442 EEG-----EQMLVYEFMSNGTLRDQLSA----KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 512 (707)
Q Consensus 442 ~~~-----~~~lV~E~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~ 512 (707)
..+ ..++||||+++|+|.+++.. .....+++..++.++.|+++||.|||+.+ |+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 655 35999999999999999854 23456999999999999999999999998 9999999999999999
Q ss_pred CcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHH
Q 005224 513 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 591 (707)
Q Consensus 513 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~ 591 (707)
+.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp SCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CcEEEeecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 9999999999986543221 112233456889999999999999999999999999999999 8888865443211
Q ss_pred HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 592 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
...+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+....++
T Consensus 259 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 259 ----------YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp ----------HHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred ----------HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 111222233345566778899999999999999999999999999999887664
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.45 Aligned_cols=269 Identities=25% Similarity=0.402 Sum_probs=211.6
Q ss_pred hcCCCccceEeeeCceEEEEEEe-----CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeC--Ce
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GE 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~ 445 (707)
..+|+..+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+++++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34588899999999999999984 3689999999975432 3346789999999999999999999999876 67
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 899999999999999996543 45899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHH-----hhcc
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA-----YQSS 600 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~-----~~~~ 600 (707)
....... ........||..|+|||++.+..++.++|||||||++|||++|..|+............. ....
T Consensus 176 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 176 IETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp CCTTCCE----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccCCCcc----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 6543210 122334567888999999999999999999999999999999998864321110000000 0000
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 601 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
....+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 01112223334456677788999999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=352.35 Aligned_cols=271 Identities=25% Similarity=0.423 Sum_probs=220.2
Q ss_pred ccHHHHHHHhcCCCccceEeeeCceEEEEEEe------CCCcEEEEEEeccCChh-hHHHHHHHHHHHHcc-CCCcceeE
Q 005224 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSL 436 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~nIv~l 436 (707)
+...++....++|++.+.||+|+||+||+|.+ .+++.||||++...... ..+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455666678999999999999999999984 35689999999764433 346789999999999 79999999
Q ss_pred EEEEEeCC-eEEEEEecCCCCCHHHHHhhcCC--------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 005224 437 VGYCDEEG-EQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501 (707)
Q Consensus 437 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 501 (707)
++++...+ ..++||||+++|+|.+++..... ..+++..++.++.|+++||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99997654 58999999999999999976442 23899999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CC
Q 005224 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 580 (707)
Q Consensus 502 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~ 580 (707)
|||+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccceEEECCCCCEEECCCccccccccCcc-----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999986543221 122344567889999999999999999999999999999998 99
Q ss_pred CCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 581 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 581 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
.||............. ..+.....+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 249 ~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 249 SPYPGVKIDEEFCRRL---------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CSSTTCCCSHHHHHHH---------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccchhHHHHHHh---------ccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 9997544322211111 11122234455667899999999999999999999999999988654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=344.27 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=214.0
Q ss_pred hcCCCccc-eEeeeCceEEEEEEeC---CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|.+.+ .||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566666 9999999999999853 67889999998643 33457799999999999999999999999 5567899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999999653 345999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+..
T Consensus 163 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~---------~i~~ 228 (287)
T 1u59_A 163 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMA---------FIEQ 228 (287)
T ss_dssp CSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-HHH---------HHHT
T ss_pred Ccce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-HHH---------HHhc
Confidence 2210 111223456889999999998999999999999999999998 999997544321 111 1112
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
+.....+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 233445667778999999999999999999999999999988764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.82 Aligned_cols=254 Identities=31% Similarity=0.531 Sum_probs=206.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhH-------HHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGE-------KEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~-------~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
.++|+..+.||+|+||+||+|... +++.||||++........ +.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467889999999999999999974 789999999865332211 57899999999999999999999996654
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEeee
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADF 520 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~DF 520 (707)
++||||+++|+|.+.+... ...+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6999999999999988654 346999999999999999999999875 45999999999999988776 999999
Q ss_pred cccccCCCCCCCCccccceecccccCCCccchhhhc--cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhh
Q 005224 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598 (707)
Q Consensus 521 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~ 598 (707)
|+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...............
T Consensus 174 g~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 243 (287)
T 4f0f_A 174 GLSQQSVH----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243 (287)
T ss_dssp TTCBCCSS----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred Cccccccc----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence 99975321 233456899999999994 456788999999999999999999999754432111111111
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 599 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
........+..++..+.+++..||+.+|.+||++.++++.|++
T Consensus 244 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 -------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1122234556677889999999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.11 Aligned_cols=264 Identities=31% Similarity=0.471 Sum_probs=209.7
Q ss_pred cCCCccceEeeeCceEEEEEEeCC----CcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEE-eCCeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~l 448 (707)
.+|+..+.||+|+||+||+|.+.+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467888999999999999999642 23689999876433 34567899999999999999999999864 4567899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999653 345899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcC-CCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG-MQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.... .........+|+.|+|||.+.+..++.++|||||||++|||++| ..||..... .+... .+..
T Consensus 181 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~---------~~~~ 247 (298)
T 3f66_A 181 KEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV---------YLLQ 247 (298)
T ss_dssp GGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHH---------HHHT
T ss_pred cchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHH---------HHhc
Confidence 2211 11223345678899999999999999999999999999999995 455543322 11111 1112
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
+.....+..++..+.+++.+||+.+|.+||++.++++.|+++...+..
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 248 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 222334555667899999999999999999999999999999876654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.39 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=209.4
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCC----CcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
..++|...+.||+|+||+||+|.+.+ +..||||++.... ....+.+.+|+++++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45688899999999999999998542 3469999987653 3345789999999999999999999999865 4568
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997643 45899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||........ .. .+.
T Consensus 165 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-~~---------~~~ 228 (281)
T 3cc6_A 165 DED------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-IG---------VLE 228 (281)
T ss_dssp --------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-HH---------HHH
T ss_pred ccc------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-HH---------HHh
Confidence 322 112233456789999999999999999999999999999998 9999975433211 11 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
.......+..++..+.+++.+|++.+|.+||++.++++.|+.+...
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 229 KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1222334455667899999999999999999999999999987653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=349.51 Aligned_cols=262 Identities=22% Similarity=0.328 Sum_probs=208.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999975 78999999986533 2345688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 9999999999854 345899999999999999999999999 99999999999999999999999999976532210
Q ss_pred CCccccceecccccCCCccchhhhccCCC-CCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
........|++.|+|||++.+..+ +.++|||||||++|||++|+.||............
T Consensus 161 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------------- 220 (276)
T 2yex_A 161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD--------------- 220 (276)
T ss_dssp -----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---------------
T ss_pred -----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---------------
Confidence 112234568999999999988665 77899999999999999999999754321111000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
... .....+. ....+....++|.+||..||++|||++|+++||||...
T Consensus 221 -------------~~~-----~~~~~~~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 221 -------------WKE-----KKTYLNP--------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp -------------HHT-----TCTTSTT--------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -------------hhh-----cccccCc--------------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 000 0000000 00112233468888999999999999999999999876
Q ss_pred CC
Q 005224 691 VS 692 (707)
Q Consensus 691 ~~ 692 (707)
..
T Consensus 269 ~~ 270 (276)
T 2yex_A 269 LK 270 (276)
T ss_dssp CC
T ss_pred hh
Confidence 54
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.93 Aligned_cols=255 Identities=26% Similarity=0.427 Sum_probs=199.9
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEe----CCeEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQML 448 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~l 448 (707)
.|.+.+.||+|+||+||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677889999999999999975 68899999987532 3345678999999999999999999999865 356899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEeeecccccCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAP 527 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~~~ 527 (707)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||||+||+++ +++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999999764 34899999999999999999999875 4599999999999998 78999999999997543
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.. ......||+.|+|||++. ..++.++|||||||++|||++|+.||.................
T Consensus 184 ~~---------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 246 (290)
T 1t4h_A 184 AS---------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV------- 246 (290)
T ss_dssp TT---------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-------
T ss_pred cc---------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC-------
Confidence 22 223456899999999886 4589999999999999999999999976444322221110000
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
+|.. ......+...++|.+||..||++|||++|+|+||||
T Consensus 247 ----------------------------~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f 286 (290)
T 1t4h_A 247 ----------------------------KPAS------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp ----------------------------CCGG------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ----------------------------Cccc------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence 0000 000011123467888999999999999999999999
Q ss_pred CCC
Q 005224 688 SSD 690 (707)
Q Consensus 688 ~~~ 690 (707)
..+
T Consensus 287 ~~~ 289 (290)
T 1t4h_A 287 QEE 289 (290)
T ss_dssp C--
T ss_pred ccC
Confidence 865
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=363.95 Aligned_cols=287 Identities=23% Similarity=0.337 Sum_probs=211.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC-----CeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 446 (707)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999965 78999999997533 23346789999999999999999999999654 468
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||++ |+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 5999999653 4899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. . .
T Consensus 179 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-~------~ 247 (364)
T 3qyz_A 179 DPDHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL-G------I 247 (364)
T ss_dssp CGGGCB----CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH-H------H
T ss_pred CCCCCc----cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH-H------H
Confidence 432110 111234578999999998765 558999999999999999999999997544321111110 0 0
Q ss_pred ccCCCCCCChHHHHHHHHH--HHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCC
Q 005224 606 IDGNMGSYPSECVEKFIKL--ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 683 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l--~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 683 (707)
.+..+.+....+... ...........+.... ...+..+..+.+||.+||..||++|||++|+|+
T Consensus 248 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 248 ----LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN----------RLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp ----HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH----------HHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHH----------HhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 001111111100000 0000111111111111 122344555678999999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 684 HPYVSSDVS 692 (707)
Q Consensus 684 Hp~f~~~~~ 692 (707)
||||.....
T Consensus 314 hp~~~~~~~ 322 (364)
T 3qyz_A 314 HPYLEQYYD 322 (364)
T ss_dssp SGGGTTTCC
T ss_pred CcchhhccC
Confidence 999987643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=360.18 Aligned_cols=264 Identities=31% Similarity=0.509 Sum_probs=202.9
Q ss_pred CCCccceEeeeCceEEEEEEeC--CC--cEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEe-CCeEEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP--DG--TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLV 449 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV 449 (707)
.|+..+.||+|+||+||+|.+. ++ ..||||.+.... ....+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999863 32 468999987533 3345789999999999999999999999754 5678999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999654 345899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||....... . ...+..+
T Consensus 246 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-~---------~~~~~~~ 312 (373)
T 3c1x_A 246 EFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-I---------TVYLLQG 312 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-H---------HHHHHTT
T ss_pred cccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-H---------HHHHHcC
Confidence 2111 112234457889999999999999999999999999999999 666775433211 1 1111222
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 656 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~ 656 (707)
.....+..++..+.+++.+||+.+|++||++.++++.|+.+...+...
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 333345667788999999999999999999999999999998776543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=355.99 Aligned_cols=269 Identities=26% Similarity=0.447 Sum_probs=220.0
Q ss_pred ccHHHHHHHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEE
Q 005224 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLV 437 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~ 437 (707)
+..+++....++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+++++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344566677889999999999999999999854 368899999976433 3346789999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcC--------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005224 438 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 509 (707)
Q Consensus 438 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 509 (707)
+++.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999997532 245799999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCch
Q 005224 510 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 588 (707)
Q Consensus 510 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~ 588 (707)
+.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred cCCCeEEECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 9999999999999976532110 112233456889999999999999999999999999999999 8888865433
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
. .... .+..+.....+..++..+.+++.+|++.+|.+||++.++++.|+....
T Consensus 247 ~-~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 E-QVLR---------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp H-HHHH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H-HHHH---------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1 1111 112223334456677889999999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=347.19 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=204.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh------hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
.++|++.+.||+|+||+||+|... +++.||+|++...... ..+.+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357889999999999999999976 7899999998753321 357899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeeecc
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 522 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFGl 522 (707)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999999764 35899999999999999999999998 99999999999998877 899999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
+....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||........ .....
T Consensus 159 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----- 224 (283)
T 3bhy_A 159 AHKIEAGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTNIS----- 224 (283)
T ss_dssp CEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH-----
T ss_pred ceeccCCC--------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHHhH-----
Confidence 98654321 12344689999999999999999999999999999999999999975433111 00000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
......+.. ..+..+....+++.+||..||++|||++|+|
T Consensus 225 -----~~~~~~~~~-----------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 264 (283)
T 3bhy_A 225 -----AVNYDFDEE-----------------------------------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264 (283)
T ss_dssp -----TTCCCCCHH-----------------------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred -----hcccCCcch-----------------------------------hcccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 000000100 0011222345788999999999999999999
Q ss_pred CCCCCCC
Q 005224 683 KHPYVSS 689 (707)
Q Consensus 683 ~Hp~f~~ 689 (707)
+||||..
T Consensus 265 ~h~~~~~ 271 (283)
T 3bhy_A 265 EHSWIKA 271 (283)
T ss_dssp HCHHHHH
T ss_pred hCHHHHH
Confidence 9999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=345.40 Aligned_cols=254 Identities=30% Similarity=0.458 Sum_probs=206.2
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC-CeEEEEEe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-GEQMLVYE 451 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~E 451 (707)
..++|+..+.||+|+||+||+|.. +|+.||||++.... ..+.+.+|++++++++||||+++++++... +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 356789999999999999999988 48899999997643 446789999999999999999999997554 47899999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.+++.......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999997654445889999999999999999999999 999999999999999999999999998754321
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... +.. ..+..+..
T Consensus 171 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~---------~~~~~~~~ 232 (278)
T 1byg_A 171 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVV---------PRVEKGYK 232 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHH---------HHHTTTCC
T ss_pred --------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHH---------HHHhcCCC
Confidence 123357889999999999999999999999999999998 99999754321 111 11112223
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
...+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 345566778899999999999999999999999999988653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=364.01 Aligned_cols=281 Identities=22% Similarity=0.327 Sum_probs=202.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC------eEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------EQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~ 447 (707)
..+|+..+.||+|+||+||+|...++..||+|++..... ...+|+++++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346889999999999999999987777799998765332 2236999999999999999999995543 378
Q ss_pred EEEecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEeeecccc
Q 005224 448 LVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSR 524 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~ 524 (707)
+||||+++ ++.+.+.. .....+++..++.++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+|+
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999976 44444432 23456999999999999999999999999 99999999999999 79999999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||............ ...
T Consensus 191 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i-~~~---- 257 (394)
T 4e7w_A 191 ILIAGE--------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI-IKV---- 257 (394)
T ss_dssp ECCTTC--------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHH----
T ss_pred cccCCC--------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHH----
Confidence 764322 22345689999999999764 5899999999999999999999999765432221111 100
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS-MSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt-~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
.+..+.+....+.. ...-..-|..++. ...+ ..+..++.+.+||.+||+.||++|+|++|+|
T Consensus 258 ------~g~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 258 ------LGTPSREQIKTMNP--NYMEHKFPQIRPHPFSKV---------FRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp ------HCCCCHHHHHHHCG--GGSSSCCCCCCCCCHHHH---------SCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred ------hCCCCHHHHHhhCh--hhhhhccccccCCcHHHh---------ccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 00011111110000 0000011111211 1110 1122445567899999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 683 KHPYVSSDVS 692 (707)
Q Consensus 683 ~Hp~f~~~~~ 692 (707)
+||||..-..
T Consensus 321 ~hp~f~~~~~ 330 (394)
T 4e7w_A 321 CHPFFDELRT 330 (394)
T ss_dssp TSGGGSTTTS
T ss_pred cChhhhhhcc
Confidence 9999986544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.40 Aligned_cols=207 Identities=25% Similarity=0.407 Sum_probs=170.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCC-------
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------- 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------- 444 (707)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357889999999999999999976 799999999875433 34578999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEecCCCCCHHHHHhhcCC-CCcCHH
Q 005224 445 --------------------------------------------------EQMLVYEFMSNGTLRDQLSAKSK-EPLGFA 473 (707)
Q Consensus 445 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~ 473 (707)
..++||||+++++|.+++..... ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999976433 345677
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc-----ccceecccccCCC
Q 005224 474 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV-----PAHVSTVVKGTPG 548 (707)
Q Consensus 474 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~-----~~~~~~~~~gt~~ 548 (707)
.++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........... .........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 88999999999999999999 999999999999999999999999999876543211100 0112234569999
Q ss_pred ccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCC
Q 005224 549 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 583 (707)
Q Consensus 549 y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf 583 (707)
|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999986654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.33 Aligned_cols=264 Identities=27% Similarity=0.480 Sum_probs=202.8
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
+...++|++.+.||+|+||+||+|...+ .||||++.... ....+.+.+|++++++++|+||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 3446789999999999999999998643 59999987543 33346789999999999999999999965 4567899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999999654 345999999999999999999999999 99999999999999999999999999976542
Q ss_pred CCCCCccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
.. .........||+.|+|||++. +..++.++|||||||++|||++|+.||............... . .
T Consensus 173 ~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~----~ 242 (289)
T 3og7_A 173 WS-----GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR-G----S 242 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH-T----S
T ss_pred cc-----ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc-c----c
Confidence 11 112233456899999999997 567888999999999999999999999765543322222111 1 1
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
...........++..+.+++..|++.+|.+||++.++++.|+++..
T Consensus 243 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1122223445667889999999999999999999999999998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=369.30 Aligned_cols=277 Identities=21% Similarity=0.294 Sum_probs=199.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC----C--eEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE----G--EQM 447 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----~--~~~ 447 (707)
.+|+..+.||+|+||+||+|.+. +|+.||||++..... ...+|+++++.++||||++++++|... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999975 699999999865322 234699999999999999999998542 1 367
Q ss_pred EEEecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeeecccc
Q 005224 448 LVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSR 524 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~ 524 (707)
+||||+++ +|.+.+.. .....+++..++.++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 77776653 34557999999999999999999999998 9999999999999965 678999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +......
T Consensus 206 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-l~~i~~~---- 272 (420)
T 1j1b_A 206 QLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKV---- 272 (420)
T ss_dssp ECCTTC--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHH----
T ss_pred hcccCC--------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH----
Confidence 754321 12345689999999999774 799999999999999999999999976543221 1111110
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcc-cCCCC-CCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQ-DETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 681 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~-~~p~~-RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 681 (707)
.+....+....+ -..... ..|.. +.....+ ..+...+.+.+||.+||+.||++|+|++|+
T Consensus 273 ------lg~p~~~~~~~~---~~~~~~~~~p~~~~~~~~~~---------~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~ 334 (420)
T 1j1b_A 273 ------LGTPTREQIREM---NPNYTEFKFPQIKAHPWTKV---------FRPRTPPEAIALCSRLLEYTPTARLTPLEA 334 (420)
T ss_dssp ------HCSCCHHHHHHH---CSCCCCCCCCCCCCCCHHHH---------SCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ------hCCCCHHHHHhh---ChhhhhhccCccCCCCHHHh---------cCCCCCHHHHHHHHHhccCChhHCCCHHHH
Confidence 000011111000 000000 00000 0000000 012233456789999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 682 LKHPYVSSD 690 (707)
Q Consensus 682 L~Hp~f~~~ 690 (707)
|+||||..-
T Consensus 335 l~hp~f~~~ 343 (420)
T 1j1b_A 335 CAHSFFDEL 343 (420)
T ss_dssp HTSGGGGGG
T ss_pred hCCHhhccc
Confidence 999999653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=353.42 Aligned_cols=293 Identities=24% Similarity=0.319 Sum_probs=212.3
Q ss_pred HHhcCCCccceEeeeCceEEEEEEe--CCCcEEEEEEeccCChh--hHHHHHHHHHHHHcc---CCCcceeEEEEEE---
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGIL--PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCD--- 441 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~nIv~l~~~~~--- 441 (707)
...++|++.+.||+|+||+||+|.. .+|+.||||++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999997 46899999998643221 123566777777766 8999999999987
Q ss_pred --eCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 005224 442 --EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 519 (707)
Q Consensus 442 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 519 (707)
.....++||||++ |+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999997 69999998776667999999999999999999999999 99999999999999999999999
Q ss_pred ecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhc
Q 005224 520 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599 (707)
Q Consensus 520 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~ 599 (707)
||+++.... ........||..|+|||++.+..++.++|||||||++|||++|+.||........ .......
T Consensus 164 fg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~ 234 (326)
T 1blx_A 164 FGLARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDV 234 (326)
T ss_dssp CCSCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred CcccccccC--------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHH
Confidence 999976532 1123345689999999999999999999999999999999999999976544221 1111100
Q ss_pred ccch-hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCC
Q 005224 600 SMMF-SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS 678 (707)
Q Consensus 600 ~~~~-~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa 678 (707)
.... ...-......+. ..+... .... +....+..+....+|+.+||..||++|||+
T Consensus 235 ~~~~~~~~~~~~~~~~~-----------~~~~~~--~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 291 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPR-----------QAFHSK--SAQP----------IEKFVTDIDELGKDLLLKCLTFNPAKRISA 291 (326)
T ss_dssp HCCCCGGGSCTTCSSCG-----------GGSCCC--CCCC----------GGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred cCCCCcccCccccccch-----------hhhccc--Ccch----------hhhccccCCHHHHHHHHHHcCCCcccCCCH
Confidence 0000 000000000000 000000 0000 011122333444689999999999999999
Q ss_pred CcCCCCCCCCCCCCCCCccccc
Q 005224 679 SSMLKHPYVSSDVSGSNLVSGV 700 (707)
Q Consensus 679 ~e~L~Hp~f~~~~~~~~~~~~~ 700 (707)
+|+|+||||.........+...
T Consensus 292 ~e~l~hp~~~~~~~~~~~~~~~ 313 (326)
T 1blx_A 292 YSALSHPYFQDLERCKENLDSH 313 (326)
T ss_dssp HHHHTSGGGTTCCCCCCC----
T ss_pred HHHhcCccccccchhhhhhccC
Confidence 9999999998766554444433
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.18 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=211.8
Q ss_pred HHHhcCCCccc-eEeeeCceEEEEEEe---CCCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCC
Q 005224 371 ALATNNFNSST-QIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 444 (707)
Q Consensus 371 ~~~~~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 444 (707)
....++|.+.+ .||+|+||+||+|.+ .+++.||||++..... ...+++.+|+++++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34456788887 999999999999964 2478999999976432 2256799999999999999999999999 567
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..++||||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 789999999999999999764 35899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccch
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
........ ........+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 166 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~-------- 231 (291)
T 1xbb_A 166 ALRADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTA-------- 231 (291)
T ss_dssp ECCTTCSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH--------
T ss_pred eeccCCCc----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH--------
Confidence 76433210 111223346788999999999899999999999999999999 999997654321 111
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
.+..+.....+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 232 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 232 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1112223345566778899999999999999999999999999988764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=351.18 Aligned_cols=261 Identities=24% Similarity=0.398 Sum_probs=202.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999976 6899999999876656667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 170 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--- 170 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH---
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc---
Confidence 99999999987643 35899999999999999999999998 999999999999999999999999987532110
Q ss_pred CccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
........||+.|+|||++. +..++.++|||||||++|||++|+.||..........
T Consensus 171 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------- 232 (302)
T 2j7t_A 171 ----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-------------- 232 (302)
T ss_dssp ----HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--------------
T ss_pred ----ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--------------
Confidence 11123346899999999984 6778999999999999999999999996543211100
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
++. ...+...+.. ...+....+++.+||..||++|||++|+++||||
T Consensus 233 ---------------~~~----~~~~~~~~~~--------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 279 (302)
T 2j7t_A 233 ---------------KIA----KSDPPTLLTP--------------SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279 (302)
T ss_dssp ---------------HHH----HSCCCCCSSG--------------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred ---------------HHh----ccCCcccCCc--------------cccCHHHHHHHHHHcccChhhCCCHHHHhcChHH
Confidence 000 0000000000 0011123467888899999999999999999999
Q ss_pred CCCCC
Q 005224 688 SSDVS 692 (707)
Q Consensus 688 ~~~~~ 692 (707)
.+...
T Consensus 280 ~~~~~ 284 (302)
T 2j7t_A 280 SSITS 284 (302)
T ss_dssp TTCCC
T ss_pred hhhcc
Confidence 87654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=376.11 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=200.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|+.+++.++||||++++++|.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456889999999999999999975 78999999987543 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeeecccccCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLAP 527 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~~~~ 527 (707)
||+++|+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999988664 34899999999999999999999999 999999999999976 4559999999998764
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.. .......||+.|+|||++. ..++.++||||+||++|||++|+.||...... +...
T Consensus 191 ~~--------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~------------- 247 (494)
T 3lij_A 191 NQ--------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILR------------- 247 (494)
T ss_dssp TT--------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH-------------
T ss_pred CC--------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH-------------
Confidence 32 1233456999999999986 56899999999999999999999999654321 1100
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
.+........+ | .....++.+.+||.+||+.||++|||++|+|+||||
T Consensus 248 ---------------~i~~~~~~~~~---~--------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 248 ---------------KVEKGKYTFDS---P--------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp ---------------HHHHTCCCCCS---G--------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred ---------------HHHhCCCCCCc---h--------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 00000000000 0 001122334578999999999999999999999999
Q ss_pred CC
Q 005224 688 SS 689 (707)
Q Consensus 688 ~~ 689 (707)
..
T Consensus 296 ~~ 297 (494)
T 3lij_A 296 KE 297 (494)
T ss_dssp HH
T ss_pred cc
Confidence 65
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=374.82 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=205.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-------------hhHHHHHHHHHHHHccCCCcceeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-------------QGEKEFLTEIQFLSRLHHRNLVSLVGY 439 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~~~ 439 (707)
.++|.+.++||+|+||+||+|... +++.||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 468999999999999999999975 689999999875331 224678999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEE
Q 005224 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAK 516 (707)
Q Consensus 440 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~k 516 (707)
+.+.+..++||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999997643 4899999999999999999999999 99999999999998776 699
Q ss_pred EeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005224 517 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 596 (707)
Q Consensus 517 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~ 596 (707)
|+|||+++..... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... +...
T Consensus 190 l~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~-- 257 (504)
T 3q5i_A 190 IVDFGLSSFFSKD--------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DIIK-- 257 (504)
T ss_dssp ECCCTTCEECCTT--------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH--
T ss_pred EEECCCCEEcCCC--------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHH--
Confidence 9999999876432 1223456999999999987 46899999999999999999999999754321 1111
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 676 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 676 (707)
.+.... . +.... .....++.+.+||.+||+.||++||
T Consensus 258 ---------------------------~i~~~~---~--~~~~~-----------~~~~~s~~~~~li~~~L~~dp~~R~ 294 (504)
T 3q5i_A 258 ---------------------------KVEKGK---Y--YFDFN-----------DWKNISDEAKELIKLMLTYDYNKRC 294 (504)
T ss_dssp ---------------------------HHHHCC---C--CCCHH-----------HHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred ---------------------------HHHcCC---C--CCCcc-----------ccCCCCHHHHHHHHHHcCCChhHCC
Confidence 011000 0 00000 0012233455799999999999999
Q ss_pred CCCcCCCCCCCCCCCC
Q 005224 677 SSSSMLKHPYVSSDVS 692 (707)
Q Consensus 677 sa~e~L~Hp~f~~~~~ 692 (707)
|++|+|+||||.....
T Consensus 295 t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 295 TAEEALNSRWIKKYAN 310 (504)
T ss_dssp CHHHHHTSHHHHHTCC
T ss_pred CHHHHhcCHhhhhchh
Confidence 9999999999976543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=370.28 Aligned_cols=260 Identities=23% Similarity=0.398 Sum_probs=195.4
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHHccCCCcceeEEEEEEe
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 442 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 442 (707)
...++|.+.+.||+|+||+||+|... +++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999965 689999999865321 11234789999999999999999999985
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEee
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVAD 519 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~D 519 (707)
.+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 45689999999999999988543 45999999999999999999999998 9999999999999754 4599999
Q ss_pred ecccccCCCCCCCCccccceecccccCCCccchhhhcc---CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005224 520 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 596 (707)
Q Consensus 520 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~ 596 (707)
||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 286 FG~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~-- 355 (419)
T 3i6u_A 286 FGHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD-- 355 (419)
T ss_dssp SSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH--
T ss_pred cccceecCCC--------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH--
Confidence 9999876432 22334679999999999864 6788899999999999999999999964332100000
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 676 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 676 (707)
.+......+..+ ........+.+|+.+||..||++||
T Consensus 356 --------~i~~~~~~~~~~-----------------------------------~~~~~~~~~~~li~~~L~~dP~~Rp 392 (419)
T 3i6u_A 356 --------QITSGKYNFIPE-----------------------------------VWAEVSEKALDLVKKLLVVDPKARF 392 (419)
T ss_dssp --------HHHTTCCCCCHH-----------------------------------HHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred --------HHhcCCCCCCch-----------------------------------hhcccCHHHHHHHHHHccCChhHCc
Confidence 000000000000 0011233345788999999999999
Q ss_pred CCCcCCCCCCCCCC
Q 005224 677 SSSSMLKHPYVSSD 690 (707)
Q Consensus 677 sa~e~L~Hp~f~~~ 690 (707)
|++|+|+||||...
T Consensus 393 s~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 393 TTEEALRHPWLQDE 406 (419)
T ss_dssp CHHHHHHSGGGCCH
T ss_pred CHHHHhCCcccCCh
Confidence 99999999999753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.39 Aligned_cols=263 Identities=26% Similarity=0.370 Sum_probs=206.1
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHcc--CCCcceeEEEEEEeC----C
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL--HHRNLVSLVGYCDEE----G 444 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~----~ 444 (707)
....++|++.+.||+|+||.||+|... ++.||||++... ....+..|.+++... +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999985 899999998643 234555666666665 899999999999887 7
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEecCCCCCCEEEcCCCcEE
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------ADPPVFHRDIKASNILLDHKFTAK 516 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------~~~~ivH~Dlkp~NILl~~~~~~k 516 (707)
..++||||+++|+|.++++.. .+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+|
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEE
T ss_pred ceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEE
Confidence 899999999999999999654 499999999999999999999988 6 99999999999999999999
Q ss_pred EeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCc------hhhHHHHHHHHHHHcC----------C
Q 005224 517 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK------SDVYSLGVVFLELLTG----------M 580 (707)
Q Consensus 517 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~------sDVwS~Gvll~elltG----------~ 580 (707)
|+|||+++......... ........||+.|+|||++.+...+.+ +|||||||++|||++| .
T Consensus 183 l~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEV---DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp ECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEeCCCceeeccccccc---cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999997654322110 111224578999999999988776665 9999999999999999 6
Q ss_pred CCCCCCch---hHHHHHHHhhcccchhhccCCCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 581 QPISHGKN---IVREVNIAYQSSMMFSVIDGNMGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 581 ~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
.||..... .......... ........+ .+++..+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVC-------IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHT-------TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccHhhhcCCCCchhhhHHHHh-------hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 66643211 1111111111 111112222 37889999999999999999999999999999988764
Q ss_pred C
Q 005224 653 M 653 (707)
Q Consensus 653 ~ 653 (707)
.
T Consensus 333 ~ 333 (337)
T 3mdy_A 333 Q 333 (337)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=376.89 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=208.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457899999999999999999976 78999999986532 23457899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeeecccccC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLA 526 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~ 526 (707)
|||+.+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999999654 45999999999999999999999999 9999999999999 56789999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||...... +....
T Consensus 180 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~----------- 238 (484)
T 3nyv_A 180 EASK--------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKK----------- 238 (484)
T ss_dssp CCCC--------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-----------
T ss_pred cccc--------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHH-----------
Confidence 4321 2334569999999999876 6899999999999999999999999754321 11110
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCC
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 686 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 686 (707)
+........ .|. ....++.+.+||.+||+.||++|||++|+|+|||
T Consensus 239 -----------------i~~~~~~~~---~~~--------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 239 -----------------VEKGKYTFE---LPQ--------------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp -----------------HHHCCCCCC---SGG--------------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred -----------------HHcCCCCCC---Ccc--------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 000000000 000 0111233457899999999999999999999999
Q ss_pred CCCCCC
Q 005224 687 VSSDVS 692 (707)
Q Consensus 687 f~~~~~ 692 (707)
|.....
T Consensus 285 ~~~~~~ 290 (484)
T 3nyv_A 285 IQTYTK 290 (484)
T ss_dssp HHHHTC
T ss_pred hccccc
Confidence 976443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=362.66 Aligned_cols=281 Identities=20% Similarity=0.335 Sum_probs=207.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE----
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ---- 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---- 446 (707)
.++|...+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468889999999999999999965 79999999997643 23356788999999999999999999999877654
Q ss_pred --EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 447 --MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 447 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
++||||+. ++|.+++. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999996 68888873 23899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhc-ccc
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS-SMM 602 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~-~~~ 602 (707)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....... ...
T Consensus 193 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~ 261 (371)
T 4exu_A 193 HADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVP 261 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred cccc----------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCC
Confidence 6432 1234568999999999987 7899999999999999999999999976543221 1111110 000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
..... ..........+ ... .....+....+ ..+..++.+.+||.+||+.||++|||++|+|
T Consensus 262 ~~~~~---~~~~~~~~~~~---~~~---~~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 322 (371)
T 4exu_A 262 GTEFV---QKLNDKAAKSY---IQS---LPQTPRKDFTQ----------LFPRASPQAADLLEKMLELDVDKRLTAAQAL 322 (371)
T ss_dssp CHHHH---TTCSCHHHHHH---HHH---SCCCCCCCHHH----------HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred cHHHH---HHhhhhhhhhh---hhc---cCCCcchhHHH----------hccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence 00000 00011111111 111 11111222211 2234455667899999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 683 KHPYVSSDVS 692 (707)
Q Consensus 683 ~Hp~f~~~~~ 692 (707)
+||||+.-..
T Consensus 323 ~hp~f~~~~~ 332 (371)
T 4exu_A 323 THPFFEPFRD 332 (371)
T ss_dssp TSGGGTTTCC
T ss_pred cCcccccCCC
Confidence 9999986433
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=341.82 Aligned_cols=264 Identities=26% Similarity=0.381 Sum_probs=212.0
Q ss_pred CCCccceEeeeCceEEEEEEeC-C---CcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE-EEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ-MLV 449 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lV 449 (707)
.|...++||+|+||+||+|.+. + +..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556789999999999999853 2 33799999876433 3456789999999999999999999999766655 999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999763 346899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
... .........+++.|+|||.+.+..++.++|||||||++|||++|..|+....+....... +....
T Consensus 178 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~---------~~~~~ 245 (298)
T 3pls_A 178 EYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---------LAQGR 245 (298)
T ss_dssp GGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH---------HHTTC
T ss_pred ccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH---------hhcCC
Confidence 110 112233456788999999999999999999999999999999966665443332221111 11122
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
....+..++..+.+++..|++.+|.+||++.++++.|+++...+..
T Consensus 246 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 2334555667899999999999999999999999999998876644
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=341.08 Aligned_cols=200 Identities=30% Similarity=0.461 Sum_probs=173.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||+||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467899999999999999999975 678999999865322 2246788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999997643 4899999999999999999999998 999999999999999999999999998654321
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
......|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 163 ---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp --------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 2234568999999999999999999999999999999999999997543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=344.68 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=206.2
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---------hhhHHHHHHHHHHHHccC-CCcceeEEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---------LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE 442 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~ 442 (707)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999975 78999999987543 112356789999999995 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999764 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhc------cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 596 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~ 596 (707)
+....... ......|++.|+|||++. ...++.++|||||||++|||++|+.||........ ..
T Consensus 171 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~-- 239 (298)
T 1phk_A 171 SCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LR-- 239 (298)
T ss_dssp CEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH--
T ss_pred hhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-HH--
Confidence 98754321 223456899999999985 45688999999999999999999999965432110 00
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 676 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 676 (707)
.+........+ |.. ...+....+++.+||..||++||
T Consensus 240 --------------------------~~~~~~~~~~~---~~~--------------~~~~~~l~~li~~~l~~dp~~Rp 276 (298)
T 1phk_A 240 --------------------------MIMSGNYQFGS---PEW--------------DDYSDTVKDLVSRFLVVQPQKRY 276 (298)
T ss_dssp --------------------------HHHHTCCCCCT---TTG--------------GGSCHHHHHHHHHHCCSSGGGSC
T ss_pred --------------------------HHhcCCcccCc---ccc--------------cccCHHHHHHHHHHccCCcccCC
Confidence 00110000000 000 01122234688889999999999
Q ss_pred CCCcCCCCCCCCCCCC
Q 005224 677 SSSSMLKHPYVSSDVS 692 (707)
Q Consensus 677 sa~e~L~Hp~f~~~~~ 692 (707)
|++|+|+||||.....
T Consensus 277 s~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 277 TAEEALAHPFFQQYVV 292 (298)
T ss_dssp CHHHHTTSGGGCTTC-
T ss_pred CHHHHHhChHhhhccc
Confidence 9999999999986654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=354.45 Aligned_cols=295 Identities=21% Similarity=0.301 Sum_probs=210.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC-----CeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 446 (707)
.++|++.+.||+|+||+||+|... +|+.||||++.... ......+.+|+++++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999975 78999999997533 33356788999999999999999999998654 678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+. ++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6999998653 5899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccc---cceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 527 PVPDIEGIVP---AHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 527 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
.......... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCC
Confidence 5322111000 011233568999999998765 7789999999999999999999999976543221 1111000000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
.. .+.......... ..+.... +...+ +.... ...+..++...+||.+||..||++|||++|+|
T Consensus 242 ~~-~~~~~~~~~~~~---~~~~~~~-~~~~~--~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (353)
T 2b9h_A 242 PH-SDNDLRCIESPR---AREYIKS-LPMYP--AAPLE----------KMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304 (353)
T ss_dssp CC-STTTTTTCCCHH---HHHHHHT-SCCCC--CCCHH----------HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred Cc-hhccccccccch---hhHHhhc-ccCCC--Ccchh----------hhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 00 000000000010 0111100 00000 11111 11234445566899999999999999999999
Q ss_pred CCCCCCCCCCC
Q 005224 683 KHPYVSSDVSG 693 (707)
Q Consensus 683 ~Hp~f~~~~~~ 693 (707)
+||||......
T Consensus 305 ~hp~~~~~~~~ 315 (353)
T 2b9h_A 305 EHPYLQTYHDP 315 (353)
T ss_dssp TSGGGTTTCCT
T ss_pred cCccccccCCc
Confidence 99999876543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=342.58 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=208.2
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEe---------
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------- 442 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------- 442 (707)
...+|+..+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457899999999999999999976 79999999997643 356789999999999999999998854
Q ss_pred -------CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 005224 443 -------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 515 (707)
Q Consensus 443 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 515 (707)
....++||||+++++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 345799999999999999998765567999999999999999999999998 9999999999999999999
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 595 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~ 595 (707)
||+|||++....... ......|++.|+|||++.+..++.++|||||||++|||++|..|+....... ..
T Consensus 162 kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~ 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF---TD 230 (284)
T ss_dssp EECCCTTCEESSCCS--------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHH---HH
T ss_pred EECcchhheeccccc--------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHH---HH
Confidence 999999998764321 1233468999999999999999999999999999999999988874221111 10
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
+..+ ..+..++..+.+++.+|++.+|.+||++.++++.+..+...
T Consensus 231 ---------~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 231 ---------LRDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ---------HHTT---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ---------hhcc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1111 12233456788999999999999999999999999887654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=373.25 Aligned_cols=197 Identities=17% Similarity=0.188 Sum_probs=164.7
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHH---HHHccCCCcceeEE-------EE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG---SLQGEKEFLTEIQ---FLSRLHHRNLVSLV-------GY 439 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~---~l~~l~H~nIv~l~-------~~ 439 (707)
.++|.+.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|++ .+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999996 47999999998742 3334578899994 55556899999998 77
Q ss_pred EEeCCe-----------------EEEEEecCCCCCHHHHHhhcCC-----CCcCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005224 440 CDEEGE-----------------QMLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPV 497 (707)
Q Consensus 440 ~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 497 (707)
+...+. .++||||+ +|+|.+++..... ..+++..++.++.||++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 765542 78999999 6899999976321 23456888999999999999999999 9
Q ss_pred EecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccC-----------CCCCchhh
Q 005224 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----------KLTDKSDV 566 (707)
Q Consensus 498 vH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDV 566 (707)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----------CcccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999999999999999999998532 12334567 999999999987 89999999
Q ss_pred HHHHHHHHHHHcCCCCCCC
Q 005224 567 YSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 567 wS~Gvll~elltG~~pf~~ 585 (707)
|||||++|||++|+.||..
T Consensus 297 wSlG~il~elltg~~Pf~~ 315 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITK 315 (377)
T ss_dssp HHHHHHHHHHHHSSCCC--
T ss_pred HHHHHHHHHHHHCCCCCcc
Confidence 9999999999999999954
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.26 Aligned_cols=268 Identities=20% Similarity=0.282 Sum_probs=211.7
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEE-EeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++.++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999996 5899999999875432 24688999999999988877666655 66778899999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeeecccccCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~~ 528 (707)
|+ +++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 89999999753 346999999999999999999999999 9999999999999 5889999999999987654
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch-----hHHHHHHHhhcccch
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-----IVREVNIAYQSSMMF 603 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~-----~~~~~~~~~~~~~~~ 603 (707)
.......+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 236 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---- 236 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH----
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC----
Confidence 332211111223456799999999999999999999999999999999999999975321 11111110000
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 656 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~ 656 (707)
......+..++..+.+++.+||+.+|.+||++.++++.|+.+.......
T Consensus 237 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 237 ----TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp ----SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ----CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 0000011334577999999999999999999999999999988765443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=357.19 Aligned_cols=269 Identities=17% Similarity=0.168 Sum_probs=202.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCChhh-----------HHHHHHHHHHHHccCCCcceeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQG-----------EKEFLTEIQFLSRLHHRNLVSLVG 438 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~~ 438 (707)
.++|.+.+.||+|+||+||+|... ++..||||+........ ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357889999999999999999975 57889999987643211 124667889999999999999999
Q ss_pred EEEe----CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-
Q 005224 439 YCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF- 513 (707)
Q Consensus 439 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~- 513 (707)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 9987 67899999999 999999997644 6999999999999999999999998 99999999999999887
Q ss_pred -cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhH--
Q 005224 514 -TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-- 590 (707)
Q Consensus 514 -~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~-- 590 (707)
.+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 99999999998764322111111122245679999999999999999999999999999999999999995422111
Q ss_pred -HHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 591 -REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 591 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
........... ........ ....++..+.+++..||+.+|.+||++.++++.|+....
T Consensus 270 ~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAKTNLLDEL-PQSVLKWA--PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHTT-THHHHHHS--CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHhhcccc-cHHHHhhc--cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111100 00000000 011345689999999999999999999999999986543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=355.96 Aligned_cols=291 Identities=19% Similarity=0.277 Sum_probs=210.2
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CC-cEEEEEEeccCChhhHHHHHHHHHHHHccCCCc------ceeEEEEEEeCCe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DG-TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN------LVSLVGYCDEEGE 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~ 445 (707)
.++|++.+.||+|+||+||+|... ++ +.||||++... ....+.+.+|+++++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999974 44 78999999753 334567889999999997665 9999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----------------
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---------------- 509 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---------------- 509 (707)
.++||||+ ++++.+++.......+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 678888887766667999999999999999999999998 9999999999999
Q ss_pred ---cCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 510 ---DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 510 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 67889999999999864321 23456899999999999999999999999999999999999999765
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh----cCC---CCCCC
Q 005224 587 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN----MMP---ESDTK 659 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~----~~~---~~~~~ 659 (707)
.......... .. ....|.......... .... ......+......+.+..... ... .....
T Consensus 243 ~~~~~~~~~~-------~~----~~~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 243 ENREHLVMME-------KI----LGPIPSHMIHRTRKQ-KYFY-KGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp SHHHHHHHHH-------HH----HCCCCHHHHHHCSCG-GGEE-TTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred CHHHHHHHHH-------HH----cCCCcHHHhhhccch-hhhc-ccccccccccchhccccccCCcccccccccchhHHH
Confidence 4422111100 00 011222211110000 0000 000000000000011111000 000 00123
Q ss_pred CCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 660 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 660 ~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
+.+||.+||..||++|||++|+|+||||.+...
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence 457999999999999999999999999987543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=349.20 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=204.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCc----EEEEEEeccC-ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
.++|++.+.||+|+||+||+|.+. +++ .||+|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999964 444 3577877543 3344678999999999999999999999998754 78
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997643 45999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......- . ..+.
T Consensus 169 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~---------~~~~ 233 (327)
T 3lzb_A 169 AEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-S---------SILE 233 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-H---------HHHH
T ss_pred Cccc-----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-H---------HHHH
Confidence 3221 112233456788999999999999999999999999999999 9999975433111 0 1111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.......+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 234 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222333455677789999999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.24 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=203.2
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688999999999999999996 479999999987532 334567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 451 EFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 451 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||+++++|.+++.. .....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999965 23456899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||............... ..
T Consensus 189 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~ 253 (310)
T 2wqm_A 189 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE--------QC 253 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH--------TT
T ss_pred CC-------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh--------cc
Confidence 21 1123456899999999999999999999999999999999999999654322111111111 11
Q ss_pred CCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 609 NMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 609 ~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
.... ....++..+.+++..||+.+|.+||++.++++.|+++....
T Consensus 254 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 1111 12445678999999999999999999999999999887643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.59 Aligned_cols=287 Identities=23% Similarity=0.357 Sum_probs=206.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEE-----------
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----------- 441 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~----------- 441 (707)
.++|++.+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 368899999999999999999976 58999999998766666778999999999999999999999873
Q ss_pred ---eCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEE
Q 005224 442 ---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKV 517 (707)
Q Consensus 442 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl 517 (707)
.....++||||++ |+|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999997 699999954 35899999999999999999999999 99999999999997 5679999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 596 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~ 596 (707)
+|||+++........ ........++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 163 ~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~ 237 (320)
T 2i6l_A 163 GDFGLARIMDPHYSH----KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLI 237 (320)
T ss_dssp CCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH
T ss_pred ccCccccccCCCccc----ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 999999875432110 112234457899999999876 7789999999999999999999999976544221 1111
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhccc-CCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCC
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQD-ETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 675 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~-~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R 675 (707)
... ......+...++...+...+.. ....+.... ...+..+....+|+.+||..||++|
T Consensus 238 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 238 LES----------IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT----------QLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp HHH----------SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHH----------HHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HHh----------cCCCchhhhhhhhhcCcccccccccCCCCChh----------HhcchhhHHHHHHHHHHcCCCcccc
Confidence 110 0111122222211110000000 000011111 1123344556789999999999999
Q ss_pred CCCCcCCCCCCCCCCCC
Q 005224 676 PSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 676 ~sa~e~L~Hp~f~~~~~ 692 (707)
||++|+|+||||+....
T Consensus 298 pt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 298 LTAEEALSHPYMSIYSF 314 (320)
T ss_dssp CCHHHHHTSHHHHTTCC
T ss_pred CCHHHHhCCcccccccC
Confidence 99999999999986544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=350.01 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=200.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCC--CcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|+++++.++| +||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45789999999999999999998889999999987543 2334678999999999976 9999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
||| .+++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp ECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 995 588999999764 35899999999999999999999999 99999999999997 578999999999876432
Q ss_pred CCCCccccceecccccCCCccchhhhcc-----------CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhh
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~ 598 (707)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+..........
T Consensus 161 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 161 TT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cc-----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 21 112334579999999999975 67889999999999999999999999765443332222111
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005224 599 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 645 (707)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~ 645 (707)
. .....++......+.+++..||+.+|.+||++.++++.
T Consensus 236 ~--------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 236 P--------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp T--------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1 11223444445678899999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=347.72 Aligned_cols=258 Identities=29% Similarity=0.479 Sum_probs=210.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcE--EEEEEeccCC-hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTV--VAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 449 (707)
++|+..+.||+|+||.||+|... ++.. ||||++.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67889999999999999999964 5664 4999887532 23345789999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 005224 450 YEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 515 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 515 (707)
|||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 246899999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHH
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 594 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~ 594 (707)
||+|||+++.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||...... +...
T Consensus 182 kL~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYE 252 (327)
T ss_dssp EECCTTCEESSCE--------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH
T ss_pred EEcccCcCccccc--------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-HHHH
Confidence 9999999974321 111233456889999999999999999999999999999998 99999754431 1111
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcC
Q 005224 595 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 653 (707)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~ 653 (707)
.+..+.....+..++..+.+++.+|++.+|.+||++.++++.|+.+....
T Consensus 253 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 253 ---------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp ---------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---------HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11122223345566788999999999999999999999999999887654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=348.32 Aligned_cols=269 Identities=26% Similarity=0.430 Sum_probs=214.9
Q ss_pred hcCCCccceEeeeCceEEEEEEe-----CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC--eE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~ 446 (707)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688899999999999999984 368999999998766666678999999999999999999999986544 78
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999997643 45899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhc-------
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS------- 599 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~------- 599 (707)
...... ........++..|+|||++.+..++.++|||||||++|||++|..|+........ ......
T Consensus 196 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~--~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 196 PQDKEY----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM--RMIGNDKQGQMIV 269 (326)
T ss_dssp CSSCSE----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH--HHHCTTCCTHHHH
T ss_pred cccccc----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH--HhhccccchhhhH
Confidence 532210 1112234567789999999999999999999999999999999998853211100 000000
Q ss_pred -ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 600 -SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 600 -~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
.....+........+..++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00011112223345566778899999999999999999999999999988754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=341.60 Aligned_cols=268 Identities=19% Similarity=0.280 Sum_probs=208.0
Q ss_pred HhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEE-EeCCeEEEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVY 450 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~ 450 (707)
..++|++.+.||+|+||+||+|.. .+++.||||++..... .+.+.+|+++++.++|++++..+.++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 357899999999999999999996 5789999998765332 23578899999999988877766665 6777889999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeeecccccCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 527 (707)
||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 99999999754 335999999999999999999999999 9999999999999 789999999999998765
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch-----hHHHHHHHhhcccc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-----IVREVNIAYQSSMM 602 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~-----~~~~~~~~~~~~~~ 602 (707)
........+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-
Confidence 4332221112233456789999999999999999999999999999999999999965322 1111111000000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
.......++..+.+++..||+.+|++||++.++++.|+++......
T Consensus 239 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 239 -------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred -------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 0001123357899999999999999999999999999998876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=354.47 Aligned_cols=297 Identities=22% Similarity=0.265 Sum_probs=200.6
Q ss_pred HHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe-
Q 005224 368 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE- 445 (707)
Q Consensus 368 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~- 445 (707)
.+.....++|++.+.||+|+||+||+|... +|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999975 78999999886533 223456778888999999999999999965433
Q ss_pred ------EEEEEecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCEEEcC-CCc
Q 005224 446 ------QMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLH--TEADPPVFHRDIKASNILLDH-KFT 514 (707)
Q Consensus 446 ------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dlkp~NILl~~-~~~ 514 (707)
.++||||+++ +|.+.+.. .....+++..++.++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999975 66655543 34456899999999999999999999 888 999999999999996 899
Q ss_pred EEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005224 515 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 593 (707)
Q Consensus 515 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~ 593 (707)
+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .
T Consensus 171 ~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~ 241 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-L 241 (360)
T ss_dssp EEECCCTTCBCCCTTS--------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H
T ss_pred EEEeeCCCceecCCCC--------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-H
Confidence 9999999998764322 22345689999999999765 489999999999999999999999976543221 1
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCC
Q 005224 594 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 673 (707)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~ 673 (707)
...... ....+.+....+..- ..........+.....+. ........+.+.+||.+||+.||+
T Consensus 242 ~~~~~~----------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~ 304 (360)
T 3e3p_A 242 HEIVRV----------LGCPSREVLRKLNPS-HTDVDLYNSKGIPWSNVF------SDHSLKDAKEAYDLLSALLQYLPE 304 (360)
T ss_dssp HHHHHH----------HCCCCHHHHHHHCTT-CCCGGGGCCCCCCHHHHT------TTCCCTTHHHHHHHHHHHTCSSGG
T ss_pred HHHHHH----------cCCCCHHHHHhcccc-hhhccccccccCCccccc------chhhccccHHHHHHHHHHhccCcc
Confidence 111100 000111111110000 000000000111111110 001111223456899999999999
Q ss_pred CCCCCCcCCCCCCCCCCCCCCC
Q 005224 674 TPPSSSSMLKHPYVSSDVSGSN 695 (707)
Q Consensus 674 ~R~sa~e~L~Hp~f~~~~~~~~ 695 (707)
+|||++|+|+||||........
T Consensus 305 ~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 305 ERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp GSCCHHHHTTSGGGGGGGCTTC
T ss_pred ccCCHHHHhcCccccccCCccc
Confidence 9999999999999987655433
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=374.87 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=205.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999975 78999999986422 223567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeeecccccCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAP 527 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~~~ 527 (707)
||+++|+|.+.+.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999986643 5899999999999999999999999 99999999999995 56689999999998654
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.. .......||+.|+|||++.+ .++.++||||+||++|||++|+.||...... +....
T Consensus 176 ~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~------------ 233 (486)
T 3mwu_A 176 QN--------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKR------------ 233 (486)
T ss_dssp CC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH------------
T ss_pred CC--------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH------------
Confidence 32 12234568999999999876 5899999999999999999999999654321 11110
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
+...-.. ...|. ....++.+.+||.+||+.||++|||++|+|+||||
T Consensus 234 ----------------i~~~~~~---~~~~~--------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 234 ----------------VETGKYA---FDLPQ--------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp ----------------HHHTCCC---SCSGG--------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred ----------------HHhCCCC---CCCcc--------------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 0000000 00010 01112334578999999999999999999999999
Q ss_pred CCCCC
Q 005224 688 SSDVS 692 (707)
Q Consensus 688 ~~~~~ 692 (707)
.....
T Consensus 281 ~~~~~ 285 (486)
T 3mwu_A 281 QKYSS 285 (486)
T ss_dssp HHTCC
T ss_pred ccCcc
Confidence 76544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=361.26 Aligned_cols=291 Identities=17% Similarity=0.271 Sum_probs=208.0
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccC-----------CCcceeEEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----------HRNLVSLVGYCD 441 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~ 441 (707)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999996 47899999999753 334567889999999886 899999999997
Q ss_pred eCC----eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEc------
Q 005224 442 EEG----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLD------ 510 (707)
Q Consensus 442 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~------ 510 (707)
..+ ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 654 789999999 88999999876666799999999999999999999998 8 99999999999994
Q ss_pred CCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchh-
Q 005224 511 HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI- 589 (707)
Q Consensus 511 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~- 589 (707)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CcceEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4458999999999865321 22346899999999999999999999999999999999999999743321
Q ss_pred ----HHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccC-------CCCCCCHHHHHHHHHHhhhcCCCCCC
Q 005224 590 ----VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDE-------TDARPSMSEVMRELESIWNMMPESDT 658 (707)
Q Consensus 590 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~-------p~~RPt~~~v~~~L~~~~~~~~~~~~ 658 (707)
.+...... .. .+..|......- +.....+... ........+++. ...........
T Consensus 243 ~~~~~~~~~~~~------~~----~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 308 (373)
T 1q8y_A 243 YTKDDDHIAQII------EL----LGELPSYLLRNG-KYTRTFFNSRGLLRNISKLKFWPLEDVLT---EKYKFSKDEAK 308 (373)
T ss_dssp --CHHHHHHHHH------HH----HCSCCHHHHHHC-TTHHHHBCC--CBSSCCCCCBCCHHHHHH---HTTCCCHHHHH
T ss_pred cCChHHHHHHHH------Hh----cCCCCHHHHhcc-chhhhhcCCcchhcccccccccchhhhhh---hcccCCcchHH
Confidence 11111000 00 011121111000 0000001000 000111222211 11000111122
Q ss_pred CCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCCC
Q 005224 659 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 693 (707)
Q Consensus 659 ~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~~ 693 (707)
.+.+||.+||+.||++|||++|+|+||||......
T Consensus 309 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 309 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred HHHHHHHHHhccCccccCCHHHHhhChhhhcccCc
Confidence 34579999999999999999999999999876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=351.70 Aligned_cols=276 Identities=24% Similarity=0.338 Sum_probs=189.5
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
....++|++.+.||+|+||+||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 445678999999999999999999954 78999999986543 2334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhh------cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 449 VYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
||||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999964 12446899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 601 (707)
+......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 168 ~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------ 239 (303)
T 2vwi_A 168 SAFLATGGDI--TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT------ 239 (303)
T ss_dssp HHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH------
T ss_pred hheeccCCCc--cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH------
Confidence 9765432110 01112234568999999999976 57899999999999999999999999754332111000
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC
Q 005224 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 681 (707)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 681 (707)
.+..+...+... . .............+++.+||..||++|||++|+
T Consensus 240 ---------------------------~~~~~~~~~~~~---~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 285 (303)
T 2vwi_A 240 ---------------------------LQNDPPSLETGV---Q----DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285 (303)
T ss_dssp ---------------------------HTSSCCCTTC------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ---------------------------hccCCCcccccc---c----cchhhhhhhHHHHHHHHHHccCChhhCcCHHHH
Confidence 000000000000 0 000111122234468889999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 682 LKHPYVSSDV 691 (707)
Q Consensus 682 L~Hp~f~~~~ 691 (707)
++||||....
T Consensus 286 l~h~~~~~~~ 295 (303)
T 2vwi_A 286 LRHKFFQKAK 295 (303)
T ss_dssp HTSTTC----
T ss_pred hhChhhhcCC
Confidence 9999997644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=377.48 Aligned_cols=252 Identities=27% Similarity=0.393 Sum_probs=205.4
Q ss_pred ceEeeeCceEEEEEEeC---CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
+.||+|+||+||+|.+. +++.||||+++.... ...+++.+|+++|++++||||+++++++.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 468899999976432 335789999999999999999999999964 568899999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~--- 525 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 525 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc---
Confidence 9999999654 35899999999999999999999999 999999999999999999999999999876533211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (707)
........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... .. ..+..+.....+
T Consensus 526 -~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~---------~~i~~~~~~~~p 594 (635)
T 4fl3_A 526 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VT---------AMLEKGERMGCP 594 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HH---------HHHHTTCCCCCC
T ss_pred -cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HH---------HHHHcCCCCCCC
Confidence 112233456788999999999999999999999999999998 999997654321 11 112223344466
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 615 ~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
..++..+.+++..||+.+|++||++.++++.|+.+...
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 77888999999999999999999999999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.40 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=203.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 7899999998754322 246789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999997643 5899999999999999999999999 999999999999999999999999999765432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
. ........|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......... ..
T Consensus 188 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~------~~ 253 (309)
T 2h34_A 188 K------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAI------PR 253 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCC------CC
T ss_pred c------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCC------CC
Confidence 2 11223456899999999999999999999999999999999999999764432 1111111100 01
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhh
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWN 651 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RP-t~~~v~~~L~~~~~ 651 (707)
....+..++..+.+++.+||+.+|++|| ++.++++.|+....
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 1123345567789999999999999999 99999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=349.61 Aligned_cols=198 Identities=31% Similarity=0.509 Sum_probs=173.0
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|+..+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999996 5799999999875432 22357889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+. |+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9996 6888888654 346899999999999999999999998 99999999999999999999999999976532
Q ss_pred CCCccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 207 ---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 258 (348)
T 1u5q_A 207 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258 (348)
T ss_dssp ---------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ---------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 12346899999999985 56789999999999999999999999975443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.64 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=199.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||+||+|... +++.||||++.... .....++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999976 79999999987532 33456788999999999 999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC----------------
Q 005224 450 YEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---------------- 511 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---------------- 511 (707)
|||+++++|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997642 256899999999999999999999999 999999999999984
Q ss_pred ---CCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 512 ---KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 512 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
...+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|||++|..++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred cCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 4489999999998764321 23489999999999875 66689999999999999999987764332
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCC
Q 005224 588 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSE 667 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~ 667 (707)
.. .. +..+.....+. ..++...+++.+|
T Consensus 236 ~~-~~------------~~~~~~~~~~~---------------------------------------~~~~~~~~li~~~ 263 (289)
T 1x8b_A 236 QW-HE------------IRQGRLPRIPQ---------------------------------------VLSQEFTELLKVM 263 (289)
T ss_dssp HH-HH------------HHTTCCCCCSS---------------------------------------CCCHHHHHHHHHH
T ss_pred HH-HH------------HHcCCCCCCCc---------------------------------------ccCHHHHHHHHHH
Confidence 11 00 01111111111 1122234677788
Q ss_pred CCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 668 HTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 668 L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
|..||++|||++|+|+||||.+..
T Consensus 264 l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 264 IHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp TCSSGGGSCCHHHHHTCTTC----
T ss_pred hCCCcccCCCHHHHhhChHhhhhc
Confidence 889999999999999999998653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=356.44 Aligned_cols=267 Identities=22% Similarity=0.276 Sum_probs=213.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCC--eEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV 449 (707)
.++|.+.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357889999999999999999976 589999999975432 33567889999999999999999999998765 78999
Q ss_pred EecCCCCCHHHHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEeeecccc
Q 005224 450 YEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSR 524 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla~ 524 (707)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997643 234999999999999999999999999 9999999999999 788889999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhcc--------CCCCCchhhHHHHHHHHHHHcCCCCCCCCch---hHHHH
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--------HKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREV 593 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDVwS~Gvll~elltG~~pf~~~~~---~~~~~ 593 (707)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+..
T Consensus 165 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 165 ELEDD--------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp ECCCG--------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred EccCC--------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 76432 12234568999999999875 5677899999999999999999999964221 11222
Q ss_pred HHHhhccc---chhh------------ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 594 NIAYQSSM---MFSV------------IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 594 ~~~~~~~~---~~~~------------~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
........ ...+ ..+.....+......+.+++.+|++.||++||++.++++.++.+..
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 21111110 0000 0011123457888999999999999999999999999999988765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=347.62 Aligned_cols=261 Identities=27% Similarity=0.449 Sum_probs=210.2
Q ss_pred HhcCCCccceEeeeCceEEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... .....++.+|+.++++++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 356899999999999999999984 257789999997543 3445678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCC-----CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEE
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKV 517 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl 517 (707)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999986532 45899999999999999999999998 999999999999984 456999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 596 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~ 596 (707)
+|||+++....... ........|++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 185 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~- 257 (327)
T 2yfx_A 185 GDFGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLEF- 257 (327)
T ss_dssp CCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHH-
T ss_pred Cccccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-HHHHH-
Confidence 99999975432211 112234457889999999999999999999999999999998 99999754432 11111
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 597 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
+..+.....+..++..+.+++..||+.+|.+||++.++++.++.+..
T Consensus 258 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 258 --------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11222333455667789999999999999999999999999987765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.92 Aligned_cols=272 Identities=23% Similarity=0.314 Sum_probs=210.8
Q ss_pred HHhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEe----CCeE
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQ 446 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~ 446 (707)
...++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+++++.++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3456899999999999999999997 5799999999877666667789999999999999999999999863 3478
Q ss_pred EEEEecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 447 MLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
++||||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 9999999999999999762 3456999999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCCCc--cccceecccccCCCccchhhhccCC---CCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhc
Q 005224 525 LAPVPDIEGI--VPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599 (707)
Q Consensus 525 ~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~ 599 (707)
.......... ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||............
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---- 258 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---- 258 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----
Confidence 6432110000 0000112345799999999997654 788999999999999999999999421100000000
Q ss_pred ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
..........+..++..+.+++.+||+.+|.+||++.++++.|+.+....+
T Consensus 259 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 259 ----AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp ----HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred ----HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 001111112234556789999999999999999999999999998765443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.42 Aligned_cols=268 Identities=24% Similarity=0.395 Sum_probs=201.1
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHH--HHccCCCcceeEEEEEEe-----CCe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF--LSRLHHRNLVSLVGYCDE-----EGE 445 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~-----~~~ 445 (707)
..++|++.+.||+|+||+||+|+. +++.||||++.... ...+..|.++ +..++|+||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 346889999999999999999987 68999999986532 3344445444 445899999999986642 235
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCCEEEcCCCcEE
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE---------ADPPVFHRDIKASNILLDHKFTAK 516 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~ivH~Dlkp~NILl~~~~~~k 516 (707)
.++||||+++|+|.+++.... .++..++.++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 789999999999999996543 58899999999999999999998 7 99999999999999999999
Q ss_pred EeeecccccCCCCCCCCc-cccceecccccCCCccchhhhcc-------CCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 517 VADFGLSRLAPVPDIEGI-VPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 517 l~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
|+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987653221110 01122334569999999999987 4566789999999999999999887754322
Q ss_pred h----------------HHHHHHHhhcccchhhccCCCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 589 I----------------VREVNIAYQSSMMFSVIDGNMG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 589 ~----------------~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
. ............ ...... .....++..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 1 000010000000 001111 12335778899999999999999999999999999998
Q ss_pred hhcCC
Q 005224 650 WNMMP 654 (707)
Q Consensus 650 ~~~~~ 654 (707)
...+.
T Consensus 317 l~~~~ 321 (336)
T 3g2f_A 317 MMIWE 321 (336)
T ss_dssp HHCCC
T ss_pred HHHHH
Confidence 76554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.18 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=200.2
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccC--CCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.+|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|++++++++ |+||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4688999999999999999998889999999986543 334567899999999996 599999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
| +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 55889999997653 5889999999999999999999998 99999999999995 5899999999998764321
Q ss_pred CCCccccceecccccCCCccchhhhcc-----------CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~ 599 (707)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+........
T Consensus 209 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~--- 280 (390)
T 2zmd_A 209 T-----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI--- 280 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH---
T ss_pred c-----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH---
Confidence 1 112234579999999999975 468889999999999999999999997654433322221
Q ss_pred ccchhhccCC-CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005224 600 SMMFSVIDGN-MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 645 (707)
Q Consensus 600 ~~~~~~~~~~-~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~ 645 (707)
+++. ...++...+..+.+++.+||+.+|.+||++.++++.
T Consensus 281 ------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 ------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111 122333445678899999999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=348.44 Aligned_cols=199 Identities=28% Similarity=0.450 Sum_probs=168.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHHccCCCcceeEEEEEEeCC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 444 (707)
.++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999975 689999999865321 11235789999999999999999999987654
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEeeec
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFG 521 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFG 521 (707)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 8999999999999999854 346899999999999999999999999 999999999999987664 9999999
Q ss_pred ccccCCCCCCCCccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 522 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 163 HSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp TCEECCCC--------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred cceecccc--------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99865421 1223456899999999974 467899999999999999999999999643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=348.08 Aligned_cols=269 Identities=16% Similarity=0.197 Sum_probs=213.8
Q ss_pred HHhcCCCccceEeeeCceEEEEEE------eCCCcEEEEEEeccCChhhHHHHHHHHHHHHccC---CCcceeEEEEEEe
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDE 442 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~ 442 (707)
...++|.+.+.||+|+||+||+|. ..+++.||||++.... ..++..|+++++.++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345778999999999999999994 3468999999997643 456778888888886 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------- 511 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-------- 511 (707)
.+..++||||+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999752 3456999999999999999999999998 999999999999998
Q ss_pred ---CCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 512 ---KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 512 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
++.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFP-----KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSC-----TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccCCEEEeeCchhhhhhccC-----CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 8999999999997543211 12334556799999999999999999999999999999999999999954322
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhcCCCCCCCCCccccCC
Q 005224 589 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSE 667 (707)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Pt~~~v~~~L~~~~~~~~~~~~~~~dll~~~ 667 (707)
. . ..+.......+ ..+.+.+++..|++.+|.+| |++.++.+.|+.+..... ....+++.++
T Consensus 291 ~------------~-~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~---~~~~~~l~~~ 352 (365)
T 3e7e_A 291 G------------E-CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY---TNKIRALRNR 352 (365)
T ss_dssp T------------E-EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT---TTTHHHHHHH
T ss_pred C------------c-eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh---hhchHHHHHH
Confidence 0 0 00111122222 24567788999999999988 688888888888776533 2334555554
Q ss_pred CC
Q 005224 668 HT 669 (707)
Q Consensus 668 L~ 669 (707)
|.
T Consensus 353 l~ 354 (365)
T 3e7e_A 353 LI 354 (365)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=335.18 Aligned_cols=200 Identities=27% Similarity=0.391 Sum_probs=171.4
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
+|.....||+|+||+||+|... +++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3555669999999999999964 789999999987665556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeeecccccCCCCCCC
Q 005224 455 NGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 455 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 999999997653 345779999999999999999999998 999999999999987 8999999999998654321
Q ss_pred CccccceecccccCCCccchhhhccCC--CCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
.......|++.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 178 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 178 -----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred -----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 1123456899999999997643 88999999999999999999999964
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=336.84 Aligned_cols=200 Identities=29% Similarity=0.456 Sum_probs=176.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357889999999999999999975 688999999865321 2246789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++.... .+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999997653 4899999999999999999999998 999999999999999999999999998765321
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
......|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 168 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 168 ---------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp ---------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 1234568999999999999999999999999999999999999997544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=349.11 Aligned_cols=199 Identities=24% Similarity=0.378 Sum_probs=174.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh--------hHHHHHHHHHHHHccCCCcceeEEEEEEeCC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 444 (707)
.++|++.+.||+|+||+||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 568999999999999999999964 7899999998764321 2235778999999999999999999999999
Q ss_pred eEEEEEecCCCC-CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 445 EQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 445 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
..++||||+.+| +|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999777 999999654 35999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCCC-CCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
+...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 178 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 178 AYLERGK--------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp EECCTTC--------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred eECCCCC--------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 8764322 2234568999999999998876 7889999999999999999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.71 Aligned_cols=207 Identities=27% Similarity=0.435 Sum_probs=174.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEe--CCeEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l 448 (707)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999975 78999999987543 2345678999999999999999999998854 568999
Q ss_pred EEecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 449 VYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 3456999999999999999999999876 2349999999999999999999999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDT-------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---C-------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc-------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 654221 11234568999999999999999999999999999999999999997543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=338.16 Aligned_cols=201 Identities=29% Similarity=0.441 Sum_probs=177.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.+.|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356889999999999999999964 78999999987543 2345789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999954 35899999999999999999999999 9999999999999999999999999997654321
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 12234568999999999999999999999999999999999999997543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=363.63 Aligned_cols=260 Identities=10% Similarity=-0.008 Sum_probs=183.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHcc--CCCcceeEE-------EEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL--HHRNLVSLV-------GYC 440 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~H~nIv~l~-------~~~ 440 (707)
..+|...+.||+|+||+||+|.+. +|+.||||++..... ...+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999975 789999999987543 2345677885544444 699988755 555
Q ss_pred EeCC-----------------eEEEEEecCCCCCHHHHHhhcCCCCcCHHHH------HHHHHHHHHHHHHHHhCCCCCe
Q 005224 441 DEEG-----------------EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR------LSIALGSSRGILYLHTEADPPV 497 (707)
Q Consensus 441 ~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i 497 (707)
...+ ..++||||++ |+|.+++..... .+.+..+ +.++.||++||+|||+++ |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 4432 3799999998 899999976422 2345555 788899999999999999 9
Q ss_pred EecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHH
Q 005224 498 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLE 575 (707)
Q Consensus 498 vH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~e 575 (707)
+||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++|||||||++||
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC----------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC----------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 9999999999999999999999999986531 1224456799999999987 789999999999999999
Q ss_pred HHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 576 LLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 576 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
|++|+.||........ .......... ....++.+ ...+.
T Consensus 286 lltg~~Pf~~~~~~~~--------~~~~~~~~~~----------------------~~~~~~~~-----------~~~~~ 324 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIK--------GSWKRPSLRV----------------------PGTDSLAF-----------GSCTP 324 (371)
T ss_dssp HHHSSCSTTBCCTTCT--------TCCCBCCTTS----------------------CCCCSCCC-----------TTSSC
T ss_pred HHhCCCCCCCcCcccc--------cchhhhhhhh----------------------ccccccch-----------hhccC
Confidence 9999999975422100 0000000000 00000000 00012
Q ss_pred CCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 656 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 656 ~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
.++...+||.+||..||++|||++|+|+||||..
T Consensus 325 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 2233446888899999999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=333.64 Aligned_cols=200 Identities=28% Similarity=0.414 Sum_probs=168.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467899999999999999999976 799999999865321 2345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999997653 4899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCC-CCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
. ......|++.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 165 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 165 E--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp --------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1234468999999999988765 57999999999999999999999654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=341.50 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=210.2
Q ss_pred HHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHc--cCCCcceeEEEEEEeCC---
Q 005224 370 MALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDEEG--- 444 (707)
Q Consensus 370 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~--- 444 (707)
.....++|++.+.||+|+||+||+|.. +++.||||++... ..+.+.+|+++++. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344567899999999999999999998 5899999998643 34577889999887 78999999999998776
Q ss_pred -eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEcCCCcE
Q 005224 445 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH--------TEADPPVFHRDIKASNILLDHKFTA 515 (707)
Q Consensus 445 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~ 515 (707)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 789999999999999999753 4899999999999999999999 677 9999999999999999999
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCC------CCCchhhHHHHHHHHHHHcC----------
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTG---------- 579 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDVwS~Gvll~elltG---------- 579 (707)
||+|||+++........ .........||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 187 kL~Dfg~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp EECCCTTCEEEETTTTE---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred EEEECCCceeccccccc---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999765432210 011223456899999999998753 33689999999999999999
Q ss_pred CCCCCCCch---hHHHHHHHhhcccchhhccCCCCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 580 MQPISHGKN---IVREVNIAYQSSMMFSVIDGNMGS--YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 580 ~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
..||..... ............. ....... ...+++..+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccCccccCcCcccHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 778854321 1111111111110 1111111 1247788999999999999999999999999999998764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=353.23 Aligned_cols=278 Identities=22% Similarity=0.364 Sum_probs=203.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe-----
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 445 (707)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357889999999999999999975 79999999987532 2334678899999999999999999999977653
Q ss_pred -EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 446 -QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 446 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
.++||||++ ++|.+++. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999996 68877763 24899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.........
T Consensus 175 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~--- 240 (353)
T 3coi_A 175 HADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVT--- 240 (353)
T ss_dssp C------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHH---
T ss_pred CCCC----------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh---
Confidence 6432 1234568999999999987 78899999999999999999999999754432 1111111100
Q ss_pred hhccCCCCCCChHHHHHH----HHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCC
Q 005224 604 SVIDGNMGSYPSECVEKF----IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 679 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l----~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~ 679 (707)
+..+.+....+ .......+...+ ++.. ....+..++...+||.+||..||++|||++
T Consensus 241 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 301 (353)
T 3coi_A 241 -------GVPGTEFVQKLNDKAAKSYIQSLPQTP--RKDF----------TQLFPRASPQAADLLEKMLELDVDKRLTAA 301 (353)
T ss_dssp -------CBCCHHHHTTCSCHHHHHHHHTSCBCS--SCCT----------TTTCTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred -------CCCCHHHHHHHhhHHHHHHHHhCcCCC--CccH----------HHhcCCcCHHHHHHHHHHcCCCcccCCCHH
Confidence 00011100000 000001111111 1111 011223344556899999999999999999
Q ss_pred cCCCCCCCCCCCC
Q 005224 680 SMLKHPYVSSDVS 692 (707)
Q Consensus 680 e~L~Hp~f~~~~~ 692 (707)
|+|+||||.....
T Consensus 302 e~l~hp~f~~~~~ 314 (353)
T 3coi_A 302 QALTHPFFEPFRD 314 (353)
T ss_dssp HHHTSGGGTTTCC
T ss_pred HHhcCcchhhccC
Confidence 9999999976443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=335.78 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=201.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC----hhhHHHHHHHHHHHHccCCCcceeEEEEEE--eCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~ 446 (707)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999974 78999999987532 233567899999999999999999999984 45678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||++++ |.+++.......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999875 888887766677999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCC--CCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
..... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .......
T Consensus 160 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~i~------- 226 (305)
T 2wtk_C 160 HPFAA-----DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-KLFENIG------- 226 (305)
T ss_dssp CTTCS-----SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH-------
T ss_pred Ccccc-----ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHHHh-------
Confidence 43221 12233456899999999998754 377999999999999999999999754331 1111111
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 645 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~ 645 (707)
......+..++..+.+++.+|++.+|.+||++.++++.
T Consensus 227 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 227 ---KGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---HCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---cCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11122344556778888899999999999998888763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.44 Aligned_cols=212 Identities=29% Similarity=0.448 Sum_probs=174.6
Q ss_pred ccHHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEe
Q 005224 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 442 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 442 (707)
+.+.++....++|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 334455556789999999999999999999974 78999999987543 2346789999999999 89999999999976
Q ss_pred ------CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 005224 443 ------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 516 (707)
Q Consensus 443 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 516 (707)
.+..++||||+++|+|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 468899999999999999998765567999999999999999999999998 99999999999999999999
Q ss_pred EeeecccccCCCCCCCCccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 517 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 517 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
|+|||++....... .......|++.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 170 l~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp ECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EeeCcCceecCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999997653211 1223456899999999997 5678999999999999999999999996544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=342.76 Aligned_cols=268 Identities=24% Similarity=0.384 Sum_probs=196.1
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEEE-------
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCD------- 441 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~------- 441 (707)
.....+|++.+.||+|+||.||+|... +++.||||++........+.+.+|+.+++++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 334568999999999999999999965 78999999987766666778999999999996 999999999994
Q ss_pred -eCCeEEEEEecCCCCCHHHHHhh-cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 005224 442 -EEGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 519 (707)
Q Consensus 442 -~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 519 (707)
.....++||||+. |+|.+++.. .....+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 3345899999995 799998865 23456999999999999999999999875 4599999999999999999999999
Q ss_pred ecccccCCCCCCCCcc-----ccceecccccCCCccchhhh---ccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHH
Q 005224 520 FGLSRLAPVPDIEGIV-----PAHVSTVVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 591 (707)
Q Consensus 520 FGla~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~---~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~ 591 (707)
||+++........... .........||+.|+|||++ .+..++.++|||||||++|||++|+.||...... .
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~ 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-R 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-H
Confidence 9999876532211000 00111245689999999998 5677889999999999999999999999643321 0
Q ss_pred HHHHHhhcccchhhccCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 592 EVNIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
+..... ...+...+..+.+++..||+.+|.+||++.++++.|+.+.....
T Consensus 261 -------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 -------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 011111 11222334568899999999999999999999999998876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=332.92 Aligned_cols=259 Identities=20% Similarity=0.318 Sum_probs=188.6
Q ss_pred HhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChh-hH-HHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ-GE-KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-~~-~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
..++|++.+.||+|+||+||+|.. .+++.||||++...... .. +.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 356899999999999999999997 47999999999764322 22 3344555568888999999999999999999999
Q ss_pred EecCCCCCHHHHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 450 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
|||++ |+|.+++.. .....+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99996 599888764 2445699999999999999999999997 8 999999999999999999999999999765
Q ss_pred CCCCCCCccccceecccccCCCccchhhh----ccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
.... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||...............
T Consensus 161 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---- 228 (290)
T 3fme_A 161 VDDV--------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE---- 228 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH----
T ss_pred cccc--------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc----
Confidence 4321 22334689999999996 4567899999999999999999999999754332222211111
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
......+.. ..++...+++.+||..||++|||++|++
T Consensus 229 ------------------------~~~~~~~~~-------------------~~~~~~~~li~~~l~~~p~~Rpt~~e~l 265 (290)
T 3fme_A 229 ------------------------EPSPQLPAD-------------------KFSAEFVDFTSQCLKKNSKERPTYPELM 265 (290)
T ss_dssp ------------------------SCCCCCCTT-------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred ------------------------cCCCCcccc-------------------cCCHHHHHHHHHHhhcChhhCcCHHHHH
Confidence 100000000 1112233577778888888888888888
Q ss_pred CCCCCCCC
Q 005224 683 KHPYVSSD 690 (707)
Q Consensus 683 ~Hp~f~~~ 690 (707)
+||||...
T Consensus 266 ~hp~f~~~ 273 (290)
T 3fme_A 266 QHPFFTLH 273 (290)
T ss_dssp TSHHHHHH
T ss_pred hCcccccC
Confidence 88888644
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=355.27 Aligned_cols=270 Identities=20% Similarity=0.283 Sum_probs=211.5
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccCC-CcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.++||+|+||.||+|.. .+++.||||++...... .++.+|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 47999999987654322 357889999999987 556666667788889999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeeecccccCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~~ 528 (707)
|+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 99999999754 345999999999999999999999999 9999999999999 6889999999999987654
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch--hHHHHHHHhhcccchhhc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 606 (707)
.......+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+...... .....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-~~~~~- 236 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-KVATS- 236 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-HHHSC-
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-ccccc-
Confidence 332211112223356799999999999999999999999999999999999999975332 11111111110 00000
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
.......++.++.+++..||+.+|++||++.++++.|+.+......
T Consensus 237 ---~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 237 ---IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF 282 (483)
T ss_dssp ---HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ---HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence 0001123356889999999999999999999999999998765443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.11 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=201.2
Q ss_pred hcCCCccceEeeeCceEEEEEEeC--CCc--EEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP--DGT--VVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
.++|++.+.||+|+||+||+|.+. +++ .||||++.... ....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457889999999999999999853 333 68999887542 234567899999999999999999999997654 8
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
++||||+++++|.+++.... ..+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999997642 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
...... ........+|..|+|||++.+..++.++||||||+++|||++ |+.||...... +.......
T Consensus 172 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~------- 239 (291)
T 1u46_A 172 PQNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK------- 239 (291)
T ss_dssp CC-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHT-------
T ss_pred cccccc----hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-HHHHHHHc-------
Confidence 433211 112233457788999999999899999999999999999999 99999755432 11111111
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.......+..++..+.+++.+|++.+|.+||++.++++.|+++..
T Consensus 240 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 240 -EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111223345667889999999999999999999999999987754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=334.00 Aligned_cols=203 Identities=29% Similarity=0.451 Sum_probs=173.2
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
..++|++.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4568999999999999999999975 68999999997643 33578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 99999999999643 345899999999999999999999999 9999999999999999999999999997654221
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 180 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 230 (314)
T 3com_A 180 ------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230 (314)
T ss_dssp ------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh
Confidence 122345689999999999999999999999999999999999999975443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.14 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=201.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 468999999999999999999975 78999999986532 234568899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEeeecccccCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAP 527 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFGla~~~~ 527 (707)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+|||++....
T Consensus 101 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999886543 4899999999999999999999998 9999999999999754 479999999998654
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
... ......|++.|+|||++.+ .++.++||||||+++|||++|+.||...... +....
T Consensus 176 ~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~------------ 233 (287)
T 2wei_A 176 QNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKR------------ 233 (287)
T ss_dssp CCS--------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH------------
T ss_pred CCC--------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHH------------
Confidence 321 1223458899999999876 4899999999999999999999999654321 11100
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
+........ .| .....+....++|.+||..||++|||++|+|+||||
T Consensus 234 ----------------~~~~~~~~~---~~--------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~ 280 (287)
T 2wei_A 234 ----------------VETGKYAFD---LP--------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (287)
T ss_dssp ----------------HHHCCCCCC---SG--------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred ----------------HHcCCCCCC---ch--------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence 000000000 00 001112233467888888899999999999999998
Q ss_pred CCC
Q 005224 688 SSD 690 (707)
Q Consensus 688 ~~~ 690 (707)
...
T Consensus 281 ~~~ 283 (287)
T 2wei_A 281 QKY 283 (287)
T ss_dssp HHH
T ss_pred hcc
Confidence 643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=370.55 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=213.0
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 443 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 443 (707)
+.....++|++.+.||+|+||+||+|.+. .+..||||++.... ....+.+.+|+.++++++||||+++++++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 44455678889999999999999999964 25689999987643 333467999999999999999999999985 4
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 6789999999999999999754 345899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccc
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
+...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...... +...
T Consensus 539 ~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-~~~~-------- 603 (656)
T 2j0j_A 539 RYMEDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIG-------- 603 (656)
T ss_dssp CSCCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH--------
T ss_pred eecCCCc------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-HHHH--------
Confidence 8764322 112223456789999999999999999999999999999997 99999754432 1111
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 604 -~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 604 -RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 112233344566777889999999999999999999999999998764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=353.41 Aligned_cols=201 Identities=25% Similarity=0.315 Sum_probs=157.9
Q ss_pred CCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44556889999999998776678999999998653 235678999999886 89999999999999999999999995
Q ss_pred CCCHHHHHhhcCCCC-----cCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-------------CcEE
Q 005224 455 NGTLRDQLSAKSKEP-----LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-------------FTAK 516 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-------------~~~k 516 (707)
|+|.+++....... ..+..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999997643221 133346789999999999999998 9999999999999754 4899
Q ss_pred EeeecccccCCCCCCCCccccceecccccCCCccchhhhcc-------CCCCCchhhHHHHHHHHHHHc-CCCCCCCC
Q 005224 517 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHG 586 (707)
Q Consensus 517 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvll~ellt-G~~pf~~~ 586 (707)
|+|||+++......... ........||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...
T Consensus 169 L~DFG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSF---RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp ECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EcccccceecCCCCccc---eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999998765422110 111234579999999999976 678999999999999999999 99999643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=345.56 Aligned_cols=275 Identities=20% Similarity=0.301 Sum_probs=211.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhh-----------------HHHHHHHHHHHHccCCCcceeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-----------------EKEFLTEIQFLSRLHHRNLVSL 436 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l 436 (707)
.++|++.+.||+|+||.||+|.. +++.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999986432211 1689999999999999999999
Q ss_pred EEEEEeCCeEEEEEecCCCCCHHHH------HhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEE
Q 005224 437 VGYCDEEGEQMLVYEFMSNGTLRDQ------LSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILL 509 (707)
Q Consensus 437 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl 509 (707)
++++.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||.|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998 655446679999999999999999999999 88 9999999999999
Q ss_pred cCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccC-CCCC-chhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 510 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTD-KSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 510 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
+.++.+||+|||++...... ......|+..|+|||++.+. .++. ++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999865321 23445689999999999887 6666 9999999999999999999997654
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCC
Q 005224 588 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSE 667 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~ 667 (707)
...+......... ..++..... .. .+...... .......+....+|+.+|
T Consensus 257 ~~~~~~~~i~~~~----------~~~~~~~~~--------~~--~~~~~~~~----------~~~~~~~~~~l~~li~~~ 306 (348)
T 2pml_X 257 SLVELFNNIRTKN----------IEYPLDRNH--------FL--YPLTNKKS----------TCSNNFLSNEDIDFLKLF 306 (348)
T ss_dssp CSHHHHHHHTSCC----------CCCCCSSSS--------ST--TTTCC------------------CCCHHHHHHHHHH
T ss_pred cHHHHHHHHhccC----------cCCccchhh--------hh--cccccccc----------ccchhhcCHHHHHHHHHH
Confidence 4222222111110 001100000 00 00000000 001123344556899999
Q ss_pred CCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 668 HTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 668 L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
|..||++|||++|+|+||||....
T Consensus 307 L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 307 LRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp CCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccCChhhCCCHHHHhcCccccCCC
Confidence 999999999999999999998643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=352.97 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=188.6
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEEEe
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
...+|...+.||+|+||+||.....+++.||||++...... .+.+|+++++.+ +||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 44568889999999999976655668999999998754332 356799999999 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCcEEEeeecccccC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLA 526 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFGla~~~ 526 (707)
|++ |+|.+++..... ...+..++.++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 99 ~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 995 699999976542 3444556789999999999999999 999999999999943 346889999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhc---cCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
...... ........||+.|+|||++. ...++.++|||||||++|||++ |..||....... .......
T Consensus 174 ~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--~~~~~~~--- 244 (432)
T 3p23_A 174 AVGRHS----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--ANILLGA--- 244 (432)
T ss_dssp ----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--HHHHTTC---
T ss_pred cCCCcc----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--HHHHhcc---
Confidence 432110 11234467999999999998 4677889999999999999999 888985432211 1100000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
+ .......+.... ..+.+||.+||..||++|||++|+|
T Consensus 245 -------------------------~-~~~~~~~~~~~~----------------~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 245 -------------------------C-SLDCLHPEKHED----------------VIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp -------------------------C-CCTTSCTTCHHH----------------HHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred -------------------------C-CccccCcccccc----------------HHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 0 000000000000 0123678888999999999999999
Q ss_pred CCCCCCC
Q 005224 683 KHPYVSS 689 (707)
Q Consensus 683 ~Hp~f~~ 689 (707)
+||||.+
T Consensus 283 ~hp~f~~ 289 (432)
T 3p23_A 283 KHPFFWS 289 (432)
T ss_dssp TSTTTCC
T ss_pred hCccccC
Confidence 9999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.47 Aligned_cols=212 Identities=25% Similarity=0.346 Sum_probs=172.8
Q ss_pred ccHHHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccC--CCcceeEEEEE
Q 005224 365 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH--HRNLVSLVGYC 440 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~ 440 (707)
+.+..+....++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 34444555667899999999999999999998889999999986533 334567899999999997 59999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeee
Q 005224 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 520 (707)
Q Consensus 441 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 520 (707)
...+..++||| +.+++|.+++... ..+++..++.++.|+++||.|||+.+ |+||||||+|||+++ +.+||+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeec
Confidence 99999999999 5588999999764 35899999999999999999999998 999999999999975 89999999
Q ss_pred cccccCCCCCCCCccccceecccccCCCccchhhhcc-----------CCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 521 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 521 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
|+++....... ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 171 g~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 171 GIANQMQPDTT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp SSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cccccccCccc-----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 99986543211 112234568999999999976 4788899999999999999999999975443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=326.76 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=162.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEe----------
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE---------- 442 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~---------- 442 (707)
.++|++.+.||+|+||+||+|... +++.||||++.. .....+.+.+|+++++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999974 799999999865 23345678999999999999999999999865
Q ss_pred ---CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 005224 443 ---EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 519 (707)
Q Consensus 443 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 519 (707)
.+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 35679999999999999999764 345788999999999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCCCCCc-------cccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHc
Q 005224 520 FGLSRLAPVPDIEGI-------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLT 578 (707)
Q Consensus 520 FGla~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~ellt 578 (707)
||+++.......... ..........||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999986543210000 001123345689999999999864 78999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=332.14 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=172.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHH-HHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.++|+..+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999999999999975 799999999976432 33445666666 777789999999999999999999999
Q ss_pred ecCCCCCHHHHHhh---cCCCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEeeecccccC
Q 005224 451 EFMSNGTLRDQLSA---KSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 451 E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
||+++ +|.+++.. .....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 88888753 2345699999999999999999999998 8 999999999999999999999999999765
Q ss_pred CCCCCCCccccceecccccCCCccchhhh----ccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
.... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.......+. .
T Consensus 177 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~ 239 (327)
T 3aln_A 177 VDSI--------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------L 239 (327)
T ss_dssp -------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------
T ss_pred cccc--------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------H
Confidence 4221 12234689999999999 4667899999999999999999999999754331111 1
Q ss_pred hhhccCCCCCC----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 603 FSVIDGNMGSY----PSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 603 ~~~~~~~~~~~----~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
.....+..... ...++..+.+++..||+.+|.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111111 1234455666666666666666666666543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=340.50 Aligned_cols=268 Identities=22% Similarity=0.312 Sum_probs=206.0
Q ss_pred cHHHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeC
Q 005224 366 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 443 (707)
Q Consensus 366 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 443 (707)
...++....++|++.+.||+|+||.||+|..++ .||+|++..... ...+.+.+|+.++++++|+||+++++++...
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 344555667889999999999999999999854 499999875322 2234677899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
+..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++ ++.+||+|||++
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred CceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 9999999999999999999654 346899999999999999999999999 99999999999998 679999999998
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhcc---------CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 594 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~ 594 (707)
+........ ..........|++.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 177 ~~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~ 253 (319)
T 2y4i_B 177 SISGVLQAG--RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IW 253 (319)
T ss_dssp C------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-HH
T ss_pred ccccccccc--ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH
Confidence 765322111 01122234568999999999975 4578899999999999999999999975543211 11
Q ss_pred HHhhcccchhhccCCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 595 IAYQSSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
.. ..+.... .+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 254 ~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 254 QM---------GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HH---------HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred Hh---------ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11 1111111 1223456788999999999999999999999999877654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=363.51 Aligned_cols=203 Identities=28% Similarity=0.423 Sum_probs=174.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHHccCCCcceeEEEEEEe------CCeE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGEQ 446 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~~ 446 (707)
++|++.+.||+|+||+||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999974 7899999998764 33345678999999999999999999999755 6678
Q ss_pred EEEEecCCCCCHHHHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEeeecc
Q 005224 447 MLVYEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGL 522 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGl 522 (707)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 335889999999999999999999998 999999999999997765 99999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 588 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~ 588 (707)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 171 a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 171 AKELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp CCBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred cccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 98764322 22345789999999999999999999999999999999999999976544
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=332.44 Aligned_cols=197 Identities=23% Similarity=0.354 Sum_probs=148.1
Q ss_pred hcCCCccc-eEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEe----CCeEE
Q 005224 374 TNNFNSST-QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQM 447 (707)
Q Consensus 374 ~~~~~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 447 (707)
.++|.+.+ .||+|+||+||+|... +++.||||++.... +...+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788854 6999999999999976 79999999986532 122223334566799999999999976 44589
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeeecccc
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 524 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~ 524 (707)
+||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998776677999999999999999999999999 999999999999976 4559999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 ~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 180 ETTQN---------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp EC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ecccc---------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 65421 223456799999999999889999999999999999999999999643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=330.54 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=164.9
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChh------hHHHHHHHHHHHHcc----CCCcceeEEEE
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRL----HHRNLVSLVGY 439 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~~~ 439 (707)
....++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.+++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34467899999999999999999996 47899999999764332 223456799999998 89999999999
Q ss_pred EEeCCeEEEEEec-CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEE
Q 005224 440 CDEEGEQMLVYEF-MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKV 517 (707)
Q Consensus 440 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl 517 (707)
+...+..++|||| +.+++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++ +++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 78999999997643 5899999999999999999999998 99999999999999 8899999
Q ss_pred eeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCC-CchhhHHHHHHHHHHHcCCCCCCC
Q 005224 518 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 518 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
+|||+++...... .....|+..|+|||++.+..+. .++|||||||++|||++|+.||..
T Consensus 182 ~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 182 IDFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp CCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 9999998764321 2345689999999999877664 489999999999999999999964
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=333.18 Aligned_cols=202 Identities=26% Similarity=0.432 Sum_probs=172.6
Q ss_pred HHHHhcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChh------hHHHHHHHHHHHHccC--CCcceeEEEEE
Q 005224 370 MALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLH--HRNLVSLVGYC 440 (707)
Q Consensus 370 l~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~~~ 440 (707)
.....++|++.+.||+|+||+||+|.. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344567899999999999999999996 47899999998753221 2245678999999996 59999999999
Q ss_pred EeCCeEEEEEecCCC-CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEe
Q 005224 441 DEEGEQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVA 518 (707)
Q Consensus 441 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~ 518 (707)
...+..++||||+.+ ++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 999999999999976 8999999764 35899999999999999999999999 99999999999999 78999999
Q ss_pred eecccccCCCCCCCCccccceecccccCCCccchhhhccCCC-CCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 519 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 519 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 193 Dfg~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 193 DFGSGALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CCTTCEECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred eCccccccccc---------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99999876432 1223468999999999987765 6789999999999999999999964
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=324.71 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=175.2
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh-hH-HHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GE-KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~-~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.++|+..+.||+|+||.||+|... +|+.||||++...... .. +.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999975 7899999999764332 22 33445556788889999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
||+ ++.+..+.... ...+++..++.++.|+++||.|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 55666655432 34689999999999999999999985 8 999999999999999999999999999765432
Q ss_pred CCCCccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
. ......|++.|+|||++. ...++.++|||||||++|||++|+.||..................
T Consensus 179 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 247 (318)
T 2dyl_A 179 K--------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP--- 247 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC---
T ss_pred c--------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC---
Confidence 1 223446899999999994 567889999999999999999999999764443322222111100
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
........++..+.+++.+||+.+|.+||++.++++
T Consensus 248 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ----PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000011123445666666666666666666666554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=334.63 Aligned_cols=191 Identities=24% Similarity=0.279 Sum_probs=161.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCCh--------hhHHHHHHHHHHHHccC---------CCcceeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLH---------HRNLVSL 436 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---------H~nIv~l 436 (707)
.++|++.+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788899999999999999998 789999999875421 22367889999998885 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHH
Q 005224 437 VGYCD------------------------------EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 486 (707)
Q Consensus 437 ~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL 486 (707)
.+.+. ..+..++||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 87653 26789999999999976666633 4589999999999999999
Q ss_pred HHHH-hCCCCCeEecCCCCCCEEEcCCC--------------------cEEEeeecccccCCCCCCCCccccceeccccc
Q 005224 487 LYLH-TEADPPVFHRDIKASNILLDHKF--------------------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545 (707)
Q Consensus 487 ~yLH-~~~~~~ivH~Dlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~g 545 (707)
+||| +.+ |+||||||+|||++.++ .+||+|||+|+.... ....|
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------~~~~g 239 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------GIVVF 239 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------TEEEC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------CcEEE
Confidence 9999 888 99999999999999887 899999999986532 23479
Q ss_pred CCCccchhhhccCCCCCchhhHHHHHH-HHHHHcCCCCCC
Q 005224 546 TPGYLDPEYFLTHKLTDKSDVYSLGVV-FLELLTGMQPIS 584 (707)
Q Consensus 546 t~~y~aPE~~~~~~~s~~sDVwS~Gvl-l~elltG~~pf~ 584 (707)
|+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 99999999998776 889999998777 777888988873
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.53 Aligned_cols=230 Identities=12% Similarity=0.075 Sum_probs=185.8
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999975 589999999976433 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++... .....+..++.|++.||+|||+++ |+||||||+|||+++++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999532 355578889999999999999999 9999999999999999999998544
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
|++ .++.++|||||||++|||++|+.||........ ...........
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-------~~~~~~~~~~~ 221 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-------LAPAERDTAGQ 221 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-------SEECCBCTTSC
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-------hHHHHHHhccC
Confidence 333 368899999999999999999999975432100 00000111111
Q ss_pred CC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 610 MG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 610 ~~---~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
.. ....+++..+.+++.+||+.+|.+| |+.++++.|+.+...
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 11 1123456789999999999999999 999999999987653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.22 Aligned_cols=175 Identities=23% Similarity=0.375 Sum_probs=152.9
Q ss_pred cCCCcc-ceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHH-HccCCCcceeEEEEEEe----CCeEE
Q 005224 375 NNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFL-SRLHHRNLVSLVGYCDE----EGEQM 447 (707)
Q Consensus 375 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~ 447 (707)
++|.+. +.||+|+||.||+|... +++.||||++... ..+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 78999999999999974 7899999998642 3567888888 55699999999999977 66789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeeecccc
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 524 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~ 524 (707)
+||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999998876667999999999999999999999999 999999999999998 7899999999986
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
... +..++.++|||||||++|||++|+.||...
T Consensus 169 ~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 169 ETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp ECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 532 134577999999999999999999999643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=344.91 Aligned_cols=239 Identities=21% Similarity=0.334 Sum_probs=194.1
Q ss_pred hcCCCccceEeeeCceEEEEEEeC--CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe-----
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 445 (707)
.++|++.+.||+|+||+||+|.+. +|+.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 68999999986533 3345678999999999999999999999987665
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+++++|.+++.. .+++..++.++.||++||.|||+++ |+||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988743 5999999999999999999999999 9999999999999986 999999999986
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
.... ....||+.|+|||++.+.. +.++|||||||++|||++|..||.....
T Consensus 231 ~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~----------------- 281 (681)
T 2pzi_A 231 INSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV----------------- 281 (681)
T ss_dssp TTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-----------------
T ss_pred cccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-----------------
Confidence 5321 3456899999999998764 8899999999999999999888753110
Q ss_pred ccCCCCC-CChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHhh
Q 005224 606 IDGNMGS-YPSECVEKFIKLALKCCQDETDARPS-MSEVMRELESIW 650 (707)
Q Consensus 606 ~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPt-~~~v~~~L~~~~ 650 (707)
+..... ........+.+++.+|++.+|.+||+ +.++...+..+.
T Consensus 282 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 282 -DGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -SSCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -ccccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000001 11234567899999999999999995 566666666543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=323.29 Aligned_cols=240 Identities=15% Similarity=0.133 Sum_probs=180.6
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChh---hHHHHHHHHHHHHccCC-Ccc---------e------
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHH-RNL---------V------ 434 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H-~nI---------v------ 434 (707)
.+|...+.||+|+||+||+|.+ .+|+.||||++...... ..+.+.+|+.+++.++| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4566788999999999999995 47999999998743322 24678999999999987 221 1
Q ss_pred ------eEEEEEEe-----CCeEEEEEecCCCCCHHHHHh-----hcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 005224 435 ------SLVGYCDE-----EGEQMLVYEFMSNGTLRDQLS-----AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498 (707)
Q Consensus 435 ------~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 498 (707)
.+..++.. ....+++|+++ +++|.+++. ......+++..++.++.|+++||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 11111111 22467788876 689999985 223445889999999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhh----------ccCCCCCchhhHH
Q 005224 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF----------LTHKLTDKSDVYS 568 (707)
Q Consensus 499 H~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDVwS 568 (707)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++ .+..++.++||||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE----------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC----------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 999999999999999999999999876431 2344567 999999999 5556888999999
Q ss_pred HHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 569 LGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 569 ~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
|||++|||++|+.||...... .....++. .... .+..+.+++.+||+.+|.+||++.++++
T Consensus 303 lGvil~elltg~~Pf~~~~~~----------~~~~~~~~-~~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAAL----------GGSEWIFR-SCKN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGG----------SCSGGGGS-SCCC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHCCCCCCCcchh----------hhHHHHHh-hccc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999999754321 11111111 1122 3367889999999999999999777643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-29 Score=287.54 Aligned_cols=185 Identities=18% Similarity=0.115 Sum_probs=130.6
Q ss_pred eEeeeCceEEEEEE-eCCCcEEEEEEeccCC----------hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEE
Q 005224 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS----------LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 382 ~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 449 (707)
..+.|++|.+..++ .-.|+.||||++.... ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35567777666655 3358899999986532 12235799999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||++|++|.++|.+.+ +++.. +|+.||+.||+|+|+++ ||||||||+|||+++++++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999997643 46654 58899999999999999 999999999999999999999999999876432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~p 582 (707)
.......+||++|||||++.+. +..++|+||+|++++++.++..+
T Consensus 393 -------~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 -------CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -------CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 1233456799999999999764 56789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-27 Score=262.69 Aligned_cols=190 Identities=14% Similarity=0.187 Sum_probs=146.0
Q ss_pred CccceEeeeCceEEEEEEeCCCcEEEEEEeccCChh--------hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 378 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 378 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
...+.||+|+||+||+|.. .++.+++|+....... ..+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999955 5788889876542211 134589999999999999999666666677788999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999954 5689999999999999999 999999999999999 9999999999876432
Q ss_pred CCCCccccceecccccCCCccchhhhcc--CCCCCchhhHHHHHHHHHHHcCCCCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPI 583 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvll~elltG~~pf 583 (707)
...............||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1000000001235679999999999987 67888899999999999988877666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=215.65 Aligned_cols=153 Identities=12% Similarity=0.051 Sum_probs=122.8
Q ss_pred HHHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHHcc
Q 005224 367 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL------------------QGEKEFLTEIQFLSRL 428 (707)
Q Consensus 367 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l 428 (707)
...+......|...+.||+|+||.||+|...+|+.||||++..... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3445555667778899999999999999997899999999864321 1345689999999999
Q ss_pred CCCcceeEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 005224 429 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 508 (707)
Q Consensus 429 ~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 508 (707)
+| +++.+++.. +..++||||+++++|.+ +.. .....++.|+++||.|||+.+ |+||||||+|||
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 94 555555543 45699999999999988 421 124579999999999999999 999999999999
Q ss_pred EcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhc
Q 005224 509 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556 (707)
Q Consensus 509 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 556 (707)
++ ++.+||+|||+|+. +..|+|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~--------------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------------CCCCCHHHHHH
Confidence 99 99999999999864 33578999885
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.4e-19 Score=176.28 Aligned_cols=142 Identities=25% Similarity=0.339 Sum_probs=124.9
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
++|+.|+|++|+|+++++ .|..+++|++|+|++|+|++..|..+..+ +|++|+|++|+|+...+..|.++++|+.|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 478999999999999888 79999999999999999995446666555 8999999999999666666899999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCccccCCcccccCCC
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQFCGSH 148 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~~~~~~~~~~~ 148 (707)
++|+|++..|..+..+++|+ .|+|++|+|+++++. + .+++|+.|+|++|+|.|+|.+..+-.|.
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l~~l~~~l 177 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLN-----LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHLKWLADYL 177 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCC-----EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHH
T ss_pred CCCCCCEeCHHHcCCCCCCC-----EEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCccHHHHHHH
Confidence 99999988788888877666 999999999999875 4 7899999999999999999988776554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.6e-19 Score=181.42 Aligned_cols=137 Identities=19% Similarity=0.100 Sum_probs=107.7
Q ss_pred CCCccceEeeeCceEEEEEEe-CCCcE--EEEEEeccCChh------------------------hHHHHHHHHHHHHcc
Q 005224 376 NFNSSTQIGQGGYGKVYKGIL-PDGTV--VAVKRAQEGSLQ------------------------GEKEFLTEIQFLSRL 428 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l 428 (707)
-|++.+.||+|+||.||+|.. .+|+. ||||++...... ....+.+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999997 68999 999987543111 123678999999999
Q ss_pred CCCcc--eeEEEEEEeCCeEEEEEecCCC-C----CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHH-hCCCCCeEec
Q 005224 429 HHRNL--VSLVGYCDEEGEQMLVYEFMSN-G----TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH-TEADPPVFHR 500 (707)
Q Consensus 429 ~H~nI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~ 500 (707)
+|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 88754 444442 356899999942 3 77776532 234457789999999999999 888 9999
Q ss_pred CCCCCCEEEcCCCcEEEeeecccccC
Q 005224 501 DIKASNILLDHKFTAKVADFGLSRLA 526 (707)
Q Consensus 501 Dlkp~NILl~~~~~~kl~DFGla~~~ 526 (707)
||||+|||+++ .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-18 Score=173.18 Aligned_cols=139 Identities=27% Similarity=0.354 Sum_probs=122.6
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|+|+++++ .|..+++|++|+|++|+|+ .+|...+. + +|+.|+|++|+|++..+..|..+++|+.|+
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 118 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF 118 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEe
Confidence 579999999999999987 6999999999999999998 88877654 3 899999999999977777789999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCC-cccccCC
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN-AEQFCGS 147 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~-~~~~~~~ 147 (707)
|++|+|+ .+|..+..+++|+ .|+|++|+|+.+++.. .+++|+.|++.+|||.|+|. +..+-.|
T Consensus 119 Ls~N~l~-~lp~~~~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~l~~~ 184 (229)
T 3e6j_A 119 MCCNKLT-ELPRGIERLTHLT-----HLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRDIMYLRNW 184 (229)
T ss_dssp CCSSCCC-SCCTTGGGCTTCS-----EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBGGGHHHHHH
T ss_pred ccCCccc-ccCcccccCCCCC-----EEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcchhHHHHHH
Confidence 9999999 9999998777665 9999999999998753 78999999999999999996 4444333
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=8.1e-19 Score=174.34 Aligned_cols=142 Identities=21% Similarity=0.308 Sum_probs=124.4
Q ss_pred CCceEEEeeCCcCCCCCC--CcCCCCcccEEeccCCcCcccCCCc-cccc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 2 SKLLKLSLRNCSLQGPMP--DLSRIPNLGYLDLSSNQLNGSIPPG-RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
..++.|+|++|+|+++++ .|..+++|++|+|++|+|+ .++.. +..+ +|+.|+|++|+|++..|..|.++++|++|
T Consensus 32 ~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 110 (220)
T 2v70_A 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTL 110 (220)
T ss_dssp TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEE
T ss_pred CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC-EECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEE
Confidence 357899999999999865 3899999999999999999 66664 4444 89999999999998888889999999999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCC-CC-CCCCCceeeccCCCccccCCcccccCCCC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG-SF-NIPPNVTVRLRGNPFCLNTNAEQFCGSHS 149 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~-~~-~~~~l~~l~l~~N~~~~~~~~~~~~~~~~ 149 (707)
+|++|+|++..|..+..+++|+ .|+|++|+|+++++ .+ .+++|+.|++++|+|.|+|.+..+-.|..
T Consensus 111 ~Ls~N~l~~~~~~~~~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~l~~~~~ 179 (220)
T 2v70_A 111 MLRSNRITCVGNDSFIGLSSVR-----LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAWLGEWLR 179 (220)
T ss_dssp ECTTSCCCCBCTTSSTTCTTCS-----EEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGGHHHHHHHH
T ss_pred ECCCCcCCeECHhHcCCCccCC-----EEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCchHHHHHHHH
Confidence 9999999988888888776665 99999999999954 45 79999999999999999999888766653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=179.30 Aligned_cols=144 Identities=30% Similarity=0.379 Sum_probs=118.3
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccc-cc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL-SL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
+++|+.|+|++|+|+.++..+..+++|++|+|++|+|+ .+|...+ .+ +|+.|+|++|+|++..+..|..+++|+.|+
T Consensus 76 l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 76 LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp CTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCc-ccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 46788888888888876667888999999999999999 7776544 34 899999999999977777788899999999
Q ss_pred ccCcccccCCCC-CccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCccccCCcccccCCCCCC
Q 005224 79 IANNSLSGSIPS-SIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDD 151 (707)
Q Consensus 79 ls~N~l~g~~p~-~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~~~~~~~~~~~~~~~ 151 (707)
|++|+|+ .+|. .+..+++|+ .|+|++|+|+.+|..+ ..++++.++|.+|||.|+|.+..+-.|...+
T Consensus 155 L~~N~l~-~l~~~~~~~l~~L~-----~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~~~~l~~wl~~~ 223 (290)
T 1p9a_G 155 LANNNLT-ELPAGLLNGLENLD-----TLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDN 223 (290)
T ss_dssp CTTSCCS-CCCTTTTTTCTTCC-----EEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGGHHHHHHHHHT
T ss_pred CCCCcCC-ccCHHHhcCcCCCC-----EEECCCCcCCccChhhcccccCCeEEeCCCCccCcCccHHHHHHHHhC
Confidence 9999998 5554 445555554 9999999999998877 7889999999999999999988877776543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.4e-18 Score=172.64 Aligned_cols=143 Identities=25% Similarity=0.334 Sum_probs=111.3
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++|++|+|++|+|+++++ .|..+++|++|+|++|+|+ .+|...+. + +|+.|+|++|+|++..+..|.++++|+.|
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 136 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL 136 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccc-ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEE
Confidence 4678888888888888777 4788888888888888888 66655443 3 78888888888886666667888888888
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCcccc-CCcccccCCCC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLN-TNAEQFCGSHS 149 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~-~~~~~~~~~~~ 149 (707)
+|++|+|++..+..+..+++|+ +|+|++|+|+++++. + .+++|+.|++++|+|.|+ |.+..+-.|..
T Consensus 137 ~Ls~N~l~~~~~~~~~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~l~~~~~ 206 (251)
T 3m19_A 137 RLNTNQLQSIPAGAFDKLTNLQ-----TLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQWIR 206 (251)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCC-----EEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTTHHHHHHHHH
T ss_pred ECcCCcCCccCHHHcCcCcCCC-----EEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCccccHHHHHHHH
Confidence 8888888855555676665555 999999999998774 3 788999999999999998 87777766654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.7e-18 Score=164.56 Aligned_cols=137 Identities=20% Similarity=0.304 Sum_probs=121.5
Q ss_pred eEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcc
Q 005224 5 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 83 (707)
Q Consensus 5 ~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 83 (707)
+.+++++|+|+.++..+. ++|++|+|++|+|+ .+|..+..+ +|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 578999999998776654 68999999999999 999766665 89999999999998888899999999999999999
Q ss_pred cccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCccccCCcccccCCCC
Q 005224 84 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQFCGSHS 149 (707)
Q Consensus 84 l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~~~~~~~~~~~~ 149 (707)
|++..|..+..+++|+ .|+|++|+|+.+++. + .+++|+.|+|++|||.|+|.+..|-.|..
T Consensus 90 l~~i~~~~f~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~ 152 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLR-----LLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVK 152 (193)
T ss_dssp CCBCCTTTTTTCTTCC-----EEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHH
T ss_pred cCEeCHHHhCCCCCCC-----EEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHH
Confidence 9977777888776665 999999999999886 4 79999999999999999999988877653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.6e-17 Score=159.40 Aligned_cols=133 Identities=23% Similarity=0.308 Sum_probs=116.7
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|++|+|++|+|+++++ .|..+++|++|+|++|+|+ .+|...+. + +|++|+|++|+|++..+..|.++++|++|+
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 106 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA 106 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence 579999999999998887 5899999999999999999 78876543 4 899999999999977777789999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCC
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN 140 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~ 140 (707)
|++|+|++..+..+..+++|+ .|+|++|+|+++++.. .+++|+.|++++|+|.|+|.
T Consensus 107 L~~N~l~~~~~~~~~~l~~L~-----~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 107 LNTNQLQSLPDGVFDKLTQLK-----DLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCC-----EEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred cCCCcCcccCHhHhccCCcCC-----EEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 999999965555577766665 9999999999998863 78999999999999998875
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=2.2e-17 Score=160.24 Aligned_cols=136 Identities=23% Similarity=0.331 Sum_probs=117.6
Q ss_pred eEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCC-c-cccc-CccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 5 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-G-RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 5 ~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~-~-~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
+.|++++|+|+.++..+.. +|++|+|++|+|+ .++. . +..+ +|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCC-SBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCC-ccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 6899999999877766654 8999999999999 6665 3 3344 899999999999998899999999999999999
Q ss_pred cccccCCCCCccccccCCCCccceEEccCccCCCCCC-CC-CCCCCceeeccCCCccccCCcccccCCC
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG-SF-NIPPNVTVRLRGNPFCLNTNAEQFCGSH 148 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~-~~-~~~~l~~l~l~~N~~~~~~~~~~~~~~~ 148 (707)
|+|++..|..+..+++|+ +|+|++|+|+++++ .+ .+++|+.|+|++|+|.|+|.+..+-.|.
T Consensus 88 N~l~~~~~~~~~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l 151 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLK-----TLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWL 151 (192)
T ss_dssp CCCCEECSSSSTTCTTCC-----EEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHH
T ss_pred CcCCccCHHHhcCCCCCC-----EEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHH
Confidence 999988887788776665 99999999999855 44 7899999999999999999987776554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=7e-17 Score=165.61 Aligned_cols=132 Identities=27% Similarity=0.330 Sum_probs=70.1
Q ss_pred CceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccc-cc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 3 KLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
+|++|+|++|+|+++++ .|..+++|++|+|++|+|+ .+|...+ .+ +|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 86 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 164 (270)
T 2o6q_A 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRL 164 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEe
Confidence 34444444444444333 2344444444444444444 3333222 12 4555555555555333333555555555555
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCC
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN 140 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~ 140 (707)
++|++++..+..+..++ +|+.|+|++|+|+++++.. .+++|+.|++++|||.|+|.
T Consensus 165 ~~n~l~~~~~~~~~~l~-----~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 165 YNNQLKRVPEGAFDKLT-----ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CSSCCSCCCTTTTTTCT-----TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred cCCcCcEeChhHhccCC-----CcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 55555533333344433 3447888888888776653 57778888888888888876
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.71 E-value=7.3e-17 Score=165.69 Aligned_cols=134 Identities=25% Similarity=0.302 Sum_probs=87.1
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcc-ccc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGR-LSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++|++|+|++|+|+++++ .|..+++|++|+|++|+++ .+|... ..+ +|++|+|++|+|++..+..|.++++|+.|
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 162 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTEL 162 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCC-ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEE
Confidence 3566677777777776666 3666777777777777777 454443 223 67777777777775555556677777777
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN 140 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~ 140 (707)
+|++|++++..+..+..+++|+ .|+|++|+|+++++.. .+++|+.|++++|+|.|.|.
T Consensus 163 ~l~~n~l~~~~~~~~~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 163 DLSYNQLQSLPEGVFDKLTQLK-----DLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCC-----EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCCcCccCHHHhcCCccCC-----EEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 7777777754444455544444 7777777777776543 56777777777777776664
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.1e-17 Score=169.55 Aligned_cols=142 Identities=26% Similarity=0.419 Sum_probs=106.7
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccc-cc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++|++|+|++|++++.++ .|.++++|++|+|++|+++ .+|...+ .+ +|+.|+|++|+|++..+..|.++++|+.|
T Consensus 104 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 182 (285)
T 1ozn_A 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182 (285)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-ccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEE
Confidence 3567777777777777665 4677777777777777777 5555433 33 67788888887775555567777888888
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCccccCCcccccCCC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQFCGSH 148 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~~~~~~~~~~~ 148 (707)
+|++|++++..|..+..+++|+ .|+|++|+|+++++. + .+++|+.|++++|+|.|+|....+..|.
T Consensus 183 ~l~~n~l~~~~~~~~~~l~~L~-----~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l 250 (285)
T 1ozn_A 183 LLHQNRVAHVHPHAFRDLGRLM-----TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL 250 (285)
T ss_dssp ECCSSCCCEECTTTTTTCTTCC-----EEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHH
T ss_pred ECCCCcccccCHhHccCccccc-----EeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHH
Confidence 8888888776677777665554 999999999998765 3 7899999999999999999987766654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1e-16 Score=177.07 Aligned_cols=142 Identities=18% Similarity=0.210 Sum_probs=125.0
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
++|+.|+|++|++++.+| .|..+++|++|+|++|++++..|..+..+ +|+.|+|++|+|++..|..|.++++|++|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 479999999999999888 69999999999999999995555566555 8999999999999888999999999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCC-cccccCCC
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN-AEQFCGSH 148 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~-~~~~~~~~ 148 (707)
++|++++..|..+..+++|+ +|+|++|+|+++++.. .+++|+.|++++|+|.|+|. ...+-.|.
T Consensus 355 s~N~l~~~~~~~~~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l 421 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLK-----ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 421 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCC-----EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHH
T ss_pred CCCcccccChhhcccccccc-----EEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcchHHHHHH
Confidence 99999988899998877666 9999999999998754 78999999999999999998 34444444
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.8e-17 Score=177.48 Aligned_cols=140 Identities=26% Similarity=0.417 Sum_probs=93.2
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
|++|+.|+|++|+|+++++ .|.++++|++|+|++|+|+ .+|...+. + +|+.|+|++|+|++..|..|.++++|+.|
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCC-cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 3567777777777777666 4777777777777777777 55554333 3 67777777777776667777777777777
Q ss_pred eccCcccccCCCCCcc-ccccCCCCccceEEccCccCCCCCCCC--CCCC--CceeeccCCCccccCCcccc
Q 005224 78 FIANNSLSGSIPSSIW-QSRTLNATETFILDFQNNNLTNISGSF--NIPP--NVTVRLRGNPFCLNTNAEQF 144 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~-~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~--l~~l~l~~N~~~~~~~~~~~ 144 (707)
+|++|+|+ .+|..+. .+. .+++|+.|+|++|+|+.++... .++. +..|+|++|||.|+|.+..+
T Consensus 142 ~L~~N~l~-~l~~~~~~~~~--~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l~~~ 210 (361)
T 2xot_A 142 YLSQNQIS-RFPVELIKDGN--KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQL 210 (361)
T ss_dssp ECCSSCCC-SCCGGGTC------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHHHHH
T ss_pred ECCCCcCC-eeCHHHhcCcc--cCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCcHHH
Confidence 77777777 4554431 101 1234447888888888776432 4554 36789999999999987653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=5.4e-17 Score=186.13 Aligned_cols=146 Identities=21% Similarity=0.213 Sum_probs=123.3
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCccc-CCCccccc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGS-IPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~-ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++|+.|+|++|++++.+| .|..+++|++|+|++|++++. +|..+..+ +|+.|+|++|++++..|..|.++++|+.|
T Consensus 423 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 502 (606)
T 3vq2_A 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502 (606)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEE
Confidence 4678888888888888776 588888888888888888864 56655555 89999999999998888889999999999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCC-CCceeeccCCCccccCCcccccCCCCCC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIP-PNVTVRLRGNPFCLNTNAEQFCGSHSDD 151 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~-~l~~l~l~~N~~~~~~~~~~~~~~~~~~ 151 (707)
+|++|++++.+|..+..+++|+ .|+|++|+|+.+|..+ .++ +|+.|++++|||.|+|....+..|....
T Consensus 503 ~Ls~N~l~~~~~~~~~~l~~L~-----~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~l~~~ 573 (606)
T 3vq2_A 503 NMSHNNLLFLDSSHYNQLYSLS-----TLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQ 573 (606)
T ss_dssp ECCSSCCSCEEGGGTTTCTTCC-----EEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTTTTTS
T ss_pred ECCCCcCCCcCHHHccCCCcCC-----EEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHHHHHHHHcC
Confidence 9999999977788888776665 9999999999998877 676 5999999999999999999999998653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.6e-16 Score=174.96 Aligned_cols=122 Identities=24% Similarity=0.360 Sum_probs=96.7
Q ss_pred cCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCC
Q 005224 21 LSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 99 (707)
Q Consensus 21 ~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 99 (707)
|.++++|++|+|++|+|+ .+|. +..+ +|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+..+++|+
T Consensus 181 ~~~l~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 258 (440)
T 3zyj_A 181 FEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258 (440)
T ss_dssp TTTCSSCCEEECTTSCCS-SCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCC
T ss_pred hhcccccCeecCCCCcCc-cccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCC
Confidence 556666777777777777 6664 2223 788888888888877788888888888888888888877777777666555
Q ss_pred CCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCCcccccCCCC
Q 005224 100 ATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHS 149 (707)
Q Consensus 100 ~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~~~~~~~~~~ 149 (707)
.|+|++|+|+.++... .+++|+.|+|++|||.|+|.+..+-.|..
T Consensus 259 -----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l~~~~~ 305 (440)
T 3zyj_A 259 -----EINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLSWWIK 305 (440)
T ss_dssp -----EEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHHHHHHH
T ss_pred -----EEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHHHHHHH
Confidence 9999999999998765 78999999999999999999988766653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-16 Score=164.42 Aligned_cols=147 Identities=17% Similarity=0.223 Sum_probs=105.2
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCC-ccccc-CccEEEccCccCCCC-CCcccCCCcccceE
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPP-GRLSL-NITTIKLSNNKLTGT-IPSNFSGLPRLQRL 77 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~~-~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L 77 (707)
++|++|+|++|+|++.++ .|.++++|++|+|++|+++ .++. .+..+ +|++|+|++|++++. +|..|.++++|++|
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L 154 (276)
T 2z62_A 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred cCCCEEECCCCccCccChhhhcCCccccEEECCCCCcc-ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEE
Confidence 456666666666666655 4666666666666666666 4444 33333 788888888888753 57888888888888
Q ss_pred eccCcccccCCCCCccccccCC----------------------CCccceEEccCccCCCCCCCC--CCCCCceeeccCC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLN----------------------ATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGN 133 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~----------------------~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N 133 (707)
+|++|++++..+..+..+.+|+ ..+|+.|+|++|+|++++... .+++|+.|++++|
T Consensus 155 ~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N 234 (276)
T 2z62_A 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234 (276)
T ss_dssp ECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSS
T ss_pred ECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCC
Confidence 8888888865555555444332 126789999999999998764 7899999999999
Q ss_pred CccccCC-cccccCCCC
Q 005224 134 PFCLNTN-AEQFCGSHS 149 (707)
Q Consensus 134 ~~~~~~~-~~~~~~~~~ 149 (707)
+|.|+|. +..++.|..
T Consensus 235 ~~~c~c~~l~~l~~~~~ 251 (276)
T 2z62_A 235 PWDCSCPRIDYLSRWLN 251 (276)
T ss_dssp CBCCCTTTTHHHHHHHH
T ss_pred cccccCCchHHHHHHHH
Confidence 9999996 555666653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=166.25 Aligned_cols=144 Identities=19% Similarity=0.268 Sum_probs=105.2
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcc-cCCCccccc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNG-SIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++|+.|+|++|.+++..+ .|..+++|++|+|++|.+++ .+|..+..+ +|+.|+|++|+|++..|..|.++++|+.|
T Consensus 125 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 204 (306)
T 2z66_A 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204 (306)
T ss_dssp CTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence 3567777777777776666 46777777777777777774 355555544 78888888888887667778788888888
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCC-CCceeeccCCCccccCCcccccCCCC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIP-PNVTVRLRGNPFCLNTNAEQFCGSHS 149 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~-~l~~l~l~~N~~~~~~~~~~~~~~~~ 149 (707)
+|++|++++..+..+..+++| +.|+|++|++++.++. + .++ +|+.|++++|+|.|+|....+-.|..
T Consensus 205 ~L~~N~l~~~~~~~~~~l~~L-----~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~ 274 (306)
T 2z66_A 205 NMSHNNFFSLDTFPYKCLNSL-----QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 274 (306)
T ss_dssp ECTTSCCSBCCSGGGTTCTTC-----CEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHH
T ss_pred ECCCCccCccChhhccCcccC-----CEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHH
Confidence 888888875444455555444 4899999999887554 3 564 89999999999999998877776653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.1e-16 Score=186.31 Aligned_cols=135 Identities=31% Similarity=0.492 Sum_probs=102.0
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccc--------------------------------
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-------------------------------- 47 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-------------------------------- 47 (707)
|++|+.|+|++|++++.+| .++.+++|++|+|++|+++|.+|..++.
T Consensus 513 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (768)
T 3rgz_A 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN 592 (768)
T ss_dssp CTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEE
T ss_pred CCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccc
Confidence 3566667777777766655 5667777777777777777777754321
Q ss_pred --------------------------------------c-CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCC
Q 005224 48 --------------------------------------L-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 88 (707)
Q Consensus 48 --------------------------------------~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~ 88 (707)
. +|+.|||++|+|+|.+|.+|+++++|+.|+|++|+|+|.+
T Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~i 672 (768)
T 3rgz_A 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672 (768)
T ss_dssp EEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred ccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCC
Confidence 1 4778888888888888888888888888888888888888
Q ss_pred CCCccccccCCCCccceEEccCccCCCC-CCCC-CCCCCceeeccCCCccccCC
Q 005224 89 PSSIWQSRTLNATETFILDFQNNNLTNI-SGSF-NIPPNVTVRLRGNPFCLNTN 140 (707)
Q Consensus 89 p~~~~~l~~L~~~~L~~l~l~~N~l~~~-~~~~-~~~~l~~l~l~~N~~~~~~~ 140 (707)
|..+++++.|+ .|||++|+|++. |..+ .++.|+.|++++|++.+..+
T Consensus 673 p~~l~~L~~L~-----~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP 721 (768)
T 3rgz_A 673 PDEVGDLRGLN-----ILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721 (768)
T ss_dssp CGGGGGCTTCC-----EEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECC
T ss_pred ChHHhCCCCCC-----EEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCC
Confidence 88888877666 889999998865 4444 78888889999888876544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.5e-16 Score=173.94 Aligned_cols=141 Identities=23% Similarity=0.350 Sum_probs=108.8
Q ss_pred CCCceEEEeeCCcCCCCCC--------------------------CcCCCCcccEEeccCCcCcccCCCccccc-CccEE
Q 005224 1 MSKLLKLSLRNCSLQGPMP--------------------------DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTI 53 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~--------------------------~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L 53 (707)
|++|+.|+|++|+|+.+++ .|.++++|++|+|++|+|+ .+|. +..+ +|+.|
T Consensus 146 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L 223 (452)
T 3zyi_A 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEEL 223 (452)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCCC-CTTCTTCCEE
T ss_pred cCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-cccc-ccccccccEE
Confidence 3566667777666665544 2555666677777777777 5554 2233 78888
Q ss_pred EccCccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeecc
Q 005224 54 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLR 131 (707)
Q Consensus 54 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~ 131 (707)
+|++|+|++..|..|.++++|+.|+|++|++++..|..+..+++|+ .|+|++|+|++++... .+++|+.|+|+
T Consensus 224 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 298 (452)
T 3zyi_A 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV-----ELNLAHNNLSSLPHDLFTPLRYLVELHLH 298 (452)
T ss_dssp ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCC-----EEECCSSCCSCCCTTSSTTCTTCCEEECC
T ss_pred ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCC-----EEECCCCcCCccChHHhccccCCCEEEcc
Confidence 8888888877788888888888889988888877777777766655 9999999999998765 78999999999
Q ss_pred CCCccccCCcccccCCC
Q 005224 132 GNPFCLNTNAEQFCGSH 148 (707)
Q Consensus 132 ~N~~~~~~~~~~~~~~~ 148 (707)
+|||.|+|.+..+-.|.
T Consensus 299 ~Np~~CdC~~~~l~~~l 315 (452)
T 3zyi_A 299 HNPWNCDCDILWLAWWL 315 (452)
T ss_dssp SSCEECSTTTHHHHHHH
T ss_pred CCCcCCCCCchHHHHHH
Confidence 99999999988776554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2e-16 Score=181.88 Aligned_cols=145 Identities=19% Similarity=0.263 Sum_probs=125.6
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCccc-CCCccccc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGS-IPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~-ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++|+.+++++|.+++..+ .+..+++|+.|+|++|++... +|..+..+ +|+.|+|++|+|++..|..|.++++|++|
T Consensus 444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 4678899999999999888 688899999999999986544 45555445 89999999999999999999999999999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CC-CCCceeeccCCCccccCCcccccCCCCC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NI-PPNVTVRLRGNPFCLNTNAEQFCGSHSD 150 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~-~~l~~l~l~~N~~~~~~~~~~~~~~~~~ 150 (707)
+|++|+|++..|..+..+++|+ +|||++|+|+++++.. .+ ++|+.|+|++|||.|+|.+..|-.|...
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~-----~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~~ 594 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQ-----VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKD 594 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCC-----EEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHHHH
T ss_pred ECCCCcCCCCChhHHhCCCCCC-----EEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHHHh
Confidence 9999999977777888776665 9999999999997654 56 5799999999999999999999888743
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-15 Score=153.80 Aligned_cols=130 Identities=25% Similarity=0.350 Sum_probs=110.9
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCc-cccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPG-RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|+|+++.+ .|.++++|++|+|++|+|+ .++.. +..+ +|++|+|++|+|++..+..|..+++|++|+
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLY 113 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCC-ccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEE
Confidence 468999999999999888 6999999999999999999 55554 4444 899999999999977778899999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCccc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~ 137 (707)
|++|+|++..+..+..+++|+ .|+|++|+|+++++. + .+++|+.|+|++|.+..
T Consensus 114 L~~N~l~~~~~~~~~~l~~L~-----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 169 (251)
T 3m19_A 114 LGGNQLKSLPSGVFDRLTKLK-----ELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS 169 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCC-----EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred cCCCcCCCcChhHhccCCccc-----EEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCc
Confidence 999999955555566666555 999999999999874 4 78999999999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4e-16 Score=165.43 Aligned_cols=137 Identities=17% Similarity=0.201 Sum_probs=101.2
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCCh--------------hhH--------HHHHHHHHHHHccCCCc
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--------------QGE--------KEFLTEIQFLSRLHHRN 432 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------------~~~--------~~~~~E~~~l~~l~H~n 432 (707)
.-|++...||+|+||.||+|...+|+.||||+++.... ... ....+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34889999999999999999998999999998753210 000 11345677777775444
Q ss_pred ce--eEEEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005224 433 LV--SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD 510 (707)
Q Consensus 433 Iv--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 510 (707)
+. ..++. . ..+|||||+++++|.++... .....++.|++.+|.|||+.+ ||||||||.|||++
T Consensus 175 v~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE--E--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCeeeec--c--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 32 22322 1 23799999999888654311 123567899999999999999 99999999999998
Q ss_pred CCC----------cEEEeeecccccC
Q 005224 511 HKF----------TAKVADFGLSRLA 526 (707)
Q Consensus 511 ~~~----------~~kl~DFGla~~~ 526 (707)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 3899999977643
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.8e-15 Score=144.63 Aligned_cols=129 Identities=21% Similarity=0.315 Sum_probs=110.9
Q ss_pred ceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccc-cc-CccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 4 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL-SL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 4 L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
.+.+++++|+++.++..+. ++|++|+|++|+|+ .+|...+ .+ +|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCccCCCCCC--CCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 4689999999998776543 79999999999999 7777654 34 899999999999977777789999999999999
Q ss_pred cccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCC
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN 140 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~ 140 (707)
|+|++..+..+..+++|+ +|+|++|+|+++++.. .+++|+.|++++|+|.|+|.
T Consensus 86 N~l~~~~~~~~~~l~~L~-----~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLK-----ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCC-----EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccC-----EEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999966666667766665 9999999999998865 68999999999999999886
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=5.7e-16 Score=182.56 Aligned_cols=112 Identities=27% Similarity=0.400 Sum_probs=98.3
Q ss_pred cCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCC
Q 005224 21 LSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 99 (707)
Q Consensus 21 ~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 99 (707)
++.+++|++|||++|+|+|.+|..+..+ +|+.|+|++|+|+|.+|..|+++++|+.|||++|+++|.+|..+..++.|+
T Consensus 628 ~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~ 707 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707 (768)
T ss_dssp CSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCS
T ss_pred hhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence 3446789999999999999999998887 899999999999999999999999999999999999999999999887776
Q ss_pred CCccceEEccCccCCCCCCCC-CCCCCceeeccCCCccc
Q 005224 100 ATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 100 ~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~ 137 (707)
+|||++|+|++..+.. .+..+....+.+||.-|
T Consensus 708 -----~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lc 741 (768)
T 3rgz_A 708 -----EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741 (768)
T ss_dssp -----EEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEE
T ss_pred -----EEECcCCcccccCCCchhhccCCHHHhcCCchhc
Confidence 9999999999865443 55566667788998544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.61 E-value=1e-15 Score=161.58 Aligned_cols=130 Identities=19% Similarity=0.311 Sum_probs=109.6
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++|+.|+|++|+|+.+++.++++++|++|+|++|.|+ .+|..+..+ +|++|+|++|+|+ .+|..|+++++|++|+|+
T Consensus 81 ~~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 81 PGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158 (328)
T ss_dssp TTCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred cceeEEEccCCCchhcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence 5788999999999977778888999999999999999 899877766 8999999999999 888889999999999999
Q ss_pred CcccccCCCCCccc---------cccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCcccc
Q 005224 81 NNSLSGSIPSSIWQ---------SRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 81 ~N~l~g~~p~~~~~---------l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~~ 138 (707)
+|++.+.+|..+.. +++| ++|+|++|+|+.+|..+ .+++|+.|++++|.+...
T Consensus 159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L-----~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l 221 (328)
T 4fcg_A 159 ACPELTELPEPLASTDASGEHQGLVNL-----QSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSAL 221 (328)
T ss_dssp EETTCCCCCSCSEEEC-CCCEEESTTC-----CEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCC
T ss_pred CCCCccccChhHhhccchhhhccCCCC-----CEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcC
Confidence 98888888887754 4444 48888888888887766 788888888888888643
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.3e-15 Score=155.93 Aligned_cols=128 Identities=21% Similarity=0.199 Sum_probs=79.3
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++|+.|+|++|+|+++.+ .|..+++|++|+|++|.|+ .++......+|+.|+|++|+|+ .+|..+..+++|++|+|+
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-cccCCCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 356777777777776665 5677777777777777776 4554321126666666666666 566666666666666666
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~ 136 (707)
+|+|++..|..+..+++|+ .|+|++|+|+++++.. .+++|+.|+|++|.+.
T Consensus 109 ~N~l~~l~~~~~~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQ-----ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCC-----EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred CCcCcccCHHHHcCCCCCC-----EEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence 6666644445555544443 6666666666665543 5566666666666654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.60 E-value=4.7e-16 Score=163.05 Aligned_cols=131 Identities=28% Similarity=0.450 Sum_probs=105.4
Q ss_pred CCCceEEEeeC-CcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRN-CSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~-N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
|++|++|+|++ |++++.+| .|+++++|++|+|++|+|+|.+|..+..+ +|++|+|++|+|++.+|..|.++++|++|
T Consensus 75 l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 154 (313)
T 1ogq_A 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred CCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeE
Confidence 56889999994 88888777 68889999999999999988888877766 89999999999998889889999999999
Q ss_pred eccCcccccCCCCCccccc-cCCCCccceEEccCccCCCC-CCCC-CCCCCceeeccCCCccc
Q 005224 78 FIANNSLSGSIPSSIWQSR-TLNATETFILDFQNNNLTNI-SGSF-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~-~L~~~~L~~l~l~~N~l~~~-~~~~-~~~~l~~l~l~~N~~~~ 137 (707)
+|++|+++|.+|..+..+. .|+ .|+|++|++++. |..+ .+. |+.|++++|.+..
T Consensus 155 ~L~~N~l~~~~p~~l~~l~~~L~-----~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~ 211 (313)
T 1ogq_A 155 TFDGNRISGAIPDSYGSFSKLFT-----SMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG 211 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCC-----EEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEE
T ss_pred ECcCCcccCcCCHHHhhhhhcCc-----EEECcCCeeeccCChHHhCCc-ccEEECcCCcccC
Confidence 9999999888888887765 554 788888887743 4444 333 7777777777653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=6.1e-15 Score=151.08 Aligned_cols=131 Identities=24% Similarity=0.326 Sum_probs=108.7
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|+|+++++ .|.++++|++|+|++|+|+ .+|...+. + +|++|+|++|+|++..+..|.++++|++|+
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 115 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELR 115 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEE
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEE
Confidence 368899999999998887 6899999999999999999 88887654 3 899999999999976667788999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCcccc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~ 138 (707)
|++|++++..|..+..+++|+ +|+|++|+|+.++... .+++|+.|++++|.+...
T Consensus 116 l~~n~l~~~~~~~~~~l~~L~-----~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 116 LDRNQLKSLPPRVFDSLTKLT-----YLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCC-----EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCCccCeeCHHHhCcCcCCC-----EEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 999999966666677666555 8999999999887753 788899999999887643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.60 E-value=5.8e-15 Score=151.46 Aligned_cols=129 Identities=27% Similarity=0.345 Sum_probs=83.8
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcc-ccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR-LSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
+++|++|+|++|++++. +.+..+++|++|+|++|.|+ .+|... ..+ +|++|+|++|+|++..+..|.++++|++|+
T Consensus 62 l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI-SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC-GGGTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc-hhhcCCCCCCEEECCCCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 45677777777777653 45666777777777777777 455443 233 677777777777765556667777777777
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCcc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~ 136 (707)
|++|++++..|..+..+++|+ .|+|++|+|+++++.. .+++|+.|++++|.+.
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~-----~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLT-----ELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCC-----EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCccCccCHHHhccCccCC-----EEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 777777744444455544444 7777777777766543 5677777777777664
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.60 E-value=9.5e-16 Score=160.75 Aligned_cols=132 Identities=28% Similarity=0.507 Sum_probs=116.3
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCc-ccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLP-RLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L 77 (707)
|++|++|+|++|++++.+| .|.++++|++|+|++|+|+|.+|..+..+ +|++|+|++|+|++.+|..|++++ +|+.|
T Consensus 100 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L 179 (313)
T 1ogq_A 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179 (313)
T ss_dssp CTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEE
T ss_pred CCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEE
Confidence 5789999999999998777 69999999999999999998899887776 899999999999999999999998 99999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCcccc
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~ 138 (707)
+|++|+++|.+|..+..+. | +.|+|++|++++.++. + .+++|+.|++++|.+...
T Consensus 180 ~L~~N~l~~~~~~~~~~l~-L-----~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 236 (313)
T 1ogq_A 180 TISRNRLTGKIPPTFANLN-L-----AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236 (313)
T ss_dssp ECCSSEEEEECCGGGGGCC-C-----SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred ECcCCeeeccCChHHhCCc-c-----cEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeee
Confidence 9999999999999888764 4 4999999999876443 3 788999999999988644
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.9e-15 Score=171.70 Aligned_cols=138 Identities=19% Similarity=0.244 Sum_probs=88.8
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCC---ccccc-CccEEEccCccCCCCCCcc-cCCC----
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPP---GRLSL-NITTIKLSNNKLTGTIPSN-FSGL---- 71 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~---~~~~~-~L~~L~Ls~N~l~~~~p~~-~~~l---- 71 (707)
++|+.|+|++|++++..| .+.++++|++|+|++|+|+ .++. .+..+ +|+.|+|++|++++.+|.. |..+
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCC-BTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcC-CcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 456666666666666444 4556666666666666665 3332 22222 5555555555555433332 3333
Q ss_pred ------------------cccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeecc
Q 005224 72 ------------------PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLR 131 (707)
Q Consensus 72 ------------------~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~ 131 (707)
++|+.|+|++|+|+ .+|..+..++ +|+.|+|++|+|+.+|.. + .+++|+.|+++
T Consensus 432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~-----~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~ 505 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQ-----ALQELNVASNQLKSVPDGVFDRLTSLQYIWLH 505 (562)
T ss_dssp EEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSC-----CCSEEECCSSCCCCCCTTSTTTCTTCCCEECC
T ss_pred EEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCC-----CCCEEECCCCCCCCCCHHHHhcCCCCCEEEec
Confidence 45666666666666 5666555544 445999999999999887 4 78999999999
Q ss_pred CCCccccCCcccccC
Q 005224 132 GNPFCLNTNAEQFCG 146 (707)
Q Consensus 132 ~N~~~~~~~~~~~~~ 146 (707)
+|||.|+|....+-.
T Consensus 506 ~N~~~c~c~~~~~~~ 520 (562)
T 3a79_B 506 DNPWDCTCPGIRYLS 520 (562)
T ss_dssp SCCBCCCHHHHHHHH
T ss_pred CCCcCCCcchHHHHH
Confidence 999999999877644
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.7e-15 Score=158.29 Aligned_cols=131 Identities=22% Similarity=0.348 Sum_probs=118.7
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCC---------
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSG--------- 70 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~--------- 70 (707)
|++|++|+|++|+|+.++..|+.+++|++|+|++|+|+ .+|..+..+ +|++|+|++|++.+.+|..+..
T Consensus 103 l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp GTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 46899999999999955558999999999999999999 999988777 8999999999999999998765
Q ss_pred CcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCcccc
Q 005224 71 LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 71 l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~~ 138 (707)
+++|++|+|++|+|+ .+|..+..+++|+ +|+|++|+++++|+.+ .+++|+.|++++|.+...
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~-----~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~ 244 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLK-----SLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN 244 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCC-----EEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCB
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCC-----EEEccCCCCCcCchhhccCCCCCEEECcCCcchhh
Confidence 999999999999999 9999998877666 9999999999998877 899999999999987543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.58 E-value=3.3e-15 Score=141.83 Aligned_cols=118 Identities=25% Similarity=0.288 Sum_probs=100.8
Q ss_pred cccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCCCCccce
Q 005224 26 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 105 (707)
Q Consensus 26 ~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~ 105 (707)
..+.|++++|+|+ .+|..+. .+|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+++|+ +
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~-~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~-----~ 82 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP-TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLT-----Q 82 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC-TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCC-----E
T ss_pred CCCEEEeCCCCcC-ccCccCC-CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCC-----E
Confidence 4678999999999 8998775 3899999999999988899999999999999999999955555566766665 9
Q ss_pred EEccCccCCCCCCC-C-CCCCCceeeccCCCccccCC-cccccCCCCC
Q 005224 106 LDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTN-AEQFCGSHSD 150 (707)
Q Consensus 106 l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~~~-~~~~~~~~~~ 150 (707)
|+|++|+|+++++. + .+++|+.|+|++|+|.|+|. +..+-.|...
T Consensus 83 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l~~l~~~l~~ 130 (170)
T 3g39_A 83 LSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDILYLSRWISQ 130 (170)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGGHHHHHHHHH
T ss_pred EECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhHHHHHHHHHh
Confidence 99999999999875 4 79999999999999999995 6666666543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.5e-15 Score=142.24 Aligned_cols=128 Identities=24% Similarity=0.326 Sum_probs=109.6
Q ss_pred CCceEEEeeCCcCC-CCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQ-GPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~-~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|+++ +.+| .+..+++|++|+|++|.|+ .+ ..+..+ +|+.|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~-~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC-CC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC-Ch-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 57999999999999 5555 6899999999999999999 56 445444 899999999999987998888899999999
Q ss_pred ccCcccccCCC--CCccccccCCCCccceEEccCccCCCCCC----CC-CCCCCceeeccCCCccc
Q 005224 79 IANNSLSGSIP--SSIWQSRTLNATETFILDFQNNNLTNISG----SF-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 79 ls~N~l~g~~p--~~~~~l~~L~~~~L~~l~l~~N~l~~~~~----~~-~~~~l~~l~l~~N~~~~ 137 (707)
|++|+|+ .+| ..+..+++|+ .|+|++|.+++++. .+ .+++|+.|++.+|++..
T Consensus 102 Ls~N~l~-~~~~~~~l~~l~~L~-----~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 102 LSGNKLK-DISTLEPLKKLECLK-----SLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp CBSSSCC-SSGGGGGGSSCSCCC-----EEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred ccCCccC-cchhHHHHhcCCCCC-----EEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 9999999 554 5676666555 99999999999987 34 79999999999998743
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.6e-15 Score=145.13 Aligned_cols=128 Identities=19% Similarity=0.226 Sum_probs=91.3
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++|+.|+|++|+++.++ .+..+++|++|+|++|.++ .++ .+..+ +|++|+|++|++++..|..|+.+++|++|+|+
T Consensus 44 ~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 44 NSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHAT-NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp HTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCS-CCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCC-cch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 46778888888887444 6777778888888888766 444 33333 78888888888877677777778888888888
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCcc-CCCCCCCCCCCCCceeeccCCCccc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNN-LTNISGSFNIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~-l~~~~~~~~~~~l~~l~l~~N~~~~ 137 (707)
+|++++..|..+..+++|+ .|+|++|+ ++.++....+++|+.|++++|++..
T Consensus 121 ~n~i~~~~~~~l~~l~~L~-----~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVN-----SIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCC-----EEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC
T ss_pred CCccCcHhHHHHhhCCCCC-----EEEccCCCCccccHhhcCCCCCCEEECCCCCCcC
Confidence 8888766666666655554 77888876 7777633367777777777777654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=4.1e-15 Score=172.92 Aligned_cols=144 Identities=21% Similarity=0.230 Sum_probs=115.7
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCc---------cccc-CccEEEccCccCCCCCCcccC
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPG---------RLSL-NITTIKLSNNKLTGTIPSNFS 69 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~---------~~~~-~L~~L~Ls~N~l~~~~p~~~~ 69 (707)
+++|+.|+|++|+|+++++ .|.++++|++|+|++|+|+ .++.. +..+ +|+.|+|++|+|+...+..|.
T Consensus 479 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~ 557 (680)
T 1ziw_A 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK 557 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCG-GGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCcc-ccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcc
Confidence 4678999999999998887 5888999999999999998 44321 2233 799999999999944445689
Q ss_pred CCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC---CCCCCceeeccCCCccccCCc-cccc
Q 005224 70 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF---NIPPNVTVRLRGNPFCLNTNA-EQFC 145 (707)
Q Consensus 70 ~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~---~~~~l~~l~l~~N~~~~~~~~-~~~~ 145 (707)
++++|+.|+|++|+|++..+..+..+++|+ .|+|++|+|+++++.. .+++++.|++++|||.|+|.. ..|-
T Consensus 558 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~-----~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~ 632 (680)
T 1ziw_A 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLK-----SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFV 632 (680)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCC-----EEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEE
T ss_pred cccCcceeECCCCCCCcCCHhHhCCCCCCC-----EEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHH
Confidence 999999999999999944444456665555 9999999999987753 478999999999999999996 8888
Q ss_pred CCCCC
Q 005224 146 GSHSD 150 (707)
Q Consensus 146 ~~~~~ 150 (707)
.|...
T Consensus 633 ~~~~~ 637 (680)
T 1ziw_A 633 NWINE 637 (680)
T ss_dssp CCSSC
T ss_pred HHHHh
Confidence 88754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.5e-15 Score=170.69 Aligned_cols=142 Identities=20% Similarity=0.285 Sum_probs=94.1
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcc--cCCCccccc-CccEEEccCccCCCCCCcc-cCCC----
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNG--SIPPGRLSL-NITTIKLSNNKLTGTIPSN-FSGL---- 71 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g--~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~-~~~l---- 71 (707)
+++|++|+|++|++++..| .++.+++|++|+|++|+|++ .+|..+..+ +|+.|+|++|++++.+|.. |..+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 3566677777777766544 56666666666666666663 223323333 5555555555555434432 4433
Q ss_pred ------------------cccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeecc
Q 005224 72 ------------------PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLR 131 (707)
Q Consensus 72 ------------------~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~ 131 (707)
++|+.|+|++|+|+ .+|..+..+++ |++|+|++|+|+.+|.. + .+++|+.|+++
T Consensus 403 ~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~-----L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~ 476 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEA-----LQELNVASNQLKSVPDGIFDRLTSLQKIWLH 476 (520)
T ss_dssp EEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTT-----CCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred EEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCC-----CCEEECCCCcCCccCHHHhccCCcccEEECc
Confidence 45566666666665 66666655544 45999999999999886 4 78999999999
Q ss_pred CCCccccCCcccc-cCCC
Q 005224 132 GNPFCLNTNAEQF-CGSH 148 (707)
Q Consensus 132 ~N~~~~~~~~~~~-~~~~ 148 (707)
+|+|.|+|....+ -.|.
T Consensus 477 ~N~~~c~c~~~~~~~~~~ 494 (520)
T 2z7x_B 477 TNPWDCSCPRIDYLSRWL 494 (520)
T ss_dssp SSCBCCCHHHHHHHHHHH
T ss_pred CCCCcccCCchHHHHHHH
Confidence 9999999998887 5554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.57 E-value=8.4e-15 Score=141.96 Aligned_cols=110 Identities=27% Similarity=0.366 Sum_probs=98.7
Q ss_pred CCceEEEeeCCcCCCCCCC--cCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
.+|+.|+|++|+|+++++. |..+++|++|+|++|+|++..|..+..+ +|+.|+|++|+|++..|..|.++++|++|+
T Consensus 29 ~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 3789999999999998873 8999999999999999995556666665 899999999999998888899999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCC
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~ 116 (707)
|++|+|++.+|..+..+++|+ +|+|++|.++.-
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~-----~L~L~~N~l~c~ 141 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLT-----SLNLASNPFNCN 141 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCC-----EEECTTCCBCCS
T ss_pred CCCCcCCeeCHHHhhcCCCCC-----EEEeCCCCccCc
Confidence 999999998899998876665 999999999863
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.6e-15 Score=173.78 Aligned_cols=144 Identities=20% Similarity=0.250 Sum_probs=114.9
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCccc-CC--Cccccc-CccEEEccCccCCCCCCcccCCCcccc
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGS-IP--PGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQ 75 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~-ip--~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 75 (707)
+++|+.|+|++|.+++.++ .|..+++|++|+|++|++++. +| ..+..+ +|+.|+|++|++++..|..|.++++|+
T Consensus 424 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 503 (606)
T 3t6q_A 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503 (606)
T ss_dssp CTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred cccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCC
Confidence 4577888888888887776 577788888888888888752 22 223333 788888888888888888888888999
Q ss_pred eEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCCcccccCCCCC
Q 005224 76 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 150 (707)
Q Consensus 76 ~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~~~~~~~~~~~ 150 (707)
.|+|++|++++..|..+.+++ +| .|+|++|+++++++.. .+++|+.|++++|||.|+|....|..|...
T Consensus 504 ~L~Ls~N~l~~~~~~~l~~l~-----~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~w~~~ 574 (606)
T 3t6q_A 504 HVDLSHNRLTSSSIEALSHLK-----GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKE 574 (606)
T ss_dssp EEECCSSCCCGGGGGGGTTCC-----SC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHHHHHHHHH
T ss_pred EEECCCCccCcCChhHhCccc-----cc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHHHHHHHHh
Confidence 999999998888887776654 44 7999999999987764 788999999999999999999888888754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.8e-15 Score=157.97 Aligned_cols=130 Identities=25% Similarity=0.236 Sum_probs=111.1
Q ss_pred CCceEEEeeCCcCCCCCC-CcC-CCCcccEEeccCCcCcccCCCc-cccc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLS-RIPNLGYLDLSSNQLNGSIPPG-RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~-~l~~L~~L~Ls~N~l~g~ip~~-~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+.|+.|+|++|+|+++++ .|. ++++|++|+|++|+|+ .++.. +..+ +|+.|+|++|+|++..+..|.++++|+.|
T Consensus 39 ~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 117 (361)
T 2xot_A 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVL 117 (361)
T ss_dssp TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC-ccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEE
Confidence 358899999999999888 476 8999999999999999 66654 4444 89999999999997777789999999999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-----CCCCCceeeccCCCccc
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-----NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-----~~~~l~~l~l~~N~~~~ 137 (707)
+|++|+|++..|..+..+++|+ .|+|++|+|+.+|... .+++|+.|+|++|++..
T Consensus 118 ~L~~N~i~~~~~~~~~~l~~L~-----~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 118 LLYNNHIVVVDRNAFEDMAQLQ-----KLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp ECCSSCCCEECTTTTTTCTTCC-----EEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred ECCCCcccEECHHHhCCcccCC-----EEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 9999999977788888776665 9999999999998764 48899999999999863
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=5.7e-15 Score=167.83 Aligned_cols=144 Identities=18% Similarity=0.275 Sum_probs=122.8
Q ss_pred CCCceEEEeeCCcCCCCCC--CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCC-CCCCcccCCCcccce
Q 005224 1 MSKLLKLSLRNCSLQGPMP--DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLT-GTIPSNFSGLPRLQR 76 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~ 76 (707)
+++|+.|+|++|.+++.++ .+..+++|++|+|++|.+++.+|..+..+ +|+.|+|++|+++ +.+|..|..+++|+.
T Consensus 395 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~ 474 (570)
T 2z63_A 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474 (570)
T ss_dssp CTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred cCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCE
Confidence 4678899999999988776 58889999999999999996666655555 8999999999998 678999999999999
Q ss_pred EeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCCccccc-CCCC
Q 005224 77 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFC-GSHS 149 (707)
Q Consensus 77 L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~~~~~~-~~~~ 149 (707)
|+|++|++++..|..+..+++|+ .|+|++|+|+++++.. .+++|+.|++++|+|.|+|....+- .|..
T Consensus 475 L~l~~n~l~~~~~~~~~~l~~L~-----~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~ 545 (570)
T 2z63_A 475 LDLSQCQLEQLSPTAFNSLSSLQ-----VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 545 (570)
T ss_dssp EECTTSCCCEECTTTTTTCTTCC-----EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHH
T ss_pred EECCCCccccCChhhhhcccCCC-----EEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHH
Confidence 99999999988898888776665 9999999999997753 7899999999999999999876655 5543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=6.5e-15 Score=169.31 Aligned_cols=131 Identities=24% Similarity=0.298 Sum_probs=114.2
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
+++++|||++|+|+++++ +|.++++|++|+|++|+|+ .||++.+. + +|++|+|++|+|++..+..|.+|++|++|+
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 368999999999999988 7999999999999999999 88876554 4 899999999999977777899999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCC--CCC-CCCCCceeeccCCCcccc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS--GSF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~--~~~-~~~~l~~l~l~~N~~~~~ 138 (707)
|++|+|++..+..+.++++|+ +|+|++|+|+.++ ..+ .+++|+.|++++|.+...
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~-----~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 188 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLK-----ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 188 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCC-----EEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred CCCCcCCCCChhhhhcCcccC-----eeccccCccccCCCchhhccchhhhhhcccCcccccc
Confidence 999999966566788777665 9999999999864 334 789999999999998654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.9e-14 Score=148.56 Aligned_cols=131 Identities=24% Similarity=0.273 Sum_probs=104.5
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCcc-CCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNK-LTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|+|+++++ .|..+++|++|+|++|.|++..|..+..+ +|++|+|++|+ ++...|..|.++++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 468889999999988877 58888899999999999884445555554 78999999987 7766678888888999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCccc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~ 137 (707)
|++|++++..|..+..+++|+ +|+|++|+++.++.. + .+++|+.|++++|.+..
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~-----~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 167 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQ-----YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCC-----EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCC-----EEECCCCcccccCHhHhccCCCccEEECCCCcccc
Confidence 999998876677777666555 888888888888765 3 68888888888888754
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=6.5e-15 Score=157.04 Aligned_cols=145 Identities=19% Similarity=0.304 Sum_probs=83.8
Q ss_pred CCceEEEeeCCcCCCCCCC-cCCCCcccEEeccCCcCcccCCC-ccc-cc-CccEEEccCc-cCCCCCCcccCCCcccce
Q 005224 2 SKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP-GRL-SL-NITTIKLSNN-KLTGTIPSNFSGLPRLQR 76 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~g~ip~-~~~-~~-~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~ 76 (707)
++|++|+|++|+|+++++. |.++++|++|+|++|+++ .+|. ..+ .+ +|+.|+|++| .+++..|..|.++++|+.
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~ 178 (353)
T 2z80_A 100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178 (353)
T ss_dssp TTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEE
T ss_pred CCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCE
Confidence 4556666666666655543 555666666666666666 5554 222 22 5555555555 344444455555556666
Q ss_pred EeccCcccccCCCCCccccccC----------------------------------------------------------
Q 005224 77 LFIANNSLSGSIPSSIWQSRTL---------------------------------------------------------- 98 (707)
Q Consensus 77 L~ls~N~l~g~~p~~~~~l~~L---------------------------------------------------------- 98 (707)
|++++|++++..|..+..+++|
T Consensus 179 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~ 258 (353)
T 2z80_A 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258 (353)
T ss_dssp EEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEES
T ss_pred EECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcccccc
Confidence 6666666555445444433221
Q ss_pred ----------------CCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCC-cccccCC
Q 005224 99 ----------------NATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN-AEQFCGS 147 (707)
Q Consensus 99 ----------------~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~-~~~~~~~ 147 (707)
.+++|+.|+|++|+|+.+|..+ .+++|+.|++++|+|.|+|. +..+-.|
T Consensus 259 ~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~l~~l~~~ 326 (353)
T 2z80_A 259 VKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 326 (353)
T ss_dssp CBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHHHHHHHH
T ss_pred ccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCCcHHHHHH
Confidence 1235667777777777777653 67778888888888888775 4344333
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.55 E-value=4e-15 Score=165.67 Aligned_cols=129 Identities=19% Similarity=0.176 Sum_probs=76.9
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccc-cc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|+|++.+| .|+.+++|++|+|++|.|++.+|..+. .+ +|+.|+|++|+|++. |. +..+++|+.|+
T Consensus 120 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~ 197 (487)
T 3oja_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLD 197 (487)
T ss_dssp SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEE
Confidence 456666666666666555 566666666666666666655555444 22 566666666666644 22 33466666666
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCcccc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~~ 138 (707)
|++|+|++ +|..+..+++|+ .|+|++|+|+++|..+ .+++|..|++++|++.|.
T Consensus 198 Ls~N~l~~-~~~~~~~l~~L~-----~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 198 LSSNKLAF-MGPEFQSAAGVT-----WISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CCSSCCCE-ECGGGGGGTTCS-----EEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred CCCCCCCC-CCHhHcCCCCcc-----EEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 66666663 343455544443 6666666666666655 556666666666666554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.55 E-value=2e-14 Score=136.95 Aligned_cols=115 Identities=23% Similarity=0.318 Sum_probs=97.7
Q ss_pred ccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCCCCccceE
Q 005224 27 LGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 106 (707)
Q Consensus 27 L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l 106 (707)
-+.+++++|+|+ .+|..+. .+|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..+..+++|+ +|
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~-----~L 86 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP-TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLT-----QL 86 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC-TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC-----EE
T ss_pred CcEEEeCCCCCC-ccCCCcC-CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhh-----EE
Confidence 478999999998 9998776 4899999999999988899999999999999999999954444456666655 99
Q ss_pred EccCccCCCCCCC-C-CCCCCceeeccCCCccccCC-cccccCCC
Q 005224 107 DFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTN-AEQFCGSH 148 (707)
Q Consensus 107 ~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~~~-~~~~~~~~ 148 (707)
+|++|+|+++++. + .+++|+.|+|++|+|.|+|. +..+-.|.
T Consensus 87 ~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~~~l~~~~ 131 (174)
T 2r9u_A 87 DLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDIMYLRNWV 131 (174)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGGHHHHHHH
T ss_pred ECCCCccceeCHHHhccccCCCEEEeCCCCcccccccHHHHHHHH
Confidence 9999999999886 4 79999999999999999986 44454444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.54 E-value=6.2e-15 Score=154.81 Aligned_cols=132 Identities=18% Similarity=0.166 Sum_probs=102.7
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++|+.|+|++|++++.++ .+..+++|++|+|++|.|++..|..+.. + +|++|+|++|+|++. |. ...+++|++|
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L 196 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTL 196 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEE
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEE
Confidence 3568888888888888777 6888888999999999988544454442 3 789999999998854 33 3358889999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCccccCC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNTN 140 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~~~~ 140 (707)
+|++|+|+ .+|..+..+++|+ .|+|++|+|+.+|..+ .+++|+.|++++|+|.|.+.
T Consensus 197 ~Ls~N~l~-~l~~~~~~l~~L~-----~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~~~ 254 (317)
T 3o53_A 197 DLSSNKLA-FMGPEFQSAAGVT-----WISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTL 254 (317)
T ss_dssp ECCSSCCC-EECGGGGGGTTCS-----EEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHHHH
T ss_pred ECCCCcCC-cchhhhcccCccc-----EEECcCCcccchhhHhhcCCCCCEEEccCCCccCcCH
Confidence 99999998 5666677666555 8999999999888777 77889999999999887653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=2.2e-14 Score=162.39 Aligned_cols=128 Identities=20% Similarity=0.329 Sum_probs=93.3
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
|++|+.|+|++|+|++++..+..+++|++|+|++|+|+ .+|..+.. +|+.|+|++|+|++.+ ..+++|++|+|+
T Consensus 386 l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~-~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls 459 (549)
T 2z81_A 386 LKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ-TLEVLDVSNNNLDSFS----LFLPRLQELYIS 459 (549)
T ss_dssp CTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCS-CCCTTSCT-TCSEEECCSSCCSCCC----CCCTTCCEEECC
T ss_pred CCCCCEEECCCCCCccCChhhcccccccEEECCCCCcc-cccchhcC-CceEEECCCCChhhhc----ccCChhcEEECC
Confidence 34566666666666654445666666666666666666 55554432 6677777777776432 478899999999
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCccccCCc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNA 141 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~~~~ 141 (707)
+|+|+ .+|. ...++ +|++|+|++|+|+++++. + .+++|+.|++++|+|.|+|..
T Consensus 460 ~N~l~-~ip~-~~~l~-----~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 460 RNKLK-TLPD-ASLFP-----VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp SSCCS-SCCC-GGGCT-----TCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred CCccC-cCCC-cccCc-----cCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 99998 8887 34444 455999999999999876 3 899999999999999999973
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.9e-14 Score=146.84 Aligned_cols=122 Identities=26% Similarity=0.358 Sum_probs=56.0
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++|+.|+|++|+|+.++ .+..+++|++|+|++|+|+ .+|. +..+ +|+.|+|++|+|++ +|... . ++|+.|+|+
T Consensus 41 ~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~-~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L~ 114 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFLD 114 (263)
T ss_dssp TTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEECC
T ss_pred CcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccC-CChh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEcc
Confidence 34555555555555332 4555555555555555555 3433 2222 45555555555552 33211 1 455555555
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
+|++++ +| .+..+++|+ .|+|++|+|++++....+++|+.|++++|++.
T Consensus 115 ~N~l~~-~~-~l~~l~~L~-----~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 115 NNELRD-TD-SLIHLKNLE-----ILSIRNNKLKSIVMLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp SSCCSB-SG-GGTTCTTCC-----EEECTTSCCCBCGGGGGCTTCCEEECTTSCCC
T ss_pred CCccCC-Ch-hhcCccccc-----EEECCCCcCCCChHHccCCCCCEEECCCCcCc
Confidence 555542 22 233333222 45555555555432224445555555555443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=7e-15 Score=163.49 Aligned_cols=142 Identities=21% Similarity=0.254 Sum_probs=104.7
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcc-----------------------cCCCccc-cc-CccEEE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNG-----------------------SIPPGRL-SL-NITTIK 54 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g-----------------------~ip~~~~-~~-~L~~L~ 54 (707)
+++|+.|+|++|+++++.+ .|..+++|++|+|++|.+.+ .+|...+ .+ +|+.|+
T Consensus 175 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 254 (477)
T 2id5_A 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLN 254 (477)
T ss_dssp CTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEE
T ss_pred cCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeE
Confidence 4577888888888877666 56666666665555544443 4443222 22 677777
Q ss_pred ccCccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccC
Q 005224 55 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRG 132 (707)
Q Consensus 55 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~ 132 (707)
|++|+|++..+..|.++++|+.|+|++|++++..|..+..+++|+ .|+|++|+|+++++.. .+++|+.|++++
T Consensus 255 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 329 (477)
T 2id5_A 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR-----VLNVSGNQLTTLEESVFHSVGNLETLILDS 329 (477)
T ss_dssp CCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCC-----EEECCSSCCSCCCGGGBSCGGGCCEEECCS
T ss_pred CCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCC-----EEECCCCcCceeCHhHcCCCcccCEEEccC
Confidence 777777766666777788888888888888877777777666555 9999999999998754 788999999999
Q ss_pred CCccccCCcccccCC
Q 005224 133 NPFCLNTNAEQFCGS 147 (707)
Q Consensus 133 N~~~~~~~~~~~~~~ 147 (707)
|+|.|+|.+..+-.+
T Consensus 330 N~l~c~c~~~~~~~~ 344 (477)
T 2id5_A 330 NPLACDCRLLWVFRR 344 (477)
T ss_dssp SCEECSGGGHHHHTT
T ss_pred CCccCccchHhHHhh
Confidence 999999998766554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.5e-14 Score=141.92 Aligned_cols=127 Identities=24% Similarity=0.285 Sum_probs=108.4
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccc-cc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++|++|+|++|+|+++++ .|..+++|++|+|++|+|+ .+|...+ .+ +|++|+|++|+|++..+..|.++++|++|
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 129 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL 129 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE
Confidence 4789999999999998887 5899999999999999999 7777654 34 89999999999997777779999999999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcccc
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~~ 138 (707)
+|++|++++..+..+..+++|+ .|+|++|.+.+ .+++++.|++..|.+...
T Consensus 130 ~l~~N~l~~~~~~~~~~l~~L~-----~L~l~~N~~~~-----~~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 130 RLYQNQLKSVPDGVFDRLTSLQ-----YIWLHDNPWDC-----TCPGIRYLSEWINKHSGV 180 (208)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCC-----EEECCSCCBCC-----CTTTTHHHHHHHHHCTTT
T ss_pred ECCCCccceeCHHHhccCCCcc-----EEEecCCCeec-----CCCCHHHHHHHHHhCCce
Confidence 9999999965555577666665 99999998876 467889999988887643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.53 E-value=5.5e-15 Score=136.88 Aligned_cols=124 Identities=22% Similarity=0.299 Sum_probs=103.3
Q ss_pred CCceEEEeeCCcCC-CCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQ-GPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~-~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|+++ +.+| .+..+++|++|+|++|.|+ .+ ..+..+ +|+.|+|++|+|++.+|..+.++++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~-~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCC-CC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCC-Cc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 46899999999999 5555 6899999999999999999 55 444444 899999999999987898888899999999
Q ss_pred ccCcccccC-CCCCccccccCCCCccceEEccCccCCCCCC----CC-CCCCCceeeccC
Q 005224 79 IANNSLSGS-IPSSIWQSRTLNATETFILDFQNNNLTNISG----SF-NIPPNVTVRLRG 132 (707)
Q Consensus 79 ls~N~l~g~-~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~----~~-~~~~l~~l~l~~ 132 (707)
|++|++++. .|..+..+++|+ .|++++|+++++++ .+ .+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~-----~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLK-----SLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCC-----EEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCC-----EEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999952 337777766665 99999999999987 23 788999888753
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.53 E-value=1e-14 Score=142.00 Aligned_cols=128 Identities=16% Similarity=0.246 Sum_probs=109.6
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
+++|++|+|++|.++.. +.+..+++|++|+|++|++++..|..+..+ +|++|+|++|++++..|..|..+++|++|+|
T Consensus 65 l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L 143 (197)
T 4ezg_A 65 AHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143 (197)
T ss_dssp CTTCSEEEEESCCCSCC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred CCCCCEEEccCCCCCcc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence 57899999999987643 478999999999999999997677777766 8999999999999888999999999999999
Q ss_pred cCcc-cccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 80 ANNS-LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 80 s~N~-l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
++|. ++ .+| .+..+++|+ .|+|++|+++.++....+++|+.|++++|++.
T Consensus 144 ~~n~~i~-~~~-~l~~l~~L~-----~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 144 SYNGAIT-DIM-PLKTLPELK-----SLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CSCTBCC-CCG-GGGGCSSCC-----EEECTTBCCCCCTTGGGCSSCCEEEECBC---
T ss_pred cCCCCcc-ccH-hhcCCCCCC-----EEECCCCCCcChHHhccCCCCCEEEeeCcccC
Confidence 9998 65 777 577766655 99999999999884448999999999999973
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.6e-14 Score=143.18 Aligned_cols=109 Identities=19% Similarity=0.314 Sum_probs=98.8
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccc-cc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
|++|+.|+|++|+|+++++ .|.++++|++|+|++|+|+ .+|...+ .+ +|+.|+|++|+|++..|..|.++++|+.|
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 134 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccC-ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence 5789999999999999988 7999999999999999999 6776544 44 89999999999999889999999999999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~ 115 (707)
+|++|+|++..|..+..+++|+ .|+|++|.++.
T Consensus 135 ~L~~N~l~~~~~~~~~~l~~L~-----~L~L~~N~l~c 167 (220)
T 2v70_A 135 SLYDNQITTVAPGAFDTLHSLS-----TLNLLANPFNC 167 (220)
T ss_dssp ECTTSCCCCBCTTTTTTCTTCC-----EEECCSCCEEC
T ss_pred ECCCCcCCEECHHHhcCCCCCC-----EEEecCcCCcC
Confidence 9999999988899898877665 99999999986
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.2e-14 Score=147.34 Aligned_cols=130 Identities=25% Similarity=0.307 Sum_probs=112.7
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCc-cccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPG-RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|++|+|++|+|+++++ .|.++++|++|+|++|+++ .++.. +..+ +|++|+|++|+|++..+..|.++++|++|+
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCC-ccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 369999999999999888 7999999999999999999 66664 4444 899999999999988889999999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCC--CCCC-CCCCCceeeccCCCccc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI--SGSF-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~--~~~~-~~~~l~~l~l~~N~~~~ 137 (707)
+++|++++..+..+..+++|+ +|+|++|+++.+ |..+ .+++|+.|++++|.+..
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~-----~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~ 163 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLK-----ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCC-----EEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CCCCCccccCchhcccCCCCC-----EEECcCCccceecCchhhccCCCCCEEECCCCCCCc
Confidence 999999966666777766665 999999999984 5555 78999999999998854
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.53 E-value=5e-14 Score=140.52 Aligned_cols=127 Identities=20% Similarity=0.141 Sum_probs=107.8
Q ss_pred ceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCc
Q 005224 4 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 82 (707)
Q Consensus 4 L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 82 (707)
.+.++.++|+++.++..+. ++|++|+|++|+|++..|..+..+ +|+.|+|++|+|+...+..|.++++|+.|+|++|
T Consensus 21 ~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 3578999999998887654 899999999999995445555555 8999999999999666677899999999999999
Q ss_pred ccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCccc
Q 005224 83 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 83 ~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~ 137 (707)
+|++..+..+..+++|+ .|+|++|+|+.+|..+ .+++|+.|+|++|.+..
T Consensus 99 ~l~~l~~~~~~~l~~L~-----~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~ 149 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLK-----ELFMCCNKLTELPRGIERLTHLTHLALDQNQLKS 149 (229)
T ss_dssp CCCCCCTTTTTTCTTCC-----EEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCC
T ss_pred cCCccChhHhCcchhhC-----eEeccCCcccccCcccccCCCCCEEECCCCcCCc
Confidence 99955555567666665 9999999999998887 89999999999999864
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.9e-14 Score=150.07 Aligned_cols=131 Identities=23% Similarity=0.316 Sum_probs=87.9
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCC--ccccc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~--~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++|++|+|++|.++.+++.+..+++|++|+|++|+++ .++. .+..+ +|++|+|++|++++..|..|.++++|++|
T Consensus 77 ~~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 155 (306)
T 2z66_A 77 TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155 (306)
T ss_dssp CSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEE-SSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCccccChhhcCCCCCCCEEECCCCccc-ccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence 35677777777777765556777777777777777777 4543 23333 67777777777776667777777777777
Q ss_pred eccCccccc-CCCCCccccccCCCCccceEEccCccCCCCCC-CC-CCCCCceeeccCCCccc
Q 005224 78 FIANNSLSG-SIPSSIWQSRTLNATETFILDFQNNNLTNISG-SF-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 78 ~ls~N~l~g-~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~-~~-~~~~l~~l~l~~N~~~~ 137 (707)
+|++|.+++ .+|..+..+++|+ .|+|++|+|+++++ .+ .+++|+.|++++|.+..
T Consensus 156 ~l~~n~l~~~~~~~~~~~l~~L~-----~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (306)
T 2z66_A 156 KMAGNSFQENFLPDIFTELRNLT-----FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213 (306)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCC-----EEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB
T ss_pred ECCCCccccccchhHHhhCcCCC-----EEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc
Confidence 777777765 4666666655444 77777777777643 33 56777777777777654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=9.8e-15 Score=139.34 Aligned_cols=127 Identities=20% Similarity=0.272 Sum_probs=102.5
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCC-cccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIP-NLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
+.+|+.|+|++|+|+.+ +.+..+. +|++|+|++|.|+ .+ ..+..+ +|+.|+|++|+|++..+..|..+++|++|+
T Consensus 18 ~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~-~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCC-cc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 35789999999999966 6666665 9999999999999 56 444444 899999999999965445568999999999
Q ss_pred ccCcccccCCCC--CccccccCCCCccceEEccCccCCCCCCC----C-CCCCCceeeccCCCcc
Q 005224 79 IANNSLSGSIPS--SIWQSRTLNATETFILDFQNNNLTNISGS----F-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 79 ls~N~l~g~~p~--~~~~l~~L~~~~L~~l~l~~N~l~~~~~~----~-~~~~l~~l~l~~N~~~ 136 (707)
|++|+|+ .+|. .+..+++|+ .|+|++|.++.++.. + .+++|+.|++++|+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~-----~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLT-----YLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCC-----EEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCC-----EEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999997 7776 666655555 999999999988874 4 7899999999988864
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=4.8e-14 Score=148.79 Aligned_cols=131 Identities=22% Similarity=0.351 Sum_probs=105.7
Q ss_pred CCCceEEEeeCCcCCC--CCC-CcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQG--PMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~--~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++|+.|+|++|.++. ..+ .|.++++|++|+|++|+++ .+|..+. .+|+.|+|++|++++..|..|.++++|+.|
T Consensus 144 l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 221 (330)
T 1xku_A 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP-PSLTELHLDGNKITKVDAASLKGLNNLAKL 221 (330)
T ss_dssp CTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC-TTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred CccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc-ccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 4567777777777753 444 5777888888888888888 7887665 388999999999998888889999999999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCcccc
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~~ 138 (707)
+|++|++++..+..+..+++|+ .|+|++|+|+.+|..+ .+++|+.|++++|++...
T Consensus 222 ~Ls~n~l~~~~~~~~~~l~~L~-----~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~ 278 (330)
T 1xku_A 222 GLSFNSISAVDNGSLANTPHLR-----ELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 278 (330)
T ss_dssp ECCSSCCCEECTTTGGGSTTCC-----EEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred ECCCCcCceeChhhccCCCCCC-----EEECCCCcCccCChhhccCCCcCEEECCCCcCCcc
Confidence 9999999877677787766655 8999999999888877 788899999999988643
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.52 E-value=6e-14 Score=139.04 Aligned_cols=125 Identities=24% Similarity=0.370 Sum_probs=106.7
Q ss_pred eEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceEeccCc
Q 005224 5 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 82 (707)
Q Consensus 5 ~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 82 (707)
+.+++++|+|+.++..+. ++|+.|+|++|+|+ .+|...+. + +|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~-~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSSCCSSCC--TTCCEEECCSSCCC-EECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCcCCCccC--cCCCEEECCCCcCC-CcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 578999999998877665 78999999999999 77765443 4 8999999999999888999999999999999999
Q ss_pred ccccCCCCC-ccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCcccc
Q 005224 83 SLSGSIPSS-IWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 83 ~l~g~~p~~-~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~ 138 (707)
+|+ .+|.. +..+++|+ .|+|++|+|+++++. + .+++|+.|+|++|.+...
T Consensus 91 ~l~-~l~~~~f~~l~~L~-----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 143 (220)
T 2v9t_B 91 KIT-ELPKSLFEGLFSLQ-----LLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTI 143 (220)
T ss_dssp CCC-CCCTTTTTTCTTCC-----EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred cCC-ccCHhHccCCCCCC-----EEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEE
Confidence 999 55554 56666555 999999999999654 4 889999999999998643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.51 E-value=6.7e-15 Score=169.56 Aligned_cols=124 Identities=15% Similarity=0.165 Sum_probs=98.4
Q ss_pred cCCCCCCCcCCCCcccEEeccCCcCccc-----------------CCCccc--cc-CccEEEccCccCCCCCCcccCCCc
Q 005224 13 SLQGPMPDLSRIPNLGYLDLSSNQLNGS-----------------IPPGRL--SL-NITTIKLSNNKLTGTIPSNFSGLP 72 (707)
Q Consensus 13 ~l~~~~~~~~~l~~L~~L~Ls~N~l~g~-----------------ip~~~~--~~-~L~~L~Ls~N~l~~~~p~~~~~l~ 72 (707)
+|++++++|+++++|++|+|++|+|+|. +|..+. .+ +|++|+|++|++.+.+|..|++++
T Consensus 194 ~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 273 (636)
T 4eco_A 194 NITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP 273 (636)
T ss_dssp EEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCS
T ss_pred CCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCC
Confidence 3445333688899999999999999975 888887 66 899999999999989999999999
Q ss_pred ccceEeccCcc-ccc-CCCCCccccccC-CCCccceEEccCccCCCCCC--CC-CCCCCceeeccCCCcc
Q 005224 73 RLQRLFIANNS-LSG-SIPSSIWQSRTL-NATETFILDFQNNNLTNISG--SF-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 73 ~L~~L~ls~N~-l~g-~~p~~~~~l~~L-~~~~L~~l~l~~N~l~~~~~--~~-~~~~l~~l~l~~N~~~ 136 (707)
+|++|+|++|+ ++| .+|..++.+..+ .+++|++|+|++|+|+.+|. .+ .+++|+.|++++|.+.
T Consensus 274 ~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~ 343 (636)
T 4eco_A 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343 (636)
T ss_dssp SCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCE
T ss_pred CCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCc
Confidence 99999999998 888 888888775100 01234489999999998887 55 7888899999988876
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.7e-14 Score=150.92 Aligned_cols=131 Identities=18% Similarity=0.147 Sum_probs=79.6
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCccc--CCCcc--ccc-CccEEEccCccCCCCCCc----ccCCC
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGS--IPPGR--LSL-NITTIKLSNNKLTGTIPS----NFSGL 71 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~--ip~~~--~~~-~L~~L~Ls~N~l~~~~p~----~~~~l 71 (707)
++|++|+|++|+|++.++ .|+.+++|++|+|++|++.+. ++... ..+ +|++|+|++|+|+ .+|. .+.++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 466777777777766665 566677777777777766532 32222 122 5666777777665 3333 24566
Q ss_pred cccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 72 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 72 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
++|++|+|++|+|++.+|..+..+..+ ++|++|+|++|+|+.+|..+. ++|+.|+|++|++.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~--~~L~~L~Ls~N~l~~lp~~~~-~~L~~L~Ls~N~l~ 285 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWS--SALNSLNLSFAGLEQVPKGLP-AKLRVLDLSSNRLN 285 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCC--TTCCCEECCSSCCCSCCSCCC-SCCSCEECCSCCCC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCc--CcCCEEECCCCCCCchhhhhc-CCCCEEECCCCcCC
Confidence 677777777777776656666554322 244577777777776665543 56677777777664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.4e-14 Score=154.80 Aligned_cols=134 Identities=22% Similarity=0.221 Sum_probs=112.6
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++|+.|+|++|++++. +.+..+++|++|+|++|.+++..|..+..+ +|+.|+|++|+|+ .+|..+..+++|++|+|+
T Consensus 226 ~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~ 303 (390)
T 3o6n_A 226 VELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 303 (390)
T ss_dssp SSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECC
T ss_pred ccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECC
Confidence 4678888888888865 568889999999999999996556666555 8999999999999 577778889999999999
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccccCCcccc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQF 144 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~~~~~~~~ 144 (707)
+|+++ .+|..+..+++|+ .|+|++|+|+.++ ...+++|+.|++++|+|.|+|....+
T Consensus 304 ~n~l~-~~~~~~~~l~~L~-----~L~L~~N~i~~~~-~~~~~~L~~L~l~~N~~~~~~~~~~~ 360 (390)
T 3o6n_A 304 HNHLL-HVERNQPQFDRLE-----NLYLDHNSIVTLK-LSTHHTLKNLTLSHNDWDCNSLRALF 360 (390)
T ss_dssp SSCCC-CCGGGHHHHTTCS-----EEECCSSCCCCCC-CCTTCCCSEEECCSSCEEHHHHHHHT
T ss_pred CCcce-ecCccccccCcCC-----EEECCCCccceeC-chhhccCCEEEcCCCCccchhHHHHH
Confidence 99999 7888887776665 9999999999986 23788999999999999998854433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.9e-14 Score=143.16 Aligned_cols=130 Identities=26% Similarity=0.369 Sum_probs=113.4
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCc-CcccCCCcccc-c-CccEEEccC-ccCCCCCCcccCCCcccce
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQ-LNGSIPPGRLS-L-NITTIKLSN-NKLTGTIPSNFSGLPRLQR 76 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~-l~g~ip~~~~~-~-~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~ 76 (707)
++|+.|+|++|+|+++++ .|.++++|++|+|++|+ ++ .+|...+. + +|++|+|++ |+|++..+..|.++++|++
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 479999999999999988 79999999999999997 88 88875543 4 899999999 9999777788999999999
Q ss_pred EeccCcccccCCCCCccccccCCCCccceEEccCc-cCCCCCCC-C-CCCCCc-eeeccCCCcc
Q 005224 77 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN-NLTNISGS-F-NIPPNV-TVRLRGNPFC 136 (707)
Q Consensus 77 L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N-~l~~~~~~-~-~~~~l~-~l~l~~N~~~ 136 (707)
|+|++|+++ .+|. +..+++|+ .|++|++++| +++.+++. + .+++|+ .|++++|.+.
T Consensus 110 L~l~~n~l~-~lp~-~~~l~~L~--~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 110 LGIFNTGLK-MFPD-LTKVYSTD--IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEEEECCC-SCCC-CTTCCBCC--SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred EeCCCCCCc-cccc-cccccccc--cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 999999999 5887 77766664 2569999999 99999875 3 789999 9999999875
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.50 E-value=2e-14 Score=150.57 Aligned_cols=130 Identities=22% Similarity=0.211 Sum_probs=65.9
Q ss_pred CCceEEEeeCCcCCCCCCCcCCC-----CcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCC--CCccc--CCC
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRI-----PNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGT--IPSNF--SGL 71 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l-----~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~--~p~~~--~~l 71 (707)
++|++|+|++|+|++.++.++.+ ++|++|+|++|+|++..|..+..+ +|++|+|++|++.+. +|..+ .++
T Consensus 121 ~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 200 (312)
T 1wwl_A 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKF 200 (312)
T ss_dssp CCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSC
T ss_pred CCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccC
Confidence 45666666666666653234444 566666666666663222333333 566666666665543 22233 555
Q ss_pred cccceEeccCccccc--CCCCCc-cccccCCCCccceEEccCccCCCCCC--CC-CCCCCceeeccCCCcc
Q 005224 72 PRLQRLFIANNSLSG--SIPSSI-WQSRTLNATETFILDFQNNNLTNISG--SF-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 72 ~~L~~L~ls~N~l~g--~~p~~~-~~l~~L~~~~L~~l~l~~N~l~~~~~--~~-~~~~l~~l~l~~N~~~ 136 (707)
++|++|+|++|+|++ .++..+ ..++ +|+.|+|++|+|++.++ .+ .+++|+.|++++|.+.
T Consensus 201 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~-----~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 201 PTLQVLALRNAGMETPSGVCSALAAARV-----QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp TTCCEEECTTSCCCCHHHHHHHHHHTTC-----CCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred CCCCEEECCCCcCcchHHHHHHHHhcCC-----CCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 666666666666651 111111 1222 23356666666655432 11 3455556666666554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.50 E-value=7.4e-14 Score=160.84 Aligned_cols=125 Identities=25% Similarity=0.324 Sum_probs=72.6
Q ss_pred CceEEEeeCCcCCCCCCC-cCCCCcccEEeccCCcCcccCCCccccc---------CccEEEccCccCCCCCCcccC--C
Q 005224 3 KLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL---------NITTIKLSNNKLTGTIPSNFS--G 70 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~~---------~L~~L~Ls~N~l~~~~p~~~~--~ 70 (707)
+|+.|+|++|+|+.+++. +..+++|++|+|++|+|+ .+|...+.. +|+.|+|++|+|+ .+|..+. .
T Consensus 434 ~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~ 511 (636)
T 4eco_A 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATT 511 (636)
T ss_dssp CEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTT
T ss_pred CCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhcc
Confidence 566666666666655443 444666666666666666 666554431 5666666666666 5666555 6
Q ss_pred CcccceEeccCcccccCCCCCccccccCCCCccceEEcc------CccCCC-CCCCC-CCCCCceeeccCCCc
Q 005224 71 LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ------NNNLTN-ISGSF-NIPPNVTVRLRGNPF 135 (707)
Q Consensus 71 l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~------~N~l~~-~~~~~-~~~~l~~l~l~~N~~ 135 (707)
+++|+.|+|++|+|++ +|..+..+++|+ .|+|+ +|++.+ +|..+ .+++|+.|++++|.+
T Consensus 512 l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~-----~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 578 (636)
T 4eco_A 512 LPYLVGIDLSYNSFSK-FPTQPLNSSTLK-----GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578 (636)
T ss_dssp CTTCCEEECCSSCCSS-CCCGGGGCSSCC-----EEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred CCCcCEEECCCCCCCC-cChhhhcCCCCC-----EEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC
Confidence 6666666666666664 666665544444 56663 344443 23333 555666666666665
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=2e-14 Score=150.42 Aligned_cols=127 Identities=21% Similarity=0.293 Sum_probs=108.2
Q ss_pred CCCceEEEeeCCcCCC---CCC--CcCCCCcccEEeccCCcCcccCCCc---c-ccc-CccEEEccCccCCCCCCcccCC
Q 005224 1 MSKLLKLSLRNCSLQG---PMP--DLSRIPNLGYLDLSSNQLNGSIPPG---R-LSL-NITTIKLSNNKLTGTIPSNFSG 70 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~---~~~--~~~~l~~L~~L~Ls~N~l~g~ip~~---~-~~~-~L~~L~Ls~N~l~~~~p~~~~~ 70 (707)
+++|++|+|++|++.+ .++ .+..+++|++|+|++|+|+ .+|.. + ..+ +|++|+|++|+|++..|..+..
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 246 (310)
T 4glp_A 168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPR 246 (310)
T ss_dssp CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSS
T ss_pred CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHh
Confidence 5789999999999986 333 3578999999999999998 66653 2 233 8999999999999888988888
Q ss_pred C---cccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 71 L---PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 71 l---~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|+++|....+++|+.|++++|+|.
T Consensus 247 ~~~~~~L~~L~Ls~N~l~-~lp~~~~-------~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 247 CMWSSALNSLNLSFAGLE-QVPKGLP-------AKLRVLDLSSNRLNRAPQPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CCCCTTCCCEECCSSCCC-SCCSCCC-------SCCSCEECCSCCCCSCCCTTSCCCCSCEECSSTTTS
T ss_pred ccCcCcCCEEECCCCCCC-chhhhhc-------CCCCEEECCCCcCCCCchhhhCCCccEEECcCCCCC
Confidence 7 69999999999999 8898773 355699999999999876558999999999999985
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=4e-14 Score=156.20 Aligned_cols=132 Identities=22% Similarity=0.290 Sum_probs=115.1
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|++|+|++|+|++++| .|.++++|++|+|++|.+.+.++...+. + +|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 579999999999999877 7999999999999999998888775544 4 899999999999988899999999999999
Q ss_pred ccCcccccCCCCC--ccccccCCCCccceEEccCccCCCCCC-C-C-CCCCCceeeccCCCcccc
Q 005224 79 IANNSLSGSIPSS--IWQSRTLNATETFILDFQNNNLTNISG-S-F-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 79 ls~N~l~g~~p~~--~~~l~~L~~~~L~~l~l~~N~l~~~~~-~-~-~~~~l~~l~l~~N~~~~~ 138 (707)
|++|++++.+|.. +..+++|+ +|+|++|+++++.+ . + .+++|+.|++++|.+...
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~-----~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 169 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLE-----MLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI 169 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCC-----EEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCC
T ss_pred CCCCCCCccccCcccccCcccCC-----EEECCCCccCccCcccccCCCCcccEEeCCCCccccc
Confidence 9999999765544 76666555 99999999999854 3 4 899999999999998643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=5.5e-14 Score=158.96 Aligned_cols=119 Identities=28% Similarity=0.403 Sum_probs=100.8
Q ss_pred CceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
.|+.|+|++|+|++++ .|+.+++|+.|+|++|+|+ .+|..+..+ +|+.|+|++|+|++ +| .|+++++|+.|+|++
T Consensus 442 ~L~~L~Ls~n~l~~lp-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 442 DVRVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp TCSEEECTTSCCSSCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred CceEEEecCCCCCCCc-CccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 5788999999999865 4899999999999999999 999877776 89999999999995 77 899999999999999
Q ss_pred cccccCC-CCCccccccCCCCccceEEccCccCCCCCCCC-----CCCCCceeec
Q 005224 82 NSLSGSI-PSSIWQSRTLNATETFILDFQNNNLTNISGSF-----NIPPNVTVRL 130 (707)
Q Consensus 82 N~l~g~~-p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-----~~~~l~~l~l 130 (707)
|+|++.. |..+..+++|+ .|+|++|+|+++|+.. .+|+|+.|++
T Consensus 518 N~l~~~~~p~~l~~l~~L~-----~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLV-----LLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCC-----EEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCcHHHhcCCCCC-----EEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 9999766 88888877666 8999999999987754 3778877753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.9e-14 Score=169.48 Aligned_cols=129 Identities=18% Similarity=0.338 Sum_probs=112.6
Q ss_pred CCCceEEEeeCCcCCC------------------CCCCcC--CCCcccEEeccCCcCcccCCCccccc-CccEEEccCcc
Q 005224 1 MSKLLKLSLRNCSLQG------------------PMPDLS--RIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNK 59 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~------------------~~~~~~--~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~ 59 (707)
|++|+.|+|++|+|++ +++.++ ++++|++|+|++|++.|.+|..+..+ +|+.|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 5789999999999999 555777 99999999999999999999888777 89999999998
Q ss_pred -CCC-CCCcccCCCc-------ccceEeccCcccccCCCC--CccccccCCCCccceEEccCccCCCCCCCC-CCCCCce
Q 005224 60 -LTG-TIPSNFSGLP-------RLQRLFIANNSLSGSIPS--SIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVT 127 (707)
Q Consensus 60 -l~~-~~p~~~~~l~-------~L~~L~ls~N~l~g~~p~--~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~ 127 (707)
|+| .+|..|++++ +|+.|+|++|+|+ .+|. .+.++++|+ .|+|++|+|+.+| .+ .+++|+.
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~-----~L~Ls~N~l~~lp-~~~~L~~L~~ 599 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLG-----LLDCVHNKVRHLE-AFGTNVKLTD 599 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCC-----EEECTTSCCCBCC-CCCTTSEESE
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCC-----EEECCCCCcccch-hhcCCCcceE
Confidence 998 8898777766 9999999999999 8998 888777665 8999999999888 44 7888889
Q ss_pred eeccCCCcc
Q 005224 128 VRLRGNPFC 136 (707)
Q Consensus 128 l~l~~N~~~ 136 (707)
|+|++|.+.
T Consensus 600 L~Ls~N~l~ 608 (876)
T 4ecn_A 600 LKLDYNQIE 608 (876)
T ss_dssp EECCSSCCS
T ss_pred EECcCCccc
Confidence 999999876
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.8e-14 Score=169.91 Aligned_cols=140 Identities=21% Similarity=0.168 Sum_probs=110.8
Q ss_pred CCCceEEEeeCCcCCCCCC--CcCCCCcccEEeccCCcCcccC-----CCccccc-CccEEEccCccCCCCCCcccCCCc
Q 005224 1 MSKLLKLSLRNCSLQGPMP--DLSRIPNLGYLDLSSNQLNGSI-----PPGRLSL-NITTIKLSNNKLTGTIPSNFSGLP 72 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~g~i-----p~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~ 72 (707)
+++|+.|+|++|++++.++ .+..+++|++|+|++|.+++.. |..+..+ +|+.|+|++|+|++..|..|.+++
T Consensus 425 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 504 (844)
T 3j0a_A 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504 (844)
T ss_dssp CTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCC
T ss_pred CCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchh
Confidence 4678888888888887765 3667888888888888887222 2223333 799999999999988888899999
Q ss_pred ccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccccCCcccccCCC
Q 005224 73 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSH 148 (707)
Q Consensus 73 ~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~~~~~~~~~~~~ 148 (707)
+|+.|+|++|+|++..|..+. ++|+.|+|++|+|+++++.. +.++..|++++|||.|+|.+..|..|.
T Consensus 505 ~L~~L~Ls~N~l~~l~~~~~~-------~~L~~L~Ls~N~l~~~~~~~-~~~L~~l~l~~Np~~C~c~~~~f~~~~ 572 (844)
T 3j0a_A 505 ALRGLSLNSNRLTVLSHNDLP-------ANLEILDISRNQLLAPNPDV-FVSLSVLDITHNKFICECELSTFINWL 572 (844)
T ss_dssp SCSEEEEESCCCSSCCCCCCC-------SCCCEEEEEEECCCCCCSCC-CSSCCEEEEEEECCCCSSSCCSHHHHH
T ss_pred hhheeECCCCCCCccChhhhh-------ccccEEECCCCcCCCCChhH-hCCcCEEEecCCCcccccccHHHHHHH
Confidence 999999999999955554442 35569999999999987653 668999999999999999988877664
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.48 E-value=8.6e-14 Score=146.99 Aligned_cols=130 Identities=20% Similarity=0.280 Sum_probs=85.5
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcc------------------------cCCCcccccCccEEEcc
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNG------------------------SIPPGRLSLNITTIKLS 56 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g------------------------~ip~~~~~~~L~~L~Ls 56 (707)
++|++|+|++|+++++++ .|..+++|++|+|++|.++. .+|..++ .+|+.|+|+
T Consensus 123 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~-~~L~~L~l~ 201 (332)
T 2ft3_A 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLP-ETLNELHLD 201 (332)
T ss_dssp TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSC-SSCSCCBCC
T ss_pred ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCcccc-CCCCEEECC
Confidence 357777777777776666 46777777777777777641 2332222 156666677
Q ss_pred CccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCc
Q 005224 57 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPF 135 (707)
Q Consensus 57 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~ 135 (707)
+|++++..|..|.++++|+.|+|++|++++..|..+..+++|+ .|+|++|+|+.+|..+ .+++|+.|++++|++
T Consensus 202 ~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-----~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l 276 (332)
T 2ft3_A 202 HNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLR-----ELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNI 276 (332)
T ss_dssp SSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCC-----EEECCSSCCCBCCTTGGGCTTCCEEECCSSCC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCC-----EEECCCCcCeecChhhhcCccCCEEECCCCCC
Confidence 7777765566677777777777777777755555666555444 7777777777776665 667777777777776
Q ss_pred cc
Q 005224 136 CL 137 (707)
Q Consensus 136 ~~ 137 (707)
..
T Consensus 277 ~~ 278 (332)
T 2ft3_A 277 TK 278 (332)
T ss_dssp CB
T ss_pred Cc
Confidence 53
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=5.4e-14 Score=156.30 Aligned_cols=130 Identities=22% Similarity=0.281 Sum_probs=91.3
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
++|+.|+|++|+|+++++ .|.++++|++|+|++|.|++..|..+..+ +|+.|+|++|+|++..+..|.++++|++|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 357778888888877766 57778888888888888874445555444 7788888888877555556777778888888
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCcc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~ 136 (707)
++|++++..|..+..+++|+ .|+|++|+++.+++. + .+++|+.|++++|.+.
T Consensus 112 s~n~i~~~~~~~~~~l~~L~-----~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLK-----SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCC-----EEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred CCCccccCChhHccccccCC-----EEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 88877766676676655554 777777777766443 3 6677777777777664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-13 Score=144.87 Aligned_cols=127 Identities=24% Similarity=0.359 Sum_probs=64.5
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++|++|+|++|+++++.| .|..+++|++|+|++|+|+ .+|..++. +|+.|+|++|++++..+..|.++++|+.|+|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 153 (330)
T 1xku_A 76 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK-TLQELRVHENEITKVRKSVFNGLNQMIVVELG 153 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCT-TCCEEECCSSCCCBBCHHHHTTCTTCCEEECC
T ss_pred CCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhcc-cccEEECCCCcccccCHhHhcCCccccEEECC
Confidence 344555555555554433 3445555555555555555 44444432 45555555555554444445555555555555
Q ss_pred Ccccc--cCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 81 NNSLS--GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~--g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
+|.++ +..+..+..+++|+ .|++++|+++.+|..+. ++|+.|++++|.+.
T Consensus 154 ~n~l~~~~~~~~~~~~l~~L~-----~L~l~~n~l~~l~~~~~-~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 154 TNPLKSSGIENGAFQGMKKLS-----YIRIADTNITTIPQGLP-PSLTELHLDGNKIT 205 (330)
T ss_dssp SSCCCGGGBCTTGGGGCTTCC-----EEECCSSCCCSCCSSCC-TTCSEEECTTSCCC
T ss_pred CCcCCccCcChhhccCCCCcC-----EEECCCCccccCCcccc-ccCCEEECCCCcCC
Confidence 55553 24444454444433 56666666665554432 55555666665543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=134.03 Aligned_cols=108 Identities=24% Similarity=0.310 Sum_probs=93.4
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccc-cc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL-SL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
++|+.|+|++|+|+.++..|.++++|++|+|++|+|+ .++...+ .+ +|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus 31 ~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCC-EeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 4799999999999977668999999999999999999 6776544 44 8999999999999888889999999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCC
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~ 115 (707)
++|+|++..+..+..+++|+ .|+|++|.+..
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~-----~L~L~~N~~~C 140 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALS-----HLAIGANPLYC 140 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCC-----EEECCSSCEEC
T ss_pred CCCCCCeeChhhhhcCcccc-----EEEeCCCCeec
Confidence 99999954444576666555 99999999875
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-13 Score=151.64 Aligned_cols=134 Identities=20% Similarity=0.226 Sum_probs=91.3
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCC-ccccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPP-GRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|+|+++.+ .|.++++|++|+|++|+|+ .++. .+..+ +|+.|+|++|+|++..+..|.++++|++|+
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 153 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC-CcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence 467888888888888776 6888888888888888888 4443 34434 788888888888866666688888888888
Q ss_pred ccCcccccCCCCCccccccCC--------------------CCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 79 IANNSLSGSIPSSIWQSRTLN--------------------ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~--------------------~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
|++|+|++..+..+.++++|+ +++|++|+|++|+|+.+|....+++|+.|+|++|.+.
T Consensus 154 L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~ 231 (452)
T 3zyi_A 154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFP 231 (452)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCCTTCTTCCEEECTTSCCS
T ss_pred CCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccccccccccccEEECcCCcCc
Confidence 888888744343444443332 2344566666666666654445666666666666654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=158.11 Aligned_cols=132 Identities=24% Similarity=0.274 Sum_probs=114.2
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
++|+.|+|++|+++++++ .|.++++|++|+|++|++++..|..+..+ +|++|+|++|+|++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 478999999999999888 79999999999999999994344455555 8999999999999888999999999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCC--CCCCC-CCCCCceeeccCCCcccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN--ISGSF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~--~~~~~-~~~~l~~l~l~~N~~~~~ 138 (707)
++|++++..|..+.++++|+ +|+|++|++++ +|..+ .+++|+.|++++|.+...
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~-----~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~ 168 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLK-----KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCC-----EEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEE
T ss_pred cCCccccccccccCCCCCCC-----EEeCCCCcccceechHhHhhcCCCCEEEccCCcceec
Confidence 99999966667888776665 99999999996 56666 899999999999988653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.6e-13 Score=142.20 Aligned_cols=123 Identities=24% Similarity=0.436 Sum_probs=57.4
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++|+.|+|++|++++.++ +..+++|++|+|++|+|+ .+|. +..+ +|+.|+|++|+|++ + ..+..+++|+.|+|+
T Consensus 68 ~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~ 142 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG 142 (291)
T ss_dssp TTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CGGG-GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECC
T ss_pred CCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCC-CChh-hccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEcc
Confidence 344555555555554444 444555555555555554 3332 2222 45555555555552 2 234455555555555
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
+|++++ + ..+..+++|+ .|+|++|+|+++++...+++|+.|++++|.+.
T Consensus 143 ~n~l~~-~-~~l~~l~~L~-----~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 143 NNKITD-I-TVLSRLTKLD-----TLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp SSCCCC-C-GGGGGCTTCS-----EEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred CCcCCc-c-hhhccCCCCC-----EEEccCCccccchhhcCCCccCEEECCCCcCC
Confidence 555542 2 2333333332 55555555555544224555555555555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.1e-13 Score=130.04 Aligned_cols=110 Identities=25% Similarity=0.311 Sum_probs=93.8
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccc-cc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|+|+++++ .|..+++|++|+|++|+|+ .+|...+ .+ +|+.|+|++|+|++..+..|.++++|++|+
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 106 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA 106 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-EeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence 579999999999999888 5899999999999999999 7777654 34 899999999999977777789999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCC
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~ 117 (707)
|++|+|++..+..+..+++|+ .|+|++|.++...
T Consensus 107 l~~N~l~~~~~~~~~~l~~L~-----~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 107 LDTNQLKSVPDGIFDRLTSLQ-----KIWLHTNPWDCSC 140 (177)
T ss_dssp CCSSCCSCCCTTTTTTCTTCC-----EEECCSSCBCCCH
T ss_pred CcCCcceEeCHHHhcCCcccC-----EEEecCCCeeccC
Confidence 999999944444456665555 9999999998743
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-13 Score=151.19 Aligned_cols=134 Identities=23% Similarity=0.300 Sum_probs=81.9
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccc-cc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|+|+++.+ .|.++++|++|+|++|+|+ .++...+ .+ +|+.|+|++|+|+...+..|.++++|++|+
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC-EECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEE
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC-ccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceee
Confidence 356777777777777665 5777777777777777777 5554333 23 677777777777755555677777777777
Q ss_pred ccCcccccCCCCCccccccCC--------------------CCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 79 IANNSLSGSIPSSIWQSRTLN--------------------ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~--------------------~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
|++|+|++..+..+..+++|+ +++|+.|+|++|+|+.+|....+++|+.|+|++|.+.
T Consensus 143 L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~ 220 (440)
T 3zyj_A 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLS 220 (440)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCCTTCSSCCEEECTTSCCC
T ss_pred CCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccccccCCCcccCEEECCCCccC
Confidence 777777644343444443332 2233455555555555554335555555555555543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.8e-14 Score=149.47 Aligned_cols=133 Identities=18% Similarity=0.204 Sum_probs=108.8
Q ss_pred CCCceEEEeeCCcCCCCCC-Cc--CCCCcccEEeccCCcCcccCCCcccc------cCccEEEccCccCCCCCCcccCCC
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DL--SRIPNLGYLDLSSNQLNGSIPPGRLS------LNITTIKLSNNKLTGTIPSNFSGL 71 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~--~~l~~L~~L~Ls~N~l~g~ip~~~~~------~~L~~L~Ls~N~l~~~~p~~~~~l 71 (707)
+++|++|+|++|+|++..| .+ ..+++|++|+|++|+|++ +|..+.. .+|++|+|++|+|++..|..|+++
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSS-SSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcc-hhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 4689999999999998777 54 899999999999999994 4764432 389999999999998888999999
Q ss_pred cccceEeccCcccccCC--CCCc--cccccCCCCccceEEccCccCCCCCC---CC--CCCCCceeeccCCCccccC
Q 005224 72 PRLQRLFIANNSLSGSI--PSSI--WQSRTLNATETFILDFQNNNLTNISG---SF--NIPPNVTVRLRGNPFCLNT 139 (707)
Q Consensus 72 ~~L~~L~ls~N~l~g~~--p~~~--~~l~~L~~~~L~~l~l~~N~l~~~~~---~~--~~~~l~~l~l~~N~~~~~~ 139 (707)
++|++|+|++|++.|.+ |..+ ..++ +|++|+|++|+|++++. .+ .+++|+.|++++|.+....
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~-----~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 244 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFP-----TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCT-----TCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCC-----CCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc
Confidence 99999999999988653 3333 4544 44599999999996543 22 6789999999999986543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.46 E-value=7.4e-14 Score=140.18 Aligned_cols=128 Identities=17% Similarity=0.206 Sum_probs=97.6
Q ss_pred CCCceEEEeeCCc-CCCCCC-CcCCCCcccEEeccC-CcCcccCCCccc-cc-CccEEEccCccCCCCCCcccCCCcccc
Q 005224 1 MSKLLKLSLRNCS-LQGPMP-DLSRIPNLGYLDLSS-NQLNGSIPPGRL-SL-NITTIKLSNNKLTGTIPSNFSGLPRLQ 75 (707)
Q Consensus 1 L~~L~~L~L~~N~-l~~~~~-~~~~l~~L~~L~Ls~-N~l~g~ip~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 75 (707)
+++|+.|+|++|+ ++++++ .|.++++|++|+|++ |+|+ .+|...+ .+ +|+.|+|++|+|++ +|. |..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~ 130 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTD 130 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCC
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-EcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccc
Confidence 4678899999996 888777 688899999999998 8998 7776544 33 78999999998884 776 88888887
Q ss_pred ---eEeccCc-ccccCCCCCccccccCCCCccc-eEEccCccCCCCCCCC-CCCCCceeeccCCC-cc
Q 005224 76 ---RLFIANN-SLSGSIPSSIWQSRTLNATETF-ILDFQNNNLTNISGSF-NIPPNVTVRLRGNP-FC 136 (707)
Q Consensus 76 ---~L~ls~N-~l~g~~p~~~~~l~~L~~~~L~-~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~-~~ 136 (707)
+|++++| ++++..+..+..+ ++|+ .|+|++|+++.+|... ..++|+.|++++|+ +.
T Consensus 131 ~L~~L~l~~N~~l~~i~~~~~~~l-----~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~ 193 (239)
T 2xwt_C 131 IFFILEITDNPYMTSIPVNAFQGL-----CNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLT 193 (239)
T ss_dssp SEEEEEEESCTTCCEECTTTTTTT-----BSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCC
T ss_pred cccEEECCCCcchhhcCcccccch-----hcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcc
Confidence 8888888 8884444456543 3456 7888888888777654 44678888888885 64
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.46 E-value=8.3e-14 Score=162.33 Aligned_cols=126 Identities=25% Similarity=0.299 Sum_probs=99.9
Q ss_pred ceEEEeeCCcCCCC---------CC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCc
Q 005224 4 LLKLSLRNCSLQGP---------MP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLP 72 (707)
Q Consensus 4 L~~L~L~~N~l~~~---------~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~ 72 (707)
|+.++|++|.|.+. ++ .|..+++|+.|+|++|.|. .||..++.+ +|+.|+|++|+|+ .+|..|++|+
T Consensus 193 l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 270 (727)
T 4b8c_D 193 LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLS 270 (727)
T ss_dssp -----------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGT
T ss_pred hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCC
Confidence 45556666655542 24 5888999999999999999 999988877 8999999999999 8999999999
Q ss_pred ccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCccc
Q 005224 73 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 73 ~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~ 137 (707)
+|++|+|++|+|+ .+|..+..+++|+ +|+|++|.|+.+|..+ .+++|+.|+|++|++..
T Consensus 271 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~-----~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~ 330 (727)
T 4b8c_D 271 NLRVLDLSHNRLT-SLPAELGSCFQLK-----YFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEK 330 (727)
T ss_dssp TCCEEECTTSCCS-SCCSSGGGGTTCS-----EEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCS
T ss_pred CCCEEeCcCCcCC-ccChhhcCCCCCC-----EEECCCCCCCccChhhhcCCCccEEeCCCCccCC
Confidence 9999999999999 8999998877776 9999999999999887 89999999999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=157.35 Aligned_cols=131 Identities=21% Similarity=0.220 Sum_probs=114.8
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
++++.|+|++|+|++++| .|+++++|++|+|++|++++..|..+..+ +|++|+|++|++++..|..|+++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 368999999999999987 79999999999999999995556666666 8999999999999889999999999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCC--CCCCCCCCCceeeccCCCccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI--SGSFNIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~--~~~~~~~~l~~l~l~~N~~~~ 137 (707)
++|++++..|..+.++++|+ +|+|++|+++++ +....+++|+.|++++|.+..
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~-----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 167 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLE-----SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCC-----EEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE
T ss_pred cccCcccCCcchhccCCccc-----EEECCCCcccccCcccccCCcccCEEEcccCcccc
Confidence 99999965577787776665 999999999997 444488999999999999864
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-13 Score=144.43 Aligned_cols=127 Identities=25% Similarity=0.418 Sum_probs=94.6
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
|++|+.|+|++|+|+++ +.+..+++|++|+|++|+|+ .+|. +..+ +|+.|+|++|++++. +. +..+++|+.|+|
T Consensus 84 l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 84 LTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSI 158 (308)
T ss_dssp CCSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEEC
T ss_pred CCCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCCCCC-Cchh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEc
Confidence 46788899999988875 46888888888888888888 5664 3333 788888888888843 33 788888888888
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccccC
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNT 139 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~~~ 139 (707)
++|+++ .++. +..+++|+ .|+|++|+++++++...+++|+.|++++|++....
T Consensus 159 ~~n~l~-~~~~-l~~l~~L~-----~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 159 GNAQVS-DLTP-LANLSKLT-----TLKADDNKISDISPLASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp CSSCCC-CCGG-GTTCTTCC-----EEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCG
T ss_pred cCCcCC-CChh-hcCCCCCC-----EEECCCCccCcChhhcCCCCCCEEEccCCccCccc
Confidence 888888 4444 55544444 78888888887766447777888888888776543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.1e-13 Score=159.22 Aligned_cols=125 Identities=23% Similarity=0.350 Sum_probs=81.2
Q ss_pred CceEEEeeCCcCCCCCCC-cCCCCcccEEeccCCcCcccCCCccccc---------CccEEEccCccCCCCCCcccC--C
Q 005224 3 KLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL---------NITTIKLSNNKLTGTIPSNFS--G 70 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~~---------~L~~L~Ls~N~l~~~~p~~~~--~ 70 (707)
+|+.|+|++|+|+.+++. +..+++|+.|+|++|+|+ .+|...+.. +|+.|+|++|+|+ .+|..+. .
T Consensus 674 ~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~ 751 (876)
T 4ecn_A 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATT 751 (876)
T ss_dssp CEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTT
T ss_pred CcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhcc
Confidence 677777777777755443 346677777777777777 777655431 5777777777777 6666665 6
Q ss_pred CcccceEeccCcccccCCCCCccccccCCCCccceEEccC------ccCCCC-CCCC-CCCCCceeeccCCCc
Q 005224 71 LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN------NNLTNI-SGSF-NIPPNVTVRLRGNPF 135 (707)
Q Consensus 71 l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~------N~l~~~-~~~~-~~~~l~~l~l~~N~~ 135 (707)
+++|+.|+|++|+|++ +|..+..+++|+ .|+|++ |++.+. |..+ .+++|+.|+|++|++
T Consensus 752 l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~-----~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 752 LPYLSNMDVSYNCFSS-FPTQPLNSSQLK-----AFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818 (876)
T ss_dssp CTTCCEEECCSSCCSS-CCCGGGGCTTCC-----EEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred CCCcCEEEeCCCCCCc-cchhhhcCCCCC-----EEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC
Confidence 7777777777777774 666666655554 666655 444443 4344 566677777777766
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.6e-13 Score=138.39 Aligned_cols=126 Identities=25% Similarity=0.312 Sum_probs=100.3
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
+++|+.|+|++|+|+++++ +..+++|++|+|++|+|+ .+|.... .+|+.|+|++|+|++ ++ .+.++++|+.|+|+
T Consensus 62 l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~-~l~~~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls 136 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLK-NLNGIPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIR 136 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCS-CCTTCCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECT
T ss_pred CCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccC-CcCcccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECC
Confidence 4678899999999988777 888899999999999998 6776544 588999999999985 44 58888899999999
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcccc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~~ 138 (707)
+|+|+ .+| .+..+++|+ .|+|++|+|++++....+++|+.|++++|++.+.
T Consensus 137 ~N~i~-~~~-~l~~l~~L~-----~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 137 NNKLK-SIV-MLGFLSKLE-----VLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TSCCC-BCG-GGGGCTTCC-----EEECTTSCCCBCTTSTTCCCCCEEEEEEEEEECC
T ss_pred CCcCC-CCh-HHccCCCCC-----EEECCCCcCcchHHhccCCCCCEEeCCCCcccCC
Confidence 99988 454 566655554 8999999998883333788888999999888655
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.5e-13 Score=155.27 Aligned_cols=127 Identities=20% Similarity=0.273 Sum_probs=57.3
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcc-ccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGR-LSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|.|+++++ .|+.+++|++|+|++|.|+ .+|+.. ..+ +|+.|+|++|+|++..+..|+++++|++|+
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCC-CCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 344555555555554444 4445555555555555555 233222 222 455555555555533333344455555555
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 135 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~ 135 (707)
|++|.|++..|..+..+++|+ .|+|++|+|++++.. .+++|..|++++|.+
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~-----~L~L~~N~l~~~~~~-~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQ-----NLQLSSNRLTHVDLS-LIPSLFHANVSYNLL 204 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCC-----EEECTTSCCSBCCGG-GCTTCSEEECCSSCC
T ss_pred eeCCcCCCCChhhhhcCCcCc-----EEECcCCCCCCcChh-hhhhhhhhhcccCcc
Confidence 555555544444444433333 455555555444211 344444444444443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-13 Score=142.51 Aligned_cols=125 Identities=21% Similarity=0.261 Sum_probs=106.8
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
|++|+.|+|++|+|+++ +.+..+++|++|+|++|+|+ .++ .+..+ +|+.|+|++|+|++. ..+..+++|+.|+|
T Consensus 89 l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~i~-~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 89 LKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 163 (291)
T ss_dssp CTTCCEEECCSSCCCCG-GGGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred CCCCCEEECCCCcCCCC-hhhccCCCCCEEECCCCcCC-CCh-hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEc
Confidence 57899999999999974 45999999999999999999 664 34444 899999999999954 67999999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~ 137 (707)
++|++++. +. +..+++| +.|+|++|+|+.++....+++|+.|++++|++..
T Consensus 164 ~~N~l~~~-~~-l~~l~~L-----~~L~L~~N~i~~l~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 164 EDNQISDI-VP-LAGLTKL-----QNLYLSKNHISDLRALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CSSCCCCC-GG-GTTCTTC-----CEEECCSSCCCBCGGGTTCTTCSEEEEEEEEEEC
T ss_pred cCCccccc-hh-hcCCCcc-----CEEECCCCcCCCChhhccCCCCCEEECcCCcccC
Confidence 99999954 43 6665555 4999999999999764589999999999999865
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.44 E-value=3e-13 Score=142.81 Aligned_cols=126 Identities=21% Similarity=0.272 Sum_probs=67.9
Q ss_pred CceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 3 KLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
+|+.|+|++|+|+++++ .|.++++|++|+|++|+|++..|..+..+ +|++|+|++|+|+ .+|..+. ++|++|+|+
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~ 131 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIH 131 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECC
Confidence 46666666666666655 46666666666666666663334444333 5666666666666 4555443 566666666
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCC--C-CCCCCCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN--I-SGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~--~-~~~~~~~~l~~l~l~~N~~~ 136 (707)
+|++++..+..+..+++|+ .|++++|.++. + +..+...+|+.|++++|.+.
T Consensus 132 ~n~i~~~~~~~~~~l~~L~-----~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 132 DNRIRKVPKGVFSGLRNMN-----CIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185 (332)
T ss_dssp SSCCCCCCSGGGSSCSSCC-----EEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCS
T ss_pred CCccCccCHhHhCCCccCC-----EEECCCCccccCCCCcccccCCccCEEECcCCCCC
Confidence 6666633333344444433 56666666542 2 22221115555555555544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.7e-13 Score=161.32 Aligned_cols=132 Identities=20% Similarity=0.239 Sum_probs=114.7
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCc-cccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPG-RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|||++|.|+++.+ .|.++++|++|+|++|.+.+.|++. +..+ +|++|+|++|+|++..|..|.++++|++|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 679999999999999887 7999999999999999777788554 4444 899999999999988899999999999999
Q ss_pred ccCcccccCCCCC--ccccccCCCCccceEEccCccCCCCCC--CC-CCCCCceeeccCCCcccc
Q 005224 79 IANNSLSGSIPSS--IWQSRTLNATETFILDFQNNNLTNISG--SF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 79 ls~N~l~g~~p~~--~~~l~~L~~~~L~~l~l~~N~l~~~~~--~~-~~~~l~~l~l~~N~~~~~ 138 (707)
|++|.+++.+|.. +.++++|+ +|+|++|.+++++. .+ .+++|+.|++++|.+...
T Consensus 104 Ls~n~l~~~~~~~~~~~~L~~L~-----~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 104 LYFCGLSDAVLKDGYFRNLKALT-----RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CTTCCCSSCCSTTCCCSSCSSCC-----EEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred CcCCCCCcccccCccccccCCCC-----EEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 9999999877765 77766655 99999999998854 34 899999999999998654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.5e-13 Score=154.34 Aligned_cols=129 Identities=22% Similarity=0.189 Sum_probs=96.1
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCC--CCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTG--TIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ 78 (707)
.+|+.|++++|++.... .+..+++|++|+|++|++++.+|..+..+ +|+.|+|++|+|++ .+|..|.++++|++|+
T Consensus 302 ~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~ 380 (520)
T 2z7x_B 302 MNIKNFTVSGTRMVHML-CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380 (520)
T ss_dssp CCCSEEEEESSCCCCCC-CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred CceeEEEcCCCcccccc-chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEE
Confidence 46999999999987543 23789999999999999998788877766 89999999999996 5678899999999999
Q ss_pred ccCcccccCCCCC-ccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 79 IANNSLSGSIPSS-IWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 79 ls~N~l~g~~p~~-~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
|++|++++.+|.. +..+++|+ .|+|++|++++..+..-.++|+.|++++|.+.
T Consensus 381 Ls~N~l~~~l~~~~~~~l~~L~-----~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 381 ISQNSVSYDEKKGDCSWTKSLL-----SLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434 (520)
T ss_dssp CCSSCCBCCGGGCSCCCCTTCC-----EEECCSSCCCGGGGGSCCTTCCEEECCSSCCC
T ss_pred CCCCcCCcccccchhccCccCC-----EEECcCCCCCcchhhhhcccCCEEECCCCccc
Confidence 9999999768765 44444443 56666665543211110145555555555554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.43 E-value=4.6e-13 Score=144.69 Aligned_cols=130 Identities=22% Similarity=0.332 Sum_probs=93.9
Q ss_pred CCCceEEEeeCCcCCCCCCC-cCCCCcccEEeccCCcCcccCCC-ccccc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP-GRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~g~ip~-~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++|+.|++++|.++.+++. |..+++|++|+|++|.++ .++. .+..+ +|++|+|++|++++..|..|.++++|++|
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc-ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 35677888888888777663 677888888888888887 5554 34334 78888888888887767777888888888
Q ss_pred eccCcccccCCCCC-ccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCccc
Q 005224 78 FIANNSLSGSIPSS-IWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 78 ~ls~N~l~g~~p~~-~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~ 137 (707)
+|++|+++ .+|.. +.++++|+ +|+|++|+++++++. + .+++|+.|++++|.+..
T Consensus 123 ~L~~n~l~-~l~~~~~~~l~~L~-----~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 123 VLERNDLS-SLPRGIFHNTPKLT-----TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCC-----EEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred ECCCCccC-cCCHHHhcCCCCCc-----EEECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 88888887 55554 35555444 788888888877554 3 67778888888887654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.43 E-value=4.3e-13 Score=140.05 Aligned_cols=122 Identities=21% Similarity=0.296 Sum_probs=63.4
Q ss_pred CceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
+|+.|+|++|+++.+ +.+..+++|++|+|++|+++ .++. +..+ +|+.|+|++|+|++ ++ .+..+++|++|+|++
T Consensus 42 ~L~~L~l~~~~i~~l-~~~~~l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 42 GITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTS 116 (308)
T ss_dssp TCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTT
T ss_pred CcCEEEeeCCCccCc-hhhhccCCCCEEEccCCcCC-CChh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCC
Confidence 455666666655543 34555566666666666665 4444 3322 55666666666553 32 455555566666666
Q ss_pred cccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
|+++ .+|. +..+++| +.|+|++|+++++++...+++|+.|++++|.+.
T Consensus 117 n~l~-~~~~-l~~l~~L-----~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~ 164 (308)
T 1h6u_A 117 TQIT-DVTP-LAGLSNL-----QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVS 164 (308)
T ss_dssp SCCC-CCGG-GTTCTTC-----CEEECCSSCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCC-Cchh-hcCCCCC-----CEEECCCCccCcCccccCCCCccEEEccCCcCC
Confidence 6555 2332 3333333 255555555555544224555555555555543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.6e-13 Score=152.90 Aligned_cols=134 Identities=16% Similarity=0.228 Sum_probs=98.2
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCC--CCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTG--TIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ 78 (707)
.+|+.|++++|++.... .+..+++|++|+|++|++++.+|..+..+ +|+.|+|++|+|++ .+|..|.++++|+.|+
T Consensus 331 ~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~ 409 (562)
T 3a79_B 331 MNIKMLSISDTPFIHMV-CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD 409 (562)
T ss_dssp CCCSEEEEESSCCCCCC-CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEE
T ss_pred CcceEEEccCCCccccc-CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEE
Confidence 36999999999986433 23789999999999999997788877766 89999999999996 3356799999999999
Q ss_pred ccCcccccCCCCC-ccccccCC----------------C-CccceEEccCccCCCCCCCC-CCCCCceeeccCCCcc
Q 005224 79 IANNSLSGSIPSS-IWQSRTLN----------------A-TETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 79 ls~N~l~g~~p~~-~~~l~~L~----------------~-~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~ 136 (707)
|++|++++.+|.. +..+++|+ + ++|+.|+|++|+|+.+|..+ .+++|+.|++++|.+.
T Consensus 410 l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~ 486 (562)
T 3a79_B 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK 486 (562)
T ss_dssp CTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC
T ss_pred CCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhcCcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC
Confidence 9999999767765 44444332 0 24455555555555555443 4555555555555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.42 E-value=1.6e-13 Score=145.88 Aligned_cols=116 Identities=20% Similarity=0.207 Sum_probs=93.2
Q ss_pred cEEeccCC-cCcccCCCccccc-CccEEEccC-ccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCCCCccc
Q 005224 28 GYLDLSSN-QLNGSIPPGRLSL-NITTIKLSN-NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 104 (707)
Q Consensus 28 ~~L~Ls~N-~l~g~ip~~~~~~-~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~ 104 (707)
..+++++| +|+ .||. +..+ +|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.++++|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~----- 83 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS----- 83 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC-----
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCC-----
Confidence 35688887 888 7888 6555 788888886 888877777888888899999999998887777787766665
Q ss_pred eEEccCccCCCCCCCC-CCCCCceeeccCCCccccCCcccccCCCCC
Q 005224 105 ILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 150 (707)
Q Consensus 105 ~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~~~~~~~~~~~~~~ 150 (707)
.|+|++|+|+++|+.. ....|+.|+|.+|+|.|+|.+..|..|...
T Consensus 84 ~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~l~~~~~~~~~ 130 (347)
T 2ifg_A 84 RLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEE 130 (347)
T ss_dssp EEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHT
T ss_pred EEeCCCCccceeCHHHcccCCceEEEeeCCCccCCCccHHHHHHHHh
Confidence 8899999998887764 434489999999999999998888777543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.2e-13 Score=153.81 Aligned_cols=130 Identities=21% Similarity=0.194 Sum_probs=76.8
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCc-------------
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPS------------- 66 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~------------- 66 (707)
++|+.|+|++|+|++++| .|..+++|++|+|++|.|++.+| +..+ +|+.|+|++|+|++..+.
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l 111 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI 111 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcC
Confidence 368888888888888776 68888888888888888885444 2222 455555555544421110
Q ss_pred ---ccCCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCC-CC--CCCCCceeeccCCCcccc
Q 005224 67 ---NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG-SF--NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 67 ---~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~-~~--~~~~l~~l~l~~N~~~~~ 138 (707)
....+++|+.|+|++|.|++..|..+..+++|+ .|+|++|+|+++++ .+ .+++|..|+|++|.+...
T Consensus 112 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-----~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 112 SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQ-----YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp CCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEE-----EEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCC-----EEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 011234566666666666655555555544433 66666666666432 22 356666666666665433
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.3e-14 Score=165.73 Aligned_cols=129 Identities=21% Similarity=0.275 Sum_probs=110.8
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
+++|+.|+|++|+|..+++.+.++++|++|+|++|.|+ .||..+..+ +|+.|+|++|+|+ .+|..|++|++|++|+|
T Consensus 223 l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 300 (727)
T 4b8c_D 223 DQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF 300 (727)
T ss_dssp CCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred CCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence 46799999999999977778889999999999999999 999888777 8999999999999 88999999999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-C-C-CCCceeeccCCCccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-N-I-PPNVTVRLRGNPFCL 137 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~-~-~~l~~l~l~~N~~~~ 137 (707)
++|.|+ .+|..+..+++|+ .|+|++|+|++.++.. . + ..+..++|++|.+.+
T Consensus 301 ~~N~l~-~lp~~~~~l~~L~-----~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~ 355 (727)
T 4b8c_D 301 FDNMVT-TLPWEFGNLCNLQ-----FLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI 355 (727)
T ss_dssp CSSCCC-CCCSSTTSCTTCC-----CEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred CCCCCC-ccChhhhcCCCcc-----EEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence 999998 9999998877666 9999999999865432 1 1 112346788888754
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=5.2e-13 Score=126.54 Aligned_cols=107 Identities=21% Similarity=0.172 Sum_probs=90.1
Q ss_pred ceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCC-Cccccc-CccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 4 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP-PGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 4 L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
.+.|++++|+|+.++..+. ++|++|+|++|+|+ .++ ..+..+ +|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCC-ccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 5789999999998777664 89999999999999 554 445555 899999999999977777889999999999999
Q ss_pred cccccCCCCCccccccCCCCccceEEccCccCCCCCC
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~ 118 (707)
|+|++..+..+..+++|+ +|+|++|.++...+
T Consensus 88 N~l~~~~~~~~~~l~~L~-----~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLT-----HIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCC-----EEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCC-----EEEeCCCCCCCCch
Confidence 999965555677766665 99999999987543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.5e-13 Score=144.78 Aligned_cols=130 Identities=25% Similarity=0.228 Sum_probs=94.9
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
++|++|+|++|+|+++++ .|.++++|++|+|++|+|++..|..+..+ +|++|+|++|+|++..+..|.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 467888888888888777 68888888888888888884334444444 7888888888888544444788888888888
Q ss_pred cCcccccCCCC--CccccccCCCCccceEEccCc-cCCCCCCC-C-CCCCCceeeccCCCccc
Q 005224 80 ANNSLSGSIPS--SIWQSRTLNATETFILDFQNN-NLTNISGS-F-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 80 s~N~l~g~~p~--~~~~l~~L~~~~L~~l~l~~N-~l~~~~~~-~-~~~~l~~l~l~~N~~~~ 137 (707)
++|+++ .+|. .+..+++|+ +|++++| .++.+++. + .+++|+.|++++|.+..
T Consensus 132 ~~n~l~-~l~~~~~~~~l~~L~-----~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 188 (353)
T 2z80_A 132 LGNPYK-TLGETSLFSHLTKLQ-----ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188 (353)
T ss_dssp TTCCCS-SSCSSCSCTTCTTCC-----EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CCCCCc-ccCchhhhccCCCCc-----EEECCCCccccccCHHHccCCCCCCEEECCCCCcCc
Confidence 888888 5665 566655554 8888888 47776543 3 67788888888887643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=2.3e-13 Score=153.93 Aligned_cols=131 Identities=21% Similarity=0.222 Sum_probs=109.1
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
++|++|+|++|+|++++| .|.++++|++|+|++|+|++..|..+..+ +|++|+|++|+|++..|..|+++++|++|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 478999999999999887 79999999999999999995444555555 8999999999999777777999999999999
Q ss_pred cCccccc-CCCCCccccccCCCCccceEEccCcc-CCCCCC-CC-CCCCCceeeccCCCccc
Q 005224 80 ANNSLSG-SIPSSIWQSRTLNATETFILDFQNNN-LTNISG-SF-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 80 s~N~l~g-~~p~~~~~l~~L~~~~L~~l~l~~N~-l~~~~~-~~-~~~~l~~l~l~~N~~~~ 137 (707)
++|++++ .+|..+.++++|+ +|+|++|+ +..++. .+ .+++|+.|++++|.+..
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~-----~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 162 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQ-----TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCC-----EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CCCcccccchhhhhhccCCcc-----EEECCCCccccccCHhhhhcccccCeeeccCCcccc
Confidence 9999986 4567777766665 99999998 666764 34 78889999999998754
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.41 E-value=4.3e-13 Score=152.56 Aligned_cols=125 Identities=23% Similarity=0.429 Sum_probs=86.1
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
|++|+.|+|++|+|+++++ +..+++|+.|+|++|+|+ .+| .+..+ +|+.|+|++|+|++ + ..|..|++|+.|+|
T Consensus 64 l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCC-CCT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCC-CCh-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 4678888888888887666 777888888888888887 555 33333 67777777777774 3 34777777777777
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~ 137 (707)
++|+|++ + ..+..+++|+ .|+|++|+|+++++...+++|+.|+|++|++..
T Consensus 139 s~N~l~~-l-~~l~~l~~L~-----~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 139 GNNKITD-I-TVLSRLTKLD-----TLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp CSSCCCC-C-GGGGSCTTCS-----EEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred CCCccCC-c-hhhcccCCCC-----EEECcCCcCCCchhhccCCCCCEEECcCCCCCC
Confidence 7777773 3 3455544443 777777777776553366777777777776654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.41 E-value=6e-13 Score=151.39 Aligned_cols=123 Identities=21% Similarity=0.287 Sum_probs=54.5
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++|+.|+|++|+|+++ +.|..+++|+.|+|++|+|+ .++. +..+ +|+.|+|++|+|++. ..|..|++|+.|+|+
T Consensus 87 ~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~-~l~~-l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls 161 (605)
T 1m9s_A 87 KNLGWLFLDENKIKDL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLE 161 (605)
T ss_dssp TTCCEEECCSSCCCCC-TTSTTCTTCCEEECTTSCCC-CCGG-GGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECC
T ss_pred CCCCEEECcCCCCCCC-hhhccCCCCCEEEecCCCCC-CCcc-ccCCCccCEEECCCCccCCc--hhhcccCCCCEEECc
Confidence 3444555555554432 23444455555555555544 3322 2222 455555555555432 344444555555555
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
+|+|++..| +..+++|+ .|+|++|+|++++....+++|+.|+|++|++.
T Consensus 162 ~N~l~~~~~--l~~l~~L~-----~L~Ls~N~i~~l~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 162 DNQISDIVP--LAGLTKLQ-----NLYLSKNHISDLRALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp SSCCCCCGG--GTTCTTCC-----EEECCSSCCCBCGGGTTCTTCSEEECCSEEEE
T ss_pred CCcCCCchh--hccCCCCC-----EEECcCCCCCCChHHccCCCCCEEEccCCcCc
Confidence 555543322 33332222 45555555544432224444455555554443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.41 E-value=2.6e-13 Score=128.18 Aligned_cols=111 Identities=28% Similarity=0.316 Sum_probs=94.8
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCC--cccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIP--SNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L 77 (707)
+++|+.|+|++|.|++. +.+..+++|++|+|++|++++.+|..+..+ +|+.|+|++|+|++ +| ..|..+++|+.|
T Consensus 48 l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L 125 (168)
T 2ell_A 48 FVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKSL 125 (168)
T ss_dssp GGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCEE
T ss_pred CCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCEE
Confidence 46899999999999988 889999999999999999995566655434 89999999999995 44 789999999999
Q ss_pred eccCcccccCCCC----CccccccCCCCccceEEccCccCCCCCCC
Q 005224 78 FIANNSLSGSIPS----SIWQSRTLNATETFILDFQNNNLTNISGS 119 (707)
Q Consensus 78 ~ls~N~l~g~~p~----~~~~l~~L~~~~L~~l~l~~N~l~~~~~~ 119 (707)
+|++|.++ .+|. .+..+++|+ .|++++|.++.+|..
T Consensus 126 ~l~~N~l~-~~~~~~~~~~~~l~~L~-----~L~l~~n~~~~~~~~ 165 (168)
T 2ell_A 126 DLFNCEVT-NLNDYRESVFKLLPQLT-----YLDGYDREDQEAPDS 165 (168)
T ss_dssp ECCSSGGG-TSTTHHHHHHTTCSSCC-----EETTEETTSCBCCSS
T ss_pred EeeCCcCc-chHHHHHHHHHhCccCc-----EecCCCCChhhcccc
Confidence 99999999 5554 666666555 999999999988764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=8.5e-13 Score=125.57 Aligned_cols=108 Identities=20% Similarity=0.178 Sum_probs=88.9
Q ss_pred ceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCc
Q 005224 4 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 82 (707)
Q Consensus 4 L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 82 (707)
-+.+++++|+|+.++..+. ++|++|+|++|+|++..|..+..+ +|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 3689999999998777664 899999999999994445455555 8999999999999766667899999999999999
Q ss_pred ccccCCCCCccccccCCCCccceEEccCccCCCCCC
Q 005224 83 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 118 (707)
Q Consensus 83 ~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~ 118 (707)
+|++..+..+..+++|+ .|+|++|.++..+.
T Consensus 92 ~l~~l~~~~~~~l~~L~-----~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLT-----HIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCS-----EEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCC-----EEEeCCCCcccccc
Confidence 99954444577766665 99999999997654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=6.4e-13 Score=154.39 Aligned_cols=132 Identities=19% Similarity=0.221 Sum_probs=107.6
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
++|++|+|++|+|+++++ .|.++++|++|+|++|.+++..|..+..+ +|++|+|++|+|++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 468999999999998887 69999999999999999995445544445 8999999999999555557999999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCcccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~ 138 (707)
++|++++..|..+.++++|+ +|+|++|+++++++. + .+++|+.|++++|.+...
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~-----~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLI-----TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCC-----EEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred CCCccCccChhHccccCCCC-----EEECCCCcccccCchhhcccccCCEEEccCCccccc
Confidence 99999866667787776665 899999999987654 3 788899999999987543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.5e-13 Score=153.21 Aligned_cols=132 Identities=20% Similarity=0.280 Sum_probs=113.6
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
+++++.|++++|.++.+++ .|..+++|++|+|++|.|++..|..+..+ +|+.|+|++|.|++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 4678999999999999888 48899999999999999994444455555 899999999999988888999999999999
Q ss_pred ccCcccccCCCCC-ccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCcccc
Q 005224 79 IANNSLSGSIPSS-IWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 79 ls~N~l~g~~p~~-~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~ 138 (707)
|++|.|+ .+|.. +.++++|+ +|+|++|.|+++++. + .+++|+.|++++|.+...
T Consensus 130 L~~n~l~-~l~~~~~~~l~~L~-----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 130 LERNDLS-SLPRGIFHNTPKLT-----TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCC-----EEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred eeCCCCC-CCCHHHhccCCCCC-----EEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence 9999999 55554 56766665 999999999999775 4 899999999999998653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=6.8e-13 Score=150.63 Aligned_cols=131 Identities=25% Similarity=0.302 Sum_probs=112.3
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCc-cccc-CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPG-RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++|+.|+|++|+++++.+ .|.++++|++|+|++|+++ .+++. +..+ +|++|+|++|++++..|..|.++++|++|+
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCC-ccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 468999999999999887 7999999999999999999 66654 4444 899999999999988889999999999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCC--CCCCC-CCCCCceeeccCCCcccc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN--ISGSF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~--~~~~~-~~~~l~~l~l~~N~~~~~ 138 (707)
|++|++++..+..+.++++|+ +|+|++|.+++ +|..+ .+++|+.|++++|.+...
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~-----~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~ 164 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLK-----ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCC-----EEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEE
T ss_pred ccccccccCCCcccccccccc-----EEecCCCccceecChhhhcccCCCCEEeCcCCcccee
Confidence 999999954444677766665 99999999997 46666 799999999999988643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.38 E-value=8.7e-13 Score=148.52 Aligned_cols=116 Identities=28% Similarity=0.293 Sum_probs=80.9
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
+++|+.|+|++|+|+++++ |.+ +|++|+|++|+|+ .||. ...+|+.|+|++|+|++ +|. .+++|+.|+|+
T Consensus 99 l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~-~lp~--~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 168 (571)
T 3cvr_A 99 PASLEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLT-MLPE--LPALLEYINADNNQLTM-LPE---LPTSLEVLSVR 168 (571)
T ss_dssp CTTCCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCS-CCCC--CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred cCCCCEEEccCCCCCCcch-hhc--CCCEEECCCCcCC-CCCC--cCccccEEeCCCCccCc-CCC---cCCCcCEEECC
Confidence 4678888888888888555 554 7888888888888 4777 22278888888888884 665 46778888888
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCC-------ceeeccCCCccc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPN-------VTVRLRGNPFCL 137 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l-------~~l~l~~N~~~~ 137 (707)
+|+|++ +|. +. ++|+.|+|++|+|+.+|. +. .+| +.|+|++|.+..
T Consensus 169 ~N~L~~-lp~-l~-------~~L~~L~Ls~N~L~~lp~-~~-~~L~~~~~~L~~L~Ls~N~l~~ 221 (571)
T 3cvr_A 169 NNQLTF-LPE-LP-------ESLEALDVSTNLLESLPA-VP-VRNHHSEETEIFFRCRENRITH 221 (571)
T ss_dssp SSCCSC-CCC-CC-------TTCCEEECCSSCCSSCCC-CC---------CCEEEECCSSCCCC
T ss_pred CCCCCC-cch-hh-------CCCCEEECcCCCCCchhh-HH-HhhhcccccceEEecCCCccee
Confidence 888874 776 43 344477777777777766 41 155 777777777764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.4e-13 Score=141.59 Aligned_cols=128 Identities=20% Similarity=0.303 Sum_probs=86.3
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
+++|+.|++++|++++..+ +..+++|++|+|++|+++ .++. +..+ +|+.|+|++|++++ + ..+..+++|+.|++
T Consensus 198 l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 198 LTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred CCccceeecccCCCCCCch-hhcCCcCCEEEccCCccC-CCcc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 4567777888877776655 677777777888777777 5554 3333 67777777777774 3 35777777777777
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeeccCCCccccCC
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTN 140 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l~~N~~~~~~~ 140 (707)
++|+++ .+| .+..+++|+ .|+|++|++++.++. + .+++|+.|++++|++.....
T Consensus 273 ~~n~l~-~~~-~~~~l~~L~-----~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 273 GSNQIS-DIS-VLNNLSQLN-----SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp CSSCCC-CCG-GGGGCTTCS-----EEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred cCCccC-CCh-hhcCCCCCC-----EEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 777777 343 344444443 777777777766443 2 67777777777777765543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.35 E-value=4.2e-13 Score=140.73 Aligned_cols=128 Identities=26% Similarity=0.246 Sum_probs=82.9
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCc-------------------ccccCccEEEccCccCC
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG-------------------RLSLNITTIKLSNNKLT 61 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~-------------------~~~~~L~~L~Ls~N~l~ 61 (707)
+++|+.|+|++|++++.++ |..+++|++|+|++|+|+ .+|.. .+ .+|+.|+|++|+|+
T Consensus 57 l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~-~l~~~~~L~~L~l~~n~l~~~~~~~~-~~L~~L~l~~N~l~ 133 (317)
T 3o53_A 57 FTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNNISRVSCSRG-QGKKNIYLANNKIT 133 (317)
T ss_dssp CTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEE-EEEECTTCCEEECCSSCCSEEEECCC-SSCEEEECCSSCCC
T ss_pred CCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCccc-cccCCCCcCEEECCCCccCCcCcccc-CCCCEEECCCCCCC
Confidence 4688999999999987766 888888888888888888 44421 11 14566666666666
Q ss_pred CCCCcccCCCcccceEeccCcccccCCCCCcc-ccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 62 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW-QSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 62 ~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
+..|..|..+++|++|+|++|++++..|..+. .+++| ++|+|++|+|+.++....+++|+.|++++|.+.
T Consensus 134 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L-----~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~ 204 (317)
T 3o53_A 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL-----EHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA 204 (317)
T ss_dssp SGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTC-----CEEECTTSCCCEEECCCCCTTCCEEECCSSCCC
T ss_pred CccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcC-----CEEECCCCcCcccccccccccCCEEECCCCcCC
Confidence 55555666666666666666666654444442 33333 366666666666655545666666666666654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.35 E-value=7.9e-15 Score=142.85 Aligned_cols=129 Identities=23% Similarity=0.344 Sum_probs=110.1
Q ss_pred CCceEEEeeCCcCCCCCC-------CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcc
Q 005224 2 SKLLKLSLRNCSLQGPMP-------DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPR 73 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-------~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~ 73 (707)
.+++.++|+.|.+++..| .|..+++|++|+|++|+|+ .+| .+..+ +|+.|+|++|+|+ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~-~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEES-CCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCc-ccc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 467788899999988766 4788999999999999999 688 54444 8999999999999 78988888999
Q ss_pred cceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCC--CC-CCCCCceeeccCCCccccCC
Q 005224 74 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG--SF-NIPPNVTVRLRGNPFCLNTN 140 (707)
Q Consensus 74 L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~--~~-~~~~l~~l~l~~N~~~~~~~ 140 (707)
|+.|+|++|+++ .+| .+..+++|+ .|+|++|+|+.++. .+ .+++|+.|++++|++.+.|.
T Consensus 95 L~~L~L~~N~l~-~l~-~~~~l~~L~-----~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 95 LEELWISYNQIA-SLS-GIEKLVNLR-----VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp CSEEEEEEEECC-CHH-HHHHHHHSS-----EEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred CCEEECcCCcCC-cCC-ccccCCCCC-----EEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 999999999999 466 577766665 99999999998765 33 79999999999999977653
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.34 E-value=1.4e-12 Score=120.48 Aligned_cols=109 Identities=17% Similarity=0.228 Sum_probs=95.3
Q ss_pred CCCcccEEeccCCcCc-ccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCCC
Q 005224 23 RIPNLGYLDLSSNQLN-GSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 100 (707)
Q Consensus 23 ~l~~L~~L~Ls~N~l~-g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 100 (707)
..++|+.|+|++|.++ |.+|..+... +|+.|+|++|+|++. ..|.++++|++|+|++|++++.+|..+..+++|+
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~- 91 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT- 91 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCC-
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCC-
Confidence 4578999999999999 8999876665 899999999999965 7899999999999999999977888777776665
Q ss_pred CccceEEccCccCCCCC--CCC-CCCCCceeeccCCCcccc
Q 005224 101 TETFILDFQNNNLTNIS--GSF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 101 ~~L~~l~l~~N~l~~~~--~~~-~~~~l~~l~l~~N~~~~~ 138 (707)
+|++++|++++++ ..+ .+++|+.|++++|++...
T Consensus 92 ----~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 128 (149)
T 2je0_A 92 ----HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNL 128 (149)
T ss_dssp ----EEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGS
T ss_pred ----EEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccch
Confidence 9999999999975 455 899999999999998644
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.33 E-value=5.8e-12 Score=141.83 Aligned_cols=116 Identities=22% Similarity=0.339 Sum_probs=87.4
Q ss_pred CceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccCc
Q 005224 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 82 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 82 (707)
+|+.|+|++|+|+++++.+. ++|++|+|++|+|+ .|| ... .+|+.|+|++|+|++ +|. |.+ +|+.|+|++|
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~--~~L~~L~Ls~N~l~-~ip-~~l-~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N 130 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLP--PQITVLEITQNALI-SLP-ELP-ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNN 130 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCC--TTCSEEECCSSCCS-CCC-CCC-TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSS
T ss_pred CccEEEeCCCCCCccCHhHc--CCCCEEECcCCCCc-ccc-ccc-CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCC
Confidence 68889999999888665553 78888888888888 888 332 278888888888885 777 665 8888888888
Q ss_pred ccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcccc
Q 005224 83 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 83 ~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~~ 138 (707)
+|++ +|. .++ +|+.|+|++|+|+++|. .+++|+.|+|++|.+...
T Consensus 131 ~l~~-lp~---~l~-----~L~~L~Ls~N~l~~lp~--~l~~L~~L~Ls~N~L~~l 175 (571)
T 3cvr_A 131 QLTM-LPE---LPA-----LLEYINADNNQLTMLPE--LPTSLEVLSVRNNQLTFL 175 (571)
T ss_dssp CCSC-CCC---CCT-----TCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCSCC
T ss_pred cCCC-CCC---cCc-----cccEEeCCCCccCcCCC--cCCCcCEEECCCCCCCCc
Confidence 8884 776 233 44478888888887766 466777888888877653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.31 E-value=3.5e-12 Score=141.20 Aligned_cols=127 Identities=28% Similarity=0.362 Sum_probs=95.4
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
+++|+.|+|++|++++.++ +..+++|++|+|++|.++ .+|. +..+ +|+.|+|++|++++..| +..+++|+.|+|
T Consensus 242 l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 242 LTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQIS-NISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccC-cccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 4678899999999888766 788888899999999888 5554 3333 78888888888885443 778888888888
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccccC
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNT 139 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~~~ 139 (707)
++|++++..| +..+++|+ .|++++|++++++....+++|+.|++++|++....
T Consensus 317 ~~n~l~~~~~--~~~l~~L~-----~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~ 369 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQ-----RLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLT 369 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCC-----EEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCG
T ss_pred cCCcCCCchh--hccCccCC-----EeECCCCccCCchhhccCCCCCEEeCCCCccCccc
Confidence 8888886554 55554444 78888888887754447778888888888775543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.8e-13 Score=153.17 Aligned_cols=119 Identities=24% Similarity=0.307 Sum_probs=99.1
Q ss_pred EEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCccc
Q 005224 6 KLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 84 (707)
Q Consensus 6 ~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 84 (707)
.+++++|.|+.+++ ..|+.|+|++|+|+ .+|. +..+ +|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|
T Consensus 427 ~l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l 498 (567)
T 1dce_A 427 SKFLLENSVLKMEY-----ADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498 (567)
T ss_dssp HHHHHHHHHHHHHH-----TTCSEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCC
T ss_pred hhhhhcccccccCc-----cCceEEEecCCCCC-CCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCC
Confidence 33444555554433 25899999999999 7887 5555 8999999999999 8999999999999999999999
Q ss_pred ccCCCCCccccccCCCCccceEEccCccCCCC--CCCC-CCCCCceeeccCCCccccC
Q 005224 85 SGSIPSSIWQSRTLNATETFILDFQNNNLTNI--SGSF-NIPPNVTVRLRGNPFCLNT 139 (707)
Q Consensus 85 ~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~--~~~~-~~~~l~~l~l~~N~~~~~~ 139 (707)
++ +| .+..+++|+ .|+|++|+|+++ |..+ .+++|+.|+|++|+++..+
T Consensus 499 ~~-lp-~l~~l~~L~-----~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 499 EN-VD-GVANLPRLQ-----ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp CC-CG-GGTTCSSCC-----EEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred CC-Cc-ccCCCCCCc-----EEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 95 78 787766665 999999999999 5666 8999999999999987553
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.31 E-value=4.5e-12 Score=140.33 Aligned_cols=126 Identities=28% Similarity=0.383 Sum_probs=105.7
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
+++|+.|+|++|+++++ +.+..+++|++|+|++|.++ .++. +..+ +|+.|+|++|++++..+ +..+++|+.|+|
T Consensus 220 l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 294 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQIS-NLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 294 (466)
T ss_dssp CTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred cCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccc-cchh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEc
Confidence 57899999999999975 56889999999999999999 4544 3333 89999999999996444 899999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~~ 138 (707)
++|++++..| +..+++| +.|+|++|+++++++...+++|+.|++++|++...
T Consensus 295 ~~n~l~~~~~--~~~l~~L-----~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 295 NENQLEDISP--ISNLKNL-----TYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CSSCCSCCGG--GGGCTTC-----SEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred CCCcccCchh--hcCCCCC-----CEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence 9999995433 6665555 49999999999987755899999999999998765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.31 E-value=2.7e-12 Score=122.29 Aligned_cols=112 Identities=21% Similarity=0.277 Sum_probs=94.4
Q ss_pred CCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCCCCc-cccc
Q 005224 19 PDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI-WQSR 96 (707)
Q Consensus 19 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l~ 96 (707)
+.+..+.+|+.|+|++|+|+ .+|...... +|+.|+|++|+|++. ..|..+++|++|+|++|+|+ .+|..+ ..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcCC
Confidence 45778899999999999999 887533334 899999999999964 68999999999999999999 555444 7766
Q ss_pred cCCCCccceEEccCccCCCCCC--CC-CCCCCceeeccCCCccccC
Q 005224 97 TLNATETFILDFQNNNLTNISG--SF-NIPPNVTVRLRGNPFCLNT 139 (707)
Q Consensus 97 ~L~~~~L~~l~l~~N~l~~~~~--~~-~~~~l~~l~l~~N~~~~~~ 139 (707)
+|+ +|+|++|+|+.++. .+ .+++|+.|++++|+++..+
T Consensus 89 ~L~-----~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~ 129 (176)
T 1a9n_A 89 DLT-----ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 129 (176)
T ss_dssp TCC-----EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred CCC-----EEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcH
Confidence 665 99999999999887 45 8999999999999987543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.30 E-value=1e-11 Score=136.94 Aligned_cols=120 Identities=23% Similarity=0.256 Sum_probs=101.0
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
|++|++|+|++|+|+++ |+++.+++|++|+|++|+|+ .+| +..+ +|++|+|++|+|++ +| |+++++|++|+|
T Consensus 41 l~~L~~L~Ls~n~l~~~-~~l~~l~~L~~L~Ls~n~l~-~~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC 113 (457)
T ss_dssp HTTCCEEECCSSCCCCC-TTGGGCTTCSEEECCSSCCS-CCC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred cCCCCEEEccCCCcccC-hhhcccCCCCEEEccCCcCC-eEc--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence 46899999999999987 58999999999999999999 576 4444 89999999999996 44 899999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
++|++++ +| +..+++|+ +|++++|+|++++ ...+++|+.|++++|...
T Consensus 114 ~~N~l~~-l~--~~~l~~L~-----~L~l~~N~l~~l~-l~~l~~L~~L~l~~n~~~ 161 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLT-----YLNCARNTLTEID-VSHNTQLTELDCHLNKKI 161 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCC-----EEECTTSCCSCCC-CTTCTTCCEEECTTCSCC
T ss_pred CCCcCCe-ec--CCCCCcCC-----EEECCCCccceec-cccCCcCCEEECCCCCcc
Confidence 9999995 55 66655554 9999999999974 237888999999988643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=7e-12 Score=127.52 Aligned_cols=146 Identities=14% Similarity=0.079 Sum_probs=114.1
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEE
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 449 (707)
......|+....++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 334457888888898999999999864 6889999987532222346889999999984 67788999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA------------------------------------ 493 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 493 (707)
|||++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 89 ~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999999876411 1223478889999999999811
Q ss_pred --------------------CCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 494 --------------------DPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 494 --------------------~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
.+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876666799999764
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.28 E-value=4.2e-14 Score=137.67 Aligned_cols=124 Identities=20% Similarity=0.246 Sum_probs=103.0
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
+++|+.|+|++|+|++++ .+..+++|++|+|++|+|+ .+|..+..+ +|+.|+|++|+|++ +| .+..+++|+.|+|
T Consensus 47 l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 47 LKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 578999999999999955 8999999999999999999 899866554 89999999999995 66 6899999999999
Q ss_pred cCcccccCCCC--CccccccCCCCccceEEccCccCCCCCCC-----------C-CCCCCceeeccCCCcc
Q 005224 80 ANNSLSGSIPS--SIWQSRTLNATETFILDFQNNNLTNISGS-----------F-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 80 s~N~l~g~~p~--~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-----------~-~~~~l~~l~l~~N~~~ 136 (707)
++|+++ .+|. .+..+++| ++|++++|.+++.++. + .+++|+.|+ +|++.
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L-----~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 123 SNNKIT-NWGEIDKLAALDKL-----EDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTC-----SEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCCcCC-chhHHHHHhcCCCC-----CEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 999998 4443 55555555 4999999999876432 3 678888775 77764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.27 E-value=2.6e-11 Score=133.54 Aligned_cols=121 Identities=26% Similarity=0.322 Sum_probs=88.3
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
++|++|+|++|+++++ |+|+++++|++|+|++|+++ .+|... .+|++|+|++|++++ +| .|+++++|+.|++++
T Consensus 131 ~~L~~L~L~~n~l~~l-p~~~~l~~L~~L~l~~N~l~-~lp~~~--~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~ 204 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEKL-PELQNSSFLKIIDVDNNSLK-KLPDLP--PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADN 204 (454)
T ss_dssp TTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCS-CCCCCC--TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred CCCCEEECcCCCCCCC-cccCCCCCCCEEECCCCcCc-ccCCCc--ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCC
Confidence 4677778888887774 46778888888888888888 576543 278888888888885 66 578888888888888
Q ss_pred cccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccc
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~ 137 (707)
|+++ .+|... .+|+.|++++|+++.+|....+++|+.|++++|.+..
T Consensus 205 N~l~-~l~~~~--------~~L~~L~l~~n~l~~lp~~~~l~~L~~L~l~~N~l~~ 251 (454)
T 1jl5_A 205 NSLK-KLPDLP--------LSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT 251 (454)
T ss_dssp SCCS-SCCCCC--------TTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS
T ss_pred CcCC-cCCCCc--------CcccEEECcCCcCCcccccCCCCCCCEEECCCCcCCc
Confidence 8887 355432 2445788888888877753377888888888887754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.27 E-value=1e-11 Score=131.74 Aligned_cols=125 Identities=26% Similarity=0.407 Sum_probs=101.6
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
+++|+.|+|++|++++..+ +..+++|+.|++++|.++ .++. +..+ +|+.|+|++|++++ ++. +..+++|++|++
T Consensus 176 l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~-~~~~-~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l 250 (347)
T 4fmz_A 176 LTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQIT-DITP-VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEI 250 (347)
T ss_dssp CTTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCCEEEccCCccccccc-ccCCCccceeecccCCCC-CCch-hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEEC
Confidence 4789999999999987666 888999999999999999 5554 3333 89999999999994 444 889999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~ 137 (707)
++|.++ .++ .+..+++| +.|++++|++++++....+++|+.|++++|++..
T Consensus 251 ~~n~l~-~~~-~~~~l~~L-----~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~ 301 (347)
T 4fmz_A 251 GTNQIS-DIN-AVKDLTKL-----KMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGN 301 (347)
T ss_dssp CSSCCC-CCG-GGTTCTTC-----CEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCG
T ss_pred CCCccC-CCh-hHhcCCCc-----CEEEccCCccCCChhhcCCCCCCEEECcCCcCCC
Confidence 999998 443 45555544 4999999999998644488999999999999854
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.3e-11 Score=138.59 Aligned_cols=117 Identities=26% Similarity=0.303 Sum_probs=67.4
Q ss_pred CCceEEEeeCCcCCCCCCC---cCCC--------------CcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCC
Q 005224 2 SKLLKLSLRNCSLQGPMPD---LSRI--------------PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI 64 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~---~~~l--------------~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~ 64 (707)
++|++|+|++|+|++++.. +..| ++|+.|+|++|+|+ .+|... .+|+.|+|++|+|+ .+
T Consensus 141 ~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~-~l~~~~--~~L~~L~L~~N~l~-~l 216 (622)
T 3g06_A 141 PGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLPTLP--SELYKLWAYNNRLT-SL 216 (622)
T ss_dssp TTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCS-CCCCCC--TTCCEEECCSSCCS-SC
T ss_pred CCCCEEECcCCcCCCcCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCC-CCCCcc--chhhEEECcCCccc-cc
Confidence 5677777777777765542 3333 77888888888888 666532 25666666666666 44
Q ss_pred CcccCCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 65 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 65 p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
|.. +++|+.|+|++|+|+ .+|..+ ++|+.|+|++|+|+.+|. .+++|+.|+|++|.+.
T Consensus 217 ~~~---~~~L~~L~Ls~N~L~-~lp~~l--------~~L~~L~Ls~N~L~~lp~--~~~~L~~L~Ls~N~L~ 274 (622)
T 3g06_A 217 PAL---PSGLKELIVSGNRLT-SLPVLP--------SELKELMVSGNRLTSLPM--LPSGLLSLSVYRNQLT 274 (622)
T ss_dssp CCC---CTTCCEEECCSSCCS-CCCCCC--------TTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCC
T ss_pred CCC---CCCCCEEEccCCccC-cCCCCC--------CcCcEEECCCCCCCcCCc--ccccCcEEeCCCCCCC
Confidence 432 355666666666666 345211 223355555555555544 3445555555555554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.23 E-value=4.4e-11 Score=131.88 Aligned_cols=124 Identities=27% Similarity=0.274 Sum_probs=82.4
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
|++|++|+|++|+|++++ ++.+++|++|+|++|+|+ .+| +..+ +|++|+|++|+|++ +| ++++++|++|++
T Consensus 63 l~~L~~L~Ls~n~l~~~~--~~~l~~L~~L~Ls~N~l~-~~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 63 LTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNC 134 (457)
T ss_dssp CTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCS-CCC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred cCCCCEEEccCCcCCeEc--cccCCCCCEEECcCCCCc-eee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEEC
Confidence 467888888888888763 778888888888888888 455 3334 78888888888885 44 778888888888
Q ss_pred cCcccccCCCCCccccccCC-----------------CCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 80 ANNSLSGSIPSSIWQSRTLN-----------------ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~-----------------~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
++|+|++ +| +..+++|+ +++|+.|++++|+|++++ ...+++|+.|++++|.+.
T Consensus 135 ~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~l~-l~~l~~L~~L~l~~N~l~ 204 (457)
T 3bz5_A 135 ARNTLTE-ID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELD-VSQNKLLNRLNCDTNNIT 204 (457)
T ss_dssp TTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCCCC-CTTCTTCCEEECCSSCCS
T ss_pred CCCccce-ec--cccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccceec-cccCCCCCEEECcCCcCC
Confidence 8888875 43 43333332 233445555555555554 124555555555555543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.23 E-value=5.1e-11 Score=135.71 Aligned_cols=107 Identities=25% Similarity=0.309 Sum_probs=61.0
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
+++|++|+|++|+|+++++ .+++|++|+|++|+|+ .+|. ...+|+.|+|++|+|+ .+|.. +++|++|+|+
T Consensus 80 l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~-~l~~--~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~Ls 149 (622)
T 3g06_A 80 PPELRTLEVSGNQLTSLPV---LPPGLLELSIFSNPLT-HLPA--LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVS 149 (622)
T ss_dssp CTTCCEEEECSCCCSCCCC---CCTTCCEEEECSCCCC-CCCC--CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECC
T ss_pred CCCCCEEEcCCCcCCcCCC---CCCCCCEEECcCCcCC-CCCC--CCCCcCEEECCCCCCC-cCCCC---CCCCCEEECc
Confidence 3567777777777776544 5566777777777777 5665 1125666666666666 34543 3566666666
Q ss_pred CcccccCCCCCccccccCC------------CCccceEEccCccCCCCCC
Q 005224 81 NNSLSGSIPSSIWQSRTLN------------ATETFILDFQNNNLTNISG 118 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~------------~~~L~~l~l~~N~l~~~~~ 118 (707)
+|+|+ .+|..+.++..|. .++|+.|+|++|+|+++|.
T Consensus 150 ~N~l~-~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~l~~ 198 (622)
T 3g06_A 150 DNQLA-SLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASLPT 198 (622)
T ss_dssp SSCCS-CCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCC
T ss_pred CCcCC-CcCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCCCCC
Confidence 66665 3444333333321 1345566666666665543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.8e-11 Score=129.88 Aligned_cols=103 Identities=22% Similarity=0.208 Sum_probs=87.2
Q ss_pred EEEeeCC-cCCCCCCCcCCCCcccEEeccC-CcCcccCCCc-cccc-CccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 6 KLSLRNC-SLQGPMPDLSRIPNLGYLDLSS-NQLNGSIPPG-RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 6 ~L~L~~N-~l~~~~~~~~~l~~L~~L~Ls~-N~l~g~ip~~-~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
.++++++ +|+++++ |..+++|++|+|++ |+|+ .+|+. +..+ +|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCC-CcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 5789998 9999888 99999999999996 9999 67754 4445 899999999999999999999999999999999
Q ss_pred cccccCCCCCccccccCCCCccceEEccCccCCCC
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 116 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~ 116 (707)
|+|+ .+|..+.... .|+.|+|++|.|...
T Consensus 90 N~l~-~~~~~~~~~~-----~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALE-SLSWKTVQGL-----SLQELVLSGNPLHCS 118 (347)
T ss_dssp SCCS-CCCSTTTCSC-----CCCEEECCSSCCCCC
T ss_pred Cccc-eeCHHHcccC-----CceEEEeeCCCccCC
Confidence 9999 5555443322 255999999999864
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.22 E-value=2e-11 Score=129.84 Aligned_cols=130 Identities=22% Similarity=0.234 Sum_probs=97.8
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc--Cc-cEEEccCccCCCCCCcccCCCcccceE
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NI-TTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
++|++|+|++|+|+.+++ .|.++++|++|+|++|++.+.+|.+.+.. +| +.+.+++|+|+...|..|.++++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 468999999999998887 68999999999999999876788876543 54 457778899997778889999999999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccC-ccCCCCCCCC--CC-CCCceeeccCCCcc
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQN-NNLTNISGSF--NI-PPNVTVRLRGNPFC 136 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~-N~l~~~~~~~--~~-~~l~~l~l~~N~~~ 136 (707)
++++|+|++..+..+... .++..|++.+ |+++.++... .+ ..++.|++++|.+.
T Consensus 110 ~l~~n~l~~~~~~~~~~~-----~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHS-----LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EEEEECCSSCCCCTTCCB-----SSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cccccccccCCchhhccc-----chhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 999999984444344332 2344777754 6777776543 33 34667888888875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.18 E-value=1.1e-10 Score=128.43 Aligned_cols=118 Identities=21% Similarity=0.180 Sum_probs=74.7
Q ss_pred CceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccCc
Q 005224 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 82 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 82 (707)
+|+.|+|++|+++++++. +++|++|+|++|+++ .+|... .+|++|+|++|++++ +| +|+++++|++|++++|
T Consensus 92 ~L~~L~l~~n~l~~lp~~---~~~L~~L~l~~n~l~-~l~~~~--~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N 163 (454)
T 1jl5_A 92 HLESLVASCNSLTELPEL---PQSLKSLLVDNNNLK-ALSDLP--PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNN 163 (454)
T ss_dssp TCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCS-CCCSCC--TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSS
T ss_pred CCCEEEccCCcCCccccc---cCCCcEEECCCCccC-cccCCC--CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCC
Confidence 455666666666653322 256666666666666 454321 267777777777774 66 4777777777777777
Q ss_pred ccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccc
Q 005224 83 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 83 ~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~ 137 (707)
+++ .+|..+. +|++|++++|+++++|....+++|+.|++++|.+..
T Consensus 164 ~l~-~lp~~~~--------~L~~L~L~~n~l~~l~~~~~l~~L~~L~l~~N~l~~ 209 (454)
T 1jl5_A 164 SLK-KLPDLPP--------SLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKK 209 (454)
T ss_dssp CCS-CCCCCCT--------TCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS
T ss_pred cCc-ccCCCcc--------cccEEECcCCcCCcCccccCCCCCCEEECCCCcCCc
Confidence 777 3665432 344777777777777643367777777777777653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=6.3e-11 Score=119.95 Aligned_cols=136 Identities=21% Similarity=0.159 Sum_probs=100.1
Q ss_pred CCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCc--ceeEEEEEEeCCeEEEEEecC
Q 005224 376 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~E~~ 453 (707)
.+......+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34333333455669999998777888999997653 2245778999999986544 556888888888899999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---------------------------------------- 493 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 493 (707)
+|.+|. ... .+ ...++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 98 PGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 998874 211 11 2356777888888888643
Q ss_pred ---------------CCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 494 ---------------DPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 494 ---------------~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
...++|+|++|.||+++++..+.|+|||.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1229999999999999887667799999875
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.12 E-value=3.4e-12 Score=137.71 Aligned_cols=130 Identities=18% Similarity=0.284 Sum_probs=67.1
Q ss_pred CCceEEEeeCCcCC-CCCC----CcCCCCcccEEeccCCcCc--c---cCCCccccc-CccEEEccCccCC----CCCCc
Q 005224 2 SKLLKLSLRNCSLQ-GPMP----DLSRIPNLGYLDLSSNQLN--G---SIPPGRLSL-NITTIKLSNNKLT----GTIPS 66 (707)
Q Consensus 2 ~~L~~L~L~~N~l~-~~~~----~~~~l~~L~~L~Ls~N~l~--g---~ip~~~~~~-~L~~L~Ls~N~l~----~~~p~ 66 (707)
++|++|+|++|+|+ +..+ .|..+++|++|+|++|+|+ | .+|..+... +|+.|+|++|+|+ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 45555666666554 2222 2445556666666666655 2 122233332 5666666666664 34555
Q ss_pred ccCCCcccceEeccCcccccC----CCCCccc--cccCCCCccceEEccCccCCC-----CCCCC--CCCCCceeeccCC
Q 005224 67 NFSGLPRLQRLFIANNSLSGS----IPSSIWQ--SRTLNATETFILDFQNNNLTN-----ISGSF--NIPPNVTVRLRGN 133 (707)
Q Consensus 67 ~~~~l~~L~~L~ls~N~l~g~----~p~~~~~--l~~L~~~~L~~l~l~~N~l~~-----~~~~~--~~~~l~~l~l~~N 133 (707)
.+..+++|+.|+|++|.|++. +|..+.. ++ +|+.|+|++|.|+. ++..+ .+++|+.|++++|
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~-----~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N 313 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI-----GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 313 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSC-----CCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTS
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCC-----CeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCC
Confidence 556666666666666666533 2333311 22 23366666666665 44433 3566666666666
Q ss_pred Ccc
Q 005224 134 PFC 136 (707)
Q Consensus 134 ~~~ 136 (707)
++.
T Consensus 314 ~l~ 316 (386)
T 2ca6_A 314 RFS 316 (386)
T ss_dssp BSC
T ss_pred cCC
Confidence 654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.10 E-value=6.5e-12 Score=132.55 Aligned_cols=128 Identities=13% Similarity=0.188 Sum_probs=103.1
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCccc-CCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS-IPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~-ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
++|+.|+|++|.+++.++.+..+++|++|+|++|.+++. +|..+... +|++|+|++|++++..|..|+.+++|++|+|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 149 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 149 (336)
T ss_dssp TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred ccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence 578899999999998888778899999999999998855 66555544 8999999999999888888999999999999
Q ss_pred cCc-ccccC-CCCCccccccCCCCccceEEccCc-cCCC--CCCCC-CCC-CCceeeccCCC
Q 005224 80 ANN-SLSGS-IPSSIWQSRTLNATETFILDFQNN-NLTN--ISGSF-NIP-PNVTVRLRGNP 134 (707)
Q Consensus 80 s~N-~l~g~-~p~~~~~l~~L~~~~L~~l~l~~N-~l~~--~~~~~-~~~-~l~~l~l~~N~ 134 (707)
++| .+++. +|..+..+++|+ .|+|++| +++. ++..+ .++ +|+.|++++|.
T Consensus 150 ~~~~~l~~~~l~~~~~~~~~L~-----~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~ 206 (336)
T 2ast_B 150 SGCSGFSEFALQTLLSSCSRLD-----ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 206 (336)
T ss_dssp TTCBSCCHHHHHHHHHHCTTCC-----EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred CCCCCCCHHHHHHHHhcCCCCC-----EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence 999 67752 566666666555 8999999 8885 33333 678 88999998885
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.06 E-value=7.3e-12 Score=135.03 Aligned_cols=131 Identities=19% Similarity=0.261 Sum_probs=91.0
Q ss_pred CCCceEEEeeCCcC---CCCCC-Cc-------CCCCcccEEeccCCcCcc----cCCCccccc-CccEEEccCccCCCCC
Q 005224 1 MSKLLKLSLRNCSL---QGPMP-DL-------SRIPNLGYLDLSSNQLNG----SIPPGRLSL-NITTIKLSNNKLTGTI 64 (707)
Q Consensus 1 L~~L~~L~L~~N~l---~~~~~-~~-------~~l~~L~~L~Ls~N~l~g----~ip~~~~~~-~L~~L~Ls~N~l~~~~ 64 (707)
+++|+.|+|++|.+ ++.+| .+ ..+++|++|+|++|.|++ .+|..+... +|+.|+|++|+|++..
T Consensus 59 ~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~ 138 (386)
T 2ca6_A 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQA 138 (386)
T ss_dssp CTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHH
T ss_pred CCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHH
Confidence 46788999988644 44444 33 678899999999999885 355555444 7899999999887544
Q ss_pred CcccCC----C---------cccceEeccCcccc-cCCC---CCccccccCCCCccceEEccCccCC--C----CCCCC-
Q 005224 65 PSNFSG----L---------PRLQRLFIANNSLS-GSIP---SSIWQSRTLNATETFILDFQNNNLT--N----ISGSF- 120 (707)
Q Consensus 65 p~~~~~----l---------~~L~~L~ls~N~l~-g~~p---~~~~~l~~L~~~~L~~l~l~~N~l~--~----~~~~~- 120 (707)
+..+.. + ++|++|+|++|+++ +.+| ..+..+++| +.|+|++|+|+ + ++..+
T Consensus 139 ~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L-----~~L~L~~n~l~~~g~~~l~~~~l~ 213 (386)
T 2ca6_A 139 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL-----HTVKMVQNGIRPEGIEHLLLEGLA 213 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTC-----CEEECCSSCCCHHHHHHHHHTTGG
T ss_pred HHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCc-----CEEECcCCCCCHhHHHHHHHHHhh
Confidence 444433 3 78888999998887 4445 344444444 48888888888 2 23234
Q ss_pred CCCCCceeeccCCCcc
Q 005224 121 NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 121 ~~~~l~~l~l~~N~~~ 136 (707)
.+++|+.|+|++|.+.
T Consensus 214 ~~~~L~~L~Ls~n~l~ 229 (386)
T 2ca6_A 214 YCQELKVLDLQDNTFT 229 (386)
T ss_dssp GCTTCCEEECCSSCCH
T ss_pred cCCCccEEECcCCCCC
Confidence 6788888888888874
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.03 E-value=2.3e-11 Score=129.98 Aligned_cols=133 Identities=23% Similarity=0.250 Sum_probs=69.5
Q ss_pred CceEEEeeCCcCCCCCC-----CcCCCC-cccEEeccCCcCcccCCCcccc------cCccEEEccCccCCCCCCcccCC
Q 005224 3 KLLKLSLRNCSLQGPMP-----DLSRIP-NLGYLDLSSNQLNGSIPPGRLS------LNITTIKLSNNKLTGTIPSNFSG 70 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-----~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~------~~L~~L~Ls~N~l~~~~p~~~~~ 70 (707)
+|++|+|++|+|++..+ .|..++ +|++|+|++|+|++..+..+.. .+|++|+|++|+|++..+..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 36666666666666553 245555 6666666666666333333222 25666666666666555543333
Q ss_pred C-----cccceEeccCcccccCCCCCcccc-ccCCCCccceEEccCccCCCCC-----CCC-CCC-CCceeeccCCCcc
Q 005224 71 L-----PRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFILDFQNNNLTNIS-----GSF-NIP-PNVTVRLRGNPFC 136 (707)
Q Consensus 71 l-----~~L~~L~ls~N~l~g~~p~~~~~l-~~L~~~~L~~l~l~~N~l~~~~-----~~~-~~~-~l~~l~l~~N~~~ 136 (707)
. ++|++|+|++|+|++..+..+... ..+ ..+|++|+|++|+|+... ..+ ..+ +|+.|+|++|.+.
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~-~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~ 180 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL-PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTS-CTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhC-CCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence 2 566666666666664433333221 100 023446666666666321 111 233 5666666666653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.02 E-value=5e-12 Score=133.38 Aligned_cols=130 Identities=18% Similarity=0.232 Sum_probs=103.7
Q ss_pred CCCceEEEeeCCcCCCC-CC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCc-cCCCC-CCcccCCCcccc
Q 005224 1 MSKLLKLSLRNCSLQGP-MP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNN-KLTGT-IPSNFSGLPRLQ 75 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~-~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~ 75 (707)
+++|+.|+|++|.+++. .+ .+..+++|++|+|++|.+++.+|..+... +|++|+|++| .+++. ++..+.++++|+
T Consensus 92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 46899999999999864 55 58889999999999999997777666555 8999999999 68863 777788899999
Q ss_pred eEeccCc-ccccC-CCCCccccc-cCCCCccceEEccCcc--CC--CCCCCC-CCCCCceeeccCCCc
Q 005224 76 RLFIANN-SLSGS-IPSSIWQSR-TLNATETFILDFQNNN--LT--NISGSF-NIPPNVTVRLRGNPF 135 (707)
Q Consensus 76 ~L~ls~N-~l~g~-~p~~~~~l~-~L~~~~L~~l~l~~N~--l~--~~~~~~-~~~~l~~l~l~~N~~ 135 (707)
+|+|++| .+++. ++..+..++ +|+ .|+|++|. ++ .++..+ .+++|+.|++++|.+
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~-----~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETIT-----QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCC-----EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCC-----EEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence 9999999 88854 566666666 555 99999994 44 344443 688999999999983
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.01 E-value=9.9e-10 Score=116.65 Aligned_cols=130 Identities=18% Similarity=0.249 Sum_probs=88.6
Q ss_pred CCce-EEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccC-ccCCCCCCcccCCCc-ccc
Q 005224 2 SKLL-KLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSN-NKLTGTIPSNFSGLP-RLQ 75 (707)
Q Consensus 2 ~~L~-~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~ 75 (707)
++|. .+++++|+|+.++| .|..+++|++|++++|+|+ .+|...+. . ++..|++++ |+++...+..|..+. .|+
T Consensus 79 ~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~ 157 (350)
T 4ay9_X 79 PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV 157 (350)
T ss_dssp TTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCE
T ss_pred hhhhhhhcccCCcccccCchhhhhccccccccccccccc-cCCchhhcccchhhhhhhccccccccccccchhhcchhhh
Confidence 3444 46777888888877 5888888999999988888 66654332 2 667777754 567654555666664 577
Q ss_pred eEeccCcccccCCCCCccccccCCCCccceEEcc-CccCCCCCCCC--CCCCCceeeccCCCcccc
Q 005224 76 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ-NNNLTNISGSF--NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 76 ~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~-~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~ 138 (707)
.|+|++|+|+ .+|.......+ |+.|+++ +|.++.+|... .+++|+.|++++|++..-
T Consensus 158 ~L~L~~N~i~-~i~~~~f~~~~-----L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 158 ILWLNKNGIQ-EIHNSAFNGTQ-----LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp EEECCSSCCC-EECTTSSTTEE-----EEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred hhcccccccc-CCChhhccccc-----hhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCcc
Confidence 7888888887 56655544333 3477776 47777777643 677777888888877543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.99 E-value=4.5e-11 Score=127.66 Aligned_cols=134 Identities=22% Similarity=0.273 Sum_probs=87.7
Q ss_pred CceEEEeeCCcCCCCCC-CcCCC-----CcccEEeccCCcCcccCCCcccc------cCccEEEccCccCCCCCCcccCC
Q 005224 3 KLLKLSLRNCSLQGPMP-DLSRI-----PNLGYLDLSSNQLNGSIPPGRLS------LNITTIKLSNNKLTGTIPSNFSG 70 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-~~~~l-----~~L~~L~Ls~N~l~g~ip~~~~~------~~L~~L~Ls~N~l~~~~p~~~~~ 70 (707)
+|++|+|++|+|++..+ .|..+ ++|++|+|++|+|++..+..+.. .+|+.|+|++|+|++..+..+..
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 78888888888887765 45554 88888888888888444432221 26888888888888665554433
Q ss_pred -----CcccceEeccCcccccCCCCCcccc-ccCCCCccceEEccCccCCCCCCC-----C-CC-CCCceeeccCCCccc
Q 005224 71 -----LPRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFILDFQNNNLTNISGS-----F-NI-PPNVTVRLRGNPFCL 137 (707)
Q Consensus 71 -----l~~L~~L~ls~N~l~g~~p~~~~~l-~~L~~~~L~~l~l~~N~l~~~~~~-----~-~~-~~l~~l~l~~N~~~~ 137 (707)
.++|++|+|++|+|++..+..+... ..+ ..+|+.|+|++|+|+..... + .. ++|+.|+|++|.+..
T Consensus 132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~-~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAI-PANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTS-CTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcC-CccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence 2588888888888875433333211 111 02455888888888765431 1 34 478888888888754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=8.8e-10 Score=117.43 Aligned_cols=142 Identities=23% Similarity=0.329 Sum_probs=106.6
Q ss_pred ccceEeeeCceEEEEEEeCCCcEEEEEEec--cCC-hhhHHHHHHHHHHHHccC--CCcceeEEEEEEeC---CeEEEEE
Q 005224 379 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQ--EGS-LQGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEE---GEQMLVY 450 (707)
Q Consensus 379 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~---~~~~lV~ 450 (707)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35778999999999998754 578888776 322 122456888999999997 45578899988766 4589999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA------------------------------------- 493 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 493 (707)
||++|..+.+. ....++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998776431 1223678888899999999999999731
Q ss_pred ------------------CCCeEecCCCCCCEEEcCCCc--EEEeeeccccc
Q 005224 494 ------------------DPPVFHRDIKASNILLDHKFT--AKVADFGLSRL 525 (707)
Q Consensus 494 ------------------~~~ivH~Dlkp~NILl~~~~~--~kl~DFGla~~ 525 (707)
.+.++|+|+++.||++++++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.9e-09 Score=112.08 Aligned_cols=192 Identities=16% Similarity=0.158 Sum_probs=122.3
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCc--ceeEEEEEEeCC---eEEEEEecC
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRN--LVSLVGYCDEEG---EQMLVYEFM 453 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lV~E~~ 453 (707)
.+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4669999999999864 45888886532 34567889999998883 333 344555443333 358899999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE----------------------------------------- 492 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 492 (707)
+|.++.+... ..++...+..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988865432 1366777788888888888888861
Q ss_pred --------------CCCCeEecCCCCCCEEEcC--CCcEEEeeecccccCCCCC-CCCcc------ccceecccccCCCc
Q 005224 493 --------------ADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD-IEGIV------PAHVSTVVKGTPGY 549 (707)
Q Consensus 493 --------------~~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~~-~~~~~------~~~~~~~~~gt~~y 549 (707)
..+.++|+|+++.||++++ ...+.|+||+.+..-.... ..... ...........++.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1244899999999999998 5568899999886532110 00000 00000000001111
Q ss_pred cc-hhhhccCCCCCchhhHHHHHHHHHHHcCCCCC
Q 005224 550 LD-PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 583 (707)
Q Consensus 550 ~a-PE~~~~~~~s~~sDVwS~Gvll~elltG~~pf 583 (707)
.. |+..... ....+.|++|.++|++.+|..+|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 2222111 12368999999999999997766
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.88 E-value=3.4e-11 Score=132.84 Aligned_cols=88 Identities=14% Similarity=0.130 Sum_probs=40.7
Q ss_pred CccEEEccCccCCCC----CCcccCCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCC-----CCCCC
Q 005224 49 NITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-----NISGS 119 (707)
Q Consensus 49 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~-----~~~~~ 119 (707)
+|+.|+|++|.+++. ++..+..+++|+.|+|++|++++..+..+...-.-..++|+.|+|++|+++ .++..
T Consensus 314 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 393 (461)
T 1z7x_W 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 393 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred cceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHH
Confidence 455555555555433 334444455555555555555533233222100000123345666666655 23333
Q ss_pred C-CCCCCceeeccCCCcc
Q 005224 120 F-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 120 ~-~~~~l~~l~l~~N~~~ 136 (707)
+ .+++|+.|++++|++.
T Consensus 394 l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 394 LLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHCCCCCEEECCSSSCC
T ss_pred HHhCCCccEEECCCCCCC
Confidence 3 4555666666666553
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.81 E-value=1.2e-10 Score=128.44 Aligned_cols=135 Identities=24% Similarity=0.284 Sum_probs=83.4
Q ss_pred CCceEEEeeCCcCCCC----CC-CcCCCCcccEEeccCCcCcccCCCcccc-c-----CccEEEccCccCCC----CCCc
Q 005224 2 SKLLKLSLRNCSLQGP----MP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-----NITTIKLSNNKLTG----TIPS 66 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~----~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-----~L~~L~Ls~N~l~~----~~p~ 66 (707)
++|+.|+|++|+++.. ++ .+..+++|++|+|++|.+++..+..+.. . +|++|+|++|+|+. .+|.
T Consensus 28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 5677777777777642 12 4666777777888777776432322221 1 47788888887773 4577
Q ss_pred ccCCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCC-----CCC-CCCCCceeeccCCCcc
Q 005224 67 NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-----GSF-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 67 ~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~-----~~~-~~~~l~~l~l~~N~~~ 136 (707)
.|..+++|++|+|++|.+++..+..+...-.-...+|+.|+|++|+++... ..+ .+++|+.|++++|++.
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 183 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc
Confidence 777778888888888877644333333210001224557888888777632 122 4577788888887764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.71 E-value=1.8e-08 Score=105.81 Aligned_cols=131 Identities=14% Similarity=0.142 Sum_probs=100.6
Q ss_pred CCCceEEEeeCCcCC--------------------CCCC-CcCC--------CCcccEEeccCCcCcccCCCccccc--C
Q 005224 1 MSKLLKLSLRNCSLQ--------------------GPMP-DLSR--------IPNLGYLDLSSNQLNGSIPPGRLSL--N 49 (707)
Q Consensus 1 L~~L~~L~L~~N~l~--------------------~~~~-~~~~--------l~~L~~L~Ls~N~l~g~ip~~~~~~--~ 49 (707)
+++|+.|||++|+|. .+++ .|.+ +++|+.|+|++ +++ .|+...|.. +
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~ 125 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIK-NIEDAAFKGCDN 125 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCC-EECTTTTTTCTT
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-ccc-chhHHHhhcCcc
Confidence 578999999999999 2333 5778 99999999999 999 899887764 8
Q ss_pred ccEEEccCccCCCCCCcccCCCcccceEeccCccc----ccCCCCCccccccCC--------------------------
Q 005224 50 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL----SGSIPSSIWQSRTLN-------------------------- 99 (707)
Q Consensus 50 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l----~g~~p~~~~~l~~L~-------------------------- 99 (707)
|+.|+|++|.++...+.+|.++.++..+.++.+.. ...-...+.++..|+
T Consensus 126 L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~ 205 (329)
T 3sb4_A 126 LKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDIN 205 (329)
T ss_dssp CCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCS
T ss_pred cceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccc
Confidence 99999999999877788899988888888777432 111122233333332
Q ss_pred -------------------CCccceEEccCccCCCCCCCC--CCCCCceeeccCC
Q 005224 100 -------------------ATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGN 133 (707)
Q Consensus 100 -------------------~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N 133 (707)
.++|+.|+|++|+++.++... .+.+|+.++|.+|
T Consensus 206 ~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n 260 (329)
T 3sb4_A 206 FLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN 260 (329)
T ss_dssp EEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT
T ss_pred eEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc
Confidence 457779999999999998765 7889999999887
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.62 E-value=7.7e-10 Score=118.32 Aligned_cols=36 Identities=22% Similarity=0.204 Sum_probs=16.3
Q ss_pred CceEEEeeCCcCCCCCC-CcC-----CCCcccEEeccCCcCc
Q 005224 3 KLLKLSLRNCSLQGPMP-DLS-----RIPNLGYLDLSSNQLN 38 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-~~~-----~l~~L~~L~Ls~N~l~ 38 (707)
+|+.|+|++|.|+.... .|. ..++|++|+|++|.|+
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~ 114 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLD 114 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCC
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCC
Confidence 45555555555543222 111 1145555555555554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.60 E-value=9.1e-08 Score=100.44 Aligned_cols=129 Identities=14% Similarity=0.121 Sum_probs=98.2
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCc--------------c--------------c-----
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPG--------------R--------------L----- 46 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~--------------~--------------~----- 46 (707)
|++|+.|+|.+ +++.+.+ .|.++++|+.|+|++|.++ .|+.. . +
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence 57889999988 8887776 6999999999999999864 33332 1 0
Q ss_pred ----------------------------------------------cc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 47 ----------------------------------------------SL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 47 ----------------------------------------------~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
.+ +|+.|+|++|+++...+.+|.+|++|+.|+|
T Consensus 178 L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 178 LETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp CEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred cceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 02 7899999999999666678999999999999
Q ss_pred cCcccccCCCCCccccccCCCCccc-eEEccCccCCCCCCCC--CCCCCceeeccCCCcccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETF-ILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~-~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~ 138 (707)
++| ++..-+.+|.++. +|+ .|++.+ +++.++... .+++|+.+++.+|.+...
T Consensus 258 ~~n-i~~I~~~aF~~~~-----~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I 312 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCG-----RLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTL 312 (329)
T ss_dssp CTT-CCEECTTTTTTCT-----TCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEE
T ss_pred Ccc-cceehHHHhhCCh-----hccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCcc
Confidence 998 7733345566654 455 789988 888886544 789999999988887543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.56 E-value=1.1e-09 Score=116.98 Aligned_cols=130 Identities=21% Similarity=0.230 Sum_probs=94.4
Q ss_pred CCceEEEeeCCcCCCCCC-C-cCCCCcccEEeccCCcCcccCCCccc------ccCccEEEccCccCCC----CCCcccC
Q 005224 2 SKLLKLSLRNCSLQGPMP-D-LSRIPNLGYLDLSSNQLNGSIPPGRL------SLNITTIKLSNNKLTG----TIPSNFS 69 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~-~~~l~~L~~L~Ls~N~l~g~ip~~~~------~~~L~~L~Ls~N~l~~----~~p~~~~ 69 (707)
++|+.|+|++|.|+.... . ...+++|+.|+|++|.|+..-...+. ..+|+.|+|++|+|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 479999999999875432 2 34578999999999999832212211 1279999999999974 2455567
Q ss_pred CCcccceEeccCcccccC----CCCCccccccCCCCccceEEccCccCCCCC-----CCC-CCCCCceeeccCCCcc
Q 005224 70 GLPRLQRLFIANNSLSGS----IPSSIWQSRTLNATETFILDFQNNNLTNIS-----GSF-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 70 ~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~-----~~~-~~~~l~~l~l~~N~~~ 136 (707)
.+++|++|+|++|.|+.. ++..+...+ +|+.|+|++|.|+... ..+ ..++|+.|+|++|++.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~-----~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNR-----QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCS-----CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC-----CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence 789999999999999742 233444444 4559999999998642 222 4588999999999874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.5e-06 Score=88.17 Aligned_cols=135 Identities=16% Similarity=0.141 Sum_probs=99.0
Q ss_pred ceEeeeCce-EEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEEecCCCCC
Q 005224 381 TQIGQGGYG-KVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGT 457 (707)
Q Consensus 381 ~~lG~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~gs 457 (707)
+.+..|..| .||+.... ++..+++|+-.. .....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 455666665 68988754 567889998654 23456888999998884 3336788899999999999999999988
Q ss_pred HHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 005224 458 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA-------------------------------------------- 493 (707)
Q Consensus 458 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 493 (707)
+.+..... ......++.+++..|.-||+..
T Consensus 107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87765332 1123346666777777777521
Q ss_pred -----------CCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 494 -----------DPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 494 -----------~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
.+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1238999999999999988777899999775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=2.5e-06 Score=88.48 Aligned_cols=136 Identities=21% Similarity=0.204 Sum_probs=93.8
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCC---cceeEEEEEE-eCCeEEEEEecCCC
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR---NLVSLVGYCD-EEGEQMLVYEFMSN 455 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lV~E~~~~ 455 (707)
.+.++.|....||+. |+.+++|+-. .......+.+|+++|+.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 567888999999987 5668888753 223456788999999999653 3566677764 45567899999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE------------------------------------------- 492 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 492 (707)
.++.+..-. .++...+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 887663211 133444444455555555555432
Q ss_pred --------------CCCCeEecCCCCCCEEEcC---CCc-EEEeeeccccc
Q 005224 493 --------------ADPPVFHRDIKASNILLDH---KFT-AKVADFGLSRL 525 (707)
Q Consensus 493 --------------~~~~ivH~Dlkp~NILl~~---~~~-~kl~DFGla~~ 525 (707)
..+.++|+|+++.||++++ ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 455 48999998764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.24 E-value=1.7e-07 Score=106.46 Aligned_cols=94 Identities=9% Similarity=0.083 Sum_probs=46.9
Q ss_pred ceEEEeeCCcC-CC-CCC-CcCCCCcccEEeccCCcCccc----CCCccccc-CccEEEccCccCC----CCCCcccCCC
Q 005224 4 LLKLSLRNCSL-QG-PMP-DLSRIPNLGYLDLSSNQLNGS----IPPGRLSL-NITTIKLSNNKLT----GTIPSNFSGL 71 (707)
Q Consensus 4 L~~L~L~~N~l-~~-~~~-~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~~-~L~~L~Ls~N~l~----~~~p~~~~~l 71 (707)
|++|+|++|.- +. ..+ -..++++|++|+|++|.+++. ++...... +|+.|+|++|+++ +.++..+.++
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 66666666651 10 001 123566666666666666532 11111111 5666666666665 2233344556
Q ss_pred cccceEeccCcccccCCCCCccccccC
Q 005224 72 PRLQRLFIANNSLSGSIPSSIWQSRTL 98 (707)
Q Consensus 72 ~~L~~L~ls~N~l~g~~p~~~~~l~~L 98 (707)
++|+.|+|++|.+.+ +|..+..+++|
T Consensus 220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L 245 (592)
T 3ogk_B 220 RSLVSVKVGDFEILE-LVGFFKAAANL 245 (592)
T ss_dssp TTCCEEECSSCBGGG-GHHHHHHCTTC
T ss_pred CCCcEEeccCccHHH-HHHHHhhhhHH
Confidence 666666666666653 44444443333
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.18 E-value=2.6e-07 Score=105.04 Aligned_cols=132 Identities=11% Similarity=0.148 Sum_probs=94.9
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCC-CCcccEEecc----CCcCcccCCCc------cccc-CccEEEccCc--cCCCCCC
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSR-IPNLGYLDLS----SNQLNGSIPPG------RLSL-NITTIKLSNN--KLTGTIP 65 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~-l~~L~~L~Ls----~N~l~g~ip~~------~~~~-~L~~L~Ls~N--~l~~~~p 65 (707)
+++|+.|+|+.|++++... .++. +++|+.|+|+ .|.++ ..|.. +... +|+.|+|+++ .+++..+
T Consensus 377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~-~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~ 455 (592)
T 3ogk_B 377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERIT-DLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGL 455 (592)
T ss_dssp CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCS-SCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHH
T ss_pred CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCcccc-CchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHH
Confidence 5789999999999987655 4555 8899999996 78888 44432 2223 7999999743 4776666
Q ss_pred cccCC-CcccceEeccCccccc-CCCCCccccccCCCCccceEEccCccCCCC--CCCC-CCCCCceeeccCCCcccc
Q 005224 66 SNFSG-LPRLQRLFIANNSLSG-SIPSSIWQSRTLNATETFILDFQNNNLTNI--SGSF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 66 ~~~~~-l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~--~~~~-~~~~l~~l~l~~N~~~~~ 138 (707)
..+.. +++|+.|+|++|++++ .++..+..+++| +.|+|++|.|+.. +... .+++|+.|++++|+++..
T Consensus 456 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L-----~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 456 SYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNL-----QKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTC-----CEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHhCccceEeeccCCCCCHHHHHHHHhcCccc-----CeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 55544 7889999999999875 234444444444 4999999998642 2222 688999999999997543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=1.3e-06 Score=77.99 Aligned_cols=68 Identities=21% Similarity=0.260 Sum_probs=50.5
Q ss_pred eEeccCcccc-cCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCCcccccCCCCC
Q 005224 76 RLFIANNSLS-GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 150 (707)
Q Consensus 76 ~L~ls~N~l~-g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~~~~~~~~~~~ 150 (707)
.++.+++.|+ ..+|..+. .+|+.|+|++|+|+.++... .+++|+.|+|.+|||.|+|.+..|-.|...
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp-------~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~~ 82 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP-------VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAG 82 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC-------TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHHT
T ss_pred EEEeCCCCCccccCCCCCC-------cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHHh
Confidence 5666666664 35554432 23457888888888877654 688899999999999999999988888754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.7e-06 Score=91.68 Aligned_cols=80 Identities=4% Similarity=-0.013 Sum_probs=55.6
Q ss_pred cceE-eeeCceEEEEEEeC-------CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccC-C--CcceeEEEEEEeC--
Q 005224 380 STQI-GQGGYGKVYKGILP-------DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLH-H--RNLVSLVGYCDEE-- 443 (707)
Q Consensus 380 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~-- 443 (707)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88889999998764 26788899865432 111235678888888874 2 3467788887655
Q ss_pred -CeEEEEEecCCCCCHH
Q 005224 444 -GEQMLVYEFMSNGTLR 459 (707)
Q Consensus 444 -~~~~lV~E~~~~gsL~ 459 (707)
+..++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999886643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.13 E-value=8.7e-07 Score=89.27 Aligned_cols=82 Identities=22% Similarity=0.289 Sum_probs=59.1
Q ss_pred EEeeCCcCCCCC---C-CcCCCCcccEEeccCCcCcc--cCCCccccc-CccEEEccCccCCCCCCcccCCCc--ccceE
Q 005224 7 LSLRNCSLQGPM---P-DLSRIPNLGYLDLSSNQLNG--SIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLP--RLQRL 77 (707)
Q Consensus 7 L~L~~N~l~~~~---~-~~~~l~~L~~L~Ls~N~l~g--~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L 77 (707)
++++.|+..... + ...++++|+.|+|++|+|++ .+|..+..+ +|+.|+|++|+|++. ..+..+. +|++|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 566777443222 2 12468899999999999994 344433334 899999999999964 4455555 89999
Q ss_pred eccCcccccCCCC
Q 005224 78 FIANNSLSGSIPS 90 (707)
Q Consensus 78 ~ls~N~l~g~~p~ 90 (707)
+|++|.+++.+|+
T Consensus 226 ~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 226 WLDGNSLCDTFRD 238 (267)
T ss_dssp ECTTSTTGGGCSS
T ss_pred EccCCcCccccCc
Confidence 9999999988874
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.11 E-value=1.5e-06 Score=87.59 Aligned_cols=113 Identities=19% Similarity=0.240 Sum_probs=80.9
Q ss_pred CCcCCCCCC--CcCCCCcccE--EeccCCcCcccCCCccc----cc-CccEEEccCccCCC--CCCcccCCCcccceEec
Q 005224 11 NCSLQGPMP--DLSRIPNLGY--LDLSSNQLNGSIPPGRL----SL-NITTIKLSNNKLTG--TIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 11 ~N~l~~~~~--~~~~l~~L~~--L~Ls~N~l~g~ip~~~~----~~-~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l 79 (707)
+|..++.++ .|...+.|.. ++++.|+.. .++..+. .+ +|+.|+|++|+|++ .+|..+..+++|+.|+|
T Consensus 125 yn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~L 203 (267)
T 3rw6_A 125 YDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 203 (267)
T ss_dssp EETTTTEEECTTGGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEEC
T ss_pred cchhccccCHHHcCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEEC
Confidence 344444443 3667777877 889999766 5554221 12 89999999999997 55677889999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCC-CCC-------CC-CCCCCceee
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN-ISG-------SF-NIPPNVTVR 129 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~-~~~-------~~-~~~~l~~l~ 129 (707)
++|+|++. ..+..+..+ +|+.|+|++|.|++ +|. .+ .+|+|..|+
T Consensus 204 s~N~i~~~--~~l~~l~~l---~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 204 SGNELKSE--RELDKIKGL---KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp TTSCCCSG--GGGGGGTTS---CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CCCccCCc--hhhhhcccC---CcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 99999944 345555432 67799999999986 231 12 678888765
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.04 E-value=2.1e-07 Score=88.95 Aligned_cols=111 Identities=12% Similarity=0.110 Sum_probs=55.8
Q ss_pred cCCCCcccEEeccCC-cCccc----CCCccccc-CccEEEccCccCCCC----CCcccCCCcccceEeccCcccccC---
Q 005224 21 LSRIPNLGYLDLSSN-QLNGS----IPPGRLSL-NITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGS--- 87 (707)
Q Consensus 21 ~~~l~~L~~L~Ls~N-~l~g~----ip~~~~~~-~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~--- 87 (707)
+...++|++|+|++| .|... +...+... +|++|+|++|+|... +...+...+.|++|+|++|.|...
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 344566666666666 65521 11111111 566666666666532 223334445666666666666522
Q ss_pred -CCCCccccccCCCCccceEEc--cCccCCCC-----CCCC-CCCCCceeeccCCCcc
Q 005224 88 -IPSSIWQSRTLNATETFILDF--QNNNLTNI-----SGSF-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 88 -~p~~~~~l~~L~~~~L~~l~l--~~N~l~~~-----~~~~-~~~~l~~l~l~~N~~~ 136 (707)
+...+...+ +|+.|+| ++|.|+.- ...+ ..+.|+.|+|++|.+.
T Consensus 112 ~l~~~L~~n~-----~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVEALQSNT-----SLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHGGGGCS-----SCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCC-----CceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 222333322 2336666 56666542 1111 3456677777777653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.97 E-value=1.6e-05 Score=85.53 Aligned_cols=122 Identities=20% Similarity=0.254 Sum_probs=89.6
Q ss_pred CceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 3 KLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
+|+.++|.+ .++.+.+ .|.++++|+.++|++|+++ .||...+.. +|+.+.|.+| ++..-..+|.++++|+.++|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 467777764 6666665 6888888899999888888 888877766 7888888854 775666788888899999988
Q ss_pred CcccccCCCC-CccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPS-SIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~-~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~ 136 (707)
+| ++ .|+. +|.+ . +|+.++| .|.++.++... .+++|+.+.+.+|...
T Consensus 235 ~~-l~-~I~~~aF~~-~-----~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 235 EN-VS-TIGQEAFRE-S-----GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp TT-CC-EECTTTTTT-C-----CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred CC-cc-Ccccccccc-C-----CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 75 55 4443 3433 3 4458888 56678776544 7888999988887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=2.5e-05 Score=84.03 Aligned_cols=75 Identities=16% Similarity=0.080 Sum_probs=49.8
Q ss_pred cceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-------hhHHHHHHHHHHHHccCC--Cc-ceeEEEEEEeCCeEEE
Q 005224 380 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-------QGEKEFLTEIQFLSRLHH--RN-LVSLVGYCDEEGEQML 448 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~n-Iv~l~~~~~~~~~~~l 448 (707)
.+.||.|.++.||++... +++.|+||....... .....+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999854 568899998653221 122456779999888742 33 3455543 3455689
Q ss_pred EEecCCCC
Q 005224 449 VYEFMSNG 456 (707)
Q Consensus 449 V~E~~~~g 456 (707)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.94 E-value=3.1e-05 Score=79.30 Aligned_cols=79 Identities=19% Similarity=0.235 Sum_probs=58.4
Q ss_pred CCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCC---CcceeEEEEEEeCCeEEEEEec
Q 005224 376 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH---RNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.....+.+|.|..+.||+.+..||+.|++|+...........|..|+..|+.+.- --+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 4455788999999999999999999999998765444444567889999988842 1244555542 24789999
Q ss_pred CCCCCH
Q 005224 453 MSNGTL 458 (707)
Q Consensus 453 ~~~gsL 458 (707)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.94 E-value=3.4e-07 Score=104.08 Aligned_cols=33 Identities=18% Similarity=0.154 Sum_probs=15.3
Q ss_pred CCcccEEeccCCcCcccCCCcccc-c-CccEEEcc
Q 005224 24 IPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLS 56 (707)
Q Consensus 24 l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls 56 (707)
+++|++|+++.|++++.....+.. . +|+.|+|+
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~ 405 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC 405 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEee
Confidence 455555555555555332222221 1 45555555
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.91 E-value=3.1e-06 Score=89.60 Aligned_cols=14 Identities=21% Similarity=0.437 Sum_probs=7.3
Q ss_pred CCCCcccEEeccCC
Q 005224 22 SRIPNLGYLDLSSN 35 (707)
Q Consensus 22 ~~l~~L~~L~Ls~N 35 (707)
..+++|+.|+|++|
T Consensus 169 ~~~P~L~~L~L~g~ 182 (362)
T 2ra8_A 169 DAMPLLNNLKIKGT 182 (362)
T ss_dssp HTCTTCCEEEEECC
T ss_pred hcCCCCcEEEEeCC
Confidence 34455555555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.91 E-value=2.1e-05 Score=84.59 Aligned_cols=120 Identities=12% Similarity=0.140 Sum_probs=71.5
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
|++|+.|+|++|+++.+.. .|. ..+|+.+.|.+| ++ .|+...|.. +|+.|+|.+| ++..-..+|.+ .+|+.+
T Consensus 179 c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i 253 (401)
T 4fdw_A 179 CYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTV 253 (401)
T ss_dssp CTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEE
T ss_pred cccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEE
Confidence 4689999999988887766 455 577777777744 66 777666543 6777777664 44344445555 566666
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCC-----CCCCCC--CCCCCceeecc
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-----NISGSF--NIPPNVTVRLR 131 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~-----~~~~~~--~~~~l~~l~l~ 131 (707)
.| .|.++..-+.+|.++.+|+ .+++.+|.+. .++... .+++|+.+.|.
T Consensus 254 ~l-p~~i~~I~~~aF~~c~~L~-----~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~ 308 (401)
T 4fdw_A 254 KL-PNGVTNIASRAFYYCPELA-----EVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP 308 (401)
T ss_dssp EE-ETTCCEECTTTTTTCTTCC-----EEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC
T ss_pred Ee-CCCccEEChhHhhCCCCCC-----EEEeCCccccCCcccEECHHHhhCCccCCeEEeC
Confidence 66 3334422234455554444 5666665554 333322 55556655555
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=5.5e-05 Score=79.20 Aligned_cols=140 Identities=19% Similarity=0.185 Sum_probs=79.9
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccC-----CCcceeEE-E--EEEeCCeEEEEEe
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----HRNLVSLV-G--YCDEEGEQMLVYE 451 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~-~--~~~~~~~~~lV~E 451 (707)
.+.|+.|..+.||+....+|+ +++|+.... ...+..|..+++.+. .|.++.-. | +....+..++|||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGA-VCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTEE-EEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCC-EEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 345666778999999876554 889988752 233444555555542 34443310 0 1234677899999
Q ss_pred cCCCCCHH-----------H---HHhhc--C---CC-------CcCHHHH------------------------------
Q 005224 452 FMSNGTLR-----------D---QLSAK--S---KE-------PLGFAMR------------------------------ 475 (707)
Q Consensus 452 ~~~~gsL~-----------~---~l~~~--~---~~-------~l~~~~~------------------------------ 475 (707)
|++|.++. . .+|.. . .. ...|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986532 1 12211 0 00 0122211
Q ss_pred -HHHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 476 -LSIALGSSRGILYLHT----------EADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 476 -~~i~~~ia~gL~yLH~----------~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
..+...+.+++++|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223345667763 123459999999999999888899999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00012 Score=75.80 Aligned_cols=138 Identities=16% Similarity=0.147 Sum_probs=92.8
Q ss_pred ccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccC---CCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 379 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 379 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
..+.|+.|....+|+... ++..+++|+.... ....+..|++.|+.+. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 457799999999999886 4677888987542 3457888999998883 35688899988888899999999998
Q ss_pred CCHH--------H---HHhhcCC-C-------------------CcCHHHHH---HHH----------------HHHHHH
Q 005224 456 GTLR--------D---QLSAKSK-E-------------------PLGFAMRL---SIA----------------LGSSRG 485 (707)
Q Consensus 456 gsL~--------~---~l~~~~~-~-------------------~l~~~~~~---~i~----------------~~ia~g 485 (707)
..+. . .|+.... . .-+|.... ++. ..+...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 1 1222211 1 01344321 111 111111
Q ss_pred -HHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEeeec
Q 005224 486 -ILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFG 521 (707)
Q Consensus 486 -L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 521 (707)
...|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2346699999999999999887 8899974
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.79 E-value=1.4e-06 Score=83.19 Aligned_cols=109 Identities=12% Similarity=0.194 Sum_probs=79.3
Q ss_pred CCceEEEeeCC-cCCCCC-----CCcCCCCcccEEeccCCcCccc----CCCccccc-CccEEEccCccCCCC----CCc
Q 005224 2 SKLLKLSLRNC-SLQGPM-----PDLSRIPNLGYLDLSSNQLNGS----IPPGRLSL-NITTIKLSNNKLTGT----IPS 66 (707)
Q Consensus 2 ~~L~~L~L~~N-~l~~~~-----~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~~-~L~~L~Ls~N~l~~~----~p~ 66 (707)
++|++|+|++| .|...- ..+...++|++|+|++|.|... +...+... +|++|+|++|+|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 57999999999 887521 2467788999999999999831 11122222 799999999999854 456
Q ss_pred ccCCCcccceEec--cCcccccC----CCCCccccccCCCCccceEEccCccCCC
Q 005224 67 NFSGLPRLQRLFI--ANNSLSGS----IPSSIWQSRTLNATETFILDFQNNNLTN 115 (707)
Q Consensus 67 ~~~~l~~L~~L~l--s~N~l~g~----~p~~~~~l~~L~~~~L~~l~l~~N~l~~ 115 (707)
.+...+.|++|+| ++|.|... +...+...+ +|+.|+|++|.+..
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~-----~L~~L~L~~n~i~~ 165 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNT-----TLLKFGYHFTQQGP 165 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCS-----SCCEEECCCSSHHH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCC-----CcCEEeccCCCCCh
Confidence 7778889999999 88999743 222333333 45599999998753
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.78 E-value=1.3e-06 Score=99.10 Aligned_cols=131 Identities=14% Similarity=0.091 Sum_probs=91.0
Q ss_pred CCCceEEEeeCCcCC---CCCC-C------------cCCCCcccEEeccCCcCcccCCCccc-cc-CccEEEccCc-cCC
Q 005224 1 MSKLLKLSLRNCSLQ---GPMP-D------------LSRIPNLGYLDLSSNQLNGSIPPGRL-SL-NITTIKLSNN-KLT 61 (707)
Q Consensus 1 L~~L~~L~L~~N~l~---~~~~-~------------~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~-~L~~L~Ls~N-~l~ 61 (707)
+++|+.|+|++|... +..| . +..+++|++|+|++|.+++..+..+. .. +|+.|+|++| .++
T Consensus 65 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~ 144 (594)
T 2p1m_B 65 FPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFS 144 (594)
T ss_dssp CTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEE
T ss_pred CCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCC
Confidence 468999999997632 1222 2 23578999999999998866555543 23 8999999998 565
Q ss_pred CC-CCcccCCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-----C-CCCCCceeeccCC
Q 005224 62 GT-IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-----F-NIPPNVTVRLRGN 133 (707)
Q Consensus 62 ~~-~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-----~-~~~~l~~l~l~~N 133 (707)
.. ++..+.++++|++|+|++|.+++..+..+..+.. ..++|+.|+|++|. ..+... . .+++|+.|++++|
T Consensus 145 ~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~-~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 145 TDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD-TYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp HHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT-TCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred HHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh-cCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 32 4455558899999999999988665555543321 23466699999987 322211 1 4688999999988
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.62 E-value=7.6e-06 Score=86.65 Aligned_cols=132 Identities=19% Similarity=0.181 Sum_probs=88.2
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccc--cc-CccEEEccC--ccCCCC-----CCccc--
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL--SL-NITTIKLSN--NKLTGT-----IPSNF-- 68 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~--~~-~L~~L~Ls~--N~l~~~-----~p~~~-- 68 (707)
+++|+.|+|++|.-...++ + .+++|+.|+|..|.++...-..+. .+ +|+.|+|+. |...+. +...+
T Consensus 171 ~P~L~~L~L~g~~~l~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNLSIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp CTTCCEEEEECCBTCBCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCCCcEEEEeCCCCceecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 4789999999883122333 4 389999999999988732222222 22 899999863 332221 11123
Q ss_pred CCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCC-----CCCCC-CCCCCceeeccCCCcc
Q 005224 69 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN-----ISGSF-NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 69 ~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~-----~~~~~-~~~~l~~l~l~~N~~~ 136 (707)
..+++|++|+|++|.+.+..+..+.... .+++|++|+|+.|.|+. +...+ .+++|+.|+|++|.+.
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~--~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLESD--ILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHHCS--SGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHhCc--cCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 3578999999999999854444444321 23566799999999987 33332 5789999999999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00031 Score=76.02 Aligned_cols=73 Identities=11% Similarity=0.137 Sum_probs=45.5
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccC------C---hhhHHHHHHHHHHHH-ccCCCcceeEEEEEEeCCeEEEE
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEG------S---LQGEKEFLTEIQFLS-RLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~------~---~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.+.||.|..+.||++.. +++.++||..... . ......+..|+..+. ......+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 56789999999999965 5678999943211 0 012223444443332 22234566777665 5677999
Q ss_pred EecC-CC
Q 005224 450 YEFM-SN 455 (707)
Q Consensus 450 ~E~~-~~ 455 (707)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00061 Score=71.08 Aligned_cols=141 Identities=14% Similarity=0.125 Sum_probs=73.7
Q ss_pred cceEeeeCceE-EEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCC--CcceeEEEEEEeCCeEEEEEecCCCC
Q 005224 380 STQIGQGGYGK-VYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 380 ~~~lG~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~E~~~~g 456 (707)
.+.|+.|+... +|+....+|+.+++|....... ..+..|+.+++.+.. -.+.+++.+....+ ++|||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34566565544 6677654467777886554221 234456677666632 23556666643333 7899999877
Q ss_pred CHHHHHhhc---------------------CC---CCcCHHHHH--------HH------------HHHHHHHHHHHH--
Q 005224 457 TLRDQLSAK---------------------SK---EPLGFAMRL--------SI------------ALGSSRGILYLH-- 490 (707)
Q Consensus 457 sL~~~l~~~---------------------~~---~~l~~~~~~--------~i------------~~~ia~gL~yLH-- 490 (707)
++.+++... .. ..++..... .+ ...+...++.+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 775544211 00 111111100 00 001112222221
Q ss_pred -hCCCCCeEecCCCCCCEEEcCC----CcEEEeeeccccc
Q 005224 491 -TEADPPVFHRDIKASNILLDHK----FTAKVADFGLSRL 525 (707)
Q Consensus 491 -~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFGla~~ 525 (707)
....+.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999875 6899999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0005 Score=61.10 Aligned_cols=57 Identities=25% Similarity=0.370 Sum_probs=39.6
Q ss_pred cEEeccCCcCc-ccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccCcccc
Q 005224 28 GYLDLSSNQLN-GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 85 (707)
Q Consensus 28 ~~L~Ls~N~l~-g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 85 (707)
..++.+++.|+ ..+|..+.. +|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp~-~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFPV-DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCCT-TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCCc-CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36777777775 466665443 6778888888887555556777777888888887664
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0016 Score=67.41 Aligned_cols=157 Identities=13% Similarity=0.123 Sum_probs=86.7
Q ss_pred ccHHHHHHHhcCCCc-----cceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCc--ceeEE
Q 005224 365 FTYGEMALATNNFNS-----STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLV 437 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~ 437 (707)
++.+++.....+|.. .+.|+.|....+|+....+| .+++|+..... ....+..|+.+++.+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444555555555654 34566788899999987666 57789876521 1234566777777663211 22222
Q ss_pred EE------EEeCCeEEEEEecCCCCCHH-----H---------HHhhcC----CC---C---cCHHHHHH----------
Q 005224 438 GY------CDEEGEQMLVYEFMSNGTLR-----D---------QLSAKS----KE---P---LGFAMRLS---------- 477 (707)
Q Consensus 438 ~~------~~~~~~~~lV~E~~~~gsL~-----~---------~l~~~~----~~---~---l~~~~~~~---------- 477 (707)
.. ....+..++||+|++|..+. . .++... .. . ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 11 12346678999999876431 1 112110 00 0 11222110
Q ss_pred --HHHHHHHHHHHHHhC----CCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 478 --IALGSSRGILYLHTE----ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 478 --i~~~ia~gL~yLH~~----~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
+...+.+.++++++. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001134455555532 12349999999999999987666899998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0054 Score=63.53 Aligned_cols=142 Identities=17% Similarity=0.173 Sum_probs=82.0
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCC--cceeEEEE-----EEeCCeEEEEEec
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR--NLVSLVGY-----CDEEGEQMLVYEF 452 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~-----~~~~~~~~lV~E~ 452 (707)
...++ |....||+....+|+.+++|+..... .....+..|..+++.+... .+.+++.. ....+..++||||
T Consensus 31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp CEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred EEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 34577 88889999887778789999986432 2345677788888777421 23334332 2235667899999
Q ss_pred CCCCCHH-----H------H---Hhh--c--C---CCCcCHHHH----HHH---------------HHHHHHHHHHHHhC
Q 005224 453 MSNGTLR-----D------Q---LSA--K--S---KEPLGFAMR----LSI---------------ALGSSRGILYLHTE 492 (707)
Q Consensus 453 ~~~gsL~-----~------~---l~~--~--~---~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~ 492 (707)
++|.++. . . ++. . . ....++... ..+ ...+.+.++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875431 1 1 111 0 0 111222211 001 00111223333221
Q ss_pred ----CCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 493 ----ADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 493 ----~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 233488999999999999 4 899999987753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0021 Score=65.94 Aligned_cols=71 Identities=8% Similarity=0.073 Sum_probs=44.2
Q ss_pred cceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcc-eeEEEEEEeCCeEEEEEecC-CCCC
Q 005224 380 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVYEFM-SNGT 457 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~E~~-~~gs 457 (707)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .++++++ .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 678999999999998 45888887643211 1123467777777642222 3555443 33457899999 6544
Q ss_pred H
Q 005224 458 L 458 (707)
Q Consensus 458 L 458 (707)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0022 Score=69.36 Aligned_cols=73 Identities=18% Similarity=0.214 Sum_probs=50.2
Q ss_pred cceEeeeCceEEEEEEeCC--------CcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcc-eeEEEEEEeCCeEEEEE
Q 005224 380 STQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 450 (707)
.+.|+.|....||+....+ ++.+++|+..... ....+.+|..+++.+...++ .++++.+.. .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678889899999998753 5789999884321 12455679999888843333 567766532 3899
Q ss_pred ecCCCCCH
Q 005224 451 EFMSNGTL 458 (707)
Q Consensus 451 E~~~~gsL 458 (707)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0022 Score=68.03 Aligned_cols=140 Identities=18% Similarity=0.182 Sum_probs=81.7
Q ss_pred cceEeeeCceEEEEEEeC--------CCcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEE
Q 005224 380 STQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.+.|..|-...+|+.... +++.+++|+.... ........+|.++++.+. +.-..++++++.. .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 456777888889998864 3478999986432 223456678999998884 3223566666543 2999
Q ss_pred ecCCCCCHHH--------------HH---hhcC---CCCcC--HHHHHHHHHHHH-------------------HHHHHH
Q 005224 451 EFMSNGTLRD--------------QL---SAKS---KEPLG--FAMRLSIALGSS-------------------RGILYL 489 (707)
Q Consensus 451 E~~~~gsL~~--------------~l---~~~~---~~~l~--~~~~~~i~~~ia-------------------~gL~yL 489 (707)
||++|.+|.. .| |... ..... +.++.++..++. +.+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998765421 11 1111 11122 344444443332 122333
Q ss_pred ----HhC-CCCCeEecCCCCCCEEEcCC----CcEEEeeecccc
Q 005224 490 ----HTE-ADPPVFHRDIKASNILLDHK----FTAKVADFGLSR 524 (707)
Q Consensus 490 ----H~~-~~~~ivH~Dlkp~NILl~~~----~~~kl~DFGla~ 524 (707)
... ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 23358999999999999876 789999998775
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00031 Score=65.63 Aligned_cols=82 Identities=11% Similarity=0.058 Sum_probs=42.1
Q ss_pred cccEEeccCCcCcccCCCccccc-CccEEEccCcc-CCCCCCcccCCC----cccceEeccCcc-cccCCCCCccccccC
Q 005224 26 NLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNK-LTGTIPSNFSGL----PRLQRLFIANNS-LSGSIPSSIWQSRTL 98 (707)
Q Consensus 26 ~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~ls~N~-l~g~~p~~~~~l~~L 98 (707)
+|+.|||+++.++..=-..+..+ +|+.|+|+++. |+..-=..++.+ ++|++|+|+++. +|. ..+..+..
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD---~Gl~~L~~- 137 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTD---KGIIALHH- 137 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCH---HHHHHGGG-
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCH---HHHHHHhc-
Confidence 57777777776662101112222 67777777763 554333334443 357777777764 552 12222222
Q ss_pred CCCccceEEccCcc
Q 005224 99 NATETFILDFQNNN 112 (707)
Q Consensus 99 ~~~~L~~l~l~~N~ 112 (707)
+++|+.|+|++..
T Consensus 138 -~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 138 -FRNLKYLFLSDLP 150 (176)
T ss_dssp -CTTCCEEEEESCT
T ss_pred -CCCCCEEECCCCC
Confidence 2344577777653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.014 Score=63.56 Aligned_cols=74 Identities=14% Similarity=-0.006 Sum_probs=48.1
Q ss_pred cceEeeeCceEEEEEEeCC-CcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcc-eeEEEEEEeCCeEEEEEecCCCCC
Q 005224 380 STQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVYEFMSNGT 457 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~E~~~~gs 457 (707)
.+.|+.|-...+|+....+ ++.+++|+....... .-...+|..+++.+...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 5678889999999999865 578889987542211 1112578888888865444 56777662 2 25999998754
Q ss_pred H
Q 005224 458 L 458 (707)
Q Consensus 458 L 458 (707)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.011 Score=61.62 Aligned_cols=31 Identities=26% Similarity=0.372 Sum_probs=27.4
Q ss_pred CCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 495 ~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987754
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.34 E-value=0.012 Score=62.37 Aligned_cols=119 Identities=15% Similarity=0.157 Sum_probs=66.1
Q ss_pred CceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 3 KLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
+|+.+.+..+ ++.+.. .|.++..|+.+.+..+ ++ .|....+.. +|+.+.+..+ ++..-...|.++++|+.+.+
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEE
T ss_pred ccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceeccccccccccccccccc
Confidence 3444444332 333333 4666667777777655 55 566555543 5677766543 44344456777777777777
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeecc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLR 131 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~ 131 (707)
.+|.++..-..+|.++.+|+ .++|.+| ++.+.... .+.+|..+.+.
T Consensus 294 ~~~~i~~I~~~aF~~c~~L~-----~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 294 DNSAIETLEPRVFMDCVKLS-----SVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp CCTTCCEECTTTTTTCTTCC-----EEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred cccccceehhhhhcCCCCCC-----EEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 77766622234455555554 6666543 66554432 55666665554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.33 E-value=0.00075 Score=63.01 Aligned_cols=92 Identities=13% Similarity=0.214 Sum_probs=63.7
Q ss_pred cCCCccc-ccCccEEEccCccCCCCCCcccCCCcccceEeccCcc-cccCCCCCccccccCC--CCccceEEccCc-cCC
Q 005224 40 SIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS-LSGSIPSSIWQSRTLN--ATETFILDFQNN-NLT 114 (707)
Q Consensus 40 ~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~l~~L~--~~~L~~l~l~~N-~l~ 114 (707)
.+|.... ...|+.|||+++.|+..--..+.++++|+.|+|+++. ++. ..+..+..+. .++|+.|+|+++ ++|
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD---~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIED---GCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCH---HHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCH---HHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 4455432 2389999999999987666678899999999999995 662 2233333220 124669999997 477
Q ss_pred CC--CCCCCCCCCceeeccCCC
Q 005224 115 NI--SGSFNIPPNVTVRLRGNP 134 (707)
Q Consensus 115 ~~--~~~~~~~~l~~l~l~~N~ 134 (707)
.- ..-..+++|+.|++++.+
T Consensus 129 D~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 129 DKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHHHHHGGGCTTCCEEEEESCT
T ss_pred HHHHHHHhcCCCCCEEECCCCC
Confidence 52 211268999999998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0037 Score=66.10 Aligned_cols=73 Identities=12% Similarity=0.065 Sum_probs=43.9
Q ss_pred cceEeeeCceEEEEEEeCC---------CcEEEEEEeccCChhhHHHHHHHHHHHHccCCCc-ceeEEEEEEeCCeEEEE
Q 005224 380 STQIGQGGYGKVYKGILPD---------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV 449 (707)
.+.|+.|....+|+....+ ++.+++|+...... .......|.++++.+...+ +.++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567788888999998754 26788888754321 1112356888888774333 34666544 2 3689
Q ss_pred EecCCCCC
Q 005224 450 YEFMSNGT 457 (707)
Q Consensus 450 ~E~~~~gs 457 (707)
|||++|.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0062 Score=65.02 Aligned_cols=106 Identities=17% Similarity=0.231 Sum_probs=71.0
Q ss_pred CcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCCCCcccccc
Q 005224 20 DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 97 (707)
Q Consensus 20 ~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~ 97 (707)
.|.++.+|+.+.+.++. . .|....+.. +|+.+.+. +.++..-..+|.++.+|+.++|.+| ++..-..+|.++.+
T Consensus 260 aF~~c~~L~~i~lp~~~-~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~ 335 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSV-V-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ 335 (394)
T ss_dssp TTTTCSSCCEEECCTTC-C-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred eeeecccccEEeccccc-c-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence 57778888888886554 3 466655543 68888885 4566455567888888888888765 55223455666666
Q ss_pred CCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCc
Q 005224 98 LNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPF 135 (707)
Q Consensus 98 L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~ 135 (707)
|+ .+.|.++ ++.+.... .+.+|..+.+.+|..
T Consensus 336 L~-----~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 336 LE-----RIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp CC-----EEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred CC-----EEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 65 7777544 77775543 678888888887764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.28 E-value=0.0064 Score=64.90 Aligned_cols=42 Identities=7% Similarity=0.198 Sum_probs=20.3
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccc
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL 46 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 46 (707)
++|+.+.|.. .++.+.. +|.++++|+.++|.+| ++ .|+...+
T Consensus 71 ~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF 113 (394)
T 4fs7_A 71 RKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-MIGRCTF 113 (394)
T ss_dssp TTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-EECTTTT
T ss_pred CCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-Eccchhh
Confidence 3455555542 2444433 4555555555555433 44 4444433
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.10 E-value=0.00036 Score=66.47 Aligned_cols=37 Identities=22% Similarity=0.328 Sum_probs=19.6
Q ss_pred CccEEEccCccCCCCCC----cccCCCcccceEeccCcccc
Q 005224 49 NITTIKLSNNKLTGTIP----SNFSGLPRLQRLFIANNSLS 85 (707)
Q Consensus 49 ~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~ls~N~l~ 85 (707)
.|+.|+|++|+|...-- ..+..=+.|+.|+|++|+|.
T Consensus 71 ~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 71 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 46666666666653221 22223345666666666665
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.012 Score=62.33 Aligned_cols=104 Identities=16% Similarity=0.239 Sum_probs=79.7
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
.+|+.+.+..+ ++.+.. .|.++.+|+.+.+..+ ++ .++...+.. +|+.+.+.+|.++..-..+|.++.+|+.+.
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~ 316 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVT 316 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEE
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEE
Confidence 56888888765 666655 6899999999999754 77 888877764 899999999999966678899999999999
Q ss_pred ccCcccccCC-CCCccccccCCCCccceEEccCccCCCC
Q 005224 79 IANNSLSGSI-PSSIWQSRTLNATETFILDFQNNNLTNI 116 (707)
Q Consensus 79 ls~N~l~g~~-p~~~~~l~~L~~~~L~~l~l~~N~l~~~ 116 (707)
|.++ ++ .| ..+|.++.+|+ .+.+..| ++.+
T Consensus 317 lp~~-l~-~I~~~aF~~C~~L~-----~i~ip~~-v~~I 347 (379)
T 4h09_A 317 LPTA-LK-TIQVYAFKNCKALS-----TISYPKS-ITLI 347 (379)
T ss_dssp CCTT-CC-EECTTTTTTCTTCC-----CCCCCTT-CCEE
T ss_pred cCcc-cc-EEHHHHhhCCCCCC-----EEEECCc-cCEE
Confidence 9866 66 44 45677777776 5555433 4443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.97 E-value=0.017 Score=61.47 Aligned_cols=75 Identities=17% Similarity=0.171 Sum_probs=46.0
Q ss_pred CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCC-CCCccccccCCCCccceEEccCccCCCCCCCC--CCCCC
Q 005224 49 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI-PSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPN 125 (707)
Q Consensus 49 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l 125 (707)
+|+.+.+.+| ++..-..+|.++.+|+.++|.++ ++ .| ..+|.++.+|+ .+++..| ++.+.... .+++|
T Consensus 298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~-----~i~lp~~-l~~I~~~aF~~C~~L 368 (394)
T 4fs7_A 298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLS-----NINFPLS-LRKIGANAFQGCINL 368 (394)
T ss_dssp TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCC-----EECCCTT-CCEECTTTBTTCTTC
T ss_pred cccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCC-----EEEECcc-ccEehHHHhhCCCCC
Confidence 5777777554 55344566777777777777644 55 33 34555655554 6777655 66665443 66777
Q ss_pred ceeeccC
Q 005224 126 VTVRLRG 132 (707)
Q Consensus 126 ~~l~l~~ 132 (707)
+.+.+..
T Consensus 369 ~~i~lp~ 375 (394)
T 4fs7_A 369 KKVELPK 375 (394)
T ss_dssp CEEEEEG
T ss_pred CEEEECC
Confidence 7776644
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.79 E-value=0.0095 Score=63.51 Aligned_cols=122 Identities=14% Similarity=0.285 Sum_probs=83.6
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
.+|+.+.+.++-.+ +.. .|.++++|+.+.+. +.++ .|+...|.. +|+.++|..| ++..-..+|.+|.+|+.+.
T Consensus 265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ 340 (394)
T 4gt6_A 265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIA 340 (394)
T ss_dssp SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred ccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEE
Confidence 56888888765443 444 69999999999996 6688 899888764 8999999865 7756677899999999999
Q ss_pred ccCcccccCCC-CCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCc
Q 005224 79 IANNSLSGSIP-SSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 135 (707)
Q Consensus 79 ls~N~l~g~~p-~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~ 135 (707)
|.++ ++ .|. .+|.++.+|+ .+++.+|.... ........|+.+.+..|.+
T Consensus 341 ip~s-v~-~I~~~aF~~C~~L~-----~i~~~~~~~~~-~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 341 IPSS-VT-KIPESAFSNCTALN-----NIEYSGSRSQW-NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp ECTT-CC-BCCGGGGTTCTTCC-----EEEESSCHHHH-HTCBCCCCC----------
T ss_pred ECcc-cC-EEhHhHhhCCCCCC-----EEEECCceeeh-hhhhccCCCCEEEeCCCCE
Confidence 9765 66 554 5677777776 89998875432 1122556677777766543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=95.78 E-value=0.00092 Score=69.99 Aligned_cols=59 Identities=14% Similarity=0.200 Sum_probs=41.3
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhcCC----CCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 630 QDETDARPSMSEVMRELESIWNMMP----ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 630 ~~~p~~RPt~~~v~~~L~~~~~~~~----~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
-..|-...+..+++..+..- ..+ ..++++.+||.+||+.||++|||++|+|+||||...
T Consensus 221 G~~PF~~~~~~~~~~~i~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 221 LKHAFEAGSMKNLVLKIISG--SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp SSCSCCCSSHHHHHHHHHHT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCCCCCCcCHHHHHHHHHcC--CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 44555555666665544322 222 223445789999999999999999999999999754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=95.42 E-value=0.002 Score=64.96 Aligned_cols=63 Identities=13% Similarity=0.268 Sum_probs=44.7
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhcCCC-CCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 630 QDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 630 ~~~p~~RPt~~~v~~~L~~~~~~~~~-~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
...|-...+..+..+.+.......+. ......+||.+||..||++|||++|+|+||||.....
T Consensus 203 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 203 GKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp SSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 34455555666666666554433333 2334567999999999999999999999999976543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.27 E-value=0.11 Score=49.81 Aligned_cols=103 Identities=15% Similarity=0.135 Sum_probs=66.9
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
-+|.++|... ..++++.++|.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 4799999765 45799999999999999988776221111 1233456899999999988764 2111
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 582 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~p 582 (707)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123466888763 3456788999999999998864343
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=95.25 E-value=0.0057 Score=40.82 Aligned_cols=30 Identities=20% Similarity=0.491 Sum_probs=21.4
Q ss_pred CCCCcccceeeeehhHHHHHHHHHHHHHhh
Q 005224 305 NSGISKAALAGIILGAIAGAVTISAIVSLL 334 (707)
Q Consensus 305 ~~~~~~~~~~~ii~g~~~~~~~~~~~~~~~ 334 (707)
+++.+.+++++|++|+++++.++.+++.++
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~ 34 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFR 34 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHH
Confidence 445678889999999888777665554443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=94.90 E-value=0.0016 Score=65.49 Aligned_cols=63 Identities=6% Similarity=0.106 Sum_probs=42.8
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhcCCC-CCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 630 QDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 630 ~~~p~~RPt~~~v~~~L~~~~~~~~~-~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
...|-......++.+.+..-....+. .+....+++.+||..||++|||++|+++||||.....
T Consensus 207 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 207 GTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred CCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 34454445556665554433222222 2334567999999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=94.29 E-value=0.0064 Score=61.40 Aligned_cols=63 Identities=14% Similarity=0.181 Sum_probs=41.8
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhcCC-CCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 630 QDETDARPSMSEVMRELESIWNMMP-ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 630 ~~~p~~RPt~~~v~~~L~~~~~~~~-~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
...|-.-.+..+..+.+......++ ..+....++|.+||..||++|||++|+++||||.....
T Consensus 208 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 208 GMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp SSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred CCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 3445555555555544433222222 22334567999999999999999999999999976443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.18 E-value=0.19 Score=53.90 Aligned_cols=74 Identities=11% Similarity=0.052 Sum_probs=47.6
Q ss_pred cceEeeeCceEEEEEEeCC--------CcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEE
Q 005224 380 STQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.+.+..|-...+|+....+ ++.+++|+..... ...-+..+|..+++.+. +.-..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 4567778888999998753 5789999865432 11112356888887774 22234566543 2 27899
Q ss_pred ecCCCCCH
Q 005224 451 EFMSNGTL 458 (707)
Q Consensus 451 E~~~~gsL 458 (707)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.96 E-value=0.0059 Score=62.25 Aligned_cols=63 Identities=5% Similarity=0.044 Sum_probs=42.9
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhcCC-CCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 630 QDETDARPSMSEVMRELESIWNMMP-ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 630 ~~~p~~RPt~~~v~~~L~~~~~~~~-~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
...|-...+..++.+.+.......+ ...+...+|+.+||..||++|||++|+++||||.....
T Consensus 209 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 209 GLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 3445554556666555543322222 22334568999999999999999999999999976654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=93.94 E-value=0.0063 Score=61.80 Aligned_cols=31 Identities=10% Similarity=0.223 Sum_probs=28.2
Q ss_pred CCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 660 TPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 660 ~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
..+++.+||..||++|||++|+|+||||...
T Consensus 260 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 260 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 3579999999999999999999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=93.54 E-value=0.0049 Score=63.63 Aligned_cols=28 Identities=4% Similarity=0.238 Sum_probs=23.7
Q ss_pred ccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 662 EFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 662 dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
+|+.+||..||++|||++|+|+||||.+
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 5677788888899999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=93.50 E-value=0.0026 Score=64.40 Aligned_cols=31 Identities=19% Similarity=0.582 Sum_probs=28.2
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMR 644 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~ 644 (707)
+..++..+.+++.+|++.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 4678899999999999999999999998864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=93.42 E-value=0.0027 Score=64.92 Aligned_cols=33 Identities=9% Similarity=0.260 Sum_probs=27.2
Q ss_pred CCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 660 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 660 ~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
..+|+.+||..||++|||++|+|+||||.....
T Consensus 233 ~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 233 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred HHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 346788889999999999999999999976543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.00 E-value=0.0085 Score=56.90 Aligned_cols=84 Identities=13% Similarity=0.182 Sum_probs=48.5
Q ss_pred CccEEEccCc-cCCC----CCCcccCCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCC-----CC
Q 005224 49 NITTIKLSNN-KLTG----TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-----SG 118 (707)
Q Consensus 49 ~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~-----~~ 118 (707)
.|+.|+|++| +|.. .+-..+..-+.|+.|+|++|+|...--..++..-.- -..|+.|+|++|+|..- -.
T Consensus 42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~-N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIET-SPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHH-CSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhc-CCccCeEecCCCcCCHHHHHHHHH
Confidence 5777888775 6652 133445555678888888888873322233322111 13455888888888752 11
Q ss_pred CC-CCCCCceeeccCC
Q 005224 119 SF-NIPPNVTVRLRGN 133 (707)
Q Consensus 119 ~~-~~~~l~~l~l~~N 133 (707)
.+ .-..|+.|+|++|
T Consensus 121 aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQ 136 (197)
T ss_dssp HTTTTCCCSEEECCCC
T ss_pred HHhhCCceeEEECCCC
Confidence 12 2244777888754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.88 E-value=0.0096 Score=61.95 Aligned_cols=30 Identities=13% Similarity=0.302 Sum_probs=22.1
Q ss_pred ccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 662 EFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 662 dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
+||.+||..||++|||++|+|+||||....
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 466667777777788888888888886644
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.65 E-value=0.026 Score=57.70 Aligned_cols=34 Identities=21% Similarity=0.446 Sum_probs=30.3
Q ss_pred CCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 659 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 659 ~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
.+.+++.+||..||++|||++|+|+||||.....
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 4567999999999999999999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.54 E-value=0.013 Score=59.17 Aligned_cols=30 Identities=10% Similarity=0.231 Sum_probs=22.9
Q ss_pred ccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 662 EFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 662 dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
+++.+||..||++|||++|+|+||||....
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 566777888888888888888899987544
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=92.42 E-value=0.0032 Score=65.61 Aligned_cols=33 Identities=9% Similarity=0.294 Sum_probs=26.4
Q ss_pred CCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 660 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 660 ~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
+.+||.+||..||++|||++|+|+||||.....
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 264 AKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 346788888888999999999999999876543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=92.17 E-value=0.024 Score=56.73 Aligned_cols=62 Identities=16% Similarity=0.130 Sum_probs=42.2
Q ss_pred cCCCCCCCHHHHHHHHHHhhh-cCC-CCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 631 DETDARPSMSEVMRELESIWN-MMP-ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 631 ~~p~~RPt~~~v~~~L~~~~~-~~~-~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
..|-.-.+..++.+.+..... ..+ ..+....+++.+||..||++|||++|+|+|+|+.....
T Consensus 213 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 213 MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred CCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 344444455566555543221 111 22334567999999999999999999999999988765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.98 E-value=0.01 Score=61.88 Aligned_cols=33 Identities=18% Similarity=0.302 Sum_probs=29.3
Q ss_pred CCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 659 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 659 ~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
...+|+.+||..||++|||++|+|+||||....
T Consensus 249 ~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 249 DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 356799999999999999999999999997543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=91.79 E-value=0.015 Score=60.01 Aligned_cols=31 Identities=13% Similarity=0.256 Sum_probs=24.4
Q ss_pred ccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 662 EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 662 dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
+++.+||..||++|||++|+++||||.....
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 4666677788888888888899999887654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=91.62 E-value=0.011 Score=60.70 Aligned_cols=31 Identities=19% Similarity=0.329 Sum_probs=19.5
Q ss_pred ccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 662 EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 662 dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
+++.+||..||++|||++|+|+||||.....
T Consensus 271 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 271 DVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred HHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 4555566666777777777777777765544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.53 E-value=0.019 Score=58.76 Aligned_cols=31 Identities=19% Similarity=0.358 Sum_probs=21.3
Q ss_pred ccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 662 EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 662 dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
+++.+||..||++|||++|+++||||.....
T Consensus 262 ~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred HHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 4566677777788888888888888876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.61 E-value=0.014 Score=60.22 Aligned_cols=30 Identities=23% Similarity=0.563 Sum_probs=23.1
Q ss_pred ccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 662 EFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 662 dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
+||.+||..||++|||++|+|+||||....
T Consensus 265 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 265 SFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 566777778888888888888888887543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=90.32 E-value=0.043 Score=55.72 Aligned_cols=34 Identities=18% Similarity=0.402 Sum_probs=29.7
Q ss_pred CCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 659 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 659 ~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
...+++.+||..||++|||++|+|+||||.....
T Consensus 246 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 246 PLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 3467999999999999999999999999966544
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=90.32 E-value=0.011 Score=61.07 Aligned_cols=31 Identities=29% Similarity=0.439 Sum_probs=27.9
Q ss_pred CCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 660 TPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 660 ~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
..+|+.+||..||++|||++|+++||||...
T Consensus 262 l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 262 FINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 4579999999999999999999999999643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=90.30 E-value=0.019 Score=61.16 Aligned_cols=33 Identities=18% Similarity=0.302 Sum_probs=29.4
Q ss_pred CCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 659 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 659 ~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
.+.+||.+||..||++|||++|+|+||||....
T Consensus 296 ~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 296 DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 356799999999999999999999999997554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.18 E-value=0.021 Score=58.35 Aligned_cols=33 Identities=15% Similarity=0.338 Sum_probs=29.1
Q ss_pred CCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 658 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 658 ~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
+...+++.+||..||++|||++|+|+||||...
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 345679999999999999999999999999653
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.10 E-value=0.21 Score=34.38 Aligned_cols=7 Identities=29% Similarity=0.544 Sum_probs=2.9
Q ss_pred eehhHHH
Q 005224 316 IILGAIA 322 (707)
Q Consensus 316 ii~g~~~ 322 (707)
|+.|++.
T Consensus 13 IA~gVVg 19 (44)
T 2ks1_B 13 IATGMVG 19 (44)
T ss_dssp STHHHHH
T ss_pred EEeehhH
Confidence 3444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.95 E-value=0.14 Score=35.12 Aligned_cols=7 Identities=43% Similarity=0.629 Sum_probs=2.9
Q ss_pred eehhHHH
Q 005224 316 IILGAIA 322 (707)
Q Consensus 316 ii~g~~~ 322 (707)
|+.|++.
T Consensus 12 IA~gVVg 18 (44)
T 2l2t_A 12 IAAGVIG 18 (44)
T ss_dssp HHHHHHH
T ss_pred EEEeehH
Confidence 3444443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=89.76 E-value=0.035 Score=57.98 Aligned_cols=34 Identities=24% Similarity=0.359 Sum_probs=29.9
Q ss_pred CCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 659 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 659 ~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
.+.+|+.+||..||++|||++|+|+||||.....
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 3457999999999999999999999999976544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.44 E-value=0.94 Score=48.03 Aligned_cols=28 Identities=36% Similarity=0.475 Sum_probs=24.2
Q ss_pred eEecCCCCCCEEE------cCCCcEEEeeecccc
Q 005224 497 VFHRDIKASNILL------DHKFTAKVADFGLSR 524 (707)
Q Consensus 497 ivH~Dlkp~NILl------~~~~~~kl~DFGla~ 524 (707)
++|+|+.+.|||+ +++..++++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456789999998875
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.06 E-value=0.17 Score=34.62 Aligned_cols=27 Identities=22% Similarity=0.463 Sum_probs=12.5
Q ss_pred ceeeeehhHHHHHHHHHHHHHhhhhhhc
Q 005224 312 ALAGIILGAIAGAVTISAIVSLLIVRAH 339 (707)
Q Consensus 312 ~~~~ii~g~~~~~~~~~~~~~~~~~~~~ 339 (707)
.++++++| ++.++++++++.++++|++
T Consensus 13 ~Ia~~vVG-vll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 13 SIISAVVG-ILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHH-HHHHHHHHHHHHHHHHHHC
T ss_pred chHHHHHH-HHHHHHHHHHHHhheehhh
Confidence 45666666 3333333333444444443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=86.94 E-value=0.027 Score=60.41 Aligned_cols=35 Identities=6% Similarity=-0.000 Sum_probs=30.1
Q ss_pred CCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 655 ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 655 ~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
...+...+|+.+||..||++|||+.|+|+||||..
T Consensus 335 ~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 335 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 34455678999999999999999999999999854
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=82.10 E-value=0.13 Score=52.69 Aligned_cols=35 Identities=17% Similarity=0.209 Sum_probs=23.5
Q ss_pred CCCCccccCCCCCCCCCCCC-------CCcCCCCCCCCCCCC
Q 005224 658 TKTPEFINSEHTSKEETPPS-------SSSMLKHPYVSSDVS 692 (707)
Q Consensus 658 ~~~~dll~~~L~~dP~~R~s-------a~e~L~Hp~f~~~~~ 692 (707)
....+++.+||..||++||| .+++++|||+.+...
T Consensus 266 ~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 266 EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 44567999999999999999 677889999988655
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.15 E-value=0.11 Score=53.24 Aligned_cols=26 Identities=4% Similarity=-0.023 Sum_probs=23.7
Q ss_pred CCccccCCCCCCCCCCCCCCcCCCCC
Q 005224 660 TPEFINSEHTSKEETPPSSSSMLKHP 685 (707)
Q Consensus 660 ~~dll~~~L~~dP~~R~sa~e~L~Hp 685 (707)
+.+||.+||+.||++|+|++|+|+||
T Consensus 279 l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 279 LTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred hHHHHHHhccCChhhhccHHHhhhcc
Confidence 34689999999999999999999987
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 707 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-75 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-69 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-67 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-66 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.004 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 9e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 6e-75
Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 18/277 (6%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
+IG G +G VYKG V + + Q + F E+ L + H N++ +GY
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 442 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 501
+ +V ++ +L L + + IA +++G+ YLH + HRD
Sbjct: 75 -APQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 502 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-- 559
+K++NI L T K+ DFGL+ + +H + G+ ++ PE
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWS-----GSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 560 -LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618
+ +SDVY+ G+V EL+TG P S+ N + + + + + ++ S C
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-----GYLSPDLSKVRSNCP 239
Query: 619 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655
+ +L +C + + D RP +++ +E + +P+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 7e-70
Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 20/275 (7%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 434
++G G +G+V+ G T VAVK ++GS FL E + +L H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
L + ++ E+M NG+L D L S L L +A + G+ ++ +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
HRD++A+NIL+ + K+ADFGL+RL + K + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE------YTAREGAKFPIKWTAPEA 181
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
T KSDV+S G++ E++T + G ++ ++ G P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------NPEVIQNLERGYRMVRP 232
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
C E+ +L C ++ + RP+ + LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 5e-69
Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 20/275 (7%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 434
+ +IG G +G V+ G + VA+K +EG+ E++F+ E + + +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
L G C E+ LV+EFM +G L D + L + L G + +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEG---MAYLEE 119
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
V HRD+ A N L+ KV+DFG++R ST K + PE
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY------TSSTGTKFPVKWASPEV 173
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
F + + KSDV+S GV+ E+ + + ++ S ++ + G P
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------NSEVVEDISTGFRLYKP 224
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
++ C ++ + RP+ S ++R+L I
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 7e-67
Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 23/293 (7%)
Query: 369 EMALATNNFN-SSTQIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSLQGE-KEFLTEIQ 423
++ L +N + ++G G +G V +G+ VA+K ++G+ + + +E + E Q
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 424 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 483
+ +L + +V L+G C + MLV E G L L K +E + + + S
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVS 119
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
G+ YL + HRD+ A N+LL ++ AK++DFGLS+ D +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAG 172
Query: 544 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603
K + PE K + +SDV+S GV E L+ Q +M
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---------GPEVMA 223
Query: 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 656
+ G P EC + L C + + RP V + + + + +
Sbjct: 224 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (560), Expect = 8e-67
Identities = 82/296 (27%), Positives = 128/296 (43%), Gaps = 20/296 (6%)
Query: 363 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTE 421
S Y + + + ++G G YG+VY+G+ VAVK +E +++ E EFL E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 422 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 481
+ + H NLV L+G C E ++ EFM+ G L D L +++ + + L +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 482 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 541
S + YL HRD+ A N L+ KVADFGLSRL
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHA 174
Query: 542 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601
K + PE +K + KSDV++ GV+ E+ T G ++ + +
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------ 228
Query: 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 657
+ P C EK +L C Q RPS +E+ + E+++ SD
Sbjct: 229 ---LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (558), Expect = 2e-66
Identities = 76/310 (24%), Positives = 123/310 (39%), Gaps = 46/310 (14%)
Query: 369 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKR-AQEGSLQGEKEFLTE 421
+ NN IG+G +G+V++ P T+VAVK +E S + +F E
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 422 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL------------------- 462
++ + N+V L+G C L++E+M+ G L + L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 463 ---SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 519
S+ PL A +L IA + G+ YL + HRD+ N L+ K+AD
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 520 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 579
FGLSR D ++ PE ++ T +SDV++ GVV E+ +
Sbjct: 184 FGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 580 MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSM 639
+G +++ V DGN+ + P C + L C RPS
Sbjct: 239 GLQPYYGMA---------HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF 289
Query: 640 SEVMRELESI 649
+ R L+ +
Sbjct: 290 CSIHRILQRM 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 2e-66
Identities = 77/282 (27%), Positives = 120/282 (42%), Gaps = 20/282 (7%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 434
+ ++GQG +G+V+ G T VA+K + G+ + FL E Q + +L H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
L E +V E+MS G+L D L ++ + L + +A + G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
HRD++A+NIL+ KVADFGL+RL + K + PE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEA 185
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
L + T KSDV+S G++ EL T + G ++ V G P
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYRMPCP 236
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 656
EC E L +C + E + RP+ + LE +
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 2e-66
Identities = 85/313 (27%), Positives = 139/313 (44%), Gaps = 22/313 (7%)
Query: 351 HSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKR 406
H +++ + V++ + + ++ + + IG+G +G VY G L D AVK
Sbjct: 3 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 407 AQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSA 464
+ GE +FLTE + H N++SL+G C EG ++V +M +G LR+
Sbjct: 63 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIR 121
Query: 465 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524
+ L ++G + A HRD+ A N +LD KFT KVADFGL+R
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 584
+ + + H T K ++ E T K T KSDV+S GV+ EL+T P
Sbjct: 179 DMYDKEFDSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 585 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
N + ++ G P C + ++ LKC + + RPS SE++
Sbjct: 236 PDVNTF---------DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 645 ELESIWNMMPESD 657
+ +I++
Sbjct: 287 RISAIFSTFIGEH 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 3e-66
Identities = 65/275 (23%), Positives = 109/275 (39%), Gaps = 20/275 (7%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 434
+ ++G G +G V G VA+K +EGS E EF+ E + + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
L G C ++ ++ E+M+NG L + L + L + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
HRD+ A N L++ + KV+DFGLSR + S K + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPEV 172
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
+ K + KSD+++ GV+ E+ + + S + G P
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---------NSETAEHIAQGLRLYRP 223
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
EK + C ++ D RP+ ++ + +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 3e-66
Identities = 72/276 (26%), Positives = 115/276 (41%), Gaps = 26/276 (9%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 434
IG+G +G V G G VAVK + + + FL E +++L H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 435 SLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
L+G +E+G +V E+M+ G+L D L ++ + LG L +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
HRD+ A N+L+ AKV+DFGL++ A K + PE
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----------STQDTGKLPVKWTAPE 170
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613
K + KSDV+S G++ E+ + + + ++ V G
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------KDVVPRVEKGYKMDA 221
Query: 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
P C ++ C + RPS ++ +LE I
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (556), Expect = 3e-66
Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 29/302 (9%)
Query: 362 VRSFTYGEMALATNNFNSSTQ---------IGQGGYGKVYKGILP----DGTVVAVKRAQ 408
+ FT+ + A F IG G +G+V G L VA+K +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 409 EG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 467
G + + ++FL+E + + H N++ L G + M++ EFM NG+L D ++
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQND 122
Query: 468 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527
+ + G + G+ YL D HRD+ A NIL++ KV+DFGLSR
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-- 177
Query: 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587
+ D + K + PE K T SDV+S G+V E+++ +
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 588 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
++ ++ P +C +L L C Q + + RP +++ L+
Sbjct: 238 T---------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 648 SI 649
+
Sbjct: 289 KM 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 7e-64
Identities = 73/298 (24%), Positives = 130/298 (43%), Gaps = 24/298 (8%)
Query: 372 LATNNFNSSTQIGQGGYGKVYKGILPDGT-----VVAVKRAQEGSLQGEK-EFLTEIQFL 425
+ + IG G +G+VYKG+L + VA+K + G + ++ +FL E +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 426 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 485
+ H N++ L G + M++ E+M NG L + + + G + G
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAG 122
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
+ YL + HRD+ A NIL++ KV+DFGLSR+ + + ++ K
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----DDPEATYTTSGGKI 175
Query: 546 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605
+ PE K T SDV+S G+V E++T + + +M ++
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------NHEVMKAI 226
Query: 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 663
DG P +C +L ++C Q E RP ++++ L+ + P+S +F
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-APDSLKTLADF 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 4e-63
Identities = 69/280 (24%), Positives = 111/280 (39%), Gaps = 25/280 (8%)
Query: 382 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSL 436
++G G +G V KG VAVK + + E L E + +L + +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G C+ E MLV E G L L + + + + S G+ YL +
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
HRD+ A N+LL + AK++DFGLS+ T K + PE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKWYAPECIN 183
Query: 557 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 616
+K + KSDV+S GV+ E + Q G S + + G P+
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---------GSEVTAMLEKGERMGCPAG 234
Query: 617 CVEKFIKLALKCCQDETDARPSMSEVMRELESIW-NMMPE 655
C + L C + + RP + V L + + +++ E
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 9e-62
Identities = 71/326 (21%), Positives = 127/326 (38%), Gaps = 33/326 (10%)
Query: 370 MALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSR 427
M L ++F +++G G G V+K P G V+A K + + E+Q L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 428 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 487
+ +V G +GE + E M G+L L K + + +++ +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 118
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
YL + + HRD+K SNIL++ + K+ DFG+S + ++ GT
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG---------QLIDSMANSFVGTR 167
Query: 548 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607
Y+ PE + +SD++S+G+ +E+ G PI + M ++
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-------DAKELELMFGCQVE 220
Query: 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP---ESDTKTPE-- 662
G+ P D+RP M+ + L+ I N P S + E
Sbjct: 221 GDAAETPPRP----RTPGRPLSSYGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 663 -FINSEHTSKEETPPSSSSMLKHPYV 687
F+N ++ H ++
Sbjct: 276 DFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 9e-61
Identities = 61/294 (20%), Positives = 113/294 (38%), Gaps = 34/294 (11%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441
IG+G +G+V++G G VAVK + EI L H N++ + +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 442 EEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---- 493
++ LV ++ +G+L D L+ + + + +AL ++ G+ +LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 494 -DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
P + HRD+K+ NIL+ T +AD GL+ D GT Y+ P
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH---DSATDTIDIAPNHRVGTKRYMAP 181
Query: 553 EYFLTH------KLTDKSDVYSLGVVFLELLTGMQPISHGKN-----IVREVNIAYQSSM 601
E + ++D+Y++G+VF E+ ++ + M
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 602 MFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
V + + E + K+ +C AR + + + L +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-60
Identities = 76/338 (22%), Positives = 130/338 (38%), Gaps = 58/338 (17%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPDG---TVVAVKR-AQEGSLQGEKEFLTEIQFLSRL-H 429
N+ IG+G +G+V K + A+KR + S ++F E++ L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMR 475
H N+++L+G C+ G L E+ +G L D L + + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 476 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535
L A +RG+ YL HRD+ A NIL+ + AK+ADFGLSR
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------- 178
Query: 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 595
T+ + ++ E T SDV+S GV+ E+++ G
Sbjct: 179 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---- 234
Query: 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655
+ + G P C ++ L +C +++ RPS ++++ L +
Sbjct: 235 -----LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM------ 283
Query: 656 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 693
+ +T +++ K Y D S
Sbjct: 284 -------------LEERKTYVNTTLYEKFTYAGIDCSA 308
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-60
Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 26/278 (9%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRN 432
++ IG G YG+ K DG ++ K GS+ ++ ++E+ L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 433 LVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILY 488
+V + L V E+ G L ++ K ++ L L + + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 489 LH--TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
H ++ V HRD+K +N+ LD K K+ DFGL+R+ + GT
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-------SFAKAFVGT 177
Query: 547 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606
P Y+ PE +KSD++SLG + EL M P + Q + +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----------QKELAGKIR 227
Query: 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+G P ++ ++ + + RPS+ E++
Sbjct: 228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-59
Identities = 67/273 (24%), Positives = 106/273 (38%), Gaps = 25/273 (9%)
Query: 382 QIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSL 436
IG+G +G V++GI VA+K + + +E FL E + + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+G E ++ E + G LR K L A + A S + YL
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 128
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
HRDI A N+L+ K+ DFGLSR + ++ K ++ PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESIN 182
Query: 557 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 616
+ T SDV+ GV E+L G + ++ + +G P
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---------NNDVIGRIENGERLPMPPN 233
Query: 617 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
C L KC + RP +E+ +L +I
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 6e-59
Identities = 69/303 (22%), Positives = 115/303 (37%), Gaps = 45/303 (14%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEKE-FLTEIQFLSR 427
N +G G +GKV VAVK +E + E+E ++E++ +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 428 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------------------- 467
L H N+V+L+G C G L++E+ G L + L +K +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 468 --EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525
L F L A ++G+ +L HRD+ A N+L+ H K+ DFGL+R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR- 212
Query: 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585
DI V + ++ PE T KSDV+S G++ E+ +
Sbjct: 213 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 586 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 645
G + + +G P E+ + C ++ RPS +
Sbjct: 269 GIPVDAN--------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 646 LES 648
L
Sbjct: 321 LGC 323
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 7e-59
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 31/272 (11%)
Query: 382 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG 438
+IG+G + VYKG+ + VA Q+ L + F E + L L H N+V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 439 YCDEEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
+ + +LV E M++GTL+ L K + + + S +G+ +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLH-TRT 132
Query: 495 PPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
PP+ HRD+K NI + + K+ D GL+ L A + V GTP ++ PE
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---------KRASFAKAVIGTPEFMAPE 183
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN-MGS 612
K + DVY+ G+ LE+ T P S +N + + V G S
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRVTSGVKPAS 233
Query: 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ + + ++ C + D R S+ +++
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 2e-58
Identities = 68/275 (24%), Positives = 109/275 (39%), Gaps = 32/275 (11%)
Query: 377 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRN 432
F+ +IG G +G VY + + VVA+K+ Q ++ + E++FL +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+ G E LV E+ K+PL ++ G+ +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH-- 132
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ HRD+KA NILL K+ DFG + + + GTP ++ P
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----------MAPANSFVGTPYWMAP 180
Query: 553 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609
E L + K DV+SLG+ +EL P+ + + +IA S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ----- 235
Query: 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
E F C Q RP+ +++
Sbjct: 236 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-58
Identities = 74/328 (22%), Positives = 132/328 (40%), Gaps = 33/328 (10%)
Query: 377 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRA-----QEGSLQGEKEFLTEIQFLSRLHH 430
F +G G +G VYKG+ +P+G V + A + S + KE L E ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
++ L+G C L+ + M G L D + K+ +G L+ + ++G+ YL
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
D + HRD+ A N+L+ K+ DFGL++L + E + + K ++
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-----YHAEGGKVPIKWM 180
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
E L T +SDV+S GV EL+T G S + + G
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---------ASEISSILEKGER 231
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 670
P C + +KC + D+RP E++ E + + P+
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM--------ARDPQRYLVIQGD 283
Query: 671 KEETPPSSSSMLKHPYVSSDVSGSNLVS 698
+ PS + + + + ++V
Sbjct: 284 ERMHLPSPTDSNFYRALMDEEDMDDVVD 311
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 4e-58
Identities = 66/293 (22%), Positives = 112/293 (38%), Gaps = 42/293 (14%)
Query: 382 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRL-HHRNL 433
+G G +GKV + VAVK + + E+E ++E++ LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK----------------SKEPLGFAMRLS 477
V+L+G C G +++ E+ G L + L K + L LS
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 478 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 537
+ ++G+ +L HRD+ A NILL H K+ DFGL+R
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NY 201
Query: 538 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597
V + ++ PE T +SDV+S G+ EL + G
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--------- 252
Query: 598 QSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
S + +I P + + C + RP+ ++++ +E
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-57
Identities = 67/274 (24%), Positives = 104/274 (37%), Gaps = 29/274 (10%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHH 430
+F +G+G +G VY ++A+K +AQ E + E++ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
N++ L GY + L+ E+ GT+ +L + + + + Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 123
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
V HRDIK N+LL K+ADFG S P+ T + GT YL
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH---------APSSRRTTLCGTLDYL 171
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
PE +K D++SLGV+ E L G P + I
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----------ETYKRISRVE 220
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
++P E L + + RP + EV+
Sbjct: 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-57
Identities = 66/269 (24%), Positives = 111/269 (41%), Gaps = 25/269 (9%)
Query: 382 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
++G G +GKVYK + + A K S + ++++ EI L+ H N+V L+
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E ++ EF + G + + + + PL + + + + YLH D + HR
Sbjct: 79 YYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
D+KA NIL K+ADFG+S GTP ++ PE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTI-------QRRDSFIGTPYWMAPEVVMCETS 187
Query: 561 TD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 615
D K+DV+SLG+ +E+ P + + IA + PS
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL--------AQPS 239
Query: 616 ECVEKFIKLALKCCQDETDARPSMSEVMR 644
F KC + DAR + S++++
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 4e-57
Identities = 62/276 (22%), Positives = 102/276 (36%), Gaps = 26/276 (9%)
Query: 382 QIGQGGYGKVYKGILP----DGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLV 434
++G G +G V +G VAVK + +F+ E+ + L HRNL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
L G +V E G+L D K + A+ + G+ YL
Sbjct: 75 RLYGVV-LTPPMKMVTELAPLGSLLD-RLRKHQGHFLLGTLSRYAVQVAEGMGYLE---S 129
Query: 495 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
HRD+ A N+LL + K+ DFGL R P + + K + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQEHRKVPFAWCAPES 185
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI-DGNMGSY 613
T + SD + GV E+ T Q G N + ++ + +G
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------ILHKIDKEGERLPR 236
Query: 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
P +C + + ++C + + RP+ + L
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-56
Identities = 71/308 (23%), Positives = 122/308 (39%), Gaps = 36/308 (11%)
Query: 375 NNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSR 427
S ++GQG +G VY+G+ T VA+K + S++ EFL E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 428 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------SAKSKEPLGFAMRLSIA 479
+ ++V L+G + +++ E M+ G L+ L + P + + +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 480 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 539
+ G+ YL+ HRD+ A N ++ FT K+ DFG++R D
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RK 191
Query: 540 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 599
++ PE T SDV+S GVV E+ T + G +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------NE 242
Query: 600 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 659
++ V++G + P C + +L C Q RPS E++ ++ E +
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM----EPGFR 298
Query: 660 TPEFINSE 667
F SE
Sbjct: 299 EVSFYYSE 306
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 9e-56
Identities = 62/294 (21%), Positives = 119/294 (40%), Gaps = 28/294 (9%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IGQG G VY + + G VA+++ ++ + EI + + N+V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
E +V E+++ G+L D ++ + ++ + + +LH+ V HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 501 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 560
DIK+ NILL + K+ DFG + + GTP ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQ-------SKRSTMVGTPYWMAPEVVTRKAY 193
Query: 561 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 620
K D++SLG++ +E++ G P + + IA + P +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------QNPEKLSAI 245
Query: 621 FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 674
F +C + + R S E+ L+ + + + + I + +KE T
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKEL---LQHQFLKIAKPLSSLTPLIAA---AKEAT 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-55
Identities = 61/273 (22%), Positives = 110/273 (40%), Gaps = 21/273 (7%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRN 432
+++ +G+G YG+V + VAVK + ++ + EI L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+V G+ E Q L E+ S G L D++ + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ HRDIK N+LLD + K++DFGL+ + + E + + GT Y+ P
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAP 174
Query: 553 EYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
E + + DV+S G+V +L G P + +E +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--------KEKKTYL 226
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ + + L K + AR ++ ++ +
Sbjct: 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-55
Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 39/291 (13%)
Query: 382 QIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSR-LHHRNL 433
+G+G +G+V + VAVK +EG+ E + ++E++ L HH N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 434 VSLVGYCDEEGEQ-MLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 478
V+L+G C + G M++ EF G L L +K K+ L +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 479 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 538
+ ++G+ +L + HRD+ A NILL K K+ DFGL+R
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYV 191
Query: 539 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598
+ ++ PE T +SDV+S GV+ E+ + G I E
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----- 246
Query: 599 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ +G P + + L C E RP+ SE++ L ++
Sbjct: 247 ---CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 1e-53
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKR-AQEGSLQGEKEFLTEIQFL 425
+ +G+G +G+V T VAVK + + + + ++E++ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 426 SRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPL 470
+ H+N+++L+G C ++G ++ E+ S G LR+ L S +E L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 471 GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530
+S A +RG+ YL HRD+ A N+L+ K+ADFGL+R D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----D 184
Query: 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 590
I I +T + ++ PE T +SDV+S GV+ E+ T G +
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243
Query: 591 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650
+ + +G+ PS C + + C RP+ +++ +L+ I
Sbjct: 244 --------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
Query: 651 NM 652
+
Sbjct: 296 AL 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (453), Expect = 7e-51
Identities = 65/318 (20%), Positives = 125/318 (39%), Gaps = 30/318 (9%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 433
++++ ++G G +G V++ G A K ++ EIQ +S L H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 434 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
V+L +++ E +++YEFMS G L ++++ + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA-DEHNKMSEDEAVEYMRQVCKGLCHMH--- 141
Query: 494 DPPVFHRDIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ H D+K NI+ K K+ DFGL+ + P V GT +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--------LDPKQSVKVTTGTAEFAA 193
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
PE + +D++S+GV+ LL+G+ P G+N +
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMD------D 246
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR-------ELESIWNMMPESD-TKTPEF 663
S S E K + + R ++ + + + +P S TK +
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
Query: 664 INSEHTSKEETPPSSSSM 681
I +++ + E P +
Sbjct: 307 IKTKYDAWPEPLPPLGRI 324
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 8e-51
Identities = 50/276 (18%), Positives = 91/276 (32%), Gaps = 25/276 (9%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHR 431
+F +G+G + V L A+K ++ + E E +SRL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
V L ++ + + NG L + + + + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI-----VSALEY 123
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ HRD+K NILL+ ++ DFG +++ + GT Y+
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-----KQARANSFVGTAQYVS 178
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
PE SD+++LG + +L+ G+ P G + + +I
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----------IFQKIIKLEY- 227
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647
+P + K L K + R E+
Sbjct: 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 3e-50
Identities = 59/313 (18%), Positives = 125/313 (39%), Gaps = 28/313 (8%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
++G G +G V++ + G V K + EI +++LHH L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
+++ E +L+ EF+S G L D+++A+ + A ++ + G+ ++H + + H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151
Query: 501 DIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
DIK NI+ + K + K+ DFGL+ + P + V T + PE
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATK--------LNPDEIVKVTTATAEFAAPEIVDRE 203
Query: 559 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618
+ +D++++GV+ LL+G+ P + ++ N+ S
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-------DAFSSVS 256
Query: 619 EKFIKLALKCCQDETDARPSMSEVMR------ELESIWNMMPESDTKTPEFINSEHTSKE 672
+ Q E R ++ + + + ++ + +P S E +
Sbjct: 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADW 316
Query: 673 ETPPSSSSMLKHP 685
P + + +
Sbjct: 317 PAPQPAIGRIANF 329
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 6e-47
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 25/287 (8%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLH 429
++ + +G GG +V+ L VAVK + + F E Q + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 430 HRNLVSLVGYCDEEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 485
H +V++ + E +V E++ TLRD + ++ P+ + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQA 123
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
+ + H + HRD+K +NI++ KV DFG++R + + V G
Sbjct: 124 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA----DSGNSVTQTAAVIG 176
Query: 546 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605
T YL PE + +SDVYSLG V E+LTG P + + + + S
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS- 235
Query: 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWN 651
+ + LK + R + +E+ +L + N
Sbjct: 236 ------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 8e-47
Identities = 54/273 (19%), Positives = 102/273 (37%), Gaps = 19/273 (6%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHR 431
+ ++ +G G + +V +VA+K + +L+G E EI L ++ H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
N+V+L + G L+ + +S G L D++ K + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ LD ++DFGLS++ P V + GTPGY+
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------EDPGSVLSTACGTPGYVA 177
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611
PE + D +S+GV+ LL G P + +N + ++ F
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILKAEYEFDS------ 230
Query: 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
Y + + + + + R + + ++
Sbjct: 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 52/266 (19%), Positives = 101/266 (37%), Gaps = 23/266 (8%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+G+G +G V++ + K + + EI L+ HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 441 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 500
+ E ++++EF+S + ++++ S L +S + +LH + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 501 DIKASNILLDHK--FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
DI+ NI+ + T K+ +FG +R D ++ P Y PE
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHD 178
Query: 559 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 618
++ +D++SLG + LL+G+ P N NI E
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE-------EAFKEIS 231
Query: 619 EKFIKLALKCCQDETDARPSMSEVMR 644
+ + + E +R + SE ++
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 163 bits (413), Expect = 4e-46
Identities = 67/286 (23%), Positives = 99/286 (34%), Gaps = 37/286 (12%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR---------AQEGSLQGEKEFLTEIQFL 425
N+ +G+G V + I P AVK + E + + L E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 426 SRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR 484
++ H N++ L + LV++ M G L D L K L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLE 121
Query: 485 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 544
I LH + HRD+K NILLD K+ DFG S + P V
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--------LDPGEKLREVC 170
Query: 545 GTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 598
GTP YL PE + D++S GV+ LL G P H K ++ I
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
Query: 599 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ S + + L + + R + E +
Sbjct: 231 NYQFGS-------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (415), Expect = 4e-46
Identities = 51/274 (18%), Positives = 90/274 (32%), Gaps = 15/274 (5%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IG G +G +Y G + G VA+K + + E + + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 441 DEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
EG+ ++V E + L +A I Y+H H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 500 RDIKASNIL---LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
RD+K N L + DFGL++ +P + + GT Y L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 557 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 616
+ + + D+ SLG V + G P K + S S +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL---CKG 243
Query: 617 CVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650
+F C D +P S + + +++
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 7e-45
Identities = 60/332 (18%), Positives = 116/332 (34%), Gaps = 46/332 (13%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHH 430
+F +G G +G+V+ +G A+K + L+ + E LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
++ + G + + ++ +++ G L L + P A + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ +RD+K NILLD K+ DFG ++ P V+ + GTP Y+
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----------DVTYTLCGTPDYI 168
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
PE T D +S G++ E+L G P +++ +
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----------TMKTYEKILNAEL 218
Query: 611 GSYPSECVEKFIKLALKCCQDE-----TDARPSMSEVMRE--LESI-WNMMPESDTKTP- 661
+P E L + + + + +V + + W + + +TP
Sbjct: 219 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPY 277
Query: 662 -------EFINSEHTSKEETPPSSSSMLKHPY 686
+ S+ E + + PY
Sbjct: 278 EPPIQQGQGDTSQFDKYPEEDINYGVQGEDPY 309
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 158 bits (400), Expect = 4e-44
Identities = 54/275 (19%), Positives = 95/275 (34%), Gaps = 17/275 (6%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 440
+IG+G +G +++G L + VA+K E + E + L + V Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 441 DEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
+EG +LV + + G + L A + +H + + +
Sbjct: 70 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 500 RDIKASNILLD-----HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 554
RDIK N L+ + V DFG+ + P + +P + GT Y+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 555 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614
L + + + D+ +LG VF+ L G P K + S +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---PLRELC 241
Query: 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649
+ E+F K DA P + +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (404), Expect = 7e-44
Identities = 60/275 (21%), Positives = 100/275 (36%), Gaps = 30/275 (10%)
Query: 375 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTE---IQFLSR 427
N+F+ IG+GG+G+VY D G + A+K + + QGE L E + +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 428 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 487
+V + + + + M+ G L LS + + G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLE 121
Query: 488 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 547
++H + V +RD+K +NILLD +++D GL+ GT
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD---------FSKKKPHASVGTH 169
Query: 548 GYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606
GY+ PE D +D +SLG + +LL G P K + +M
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--- 226
Query: 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 641
P + L Q + + R
Sbjct: 227 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLG 256
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-43
Identities = 60/274 (21%), Positives = 100/274 (36%), Gaps = 41/274 (14%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLH--HRN 432
+G GG+G VY GI + D VA+K + G L E+ L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
++ L+ + + +L+ E + L + S + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCH-- 127
Query: 493 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ V HRDIK NIL+D ++ K+ DFG L + V T GT Y
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---------LKDTVYTDFDGTRVYSP 177
Query: 552 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
PE+ H+ +S V+SLG++ +++ G P H + I+R
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--------------- 222
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
+ + L C RP+ E+
Sbjct: 223 --FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-43
Identities = 70/338 (20%), Positives = 127/338 (37%), Gaps = 48/338 (14%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSR-LH 429
+F +G+G +GKV+ A+K ++ + + + + E + LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 430 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 489
H L + + V E+++ G L + + K L A + + IL L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI-----ILGL 116
Query: 490 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
+ +RD+K NILLD K+ADFG+ + E ++ + GTP Y
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-------ENMLGDAKTNTFCGTPDY 169
Query: 550 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609
+ PE L K D +S GV+ E+L G P HG++ +F I +
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEE----------LFHSIRMD 218
Query: 610 MGSYPSECVEKFIKLALKCCQDETDARPSM-SEVM---------------RELESIWNMM 653
YP ++ L +K E + R + ++ +E++ +
Sbjct: 219 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPK 278
Query: 654 PESDTKT----PEFINSEHTSKEETPPSSSSMLKHPYV 687
+S EF+N + +SM ++ +
Sbjct: 279 VKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFR 316
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 71/300 (23%), Positives = 109/300 (36%), Gaps = 40/300 (13%)
Query: 373 ATNNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRL 428
A + +IG+G YGKV+K + G VA+K R Q G + E+ L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 429 ---HHRNLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 480
H N+V L C D E + LV+E + L + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMF 123
Query: 481 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 540
RG+ +LH+ V HRD+K NIL+ K+ADFGL+R+
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--------FQMAL 172
Query: 541 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP------ISHGKNIVREV- 593
T V T Y PE L D++S+G +F E+ + I+ +
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 594 ---------NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
++A S + + ++ E L LKC R S +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-42
Identities = 54/296 (18%), Positives = 108/296 (36%), Gaps = 34/296 (11%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE------KEFLTEIQFLSRLHHRNLV 434
++G G + V K G A K ++ + ++ E+ L + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 435 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 494
+L + + + +L+ E ++ G L D L+ K A + + ++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-----LNGVYYLHS 131
Query: 495 PPVFHRDIKASNILLDH----KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ H D+K NI+L K K+ DFGL+ I + + GTP ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--------IDFGNEFKNIFGTPEFV 183
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
PE L ++D++S+GV+ LL+G P N++ +
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------ 237
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESI-WNMMPESDTKTPEF 663
Y S + + R ++ + ++ ++ S P+F
Sbjct: 238 -EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 4e-41
Identities = 67/290 (23%), Positives = 107/290 (36%), Gaps = 31/290 (10%)
Query: 376 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRN 432
NF +IG+G YG VYK G VVA+K R + + EI L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 433 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+V L+ E + LV+EF+ L+ + A + + + S +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
V HRD+K N+L++ + K+ADFGL+R VP + V
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------RTYTHEVVTLWYRAPE 172
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612
+ D++SLG +F E++T I + I V+ + S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 613 YP------------------SECVEKFIKLALKCCQDETDARPSMSEVMR 644
P E L + + + R S +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-41
Identities = 56/286 (19%), Positives = 97/286 (33%), Gaps = 36/286 (12%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKR-----AQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 436
+G+G + VYK +VA+K+ E + L EI+ L L H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 437 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+ + LV++FM + + L
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT-----LQGLEYLHQHW 120
Query: 497 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 556
+ HRD+K +N+LLD K+ADFGL++ P+ T T Y PE
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-------RAYTHQVVTRWYRAPELLF 173
Query: 557 THKLTD-KSDVYSLGVVFLELLTGMQP------------ISHGKNIVREVNIAYQSSMMF 603
++ D++++G + ELL + I E S+
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 604 SVIDGNMGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMR 644
V + P S + + L AR + ++ ++
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 64/315 (20%), Positives = 109/315 (34%), Gaps = 35/315 (11%)
Query: 383 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 440
+G G GKV + A+K LQ + E++ R ++V +V
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 441 D----EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 496
+ ++V E + G L ++ + + I I YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131
Query: 497 VFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ HRD+K N+L K K+ DFG ++ + T TP Y+ PE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--------TTSHNSLTTPCYTPYYVAPE 183
Query: 554 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613
K D++SLGV+ LL G P + + + M S
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW----NMMPESDTKTPEFINSEHT 669
SE V+ I+ + E R +++E + W +P++ T + +
Sbjct: 244 VSEEVKMLIR---NLLKTEPTQRMTITEF---MNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 670 SKEETPPSSSSMLKH 684
E+ +S L
Sbjct: 298 RWEDVKEEMTSALAT 312
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (367), Expect = 1e-39
Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 31/283 (10%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 439
+IG+G YG VYK G A+K R ++ + EI L L H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499
+ +LV+E + + + L S L GI Y H D V H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 500 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 559
RD+K N+L++ + K+ADFGL+R +P + + + K
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPV------RKYTHEIVTLWYRAPDVLMGSKK 177
Query: 560 LTDKSDVYSLGVVFLELLTGMQPIS------------------HGKNIVREVNIAYQSSM 601
+ D++S+G +F E++ G + KN +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
S+ E I L K + + + R + + +
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 59/269 (21%), Positives = 95/269 (35%), Gaps = 27/269 (10%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 430
N+F+ +G+G +GKV G A+K ++ + + E +TE + L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
L +L V E+ + G L LS + A + + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI-----VSALE 119
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
V +RDIK N++LD K+ DFGL + GTP YL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-------ATMKTFCGTPEYL 172
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
PE + D + LGVV E++ G P + ++ R +F +I
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHER----------LFELILMEE 221
Query: 611 GSYPSECVEKFIKLALKCCQDETDARPSM 639
+P + L + + R
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-39
Identities = 64/320 (20%), Positives = 112/320 (35%), Gaps = 33/320 (10%)
Query: 374 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHR 431
+ + + IG+G YG V + VA+K+ Q + L EI+ L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTL-RDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
N++ + + + ++ + D + L RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
V HRD+K SN+LL+ K+ DFGL+R+A T T Y
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD----PDHDHTGFLTEYVATRWYR 179
Query: 551 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNI-----VREVNIAYQSSMMFS 604
PE L K KS D++S+G + E+L+ + + + + +
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 605 VIDGNMGSYPSECVEK---------------FIKLALKCCQDETDARPSMSEVMRE--LE 647
+I+ +Y K + L K R + + + LE
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299
Query: 648 SIWNMMPESDTKTPEFINSE 667
++ E + P + E
Sbjct: 300 QYYDPSDEPIAEAPFKFDME 319
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 33/285 (11%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+IG+G YG V+K +VA+K R + L EI L L H+N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 439 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 498
+ + LV+EF + S L + L V
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL-----LKGLGFCHSRNVL 123
Query: 499 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 558
HRD+K N+L++ K+A+FGL+R +P S V F
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPV------RCYSAEVVTLWYRPPDVLFGAK 177
Query: 559 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID----------- 607
+ D++S G +F EL +P+ G ++ ++ ++ +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 608 --------GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 644
++ + + L + R S E ++
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 66/328 (20%), Positives = 119/328 (36%), Gaps = 38/328 (11%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHR 431
+ + +IGQG +G+V+K G VA+K+ + + L EI+ L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 432 NLVSLVGYCDE--------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 483
N+V+L+ C +G LV++F + + K L R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 484 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 543
+ L+ + HRD+KA+N+L+ K+ADFGL+R + + T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS---QPNRYTNR 181
Query: 544 KGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602
T Y PE L + D++ G + E+ T + + I+ +
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 662
+ N+ +Y + +K + +D A + ++ + + P
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR----- 296
Query: 663 FINSEHTSKEETPPSSSSMLKHPYVSSD 690
S L H + SD
Sbjct: 297 -------------IDSDDALNHDFFWSD 311
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 70/339 (20%), Positives = 122/339 (35%), Gaps = 47/339 (13%)
Query: 376 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 434
++ + IG G +G VY+ L D G +VA+K+ LQ ++ E+Q + +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 435 SLVGYCDEEGEQM------LVYEFMSNGTLRDQLS-AKSKEPLGFAMRLSIALGSSRGIL 487
L + GE+ LV +++ R +++K+ L R +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 488 YLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 546
Y+H + HRDIK N+LLD K+ DFG ++ + + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-------PNVSYICSR 186
Query: 547 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP------ISHGKNIVREVNIAYQSS 600
F T DV+S G V ELL G + I++ + +
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 601 MMFSVIDGNMGSYPS------------ECVEKFIKLALKCCQDETDARPSMSEVM----- 643
+ + +P + I L + + AR + E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 644 RELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682
EL +P + TP N PP ++ ++
Sbjct: 307 DELRDPNVKLP-NGRDTPALFNFTTQELSSNPPLATILI 344
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 8e-37
Identities = 52/279 (18%), Positives = 99/279 (35%), Gaps = 35/279 (12%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 430
+ F+ +G G +G+V G A+K + + K+ L E + L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 431 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
LV L + +V E+++ G + L + A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 491 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 550
+ +RD+K N+L+D + +V DFG ++ + + GTP L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTWTLCGTPEAL 205
Query: 551 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610
PE L+ D ++LGV+ E+ G P ++ ++ I
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQ----------IYEKIVSGK 254
Query: 611 GSYPSECVEKFIKLALKCCQDE-----TDARPSMSEVMR 644
+PS L Q + + + ++++
Sbjct: 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 5e-34
Identities = 63/324 (19%), Positives = 113/324 (34%), Gaps = 49/324 (15%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G G YG V + G VA+K S K E++ L + H N++ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 439 YCDEEG------EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+ + LV FM GT +L E LG + +G+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKL--MKHEKLGEDRIQFLVYQMLKGLRYIH-- 138
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ HRD+K N+ ++ K+ DFGL+R + ++ V
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------QADSEMTGYVVTRWYRAPE 188
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI-------------AYQS 599
+ T D++S+G + E++TG ++ + I QS
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 600 SMMFSVIDG-------NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIW 650
+ + G + S + + L K + + R + E + ES+
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 651 NMMPESDTKT--PEFINSEHTSKE 672
+ E + F + + T E
Sbjct: 309 DTEDEPQVQKYDDSFDDVDRTLDE 332
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (313), Expect = 5e-32
Identities = 54/318 (16%), Positives = 119/318 (37%), Gaps = 37/318 (11%)
Query: 375 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRN 432
+++ ++G+G Y +V++ I + + V VK + +K+ EI+ L L N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 433 LVSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 490
+++L + + LV+E ++N + + L + + Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH 146
Query: 491 TEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 549
+ HRD+K N+++DH+ ++ D+GL+ P V + +
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--------YHPGQEYNVRVASRYF 195
Query: 550 LDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608
PE + +++ D D++SLG + ++ +P HG + Q + V+
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD------QLVRIAKVLGT 249
Query: 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 668
+ K ++ D S E + +F++
Sbjct: 250 ED------LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303
Query: 669 TSKEETPPSSSSMLKHPY 686
++ ++ ++HPY
Sbjct: 304 RYDHQSRLTAREAMEHPY 321
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-32
Identities = 62/282 (21%), Positives = 100/282 (35%), Gaps = 29/282 (10%)
Query: 375 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLS 426
NF +G G YGKV+ G + A+K ++ ++ + + TE Q L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 427 RL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 485
+ LV+L E + L+ ++++ G L LS + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 486 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
+L L + +RDIK NILLD + DFGLS+ + E G
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------G 192
Query: 546 TPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603
T Y+ P+ D +SLGV+ ELLTG P + + +
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD-------GEKNSQAEIS 245
Query: 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 645
I + YP E L + + R +
Sbjct: 246 RRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-30
Identities = 59/319 (18%), Positives = 111/319 (34%), Gaps = 39/319 (12%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
IG G G V VA+K + K E+ + ++H+N++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 439 YC------DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 492
+E + LV E M + E + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLH-- 136
Query: 493 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 552
+ HRD+K SNI++ T K+ DFGL+R A + + T T Y P
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--------TSFMMTPYVVTRYYRAP 187
Query: 553 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612
E L + D++S+G + E++ + + G++ + ++ + +G+
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYID----------QWNKVIEQLGT 236
Query: 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE---FINSEHT 669
E ++K ++ + + K + ++
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 670 SKEETPPSSSSMLKHPYVS 688
S L+HPY++
Sbjct: 297 IDPAKRISVDDALQHPYIN 315
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 3e-28
Identities = 58/292 (19%), Positives = 96/292 (32%), Gaps = 45/292 (15%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 438
+G G YG V G VAVK S+ K E++ L + H N++ L+
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 439 YCDE-----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 493
E + + + D + + L + RG+ Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 494 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 553
+ HRD+K SN+ ++ K+ DFGL+R T T Y PE
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTDDEMTGYVATRWYRAPE 188
Query: 554 YFLTHKLTD-KSDVYSLGVVFLELLTGMQP------------ISHGKNIVREVNIAYQSS 600
L + D++S+G + ELLTG I + SS
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 601 MMFSVIDGNMGSYPSECVEK--------FIKLALKCCQDETDARPSMSEVMR 644
++ P + L K ++D R + ++ +
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (256), Expect = 2e-24
Identities = 44/331 (13%), Positives = 101/331 (30%), Gaps = 26/331 (7%)
Query: 382 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG-- 438
++G G + V+ + + T VA+K G + EI+ L R++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 439 ------------YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 486
+ G +++ + L + + I+ G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 487 LYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 545
Y+H + H DIK N+L++ + ++ L T
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-----NACWYDEHYTNSIQ 191
Query: 546 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605
T Y PE L +D++S + EL+TG + + + +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFIN 665
+ G + SY + ++ + L + + + +F++
Sbjct: 251 L-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 666 SEHTSKEETPPSSSSMLKHPYVSSDVSGSNL 696
+ ++ HP++ + +
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEI 340
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 2e-20
Identities = 31/204 (15%), Positives = 59/204 (28%), Gaps = 29/204 (14%)
Query: 382 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----------QGEKEFLTEIQFLSRLHHR 431
+G+G V+ VK + G G+ F +R R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 432 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 491
L L G + VY + N L + + AK + + + +
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120
Query: 492 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 551
+ H D+ N+L+ + + DF S I+ V ++
Sbjct: 121 --HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIIT------- 170
Query: 552 PEYFLTHKLTDKSDVYSLGVVFLE 575
+ + + D+ S L+
Sbjct: 171 ---YFSRTYRTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.4 bits (158), Expect = 6e-12
Identities = 36/154 (23%), Positives = 60/154 (38%), Gaps = 31/154 (20%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLN----------- 49
++ L L L N + P LS + L L L +NQ++ P L+
Sbjct: 240 LTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE 298
Query: 50 ----------ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 99
+T + L N ++ P S L +LQRLF ANN +S SS+ +N
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 100 ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 133
L +N +++++ N+ + L
Sbjct: 355 -----WLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.8 bits (115), Expect = 1e-06
Identities = 32/144 (22%), Positives = 53/144 (36%), Gaps = 19/144 (13%)
Query: 7 LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPS 66
L N + P + NL L L+ NQL L+ N+T + L+NN+++ P
Sbjct: 202 LIATNNQISDITPL-GILTNLDELSLNGNQLKDIGTLASLT-NLTDLDLANNQISNLAP- 258
Query: 67 NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF---------------ILDFQNN 111
SGL +L L + N +S P + + T L N
Sbjct: 259 -LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317
Query: 112 NLTNISGSFNIPPNVTVRLRGNPF 135
N+++IS ++ + N
Sbjct: 318 NISDISPVSSLTKLQRLFFANNKV 341
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 2e-05
Identities = 26/117 (22%), Positives = 43/117 (36%), Gaps = 10/117 (8%)
Query: 29 YLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 88
L ++NQ++ I P + N+ + L+ N+L + L L L +ANN +S
Sbjct: 201 SLIATNNQISD-ITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 89 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFC 145
P S T L N ++NIS + + L N +
Sbjct: 258 PLSGLTKLT-------ELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 10/60 (16%), Positives = 21/60 (35%), Gaps = 3/60 (5%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89
L + ++ L +TT++ + L L ++ +NN L+ P
Sbjct: 27 TVLGKTNVTDTVSQTDLD-QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 9/47 (19%), Positives = 21/47 (44%), Gaps = 1/47 (2%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 47
+ ++ L ++ + + + NL ++ S+NQL P L+
Sbjct: 43 LDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITPLKNLT 88
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 17/65 (26%), Positives = 30/65 (46%), Gaps = 6/65 (9%)
Query: 49 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 108
N+ + L NN++ GT+P + L L L ++ N+L G IP + + + +
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFD-----VSAY 298
Query: 109 QNNNL 113
NN
Sbjct: 299 ANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.4 bits (124), Expect = 7e-08
Identities = 19/58 (32%), Positives = 27/58 (46%), Gaps = 1/58 (1%)
Query: 9 LRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIP 65
LRN + G +P L+++ L L++S N L G IP G +NNK P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.5 bits (93), Expect = 5e-04
Identities = 7/42 (16%), Positives = 16/42 (38%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 42
+ L L++ +L G +P + ++N+ P
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 39/252 (15%), Positives = 67/252 (26%), Gaps = 30/252 (11%)
Query: 26 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 85
+L + S L +P L + + L NNK+T +F L L L + NN +S
Sbjct: 11 HLRVVQCSDLGLE-KVPKD-LPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 86 GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFC 145
P + L L N L + P + ++
Sbjct: 69 KISPGAFAPLVKLE-----RLYLSKNQLKEL-----------------PEKMPKTLQELR 106
Query: 146 GSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFP 205
++ N T+ S F L R+ ++ P
Sbjct: 107 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 166
Query: 206 AYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVG 265
+ S +L+L I L KL +++ S A+
Sbjct: 167 ------QGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220
Query: 266 RIRSMFTGWNIP 277
+
Sbjct: 221 LRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.5 bits (127), Expect = 3e-08
Identities = 28/114 (24%), Positives = 49/114 (42%), Gaps = 12/114 (10%)
Query: 11 NCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGT 63
CS G L ++P + LDL +N++ I G N+ T+ L NNK++
Sbjct: 16 QCSDLG----LEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKI 70
Query: 64 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
P F+ L +L+RL+++ N L + L E I + + ++
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 31/143 (21%), Positives = 56/143 (39%), Gaps = 17/143 (11%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNK 59
M KL + + + ++ L P+L L L N++ L N+ + LS N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 119
++ + + P L+ L + NN L +P + + + ++ NNN++ I +
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ-----VVYLHNNNISAIGSN 260
Query: 120 FNIPPNV--------TVRLRGNP 134
PP V L NP
Sbjct: 261 DFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 5e-08
Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 6/93 (6%)
Query: 26 NLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTG----TIPSNFSGLPRLQRLFI 79
++ LD+ +L+ + L L ++L + LT I S P L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 112
+N L + Q + + L QN
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 9e-06
Identities = 12/72 (16%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 47 SLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 105
SL+I ++ + +L+ L + Q + + + L+ + I + +N
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE- 59
Query: 106 LDFQNNNLTNIS 117
L+ ++N L ++
Sbjct: 60 LNLRSNELGDVG 71
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 8e-05
Identities = 8/73 (10%), Positives = 25/73 (34%), Gaps = 4/73 (5%)
Query: 49 NITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 104
+ + L++ ++ + + + L+ L ++NN L + + +S
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 105 ILDFQNNNLTNIS 117
L + +
Sbjct: 430 QLVLYDIYWSEEM 442
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 20/96 (20%), Positives = 31/96 (32%), Gaps = 17/96 (17%)
Query: 1 MSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLDLSSNQLNGSIPPG------RLSLN 49
S L L L +C + L +L LDLS+N L + +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 50 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 85
+ + L + + + RLQ L SL
Sbjct: 428 LEQLVLYDIYWSEEMED------RLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 18/107 (16%), Positives = 34/107 (31%), Gaps = 21/107 (19%)
Query: 21 LSRIPNLGYLDLSSNQLNG----SIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPR-- 73
L L L+ ++ S+ L+ ++ + LSNN L R
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 74 ---LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 117
L++L + + S + + L+ +L IS
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQA-----------LEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 12/96 (12%), Positives = 21/96 (21%), Gaps = 5/96 (5%)
Query: 5 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNG----SIPPGRLSL-NITTIKLSNNK 59
L + S L + + L L I + + L +N+
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 60 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 95
L + I SL +
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 3e-07
Identities = 14/67 (20%), Positives = 29/67 (43%), Gaps = 2/67 (2%)
Query: 17 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 76
P+ ++S++ + ++ L ++PP L + T + LS N L + RL +
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPD-LPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 77 LFIANNS 83
L +
Sbjct: 60 LNLDRAE 66
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 3e-07
Identities = 14/77 (18%), Positives = 31/77 (40%), Gaps = 2/77 (2%)
Query: 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKL 60
++ + P+ + + ++DLS++ + S G LS + + L +L
Sbjct: 24 GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 61 TGTIPSNFSGLPRLQRL 77
+ I + + L RL
Sbjct: 84 SDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 9e-06
Identities = 20/129 (15%), Positives = 44/129 (34%), Gaps = 11/129 (8%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89
LDL+ L+ + LS + + + + + +FS R+Q + ++N+ + S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTL 63
Query: 90 SSIWQS----RTLNATETFILD------FQNNNLTNISGSFNIPPNVTVRLRGNPFCLNT 139
I + L+ + D +N+NL ++ S + C
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
Query: 140 NAEQFCGSH 148
+
Sbjct: 124 DELNLSWCF 132
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 3e-07
Identities = 21/103 (20%), Positives = 34/103 (33%), Gaps = 24/103 (23%)
Query: 7 LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNG----------------------SIPPG 44
L L + L L ++ + +LDLS N+L ++
Sbjct: 3 LHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGV 61
Query: 45 RLSLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSG 86
+ + L NN+L + PRL L + NSL
Sbjct: 62 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 5e-07
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 9/84 (10%)
Query: 11 NCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG 70
N S P+L L++S+N+L +P L + S N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL--ERLIASFNHLA-EVPEL--- 322
Query: 71 LPRLQRLFIANNSLSG--SIPSSI 92
L++L + N L IP S+
Sbjct: 323 PQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (114), Expect = 9e-07
Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 3/76 (3%)
Query: 11 NCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG 70
N P L+ + L YL L+ N L + + S++++ ++P +G
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 71 LPRLQRLFIANNSLSG 86
+ +A N L G
Sbjct: 271 RDLKR---LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 6e-04
Identities = 11/65 (16%), Positives = 25/65 (38%), Gaps = 2/65 (3%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89
L ++P G + I L N+++ ++F L L++ +N L+
Sbjct: 16 TSCPQQGLQ-AVPVG-IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 90 SSIWQ 94
++
Sbjct: 74 AAFTG 78
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 13/64 (20%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 18 MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 77
+ L+ + L L N+++ P L N+ + L NN+++ P + L +
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPLASLP-NLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 78 FIAN 81
+ N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 8e-04
Identities = 16/57 (28%), Positives = 29/57 (50%), Gaps = 2/57 (3%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSN 57
+SKL L + + + L+ +PNL + L +NQ++ P S N+ + L+N
Sbjct: 172 LSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSPLANTS-NLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 13/41 (31%), Positives = 22/41 (53%), Gaps = 2/41 (4%)
Query: 49 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89
+TT+K +NK++ P + LP L + + NN +S P
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 9e-05
Identities = 20/128 (15%), Positives = 39/128 (30%), Gaps = 7/128 (5%)
Query: 19 PDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRL 77
PD L + + S+ + N+T + + N + + GL L+ L
Sbjct: 2 PDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTVRLRGNPFC 136
++ S + L+ N L ++S + + L GNP
Sbjct: 62 -----TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
Query: 137 LNTNAEQF 144
+
Sbjct: 117 CSCALRWL 124
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 2e-04
Identities = 21/93 (22%), Positives = 37/93 (39%), Gaps = 3/93 (3%)
Query: 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIK---LSN 57
+ + L+ R+ IP L L+LS+N+L + +K LS
Sbjct: 41 QNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG 100
Query: 58 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 90
N+L + +L+ L++ NSLS +
Sbjct: 101 NELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 6e-04
Identities = 13/65 (20%), Positives = 26/65 (40%), Gaps = 2/65 (3%)
Query: 30 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89
+++ IP L N ++ KL FSG L+++ I+ N + I
Sbjct: 13 FLCQESKVT-EIPSD-LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 70
Query: 90 SSIWQ 94
+ ++
Sbjct: 71 ADVFS 75
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (84), Expect = 0.004
Identities = 14/86 (16%), Positives = 25/86 (29%), Gaps = 5/86 (5%)
Query: 7 LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTI 64
L L +Q L L+LS N +P + +S ++
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 65 PSNFSGLPRLQRLFIANNSLSGSIPS 90
L +L+ N +P+
Sbjct: 218 SYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.002
Identities = 20/131 (15%), Positives = 41/131 (31%), Gaps = 6/131 (4%)
Query: 19 PDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77
+ LDL ++ I +L I S+N++ F L RL+ L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 137
+ NN + + TE + + L ++ ++ + + NP
Sbjct: 69 LVNNNRICRIGEGLDQALP--DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126
Query: 138 NTNAEQFCGSH 148
+ +
Sbjct: 127 KKHYRLYVIYK 137
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 707 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.65 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.59 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.5 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.38 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.38 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.37 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.33 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.29 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.24 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.22 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.21 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.19 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.16 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.13 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.07 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.97 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.9 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.74 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.18 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.09 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.06 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.87 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.85 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.77 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.76 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.4 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.83 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.79 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.03 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.03 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 95.85 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 95.27 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.02 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 94.18 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 89.16 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 82.91 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 80.98 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=430.90 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=208.3
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46889999999999999999975 78999999986432 223567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
|||++|+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999997643 4899999999999999999999999 999999999999999999999999999765422
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....
T Consensus 160 --------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~--------------- 215 (263)
T d2j4za1 160 --------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QETYKR--------------- 215 (263)
T ss_dssp --------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHH---------------
T ss_pred --------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-HHHHHH---------------
Confidence 22345799999999999999999999999999999999999999964332 111110
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
+.. ..+. .| ...++.+.+||.+||..||++|||++|+|+||||++.
T Consensus 216 --------------i~~---~~~~-~p----------------~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 216 --------------ISR---VEFT-FP----------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp --------------HHT---TCCC-CC----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred --------------HHc---CCCC-CC----------------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 000 0000 01 0112234478889999999999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-54 Score=449.67 Aligned_cols=294 Identities=22% Similarity=0.358 Sum_probs=215.4
Q ss_pred HhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
..++|++.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+|++++|||||+++++|.++++.++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4678999999999999999999975 78999999987543 233567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
|||++|+|.+++.+.. .+++..++.++.|+++||.|||++ + |+||||||+|||+++++++||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 9999999999997654 489999999999999999999974 7 99999999999999999999999999986532
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.......||+.|+|||++.+..|+.++||||+||++|||++|+.||.............. ...+.
T Consensus 158 --------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~-------~~~~~ 222 (322)
T d1s9ja_ 158 --------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC-------QVEGD 222 (322)
T ss_dssp --------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred --------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-------HhcCC
Confidence 223356899999999999999999999999999999999999999976544222111000 00000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC------CCCCCCccccCCCCCCCCCCCCCCcCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE------SDTKTPEFINSEHTSKEETPPSSSSMLK 683 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~------~~~~~~dll~~~L~~dP~~R~sa~e~L~ 683 (707)
+...+.................+|... ..+.+..+....+. .+.++.|||.+||+.||++||||+|+|+
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 223 ----AAETPPRPRTPGRPLSSYGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------------------------CCCC-HHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----cccCCcccccccccccccccccccchh-HHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 001111111111222222333333221 11222222222221 1234568999999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 684 HPYVSSDVS 692 (707)
Q Consensus 684 Hp~f~~~~~ 692 (707)
||||....+
T Consensus 298 Hpf~~~~~~ 306 (322)
T d1s9ja_ 298 HAFIKRSDA 306 (322)
T ss_dssp SHHHHHHHH
T ss_pred CHhhCcCCc
Confidence 999975433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=430.00 Aligned_cols=257 Identities=22% Similarity=0.365 Sum_probs=211.8
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
++|+..+.||+|+||+||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999964 79999999987655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++|+|.+++.+. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--- 170 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc---
Confidence 999999988653 4899999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 171 ----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~------------------- 226 (293)
T d1yhwa1 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALY------------------- 226 (293)
T ss_dssp ----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHH-------------------
T ss_pred ----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHH-------------------
Confidence 22345679999999999999999999999999999999999999996543311 111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
.+... ..|.- +. .+..++.+.+||.+||..||++|||++|+|+||||....
T Consensus 227 ---------~~~~~---~~~~~-~~--------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 227 ---------LIATN---GTPEL-QN--------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp ---------HHHHH---CSCCC-SS--------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ---------HHHhC---CCCCC-CC--------------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 11100 00000 00 001122344788999999999999999999999997543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=431.69 Aligned_cols=261 Identities=22% Similarity=0.325 Sum_probs=208.1
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57899999999999999999975 799999999875433 2345789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++|+|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.....+.
T Consensus 85 ~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~- 158 (271)
T d1nvra_ 85 CSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 158 (271)
T ss_dssp CTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred cCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc-
Confidence 999999999954 346999999999999999999999999 99999999999999999999999999987643221
Q ss_pred CccccceecccccCCCccchhhhccCCC-CCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+..........
T Consensus 159 ----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~------------- 221 (271)
T d1nvra_ 159 ----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------- 221 (271)
T ss_dssp ----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT-------------
T ss_pred ----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------
Confidence 122345679999999999998776 57899999999999999999999754332111111000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
.+...+. ....++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 222 --------------------~~~~~~~--------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 222 --------------------KKTYLNP--------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp --------------------TCTTSTT--------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred --------------------CCCCCCc--------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 0000000 011123345788999999999999999999999998655
Q ss_pred C
Q 005224 692 S 692 (707)
Q Consensus 692 ~ 692 (707)
.
T Consensus 268 ~ 268 (271)
T d1nvra_ 268 K 268 (271)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=427.56 Aligned_cols=263 Identities=27% Similarity=0.439 Sum_probs=220.6
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
+++...++|++.+.||+|+||+||+|.+++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 3344557888999999999999999999888999999997643 345689999999999999999999998754 56799
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccC
Confidence 999999999999887655556999999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.. ........||+.|+|||++.+..++.++|||||||++|||+||..|+.......+... .+..+
T Consensus 162 ~~------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~---------~i~~~ 226 (272)
T d1qpca_ 162 NE------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ---------NLERG 226 (272)
T ss_dssp SC------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---------HHHTT
T ss_pred Cc------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH---------HHHhc
Confidence 32 2223445789999999999999999999999999999999997666654444322222 12233
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.....|..++.++.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 3444566777889999999999999999999999999998765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=421.27 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=208.4
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 454 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 454 (707)
++|+..+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++|||||+++|+|..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788899999999999999999889999999997643 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCc
Q 005224 455 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 534 (707)
Q Consensus 455 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 534 (707)
+|+|.+++... ...+++..++.++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~---- 155 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---- 155 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC----
Confidence 99999998754 346899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 005224 535 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614 (707)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (707)
........||+.|+|||++.+..++.++|||||||++|||+|+..|+....+..+.... +..+.....|
T Consensus 156 --~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~---------i~~~~~~~~p 224 (263)
T d1sm2a_ 156 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---------ISTGFRLYKP 224 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH---------HHHTCCCCCC
T ss_pred --ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH---------HHhcCCCCCc
Confidence 12233456899999999999999999999999999999999965555444433222221 1222334456
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 615 ~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
..++.++.+++.+||+.+|++||+++++++.|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 6677889999999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-52 Score=424.02 Aligned_cols=267 Identities=25% Similarity=0.461 Sum_probs=213.0
Q ss_pred HHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 371 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 371 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
+...++|+..+.||+|+||+||+|++++ .||||+++... ....+.|.+|+++|++++|||||++++++.. +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 3446789999999999999999998743 59999987532 3345789999999999999999999998754 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|||||++|+|.+++.... ..+++..+..++.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 81 v~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999997543 45999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCccchhhhcc---CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
... ........||+.|||||++.+ ..++.++|||||||++|||+||+.||............. ... .
T Consensus 157 ~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~-~~~----~ 226 (276)
T d1uwha_ 157 WSG-----SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV-GRG----Y 226 (276)
T ss_dssp --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-HHT----S
T ss_pred cCC-----cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH-hcC----C
Confidence 221 123345679999999999975 358899999999999999999999997654432221111 111 1
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
..+.....+.+++..+.+++.+||+.+|++|||+.++++.|+.+.+..|
T Consensus 227 ~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 227 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 1122223455677889999999999999999999999999999887665
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-52 Score=429.18 Aligned_cols=266 Identities=29% Similarity=0.457 Sum_probs=226.5
Q ss_pred HHHHHHHhcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCe
Q 005224 367 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 445 (707)
Q Consensus 367 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 445 (707)
|++++...++|+..+.||+|+||+||+|.++ +++.||||+++... ...++|.+|+++|++++|||||+++++|.+.+.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 3455666778999999999999999999976 68999999987643 345689999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999999998877778999999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
..... ........|++.|+|||++.+..++.++|||||||++|||++|..|+....+........
T Consensus 165 ~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i--------- 229 (287)
T d1opja_ 165 MTGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------- 229 (287)
T ss_dssp CCSSS------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---------
T ss_pred cCCCC------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH---------
Confidence 64322 223344568999999999999999999999999999999999877776555433322211
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
..+.....+..++.++.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1223344566778889999999999999999999999999987654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=427.06 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=209.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
+.|++.+.||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46889999999999999999975 78999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++|+|.+++.+.. .++++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 9999999986543 45999999999999999999999999 999999999999999999999999999754211
Q ss_pred ccccceecccccCCCccchhhhc-----cCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
........||+.|+|||++. +..|+.++|||||||++|||++|+.||........ .
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~--------------- 224 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-L--------------- 224 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-H---------------
T ss_pred ---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-H---------------
Confidence 12233567999999999984 45689999999999999999999999965432110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
.++. +..+..-+. .+..++.+.+||.+||+.||++|||++|+|+||||+
T Consensus 225 -------------~~i~----~~~~~~~~~--------------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 225 -------------LKIA----KSEPPTLAQ--------------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp -------------HHHH----HSCCCCCSS--------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred -------------HHHH----cCCCCCCCc--------------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 0000 001000000 011123345788899999999999999999999998
Q ss_pred CCC
Q 005224 689 SDV 691 (707)
Q Consensus 689 ~~~ 691 (707)
.+.
T Consensus 274 ~~~ 276 (288)
T d2jfla1 274 VDS 276 (288)
T ss_dssp CCC
T ss_pred CCC
Confidence 653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-51 Score=422.24 Aligned_cols=261 Identities=27% Similarity=0.461 Sum_probs=204.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CC---cEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
++|+..+.||+|+||+||+|.++ ++ ..||||.+..... ...++|.+|+++|++++|||||+++|+|...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34556789999999999999975 33 3689999876433 3456899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
||||++|+|.+++... ...+++..++.++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 106 ~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999988754 345999999999999999999999998 999999999999999999999999999876533
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
.... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +... .+..+
T Consensus 182 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-~~~~---------~i~~~ 249 (299)
T d1jpaa_ 182 TSDP--TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVIN---------AIEQD 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH---------HHHTT
T ss_pred CCcc--eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-HHHH---------HHHcC
Confidence 2111 0112223457899999999999999999999999999999998 89999754431 1111 12223
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
...+.+.+++..+.+++.+||+.+|++||++.++++.|+++.+
T Consensus 250 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 250 YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 3445667788899999999999999999999999999998765
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=420.23 Aligned_cols=258 Identities=21% Similarity=0.323 Sum_probs=207.7
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999975 799999999864321 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999987653 5999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 163 ~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~---------------- 220 (288)
T d1uu3a_ 163 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQ---------------- 220 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----------------
T ss_pred c-----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-HHHH----------------
Confidence 1 12234467999999999999999999999999999999999999999754321 1100
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC------CCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM------LKH 684 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~------L~H 684 (707)
+ +.. ..+. -| ...++.+.|||.+||..||++|+|++|+ ++|
T Consensus 221 ------------~-i~~---~~~~-~p----------------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~H 267 (288)
T d1uu3a_ 221 ------------K-IIK---LEYD-FP----------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267 (288)
T ss_dssp ------------H-HHT---TCCC-CC----------------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred ------------H-HHc---CCCC-CC----------------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcC
Confidence 0 000 0000 01 0122334578999999999999999985 689
Q ss_pred CCCCCCCC
Q 005224 685 PYVSSDVS 692 (707)
Q Consensus 685 p~f~~~~~ 692 (707)
|||++-.+
T Consensus 268 pff~~i~w 275 (288)
T d1uu3a_ 268 PFFESVTW 275 (288)
T ss_dssp GGGTTCCC
T ss_pred CccCCCCH
Confidence 99988655
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=408.75 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=217.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
.++|+..++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 368899999999999999999999899999999986443 4568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++|+|.+++.... ..+++..+++++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~--- 154 (258)
T d1k2pa_ 82 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--- 154 (258)
T ss_dssp TTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS---
T ss_pred CCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC---
Confidence 9999999976543 35899999999999999999999998 9999999999999999999999999998664332
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 612 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (707)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... + +. ..+..+....
T Consensus 155 ---~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-~-~~--------~~i~~~~~~~ 221 (258)
T d1k2pa_ 155 ---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-E-TA--------EHIAQGLRLY 221 (258)
T ss_dssp ---CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-H-HH--------HHHHTTCCCC
T ss_pred ---ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-H-HH--------HHHHhCCCCC
Confidence 122334568999999999999999999999999999999998 89999755432 1 11 1222334445
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005224 613 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 648 (707)
Q Consensus 613 ~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~ 648 (707)
.|..++.++.+++.+||+.+|++|||+.++++.|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 667777899999999999999999999999998864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-50 Score=427.59 Aligned_cols=259 Identities=21% Similarity=0.384 Sum_probs=214.0
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
++|++.+.||+|+||+||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999964 79999999998766666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEEeeecccccCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFGla~~~~~~~~ 531 (707)
++|+|.+++... ..++++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 999999987543 345999999999999999999999999 99999999999998 6789999999999876532
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||...... +..
T Consensus 183 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~------------------ 237 (352)
T d1koba_ 183 ------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETL------------------ 237 (352)
T ss_dssp ------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHH------------------
T ss_pred ------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHH------------------
Confidence 2334567899999999999999999999999999999999999999654331 111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
+-+..+--.-|.. ..+..++.+.|||.+||+.||++|+|++|+|+||||.+..
T Consensus 238 -----------~~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 238 -----------QNVKRCDWEFDED----------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp -----------HHHHHCCCCCCSS----------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -----------HHHHhCCCCCCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 1111111000100 0112233445899999999999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-50 Score=428.19 Aligned_cols=259 Identities=22% Similarity=0.364 Sum_probs=212.2
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 453 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 453 (707)
++|++.+.||+|+||+||+|..+ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 58999999999999999999975 79999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEEeeecccccCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFGla~~~~~~~~ 531 (707)
++|+|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.....
T Consensus 106 ~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 106 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 999999999653 335999999999999999999999999 99999999999996 4678999999999876432
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......||+.|||||++.+..++.++|||||||++|||++|+.||..... .+....
T Consensus 180 ------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~---------------- 236 (350)
T d1koaa2 180 ------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRN---------------- 236 (350)
T ss_dssp ------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH----------------
T ss_pred ------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHH----------------
Confidence 223456799999999999999999999999999999999999999964332 111111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
+..+-...+.. ..+..++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus 237 -------------i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 237 -------------VKSCDWNMDDS----------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp -------------HHHTCCCSCCG----------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred -------------HHhCCCCCCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 11111000000 0011223345788999999999999999999999997654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-51 Score=424.30 Aligned_cols=261 Identities=24% Similarity=0.385 Sum_probs=196.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
.+.|++.+.||+|+||+||+|..+ +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 7899999998764432 34568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeeecccccCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~~~~ 528 (707)
||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999653 45999999999999999999999999 99999999999994 578999999999986543
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......- ...
T Consensus 163 ~--------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~------------- 220 (307)
T d1a06a_ 163 G--------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-FEQ------------- 220 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH-------------
T ss_pred C--------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH-HHH-------------
Confidence 2 223446799999999999999999999999999999999999999975433111 000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
+..+-...+ .| ..+..++.+.+||.+||..||++|||++|+|+||||.
T Consensus 221 ----------------i~~~~~~~~--~~--------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 268 (307)
T d1a06a_ 221 ----------------ILKAEYEFD--SP--------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268 (307)
T ss_dssp ----------------HHTTCCCCC--TT--------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred ----------------HhccCCCCC--Cc--------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 000000000 00 0011223345789999999999999999999999998
Q ss_pred CCCCC
Q 005224 689 SDVSG 693 (707)
Q Consensus 689 ~~~~~ 693 (707)
++...
T Consensus 269 ~~~~~ 273 (307)
T d1a06a_ 269 GDTAL 273 (307)
T ss_dssp SSCCC
T ss_pred CCCcc
Confidence 76553
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=412.45 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=198.3
Q ss_pred CccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEe----CCeEEEEE
Q 005224 378 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQMLVY 450 (707)
Q Consensus 378 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 450 (707)
+..++||+|+||+||+|... +++.||+|++.... ....+.+.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45668999999999999975 68899999987532 3334678999999999999999999999865 34679999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEeeecccccCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~~~~~ 529 (707)
||+++|+|.+++.+.. .+++..++.++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 9999999999997643 5899999999999999999999875 5699999999999996 578999999999986432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.||....+.......... +
T Consensus 168 --------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~---------~- 228 (270)
T d1t4ha_ 168 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS---------G- 228 (270)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---------T-
T ss_pred --------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc---------C-
Confidence 12335679999999999875 5999999999999999999999999754432221111000 0
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
.+|. . ......+++.+||.+||..||++|||++|+|+||||.
T Consensus 229 -------------------------~~~~---------~---~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 229 -------------------------VKPA---------S---FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -------------------------CCCG---------G---GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -------------------------CCCc---------c---cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0000 0 0011122344788889999999999999999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-50 Score=421.18 Aligned_cols=258 Identities=22% Similarity=0.366 Sum_probs=209.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46899999999999999999974 79999999986432 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
|||++|+|..++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 9999999999987644 4788899999999999999999999 99999999999999999999999999987642
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +...... .+.
T Consensus 157 --------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~---------~~~- 217 (316)
T d1fota_ 157 --------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKIL---------NAE- 217 (316)
T ss_dssp --------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHH---------HCC-
T ss_pred --------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-HHHHHHH---------cCC-
Confidence 123467999999999999999999999999999999999999999754331 1111111 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
..+|...+.++.+++.+|++.+|.+|+ +..|+|++|+|+||||.+.
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~----------------------------------~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRL----------------------------------GNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCT----------------------------------TSSTTTTHHHHTSGGGSSC
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhcc----------------------------------ccchhhHHHHHcCcccccC
Confidence 123333445556666666666666664 2345699999999999875
Q ss_pred CC
Q 005224 691 VS 692 (707)
Q Consensus 691 ~~ 692 (707)
.+
T Consensus 264 ~~ 265 (316)
T d1fota_ 264 VW 265 (316)
T ss_dssp CH
T ss_pred CH
Confidence 43
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=412.49 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=215.5
Q ss_pred hcCCCccce-EeeeCceEEEEEEeC---CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 374 TNNFNSSTQ-IGQGGYGKVYKGILP---DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 374 ~~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
.++|.+.+. ||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|+|.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 345666674 999999999999864 45689999997643 3345789999999999999999999999865 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|||||++|+|.+++... +..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 vmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999998543 346999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
.+.. ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +.. ..+..
T Consensus 162 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~---------~~i~~ 227 (285)
T d1u59a_ 162 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVM---------AFIEQ 227 (285)
T ss_dssp CSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHH---------HHHHT
T ss_pred cccc----cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHH---------HHHHc
Confidence 3211 122234568999999999999999999999999999999998 89999754432 111 12223
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
+.....|..++.++.+++.+||+.+|++||++.++.+.|+..+..
T Consensus 228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 445566778889999999999999999999999999999877653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=415.91 Aligned_cols=260 Identities=29% Similarity=0.445 Sum_probs=214.5
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
...++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|+|. ++..++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEE
Confidence 4456899999999999999999999888899999997543 34578999999999999999999999985 456899999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+++|+|.+++.......++|..++.++.||++||+|||+.+ |+||||||+|||+|+++++||+|||+|+......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~- 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 167 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-
Confidence 999999999997765567999999999999999999999998 9999999999999999999999999998764322
Q ss_pred CCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
........||+.|+|||++..+.++.++|||||||++|||++|..|+.......+..... ..+...
T Consensus 168 -----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i---------~~~~~~ 233 (285)
T d1fmka3 168 -----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRM 233 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---------HTTCCC
T ss_pred -----ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---------HhcCCC
Confidence 122334568999999999999999999999999999999999777776555543332221 122334
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
+.+.+++.++.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 4566778889999999999999999999999999887654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=411.63 Aligned_cols=205 Identities=27% Similarity=0.447 Sum_probs=166.5
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEe--CCeEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV 449 (707)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999965 799999999876432 234678999999999999999999999864 4568999
Q ss_pred EecCCCCCHHHHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 450 YEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
|||+++|+|.+++.+. ....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||+++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999652 3456999999999999999999999864 23599999999999999999999999999987
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 164 ~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 164 LNHDT-------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp C------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCC-------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 64321 2234567999999999999999999999999999999999999999653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=415.06 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=210.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh------hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 446 (707)
.++|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999974 799999999864322 2357899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeeecc
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 522 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFGl 522 (707)
++|||||++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999997653 5999999999999999999999999 99999999999998776 599999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 602 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 602 (707)
|+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +......
T Consensus 164 a~~~~~~--------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~----- 229 (293)
T d1jksa_ 164 AHKIDFG--------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVS----- 229 (293)
T ss_dssp CEECTTS--------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH-----
T ss_pred hhhcCCC--------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-HHHHHHH-----
Confidence 9876432 2233457899999999999999999999999999999999999999754321 1111000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCC
Q 005224 603 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 682 (707)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 682 (707)
... ..++.. ..+..++.+.+||.+||..||++|||++|+|
T Consensus 230 ----~~~-~~~~~~-----------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 230 ----AVN-YEFEDE-----------------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp ----TTC-CCCCHH-----------------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred ----hcC-CCCCch-----------------------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000 000000 0122233445799999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 683 KHPYVSSDVS 692 (707)
Q Consensus 683 ~Hp~f~~~~~ 692 (707)
+||||.....
T Consensus 270 ~hp~~~~~~~ 279 (293)
T d1jksa_ 270 QHPWIKPKDT 279 (293)
T ss_dssp HSTTTCC---
T ss_pred cCcccCCCCh
Confidence 9999986554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=412.44 Aligned_cols=261 Identities=27% Similarity=0.441 Sum_probs=210.4
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCC-----cEEEEEEeccCCh-hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDG-----TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
.+.|+..+.||+|+||+||+|.+++. ..||||++..... ...++|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688899999999999999997532 4799999975433 33467999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+.++++.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 86 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999988654 346999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
..... ........||+.|+|||++.+..++.++|||||||++|||++|..|+.......+... .+.+
T Consensus 162 ~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~---------~i~~ 228 (283)
T d1mqba_ 162 DDPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---------AIND 228 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---------HHHT
T ss_pred CCCcc----ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH---------HHhc
Confidence 32211 1223345689999999999999999999999999999999997676655444322221 2233
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
+...+.+.+++..+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 44455677788899999999999999999999999999998765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=423.32 Aligned_cols=202 Identities=26% Similarity=0.342 Sum_probs=180.0
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357999999999999999999974 79999999987532 22346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
||||++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++++|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999997654 4899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 159 ~-------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 159 G-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp T-------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 1 22345679999999999999999999999999999999999999997543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-50 Score=423.57 Aligned_cols=198 Identities=24% Similarity=0.359 Sum_probs=177.9
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 79999999986432 123467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999997654 4899999999999999999999999 999999999999999999999999999876421
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.....||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 234579999999999999999999999999999999999999996543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=405.85 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=205.6
Q ss_pred ceEeeeCceEEEEEEeC---CCcEEEEEEeccCCh--hhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEecCCC
Q 005224 381 TQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 455 (707)
Q Consensus 381 ~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 455 (707)
++||+|+||+||+|.++ .++.||||+++.... ...++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 357899999875332 234679999999999999999999999965 467899999999
Q ss_pred CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCcc
Q 005224 456 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 535 (707)
Q Consensus 456 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 535 (707)
|+|.++++.. ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+........
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~--- 163 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 163 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE---
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc---
Confidence 9999999764 35999999999999999999999998 999999999999999999999999999876433211
Q ss_pred ccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 005224 536 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 614 (707)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (707)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... + +. ..+..+.....|
T Consensus 164 -~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~-~~--------~~i~~~~~~~~p 232 (277)
T d1xbba_ 164 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E-VT--------AMLEKGERMGCP 232 (277)
T ss_dssp -EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-H-HH--------HHHHTTCCCCCC
T ss_pred -cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-H-HH--------HHHHcCCCCCCC
Confidence 122334568999999999999999999999999999999998 89999754431 1 11 112233445567
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 615 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 615 ~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
..++.++.+++.+||+.+|++||++.++.+.|+.++.
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 7788899999999999999999999999999887653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=410.95 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=211.0
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeCC-C-----cEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEEeC
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILPD-G-----TVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 443 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 443 (707)
...++|+..+.||+|+||+||+|++.. + ..||||.+..... .....+.+|+.+++++ +|||||+++++|.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 344678899999999999999999642 2 3699999865432 2346789999999998 899999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCC---------------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSK---------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 502 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl 502 (707)
+..++|||||++|+|.++++.+.. ..+++..++.++.||++||+|||+++ ||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999976432 35899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCC
Q 005224 503 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 581 (707)
Q Consensus 503 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~ 581 (707)
||+|||++.++.+||+|||+|+....... ........||+.|||||++.+..++.++|||||||++|||+| |+.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred chhccccccCCeEEEeeccccccccCCCc-----eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence 99999999999999999999986543221 123345668999999999999999999999999999999998 899
Q ss_pred CCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005224 582 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 647 (707)
Q Consensus 582 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~ 647 (707)
||......... .... ..+...+.|..++.++.+++.+||+.+|++|||+.++++.|.
T Consensus 266 Pf~~~~~~~~~-~~~~--------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 266 PYPGIPVDANF-YKLI--------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SSTTCCCSHHH-HHHH--------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHHH-HHHH--------hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99754332111 1111 112234456677889999999999999999999999999885
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-49 Score=408.57 Aligned_cols=264 Identities=28% Similarity=0.464 Sum_probs=218.6
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCD 441 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 441 (707)
+++...++|+..+.||+|+||+||+|+++ +++.||||+++..... ..++|.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 44555678999999999999999999863 4678999999764433 3567999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcC----------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 005224 442 EEGEQMLVYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 499 (707)
Q Consensus 442 ~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 499 (707)
..+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999996422 235889999999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcC
Q 005224 500 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 579 (707)
Q Consensus 500 ~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG 579 (707)
|||||+|||+|.++.+||+|||+|+....... ........|++.|+|||++.+..++.++|||||||++|||++|
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCcc-----ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 99999999999999999999999986543221 1223445688999999999999999999999999999999998
Q ss_pred CC-CCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005224 580 MQ-PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 650 (707)
Q Consensus 580 ~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~ 650 (707)
.. ||..... .+.. ..+..+.....|..++.++.+++.+||+.+|++||||.+++++|+++.
T Consensus 239 ~~~p~~~~~~-~e~~---------~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 239 GLQPYYGMAH-EEVI---------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TCCTTTTSCH-HHHH---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCCCH-HHHH---------HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 64 5654332 2221 223344455567777889999999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=400.64 Aligned_cols=252 Identities=29% Similarity=0.463 Sum_probs=206.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEe-CCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~E~ 452 (707)
.++|+..+.||+|+||+||+|++ .|+.||||+++... ..+.+.+|++++++++||||++++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 45678899999999999999998 47889999997643 34679999999999999999999999854 4568999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+++|+|.+++.......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---- 155 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 155 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC----
Confidence 99999999997765556899999999999999999999998 99999999999999999999999999986532
Q ss_pred CccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
......+|..|+|||++.+..++.++|||||||++|||+| |+.||..... .+ ....+..+...
T Consensus 156 ------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-~~---------~~~~i~~~~~~ 219 (262)
T d1byga_ 156 ------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KD---------VVPRVEKGYKM 219 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GG---------HHHHHTTTCCC
T ss_pred ------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-HH---------HHHHHHcCCCC
Confidence 1223457899999999999999999999999999999998 6777754332 11 11222334455
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
+.+..++.++.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 6677778899999999999999999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=411.42 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=205.4
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHH-ccCCCcceeEEEEEEeCCeEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLS-RLHHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV 449 (707)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 79999999996432 122345677777665 68999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCC
Q 005224 450 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 529 (707)
||||++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997654 4889999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 609 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (707)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 157 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~------------------ 210 (320)
T d1xjda_ 157 D-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-E------------------ 210 (320)
T ss_dssp T-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H------------------
T ss_pred c-------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-H------------------
Confidence 2 2234457999999999999999999999999999999999999999643321 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCC-cCCCCCCCC
Q 005224 610 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS-SMLKHPYVS 688 (707)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~-e~L~Hp~f~ 688 (707)
+.+.+.. ..|. -| ...++.+.+||++||+.||++|+|++ |+++||||+
T Consensus 211 -----------~~~~i~~---~~~~-~p----------------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~ 259 (320)
T d1xjda_ 211 -----------LFHSIRM---DNPF-YP----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259 (320)
T ss_dssp -----------HHHHHHH---CCCC-CC----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred -----------HHHHHHc---CCCC-CC----------------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhc
Confidence 1111111 1110 01 01233445788899999999999995 799999997
Q ss_pred CC
Q 005224 689 SD 690 (707)
Q Consensus 689 ~~ 690 (707)
+-
T Consensus 260 ~~ 261 (320)
T d1xjda_ 260 EI 261 (320)
T ss_dssp TC
T ss_pred cC
Confidence 63
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.6e-49 Score=417.34 Aligned_cols=198 Identities=27% Similarity=0.391 Sum_probs=171.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHH---HHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLT---EIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~---E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+ |+++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999975 799999999864221 12233444 467777888999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+|||||++|+|.+++.... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999997653 4889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
.. ......||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 159 ~~---------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 159 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp SS---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CC---------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 32 2234579999999999975 57899999999999999999999999643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=411.46 Aligned_cols=280 Identities=22% Similarity=0.334 Sum_probs=203.7
Q ss_pred ccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhh-----HHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 379 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-----EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 379 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.+++||+|+||+||+|..+ +|+.||||+++...... .+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4688999999999999965 79999999987543221 24688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+.++++..+.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-- 154 (299)
T d1ua2a_ 82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-- 154 (299)
T ss_dssp CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--
Confidence 98877766653 3445888999999999999999999999 9999999999999999999999999998654322
Q ss_pred CccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+. +.......... .+...
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~-----~~~~~ 223 (299)
T d1ua2a_ 155 -----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLG-----TPTEE 223 (299)
T ss_dssp -----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC-----CCCTT
T ss_pred -----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcC-----CCChh
Confidence 12234578999999999875 46799999999999999999999998654432 22111111000 00000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
..+... ... ....-...|.. ......+..++.+.|||.+||+.||++|+||+|+|+||||+...
T Consensus 224 ~~~~~~-----~~~---~~~~~~~~~~~--------~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 224 QWPDMC-----SLP---DYVTFKSFPGI--------PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp TSSSTT-----SST---TCCCCCCCCCC--------CHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hccchh-----ccc---hhhhhccCCCC--------ChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 000000 000 00000001100 00112234455677899999999999999999999999998654
Q ss_pred C
Q 005224 692 S 692 (707)
Q Consensus 692 ~ 692 (707)
.
T Consensus 288 ~ 288 (299)
T d1ua2a_ 288 G 288 (299)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=399.57 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=205.3
Q ss_pred HhcCCCccceEeeeCceEEEEEEeCC----CcEEEEEEeccCChh-hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 373 ATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 373 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
..++|+..+.||+|+||+||+|++.. +..||||.++..... ..+.+.+|++++++++|||||++++++. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 35678999999999999999998642 457999998754333 3567999999999999999999999995 56789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||++++++.+||+|||+|+...
T Consensus 84 iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999987654 346899999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
... ........||+.|+|||++.+..++.++|||||||++|||++ |..||....... ....+.
T Consensus 160 ~~~------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----------~~~~i~ 223 (273)
T d1mp8a_ 160 DST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----------VIGRIE 223 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------HHHHHH
T ss_pred CCc------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----------HHHHHH
Confidence 322 222344568999999999999999999999999999999998 888886544311 112223
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.+...+.+..++..+.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 344455677788899999999999999999999999999988764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.1e-48 Score=396.18 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=207.0
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---------hHHHHHHHHHHHHccC-CCcceeEEEEEEeC
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE 443 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~ 443 (707)
++|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999964 7999999998753321 1246889999999997 99999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 444 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 444 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
+..++|||||++|+|.+++..++ .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997654 5999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhcc------CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHh
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 597 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~ 597 (707)
+...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ...
T Consensus 158 ~~~~~~~--------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~--- 225 (277)
T d1phka_ 158 CQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLR--- 225 (277)
T ss_dssp EECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH---
T ss_pred eEccCCC--------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHH---
Confidence 8764321 2234579999999999964 356889999999999999999999997543311 110
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCC
Q 005224 598 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 677 (707)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s 677 (707)
.+...-.+. +. | ..+..++++.+|+.+||+.||++|||
T Consensus 226 -------------------------~i~~~~~~~-~~--~--------------~~~~~s~~~~~li~~~L~~~p~~R~s 263 (277)
T d1phka_ 226 -------------------------MIMSGNYQF-GS--P--------------EWDDYSDTVKDLVSRFLVVQPQKRYT 263 (277)
T ss_dssp -------------------------HHHHTCCCC-CT--T--------------TGGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred -------------------------HHHhCCCCC-CC--c--------------ccccCCHHHHHHHHHHccCChhHCcC
Confidence 111100000 00 0 00112234457889999999999999
Q ss_pred CCcCCCCCCCCCC
Q 005224 678 SSSMLKHPYVSSD 690 (707)
Q Consensus 678 a~e~L~Hp~f~~~ 690 (707)
++|+|+||||+.-
T Consensus 264 ~~eil~h~~~~~~ 276 (277)
T d1phka_ 264 AEEALAHPFFQQY 276 (277)
T ss_dssp HHHHTTSGGGCTT
T ss_pred HHHHHcCHHHHHh
Confidence 9999999999753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=409.33 Aligned_cols=258 Identities=19% Similarity=0.314 Sum_probs=208.9
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
.++|++.+.||+|+||+||+|... +|+.||||+++... .....+.+|+++|+.++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367999999999999999999975 78999999997654 3345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEeeecccccCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 530 (707)
|++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999999654 335999999999999999999999999 9999999999999854 58999999999876432
Q ss_pred CCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......||+.|+|||...+..++.++||||+||++|||++|+.||...... +..
T Consensus 158 -------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~----------------- 212 (321)
T d1tkia_ 158 -------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QII----------------- 212 (321)
T ss_dssp -------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHH-----------------
T ss_pred -------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HHH-----------------
Confidence 2334567899999999999999999999999999999999999999754331 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 690 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 690 (707)
..+....... .. ...+..++.+.+||.+||+.||++|+|++|+|+||||...
T Consensus 213 -----------~~i~~~~~~~------~~-----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 213 -----------ENIMNAEYTF------DE-----------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -----------HHHHHTCCCC------CH-----------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -----------HHHHhCCCCC------Ch-----------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 1111111100 00 0011223344578899999999999999999999999654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-48 Score=403.59 Aligned_cols=197 Identities=30% Similarity=0.470 Sum_probs=173.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 450 (707)
+.|+..+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45889999999999999999964 7899999998764332 2357899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 530 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 530 (707)
|||++|+|..++... .++++..++.++.||++||.|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999997766543 45999999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCccccceecccccCCCccchhhhcc---CCCCCchhhHHHHHHHHHHHcCCCCCCCCc
Q 005224 531 IEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGK 587 (707)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvll~elltG~~pf~~~~ 587 (707)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 223569999999999964 468999999999999999999999997543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-49 Score=407.21 Aligned_cols=283 Identities=26% Similarity=0.388 Sum_probs=210.3
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+++.+|+++|++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999996 47999999999654322 24678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
|+.+ ++.+++.......+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9964 6666665555667999999999999999999999999 9999999999999999999999999998654321
Q ss_pred CCccccceecccccCCCccchhhhccCC-CCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......||+.|+|||++.... ++.++||||+||++|||++|+.||....... .......... .+..
T Consensus 157 ------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~-----~~~~ 224 (298)
T d1gz8a_ 157 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLG-----TPDE 224 (298)
T ss_dssp ------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC-----CCCT
T ss_pred ------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcC-----CCch
Confidence 2334457999999999987755 5789999999999999999999997554322 2111111000 0000
Q ss_pred CCCChHHHHHHHHHHHHhccc-CCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQD-ETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~-~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
...+ ..... ...... ....+... ....+..++++.|||.+||..||++|+|++|+|+||||+.
T Consensus 225 ~~~~-----~~~~~-~~~~~~~~~~~~~~~----------~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 225 VVWP-----GVTSM-PDYKPSFPKWARQDF----------SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp TTST-----TGGGS-TTCCTTSCCCCCCCH----------HHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred hhcc-----ccccc-cccccccccccccch----------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 0000 00000 000000 00011111 1123344556678999999999999999999999999964
Q ss_pred C
Q 005224 690 D 690 (707)
Q Consensus 690 ~ 690 (707)
-
T Consensus 289 ~ 289 (298)
T d1gz8a_ 289 V 289 (298)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=396.06 Aligned_cols=260 Identities=31% Similarity=0.504 Sum_probs=213.7
Q ss_pred cceEeeeCceEEEEEEeCC----CcEEEEEEeccC-ChhhHHHHHHHHHHHHccCCCcceeEEEEEEe-CCeEEEEEecC
Q 005224 380 STQIGQGGYGKVYKGILPD----GTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYEFM 453 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~E~~ 453 (707)
.++||+|+||+||+|.+.+ ...||||+++.. .....++|.+|+++|++++||||++++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999999753 236999999753 34445789999999999999999999999865 46899999999
Q ss_pred CCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCCC
Q 005224 454 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 533 (707)
Q Consensus 454 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 533 (707)
++|+|.+++... ....++..++.++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999998754 345788999999999999999999998 9999999999999999999999999998765433211
Q ss_pred ccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 005224 534 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 613 (707)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (707)
........||+.|+|||++.+..++.++|||||||++|||+||..||....+..+ ....+..+.....
T Consensus 188 ---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---------~~~~i~~g~~~~~ 255 (311)
T d1r0pa_ 188 ---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------ITVYLLQGRRLLQ 255 (311)
T ss_dssp ---TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------------CHHHHHTTCCCCC
T ss_pred ---ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---------HHHHHHcCCCCCC
Confidence 2223345789999999999999999999999999999999998888865443222 1222334444556
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCC
Q 005224 614 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 655 (707)
Q Consensus 614 ~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~ 655 (707)
|..++.++.+++.+||+.+|++||++.|+++.|+++...+..
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 677788999999999999999999999999999999876544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=399.61 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=207.6
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCc----EEEEEEeccC-ChhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 448 (707)
++|+..++||+|+||+||+|.+. +|+ .||||++... .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999964 444 6899988653 334467899999999999999999999999764 5678
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCC
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 528 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 528 (707)
|+||+.+|+|.+++... ...+++..++.++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 88999999999988764 456999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 005224 529 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 607 (707)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 607 (707)
... ........||+.|+|||++.++.++.++|||||||++|||+| |..||...... +.. ..+..
T Consensus 164 ~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~~~---------~~i~~ 228 (317)
T d1xkka_ 164 EEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EIS---------SILEK 228 (317)
T ss_dssp TCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-GHH---------HHHHH
T ss_pred ccc-----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-HHH---------HHHHc
Confidence 321 122234568999999999999999999999999999999999 78888643321 111 11122
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
+.....|..++..+.+++.+||+.+|.+|||+.++++.++.+..
T Consensus 229 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 34445667788899999999999999999999999999887754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5e-48 Score=399.66 Aligned_cols=281 Identities=22% Similarity=0.308 Sum_probs=207.1
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChh--hHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 452 (707)
++|++.++||+|+||+||+|+.++|+.||||++...... ..+.+.+|+.+|++++||||+++++++..++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999999999999999999764332 246899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 532 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 532 (707)
+.++.+..+... ...+++..++.++.||++||+|||+.+ ||||||||+|||++.++.+|++|||.|.......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 987666666533 356999999999999999999999998 9999999999999999999999999998754322
Q ss_pred CccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 005224 533 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 611 (707)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (707)
.......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... +........ .......
T Consensus 155 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~-----~~~~~~~ 223 (286)
T d1ob3a_ 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRI-----LGTPNSK 223 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHH-----HCCCCTT
T ss_pred -----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-HHHHHHHHh-----hCCCChh
Confidence 22334468999999999976 45789999999999999999999999754432 221111110 0000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCC
Q 005224 612 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 688 (707)
Q Consensus 612 ~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 688 (707)
..+. ..+............+.. .....+..++.+.||+.+||+.||++|+||+|+|+||||+
T Consensus 224 ~~~~-----~~~~~~~~~~~~~~~~~~----------~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 224 NWPN-----VTELPKYDPNFTVYEPLP----------WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp TSTT-----GGGSTTCCTTCCCCCCCC----------GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred hccc-----hhhhhhcccccccccCcc----------hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 0000 000000000000000000 0112233344556899999999999999999999999996
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=396.97 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=211.8
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCc--EEEEEEeccCC-hhhHHHHHHHHHHHHcc-CCCcceeEEEEEEeCCeEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 449 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 449 (707)
++|+..+.||+|+||+||+|.++ +|. .||||++.... ....+.+.+|+++|+++ +|||||+++++|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888999999999999999975 444 57888876432 23456799999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhc--------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 005224 450 YEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 515 (707)
Q Consensus 450 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 515 (707)
|||+++|+|.++++.. ....+++..++.++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999753 2356999999999999999999999998 9999999999999999999
Q ss_pred EEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005224 516 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 595 (707)
Q Consensus 516 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~ 595 (707)
||+|||+|+..... .......||..|+|||.+.+..++.++|||||||++|||++|..|+....+..+..
T Consensus 167 kl~DfG~a~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~-- 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-- 236 (309)
T ss_dssp EECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--
T ss_pred EEcccccccccccc--------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH--
Confidence 99999999865321 12234468999999999999999999999999999999999766543343322221
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 596 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
..+..+.....+..++.++.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 237 -------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 -------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp -------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 12233445556777888999999999999999999999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=395.65 Aligned_cols=267 Identities=25% Similarity=0.411 Sum_probs=206.7
Q ss_pred HHHHHHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEE
Q 005224 368 GEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGY 439 (707)
Q Consensus 368 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~ 439 (707)
..++...++|++.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|..++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344455678999999999999999999853 357899999975433 3356788888888877 68999999999
Q ss_pred EEeC-CeEEEEEecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005224 440 CDEE-GEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 504 (707)
Q Consensus 440 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 504 (707)
+... ...++|||||++|+|.++++... ...+++..++.++.||++||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8665 46899999999999999997532 235899999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCC-CCC
Q 005224 505 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM-QPI 583 (707)
Q Consensus 505 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~-~pf 583 (707)
+|||+++++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+||. .||
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTT-----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cceeECCCCcEEEccCcchhhcccccc-----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence 999999999999999999986543321 12234467999999999999999999999999999999999975 566
Q ss_pred CCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 584 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
........ +... +..+.....|..++.++.+++.+||+.+|++|||+.++++.|+++.+
T Consensus 238 ~~~~~~~~-~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 238 PGVKIDEE-FCRR--------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp TTCCCSHH-HHHH--------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHH-HHHH--------HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 54332221 1111 11233344566777889999999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.3e-46 Score=380.56 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=205.0
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHccCCCcceeEEEEEEeCC----e
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----E 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~ 445 (707)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 4799999999975433 23457899999999999999999999997654 3
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.|+||||+++++|.+++...+ .+++..++.++.||++||+|||+++ |+||||||+|||++.++..+++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999999987654 5899999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||...... +............
T Consensus 161 ~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~~~~~~~~~-- 233 (277)
T d1o6ya_ 161 IADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVREDPIP-- 233 (277)
T ss_dssp CC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHCCCCC--
T ss_pred hccccc----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-HHHHHHHhcCCCC--
Confidence 543221 122334567999999999999999999999999999999999999999755432 2222111111100
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhh
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIW 650 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-t~~~v~~~L~~~~ 650 (707)
......+.+.++.+++.+|++.+|.+|| ++.++.+.|.++.
T Consensus 234 ----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0012234567889999999999999999 8999999888764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=388.88 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=200.8
Q ss_pred cCCCccceEeeeCceEEEEEEeC--CC--cEEEEEEeccCC---hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP--DG--TVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 447 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 447 (707)
++|+..+.||+|+||+||+|+++ ++ ..||||++.... ....++|.+|+++|++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56889999999999999999853 23 478999887532 2334689999999999999999999999965 4678
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
+||||+++|++.+++..+. ..+++..++.++.|||+||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999999887643 35999999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
..... ........|+..|+|||++.+..++.++|||||||++|||+| |+.||...... +.......
T Consensus 163 ~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-~~~~~i~~-------- 229 (273)
T d1u46a_ 163 QNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK-------- 229 (273)
T ss_dssp C-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHT--------
T ss_pred cCCCc----ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-HHHHHHHh--------
Confidence 43211 122334567889999999999999999999999999999998 89999654332 22121111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 607 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 607 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
.+...+.+..++..+.+++.+||+.+|++|||+.++.+.|++.
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1223344566778899999999999999999999999988764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=399.91 Aligned_cols=281 Identities=24% Similarity=0.332 Sum_probs=203.6
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-C-CcEEEEEEeccCChh--hHHHHHHHHHHHHcc---CCCcceeEEEEEEe----
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-D-GTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCDE---- 442 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~---- 442 (707)
.++|++.+.||+|+||+||+|+.. + ++.||||++...... ....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999963 4 678999998643221 223566788777666 79999999999853
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeec
Q 005224 443 -EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 521 (707)
Q Consensus 443 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 521 (707)
....+++|||++++++.... ......+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 24689999999876665443 344566999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhccc
Q 005224 522 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601 (707)
Q Consensus 522 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 601 (707)
+++.... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||...... +..........
T Consensus 162 ~~~~~~~--------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~ 232 (305)
T d1blxa_ 162 LARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIG 232 (305)
T ss_dssp SCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHC
T ss_pred hhhhhcc--------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhC
Confidence 9876432 22334567999999999999999999999999999999999999999755432 21111110000
Q ss_pred c-hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 602 M-FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 602 ~-~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
. ....-......+.. ... .....| ........++.+.|||.+||+.||++||||+|
T Consensus 233 ~~~~~~~~~~~~~~~~-----------~~~-~~~~~~-----------~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e 289 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQ-----------AFH-SKSAQP-----------IEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289 (305)
T ss_dssp CCCGGGSCTTCSSCGG-----------GSC-CCCCCC-----------GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCchhcccccccchhh-----------hhc-cccccc-----------hhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 0 00000000000000 000 000000 11112333445568999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 681 MLKHPYVSSD 690 (707)
Q Consensus 681 ~L~Hp~f~~~ 690 (707)
+|+||||+.-
T Consensus 290 ~L~Hpff~~i 299 (305)
T d1blxa_ 290 ALSHPYFQDL 299 (305)
T ss_dssp HHTSGGGTTC
T ss_pred HhcChhhcCc
Confidence 9999999753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=395.61 Aligned_cols=264 Identities=26% Similarity=0.442 Sum_probs=218.3
Q ss_pred HHHHHhcCCCccceEeeeCceEEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEE
Q 005224 369 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 441 (707)
Q Consensus 369 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 441 (707)
+++...++|+..+.||+|+||+||+|.++ +++.||||+++... ......|.+|++++++++||||++++++|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 44555678899999999999999999863 35789999997543 333457899999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhc--------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 005224 442 EEGEQMLVYEFMSNGTLRDQLSAK--------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 513 (707)
Q Consensus 442 ~~~~~~lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 513 (707)
.++..++||||+++|+|.+++... ....+++..+..++.|+|+||.|||+++ |+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence 999999999999999999998642 2245799999999999999999999998 99999999999999999
Q ss_pred cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005224 514 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 593 (707)
Q Consensus 514 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~ 593 (707)
++||+|||+|+...... .........||+.|+|||.+.+..++.++|||||||++|||+||..|+....+..+..
T Consensus 171 ~~Kl~DFGla~~~~~~~-----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp CEEECCTTCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred eEEEeecccceeccCCc-----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999998654322 1222334568999999999999999999999999999999999864433333333322
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005224 594 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 649 (707)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~ 649 (707)
. .+.++.....|..++..+.+++.+||+.+|++|||+.++++.|++.
T Consensus 246 ~---------~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 246 R---------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp H---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred H---------HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2 2234445556677788999999999999999999999999998765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=396.11 Aligned_cols=248 Identities=23% Similarity=0.400 Sum_probs=200.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChh------hHHHHHHHHHHHHccC--CCcceeEEEEEEeCC
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLH--HRNLVSLVGYCDEEG 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~ 444 (707)
.++|++.+.||+|+||+||+|+.. +|+.||||++...... ..+++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999964 7999999998643211 1234678999999996 899999999999999
Q ss_pred eEEEEEecCCC-CCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeeecc
Q 005224 445 EQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGL 522 (707)
Q Consensus 445 ~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGl 522 (707)
..++||||+.+ +++.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 99999999975 68888886543 5899999999999999999999999 999999999999985 47999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccCCC-CCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 601 (707)
|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... ...
T Consensus 158 a~~~~~~---------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i-------~~~-- 219 (273)
T d1xwsa_ 158 GALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRG-- 219 (273)
T ss_dssp CEECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHC--
T ss_pred ceecccc---------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH-------hhc--
Confidence 9865422 2334679999999999988765 56789999999999999999999642110 000
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC
Q 005224 602 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 681 (707)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 681 (707)
...-++ ..++++.+||.+||..||++|||++|+
T Consensus 220 ------------------------------~~~~~~-----------------~~s~~~~~li~~~L~~dp~~R~s~~ei 252 (273)
T d1xwsa_ 220 ------------------------------QVFFRQ-----------------RVSSECQHLIRWCLALRPSDRPTFEEI 252 (273)
T ss_dssp ------------------------------CCCCSS-----------------CCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------------------------ccCCCC-----------------CCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 000000 112234478899999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 682 LKHPYVSSDV 691 (707)
Q Consensus 682 L~Hp~f~~~~ 691 (707)
|+||||..-.
T Consensus 253 l~hp~~~~~~ 262 (273)
T d1xwsa_ 253 QNHPWMQDVL 262 (273)
T ss_dssp HTSGGGSSCC
T ss_pred hcCHhhCCCC
Confidence 9999997643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=391.40 Aligned_cols=267 Identities=24% Similarity=0.380 Sum_probs=218.2
Q ss_pred HHHHhcCCCccceEeeeCceEEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEE
Q 005224 370 MALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 441 (707)
Q Consensus 370 l~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 441 (707)
++...++|+..++||+|+||.||+|++ .+++.||||+++.... .....+.+|+.+++++ +|||||+++++|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 334557888999999999999999985 2467899999976443 3456789999999999 6999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcC----------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 005224 442 EEGEQMLVYEFMSNGTLRDQLSAKS----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 505 (707)
Q Consensus 442 ~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 505 (707)
+.+..++|||||++|+|.++++... ...+++..+..++.||++||+|||+++ ||||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 9999999999999999999997642 235899999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 005224 506 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 585 (707)
Q Consensus 506 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~ 585 (707)
||+++.++.+|++|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+|+..|+..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccCcccccccchheeccCCCc-----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 99999999999999999987653321 2233456789999999999999999999999999999999995555443
Q ss_pred CchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 586 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
..+....+..... .+.....+..++..+.+++.+||+.+|++|||+.+++++|+++...
T Consensus 250 ~~~~~~~~~~~i~--------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 250 GMPVDSKFYKMIK--------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp TCCSSHHHHHHHH--------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHh--------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 3332222221111 1223345566778899999999999999999999999999887553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=393.19 Aligned_cols=291 Identities=21% Similarity=0.294 Sum_probs=208.3
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEe--------
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-------- 442 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-------- 442 (707)
.++|++.++||+|+||+||+|+.. +|+.||||++.... ....+++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999974 79999999986432 2234678999999999999999999999854
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecc
Q 005224 443 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 522 (707)
Q Consensus 443 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 522 (707)
.+..++||||+.++.+.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 34689999999877665444 33456899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhccc
Q 005224 523 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 601 (707)
Q Consensus 523 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 601 (707)
++......... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||....+.. ........
T Consensus 164 ~~~~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~-- 237 (318)
T d3blha1 164 ARAFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQL-- 237 (318)
T ss_dssp CEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH--
T ss_pred eeecccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHh--
Confidence 98765432111 1223345799999999999865 68999999999999999999999997544322 11111110
Q ss_pred chhhccCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 602 MFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 602 ~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
........ ...... .. ..........++...+.+.... .++.+.|||.+||++||++|+||+|
T Consensus 238 -~~~~~~~~~~~~~~~---~~----~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 238 -CGSITPEVWPNVDNY---EL----YEKLELVKGQKRKVKDRLKAYV--------RDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp -HCCCCTTTSTTCCCC--------------CCSSCCBCHHHHHHHHH--------CCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred -cCCCChhhccccchh---hh----hhhhcccccccccchhhhcccc--------CCHHHHHHHHHHCcCChhHCcCHHH
Confidence 00000000 000000 00 0111222333444444333211 2345568999999999999999999
Q ss_pred CCCCCCCCCCC
Q 005224 681 MLKHPYVSSDV 691 (707)
Q Consensus 681 ~L~Hp~f~~~~ 691 (707)
+|+||||..+.
T Consensus 302 lL~Hpff~~~p 312 (318)
T d3blha1 302 ALNHDFFWSDP 312 (318)
T ss_dssp HHHSGGGSSSS
T ss_pred HHcChhhccCC
Confidence 99999998653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=389.20 Aligned_cols=262 Identities=26% Similarity=0.462 Sum_probs=212.6
Q ss_pred HHhcCCCccceEeeeCceEEEEEEeC--------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHcc-CCCcceeEEEEEE
Q 005224 372 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 441 (707)
Q Consensus 372 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 441 (707)
...++|++.+.||+|+||.||+|+.. ++..||||+++.... ....++.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 34467888999999999999999853 235799999976543 3347889999999888 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 005224 442 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 507 (707)
Q Consensus 442 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 507 (707)
+++..++||||+++|+|.+++.... ...+++..++.++.||++||+|||+.+ ||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 9999999999999999999997543 245899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHc-CCCCCCCC
Q 005224 508 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 586 (707)
Q Consensus 508 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~ellt-G~~pf~~~ 586 (707)
|++.++.+||+|||+++....... ........||+.|+|||.+.++.|+.++|||||||++|||++ |..||...
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCT-----TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eecCCCCeEeccchhhcccccccc-----ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 999999999999999987643221 223345668999999999999999999999999999999998 67777543
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 587 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.. .. +.. .+..+.....|..++..+.+++.+||+.+|.+|||+.|+++.|+++..
T Consensus 242 ~~-~~-~~~--------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 242 PV-EE-LFK--------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CH-HH-HHH--------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CH-HH-HHH--------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 32 11 111 122333445666777889999999999999999999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=387.87 Aligned_cols=283 Identities=24% Similarity=0.379 Sum_probs=213.0
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCCeEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 451 (707)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+++.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999964 78999999986533 2335788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCCCCCC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 531 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 531 (707)
++.+++|..++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 99999988887543 45889999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCccccceecccccCCCccchhhhccCC-CCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 005224 532 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 610 (707)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (707)
.......++..|+|||++.... ++.++||||+||++|||++|+.||..+.+..+........... ...
T Consensus 156 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~---~~~-- 224 (292)
T d1unla_ 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT---PTE-- 224 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC---CCT--
T ss_pred ------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC---CCh--
Confidence 1223345678899999998754 6899999999999999999999987766654443322111000 000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCCCCCC
Q 005224 611 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 689 (707)
Q Consensus 611 ~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 689 (707)
...+. ..+... .. .-..++.. .......+..++.+.|||.+||+.||++|+||+|+|+||||+.
T Consensus 225 ~~~~~-----~~~~~~--~~-~~~~~~~~-------~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 225 EQWPS-----MTKLPD--YK-PYPMYPAT-------TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCTT-----GGGSTT--CC-CCCCCCTT-------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred hhhhh-----hhhccc--cc-cccccccc-------chhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 00000 000000 00 00000000 0111122333445568999999999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=386.97 Aligned_cols=196 Identities=24% Similarity=0.368 Sum_probs=171.2
Q ss_pred cCCCccc-eEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHcc-CCCcceeEEEEEEe----CCeEE
Q 005224 375 NNFNSST-QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGEQM 447 (707)
Q Consensus 375 ~~~~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~~ 447 (707)
++|.+.. .||+|+||+||+|.. .+++.||||+++.. +.+.+|++++.++ +|||||+++++|.+ ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5788775 599999999999996 47999999998642 4677899987655 89999999999865 35689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeeecccc
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 524 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~ 524 (707)
+|||||+||+|.+++...+...+++..++.++.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceee
Confidence 9999999999999998766667999999999999999999999999 999999999999985 5679999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 586 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~ 586 (707)
...... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||...
T Consensus 163 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 163 ETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp ECCCCC--------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred eccCCC--------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 764322 233467999999999999999999999999999999999999999643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=384.15 Aligned_cols=264 Identities=23% Similarity=0.364 Sum_probs=199.7
Q ss_pred cCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHH--HHHHHHHccCCCcceeEEEEEEeCC----eEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGYCDEEG----EQML 448 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~--~E~~~l~~l~H~nIv~l~~~~~~~~----~~~l 448 (707)
.+|...+.||+|+||+||+|++ +|+.||||++.... .+++. .|+..+..++||||++++++|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3566788999999999999997 68999999996532 23343 4555556789999999999997654 6799
Q ss_pred EEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEEcCCCcEEEeeeccc
Q 005224 449 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA-----DPPVFHRDIKASNILLDHKFTAKVADFGLS 523 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 523 (707)
|||||++|+|.+++++. .++|..++.++.|+|.||+|||+.. .++|+||||||+||||++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999764 4999999999999999999999741 234999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceecccccCCCccchhhhccCC------CCCchhhHHHHHHHHHHHcCCCCCCCCch---------
Q 005224 524 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTGMQPISHGKN--------- 588 (707)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDVwS~Gvll~elltG~~pf~~~~~--------- 588 (707)
+........ .........||+.|+|||++.+.. ++.++|||||||++|||+||..||.....
T Consensus 156 ~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 156 VRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp EEEETTTTE---ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred ccccCCCcc---eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 876432211 112234567999999999987643 56789999999999999999887742111
Q ss_pred ----hHHHHHHHhhcccchhhccCCCCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 005224 589 ----IVREVNIAYQSSMMFSVIDGNMGS--YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 652 (707)
Q Consensus 589 ----~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~ 652 (707)
............ ...+..+. .+.+....+.+++.+||+.+|.+|||+.|+++.|+++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 111111111110 11111111 1235677899999999999999999999999999988654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=392.65 Aligned_cols=280 Identities=21% Similarity=0.278 Sum_probs=201.7
Q ss_pred CCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcceeEEEEEEeC------CeEEE
Q 005224 376 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GEQML 448 (707)
Q Consensus 376 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 448 (707)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++||||++++++|... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999975 799999999876432 234799999999999999999998543 35789
Q ss_pred EEecCCCCCHHHHHhh-cCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeeecccccC
Q 005224 449 VYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLA 526 (707)
Q Consensus 449 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~ 526 (707)
|||||+++.+..+.+. .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999976544443322 34557999999999999999999999998 99999999999999775 8999999999876
Q ss_pred CCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
.... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ....... .
T Consensus 174 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~------~ 238 (350)
T d1q5ka_ 174 VRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIK------V 238 (350)
T ss_dssp CTTS--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHH------H
T ss_pred cCCc--------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHH------H
Confidence 4322 2234578999999999875 578999999999999999999999997554322 1111110 0
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCCC
Q 005224 606 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 685 (707)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 685 (707)
.+..+.+.......-............| . .....+..++.+.|||.+||++||++|+||+|+|+||
T Consensus 239 ----~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~---------~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 304 (350)
T d1q5ka_ 239 ----LGTPTREQIREMNPNYTEFKFPQIKAHP-W---------TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304 (350)
T ss_dssp ----HCCCCHHHHHHHCC---CCCCCCCCCCC-G---------GGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ----hCCChHHhhhhhccchhhccccccccCc-h---------hhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 0111111111110000000000000000 0 0011223344567899999999999999999999999
Q ss_pred CCCCCC
Q 005224 686 YVSSDV 691 (707)
Q Consensus 686 ~f~~~~ 691 (707)
||....
T Consensus 305 ~f~~~~ 310 (350)
T d1q5ka_ 305 FFDELR 310 (350)
T ss_dssp GGGGGG
T ss_pred hhcccc
Confidence 997643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=396.25 Aligned_cols=279 Identities=22% Similarity=0.356 Sum_probs=203.5
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC------
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 444 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 444 (707)
.++|++.++||+|+||+||+|... +|+.||||++.... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999964 79999999997532 233567899999999999999999999997654
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 445 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 445 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
+.++||||+ +.+|..+++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 579999999 66888877543 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 525 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... ......
T Consensus 170 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~-~~~~~~---- 234 (346)
T d1cm8a_ 170 QADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIMKV---- 234 (346)
T ss_dssp ECCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHH----
T ss_pred ccCC----------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH-HHHHhc----
Confidence 6542 2234578999999999986 45789999999999999999999999765442221 111100
Q ss_pred hhccCCCCCCChHHHHHHHH-HHHHhcccCCC-CCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcC
Q 005224 604 SVIDGNMGSYPSECVEKFIK-LALKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 681 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~-l~~~c~~~~p~-~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 681 (707)
....+.+....... .........+. .+... ....+..++.+.|||.+||++||++||||+|+
T Consensus 235 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei 298 (346)
T d1cm8a_ 235 ------TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF----------ASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298 (346)
T ss_dssp ------HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG----------GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ------cCCCcHHHHhhhcchhhhhhhccCCcccccch----------HHhccCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 01111111110000 00000000011 11111 11223344556789999999999999999999
Q ss_pred CCCCCCCCC
Q 005224 682 LKHPYVSSD 690 (707)
Q Consensus 682 L~Hp~f~~~ 690 (707)
|+||||..-
T Consensus 299 L~Hp~f~~~ 307 (346)
T d1cm8a_ 299 LAHPYFESL 307 (346)
T ss_dssp HHSGGGTTT
T ss_pred hcChhhCcC
Confidence 999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=395.71 Aligned_cols=288 Identities=22% Similarity=0.300 Sum_probs=209.4
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHccCCCcceeEEEEEEeCC----eEE
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQM 447 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~ 447 (707)
+++|++.++||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999996 489999999997543 334568899999999999999999999996543 234
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeecccccCC
Q 005224 448 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 527 (707)
Q Consensus 448 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 527 (707)
++++|+.+|+|.+++... .+++..++.++.|+++||+|||+++ ||||||||+|||+++++.+||+|||+|+...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 445566699999999654 4899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccceecccccCCCccchhhhcc-CCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhc
Q 005224 528 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 606 (707)
Q Consensus 528 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 606 (707)
..... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||................
T Consensus 161 ~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~------- 229 (345)
T d1pmea_ 161 PDHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL------- 229 (345)
T ss_dssp GGGCB----CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-------
T ss_pred CCCcc----ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhc-------
Confidence 32211 112344678999999999854 567899999999999999999999997654322111110000
Q ss_pred cCCCCCCChHHH-HHHHHHHHHhcccCCCC-CCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCcCCCC
Q 005224 607 DGNMGSYPSECV-EKFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 684 (707)
Q Consensus 607 ~~~~~~~~~~~~-~~l~~l~~~c~~~~p~~-RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 684 (707)
.....+.. .....-...+....+.. ++.... ..+..++.+.+|+.+||+.||++||||+|+|+|
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 230 ----GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR----------LFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp ----CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH----------HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----cCCChhhhhhhhhhhhhcccccCCccCCCCHHH----------hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011100 00000011222222222 223322 234445567789999999999999999999999
Q ss_pred CCCCCCCC
Q 005224 685 PYVSSDVS 692 (707)
Q Consensus 685 p~f~~~~~ 692 (707)
|||+....
T Consensus 296 pf~~~~~~ 303 (345)
T d1pmea_ 296 PYLEQYYD 303 (345)
T ss_dssp GGGTTTCC
T ss_pred HhhccCCC
Confidence 99985544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=388.59 Aligned_cols=275 Identities=22% Similarity=0.271 Sum_probs=209.4
Q ss_pred cCCCccceEeeeCceEEEEEEe----CCCcEEEEEEeccCCh----hhHHHHHHHHHHHHccCC-CcceeEEEEEEeCCe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGE 445 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~ 445 (707)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999985 2588999999864321 223568899999999976 899999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++||||+.+|+|.+++.... .+.+..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999997654 3678889999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccC--CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccch
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 603 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 603 (707)
..... ........|++.|+|||.+.+. .++.++|||||||+||||++|+.||.......
T Consensus 179 ~~~~~------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~------------- 239 (322)
T d1vzoa_ 179 FVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN------------- 239 (322)
T ss_dssp CCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-------------
T ss_pred hcccc------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------------
Confidence 64322 2233456799999999999764 47889999999999999999999996432200
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCC-----CC
Q 005224 604 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SS 678 (707)
Q Consensus 604 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa 678 (707)
. ..++....+...+. .....++.+.+||.+||..||++|+ ||
T Consensus 240 -------------~---~~~i~~~~~~~~~~-----------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~ 286 (322)
T d1vzoa_ 240 -------------S---QAEISRRILKSEPP-----------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 286 (322)
T ss_dssp -------------C---HHHHHHHHHHCCCC-----------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred -------------H---HHHHHHhcccCCCC-----------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccH
Confidence 0 00111111111110 0112233455788888999999998 47
Q ss_pred CcCCCCCCCCCCCCCCCcccccCcccCC
Q 005224 679 SSMLKHPYVSSDVSGSNLVSGVIPTITP 706 (707)
Q Consensus 679 ~e~L~Hp~f~~~~~~~~~~~~~~~~~~~ 706 (707)
+|+|+||||+...+..-.-..+.+|+.|
T Consensus 287 ~eil~Hpff~~i~~~~l~~~~~~~p~~p 314 (322)
T d1vzoa_ 287 DEIKEHLFFQKINWDDLAAKKVPAPFKP 314 (322)
T ss_dssp HHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHcCHhhcCCCHHHHHhCCCCcCCCC
Confidence 8999999998754322222234455555
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.5e-46 Score=391.02 Aligned_cols=277 Identities=18% Similarity=0.305 Sum_probs=205.7
Q ss_pred cCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEEEeC--CeEEEEE
Q 005224 375 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQMLVY 450 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~ 450 (707)
++|++.++||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999997 479999999997533 457889999999995 99999999999744 5689999
Q ss_pred ecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeeecccccCCCC
Q 005224 451 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVP 529 (707)
Q Consensus 451 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~ 529 (707)
||+++++|.++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999987653 34899999999999999999999999 99999999999998655 6999999999876432
Q ss_pred CCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 608 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (707)
. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||....+..+........ ..
T Consensus 184 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~------~g- 248 (328)
T d3bqca1 184 Q--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV------LG- 248 (328)
T ss_dssp C--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH------HC-
T ss_pred C--------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHH------HC-
Confidence 2 23445689999999998875 57999999999999999999999998766543322211100 00
Q ss_pred CCCCCChHHHHHHHHHHHHhcc---------cCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCC
Q 005224 609 NMGSYPSECVEKFIKLALKCCQ---------DETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 679 (707)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~c~~---------~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~ 679 (707)
.... ......+-. .....+........ .......++++.|||++||++||++|+||+
T Consensus 249 ------~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 314 (328)
T d3bqca1 249 ------TEDL---YDYIDKYNIELDPRFNDILGRHSRKRWERFVH-----SENQHLVSPEALDFLDKLLRYDHQSRLTAR 314 (328)
T ss_dssp ------HHHH---HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCC-----TTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred ------Cchh---hhhhhhcccccCcccchhcccccccchhhccc-----ccccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 0000 000000000 00000111000000 000011234457899999999999999999
Q ss_pred cCCCCCCCCCCC
Q 005224 680 SMLKHPYVSSDV 691 (707)
Q Consensus 680 e~L~Hp~f~~~~ 691 (707)
|+|+||||.+..
T Consensus 315 e~L~Hp~F~~v~ 326 (328)
T d3bqca1 315 EAMEHPYFYTVV 326 (328)
T ss_dssp HHHTSGGGTTSC
T ss_pred HHhcCcccCCCC
Confidence 999999998754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=387.49 Aligned_cols=278 Identities=19% Similarity=0.310 Sum_probs=205.1
Q ss_pred hcCCCccceEeeeCceEEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEeC-----Ce
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 445 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 445 (707)
.++|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999996 479999999997543 33456789999999999999999999998533 34
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.++|++|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 4666777889999999954 35999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccC-CCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 604 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 604 (707)
... ......|++.|+|||+..+. .++.++||||+||++|||++|+.||.................
T Consensus 171 ~~~----------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~---- 236 (348)
T d2gfsa1 171 TDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG---- 236 (348)
T ss_dssp CTG----------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC----
T ss_pred cCc----------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC----
Confidence 432 23345689999999998775 568899999999999999999999976544222111110000
Q ss_pred hccCCCCCCChHHHH----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCccccCCCCCCCCCCCCCCc
Q 005224 605 VIDGNMGSYPSECVE----KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 680 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~----~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 680 (707)
..+.+... ....-........ .+..... .....++.+.|||.+||+.||++|+||+|
T Consensus 237 -------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 237 -------TPGAELLKKISSESARNYIQSLTQM--PKMNFAN----------VFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp -------CCCHHHHTTCCCHHHHHHHTTSCCC--CCCCHHH----------HSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred -------CCChHHhhhccchhhhhhhhhcccC--CCcchhh----------hcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 00111000 0000000111111 1122221 22344556678999999999999999999
Q ss_pred CCCCCCCCCC
Q 005224 681 MLKHPYVSSD 690 (707)
Q Consensus 681 ~L~Hp~f~~~ 690 (707)
+|+||||+.-
T Consensus 298 lL~Hp~f~~~ 307 (348)
T d2gfsa1 298 ALAHAYFAQY 307 (348)
T ss_dssp HHTSGGGTTT
T ss_pred HhcCHhhCCC
Confidence 9999999853
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=385.29 Aligned_cols=284 Identities=21% Similarity=0.263 Sum_probs=198.2
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHccCCCcceeEEEEEEe------CCe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGE 445 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~ 445 (707)
++|++.++||+|+||+||+|.+. +|+.||||++.... ....+++.+|+.++++++||||++++++|.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999975 79999999997543 3334578999999999999999999999953 368
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeeeccccc
Q 005224 446 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 525 (707)
Q Consensus 446 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 525 (707)
.|+||||+.+ ++.+.+. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 8999999965 4555552 34899999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHHHHHHhhcccchhh
Q 005224 526 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 605 (707)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 605 (707)
.... .......||+.|+|||++.+..++.++||||+||+++||++|+.||................
T Consensus 169 ~~~~--------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~------ 234 (355)
T d2b1pa1 169 AGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL------ 234 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH------
T ss_pred cccc--------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhc------
Confidence 5432 23345578999999999999999999999999999999999999997554422211111000
Q ss_pred ccCCCCCCChHHH----HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc----CCCCCCCCCccccCCCCCCCCCCCC
Q 005224 606 IDGNMGSYPSECV----EKFIKLALKCCQDETDARPSMSEVMRELESIWNM----MPESDTKTPEFINSEHTSKEETPPS 677 (707)
Q Consensus 606 ~~~~~~~~~~~~~----~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~----~~~~~~~~~dll~~~L~~dP~~R~s 677 (707)
. ....+.. ....++.. ...+....+...+.. +..... ....++.+.|||++||.+||++|||
T Consensus 235 -~----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 304 (355)
T d2b1pa1 235 -G----TPCPEFMKKLQPTVRNYVE---NRPKYAGLTFPKLFP--DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304 (355)
T ss_dssp -C----CCCHHHHTTSCHHHHHHHH---TSCCCCCCCHHHHSC--GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred -c----CCCHHHHHHhhhhHHHHhh---cCccccccccccccc--cccccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence 0 0111111 11111111 111111122221110 000000 0001123468999999999999999
Q ss_pred CCcCCCCCCCCCC
Q 005224 678 SSSMLKHPYVSSD 690 (707)
Q Consensus 678 a~e~L~Hp~f~~~ 690 (707)
|+|+|+||||...
T Consensus 305 a~elL~Hpw~~~~ 317 (355)
T d2b1pa1 305 VDDALQHPYINVW 317 (355)
T ss_dssp HHHHHTSTTTGGG
T ss_pred HHHHhcCcccCCC
Confidence 9999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.9e-43 Score=361.73 Aligned_cols=269 Identities=19% Similarity=0.250 Sum_probs=212.7
Q ss_pred hcCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCC-CcceeEEEEEEeCCeEEEEEe
Q 005224 374 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVYE 451 (707)
Q Consensus 374 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~E 451 (707)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|++.++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999965 78999999886533 22457789999999965 899999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCcEEEeeecccccC
Q 005224 452 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLA 526 (707)
Q Consensus 452 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFGla~~~ 526 (707)
|+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+..
T Consensus 82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 789999986543 46999999999999999999999999 999999999999974 578999999999886
Q ss_pred CCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCch--hHHHHHHHhhcccchh
Q 005224 527 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFS 604 (707)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~ 604 (707)
.........+........||+.|||||++.+..++.++|||||||++|||++|+.||..... ............. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~- 234 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-S- 234 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-H-
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-C-
Confidence 54432222223344556899999999999999999999999999999999999999964322 1111111110000 0
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcCC
Q 005224 605 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 654 (707)
Q Consensus 605 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~~~~ 654 (707)
.........++.++.+++..|++.+|++||++..+.+.++++.+...
T Consensus 235 ---~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 235 ---TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp ---SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ---CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 00000112345678999999999999999999999998888766543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.9e-43 Score=362.85 Aligned_cols=265 Identities=19% Similarity=0.269 Sum_probs=204.1
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcce-eEEEEEEeCCeEEEEEec
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV-SLVGYCDEEGEQMLVYEF 452 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~E~ 452 (707)
++|++.+.||+|+||+||+|++. +|+.||||++..... .+++..|+++++.++|+|++ .+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999964 789999998875432 24678899999999877655 455566788899999999
Q ss_pred CCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeeecccccCCCC
Q 005224 453 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPVP 529 (707)
Q Consensus 453 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~~~~~ 529 (707)
+ ++++.+.+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 56777766543 346999999999999999999999999 99999999999986 4567999999999987544
Q ss_pred CCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHHH--HHHHhhcccchhhcc
Q 005224 530 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE--VNIAYQSSMMFSVID 607 (707)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~~ 607 (707)
...............||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... .. .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~----~ 234 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-KM----S 234 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH-HH----H
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc-cC----C
Confidence 332222233345667999999999999999999999999999999999999999754331111 1100000 00 0
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 005224 608 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 651 (707)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPt~~~v~~~L~~~~~ 651 (707)
.........++.++.+++..||+.+|++||++.++.+.|+.+..
T Consensus 235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00001123455778999999999999999999999998888754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-40 Score=355.07 Aligned_cols=292 Identities=18% Similarity=0.242 Sum_probs=200.1
Q ss_pred cCCCccceEeeeCceEEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHccC-----------CCcceeEEEEEEe
Q 005224 375 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----------HRNLVSLVGYCDE 442 (707)
Q Consensus 375 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~ 442 (707)
++|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999974 79999999997643 33457788999988875 5789999998854
Q ss_pred --CCeEEEEEecCCCC-CHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCC-----
Q 005224 443 --EGEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKF----- 513 (707)
Q Consensus 443 --~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~----- 513 (707)
....++||+++..+ +............+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 35566666665444 34444444556678999999999999999999998 77 99999999999998665
Q ss_pred -cEEEeeecccccCCCCCCCCccccceecccccCCCccchhhhccCCCCCchhhHHHHHHHHHHHcCCCCCCCCchhHH-
Q 005224 514 -TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR- 591 (707)
Q Consensus 514 -~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvll~elltG~~pf~~~~~~~~- 591 (707)
.+|++|||.|..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||........
T Consensus 169 ~~~kl~dfg~s~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp EEEEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ceeeEeeccccccccc----------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 399999999976532 22345689999999999999999999999999999999999999964322100
Q ss_pred -HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhc-------ccCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCcc
Q 005224 592 -EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCC-------QDETDARPSMSEVMRELESIWNMMPESDTKTPEF 663 (707)
Q Consensus 592 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~-------~~~p~~RPt~~~v~~~L~~~~~~~~~~~~~~~dl 663 (707)
....... .... ++..+.+....- .-....+ ......+....+.... ........++.+.||
T Consensus 239 ~~~~~~~~---~~~~----lg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 239 KDDDHIAQ---IIEL----LGELPSYLLRNG-KYTRTFFNSRGLLRNISKLKFWPLEDVLTE---KYKFSKDEAKEISDF 307 (362)
T ss_dssp CHHHHHHH---HHHH----HCSCCHHHHHHC-TTHHHHBCC--CBSSCCCCCBCCHHHHHHH---TTCCCHHHHHHHHHH
T ss_pred chhHHHHH---HHHH----hCCCCHHHhhcc-cccccccccchhhhccccccCCchhhhccc---ccccCcccCHHHHHH
Confidence 0000000 0000 011122111100 0001111 1111122333333321 111111223456789
Q ss_pred ccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 664 INSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 664 l~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
|.+||++||++||||+|+|+||||....
T Consensus 308 l~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999998443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.6e-23 Score=199.84 Aligned_cols=163 Identities=13% Similarity=0.124 Sum_probs=120.6
Q ss_pred CccceEeeeCceEEEEEEeCCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHHccCCCcceeEEEE
Q 005224 378 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL------------------QGEKEFLTEIQFLSRLHHRNLVSLVGY 439 (707)
Q Consensus 378 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~~ 439 (707)
.+.++||+|+||+||+|...+|+.||||+++.... .....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999988999999998653211 011345678899999999999998865
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 005224 440 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 519 (707)
Q Consensus 440 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 519 (707)
.. .++||||+++..+.+ ++......++.|++++|+|||+++ |+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 42 379999998755432 333445679999999999999999 9999999999999965 589999
Q ss_pred ecccccCCCCCCCCccccceecccccCCCccc------hhhhccCCCCCchhhHHHHHHH
Q 005224 520 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD------PEYFLTHKLTDKSDVYSLGVVF 573 (707)
Q Consensus 520 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~~sDVwS~Gvll 573 (707)
||.|.....+.. ..|.. .|. ....|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~---------------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGW---------------REILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTH---------------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCc---------------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 999976543210 00111 111 135678899999975443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.2e-18 Score=171.95 Aligned_cols=144 Identities=28% Similarity=0.316 Sum_probs=114.6
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceEe
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
|++|+.|+|++|+|++.++.+..+++|++|+|++|.+. .++...+.. +++.|++++|.++...+..+..+++|+.|+
T Consensus 76 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~-~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~ 154 (266)
T d1p9ag_ 76 LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (266)
T ss_dssp CTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccccccccccccccccccccccc-eeeccccccccccccccccccccceeccccccccccchhcc
Confidence 45667777777777766556677777777777777777 555544432 788888888888866677788899999999
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC-CCCCCceeeccCCCccccCCcccccCCCCC
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 150 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~~~~~~~~~~~~~~ 150 (707)
+++|+|++..+..+..+++|+ +|+|++|+|+.+|+.+ .+++|+.|+|++|||.|+|.+..|-.|...
T Consensus 155 l~~N~l~~~~~~~~~~l~~L~-----~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~~~l~~wl~~ 222 (266)
T d1p9ag_ 155 LANNNLTELPAGLLNGLENLD-----TLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQD 222 (266)
T ss_dssp CTTSCCSCCCTTTTTTCTTCC-----EEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGGHHHHHHHHH
T ss_pred cccccccccCccccccccccc-----eeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcchHHHHHHHHh
Confidence 999999966667777766665 9999999999999877 899999999999999999999888777643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=1.7e-17 Score=158.75 Aligned_cols=138 Identities=20% Similarity=0.284 Sum_probs=120.3
Q ss_pred ceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 4 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 4 L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
.+.++.++|+|+.+|+.+. +++++|+|++|+|++.++...+. + +|+.|+|++|++++..+..|..+++|++|+|++
T Consensus 10 ~~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 4678999999998877664 78999999999998667776654 3 899999999999999999999999999999999
Q ss_pred cccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCCcccccCCC
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSH 148 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~~~~~~~~~ 148 (707)
|+|++..|..|.++++|+ +|+|++|+|+++++.. .+++|+.|+|++|+|.|+|....+-.|.
T Consensus 88 N~l~~l~~~~F~~l~~L~-----~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l 151 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLK-----TLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWL 151 (192)
T ss_dssp CCCCEECSSSSTTCTTCC-----EEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHH
T ss_pred ccccccCHHHHhCCCccc-----ccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhh
Confidence 999966677787777665 9999999999998764 8999999999999999999887765543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=1.3e-16 Score=162.39 Aligned_cols=143 Identities=25% Similarity=0.386 Sum_probs=127.3
Q ss_pred CCCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc--CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
|++|+.|+|++|.+..+.+ .+..+.+|+.+++++|+|+ .+|...+.. +|+.|+|++|+|++..+..|.++++|+.|
T Consensus 104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l 182 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182 (284)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccCCEEecCCcccccccccccchhcccchhhhcccccc-ccChhHhccccchhhcccccCcccccchhhhccccccchh
Confidence 5789999999999998877 6888999999999999999 888766643 89999999999998888999999999999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccccCCcccccCCCC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHS 149 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~~~~~~~~~~~~~ 149 (707)
++++|++++..|..|..+++|+ +||+++|+++++++.. .+++|+.|++++|||.|+|....+-.|..
T Consensus 183 ~l~~N~l~~i~~~~f~~l~~L~-----~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~ 251 (284)
T d1ozna_ 183 LLHQNRVAHVHPHAFRDLGRLM-----TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ 251 (284)
T ss_dssp ECCSSCCCEECTTTTTTCTTCC-----EEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHH
T ss_pred hhhhccccccChhHhhhhhhcc-----cccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHH
Confidence 9999999988899998877665 9999999999997654 88999999999999999999876665553
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.59 E-value=1.9e-15 Score=144.20 Aligned_cols=130 Identities=24% Similarity=0.270 Sum_probs=102.4
Q ss_pred CCceEEEeeCCcCCCCCC--CcCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 2 SKLLKLSLRNCSLQGPMP--DLSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++++|+|++|+|++.++ .|.++++|+.|+|++|+++ .++.+.+. . +|+.|+|++|+|+...|..|.++++|++|
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~-~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L 107 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTL 107 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccc-cccccccccccccceeeeccccccccCHHHHhCCCccccc
Confidence 478999999999987554 5899999999999999999 66655444 4 89999999999998888899999999999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCC-CCCCceeeccCCCccc
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN-IPPNVTVRLRGNPFCL 137 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~-~~~l~~l~l~~N~~~~ 137 (707)
+|++|+|++..|..|..+++|+ +|+|++|.+........ ...+..+.+..|.+.|
T Consensus 108 ~L~~N~l~~i~~~~f~~l~~L~-----~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c 163 (192)
T d1w8aa_ 108 NLYDNQISCVMPGSFEHLNSLT-----SLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARC 163 (192)
T ss_dssp ECCSSCCCEECTTSSTTCTTCC-----EEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBB
T ss_pred ccCCccccccCHHHhcCCcccc-----cccccccccccccchHHHhhhhhhhcccCCCeEe
Confidence 9999999976677787766665 99999999886433211 1123334455555544
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.55 E-value=2.3e-15 Score=155.30 Aligned_cols=97 Identities=30% Similarity=0.530 Sum_probs=64.4
Q ss_pred CCCceEEEeeC-CcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 1 MSKLLKLSLRN-CSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 1 L~~L~~L~L~~-N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
|++|++|+|++ |+++|.+| +|++|++|++|+|++|+|+|..|..+... .|+.+++++|++.+.+|..|+++++|+.+
T Consensus 75 L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l 154 (313)
T d1ogqa_ 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred CccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccccee
Confidence 45666666664 66666555 56666666777776666664444433333 56666666666776777778888888888
Q ss_pred eccCcccccCCCCCcccccc
Q 005224 78 FIANNSLSGSIPSSIWQSRT 97 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~ 97 (707)
++++|.++|.+|..+..+..
T Consensus 155 ~l~~n~l~~~ip~~~~~l~~ 174 (313)
T d1ogqa_ 155 TFDGNRISGAIPDSYGSFSK 174 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCT
T ss_pred eccccccccccccccccccc
Confidence 88888887777766555443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=6.9e-15 Score=129.39 Aligned_cols=114 Identities=28% Similarity=0.423 Sum_probs=88.5
Q ss_pred eEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcc
Q 005224 5 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 83 (707)
Q Consensus 5 ~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 83 (707)
+.|+|++|+|+.+ +.+..+++|++|+|++|+|+ .+|+.+..+ +|+.|++++|+|+ .+| .|.++++|++|++++|+
T Consensus 1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCCCC-cccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 5789999999855 46889999999999999999 898876666 8999999999999 555 48899999999999999
Q ss_pred cccCCCC--CccccccCCCCccceEEccCccCCCCCCCC-----CCCCCcee
Q 005224 84 LSGSIPS--SIWQSRTLNATETFILDFQNNNLTNISGSF-----NIPPNVTV 128 (707)
Q Consensus 84 l~g~~p~--~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~-----~~~~l~~l 128 (707)
|+ .+|. .+..+++|+ .|++++|.++..+... .+|++..+
T Consensus 77 i~-~~~~~~~l~~~~~L~-----~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQ-QSAAIQPLVSCPRLV-----LLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CC-SSSTTGGGGGCTTCC-----EEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cC-CCCCchhhcCCCCCC-----EEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 98 5553 455555444 8899998888765322 35665543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=2.5e-14 Score=131.16 Aligned_cols=123 Identities=17% Similarity=0.121 Sum_probs=93.9
Q ss_pred CCCCcccEEeccCCcCcccCCCccccc-CccEEEccCc-cCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCC
Q 005224 22 SRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNN-KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 99 (707)
Q Consensus 22 ~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 99 (707)
......+.++++++.+. .+|..+... +|+.|+|++| .|+..-+..|.++++|+.|+|++|+|+..-|.+|..+++|+
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 34455667888888888 777776655 7888888665 47755556788888888888888888855566677666555
Q ss_pred CCccceEEccCccCCCCCCCC-CCCCCceeeccCCCccccCCcccccCCCCC
Q 005224 100 ATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 150 (707)
Q Consensus 100 ~~~L~~l~l~~N~l~~~~~~~-~~~~l~~l~l~~N~~~~~~~~~~~~~~~~~ 150 (707)
+|+|++|+|+.++... ...+++.|+|++|||.|+|.+..+-.|...
T Consensus 84 -----~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~~~~~ 130 (156)
T d2ifga3 84 -----RLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEE 130 (156)
T ss_dssp -----EEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHT
T ss_pred -----ceeccCCCCcccChhhhccccccccccCCCcccCCchHHHHHHHHHh
Confidence 8888888888887765 556799999999999999999887777644
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=5e-14 Score=141.50 Aligned_cols=128 Identities=21% Similarity=0.199 Sum_probs=93.3
Q ss_pred CCceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++|++|+|++|+|+++++ .|.++++|++|+|++|+|+ .+|......+|+.|+|++|+|+ .++..+.++++|+.|+++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccccccccccccccccccccc-cccccccccccccccccc
Confidence 468889999999988776 6888999999999999988 7876433338889999999888 567788888888888888
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~ 136 (707)
+|.+.+..+..+..+..+. .|++++|.++.+++.. .++.+..+++++|.+.
T Consensus 109 ~~~~~~~~~~~~~~l~~l~-----~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQ-----ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCC-----EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred ccccceeeccccccccccc-----cccccccccceeccccccccccchhccccccccc
Confidence 8888754444444444433 6666666666665544 4566666666666654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=8.4e-14 Score=122.30 Aligned_cols=103 Identities=25% Similarity=0.382 Sum_probs=87.9
Q ss_pred cEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCCCCccceE
Q 005224 28 GYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 106 (707)
Q Consensus 28 ~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l 106 (707)
+.|+|++|+|+ .++. +..+ +|++|+|++|+|+ .+|..|+.+++|+.|++++|+|+ .+|. +..+++|+ .|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~-----~L 70 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQ-----EL 70 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCC-----EE
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc-cccccccC-----eE
Confidence 58999999999 8875 4444 8999999999999 78989999999999999999999 6663 66665555 99
Q ss_pred EccCccCCCCCCC--C-CCCCCceeeccCCCccccCC
Q 005224 107 DFQNNNLTNISGS--F-NIPPNVTVRLRGNPFCLNTN 140 (707)
Q Consensus 107 ~l~~N~l~~~~~~--~-~~~~l~~l~l~~N~~~~~~~ 140 (707)
++++|+|+.++.. + .+++|+.|++++|+++....
T Consensus 71 ~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~ 107 (124)
T d1dcea3 71 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 107 (124)
T ss_dssp ECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred ECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcCcc
Confidence 9999999998752 3 78999999999999876543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.45 E-value=3.9e-14 Score=145.80 Aligned_cols=132 Identities=26% Similarity=0.475 Sum_probs=116.4
Q ss_pred CceEEEeeCCcCCCC--CC-CcCCCCcccEEeccC-CcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceE
Q 005224 3 KLLKLSLRNCSLQGP--MP-DLSRIPNLGYLDLSS-NQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 77 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~--~~-~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 77 (707)
+++.|+|++|+++|. +| ++++|++|++|+|++ |+++|.||..+..+ +|++|+|++|+|++..|..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 589999999999984 44 799999999999997 89999999998887 89999999999999999999999999999
Q ss_pred eccCcccccCCCCCccccccCCCCccceEEccCccCCCC-CCCC-CCCCC-ceeeccCCCccccC
Q 005224 78 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSF-NIPPN-VTVRLRGNPFCLNT 139 (707)
Q Consensus 78 ~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~-~~~~-~~~~l-~~l~l~~N~~~~~~ 139 (707)
++++|++.+.+|..+.+++.|+ .+++++|.+++. |..+ .+..+ ..+.+.+|.+....
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~-----~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~ 190 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLV-----GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCC-----EEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEEC
T ss_pred ccccccccccCchhhccCcccc-----eeeccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999887776 999999999964 5544 66665 67889999886543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=4.3e-14 Score=130.51 Aligned_cols=109 Identities=21% Similarity=0.273 Sum_probs=54.4
Q ss_pred cCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCCCC-ccccccC
Q 005224 21 LSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS-IWQSRTL 98 (707)
Q Consensus 21 ~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L 98 (707)
|.++.+|++|+|++|+|+ .||.....+ +|+.|+|++|+|+ .++ .|..+++|++|+|++|+++ .+|.. +..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L 89 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDL 89 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCcccccccccc
Confidence 444555555555555555 554322222 5555555555555 332 3555555555555555555 33332 2233333
Q ss_pred CCCccceEEccCccCCCCCC--CC-CCCCCceeeccCCCcccc
Q 005224 99 NATETFILDFQNNNLTNISG--SF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 99 ~~~~L~~l~l~~N~l~~~~~--~~-~~~~l~~l~l~~N~~~~~ 138 (707)
+ .|+|++|+|+.++. .+ .+++|+.|++++|+++..
T Consensus 90 ~-----~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 90 T-----ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp C-----EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred c-----cceeccccccccccccccccccccchhhcCCCccccc
Confidence 3 55555555555543 12 455555555555555443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.38 E-value=7.3e-13 Score=126.67 Aligned_cols=123 Identities=26% Similarity=0.410 Sum_probs=61.5
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++|++|+|++|+|++..+ ++++++|++|++++|.+. .++. +..+ .|+.|++++|.+.. + ..+..+++|+.|+++
T Consensus 62 ~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~ 136 (199)
T d2omxa2 62 NNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELS 136 (199)
T ss_dssp TTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECC
T ss_pred CCcCcCccccccccCccc-ccCCcccccccccccccc-cccc-ccccccccccccccccccc-c-cccchhhhhHHhhhh
Confidence 445555555555554333 445555555555555554 4442 1122 45555555555542 1 234555555555555
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
+|++. .+| .+..+++| +.|++++|+++++++-..+++|+.|++++|++.
T Consensus 137 ~n~l~-~~~-~l~~~~~L-----~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 137 SNTIS-DIS-ALSGLTSL-----QQLNFSSNQVTDLKPLANLTTLERLDISSNKVS 185 (199)
T ss_dssp SSCCC-CCG-GGTTCTTC-----SEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred hhhhc-ccc-cccccccc-----cccccccccccCCccccCCCCCCEEECCCCCCC
Confidence 55554 333 23333333 366666666666554335666666666666653
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.38 E-value=9.6e-13 Score=134.60 Aligned_cols=129 Identities=22% Similarity=0.344 Sum_probs=95.9
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
+++|+.+++++|+++.++..+ +++|+.|++++|.+++..+..+... .++.|++++|++++..+..|.++++|++|+|
T Consensus 149 l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 149 MKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp CTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred ccccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 457788888888887654433 5678888888888885555544444 6888888888888777778888888888888
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--------CCCCCceeeccCCCccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--------NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--------~~~~l~~l~l~~N~~~~ 137 (707)
++|+|+ .+|.++..+++|+ +|+|++|+|+.++... ..+++..|+|.+|||.+
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~-----~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQ-----VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCC-----EEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred cccccc-ccccccccccCCC-----EEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 888888 7787777666555 8888888888875421 34667788888888753
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=3.5e-13 Score=124.19 Aligned_cols=120 Identities=19% Similarity=0.214 Sum_probs=97.5
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
.+|+.|+|++|+|+.+...+..+++|+.|+|++|+|+ .++. +..+ +|+.|+|++|+|+...+..+..+++|+.|+|+
T Consensus 18 ~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 18 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp TSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCC-EECC-CCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CcCcEEECCCCCCCccCccccccccCCEEECCCCCCC-ccCC-cccCcchhhhhcccccccCCCccccccccccccceec
Confidence 4789999999999988655678999999999999999 8864 4444 89999999999996555556789999999999
Q ss_pred CcccccCCCC--CccccccCCCCccceEEccCccCCCCCCC----C-CCCCCceee
Q 005224 81 NNSLSGSIPS--SIWQSRTLNATETFILDFQNNNLTNISGS----F-NIPPNVTVR 129 (707)
Q Consensus 81 ~N~l~g~~p~--~~~~l~~L~~~~L~~l~l~~N~l~~~~~~----~-~~~~l~~l~ 129 (707)
+|+|+ .+++ .+..++ +|+.|++++|.++..+.. + .+|+|+.|+
T Consensus 96 ~N~i~-~~~~l~~l~~l~-----~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 96 NNSLV-ELGDLDPLASLK-----SLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp SCCCC-CGGGGGGGGGCT-----TCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccccc-cccccccccccc-----ccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 99998 5553 344444 455999999999988752 2 678888765
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.33 E-value=2.4e-12 Score=124.10 Aligned_cols=128 Identities=21% Similarity=0.325 Sum_probs=74.5
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
.+|+.|++++|.++.+. .+..+++|++|+|++|+|+ .+++ +..+ +|+.|++++|+|+ .+| .+.++++|+.|+++
T Consensus 46 ~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~L~~n~i~-~l~~-~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp HTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred cCccEEECcCCCCCCch-hHhhCCCCCEEeCCCcccc-Cccc-cccCcccccccccccccc-ccc-cccccccccccccc
Confidence 35667777777776543 3666777777777777777 4553 2223 6777777777776 344 46667777777777
Q ss_pred CcccccCCCCCccccccCC-----------------CCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPSSIWQSRTLN-----------------ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~-----------------~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
+|.+. .++ .+..++.++ +++|+.+++++|+++++++...+++|+.|++++|.+.
T Consensus 121 ~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 121 HNGIS-DIN-GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp TSCCC-CCG-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred ccccc-ccc-cccccccccccccccccccccccccccccccccccccccccccccccCCCCCCEEECCCCCCC
Confidence 77665 333 233333222 1234466666666665544335566666666666553
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.29 E-value=7e-12 Score=128.02 Aligned_cols=58 Identities=29% Similarity=0.406 Sum_probs=29.7
Q ss_pred CceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCc-cccc-CccEEEccCccCC
Q 005224 3 KLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPG-RLSL-NITTIKLSNNKLT 61 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~~-~L~~L~Ls~N~l~ 61 (707)
+|++|+|++|+|+.+++ .|.++++|++|++++|.++ .+++. +..+ +|+.|+|++|+|+
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~-~i~~~~f~~l~~L~~L~l~~n~l~ 92 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK 92 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCEEECcCCcCCCcChhHhhcccccccccccccccc-ccchhhhhCCCccCEecccCCccC
Confidence 45555555555555554 4555555555555555555 44332 2222 4555555555443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=1.2e-11 Score=124.96 Aligned_cols=130 Identities=22% Similarity=0.284 Sum_probs=84.5
Q ss_pred CCCceEEEeeCCcCCCCC-------------------------C-CcCCCCcccEEeccCCcCcccCCCccccc--CccE
Q 005224 1 MSKLLKLSLRNCSLQGPM-------------------------P-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITT 52 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~-------------------------~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~ 52 (707)
+++|++|++++|+|..+. + .|.++++|++|+|++|.+. .++...+.. +|+.
T Consensus 55 l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~ 133 (284)
T d1ozna_ 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133 (284)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccc-cccccccchhcccch
Confidence 356677777777665432 3 3556677777777777776 555443332 6777
Q ss_pred EEccCccCCCCCCcccCCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCC-C-CCCCCceeec
Q 005224 53 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRL 130 (707)
Q Consensus 53 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~-~-~~~~l~~l~l 130 (707)
+++++|+|++..+..|..+++|+.|+|++|+|++..|..+.++++|. .+++++|+++++++. + .+++++.|++
T Consensus 134 l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~-----~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD-----RLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC-----EEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred hhhccccccccChhHhccccchhhcccccCcccccchhhhccccccc-----hhhhhhccccccChhHhhhhhhcccccc
Confidence 77777777755556677777777777777777755555565555444 777777777776433 3 6677777777
Q ss_pred cCCCcc
Q 005224 131 RGNPFC 136 (707)
Q Consensus 131 ~~N~~~ 136 (707)
++|.+.
T Consensus 209 ~~N~i~ 214 (284)
T d1ozna_ 209 FANNLS 214 (284)
T ss_dssp CSSCCS
T ss_pred cccccc
Confidence 777764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=1.1e-11 Score=113.23 Aligned_cols=105 Identities=22% Similarity=0.222 Sum_probs=90.1
Q ss_pred CceEEEeeCCcCCCCCCCcCCCCcccEEeccCC-cCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN-QLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N-~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
..+.++++++++...+..+..+++|++|+|++| .|+ .|+...+. + +|+.|+|++|+|+...|.+|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCccCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 456789999999988778999999999999876 599 89887655 3 8999999999999877889999999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCC
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 114 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~ 114 (707)
++|+|+ .+|..+..... |+.|+|++|.+.
T Consensus 88 s~N~l~-~l~~~~~~~~~-----l~~L~L~~Np~~ 116 (156)
T d2ifga3 88 SFNALE-SLSWKTVQGLS-----LQELVLSGNPLH 116 (156)
T ss_dssp CSSCCS-CCCSTTTCSCC-----CCEEECCSSCCC
T ss_pred cCCCCc-ccChhhhcccc-----ccccccCCCccc
Confidence 999999 78776654333 559999999986
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.24 E-value=1.3e-11 Score=117.77 Aligned_cols=125 Identities=21% Similarity=0.336 Sum_probs=102.5
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
|.+|+.|++++|+++.+ +.+..+++|++|+|++|+|+ .+++ +..+ +|+.|++++|.+. .++ .+.++++|+.|++
T Consensus 39 l~~l~~L~l~~~~i~~l-~~l~~l~nL~~L~Ls~N~l~-~~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp HTTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred hcCCCEEECCCCCCCCc-cccccCCCcCcCcccccccc-Cccc-ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 36789999999999864 56888999999999999999 6664 4444 8999999999998 555 4889999999999
Q ss_pred cCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccc
Q 005224 80 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 80 s~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~ 137 (707)
++|.+.. ++ .+..+++| +.|++++|+++.++....+++++.|++.+|.+..
T Consensus 114 ~~~~~~~-~~-~~~~l~~L-----~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 114 FNNQITD-ID-PLKNLTNL-----NRLELSSNTISDISALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp CSSCCCC-CG-GGTTCTTC-----SEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCC
T ss_pred ccccccc-cc-ccchhhhh-----HHhhhhhhhhcccccccccccccccccccccccC
Confidence 9999983 33 35555544 5999999999988755588999999999998753
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.22 E-value=1.2e-11 Score=119.07 Aligned_cols=122 Identities=21% Similarity=0.319 Sum_probs=89.1
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCC----------------
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGT---------------- 63 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~---------------- 63 (707)
|++|++|+|++|+|+++.+ ++.+++|++|+|++|+|+ .+|. +..+ +|+.|++++|.+...
T Consensus 67 l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~i~-~l~~-l~~l~~L~~L~l~~~~~~~~~~l~~l~~l~~l~~~~ 143 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGN 143 (210)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CGGG-GTTCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCS
T ss_pred CCCCCEEeCCCccccCccc-cccCcccccccccccccc-cccc-cccccccccccccccccccccccccccccccccccc
Confidence 5788999999999987654 678889999999999988 6764 2222 666777766655411
Q ss_pred ----CCcccCCCcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccC
Q 005224 64 ----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRG 132 (707)
Q Consensus 64 ----~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~ 132 (707)
-+..+..+++|+.+++++|+++ .++. +.++++| +.|+|++|+|+.++.-..+++|+.|+|++
T Consensus 144 n~l~~~~~~~~l~~L~~l~l~~n~l~-~i~~-l~~l~~L-----~~L~Ls~N~i~~l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 144 NKITDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKL-----QNLYLSKNHISDLRALAGLKNLDVLELFS 209 (210)
T ss_dssp SCCCCCGGGGGCTTCSEEECCSSCCC-CCGG-GTTCTTC-----CEEECCSSCCCBCGGGTTCTTCSEEEEEE
T ss_pred cccccccccccccccccccccccccc-cccc-ccCCCCC-----CEEECCCCCCCCChhhcCCCCCCEEEccC
Confidence 1223556778888888888887 4443 5555544 59999999999997544899999998853
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.21 E-value=1.3e-13 Score=131.76 Aligned_cols=125 Identities=23% Similarity=0.310 Sum_probs=89.6
Q ss_pred ceEEEeeCC--cCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 4 LLKLSLRNC--SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 4 L~~L~L~~N--~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
++.++|+.+ .++.++..+..|++|++|+|++|+|+ .++. +..+ +|+.|+|++|+|+ .+|..+..+++|+.|+++
T Consensus 25 ~~~~~l~~~~~~i~~l~~sl~~L~~L~~L~Ls~n~I~-~i~~-l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~ 101 (198)
T d1m9la_ 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWIS 101 (198)
T ss_dssp CSCEECCBCCTTCCCCHHHHHHTTTCCEEECSEEEES-CCCC-HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECS
T ss_pred cceeeeecccCchhhhhhHHhcccccceeECcccCCC-Cccc-ccCCccccChhhcccccc-cccccccccccccccccc
Confidence 344555443 23322224777888999999999998 7763 4344 7999999999988 677666667789999999
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCC--CC-CCCCCceeeccCCCcccc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG--SF-NIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~--~~-~~~~l~~l~l~~N~~~~~ 138 (707)
+|+|+ .++ .+..+++|+ .|+|++|+|+.++. .+ .+++|+.|++++||+...
T Consensus 102 ~N~i~-~l~-~~~~l~~L~-----~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 102 YNQIA-SLS-GIEKLVNLR-----VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp EEECC-CHH-HHHHHHHSS-----EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred ccccc-ccc-ccccccccc-----ccccccchhccccccccccCCCccceeecCCCccccC
Confidence 99888 444 355555554 89999999888753 23 788889999999987543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.19 E-value=1.9e-11 Score=128.55 Aligned_cols=125 Identities=28% Similarity=0.350 Sum_probs=71.5
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
+++|+.|++++|++++.++ +..+++|+.|++++|+++ .+++......++.+++++|++++ + ..+..+++|+.|+++
T Consensus 240 l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~-~~~~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls 315 (384)
T d2omza2 240 LTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQIS-NISPLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLY 315 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCC-CCGGGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECC
T ss_pred ccccchhccccCccCCCCc-ccccccCCEeeccCcccC-CCCcccccccccccccccccccc-c-cccchhcccCeEECC
Confidence 4678999999999987665 778889999999999888 55432211245555555555552 2 234455555555555
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
+|++++ ++ .+..+++|+ .|+|++|+|+.++.-..+++|+.|++++|++.
T Consensus 316 ~n~l~~-l~-~l~~l~~L~-----~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 316 FNNISD-IS-PVSSLTKLQ-----RLFFANNKVSDVSSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp SSCCSC-CG-GGGGCTTCC-----EEECCSSCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCCC-Cc-ccccCCCCC-----EEECCCCCCCCChhHcCCCCCCEEECCCCcCC
Confidence 555552 22 133333332 55555555555442224555555555555544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.16 E-value=3.7e-13 Score=128.50 Aligned_cols=108 Identities=19% Similarity=0.225 Sum_probs=88.8
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEec
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 79 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 79 (707)
|++|++|+|++|+|+.+ +.|..+++|++|+|++|+|+ .+|...... +|+.|++++|+|+ .++ .+..+++|+.|+|
T Consensus 47 L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 47 LKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred ccccceeECcccCCCCc-ccccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 57899999999999965 56999999999999999999 888644433 7999999999999 444 5889999999999
Q ss_pred cCcccccCCCC--CccccccCCCCccceEEccCccCCCCCC
Q 005224 80 ANNSLSGSIPS--SIWQSRTLNATETFILDFQNNNLTNISG 118 (707)
Q Consensus 80 s~N~l~g~~p~--~~~~l~~L~~~~L~~l~l~~N~l~~~~~ 118 (707)
++|+|+ .++. .+..+++ |+.|+|++|.++..+.
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~-----L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDK-----LEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTT-----CSEEEECSSHHHHHHC
T ss_pred ccchhc-cccccccccCCCc-----cceeecCCCccccCcc
Confidence 999998 5542 3555444 4599999999887644
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.13 E-value=7.8e-11 Score=114.65 Aligned_cols=130 Identities=21% Similarity=0.299 Sum_probs=81.9
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
.+|+.|++++|+|+.+ +.+..+++|++|+|++|+++ .+++ +..+ +|+.|++++|.++ .++ .|.++++|+.|+++
T Consensus 41 ~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~ls~n~i~-~~~~-l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~ 115 (227)
T d1h6ua2 41 DGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLT 115 (227)
T ss_dssp HTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECT
T ss_pred CCcCEEECCCCCCCcc-hhHhcCCCCcEeecCCceee-cccc-cccccccccccccccccc-ccc-cccccccccccccc
Confidence 4678888888888865 56888888888888888888 4443 2222 7888888888777 444 46777777777777
Q ss_pred CcccccCCCCC--------------cccccc-CCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcc
Q 005224 81 NNSLSGSIPSS--------------IWQSRT-LNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 136 (707)
Q Consensus 81 ~N~l~g~~p~~--------------~~~l~~-L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~ 136 (707)
+|...+..+-. +..... -...+|+.|++++|.++..++...+++|+.|++++|.+.
T Consensus 116 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186 (227)
T ss_dssp TSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred cccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchhhcccccceecccCCCccC
Confidence 77765321100 000000 012345567777776666554335666677777766654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.07 E-value=1.8e-10 Score=120.97 Aligned_cols=125 Identities=26% Similarity=0.340 Sum_probs=97.0
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
++|+.|++++|+++.+ +.+..+++|+.|++++|.++ .++......+|+.|++++|++++. + .+.++..++.+++++
T Consensus 219 ~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQIS-NLAPLSGLTKLTELKLGANQISNI-S-PLAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC-CCGGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCCc-chhhcccccchhccccCccC-CCCcccccccCCEeeccCcccCCC-C-ccccccccccccccc
Confidence 5788999999998864 46788899999999999999 555422223899999999999853 3 377888999999999
Q ss_pred cccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccc
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~ 137 (707)
|++++ ++ .+..+..+ +.|+|++|+|+++++...+++|+.|++++|++..
T Consensus 295 n~l~~-~~-~~~~~~~l-----~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 295 NQLED-IS-PISNLKNL-----TYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD 343 (384)
T ss_dssp SCCSC-CG-GGGGCTTC-----SEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC
T ss_pred ccccc-cc-ccchhccc-----CeEECCCCCCCCCcccccCCCCCEEECCCCCCCC
Confidence 99884 33 35444444 4899999999988754478899999999998764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.97 E-value=7e-10 Score=107.71 Aligned_cols=126 Identities=25% Similarity=0.386 Sum_probs=87.7
Q ss_pred CCCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEecc
Q 005224 1 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 80 (707)
Q Consensus 1 L~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 80 (707)
+++|+.|++++|.++. ++.+.++++|++|++++|... .++.......++.+.++++.+... ..+.++++|+.|+++
T Consensus 84 l~~l~~l~~~~n~~~~-i~~l~~l~~L~~l~l~~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~ 159 (227)
T d1h6ua2 84 LTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQIT-DVTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIG 159 (227)
T ss_dssp CCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCC-CCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECC
T ss_pred cccccccccccccccc-ccccccccccccccccccccc-ccchhccccchhhhhchhhhhchh--hhhcccccccccccc
Confidence 5689999999999985 456889999999999999988 444322223677777777777632 235667777777777
Q ss_pred CcccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCccc
Q 005224 81 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 81 ~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~ 137 (707)
+|.+++ ++ .+.++++| +.|+|++|+|+++++...+++|+.|++++|++..
T Consensus 160 ~n~~~~-~~-~l~~l~~L-----~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt~ 209 (227)
T d1h6ua2 160 NAQVSD-LT-PLANLSKL-----TTLKADDNKISDISPLASLPNLIEVHLKNNQISD 209 (227)
T ss_dssp SSCCCC-CG-GGTTCTTC-----CEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCB
T ss_pred cccccc-ch-hhcccccc-----eecccCCCccCCChhhcCCCCCCEEECcCCcCCC
Confidence 777762 22 24444444 3777777777777654467777777777777653
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.90 E-value=1.5e-09 Score=106.19 Aligned_cols=130 Identities=22% Similarity=0.315 Sum_probs=72.3
Q ss_pred CceEEEeeCCcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccccc--CccEEEcc-CccCCCCCCcccCCCcccceEe
Q 005224 3 KLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLS-NNKLTGTIPSNFSGLPRLQRLF 78 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~--~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~ 78 (707)
++++|+|++|+|+.+++ .|.++++|++|+|++|.+...+|...+.. +++.|.+. .|++....+..|.++++|+.|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 56667777777766555 46666777777777776664555544432 56666554 3566655566666667777777
Q ss_pred ccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCC-CCceeeccCCCcc
Q 005224 79 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIP-PNVTVRLRGNPFC 136 (707)
Q Consensus 79 ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~-~l~~l~l~~N~~~ 136 (707)
+++|+++ .++. +..+..++ .+..+..+++++..++... .++ .+..+++++|.+.
T Consensus 110 l~~~~l~-~~~~-~~~~~~l~--~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 110 ISNTGIK-HLPD-VHKIHSLQ--KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp EESCCCC-SCCC-CTTTCBSS--CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cchhhhc-cccc-cccccccc--ccccccccccccccccccccccccccceeeeccccccc
Confidence 7777665 3332 11222221 2334555555666554432 222 4455666666553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.83 E-value=1.1e-08 Score=105.19 Aligned_cols=113 Identities=27% Similarity=0.331 Sum_probs=83.6
Q ss_pred CceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccCc
Q 005224 3 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 82 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 82 (707)
+|++|||++|+|+.+++. +++|++|+|++|+|+ ++|..+. +|+.|++++|+++ .++.-. +.|++|+|++|
T Consensus 39 ~l~~LdLs~~~L~~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~--~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~~n 108 (353)
T d1jl5a_ 39 QAHELELNNLGLSSLPEL---PPHLESLVASCNSLT-ELPELPQ--SLKSLLVDNNNLK-ALSDLP---PLLEYLGVSNN 108 (353)
T ss_dssp TCSEEECTTSCCSCCCSC---CTTCSEEECCSSCCS-SCCCCCT--TCCEEECCSSCCS-CCCSCC---TTCCEEECCSS
T ss_pred CCCEEEeCCCCCCCCCCC---CCCCCEEECCCCCCc-ccccchh--hhhhhhhhhcccc-hhhhhc---ccccccccccc
Confidence 588999999999876542 468999999999999 9986532 7999999999998 555321 46899999999
Q ss_pred ccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCC
Q 005224 83 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 134 (707)
Q Consensus 83 ~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~ 134 (707)
.++ .+|. ++.++.| +.|++++|.++..+.. .+.+..+.+..+.
T Consensus 109 ~l~-~lp~-~~~l~~L-----~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~ 151 (353)
T d1jl5a_ 109 QLE-KLPE-LQNSSFL-----KIIDVDNNSLKKLPDL--PPSLEFIAAGNNQ 151 (353)
T ss_dssp CCS-SCCC-CTTCTTC-----CEEECCSSCCSCCCCC--CTTCCEEECCSSC
T ss_pred ccc-cccc-hhhhccc-----eeeccccccccccccc--cccccchhhcccc
Confidence 998 7775 4555544 4899999998876654 3344455554444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.74 E-value=1.4e-08 Score=99.02 Aligned_cols=131 Identities=20% Similarity=0.290 Sum_probs=91.8
Q ss_pred CCCceEEEeeC-CcCCCCCC-CcCCCCcccEEeccCCcCcccCCCccc--cc-CccEEEccCccCCCCCCcccCCCc-cc
Q 005224 1 MSKLLKLSLRN-CSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL--SL-NITTIKLSNNKLTGTIPSNFSGLP-RL 74 (707)
Q Consensus 1 L~~L~~L~L~~-N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~--~~-~L~~L~Ls~N~l~~~~p~~~~~l~-~L 74 (707)
+++++.|++.. |++....+ .|.++++|+.|++++|++. .++.... .. .+..+..+++++....+..|.+++ .+
T Consensus 77 l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~-~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l 155 (242)
T d1xwdc1 77 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 155 (242)
T ss_dssp CTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCC-SCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSC
T ss_pred ccccccccccccccccccccccccccccccccccchhhhc-ccccccccccccccccccccccccccccccccccccccc
Confidence 35677777664 67777776 5888889999999999888 6655322 22 566677777788766666777665 67
Q ss_pred ceEeccCcccccCCCCCccccccCCCCccceEEccCccCCCCCCCC--CCCCCceeeccCCCccc
Q 005224 75 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 75 ~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~--~~~~l~~l~l~~N~~~~ 137 (707)
+.|++++|+++ .++....+..++. +.+++++|+|+.++... .+++|+.|++++|++..
T Consensus 156 ~~L~l~~n~l~-~i~~~~~~~~~l~----~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~ 215 (242)
T d1xwdc1 156 VILWLNKNGIQ-EIHNCAFNGTQLD----ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215 (242)
T ss_dssp EEEECCSSCCC-EECTTTTTTCCEE----EEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCC
T ss_pred eeeeccccccc-ccccccccchhhh----ccccccccccccccHHHhcCCCCCCEEECCCCcCCc
Confidence 88888888888 5555554433322 24457778888887653 67888888888888763
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.60 E-value=1.9e-07 Score=95.69 Aligned_cols=120 Identities=21% Similarity=0.173 Sum_probs=92.1
Q ss_pred CCceEEEeeCCcCCCCCCCcCCCCcccEEeccCCcCcccCCCcccccCccEEEccCccCCCCCCcccCCCcccceEeccC
Q 005224 2 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 81 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 81 (707)
++|++|+|++|+|+.++.. +.+|+.|++++|+++ .++. +. ..|++|+|++|+|+ .+|. ++.+++|+.|++++
T Consensus 58 ~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~-~l~~-lp-~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~ 129 (353)
T d1jl5a_ 58 PHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLK-ALSD-LP-PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDN 129 (353)
T ss_dssp TTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCS-CCCS-CC-TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCS
T ss_pred CCCCEEECCCCCCcccccc---hhhhhhhhhhhcccc-hhhh-hc-cccccccccccccc-cccc-hhhhccceeecccc
Confidence 6899999999999966544 458999999999999 8875 22 27999999999999 6775 68899999999999
Q ss_pred cccccCCCCCccccccCCCCccceEEccCccCCCCCCCCCCCCCceeeccCCCcccc
Q 005224 82 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLN 138 (707)
Q Consensus 82 N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~~~~~~~~~~l~~l~l~~N~~~~~ 138 (707)
|.++ ..|.... .+..+++.++..........++.+..+.+.+|.....
T Consensus 130 ~~~~-~~~~~~~--------~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 130 NSLK-KLPDLPP--------SLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp SCCS-CCCCCCT--------TCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSC
T ss_pred cccc-ccccccc--------cccchhhccccccccccccccccceeccccccccccc
Confidence 9998 5554432 2336777777766544333667778888888876543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=1.5e-07 Score=92.69 Aligned_cols=149 Identities=14% Similarity=0.104 Sum_probs=102.4
Q ss_pred HHHHHHhcCCCccceEeeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeE
Q 005224 368 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQ 446 (707)
Q Consensus 368 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 446 (707)
.++...-+.|+..+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35555566776655544455578998875 45567788876544333445778888888774 33356788888888999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 005224 447 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA--------------------------------- 493 (707)
Q Consensus 447 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 493 (707)
++||++++|.++.+..... . ....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886654211 1 12334555666666666411
Q ss_pred -----------------------CCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 494 -----------------------DPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 494 -----------------------~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
.+.++|+|+.|.||++++++.+-|.||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1227999999999999987767799999775
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=3.1e-08 Score=90.33 Aligned_cols=37 Identities=30% Similarity=0.437 Sum_probs=17.1
Q ss_pred CccEEEccCccCCCC--CCcccCCCcccceEeccCcccc
Q 005224 49 NITTIKLSNNKLTGT--IPSNFSGLPRLQRLFIANNSLS 85 (707)
Q Consensus 49 ~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~ 85 (707)
+|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+
T Consensus 66 ~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp TCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred CCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 455555555555421 1122344455555555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.09 E-value=1.8e-07 Score=85.09 Aligned_cols=67 Identities=28% Similarity=0.340 Sum_probs=43.7
Q ss_pred CCCCcccEEeccCCcCcccCCCc---cccc-CccEEEccCccCCCCCCcccCCCcccceEeccCcccccCCC
Q 005224 22 SRIPNLGYLDLSSNQLNGSIPPG---RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 89 (707)
Q Consensus 22 ~~l~~L~~L~Ls~N~l~g~ip~~---~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p 89 (707)
..+++|++|+|++|+|+ .++.. +..+ +|+.|+|++|+|+..-+-.+....+|+.|+|++|.++....
T Consensus 62 ~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 62 ENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred HhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence 45778888888888888 66532 1122 78888888888883322233344567888888888875444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.06 E-value=1.4e-07 Score=97.09 Aligned_cols=135 Identities=16% Similarity=0.187 Sum_probs=74.0
Q ss_pred CceEEEeeCCcCCCCCC-----CcCCCCcccEEeccCCcCccc-----CCCccccc-CccEEEccCccCCCC----CCcc
Q 005224 3 KLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSSNQLNGS-----IPPGRLSL-NITTIKLSNNKLTGT----IPSN 67 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~g~-----ip~~~~~~-~L~~L~Ls~N~l~~~----~p~~ 67 (707)
.|+.|++++|+++..-- .+...+.|++|+|++|+|+.. +...+... +|+.|+|++|.|+.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 45556666655542111 134566777777777777621 11122222 677777777776532 3345
Q ss_pred cCCCcccceEeccCcccccCCCCCccc-cccCCCCccceEEccCccCCCC-----CCCC--CCCCCceeeccCCCccc
Q 005224 68 FSGLPRLQRLFIANNSLSGSIPSSIWQ-SRTLNATETFILDFQNNNLTNI-----SGSF--NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 68 ~~~l~~L~~L~ls~N~l~g~~p~~~~~-l~~L~~~~L~~l~l~~N~l~~~-----~~~~--~~~~l~~l~l~~N~~~~ 137 (707)
+..+++|++|+|++|.|++.-...++. +.......|+.|++++|+|+.- ...+ ..+.|+.|++++|.+..
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 566777777777777776321222211 1112223455778887777641 1111 35667777777777743
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=4.9e-06 Score=80.99 Aligned_cols=130 Identities=22% Similarity=0.184 Sum_probs=85.4
Q ss_pred eEeeeCc-eEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCC--CcceeEEEEEEeCCeEEEEEecCCCCCH
Q 005224 382 QIGQGGY-GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNGTL 458 (707)
Q Consensus 382 ~lG~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~E~~~~gsL 458 (707)
.+..|.. +.||+...+++..+++|....... ..+..|+..++.+.. -.+.+++.+..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455554 679999988888899998765432 246678888777632 3356788888888899999999987655
Q ss_pred HHHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 005224 459 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT----------------------------------------------- 491 (707)
Q Consensus 459 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~----------------------------------------------- 491 (707)
.+.. ... ...+.++++.|+-||+
T Consensus 94 ~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 2210 110 0111222233333332
Q ss_pred ----C----CCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 492 ----E----ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 492 ----~----~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
. ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12238999999999999987777899999764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.87 E-value=1.1e-06 Score=87.64 Aligned_cols=133 Identities=19% Similarity=0.209 Sum_probs=75.9
Q ss_pred CCceEEEeeCCcCCCCC-C-CcCCCCcccEEeccCCcCcccCCCccccc-CccEEEccC-ccCCCC-CCcccCCCcccce
Q 005224 2 SKLLKLSLRNCSLQGPM-P-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSN-NKLTGT-IPSNFSGLPRLQR 76 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~-~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~L~~L~Ls~-N~l~~~-~p~~~~~l~~L~~ 76 (707)
.+|++|||+++.++... . -+.++++|++|+|++|.+++..+..+... +|+.|+|++ ++++.. +..-+.++++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 35777788777766432 2 36677778888887777775555444443 677777777 355421 1222345677777
Q ss_pred EeccCc-ccccC--------CCCCcccc------ccC----------CCCccceEEccCc-cCCCC-CCCC-CCCCCcee
Q 005224 77 LFIANN-SLSGS--------IPSSIWQS------RTL----------NATETFILDFQNN-NLTNI-SGSF-NIPPNVTV 128 (707)
Q Consensus 77 L~ls~N-~l~g~--------~p~~~~~l------~~L----------~~~~L~~l~l~~N-~l~~~-~~~~-~~~~l~~l 128 (707)
|+++++ .++.. .+..+..+ ..+ ..++|+.|+|++| .++.- ...+ .+++|+.|
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 777763 23210 01111000 000 1246779999885 46642 2222 78899999
Q ss_pred eccCCC
Q 005224 129 RLRGNP 134 (707)
Q Consensus 129 ~l~~N~ 134 (707)
+++++.
T Consensus 206 ~L~~C~ 211 (284)
T d2astb2 206 SLSRCY 211 (284)
T ss_dssp ECTTCT
T ss_pred ECCCCC
Confidence 998843
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=2.7e-07 Score=98.04 Aligned_cols=108 Identities=17% Similarity=0.221 Sum_probs=63.8
Q ss_pred CceEEEeeCCcCCCCC-C-CcCCCCcccEEeccCCcCcc----cCCCccccc-CccEEEccCccCCCC----CCcccC-C
Q 005224 3 KLLKLSLRNCSLQGPM-P-DLSRIPNLGYLDLSSNQLNG----SIPPGRLSL-NITTIKLSNNKLTGT----IPSNFS-G 70 (707)
Q Consensus 3 ~L~~L~L~~N~l~~~~-~-~~~~l~~L~~L~Ls~N~l~g----~ip~~~~~~-~L~~L~Ls~N~l~~~----~p~~~~-~ 70 (707)
+|++|||++|+++... . -+..+++|+.|+|++|.|+- .|...+... +|+.|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5788888888887632 2 25667888888888888771 111112222 688888888877521 222222 2
Q ss_pred CcccceEeccCcccccC----CCCCccccccCCCCccceEEccCccCCC
Q 005224 71 LPRLQRLFIANNSLSGS----IPSSIWQSRTLNATETFILDFQNNNLTN 115 (707)
Q Consensus 71 l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~~~L~~l~l~~N~l~~ 115 (707)
..+|++|+|++|+++.. ++..+..++ +|+.|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~-----~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLP-----TLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCT-----TCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccc-----cccccccccccchh
Confidence 24677888888777632 222233333 34477777777654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.77 E-value=6.2e-07 Score=95.10 Aligned_cols=113 Identities=22% Similarity=0.241 Sum_probs=78.2
Q ss_pred CcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCC----CCCcccCCCcccceEeccCcccccCCCCCccccccC
Q 005224 25 PNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTG----TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 98 (707)
Q Consensus 25 ~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L 98 (707)
.+|++|||++|++++.-=..+.. + ++++|+|++|+|+. .+...+..+++|+.|||++|.|+..--..+...-..
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 47999999999999321012222 2 89999999999883 345567789999999999999862100112211111
Q ss_pred CCCccceEEccCccCCCC-----CCCC-CCCCCceeeccCCCccc
Q 005224 99 NATETFILDFQNNNLTNI-----SGSF-NIPPNVTVRLRGNPFCL 137 (707)
Q Consensus 99 ~~~~L~~l~l~~N~l~~~-----~~~~-~~~~l~~l~l~~N~~~~ 137 (707)
...+|+.|+|++|+++.. +..+ ..++|+.|++++|++..
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 224577999999999864 2233 67899999999998753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.76 E-value=9.6e-07 Score=90.59 Aligned_cols=114 Identities=16% Similarity=0.178 Sum_probs=78.0
Q ss_pred CCceEEEeeCCcCCCC-----C-CCcCCCCcccEEeccCCcCccc----CCCccccc-CccEEEccCccCCCCCCccc--
Q 005224 2 SKLLKLSLRNCSLQGP-----M-PDLSRIPNLGYLDLSSNQLNGS----IPPGRLSL-NITTIKLSNNKLTGTIPSNF-- 68 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~-----~-~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~~-~L~~L~Ls~N~l~~~~p~~~-- 68 (707)
+.|+.|+|++|+|+.. + ..+..+++|+.|+|++|.++.. +...+... +|++|+|++|.|++.-...+
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 5799999999999742 2 2477899999999999998722 22223333 79999999999985433322
Q ss_pred --CC--CcccceEeccCcccccCCCCCccccccCCCCccceEEccCccCCC
Q 005224 69 --SG--LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 115 (707)
Q Consensus 69 --~~--l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~~~L~~l~l~~N~l~~ 115 (707)
.. .+.|++|+|++|+|+..--..+...-.-..++|+.|+|++|++..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 22 367999999999987321111221100012456699999999976
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.40 E-value=0.00023 Score=73.63 Aligned_cols=76 Identities=18% Similarity=0.096 Sum_probs=48.5
Q ss_pred cceEeeeCceEEEEEEeC-CCcEEEEEEeccC------C-hhhHHHHHHHHHHHHccC-C--CcceeEEEEEEeCCeEEE
Q 005224 380 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEG------S-LQGEKEFLTEIQFLSRLH-H--RNLVSLVGYCDEEGEQML 448 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~l 448 (707)
.+.||.|....||+.... +++.|+||.-... . .....+...|.+.|+.+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 456899999999999865 4678999965321 1 112234566888887662 2 345556544 4556689
Q ss_pred EEecCCCCC
Q 005224 449 VYEFMSNGT 457 (707)
Q Consensus 449 V~E~~~~gs 457 (707)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.40 E-value=8.8e-06 Score=80.81 Aligned_cols=65 Identities=22% Similarity=0.230 Sum_probs=40.4
Q ss_pred cCCCCcccEEeccCCcCcccCCCcccc-c-CccEEEccCccCCCCCCcccCCCcccceEeccCc-ccc
Q 005224 21 LSRIPNLGYLDLSSNQLNGSIPPGRLS-L-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN-SLS 85 (707)
Q Consensus 21 ~~~l~~L~~L~Ls~N~l~g~ip~~~~~-~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N-~l~ 85 (707)
.....+|++|||++|.+++.....++. . +|++|+|++|.+++..+..++.+++|++|+|+++ .++
T Consensus 42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~it 109 (284)
T d2astb2 42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109 (284)
T ss_dssp CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccc
Confidence 344556777777777766332222222 2 6777777777777666667777777777777773 444
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.83 E-value=0.0016 Score=65.09 Aligned_cols=68 Identities=19% Similarity=0.162 Sum_probs=46.5
Q ss_pred ceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCCCcc--eeEE-----EEEEeCCeEEEEEecCCCC
Q 005224 388 YGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL--VSLV-----GYCDEEGEQMLVYEFMSNG 456 (707)
Q Consensus 388 ~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~-----~~~~~~~~~~lV~E~~~~g 456 (707)
--.||++..++|+.|++|+.... ....+++..|...+..+....+ +..+ ..+...+..+.|+++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 35799999999999999998653 2345678889988887742221 1111 1234567788999998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.79 E-value=7.1e-05 Score=67.61 Aligned_cols=65 Identities=12% Similarity=0.143 Sum_probs=27.9
Q ss_pred cCCCCcccEEeccCCcCcccCCCccc----cc-CccEEEccCccCCCC----CCcccCCCcccceEeccCcccc
Q 005224 21 LSRIPNLGYLDLSSNQLNGSIPPGRL----SL-NITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLS 85 (707)
Q Consensus 21 ~~~l~~L~~L~Ls~N~l~g~ip~~~~----~~-~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 85 (707)
+...+.|++|+|++|.|...--..+. .. .|+.|+|++|.|+.. +-..+...+.|++|+|++|.+.
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 44445555555555555421111111 01 455555555555422 1112333344555555555443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.03 E-value=0.023 Score=55.95 Aligned_cols=157 Identities=10% Similarity=0.047 Sum_probs=83.0
Q ss_pred ccHHHHHHHhcCCCccceE-----eeeCceEEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHccCC-----Ccce
Q 005224 365 FTYGEMALATNNFNSSTQI-----GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-----RNLV 434 (707)
Q Consensus 365 ~~~~~l~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-----~nIv 434 (707)
.+.+|++....+|...+.. ..|---+.|+...++|+ +++|+..... ..+++..|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4556777777888775443 45666788999887665 8899876432 22355567777776632 2222
Q ss_pred eEEE---EEEeCCeEEEEEecCCCCCHHH--------------HHhhc---C--C--CCcC------------------H
Q 005224 435 SLVG---YCDEEGEQMLVYEFMSNGTLRD--------------QLSAK---S--K--EPLG------------------F 472 (707)
Q Consensus 435 ~l~~---~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~---~--~--~~l~------------------~ 472 (707)
...+ +....+....++.++.+..... .++.. . . .... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1100 1233455667777765533210 01100 0 0 0000 0
Q ss_pred HHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEeeecccc
Q 005224 473 AMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 524 (707)
Q Consensus 473 ~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 524 (707)
......+..+...+.-.+.. -..++||+|+.++||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01112222222222222221 12349999999999999998777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.03 E-value=0.0088 Score=61.27 Aligned_cols=73 Identities=15% Similarity=0.146 Sum_probs=49.5
Q ss_pred cceEeeeCceEEEEEEeCC--------CcEEEEEEeccCChhhHHHHHHHHHHHHccC-CCcceeEEEEEEeCCeEEEEE
Q 005224 380 STQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 450 (707)
Q Consensus 380 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 450 (707)
.+.|+.|-.-.+|+...++ .+.|.+++.... .......+|..+++.+. +.-..++++++.. .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4678888888999998654 345777766532 22335567888888884 4334577777743 6899
Q ss_pred ecCCCCCH
Q 005224 451 EFMSNGTL 458 (707)
Q Consensus 451 E~~~~gsL 458 (707)
||+++.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.00 E-value=0.00032 Score=63.09 Aligned_cols=110 Identities=10% Similarity=0.130 Sum_probs=67.0
Q ss_pred CCCcccEEeccCC-cCccc----CCCccccc-CccEEEccCccCCCCC----CcccCCCcccceEeccCcccccCCCCCc
Q 005224 23 RIPNLGYLDLSSN-QLNGS----IPPGRLSL-NITTIKLSNNKLTGTI----PSNFSGLPRLQRLFIANNSLSGSIPSSI 92 (707)
Q Consensus 23 ~l~~L~~L~Ls~N-~l~g~----ip~~~~~~-~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~ls~N~l~g~~p~~~ 92 (707)
+.++|++|+|+++ .++.. +-..+... +|+.|+|++|.|+... ...+...+.|+.|+|++|.|+..--..+
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4578999999874 45521 10111122 7999999999987432 2344556789999999999883211112
Q ss_pred cc-cccCCCCccceEEccCccCCCCCCC----C-----CCCCCceeeccCCC
Q 005224 93 WQ-SRTLNATETFILDFQNNNLTNISGS----F-----NIPPNVTVRLRGNP 134 (707)
Q Consensus 93 ~~-l~~L~~~~L~~l~l~~N~l~~~~~~----~-----~~~~l~~l~l~~N~ 134 (707)
.. +. .-.+|+.|+|++|.+..+... + .-+.+..|+++.+.
T Consensus 93 ~~aL~--~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 93 LRSTL--VTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHTT--TTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHH--hCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 11 11 124566999999987765321 1 34566777765543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.85 E-value=0.00055 Score=66.72 Aligned_cols=60 Identities=18% Similarity=0.212 Sum_probs=41.2
Q ss_pred hcccCCCCCCCHHHHHHHHHHhhh-cCC-CCCCCCCccccCCCCCCCCCCCCCCcCCCCCCC
Q 005224 628 CCQDETDARPSMSEVMRELESIWN-MMP-ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 687 (707)
Q Consensus 628 c~~~~p~~RPt~~~v~~~L~~~~~-~~~-~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 687 (707)
|.-..|-.-.+..++.+.+..... ..+ ..++++.+||.+||+.||++|||++|+|+|||+
T Consensus 208 ~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 208 CALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 334455555566666665543221 111 233456789999999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=95.27 E-value=0.00081 Score=66.92 Aligned_cols=35 Identities=23% Similarity=0.348 Sum_probs=30.7
Q ss_pred CCCCccccCCCCCCCCCCCCCCcCCCCCCCCCCCC
Q 005224 658 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 692 (707)
Q Consensus 658 ~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~~ 692 (707)
+.+.+||.+||..||++|||++|+|+||||.....
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 34578999999999999999999999999976544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.02 E-value=0.00064 Score=60.92 Aligned_cols=18 Identities=11% Similarity=0.128 Sum_probs=9.4
Q ss_pred cCCCCcccEEeccCCcCc
Q 005224 21 LSRIPNLGYLDLSSNQLN 38 (707)
Q Consensus 21 ~~~l~~L~~L~Ls~N~l~ 38 (707)
+...++|++|+|++|.++
T Consensus 42 l~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HTTCCSCCEEECTTSCCC
T ss_pred HhcCCccCeeeccCCccc
Confidence 334455555555555554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.18 E-value=0.00062 Score=68.64 Aligned_cols=32 Identities=9% Similarity=0.267 Sum_probs=26.6
Q ss_pred CCccccCCCCCCCCCCCCCCcCCCCCCCCCCC
Q 005224 660 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 691 (707)
Q Consensus 660 ~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~~ 691 (707)
+.+||.+||+.||++|||++|+|+||||....
T Consensus 248 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 248 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 44788889999999999999999999996443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=89.16 E-value=0.0089 Score=53.00 Aligned_cols=83 Identities=17% Similarity=0.153 Sum_probs=52.1
Q ss_pred CCceEEEeeCCcCCCCCC-----CcCCCCcccEEeccCCcCcccCC----Cccccc-CccEEEc--cCccCCC----CCC
Q 005224 2 SKLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSSNQLNGSIP----PGRLSL-NITTIKL--SNNKLTG----TIP 65 (707)
Q Consensus 2 ~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~g~ip----~~~~~~-~L~~L~L--s~N~l~~----~~p 65 (707)
++|++|+|++|.++...- .+...++|+.|++++|.++..-- ..+... +|+.++| ++|.+.. .+.
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 578999999998875321 25667889999999998873211 111222 5665444 4566653 233
Q ss_pred cccCCCcccceEeccCccc
Q 005224 66 SNFSGLPRLQRLFIANNSL 84 (707)
Q Consensus 66 ~~~~~l~~L~~L~ls~N~l 84 (707)
..+...++|+.|+++.|..
T Consensus 126 ~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCcCEEeCcCCCC
Confidence 3455667777777776654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.91 E-value=0.14 Score=48.51 Aligned_cols=55 Identities=16% Similarity=0.178 Sum_probs=38.7
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhcC-CC-CCCCCCccccCCCCCCCCCCCCCCcCCCC
Q 005224 630 QDETDARPSMSEVMRELESIWNMM-PE-SDTKTPEFINSEHTSKEETPPSSSSMLKH 684 (707)
Q Consensus 630 ~~~p~~RPt~~~v~~~L~~~~~~~-~~-~~~~~~dll~~~L~~dP~~R~sa~e~L~H 684 (707)
...|-..-+..++.+.+.+..... |. ..+...+|+.+|++.||++|||++|+|+|
T Consensus 198 g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 198 GKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp SCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 356677778888877666532211 11 11234689999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.98 E-value=0.047 Score=52.37 Aligned_cols=57 Identities=14% Similarity=0.250 Sum_probs=39.2
Q ss_pred CCCCCCHHHHHHHHHHhhhcC-C-CCCCCCCccccCCCCCCCCCCCCCCcCCC--CCCCCC
Q 005224 633 TDARPSMSEVMRELESIWNMM-P-ESDTKTPEFINSEHTSKEETPPSSSSMLK--HPYVSS 689 (707)
Q Consensus 633 p~~RPt~~~v~~~L~~~~~~~-~-~~~~~~~dll~~~L~~dP~~R~sa~e~L~--Hp~f~~ 689 (707)
|..-.+..++++.+....... + ...+...+|+.+|+..||++|||++|+++ |+||++
T Consensus 210 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 210 PYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 444456667766665432211 1 12234567999999999999999999998 888865
|